data_4uqt_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 4uqt _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.508 ' HB3' ' NE2' ' A' ' 82' ' ' GLN . . . . . . . . 0 N--CA 1.452 -0.357 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -108.9 145.67 35.01 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 115.056 -0.974 . . . . 0.0 109.049 -173.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 26.7 pt -142.57 163.1 18.14 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 CA-C-O 121.408 0.623 . . . . 0.0 111.045 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -114.52 127.07 55.61 Favored 'General case' 0 N--CA 1.415 -2.188 0 CA-C-N 114.383 -1.281 . . . . 0.0 108.787 176.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.476 HG21 ' CD1' ' A' ' 104' ' ' ILE . 9.5 mt -110.09 127.79 66.75 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.795 0 N-CA-C 107.335 -1.358 . . . . 0.0 107.335 177.613 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -127.43 165.69 20.45 Favored Glycine 0 C--N 1.284 -2.314 0 N-CA-C 110.607 -0.997 . . . . 0.0 110.607 179.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 71.7 m-20 72.18 40.58 0.69 Allowed 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.742 1.217 . . . . 0.0 110.038 -178.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.4 HD12 HD12 ' A' ' 47' ' ' ILE . 3.9 mm? -72.71 144.84 47.53 Favored 'General case' 0 CA--C 1.495 -1.153 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.551 178.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.407 ' HB3' ' HG ' ' A' ' 42' ' ' LEU . 42.0 t-20 -83.13 146.09 28.85 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 106.549 -1.649 . . . . 0.0 106.549 176.673 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.526 ' HD2' ' N ' ' A' ' 41' ' ' GLU . 5.8 ppt_? -60.76 -19.22 58.74 Favored 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 123.3 0.64 . . . . 0.0 112.051 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.526 ' N ' ' HD2' ' A' ' 40' ' ' ARG . 8.9 pt-20 -99.99 5.66 45.13 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.965 -178.046 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.407 ' HG ' ' HB3' ' A' ' 39' ' ' ASN . 71.1 mt -96.51 126.22 41.54 Favored 'General case' 0 C--N 1.309 -1.179 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.701 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 12.5 t -117.67 175.84 5.46 Favored 'General case' 0 N--CA 1.428 -1.53 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.18 -179.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.404 ' CG ' ' HB2' ' A' ' 62' ' ' LEU . 42.1 mt-10 -54.39 -39.62 67.41 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 123.743 0.817 . . . . 0.0 111.401 -176.014 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.87 -37.73 94.21 Favored Glycine 0 CA--C 1.521 0.417 0 C-N-CA 121.317 -0.468 . . . . 0.0 113.402 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -67.12 -49.17 65.84 Favored 'General case' 0 CA--C 1.499 -0.995 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.4 HD12 HD12 ' A' ' 38' ' ' LEU . 38.6 mt -61.01 -45.3 98.83 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.902 0 CA-C-N 114.861 -1.063 . . . . 0.0 110.854 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 38.1 mt -60.07 -45.75 91.86 Favored 'General case' 0 CA--C 1.494 -1.186 0 N-CA-C 111.676 0.25 . . . . 0.0 111.676 -176.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 100.0 m -62.77 -45.59 91.99 Favored 'General case' 0 C--N 1.307 -1.263 0 O-C-N 123.551 0.532 . . . . 0.0 111.913 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.41 ' O ' ' HG2' ' A' ' 53' ' ' GLU . 54.6 t -66.13 -49.12 78.66 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.633 -179.794 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -65.21 -23.03 66.97 Favored 'General case' 0 N--CA 1.425 -1.697 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.409 -178.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.494 ' OG ' ' HB2' ' B' ' 231' ' ' ARG . 58.7 m -69.35 -22.03 63.78 Favored 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 177.099 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.41 ' HG2' ' O ' ' A' ' 50' ' ' VAL . 7.8 pt-20 -73.52 -20.21 60.72 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 117.642 -1.623 . . . . 0.0 110.4 177.326 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 48.0 m-85 -92.36 -10.3 38.69 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-O 121.225 0.536 . . . . 0.0 111.135 -178.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 157.21 -154.9 25.93 Favored Glycine 0 N--CA 1.422 -2.296 0 C-N-CA 120.323 -0.941 . . . . 0.0 111.721 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 87.2 t -104.52 111.14 65.15 Favored Pre-proline 0 C--N 1.3 -1.557 0 N-CA-C 111.245 0.091 . . . . 0.0 111.245 -177.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -79.84 137.34 12.52 Favored 'Trans proline' 0 N--CA 1.449 -1.133 0 C-N-CA 122.652 2.234 . . . . 0.0 109.676 175.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 30.7 m -111.76 -33.56 2.25 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 C-N-CA 119.355 -0.938 . . . . 0.0 111.553 179.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.421 ' HB3' ' HG2' ' A' ' 78' ' ' LYS . 29.3 t70 -146.13 145.59 30.55 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 -179.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 14.5 p -143.65 135.33 23.04 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.482 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 99.3 mt -121.05 118.76 57.26 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 175.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.404 ' HB2' ' CG ' ' A' ' 44' ' ' GLU . 0.1 OUTLIER -98.1 114.4 26.57 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 106.014 -1.847 . . . . 0.0 106.014 174.781 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 43.7 m -76.85 116.59 17.66 Favored 'General case' 0 N--CA 1.404 -2.773 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 178.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 34.1 mtm180 . . . . . 0 C--N 1.294 -1.811 0 CA-C-N 115.336 -0.847 . . . . 0.0 108.83 -176.552 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 . . . . . 0 CA--C 1.518 -0.265 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 84.71 8.95 82.07 Favored Glycine 0 C--N 1.308 -0.975 0 C-N-CA 120.926 -0.654 . . . . 0.0 113.569 179.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 36.7 p90 -154.98 157.79 38.21 Favored 'General case' 0 N--CA 1.436 -1.139 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 178.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -153.11 176.23 12.14 Favored 'General case' 0 N--CA 1.436 -1.143 0 O-C-N 123.556 0.535 . . . . 0.0 110.321 179.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -137.04 146.26 45.03 Favored 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 123.966 0.906 . . . . 0.0 109.856 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.0 tt -152.28 140.6 20.5 Favored 'General case' 0 N--CA 1.436 -1.143 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 175.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.421 ' HG2' ' HB3' ' A' ' 59' ' ' ASP . 18.8 ptmt -123.15 144.35 49.4 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 178.465 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.412 ' HH ' ' CB ' ' A' ' 88' ' ' ALA . 69.8 m-85 -102.47 164.88 11.42 Favored 'General case' 0 C--N 1.281 -2.378 0 CA-C-N 115.21 -0.905 . . . . 0.0 111.368 -178.451 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -79.1 -26.63 42.92 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 114.436 -1.256 . . . . 0.0 108.521 175.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -122.99 132.37 54.11 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.249 -175.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.508 ' NE2' ' HB3' ' A' ' 31' ' ' ALA . 15.9 mp0 -64.03 -30.33 71.41 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 179.547 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.88 -33.29 74.44 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-O 122.348 1.071 . . . . 0.0 110.353 -179.279 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 48.8 m -58.04 -36.47 72.8 Favored 'General case' 0 C--N 1.278 -2.511 0 CA-C-N 114.965 -1.016 . . . . 0.0 111.452 175.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.42 ' O ' HG21 ' A' ' 89' ' ' VAL . 36.9 p -63.91 -45.21 90.29 Favored 'General case' 0 C--O 1.213 -0.858 0 C-N-CA 120.332 -0.547 . . . . 0.0 110.9 -178.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 3.2 pt -64.94 -38.52 82.98 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.6 0 C-N-CA 122.391 0.276 . . . . 0.0 110.793 178.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 16.1 mt -59.09 -44.31 91.92 Favored 'General case' 0 CA--C 1.509 -0.601 0 O-C-N 123.659 0.599 . . . . 0.0 110.61 175.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.44 ' O ' ' HB2' ' A' ' 92' ' ' LEU . . . -72.92 -47.67 43.74 Favored 'General case' 0 N--CA 1.435 -1.195 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 179.464 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.42 HG21 ' O ' ' A' ' 85' ' ' THR . 72.4 t -59.26 -48.99 85.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 N-CA-C 112.127 0.418 . . . . 0.0 112.127 -176.325 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -73.27 -27.14 61.4 Favored 'General case' 0 C--N 1.294 -1.824 0 CA-C-O 121.466 0.65 . . . . 0.0 111.893 -172.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -91.59 -31.51 15.87 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.945 -177.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.44 ' HB2' ' O ' ' A' ' 88' ' ' ALA . 9.9 mt -91.69 -29.7 16.7 Favored 'General case' 0 C--N 1.313 -1.006 0 C-N-CA 122.509 0.324 . . . . 0.0 111.566 -174.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 51.5 t-20 -65.49 124.72 23.06 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 86.9 -5.54 84.88 Favored Glycine 0 N--CA 1.435 -1.412 0 C-N-CA 121.256 -0.497 . . . . 0.0 112.568 179.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -85.7 139.04 31.69 Favored 'General case' 0 N--CA 1.44 -0.96 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 -178.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 11.7 mptt -94.6 119.18 32.85 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-O 121.056 0.455 . . . . 0.0 111.652 -176.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 54.2 mt -126.03 141.34 45.97 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 N-CA-C 106.144 -1.798 . . . . 0.0 106.144 174.162 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 59.22 21.23 53.02 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 121.539 -0.363 . . . . 0.0 113.345 -179.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 85.04 6.84 84.44 Favored Glycine 0 N--CA 1.435 -1.406 0 C-N-CA 121.27 -0.49 . . . . 0.0 113.335 -179.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 19.3 ptp180 -132.15 146.77 52.26 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 117.772 0.786 . . . . 0.0 111.668 179.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -80.1 118.03 21.45 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.59 -178.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 11.6 mt -70.76 144.64 50.84 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-O 121.604 0.716 . . . . 0.0 112.702 178.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 23.4 tptm -118.14 116.96 27.9 Favored 'General case' 0 N--CA 1.419 -1.981 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.141 177.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.476 ' CD1' HG21 ' A' ' 35' ' ' ILE . 5.7 mm -117.86 138.32 48.92 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 179.022 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -143.36 150.64 39.42 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 179.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 82.7 m-70 -83.23 133.81 34.98 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 178.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 7.3 t -154.66 152.95 30.57 Favored 'General case' 0 N--CA 1.423 -1.777 0 N-CA-C 107.262 -1.385 . . . . 0.0 107.262 -178.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 41.5 p90 -91.74 112.24 24.08 Favored 'General case' 0 N--CA 1.429 -1.517 0 N-CA-C 106.474 -1.676 . . . . 0.0 106.474 171.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 43.8 t80 . . . . . 0 C--N 1.28 -2.425 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 -179.441 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 4.6 mp . . . . . 0 N--CA 1.45 -0.473 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 227' ' ' MET . . . . . . . . . . . . . 65.6 mtt -81.85 135.08 49.08 Favored Pre-proline 0 C--N 1.305 -1.36 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.727 -178.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 228' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -57.2 148.64 68.79 Favored 'Trans proline' 0 C--O 1.255 1.341 0 C-N-CA 123.692 2.928 . . . . 0.0 114.419 -177.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . -74.07 170.87 52.93 Favored Glycine 0 N--CA 1.44 -1.05 0 CA-C-N 114.71 -1.132 . . . . 0.0 112.972 -179.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 18.9 m -77.71 -14.17 59.69 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 -172.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 231' ' ' ARG . . . . . 0.494 ' HB2' ' OG ' ' A' ' 52' ' ' SER . 10.7 mmm180 -84.93 -1.63 56.9 Favored 'General case' 0 C--N 1.32 -0.703 0 O-C-N 121.84 -0.537 . . . . 0.0 110.347 -179.229 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 232' ' ' TRP . . . . . . . . . . . . . 22.8 t90 -76.95 125.19 28.89 Favored 'General case' 0 N--CA 1.436 -1.161 0 CA-C-O 122.496 1.141 . . . . 0.0 112.599 -176.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 233' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -120.59 148.19 44.21 Favored 'General case' 0 C--N 1.271 -2.846 0 N-CA-C 102.326 -3.213 . . . . 0.0 102.326 172.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.502 3.072 0 C-N-CA 128.312 2.863 . . . . 0.0 116.526 -176.939 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 240' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.426 -1.999 0 N-CA-C 110.624 -0.991 . . . . 0.0 110.624 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 20.7 p90 -76.29 -32.68 58.92 Favored 'General case' 0 C--N 1.297 -1.701 0 CA-C-O 121.045 0.45 . . . . 0.0 109.863 175.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -60.54 -39.23 87.15 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.934 -178.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -65.52 -34.99 79.55 Favored 'General case' 0 C--O 1.208 -1.128 0 C-N-CA 121.158 -0.217 . . . . 0.0 111.094 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 68.3 mmtt -68.0 -39.87 83.14 Favored 'General case' 0 CA--C 1.509 -0.616 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 -178.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 245' ' ' TRP . . . . . . . . . . . . . 51.0 m0 -65.95 -43.56 87.6 Favored 'General case' 0 N--CA 1.438 -1.044 0 CA-C-N 114.795 -1.093 . . . . 0.0 109.492 176.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 246' ' ' PHE . . . . . 0.516 ' O ' ' HG2' ' B' ' 249' ' ' GLN . 2.4 t80 -61.98 -39.85 93.59 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.215 178.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.96 -33.71 76.33 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.928 -178.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.69 -17.37 20.38 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -178.101 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 249' ' ' GLN . . . . . 0.516 ' HG2' ' O ' ' B' ' 246' ' ' PHE . 2.2 pt20 -80.04 3.44 20.24 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 177.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 250' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -51.45 -28.76 14.01 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.873 1.269 . . . . 0.0 112.094 -179.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -58.59 150.48 22.93 Favored 'General case' 0 N--CA 1.426 -1.63 0 N-CA-C 115.272 1.582 . . . . 0.0 115.272 -179.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 252' ' ' ILE . . . . . . . . . . . . . 31.7 pt -110.17 -29.32 2.49 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 CA-C-N 113.829 -1.532 . . . . 0.0 109.905 -178.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -115.82 -34.71 4.71 Favored 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 120.233 -0.587 . . . . 0.0 110.511 -178.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 254' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 . . . . . 0 N--CA 1.436 -1.15 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.777 -174.202 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.484 ' HA ' HG22 ' A' ' 85' ' ' THR . . . . . . . . 0 N--CA 1.438 -1.032 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 -100.95 144.54 29.77 Favored 'General case' 0 N--CA 1.436 -1.14 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 -177.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 26.9 pt -142.85 156.68 17.96 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 CA-C-O 121.151 0.5 . . . . 0.0 110.224 178.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 20.4 t80 -108.45 124.32 50.22 Favored 'General case' 0 C--N 1.285 -2.229 0 CA-C-N 114.566 -1.197 . . . . 0.0 108.624 177.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.431 HG21 ' CD1' ' A' ' 104' ' ' ILE . 10.3 mt -108.28 127.52 64.51 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.935 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 175.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -124.65 157.91 19.05 Favored Glycine 0 C--N 1.279 -2.599 0 N-CA-C 111.155 -0.778 . . . . 0.0 111.155 -179.249 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 50.6 m-20 68.35 70.12 0.31 Allowed 'General case' 0 C--N 1.31 -1.133 0 C-N-CA 125.745 1.618 . . . . 0.0 109.908 -177.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -100.6 141.47 33.41 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 115.114 -0.948 . . . . 0.0 111.846 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.446 ' HB2' ' NH1' ' A' ' 100' ' ' ARG . 39.1 t-20 -76.41 144.21 40.15 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 174.73 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.447 ' HD2' ' C ' ' A' ' 40' ' ' ARG . 0.9 OUTLIER -59.46 -26.24 65.06 Favored 'General case' 0 C--N 1.312 -1.061 0 C-N-CA 123.278 0.631 . . . . 0.0 111.665 179.057 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -85.98 -0.89 56.63 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.383 -0.372 . . . . 0.0 111.767 -176.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 87.6 mt -94.3 127.38 40.13 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-O 121.081 0.467 . . . . 0.0 110.882 -179.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 63.2 p -116.52 175.03 5.75 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-N 115.072 -0.967 . . . . 0.0 108.678 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 -54.2 -40.6 67.74 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 122.716 0.406 . . . . 0.0 110.983 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -59.07 -38.08 92.51 Favored Glycine 0 N--CA 1.449 -0.498 0 CA-C-N 116.384 -0.371 . . . . 0.0 113.183 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -68.05 -49.23 62.64 Favored 'General case' 0 CA--C 1.496 -1.096 0 CA-C-O 121.022 0.439 . . . . 0.0 109.852 179.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 26.3 mt -60.31 -41.04 85.69 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.559 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.639 179.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 57.1 mt -59.52 -42.44 92.25 Favored 'General case' 0 C--O 1.206 -1.189 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.095 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 90.7 m -61.47 -46.01 91.86 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 120.842 0.353 . . . . 0.0 111.458 179.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 97.8 t -67.1 -49.04 76.86 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.77 -179.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -67.89 -24.15 65.19 Favored 'General case' 0 N--CA 1.426 -1.627 0 CA-C-N 115.423 -0.808 . . . . 0.0 112.558 -176.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.455 ' OG ' ' HB2' ' B' ' 231' ' ' ARG . 66.1 m -68.93 -19.56 64.19 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 116.188 -0.46 . . . . 0.0 112.059 176.344 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -67.08 -29.13 68.82 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 176.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -89.93 -23.2 21.65 Favored 'General case' 0 N--CA 1.441 -0.897 0 CA-C-N 115.899 -0.591 . . . . 0.0 112.245 -174.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 171.54 -152.57 18.1 Favored Glycine 0 N--CA 1.426 -1.985 0 N-CA-C 111.312 -0.715 . . . . 0.0 111.312 179.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 86.7 t -106.62 112.87 63.48 Favored Pre-proline 0 C--N 1.297 -1.674 0 CA-C-O 120.793 0.33 . . . . 0.0 110.376 -178.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.415 ' HB3' HD22 ' A' ' 77' ' ' LEU . 88.6 Cg_endo -80.47 136.78 11.29 Favored 'Trans proline' 0 N--CA 1.442 -1.543 0 C-N-CA 122.371 2.047 . . . . 0.0 110.439 176.287 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 28.4 m -111.17 -28.32 2.63 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 C-N-CA 120.022 -0.671 . . . . 0.0 111.469 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -152.16 145.05 24.41 Favored 'General case' 0 CA--C 1.498 -1.043 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 178.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 10.7 p -145.95 135.45 17.53 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 123.775 0.672 . . . . 0.0 110.006 -178.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 94.1 mt -121.38 121.94 66.0 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 175.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -98.24 117.94 33.76 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 104.988 -2.226 . . . . 0.0 104.988 174.162 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 69.8 m -71.66 116.09 11.62 Favored 'General case' 0 N--CA 1.405 -2.681 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 177.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 43.3 mtm180 . . . . . 0 C--N 1.295 -1.786 0 CA-C-N 115.34 -0.845 . . . . 0.0 108.844 -177.347 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 . . . . . 0 N--CA 1.449 -0.485 0 CA-C-O 121.675 0.75 . . . . 0.0 109.779 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 90.78 15.73 55.98 Favored Glycine 0 N--CA 1.426 -1.995 0 CA-C-N 114.915 -1.039 . . . . 0.0 112.993 176.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 33.7 p90 -155.35 163.1 40.55 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 177.233 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -155.6 176.14 12.99 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-O 121.095 0.474 . . . . 0.0 111.228 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -137.64 146.0 43.38 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 124.334 1.054 . . . . 0.0 109.965 179.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.415 HD22 ' HB3' ' A' ' 57' ' ' PRO . 9.8 tt -151.88 140.86 21.13 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 175.517 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -121.76 144.09 49.0 Favored 'General case' 0 C--O 1.257 1.482 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 178.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 50.2 m-85 -103.89 164.72 11.51 Favored 'General case' 0 C--N 1.288 -2.072 0 CA-C-N 115.595 -0.729 . . . . 0.0 111.688 -178.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -69.77 -39.52 76.62 Favored 'General case' 0 N--CA 1.429 -1.522 0 CA-C-N 114.388 -1.278 . . . . 0.0 108.665 174.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.409 ' OD2' ' HB2' ' A' ' 83' ' ' ARG . 26.6 t70 -124.13 140.0 53.39 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.932 -176.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 -69.46 -19.75 63.76 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 115.187 1.551 . . . . 0.0 115.187 -178.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.409 ' HB2' ' OD2' ' A' ' 81' ' ' ASP . 0.0 OUTLIER -67.23 -33.91 76.34 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-O 122.175 0.988 . . . . 0.0 109.743 173.382 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.451 ' OG ' HG22 ' B' ' 226' ' ' ILE . 45.8 m -65.31 -36.91 85.5 Favored 'General case' 0 C--N 1.289 -2.062 0 CA-C-N 115.06 -0.973 . . . . 0.0 112.199 177.652 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.484 HG22 ' HA ' ' A' ' 31' ' ' ALA . 68.6 p -64.7 -45.59 85.96 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 120.26 -0.576 . . . . 0.0 110.841 -177.749 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 5.3 pt -63.51 -38.65 82.78 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.249 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.754 176.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 19.5 mt -58.79 -43.86 90.57 Favored 'General case' 0 C--O 1.247 0.969 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.302 176.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -71.53 -46.8 58.6 Favored 'General case' 0 N--CA 1.438 -1.067 0 CA-C-N 115.573 -0.739 . . . . 0.0 111.56 -179.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.407 HG21 ' O ' ' A' ' 85' ' ' THR . 75.8 t -57.88 -48.07 84.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-O 121.072 0.463 . . . . 0.0 111.113 -179.344 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -62.09 -32.83 73.43 Favored 'General case' 0 C--N 1.296 -1.744 0 CA-C-N 115.047 -0.979 . . . . 0.0 112.003 -173.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 36.7 m-80 -97.98 -25.08 15.1 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 113.367 0.877 . . . . 0.0 113.367 -178.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 15.4 mt -96.33 -31.29 12.96 Favored 'General case' 0 CA--C 1.484 -1.568 0 CA-C-O 120.898 0.38 . . . . 0.0 111.875 -172.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 57.7 t30 -66.51 125.28 25.21 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 -179.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 82.94 -1.12 89.15 Favored Glycine 0 N--CA 1.444 -0.821 0 O-C-N 123.414 0.446 . . . . 0.0 112.556 179.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 82.7 t80 -88.05 143.75 26.9 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 -178.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.412 ' HD2' ' N ' ' A' ' 96' ' ' LYS . 11.5 mptt -96.9 118.7 33.91 Favored 'General case' 0 N--CA 1.436 -1.151 0 CA-C-O 121.088 0.47 . . . . 0.0 111.27 -177.143 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 53.1 mt -124.53 141.73 43.69 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 N-CA-C 105.098 -2.186 . . . . 0.0 105.098 173.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 56.93 29.27 58.82 Favored Glycine 0 C--O 1.22 -0.727 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.702 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 76.55 2.1 73.67 Favored Glycine 0 CA--C 1.537 1.455 0 C-N-CA 121.71 -0.281 . . . . 0.0 113.8 -179.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.446 ' NH1' ' HB2' ' A' ' 39' ' ' ASN . 0.2 OUTLIER -124.37 143.77 50.41 Favored 'General case' 0 C--N 1.316 -0.868 0 O-C-N 122.176 -0.603 . . . . 0.0 111.543 -177.125 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -87.23 118.45 26.65 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.644 -177.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 11.9 mt -70.22 147.92 49.23 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 115.431 -0.804 . . . . 0.0 112.513 179.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 59.3 tptt -120.83 116.23 24.8 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 175.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.431 ' CD1' HG21 ' A' ' 35' ' ' ILE . 4.7 mm -119.41 131.01 73.25 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.809 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 179.326 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -144.01 151.02 39.14 Favored 'General case' 0 C--N 1.285 -2.202 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 179.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 28.8 m-70 -78.68 135.03 37.07 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 178.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 12.0 t -149.59 161.51 42.03 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 106.199 -1.778 . . . . 0.0 106.199 -177.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -103.62 110.15 22.11 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 174.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 28.1 t80 . . . . . 0 C--N 1.294 -1.835 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.389 -176.426 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 226' ' ' ILE . . . . . 0.451 HG22 ' OG ' ' A' ' 84' ' ' SER . 4.2 mp . . . . . 0 CA--C 1.503 -0.832 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 227' ' ' MET . . . . . . . . . . . . . 26.6 mmt -78.65 144.3 64.74 Favored Pre-proline 0 C--N 1.295 -1.802 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.721 178.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 228' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -68.57 160.64 48.51 Favored 'Trans proline' 0 C--O 1.248 0.984 0 C-N-CA 123.211 2.607 . . . . 0.0 113.673 -176.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . -82.77 172.86 52.22 Favored Glycine 0 N--CA 1.442 -0.927 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.991 178.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 14.8 m -74.76 -17.49 60.63 Favored 'General case' 0 C--N 1.307 -1.248 0 C-N-CA 123.29 0.636 . . . . 0.0 112.502 -175.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 231' ' ' ARG . . . . . 0.455 ' HB2' ' OG ' ' A' ' 52' ' ' SER . 23.0 mmm180 -79.75 -11.48 59.84 Favored 'General case' 0 CA--C 1.5 -0.949 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -179.768 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 232' ' ' TRP . . . . . . . . . . . . . 21.3 t90 -69.28 121.55 17.07 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-O 122.334 1.064 . . . . 0.0 111.922 -178.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 233' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -116.77 149.11 40.46 Favored 'General case' 0 C--N 1.278 -2.543 0 N-CA-C 102.486 -3.154 . . . . 0.0 102.486 171.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.501 2.998 0 C-N-CA 128.114 2.769 . . . . 0.0 116.919 -177.987 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 240' ' ' GLY . . . . . 0.409 ' O ' ' HG2' ' B' ' 244' ' ' LYS . . . . . . . . 0 N--CA 1.431 -1.672 0 N-CA-C 109.03 -1.628 . . . . 0.0 109.03 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 22.9 p90 -73.2 -33.26 65.28 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 -176.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -59.66 -47.43 85.63 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 120.731 -0.388 . . . . 0.0 111.362 -177.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -61.36 -34.99 76.22 Favored 'General case' 0 C--O 1.21 -1.015 0 O-C-N 123.659 0.599 . . . . 0.0 112.045 -179.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 244' ' ' LYS . . . . . 0.409 ' HG2' ' O ' ' B' ' 240' ' ' GLY . 43.6 mmtm -64.33 -48.39 75.77 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.248 0.547 . . . . 0.0 110.186 -178.37 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 245' ' ' TRP . . . . . . . . . . . . . 24.9 m0 -67.29 -37.69 83.83 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.103 179.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 246' ' ' PHE . . . . . 0.492 ' O ' ' HG2' ' B' ' 249' ' ' GLN . 2.4 t80 -65.04 -35.21 80.43 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.554 177.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -70.5 -36.33 73.72 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.656 -178.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.5 -14.09 36.03 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 120.974 0.416 . . . . 0.0 111.703 -177.63 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 249' ' ' GLN . . . . . 0.492 ' HG2' ' O ' ' B' ' 246' ' ' PHE . 2.6 pt20 -84.79 3.74 36.23 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 109.192 -0.669 . . . . 0.0 109.192 177.007 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 250' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -50.35 -32.09 16.38 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 114.788 -1.096 . . . . 0.0 111.938 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -64.7 123.76 20.16 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.578 -178.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 252' ' ' ILE . . . . . . . . . . . . . 27.5 pt -98.63 -31.98 3.76 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 CA-C-O 121.274 0.559 . . . . 0.0 111.937 -177.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -89.86 -16.9 29.12 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-O 121.584 0.706 . . . . 0.0 109.71 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 254' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 . . . . . 0 C--N 1.293 -1.888 0 CA-C-N 114.691 -1.14 . . . . 0.0 108.799 179.888 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.737 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 12.6 m-85 -108.24 144.89 35.1 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.217 -175.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 26.4 pt -139.47 155.51 25.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 CA-C-O 121.3 0.572 . . . . 0.0 110.374 176.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 50.9 t80 -106.38 123.1 47.54 Favored 'General case' 0 N--CA 1.411 -2.396 0 CA-C-N 114.31 -1.314 . . . . 0.0 107.772 177.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.434 HG21 ' CD1' ' A' ' 104' ' ' ILE . 8.1 mt -108.67 127.9 64.8 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.098 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 175.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -129.97 164.38 22.68 Favored Glycine 0 C--N 1.278 -2.685 0 N-CA-C 110.806 -0.918 . . . . 0.0 110.806 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 72.67 34.16 1.24 Allowed 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.92 1.288 . . . . 0.0 110.982 -179.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -64.57 146.33 54.78 Favored 'General case' 0 CA--C 1.497 -1.064 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.031 176.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.422 ' HB3' ' HG ' ' A' ' 42' ' ' LEU . 60.7 t30 -84.27 139.6 32.23 Favored 'General case' 0 C--N 1.289 -2.062 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 176.571 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.419 ' HD2' ' C ' ' A' ' 40' ' ' ARG . 6.9 ppt_? -58.53 -16.83 17.15 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 113.556 0.947 . . . . 0.0 113.556 -174.744 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -100.85 0.24 38.19 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -178.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.422 ' HG ' ' HB3' ' A' ' 39' ' ' ASN . 57.4 mt -80.94 128.66 33.93 Favored 'General case' 0 C--O 1.245 0.823 0 CA-C-O 121.235 0.541 . . . . 0.0 111.223 178.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 72.4 p -108.37 173.07 6.48 Favored 'General case' 0 N--CA 1.425 -1.708 0 CA-C-N 114.657 -1.156 . . . . 0.0 109.977 -177.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.5 ' HG3' ' HB2' ' A' ' 62' ' ' LEU . 2.3 mp0 -56.0 -43.1 77.36 Favored 'General case' 0 C--N 1.316 -0.886 0 C-N-CA 124.061 0.944 . . . . 0.0 110.824 178.361 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -62.62 -35.38 91.75 Favored Glycine 0 C--O 1.24 0.525 0 CA-C-N 115.867 -0.606 . . . . 0.0 112.557 -179.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 39.2 m-20 -64.84 -48.99 72.35 Favored 'General case' 0 CA--C 1.49 -1.337 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 178.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 52.5 mt -61.54 -48.03 90.64 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.856 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.402 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 40.1 mt -59.98 -42.44 94.19 Favored 'General case' 0 CA--C 1.494 -1.189 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.805 -176.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 90.0 m -63.55 -45.9 88.38 Favored 'General case' 0 C--N 1.309 -1.191 0 O-C-N 123.456 0.473 . . . . 0.0 111.225 -179.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 98.1 t -67.69 -46.33 82.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.769 -178.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -66.12 -24.33 66.66 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.952 -178.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.527 ' OG ' ' HB2' ' B' ' 231' ' ' ARG . 70.2 m -70.81 -19.1 62.71 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.943 175.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -72.64 -27.2 61.99 Favored 'General case' 0 CA--C 1.551 1.009 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 177.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 58.3 m-85 -89.98 -16.45 29.84 Favored 'General case' 0 CA--C 1.511 -0.539 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.888 -177.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.419 ' O ' ' HA ' ' A' ' 52' ' ' SER . . . 163.13 -153.47 24.01 Favored Glycine 0 N--CA 1.417 -2.615 0 C-N-CA 120.325 -0.94 . . . . 0.0 111.738 178.795 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 59.7 t -105.23 107.65 59.5 Favored Pre-proline 0 C--N 1.294 -1.83 0 CA-C-N 116.105 -0.048 . . . . 0.0 110.92 -176.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.415 ' HB3' HD22 ' A' ' 77' ' ' LEU . 97.5 Cg_endo -78.51 136.97 14.31 Favored 'Trans proline' 0 N--CA 1.448 -1.161 0 C-N-CA 122.698 2.266 . . . . 0.0 110.194 176.126 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 35.5 m -112.86 -27.39 2.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 C-N-CA 119.84 -0.744 . . . . 0.0 111.601 -178.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.465 ' HB3' ' HG2' ' A' ' 78' ' ' LYS . 38.8 t70 -152.01 144.33 24.02 Favored 'General case' 0 CA--C 1.5 -0.952 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -179.197 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 13.0 p -145.38 134.73 17.88 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 179.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 91.2 mt -121.07 121.75 65.81 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 175.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.5 ' HB2' ' HG3' ' A' ' 44' ' ' GLU . 0.1 OUTLIER -94.58 115.91 28.13 Favored 'General case' 0 N--CA 1.422 -1.872 0 N-CA-C 105.838 -1.912 . . . . 0.0 105.838 176.039 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 11.3 m -76.89 116.93 18.0 Favored 'General case' 0 N--CA 1.409 -2.485 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 178.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 53.8 mtt180 . . . . . 0 C--N 1.298 -1.651 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.752 -177.256 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 14.1 mm-40 . . . . . 0 CA--C 1.507 -0.7 0 CA-C-O 121.055 0.455 . . . . 0.0 112.056 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 113.44 7.2 20.96 Favored Glycine 0 N--CA 1.427 -1.953 0 C-N-CA 119.888 -1.148 . . . . 0.0 111.423 -175.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 31.4 p90 -151.02 156.76 41.79 Favored 'General case' 0 N--CA 1.427 -1.584 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 178.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -154.64 174.6 14.76 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 123.647 0.592 . . . . 0.0 110.09 178.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -132.17 141.16 49.0 Favored 'General case' 0 C--N 1.305 -1.362 0 C-N-CA 123.605 0.762 . . . . 0.0 110.076 -178.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.415 HD22 ' HB3' ' A' ' 57' ' ' PRO . 9.7 tt -148.08 140.72 24.57 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 175.372 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.465 ' HG2' ' HB3' ' A' ' 59' ' ' ASP . 21.2 ptmt -123.55 144.5 49.53 Favored 'General case' 0 C--O 1.258 1.551 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 178.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 59.2 m-85 -105.83 164.42 11.95 Favored 'General case' 0 C--N 1.288 -2.079 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.011 -179.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -80.15 -33.84 38.14 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 114.88 -1.055 . . . . 0.0 108.763 175.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -111.96 129.31 56.23 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -177.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -70.03 -20.42 63.25 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 113.883 1.068 . . . . 0.0 113.883 -178.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.76 -33.39 75.52 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 122.193 0.997 . . . . 0.0 109.448 174.791 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 63.7 m -64.13 -37.06 86.1 Favored 'General case' 0 C--N 1.292 -1.906 0 CA-C-N 115.184 -0.916 . . . . 0.0 112.901 178.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 68.6 p -64.68 -45.45 86.64 Favored 'General case' 0 C--N 1.346 0.43 0 C-N-CA 120.469 -0.493 . . . . 0.0 110.818 -177.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 4.0 pt -65.08 -39.1 84.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.759 177.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 12.2 mt -59.47 -43.51 93.22 Favored 'General case' 0 CA--C 1.505 -0.784 0 O-C-N 123.35 0.406 . . . . 0.0 111.703 176.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.403 ' O ' ' HB2' ' A' ' 92' ' ' LEU . . . -69.35 -45.99 68.09 Favored 'General case' 0 N--CA 1.428 -1.555 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.739 -178.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 86.8 t -58.76 -45.28 91.3 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.134 0 CA-C-O 121.21 0.529 . . . . 0.0 110.643 177.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -58.91 -37.63 77.07 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 125.103 1.361 . . . . 0.0 112.321 -178.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 41.5 m-80 -98.17 -26.67 14.48 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 -176.002 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.403 ' HB2' ' O ' ' A' ' 88' ' ' ALA . 19.0 mt -96.13 -30.82 13.31 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -172.489 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -65.84 123.92 21.09 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 88.48 -12.2 65.78 Favored Glycine 0 CA--C 1.53 1.012 0 CA-C-N 116.026 -0.534 . . . . 0.0 112.422 -178.066 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 73.4 t80 -79.73 138.0 37.19 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 -176.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.46 ' HA ' ' O ' ' A' ' 100' ' ' ARG . 0.3 OUTLIER -95.66 123.28 39.15 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 112.111 0.411 . . . . 0.0 112.111 -177.035 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 59.4 mt -128.15 142.12 44.65 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 N-CA-C 105.737 -1.949 . . . . 0.0 105.737 173.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 64.14 14.32 55.99 Favored Glycine 0 C--N 1.319 -0.416 0 C-N-CA 121.262 -0.494 . . . . 0.0 112.701 -178.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 90.31 -1.18 79.25 Favored Glycine 0 N--CA 1.43 -1.73 0 CA-C-O 119.923 -0.376 . . . . 0.0 112.731 -178.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.46 ' O ' ' HA ' ' A' ' 96' ' ' LYS . 11.4 ptp180 -124.22 151.34 44.22 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 117.714 0.757 . . . . 0.0 111.96 -177.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -86.54 116.35 24.62 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -175.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 11.9 mt -65.61 148.72 51.27 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.469 -0.787 . . . . 0.0 112.56 178.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 57.7 tptt -122.12 118.06 27.76 Favored 'General case' 0 N--CA 1.422 -1.846 0 CA-C-N 115.14 -0.936 . . . . 0.0 108.663 175.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.434 ' CD1' HG21 ' A' ' 35' ' ' ILE . 4.3 mm -117.61 135.4 58.13 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 N-CA-C 107.143 -1.428 . . . . 0.0 107.143 178.515 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -143.94 149.71 37.24 Favored 'General case' 0 C--N 1.285 -2.229 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 -178.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 45.2 m-70 -81.56 131.17 35.26 Favored 'General case' 0 C--N 1.29 -1.981 0 N-CA-C 109.487 -0.561 . . . . 0.0 109.487 178.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 12.5 t -145.35 165.82 27.37 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 -177.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -110.16 109.77 20.4 Favored 'General case' 0 N--CA 1.428 -1.568 0 N-CA-C 106.649 -1.611 . . . . 0.0 106.649 174.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 35.6 t80 . . . . . 0 C--N 1.305 -1.341 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.719 -176.984 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 4.1 mp . . . . . 0 N--CA 1.448 -0.544 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 227' ' ' MET . . . . . . . . . . . . . 91.4 mtp -70.35 137.7 86.51 Favored Pre-proline 0 C--N 1.313 -0.994 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 177.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 228' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -64.75 157.02 58.33 Favored 'Trans proline' 0 C--O 1.251 1.166 0 C-N-CA 123.398 2.732 . . . . 0.0 113.489 -176.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . -74.75 168.68 54.63 Favored Glycine 0 N--CA 1.435 -1.409 0 CA-C-N 115.122 -0.945 . . . . 0.0 111.83 178.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 15.0 m -75.04 -16.8 60.58 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 111.856 0.317 . . . . 0.0 111.856 -175.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 231' ' ' ARG . . . . . 0.527 ' HB2' ' OG ' ' A' ' 52' ' ' SER . 26.6 mmt180 -79.2 -10.21 59.76 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.933 0.397 . . . . 0.0 110.261 -177.627 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 232' ' ' TRP . . . . . . . . . . . . . 25.4 t90 -70.13 130.07 41.1 Favored 'General case' 0 N--CA 1.432 -1.329 0 CA-C-O 122.481 1.134 . . . . 0.0 112.059 -178.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 233' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -124.03 139.45 53.93 Favored 'General case' 0 C--N 1.269 -2.906 0 N-CA-C 101.934 -3.358 . . . . 0.0 101.934 171.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.508 3.437 0 C-N-CA 128.747 3.07 . . . . 0.0 117.926 -177.626 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 240' ' ' GLY . . . . . 0.447 ' O ' ' HG2' ' B' ' 243' ' ' GLU . . . . . . . . 0 N--CA 1.403 -3.505 0 N-CA-C 110.39 -1.084 . . . . 0.0 110.39 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 29.3 p90 -77.26 -36.71 54.18 Favored 'General case' 0 C--N 1.294 -1.829 0 CA-C-O 121.477 0.656 . . . . 0.0 110.857 176.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 242' ' ' GLU . . . . . 0.502 ' HA ' ' CE3' ' B' ' 245' ' ' TRP . 42.4 tt0 -67.55 -38.95 84.91 Favored 'General case' 0 C--O 1.251 1.145 0 CA-C-N 115.093 -0.958 . . . . 0.0 111.657 -178.504 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 243' ' ' GLU . . . . . 0.447 ' HG2' ' O ' ' B' ' 240' ' ' GLY . 12.2 pt-20 -58.3 -35.02 71.19 Favored 'General case' 0 C--O 1.212 -0.9 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.229 178.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 244' ' ' LYS . . . . . 0.416 ' HE2' ' O ' ' B' ' 240' ' ' GLY . 72.2 mmtt -62.79 -46.17 89.25 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.598 -176.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 245' ' ' TRP . . . . . 0.502 ' CE3' ' HA ' ' B' ' 242' ' ' GLU . 11.8 m0 -63.98 -40.65 96.86 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.675 179.308 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 246' ' ' PHE . . . . . 0.567 ' O ' ' HG2' ' B' ' 249' ' ' GLN . 2.5 t80 -66.64 -31.12 71.59 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.075 179.069 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -77.54 -39.91 44.39 Favored 'General case' 0 C--N 1.29 -2.004 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.079 178.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.47 -13.28 55.05 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-O 121.395 0.617 . . . . 0.0 111.606 -175.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 249' ' ' GLN . . . . . 0.567 ' HG2' ' O ' ' B' ' 246' ' ' PHE . 3.2 pt20 -74.48 2.68 9.01 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.597 -179.635 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 250' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -61.24 -31.08 70.88 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 174.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -91.63 158.32 16.48 Favored 'General case' 0 N--CA 1.414 -2.263 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.439 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 252' ' ' ILE . . . . . . . . . . . . . 35.0 pt -108.11 -29.17 2.62 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 CA-C-N 114.927 -1.033 . . . . 0.0 110.265 -176.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -120.04 -32.39 4.2 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.918 0.389 . . . . 0.0 110.85 -175.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 254' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 . . . . . 0 N--CA 1.43 -1.431 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 -170.584 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.532 0 N-CA-C 111.748 0.277 . . . . 0.0 111.748 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 16.9 m-30 -93.92 145.39 24.67 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 120.933 -0.307 . . . . 0.0 110.598 -176.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 26.4 pt -143.8 162.26 15.83 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 C-N-CA 123.229 0.612 . . . . 0.0 110.233 176.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 29.8 t80 -114.46 124.5 52.08 Favored 'General case' 0 N--CA 1.421 -1.913 0 C-N-CA 124.355 1.062 . . . . 0.0 108.616 177.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 7.5 mt -109.6 127.72 66.19 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.976 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 175.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -127.88 164.37 21.25 Favored Glycine 0 C--N 1.281 -2.501 0 N-CA-C 110.622 -0.991 . . . . 0.0 110.622 -179.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 16.9 m120 71.38 36.93 1.23 Allowed 'General case' 0 CA--C 1.503 -0.83 0 C-N-CA 124.177 0.991 . . . . 0.0 111.082 -177.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.409 HD21 ' HA ' ' A' ' 74' ' ' PHE . 4.1 mm? -69.79 153.87 42.75 Favored 'General case' 0 CA--C 1.499 -0.984 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.105 176.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.42 ' HB3' ' HG ' ' A' ' 42' ' ' LEU . 38.2 t-20 -92.07 152.96 19.69 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 175.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -67.38 -23.59 65.59 Favored 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 122.535 0.334 . . . . 0.0 110.41 -179.162 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -90.55 -10.97 41.51 Favored 'General case' 0 C--O 1.224 -0.259 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.291 -178.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.42 ' HG ' ' HB3' ' A' ' 39' ' ' ASN . 55.3 mt -77.43 120.38 22.34 Favored 'General case' 0 CA--C 1.495 -1.171 0 CA-C-O 121.596 0.712 . . . . 0.0 110.947 -178.218 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 73.0 p -102.07 173.49 6.36 Favored 'General case' 0 C--N 1.287 -2.142 0 CA-C-N 114.508 -1.224 . . . . 0.0 109.771 -177.215 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -64.07 -34.61 78.43 Favored 'General case' 0 C--O 1.205 -1.276 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 177.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -59.31 -39.26 94.45 Favored Glycine 0 N--CA 1.443 -0.854 0 O-C-N 123.969 0.793 . . . . 0.0 111.438 178.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -67.54 -50.09 60.26 Favored 'General case' 0 CA--C 1.496 -1.107 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 177.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 46.3 mt -60.1 -47.22 92.79 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 CA-C-N 115.19 -0.913 . . . . 0.0 111.085 -178.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 41.4 mt -60.46 -45.45 93.66 Favored 'General case' 0 CA--C 1.49 -1.342 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.204 -176.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 90.4 m -63.08 -45.66 91.06 Favored 'General case' 0 N--CA 1.432 -1.356 0 O-C-N 123.74 0.65 . . . . 0.0 111.507 -178.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 98.2 t -67.48 -48.17 78.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.831 -179.182 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -63.82 -25.37 68.15 Favored 'General case' 0 N--CA 1.438 -1.064 0 C-N-CA 123.769 0.827 . . . . 0.0 112.208 -179.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.551 ' OG ' ' HB2' ' B' ' 231' ' ' ARG . 62.8 m -67.75 -19.86 65.17 Favored 'General case' 0 N--CA 1.439 -1.011 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 176.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -66.03 -32.0 73.22 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-O 121.803 0.811 . . . . 0.0 109.305 174.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 57.2 m-85 -88.89 -22.78 22.96 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.56 -0.746 . . . . 0.0 111.691 -173.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.462 ' O ' ' HA ' ' A' ' 52' ' ' SER . . . 173.7 -162.49 33.37 Favored Glycine 0 N--CA 1.428 -1.872 0 C-N-CA 120.633 -0.794 . . . . 0.0 111.795 178.303 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 59.4 t -100.43 110.57 60.54 Favored Pre-proline 0 C--N 1.304 -1.395 0 N-CA-C 110.511 -0.181 . . . . 0.0 110.511 -178.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.439 ' HB3' HD22 ' A' ' 77' ' ' LEU . 97.1 Cg_endo -79.69 136.67 12.29 Favored 'Trans proline' 0 N--CA 1.45 -1.049 0 C-N-CA 122.535 2.157 . . . . 0.0 110.603 177.502 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 35.0 m -111.35 -28.22 2.64 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 C-N-CA 119.786 -0.765 . . . . 0.0 111.834 -178.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.448 ' HB3' ' HG2' ' A' ' 78' ' ' LYS . 36.3 t70 -151.23 141.86 22.68 Favored 'General case' 0 CA--C 1.504 -0.789 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 -179.48 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 13.8 p -142.33 133.52 25.25 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 O-C-N 123.609 0.568 . . . . 0.0 109.809 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 83.4 mt -120.54 118.5 56.77 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.213 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 177.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -97.5 117.39 31.66 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 106.765 -1.569 . . . . 0.0 106.765 177.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 22.4 m -77.69 120.23 22.34 Favored 'General case' 0 C--N 1.29 -2.0 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 178.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 72.0 mtm180 . . . . . 0 C--N 1.306 -1.31 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.785 -175.076 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 . . . . . 0 N--CA 1.468 0.466 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 91.7 8.31 63.89 Favored Glycine 0 N--CA 1.44 -1.041 0 C-N-CA 120.85 -0.69 . . . . 0.0 113.535 177.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.409 ' HA ' HD21 ' A' ' 38' ' ' LEU . 32.6 p90 -152.77 157.72 41.22 Favored 'General case' 0 C--O 1.248 1.025 0 CA-C-N 117.566 0.683 . . . . 0.0 109.251 178.71 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -153.12 173.15 15.85 Favored 'General case' 0 N--CA 1.433 -1.322 0 O-C-N 123.569 0.543 . . . . 0.0 110.763 178.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -132.36 142.74 49.44 Favored 'General case' 0 C--N 1.306 -1.291 0 C-N-CA 124.17 0.988 . . . . 0.0 109.584 -178.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.439 HD22 ' HB3' ' A' ' 57' ' ' PRO . 9.8 tt -149.71 140.73 22.92 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 176.608 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.448 ' HG2' ' HB3' ' A' ' 59' ' ' ASP . 22.2 ptmt -123.46 144.25 49.64 Favored 'General case' 0 C--O 1.253 1.278 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 178.497 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -105.28 165.5 11.07 Favored 'General case' 0 C--N 1.29 -2.0 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.97 -178.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -73.62 -27.07 61.09 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.354 175.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -131.13 141.19 50.09 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 120.714 0.292 . . . . 0.0 110.606 -178.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 25.2 mp0 -70.08 -21.27 63.16 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 123.971 0.908 . . . . 0.0 113.279 -178.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 89.5 mtm180 -65.3 -34.46 78.39 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-O 122.313 1.054 . . . . 0.0 109.512 176.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.456 ' OG ' HG22 ' B' ' 226' ' ' ILE . 53.3 m -65.59 -36.85 84.95 Favored 'General case' 0 C--N 1.282 -2.33 0 CA-C-N 114.561 -1.199 . . . . 0.0 112.288 177.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 63.8 p -65.38 -44.94 85.98 Favored 'General case' 0 C--N 1.344 0.356 0 C-N-CA 120.168 -0.613 . . . . 0.0 110.875 -177.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 3.5 pt -63.5 -38.91 83.46 Favored 'Isoleucine or valine' 0 C--O 1.243 0.731 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.036 177.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 49.2 mt -60.4 -44.04 96.08 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.385 176.211 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.462 ' O ' ' HB2' ' A' ' 92' ' ' LEU . . . -71.81 -46.61 57.59 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.838 -179.264 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 53.3 t -56.47 -48.89 79.42 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.902 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -178.004 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -62.24 -43.88 97.83 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -173.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -93.33 -19.98 20.82 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-N 115.758 -0.656 . . . . 0.0 112.373 -170.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.462 ' HB2' ' O ' ' A' ' 88' ' ' ALA . 9.8 mt -92.6 -27.85 17.09 Favored 'General case' 0 CA--C 1.491 -1.313 0 CA-C-O 120.824 0.345 . . . . 0.0 111.142 179.397 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -65.6 124.48 22.47 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 178.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 88.32 -1.09 84.11 Favored Glycine 0 N--CA 1.434 -1.493 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.435 -178.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -79.36 129.87 34.89 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 -179.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 11.9 mptt -90.06 115.63 27.47 Favored 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 120.602 -0.439 . . . . 0.0 110.245 179.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 54.1 mt -122.19 141.31 43.13 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 N-CA-C 105.803 -1.925 . . . . 0.0 105.803 174.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 57.32 21.9 42.19 Favored Glycine 0 CA--C 1.523 0.579 0 C-N-CA 121.79 -0.243 . . . . 0.0 113.411 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 85.8 7.53 81.13 Favored Glycine 0 N--CA 1.437 -1.29 0 C-N-CA 121.149 -0.548 . . . . 0.0 113.59 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 18.6 ptp180 -132.01 139.25 48.54 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 117.726 0.763 . . . . 0.0 110.622 -179.145 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -81.25 119.83 24.13 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.756 -177.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 12.1 mt -66.47 146.73 54.21 Favored 'General case' 0 CA--C 1.501 -0.917 0 O-C-N 124.114 0.884 . . . . 0.0 112.737 178.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 28.6 tptp -120.44 118.82 31.29 Favored 'General case' 0 N--CA 1.421 -1.906 0 CA-C-N 115.222 -0.899 . . . . 0.0 108.922 174.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 3.2 mm -115.13 139.04 43.42 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.867 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 178.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -145.32 150.65 36.99 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 178.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 56.4 m-70 -83.64 130.71 34.98 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 176.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 5.4 t -148.79 163.55 37.05 Favored 'General case' 0 C--N 1.29 -1.98 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 -176.148 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -109.73 111.77 23.43 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 172.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 36.3 t80 . . . . . 0 C--N 1.286 -2.159 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.083 -173.527 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 226' ' ' ILE . . . . . 0.456 HG22 ' OG ' ' A' ' 84' ' ' SER . 3.7 mp . . . . . 0 N--CA 1.433 -1.314 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 227' ' ' MET . . . . . . . . . . . . . 63.6 mtt -68.42 137.43 91.14 Favored Pre-proline 0 C--N 1.31 -1.12 0 O-C-N 124.016 0.822 . . . . 0.0 109.681 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 228' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -67.94 146.39 71.34 Favored 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 122.196 1.931 . . . . 0.0 111.206 178.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . -66.1 161.08 44.9 Favored Glycine 0 N--CA 1.44 -1.037 0 CA-C-N 116.084 -0.507 . . . . 0.0 112.363 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 23.2 m -74.6 -12.67 60.51 Favored 'General case' 0 C--N 1.298 -1.654 0 C-N-CA 123.037 0.535 . . . . 0.0 111.794 -177.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 231' ' ' ARG . . . . . 0.551 ' HB2' ' OG ' ' A' ' 52' ' ' SER . 4.0 mmp_? -79.0 -14.53 59.14 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.044 0.45 . . . . 0.0 109.992 178.491 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 232' ' ' TRP . . . . . . . . . . . . . 28.9 t90 -72.12 122.88 21.73 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.984 -0.553 . . . . 0.0 112.052 -176.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 233' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -126.63 106.02 9.12 Favored 'General case' 0 C--O 1.207 -1.169 0 CA-C-O 118.665 -0.684 . . . . 0.0 110.057 177.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.491 0 N-CA-C 115.9 1.12 . . . . 0.0 115.9 176.241 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 240' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.406 -3.339 0 N-CA-C 108.751 -1.74 . . . . 0.0 108.751 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 28.9 p90 -76.37 -35.53 58.61 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-O 120.84 0.352 . . . . 0.0 111.923 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 242' ' ' GLU . . . . . 0.459 ' HA ' ' CE3' ' B' ' 245' ' ' TRP . 44.2 tt0 -67.33 -42.07 84.2 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.576 -176.608 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -57.95 -34.02 69.46 Favored 'General case' 0 C--O 1.22 -0.47 0 C-N-CA 123.105 0.562 . . . . 0.0 111.541 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -62.03 -45.96 91.25 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.394 -178.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 245' ' ' TRP . . . . . 0.459 ' CE3' ' HA ' ' B' ' 242' ' ' GLU . 11.2 m0 -69.6 -39.05 77.5 Favored 'General case' 0 CA--C 1.505 -0.756 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.425 178.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 246' ' ' PHE . . . . . 0.477 ' O ' ' HG2' ' B' ' 249' ' ' GLN . 6.1 t80 -62.12 -33.4 74.38 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.973 179.492 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -76.43 -30.85 57.57 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.632 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 248' ' ' LYS . . . . . 0.564 ' O ' ' HG2' ' B' ' 251' ' ' GLU . 0.0 OUTLIER -97.15 -12.61 22.89 Favored 'General case' 0 C--O 1.203 -1.378 0 O-C-N 121.895 -0.503 . . . . 0.0 112.11 -176.488 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 249' ' ' GLN . . . . . 0.477 ' HG2' ' O ' ' B' ' 246' ' ' PHE . 3.0 pt20 -70.17 2.51 3.61 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.137 0.575 . . . . 0.0 112.548 -176.327 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 250' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -63.64 -30.14 71.29 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.516 176.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 251' ' ' GLU . . . . . 0.564 ' HG2' ' O ' ' B' ' 248' ' ' LYS . 11.3 pt-20 -75.18 108.35 7.88 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-O 122.502 1.144 . . . . 0.0 111.067 -179.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 252' ' ' ILE . . . . . . . . . . . . . 30.4 pt -110.07 -34.28 2.48 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.334 0 CA-C-N 114.183 -1.372 . . . . 0.0 111.01 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -101.47 -26.01 13.72 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 178.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 254' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 . . . . . 0 N--CA 1.42 -1.945 0 CA-C-N 115.131 -0.94 . . . . 0.0 108.589 -176.28 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.514 -0.407 0 N-CA-C 111.772 0.286 . . . . 0.0 111.772 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -95.93 145.83 25.08 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.064 -175.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 21.2 pt -140.79 160.64 23.86 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 C-N-CA 122.709 0.404 . . . . 0.0 110.175 175.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 61.6 t80 -110.81 125.9 54.07 Favored 'General case' 0 N--CA 1.409 -2.508 0 CA-C-N 115.272 -0.876 . . . . 0.0 108.757 178.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.422 HG21 ' CD1' ' A' ' 104' ' ' ILE . 8.0 mt -110.76 129.07 66.61 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.935 0 N-CA-C 107.297 -1.371 . . . . 0.0 107.297 176.454 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -129.65 166.16 21.94 Favored Glycine 0 C--N 1.283 -2.394 0 N-CA-C 110.318 -1.113 . . . . 0.0 110.318 179.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 70.02 38.35 1.56 Allowed 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 125.055 1.342 . . . . 0.0 111.389 -178.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -70.21 154.05 42.37 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.405 0.621 . . . . 0.0 111.687 177.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.415 ' HB3' ' HG ' ' A' ' 42' ' ' LEU . 45.2 t-20 -90.47 150.24 21.88 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 176.438 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 7.3 ppt_? -62.91 -21.62 66.16 Favored 'General case' 0 C--N 1.314 -0.937 0 C-N-CA 122.991 0.516 . . . . 0.0 111.29 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -94.89 -0.74 53.74 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 115.965 -0.562 . . . . 0.0 111.73 -178.097 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.415 ' HG ' ' HB3' ' A' ' 39' ' ' ASN . 68.9 mt -89.95 124.33 34.63 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-O 121.365 0.602 . . . . 0.0 110.762 -179.667 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 75.8 p -108.78 174.25 5.96 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.241 -179.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -54.79 -41.17 70.24 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 123.667 0.787 . . . . 0.0 110.131 177.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -64.19 -38.87 96.52 Favored Glycine 0 N--CA 1.444 -0.828 0 CA-C-N 115.492 -0.777 . . . . 0.0 113.027 -178.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -65.96 -47.06 75.86 Favored 'General case' 0 CA--C 1.496 -1.125 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 -179.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 44.6 mt -58.5 -45.14 90.22 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.632 179.066 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 45.1 mt -59.09 -45.83 89.85 Favored 'General case' 0 C--O 1.209 -1.031 0 CA-C-O 119.481 -0.295 . . . . 0.0 111.428 -179.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 99.0 m -61.53 -45.54 93.74 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 64.3 t -65.52 -47.8 85.21 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 CA-C-O 121.349 0.595 . . . . 0.0 110.708 -179.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -67.1 -23.04 65.8 Favored 'General case' 0 N--CA 1.436 -1.169 0 C-N-CA 124.022 0.929 . . . . 0.0 111.88 -179.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.453 ' OG ' ' HB2' ' B' ' 231' ' ' ARG . 65.9 m -69.7 -19.85 63.56 Favored 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 176.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -75.9 -25.47 56.08 Favored 'General case' 0 C--O 1.247 0.947 0 C-N-CA 118.247 -1.381 . . . . 0.0 108.853 177.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -88.04 -22.68 24.07 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.603 -176.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 175.73 -156.67 22.26 Favored Glycine 0 N--CA 1.425 -2.07 0 C-N-CA 120.624 -0.798 . . . . 0.0 111.562 177.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.446 ' HB ' ' HG2' ' A' ' 80' ' ' GLU . 94.5 t -106.46 102.56 41.65 Favored Pre-proline 0 C--N 1.3 -1.559 0 CA-C-O 120.851 0.357 . . . . 0.0 110.341 -178.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.436 ' HB3' HD22 ' A' ' 77' ' ' LEU . 89.7 Cg_endo -77.81 136.86 15.46 Favored 'Trans proline' 0 C--O 1.252 1.206 0 C-N-CA 122.534 2.156 . . . . 0.0 110.167 177.281 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 34.0 m -113.9 -18.47 7.51 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 C-N-CA 120.221 -0.592 . . . . 0.0 112.274 -177.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.468 ' HB3' ' HG2' ' A' ' 78' ' ' LYS . 20.3 t70 -160.14 139.13 10.69 Favored 'General case' 0 C--O 1.242 0.7 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 -178.494 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 12.7 p -140.62 137.59 35.83 Favored 'Isoleucine or valine' 0 C--O 1.245 0.845 0 O-C-N 123.35 0.406 . . . . 0.0 110.056 179.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 90.4 mt -121.33 124.76 72.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 C-N-CA 123.391 0.676 . . . . 0.0 109.394 175.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -100.12 121.06 40.83 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 106.056 -1.831 . . . . 0.0 106.056 175.501 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 20.4 m -79.91 117.37 20.71 Favored 'General case' 0 C--N 1.284 -2.249 0 N-CA-C 107.016 -1.476 . . . . 0.0 107.016 175.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 57.8 mtp180 . . . . . 0 C--N 1.3 -1.559 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.573 -172.959 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 16.0 mm-40 . . . . . 0 CA--C 1.509 -0.616 0 CA-C-O 120.876 0.37 . . . . 0.0 111.709 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 87.63 8.1 74.19 Favored Glycine 0 N--CA 1.431 -1.655 0 C-N-CA 120.186 -1.007 . . . . 0.0 112.48 -177.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 32.1 p90 -149.27 155.41 40.53 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 177.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -154.19 176.11 12.66 Favored 'General case' 0 C--N 1.316 -0.852 0 O-C-N 123.403 0.439 . . . . 0.0 111.0 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -132.82 144.02 49.94 Favored 'General case' 0 C--N 1.314 -0.971 0 C-N-CA 124.376 1.07 . . . . 0.0 109.975 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.436 HD22 ' HB3' ' A' ' 57' ' ' PRO . 9.9 tt -150.3 141.46 23.11 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 176.485 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.468 ' HG2' ' HB3' ' A' ' 59' ' ' ASP . 21.8 ptmt -123.3 143.8 49.84 Favored 'General case' 0 C--O 1.256 1.401 0 CA-C-O 121.215 0.531 . . . . 0.0 109.983 178.279 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.416 ' HH ' ' CB ' ' A' ' 88' ' ' ALA . 68.7 m-85 -106.67 165.41 11.32 Favored 'General case' 0 C--N 1.293 -1.88 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.822 179.615 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.446 ' HG2' ' HB ' ' A' ' 56' ' ' VAL . 6.9 pt-20 -76.49 -23.92 53.78 Favored 'General case' 0 C--N 1.315 -0.918 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.318 175.561 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -133.58 144.94 49.62 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 119.497 -0.881 . . . . 0.0 111.891 177.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 25.0 mp0 -69.41 -20.82 63.8 Favored 'General case' 0 C--N 1.309 -1.177 0 C-N-CA 124.32 1.048 . . . . 0.0 113.239 -177.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 76.2 mtm180 -62.74 -35.42 79.71 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 122.092 0.949 . . . . 0.0 109.976 176.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 49.5 m -69.11 -37.32 78.3 Favored 'General case' 0 C--N 1.286 -2.184 0 CA-C-N 114.905 -1.043 . . . . 0.0 112.951 178.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 72.1 p -62.66 -45.28 93.55 Favored 'General case' 0 C--N 1.344 0.336 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.456 -177.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 3.3 pt -65.71 -39.9 86.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.197 178.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 49.0 mt -60.31 -43.6 96.2 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 120.852 0.358 . . . . 0.0 111.319 176.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.455 ' O ' ' HB2' ' A' ' 92' ' ' LEU . . . -71.29 -46.47 60.74 Favored 'General case' 0 N--CA 1.433 -1.3 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.339 -178.498 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 66.9 t -57.56 -49.29 80.96 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.906 0 CA-C-O 121.054 0.454 . . . . 0.0 111.083 179.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -64.88 -34.66 78.93 Favored 'General case' 0 C--N 1.295 -1.798 0 C-N-CA 124.029 0.932 . . . . 0.0 111.779 -174.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -93.42 -28.53 16.08 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 -176.235 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.455 ' HB2' ' O ' ' A' ' 88' ' ' ALA . 13.9 mt -92.84 -30.46 15.44 Favored 'General case' 0 CA--C 1.488 -1.405 0 N-CA-C 111.797 0.295 . . . . 0.0 111.797 -175.046 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -66.41 124.76 23.63 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 177.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 85.95 -0.72 87.81 Favored Glycine 0 CA--C 1.535 1.328 0 C-N-CA 120.496 -0.859 . . . . 0.0 112.325 -177.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 21.7 t80 -89.23 133.5 34.41 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 -179.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -96.13 123.8 39.89 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-O 121.093 0.473 . . . . 0.0 111.647 -178.084 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 55.0 mt -127.74 141.32 46.73 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 N-CA-C 105.581 -2.007 . . . . 0.0 105.581 173.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 58.22 24.58 55.59 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 121.544 -0.36 . . . . 0.0 113.344 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 81.8 3.11 90.69 Favored Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 121.673 -0.299 . . . . 0.0 113.132 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 19.4 ptp180 -125.06 144.96 50.14 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 117.271 0.535 . . . . 0.0 110.978 -178.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -85.71 117.7 24.75 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.372 -177.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 11.9 mt -66.4 147.04 53.87 Favored 'General case' 0 C--O 1.25 1.118 0 CA-C-O 121.57 0.7 . . . . 0.0 112.566 178.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 60.1 tptt -119.19 117.97 30.08 Favored 'General case' 0 N--CA 1.416 -2.149 0 CA-C-N 114.777 -1.101 . . . . 0.0 108.046 176.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.422 ' CD1' HG21 ' A' ' 35' ' ' ILE . 4.9 mm -119.89 136.2 57.74 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.052 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 179.081 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -143.31 151.24 40.27 Favored 'General case' 0 C--N 1.283 -2.323 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 -179.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 79.9 m-70 -80.98 131.33 35.31 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 179.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 5.9 t -151.34 160.46 43.77 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 105.724 -1.954 . . . . 0.0 105.724 -178.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -110.64 110.01 20.53 Favored 'General case' 0 N--CA 1.422 -1.866 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 172.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 76.1 t80 . . . . . 0 C--N 1.291 -1.946 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.756 -178.748 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 3.9 mp . . . . . 0 C--O 1.25 1.083 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 227' ' ' MET . . . . . . . . . . . . . 18.9 ptp -66.93 154.1 92.98 Favored Pre-proline 0 C--N 1.318 -0.79 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.16 178.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 228' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -73.4 145.02 37.48 Favored 'Trans proline' 0 N--CA 1.44 -1.634 0 C-N-CA 122.17 1.913 . . . . 0.0 111.565 175.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . -67.92 166.58 43.55 Favored Glycine 0 N--CA 1.437 -1.274 0 CA-C-N 115.497 -0.774 . . . . 0.0 112.59 179.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 16.2 m -74.74 -14.51 60.73 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-O 121.022 0.439 . . . . 0.0 111.738 -175.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 231' ' ' ARG . . . . . 0.453 ' HB2' ' OG ' ' A' ' 52' ' ' SER . 39.7 mmt180 -84.83 -3.45 58.66 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.018 0.437 . . . . 0.0 110.409 -179.113 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 232' ' ' TRP . . . . . . . . . . . . . 22.1 t90 -76.29 128.62 35.26 Favored 'General case' 0 CA--C 1.5 -0.975 0 CA-C-O 122.31 1.053 . . . . 0.0 111.846 -179.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 233' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -124.17 142.87 50.86 Favored 'General case' 0 C--N 1.269 -2.896 0 N-CA-C 101.978 -3.342 . . . . 0.0 101.978 172.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.251 0 C-N-CA 128.207 2.813 . . . . 0.0 116.249 -179.988 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 240' ' ' GLY . . . . . 0.563 ' O ' ' HG2' ' B' ' 244' ' ' LYS . . . . . . . . 0 C--O 1.187 -2.832 0 CA-C-O 120.122 -0.266 . . . . 0.0 112.512 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 47.1 p90 -75.44 -33.82 60.92 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 117.667 0.734 . . . . 0.0 110.952 -179.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -63.45 -39.72 95.21 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.894 -175.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -67.29 -35.74 80.1 Favored 'General case' 0 C--O 1.21 -0.979 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.249 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 244' ' ' LYS . . . . . 0.563 ' HG2' ' O ' ' B' ' 240' ' ' GLY . 68.9 mmtt -67.05 -45.74 76.49 Favored 'General case' 0 CA--C 1.507 -0.675 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 -176.249 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 245' ' ' TRP . . . . . 0.412 ' O ' ' HB3' ' B' ' 249' ' ' GLN . 46.7 m0 -64.44 -37.54 87.87 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.059 -179.338 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 246' ' ' PHE . . . . . 0.542 ' O ' ' HG2' ' B' ' 249' ' ' GLN . 2.9 t80 -70.65 -30.44 67.07 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.086 176.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -78.59 -40.66 34.01 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 178.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.65 -15.96 52.91 Favored 'General case' 0 CA--C 1.501 -0.917 0 CA-C-O 121.158 0.504 . . . . 0.0 111.497 -175.351 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 249' ' ' GLN . . . . . 0.542 ' HG2' ' O ' ' B' ' 246' ' ' PHE . 3.1 pt20 -70.3 -0.31 7.85 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.703 -178.352 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 250' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -64.04 -30.13 71.22 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 175.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -85.59 111.62 20.22 Favored 'General case' 0 N--CA 1.429 -1.521 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 176.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 252' ' ' ILE . . . . . . . . . . . . . 34.6 pt -109.77 -24.15 4.15 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 CA-C-N 114.985 -1.007 . . . . 0.0 113.639 -170.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -116.83 -19.89 9.69 Favored 'General case' 0 C--N 1.31 -1.114 0 C-N-CA 120.01 -0.676 . . . . 0.0 112.362 -176.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 254' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.565 1.55 0 C-N-CA 123.766 0.826 . . . . 0.0 111.966 -173.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.506 -0.747 0 CA-C-O 120.725 0.298 . . . . 0.0 110.263 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -109.93 145.65 36.53 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.127 -175.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 27.5 pt -138.21 156.68 30.84 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.453 176.109 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 34.3 t80 -106.67 123.02 47.5 Favored 'General case' 0 N--CA 1.414 -2.228 0 CA-C-N 114.91 -1.041 . . . . 0.0 108.264 177.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.458 HG21 ' CD1' ' A' ' 104' ' ' ILE . 8.7 mt -108.43 127.69 64.6 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.07 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 175.256 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -123.29 160.45 17.81 Favored Glycine 0 C--N 1.283 -2.366 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 -179.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 68.52 48.35 0.84 Allowed 'General case' 0 CA--C 1.491 -1.325 0 C-N-CA 125.112 1.365 . . . . 0.0 111.807 -174.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -72.65 145.46 47.25 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 115.078 -0.965 . . . . 0.0 110.78 175.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -96.89 144.86 26.43 Favored 'General case' 0 C--N 1.286 -2.18 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 179.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.497 ' HD2' ' N ' ' A' ' 41' ' ' GLU . 7.0 ppt_? -58.36 -21.3 49.44 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -176.594 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.497 ' N ' ' HD2' ' A' ' 40' ' ' ARG . 12.2 pt-20 -98.18 5.77 48.16 Favored 'General case' 0 C--N 1.318 -0.773 0 C-N-CA 120.464 -0.495 . . . . 0.0 111.518 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 75.6 mt -95.16 113.62 25.33 Favored 'General case' 0 N--CA 1.435 -1.206 0 CA-C-O 121.579 0.704 . . . . 0.0 109.955 175.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 58.8 p -102.98 174.86 5.68 Favored 'General case' 0 C--N 1.286 -2.159 0 CA-C-N 114.507 -1.224 . . . . 0.0 109.785 -179.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -54.65 -43.33 72.27 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 177.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -59.6 -41.97 97.56 Favored Glycine 0 CA--C 1.529 0.924 0 CA-C-N 115.603 -0.726 . . . . 0.0 113.51 178.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -63.94 -49.05 74.12 Favored 'General case' 0 CA--C 1.506 -0.743 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 46.8 mt -58.86 -44.31 90.31 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.892 -179.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 41.8 mt -59.27 -45.79 90.26 Favored 'General case' 0 CA--C 1.497 -1.093 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.66 -177.005 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 92.0 m -61.05 -45.96 92.64 Favored 'General case' 0 C--N 1.307 -1.278 0 O-C-N 123.379 0.425 . . . . 0.0 112.116 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 99.3 t -66.07 -46.59 87.54 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-O 121.219 0.533 . . . . 0.0 110.8 -179.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -68.74 -20.87 64.4 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 115.57 -0.741 . . . . 0.0 112.185 -178.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.456 ' OG ' ' HB2' ' B' ' 231' ' ' ARG . 73.7 m -71.61 -19.38 62.13 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.771 176.265 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -69.58 -28.97 66.42 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 175.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 54.5 m-85 -95.21 -3.83 46.99 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.698 -174.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 156.49 -155.48 26.37 Favored Glycine 0 N--CA 1.423 -2.174 0 C-N-CA 119.67 -1.252 . . . . 0.0 112.749 177.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 60.8 t -108.07 103.99 52.0 Favored Pre-proline 0 C--N 1.305 -1.334 0 N-CA-C 110.475 -0.194 . . . . 0.0 110.475 -178.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.413 ' HB3' HD22 ' A' ' 77' ' ' LEU . 88.0 Cg_endo -79.43 138.93 14.2 Favored 'Trans proline' 0 N--CA 1.451 -0.979 0 C-N-CA 122.799 2.333 . . . . 0.0 110.775 177.602 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 33.1 m -114.71 -22.84 4.51 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 C-N-CA 119.605 -0.838 . . . . 0.0 112.548 -179.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.471 ' HB3' ' HG2' ' A' ' 78' ' ' LYS . 31.4 t70 -155.75 143.39 19.58 Favored 'General case' 0 CA--C 1.504 -0.8 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 -178.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 14.6 p -146.1 132.48 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.116 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 -179.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 90.3 mt -120.9 128.15 76.03 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 177.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -103.09 127.29 50.41 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 177.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.552 ' OG ' ' HB2' ' A' ' 72' ' ' GLN . 97.6 p -89.27 117.74 28.45 Favored 'General case' 0 N--CA 1.422 -1.867 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 178.549 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 19.4 mtp180 . . . . . 0 N--CA 1.423 -1.788 0 C-N-CA 119.41 -0.916 . . . . 0.0 109.856 179.46 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.552 ' HB2' ' OG ' ' A' ' 63' ' ' SER . 18.8 mm-40 . . . . . 0 N--CA 1.445 -0.684 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 86.44 16.73 61.71 Favored Glycine 0 N--CA 1.423 -2.208 0 CA-C-N 115.09 -0.959 . . . . 0.0 112.946 178.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -145.15 157.7 44.02 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 176.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -151.15 168.79 23.6 Favored 'General case' 0 C--N 1.292 -1.924 0 CA-C-O 120.999 0.428 . . . . 0.0 110.258 177.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -126.06 137.59 53.64 Favored 'General case' 0 C--N 1.292 -1.902 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.834 -177.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.413 HD22 ' HB3' ' A' ' 57' ' ' PRO . 9.9 tt -144.73 140.59 28.65 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 174.432 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.471 ' HG2' ' HB3' ' A' ' 59' ' ' ASP . 20.5 ptmt -124.7 144.8 50.02 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.107 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.402 ' HH ' ' CB ' ' A' ' 88' ' ' ALA . 69.5 m-85 -105.43 164.43 11.87 Favored 'General case' 0 C--N 1.284 -2.266 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.226 -178.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -71.86 -27.17 62.7 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-N 114.794 -1.094 . . . . 0.0 108.654 175.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.627 ' OD1' ' HG2' ' A' ' 83' ' ' ARG . 8.4 t70 -132.45 139.63 48.09 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.49 -179.304 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -69.88 -20.65 63.38 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 -179.087 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.627 ' HG2' ' OD1' ' A' ' 81' ' ' ASP . 22.8 mmm180 -62.62 -34.45 77.05 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 122.2 1.0 . . . . 0.0 109.712 174.486 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 52.7 m -68.96 -37.02 78.58 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 114.865 -1.061 . . . . 0.0 113.559 179.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.476 ' O ' HG21 ' A' ' 89' ' ' VAL . 76.2 p -61.2 -45.0 96.37 Favored 'General case' 0 C--N 1.342 0.276 0 C-N-CA 120.473 -0.491 . . . . 0.0 110.418 -177.125 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 3.1 pt -64.46 -39.06 84.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.562 177.28 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 40.8 mt -58.8 -44.03 90.69 Favored 'General case' 0 N--CA 1.478 0.925 0 O-C-N 123.763 0.664 . . . . 0.0 111.254 178.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.402 ' CB ' ' HH ' ' A' ' 79' ' ' TYR . . . -71.16 -41.12 70.82 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.393 -178.548 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.476 HG21 ' O ' ' A' ' 85' ' ' THR . 68.9 t -57.86 -45.73 87.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -58.5 -44.61 89.48 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 121.814 0.816 . . . . 0.0 111.347 -175.269 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -97.46 -20.31 17.85 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-N 114.744 -1.116 . . . . 0.0 113.296 -168.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 20.8 mt -95.15 -30.96 13.76 Favored 'General case' 0 C--N 1.285 -2.221 0 C-N-CA 119.615 -0.834 . . . . 0.0 110.705 -178.01 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 60.4 t30 -66.44 124.24 22.23 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 87.51 -1.22 85.71 Favored Glycine 0 C--N 1.304 -1.197 0 C-N-CA 121.107 -0.568 . . . . 0.0 113.021 -178.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -90.32 135.83 33.43 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 10.9 mptt -95.6 123.17 39.02 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-O 121.242 0.544 . . . . 0.0 111.397 -176.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 52.0 mt -126.36 141.37 46.08 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 N-CA-C 106.237 -1.764 . . . . 0.0 106.237 174.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 56.8 22.32 40.26 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 114.102 0.401 . . . . 0.0 114.102 178.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 85.52 14.07 69.04 Favored Glycine 0 N--CA 1.439 -1.116 0 C-N-CA 120.784 -0.722 . . . . 0.0 113.579 179.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 12.1 ptp180 -140.25 146.46 38.65 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 117.456 0.628 . . . . 0.0 110.838 177.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -88.58 119.76 29.34 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.731 -175.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 13.2 mt -65.53 138.56 58.14 Favored 'General case' 0 CA--C 1.488 -1.415 0 CA-C-O 121.646 0.736 . . . . 0.0 112.35 179.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 58.0 tptt -114.65 115.85 27.77 Favored 'General case' 0 C--N 1.279 -2.491 0 CA-C-N 114.822 -1.081 . . . . 0.0 108.392 177.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.458 ' CD1' HG21 ' A' ' 35' ' ' ILE . 4.1 mm -118.44 129.9 74.07 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -143.96 151.65 40.03 Favored 'General case' 0 C--N 1.289 -2.063 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 84.1 m-70 -79.67 140.16 37.14 Favored 'General case' 0 C--N 1.298 -1.663 0 C-N-CA 120.124 -0.63 . . . . 0.0 109.779 179.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 13.5 t -149.34 162.98 39.0 Favored 'General case' 0 C--N 1.279 -2.469 0 N-CA-C 106.094 -1.817 . . . . 0.0 106.094 -178.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -109.69 109.42 20.14 Favored 'General case' 0 N--CA 1.424 -1.767 0 N-CA-C 106.065 -1.828 . . . . 0.0 106.065 173.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 58.0 t80 . . . . . 0 C--N 1.289 -2.062 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.843 -177.788 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 4.6 mp . . . . . 0 N--CA 1.439 -0.995 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 227' ' ' MET . . . . . . . . . . . . . 73.0 mtm -77.24 140.13 65.23 Favored Pre-proline 0 C--N 1.318 -0.783 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.983 -178.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 228' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -61.7 144.32 97.16 Favored 'Trans proline' 0 C--O 1.243 0.733 0 C-N-CA 123.31 2.674 . . . . 0.0 113.412 -178.355 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . -68.69 172.11 36.54 Favored Glycine 0 C--O 1.242 0.625 0 CA-C-N 115.082 -0.963 . . . . 0.0 113.854 -178.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 23.0 t -77.02 -13.98 59.89 Favored 'General case' 0 C--N 1.314 -0.978 0 C-N-CA 123.011 0.524 . . . . 0.0 111.46 -176.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 231' ' ' ARG . . . . . 0.456 ' HB2' ' OG ' ' A' ' 52' ' ' SER . 31.7 mmt180 -84.94 -3.85 58.9 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.922 -0.311 . . . . 0.0 110.449 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 232' ' ' TRP . . . . . . . . . . . . . 21.5 t90 -78.96 131.94 36.51 Favored 'General case' 0 N--CA 1.433 -1.314 0 CA-C-O 122.333 1.063 . . . . 0.0 111.966 -178.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 233' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -122.08 137.94 54.63 Favored 'General case' 0 C--N 1.267 -2.982 0 N-CA-C 101.388 -3.56 . . . . 0.0 101.388 168.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.413 0 C-N-CA 128.193 2.806 . . . . 0.0 116.093 179.96 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 240' ' ' GLY . . . . . 0.434 ' O ' ' HG2' ' B' ' 244' ' ' LYS . . . . . . . . 0 C--O 1.202 -1.869 0 N-CA-C 112.113 -0.395 . . . . 0.0 112.113 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 29.7 p90 -76.79 -34.48 57.97 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 112.705 0.632 . . . . 0.0 112.705 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -64.73 -39.16 93.17 Favored 'General case' 0 CA--C 1.504 -0.789 0 C-N-CA 122.899 0.479 . . . . 0.0 110.731 -175.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -63.47 -35.01 79.02 Favored 'General case' 0 C--O 1.197 -1.685 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.372 -179.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 244' ' ' LYS . . . . . 0.434 ' HG2' ' O ' ' B' ' 240' ' ' GLY . 70.1 mmtt -65.8 -41.95 91.31 Favored 'General case' 0 N--CA 1.439 -0.986 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 -178.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 245' ' ' TRP . . . . . . . . . . . . . 44.5 m0 -64.72 -40.81 95.98 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.265 -0.88 . . . . 0.0 109.635 179.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 246' ' ' PHE . . . . . 0.652 ' O ' ' HG2' ' B' ' 249' ' ' GLN . 3.0 t80 -72.01 -31.57 66.33 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.577 177.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -74.4 -38.48 63.09 Favored 'General case' 0 C--N 1.294 -1.819 0 O-C-N 121.671 -0.643 . . . . 0.0 111.246 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.47 -14.01 55.77 Favored 'General case' 0 CA--C 1.508 -0.64 0 CA-C-O 121.118 0.485 . . . . 0.0 111.635 -176.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 249' ' ' GLN . . . . . 0.652 ' HG2' ' O ' ' B' ' 246' ' ' PHE . 3.3 pt20 -77.89 -1.16 30.43 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.578 -178.703 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 250' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -53.15 -39.16 63.34 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.078 -179.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -131.39 108.24 9.48 Favored 'General case' 0 N--CA 1.432 -1.326 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 174.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 252' ' ' ILE . . . . . . . . . . . . . 28.3 pt -86.83 -31.57 6.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 CA-C-N 114.973 -1.012 . . . . 0.0 112.71 -173.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -92.25 -20.25 21.34 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-O 121.416 0.627 . . . . 0.0 111.075 -175.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 254' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.295 -1.763 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.198 -175.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.435 -1.213 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -95.01 145.21 25.1 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 -175.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 26.1 pt -141.01 162.17 22.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-O 121.029 0.442 . . . . 0.0 111.033 175.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 66.5 t80 -109.84 121.78 46.02 Favored 'General case' 0 N--CA 1.415 -2.21 0 CA-C-N 114.702 -1.136 . . . . 0.0 108.436 178.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 9.4 mt -109.15 127.94 65.45 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.963 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 174.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -130.52 168.12 21.79 Favored Glycine 0 C--N 1.29 -2.008 0 N-CA-C 111.305 -0.718 . . . . 0.0 111.305 -178.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 68.25 33.73 4.18 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.663 1.185 . . . . 0.0 110.503 -176.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.402 HD21 ' HA ' ' A' ' 74' ' ' PHE . 4.0 mm? -65.8 151.67 46.1 Favored 'General case' 0 CA--C 1.5 -0.969 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.606 178.083 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 39.2 t-20 -90.85 148.81 22.25 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 176.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.412 HH11 ' HB3' ' A' ' 41' ' ' GLU . 0.6 OUTLIER -64.76 -17.12 63.88 Favored 'General case' 0 C--N 1.297 -1.7 0 C-N-CA 123.765 0.826 . . . . 0.0 113.149 -179.001 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.412 ' HB3' HH11 ' A' ' 40' ' ' ARG . 10.2 pt-20 -92.91 -13.64 28.64 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.555 179.162 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 74.8 mt -78.83 123.25 27.03 Favored 'General case' 0 CA--C 1.504 -0.82 0 CA-C-O 121.564 0.697 . . . . 0.0 111.809 -176.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 10.7 t -114.22 174.15 6.09 Favored 'General case' 0 C--N 1.293 -1.876 0 CA-C-N 114.737 -1.12 . . . . 0.0 108.965 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.405 ' CG ' ' HB2' ' A' ' 62' ' ' LEU . 52.3 mt-10 -55.42 -45.1 76.76 Favored 'General case' 0 C--O 1.214 -0.782 0 C-N-CA 124.016 0.927 . . . . 0.0 110.62 -176.47 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -59.35 -39.0 94.18 Favored Glycine 0 C--O 1.244 0.731 0 CA-C-N 116.117 -0.492 . . . . 0.0 113.466 -178.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -67.64 -48.44 66.71 Favored 'General case' 0 C--O 1.243 0.745 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 -179.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 36.2 mt -58.22 -46.21 88.76 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.318 0 CA-C-N 114.924 -1.035 . . . . 0.0 110.291 178.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 44.6 mt -59.21 -40.26 85.25 Favored 'General case' 0 CA--C 1.492 -1.259 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.397 -178.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 84.3 m -65.16 -46.22 81.72 Favored 'General case' 0 N--CA 1.431 -1.381 0 O-C-N 123.502 0.501 . . . . 0.0 110.977 -178.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 57.6 t -67.53 -48.01 78.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.42 -178.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -64.84 -21.27 66.76 Favored 'General case' 0 N--CA 1.436 -1.17 0 C-N-CA 124.408 1.083 . . . . 0.0 112.545 -179.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.437 ' CB ' ' HB2' ' B' ' 232' ' ' TRP . 51.2 m -71.65 -20.75 61.91 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 176.736 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -74.26 -24.55 59.3 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 118.022 -1.471 . . . . 0.0 109.523 174.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 -89.85 -8.81 51.13 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.221 0.534 . . . . 0.0 111.434 -175.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 158.99 -163.21 33.13 Favored Glycine 0 N--CA 1.425 -2.075 0 N-CA-C 110.981 -0.848 . . . . 0.0 110.981 177.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 60.1 t -101.33 109.37 58.62 Favored Pre-proline 0 C--N 1.297 -1.713 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 -179.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.428 ' HB3' HD22 ' A' ' 77' ' ' LEU . 79.0 Cg_endo -77.53 137.08 16.14 Favored 'Trans proline' 0 N--CA 1.445 -1.375 0 C-N-CA 122.17 1.914 . . . . 0.0 109.701 176.73 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 35.0 m -111.48 -26.54 3.09 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 C-N-CA 119.46 -0.896 . . . . 0.0 111.992 -178.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.412 ' HB3' ' HG2' ' A' ' 78' ' ' LYS . 10.5 t70 -155.06 144.43 21.18 Favored 'General case' 0 C--O 1.247 0.946 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 -179.062 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 14.6 p -146.34 138.17 19.34 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 O-C-N 123.415 0.447 . . . . 0.0 110.103 -178.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 98.4 mt -121.31 126.21 74.69 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 174.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.405 ' HB2' ' CG ' ' A' ' 44' ' ' GLU . 0.1 OUTLIER -98.58 115.77 29.36 Favored 'General case' 0 N--CA 1.425 -1.677 0 N-CA-C 106.222 -1.77 . . . . 0.0 106.222 171.396 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 6.8 m -74.96 117.24 16.59 Favored 'General case' 0 N--CA 1.412 -2.344 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 178.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 66.9 mtm180 . . . . . 0 C--N 1.299 -1.63 0 CA-C-O 121.269 0.557 . . . . 0.0 111.189 -176.181 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 . . . . . 0 CA--C 1.518 -0.275 0 CA-C-O 120.909 0.385 . . . . 0.0 111.668 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 83.44 11.14 80.81 Favored Glycine 0 N--CA 1.435 -1.405 0 C-N-CA 121.126 -0.559 . . . . 0.0 113.336 178.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.402 ' HA ' HD21 ' A' ' 38' ' ' LEU . 38.3 p90 -154.06 159.49 41.57 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 177.13 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -154.12 171.94 18.33 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 123.917 0.761 . . . . 0.0 109.77 178.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -131.12 141.45 50.13 Favored 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 123.61 0.764 . . . . 0.0 109.903 -178.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.428 HD22 ' HB3' ' A' ' 57' ' ' PRO . 10.0 tt -148.86 141.48 24.43 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 176.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.412 ' HG2' ' HB3' ' A' ' 59' ' ' ASP . 21.5 ptmt -124.11 143.98 50.15 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 178.465 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -103.84 165.66 10.9 Favored 'General case' 0 C--N 1.288 -2.071 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.724 -178.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -75.13 -39.43 60.5 Favored 'General case' 0 N--CA 1.425 -1.715 0 CA-C-N 114.956 -1.02 . . . . 0.0 108.381 174.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -116.84 144.14 44.85 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 121.378 0.609 . . . . 0.0 111.364 179.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 21.4 mp0 -69.83 -28.78 65.98 Favored 'General case' 0 C--N 1.311 -1.086 0 C-N-CA 124.063 0.945 . . . . 0.0 113.15 -177.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.1 -33.88 76.77 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 122.142 0.972 . . . . 0.0 110.343 177.092 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 50.5 m -60.88 -37.34 81.84 Favored 'General case' 0 C--N 1.284 -2.258 0 CA-C-N 115.106 -0.952 . . . . 0.0 112.029 176.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.405 ' O ' HG21 ' A' ' 89' ' ' VAL . 59.5 p -63.7 -45.3 90.64 Favored 'General case' 0 C--N 1.347 0.488 0 C-N-CA 120.507 -0.477 . . . . 0.0 110.836 -177.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 4.0 pt -66.13 -38.24 81.54 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.687 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.408 179.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 13.5 mt -59.66 -44.4 93.58 Favored 'General case' 0 CA--C 1.511 -0.547 0 O-C-N 123.284 0.365 . . . . 0.0 111.751 175.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.449 ' O ' ' HB2' ' A' ' 92' ' ' LEU . . . -69.72 -43.98 71.24 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.106 -179.533 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.405 HG21 ' O ' ' A' ' 85' ' ' THR . 85.3 t -60.99 -45.44 98.52 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-O 121.488 0.661 . . . . 0.0 110.98 178.798 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -65.76 -37.3 85.96 Favored 'General case' 0 C--N 1.284 -2.262 0 C-N-CA 124.196 0.998 . . . . 0.0 111.828 -176.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -91.62 -28.09 17.72 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 112.94 0.719 . . . . 0.0 112.94 -176.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.449 ' HB2' ' O ' ' A' ' 88' ' ' ALA . 14.8 mt -97.06 -28.91 13.93 Favored 'General case' 0 CA--C 1.491 -1.305 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -173.117 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -65.56 125.26 24.65 Favored 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 120.03 -0.668 . . . . 0.0 109.465 -178.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 88.53 -8.36 79.26 Favored Glycine 0 C--N 1.31 -0.876 0 CA-C-N 115.643 -0.708 . . . . 0.0 112.501 -178.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -81.17 137.59 35.9 Favored 'General case' 0 CA--C 1.516 -0.332 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 -178.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 11.2 mptt -95.51 122.86 38.69 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-O 120.969 0.414 . . . . 0.0 111.571 -175.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 54.5 mt -127.02 141.37 46.44 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 N-CA-C 105.734 -1.95 . . . . 0.0 105.734 172.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 56.84 26.83 55.23 Favored Glycine 0 CA--C 1.521 0.438 0 O-C-N 123.035 0.209 . . . . 0.0 113.395 -179.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 79.5 8.19 87.93 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 121.296 -0.478 . . . . 0.0 113.786 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 15.8 ptp180 -131.2 142.08 50.14 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 117.87 0.835 . . . . 0.0 110.321 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -82.83 120.31 25.48 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.686 -177.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 11.4 mt -65.78 143.96 57.17 Favored 'General case' 0 C--O 1.249 1.047 0 CA-C-O 121.858 0.837 . . . . 0.0 112.683 179.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 22.7 tptm -116.59 118.7 33.33 Favored 'General case' 0 N--CA 1.418 -2.056 0 CA-C-N 114.771 -1.104 . . . . 0.0 108.548 175.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 4.4 mm -117.63 136.01 56.19 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.185 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 178.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -143.43 152.66 41.81 Favored 'General case' 0 C--N 1.287 -2.151 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -178.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 74.4 m-70 -83.81 131.96 34.86 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 178.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 5.8 t -156.27 161.73 40.2 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 -177.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 41.7 m-85 -109.91 109.21 19.76 Favored 'General case' 0 N--CA 1.42 -1.963 0 C-N-CA 118.351 -1.34 . . . . 0.0 107.466 169.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 25.5 t80 . . . . . 0 C--N 1.277 -2.546 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 -179.915 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 4.0 mp . . . . . 0 C--O 1.246 0.871 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 227' ' ' MET . . . . . . . . . . . . . 26.1 ptt? -69.71 151.03 96.59 Favored Pre-proline 0 C--N 1.318 -0.797 0 O-C-N 123.485 0.491 . . . . 0.0 110.077 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 228' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -71.7 161.2 45.93 Favored 'Trans proline' 0 C--O 1.252 1.176 0 C-N-CA 123.141 2.561 . . . . 0.0 114.327 -175.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . -83.66 173.28 51.01 Favored Glycine 0 N--CA 1.436 -1.326 0 CA-C-N 114.736 -1.12 . . . . 0.0 112.318 177.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 9.6 m -74.35 -14.49 60.89 Favored 'General case' 0 C--N 1.306 -1.288 0 C-N-CA 123.456 0.703 . . . . 0.0 112.369 -174.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 38.9 mmt180 -91.41 -6.22 53.16 Favored 'General case' 0 C--N 1.318 -0.791 0 C-N-CA 120.076 -0.65 . . . . 0.0 111.693 -177.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 232' ' ' TRP . . . . . 0.437 ' HB2' ' CB ' ' A' ' 52' ' ' SER . 21.0 t90 -76.4 121.11 22.57 Favored 'General case' 0 CA--C 1.497 -1.062 0 CA-C-O 122.45 1.119 . . . . 0.0 112.324 -178.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 233' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -118.04 148.68 42.02 Favored 'General case' 0 N--CA 1.407 -2.623 0 N-CA-C 102.541 -3.133 . . . . 0.0 102.541 171.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.208 0 C-N-CA 127.967 2.699 . . . . 0.0 116.418 -176.987 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 240' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.418 -2.547 0 N-CA-C 111.568 -0.613 . . . . 0.0 111.568 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 35.0 p90 -76.96 -33.51 57.66 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-O 121.481 0.657 . . . . 0.0 110.273 174.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -67.23 -39.45 86.21 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.518 -176.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -60.13 -34.35 73.4 Favored 'General case' 0 C--O 1.202 -1.43 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.826 177.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -62.09 -37.81 86.48 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 122.817 0.447 . . . . 0.0 109.96 -179.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 245' ' ' TRP . . . . . 0.511 ' O ' ' HG3' ' B' ' 248' ' ' LYS . 36.8 m0 -69.6 -39.73 77.07 Favored 'General case' 0 C--O 1.242 0.702 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.551 178.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 246' ' ' PHE . . . . . 0.728 ' O ' ' HG2' ' B' ' 249' ' ' GLN . 2.8 t80 -70.2 -33.05 71.23 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 114.879 -1.055 . . . . 0.0 110.812 177.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -73.15 -31.01 64.0 Favored 'General case' 0 C--N 1.285 -2.237 0 O-C-N 121.817 -0.552 . . . . 0.0 110.663 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 248' ' ' LYS . . . . . 0.511 ' HG3' ' O ' ' B' ' 245' ' ' TRP . 2.2 pptp? -87.22 -12.1 47.81 Favored 'General case' 0 C--O 1.221 -0.414 0 CA-C-O 120.86 0.362 . . . . 0.0 111.594 -177.259 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 249' ' ' GLN . . . . . 0.728 ' HG2' ' O ' ' B' ' 246' ' ' PHE . 2.9 pt20 -79.33 2.99 19.54 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.002 -178.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 250' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -56.98 -36.99 70.99 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.267 176.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -116.27 152.92 32.86 Favored 'General case' 0 N--CA 1.411 -2.379 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 175.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 252' ' ' ILE . . . . . . . . . . . . . 28.5 pt -128.79 -28.21 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 -173.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -117.32 -24.7 7.32 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-O 121.061 0.457 . . . . 0.0 109.806 -174.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 254' ' ' GLU . . . . . . . . . . . . . 48.4 mp0 . . . . . 0 N--CA 1.438 -1.032 0 C-N-CA 126.084 1.754 . . . . 0.0 114.622 -172.754 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.24 0.6 0 N-CA-C 112.33 0.492 . . . . 0.0 112.33 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -108.25 145.85 33.71 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-O 121.124 0.488 . . . . 0.0 111.548 -173.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 26.7 pt -138.23 154.99 28.61 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.503 175.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -106.81 122.86 47.22 Favored 'General case' 0 C--N 1.286 -2.158 0 CA-C-N 114.67 -1.15 . . . . 0.0 108.802 176.009 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.521 HG21 ' CD1' ' A' ' 104' ' ' ILE . 11.5 mt -107.97 127.04 64.43 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 N-CA-C 106.182 -1.784 . . . . 0.0 106.182 176.543 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -129.07 167.94 20.96 Favored Glycine 0 C--N 1.28 -2.566 0 N-CA-C 110.357 -1.097 . . . . 0.0 110.357 179.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 75.7 30.32 0.79 Allowed 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.644 1.178 . . . . 0.0 111.179 -179.056 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.431 HD21 ' HA ' ' A' ' 74' ' ' PHE . 4.1 mm? -66.94 154.54 40.83 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.639 -0.71 . . . . 0.0 112.047 178.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 42.8 t-20 -95.03 146.06 24.52 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 106.225 -1.768 . . . . 0.0 106.225 174.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 8.0 ppt_? -60.52 -23.31 64.47 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 122.96 0.504 . . . . 0.0 112.332 178.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -88.61 -9.53 51.86 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.798 -178.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 67.1 mt -80.99 125.96 30.79 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 121.188 0.518 . . . . 0.0 110.874 -177.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 66.9 p -107.31 173.36 6.36 Favored 'General case' 0 C--N 1.293 -1.867 0 CA-C-N 114.885 -1.052 . . . . 0.0 110.063 -178.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.8 mp0 -57.66 -40.54 79.59 Favored 'General case' 0 N--CA 1.433 -1.282 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.449 177.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -59.42 -38.49 93.54 Favored Glycine 0 N--CA 1.445 -0.716 0 O-C-N 123.681 0.613 . . . . 0.0 112.629 179.119 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -67.25 -49.19 65.36 Favored 'General case' 0 CA--C 1.499 -1.002 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 179.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 54.4 mt -59.73 -47.39 91.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.074 -0.966 . . . . 0.0 110.616 179.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 49.4 mt -59.72 -44.55 93.68 Favored 'General case' 0 CA--C 1.49 -1.345 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.468 -177.138 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 62.5 m -61.69 -46.27 90.41 Favored 'General case' 0 C--N 1.31 -1.13 0 O-C-N 123.454 0.471 . . . . 0.0 111.636 -178.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 86.8 t -67.3 -47.59 80.73 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.777 -178.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -65.92 -23.82 66.7 Favored 'General case' 0 N--CA 1.435 -1.177 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.725 -179.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.524 ' OG ' ' HB2' ' B' ' 231' ' ' ARG . 70.0 m -70.69 -18.53 62.82 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 176.255 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -76.06 -28.96 57.82 Favored 'General case' 0 C--O 1.249 1.051 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 176.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 51.7 m-85 -86.23 -23.19 26.52 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.279 -176.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 177.4 -155.89 18.81 Favored Glycine 0 N--CA 1.43 -1.74 0 C-N-CA 120.4 -0.905 . . . . 0.0 112.546 177.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 69.3 t -107.66 108.66 61.84 Favored Pre-proline 0 C--N 1.303 -1.438 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 -179.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -76.24 137.0 18.57 Favored 'Trans proline' 0 N--CA 1.439 -1.686 0 C-N-CA 122.175 1.917 . . . . 0.0 109.905 177.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 35.4 m -113.45 -23.83 4.14 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.864 0 C-N-CA 119.699 -0.8 . . . . 0.0 111.146 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.422 ' HB3' ' HG2' ' A' ' 78' ' ' LYS . 32.7 t70 -158.02 142.87 16.46 Favored 'General case' 0 C--O 1.244 0.812 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 178.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 14.1 p -140.57 135.95 35.41 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.238 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 178.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 78.7 mt -121.3 128.47 75.95 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 176.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -102.02 120.96 41.26 Favored 'General case' 0 C--N 1.29 -1.984 0 N-CA-C 105.742 -1.947 . . . . 0.0 105.742 175.251 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 15.7 m -80.98 117.6 21.74 Favored 'General case' 0 N--CA 1.415 -2.192 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 70.0 mtt85 . . . . . 0 C--N 1.299 -1.603 0 CA-C-O 120.981 0.42 . . . . 0.0 111.298 -178.072 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 . . . . . 0 N--CA 1.446 -0.672 0 CA-C-O 120.949 0.404 . . . . 0.0 111.828 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 90.3 13.01 60.73 Favored Glycine 0 N--CA 1.429 -1.769 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.027 179.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.431 ' HA ' HD21 ' A' ' 38' ' ' LEU . 45.6 p90 -154.08 158.85 41.09 Favored 'General case' 0 N--CA 1.431 -1.396 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 177.745 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -152.14 176.44 11.55 Favored 'General case' 0 N--CA 1.438 -1.043 0 O-C-N 123.568 0.543 . . . . 0.0 110.085 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -136.64 144.71 44.17 Favored 'General case' 0 C--N 1.306 -1.324 0 C-N-CA 123.292 0.637 . . . . 0.0 110.037 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.9 tt -149.28 140.68 23.27 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 176.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.422 ' HG2' ' HB3' ' A' ' 59' ' ' ASP . 22.0 ptmt -122.93 144.57 49.15 Favored 'General case' 0 C--O 1.257 1.486 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -108.96 165.24 11.73 Favored 'General case' 0 C--N 1.29 -2.021 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.34 -177.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -68.4 -38.09 80.95 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 114.703 -1.135 . . . . 0.0 108.786 174.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -126.23 145.9 50.21 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-O 121.324 0.583 . . . . 0.0 111.967 -178.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 20.0 mp0 -67.1 -29.28 68.99 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 124.495 1.118 . . . . 0.0 112.271 -178.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 58.3 mtm180 -61.06 -33.81 73.89 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-O 122.145 0.974 . . . . 0.0 111.692 178.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 51.1 m -64.27 -37.34 87.14 Favored 'General case' 0 C--N 1.28 -2.424 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.541 174.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 52.6 p -63.18 -44.75 94.51 Favored 'General case' 0 C--O 1.22 -0.496 0 C-N-CA 120.424 -0.51 . . . . 0.0 110.432 -178.15 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 5.4 pt -65.86 -39.21 84.05 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 C-N-CA 122.49 0.316 . . . . 0.0 111.459 179.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 18.7 mt -60.21 -43.94 95.54 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 123.662 0.601 . . . . 0.0 110.903 175.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -71.69 -46.47 58.7 Favored 'General case' 0 N--CA 1.435 -1.189 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.757 -178.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 72.4 t -57.03 -48.29 82.06 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.71 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -179.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -63.63 -37.17 86.31 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-O 120.951 0.405 . . . . 0.0 111.437 -175.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -93.02 -21.09 19.95 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 -174.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.418 ' HB2' HG13 ' A' ' 104' ' ' ILE . 20.4 mt -99.3 -28.89 13.1 Favored 'General case' 0 C--N 1.291 -1.976 0 C-N-CA 120.455 -0.498 . . . . 0.0 111.506 -176.361 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -66.28 124.6 23.11 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 177.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 83.18 -0.59 89.65 Favored Glycine 0 C--N 1.304 -1.242 0 C-N-CA 121.099 -0.572 . . . . 0.0 112.608 -179.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 69.4 t80 -85.2 131.66 34.4 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 -178.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -90.62 119.42 30.85 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-O 121.172 0.51 . . . . 0.0 112.241 -176.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 48.5 mt -127.67 141.35 46.64 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 N-CA-C 105.866 -1.902 . . . . 0.0 105.866 172.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 60.34 18.24 49.3 Favored Glycine 0 CA--C 1.526 0.774 0 C-N-CA 121.41 -0.424 . . . . 0.0 113.939 178.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 85.44 11.26 75.43 Favored Glycine 0 N--CA 1.437 -1.266 0 C-N-CA 121.058 -0.592 . . . . 0.0 112.721 -179.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 16.1 ptp180 -135.5 145.3 46.96 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 117.115 0.458 . . . . 0.0 110.913 179.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -87.49 120.58 28.94 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.067 -177.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 12.4 mt -67.33 148.92 51.03 Favored 'General case' 0 C--N 1.31 -1.118 0 C-N-CA 123.789 0.836 . . . . 0.0 112.822 178.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 17.3 tppt? -124.6 118.75 27.23 Favored 'General case' 0 N--CA 1.422 -1.84 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.191 176.231 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.521 ' CD1' HG21 ' A' ' 35' ' ' ILE . 5.1 mm -119.96 136.38 57.25 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 179.372 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -142.09 146.47 35.45 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 81.1 m-70 -79.34 132.71 36.52 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 4.7 t -162.41 163.73 27.58 Favored 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 -175.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -99.34 112.94 25.02 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 174.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 35.5 t80 . . . . . 0 C--N 1.297 -1.696 0 CA-C-N 115.945 -0.571 . . . . 0.0 109.667 179.785 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 4.2 mp . . . . . 0 N--CA 1.434 -1.229 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 227' ' ' MET . . . . . . . . . . . . . 27.8 ptm -89.11 149.31 42.87 Favored Pre-proline 0 C--N 1.307 -1.251 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 177.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 228' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -63.62 151.04 86.92 Favored 'Trans proline' 0 C--O 1.244 0.806 0 C-N-CA 123.443 2.762 . . . . 0.0 113.564 -177.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . -77.79 174.92 54.68 Favored Glycine 0 C--O 1.246 0.869 0 CA-C-N 115.432 -0.804 . . . . 0.0 112.546 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 17.6 m -76.3 -17.06 59.62 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -176.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 231' ' ' ARG . . . . . 0.524 ' HB2' ' OG ' ' A' ' 52' ' ' SER . 9.8 mmm180 -79.82 -8.27 59.18 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 120.794 0.33 . . . . 0.0 111.324 179.63 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 232' ' ' TRP . . . . . . . . . . . . . 24.5 t90 -72.02 128.62 36.29 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-O 122.125 0.964 . . . . 0.0 111.383 179.078 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 233' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -123.33 140.2 53.25 Favored 'General case' 0 C--N 1.265 -3.106 0 N-CA-C 101.586 -3.487 . . . . 0.0 101.586 173.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.501 3.024 0 C-N-CA 128.622 3.011 . . . . 0.0 116.72 -179.447 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 240' ' ' GLY . . . . . 0.457 ' O ' ' HG2' ' B' ' 244' ' ' LYS . . . . . . . . 0 N--CA 1.416 -2.664 0 N-CA-C 110.489 -1.045 . . . . 0.0 110.489 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 49.7 p90 -75.95 -35.94 59.51 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -178.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -66.35 -38.74 88.3 Favored 'General case' 0 CA--C 1.5 -0.979 0 CA-C-N 116.727 -0.215 . . . . 0.0 111.04 -176.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -60.51 -35.16 75.28 Favored 'General case' 0 C--O 1.202 -1.396 0 O-C-N 123.597 0.561 . . . . 0.0 110.483 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 244' ' ' LYS . . . . . 0.457 ' HG2' ' O ' ' B' ' 240' ' ' GLY . 70.4 mmtt -67.14 -41.82 85.44 Favored 'General case' 0 CA--C 1.509 -0.628 0 CA-C-O 121.662 0.744 . . . . 0.0 109.137 -178.091 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 245' ' ' TRP . . . . . . . . . . . . . 45.3 m0 -68.93 -41.07 78.61 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 114.853 -1.067 . . . . 0.0 109.58 179.107 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 246' ' ' PHE . . . . . 0.529 ' O ' ' HG2' ' B' ' 249' ' ' GLN . 5.2 t80 -65.86 -37.86 87.3 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.777 179.155 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -68.02 -33.33 74.4 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.556 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.9 -21.05 21.58 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 120.669 -0.413 . . . . 0.0 111.946 -177.607 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 249' ' ' GLN . . . . . 0.529 ' HG2' ' O ' ' B' ' 246' ' ' PHE . 3.0 pt20 -75.42 2.29 11.79 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.092 0.472 . . . . 0.0 111.287 -178.056 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 250' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -56.91 -38.57 73.03 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.319 178.077 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -139.57 113.55 8.76 Favored 'General case' 0 N--CA 1.439 -0.987 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 175.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 252' ' ' ILE . . . . . . . . . . . . . 27.8 pt -102.54 -37.48 4.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 -172.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -108.87 -18.07 13.78 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-O 121.846 0.832 . . . . 0.0 110.048 -175.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 254' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 . . . . . 0 C--N 1.29 -2.018 0 CA-C-N 114.205 -1.361 . . . . 0.0 112.054 -176.476 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.459 ' HB3' ' NE2' ' A' ' 82' ' ' GLN . . . . . . . . 0 N--CA 1.435 -1.181 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -103.68 144.65 31.17 Favored 'General case' 0 N--CA 1.429 -1.518 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.831 -174.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 25.1 pt -141.37 157.05 21.7 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.742 0 CA-C-N 115.476 -0.783 . . . . 0.0 109.462 178.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 16.5 t80 -108.81 123.04 48.42 Favored 'General case' 0 N--CA 1.411 -2.378 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 176.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.495 HG21 ' CD1' ' A' ' 104' ' ' ILE . 12.0 mt -107.83 126.97 64.26 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.931 0 N-CA-C 105.792 -1.929 . . . . 0.0 105.792 176.518 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -129.01 165.4 21.8 Favored Glycine 0 N--CA 1.418 -2.556 0 N-CA-C 112.041 -0.424 . . . . 0.0 112.041 -177.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 8.3 t30 63.57 51.97 2.39 Favored 'General case' 0 C--N 1.314 -0.951 0 C-N-CA 125.146 1.378 . . . . 0.0 109.876 -177.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.4 HD21 ' HA ' ' A' ' 74' ' ' PHE . 3.1 mm? -78.37 161.2 27.34 Favored 'General case' 0 CA--C 1.502 -0.884 0 CA-C-N 113.99 -1.459 . . . . 0.0 111.482 178.499 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.458 ' CG ' ' HG2' ' A' ' 41' ' ' GLU . 49.8 t-20 -98.12 145.5 26.51 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 174.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.558 ' HD2' ' N ' ' A' ' 41' ' ' GLU . 7.4 ppt_? -58.79 -27.13 64.73 Favored 'General case' 0 C--N 1.31 -1.137 0 C-N-CA 123.543 0.737 . . . . 0.0 111.924 179.592 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.558 ' N ' ' HD2' ' A' ' 40' ' ' ARG . 11.4 pt-20 -85.59 -11.82 53.04 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.543 -176.366 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.439 ' HG ' ' HB3' ' A' ' 39' ' ' ASN . 79.0 mt -84.21 118.73 24.34 Favored 'General case' 0 CA--C 1.492 -1.279 0 CA-C-O 121.474 0.654 . . . . 0.0 111.09 -176.695 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 46.6 p -107.82 173.92 6.11 Favored 'General case' 0 N--CA 1.414 -2.273 0 CA-C-N 114.417 -1.265 . . . . 0.0 109.445 -178.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.437 ' HG3' ' HB2' ' A' ' 62' ' ' LEU . 1.7 mp0 -54.92 -41.37 70.93 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 123.871 0.868 . . . . 0.0 109.759 178.757 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.17 -43.28 98.56 Favored Glycine 0 N--CA 1.439 -1.126 0 CA-C-N 115.545 -0.752 . . . . 0.0 112.894 -179.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -68.1 -45.29 74.13 Favored 'General case' 0 CA--C 1.513 -0.444 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 -179.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 37.9 mt -58.55 -44.12 88.61 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.488 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.707 178.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 43.8 mt -59.37 -44.7 92.68 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 89.4 m -61.66 -46.26 90.48 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 120.804 0.335 . . . . 0.0 111.619 178.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 84.6 t -63.18 -49.47 83.09 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.379 179.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -69.43 -23.08 63.63 Favored 'General case' 0 N--CA 1.433 -1.318 0 C-N-CA 123.583 0.753 . . . . 0.0 112.868 -177.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.462 ' OG ' ' HB2' ' B' ' 231' ' ' ARG . 72.6 m -68.57 -20.1 64.51 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 111.917 0.34 . . . . 0.0 111.917 176.655 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -63.47 -28.0 69.66 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-O 122.029 0.919 . . . . 0.0 109.007 173.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 50.9 m-85 -96.3 -2.87 45.0 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.262 -174.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 148.21 -152.96 24.96 Favored Glycine 0 N--CA 1.42 -2.432 0 C-N-CA 119.975 -1.107 . . . . 0.0 112.015 178.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 61.8 t -107.52 111.01 63.06 Favored Pre-proline 0 C--N 1.296 -1.742 0 CA-C-O 120.717 0.294 . . . . 0.0 110.948 -177.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.442 ' HB3' HD22 ' A' ' 77' ' ' LEU . 58.7 Cg_endo -74.74 145.49 32.6 Favored 'Trans proline' 0 N--CA 1.45 -1.081 0 C-N-CA 122.719 2.279 . . . . 0.0 110.041 174.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.403 ' CG2' ' HG3' ' A' ' 78' ' ' LYS . 34.4 m -116.45 -24.97 3.3 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 C-N-CA 119.674 -0.81 . . . . 0.0 111.463 177.5 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -158.36 147.57 19.26 Favored 'General case' 0 C--O 1.249 1.07 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 12.5 p -145.78 132.47 14.53 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-O 121.002 0.429 . . . . 0.0 110.432 -179.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 84.2 mt -120.62 126.85 75.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 177.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.437 ' HB2' ' HG3' ' A' ' 44' ' ' GLU . 0.2 OUTLIER -100.3 122.73 43.54 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 105.753 -1.944 . . . . 0.0 105.753 175.533 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 15.4 m -82.13 116.8 21.86 Favored 'General case' 0 N--CA 1.406 -2.648 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 178.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 84.3 mtt180 . . . . . 0 C--N 1.303 -1.418 0 CA-C-O 121.43 0.634 . . . . 0.0 110.82 -175.543 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 . . . . . 0 N--CA 1.435 -1.194 0 CA-C-O 121.433 0.635 . . . . 0.0 110.111 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 100.19 17.65 24.19 Favored Glycine 0 N--CA 1.429 -1.781 0 CA-C-N 115.475 -0.784 . . . . 0.0 112.536 178.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.4 ' HA ' HD21 ' A' ' 38' ' ' LEU . 36.4 p90 -160.86 156.83 25.63 Favored 'General case' 0 C--O 1.244 0.801 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 177.38 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -152.81 175.98 12.29 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-O 120.789 0.328 . . . . 0.0 110.995 179.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -134.88 143.18 46.82 Favored 'General case' 0 C--N 1.317 -0.813 0 C-N-CA 123.989 0.915 . . . . 0.0 110.425 -177.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.442 HD22 ' HB3' ' A' ' 57' ' ' PRO . 10.0 tt -150.07 140.59 22.48 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 175.571 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.403 ' HG3' ' CG2' ' A' ' 58' ' ' VAL . 20.8 ptmt -122.56 144.18 49.26 Favored 'General case' 0 C--O 1.255 1.394 0 CA-C-O 121.02 0.438 . . . . 0.0 109.951 179.61 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -108.9 164.58 12.27 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.539 -178.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -74.59 -25.64 59.39 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 114.822 -1.081 . . . . 0.0 109.736 175.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -127.77 136.76 51.93 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.073 -175.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.459 ' NE2' ' HB3' ' A' ' 31' ' ' ALA . 22.5 mp0 -69.74 -19.9 63.53 Favored 'General case' 0 C--N 1.313 -1.022 0 N-CA-C 113.191 0.811 . . . . 0.0 113.191 177.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 90.9 mtm180 -68.24 -34.64 76.6 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-O 122.261 1.029 . . . . 0.0 109.592 174.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 67.2 m -65.21 -37.37 87.08 Favored 'General case' 0 C--N 1.286 -2.173 0 CA-C-N 114.702 -1.135 . . . . 0.0 112.226 178.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.441 ' O ' HG21 ' A' ' 89' ' ' VAL . 77.3 p -64.93 -45.62 85.05 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 120.438 -0.505 . . . . 0.0 110.577 -178.455 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 6.7 pt -64.8 -38.63 83.2 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.093 177.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 13.2 mt -58.87 -43.6 90.92 Favored 'General case' 0 C--O 1.242 0.696 0 O-C-N 123.296 0.372 . . . . 0.0 111.006 176.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.406 ' O ' ' HB2' ' A' ' 92' ' ' LEU . . . -70.84 -46.75 62.16 Favored 'General case' 0 N--CA 1.435 -1.204 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.208 -178.626 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.441 HG21 ' O ' ' A' ' 85' ' ' THR . 78.2 t -56.73 -47.05 83.2 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.581 0 CA-C-O 121.446 0.641 . . . . 0.0 110.739 179.229 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -59.02 -39.16 81.06 Favored 'General case' 0 C--N 1.295 -1.78 0 C-N-CA 125.221 1.408 . . . . 0.0 112.518 -176.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 48.9 m-80 -98.49 -22.5 15.98 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 113.798 1.036 . . . . 0.0 113.798 -175.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.416 ' HB2' HG13 ' A' ' 104' ' ' ILE . 18.6 mt -94.92 -30.05 14.35 Favored 'General case' 0 C--N 1.293 -1.889 0 C-N-CA 120.685 -0.406 . . . . 0.0 111.435 -174.284 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 50.2 t-20 -65.64 124.25 21.87 Favored 'General case' 0 N--CA 1.434 -1.265 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 176.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 84.38 -0.33 89.32 Favored Glycine 0 C--N 1.3 -1.468 0 C-N-CA 119.888 -1.148 . . . . 0.0 113.1 -179.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -92.24 136.8 32.9 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -95.57 120.06 35.17 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-O 121.061 0.458 . . . . 0.0 112.069 -176.127 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 55.3 mt -126.89 141.69 45.49 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 N-CA-C 106.565 -1.643 . . . . 0.0 106.565 174.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 60.08 19.79 52.18 Favored Glycine 0 CA--C 1.527 0.836 0 O-C-N 122.929 0.143 . . . . 0.0 113.275 -179.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 85.89 12.14 72.13 Favored Glycine 0 N--CA 1.438 -1.184 0 C-N-CA 121.497 -0.383 . . . . 0.0 113.07 -179.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.432 ' NH1' ' HA ' ' A' ' 39' ' ' ASN . 17.4 ptp180 -137.87 149.69 46.49 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 117.861 0.831 . . . . 0.0 110.719 178.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -83.7 126.18 32.63 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-O 120.64 0.257 . . . . 0.0 110.84 -178.136 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.406 HD22 ' HA ' ' A' ' 102' ' ' LEU . 12.1 mt -76.24 143.75 40.79 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-O 121.705 0.764 . . . . 0.0 112.629 178.024 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 5.3 tppp? -115.73 119.4 35.92 Favored 'General case' 0 N--CA 1.416 -2.146 0 CA-C-N 114.875 -1.057 . . . . 0.0 109.159 176.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.495 ' CD1' HG21 ' A' ' 35' ' ' ILE . 5.0 mm -121.42 135.99 59.8 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 178.777 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -144.05 150.46 38.23 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 177.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -75.17 144.13 42.88 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 177.213 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 12.3 t -163.21 165.98 23.78 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 106.7 -1.593 . . . . 0.0 106.7 -178.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -109.9 110.91 22.03 Favored 'General case' 0 N--CA 1.428 -1.536 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 171.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 16.5 t80 . . . . . 0 C--N 1.288 -2.074 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 -178.884 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 4.4 mp . . . . . 0 N--CA 1.442 -0.853 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 227' ' ' MET . . . . . . . . . . . . . 26.7 ptt? -67.67 147.93 98.61 Favored Pre-proline 0 C--N 1.321 -0.657 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.061 179.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 228' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -78.56 150.65 24.89 Favored 'Trans proline' 0 C--O 1.253 1.23 0 C-N-CA 123.057 2.505 . . . . 0.0 112.393 -179.38 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . -73.04 167.04 54.37 Favored Glycine 0 C--N 1.315 -0.603 0 CA-C-N 116.003 -0.544 . . . . 0.0 112.52 178.137 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 21.6 t -70.5 -13.89 62.3 Favored 'General case' 0 C--N 1.317 -0.825 0 C-N-CA 123.228 0.611 . . . . 0.0 111.332 -177.183 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 231' ' ' ARG . . . . . 0.462 ' HB2' ' OG ' ' A' ' 52' ' ' SER . 31.5 mmt180 -78.94 -9.02 59.38 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.658 -0.246 . . . . 0.0 111.041 179.628 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 232' ' ' TRP . . . . . . . . . . . . . 19.2 t90 -77.34 129.47 35.88 Favored 'General case' 0 N--CA 1.427 -1.603 0 CA-C-O 122.29 1.043 . . . . 0.0 111.319 -179.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 233' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -123.35 136.15 54.52 Favored 'General case' 0 C--N 1.265 -3.093 0 N-CA-C 100.926 -3.731 . . . . 0.0 100.926 175.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 2.778 0 C-N-CA 128.4 2.905 . . . . 0.0 116.87 -177.222 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 240' ' ' GLY . . . . . 0.502 ' O ' ' HE2' ' B' ' 244' ' ' LYS . . . . . . . . 0 C--O 1.19 -2.644 0 N-CA-C 112.622 -0.191 . . . . 0.0 112.622 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 26.2 p90 -76.51 -33.82 58.6 Favored 'General case' 0 C--N 1.29 -2.001 0 CA-C-N 117.531 0.665 . . . . 0.0 111.094 178.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -66.79 -38.84 87.31 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.722 -178.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -62.15 -35.2 78.06 Favored 'General case' 0 C--O 1.21 -0.989 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.83 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 244' ' ' LYS . . . . . 0.502 ' HE2' ' O ' ' B' ' 240' ' ' GLY . 68.9 mmtt -65.61 -44.04 87.77 Favored 'General case' 0 CA--C 1.502 -0.884 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 -177.128 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 245' ' ' TRP . . . . . 0.459 ' O ' ' HB3' ' B' ' 249' ' ' GLN . 39.6 m0 -61.82 -43.23 99.27 Favored 'General case' 0 C--O 1.208 -1.107 0 CA-C-N 115.075 -0.966 . . . . 0.0 109.315 178.566 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 246' ' ' PHE . . . . . 0.562 ' HA ' ' NE2' ' B' ' 249' ' ' GLN . 4.5 t80 -66.94 -32.44 73.69 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.405 179.037 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -77.41 -39.88 45.51 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.301 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.23 -12.78 36.98 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 -175.686 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 249' ' ' GLN . . . . . 0.562 ' NE2' ' HA ' ' B' ' 246' ' ' PHE . 3.2 pt20 -66.27 -8.51 25.27 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 120.946 0.403 . . . . 0.0 111.038 -178.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 250' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -68.04 -28.58 67.51 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 177.074 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 251' ' ' GLU . . . . . 0.423 ' HB3' ' HB2' ' B' ' 254' ' ' GLU . 42.7 mt-10 -86.19 114.52 23.09 Favored 'General case' 0 N--CA 1.421 -1.905 0 CA-C-N 114.145 -1.388 . . . . 0.0 107.552 177.403 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 252' ' ' ILE . . . . . . . . . . . . . 41.2 pt -118.5 -25.92 2.72 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -174.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -105.61 -15.65 14.92 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 -177.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 254' ' ' GLU . . . . . 0.423 ' HB2' ' HB3' ' B' ' 251' ' ' GLU . 11.7 mp0 . . . . . 0 C--N 1.303 -1.42 0 C-N-CA 125.585 1.554 . . . . 0.0 114.722 -177.065 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.741 0 N-CA-C 111.711 0.263 . . . . 0.0 111.711 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 13.2 m-30 -93.85 144.83 25.08 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 120.196 -0.602 . . . . 0.0 110.359 -176.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 23.6 pt -142.64 161.01 18.8 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.096 175.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 65.2 t80 -111.52 123.28 49.9 Favored 'General case' 0 N--CA 1.413 -2.305 0 CA-C-N 114.742 -1.117 . . . . 0.0 108.049 178.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 13.1 mt -108.39 127.26 64.88 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.047 0 N-CA-C 105.975 -1.861 . . . . 0.0 105.975 175.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -124.44 156.36 18.5 Favored Glycine 0 N--CA 1.42 -2.374 0 N-CA-C 111.802 -0.519 . . . . 0.0 111.802 -177.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 64.3 t30 67.07 57.57 0.6 Allowed 'General case' 0 C--N 1.314 -0.946 0 C-N-CA 125.4 1.48 . . . . 0.0 110.682 -177.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -82.96 143.91 30.35 Favored 'General case' 0 CA--C 1.485 -1.553 0 CA-C-N 114.426 -1.261 . . . . 0.0 110.002 176.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 38.4 t-20 -79.32 144.92 33.78 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 176.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.57 ' HD2' ' N ' ' A' ' 41' ' ' GLU . 0.8 OUTLIER -59.4 -24.69 63.66 Favored 'General case' 0 C--N 1.302 -1.458 0 C-N-CA 123.471 0.709 . . . . 0.0 112.23 179.528 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.57 ' N ' ' HD2' ' A' ' 40' ' ' ARG . 11.4 pt-20 -89.0 -14.32 36.82 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.609 -177.386 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 54.0 mt -75.51 132.09 40.53 Favored 'General case' 0 CA--C 1.5 -0.974 0 CA-C-O 121.548 0.69 . . . . 0.0 111.781 -176.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 42.0 p -114.81 172.7 6.88 Favored 'General case' 0 N--CA 1.418 -2.03 0 CA-C-N 114.725 -1.125 . . . . 0.0 111.046 -177.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -56.19 -42.46 77.17 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 123.707 0.803 . . . . 0.0 110.503 179.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -59.99 -38.27 93.96 Favored Glycine 0 C--O 1.24 0.484 0 CA-C-N 115.497 -0.774 . . . . 0.0 112.541 -179.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 49.9 m-20 -67.19 -49.61 63.99 Favored 'General case' 0 CA--C 1.494 -1.198 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 47.0 mt -58.87 -46.35 91.21 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 CA-C-N 115.131 -0.94 . . . . 0.0 110.706 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 40.9 mt -59.81 -43.7 94.35 Favored 'General case' 0 CA--C 1.499 -1.017 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.605 -178.224 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 85.6 m -63.36 -46.43 86.58 Favored 'General case' 0 C--N 1.313 -1.016 0 O-C-N 123.408 0.443 . . . . 0.0 111.165 -178.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 97.2 t -66.22 -49.77 73.51 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.368 -178.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -64.99 -19.89 66.22 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 123.974 0.909 . . . . 0.0 112.767 -178.132 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.51 ' OG ' ' HB2' ' B' ' 231' ' ' ARG . 60.2 m -72.97 -23.59 60.68 Favored 'General case' 0 N--CA 1.439 -0.989 0 N-CA-C 112.319 0.489 . . . . 0.0 112.319 176.657 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 50.2 tt0 -67.83 -20.52 65.17 Favored 'General case' 0 CA--C 1.56 1.349 0 CA-C-O 121.726 0.775 . . . . 0.0 110.115 177.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.462 ' OH ' ' HG ' ' A' ' 92' ' ' LEU . 41.3 m-85 -97.02 -10.2 26.62 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.608 -178.41 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 156.5 -159.12 29.25 Favored Glycine 0 N--CA 1.43 -1.747 0 C-N-CA 119.951 -1.118 . . . . 0.0 112.29 -179.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 77.5 t -103.58 110.17 63.34 Favored Pre-proline 0 C--N 1.306 -1.318 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 -176.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.443 ' HB3' HD22 ' A' ' 77' ' ' LEU . 99.0 Cg_endo -80.01 137.12 12.12 Favored 'Trans proline' 0 C--O 1.247 0.954 0 C-N-CA 123.034 2.489 . . . . 0.0 110.914 176.203 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 28.4 m -113.49 -20.06 6.4 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 -178.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.449 ' HB3' ' HG2' ' A' ' 78' ' ' LYS . 37.8 t70 -159.88 145.34 15.42 Favored 'General case' 0 C--O 1.249 1.038 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 14.3 p -144.68 134.43 19.17 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 86.1 mt -120.47 118.14 55.64 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.774 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 176.239 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -92.13 116.48 28.98 Favored 'General case' 0 C--N 1.28 -2.441 0 N-CA-C 104.677 -2.342 . . . . 0.0 104.677 175.728 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 33.6 m -79.77 115.93 19.65 Favored 'General case' 0 N--CA 1.414 -2.239 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 179.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 72.0 mtp180 . . . . . 0 CA--C 1.483 -1.617 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 -176.419 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 . . . . . 0 N--CA 1.432 -1.343 0 CA-C-O 121.556 0.693 . . . . 0.0 111.338 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 107.28 15.88 14.75 Favored Glycine 0 N--CA 1.427 -1.913 0 CA-C-N 115.386 -0.824 . . . . 0.0 112.472 -179.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 30.0 p90 -157.41 159.12 37.04 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 177.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -151.63 172.5 15.97 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-O 120.863 0.363 . . . . 0.0 110.582 179.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -130.75 142.66 50.42 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 123.762 0.825 . . . . 0.0 109.539 -179.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.443 HD22 ' HB3' ' A' ' 57' ' ' PRO . 10.2 tt -148.11 140.96 24.72 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 176.167 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.449 ' HG2' ' HB3' ' A' ' 59' ' ' ASP . 21.9 ptmt -123.82 144.3 49.81 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-O 121.356 0.598 . . . . 0.0 109.673 178.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -104.77 165.68 10.9 Favored 'General case' 0 C--N 1.282 -2.331 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.833 -178.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -77.31 -30.65 54.21 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 115.384 -0.825 . . . . 0.0 108.967 174.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.439 ' OD1' ' HB2' ' A' ' 83' ' ' ARG . 12.5 t70 -119.91 137.56 53.96 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 -176.437 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 26.0 mp0 -69.49 -25.71 64.19 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 113.377 0.88 . . . . 0.0 113.377 -177.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.439 ' HB2' ' OD1' ' A' ' 81' ' ' ASP . 0.1 OUTLIER -67.35 -33.34 75.03 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-O 122.014 0.911 . . . . 0.0 110.291 -179.342 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.45 ' OG ' HG22 ' B' ' 226' ' ' ILE . 51.5 m -59.39 -36.99 76.84 Favored 'General case' 0 C--N 1.281 -2.372 0 CA-C-N 115.307 -0.861 . . . . 0.0 111.657 175.295 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.405 ' O ' HG21 ' A' ' 89' ' ' VAL . 50.3 p -62.58 -45.3 93.55 Favored 'General case' 0 C--O 1.213 -0.823 0 C-N-CA 120.524 -0.47 . . . . 0.0 110.818 -178.17 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 3.3 pt -66.34 -38.72 82.43 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.479 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.498 179.147 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 38.4 mt -59.63 -44.1 93.6 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.236 175.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.508 ' O ' ' HB2' ' A' ' 92' ' ' LEU . . . -72.08 -47.13 53.66 Favored 'General case' 0 N--CA 1.437 -1.112 0 CA-C-N 115.992 -0.549 . . . . 0.0 112.313 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.405 HG21 ' O ' ' A' ' 85' ' ' THR . 77.0 t -57.49 -49.12 81.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 -177.547 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -67.71 -38.94 84.3 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.783 -173.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -92.91 -20.27 20.82 Favored 'General case' 0 C--N 1.297 -1.701 0 CA-C-N 115.864 -0.607 . . . . 0.0 112.378 -172.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.508 ' HB2' ' O ' ' A' ' 88' ' ' ALA . 6.6 mt -93.19 -30.29 15.29 Favored 'General case' 0 C--N 1.315 -0.919 0 O-C-N 122.346 -0.221 . . . . 0.0 111.568 178.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 31.9 t-20 -59.25 124.2 19.22 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 179.043 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 88.86 -1.21 83.2 Favored Glycine 0 N--CA 1.442 -0.947 0 C-N-CA 121.064 -0.589 . . . . 0.0 113.417 177.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 67.3 t80 -86.51 141.75 28.85 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 117.579 0.69 . . . . 0.0 110.096 -179.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.415 ' HD2' ' N ' ' A' ' 96' ' ' LYS . 0.2 OUTLIER -98.05 116.15 29.69 Favored 'General case' 0 C--O 1.248 0.997 0 CA-C-O 121.153 0.502 . . . . 0.0 112.11 -177.137 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 58.1 mt -124.12 141.53 43.98 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 174.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 60.37 18.38 49.98 Favored Glycine 0 CA--C 1.521 0.438 0 N-CA-C 113.76 0.264 . . . . 0.0 113.76 179.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 83.88 14.31 72.91 Favored Glycine 0 N--CA 1.438 -1.223 0 C-N-CA 120.786 -0.721 . . . . 0.0 113.017 -178.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 17.5 ptp180 -136.78 150.12 48.18 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 117.696 0.748 . . . . 0.0 110.081 177.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -87.87 121.89 30.84 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 120.592 0.234 . . . . 0.0 111.368 -178.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 11.4 mt -73.02 145.63 46.51 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-O 121.675 0.75 . . . . 0.0 112.769 179.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 17.4 tptm -121.33 122.17 39.26 Favored 'General case' 0 N--CA 1.413 -2.303 0 CA-C-N 115.017 -0.992 . . . . 0.0 108.783 174.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 5.1 mm -116.17 135.09 57.47 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.018 0 N-CA-C 105.358 -2.09 . . . . 0.0 105.358 176.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -141.51 151.94 43.72 Favored 'General case' 0 C--N 1.285 -2.218 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 -176.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 75.2 m-70 -83.86 138.24 33.29 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 9.8 t -157.79 168.5 27.03 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 -178.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -110.16 113.04 25.41 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 106.317 -1.735 . . . . 0.0 106.317 169.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 56.8 t80 . . . . . 0 C--N 1.287 -2.12 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.703 -175.188 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 226' ' ' ILE . . . . . 0.45 HG22 ' OG ' ' A' ' 84' ' ' SER . 4.5 mp . . . . . 0 C--O 1.243 0.723 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 227' ' ' MET . . . . . . . . . . . . . 22.4 ptp -71.39 144.84 89.76 Favored Pre-proline 0 C--N 1.31 -1.115 0 O-C-N 123.608 0.568 . . . . 0.0 110.098 -178.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 228' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -68.56 147.59 70.77 Favored 'Trans proline' 0 C--N 1.317 -1.087 0 C-N-CA 123.284 2.656 . . . . 0.0 112.25 178.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . -68.46 167.64 43.79 Favored Glycine 0 N--CA 1.443 -0.839 0 CA-C-N 115.663 -0.699 . . . . 0.0 113.073 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 40.9 m -74.85 -12.92 60.49 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -176.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 231' ' ' ARG . . . . . 0.51 ' HB2' ' OG ' ' A' ' 52' ' ' SER . 27.8 mmt180 -78.93 -11.74 60.01 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 178.136 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 232' ' ' TRP . . . . . . . . . . . . . 23.1 t90 -71.15 121.68 18.76 Favored 'General case' 0 N--CA 1.435 -1.198 0 CA-C-O 122.108 0.956 . . . . 0.0 112.184 -177.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 233' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -114.94 144.62 43.28 Favored 'General case' 0 C--N 1.273 -2.742 0 N-CA-C 101.791 -3.411 . . . . 0.0 101.791 171.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.506 3.333 0 C-N-CA 128.295 2.855 . . . . 0.0 116.973 -176.146 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 240' ' ' GLY . . . . . 0.423 ' O ' ' HG2' ' B' ' 244' ' ' LYS . . . . . . . . 0 N--CA 1.417 -2.581 0 N-CA-C 110.77 -0.932 . . . . 0.0 110.77 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 14.6 p90 -76.97 -34.35 57.57 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-O 121.015 0.436 . . . . 0.0 111.403 177.046 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -61.27 -42.39 98.56 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 123.761 0.824 . . . . 0.0 109.972 -177.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -64.26 -34.34 77.89 Favored 'General case' 0 C--O 1.198 -1.65 0 CA-C-N 115.459 -0.791 . . . . 0.0 112.218 -179.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 244' ' ' LYS . . . . . 0.423 ' HG2' ' O ' ' B' ' 240' ' ' GLY . 74.2 mmtt -62.42 -42.87 99.76 Favored 'General case' 0 C--N 1.316 -0.879 0 C-N-CA 122.788 0.435 . . . . 0.0 111.625 -175.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 245' ' ' TRP . . . . . . . . . . . . . 6.9 m0 -69.86 -37.5 76.13 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 121.734 0.778 . . . . 0.0 109.17 178.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 246' ' ' PHE . . . . . 0.537 ' O ' ' HG2' ' B' ' 249' ' ' GLN . 5.1 t80 -65.23 -40.71 94.42 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 114.909 -1.042 . . . . 0.0 110.31 177.545 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -67.06 -22.11 65.87 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 115.781 -0.645 . . . . 0.0 112.142 -179.03 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -100.68 -25.7 14.06 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 120.156 -0.618 . . . . 0.0 112.381 178.723 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 249' ' ' GLN . . . . . 0.537 ' HG2' ' O ' ' B' ' 246' ' ' PHE . 3.2 pt20 -69.77 -11.98 61.27 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-O 121.126 0.488 . . . . 0.0 110.504 -177.26 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 250' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -58.67 -23.06 58.62 Favored 'General case' 0 N--CA 1.482 1.142 0 CA-C-N 114.692 -1.14 . . . . 0.0 111.832 179.415 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -121.22 130.39 53.67 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 178.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 252' ' ' ILE . . . . . . . . . . . . . 32.8 pt -92.45 -36.81 8.02 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 -176.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -97.84 -25.85 14.89 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-O 121.865 0.84 . . . . 0.0 110.494 -175.046 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 254' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 . . . . . 0 N--CA 1.409 -2.479 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.17 -173.273 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.619 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -107.89 145.11 34.18 Favored 'General case' 0 C--N 1.317 -0.846 0 C-N-CA 120.876 -0.33 . . . . 0.0 110.178 -174.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 30.5 pt -139.55 156.78 26.73 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 CA-C-O 120.986 0.422 . . . . 0.0 110.524 177.028 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 28.5 t80 -107.41 122.83 47.4 Favored 'General case' 0 N--CA 1.423 -1.796 0 CA-C-N 114.671 -1.149 . . . . 0.0 108.364 177.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.418 HG21 ' CD1' ' A' ' 104' ' ' ILE . 7.7 mt -108.77 128.17 64.73 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.977 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 176.51 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -129.66 173.92 19.55 Favored Glycine 0 C--N 1.287 -2.154 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.976 -178.221 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 19.5 m120 65.82 24.2 11.37 Favored 'General case' 0 CA--C 1.512 -0.517 0 C-N-CA 125.123 1.369 . . . . 0.0 111.922 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -58.27 140.77 52.67 Favored 'General case' 0 CA--C 1.495 -1.154 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 -178.357 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.495 ' CG ' ' HG2' ' A' ' 41' ' ' GLU . 49.8 t-20 -71.5 142.64 50.14 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 172.298 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.491 ' HD2' ' N ' ' A' ' 41' ' ' GLU . 7.5 ppt_? -58.99 -22.94 61.32 Favored 'General case' 0 C--N 1.303 -1.43 0 C-N-CA 123.869 0.867 . . . . 0.0 112.62 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.495 ' HG2' ' CG ' ' A' ' 39' ' ' ASN . 12.8 pt-20 -87.19 -14.8 40.15 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.85 -176.175 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.425 ' HG ' ' HB3' ' A' ' 39' ' ' ASN . 79.6 mt -76.42 126.13 30.44 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.564 0.697 . . . . 0.0 112.598 -174.747 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 66.8 p -109.26 173.71 6.2 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 114.071 -1.422 . . . . 0.0 109.538 -177.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.7 mp0 -57.56 -42.31 82.76 Favored 'General case' 0 C--O 1.211 -0.933 0 C-N-CA 123.616 0.766 . . . . 0.0 109.92 178.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.43 -37.41 93.15 Favored Glycine 0 N--CA 1.446 -0.649 0 O-C-N 123.618 0.574 . . . . 0.0 112.814 -179.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 32.5 m-20 -67.42 -49.76 62.37 Favored 'General case' 0 CA--C 1.501 -0.934 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 179.306 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 51.4 mt -60.25 -45.78 95.72 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.777 0 CA-C-N 114.748 -1.115 . . . . 0.0 110.682 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 41.4 mt -59.96 -45.24 93.31 Favored 'General case' 0 CA--C 1.496 -1.099 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.322 -178.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 87.8 m -61.88 -45.72 92.52 Favored 'General case' 0 C--N 1.313 -1.018 0 O-C-N 123.595 0.56 . . . . 0.0 111.585 -178.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 98.9 t -66.79 -50.19 67.63 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.489 -179.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -62.49 -25.66 68.13 Favored 'General case' 0 N--CA 1.433 -1.276 0 C-N-CA 123.883 0.873 . . . . 0.0 112.381 -178.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 65.9 m -67.07 -20.22 65.79 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.287 176.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -70.07 -20.71 63.21 Favored 'General case' 0 CA--C 1.555 1.158 0 CA-C-O 121.302 0.572 . . . . 0.0 109.721 176.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 41.5 m-85 -97.51 -19.98 18.03 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-O 121.03 0.443 . . . . 0.0 111.59 -175.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 167.92 -159.49 32.75 Favored Glycine 0 N--CA 1.42 -2.379 0 N-CA-C 110.825 -0.91 . . . . 0.0 110.825 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 59.1 t -102.66 110.83 64.02 Favored Pre-proline 0 C--N 1.296 -1.746 0 O-C-N 123.471 0.159 . . . . 0.0 111.062 -177.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.415 ' HB3' HD22 ' A' ' 77' ' ' LEU . 92.7 Cg_endo -77.39 140.75 19.61 Favored 'Trans proline' 0 N--CA 1.451 -1.018 0 C-N-CA 122.849 2.366 . . . . 0.0 110.18 175.469 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 31.2 m -116.39 -19.08 6.63 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 C-N-CA 120.0 -0.68 . . . . 0.0 112.167 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.444 ' HB3' ' HG2' ' A' ' 78' ' ' LYS . 36.0 t70 -161.26 141.41 10.83 Favored 'General case' 0 C--O 1.242 0.682 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 -179.804 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 14.4 p -141.71 133.96 28.22 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 178.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 91.6 mt -120.46 125.37 74.07 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 177.443 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -100.77 134.18 44.13 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 178.203 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 22.3 t -92.62 131.52 37.65 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 176.256 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 68.7 mtt85 . . . . . 0 C--N 1.307 -1.249 0 CA-C-O 120.879 0.371 . . . . 0.0 111.233 -177.742 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 15.7 mm-40 . . . . . 0 N--CA 1.478 0.973 0 CA-C-O 121.324 0.583 . . . . 0.0 111.692 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 110.2 8.29 25.61 Favored Glycine 0 N--CA 1.421 -2.35 0 C-N-CA 119.88 -1.153 . . . . 0.0 112.269 -179.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 40.8 p90 -148.82 153.36 38.0 Favored 'General case' 0 C--O 1.252 1.194 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 177.125 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -149.52 172.83 14.36 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-O 120.915 0.388 . . . . 0.0 110.874 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -130.3 139.41 50.73 Favored 'General case' 0 C--N 1.303 -1.424 0 C-N-CA 124.161 0.984 . . . . 0.0 109.617 -179.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.415 HD22 ' HB3' ' A' ' 57' ' ' PRO . 9.9 tt -146.01 140.76 27.07 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 175.587 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.444 ' HG2' ' HB3' ' A' ' 59' ' ' ASP . 20.8 ptmt -124.37 144.27 50.12 Favored 'General case' 0 C--O 1.256 1.433 0 CA-C-O 121.259 0.552 . . . . 0.0 109.787 179.344 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 66.3 m-85 -108.16 164.31 12.41 Favored 'General case' 0 C--N 1.29 -1.983 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.719 179.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -77.99 -33.59 51.24 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 174.304 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -109.8 130.09 55.56 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.94 -176.163 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 83.7 mt-30 -71.02 -20.37 62.4 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 -178.095 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 88.1 mtm180 -68.03 -34.1 75.85 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-O 121.946 0.879 . . . . 0.0 108.654 174.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.492 ' OG ' HG22 ' B' ' 226' ' ' ILE . 61.9 m -63.59 -37.11 86.07 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 115.078 -0.964 . . . . 0.0 112.511 178.299 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.434 ' O ' HG21 ' A' ' 89' ' ' VAL . 80.7 p -65.31 -45.84 82.72 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 120.325 -0.55 . . . . 0.0 110.476 -177.303 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 3.4 pt -64.83 -39.23 84.96 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.884 177.179 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 19.9 mt -59.65 -44.54 93.51 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.653 176.393 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.468 ' O ' ' HB2' ' A' ' 92' ' ' LEU . . . -71.48 -45.88 61.32 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.035 -177.329 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.434 HG21 ' O ' ' A' ' 85' ' ' THR . 70.2 t -56.65 -49.02 79.7 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.797 0 CA-C-O 121.057 0.456 . . . . 0.0 110.95 178.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -63.25 -39.15 93.79 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 115.366 -0.834 . . . . 0.0 112.034 -175.062 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 63.3 t30 -96.42 -20.09 18.7 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.431 -171.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.468 ' HB2' ' O ' ' A' ' 88' ' ' ALA . 10.3 mt -96.59 -31.24 12.84 Favored 'General case' 0 CA--C 1.494 -1.176 0 CA-C-O 120.909 0.385 . . . . 0.0 111.655 -178.236 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 56.1 t30 -65.44 125.82 26.34 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.981 -177.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 88.13 -1.15 84.51 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 121.341 -0.457 . . . . 0.0 112.883 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 67.7 t80 -90.12 137.78 32.06 Favored 'General case' 0 C--N 1.32 -0.689 0 O-C-N 122.378 -0.483 . . . . 0.0 110.069 -178.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -92.45 116.74 29.25 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 121.56 0.695 . . . . 0.0 111.806 -176.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.583 ' HB ' HH21 ' A' ' 100' ' ' ARG . 62.7 mt -127.34 140.36 49.33 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 175.621 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 62.88 19.27 60.83 Favored Glycine 0 C--N 1.307 -1.066 0 C-N-CA 121.387 -0.435 . . . . 0.0 112.869 -179.007 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 91.72 -9.55 76.65 Favored Glycine 0 N--CA 1.438 -1.182 0 C-N-CA 121.218 -0.515 . . . . 0.0 112.953 -178.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.583 HH21 ' HB ' ' A' ' 97' ' ' ILE . 0.0 OUTLIER -125.54 146.88 49.47 Favored 'General case' 0 N--CA 1.418 -2.049 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 -175.764 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -79.8 136.54 36.75 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.692 -176.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.419 ' HG ' ' NH2' ' A' ' 100' ' ' ARG . 11.0 mt -82.47 148.39 28.17 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 115.457 -0.792 . . . . 0.0 112.445 176.253 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 4.3 tppp? -124.27 119.96 30.82 Favored 'General case' 0 N--CA 1.423 -1.825 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 174.271 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.418 ' CD1' HG21 ' A' ' 35' ' ' ILE . 4.6 mm -122.09 135.12 63.25 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 N-CA-C 107.108 -1.441 . . . . 0.0 107.108 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -143.63 158.82 43.38 Favored 'General case' 0 C--N 1.291 -1.947 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 178.335 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 38.3 m-70 -83.63 141.76 31.29 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 177.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 9.3 t -156.04 161.78 40.39 Favored 'General case' 0 C--N 1.285 -2.216 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 -178.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 26.0 p90 -109.88 110.35 21.28 Favored 'General case' 0 C--N 1.297 -1.674 0 C-N-CA 118.592 -1.243 . . . . 0.0 108.879 172.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 62.3 t80 . . . . . 0 C--N 1.294 -1.819 0 CA-C-N 115.351 -0.841 . . . . 0.0 110.98 -178.79 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 226' ' ' ILE . . . . . 0.492 HG22 ' OG ' ' A' ' 84' ' ' SER . 3.8 mp . . . . . 0 N--CA 1.44 -0.947 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 227' ' ' MET . . . . . . . . . . . . . 24.8 mmt -59.53 140.19 88.91 Favored Pre-proline 0 C--N 1.323 -0.577 0 O-C-N 124.061 0.851 . . . . 0.0 111.405 179.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 228' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -71.18 156.01 60.08 Favored 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 122.555 2.17 . . . . 0.0 111.444 179.119 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . -74.38 168.9 54.33 Favored Glycine 0 C--N 1.307 -1.041 0 CA-C-N 116.167 -0.47 . . . . 0.0 112.642 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 22.6 t -77.41 -15.21 59.47 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-O 120.954 0.407 . . . . 0.0 110.315 -178.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 13.6 mmp_? -80.83 -5.2 56.97 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 121.974 -0.454 . . . . 0.0 111.192 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 232' ' ' TRP . . . . . . . . . . . . . 19.2 t90 -70.94 127.02 31.19 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-O 122.659 1.219 . . . . 0.0 111.878 -178.076 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 233' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -118.09 145.5 44.8 Favored 'General case' 0 C--N 1.271 -2.833 0 N-CA-C 101.059 -3.682 . . . . 0.0 101.059 172.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.749 0 C-N-CA 127.211 2.339 . . . . 0.0 116.175 -177.912 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 240' ' ' GLY . . . . . 0.415 ' O ' ' HG2' ' B' ' 244' ' ' LYS . . . . . . . . 0 C--O 1.201 -1.928 0 N-CA-C 111.603 -0.599 . . . . 0.0 111.603 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -76.14 -33.56 59.42 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-O 120.899 0.38 . . . . 0.0 110.709 179.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -60.89 -43.84 97.92 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.106 -178.347 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -62.08 -34.62 76.64 Favored 'General case' 0 C--O 1.206 -1.219 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.307 179.189 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 244' ' ' LYS . . . . . 0.415 ' HG2' ' O ' ' B' ' 240' ' ' GLY . 72.9 mmtt -64.76 -45.52 86.05 Favored 'General case' 0 CA--C 1.508 -0.653 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 -179.268 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 245' ' ' TRP . . . . . . . . . . . . . 49.3 m0 -66.03 -42.45 89.59 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.26 178.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 246' ' ' PHE . . . . . 0.515 ' HA ' ' CD ' ' B' ' 249' ' ' GLN . 6.0 t80 -63.88 -36.95 85.62 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.246 179.743 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -70.33 -32.37 70.07 Favored 'General case' 0 C--N 1.292 -1.923 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.687 -179.244 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.46 -19.94 20.78 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -177.529 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 249' ' ' GLN . . . . . 0.515 ' CD ' ' HA ' ' B' ' 246' ' ' PHE . 2.9 pt20 -74.11 2.79 8.14 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.093 0.557 . . . . 0.0 110.71 -177.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 250' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -57.93 -30.62 66.09 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.373 178.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -84.59 120.89 26.88 Favored 'General case' 0 N--CA 1.437 -1.106 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.195 179.358 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 252' ' ' ILE . . . . . . . . . . . . . 37.6 pt -101.63 -28.65 3.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.759 -175.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -107.45 -26.52 10.91 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-O 121.573 0.701 . . . . 0.0 110.123 -178.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 254' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.292 -1.907 0 CA-C-N 115.306 -0.861 . . . . 0.0 108.68 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.515 -0.366 0 CA-C-O 120.633 0.254 . . . . 0.0 110.341 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -108.69 145.33 35.2 Favored 'General case' 0 N--CA 1.434 -1.248 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.868 -176.137 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 28.4 pt -136.86 160.36 36.85 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.753 177.233 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 34.4 t80 -112.8 124.12 51.88 Favored 'General case' 0 N--CA 1.413 -2.31 0 CA-C-N 115.26 -0.882 . . . . 0.0 108.831 177.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.448 HG21 ' CD1' ' A' ' 104' ' ' ILE . 10.4 mt -108.55 127.75 64.73 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.036 0 N-CA-C 106.846 -1.539 . . . . 0.0 106.846 176.136 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -130.07 160.99 23.05 Favored Glycine 0 N--CA 1.425 -2.04 0 N-CA-C 112.02 -0.432 . . . . 0.0 112.02 -179.094 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 66.4 t30 70.39 41.27 1.02 Allowed 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.82 1.648 . . . . 0.0 110.604 -179.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -69.39 151.73 45.78 Favored 'General case' 0 CA--C 1.499 -0.987 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.864 175.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.412 ' HB3' ' HG ' ' A' ' 42' ' ' LEU . 45.9 t-20 -84.66 149.94 25.48 Favored 'General case' 0 C--N 1.284 -2.273 0 N-CA-C 106.344 -1.724 . . . . 0.0 106.344 175.758 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.517 ' HD2' ' C ' ' A' ' 40' ' ' ARG . 5.8 ppt_? -59.1 -24.45 62.97 Favored 'General case' 0 C--N 1.307 -1.242 0 C-N-CA 123.354 0.662 . . . . 0.0 111.025 178.606 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.429 ' N ' ' HD2' ' A' ' 40' ' ' ARG . 13.8 pt-20 -95.39 0.11 53.13 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.825 -0.625 . . . . 0.0 112.317 -175.81 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.412 ' HG ' ' HB3' ' A' ' 39' ' ' ASN . 68.6 mt -89.81 121.69 32.18 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-O 121.132 0.492 . . . . 0.0 110.407 179.503 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 70.6 p -108.43 174.44 5.87 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-N 114.674 -1.148 . . . . 0.0 110.279 -176.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.423 ' CG ' ' HB2' ' A' ' 62' ' ' LEU . 33.6 mt-10 -55.15 -40.87 71.09 Favored 'General case' 0 C--O 1.212 -0.914 0 O-C-N 123.616 0.572 . . . . 0.0 109.689 176.622 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -59.76 -39.83 95.84 Favored Glycine 0 C--O 1.243 0.7 0 CA-C-N 116.079 -0.51 . . . . 0.0 112.738 179.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -66.82 -49.65 65.1 Favored 'General case' 0 CA--C 1.499 -1.017 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 179.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 47.2 mt -60.07 -46.68 94.01 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.808 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.842 -179.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 47.5 mt -60.07 -42.49 94.67 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 116.592 -0.277 . . . . 0.0 111.705 -177.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 90.8 m -63.98 -46.28 85.32 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 120.869 0.366 . . . . 0.0 111.256 -179.134 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 95.7 t -66.98 -48.63 78.91 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.692 -178.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -64.88 -23.08 67.12 Favored 'General case' 0 N--CA 1.426 -1.636 0 CA-C-N 115.28 -0.873 . . . . 0.0 112.416 -178.413 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.468 ' HA ' ' O ' ' A' ' 55' ' ' GLY . 61.5 m -72.3 -20.8 61.44 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 176.64 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -71.46 -22.18 61.86 Favored 'General case' 0 C--O 1.246 0.894 0 C-N-CA 119.859 -0.736 . . . . 0.0 109.596 177.275 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -92.0 -22.82 19.77 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.818 -178.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.468 ' O ' ' HA ' ' A' ' 52' ' ' SER . . . 169.79 -164.47 37.91 Favored Glycine 0 N--CA 1.427 -1.965 0 N-CA-C 110.927 -0.869 . . . . 0.0 110.927 -179.588 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 54.8 t -99.03 111.0 59.82 Favored Pre-proline 0 C--N 1.302 -1.498 0 CA-C-N 116.548 0.174 . . . . 0.0 111.039 -176.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.426 ' HB3' HD22 ' A' ' 77' ' ' LEU . 85.9 Cg_endo -78.13 141.77 18.84 Favored 'Trans proline' 0 C--O 1.246 0.895 0 C-N-CA 122.975 2.45 . . . . 0.0 110.627 175.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 29.7 m -120.53 -15.38 7.43 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 C-N-CA 120.264 -0.575 . . . . 0.0 112.132 179.226 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.477 ' HB3' ' HG2' ' A' ' 78' ' ' LYS . 28.3 t70 -163.27 135.92 5.4 Favored 'General case' 0 C--O 1.244 0.799 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 -176.835 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 14.4 p -143.97 136.88 23.71 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 90.2 mt -120.92 121.63 65.62 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.799 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 177.234 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.423 ' HB2' ' CG ' ' A' ' 44' ' ' GLU . 0.1 OUTLIER -100.2 113.54 26.28 Favored 'General case' 0 N--CA 1.42 -1.93 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 175.267 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 13.6 m -78.32 117.91 20.01 Favored 'General case' 0 C--N 1.274 -2.693 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 178.406 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 84.2 mtm180 . . . . . 0 C--N 1.301 -1.514 0 CA-C-O 121.052 0.454 . . . . 0.0 110.125 179.353 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 12.9 mm-40 . . . . . 0 CA--C 1.502 -0.878 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 96.54 2.99 59.9 Favored Glycine 0 N--CA 1.426 -2.031 0 C-N-CA 119.651 -1.261 . . . . 0.0 112.113 -179.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 34.5 p90 -145.65 151.58 38.28 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 178.294 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -149.49 170.16 19.24 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 123.266 0.354 . . . . 0.0 110.529 -179.217 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -131.5 140.12 49.46 Favored 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 123.649 0.78 . . . . 0.0 109.427 -178.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.426 HD22 ' HB3' ' A' ' 57' ' ' PRO . 9.9 tt -147.33 140.45 25.19 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 177.183 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.477 ' HG2' ' HB3' ' A' ' 59' ' ' ASP . 18.7 ptmt -124.0 144.43 49.83 Favored 'General case' 0 C--O 1.259 1.567 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 178.122 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 58.7 m-85 -106.9 164.89 11.75 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.956 -178.32 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -77.83 -25.73 49.01 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 114.813 -1.085 . . . . 0.0 109.293 176.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -124.1 130.39 52.48 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 -179.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -69.3 -21.05 63.89 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 113.137 0.792 . . . . 0.0 113.137 -177.262 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 89.6 mtm180 -63.64 -33.13 74.95 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-O 122.352 1.073 . . . . 0.0 110.109 177.374 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.423 ' OG ' HG22 ' B' ' 226' ' ' ILE . 48.9 m -63.53 -36.98 85.59 Favored 'General case' 0 C--N 1.282 -2.335 0 CA-C-N 114.628 -1.169 . . . . 0.0 112.22 178.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.402 ' O ' HG21 ' A' ' 89' ' ' VAL . 81.8 p -64.74 -45.05 88.11 Favored 'General case' 0 C--O 1.219 -0.501 0 C-N-CA 120.279 -0.568 . . . . 0.0 110.525 -177.015 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 3.3 pt -63.89 -39.45 85.46 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.103 177.225 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 29.2 mt -60.32 -43.61 96.21 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 120.902 0.382 . . . . 0.0 111.011 175.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.456 ' O ' ' HB2' ' A' ' 92' ' ' LEU . . . -71.47 -47.16 57.37 Favored 'General case' 0 C--O 1.211 -0.959 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.67 -178.64 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.402 HG21 ' O ' ' A' ' 85' ' ' THR . 79.5 t -57.21 -48.7 81.72 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.492 0 CA-C-O 120.915 0.388 . . . . 0.0 111.006 -179.44 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -68.38 -31.9 71.6 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 115.509 -0.769 . . . . 0.0 112.466 -173.413 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -97.56 -20.77 17.48 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 -176.302 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.456 ' HB2' ' O ' ' A' ' 88' ' ' ALA . 9.6 mt -93.43 -28.56 16.06 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-O 120.574 0.226 . . . . 0.0 111.07 -179.15 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -60.26 124.74 21.22 Favored 'General case' 0 C--O 1.244 0.79 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 178.056 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 83.86 -1.07 89.23 Favored Glycine 0 C--N 1.306 -1.128 0 C-N-CA 120.499 -0.858 . . . . 0.0 113.447 177.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 86.4 t80 -85.3 134.4 34.12 Favored 'General case' 0 N--CA 1.443 -0.825 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 178.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 11.1 mptt -92.88 118.87 31.6 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.229 -176.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 54.1 mt -121.72 141.16 43.33 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 N-CA-C 105.257 -2.127 . . . . 0.0 105.257 172.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 58.92 22.48 54.77 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 121.191 -0.528 . . . . 0.0 112.821 -179.04 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 82.21 7.41 87.77 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 121.492 -0.385 . . . . 0.0 113.546 -179.435 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 16.7 ptp180 -129.52 141.04 51.08 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 117.688 0.744 . . . . 0.0 110.894 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -79.61 122.08 26.07 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.012 0.434 . . . . 0.0 111.387 -179.215 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 9.5 mt -68.7 141.23 55.35 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.671 177.2 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -113.98 116.01 28.55 Favored 'General case' 0 N--CA 1.409 -2.517 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 176.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.448 ' CD1' HG21 ' A' ' 35' ' ' ILE . 4.8 mm -116.65 136.11 54.78 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.861 0 N-CA-C 106.423 -1.695 . . . . 0.0 106.423 178.417 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -144.0 151.85 40.26 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.331 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -80.63 135.6 36.08 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-O 120.975 0.417 . . . . 0.0 110.223 177.648 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 6.5 t -153.64 168.35 26.52 Favored 'General case' 0 C--N 1.291 -1.972 0 N-CA-C 107.427 -1.324 . . . . 0.0 107.427 -177.065 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -108.91 110.82 22.24 Favored 'General case' 0 N--CA 1.421 -1.888 0 N-CA-C 105.208 -2.145 . . . . 0.0 105.208 169.143 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 84.9 t80 . . . . . 0 C--N 1.291 -1.967 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 178.879 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 226' ' ' ILE . . . . . 0.423 HG22 ' OG ' ' A' ' 84' ' ' SER . 4.2 mp . . . . . 0 N--CA 1.451 -0.421 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 227' ' ' MET . . . . . . . . . . . . . 86.8 mtp -71.2 133.54 85.54 Favored Pre-proline 0 C--N 1.315 -0.903 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 176.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 228' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -64.27 160.89 36.59 Favored 'Trans proline' 0 C--O 1.24 0.622 0 C-N-CA 123.43 2.753 . . . . 0.0 113.455 -177.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . -77.19 167.48 54.25 Favored Glycine 0 N--CA 1.439 -1.128 0 CA-C-N 115.155 -0.929 . . . . 0.0 113.429 -178.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 6.5 m -77.42 -17.58 57.99 Favored 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 123.14 0.576 . . . . 0.0 111.635 -175.169 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 7.9 mmp_? -87.29 -0.46 56.77 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.196 0.522 . . . . 0.0 110.995 -176.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 232' ' ' TRP . . . . . . . . . . . . . 21.1 t90 -76.93 127.82 33.41 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-O 122.307 1.051 . . . . 0.0 112.206 -178.063 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 233' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -122.07 147.1 46.53 Favored 'General case' 0 C--N 1.277 -2.585 0 N-CA-C 102.82 -3.029 . . . . 0.0 102.82 171.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.505 3.272 0 C-N-CA 128.372 2.891 . . . . 0.0 117.139 -175.654 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 240' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.417 -2.604 0 N-CA-C 108.443 -1.863 . . . . 0.0 108.443 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 22.7 p90 -77.09 -33.34 56.99 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 179.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -61.27 -45.34 94.89 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.226 0.536 . . . . 0.0 112.089 -177.094 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -60.46 -34.74 74.46 Favored 'General case' 0 C--O 1.204 -1.307 0 CA-C-N 115.166 -0.924 . . . . 0.0 111.411 -179.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -63.97 -42.46 97.24 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 -178.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 245' ' ' TRP . . . . . . . . . . . . . 23.7 m0 -66.23 -38.43 87.89 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.329 0.585 . . . . 0.0 109.954 178.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 246' ' ' PHE . . . . . 0.627 ' O ' ' HG2' ' B' ' 249' ' ' GLN . 3.1 t80 -67.96 -32.89 73.63 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.433 176.302 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -74.93 -38.96 61.65 Favored 'General case' 0 C--N 1.294 -1.839 0 O-C-N 121.948 -0.47 . . . . 0.0 111.023 179.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.35 -14.57 55.08 Favored 'General case' 0 CA--C 1.504 -0.8 0 CA-C-O 121.045 0.45 . . . . 0.0 111.758 -175.235 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 249' ' ' GLN . . . . . 0.627 ' HG2' ' O ' ' B' ' 246' ' ' PHE . 3.0 pt20 -75.22 2.4 11.07 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 121.698 0.761 . . . . 0.0 110.332 -179.068 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 250' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -67.24 -25.83 66.28 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.21 176.235 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -64.29 115.88 5.48 Favored 'General case' 0 N--CA 1.437 -1.118 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.134 178.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 252' ' ' ILE . . . . . . . . . . . . . 16.3 pt -99.67 -27.63 3.52 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.317 0 CA-C-N 113.783 -1.553 . . . . 0.0 110.944 -174.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 10.6 p30 -121.01 -26.32 5.17 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.908 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 254' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 . . . . . 0 N--CA 1.428 -1.571 0 N-CA-C 114.089 1.144 . . . . 0.0 114.089 -177.322 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.407 ' HA ' HG22 ' A' ' 85' ' ' THR . . . . . . . . 0 N--CA 1.441 -0.878 0 CA-C-O 120.579 0.228 . . . . 0.0 110.644 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 9.9 m-30 -104.85 145.23 30.67 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.89 -175.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 22.8 pt -140.82 158.4 23.69 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 CA-C-O 121.137 0.494 . . . . 0.0 110.628 178.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 61.8 t80 -105.26 118.91 37.74 Favored 'General case' 0 N--CA 1.412 -2.374 0 CA-C-N 114.504 -1.226 . . . . 0.0 108.057 177.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.468 HG21 ' CD1' ' A' ' 104' ' ' ILE . 10.9 mt -108.41 127.53 64.7 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.18 0 N-CA-C 105.427 -2.064 . . . . 0.0 105.427 173.359 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -132.31 170.86 21.71 Favored Glycine 0 C--N 1.269 -3.18 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 71.74 32.84 1.87 Allowed 'General case' 0 N--CA 1.471 0.604 0 O-C-N 124.485 0.756 . . . . 0.0 109.873 -178.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -66.19 143.02 57.51 Favored 'General case' 0 CA--C 1.492 -1.267 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.465 177.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 61.2 t30 -83.49 156.5 22.83 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.061 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 18.4 ptt180 -58.01 -28.92 64.88 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 123.701 0.801 . . . . 0.0 112.664 -177.188 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -107.48 4.76 26.51 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 113.74 1.015 . . . . 0.0 113.74 -172.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 61.3 mt -84.56 121.69 27.97 Favored 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 120.348 -0.541 . . . . 0.0 110.776 178.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 69.6 p -107.58 173.47 6.31 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-N 115.096 -0.956 . . . . 0.0 109.675 -179.236 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.409 ' CG ' ' HB2' ' A' ' 62' ' ' LEU . 52.3 mt-10 -55.3 -38.97 69.34 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 123.46 0.704 . . . . 0.0 111.652 179.497 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -65.6 -37.98 94.17 Favored Glycine 0 N--CA 1.44 -1.078 0 CA-C-N 116.076 -0.511 . . . . 0.0 113.105 -178.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -67.25 -43.95 80.64 Favored 'General case' 0 CA--C 1.505 -0.773 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 -178.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 35.9 mt -60.77 -45.51 97.71 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.421 0 CA-C-N 114.922 -1.035 . . . . 0.0 110.593 178.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 50.0 mt -59.64 -44.85 93.35 Favored 'General case' 0 C--O 1.207 -1.135 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.704 -176.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 96.4 m -60.63 -46.05 91.76 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 179.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 85.5 t -65.95 -48.44 81.84 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 CA-C-O 121.099 0.476 . . . . 0.0 110.679 179.251 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -66.27 -24.39 66.56 Favored 'General case' 0 N--CA 1.431 -1.39 0 CA-C-N 115.595 -0.73 . . . . 0.0 112.331 -178.004 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.406 ' HA ' ' O ' ' A' ' 55' ' ' GLY . 73.3 m -68.59 -19.8 64.48 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.958 176.3 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -70.29 -25.3 63.27 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 119.553 -0.859 . . . . 0.0 108.953 175.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -93.01 -7.55 45.51 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-N 115.877 -0.602 . . . . 0.0 112.069 -175.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.406 ' O ' ' HA ' ' A' ' 52' ' ' SER . . . 152.39 -159.63 28.5 Favored Glycine 0 N--CA 1.419 -2.48 0 C-N-CA 120.699 -0.762 . . . . 0.0 111.304 178.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 98.8 t -99.83 110.9 60.69 Favored Pre-proline 0 C--N 1.298 -1.634 0 O-C-N 123.382 0.107 . . . . 0.0 110.95 -178.075 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.43 ' HB3' HD22 ' A' ' 77' ' ' LEU . 92.1 Cg_endo -79.68 137.26 12.68 Favored 'Trans proline' 0 N--CA 1.452 -0.926 0 C-N-CA 122.779 2.319 . . . . 0.0 110.16 175.694 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 27.0 m -114.39 -20.41 6.06 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 C-N-CA 119.624 -0.83 . . . . 0.0 112.038 -178.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.454 ' HB3' ' HG2' ' A' ' 78' ' ' LYS . 37.5 t70 -157.24 138.24 13.45 Favored 'General case' 0 CA--C 1.499 -0.992 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.411 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 13.6 p -139.68 134.32 38.28 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 O-C-N 123.674 0.609 . . . . 0.0 109.379 178.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 84.5 mt -121.9 126.91 75.16 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.051 177.023 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.409 ' HB2' ' CG ' ' A' ' 44' ' ' GLU . 0.1 OUTLIER -105.99 112.46 25.51 Favored 'General case' 0 N--CA 1.424 -1.763 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 173.54 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 24.2 m -79.23 119.54 22.46 Favored 'General case' 0 C--N 1.281 -2.387 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 177.208 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 81.8 mtp180 . . . . . 0 C--N 1.307 -1.274 0 O-C-N 121.992 -0.442 . . . . 0.0 111.89 -175.951 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 28.8 mm-40 . . . . . 0 CA--C 1.506 -0.723 0 CA-C-O 121.167 0.508 . . . . 0.0 110.383 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 98.33 1.38 58.03 Favored Glycine 0 N--CA 1.43 -1.739 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.89 -177.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 37.3 p90 -140.53 151.72 44.99 Favored 'General case' 0 N--CA 1.432 -1.335 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 178.329 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -146.49 172.25 13.83 Favored 'General case' 0 N--CA 1.42 -1.927 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 178.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 8.0 t80 -135.07 143.76 46.85 Favored 'General case' 0 C--N 1.293 -1.857 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.047 -177.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.43 HD22 ' HB3' ' A' ' 57' ' ' PRO . 9.7 tt -149.83 140.52 22.63 Favored 'General case' 0 N--CA 1.434 -1.244 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 175.696 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.454 ' HG2' ' HB3' ' A' ' 59' ' ' ASP . 21.1 ptmt -123.34 144.44 49.45 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 178.33 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.402 ' HH ' ' CB ' ' A' ' 88' ' ' ALA . 70.1 m-85 -105.79 165.15 11.39 Favored 'General case' 0 C--N 1.289 -2.037 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.067 -177.641 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -75.08 -31.52 61.23 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 114.702 -1.136 . . . . 0.0 108.918 173.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.428 ' O ' ' HB2' ' A' ' 84' ' ' SER . 8.8 t70 -119.88 134.11 55.35 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 -178.31 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -70.62 -20.42 62.74 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 -179.118 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 87.0 mtm180 -67.91 -33.3 74.44 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-O 122.44 1.114 . . . . 0.0 109.239 175.1 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.485 ' OG ' HG22 ' B' ' 226' ' ' ILE . 50.3 m -62.27 -37.13 84.28 Favored 'General case' 0 C--N 1.285 -2.222 0 CA-C-N 114.6 -1.182 . . . . 0.0 112.323 177.016 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.453 ' O ' HG21 ' A' ' 89' ' ' VAL . 78.7 p -65.2 -45.49 84.58 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 120.208 -0.597 . . . . 0.0 110.179 -177.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 5.6 pt -64.72 -38.11 81.84 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.492 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.099 177.222 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 12.0 mt -59.09 -44.69 91.94 Favored 'General case' 0 CA--C 1.502 -0.87 0 CA-C-O 120.944 0.402 . . . . 0.0 111.089 175.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.536 ' O ' ' HB2' ' A' ' 92' ' ' LEU . . . -71.4 -40.93 70.22 Favored 'General case' 0 N--CA 1.427 -1.59 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.303 -178.351 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.453 HG21 ' O ' ' A' ' 85' ' ' THR . 86.0 t -62.2 -49.4 84.19 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-O 120.889 0.376 . . . . 0.0 110.671 178.21 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -66.07 -35.75 81.37 Favored 'General case' 0 C--N 1.302 -1.468 0 C-N-CA 123.59 0.756 . . . . 0.0 112.13 -175.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -87.74 -29.22 21.23 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -177.361 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.536 ' HB2' ' O ' ' A' ' 88' ' ' ALA . 10.1 mt -97.68 -26.56 14.71 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 112.84 0.682 . . . . 0.0 112.84 -173.648 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -60.38 125.1 22.4 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 109.551 -0.536 . . . . 0.0 109.551 -179.557 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 81.44 -1.12 86.65 Favored Glycine 0 N--CA 1.441 -0.987 0 C-N-CA 120.986 -0.626 . . . . 0.0 113.649 177.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 59.4 t80 -85.67 138.16 32.32 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 117.611 0.706 . . . . 0.0 109.122 -178.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 11.7 mptt -92.47 117.2 29.7 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 -176.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 56.6 mt -126.08 141.99 44.08 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 N-CA-C 105.253 -2.129 . . . . 0.0 105.253 173.019 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 60.58 19.98 55.23 Favored Glycine 0 CA--C 1.525 0.687 0 C-N-CA 121.598 -0.334 . . . . 0.0 113.595 179.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 84.33 10.61 79.74 Favored Glycine 0 N--CA 1.441 -0.989 0 C-N-CA 121.292 -0.48 . . . . 0.0 112.539 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 12.9 ptp180 -135.82 145.9 46.95 Favored 'General case' 0 N--CA 1.439 -0.996 0 O-C-N 122.435 -0.45 . . . . 0.0 111.511 -179.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -84.38 118.07 24.01 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.015 -177.543 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 10.3 mt -65.73 139.28 58.35 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-O 121.653 0.739 . . . . 0.0 112.49 179.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 60.2 tptt -109.98 115.47 29.84 Favored 'General case' 0 N--CA 1.413 -2.275 0 CA-C-N 115.106 -0.952 . . . . 0.0 108.456 178.12 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.468 ' CD1' HG21 ' A' ' 35' ' ' ILE . 5.0 mm -121.34 131.31 73.35 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.898 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 178.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -143.91 155.09 43.95 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 -179.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -83.55 132.08 34.94 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 117.994 0.361 . . . . 0.0 110.716 177.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 5.8 t -153.86 159.78 41.93 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 107.848 -1.168 . . . . 0.0 107.848 -176.304 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -99.71 112.64 24.85 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 169.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 32.3 t80 . . . . . 0 C--N 1.29 -2.021 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.363 -176.874 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 226' ' ' ILE . . . . . 0.485 HG22 ' OG ' ' A' ' 84' ' ' SER . 4.2 mp . . . . . 0 CA--C 1.501 -0.927 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 227' ' ' MET . . . . . . . . . . . . . 91.1 mtp -67.49 133.16 92.89 Favored Pre-proline 0 C--N 1.312 -1.022 0 O-C-N 123.528 0.518 . . . . 0.0 110.12 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 228' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -68.67 158.78 56.35 Favored 'Trans proline' 0 N--CA 1.452 -0.96 0 C-N-CA 122.761 2.307 . . . . 0.0 112.25 179.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . -75.6 163.55 53.71 Favored Glycine 0 N--CA 1.437 -1.25 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.329 179.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 14.6 m -77.79 -14.36 59.61 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 123.103 0.561 . . . . 0.0 110.974 -178.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 27.9 mmt180 -81.82 0.26 40.18 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 121.461 0.648 . . . . 0.0 109.952 -178.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 232' ' ' TRP . . . . . . . . . . . . . 22.8 t90 -81.82 130.5 35.09 Favored 'General case' 0 N--CA 1.427 -1.593 0 CA-C-O 122.228 1.013 . . . . 0.0 111.441 -177.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 233' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -117.86 147.74 42.78 Favored 'General case' 0 C--N 1.273 -2.758 0 N-CA-C 101.201 -3.629 . . . . 0.0 101.201 171.457 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.511 3.679 0 C-N-CA 128.248 2.832 . . . . 0.0 118.213 -175.447 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 240' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.2 -1.972 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 26.8 p90 -76.38 -34.55 58.87 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -179.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -63.61 -42.42 98.23 Favored 'General case' 0 C--O 1.219 -0.543 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.843 -174.048 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -61.16 -34.36 74.9 Favored 'General case' 0 CA--C 1.509 -0.623 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.397 178.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -67.15 -47.52 70.8 Favored 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 -179.029 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 245' ' ' TRP . . . . . . . . . . . . . 49.2 m0 -65.3 -40.15 93.43 Favored 'General case' 0 C--O 1.208 -1.089 0 CA-C-N 114.77 -1.105 . . . . 0.0 109.83 179.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 246' ' ' PHE . . . . . 0.468 ' O ' ' HG2' ' B' ' 249' ' ' GLN . 3.1 t80 -66.18 -30.75 71.28 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 124.091 0.956 . . . . 0.0 110.892 179.318 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -78.13 -39.87 39.86 Favored 'General case' 0 C--N 1.294 -1.836 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.24 178.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 248' ' ' LYS . . . . . 0.476 ' HZ2' ' HB2' ' B' ' 248' ' ' LYS . 0.0 OUTLIER -87.89 -11.7 46.92 Favored 'General case' 0 CA--C 1.51 -0.584 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -175.915 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 249' ' ' GLN . . . . . 0.468 ' HG2' ' O ' ' B' ' 246' ' ' PHE . 3.2 pt20 -74.46 2.74 8.84 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.635 -179.234 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 250' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -57.42 -35.89 70.66 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.433 177.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -88.95 107.46 19.03 Favored 'General case' 0 N--CA 1.421 -1.89 0 CA-C-O 122.179 0.99 . . . . 0.0 110.239 177.286 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 252' ' ' ILE . . . . . . . . . . . . . 9.2 pt -116.88 -34.3 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.281 -2.4 0 CA-C-N 114.27 -1.332 . . . . 0.0 110.998 -179.206 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -115.4 -26.44 7.56 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 -178.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 254' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 . . . . . 0 N--CA 1.432 -1.353 0 CA-C-N 114.631 -1.168 . . . . 0.0 110.181 -175.518 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.509 -0.614 0 N-CA-C 111.563 0.209 . . . . 0.0 111.563 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -108.0 145.39 33.98 Favored 'General case' 0 C--N 1.311 -1.088 0 C-N-CA 120.816 -0.354 . . . . 0.0 110.32 -174.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 24.2 pt -142.74 161.97 18.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.984 178.085 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 63.1 t80 -111.55 122.72 48.59 Favored 'General case' 0 N--CA 1.42 -1.975 0 C-N-CA 124.655 1.182 . . . . 0.0 108.485 178.522 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.447 HG21 ' CD1' ' A' ' 104' ' ' ILE . 9.9 mt -108.85 128.32 64.74 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.933 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 175.018 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -130.15 168.74 21.34 Favored Glycine 0 C--N 1.288 -2.112 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 -179.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 72.75 27.46 2.23 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 124.766 1.226 . . . . 0.0 110.788 -177.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -62.84 143.2 57.8 Favored 'General case' 0 CA--C 1.499 -0.993 0 CA-C-O 121.407 0.622 . . . . 0.0 112.474 179.541 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.43 ' HB3' ' HG ' ' A' ' 42' ' ' LEU . 47.5 t-20 -85.38 147.11 26.67 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 175.707 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.02 -17.3 56.83 Favored 'General case' 0 C--N 1.299 -1.592 0 C-N-CA 123.949 0.9 . . . . 0.0 112.899 178.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -98.88 0.52 44.34 Favored 'General case' 0 C--O 1.244 0.768 0 CA-C-O 121.035 0.445 . . . . 0.0 111.253 -179.475 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.43 ' HG ' ' HB3' ' A' ' 39' ' ' ASN . 77.5 mt -90.68 120.35 31.67 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-O 121.637 0.732 . . . . 0.0 110.062 179.128 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 72.1 p -102.95 173.22 6.41 Favored 'General case' 0 C--N 1.29 -2.005 0 CA-C-N 114.382 -1.281 . . . . 0.0 108.973 -177.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -56.13 -39.07 71.69 Favored 'General case' 0 C--O 1.209 -1.057 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 175.431 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -59.25 -40.07 95.39 Favored Glycine 0 N--CA 1.444 -0.827 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.948 -178.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -67.04 -49.14 66.17 Favored 'General case' 0 CA--C 1.496 -1.109 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 48.4 mt -58.45 -46.44 89.55 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.762 0 CA-C-N 114.866 -1.061 . . . . 0.0 110.304 179.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 44.4 mt -59.71 -45.5 91.95 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.843 -178.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 98.2 m -62.63 -45.46 92.73 Favored 'General case' 0 N--CA 1.442 -0.869 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 179.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 91.3 t -65.89 -47.91 83.83 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.192 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.505 -178.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -66.45 -24.44 66.44 Favored 'General case' 0 N--CA 1.428 -1.564 0 CA-C-N 115.412 -0.813 . . . . 0.0 112.354 -178.27 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.499 ' OG ' ' HB2' ' B' ' 231' ' ' ARG . 62.3 m -68.09 -18.07 64.56 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 176.724 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -69.92 -26.78 64.31 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 119.546 -0.862 . . . . 0.0 109.226 176.165 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 -89.61 -23.26 21.98 Favored 'General case' 0 CA--C 1.505 -0.774 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.845 -175.032 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.419 ' O ' ' HA ' ' A' ' 52' ' ' SER . . . 170.41 -155.74 25.58 Favored Glycine 0 N--CA 1.418 -2.558 0 N-CA-C 110.577 -1.009 . . . . 0.0 110.577 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 49.0 t -104.46 105.57 50.47 Favored Pre-proline 0 C--N 1.289 -2.04 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 -177.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.449 ' HB3' HD22 ' A' ' 77' ' ' LEU . 64.0 Cg_endo -74.74 136.4 20.93 Favored 'Trans proline' 0 N--CA 1.447 -1.263 0 C-N-CA 121.793 1.662 . . . . 0.0 109.522 175.495 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 26.8 m -111.66 -25.54 3.47 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 C-N-CA 120.354 -0.538 . . . . 0.0 111.693 -178.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.457 ' HB3' ' HG2' ' A' ' 78' ' ' LYS . 27.9 t70 -152.92 145.38 24.11 Favored 'General case' 0 CA--C 1.491 -1.295 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 14.6 p -145.96 135.47 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.799 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 179.321 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 92.7 mt -120.51 123.91 71.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 175.607 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -97.11 114.52 26.19 Favored 'General case' 0 N--CA 1.422 -1.844 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 176.46 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 9.2 m -75.25 117.85 17.52 Favored 'General case' 0 C--N 1.276 -2.594 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 178.244 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 25.9 mtp180 . . . . . 0 C--N 1.305 -1.334 0 CA-C-O 120.991 0.424 . . . . 0.0 110.991 -176.143 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 12.4 mm-40 . . . . . 0 CA--C 1.511 -0.526 0 CA-C-O 121.067 0.461 . . . . 0.0 111.794 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 85.81 6.74 82.29 Favored Glycine 0 N--CA 1.427 -1.939 0 C-N-CA 120.951 -0.643 . . . . 0.0 112.11 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -148.03 156.87 43.12 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 178.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -154.5 171.79 18.83 Favored 'General case' 0 C--N 1.307 -1.252 0 O-C-N 123.741 0.651 . . . . 0.0 110.295 178.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -128.33 140.94 51.6 Favored 'General case' 0 C--N 1.31 -1.125 0 C-N-CA 123.71 0.804 . . . . 0.0 110.222 -178.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.449 HD22 ' HB3' ' A' ' 57' ' ' PRO . 9.8 tt -147.06 140.72 25.68 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 175.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.457 ' HG2' ' HB3' ' A' ' 59' ' ' ASP . 21.6 ptmt -123.93 144.84 49.54 Favored 'General case' 0 C--O 1.259 1.59 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 178.645 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 59.0 m-85 -106.78 164.59 11.98 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-O 121.39 0.614 . . . . 0.0 112.232 -178.284 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -71.98 -34.3 68.83 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 114.053 -1.431 . . . . 0.0 109.093 175.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -124.65 135.01 52.71 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.403 -179.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -70.55 -20.09 62.83 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 114.316 1.228 . . . . 0.0 114.316 -177.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 87.5 mtm180 -61.27 -33.92 74.34 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 122.378 1.085 . . . . 0.0 109.475 173.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 50.6 m -66.02 -36.6 83.7 Favored 'General case' 0 C--N 1.288 -2.068 0 CA-C-N 114.777 -1.101 . . . . 0.0 112.662 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 71.3 p -63.46 -45.09 92.4 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 120.34 -0.544 . . . . 0.0 110.995 -177.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 3.9 pt -65.63 -38.54 82.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.048 177.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 16.1 mt -59.34 -43.74 92.73 Favored 'General case' 0 CA--C 1.502 -0.878 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.439 175.4 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.51 ' O ' ' HB2' ' A' ' 92' ' ' LEU . . . -69.93 -44.97 68.5 Favored 'General case' 0 N--CA 1.425 -1.678 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.648 -178.648 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 71.2 t -59.69 -44.27 93.24 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.898 0 CA-C-O 121.189 0.519 . . . . 0.0 111.229 177.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -63.15 -39.1 93.7 Favored 'General case' 0 C--N 1.291 -1.94 0 C-N-CA 124.095 0.958 . . . . 0.0 112.612 -177.403 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 50.8 t-20 -93.44 -33.27 13.89 Favored 'General case' 0 C--N 1.292 -1.924 0 CA-C-O 121.196 0.522 . . . . 0.0 111.355 -175.01 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.51 ' HB2' ' O ' ' A' ' 88' ' ' ALA . 12.9 mt -88.37 -28.13 21.17 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 112.597 0.591 . . . . 0.0 112.597 -171.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -64.26 123.83 20.14 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 81.89 -0.57 88.25 Favored Glycine 0 CA--C 1.535 1.321 0 C-N-CA 120.979 -0.629 . . . . 0.0 113.763 179.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -85.11 141.76 30.0 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -179.091 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.56 119.74 34.59 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 112.832 0.678 . . . . 0.0 112.832 -176.34 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 52.2 mt -127.56 141.25 46.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 N-CA-C 105.415 -2.069 . . . . 0.0 105.415 172.107 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 61.22 20.74 58.72 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 121.135 -0.555 . . . . 0.0 113.567 179.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 82.1 10.05 84.37 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 121.159 -0.543 . . . . 0.0 112.835 -178.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 12.7 ptp180 -134.81 143.68 47.2 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 117.128 0.464 . . . . 0.0 111.564 -179.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -81.33 121.16 25.86 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.508 -179.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 10.5 mt -70.03 138.7 52.37 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 179.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 24.2 tptm -106.4 116.2 31.51 Favored 'General case' 0 N--CA 1.415 -2.193 0 CA-C-N 115.181 -0.918 . . . . 0.0 108.575 177.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.447 ' CD1' HG21 ' A' ' 35' ' ' ILE . 5.8 mm -118.76 135.9 57.68 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.096 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 177.686 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -143.48 152.96 42.13 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 -178.105 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 47.3 m-70 -84.16 135.01 34.55 Favored 'General case' 0 C--N 1.289 -2.055 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 176.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 5.9 t -154.49 163.49 40.12 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 106.024 -1.843 . . . . 0.0 106.024 -178.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -110.16 110.61 21.52 Favored 'General case' 0 N--CA 1.422 -1.829 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 171.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 26.5 t80 . . . . . 0 C--N 1.285 -2.213 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 -179.186 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 4.2 mp . . . . . 0 C--O 1.249 1.035 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 227' ' ' MET . . . . . . . . . . . . . 93.1 mmm -72.35 137.92 81.18 Favored Pre-proline 0 C--N 1.317 -0.833 0 O-C-N 123.621 0.576 . . . . 0.0 110.337 178.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 228' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -63.16 160.81 32.78 Favored 'Trans proline' 0 CA--C 1.536 0.623 0 C-N-CA 123.752 2.968 . . . . 0.0 114.615 -174.28 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . -80.1 171.11 54.23 Favored Glycine 0 N--CA 1.442 -0.938 0 CA-C-N 115.077 -0.965 . . . . 0.0 113.438 -178.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 7.9 m -72.15 -15.7 61.97 Favored 'General case' 0 C--N 1.307 -1.261 0 C-N-CA 124.318 1.047 . . . . 0.0 111.772 -175.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 231' ' ' ARG . . . . . 0.499 ' HB2' ' OG ' ' A' ' 52' ' ' SER . 9.9 mmm180 -93.34 -0.03 56.76 Favored 'General case' 0 C--N 1.313 -1.007 0 O-C-N 122.175 -0.328 . . . . 0.0 110.946 -174.56 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 232' ' ' TRP . . . . . . . . . . . . . 21.2 t90 -75.15 127.41 33.14 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-O 122.655 1.216 . . . . 0.0 112.419 -176.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 233' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -123.95 144.17 49.95 Favored 'General case' 0 C--N 1.263 -3.161 0 N-CA-C 102.424 -3.176 . . . . 0.0 102.424 174.444 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.276 0 C-N-CA 128.415 2.912 . . . . 0.0 116.375 -178.239 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 240' ' ' GLY . . . . . 0.433 ' O ' ' HG2' ' B' ' 244' ' ' LYS . . . . . . . . 0 N--CA 1.426 -1.98 0 N-CA-C 110.204 -1.158 . . . . 0.0 110.204 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 37.8 p90 -75.18 -33.72 61.48 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -176.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -61.57 -45.33 94.6 Favored 'General case' 0 CA--C 1.507 -0.703 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.52 -178.033 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -62.28 -34.31 76.32 Favored 'General case' 0 C--O 1.212 -0.892 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.266 -179.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 244' ' ' LYS . . . . . 0.433 ' HG2' ' O ' ' B' ' 240' ' ' GLY . 71.6 mmtt -64.87 -47.79 76.59 Favored 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 -179.028 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 245' ' ' TRP . . . . . . . . . . . . . 37.8 m0 -66.14 -37.28 85.3 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.677 178.079 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 246' ' ' PHE . . . . . 0.551 ' O ' ' HG2' ' B' ' 249' ' ' GLN . 2.5 t80 -66.89 -30.36 70.5 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.809 176.612 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -77.7 -40.02 42.74 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.954 179.379 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.36 -19.26 43.09 Favored 'General case' 0 CA--C 1.506 -0.718 0 CA-C-O 120.84 0.352 . . . . 0.0 111.678 -175.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 249' ' ' GLN . . . . . 0.551 ' HG2' ' O ' ' B' ' 246' ' ' PHE . 3.0 pt20 -70.44 -0.56 8.58 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.739 -178.268 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 250' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -57.78 -32.18 67.27 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.992 177.2 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -89.83 106.56 18.55 Favored 'General case' 0 N--CA 1.428 -1.542 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 176.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 252' ' ' ILE . . . . . . . . . . . . . 37.9 pt -92.8 -33.93 5.69 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.851 0 CA-C-N 115.028 -0.987 . . . . 0.0 112.316 -174.004 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -89.26 -11.45 43.53 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-O 121.349 0.595 . . . . 0.0 110.745 -176.123 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 254' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.287 -2.126 0 CA-C-N 114.971 -1.013 . . . . 0.0 111.16 -177.024 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.417 ' HA ' HG22 ' A' ' 85' ' ' THR . . . . . . . . 0 N--CA 1.44 -0.953 0 CA-C-O 120.567 0.223 . . . . 0.0 110.46 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 16.3 m-85 -99.72 145.18 27.95 Favored 'General case' 0 N--CA 1.433 -1.283 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 -177.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 24.7 pt -140.1 156.44 24.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 CA-C-O 121.157 0.504 . . . . 0.0 110.636 175.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 49.0 t80 -106.87 123.73 48.58 Favored 'General case' 0 N--CA 1.408 -2.564 0 CA-C-N 114.396 -1.275 . . . . 0.0 107.607 177.168 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.407 HG21 ' CD1' ' A' ' 104' ' ' ILE . 8.3 mt -107.89 127.57 63.88 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.55 0 N-CA-C 105.831 -1.915 . . . . 0.0 105.831 175.224 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -126.61 164.06 20.31 Favored Glycine 0 C--N 1.272 -2.975 0 N-CA-C 110.612 -0.995 . . . . 0.0 110.612 -179.076 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 70.94 39.9 0.97 Allowed 'General case' 0 CA--C 1.506 -0.74 0 C-N-CA 124.18 0.992 . . . . 0.0 110.715 -177.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.4 HD21 ' HA ' ' A' ' 74' ' ' PHE . 4.4 mm? -73.44 151.81 40.98 Favored 'General case' 0 CA--C 1.497 -1.07 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.867 176.007 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.45 ' HB3' ' HG ' ' A' ' 42' ' ' LEU . 50.2 t-20 -96.14 147.98 23.17 Favored 'General case' 0 C--N 1.286 -2.188 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 177.657 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.403 HH11 ' HD3' ' A' ' 40' ' ' ARG . 0.3 OUTLIER -63.39 -19.41 64.65 Favored 'General case' 0 C--N 1.298 -1.672 0 C-N-CA 123.326 0.651 . . . . 0.0 111.985 179.944 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.427 ' HG2' ' CG ' ' A' ' 39' ' ' ASN . 12.9 pt-20 -91.93 -3.54 55.81 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.903 -179.179 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.45 ' HG ' ' HB3' ' A' ' 39' ' ' ASN . 78.3 mt -91.09 124.03 35.0 Favored 'General case' 0 CA--C 1.504 -0.818 0 CA-C-O 121.117 0.485 . . . . 0.0 110.285 -179.63 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 67.2 p -109.72 173.78 6.17 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 114.705 -1.134 . . . . 0.0 109.409 -178.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.517 ' CG ' ' HB2' ' A' ' 62' ' ' LEU . 51.9 mt-10 -55.66 -38.91 70.2 Favored 'General case' 0 C--N 1.328 -0.333 0 O-C-N 123.47 0.481 . . . . 0.0 110.293 178.354 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -59.96 -43.11 98.43 Favored Glycine 0 C--O 1.24 0.483 0 CA-C-N 115.928 -0.578 . . . . 0.0 113.105 179.266 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -61.68 -49.17 77.57 Favored 'General case' 0 CA--C 1.499 -0.981 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 41.7 mt -60.86 -46.07 96.97 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.931 0 CA-C-N 114.833 -1.076 . . . . 0.0 110.63 -179.529 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 36.1 mt -60.07 -45.73 91.91 Favored 'General case' 0 CA--C 1.491 -1.293 0 C-N-CA 122.511 0.325 . . . . 0.0 111.81 -176.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 97.5 m -62.88 -45.32 93.1 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 123.39 0.431 . . . . 0.0 111.751 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 76.6 t -67.28 -45.51 85.94 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.92 -179.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -66.96 -22.8 65.91 Favored 'General case' 0 N--CA 1.435 -1.184 0 C-N-CA 123.483 0.713 . . . . 0.0 111.941 -179.355 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.597 ' OG ' ' HB2' ' B' ' 231' ' ' ARG . 73.2 m -71.73 -16.54 62.22 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 116.177 -0.465 . . . . 0.0 112.141 176.139 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -73.53 -20.75 60.57 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 175.319 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.442 ' CE1' ' HB2' ' A' ' 91' ' ' ASN . 68.3 m-85 -97.76 -5.1 35.71 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-N 115.898 -0.592 . . . . 0.0 112.315 -176.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 151.7 -153.65 25.07 Favored Glycine 0 N--CA 1.423 -2.2 0 C-N-CA 120.511 -0.852 . . . . 0.0 111.317 179.212 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 99.5 t -106.61 104.51 51.26 Favored Pre-proline 0 C--N 1.305 -1.364 0 CA-C-O 120.469 0.176 . . . . 0.0 111.28 -177.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.411 ' HB3' HD22 ' A' ' 77' ' ' LEU . 87.8 Cg_endo -76.8 140.09 20.4 Favored 'Trans proline' 0 C--O 1.24 0.61 0 C-N-CA 123.011 2.474 . . . . 0.0 110.141 175.342 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 34.1 m -117.78 -26.04 2.77 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 C-N-CA 119.815 -0.754 . . . . 0.0 111.84 -179.35 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.518 ' HB3' ' HG2' ' A' ' 78' ' ' LYS . 30.5 t70 -149.52 136.48 19.65 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 -173.434 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 14.3 p -145.96 134.1 16.05 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.051 0 O-C-N 123.548 0.53 . . . . 0.0 110.165 -178.361 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 97.3 mt -121.37 120.15 61.12 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 175.173 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.517 ' HB2' ' CG ' ' A' ' 44' ' ' GLU . 0.1 OUTLIER -91.43 115.56 28.14 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 105.957 -1.868 . . . . 0.0 105.957 173.409 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 13.2 m -72.62 116.68 13.38 Favored 'General case' 0 N--CA 1.411 -2.379 0 N-CA-C 107.535 -1.284 . . . . 0.0 107.535 177.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 75.8 mtm180 . . . . . 0 C--N 1.287 -2.133 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 -174.753 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 15.6 mm-40 . . . . . 0 CA--C 1.516 -0.328 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 102.35 8.59 43.54 Favored Glycine 0 N--CA 1.431 -1.644 0 C-N-CA 120.27 -0.967 . . . . 0.0 111.636 179.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.4 ' HA ' HD21 ' A' ' 38' ' ' LEU . 34.9 p90 -148.78 159.86 43.75 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 177.044 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -156.07 172.73 17.9 Favored 'General case' 0 C--N 1.308 -1.231 0 O-C-N 123.581 0.551 . . . . 0.0 110.561 178.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -130.22 141.37 50.64 Favored 'General case' 0 C--N 1.308 -1.235 0 C-N-CA 123.723 0.809 . . . . 0.0 110.089 -179.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.411 HD22 ' HB3' ' A' ' 57' ' ' PRO . 9.4 tt -149.21 140.85 23.48 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 175.104 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.518 ' HG2' ' HB3' ' A' ' 59' ' ' ASP . 16.5 ptmt -125.93 144.28 50.75 Favored 'General case' 0 N--CA 1.431 -1.425 0 CA-C-O 121.421 0.629 . . . . 0.0 109.821 176.51 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.419 ' HH ' ' CB ' ' A' ' 88' ' ' ALA . 32.6 m-85 -102.6 165.08 11.28 Favored 'General case' 0 C--N 1.283 -2.291 0 CA-C-N 115.164 -0.926 . . . . 0.0 109.362 179.518 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -76.95 -21.49 54.7 Favored 'General case' 0 N--CA 1.428 -1.563 0 C-N-CA 119.997 -0.681 . . . . 0.0 110.07 174.052 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -123.59 132.56 53.91 Favored 'General case' 0 N--CA 1.443 -0.815 0 C-N-CA 120.424 -0.51 . . . . 0.0 110.399 179.164 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -70.47 -19.87 62.91 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 -179.318 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 86.5 mtm180 -66.11 -33.66 76.29 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-O 122.166 0.984 . . . . 0.0 108.978 174.093 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 48.7 m -67.97 -36.98 80.98 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-N 114.86 -1.063 . . . . 0.0 112.208 177.531 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.458 ' O ' HG21 ' A' ' 89' ' ' VAL . 73.1 p -64.96 -45.3 86.27 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 120.244 -0.583 . . . . 0.0 110.9 -177.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 7.1 pt -63.25 -38.69 82.79 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.466 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.161 177.178 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.6 mt -59.23 -43.83 92.35 Favored 'General case' 0 CA--C 1.502 -0.893 0 O-C-N 123.785 0.678 . . . . 0.0 111.423 177.267 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.446 ' O ' ' HB2' ' A' ' 92' ' ' LEU . . . -69.09 -46.53 67.53 Favored 'General case' 0 N--CA 1.424 -1.728 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.745 -179.418 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.458 HG21 ' O ' ' A' ' 85' ' ' THR . 92.7 t -56.64 -46.39 82.81 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.745 0 CA-C-O 121.648 0.737 . . . . 0.0 110.569 178.136 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -58.87 -40.14 83.44 Favored 'General case' 0 C--N 1.292 -1.926 0 C-N-CA 125.843 1.657 . . . . 0.0 112.329 -175.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.442 ' HB2' ' CE1' ' A' ' 54' ' ' TYR . 47.0 m-80 -98.46 -27.88 13.86 Favored 'General case' 0 C--N 1.294 -1.846 0 N-CA-C 113.129 0.788 . . . . 0.0 113.129 -175.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.446 ' HB2' ' O ' ' A' ' 88' ' ' ALA . 15.5 mt -90.07 -30.73 17.51 Favored 'General case' 0 CA--C 1.471 -2.091 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.706 -171.796 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -65.98 124.74 23.35 Favored 'General case' 0 N--CA 1.425 -1.685 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 88.75 -5.48 84.57 Favored Glycine 0 C--N 1.308 -1.003 0 C-N-CA 121.167 -0.539 . . . . 0.0 112.65 -178.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 53.6 t80 -88.69 139.75 30.15 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 -179.041 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 12.3 mptt -95.87 118.18 32.01 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-O 120.92 0.391 . . . . 0.0 111.649 -176.292 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 53.0 mt -121.33 140.73 44.52 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 173.081 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 57.22 27.22 57.43 Favored Glycine 0 C--O 1.22 -0.756 0 C-N-CA 121.327 -0.463 . . . . 0.0 112.567 -179.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 88.07 -5.81 84.34 Favored Glycine 0 CA--C 1.536 1.376 0 N-CA-C 114.541 0.577 . . . . 0.0 114.541 179.028 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 16.8 ptp180 -126.34 149.89 48.89 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 118.16 0.98 . . . . 0.0 111.901 -177.039 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -84.84 116.8 23.5 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.525 -175.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 12.9 mt -66.51 141.4 57.89 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-O 121.76 0.791 . . . . 0.0 112.797 178.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 4.3 tppp? -117.2 116.59 27.58 Favored 'General case' 0 N--CA 1.411 -2.419 0 CA-C-N 114.67 -1.15 . . . . 0.0 108.123 176.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.407 ' CD1' HG21 ' A' ' 35' ' ' ILE . 4.1 mm -115.64 133.64 61.36 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.931 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 -179.69 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -143.6 150.89 39.47 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 -179.405 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 41.7 m-70 -79.42 131.63 36.14 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-O 121.132 0.492 . . . . 0.0 110.33 177.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 15.1 t -143.77 156.38 44.48 Favored 'General case' 0 C--N 1.288 -2.068 0 N-CA-C 106.072 -1.825 . . . . 0.0 106.072 -179.445 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 30.3 p90 -101.13 109.17 21.02 Favored 'General case' 0 N--CA 1.42 -1.944 0 C-N-CA 117.173 -1.811 . . . . 0.0 107.08 169.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 42.8 t80 . . . . . 0 C--N 1.29 -2.008 0 CA-C-N 114.87 -1.059 . . . . 0.0 108.647 -178.876 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 4.6 mp . . . . . 0 C--O 1.241 0.619 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 227' ' ' MET . . . . . . . . . . . . . 26.3 ptm -71.56 151.72 93.77 Favored Pre-proline 0 C--N 1.318 -0.778 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.387 178.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 228' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -70.94 157.28 58.53 Favored 'Trans proline' 0 C--O 1.245 0.865 0 C-N-CA 123.225 2.617 . . . . 0.0 112.991 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . -84.37 173.44 49.85 Favored Glycine 0 C--N 1.317 -0.51 0 CA-C-N 115.704 -0.68 . . . . 0.0 113.089 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 24.8 m -77.71 -14.3 59.65 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -175.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 231' ' ' ARG . . . . . 0.597 ' HB2' ' OG ' ' A' ' 52' ' ' SER . 3.1 mmp_? -80.16 -7.15 58.8 Favored 'General case' 0 C--N 1.326 -0.43 0 O-C-N 121.964 -0.46 . . . . 0.0 110.365 177.657 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 232' ' ' TRP . . . . . . . . . . . . . 22.8 t90 -73.1 127.17 31.8 Favored 'General case' 0 CA--C 1.5 -0.966 0 CA-C-O 122.355 1.074 . . . . 0.0 111.819 -178.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 233' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -123.23 146.47 47.81 Favored 'General case' 0 C--N 1.269 -2.92 0 N-CA-C 102.436 -3.172 . . . . 0.0 102.436 173.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.611 0 C-N-CA 128.101 2.763 . . . . 0.0 116.129 -179.472 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 240' ' ' GLY . . . . . 0.42 ' O ' ' HG2' ' B' ' 244' ' ' LYS . . . . . . . . 0 N--CA 1.412 -2.93 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 10.0 p90 -75.42 -32.85 60.84 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 178.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -60.5 -42.38 96.24 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.148 0.499 . . . . 0.0 110.285 -179.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -64.79 -35.42 81.03 Favored 'General case' 0 C--O 1.202 -1.439 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.677 179.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 244' ' ' LYS . . . . . 0.42 ' HG2' ' O ' ' B' ' 240' ' ' GLY . 39.6 mmtm -60.78 -47.46 86.23 Favored 'General case' 0 C--O 1.242 0.665 0 CA-C-O 121.29 0.567 . . . . 0.0 109.865 -178.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 245' ' ' TRP . . . . . . . . . . . . . 19.4 m0 -63.55 -41.05 98.45 Favored 'General case' 0 N--CA 1.437 -1.096 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.225 179.174 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 246' ' ' PHE . . . . . 0.464 ' HA ' ' HG2' ' B' ' 249' ' ' GLN . 3.6 t80 -68.14 -34.35 76.19 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.348 179.271 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -70.19 -35.35 73.89 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.699 -178.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.41 -21.73 22.89 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 120.357 -0.537 . . . . 0.0 111.789 -178.18 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 249' ' ' GLN . . . . . 0.464 ' HG2' ' HA ' ' B' ' 246' ' ' PHE . 3.5 pt20 -78.31 2.24 19.17 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.386 0.612 . . . . 0.0 110.402 -179.494 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 250' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -57.28 -31.93 66.1 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 114.892 -1.049 . . . . 0.0 112.864 178.917 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -77.18 142.66 39.53 Favored 'General case' 0 N--CA 1.433 -1.28 0 CA-C-O 121.986 0.898 . . . . 0.0 113.292 -176.768 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 252' ' ' ILE . . . . . . . . . . . . . 34.3 pt -130.67 -32.01 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 CA-C-N 114.487 -1.233 . . . . 0.0 113.078 -171.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -110.79 -23.05 11.25 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 121.624 0.726 . . . . 0.0 110.296 -175.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 254' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 . . . . . 0 C--N 1.295 -1.787 0 CA-C-N 114.038 -1.437 . . . . 0.0 114.117 -173.868 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.437 -1.081 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -100.31 145.23 28.38 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 -177.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 23.1 pt -141.06 159.81 23.12 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 CA-C-O 121.025 0.44 . . . . 0.0 110.953 175.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 45.0 t80 -109.42 122.49 47.49 Favored 'General case' 0 N--CA 1.421 -1.901 0 CA-C-N 114.485 -1.234 . . . . 0.0 108.206 177.533 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.401 HG21 ' CD1' ' A' ' 104' ' ' ILE . 8.2 mt -108.56 128.0 64.55 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.164 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 174.562 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -129.98 165.6 22.33 Favored Glycine 0 C--N 1.283 -2.415 0 N-CA-C 110.832 -0.907 . . . . 0.0 110.832 -179.571 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 71.13 35.16 1.67 Allowed 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.865 1.266 . . . . 0.0 110.667 -177.359 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -68.47 152.77 44.93 Favored 'General case' 0 CA--C 1.497 -1.085 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.25 176.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.404 ' HB3' ' HG ' ' A' ' 42' ' ' LEU . 39.7 t-20 -91.63 151.94 20.47 Favored 'General case' 0 C--N 1.29 -1.988 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 176.55 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -64.16 -17.21 63.27 Favored 'General case' 0 C--N 1.307 -1.253 0 C-N-CA 122.997 0.519 . . . . 0.0 111.734 179.837 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -97.27 3.55 51.26 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.107 -178.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.404 ' HG ' ' HB3' ' A' ' 39' ' ' ASN . 86.3 mt -98.46 117.33 32.64 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-O 121.589 0.709 . . . . 0.0 111.029 -179.128 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 68.2 p -107.23 174.74 5.76 Favored 'General case' 0 C--N 1.293 -1.866 0 CA-C-N 114.346 -1.297 . . . . 0.0 109.186 -179.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -54.46 -41.34 69.35 Favored 'General case' 0 C--O 1.209 -1.032 0 C-N-CA 123.19 0.596 . . . . 0.0 110.158 178.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.27 -39.47 96.08 Favored Glycine 0 CA--C 1.526 0.742 0 O-C-N 123.26 0.35 . . . . 0.0 112.901 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -66.8 -48.02 70.27 Favored 'General case' 0 CA--C 1.499 -1.004 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 179.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 42.0 mt -60.26 -46.36 94.92 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.782 0 CA-C-N 114.844 -1.071 . . . . 0.0 110.762 178.453 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 52.3 mt -59.77 -38.59 82.27 Favored 'General case' 0 CA--C 1.486 -1.502 0 C-N-CA 122.86 0.464 . . . . 0.0 111.525 -177.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 62.1 m -64.38 -46.79 81.83 Favored 'General case' 0 N--CA 1.433 -1.281 0 O-C-N 123.615 0.572 . . . . 0.0 110.716 -179.115 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 89.6 t -67.72 -47.91 78.0 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.624 -179.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -65.02 -25.07 67.69 Favored 'General case' 0 N--CA 1.435 -1.196 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.881 -177.145 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 59.8 m -67.59 -22.17 65.38 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.239 -0.437 . . . . 0.0 112.031 176.325 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -64.91 -28.94 69.88 Favored 'General case' 0 CA--C 1.559 1.322 0 CA-C-O 121.485 0.66 . . . . 0.0 109.917 175.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 49.1 m-85 -91.3 -18.24 24.65 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-O 121.24 0.543 . . . . 0.0 112.097 -175.204 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 165.19 -160.49 33.83 Favored Glycine 0 N--CA 1.419 -2.457 0 N-CA-C 111.011 -0.836 . . . . 0.0 111.011 179.484 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 62.2 t -100.2 110.8 60.92 Favored Pre-proline 0 C--N 1.294 -1.833 0 N-CA-C 110.347 -0.242 . . . . 0.0 110.347 -178.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.446 ' HB3' HD22 ' A' ' 77' ' ' LEU . 73.2 Cg_endo -76.05 141.07 23.33 Favored 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 122.645 2.23 . . . . 0.0 109.764 175.075 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 33.7 m -119.9 -13.57 9.1 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 C-N-CA 120.117 -0.633 . . . . 0.0 112.188 -179.275 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.42 ' HB3' ' HG2' ' A' ' 78' ' ' LYS . 33.2 t70 -164.09 136.85 5.07 Favored 'General case' 0 CA--C 1.501 -0.911 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.219 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 13.0 p -144.72 133.36 17.83 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 O-C-N 123.729 0.643 . . . . 0.0 110.01 -179.172 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 94.1 mt -121.9 128.98 75.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 176.019 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -99.36 117.28 33.45 Favored 'General case' 0 N--CA 1.419 -1.99 0 N-CA-C 105.364 -2.088 . . . . 0.0 105.364 173.394 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 62.8 m -78.61 117.82 20.14 Favored 'General case' 0 C--N 1.275 -2.655 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 176.131 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 85.8 mtt180 . . . . . 0 C--N 1.304 -1.394 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 -175.401 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 13.4 mm-40 . . . . . 0 CA--C 1.504 -0.815 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 87.21 4.23 81.44 Favored Glycine 0 N--CA 1.433 -1.514 0 C-N-CA 120.221 -0.99 . . . . 0.0 112.344 -179.393 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 31.5 p90 -142.1 155.34 45.35 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 177.509 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -149.75 171.84 16.07 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-O 120.94 0.4 . . . . 0.0 110.88 -179.375 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -130.3 140.85 50.63 Favored 'General case' 0 C--N 1.31 -1.118 0 C-N-CA 123.854 0.861 . . . . 0.0 109.963 -178.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.446 HD22 ' HB3' ' A' ' 57' ' ' PRO . 9.8 tt -149.94 140.55 22.55 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 175.532 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.42 ' HG2' ' HB3' ' A' ' 59' ' ' ASP . 16.9 ptmt -125.05 144.56 50.34 Favored 'General case' 0 N--CA 1.433 -1.276 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 177.781 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 61.3 m-85 -104.48 164.94 11.39 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-O 121.614 0.721 . . . . 0.0 112.321 -177.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -75.86 -30.74 59.0 Favored 'General case' 0 N--CA 1.437 -1.089 0 CA-C-N 114.33 -1.304 . . . . 0.0 109.4 175.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -122.01 133.22 54.81 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 -179.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -70.06 -19.93 63.26 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 114.254 1.205 . . . . 0.0 114.254 -177.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 88.4 mtm180 -65.8 -33.21 75.33 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-O 122.299 1.047 . . . . 0.0 109.863 174.135 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.498 ' OG ' HG22 ' B' ' 226' ' ' ILE . 66.2 m -63.27 -36.77 84.78 Favored 'General case' 0 C--N 1.288 -2.101 0 CA-C-N 114.985 -1.007 . . . . 0.0 112.947 178.852 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 77.2 p -64.2 -45.54 87.85 Favored 'General case' 0 C--O 1.224 -0.25 0 C-N-CA 120.229 -0.588 . . . . 0.0 110.779 -177.554 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 5.2 pt -64.94 -38.86 83.85 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.309 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.837 177.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 6.4 mt -58.55 -43.53 89.32 Favored 'General case' 0 CA--C 1.505 -0.779 0 O-C-N 123.812 0.695 . . . . 0.0 110.668 177.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.496 ' O ' ' HB2' ' A' ' 92' ' ' LEU . . . -71.97 -43.76 64.65 Favored 'General case' 0 N--CA 1.42 -1.933 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.708 179.536 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 79.3 t -58.85 -49.04 84.35 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.751 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -71.18 -27.8 63.79 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -172.488 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -96.58 -25.62 15.54 Favored 'General case' 0 C--N 1.296 -1.759 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.761 -177.367 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.496 ' HB2' ' O ' ' A' ' 88' ' ' ALA . 12.1 mt -95.33 -22.66 17.61 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 122.052 -0.405 . . . . 0.0 111.471 -178.049 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -65.21 124.93 23.46 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 177.361 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 81.79 -0.99 87.59 Favored Glycine 0 C--O 1.243 0.666 0 C-N-CA 120.882 -0.675 . . . . 0.0 113.143 177.564 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 62.0 t80 -85.35 144.1 28.25 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 -178.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 11.8 mptt -99.88 118.78 37.05 Favored 'General case' 0 N--CA 1.44 -0.955 0 CA-C-O 121.336 0.589 . . . . 0.0 112.512 -176.396 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 58.6 mt -127.59 141.46 46.32 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.188 0 N-CA-C 105.842 -1.91 . . . . 0.0 105.842 173.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 61.1 20.06 57.66 Favored Glycine 0 CA--C 1.519 0.312 0 C-N-CA 121.143 -0.551 . . . . 0.0 112.373 -177.406 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 78.13 7.49 87.65 Favored Glycine 0 N--CA 1.436 -1.362 0 CA-C-N 115.834 -0.183 . . . . 0.0 113.217 -178.011 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 16.7 ptp180 -124.78 147.95 48.4 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 117.534 0.667 . . . . 0.0 110.405 -179.555 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -87.7 116.32 25.75 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 116.585 -0.28 . . . . 0.0 111.587 -175.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 12.7 mt -65.84 144.62 56.72 Favored 'General case' 0 C--O 1.252 1.186 0 CA-C-O 121.875 0.845 . . . . 0.0 113.103 179.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 29.2 tptp -118.72 115.47 24.55 Favored 'General case' 0 N--CA 1.416 -2.148 0 CA-C-N 114.806 -1.088 . . . . 0.0 108.216 176.076 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.401 ' CD1' HG21 ' A' ' 35' ' ' ILE . 4.7 mm -114.69 134.46 57.61 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.966 0 N-CA-C 105.859 -1.904 . . . . 0.0 105.859 178.328 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -143.12 151.99 41.32 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -176.138 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 56.2 m-70 -83.34 130.48 35.06 Favored 'General case' 0 C--N 1.295 -1.804 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 177.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 7.3 t -147.28 163.42 36.45 Favored 'General case' 0 C--N 1.291 -1.973 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 -178.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 46.5 m-85 -110.13 111.03 22.11 Favored 'General case' 0 N--CA 1.42 -1.96 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 171.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 63.7 t80 . . . . . 0 C--N 1.294 -1.819 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.783 -176.41 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 226' ' ' ILE . . . . . 0.498 HG22 ' OG ' ' A' ' 84' ' ' SER . 4.0 mp . . . . . 0 N--CA 1.437 -1.087 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 227' ' ' MET . . . . . . . . . . . . . 65.8 mtt -61.92 134.2 94.13 Favored Pre-proline 0 C--N 1.322 -0.626 0 O-C-N 123.466 0.479 . . . . 0.0 111.516 -179.161 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 228' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -72.34 140.28 33.36 Favored 'Trans proline' 0 C--O 1.251 1.138 0 C-N-CA 123.13 2.554 . . . . 0.0 112.703 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . -65.65 164.01 39.16 Favored Glycine 0 C--N 1.317 -0.526 0 CA-C-N 115.573 -0.739 . . . . 0.0 113.372 -179.528 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 14.6 m -72.06 -18.08 61.96 Favored 'General case' 0 C--N 1.31 -1.149 0 C-N-CA 123.331 0.652 . . . . 0.0 112.375 -175.172 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 13.6 mmm180 -82.06 -3.45 54.67 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.92 0.391 . . . . 0.0 111.146 -177.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 232' ' ' TRP . . . . . . . . . . . . . 24.9 t90 -72.04 123.52 22.97 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-O 122.405 1.097 . . . . 0.0 111.502 179.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 233' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -113.14 144.48 42.59 Favored 'General case' 0 C--N 1.276 -2.617 0 N-CA-C 101.095 -3.669 . . . . 0.0 101.095 171.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.059 0 C-N-CA 127.361 2.41 . . . . 0.0 115.836 -178.795 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 240' ' ' GLY . . . . . 0.465 ' O ' ' HG2' ' B' ' 244' ' ' LYS . . . . . . . . 0 N--CA 1.423 -2.199 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 20.8 p90 -76.27 -38.12 56.63 Favored 'General case' 0 C--N 1.293 -1.868 0 C-N-CA 123.768 0.827 . . . . 0.0 112.318 179.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -60.71 -42.78 97.93 Favored 'General case' 0 C--O 1.243 0.741 0 C-N-CA 122.353 0.261 . . . . 0.0 111.281 -177.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -62.0 -34.99 77.2 Favored 'General case' 0 C--O 1.211 -0.935 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.476 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 244' ' ' LYS . . . . . 0.465 ' HG2' ' O ' ' B' ' 240' ' ' GLY . 43.9 mmtm -64.45 -47.85 77.52 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-O 121.133 0.492 . . . . 0.0 110.523 -177.718 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 245' ' ' TRP . . . . . . . . . . . . . 13.6 m0 -65.8 -39.12 90.6 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.225 178.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 246' ' ' PHE . . . . . 0.485 ' O ' ' HG2' ' B' ' 249' ' ' GLN . 2.7 t80 -64.97 -37.12 86.61 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.634 178.181 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -68.49 -35.42 77.5 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.591 -179.536 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.33 -16.71 28.67 Favored 'General case' 0 CA--C 1.509 -0.6 0 N-CA-C 111.887 0.329 . . . . 0.0 111.887 -177.782 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 249' ' ' GLN . . . . . 0.485 ' HG2' ' O ' ' B' ' 246' ' ' PHE . 3.2 pt20 -81.07 2.8 25.64 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-O 120.839 0.352 . . . . 0.0 110.456 -179.299 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 250' ' ' ASN . . . . . 0.434 ' OD1' ' HG3' ' B' ' 251' ' ' GLU . 7.9 p30 -52.37 -39.69 61.09 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.514 178.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 251' ' ' GLU . . . . . 0.434 ' HG3' ' OD1' ' B' ' 250' ' ' ASN . 46.2 mt-10 -133.66 121.36 21.88 Favored 'General case' 0 N--CA 1.435 -1.205 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 174.43 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 252' ' ' ILE . . . . . . . . . . . . . 38.1 pt -96.91 -34.34 4.91 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -174.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -100.46 -17.76 17.02 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-O 121.969 0.89 . . . . 0.0 109.58 -178.471 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 254' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.293 -1.88 0 CA-C-N 114.35 -1.295 . . . . 0.0 108.409 179.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.452 ' HA ' HG22 ' A' ' 85' ' ' THR . . . . . . . . 0 CA--C 1.503 -0.847 0 CA-C-O 120.869 0.366 . . . . 0.0 110.322 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 57.5 m-85 -102.13 144.49 30.62 Favored 'General case' 0 N--CA 1.429 -1.496 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 -178.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 27.5 pt -143.24 162.55 16.85 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 CA-C-O 121.458 0.646 . . . . 0.0 110.869 -179.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -114.45 125.88 54.33 Favored 'General case' 0 N--CA 1.412 -2.359 0 CA-C-N 114.085 -1.416 . . . . 0.0 108.123 175.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 10.2 mt -108.51 127.53 64.85 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.998 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 176.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -125.68 164.2 19.35 Favored Glycine 0 C--N 1.279 -2.596 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 -179.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 66.9 m-20 71.46 45.0 0.49 Allowed 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 125.346 1.458 . . . . 0.0 110.219 -177.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.405 HD21 ' HA ' ' A' ' 74' ' ' PHE . 4.2 mm? -76.21 144.63 40.31 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.281 177.08 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 42.8 t-20 -83.88 147.23 27.64 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 176.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.518 ' HD2' ' C ' ' A' ' 40' ' ' ARG . 6.6 ppt_? -59.2 -22.02 60.36 Favored 'General case' 0 C--N 1.311 -1.068 0 C-N-CA 123.78 0.832 . . . . 0.0 111.921 -179.73 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.442 ' N ' ' HD2' ' A' ' 40' ' ' ARG . 12.9 pt-20 -92.8 -10.99 34.9 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.818 -176.207 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 71.6 mt -79.86 132.5 36.12 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.214 0.531 . . . . 0.0 111.504 -176.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 35.1 p -119.86 173.73 6.87 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 114.852 -1.067 . . . . 0.0 110.44 -178.317 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 -55.35 -39.31 69.88 Favored 'General case' 0 C--O 1.221 -0.417 0 C-N-CA 123.2 0.6 . . . . 0.0 111.05 179.33 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.95 -38.58 95.69 Favored Glycine 0 N--CA 1.448 -0.559 0 CA-C-N 116.013 -0.54 . . . . 0.0 112.597 -179.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -67.08 -49.51 64.8 Favored 'General case' 0 CA--C 1.492 -1.273 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 37.7 mt -60.43 -47.12 93.89 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.931 0 CA-C-N 114.791 -1.095 . . . . 0.0 110.78 -179.246 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 36.7 mt -59.68 -42.36 92.78 Favored 'General case' 0 CA--C 1.494 -1.179 0 CA-C-N 116.572 -0.285 . . . . 0.0 111.714 -176.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 68.8 m -65.66 -46.02 80.73 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 123.541 0.526 . . . . 0.0 111.649 -178.235 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 58.4 t -67.69 -45.74 84.12 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-O 121.42 0.629 . . . . 0.0 110.39 -178.127 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -64.63 -25.3 67.9 Favored 'General case' 0 N--CA 1.431 -1.387 0 CA-C-N 115.082 -0.963 . . . . 0.0 111.921 -179.452 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.576 ' OG ' ' HB2' ' B' ' 231' ' ' ARG . 66.9 m -70.23 -19.43 63.14 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 176.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -72.54 -20.9 61.26 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-O 121.669 0.747 . . . . 0.0 109.68 176.209 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.406 ' CE1' ' HB2' ' A' ' 91' ' ' ASN . 60.1 m-85 -94.65 -19.98 19.97 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.853 -178.663 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.427 ' O ' ' HA ' ' A' ' 52' ' ' SER . . . 167.17 -152.91 22.06 Favored Glycine 0 N--CA 1.424 -2.139 0 C-N-CA 120.741 -0.742 . . . . 0.0 111.403 179.017 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 87.7 t -105.58 110.57 64.38 Favored Pre-proline 0 C--N 1.295 -1.766 0 N-CA-C 110.307 -0.257 . . . . 0.0 110.307 -177.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.422 ' HB3' HD22 ' A' ' 77' ' ' LEU . 73.9 Cg_endo -78.24 135.99 14.01 Favored 'Trans proline' 0 N--CA 1.44 -1.65 0 C-N-CA 121.846 1.697 . . . . 0.0 109.2 174.685 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 35.8 m -113.18 -19.95 6.51 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 C-N-CA 119.726 -0.789 . . . . 0.0 111.57 -177.33 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.435 ' HB3' ' HG2' ' A' ' 78' ' ' LYS . 36.1 t70 -159.34 140.68 12.95 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 179.801 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 13.1 p -143.67 136.31 23.99 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 O-C-N 123.793 0.683 . . . . 0.0 109.868 -179.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 99.1 mt -122.37 125.82 73.32 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 C-N-CA 123.112 0.565 . . . . 0.0 109.503 173.19 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -98.71 118.64 35.9 Favored 'General case' 0 N--CA 1.419 -1.998 0 N-CA-C 104.963 -2.236 . . . . 0.0 104.963 173.252 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 17.8 m -81.03 116.52 21.02 Favored 'General case' 0 N--CA 1.408 -2.561 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 179.349 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 64.8 mtm180 . . . . . 0 C--N 1.299 -1.614 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 -178.132 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 . . . . . 0 N--CA 1.442 -0.84 0 CA-C-O 121.345 0.593 . . . . 0.0 110.446 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 95.54 11.69 55.1 Favored Glycine 0 N--CA 1.421 -2.335 0 CA-C-N 115.494 -0.775 . . . . 0.0 112.604 179.078 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.405 ' HA ' HD21 ' A' ' 38' ' ' LEU . 33.0 p90 -152.43 157.52 41.33 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 177.936 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -153.25 172.64 16.67 Favored 'General case' 0 N--CA 1.427 -1.583 0 O-C-N 123.509 0.506 . . . . 0.0 110.2 179.31 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -132.15 144.62 50.81 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 123.761 0.825 . . . . 0.0 110.053 -178.428 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.422 HD22 ' HB3' ' A' ' 57' ' ' PRO . 9.9 tt -153.78 140.72 19.23 Favored 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 175.634 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.435 ' HG2' ' HB3' ' A' ' 59' ' ' ASP . 18.8 ptmt -123.91 144.1 49.97 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 177.578 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.411 ' CD1' HG23 ' A' ' 85' ' ' THR . 39.9 m-85 -102.5 165.04 11.32 Favored 'General case' 0 C--N 1.29 -2.013 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.611 -178.348 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -73.48 -35.32 65.66 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 114.702 -1.136 . . . . 0.0 109.133 175.402 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -124.78 137.59 54.31 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.806 -178.045 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -70.19 -20.08 63.14 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -179.49 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 80.8 mtm180 -65.08 -34.55 78.68 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 122.219 1.009 . . . . 0.0 109.478 174.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.455 ' OG ' HG22 ' B' ' 226' ' ' ILE . 60.3 m -67.43 -37.41 82.97 Favored 'General case' 0 C--N 1.292 -1.92 0 CA-C-N 114.821 -1.082 . . . . 0.0 112.185 178.369 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.47 ' O ' HG21 ' A' ' 89' ' ' VAL . 71.1 p -65.45 -45.12 85.02 Favored 'General case' 0 C--O 1.217 -0.635 0 C-N-CA 120.249 -0.58 . . . . 0.0 110.685 -177.792 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 3.7 pt -63.26 -39.2 84.36 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.317 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.075 177.409 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 30.0 mt -59.79 -43.24 94.5 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 123.44 0.463 . . . . 0.0 110.911 174.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.414 ' O ' ' HB2' ' A' ' 92' ' ' LEU . . . -68.99 -46.5 67.9 Favored 'General case' 0 C--O 1.203 -1.374 0 CA-C-N 115.712 -0.677 . . . . 0.0 110.928 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.47 HG21 ' O ' ' A' ' 85' ' ' THR . 85.9 t -58.88 -48.93 84.78 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.062 0 CA-C-O 120.712 0.291 . . . . 0.0 110.954 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -67.36 -29.77 69.39 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 -174.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.406 ' HB2' ' CE1' ' A' ' 54' ' ' TYR . 11.0 m120 -97.98 -21.02 17.06 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 113.684 0.994 . . . . 0.0 113.684 -178.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.414 ' HB2' ' O ' ' A' ' 88' ' ' ALA . 14.0 mt -98.92 -31.42 11.84 Favored 'General case' 0 CA--C 1.495 -1.172 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -176.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 52.6 t30 -66.39 124.98 24.21 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 85.21 -1.81 88.48 Favored Glycine 0 C--N 1.306 -1.128 0 C-N-CA 121.411 -0.423 . . . . 0.0 112.909 -179.151 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 64.1 t80 -90.09 137.85 32.0 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 179.468 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -93.38 119.5 32.57 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-O 120.914 0.388 . . . . 0.0 111.712 -177.213 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 35.4 mt -118.35 142.45 33.01 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 173.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 71.58 -84.67 0.44 Allowed Glycine 0 N--CA 1.438 -1.195 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 -174.257 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -161.99 17.72 0.16 Allowed Glycine 0 N--CA 1.427 -1.955 0 N-CA-C 110.199 -1.161 . . . . 0.0 110.199 175.268 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 16.6 ptp180 -137.23 149.79 47.41 Favored 'General case' 0 N--CA 1.445 -0.719 0 O-C-N 122.798 -0.236 . . . . 0.0 110.532 -175.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -87.36 122.97 31.82 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.789 -177.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 14.8 mt -66.92 148.24 52.2 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-O 121.745 0.783 . . . . 0.0 112.923 179.013 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 54.3 tptt -121.94 116.47 24.42 Favored 'General case' 0 N--CA 1.418 -2.025 0 CA-C-N 114.911 -1.04 . . . . 0.0 108.824 175.131 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 3.9 mm -116.39 136.09 54.51 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.868 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -143.81 150.57 38.73 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 178.139 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 74.4 m-70 -83.34 137.8 33.81 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 178.057 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 9.0 t -158.62 155.38 28.12 Favored 'General case' 0 C--N 1.291 -1.959 0 N-CA-C 106.247 -1.76 . . . . 0.0 106.247 -177.215 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -93.82 111.83 23.59 Favored 'General case' 0 N--CA 1.435 -1.2 0 C-N-CA 117.571 -1.651 . . . . 0.0 108.057 172.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 30.5 t80 . . . . . 0 C--N 1.294 -1.845 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.676 -179.653 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 226' ' ' ILE . . . . . 0.455 HG22 ' OG ' ' A' ' 84' ' ' SER . 4.3 mp . . . . . 0 C--O 1.245 0.855 0 CA-C-O 120.658 0.266 . . . . 0.0 110.295 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 227' ' ' MET . . . . . . . . . . . . . 90.5 mmm -66.81 137.95 95.09 Favored Pre-proline 0 C--N 1.321 -0.656 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.561 177.156 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 228' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -66.25 157.18 61.31 Favored 'Trans proline' 0 C--O 1.248 0.975 0 C-N-CA 122.938 2.425 . . . . 0.0 113.183 -178.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . -73.36 170.34 52.43 Favored Glycine 0 N--CA 1.439 -1.127 0 CA-C-N 115.412 -0.813 . . . . 0.0 112.237 179.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 20.9 m -77.44 -18.24 57.37 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-O 121.101 0.477 . . . . 0.0 111.23 -177.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 231' ' ' ARG . . . . . 0.576 ' HB2' ' OG ' ' A' ' 52' ' ' SER . 37.9 mmt180 -79.64 -8.16 59.03 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.583 -178.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 232' ' ' TRP . . . . . . . . . . . . . 21.6 t90 -73.54 122.96 23.04 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-O 122.279 1.038 . . . . 0.0 113.05 -176.078 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 233' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -120.47 137.52 54.3 Favored 'General case' 0 C--N 1.276 -2.622 0 N-CA-C 100.773 -3.788 . . . . 0.0 100.773 172.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.513 3.833 0 C-N-CA 128.979 3.18 . . . . 0.0 118.257 -175.674 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 240' ' ' GLY . . . . . 0.401 ' O ' ' HG2' ' B' ' 244' ' ' LYS . . . . . . . . 0 C--O 1.198 -2.098 0 N-CA-C 110.88 -0.888 . . . . 0.0 110.88 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 39.9 p90 -77.26 -34.18 55.83 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-O 120.932 0.396 . . . . 0.0 111.694 177.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -62.79 -41.65 99.36 Favored 'General case' 0 C--O 1.243 0.74 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.459 -174.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -62.98 -35.29 79.69 Favored 'General case' 0 C--O 1.21 -1.002 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.581 -178.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 244' ' ' LYS . . . . . 0.401 ' HG2' ' O ' ' B' ' 240' ' ' GLY . 69.8 mmtt -65.95 -42.99 89.28 Favored 'General case' 0 N--CA 1.439 -1.021 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 -177.381 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 245' ' ' TRP . . . . . . . . . . . . . 46.1 m0 -65.44 -41.99 92.87 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.695 178.182 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 246' ' ' PHE . . . . . 0.466 ' O ' ' HG2' ' B' ' 249' ' ' GLN . 3.0 t80 -66.53 -30.23 70.5 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 121.803 0.811 . . . . 0.0 110.949 178.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -77.44 -39.39 46.99 Favored 'General case' 0 C--N 1.295 -1.786 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.384 178.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.83 -15.33 39.5 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.083 0.468 . . . . 0.0 111.793 -175.117 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 249' ' ' GLN . . . . . 0.466 ' HG2' ' O ' ' B' ' 246' ' ' PHE . 3.9 pt20 -71.46 1.77 5.94 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.804 -179.169 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 250' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -65.34 -29.2 69.91 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 176.014 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -78.29 112.18 15.02 Favored 'General case' 0 N--CA 1.426 -1.642 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 176.4 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 252' ' ' ILE . . . . . . . . . . . . . 29.4 pt -103.51 -34.23 3.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.812 -172.164 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -100.67 -15.52 17.71 Favored 'General case' 0 CA--C 1.497 -1.077 0 CA-C-O 122.224 1.011 . . . . 0.0 108.668 179.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 254' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 . . . . . 0 N--CA 1.417 -2.097 0 CA-C-N 113.843 -1.526 . . . . 0.0 110.493 177.415 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.512 -0.508 0 N-CA-C 110.415 -0.217 . . . . 0.0 110.415 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 16.9 m-85 -111.9 145.01 40.29 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 -175.013 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 28.3 pt -138.65 157.03 29.78 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.172 176.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 56.7 t80 -106.72 121.7 44.89 Favored 'General case' 0 N--CA 1.41 -2.429 0 CA-C-N 114.619 -1.173 . . . . 0.0 107.978 177.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 10.8 mt -108.38 128.03 64.26 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.18 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 175.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -130.25 173.35 19.99 Favored Glycine 0 C--N 1.28 -2.583 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 179.599 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 69.98 31.03 3.47 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.312 0.645 . . . . 0.0 111.16 -178.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -68.55 155.14 40.54 Favored 'General case' 0 CA--C 1.503 -0.85 0 CA-C-O 121.955 0.883 . . . . 0.0 112.231 178.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.483 ' HB3' ' HG ' ' A' ' 42' ' ' LEU . 54.5 t-20 -95.38 146.52 24.33 Favored 'General case' 0 C--N 1.288 -2.104 0 N-CA-C 105.955 -1.868 . . . . 0.0 105.955 174.541 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.484 ' HD2' ' C ' ' A' ' 40' ' ' ARG . 7.2 ppt_? -61.83 -23.01 65.98 Favored 'General case' 0 C--N 1.298 -1.654 0 C-N-CA 123.396 0.678 . . . . 0.0 111.435 179.087 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.442 ' HG2' ' CG ' ' A' ' 39' ' ' ASN . 12.7 pt-20 -88.9 -1.18 57.97 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-O 120.857 0.361 . . . . 0.0 111.33 -178.657 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.483 ' HG ' ' HB3' ' A' ' 39' ' ' ASN . 87.3 mt -91.48 124.63 35.79 Favored 'General case' 0 N--CA 1.432 -1.353 0 CA-C-O 121.618 0.723 . . . . 0.0 110.464 179.792 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 68.0 p -113.66 174.57 5.86 Favored 'General case' 0 C--N 1.286 -2.168 0 CA-C-N 114.213 -1.358 . . . . 0.0 108.82 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.3 mp0 -55.29 -41.4 72.24 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 123.423 0.689 . . . . 0.0 110.739 -179.553 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -61.54 -38.35 95.66 Favored Glycine 0 C--O 1.241 0.557 0 CA-C-N 116.168 -0.469 . . . . 0.0 113.207 -179.127 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -67.4 -48.44 67.34 Favored 'General case' 0 CA--C 1.503 -0.853 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 51.4 mt -59.08 -44.77 92.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 CA-C-N 114.595 -1.184 . . . . 0.0 110.788 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 48.2 mt -59.36 -45.47 91.31 Favored 'General case' 0 CA--C 1.502 -0.891 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.538 -178.394 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 98.0 m -62.11 -45.83 91.73 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 98.7 t -65.39 -49.19 79.91 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 CA-C-O 121.246 0.545 . . . . 0.0 110.41 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -66.17 -24.04 66.57 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 123.885 0.874 . . . . 0.0 113.04 -178.121 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.45 ' OG ' ' HB2' ' B' ' 231' ' ' ARG . 63.0 m -70.59 -17.91 62.9 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 177.072 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -68.56 -25.12 64.74 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 119.683 -0.807 . . . . 0.0 109.285 176.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -92.6 -15.96 26.23 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.114 -175.575 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.408 ' O ' ' HA ' ' A' ' 52' ' ' SER . . . 160.9 -158.61 30.2 Favored Glycine 0 N--CA 1.421 -2.353 0 C-N-CA 120.501 -0.857 . . . . 0.0 111.132 -179.556 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 57.5 t -102.26 111.02 64.0 Favored Pre-proline 0 C--N 1.302 -1.485 0 N-CA-C 111.798 0.296 . . . . 0.0 111.798 -175.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.443 ' HB3' HD22 ' A' ' 77' ' ' LEU . 87.1 Cg_endo -79.05 140.12 15.62 Favored 'Trans proline' 0 N--CA 1.449 -1.131 0 C-N-CA 122.96 2.44 . . . . 0.0 110.354 175.243 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 26.9 m -114.85 -21.95 5.04 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 C-N-CA 120.102 -0.639 . . . . 0.0 111.95 179.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -158.43 145.02 17.38 Favored 'General case' 0 C--O 1.247 0.944 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 -179.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 13.1 p -146.18 133.02 14.43 Favored 'Isoleucine or valine' 0 C--O 1.245 0.819 0 CA-C-O 121.5 0.667 . . . . 0.0 110.356 179.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 95.5 mt -121.06 126.98 75.82 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 177.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -99.55 122.04 42.05 Favored 'General case' 0 C--N 1.292 -1.902 0 N-CA-C 105.469 -2.049 . . . . 0.0 105.469 175.314 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 7.0 t -85.04 123.56 30.72 Favored 'General case' 0 N--CA 1.418 -2.062 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 179.198 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 73.4 mtt85 . . . . . 0 C--N 1.295 -1.777 0 CA-C-O 120.901 0.381 . . . . 0.0 111.038 -179.368 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 17.1 mm-40 . . . . . 0 CA--C 1.511 -0.546 0 CA-C-O 121.108 0.48 . . . . 0.0 110.303 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 92.54 5.59 64.89 Favored Glycine 0 N--CA 1.425 -2.058 0 C-N-CA 120.594 -0.813 . . . . 0.0 111.651 -178.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 31.4 p90 -143.56 152.79 41.86 Favored 'General case' 0 N--CA 1.435 -1.181 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 178.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -148.12 171.97 15.03 Favored 'General case' 0 N--CA 1.427 -1.606 0 O-C-N 123.362 0.414 . . . . 0.0 110.165 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -130.37 139.99 50.62 Favored 'General case' 0 C--N 1.298 -1.655 0 C-N-CA 124.024 0.929 . . . . 0.0 109.952 -178.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.443 HD22 ' HB3' ' A' ' 57' ' ' PRO . 10.3 tt -146.93 140.85 25.95 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 175.739 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -125.04 144.3 50.47 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 178.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 55.8 m-85 -108.49 164.59 12.21 Favored 'General case' 0 C--N 1.29 -2.013 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.614 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -79.0 -35.49 42.78 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 174.165 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -106.49 123.73 48.53 Favored 'General case' 0 N--CA 1.439 -0.999 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 -177.451 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -69.47 -19.3 63.76 Favored 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 113.391 0.886 . . . . 0.0 113.391 -178.518 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 90.6 mtm180 -66.19 -33.24 75.31 Favored 'General case' 0 C--N 1.302 -1.5 0 CA-C-O 121.914 0.864 . . . . 0.0 109.261 173.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 56.9 m -65.33 -37.15 86.23 Favored 'General case' 0 N--CA 1.426 -1.639 0 CA-C-N 115.29 -0.868 . . . . 0.0 112.43 178.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.447 ' O ' HG21 ' A' ' 89' ' ' VAL . 64.9 p -62.73 -45.66 91.69 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 121.061 0.457 . . . . 0.0 110.741 -177.819 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 4.3 pt -66.17 -37.93 80.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.831 177.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 14.0 mt -59.41 -44.12 92.89 Favored 'General case' 0 CA--C 1.509 -0.62 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.641 175.26 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.482 ' O ' ' HB2' ' A' ' 92' ' ' LEU . . . -70.16 -45.51 66.61 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.848 -178.313 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.447 HG21 ' O ' ' A' ' 85' ' ' THR . 87.7 t -56.55 -47.79 81.43 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.967 0 CA-C-O 121.43 0.634 . . . . 0.0 111.119 178.47 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -62.08 -33.74 74.98 Favored 'General case' 0 C--N 1.297 -1.695 0 C-N-CA 125.042 1.337 . . . . 0.0 112.722 -176.337 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -98.44 -30.86 12.3 Favored 'General case' 0 C--N 1.293 -1.874 0 CA-C-N 116.145 -0.479 . . . . 0.0 112.232 -175.55 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.482 ' HB2' ' O ' ' A' ' 88' ' ' ALA . 12.5 mt -93.8 -30.16 14.99 Favored 'General case' 0 CA--C 1.482 -1.648 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 -170.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 57.4 t30 -66.12 125.04 24.26 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 179.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 83.61 -0.69 89.48 Favored Glycine 0 CA--C 1.535 1.287 0 C-N-CA 120.424 -0.893 . . . . 0.0 112.502 -177.48 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 67.8 t80 -89.36 138.42 31.46 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -178.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.46 ' HA ' ' O ' ' A' ' 100' ' ' ARG . 0.3 OUTLIER -92.51 118.52 31.06 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 -175.824 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 55.0 mt -127.64 142.08 44.63 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.259 0 N-CA-C 106.193 -1.78 . . . . 0.0 106.193 172.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 58.47 21.88 50.18 Favored Glycine 0 CA--C 1.524 0.656 0 C-N-CA 121.63 -0.319 . . . . 0.0 113.514 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 87.25 10.75 70.66 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 121.647 -0.311 . . . . 0.0 113.483 179.07 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.46 ' O ' ' HA ' ' A' ' 96' ' ' LYS . 13.6 ptp180 -140.56 148.66 41.33 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 117.985 0.892 . . . . 0.0 111.889 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -82.83 118.02 23.12 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.956 -179.374 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 12.7 mt -65.88 149.56 50.0 Favored 'General case' 0 C--N 1.309 -1.189 0 C-N-CA 124.134 0.974 . . . . 0.0 113.611 178.666 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 55.3 tptt -116.09 120.16 38.15 Favored 'General case' 0 N--CA 1.423 -1.801 0 CA-C-N 114.964 -1.016 . . . . 0.0 108.734 174.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 4.8 mm -121.44 135.36 61.85 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 178.35 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -143.57 153.25 42.37 Favored 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 109.273 -0.639 . . . . 0.0 109.273 -179.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -83.54 137.7 33.74 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 177.645 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 12.3 t -155.16 156.48 35.81 Favored 'General case' 0 N--CA 1.425 -1.724 0 N-CA-C 107.929 -1.138 . . . . 0.0 107.929 -177.117 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 7.7 p90 -97.67 109.86 22.53 Favored 'General case' 0 N--CA 1.423 -1.808 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 168.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 29.1 t80 . . . . . 0 C--N 1.296 -1.746 0 CA-C-N 115.055 -0.975 . . . . 0.0 110.207 -178.175 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 3.7 mp . . . . . 0 C--O 1.24 0.562 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 227' ' ' MET . . . . . . . . . . . . . 68.6 mtt -69.29 139.08 89.52 Favored Pre-proline 0 N--CA 1.452 -0.341 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.354 177.568 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 228' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -69.09 159.0 55.67 Favored 'Trans proline' 0 C--O 1.243 0.726 0 C-N-CA 122.739 2.293 . . . . 0.0 112.893 -178.485 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . -75.3 168.76 54.79 Favored Glycine 0 N--CA 1.441 -0.98 0 CA-C-N 115.442 -0.799 . . . . 0.0 112.749 -179.685 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 9.4 t -77.61 -14.44 59.64 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 121.293 0.568 . . . . 0.0 110.305 -177.511 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 231' ' ' ARG . . . . . 0.45 ' HB2' ' OG ' ' A' ' 52' ' ' SER . 37.2 mmt180 -86.75 -3.93 59.11 Favored 'General case' 0 C--N 1.321 -0.644 0 O-C-N 122.139 -0.351 . . . . 0.0 111.08 -179.178 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 232' ' ' TRP . . . . . . . . . . . . . 21.7 t90 -74.77 128.25 35.12 Favored 'General case' 0 CA--C 1.497 -1.064 0 CA-C-O 122.385 1.088 . . . . 0.0 111.7 -179.142 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 233' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -124.42 147.42 48.29 Favored 'General case' 0 C--N 1.263 -3.158 0 N-CA-C 103.038 -2.949 . . . . 0.0 103.038 172.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.501 3.022 0 C-N-CA 128.702 3.049 . . . . 0.0 116.93 -178.993 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 240' ' ' GLY . . . . . 0.585 ' O ' ' HG2' ' B' ' 243' ' ' GLU . . . . . . . . 0 C--O 1.194 -2.374 0 N-CA-C 111.309 -0.716 . . . . 0.0 111.309 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 17.7 p90 -55.76 -33.81 64.67 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -179.018 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -65.06 -40.9 95.38 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 111.885 0.328 . . . . 0.0 111.885 -176.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 243' ' ' GLU . . . . . 0.585 ' HG2' ' O ' ' B' ' 240' ' ' GLY . 11.4 pt-20 -66.31 -34.87 78.96 Favored 'General case' 0 C--O 1.207 -1.178 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 178.33 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 244' ' ' LYS . . . . . 0.553 ' HG2' ' O ' ' B' ' 240' ' ' GLY . 70.4 mmtt -66.0 -43.55 87.41 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 121.088 0.471 . . . . 0.0 110.555 -177.267 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 245' ' ' TRP . . . . . . . . . . . . . 46.7 m0 -63.94 -41.95 97.46 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.653 0.739 . . . . 0.0 109.358 178.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 246' ' ' PHE . . . . . 0.605 ' O ' ' HG2' ' B' ' 249' ' ' GLN . 1.7 t80 -68.46 -27.59 66.29 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 114.326 -1.306 . . . . 0.0 111.633 178.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -76.77 -39.64 50.98 Favored 'General case' 0 C--N 1.287 -2.12 0 O-C-N 121.907 -0.496 . . . . 0.0 111.597 -177.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 248' ' ' LYS . . . . . 0.41 ' C ' ' H ' ' B' ' 250' ' ' ASN . 2.6 pptp? -85.89 -14.75 43.9 Favored 'General case' 0 CA--C 1.507 -0.675 0 C-N-CA 120.231 -0.588 . . . . 0.0 112.328 -173.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 249' ' ' GLN . . . . . 0.605 ' HG2' ' O ' ' B' ' 246' ' ' PHE . 3.5 pt20 -67.75 -0.6 4.25 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.755 -176.867 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 250' ' ' ASN . . . . . 0.41 ' H ' ' C ' ' B' ' 248' ' ' LYS . 6.7 p30 -74.97 -20.78 59.52 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.975 177.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 27.0 mm-40 -64.83 146.49 54.81 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 115.136 -0.938 . . . . 0.0 113.193 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 252' ' ' ILE . . . . . . . . . . . . . 23.9 pt -97.71 -26.33 3.95 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 CA-C-N 115.045 -0.98 . . . . 0.0 111.118 177.179 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -85.22 -27.98 25.72 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 121.466 0.651 . . . . 0.0 109.696 178.19 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 254' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 . . . . . 0 N--CA 1.422 -1.868 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.703 176.909 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.448 ' HB3' ' NE2' ' A' ' 82' ' ' GLN . . . . . . . . 0 N--CA 1.444 -0.734 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 -99.13 144.5 28.2 Favored 'General case' 0 C--N 1.315 -0.929 0 C-N-CA 120.309 -0.556 . . . . 0.0 109.866 -175.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 33.6 pt -138.14 157.04 31.49 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 CA-C-O 121.107 0.479 . . . . 0.0 110.616 178.096 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 38.9 t80 -107.74 121.07 43.97 Favored 'General case' 0 N--CA 1.417 -2.091 0 CA-C-N 114.728 -1.124 . . . . 0.0 108.444 178.469 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.42 HG21 ' CD1' ' A' ' 104' ' ' ILE . 9.9 mt -108.58 127.79 64.75 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.882 0 N-CA-C 106.714 -1.587 . . . . 0.0 106.714 175.694 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -130.5 163.7 23.14 Favored Glycine 0 C--N 1.284 -2.32 0 N-CA-C 111.232 -0.747 . . . . 0.0 111.232 -179.478 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 67.2 m-20 73.73 38.68 0.59 Allowed 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.743 1.617 . . . . 0.0 110.219 -178.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -68.69 144.69 54.35 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.451 -0.795 . . . . 0.0 112.29 178.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 41.4 t-20 -89.34 151.5 22.04 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 177.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.504 ' HD2' ' N ' ' A' ' 41' ' ' GLU . 5.3 ppt_? -59.56 -26.42 65.36 Favored 'General case' 0 C--N 1.31 -1.135 0 C-N-CA 123.103 0.561 . . . . 0.0 111.828 177.745 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.504 ' N ' ' HD2' ' A' ' 40' ' ' ARG . 10.4 pt-20 -89.55 0.89 56.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.897 -177.655 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 80.8 mt -97.32 111.87 23.93 Favored 'General case' 0 CA--C 1.494 -1.177 0 CA-C-O 121.59 0.709 . . . . 0.0 111.211 -178.551 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 82.2 p -103.51 174.53 5.83 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-N 114.344 -1.298 . . . . 0.0 109.451 -178.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.456 ' HG3' ' HB2' ' A' ' 62' ' ' LEU . 2.0 mp0 -54.62 -40.66 69.16 Favored 'General case' 0 C--O 1.216 -0.676 0 C-N-CA 123.599 0.76 . . . . 0.0 109.586 177.738 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -59.48 -41.63 97.23 Favored Glycine 0 N--CA 1.445 -0.75 0 O-C-N 123.659 0.6 . . . . 0.0 113.163 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -66.69 -49.13 67.09 Favored 'General case' 0 CA--C 1.497 -1.071 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 -179.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 52.6 mt -58.37 -45.88 89.42 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.926 0 CA-C-N 114.992 -1.003 . . . . 0.0 110.493 179.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 35.0 mt -60.55 -45.71 92.87 Favored 'General case' 0 CA--C 1.5 -0.963 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 -177.365 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 80.2 m -62.92 -45.59 91.78 Favored 'General case' 0 N--CA 1.439 -1.016 0 O-C-N 123.308 0.38 . . . . 0.0 111.563 179.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 77.4 t -65.79 -47.18 86.66 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.157 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.036 -179.156 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -67.43 -22.95 65.49 Favored 'General case' 0 N--CA 1.429 -1.496 0 C-N-CA 123.624 0.77 . . . . 0.0 112.144 -178.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.408 ' OG ' ' HB2' ' B' ' 231' ' ' ARG . 68.3 m -69.13 -16.92 63.77 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.937 175.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -67.02 -26.63 66.87 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-O 121.246 0.546 . . . . 0.0 109.659 175.206 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -95.73 -15.19 22.78 Favored 'General case' 0 CA--C 1.505 -0.784 0 CA-C-O 121.245 0.545 . . . . 0.0 112.392 -173.222 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 160.1 -152.19 22.96 Favored Glycine 0 N--CA 1.413 -2.849 0 N-CA-C 110.245 -1.142 . . . . 0.0 110.245 -179.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 65.3 t -104.74 109.21 62.7 Favored Pre-proline 0 C--N 1.288 -2.068 0 O-C-N 123.554 0.208 . . . . 0.0 110.466 -176.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.427 ' HB3' HD22 ' A' ' 77' ' ' LEU . 73.2 Cg_endo -77.57 135.58 14.74 Favored 'Trans proline' 0 N--CA 1.435 -1.966 0 C-N-CA 121.525 1.483 . . . . 0.0 108.595 174.259 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.402 ' CG2' ' HG3' ' A' ' 78' ' ' LYS . 35.2 m -109.85 -23.21 4.58 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 C-N-CA 119.309 -0.956 . . . . 0.0 111.81 -177.753 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -158.68 142.94 15.67 Favored 'General case' 0 CA--C 1.503 -0.836 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 14.6 p -140.79 135.12 33.72 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 178.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 86.4 mt -120.72 123.06 69.5 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.311 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 176.242 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.456 ' HB2' ' HG3' ' A' ' 44' ' ' GLU . 0.1 OUTLIER -98.61 119.64 37.69 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 177.298 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 28.3 m -83.91 116.79 22.95 Favored 'General case' 0 N--CA 1.404 -2.772 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 176.235 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 58.9 mtt180 . . . . . 0 C--N 1.304 -1.374 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 -175.625 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 . . . . . 0 CA--C 1.506 -0.721 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 94.8 8.35 59.38 Favored Glycine 0 N--CA 1.427 -1.962 0 CA-C-N 114.96 -1.018 . . . . 0.0 112.472 178.582 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 37.2 p90 -150.09 154.99 39.05 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 179.258 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -150.1 170.47 18.83 Favored 'General case' 0 N--CA 1.427 -1.595 0 CA-C-O 120.925 0.393 . . . . 0.0 110.264 178.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -128.9 142.2 51.03 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.404 -179.021 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.427 HD22 ' HB3' ' A' ' 57' ' ' PRO . 9.8 tt -148.99 140.9 23.72 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 175.696 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.402 ' HG3' ' CG2' ' A' ' 58' ' ' VAL . 20.8 ptmt -122.66 144.02 49.41 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 178.665 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.42 ' HH ' ' CB ' ' A' ' 88' ' ' ALA . 45.8 m-85 -104.65 164.88 11.44 Favored 'General case' 0 C--N 1.29 -1.992 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.575 -179.233 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -71.15 -37.49 72.26 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 114.824 -1.08 . . . . 0.0 108.607 175.062 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -125.28 143.63 50.87 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.298 0.57 . . . . 0.0 111.74 -179.019 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.448 ' NE2' ' HB3' ' A' ' 31' ' ' ALA . 20.8 mp0 -69.93 -24.0 63.29 Favored 'General case' 0 C--N 1.312 -1.061 0 C-N-CA 124.91 1.284 . . . . 0.0 112.94 -177.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 56.1 mtm180 -67.88 -34.63 77.04 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-O 122.083 0.944 . . . . 0.0 109.592 175.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.448 ' OG ' HG22 ' B' ' 226' ' ' ILE . 48.6 m -66.04 -37.71 86.55 Favored 'General case' 0 C--N 1.286 -2.177 0 CA-C-N 114.808 -1.087 . . . . 0.0 111.619 175.798 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.5 ' O ' HG21 ' A' ' 89' ' ' VAL . 71.6 p -66.02 -45.33 81.87 Favored 'General case' 0 C--O 1.221 -0.402 0 C-N-CA 120.134 -0.626 . . . . 0.0 110.52 -178.058 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 8.3 pt -64.79 -37.39 80.03 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 C-N-CA 122.481 0.312 . . . . 0.0 111.111 177.521 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 9.7 mt -58.51 -44.08 89.35 Favored 'General case' 0 CA--C 1.504 -0.822 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.203 175.034 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.452 ' O ' ' HB2' ' A' ' 92' ' ' LEU . . . -71.56 -46.67 58.78 Favored 'General case' 0 N--CA 1.434 -1.269 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.953 -179.27 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.5 HG21 ' O ' ' A' ' 85' ' ' THR . 86.5 t -56.79 -49.9 76.83 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.201 0 CA-C-O 120.844 0.354 . . . . 0.0 111.429 -178.375 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -73.53 -28.65 62.0 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 112.751 0.649 . . . . 0.0 112.751 -173.127 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -87.76 -31.79 19.46 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-O 121.011 0.434 . . . . 0.0 110.572 -177.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.452 ' HB2' ' O ' ' A' ' 88' ' ' ALA . 10.0 mt -94.26 -30.32 14.62 Favored 'General case' 0 CA--C 1.501 -0.922 0 CA-C-N 116.03 -0.532 . . . . 0.0 112.386 -173.703 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 46.1 t30 -65.74 125.24 24.68 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 179.09 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 88.47 -7.73 80.91 Favored Glycine 0 N--CA 1.436 -1.35 0 CA-C-N 115.599 -0.728 . . . . 0.0 112.268 -178.048 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -81.94 138.96 34.88 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 -178.124 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.403 ' HA ' ' O ' ' A' ' 100' ' ' ARG . 11.7 mptt -99.2 125.12 44.72 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-O 121.14 0.495 . . . . 0.0 111.68 -177.295 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 58.7 mt -127.69 141.39 46.51 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 N-CA-C 105.761 -1.94 . . . . 0.0 105.761 173.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 64.17 7.42 24.65 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 121.12 -0.562 . . . . 0.0 114.311 179.173 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 97.22 0.13 59.93 Favored Glycine 0 N--CA 1.436 -1.312 0 C-N-CA 121.118 -0.563 . . . . 0.0 112.492 -176.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.403 ' O ' ' HA ' ' A' ' 96' ' ' LYS . 17.3 ptp180 -124.29 151.56 44.09 Favored 'General case' 0 C--N 1.317 -0.806 0 O-C-N 122.233 -0.569 . . . . 0.0 110.997 -179.493 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -89.73 120.03 30.65 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.513 -176.351 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 11.7 mt -68.7 145.15 54.11 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-O 121.71 0.766 . . . . 0.0 112.343 177.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 50.1 tptt -120.96 116.66 25.53 Favored 'General case' 0 N--CA 1.417 -2.106 0 CA-C-N 114.822 -1.081 . . . . 0.0 109.184 176.348 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.42 ' CD1' HG21 ' A' ' 35' ' ' ILE . 4.7 mm -119.37 134.31 63.38 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 179.574 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -144.89 157.74 44.05 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 177.417 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 2.8 m80 -81.96 131.63 35.25 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-O 121.236 0.541 . . . . 0.0 112.122 177.019 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 13.3 t -146.35 162.86 37.25 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 -177.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -110.25 110.91 21.91 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 107.046 -1.465 . . . . 0.0 107.046 171.057 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 74.4 t80 . . . . . 0 C--N 1.294 -1.827 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.228 -179.063 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 226' ' ' ILE . . . . . 0.448 HG22 ' OG ' ' A' ' 84' ' ' SER . 4.1 mp . . . . . 0 C--O 1.251 1.156 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 227' ' ' MET . . . . . . . . . . . . . 65.9 mtt -69.22 137.64 89.25 Favored Pre-proline 0 C--N 1.311 -1.077 0 O-C-N 123.706 0.629 . . . . 0.0 110.135 179.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 228' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -67.43 154.03 75.0 Favored 'Trans proline' 0 C--O 1.248 1.023 0 C-N-CA 122.787 2.324 . . . . 0.0 112.269 179.606 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . -73.11 168.98 53.4 Favored Glycine 0 C--N 1.314 -0.668 0 CA-C-N 115.558 -0.747 . . . . 0.0 112.879 -179.65 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 23.4 m -76.67 -13.93 60.01 Favored 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 123.236 0.614 . . . . 0.0 112.157 -175.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 231' ' ' ARG . . . . . 0.408 ' HB2' ' OG ' ' A' ' 52' ' ' SER . 19.7 mmt180 -87.16 -0.05 56.08 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.954 0.406 . . . . 0.0 110.095 -178.313 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 232' ' ' TRP . . . . . . . . . . . . . 21.0 t90 -77.63 126.47 30.93 Favored 'General case' 0 N--CA 1.433 -1.3 0 CA-C-O 122.428 1.109 . . . . 0.0 112.392 -176.399 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 233' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -121.84 144.3 48.91 Favored 'General case' 0 C--N 1.264 -3.117 0 N-CA-C 101.829 -3.397 . . . . 0.0 101.829 171.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.05 0 C-N-CA 128.065 2.745 . . . . 0.0 116.113 -178.976 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 240' ' ' GLY . . . . . 0.501 ' O ' ' HG2' ' B' ' 244' ' ' LYS . . . . . . . . 0 C--O 1.199 -2.077 0 N-CA-C 110.456 -1.058 . . . . 0.0 110.456 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 51.1 p90 -64.42 -34.01 77.2 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 -176.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -63.8 -42.44 97.72 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 112.003 0.371 . . . . 0.0 112.003 -174.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 243' ' ' GLU . . . . . 0.474 ' HG2' ' O ' ' B' ' 240' ' ' GLY . 11.1 pt-20 -63.13 -34.7 78.19 Favored 'General case' 0 C--O 1.208 -1.08 0 N-CA-C 110.466 -0.198 . . . . 0.0 110.466 178.325 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 244' ' ' LYS . . . . . 0.501 ' HG2' ' O ' ' B' ' 240' ' ' GLY . 68.8 mmtt -67.72 -44.58 77.32 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 -179.046 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 245' ' ' TRP . . . . . . . . . . . . . 50.9 m0 -62.55 -41.52 98.95 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.725 178.036 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 246' ' ' PHE . . . . . 0.493 ' O ' ' HG2' ' B' ' 249' ' ' GLN . 5.1 t80 -65.53 -36.25 83.26 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.902 177.793 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -71.69 -35.67 70.34 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.206 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.19 -15.34 36.27 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 120.991 0.424 . . . . 0.0 111.704 -178.67 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 249' ' ' GLN . . . . . 0.493 ' HG2' ' O ' ' B' ' 246' ' ' PHE . 2.9 pt20 -81.53 2.96 26.69 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-O 120.982 0.42 . . . . 0.0 110.326 179.5 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 250' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -54.01 -27.83 34.33 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.911 177.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 251' ' ' GLU . . . . . 0.418 ' HB3' ' HB2' ' B' ' 254' ' ' GLU . 45.5 mt-10 -80.58 110.52 16.13 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 176.039 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 252' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -112.72 -33.98 2.2 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 CA-C-N 115.843 -0.617 . . . . 0.0 112.165 -173.475 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -118.89 -6.26 10.55 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 -178.099 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 254' ' ' GLU . . . . . 0.418 ' HB2' ' HB3' ' B' ' 251' ' ' GLU . 16.8 mp0 . . . . . 0 C--N 1.294 -1.829 0 CA-C-N 112.549 -2.114 . . . . 0.0 111.957 -179.177 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.589 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 11.3 m-30 -93.24 144.95 24.81 Favored 'General case' 0 C--N 1.309 -1.183 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.524 -176.603 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 21.4 pt -142.81 165.84 15.76 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.981 0 C-N-CA 123.291 0.636 . . . . 0.0 110.152 175.265 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.405 ' HB2' HG22 ' A' ' 107' ' ' THR . 54.7 t80 -116.2 126.4 53.59 Favored 'General case' 0 N--CA 1.413 -2.28 0 CA-C-N 114.776 -1.102 . . . . 0.0 109.114 178.217 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.442 HG21 ' CD1' ' A' ' 104' ' ' ILE . 9.1 mt -110.74 127.98 67.42 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.016 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 175.601 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -127.65 165.61 20.66 Favored Glycine 0 C--N 1.281 -2.494 0 N-CA-C 111.346 -0.701 . . . . 0.0 111.346 -178.486 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 66.39 41.52 3.26 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.708 1.203 . . . . 0.0 110.824 -176.506 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.406 HD21 ' HA ' ' A' ' 74' ' ' PHE . 4.1 mm? -68.56 146.57 52.97 Favored 'General case' 0 CA--C 1.496 -1.122 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.489 177.375 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.452 ' ND2' ' HA3' ' A' ' 98' ' ' GLY . 61.1 t30 -89.84 147.84 23.54 Favored 'General case' 0 C--N 1.291 -1.945 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 178.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.476 ' HD2' ' C ' ' A' ' 40' ' ' ARG . 2.3 ppt_? -58.87 -21.75 57.8 Favored 'General case' 0 C--N 1.318 -0.772 0 O-C-N 123.623 0.577 . . . . 0.0 112.494 -175.353 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.402 ' HG2' ' ND2' ' A' ' 39' ' ' ASN . 13.4 pt-20 -99.86 -1.01 38.54 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.383 -175.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 81.3 mt -87.71 118.54 27.28 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-O 121.33 0.586 . . . . 0.0 110.459 178.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 77.0 p -105.31 174.09 6.03 Favored 'General case' 0 C--N 1.291 -1.943 0 CA-C-N 114.816 -1.084 . . . . 0.0 108.864 -178.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.497 ' CG ' ' HB2' ' A' ' 62' ' ' LEU . 70.2 mt-10 -56.38 -37.67 70.41 Favored 'General case' 0 C--O 1.216 -0.67 0 N-CA-C 109.954 -0.388 . . . . 0.0 109.954 177.598 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -61.62 -37.46 94.25 Favored Glycine 0 N--CA 1.445 -0.758 0 CA-C-N 115.722 -0.672 . . . . 0.0 113.113 179.529 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -67.26 -49.02 65.98 Favored 'General case' 0 CA--C 1.488 -1.432 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.279 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 46.7 mt -59.17 -45.67 92.62 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.14 0 CA-C-N 114.557 -1.202 . . . . 0.0 110.597 179.129 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 42.8 mt -59.65 -43.53 93.88 Favored 'General case' 0 CA--C 1.489 -1.369 0 C-N-CA 122.249 0.22 . . . . 0.0 111.137 -178.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 72.3 m -63.26 -46.6 86.09 Favored 'General case' 0 C--N 1.309 -1.157 0 O-C-N 123.531 0.519 . . . . 0.0 111.137 -178.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 93.5 t -67.55 -46.89 82.18 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.702 -178.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -68.54 -20.09 64.53 Favored 'General case' 0 N--CA 1.424 -1.751 0 CA-C-N 115.141 -0.936 . . . . 0.0 112.537 -177.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.423 ' HA ' ' O ' ' A' ' 55' ' ' GLY . 59.1 m -71.1 -22.44 62.09 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 176.179 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -73.27 -20.69 60.77 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 119.164 -1.015 . . . . 0.0 109.97 176.233 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 62.0 m-85 -92.97 -11.01 34.32 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-O 121.232 0.539 . . . . 0.0 111.865 -179.208 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.423 ' O ' ' HA ' ' A' ' 52' ' ' SER . . . 156.96 -164.04 32.57 Favored Glycine 0 N--CA 1.424 -2.108 0 N-CA-C 110.954 -0.858 . . . . 0.0 110.954 179.091 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 80.9 t -96.31 109.75 49.04 Favored Pre-proline 0 C--N 1.299 -1.623 0 N-CA-C 110.078 -0.342 . . . . 0.0 110.078 -179.301 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.4 ' HB3' HD22 ' A' ' 77' ' ' LEU . 86.9 Cg_endo -79.41 136.87 12.8 Favored 'Trans proline' 0 N--CA 1.443 -1.442 0 C-N-CA 122.461 2.108 . . . . 0.0 109.301 176.14 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 33.8 m -110.84 -24.11 4.14 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 C-N-CA 119.2 -1.0 . . . . 0.0 111.67 -178.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.446 ' HB3' ' HG2' ' A' ' 78' ' ' LYS . 27.4 t70 -155.03 142.29 19.45 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -179.467 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 14.4 p -143.58 136.94 24.85 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 179.411 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 90.8 mt -121.88 121.17 63.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 175.08 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.497 ' HB2' ' CG ' ' A' ' 44' ' ' GLU . 0.2 OUTLIER -95.89 116.82 29.49 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 106.245 -1.761 . . . . 0.0 106.245 172.544 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 44.3 m -77.21 116.32 17.74 Favored 'General case' 0 N--CA 1.419 -1.998 0 N-CA-C 107.37 -1.345 . . . . 0.0 107.37 176.2 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 21.1 mtp180 . . . . . 0 C--N 1.307 -1.28 0 CA-C-O 120.819 0.342 . . . . 0.0 110.332 -175.854 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 18.3 mm-40 . . . . . 0 CA--C 1.504 -0.818 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 94.73 12.76 55.25 Favored Glycine 0 N--CA 1.427 -1.962 0 C-N-CA 120.44 -0.886 . . . . 0.0 112.164 -177.416 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.406 ' HA ' HD21 ' A' ' 38' ' ' LEU . 33.4 p90 -151.59 153.32 34.27 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 176.397 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -150.11 175.71 11.49 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-O 120.836 0.351 . . . . 0.0 110.818 -179.44 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -136.5 144.12 44.15 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 123.576 0.75 . . . . 0.0 110.003 -177.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.4 HD22 ' HB3' ' A' ' 57' ' ' PRO . 10.2 tt -150.38 141.59 23.17 Favored 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 176.065 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.446 ' HG2' ' HB3' ' A' ' 59' ' ' ASP . 22.0 ptmt -124.03 144.34 49.89 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-O 121.294 0.569 . . . . 0.0 109.516 178.584 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -107.6 165.92 11.06 Favored 'General case' 0 C--N 1.286 -2.177 0 CA-C-N 115.406 -0.815 . . . . 0.0 111.683 -178.019 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -75.32 -29.05 59.9 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 115.002 -0.999 . . . . 0.0 108.77 172.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -119.63 136.72 54.27 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 -176.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 19.8 mp0 -69.77 -27.61 65.07 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.449 ' O ' HG12 ' A' ' 86' ' ' ILE . 90.0 mtm180 -65.61 -33.85 76.87 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 122.301 1.048 . . . . 0.0 110.032 179.0 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.452 ' OG ' HG22 ' B' ' 226' ' ' ILE . 51.6 m -58.53 -37.14 75.02 Favored 'General case' 0 C--N 1.281 -2.379 0 CA-C-N 114.781 -1.1 . . . . 0.0 111.734 176.237 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.429 ' O ' HG21 ' A' ' 89' ' ' VAL . 43.9 p -63.33 -45.07 92.95 Favored 'General case' 0 C--N 1.347 0.487 0 C-N-CA 120.452 -0.499 . . . . 0.0 110.731 -178.482 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.449 HG12 ' O ' ' A' ' 83' ' ' ARG . 4.1 pt -66.64 -38.15 81.01 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.508 178.894 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 13.6 mt -59.4 -44.25 92.84 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 123.38 0.425 . . . . 0.0 111.28 175.437 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -71.74 -46.42 58.57 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.212 -178.586 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.429 HG21 ' O ' ' A' ' 85' ' ' THR . 69.6 t -56.93 -44.09 81.78 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.104 0 CA-C-O 121.297 0.57 . . . . 0.0 111.09 178.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -63.69 -41.53 98.13 Favored 'General case' 0 C--N 1.29 -1.996 0 C-N-CA 123.291 0.637 . . . . 0.0 112.239 -176.064 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 40.0 m-80 -90.28 -29.73 17.96 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-N 115.632 -0.713 . . . . 0.0 112.869 -173.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 15.2 mt -93.37 -31.18 14.74 Favored 'General case' 0 CA--C 1.486 -1.502 0 N-CA-C 112.257 0.466 . . . . 0.0 112.257 -172.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -66.32 124.6 23.13 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.039 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 89.19 -2.59 83.76 Favored Glycine 0 C--N 1.308 -1.004 0 C-N-CA 121.33 -0.462 . . . . 0.0 112.269 -178.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 37.2 t80 -89.23 134.98 33.82 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 -179.096 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.462 ' HA ' ' O ' ' A' ' 100' ' ' ARG . 12.1 mptt -95.42 116.38 28.72 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-O 120.914 0.388 . . . . 0.0 111.826 -177.67 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 60.6 mt -119.3 141.45 39.23 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 N-CA-C 104.946 -2.242 . . . . 0.0 104.946 172.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.452 ' HA3' ' ND2' ' A' ' 39' ' ' ASN . . . 58.19 28.02 60.92 Favored Glycine 0 C--N 1.317 -0.496 0 C-N-CA 121.331 -0.461 . . . . 0.0 112.646 -178.775 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 79.99 -5.84 61.19 Favored Glycine 0 CA--C 1.529 0.907 0 CA-C-O 119.933 -0.37 . . . . 0.0 113.863 -179.447 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.462 ' O ' ' HA ' ' A' ' 96' ' ' LYS . 16.6 ptp180 -116.43 149.71 39.0 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 117.721 0.76 . . . . 0.0 111.198 -176.311 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -88.44 117.2 27.2 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.537 -175.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 10.4 mt -65.71 136.07 55.78 Favored 'General case' 0 CA--C 1.494 -1.191 0 CA-C-O 121.491 0.663 . . . . 0.0 111.961 178.503 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 27.4 tptp -113.6 116.29 29.26 Favored 'General case' 0 N--CA 1.41 -2.45 0 CA-C-N 115.218 -0.901 . . . . 0.0 108.633 176.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.442 ' CD1' HG21 ' A' ' 35' ' ' ILE . 5.3 mm -111.02 142.32 23.75 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.192 0 N-CA-C 106.265 -1.754 . . . . 0.0 106.265 177.858 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -144.6 151.66 39.36 Favored 'General case' 0 C--N 1.29 -1.995 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 178.564 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 69.7 m-70 -83.42 130.53 35.04 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 175.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.405 HG22 ' HB2' ' A' ' 34' ' ' TYR . 6.2 t -153.79 165.19 36.79 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 -177.839 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -107.6 112.28 24.93 Favored 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 105.604 -1.999 . . . . 0.0 105.604 168.214 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 25.8 t80 . . . . . 0 C--N 1.295 -1.769 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 -175.943 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 226' ' ' ILE . . . . . 0.452 HG22 ' OG ' ' A' ' 84' ' ' SER . 3.9 mp . . . . . 0 N--CA 1.433 -1.32 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 227' ' ' MET . . . . . . . . . . . . . 67.5 mtt -70.24 133.55 87.47 Favored Pre-proline 0 C--N 1.309 -1.162 0 O-C-N 123.427 0.454 . . . . 0.0 110.306 178.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 228' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -68.05 154.36 72.77 Favored 'Trans proline' 0 C--O 1.245 0.851 0 C-N-CA 122.785 2.323 . . . . 0.0 112.272 -179.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . -72.44 168.2 52.85 Favored Glycine 0 N--CA 1.44 -1.04 0 CA-C-N 115.557 -0.747 . . . . 0.0 113.035 -179.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 5.0 p -77.44 -23.52 50.51 Favored 'General case' 0 C--N 1.298 -1.646 0 C-N-CA 123.431 0.692 . . . . 0.0 112.354 -177.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 1.8 mmp_? -79.33 1.88 23.5 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.729 -176.127 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 232' ' ' TRP . . . . . 0.406 ' HB2' ' CB ' ' A' ' 52' ' ' SER . 24.4 t90 -79.33 123.37 27.41 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 122.031 0.919 . . . . 0.0 111.908 -178.83 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 233' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -113.2 149.35 33.83 Favored 'General case' 0 C--N 1.284 -2.271 0 N-CA-C 102.645 -3.094 . . . . 0.0 102.645 172.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.331 0 C-N-CA 127.53 2.49 . . . . 0.0 115.884 -178.101 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 240' ' ' GLY . . . . . 0.578 ' O ' ' HG2' ' B' ' 244' ' ' LYS . . . . . . . . 0 C--O 1.191 -2.546 0 N-CA-C 112.083 -0.407 . . . . 0.0 112.083 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -61.89 -33.08 73.56 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 116.914 0.357 . . . . 0.0 111.618 -179.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -60.34 -44.88 95.11 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.307 -175.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 243' ' ' GLU . . . . . 0.45 ' HG2' ' O ' ' B' ' 240' ' ' GLY . 9.8 pt-20 -67.59 -35.46 79.03 Favored 'General case' 0 C--O 1.201 -1.472 0 C-N-CA 120.799 -0.36 . . . . 0.0 110.543 179.532 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 244' ' ' LYS . . . . . 0.578 ' HG2' ' O ' ' B' ' 240' ' ' GLY . 67.7 mmtt -68.1 -42.15 80.73 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-O 121.004 0.431 . . . . 0.0 110.408 -176.497 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 245' ' ' TRP . . . . . . . . . . . . . 50.9 m0 -63.39 -43.04 98.72 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 178.545 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 246' ' ' PHE . . . . . 0.413 ' HA ' ' CD ' ' B' ' 249' ' ' GLN . 5.5 t80 -67.14 -33.21 74.94 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 114.866 -1.061 . . . . 0.0 110.869 178.237 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -77.21 -21.4 53.92 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.98 -177.412 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.33 -30.04 13.64 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 119.934 -0.706 . . . . 0.0 110.806 179.255 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 249' ' ' GLN . . . . . 0.413 ' CD ' ' HA ' ' B' ' 246' ' ' PHE . 3.7 pt20 -68.52 -12.19 60.9 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.074 -176.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 250' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -57.39 -30.13 64.65 Favored 'General case' 0 N--CA 1.482 1.153 0 CA-C-N 115.538 -0.755 . . . . 0.0 112.093 177.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -117.39 166.85 11.83 Favored 'General case' 0 N--CA 1.414 -2.261 0 CA-C-N 115.412 -0.813 . . . . 0.0 112.836 -175.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 252' ' ' ILE . . . . . . . . . . . . . 32.3 pt -126.26 -27.66 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 CA-C-N 113.879 -1.51 . . . . 0.0 109.8 176.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -125.99 -34.0 2.62 Favored 'General case' 0 C--O 1.221 -0.397 0 N-CA-C 113.356 0.872 . . . . 0.0 113.356 -175.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 254' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 . . . . . 0 C--N 1.309 -1.153 0 N-CA-C 113.963 1.098 . . . . 0.0 113.963 -179.097 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 50.8 t-20 . . . . . 0 C--O 1.234 0.288 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -86.35 -30.89 21.85 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-O 121.426 0.631 . . . . 0.0 111.222 -177.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 33.7 m-85 -88.23 66.9 8.62 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-O 123.348 1.547 . . . . 0.0 112.287 -177.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 30.1 mmmt -121.72 169.98 10.19 Favored 'General case' 0 C--N 1.277 -2.575 0 CA-C-N 112.303 -2.226 . . . . 0.0 107.352 174.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -98.86 23.24 9.09 Favored 'General case' 0 C--N 1.292 -1.898 0 CA-C-O 122.407 1.099 . . . . 0.0 109.326 -178.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -83.87 9.43 12.1 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 114.204 -1.362 . . . . 0.0 109.106 178.016 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.508 ' HB3' ' NE2' ' A' ' 82' ' ' GLN . . . -98.05 0.92 47.1 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.284 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -108.9 145.67 35.01 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 115.056 -0.974 . . . . 0.0 109.049 -173.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 26.7 pt -142.57 163.1 18.14 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 CA-C-O 121.408 0.623 . . . . 0.0 111.045 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -114.52 127.07 55.61 Favored 'General case' 0 N--CA 1.415 -2.188 0 CA-C-N 114.383 -1.281 . . . . 0.0 108.787 176.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.476 HG21 ' CD1' ' A' ' 104' ' ' ILE . 9.5 mt -110.09 127.79 66.75 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.795 0 N-CA-C 107.335 -1.358 . . . . 0.0 107.335 177.613 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -127.43 165.69 20.45 Favored Glycine 0 C--N 1.284 -2.314 0 N-CA-C 110.607 -0.997 . . . . 0.0 110.607 179.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 71.7 m-20 72.18 40.58 0.69 Allowed 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.742 1.217 . . . . 0.0 110.038 -178.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.4 HD12 HD12 ' A' ' 47' ' ' ILE . 3.9 mm? -72.71 144.84 47.53 Favored 'General case' 0 CA--C 1.495 -1.153 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.551 178.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.407 ' HB3' ' HG ' ' A' ' 42' ' ' LEU . 42.0 t-20 -83.13 146.09 28.85 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 106.549 -1.649 . . . . 0.0 106.549 176.673 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.526 ' HD2' ' N ' ' A' ' 41' ' ' GLU . 5.8 ppt_? -60.76 -19.22 58.74 Favored 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 123.3 0.64 . . . . 0.0 112.051 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.526 ' N ' ' HD2' ' A' ' 40' ' ' ARG . 8.9 pt-20 -99.99 5.66 45.13 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.965 -178.046 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.407 ' HG ' ' HB3' ' A' ' 39' ' ' ASN . 71.1 mt -96.51 126.22 41.54 Favored 'General case' 0 C--N 1.309 -1.179 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.701 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 12.5 t -117.67 175.84 5.46 Favored 'General case' 0 N--CA 1.428 -1.53 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.18 -179.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.404 ' CG ' ' HB2' ' A' ' 62' ' ' LEU . 42.1 mt-10 -54.39 -39.62 67.41 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 123.743 0.817 . . . . 0.0 111.401 -176.014 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.87 -37.73 94.21 Favored Glycine 0 CA--C 1.521 0.417 0 C-N-CA 121.317 -0.468 . . . . 0.0 113.402 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -67.12 -49.17 65.84 Favored 'General case' 0 CA--C 1.499 -0.995 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.4 HD12 HD12 ' A' ' 38' ' ' LEU . 38.6 mt -61.01 -45.3 98.83 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.902 0 CA-C-N 114.861 -1.063 . . . . 0.0 110.854 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 38.1 mt -60.07 -45.75 91.86 Favored 'General case' 0 CA--C 1.494 -1.186 0 N-CA-C 111.676 0.25 . . . . 0.0 111.676 -176.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 100.0 m -62.77 -45.59 91.99 Favored 'General case' 0 C--N 1.307 -1.263 0 O-C-N 123.551 0.532 . . . . 0.0 111.913 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.449 ' CG1' ' HG3' ' B' ' 237' ' ' ARG . 54.6 t -66.13 -49.12 78.66 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.633 -179.794 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -65.21 -23.03 66.97 Favored 'General case' 0 N--CA 1.425 -1.697 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.409 -178.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.494 ' OG ' ' HB2' ' B' ' 231' ' ' ARG . 58.7 m -69.35 -22.03 63.78 Favored 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 177.099 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.41 ' HG2' ' O ' ' A' ' 50' ' ' VAL . 7.8 pt-20 -73.52 -20.21 60.72 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 117.642 -1.623 . . . . 0.0 110.4 177.326 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.409 ' OH ' ' HB2' ' B' ' 237' ' ' ARG . 48.0 m-85 -92.36 -10.3 38.69 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-O 121.225 0.536 . . . . 0.0 111.135 -178.327 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 157.21 -154.9 25.93 Favored Glycine 0 N--CA 1.422 -2.296 0 C-N-CA 120.323 -0.941 . . . . 0.0 111.721 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 87.2 t -104.52 111.14 65.15 Favored Pre-proline 0 C--N 1.3 -1.557 0 N-CA-C 111.245 0.091 . . . . 0.0 111.245 -177.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -79.84 137.34 12.52 Favored 'Trans proline' 0 N--CA 1.449 -1.133 0 C-N-CA 122.652 2.234 . . . . 0.0 109.676 175.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 30.7 m -111.76 -33.56 2.25 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 C-N-CA 119.355 -0.938 . . . . 0.0 111.553 179.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.421 ' HB3' ' HG2' ' A' ' 78' ' ' LYS . 29.3 t70 -146.13 145.59 30.55 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 -179.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 14.5 p -143.65 135.33 23.04 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.482 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 99.3 mt -121.05 118.76 57.26 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 175.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.404 ' HB2' ' CG ' ' A' ' 44' ' ' GLU . 0.1 OUTLIER -98.1 114.4 26.57 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 106.014 -1.847 . . . . 0.0 106.014 174.781 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 43.7 m -76.85 116.59 17.66 Favored 'General case' 0 N--CA 1.404 -2.773 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 178.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 34.1 mtm180 -128.45 138.97 52.56 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-N 115.336 -0.847 . . . . 0.0 108.83 -176.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -79.92 125.91 30.33 Favored 'General case' 0 C--N 1.292 -1.926 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.453 -177.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -61.3 -24.52 66.48 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 -178.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 22.7 m-80 -81.68 -47.46 12.94 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-O 121.154 0.502 . . . . 0.0 110.662 -174.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 39.2 p -90.03 -24.16 21.27 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.986 -177.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.41 6.16 86.3 Favored Glycine 0 N--CA 1.439 -1.115 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.714 -177.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -111.88 163.93 13.66 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 110.346 -0.242 . . . . 0.0 110.346 -176.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 6.1 m -56.37 143.76 33.24 Favored 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 124.85 1.26 . . . . 0.0 111.419 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -87.84 10.93 16.95 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -177.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 84.71 8.95 82.07 Favored Glycine 0 C--N 1.308 -0.975 0 C-N-CA 120.926 -0.654 . . . . 0.0 113.569 179.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 36.7 p90 -154.98 157.79 38.21 Favored 'General case' 0 N--CA 1.436 -1.139 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 178.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -153.11 176.23 12.14 Favored 'General case' 0 N--CA 1.436 -1.143 0 O-C-N 123.556 0.535 . . . . 0.0 110.321 179.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -137.04 146.26 45.03 Favored 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 123.966 0.906 . . . . 0.0 109.856 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.0 tt -152.28 140.6 20.5 Favored 'General case' 0 N--CA 1.436 -1.143 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 175.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.421 ' HG2' ' HB3' ' A' ' 59' ' ' ASP . 18.8 ptmt -123.15 144.35 49.4 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 178.465 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.412 ' HH ' ' CB ' ' A' ' 88' ' ' ALA . 69.8 m-85 -102.47 164.88 11.42 Favored 'General case' 0 C--N 1.281 -2.378 0 CA-C-N 115.21 -0.905 . . . . 0.0 111.368 -178.451 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -79.1 -26.63 42.92 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 114.436 -1.256 . . . . 0.0 108.521 175.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -122.99 132.37 54.11 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.249 -175.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.508 ' NE2' ' HB3' ' A' ' 31' ' ' ALA . 15.9 mp0 -64.03 -30.33 71.41 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 179.547 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.88 -33.29 74.44 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-O 122.348 1.071 . . . . 0.0 110.353 -179.279 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 48.8 m -58.04 -36.47 72.8 Favored 'General case' 0 C--N 1.278 -2.511 0 CA-C-N 114.965 -1.016 . . . . 0.0 111.452 175.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.42 ' O ' HG21 ' A' ' 89' ' ' VAL . 36.9 p -63.91 -45.21 90.29 Favored 'General case' 0 C--O 1.213 -0.858 0 C-N-CA 120.332 -0.547 . . . . 0.0 110.9 -178.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 3.2 pt -64.94 -38.52 82.98 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.6 0 C-N-CA 122.391 0.276 . . . . 0.0 110.793 178.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.457 HD12 ' HB2' ' B' ' 224' ' ' PHE . 16.1 mt -59.09 -44.31 91.92 Favored 'General case' 0 CA--C 1.509 -0.601 0 O-C-N 123.659 0.599 . . . . 0.0 110.61 175.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.44 ' O ' ' HB2' ' A' ' 92' ' ' LEU . . . -72.92 -47.67 43.74 Favored 'General case' 0 N--CA 1.435 -1.195 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 179.464 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.42 HG21 ' O ' ' A' ' 85' ' ' THR . 72.4 t -59.26 -48.99 85.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 N-CA-C 112.127 0.418 . . . . 0.0 112.127 -176.325 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -73.27 -27.14 61.4 Favored 'General case' 0 C--N 1.294 -1.824 0 CA-C-O 121.466 0.65 . . . . 0.0 111.893 -172.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -91.59 -31.51 15.87 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.945 -177.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.44 ' HB2' ' O ' ' A' ' 88' ' ' ALA . 9.9 mt -91.69 -29.7 16.7 Favored 'General case' 0 C--N 1.313 -1.006 0 C-N-CA 122.509 0.324 . . . . 0.0 111.566 -174.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 51.5 t-20 -65.49 124.72 23.06 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 86.9 -5.54 84.88 Favored Glycine 0 N--CA 1.435 -1.412 0 C-N-CA 121.256 -0.497 . . . . 0.0 112.568 179.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -85.7 139.04 31.69 Favored 'General case' 0 N--CA 1.44 -0.96 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 -178.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 11.7 mptt -94.6 119.18 32.85 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-O 121.056 0.455 . . . . 0.0 111.652 -176.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 54.2 mt -126.03 141.34 45.97 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 N-CA-C 106.144 -1.798 . . . . 0.0 106.144 174.162 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 59.22 21.23 53.02 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 121.539 -0.363 . . . . 0.0 113.345 -179.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 85.04 6.84 84.44 Favored Glycine 0 N--CA 1.435 -1.406 0 C-N-CA 121.27 -0.49 . . . . 0.0 113.335 -179.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 19.3 ptp180 -132.15 146.77 52.26 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 117.772 0.786 . . . . 0.0 111.668 179.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -80.1 118.03 21.45 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.59 -178.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 11.6 mt -70.76 144.64 50.84 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-O 121.604 0.716 . . . . 0.0 112.702 178.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 23.4 tptm -118.14 116.96 27.9 Favored 'General case' 0 N--CA 1.419 -1.981 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.141 177.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.476 ' CD1' HG21 ' A' ' 35' ' ' ILE . 5.7 mm -117.86 138.32 48.92 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 179.022 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -143.36 150.64 39.42 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 179.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 82.7 m-70 -83.23 133.81 34.98 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 178.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 7.3 t -154.66 152.95 30.57 Favored 'General case' 0 N--CA 1.423 -1.777 0 N-CA-C 107.262 -1.385 . . . . 0.0 107.262 -178.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 41.5 p90 -91.74 112.24 24.08 Favored 'General case' 0 N--CA 1.429 -1.517 0 N-CA-C 106.474 -1.676 . . . . 0.0 106.474 171.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 43.8 t80 -105.81 135.56 47.02 Favored 'General case' 0 C--N 1.28 -2.425 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 -179.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 18.1 mmm180 -120.46 115.55 32.51 Favored Pre-proline 0 C--N 1.289 -2.042 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 174.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -71.28 153.28 61.78 Favored 'Trans proline' 0 C--O 1.246 0.907 0 C-N-CA 123.518 2.812 . . . . 0.0 114.689 -176.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.437 ' C ' ' HD3' ' A' ' 112' ' ' LYS . 12.7 tmtt? -108.91 134.08 52.06 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 105.747 -1.946 . . . . 0.0 105.747 174.406 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 35.7 mmt180 . . . . . 0 C--N 1.303 -1.44 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 -179.147 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 . . . . . 0 N--CA 1.479 0.989 0 N-CA-C 113.461 0.912 . . . . 0.0 113.461 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 223' ' ' ARG . . . . . . . . . . . . 0.417 53.3 mtp180 70.69 51.49 0.33 Allowed 'General case' 0 CA--C 1.501 -0.938 0 N-CA-C 117.192 2.293 . . . . 0.0 117.192 178.26 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 224' ' ' PHE . . . . . 0.457 ' HB2' HD12 ' A' ' 87' ' ' LEU . 30.2 m-85 -105.99 166.0 10.81 Favored 'General case' 0 C--N 1.273 -2.719 0 CA-C-N 114.792 -1.095 . . . . 0.0 109.569 176.419 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 225' ' ' ALA . . . . . . . . . . . . . . . -107.17 22.25 16.28 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 111.957 0.355 . . . . 0.0 111.957 -172.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 4.6 mp -83.46 132.17 32.07 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 178.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 227' ' ' MET . . . . . . . . . . . . . 65.6 mtt -81.85 135.08 49.08 Favored Pre-proline 0 C--N 1.305 -1.36 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.727 -178.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 228' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -57.2 148.64 68.79 Favored 'Trans proline' 0 C--O 1.255 1.341 0 C-N-CA 123.692 2.928 . . . . 0.0 114.419 -177.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . -74.07 170.87 52.93 Favored Glycine 0 N--CA 1.44 -1.05 0 CA-C-N 114.71 -1.132 . . . . 0.0 112.972 -179.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 18.9 m -77.71 -14.17 59.69 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 -172.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 231' ' ' ARG . . . . . 0.494 ' HB2' ' OG ' ' A' ' 52' ' ' SER . 10.7 mmm180 -84.93 -1.63 56.9 Favored 'General case' 0 C--N 1.32 -0.703 0 O-C-N 121.84 -0.537 . . . . 0.0 110.347 -179.229 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 232' ' ' TRP . . . . . . . . . . . . . 22.8 t90 -76.95 125.19 28.89 Favored 'General case' 0 N--CA 1.436 -1.161 0 CA-C-O 122.496 1.141 . . . . 0.0 112.599 -176.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 233' ' ' ASP . . . . . 0.417 ' O ' ' N ' ' B' ' 235' ' ' VAL . 16.0 t70 -120.59 148.19 44.21 Favored 'General case' 0 C--N 1.271 -2.846 0 N-CA-C 102.326 -3.213 . . . . 0.0 102.326 172.665 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -43.25 60.47 0.0 OUTLIER Glycine 0 N--CA 1.502 3.072 0 C-N-CA 128.312 2.863 . . . . 0.0 116.526 -176.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 235' ' ' VAL . . . . . 0.417 ' N ' ' O ' ' B' ' 233' ' ' ASP . 75.7 t -111.29 118.93 58.61 Favored 'Isoleucine or valine' 0 C--N 1.25 -3.741 0 C-N-CA 127.309 2.244 . . . . 0.0 107.634 176.526 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 236' ' ' HIS . . . . . . . . . . . . . 15.5 t-80 -113.38 107.88 16.46 Favored 'General case' 0 C--N 1.282 -2.347 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.474 179.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 237' ' ' ARG . . . . . 0.449 ' HG3' ' CG1' ' A' ' 50' ' ' VAL . 3.3 mmp_? -108.4 114.96 29.21 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 104.957 -2.238 . . . . 0.0 104.957 173.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 238' ' ' SER . . . . . . . . . . . . . 23.8 t -131.31 134.15 46.06 Favored 'General case' 0 C--N 1.275 -2.657 0 C-N-CA 119.982 -0.687 . . . . 0.0 112.504 -175.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 239' ' ' ASN . . . . . . . . . . . . . 39.4 p30 -72.59 174.76 7.08 Favored 'General case' 0 C--O 1.244 0.799 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.325 174.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 240' ' ' GLY . . . . . . . . . . . . . . . 76.57 35.37 41.46 Favored Glycine 0 N--CA 1.426 -1.999 0 C-N-CA 119.549 -1.31 . . . . 0.0 110.624 -179.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 20.7 p90 -76.29 -32.68 58.92 Favored 'General case' 0 C--N 1.297 -1.701 0 CA-C-O 121.045 0.45 . . . . 0.0 109.863 175.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -60.54 -39.23 87.15 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.934 -178.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -65.52 -34.99 79.55 Favored 'General case' 0 C--O 1.208 -1.128 0 C-N-CA 121.158 -0.217 . . . . 0.0 111.094 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 68.3 mmtt -68.0 -39.87 83.14 Favored 'General case' 0 CA--C 1.509 -0.616 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 -178.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 245' ' ' TRP . . . . . . . . . . . . . 51.0 m0 -65.95 -43.56 87.6 Favored 'General case' 0 N--CA 1.438 -1.044 0 CA-C-N 114.795 -1.093 . . . . 0.0 109.492 176.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 246' ' ' PHE . . . . . 0.516 ' O ' ' HG2' ' B' ' 249' ' ' GLN . 2.4 t80 -61.98 -39.85 93.59 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.215 178.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.96 -33.71 76.33 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.928 -178.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.69 -17.37 20.38 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -178.101 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 249' ' ' GLN . . . . . 0.516 ' HG2' ' O ' ' B' ' 246' ' ' PHE . 2.2 pt20 -80.04 3.44 20.24 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 177.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 250' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -51.45 -28.76 14.01 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.873 1.269 . . . . 0.0 112.094 -179.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -58.59 150.48 22.93 Favored 'General case' 0 N--CA 1.426 -1.63 0 N-CA-C 115.272 1.582 . . . . 0.0 115.272 -179.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 252' ' ' ILE . . . . . . . . . . . . . 31.7 pt -110.17 -29.32 2.49 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 CA-C-N 113.829 -1.532 . . . . 0.0 109.905 -178.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -115.82 -34.71 4.71 Favored 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 120.233 -0.587 . . . . 0.0 110.511 -178.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 254' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -83.67 -174.37 5.25 Favored 'General case' 0 N--CA 1.436 -1.15 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.777 -174.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 255' ' ' LYS . . . . . . . . . . . . . 24.9 pttm -48.59 139.11 9.77 Favored 'General case' 0 C--O 1.241 0.651 0 C-N-CA 125.142 1.377 . . . . 0.0 112.122 178.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 256' ' ' LYS . . . . . . . . . . . . . 43.3 mmtm . . . . . 0 C--N 1.302 -1.468 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 179.743 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 50.7 t-20 . . . . . 0 N--CA 1.451 -0.415 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 29.4 mm-40 -85.67 -23.44 27.44 Favored 'General case' 0 C--N 1.314 -0.944 0 C-N-CA 122.845 0.458 . . . . 0.0 111.3 -176.181 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 56.6 m-85 -88.07 6.07 37.99 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.593 -0.73 . . . . 0.0 112.099 -172.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -127.82 163.35 24.58 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 176.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.46 ' C ' ' H ' ' A' ' 31' ' ' ALA . 7.8 m-20 -121.77 19.65 11.02 Favored 'General case' 0 C--N 1.291 -1.96 0 CA-C-O 121.965 0.888 . . . . 0.0 108.659 -175.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -76.59 11.03 1.79 Allowed 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 114.747 -1.115 . . . . 0.0 109.92 -178.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.484 ' HA ' HG22 ' A' ' 85' ' ' THR . . . -84.55 -11.33 56.26 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-N 115.272 -0.877 . . . . 0.0 109.401 178.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 -100.95 144.54 29.77 Favored 'General case' 0 N--CA 1.436 -1.14 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 -177.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 26.9 pt -142.85 156.68 17.96 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 CA-C-O 121.151 0.5 . . . . 0.0 110.224 178.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 20.4 t80 -108.45 124.32 50.22 Favored 'General case' 0 C--N 1.285 -2.229 0 CA-C-N 114.566 -1.197 . . . . 0.0 108.624 177.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.431 HG21 ' CD1' ' A' ' 104' ' ' ILE . 10.3 mt -108.28 127.52 64.51 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.935 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 175.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -124.65 157.91 19.05 Favored Glycine 0 C--N 1.279 -2.599 0 N-CA-C 111.155 -0.778 . . . . 0.0 111.155 -179.249 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 50.6 m-20 68.35 70.12 0.31 Allowed 'General case' 0 C--N 1.31 -1.133 0 C-N-CA 125.745 1.618 . . . . 0.0 109.908 -177.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -100.6 141.47 33.41 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 115.114 -0.948 . . . . 0.0 111.846 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.446 ' HB2' ' NH1' ' A' ' 100' ' ' ARG . 39.1 t-20 -76.41 144.21 40.15 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 174.73 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.447 ' HD2' ' C ' ' A' ' 40' ' ' ARG . 0.9 OUTLIER -59.46 -26.24 65.06 Favored 'General case' 0 C--N 1.312 -1.061 0 C-N-CA 123.278 0.631 . . . . 0.0 111.665 179.057 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -85.98 -0.89 56.63 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.383 -0.372 . . . . 0.0 111.767 -176.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 87.6 mt -94.3 127.38 40.13 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-O 121.081 0.467 . . . . 0.0 110.882 -179.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 63.2 p -116.52 175.03 5.75 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-N 115.072 -0.967 . . . . 0.0 108.678 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 -54.2 -40.6 67.74 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 122.716 0.406 . . . . 0.0 110.983 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -59.07 -38.08 92.51 Favored Glycine 0 N--CA 1.449 -0.498 0 CA-C-N 116.384 -0.371 . . . . 0.0 113.183 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -68.05 -49.23 62.64 Favored 'General case' 0 CA--C 1.496 -1.096 0 CA-C-O 121.022 0.439 . . . . 0.0 109.852 179.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 26.3 mt -60.31 -41.04 85.69 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.559 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.639 179.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 57.1 mt -59.52 -42.44 92.25 Favored 'General case' 0 C--O 1.206 -1.189 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.095 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 90.7 m -61.47 -46.01 91.86 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 120.842 0.353 . . . . 0.0 111.458 179.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.409 HG11 ' HG3' ' B' ' 237' ' ' ARG . 97.8 t -67.1 -49.04 76.86 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.77 -179.204 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -67.89 -24.15 65.19 Favored 'General case' 0 N--CA 1.426 -1.627 0 CA-C-N 115.423 -0.808 . . . . 0.0 112.558 -176.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.455 ' OG ' ' HB2' ' B' ' 231' ' ' ARG . 66.1 m -68.93 -19.56 64.19 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 116.188 -0.46 . . . . 0.0 112.059 176.344 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -67.08 -29.13 68.82 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 176.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -89.93 -23.2 21.65 Favored 'General case' 0 N--CA 1.441 -0.897 0 CA-C-N 115.899 -0.591 . . . . 0.0 112.245 -174.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 171.54 -152.57 18.1 Favored Glycine 0 N--CA 1.426 -1.985 0 N-CA-C 111.312 -0.715 . . . . 0.0 111.312 179.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 86.7 t -106.62 112.87 63.48 Favored Pre-proline 0 C--N 1.297 -1.674 0 CA-C-O 120.793 0.33 . . . . 0.0 110.376 -178.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.415 ' HB3' HD22 ' A' ' 77' ' ' LEU . 88.6 Cg_endo -80.47 136.78 11.29 Favored 'Trans proline' 0 N--CA 1.442 -1.543 0 C-N-CA 122.371 2.047 . . . . 0.0 110.439 176.287 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 28.4 m -111.17 -28.32 2.63 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 C-N-CA 120.022 -0.671 . . . . 0.0 111.469 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -152.16 145.05 24.41 Favored 'General case' 0 CA--C 1.498 -1.043 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 178.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 10.7 p -145.95 135.45 17.53 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 123.775 0.672 . . . . 0.0 110.006 -178.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 94.1 mt -121.38 121.94 66.0 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 175.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -98.24 117.94 33.76 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 104.988 -2.226 . . . . 0.0 104.988 174.162 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 69.8 m -71.66 116.09 11.62 Favored 'General case' 0 N--CA 1.405 -2.681 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 177.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 43.3 mtm180 -130.21 130.59 44.85 Favored 'General case' 0 C--N 1.295 -1.786 0 CA-C-N 115.34 -0.845 . . . . 0.0 108.844 -177.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -79.63 126.44 30.91 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.861 -177.081 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -61.67 -27.42 68.67 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 179.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 25.7 m-80 -79.77 -49.84 11.44 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 121.184 0.516 . . . . 0.0 110.511 -173.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 39.5 p -85.75 -24.35 26.94 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 115.646 -0.707 . . . . 0.0 111.542 -177.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.2 20.88 79.36 Favored Glycine 0 N--CA 1.443 -0.845 0 N-CA-C 110.686 -0.965 . . . . 0.0 110.686 -176.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -121.39 174.1 6.95 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 -177.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 48.3 t -67.95 146.2 53.81 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 178.132 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -83.2 -2.06 54.59 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 121.675 0.75 . . . . 0.0 109.779 177.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 90.78 15.73 55.98 Favored Glycine 0 N--CA 1.426 -1.995 0 CA-C-N 114.915 -1.039 . . . . 0.0 112.993 176.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 33.7 p90 -155.35 163.1 40.55 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 177.233 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -155.6 176.14 12.99 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-O 121.095 0.474 . . . . 0.0 111.228 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -137.64 146.0 43.38 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 124.334 1.054 . . . . 0.0 109.965 179.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.415 HD22 ' HB3' ' A' ' 57' ' ' PRO . 9.8 tt -151.88 140.86 21.13 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 175.517 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -121.76 144.09 49.0 Favored 'General case' 0 C--O 1.257 1.482 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 178.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 50.2 m-85 -103.89 164.72 11.51 Favored 'General case' 0 C--N 1.288 -2.072 0 CA-C-N 115.595 -0.729 . . . . 0.0 111.688 -178.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -69.77 -39.52 76.62 Favored 'General case' 0 N--CA 1.429 -1.522 0 CA-C-N 114.388 -1.278 . . . . 0.0 108.665 174.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.409 ' OD2' ' HB2' ' A' ' 83' ' ' ARG . 26.6 t70 -124.13 140.0 53.39 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.932 -176.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 -69.46 -19.75 63.76 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 115.187 1.551 . . . . 0.0 115.187 -178.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.409 ' HB2' ' OD2' ' A' ' 81' ' ' ASP . 0.0 OUTLIER -67.23 -33.91 76.34 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-O 122.175 0.988 . . . . 0.0 109.743 173.382 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.451 ' OG ' HG22 ' B' ' 226' ' ' ILE . 45.8 m -65.31 -36.91 85.5 Favored 'General case' 0 C--N 1.289 -2.062 0 CA-C-N 115.06 -0.973 . . . . 0.0 112.199 177.652 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.484 HG22 ' HA ' ' A' ' 31' ' ' ALA . 68.6 p -64.7 -45.59 85.96 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 120.26 -0.576 . . . . 0.0 110.841 -177.749 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 5.3 pt -63.51 -38.65 82.78 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.249 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.754 176.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.597 HD23 ' CD1' ' B' ' 224' ' ' PHE . 19.5 mt -58.79 -43.86 90.57 Favored 'General case' 0 C--O 1.247 0.969 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.302 176.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -71.53 -46.8 58.6 Favored 'General case' 0 N--CA 1.438 -1.067 0 CA-C-N 115.573 -0.739 . . . . 0.0 111.56 -179.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.407 HG21 ' O ' ' A' ' 85' ' ' THR . 75.8 t -57.88 -48.07 84.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-O 121.072 0.463 . . . . 0.0 111.113 -179.344 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -62.09 -32.83 73.43 Favored 'General case' 0 C--N 1.296 -1.744 0 CA-C-N 115.047 -0.979 . . . . 0.0 112.003 -173.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 36.7 m-80 -97.98 -25.08 15.1 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 113.367 0.877 . . . . 0.0 113.367 -178.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 15.4 mt -96.33 -31.29 12.96 Favored 'General case' 0 CA--C 1.484 -1.568 0 CA-C-O 120.898 0.38 . . . . 0.0 111.875 -172.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 57.7 t30 -66.51 125.28 25.21 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 -179.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 82.94 -1.12 89.15 Favored Glycine 0 N--CA 1.444 -0.821 0 O-C-N 123.414 0.446 . . . . 0.0 112.556 179.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 82.7 t80 -88.05 143.75 26.9 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 -178.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.412 ' HD2' ' N ' ' A' ' 96' ' ' LYS . 11.5 mptt -96.9 118.7 33.91 Favored 'General case' 0 N--CA 1.436 -1.151 0 CA-C-O 121.088 0.47 . . . . 0.0 111.27 -177.143 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 53.1 mt -124.53 141.73 43.69 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 N-CA-C 105.098 -2.186 . . . . 0.0 105.098 173.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 56.93 29.27 58.82 Favored Glycine 0 C--O 1.22 -0.727 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.702 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 76.55 2.1 73.67 Favored Glycine 0 CA--C 1.537 1.455 0 C-N-CA 121.71 -0.281 . . . . 0.0 113.8 -179.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.446 ' NH1' ' HB2' ' A' ' 39' ' ' ASN . 0.2 OUTLIER -124.37 143.77 50.41 Favored 'General case' 0 C--N 1.316 -0.868 0 O-C-N 122.176 -0.603 . . . . 0.0 111.543 -177.125 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -87.23 118.45 26.65 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.644 -177.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 11.9 mt -70.22 147.92 49.23 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 115.431 -0.804 . . . . 0.0 112.513 179.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 59.3 tptt -120.83 116.23 24.8 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 175.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.431 ' CD1' HG21 ' A' ' 35' ' ' ILE . 4.7 mm -119.41 131.01 73.25 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.809 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 179.326 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -144.01 151.02 39.14 Favored 'General case' 0 C--N 1.285 -2.202 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 179.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 28.8 m-70 -78.68 135.03 37.07 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 178.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 12.0 t -149.59 161.51 42.03 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 106.199 -1.778 . . . . 0.0 106.199 -177.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -103.62 110.15 22.11 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 174.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 28.1 t80 -107.82 133.08 52.72 Favored 'General case' 0 C--N 1.294 -1.835 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.389 -176.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 21.9 mmm180 -121.11 118.28 30.29 Favored Pre-proline 0 C--N 1.297 -1.705 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 173.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -65.0 139.32 61.0 Favored 'Trans proline' 0 C--O 1.252 1.202 0 C-N-CA 123.577 2.851 . . . . 0.0 113.644 -178.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.472 ' C ' ' HD3' ' A' ' 112' ' ' LYS . 11.2 tmtt? -91.46 123.91 35.24 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 178.088 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 . . . . . 0 C--N 1.303 -1.418 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.173 179.538 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 222' ' ' ASN . . . . . 0.545 ' HB3' ' CD2' ' A' ' 87' ' ' LEU . 62.8 t30 . . . . . 0 N--CA 1.477 0.921 0 CA-C-O 120.447 0.165 . . . . 0.0 111.437 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 223' ' ' ARG . . . . . . . . . . . . . 3.1 mmp_? 80.08 24.88 0.38 Allowed 'General case' 0 N--CA 1.505 2.3 0 C-N-CA 124.916 1.286 . . . . 0.0 112.477 174.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 224' ' ' PHE . . . . . 0.597 ' CD1' HD23 ' A' ' 87' ' ' LEU . 12.6 m-85 -115.37 166.06 12.29 Favored 'General case' 0 C--N 1.28 -2.442 0 CA-C-N 114.386 -1.279 . . . . 0.0 108.714 176.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 225' ' ' ALA . . . . . . . . . . . . . . . -114.32 17.78 17.33 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-O 120.801 0.334 . . . . 0.0 111.682 -173.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 226' ' ' ILE . . . . . 0.451 HG22 ' OG ' ' A' ' 84' ' ' SER . 4.2 mp -77.85 127.04 38.57 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.112 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 -179.664 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 227' ' ' MET . . . . . . . . . . . . . 26.6 mmt -78.65 144.3 64.74 Favored Pre-proline 0 C--N 1.295 -1.802 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.721 178.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 228' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -68.57 160.64 48.51 Favored 'Trans proline' 0 C--O 1.248 0.984 0 C-N-CA 123.211 2.607 . . . . 0.0 113.673 -176.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . -82.77 172.86 52.22 Favored Glycine 0 N--CA 1.442 -0.927 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.991 178.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 14.8 m -74.76 -17.49 60.63 Favored 'General case' 0 C--N 1.307 -1.248 0 C-N-CA 123.29 0.636 . . . . 0.0 112.502 -175.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 231' ' ' ARG . . . . . 0.455 ' HB2' ' OG ' ' A' ' 52' ' ' SER . 23.0 mmm180 -79.75 -11.48 59.84 Favored 'General case' 0 CA--C 1.5 -0.949 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -179.768 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 232' ' ' TRP . . . . . . . . . . . . . 21.3 t90 -69.28 121.55 17.07 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-O 122.334 1.064 . . . . 0.0 111.922 -178.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 233' ' ' ASP . . . . . 0.446 ' O ' ' N ' ' B' ' 235' ' ' VAL . 30.3 t70 -116.77 149.11 40.46 Favored 'General case' 0 C--N 1.278 -2.543 0 N-CA-C 102.486 -3.154 . . . . 0.0 102.486 171.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -45.06 56.68 0.0 OUTLIER Glycine 0 N--CA 1.501 2.998 0 C-N-CA 128.114 2.769 . . . . 0.0 116.919 -177.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 235' ' ' VAL . . . . . 0.446 ' N ' ' O ' ' B' ' 233' ' ' ASP . 52.1 t -104.97 131.32 54.41 Favored 'Isoleucine or valine' 0 C--N 1.251 -3.678 0 C-N-CA 128.115 2.566 . . . . 0.0 106.926 176.255 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 236' ' ' HIS . . . . . . . . . . . . . 45.0 t60 -112.25 115.92 29.58 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 -178.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 237' ' ' ARG . . . . . 0.409 ' HG3' HG11 ' A' ' 50' ' ' VAL . 39.0 mmt180 -127.09 109.24 11.67 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 177.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 238' ' ' SER . . . . . . . . . . . . . 27.4 t -146.51 143.13 28.71 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 116.726 -0.215 . . . . 0.0 110.523 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 239' ' ' ASN . . . . . . . . . . . . . 27.2 p-10 -75.17 -22.86 57.78 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 121.482 0.658 . . . . 0.0 110.298 179.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 240' ' ' GLY . . . . . 0.409 ' O ' ' HG2' ' B' ' 244' ' ' LYS . . . -96.5 60.74 1.25 Allowed Glycine 0 N--CA 1.431 -1.672 0 N-CA-C 109.03 -1.628 . . . . 0.0 109.03 176.382 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 22.9 p90 -73.2 -33.26 65.28 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 -176.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -59.66 -47.43 85.63 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 120.731 -0.388 . . . . 0.0 111.362 -177.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -61.36 -34.99 76.22 Favored 'General case' 0 C--O 1.21 -1.015 0 O-C-N 123.659 0.599 . . . . 0.0 112.045 -179.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 244' ' ' LYS . . . . . 0.409 ' HG2' ' O ' ' B' ' 240' ' ' GLY . 43.6 mmtm -64.33 -48.39 75.77 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.248 0.547 . . . . 0.0 110.186 -178.37 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 245' ' ' TRP . . . . . . . . . . . . . 24.9 m0 -67.29 -37.69 83.83 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.103 179.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 246' ' ' PHE . . . . . 0.492 ' O ' ' HG2' ' B' ' 249' ' ' GLN . 2.4 t80 -65.04 -35.21 80.43 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.554 177.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -70.5 -36.33 73.72 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.656 -178.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.5 -14.09 36.03 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 120.974 0.416 . . . . 0.0 111.703 -177.63 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 249' ' ' GLN . . . . . 0.492 ' HG2' ' O ' ' B' ' 246' ' ' PHE . 2.6 pt20 -84.79 3.74 36.23 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 109.192 -0.669 . . . . 0.0 109.192 177.007 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 250' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -50.35 -32.09 16.38 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 114.788 -1.096 . . . . 0.0 111.938 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -64.7 123.76 20.16 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.578 -178.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 252' ' ' ILE . . . . . . . . . . . . . 27.5 pt -98.63 -31.98 3.76 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 CA-C-O 121.274 0.559 . . . . 0.0 111.937 -177.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -89.86 -16.9 29.12 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-O 121.584 0.706 . . . . 0.0 109.71 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 254' ' ' GLU . . . . . 0.578 ' OE1' ' HG3' ' B' ' 255' ' ' LYS . 1.2 tm-20 -105.58 -170.99 1.83 Allowed 'General case' 0 C--N 1.293 -1.888 0 CA-C-N 114.691 -1.14 . . . . 0.0 108.799 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 255' ' ' LYS . . . . . 0.578 ' HG3' ' OE1' ' B' ' 254' ' ' GLU . 0.0 OUTLIER -75.72 176.02 8.11 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 114.55 1.315 . . . . 0.0 114.55 -178.25 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 256' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt . . . . . 0 C--N 1.31 -1.141 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 -179.113 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.445 ' ND2' ' HA ' ' A' ' 29' ' ' ASP . 34.4 t30 . . . . . 0 CA--C 1.497 -1.083 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 33.9 mm-40 -115.66 -50.58 2.7 Favored 'General case' 0 N--CA 1.428 -1.526 0 C-N-CA 120.248 -0.581 . . . . 0.0 109.676 174.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -137.08 17.4 3.0 Favored 'General case' 0 C--O 1.241 0.606 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 -176.139 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -94.54 -42.61 8.74 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-O 121.651 0.738 . . . . 0.0 110.19 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.445 ' HA ' ' ND2' ' A' ' 25' ' ' ASN . 79.4 m-20 60.72 18.54 8.64 Favored 'General case' 0 C--O 1.213 -0.829 0 C-N-CA 125.771 1.628 . . . . 0.0 113.257 179.469 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 57.9 t30 -89.39 19.69 4.3 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 114.08 -1.418 . . . . 0.0 108.964 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -96.86 -5.14 38.9 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 114.67 -1.15 . . . . 0.0 108.768 178.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 12.6 m-85 -108.24 144.89 35.1 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.217 -175.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 26.4 pt -139.47 155.51 25.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 CA-C-O 121.3 0.572 . . . . 0.0 110.374 176.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 50.9 t80 -106.38 123.1 47.54 Favored 'General case' 0 N--CA 1.411 -2.396 0 CA-C-N 114.31 -1.314 . . . . 0.0 107.772 177.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.434 HG21 ' CD1' ' A' ' 104' ' ' ILE . 8.1 mt -108.67 127.9 64.8 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.098 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 175.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -129.97 164.38 22.68 Favored Glycine 0 C--N 1.278 -2.685 0 N-CA-C 110.806 -0.918 . . . . 0.0 110.806 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 72.67 34.16 1.24 Allowed 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.92 1.288 . . . . 0.0 110.982 -179.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -64.57 146.33 54.78 Favored 'General case' 0 CA--C 1.497 -1.064 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.031 176.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.422 ' HB3' ' HG ' ' A' ' 42' ' ' LEU . 60.7 t30 -84.27 139.6 32.23 Favored 'General case' 0 C--N 1.289 -2.062 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 176.571 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.419 ' HD2' ' C ' ' A' ' 40' ' ' ARG . 6.9 ppt_? -58.53 -16.83 17.15 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 113.556 0.947 . . . . 0.0 113.556 -174.744 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -100.85 0.24 38.19 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -178.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.422 ' HG ' ' HB3' ' A' ' 39' ' ' ASN . 57.4 mt -80.94 128.66 33.93 Favored 'General case' 0 C--O 1.245 0.823 0 CA-C-O 121.235 0.541 . . . . 0.0 111.223 178.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 72.4 p -108.37 173.07 6.48 Favored 'General case' 0 N--CA 1.425 -1.708 0 CA-C-N 114.657 -1.156 . . . . 0.0 109.977 -177.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.5 ' HG3' ' HB2' ' A' ' 62' ' ' LEU . 2.3 mp0 -56.0 -43.1 77.36 Favored 'General case' 0 C--N 1.316 -0.886 0 C-N-CA 124.061 0.944 . . . . 0.0 110.824 178.361 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -62.62 -35.38 91.75 Favored Glycine 0 C--O 1.24 0.525 0 CA-C-N 115.867 -0.606 . . . . 0.0 112.557 -179.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 39.2 m-20 -64.84 -48.99 72.35 Favored 'General case' 0 CA--C 1.49 -1.337 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 178.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 52.5 mt -61.54 -48.03 90.64 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.856 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.402 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 40.1 mt -59.98 -42.44 94.19 Favored 'General case' 0 CA--C 1.494 -1.189 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.805 -176.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 90.0 m -63.55 -45.9 88.38 Favored 'General case' 0 C--N 1.309 -1.191 0 O-C-N 123.456 0.473 . . . . 0.0 111.225 -179.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 98.1 t -67.69 -46.33 82.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.769 -178.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -66.12 -24.33 66.66 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.952 -178.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.527 ' OG ' ' HB2' ' B' ' 231' ' ' ARG . 70.2 m -70.81 -19.1 62.71 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.943 175.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -72.64 -27.2 61.99 Favored 'General case' 0 CA--C 1.551 1.009 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 177.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 58.3 m-85 -89.98 -16.45 29.84 Favored 'General case' 0 CA--C 1.511 -0.539 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.888 -177.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.419 ' O ' ' HA ' ' A' ' 52' ' ' SER . . . 163.13 -153.47 24.01 Favored Glycine 0 N--CA 1.417 -2.615 0 C-N-CA 120.325 -0.94 . . . . 0.0 111.738 178.795 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 59.7 t -105.23 107.65 59.5 Favored Pre-proline 0 C--N 1.294 -1.83 0 CA-C-N 116.105 -0.048 . . . . 0.0 110.92 -176.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.415 ' HB3' HD22 ' A' ' 77' ' ' LEU . 97.5 Cg_endo -78.51 136.97 14.31 Favored 'Trans proline' 0 N--CA 1.448 -1.161 0 C-N-CA 122.698 2.266 . . . . 0.0 110.194 176.126 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 35.5 m -112.86 -27.39 2.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 C-N-CA 119.84 -0.744 . . . . 0.0 111.601 -178.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.465 ' HB3' ' HG2' ' A' ' 78' ' ' LYS . 38.8 t70 -152.01 144.33 24.02 Favored 'General case' 0 CA--C 1.5 -0.952 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -179.197 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 13.0 p -145.38 134.73 17.88 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 179.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 91.2 mt -121.07 121.75 65.81 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 175.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.5 ' HB2' ' HG3' ' A' ' 44' ' ' GLU . 0.1 OUTLIER -94.58 115.91 28.13 Favored 'General case' 0 N--CA 1.422 -1.872 0 N-CA-C 105.838 -1.912 . . . . 0.0 105.838 176.039 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 11.3 m -76.89 116.93 18.0 Favored 'General case' 0 N--CA 1.409 -2.485 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 178.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 53.8 mtt180 -128.45 154.23 46.29 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.752 -177.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -88.94 115.03 26.2 Favored 'General case' 0 C--N 1.284 -2.25 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 173.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -62.0 -16.44 51.48 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 114.341 1.237 . . . . 0.0 114.341 -175.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 20.1 m-80 -81.65 -49.4 10.54 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-O 121.505 0.669 . . . . 0.0 109.501 -176.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 41.7 p -85.72 -23.27 27.43 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 115.373 -0.831 . . . . 0.0 110.984 -179.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.29 7.48 86.92 Favored Glycine 0 N--CA 1.446 -0.653 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.691 -179.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -105.72 163.43 12.7 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-O 121.16 0.505 . . . . 0.0 111.129 -175.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 14.5 m -63.4 139.54 58.78 Favored 'General case' 0 N--CA 1.425 -1.693 0 CA-C-N 114.579 -1.191 . . . . 0.0 109.932 178.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 14.1 mm-40 -74.51 -24.24 58.96 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 116.104 -0.498 . . . . 0.0 112.056 -179.269 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 113.44 7.2 20.96 Favored Glycine 0 N--CA 1.427 -1.953 0 C-N-CA 119.888 -1.148 . . . . 0.0 111.423 -175.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 31.4 p90 -151.02 156.76 41.79 Favored 'General case' 0 N--CA 1.427 -1.584 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 178.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -154.64 174.6 14.76 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 123.647 0.592 . . . . 0.0 110.09 178.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -132.17 141.16 49.0 Favored 'General case' 0 C--N 1.305 -1.362 0 C-N-CA 123.605 0.762 . . . . 0.0 110.076 -178.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.415 HD22 ' HB3' ' A' ' 57' ' ' PRO . 9.7 tt -148.08 140.72 24.57 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 175.372 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.465 ' HG2' ' HB3' ' A' ' 59' ' ' ASP . 21.2 ptmt -123.55 144.5 49.53 Favored 'General case' 0 C--O 1.258 1.551 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 178.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 59.2 m-85 -105.83 164.42 11.95 Favored 'General case' 0 C--N 1.288 -2.079 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.011 -179.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -80.15 -33.84 38.14 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 114.88 -1.055 . . . . 0.0 108.763 175.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -111.96 129.31 56.23 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -177.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -70.03 -20.42 63.25 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 113.883 1.068 . . . . 0.0 113.883 -178.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.76 -33.39 75.52 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 122.193 0.997 . . . . 0.0 109.448 174.791 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 63.7 m -64.13 -37.06 86.1 Favored 'General case' 0 C--N 1.292 -1.906 0 CA-C-N 115.184 -0.916 . . . . 0.0 112.901 178.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 68.6 p -64.68 -45.45 86.64 Favored 'General case' 0 C--N 1.346 0.43 0 C-N-CA 120.469 -0.493 . . . . 0.0 110.818 -177.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 4.0 pt -65.08 -39.1 84.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.759 177.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 12.2 mt -59.47 -43.51 93.22 Favored 'General case' 0 CA--C 1.505 -0.784 0 O-C-N 123.35 0.406 . . . . 0.0 111.703 176.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.403 ' O ' ' HB2' ' A' ' 92' ' ' LEU . . . -69.35 -45.99 68.09 Favored 'General case' 0 N--CA 1.428 -1.555 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.739 -178.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 86.8 t -58.76 -45.28 91.3 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.134 0 CA-C-O 121.21 0.529 . . . . 0.0 110.643 177.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -58.91 -37.63 77.07 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 125.103 1.361 . . . . 0.0 112.321 -178.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 41.5 m-80 -98.17 -26.67 14.48 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 -176.002 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.403 ' HB2' ' O ' ' A' ' 88' ' ' ALA . 19.0 mt -96.13 -30.82 13.31 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -172.489 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -65.84 123.92 21.09 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 88.48 -12.2 65.78 Favored Glycine 0 CA--C 1.53 1.012 0 CA-C-N 116.026 -0.534 . . . . 0.0 112.422 -178.066 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 73.4 t80 -79.73 138.0 37.19 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 -176.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.46 ' HA ' ' O ' ' A' ' 100' ' ' ARG . 0.3 OUTLIER -95.66 123.28 39.15 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 112.111 0.411 . . . . 0.0 112.111 -177.035 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 59.4 mt -128.15 142.12 44.65 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 N-CA-C 105.737 -1.949 . . . . 0.0 105.737 173.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 64.14 14.32 55.99 Favored Glycine 0 C--N 1.319 -0.416 0 C-N-CA 121.262 -0.494 . . . . 0.0 112.701 -178.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 90.31 -1.18 79.25 Favored Glycine 0 N--CA 1.43 -1.73 0 CA-C-O 119.923 -0.376 . . . . 0.0 112.731 -178.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.46 ' O ' ' HA ' ' A' ' 96' ' ' LYS . 11.4 ptp180 -124.22 151.34 44.22 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 117.714 0.757 . . . . 0.0 111.96 -177.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -86.54 116.35 24.62 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -175.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 11.9 mt -65.61 148.72 51.27 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.469 -0.787 . . . . 0.0 112.56 178.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 57.7 tptt -122.12 118.06 27.76 Favored 'General case' 0 N--CA 1.422 -1.846 0 CA-C-N 115.14 -0.936 . . . . 0.0 108.663 175.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.434 ' CD1' HG21 ' A' ' 35' ' ' ILE . 4.3 mm -117.61 135.4 58.13 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 N-CA-C 107.143 -1.428 . . . . 0.0 107.143 178.515 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -143.94 149.71 37.24 Favored 'General case' 0 C--N 1.285 -2.229 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 -178.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 45.2 m-70 -81.56 131.17 35.26 Favored 'General case' 0 C--N 1.29 -1.981 0 N-CA-C 109.487 -0.561 . . . . 0.0 109.487 178.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 12.5 t -145.35 165.82 27.37 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 -177.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -110.16 109.77 20.4 Favored 'General case' 0 N--CA 1.428 -1.568 0 N-CA-C 106.649 -1.611 . . . . 0.0 106.649 174.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 35.6 t80 -108.62 134.7 51.01 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.719 -176.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 4.4 mpt_? -121.16 114.26 32.16 Favored Pre-proline 0 C--N 1.309 -1.189 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 172.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -81.44 152.76 17.93 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 122.89 2.394 . . . . 0.0 114.998 -177.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.473 ' HD3' ' N ' ' A' ' 113' ' ' ARG . 11.7 tmtt? -120.92 134.06 55.29 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 104.943 -2.243 . . . . 0.0 104.943 172.371 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.473 ' N ' ' HD3' ' A' ' 112' ' ' LYS . 28.4 mmt180 . . . . . 0 C--N 1.299 -1.617 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 36.4 t30 . . . . . 0 N--CA 1.469 0.492 0 N-CA-C 110.495 -0.187 . . . . 0.0 110.495 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 223' ' ' ARG . . . . . . . . . . . . 0.252 12.4 ptm180 53.59 50.17 17.81 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 116.898 2.184 . . . . 0.0 116.898 173.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 224' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -104.82 165.55 10.99 Favored 'General case' 0 C--N 1.273 -2.734 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.685 173.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 225' ' ' ALA . . . . . . . . . . . . . . . -128.44 81.79 2.05 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-O 121.007 0.432 . . . . 0.0 110.959 179.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 4.1 mp -125.4 129.09 73.0 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 177.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 227' ' ' MET . . . . . . . . . . . . . 91.4 mtp -70.35 137.7 86.51 Favored Pre-proline 0 C--N 1.313 -0.994 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 177.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 228' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -64.75 157.02 58.33 Favored 'Trans proline' 0 C--O 1.251 1.166 0 C-N-CA 123.398 2.732 . . . . 0.0 113.489 -176.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . -74.75 168.68 54.63 Favored Glycine 0 N--CA 1.435 -1.409 0 CA-C-N 115.122 -0.945 . . . . 0.0 111.83 178.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 15.0 m -75.04 -16.8 60.58 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 111.856 0.317 . . . . 0.0 111.856 -175.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 231' ' ' ARG . . . . . 0.527 ' HB2' ' OG ' ' A' ' 52' ' ' SER . 26.6 mmt180 -79.2 -10.21 59.76 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.933 0.397 . . . . 0.0 110.261 -177.627 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 232' ' ' TRP . . . . . . . . . . . . . 25.4 t90 -70.13 130.07 41.1 Favored 'General case' 0 N--CA 1.432 -1.329 0 CA-C-O 122.481 1.134 . . . . 0.0 112.059 -178.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 233' ' ' ASP . . . . . 0.453 ' O ' ' N ' ' B' ' 235' ' ' VAL . 22.8 t70 -124.03 139.45 53.93 Favored 'General case' 0 C--N 1.269 -2.906 0 N-CA-C 101.934 -3.358 . . . . 0.0 101.934 171.464 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -35.56 56.28 0.0 OUTLIER Glycine 0 N--CA 1.508 3.437 0 C-N-CA 128.747 3.07 . . . . 0.0 117.926 -177.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 235' ' ' VAL . . . . . 0.453 ' N ' ' O ' ' B' ' 233' ' ' ASP . 55.3 t -111.4 120.22 61.49 Favored 'Isoleucine or valine' 0 C--N 1.249 -3.783 0 C-N-CA 127.655 2.382 . . . . 0.0 107.664 176.633 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 236' ' ' HIS . . . . . . . . . . . . . 40.3 t-80 -107.0 116.7 32.38 Favored 'General case' 0 C--N 1.291 -1.965 0 CA-C-O 121.056 0.455 . . . . 0.0 109.823 -178.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 237' ' ' ARG . . . . . . . . . . . . . 38.4 mmt180 -126.89 120.36 29.0 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 177.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 238' ' ' SER . . . . . . . . . . . . . 55.0 m -146.53 153.53 40.5 Favored 'General case' 0 C--N 1.282 -2.365 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 178.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 239' ' ' ASN . . . . . . . . . . . . . 24.7 p-10 -61.78 88.41 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.837 0 CA-C-O 122.477 1.132 . . . . 0.0 112.271 -178.052 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 240' ' ' GLY . . . . . 0.447 ' O ' ' HG2' ' B' ' 243' ' ' GLU . . . -133.41 37.81 1.94 Allowed Glycine 0 N--CA 1.403 -3.505 0 CA-C-N 113.742 -1.572 . . . . 0.0 110.39 178.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 29.3 p90 -77.26 -36.71 54.18 Favored 'General case' 0 C--N 1.294 -1.829 0 CA-C-O 121.477 0.656 . . . . 0.0 110.857 176.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 242' ' ' GLU . . . . . 0.502 ' HA ' ' CE3' ' B' ' 245' ' ' TRP . 42.4 tt0 -67.55 -38.95 84.91 Favored 'General case' 0 C--O 1.251 1.145 0 CA-C-N 115.093 -0.958 . . . . 0.0 111.657 -178.504 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 243' ' ' GLU . . . . . 0.447 ' HG2' ' O ' ' B' ' 240' ' ' GLY . 12.2 pt-20 -58.3 -35.02 71.19 Favored 'General case' 0 C--O 1.212 -0.9 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.229 178.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 244' ' ' LYS . . . . . 0.416 ' HE2' ' O ' ' B' ' 240' ' ' GLY . 72.2 mmtt -62.79 -46.17 89.25 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.598 -176.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 245' ' ' TRP . . . . . 0.502 ' CE3' ' HA ' ' B' ' 242' ' ' GLU . 11.8 m0 -63.98 -40.65 96.86 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.675 179.308 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 246' ' ' PHE . . . . . 0.567 ' O ' ' HG2' ' B' ' 249' ' ' GLN . 2.5 t80 -66.64 -31.12 71.59 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.075 179.069 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -77.54 -39.91 44.39 Favored 'General case' 0 C--N 1.29 -2.004 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.079 178.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.47 -13.28 55.05 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-O 121.395 0.617 . . . . 0.0 111.606 -175.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 249' ' ' GLN . . . . . 0.567 ' HG2' ' O ' ' B' ' 246' ' ' PHE . 3.2 pt20 -74.48 2.68 9.01 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.597 -179.635 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 250' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -61.24 -31.08 70.88 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 174.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -91.63 158.32 16.48 Favored 'General case' 0 N--CA 1.414 -2.263 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.439 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 252' ' ' ILE . . . . . . . . . . . . . 35.0 pt -108.11 -29.17 2.62 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 CA-C-N 114.927 -1.033 . . . . 0.0 110.265 -176.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -120.04 -32.39 4.2 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.918 0.389 . . . . 0.0 110.85 -175.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 254' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -77.09 155.18 32.62 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 -170.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 255' ' ' LYS . . . . . . . . . . . . . 35.5 mtmm -62.23 -74.78 0.08 Allowed 'General case' 0 C--N 1.315 -0.922 0 C-N-CA 125.436 1.495 . . . . 0.0 113.946 -174.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 256' ' ' LYS . . . . . . . . . . . . . 86.4 tttt . . . . . 0 C--N 1.296 -1.744 0 CA-C-O 118.873 -0.584 . . . . 0.0 109.595 -176.149 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 10.1 t30 . . . . . 0 CA--C 1.512 -0.494 0 CA-C-O 121.239 0.542 . . . . 0.0 109.714 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.451 ' HG2' ' CD1' ' A' ' 27' ' ' TYR . 1.4 pm0 -146.46 16.51 1.31 Allowed 'General case' 0 N--CA 1.413 -2.31 0 CA-C-N 114.955 -1.021 . . . . 0.0 111.959 -178.017 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.451 ' CD1' ' HG2' ' A' ' 26' ' ' GLU . 19.9 m-85 -113.43 6.49 17.2 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.134 0.492 . . . . 0.0 112.246 -177.283 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -96.19 -69.97 0.73 Allowed 'General case' 0 C--N 1.302 -1.481 0 CA-C-O 121.393 0.616 . . . . 0.0 109.629 178.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 56.12 21.23 4.99 Favored 'General case' 0 C--O 1.215 -0.759 0 C-N-CA 125.446 1.498 . . . . 0.0 114.98 177.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -89.79 12.65 16.5 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 171.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -92.13 22.43 4.4 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 114.809 -1.087 . . . . 0.0 111.748 -173.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 16.9 m-30 -93.92 145.39 24.67 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 120.933 -0.307 . . . . 0.0 110.598 -176.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 26.4 pt -143.8 162.26 15.83 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 C-N-CA 123.229 0.612 . . . . 0.0 110.233 176.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 29.8 t80 -114.46 124.5 52.08 Favored 'General case' 0 N--CA 1.421 -1.913 0 C-N-CA 124.355 1.062 . . . . 0.0 108.616 177.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 7.5 mt -109.6 127.72 66.19 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.976 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 175.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -127.88 164.37 21.25 Favored Glycine 0 C--N 1.281 -2.501 0 N-CA-C 110.622 -0.991 . . . . 0.0 110.622 -179.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 16.9 m120 71.38 36.93 1.23 Allowed 'General case' 0 CA--C 1.503 -0.83 0 C-N-CA 124.177 0.991 . . . . 0.0 111.082 -177.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.409 HD21 ' HA ' ' A' ' 74' ' ' PHE . 4.1 mm? -69.79 153.87 42.75 Favored 'General case' 0 CA--C 1.499 -0.984 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.105 176.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.42 ' HB3' ' HG ' ' A' ' 42' ' ' LEU . 38.2 t-20 -92.07 152.96 19.69 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 175.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.432 ' HD3' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -67.38 -23.59 65.59 Favored 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 122.535 0.334 . . . . 0.0 110.41 -179.162 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -90.55 -10.97 41.51 Favored 'General case' 0 C--O 1.224 -0.259 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.291 -178.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.42 ' HG ' ' HB3' ' A' ' 39' ' ' ASN . 55.3 mt -77.43 120.38 22.34 Favored 'General case' 0 CA--C 1.495 -1.171 0 CA-C-O 121.596 0.712 . . . . 0.0 110.947 -178.218 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 73.0 p -102.07 173.49 6.36 Favored 'General case' 0 C--N 1.287 -2.142 0 CA-C-N 114.508 -1.224 . . . . 0.0 109.771 -177.215 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -64.07 -34.61 78.43 Favored 'General case' 0 C--O 1.205 -1.276 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 177.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -59.31 -39.26 94.45 Favored Glycine 0 N--CA 1.443 -0.854 0 O-C-N 123.969 0.793 . . . . 0.0 111.438 178.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -67.54 -50.09 60.26 Favored 'General case' 0 CA--C 1.496 -1.107 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 177.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 46.3 mt -60.1 -47.22 92.79 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 CA-C-N 115.19 -0.913 . . . . 0.0 111.085 -178.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 41.4 mt -60.46 -45.45 93.66 Favored 'General case' 0 CA--C 1.49 -1.342 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.204 -176.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 90.4 m -63.08 -45.66 91.06 Favored 'General case' 0 N--CA 1.432 -1.356 0 O-C-N 123.74 0.65 . . . . 0.0 111.507 -178.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 98.2 t -67.48 -48.17 78.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.831 -179.182 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -63.82 -25.37 68.15 Favored 'General case' 0 N--CA 1.438 -1.064 0 C-N-CA 123.769 0.827 . . . . 0.0 112.208 -179.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.551 ' OG ' ' HB2' ' B' ' 231' ' ' ARG . 62.8 m -67.75 -19.86 65.17 Favored 'General case' 0 N--CA 1.439 -1.011 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 176.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -66.03 -32.0 73.22 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-O 121.803 0.811 . . . . 0.0 109.305 174.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 57.2 m-85 -88.89 -22.78 22.96 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.56 -0.746 . . . . 0.0 111.691 -173.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.462 ' O ' ' HA ' ' A' ' 52' ' ' SER . . . 173.7 -162.49 33.37 Favored Glycine 0 N--CA 1.428 -1.872 0 C-N-CA 120.633 -0.794 . . . . 0.0 111.795 178.303 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 59.4 t -100.43 110.57 60.54 Favored Pre-proline 0 C--N 1.304 -1.395 0 N-CA-C 110.511 -0.181 . . . . 0.0 110.511 -178.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.439 ' HB3' HD22 ' A' ' 77' ' ' LEU . 97.1 Cg_endo -79.69 136.67 12.29 Favored 'Trans proline' 0 N--CA 1.45 -1.049 0 C-N-CA 122.535 2.157 . . . . 0.0 110.603 177.502 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 35.0 m -111.35 -28.22 2.64 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 C-N-CA 119.786 -0.765 . . . . 0.0 111.834 -178.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.448 ' HB3' ' HG2' ' A' ' 78' ' ' LYS . 36.3 t70 -151.23 141.86 22.68 Favored 'General case' 0 CA--C 1.504 -0.789 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 -179.48 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 13.8 p -142.33 133.52 25.25 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 O-C-N 123.609 0.568 . . . . 0.0 109.809 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 83.4 mt -120.54 118.5 56.77 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.213 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 177.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -97.5 117.39 31.66 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 106.765 -1.569 . . . . 0.0 106.765 177.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 22.4 m -77.69 120.23 22.34 Favored 'General case' 0 C--N 1.29 -2.0 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 178.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 72.0 mtm180 -131.91 137.78 48.13 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.785 -175.076 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -70.35 128.73 37.2 Favored 'General case' 0 CA--C 1.499 -0.988 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.561 179.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -61.02 -29.39 69.68 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 115.416 -0.811 . . . . 0.0 112.692 -178.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 25.6 m-80 -81.83 -50.13 9.56 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-O 120.979 0.418 . . . . 0.0 111.5 -172.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 53.0 p -88.8 -23.79 22.77 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.756 -176.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 80.68 -1.63 82.28 Favored Glycine 0 N--CA 1.438 -1.201 0 N-CA-C 111.479 -0.648 . . . . 0.0 111.479 -176.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.432 ' OE2' ' HD3' ' A' ' 40' ' ' ARG . 5.5 mm-40 -91.4 168.32 11.64 Favored 'General case' 0 CA--C 1.503 -0.832 0 C-N-CA 122.842 0.457 . . . . 0.0 111.043 -174.637 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 13.1 m -68.11 145.16 54.65 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.88 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -86.06 6.05 30.73 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 -178.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 91.7 8.31 63.89 Favored Glycine 0 N--CA 1.44 -1.041 0 C-N-CA 120.85 -0.69 . . . . 0.0 113.535 177.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.409 ' HA ' HD21 ' A' ' 38' ' ' LEU . 32.6 p90 -152.77 157.72 41.22 Favored 'General case' 0 C--O 1.248 1.025 0 CA-C-N 117.566 0.683 . . . . 0.0 109.251 178.71 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -153.12 173.15 15.85 Favored 'General case' 0 N--CA 1.433 -1.322 0 O-C-N 123.569 0.543 . . . . 0.0 110.763 178.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -132.36 142.74 49.44 Favored 'General case' 0 C--N 1.306 -1.291 0 C-N-CA 124.17 0.988 . . . . 0.0 109.584 -178.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.439 HD22 ' HB3' ' A' ' 57' ' ' PRO . 9.8 tt -149.71 140.73 22.92 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 176.608 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.448 ' HG2' ' HB3' ' A' ' 59' ' ' ASP . 22.2 ptmt -123.46 144.25 49.64 Favored 'General case' 0 C--O 1.253 1.278 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 178.497 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -105.28 165.5 11.07 Favored 'General case' 0 C--N 1.29 -2.0 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.97 -178.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -73.62 -27.07 61.09 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.354 175.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -131.13 141.19 50.09 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 120.714 0.292 . . . . 0.0 110.606 -178.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 25.2 mp0 -70.08 -21.27 63.16 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 123.971 0.908 . . . . 0.0 113.279 -178.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 89.5 mtm180 -65.3 -34.46 78.39 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-O 122.313 1.054 . . . . 0.0 109.512 176.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.456 ' OG ' HG22 ' B' ' 226' ' ' ILE . 53.3 m -65.59 -36.85 84.95 Favored 'General case' 0 C--N 1.282 -2.33 0 CA-C-N 114.561 -1.199 . . . . 0.0 112.288 177.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 63.8 p -65.38 -44.94 85.98 Favored 'General case' 0 C--N 1.344 0.356 0 C-N-CA 120.168 -0.613 . . . . 0.0 110.875 -177.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 3.5 pt -63.5 -38.91 83.46 Favored 'Isoleucine or valine' 0 C--O 1.243 0.731 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.036 177.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.51 HD22 ' CD1' ' B' ' 224' ' ' PHE . 49.2 mt -60.4 -44.04 96.08 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.385 176.211 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.462 ' O ' ' HB2' ' A' ' 92' ' ' LEU . . . -71.81 -46.61 57.59 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.838 -179.264 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 53.3 t -56.47 -48.89 79.42 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.902 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -178.004 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -62.24 -43.88 97.83 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -173.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -93.33 -19.98 20.82 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-N 115.758 -0.656 . . . . 0.0 112.373 -170.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.462 ' HB2' ' O ' ' A' ' 88' ' ' ALA . 9.8 mt -92.6 -27.85 17.09 Favored 'General case' 0 CA--C 1.491 -1.313 0 CA-C-O 120.824 0.345 . . . . 0.0 111.142 179.397 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -65.6 124.48 22.47 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 178.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 88.32 -1.09 84.11 Favored Glycine 0 N--CA 1.434 -1.493 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.435 -178.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -79.36 129.87 34.89 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 -179.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 11.9 mptt -90.06 115.63 27.47 Favored 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 120.602 -0.439 . . . . 0.0 110.245 179.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 54.1 mt -122.19 141.31 43.13 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 N-CA-C 105.803 -1.925 . . . . 0.0 105.803 174.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 57.32 21.9 42.19 Favored Glycine 0 CA--C 1.523 0.579 0 C-N-CA 121.79 -0.243 . . . . 0.0 113.411 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 85.8 7.53 81.13 Favored Glycine 0 N--CA 1.437 -1.29 0 C-N-CA 121.149 -0.548 . . . . 0.0 113.59 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 18.6 ptp180 -132.01 139.25 48.54 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 117.726 0.763 . . . . 0.0 110.622 -179.145 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -81.25 119.83 24.13 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.756 -177.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 12.1 mt -66.47 146.73 54.21 Favored 'General case' 0 CA--C 1.501 -0.917 0 O-C-N 124.114 0.884 . . . . 0.0 112.737 178.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 28.6 tptp -120.44 118.82 31.29 Favored 'General case' 0 N--CA 1.421 -1.906 0 CA-C-N 115.222 -0.899 . . . . 0.0 108.922 174.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 3.2 mm -115.13 139.04 43.42 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.867 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 178.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -145.32 150.65 36.99 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 178.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 56.4 m-70 -83.64 130.71 34.98 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 176.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 5.4 t -148.79 163.55 37.05 Favored 'General case' 0 C--N 1.29 -1.98 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 -176.148 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -109.73 111.77 23.43 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 172.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 36.3 t80 -105.18 138.76 40.88 Favored 'General case' 0 C--N 1.286 -2.159 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.083 -173.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.492 ' N ' ' HD3' ' A' ' 110' ' ' ARG . 0.4 OUTLIER -113.24 113.36 48.89 Favored Pre-proline 0 C--N 1.309 -1.184 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 176.623 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.96 146.76 53.59 Favored 'Trans proline' 0 C--N 1.333 -0.26 0 C-N-CA 123.369 2.712 . . . . 0.0 114.136 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 25.8 tptp -110.53 120.87 43.83 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 174.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 36.8 mmt180 . . . . . 0 C--N 1.295 -1.762 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 -178.971 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 . . . . . 0 CA--C 1.488 -1.409 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 223' ' ' ARG . . . . . . . . . . . . . 10.6 ptm180 65.05 16.94 10.85 Favored 'General case' 0 N--CA 1.505 2.291 0 C-N-CA 126.731 2.012 . . . . 0.0 114.118 -179.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 224' ' ' PHE . . . . . 0.51 ' CD1' HD22 ' A' ' 87' ' ' LEU . 58.6 m-85 -96.35 164.68 12.54 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 175.133 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 225' ' ' ALA . . . . . . . . . . . . . . . -138.81 81.21 1.83 Allowed 'General case' 0 C--N 1.291 -1.964 0 CA-C-O 121.399 0.618 . . . . 0.0 109.365 179.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 226' ' ' ILE . . . . . 0.456 HG22 ' OG ' ' A' ' 84' ' ' SER . 3.7 mp -116.11 136.02 54.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 176.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 227' ' ' MET . . . . . . . . . . . . . 63.6 mtt -68.42 137.43 91.14 Favored Pre-proline 0 C--N 1.31 -1.12 0 O-C-N 124.016 0.822 . . . . 0.0 109.681 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 228' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -67.94 146.39 71.34 Favored 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 122.196 1.931 . . . . 0.0 111.206 178.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . -66.1 161.08 44.9 Favored Glycine 0 N--CA 1.44 -1.037 0 CA-C-N 116.084 -0.507 . . . . 0.0 112.363 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 23.2 m -74.6 -12.67 60.51 Favored 'General case' 0 C--N 1.298 -1.654 0 C-N-CA 123.037 0.535 . . . . 0.0 111.794 -177.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 231' ' ' ARG . . . . . 0.551 ' HB2' ' OG ' ' A' ' 52' ' ' SER . 4.0 mmp_? -79.0 -14.53 59.14 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.044 0.45 . . . . 0.0 109.992 178.491 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 232' ' ' TRP . . . . . . . . . . . . . 28.9 t90 -72.12 122.88 21.73 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.984 -0.553 . . . . 0.0 112.052 -176.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 233' ' ' ASP . . . . . 0.678 ' O ' HG22 ' B' ' 235' ' ' VAL . 25.7 t70 -126.63 106.02 9.12 Favored 'General case' 0 C--O 1.207 -1.169 0 CA-C-O 118.665 -0.684 . . . . 0.0 110.057 177.661 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . 35.79 39.3 0.26 Allowed Glycine 0 N--CA 1.493 2.491 0 N-CA-C 115.9 1.12 . . . . 0.0 115.9 176.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 235' ' ' VAL . . . . . 0.678 HG22 ' O ' ' B' ' 233' ' ' ASP . 64.6 t -106.05 127.21 61.36 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 CA-C-N 117.22 0.51 . . . . 0.0 110.935 -175.326 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 236' ' ' HIS . . . . . . . . . . . . . 66.5 t-80 -112.99 115.04 27.77 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 107.597 -1.261 . . . . 0.0 107.597 172.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 237' ' ' ARG . . . . . . . . . . . . . 40.7 mmt180 -126.77 109.96 12.59 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-O 121.111 0.481 . . . . 0.0 110.557 178.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 238' ' ' SER . . . . . . . . . . . . . 69.3 m -145.13 115.79 7.7 Favored 'General case' 0 C--N 1.295 -1.789 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.361 177.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 239' ' ' ASN . . . . . . . . . . . . . 33.0 t30 -80.79 -35.49 33.02 Favored 'General case' 0 CA--C 1.502 -0.868 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 174.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 240' ' ' GLY . . . . . . . . . . . . . . . -98.1 63.47 0.87 Allowed Glycine 0 N--CA 1.406 -3.339 0 N-CA-C 108.751 -1.74 . . . . 0.0 108.751 176.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 28.9 p90 -76.37 -35.53 58.61 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-O 120.84 0.352 . . . . 0.0 111.923 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 242' ' ' GLU . . . . . 0.459 ' HA ' ' CE3' ' B' ' 245' ' ' TRP . 44.2 tt0 -67.33 -42.07 84.2 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.576 -176.608 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -57.95 -34.02 69.46 Favored 'General case' 0 C--O 1.22 -0.47 0 C-N-CA 123.105 0.562 . . . . 0.0 111.541 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -62.03 -45.96 91.25 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.394 -178.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 245' ' ' TRP . . . . . 0.459 ' CE3' ' HA ' ' B' ' 242' ' ' GLU . 11.2 m0 -69.6 -39.05 77.5 Favored 'General case' 0 CA--C 1.505 -0.756 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.425 178.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 246' ' ' PHE . . . . . 0.477 ' O ' ' HG2' ' B' ' 249' ' ' GLN . 6.1 t80 -62.12 -33.4 74.38 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.973 179.492 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -76.43 -30.85 57.57 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.632 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 248' ' ' LYS . . . . . 0.564 ' O ' ' HG2' ' B' ' 251' ' ' GLU . 0.0 OUTLIER -97.15 -12.61 22.89 Favored 'General case' 0 C--O 1.203 -1.378 0 O-C-N 121.895 -0.503 . . . . 0.0 112.11 -176.488 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 249' ' ' GLN . . . . . 0.477 ' HG2' ' O ' ' B' ' 246' ' ' PHE . 3.0 pt20 -70.17 2.51 3.61 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.137 0.575 . . . . 0.0 112.548 -176.327 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 250' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -63.64 -30.14 71.29 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.516 176.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . 0.564 ' HG2' ' O ' ' B' ' 248' ' ' LYS . 11.3 pt-20 -75.18 108.35 7.88 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-O 122.502 1.144 . . . . 0.0 111.067 -179.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 252' ' ' ILE . . . . . . . . . . . . . 30.4 pt -110.07 -34.28 2.48 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.334 0 CA-C-N 114.183 -1.372 . . . . 0.0 111.01 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -101.47 -26.01 13.72 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 178.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 254' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 -84.29 154.97 22.64 Favored 'General case' 0 N--CA 1.42 -1.945 0 CA-C-N 115.131 -0.94 . . . . 0.0 108.589 -176.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 255' ' ' LYS . . . . . . . . . . . . . 61.4 pttt -63.9 116.0 5.4 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-O 121.886 0.851 . . . . 0.0 113.268 -175.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 256' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt . . . . . 0 N--CA 1.425 -1.684 0 CA-C-N 114.494 -1.23 . . . . 0.0 108.218 179.095 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 35.8 m-80 . . . . . 0 N--CA 1.48 1.032 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -75.35 -11.84 60.14 Favored 'General case' 0 CA--C 1.51 -0.586 0 CA-C-O 121.411 0.624 . . . . 0.0 111.13 -178.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 54.0 m-85 -90.79 8.43 34.76 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-O 121.851 0.834 . . . . 0.0 110.967 179.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -128.82 151.56 49.46 Favored 'General case' 0 N--CA 1.429 -1.516 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 174.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -123.22 20.02 9.81 Favored 'General case' 0 C--N 1.281 -2.384 0 CA-C-O 123.282 1.515 . . . . 0.0 107.192 174.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -84.95 21.67 1.55 Allowed 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 112.964 -1.926 . . . . 0.0 109.343 -178.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -91.07 3.5 54.6 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.772 -174.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -95.93 145.83 25.08 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.064 -175.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 21.2 pt -140.79 160.64 23.86 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 C-N-CA 122.709 0.404 . . . . 0.0 110.175 175.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 61.6 t80 -110.81 125.9 54.07 Favored 'General case' 0 N--CA 1.409 -2.508 0 CA-C-N 115.272 -0.876 . . . . 0.0 108.757 178.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.422 HG21 ' CD1' ' A' ' 104' ' ' ILE . 8.0 mt -110.76 129.07 66.61 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.935 0 N-CA-C 107.297 -1.371 . . . . 0.0 107.297 176.454 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -129.65 166.16 21.94 Favored Glycine 0 C--N 1.283 -2.394 0 N-CA-C 110.318 -1.113 . . . . 0.0 110.318 179.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 70.02 38.35 1.56 Allowed 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 125.055 1.342 . . . . 0.0 111.389 -178.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -70.21 154.05 42.37 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.405 0.621 . . . . 0.0 111.687 177.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.415 ' HB3' ' HG ' ' A' ' 42' ' ' LEU . 45.2 t-20 -90.47 150.24 21.88 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 176.438 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.491 ' HD3' ' OE2' ' A' ' 70' ' ' GLU . 7.3 ppt_? -62.91 -21.62 66.16 Favored 'General case' 0 C--N 1.314 -0.937 0 C-N-CA 122.991 0.516 . . . . 0.0 111.29 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -94.89 -0.74 53.74 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 115.965 -0.562 . . . . 0.0 111.73 -178.097 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.415 ' HG ' ' HB3' ' A' ' 39' ' ' ASN . 68.9 mt -89.95 124.33 34.63 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-O 121.365 0.602 . . . . 0.0 110.762 -179.667 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 75.8 p -108.78 174.25 5.96 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.241 -179.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -54.79 -41.17 70.24 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 123.667 0.787 . . . . 0.0 110.131 177.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -64.19 -38.87 96.52 Favored Glycine 0 N--CA 1.444 -0.828 0 CA-C-N 115.492 -0.777 . . . . 0.0 113.027 -178.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -65.96 -47.06 75.86 Favored 'General case' 0 CA--C 1.496 -1.125 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 -179.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 44.6 mt -58.5 -45.14 90.22 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.632 179.066 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 45.1 mt -59.09 -45.83 89.85 Favored 'General case' 0 C--O 1.209 -1.031 0 CA-C-O 119.481 -0.295 . . . . 0.0 111.428 -179.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 99.0 m -61.53 -45.54 93.74 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.48 HG12 ' HG3' ' B' ' 237' ' ' ARG . 64.3 t -65.52 -47.8 85.21 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 CA-C-O 121.349 0.595 . . . . 0.0 110.708 -179.262 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -67.1 -23.04 65.8 Favored 'General case' 0 N--CA 1.436 -1.169 0 C-N-CA 124.022 0.929 . . . . 0.0 111.88 -179.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.453 ' OG ' ' HB2' ' B' ' 231' ' ' ARG . 65.9 m -69.7 -19.85 63.56 Favored 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 176.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -75.9 -25.47 56.08 Favored 'General case' 0 C--O 1.247 0.947 0 C-N-CA 118.247 -1.381 . . . . 0.0 108.853 177.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -88.04 -22.68 24.07 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.603 -176.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 175.73 -156.67 22.26 Favored Glycine 0 N--CA 1.425 -2.07 0 C-N-CA 120.624 -0.798 . . . . 0.0 111.562 177.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.446 ' HB ' ' HG2' ' A' ' 80' ' ' GLU . 94.5 t -106.46 102.56 41.65 Favored Pre-proline 0 C--N 1.3 -1.559 0 CA-C-O 120.851 0.357 . . . . 0.0 110.341 -178.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.436 ' HB3' HD22 ' A' ' 77' ' ' LEU . 89.7 Cg_endo -77.81 136.86 15.46 Favored 'Trans proline' 0 C--O 1.252 1.206 0 C-N-CA 122.534 2.156 . . . . 0.0 110.167 177.281 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 34.0 m -113.9 -18.47 7.51 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 C-N-CA 120.221 -0.592 . . . . 0.0 112.274 -177.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.468 ' HB3' ' HG2' ' A' ' 78' ' ' LYS . 20.3 t70 -160.14 139.13 10.69 Favored 'General case' 0 C--O 1.242 0.7 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 -178.494 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 12.7 p -140.62 137.59 35.83 Favored 'Isoleucine or valine' 0 C--O 1.245 0.845 0 O-C-N 123.35 0.406 . . . . 0.0 110.056 179.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 90.4 mt -121.33 124.76 72.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 C-N-CA 123.391 0.676 . . . . 0.0 109.394 175.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -100.12 121.06 40.83 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 106.056 -1.831 . . . . 0.0 106.056 175.501 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 20.4 m -79.91 117.37 20.71 Favored 'General case' 0 C--N 1.284 -2.249 0 N-CA-C 107.016 -1.476 . . . . 0.0 107.016 175.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.421 ' HA ' ' HA ' ' A' ' 71' ' ' SER . 57.8 mtp180 -118.02 133.15 56.18 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.573 -172.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -65.03 123.47 19.56 Favored 'General case' 0 CA--C 1.497 -1.08 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.843 177.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -61.62 -25.09 67.14 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 115.379 -0.828 . . . . 0.0 112.379 -178.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 34.5 m-80 -81.7 -50.57 9.14 Favored 'General case' 0 CA--C 1.504 -0.794 0 CA-C-O 121.061 0.458 . . . . 0.0 111.176 -175.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 62.9 p -86.32 -23.97 26.06 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.63 -176.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.76 -0.12 78.62 Favored Glycine 0 N--CA 1.445 -0.716 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.118 -179.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.491 ' OE2' ' HD3' ' A' ' 40' ' ' ARG . 37.6 mt-10 -91.33 -89.77 0.17 Allowed 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -173.401 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.421 ' HA ' ' HA ' ' A' ' 64' ' ' ARG . 50.8 m -148.28 160.72 42.68 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 -176.122 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 16.0 mm-40 -99.11 -3.07 35.43 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 122.955 0.502 . . . . 0.0 111.709 176.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 87.63 8.1 74.19 Favored Glycine 0 N--CA 1.431 -1.655 0 C-N-CA 120.186 -1.007 . . . . 0.0 112.48 -177.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 32.1 p90 -149.27 155.41 40.53 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 177.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -154.19 176.11 12.66 Favored 'General case' 0 C--N 1.316 -0.852 0 O-C-N 123.403 0.439 . . . . 0.0 111.0 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -132.82 144.02 49.94 Favored 'General case' 0 C--N 1.314 -0.971 0 C-N-CA 124.376 1.07 . . . . 0.0 109.975 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.436 HD22 ' HB3' ' A' ' 57' ' ' PRO . 9.9 tt -150.3 141.46 23.11 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 176.485 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.468 ' HG2' ' HB3' ' A' ' 59' ' ' ASP . 21.8 ptmt -123.3 143.8 49.84 Favored 'General case' 0 C--O 1.256 1.401 0 CA-C-O 121.215 0.531 . . . . 0.0 109.983 178.279 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.416 ' HH ' ' CB ' ' A' ' 88' ' ' ALA . 68.7 m-85 -106.67 165.41 11.32 Favored 'General case' 0 C--N 1.293 -1.88 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.822 179.615 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.446 ' HG2' ' HB ' ' A' ' 56' ' ' VAL . 6.9 pt-20 -76.49 -23.92 53.78 Favored 'General case' 0 C--N 1.315 -0.918 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.318 175.561 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -133.58 144.94 49.62 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 119.497 -0.881 . . . . 0.0 111.891 177.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 25.0 mp0 -69.41 -20.82 63.8 Favored 'General case' 0 C--N 1.309 -1.177 0 C-N-CA 124.32 1.048 . . . . 0.0 113.239 -177.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 76.2 mtm180 -62.74 -35.42 79.71 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 122.092 0.949 . . . . 0.0 109.976 176.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 49.5 m -69.11 -37.32 78.3 Favored 'General case' 0 C--N 1.286 -2.184 0 CA-C-N 114.905 -1.043 . . . . 0.0 112.951 178.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 72.1 p -62.66 -45.28 93.55 Favored 'General case' 0 C--N 1.344 0.336 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.456 -177.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 3.3 pt -65.71 -39.9 86.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.197 178.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.472 HD22 ' CD1' ' B' ' 224' ' ' PHE . 49.0 mt -60.31 -43.6 96.2 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 120.852 0.358 . . . . 0.0 111.319 176.008 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.455 ' O ' ' HB2' ' A' ' 92' ' ' LEU . . . -71.29 -46.47 60.74 Favored 'General case' 0 N--CA 1.433 -1.3 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.339 -178.498 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 66.9 t -57.56 -49.29 80.96 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.906 0 CA-C-O 121.054 0.454 . . . . 0.0 111.083 179.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -64.88 -34.66 78.93 Favored 'General case' 0 C--N 1.295 -1.798 0 C-N-CA 124.029 0.932 . . . . 0.0 111.779 -174.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -93.42 -28.53 16.08 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 -176.235 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.455 ' HB2' ' O ' ' A' ' 88' ' ' ALA . 13.9 mt -92.84 -30.46 15.44 Favored 'General case' 0 CA--C 1.488 -1.405 0 N-CA-C 111.797 0.295 . . . . 0.0 111.797 -175.046 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -66.41 124.76 23.63 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 177.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 85.95 -0.72 87.81 Favored Glycine 0 CA--C 1.535 1.328 0 C-N-CA 120.496 -0.859 . . . . 0.0 112.325 -177.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 21.7 t80 -89.23 133.5 34.41 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 -179.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -96.13 123.8 39.89 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-O 121.093 0.473 . . . . 0.0 111.647 -178.084 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 55.0 mt -127.74 141.32 46.73 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 N-CA-C 105.581 -2.007 . . . . 0.0 105.581 173.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 58.22 24.58 55.59 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 121.544 -0.36 . . . . 0.0 113.344 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 81.8 3.11 90.69 Favored Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 121.673 -0.299 . . . . 0.0 113.132 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 19.4 ptp180 -125.06 144.96 50.14 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 117.271 0.535 . . . . 0.0 110.978 -178.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -85.71 117.7 24.75 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.372 -177.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 11.9 mt -66.4 147.04 53.87 Favored 'General case' 0 C--O 1.25 1.118 0 CA-C-O 121.57 0.7 . . . . 0.0 112.566 178.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 60.1 tptt -119.19 117.97 30.08 Favored 'General case' 0 N--CA 1.416 -2.149 0 CA-C-N 114.777 -1.101 . . . . 0.0 108.046 176.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.422 ' CD1' HG21 ' A' ' 35' ' ' ILE . 4.9 mm -119.89 136.2 57.74 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.052 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 179.081 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -143.31 151.24 40.27 Favored 'General case' 0 C--N 1.283 -2.323 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 -179.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 79.9 m-70 -80.98 131.33 35.31 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 179.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 5.9 t -151.34 160.46 43.77 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 105.724 -1.954 . . . . 0.0 105.724 -178.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -110.64 110.01 20.53 Favored 'General case' 0 N--CA 1.422 -1.866 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 172.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 76.1 t80 -107.39 131.54 54.15 Favored 'General case' 0 C--N 1.291 -1.946 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.756 -178.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 5.3 mpt_? -115.08 114.48 43.52 Favored Pre-proline 0 C--N 1.29 -2.016 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 174.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -71.64 137.19 29.7 Favored 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 121.861 1.707 . . . . 0.0 110.926 179.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 26.6 tptp -82.91 114.66 21.35 Favored 'General case' 0 N--CA 1.418 -2.035 0 C-N-CA 119.41 -0.916 . . . . 0.0 109.855 -179.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 38.9 mmt180 . . . . . 0 C--N 1.282 -2.365 0 N-CA-C 105.949 -1.871 . . . . 0.0 105.949 178.039 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 40.3 t-20 . . . . . 0 C--O 1.197 -1.682 0 CA-C-O 120.553 0.216 . . . . 0.0 110.685 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 223' ' ' ARG . . . . . . . . . . . . . 3.7 mmp_? 75.13 7.19 4.18 Favored 'General case' 0 N--CA 1.513 2.722 0 C-N-CA 125.072 1.349 . . . . 0.0 113.721 173.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 224' ' ' PHE . . . . . 0.472 ' CD1' HD22 ' A' ' 87' ' ' LEU . 52.9 m-85 -99.52 165.29 11.71 Favored 'General case' 0 C--N 1.275 -2.652 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 225' ' ' ALA . . . . . . . . . . . . . . . -132.68 79.49 1.85 Allowed 'General case' 0 C--N 1.302 -1.483 0 CA-C-O 121.198 0.523 . . . . 0.0 110.396 178.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 3.9 mp -117.33 134.05 62.14 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.188 0 CA-C-N 115.298 -0.864 . . . . 0.0 108.882 176.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 227' ' ' MET . . . . . . . . . . . . . 18.9 ptp -66.93 154.1 92.98 Favored Pre-proline 0 C--N 1.318 -0.79 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.16 178.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 228' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -73.4 145.02 37.48 Favored 'Trans proline' 0 N--CA 1.44 -1.634 0 C-N-CA 122.17 1.913 . . . . 0.0 111.565 175.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . -67.92 166.58 43.55 Favored Glycine 0 N--CA 1.437 -1.274 0 CA-C-N 115.497 -0.774 . . . . 0.0 112.59 179.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 16.2 m -74.74 -14.51 60.73 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-O 121.022 0.439 . . . . 0.0 111.738 -175.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 231' ' ' ARG . . . . . 0.453 ' HB2' ' OG ' ' A' ' 52' ' ' SER . 39.7 mmt180 -84.83 -3.45 58.66 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.018 0.437 . . . . 0.0 110.409 -179.113 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 232' ' ' TRP . . . . . . . . . . . . . 22.1 t90 -76.29 128.62 35.26 Favored 'General case' 0 CA--C 1.5 -0.975 0 CA-C-O 122.31 1.053 . . . . 0.0 111.846 -179.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 233' ' ' ASP . . . . . 0.444 ' O ' ' N ' ' B' ' 235' ' ' VAL . 29.7 t70 -124.17 142.87 50.86 Favored 'General case' 0 C--N 1.269 -2.896 0 N-CA-C 101.978 -3.342 . . . . 0.0 101.978 172.17 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -37.38 66.1 0.0 OUTLIER Glycine 0 N--CA 1.49 2.251 0 C-N-CA 128.207 2.813 . . . . 0.0 116.249 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 235' ' ' VAL . . . . . 0.444 ' N ' ' O ' ' B' ' 233' ' ' ASP . 58.9 t -111.81 121.56 64.53 Favored 'Isoleucine or valine' 0 C--N 1.25 -3.753 0 C-N-CA 127.714 2.406 . . . . 0.0 106.366 174.12 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 236' ' ' HIS . . . . . . . . . . . . . 57.3 t-80 -95.85 116.07 28.36 Favored 'General case' 0 C--N 1.296 -1.755 0 O-C-N 123.37 0.418 . . . . 0.0 109.966 -175.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 237' ' ' ARG . . . . . 0.48 ' HG3' HG12 ' A' ' 50' ' ' VAL . 41.3 mmt180 -120.62 110.21 16.16 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 177.361 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 238' ' ' SER . . . . . . . . . . . . . 13.9 t -126.24 124.96 41.58 Favored 'General case' 0 C--N 1.289 -2.038 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 239' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -63.02 142.26 58.45 Favored 'General case' 0 C--O 1.25 1.108 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.615 -177.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 240' ' ' GLY . . . . . 0.563 ' O ' ' HG2' ' B' ' 244' ' ' LYS . . . 66.66 46.26 77.42 Favored Glycine 0 C--O 1.187 -2.832 0 CA-C-N 114.701 -1.136 . . . . 0.0 112.512 177.353 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 47.1 p90 -75.44 -33.82 60.92 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 117.667 0.734 . . . . 0.0 110.952 -179.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -63.45 -39.72 95.21 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.894 -175.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -67.29 -35.74 80.1 Favored 'General case' 0 C--O 1.21 -0.979 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.249 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 244' ' ' LYS . . . . . 0.563 ' HG2' ' O ' ' B' ' 240' ' ' GLY . 68.9 mmtt -67.05 -45.74 76.49 Favored 'General case' 0 CA--C 1.507 -0.675 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 -176.249 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 245' ' ' TRP . . . . . 0.412 ' O ' ' HB3' ' B' ' 249' ' ' GLN . 46.7 m0 -64.44 -37.54 87.87 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.059 -179.338 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 246' ' ' PHE . . . . . 0.542 ' O ' ' HG2' ' B' ' 249' ' ' GLN . 2.9 t80 -70.65 -30.44 67.07 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.086 176.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -78.59 -40.66 34.01 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 178.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.65 -15.96 52.91 Favored 'General case' 0 CA--C 1.501 -0.917 0 CA-C-O 121.158 0.504 . . . . 0.0 111.497 -175.351 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 249' ' ' GLN . . . . . 0.542 ' HG2' ' O ' ' B' ' 246' ' ' PHE . 3.1 pt20 -70.3 -0.31 7.85 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.703 -178.352 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 250' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -64.04 -30.13 71.22 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 175.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -85.59 111.62 20.22 Favored 'General case' 0 N--CA 1.429 -1.521 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 176.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 252' ' ' ILE . . . . . . . . . . . . . 34.6 pt -109.77 -24.15 4.15 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 CA-C-N 114.985 -1.007 . . . . 0.0 113.639 -170.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -116.83 -19.89 9.69 Favored 'General case' 0 C--N 1.31 -1.114 0 C-N-CA 120.01 -0.676 . . . . 0.0 112.362 -176.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 254' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.09 163.16 6.34 Favored 'General case' 0 CA--C 1.565 1.55 0 C-N-CA 123.766 0.826 . . . . 0.0 111.966 -173.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 255' ' ' LYS . . . . . 0.432 ' O ' ' HG3' ' B' ' 256' ' ' LYS . 31.4 mtmm -70.94 95.57 1.19 Allowed 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 124.458 1.103 . . . . 0.0 111.019 -174.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 256' ' ' LYS . . . . . 0.432 ' HG3' ' O ' ' B' ' 255' ' ' LYS . 7.4 mtmm . . . . . 0 C--N 1.316 -0.856 0 C-N-CA 124.835 1.254 . . . . 0.0 109.152 179.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 17.2 m120 . . . . . 0 CA--C 1.491 -1.298 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -95.92 -10.55 28.46 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-O 121.225 0.536 . . . . 0.0 111.403 -177.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 20.6 m-85 -88.57 -4.36 58.6 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-O 122.024 0.916 . . . . 0.0 110.816 -179.067 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 61.0 mttp -120.03 152.34 37.66 Favored 'General case' 0 C--N 1.29 -2.0 0 CA-C-N 114.711 -1.131 . . . . 0.0 108.919 178.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -115.6 22.72 12.92 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-O 123.332 1.539 . . . . 0.0 107.054 179.118 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -77.9 24.79 0.22 Allowed 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 113.279 -1.782 . . . . 0.0 111.85 -175.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -88.35 -7.45 56.66 Favored 'General case' 0 CA--C 1.506 -0.747 0 CA-C-O 120.725 0.298 . . . . 0.0 110.263 -178.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -109.93 145.65 36.53 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.127 -175.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 27.5 pt -138.21 156.68 30.84 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.453 176.109 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 34.3 t80 -106.67 123.02 47.5 Favored 'General case' 0 N--CA 1.414 -2.228 0 CA-C-N 114.91 -1.041 . . . . 0.0 108.264 177.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.458 HG21 ' CD1' ' A' ' 104' ' ' ILE . 8.7 mt -108.43 127.69 64.6 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.07 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 175.256 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -123.29 160.45 17.81 Favored Glycine 0 C--N 1.283 -2.366 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 -179.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 68.52 48.35 0.84 Allowed 'General case' 0 CA--C 1.491 -1.325 0 C-N-CA 125.112 1.365 . . . . 0.0 111.807 -174.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -72.65 145.46 47.25 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 115.078 -0.965 . . . . 0.0 110.78 175.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -96.89 144.86 26.43 Favored 'General case' 0 C--N 1.286 -2.18 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 179.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.497 ' HD2' ' N ' ' A' ' 41' ' ' GLU . 7.0 ppt_? -58.36 -21.3 49.44 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -176.594 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.497 ' N ' ' HD2' ' A' ' 40' ' ' ARG . 12.2 pt-20 -98.18 5.77 48.16 Favored 'General case' 0 C--N 1.318 -0.773 0 C-N-CA 120.464 -0.495 . . . . 0.0 111.518 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 75.6 mt -95.16 113.62 25.33 Favored 'General case' 0 N--CA 1.435 -1.206 0 CA-C-O 121.579 0.704 . . . . 0.0 109.955 175.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 58.8 p -102.98 174.86 5.68 Favored 'General case' 0 C--N 1.286 -2.159 0 CA-C-N 114.507 -1.224 . . . . 0.0 109.785 -179.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -54.65 -43.33 72.27 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 177.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -59.6 -41.97 97.56 Favored Glycine 0 CA--C 1.529 0.924 0 CA-C-N 115.603 -0.726 . . . . 0.0 113.51 178.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -63.94 -49.05 74.12 Favored 'General case' 0 CA--C 1.506 -0.743 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 46.8 mt -58.86 -44.31 90.31 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.892 -179.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 41.8 mt -59.27 -45.79 90.26 Favored 'General case' 0 CA--C 1.497 -1.093 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.66 -177.005 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 92.0 m -61.05 -45.96 92.64 Favored 'General case' 0 C--N 1.307 -1.278 0 O-C-N 123.379 0.425 . . . . 0.0 112.116 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.452 HG11 ' HG3' ' B' ' 237' ' ' ARG . 99.3 t -66.07 -46.59 87.54 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-O 121.219 0.533 . . . . 0.0 110.8 -179.531 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -68.74 -20.87 64.4 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 115.57 -0.741 . . . . 0.0 112.185 -178.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.456 ' OG ' ' HB2' ' B' ' 231' ' ' ARG . 73.7 m -71.61 -19.38 62.13 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.771 176.265 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -69.58 -28.97 66.42 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 175.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 54.5 m-85 -95.21 -3.83 46.99 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.698 -174.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 156.49 -155.48 26.37 Favored Glycine 0 N--CA 1.423 -2.174 0 C-N-CA 119.67 -1.252 . . . . 0.0 112.749 177.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 60.8 t -108.07 103.99 52.0 Favored Pre-proline 0 C--N 1.305 -1.334 0 N-CA-C 110.475 -0.194 . . . . 0.0 110.475 -178.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.413 ' HB3' HD22 ' A' ' 77' ' ' LEU . 88.0 Cg_endo -79.43 138.93 14.2 Favored 'Trans proline' 0 N--CA 1.451 -0.979 0 C-N-CA 122.799 2.333 . . . . 0.0 110.775 177.602 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 33.1 m -114.71 -22.84 4.51 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 C-N-CA 119.605 -0.838 . . . . 0.0 112.548 -179.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.471 ' HB3' ' HG2' ' A' ' 78' ' ' LYS . 31.4 t70 -155.75 143.39 19.58 Favored 'General case' 0 CA--C 1.504 -0.8 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 -178.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 14.6 p -146.1 132.48 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.116 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 -179.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 90.3 mt -120.9 128.15 76.03 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 177.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -103.09 127.29 50.41 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 177.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.552 ' OG ' ' HB2' ' A' ' 72' ' ' GLN . 97.6 p -89.27 117.74 28.45 Favored 'General case' 0 N--CA 1.422 -1.867 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 178.549 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 19.4 mtp180 -119.77 123.02 42.7 Favored 'General case' 0 N--CA 1.423 -1.788 0 C-N-CA 119.41 -0.916 . . . . 0.0 109.856 179.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -66.33 119.84 12.27 Favored 'General case' 0 C--N 1.296 -1.76 0 CA-C-N 114.505 -1.225 . . . . 0.0 111.427 -178.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -61.93 -23.65 66.48 Favored 'General case' 0 C--N 1.326 -0.43 0 O-C-N 123.682 0.614 . . . . 0.0 112.519 -178.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 28.8 m-80 -76.13 -50.59 14.22 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.328 -176.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 61.5 p -87.91 -24.1 23.73 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-N 116.295 -0.411 . . . . 0.0 112.042 -176.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 68.56 16.35 69.58 Favored Glycine 0 CA--C 1.522 0.496 0 N-CA-C 111.316 -0.714 . . . . 0.0 111.316 -177.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 44.8 mm-40 -106.95 -76.7 0.61 Allowed 'General case' 0 N--CA 1.437 -1.092 0 CA-C-O 120.829 0.347 . . . . 0.0 111.178 -176.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 23.0 t -168.27 158.92 10.33 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 -176.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.552 ' HB2' ' OG ' ' A' ' 63' ' ' SER . 18.8 mm-40 -90.83 -12.64 35.73 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 171.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 86.44 16.73 61.71 Favored Glycine 0 N--CA 1.423 -2.208 0 CA-C-N 115.09 -0.959 . . . . 0.0 112.946 178.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -145.15 157.7 44.02 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 176.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -151.15 168.79 23.6 Favored 'General case' 0 C--N 1.292 -1.924 0 CA-C-O 120.999 0.428 . . . . 0.0 110.258 177.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -126.06 137.59 53.64 Favored 'General case' 0 C--N 1.292 -1.902 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.834 -177.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.413 HD22 ' HB3' ' A' ' 57' ' ' PRO . 9.9 tt -144.73 140.59 28.65 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 174.432 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.471 ' HG2' ' HB3' ' A' ' 59' ' ' ASP . 20.5 ptmt -124.7 144.8 50.02 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.107 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.402 ' HH ' ' CB ' ' A' ' 88' ' ' ALA . 69.5 m-85 -105.43 164.43 11.87 Favored 'General case' 0 C--N 1.284 -2.266 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.226 -178.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -71.86 -27.17 62.7 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-N 114.794 -1.094 . . . . 0.0 108.654 175.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.627 ' OD1' ' HG2' ' A' ' 83' ' ' ARG . 8.4 t70 -132.45 139.63 48.09 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.49 -179.304 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -69.88 -20.65 63.38 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 -179.087 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.627 ' HG2' ' OD1' ' A' ' 81' ' ' ASP . 22.8 mmm180 -62.62 -34.45 77.05 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 122.2 1.0 . . . . 0.0 109.712 174.486 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 52.7 m -68.96 -37.02 78.58 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 114.865 -1.061 . . . . 0.0 113.559 179.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.476 ' O ' HG21 ' A' ' 89' ' ' VAL . 76.2 p -61.2 -45.0 96.37 Favored 'General case' 0 C--N 1.342 0.276 0 C-N-CA 120.473 -0.491 . . . . 0.0 110.418 -177.125 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 3.1 pt -64.46 -39.06 84.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.562 177.28 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.547 HD13 ' HB2' ' B' ' 224' ' ' PHE . 40.8 mt -58.8 -44.03 90.69 Favored 'General case' 0 N--CA 1.478 0.925 0 O-C-N 123.763 0.664 . . . . 0.0 111.254 178.083 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.402 ' CB ' ' HH ' ' A' ' 79' ' ' TYR . . . -71.16 -41.12 70.82 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.393 -178.548 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.476 HG21 ' O ' ' A' ' 85' ' ' THR . 68.9 t -57.86 -45.73 87.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -58.5 -44.61 89.48 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 121.814 0.816 . . . . 0.0 111.347 -175.269 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -97.46 -20.31 17.85 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-N 114.744 -1.116 . . . . 0.0 113.296 -168.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 20.8 mt -95.15 -30.96 13.76 Favored 'General case' 0 C--N 1.285 -2.221 0 C-N-CA 119.615 -0.834 . . . . 0.0 110.705 -178.01 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 60.4 t30 -66.44 124.24 22.23 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 87.51 -1.22 85.71 Favored Glycine 0 C--N 1.304 -1.197 0 C-N-CA 121.107 -0.568 . . . . 0.0 113.021 -178.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -90.32 135.83 33.43 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 10.9 mptt -95.6 123.17 39.02 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-O 121.242 0.544 . . . . 0.0 111.397 -176.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 52.0 mt -126.36 141.37 46.08 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 N-CA-C 106.237 -1.764 . . . . 0.0 106.237 174.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 56.8 22.32 40.26 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 114.102 0.401 . . . . 0.0 114.102 178.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 85.52 14.07 69.04 Favored Glycine 0 N--CA 1.439 -1.116 0 C-N-CA 120.784 -0.722 . . . . 0.0 113.579 179.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 12.1 ptp180 -140.25 146.46 38.65 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 117.456 0.628 . . . . 0.0 110.838 177.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -88.58 119.76 29.34 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.731 -175.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 13.2 mt -65.53 138.56 58.14 Favored 'General case' 0 CA--C 1.488 -1.415 0 CA-C-O 121.646 0.736 . . . . 0.0 112.35 179.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 58.0 tptt -114.65 115.85 27.77 Favored 'General case' 0 C--N 1.279 -2.491 0 CA-C-N 114.822 -1.081 . . . . 0.0 108.392 177.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.458 ' CD1' HG21 ' A' ' 35' ' ' ILE . 4.1 mm -118.44 129.9 74.07 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -143.96 151.65 40.03 Favored 'General case' 0 C--N 1.289 -2.063 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 84.1 m-70 -79.67 140.16 37.14 Favored 'General case' 0 C--N 1.298 -1.663 0 C-N-CA 120.124 -0.63 . . . . 0.0 109.779 179.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 13.5 t -149.34 162.98 39.0 Favored 'General case' 0 C--N 1.279 -2.469 0 N-CA-C 106.094 -1.817 . . . . 0.0 106.094 -178.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -109.69 109.42 20.14 Favored 'General case' 0 N--CA 1.424 -1.767 0 N-CA-C 106.065 -1.828 . . . . 0.0 106.065 173.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 58.0 t80 -107.96 144.67 34.91 Favored 'General case' 0 C--N 1.289 -2.062 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.843 -177.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 7.9 tpp180 -120.45 113.66 33.51 Favored Pre-proline 0 C--N 1.292 -1.891 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 174.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -62.83 137.06 60.89 Favored 'Trans proline' 0 C--O 1.249 1.026 0 C-N-CA 123.326 2.684 . . . . 0.0 113.768 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 16.5 tppt? -117.63 128.24 54.74 Favored 'General case' 0 N--CA 1.418 -2.034 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 176.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 34.8 mmt180 . . . . . 0 C--N 1.292 -1.926 0 CA-C-O 118.97 -0.538 . . . . 0.0 109.976 -176.719 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 . . . . . 0 N--CA 1.467 0.407 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 223' ' ' ARG . . . . . . . . . . . . . 7.0 ttm180 63.34 52.84 2.3 Favored 'General case' 0 C--N 1.352 0.676 0 CA-C-O 122.482 1.134 . . . . 0.0 113.422 173.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 224' ' ' PHE . . . . . 0.547 ' HB2' HD13 ' A' ' 87' ' ' LEU . 4.3 m-30 -96.43 169.45 9.91 Favored 'General case' 0 C--N 1.298 -1.635 0 CA-C-N 113.779 -1.555 . . . . 0.0 109.978 -177.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 225' ' ' ALA . . . . . . . . . . . . . . . -87.77 28.26 1.04 Allowed 'General case' 0 C--N 1.309 -1.154 0 C-N-CA 123.045 0.538 . . . . 0.0 111.861 -170.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 4.6 mp -92.25 131.76 38.45 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 -179.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 227' ' ' MET . . . . . . . . . . . . . 73.0 mtm -77.24 140.13 65.23 Favored Pre-proline 0 C--N 1.318 -0.783 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.983 -178.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 228' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -61.7 144.32 97.16 Favored 'Trans proline' 0 C--O 1.243 0.733 0 C-N-CA 123.31 2.674 . . . . 0.0 113.412 -178.355 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . -68.69 172.11 36.54 Favored Glycine 0 C--O 1.242 0.625 0 CA-C-N 115.082 -0.963 . . . . 0.0 113.854 -178.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 23.0 t -77.02 -13.98 59.89 Favored 'General case' 0 C--N 1.314 -0.978 0 C-N-CA 123.011 0.524 . . . . 0.0 111.46 -176.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 231' ' ' ARG . . . . . 0.456 ' HB2' ' OG ' ' A' ' 52' ' ' SER . 31.7 mmt180 -84.94 -3.85 58.9 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.922 -0.311 . . . . 0.0 110.449 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 232' ' ' TRP . . . . . . . . . . . . . 21.5 t90 -78.96 131.94 36.51 Favored 'General case' 0 N--CA 1.433 -1.314 0 CA-C-O 122.333 1.063 . . . . 0.0 111.966 -178.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 233' ' ' ASP . . . . . 0.453 ' O ' ' N ' ' B' ' 235' ' ' VAL . 25.0 t70 -122.08 137.94 54.63 Favored 'General case' 0 C--N 1.267 -2.982 0 N-CA-C 101.388 -3.56 . . . . 0.0 101.388 168.193 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -37.87 63.8 0.0 OUTLIER Glycine 0 N--CA 1.492 2.413 0 C-N-CA 128.193 2.806 . . . . 0.0 116.093 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 235' ' ' VAL . . . . . 0.453 ' N ' ' O ' ' B' ' 233' ' ' ASP . 39.5 t -102.9 124.04 56.69 Favored 'Isoleucine or valine' 0 C--N 1.25 -3.745 0 C-N-CA 127.594 2.358 . . . . 0.0 106.875 176.04 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 236' ' ' HIS . . . . . . . . . . . . . 59.3 t-80 -99.11 109.85 22.51 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 -177.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 237' ' ' ARG . . . . . 0.452 ' HG3' HG11 ' A' ' 50' ' ' VAL . 34.4 mmt180 -121.58 109.16 14.45 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-O 121.742 0.782 . . . . 0.0 110.925 177.623 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 238' ' ' SER . . . . . . . . . . . . . 40.5 m -129.08 135.33 48.76 Favored 'General case' 0 C--N 1.294 -1.824 0 CA-C-N 115.363 -0.835 . . . . 0.0 108.78 177.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 239' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 -64.13 -49.16 73.27 Favored 'General case' 0 C--N 1.31 -1.122 0 O-C-N 124.046 0.841 . . . . 0.0 110.683 -174.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 240' ' ' GLY . . . . . 0.434 ' O ' ' HG2' ' B' ' 244' ' ' LYS . . . 157.06 -35.02 0.56 Allowed Glycine 0 C--O 1.202 -1.869 0 C-N-CA 120.174 -1.012 . . . . 0.0 112.113 177.602 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 29.7 p90 -76.79 -34.48 57.97 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 112.705 0.632 . . . . 0.0 112.705 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -64.73 -39.16 93.17 Favored 'General case' 0 CA--C 1.504 -0.789 0 C-N-CA 122.899 0.479 . . . . 0.0 110.731 -175.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -63.47 -35.01 79.02 Favored 'General case' 0 C--O 1.197 -1.685 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.372 -179.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 244' ' ' LYS . . . . . 0.434 ' HG2' ' O ' ' B' ' 240' ' ' GLY . 70.1 mmtt -65.8 -41.95 91.31 Favored 'General case' 0 N--CA 1.439 -0.986 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 -178.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 245' ' ' TRP . . . . . . . . . . . . . 44.5 m0 -64.72 -40.81 95.98 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.265 -0.88 . . . . 0.0 109.635 179.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 246' ' ' PHE . . . . . 0.652 ' O ' ' HG2' ' B' ' 249' ' ' GLN . 3.0 t80 -72.01 -31.57 66.33 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.577 177.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -74.4 -38.48 63.09 Favored 'General case' 0 C--N 1.294 -1.819 0 O-C-N 121.671 -0.643 . . . . 0.0 111.246 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.47 -14.01 55.77 Favored 'General case' 0 CA--C 1.508 -0.64 0 CA-C-O 121.118 0.485 . . . . 0.0 111.635 -176.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 249' ' ' GLN . . . . . 0.652 ' HG2' ' O ' ' B' ' 246' ' ' PHE . 3.3 pt20 -77.89 -1.16 30.43 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.578 -178.703 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 250' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -53.15 -39.16 63.34 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.078 -179.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -131.39 108.24 9.48 Favored 'General case' 0 N--CA 1.432 -1.326 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 174.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 252' ' ' ILE . . . . . . . . . . . . . 28.3 pt -86.83 -31.57 6.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 CA-C-N 114.973 -1.012 . . . . 0.0 112.71 -173.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -92.25 -20.25 21.34 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-O 121.416 0.627 . . . . 0.0 111.075 -175.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 254' ' ' GLU . . . . . 0.424 ' CD ' ' H ' ' B' ' 255' ' ' LYS . 0.5 OUTLIER -85.5 161.01 19.55 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.198 -175.293 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 255' ' ' LYS . . . . . 0.424 ' H ' ' CD ' ' B' ' 254' ' ' GLU . 28.8 mtmm -88.39 -9.67 51.89 Favored 'General case' 0 C--N 1.31 -1.149 0 C-N-CA 124.775 1.23 . . . . 0.0 112.042 -172.282 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 256' ' ' LYS . . . . . . . . . . . . . 7.7 ptpp? . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.672 -0.68 . . . . 0.0 111.367 179.2 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 20.2 m120 . . . . . 0 CA--C 1.505 -0.783 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.415 ' H ' ' CD ' ' A' ' 26' ' ' GLU . 1.6 mp0 -65.64 -32.83 74.61 Favored 'General case' 0 C--N 1.316 -0.874 0 C-N-CA 124.777 1.231 . . . . 0.0 110.616 -178.11 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -88.74 17.28 5.69 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-N 113.913 -1.494 . . . . 0.0 112.37 -172.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -134.51 150.08 50.75 Favored 'General case' 0 CA--C 1.485 -1.54 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 177.185 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.401 ' C ' ' H ' ' A' ' 31' ' ' ALA . 39.6 m-20 -112.51 8.82 19.45 Favored 'General case' 0 C--N 1.291 -1.945 0 CA-C-O 122.3 1.048 . . . . 0.0 108.427 177.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.498 ' HA ' ' CE2' ' A' ' 108' ' ' PHE . 1.9 m-20 -75.5 30.37 0.1 Allowed 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 125.746 1.618 . . . . 0.0 111.396 -176.125 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.401 ' H ' ' C ' ' A' ' 29' ' ' ASP . . . -104.58 12.86 32.58 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.978 -172.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -95.01 145.21 25.1 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 -175.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 26.1 pt -141.01 162.17 22.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-O 121.029 0.442 . . . . 0.0 111.033 175.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 66.5 t80 -109.84 121.78 46.02 Favored 'General case' 0 N--CA 1.415 -2.21 0 CA-C-N 114.702 -1.136 . . . . 0.0 108.436 178.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 9.4 mt -109.15 127.94 65.45 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.963 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 174.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -130.52 168.12 21.79 Favored Glycine 0 C--N 1.29 -2.008 0 N-CA-C 111.305 -0.718 . . . . 0.0 111.305 -178.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 68.25 33.73 4.18 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.663 1.185 . . . . 0.0 110.503 -176.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.402 HD21 ' HA ' ' A' ' 74' ' ' PHE . 4.0 mm? -65.8 151.67 46.1 Favored 'General case' 0 CA--C 1.5 -0.969 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.606 178.083 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 39.2 t-20 -90.85 148.81 22.25 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 176.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.412 HH11 ' HB3' ' A' ' 41' ' ' GLU . 0.6 OUTLIER -64.76 -17.12 63.88 Favored 'General case' 0 C--N 1.297 -1.7 0 C-N-CA 123.765 0.826 . . . . 0.0 113.149 -179.001 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.412 ' HB3' HH11 ' A' ' 40' ' ' ARG . 10.2 pt-20 -92.91 -13.64 28.64 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.555 179.162 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 74.8 mt -78.83 123.25 27.03 Favored 'General case' 0 CA--C 1.504 -0.82 0 CA-C-O 121.564 0.697 . . . . 0.0 111.809 -176.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 10.7 t -114.22 174.15 6.09 Favored 'General case' 0 C--N 1.293 -1.876 0 CA-C-N 114.737 -1.12 . . . . 0.0 108.965 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.405 ' CG ' ' HB2' ' A' ' 62' ' ' LEU . 52.3 mt-10 -55.42 -45.1 76.76 Favored 'General case' 0 C--O 1.214 -0.782 0 C-N-CA 124.016 0.927 . . . . 0.0 110.62 -176.47 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -59.35 -39.0 94.18 Favored Glycine 0 C--O 1.244 0.731 0 CA-C-N 116.117 -0.492 . . . . 0.0 113.466 -178.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -67.64 -48.44 66.71 Favored 'General case' 0 C--O 1.243 0.745 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 -179.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 36.2 mt -58.22 -46.21 88.76 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.318 0 CA-C-N 114.924 -1.035 . . . . 0.0 110.291 178.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 44.6 mt -59.21 -40.26 85.25 Favored 'General case' 0 CA--C 1.492 -1.259 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.397 -178.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 84.3 m -65.16 -46.22 81.72 Favored 'General case' 0 N--CA 1.431 -1.381 0 O-C-N 123.502 0.501 . . . . 0.0 110.977 -178.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 57.6 t -67.53 -48.01 78.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.42 -178.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -64.84 -21.27 66.76 Favored 'General case' 0 N--CA 1.436 -1.17 0 C-N-CA 124.408 1.083 . . . . 0.0 112.545 -179.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.437 ' CB ' ' HB2' ' B' ' 232' ' ' TRP . 51.2 m -71.65 -20.75 61.91 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 176.736 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -74.26 -24.55 59.3 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 118.022 -1.471 . . . . 0.0 109.523 174.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 -89.85 -8.81 51.13 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.221 0.534 . . . . 0.0 111.434 -175.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 158.99 -163.21 33.13 Favored Glycine 0 N--CA 1.425 -2.075 0 N-CA-C 110.981 -0.848 . . . . 0.0 110.981 177.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 60.1 t -101.33 109.37 58.62 Favored Pre-proline 0 C--N 1.297 -1.713 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 -179.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.428 ' HB3' HD22 ' A' ' 77' ' ' LEU . 79.0 Cg_endo -77.53 137.08 16.14 Favored 'Trans proline' 0 N--CA 1.445 -1.375 0 C-N-CA 122.17 1.914 . . . . 0.0 109.701 176.73 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 35.0 m -111.48 -26.54 3.09 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 C-N-CA 119.46 -0.896 . . . . 0.0 111.992 -178.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.412 ' HB3' ' HG2' ' A' ' 78' ' ' LYS . 10.5 t70 -155.06 144.43 21.18 Favored 'General case' 0 C--O 1.247 0.946 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 -179.062 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 14.6 p -146.34 138.17 19.34 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 O-C-N 123.415 0.447 . . . . 0.0 110.103 -178.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 98.4 mt -121.31 126.21 74.69 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 174.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.405 ' HB2' ' CG ' ' A' ' 44' ' ' GLU . 0.1 OUTLIER -98.58 115.77 29.36 Favored 'General case' 0 N--CA 1.425 -1.677 0 N-CA-C 106.222 -1.77 . . . . 0.0 106.222 171.396 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 6.8 m -74.96 117.24 16.59 Favored 'General case' 0 N--CA 1.412 -2.344 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 178.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 66.9 mtm180 -131.74 142.69 49.85 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-O 121.269 0.557 . . . . 0.0 111.189 -176.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -77.99 131.51 37.42 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 114.607 -1.178 . . . . 0.0 110.356 -179.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -61.68 -29.26 69.97 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 115.349 -0.841 . . . . 0.0 112.545 179.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 29.9 m-80 -81.84 -50.67 8.94 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 121.371 0.605 . . . . 0.0 111.314 -172.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 58.2 p -86.46 -24.65 25.55 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-O 121.401 0.62 . . . . 0.0 111.131 -176.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.48 6.03 83.47 Favored Glycine 0 N--CA 1.44 -1.091 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 -175.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -104.32 166.6 10.3 Favored 'General case' 0 N--CA 1.436 -1.13 0 CA-C-O 121.042 0.448 . . . . 0.0 110.875 -175.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 8.2 m -62.47 141.32 58.45 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 114.969 -1.014 . . . . 0.0 110.461 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 -84.98 12.89 6.71 Favored 'General case' 0 C--N 1.315 -0.899 0 C-N-CA 123.168 0.587 . . . . 0.0 111.668 -178.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 83.44 11.14 80.81 Favored Glycine 0 N--CA 1.435 -1.405 0 C-N-CA 121.126 -0.559 . . . . 0.0 113.336 178.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.402 ' HA ' HD21 ' A' ' 38' ' ' LEU . 38.3 p90 -154.06 159.49 41.57 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 177.13 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -154.12 171.94 18.33 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 123.917 0.761 . . . . 0.0 109.77 178.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -131.12 141.45 50.13 Favored 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 123.61 0.764 . . . . 0.0 109.903 -178.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.428 HD22 ' HB3' ' A' ' 57' ' ' PRO . 10.0 tt -148.86 141.48 24.43 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 176.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.412 ' HG2' ' HB3' ' A' ' 59' ' ' ASP . 21.5 ptmt -124.11 143.98 50.15 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 178.465 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -103.84 165.66 10.9 Favored 'General case' 0 C--N 1.288 -2.071 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.724 -178.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -75.13 -39.43 60.5 Favored 'General case' 0 N--CA 1.425 -1.715 0 CA-C-N 114.956 -1.02 . . . . 0.0 108.381 174.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -116.84 144.14 44.85 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 121.378 0.609 . . . . 0.0 111.364 179.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 21.4 mp0 -69.83 -28.78 65.98 Favored 'General case' 0 C--N 1.311 -1.086 0 C-N-CA 124.063 0.945 . . . . 0.0 113.15 -177.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.1 -33.88 76.77 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 122.142 0.972 . . . . 0.0 110.343 177.092 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 50.5 m -60.88 -37.34 81.84 Favored 'General case' 0 C--N 1.284 -2.258 0 CA-C-N 115.106 -0.952 . . . . 0.0 112.029 176.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.405 ' O ' HG21 ' A' ' 89' ' ' VAL . 59.5 p -63.7 -45.3 90.64 Favored 'General case' 0 C--N 1.347 0.488 0 C-N-CA 120.507 -0.477 . . . . 0.0 110.836 -177.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 4.0 pt -66.13 -38.24 81.54 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.687 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.408 179.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.41 HD22 ' HB2' ' B' ' 224' ' ' PHE . 13.5 mt -59.66 -44.4 93.58 Favored 'General case' 0 CA--C 1.511 -0.547 0 O-C-N 123.284 0.365 . . . . 0.0 111.751 175.558 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.449 ' O ' ' HB2' ' A' ' 92' ' ' LEU . . . -69.72 -43.98 71.24 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.106 -179.533 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.405 HG21 ' O ' ' A' ' 85' ' ' THR . 85.3 t -60.99 -45.44 98.52 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-O 121.488 0.661 . . . . 0.0 110.98 178.798 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -65.76 -37.3 85.96 Favored 'General case' 0 C--N 1.284 -2.262 0 C-N-CA 124.196 0.998 . . . . 0.0 111.828 -176.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.429 ' O ' ' HB3' ' B' ' 239' ' ' ASN . 4.3 m-20 -91.62 -28.09 17.72 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 112.94 0.719 . . . . 0.0 112.94 -176.188 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.449 ' HB2' ' O ' ' A' ' 88' ' ' ALA . 14.8 mt -97.06 -28.91 13.93 Favored 'General case' 0 CA--C 1.491 -1.305 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -173.117 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -65.56 125.26 24.65 Favored 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 120.03 -0.668 . . . . 0.0 109.465 -178.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 88.53 -8.36 79.26 Favored Glycine 0 C--N 1.31 -0.876 0 CA-C-N 115.643 -0.708 . . . . 0.0 112.501 -178.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -81.17 137.59 35.9 Favored 'General case' 0 CA--C 1.516 -0.332 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 -178.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 11.2 mptt -95.51 122.86 38.69 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-O 120.969 0.414 . . . . 0.0 111.571 -175.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 54.5 mt -127.02 141.37 46.44 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 N-CA-C 105.734 -1.95 . . . . 0.0 105.734 172.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 56.84 26.83 55.23 Favored Glycine 0 CA--C 1.521 0.438 0 O-C-N 123.035 0.209 . . . . 0.0 113.395 -179.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 79.5 8.19 87.93 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 121.296 -0.478 . . . . 0.0 113.786 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 15.8 ptp180 -131.2 142.08 50.14 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 117.87 0.835 . . . . 0.0 110.321 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -82.83 120.31 25.48 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.686 -177.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 11.4 mt -65.78 143.96 57.17 Favored 'General case' 0 C--O 1.249 1.047 0 CA-C-O 121.858 0.837 . . . . 0.0 112.683 179.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 22.7 tptm -116.59 118.7 33.33 Favored 'General case' 0 N--CA 1.418 -2.056 0 CA-C-N 114.771 -1.104 . . . . 0.0 108.548 175.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 4.4 mm -117.63 136.01 56.19 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.185 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 178.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -143.43 152.66 41.81 Favored 'General case' 0 C--N 1.287 -2.151 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -178.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 74.4 m-70 -83.81 131.96 34.86 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 178.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 5.8 t -156.27 161.73 40.2 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 -177.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.498 ' CE2' ' HA ' ' A' ' 30' ' ' ASN . 41.7 m-85 -109.91 109.21 19.76 Favored 'General case' 0 N--CA 1.42 -1.963 0 C-N-CA 118.351 -1.34 . . . . 0.0 107.466 169.655 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 25.5 t80 -107.18 135.63 48.38 Favored 'General case' 0 C--N 1.277 -2.546 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.424 ' N ' ' HD3' ' A' ' 110' ' ' ARG . 1.1 mpp_? -112.06 113.48 51.99 Favored Pre-proline 0 C--N 1.291 -1.955 0 C-N-CA 118.971 -1.091 . . . . 0.0 109.595 177.004 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -70.42 148.84 61.7 Favored 'Trans proline' 0 C--O 1.245 0.835 0 C-N-CA 123.63 2.887 . . . . 0.0 113.91 -179.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 27.3 tptp -120.83 118.02 28.89 Favored 'General case' 0 N--CA 1.427 -1.584 0 CA-C-N 115.063 -0.971 . . . . 0.0 108.505 172.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 33.5 mmt180 . . . . . 0 C--N 1.285 -2.236 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 177.722 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 44.7 t-20 . . . . . 0 CA--C 1.538 0.518 0 N-CA-C 111.333 0.123 . . . . 0.0 111.333 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 223' ' ' ARG . . . . . . . . . . . . 0.277 11.6 ptm180 58.51 49.94 9.91 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 117.325 2.343 . . . . 0.0 117.325 173.333 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 224' ' ' PHE . . . . . 0.41 ' HB2' HD22 ' A' ' 87' ' ' LEU . 71.3 m-85 -108.83 167.02 10.38 Favored 'General case' 0 C--N 1.272 -2.787 0 C-N-CA 123.926 0.89 . . . . 0.0 109.774 176.199 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 225' ' ' ALA . . . . . . . . . . . . . . . -129.59 75.47 1.65 Allowed 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 121.302 0.572 . . . . 0.0 110.462 177.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 4.0 mp -114.14 131.03 67.3 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 175.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 227' ' ' MET . . . . . . . . . . . . . 26.1 ptt? -69.71 151.03 96.59 Favored Pre-proline 0 C--N 1.318 -0.797 0 O-C-N 123.485 0.491 . . . . 0.0 110.077 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 228' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -71.7 161.2 45.93 Favored 'Trans proline' 0 C--O 1.252 1.176 0 C-N-CA 123.141 2.561 . . . . 0.0 114.327 -175.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . -83.66 173.28 51.01 Favored Glycine 0 N--CA 1.436 -1.326 0 CA-C-N 114.736 -1.12 . . . . 0.0 112.318 177.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 9.6 m -74.35 -14.49 60.89 Favored 'General case' 0 C--N 1.306 -1.288 0 C-N-CA 123.456 0.703 . . . . 0.0 112.369 -174.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 38.9 mmt180 -91.41 -6.22 53.16 Favored 'General case' 0 C--N 1.318 -0.791 0 C-N-CA 120.076 -0.65 . . . . 0.0 111.693 -177.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 232' ' ' TRP . . . . . 0.437 ' HB2' ' CB ' ' A' ' 52' ' ' SER . 21.0 t90 -76.4 121.11 22.57 Favored 'General case' 0 CA--C 1.497 -1.062 0 CA-C-O 122.45 1.119 . . . . 0.0 112.324 -178.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 233' ' ' ASP . . . . . 0.415 ' O ' ' N ' ' B' ' 235' ' ' VAL . 24.7 t70 -118.04 148.68 42.02 Favored 'General case' 0 N--CA 1.407 -2.623 0 N-CA-C 102.541 -3.133 . . . . 0.0 102.541 171.546 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -46.26 60.19 0.0 OUTLIER Glycine 0 N--CA 1.489 2.208 0 C-N-CA 127.967 2.699 . . . . 0.0 116.418 -176.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 235' ' ' VAL . . . . . 0.415 ' N ' ' O ' ' B' ' 233' ' ' ASP . 54.5 t -103.32 124.16 57.31 Favored 'Isoleucine or valine' 0 C--N 1.253 -3.608 0 C-N-CA 127.59 2.356 . . . . 0.0 107.302 175.532 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 236' ' ' HIS . . . . . . . . . . . . . 41.0 t60 -101.51 106.76 17.91 Favored 'General case' 0 N--CA 1.418 -2.047 0 CA-C-O 121.35 0.595 . . . . 0.0 109.664 -177.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 237' ' ' ARG . . . . . . . . . . . . . 38.7 mmt180 -128.31 111.84 13.8 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 105.361 -2.088 . . . . 0.0 105.361 172.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 238' ' ' SER . . . . . . . . . . . . . 10.5 t -145.03 151.74 39.02 Favored 'General case' 0 C--N 1.28 -2.452 0 C-N-CA 119.097 -1.041 . . . . 0.0 111.275 -175.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 239' ' ' ASN . . . . . 0.429 ' HB3' ' O ' ' A' ' 91' ' ' ASN . 28.8 p-10 -84.79 163.61 19.0 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.92 -178.643 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 240' ' ' GLY . . . . . . . . . . . . . . . 123.66 80.17 0.47 Allowed Glycine 0 N--CA 1.418 -2.547 0 C-N-CA 120.174 -1.012 . . . . 0.0 111.568 178.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 35.0 p90 -76.96 -33.51 57.66 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-O 121.481 0.657 . . . . 0.0 110.273 174.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -67.23 -39.45 86.21 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.518 -176.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -60.13 -34.35 73.4 Favored 'General case' 0 C--O 1.202 -1.43 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.826 177.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -62.09 -37.81 86.48 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 122.817 0.447 . . . . 0.0 109.96 -179.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 245' ' ' TRP . . . . . 0.511 ' O ' ' HG3' ' B' ' 248' ' ' LYS . 36.8 m0 -69.6 -39.73 77.07 Favored 'General case' 0 C--O 1.242 0.702 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.551 178.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 246' ' ' PHE . . . . . 0.728 ' O ' ' HG2' ' B' ' 249' ' ' GLN . 2.8 t80 -70.2 -33.05 71.23 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 114.879 -1.055 . . . . 0.0 110.812 177.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -73.15 -31.01 64.0 Favored 'General case' 0 C--N 1.285 -2.237 0 O-C-N 121.817 -0.552 . . . . 0.0 110.663 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 248' ' ' LYS . . . . . 0.511 ' HG3' ' O ' ' B' ' 245' ' ' TRP . 2.2 pptp? -87.22 -12.1 47.81 Favored 'General case' 0 C--O 1.221 -0.414 0 CA-C-O 120.86 0.362 . . . . 0.0 111.594 -177.259 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 249' ' ' GLN . . . . . 0.728 ' HG2' ' O ' ' B' ' 246' ' ' PHE . 2.9 pt20 -79.33 2.99 19.54 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.002 -178.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 250' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -56.98 -36.99 70.99 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.267 176.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -116.27 152.92 32.86 Favored 'General case' 0 N--CA 1.411 -2.379 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 175.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 252' ' ' ILE . . . . . . . . . . . . . 28.5 pt -128.79 -28.21 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 -173.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -117.32 -24.7 7.32 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-O 121.061 0.457 . . . . 0.0 109.806 -174.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 254' ' ' GLU . . . . . . . . . . . . . 48.4 mp0 -51.49 148.18 5.42 Favored 'General case' 0 N--CA 1.438 -1.032 0 C-N-CA 126.084 1.754 . . . . 0.0 114.622 -172.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 255' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -61.48 122.95 16.49 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 113.763 -1.562 . . . . 0.0 112.715 -178.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 256' ' ' LYS . . . . . . . . . . . . . 66.5 mttm . . . . . 0 C--N 1.306 -1.312 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 176.364 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.446 ' N ' ' HA ' ' A' ' 81' ' ' ASP . 88.2 m-20 . . . . . 0 CA--C 1.508 -0.65 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.525 ' HG3' ' CD1' ' A' ' 27' ' ' TYR . 13.2 pt-20 -81.24 -17.05 50.84 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -172.36 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.525 ' CD1' ' HG3' ' A' ' 26' ' ' GLU . 26.4 m-85 -93.85 8.41 41.3 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-O 121.653 0.74 . . . . 0.0 109.958 179.563 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -108.33 135.24 49.97 Favored 'General case' 0 N--CA 1.426 -1.633 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.502 177.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -90.41 -4.33 57.1 Favored 'General case' 0 C--N 1.275 -2.653 0 CA-C-N 114.329 -1.305 . . . . 0.0 111.858 -170.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 41.8 m-80 -83.15 30.86 0.45 Allowed 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.592 178.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -97.36 9.15 43.07 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 112.33 0.492 . . . . 0.0 112.33 -175.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -108.25 145.85 33.71 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-O 121.124 0.488 . . . . 0.0 111.548 -173.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 26.7 pt -138.23 154.99 28.61 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.503 175.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -106.81 122.86 47.22 Favored 'General case' 0 C--N 1.286 -2.158 0 CA-C-N 114.67 -1.15 . . . . 0.0 108.802 176.009 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.521 HG21 ' CD1' ' A' ' 104' ' ' ILE . 11.5 mt -107.97 127.04 64.43 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 N-CA-C 106.182 -1.784 . . . . 0.0 106.182 176.543 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -129.07 167.94 20.96 Favored Glycine 0 C--N 1.28 -2.566 0 N-CA-C 110.357 -1.097 . . . . 0.0 110.357 179.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 75.7 30.32 0.79 Allowed 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.644 1.178 . . . . 0.0 111.179 -179.056 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.431 HD21 ' HA ' ' A' ' 74' ' ' PHE . 4.1 mm? -66.94 154.54 40.83 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.639 -0.71 . . . . 0.0 112.047 178.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 42.8 t-20 -95.03 146.06 24.52 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 106.225 -1.768 . . . . 0.0 106.225 174.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.622 ' HA ' ' OG ' ' A' ' 71' ' ' SER . 8.0 ppt_? -60.52 -23.31 64.47 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 122.96 0.504 . . . . 0.0 112.332 178.734 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -88.61 -9.53 51.86 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.798 -178.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 67.1 mt -80.99 125.96 30.79 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 121.188 0.518 . . . . 0.0 110.874 -177.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 66.9 p -107.31 173.36 6.36 Favored 'General case' 0 C--N 1.293 -1.867 0 CA-C-N 114.885 -1.052 . . . . 0.0 110.063 -178.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.8 mp0 -57.66 -40.54 79.59 Favored 'General case' 0 N--CA 1.433 -1.282 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.449 177.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -59.42 -38.49 93.54 Favored Glycine 0 N--CA 1.445 -0.716 0 O-C-N 123.681 0.613 . . . . 0.0 112.629 179.119 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -67.25 -49.19 65.36 Favored 'General case' 0 CA--C 1.499 -1.002 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 179.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 54.4 mt -59.73 -47.39 91.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.074 -0.966 . . . . 0.0 110.616 179.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 49.4 mt -59.72 -44.55 93.68 Favored 'General case' 0 CA--C 1.49 -1.345 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.468 -177.138 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 62.5 m -61.69 -46.27 90.41 Favored 'General case' 0 C--N 1.31 -1.13 0 O-C-N 123.454 0.471 . . . . 0.0 111.636 -178.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 86.8 t -67.3 -47.59 80.73 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.777 -178.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -65.92 -23.82 66.7 Favored 'General case' 0 N--CA 1.435 -1.177 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.725 -179.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.524 ' OG ' ' HB2' ' B' ' 231' ' ' ARG . 70.0 m -70.69 -18.53 62.82 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 176.255 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -76.06 -28.96 57.82 Favored 'General case' 0 C--O 1.249 1.051 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 176.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 51.7 m-85 -86.23 -23.19 26.52 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.279 -176.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 177.4 -155.89 18.81 Favored Glycine 0 N--CA 1.43 -1.74 0 C-N-CA 120.4 -0.905 . . . . 0.0 112.546 177.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 69.3 t -107.66 108.66 61.84 Favored Pre-proline 0 C--N 1.303 -1.438 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 -179.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -76.24 137.0 18.57 Favored 'Trans proline' 0 N--CA 1.439 -1.686 0 C-N-CA 122.175 1.917 . . . . 0.0 109.905 177.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 35.4 m -113.45 -23.83 4.14 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.864 0 C-N-CA 119.699 -0.8 . . . . 0.0 111.146 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.422 ' HB3' ' HG2' ' A' ' 78' ' ' LYS . 32.7 t70 -158.02 142.87 16.46 Favored 'General case' 0 C--O 1.244 0.812 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 178.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 14.1 p -140.57 135.95 35.41 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.238 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 178.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 78.7 mt -121.3 128.47 75.95 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 176.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -102.02 120.96 41.26 Favored 'General case' 0 C--N 1.29 -1.984 0 N-CA-C 105.742 -1.947 . . . . 0.0 105.742 175.251 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 15.7 m -80.98 117.6 21.74 Favored 'General case' 0 N--CA 1.415 -2.192 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 70.0 mtt85 -124.02 146.31 48.63 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-O 120.981 0.42 . . . . 0.0 111.298 -178.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -79.45 123.44 27.54 Favored 'General case' 0 N--CA 1.428 -1.547 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 177.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -61.02 -20.64 62.74 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 -174.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 14.9 m-80 -83.02 -45.6 13.86 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-O 120.716 0.294 . . . . 0.0 110.99 -176.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 65.1 p -94.24 -23.96 17.66 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.265 0.555 . . . . 0.0 111.808 -176.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.34 2.75 84.73 Favored Glycine 0 N--CA 1.441 -1.023 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 -175.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -92.24 164.25 13.61 Favored 'General case' 0 CA--C 1.49 -1.361 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 -177.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.622 ' OG ' ' HA ' ' A' ' 40' ' ' ARG . 53.7 p -70.84 145.52 50.23 Favored 'General case' 0 C--N 1.29 -2.005 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.776 -179.643 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 -81.87 4.15 23.45 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-O 120.949 0.404 . . . . 0.0 111.828 -178.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 90.3 13.01 60.73 Favored Glycine 0 N--CA 1.429 -1.769 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.027 179.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.431 ' HA ' HD21 ' A' ' 38' ' ' LEU . 45.6 p90 -154.08 158.85 41.09 Favored 'General case' 0 N--CA 1.431 -1.396 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 177.745 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -152.14 176.44 11.55 Favored 'General case' 0 N--CA 1.438 -1.043 0 O-C-N 123.568 0.543 . . . . 0.0 110.085 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -136.64 144.71 44.17 Favored 'General case' 0 C--N 1.306 -1.324 0 C-N-CA 123.292 0.637 . . . . 0.0 110.037 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.9 tt -149.28 140.68 23.27 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 176.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.422 ' HG2' ' HB3' ' A' ' 59' ' ' ASP . 22.0 ptmt -122.93 144.57 49.15 Favored 'General case' 0 C--O 1.257 1.486 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -108.96 165.24 11.73 Favored 'General case' 0 C--N 1.29 -2.021 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.34 -177.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -68.4 -38.09 80.95 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 114.703 -1.135 . . . . 0.0 108.786 174.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.446 ' HA ' ' N ' ' A' ' 25' ' ' ASN . 12.3 t70 -126.23 145.9 50.21 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-O 121.324 0.583 . . . . 0.0 111.967 -178.574 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 20.0 mp0 -67.1 -29.28 68.99 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 124.495 1.118 . . . . 0.0 112.271 -178.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 58.3 mtm180 -61.06 -33.81 73.89 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-O 122.145 0.974 . . . . 0.0 111.692 178.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 51.1 m -64.27 -37.34 87.14 Favored 'General case' 0 C--N 1.28 -2.424 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.541 174.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 52.6 p -63.18 -44.75 94.51 Favored 'General case' 0 C--O 1.22 -0.496 0 C-N-CA 120.424 -0.51 . . . . 0.0 110.432 -178.15 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 5.4 pt -65.86 -39.21 84.05 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 C-N-CA 122.49 0.316 . . . . 0.0 111.459 179.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 18.7 mt -60.21 -43.94 95.54 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 123.662 0.601 . . . . 0.0 110.903 175.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -71.69 -46.47 58.7 Favored 'General case' 0 N--CA 1.435 -1.189 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.757 -178.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 72.4 t -57.03 -48.29 82.06 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.71 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -179.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -63.63 -37.17 86.31 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-O 120.951 0.405 . . . . 0.0 111.437 -175.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.465 ' O ' ' HB2' ' B' ' 239' ' ' ASN . 85.4 m-20 -93.02 -21.09 19.95 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 -174.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.418 ' HB2' HG13 ' A' ' 104' ' ' ILE . 20.4 mt -99.3 -28.89 13.1 Favored 'General case' 0 C--N 1.291 -1.976 0 C-N-CA 120.455 -0.498 . . . . 0.0 111.506 -176.361 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -66.28 124.6 23.11 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 177.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 83.18 -0.59 89.65 Favored Glycine 0 C--N 1.304 -1.242 0 C-N-CA 121.099 -0.572 . . . . 0.0 112.608 -179.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 69.4 t80 -85.2 131.66 34.4 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 -178.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -90.62 119.42 30.85 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-O 121.172 0.51 . . . . 0.0 112.241 -176.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 48.5 mt -127.67 141.35 46.64 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 N-CA-C 105.866 -1.902 . . . . 0.0 105.866 172.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 60.34 18.24 49.3 Favored Glycine 0 CA--C 1.526 0.774 0 C-N-CA 121.41 -0.424 . . . . 0.0 113.939 178.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 85.44 11.26 75.43 Favored Glycine 0 N--CA 1.437 -1.266 0 C-N-CA 121.058 -0.592 . . . . 0.0 112.721 -179.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 16.1 ptp180 -135.5 145.3 46.96 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 117.115 0.458 . . . . 0.0 110.913 179.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -87.49 120.58 28.94 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.067 -177.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 12.4 mt -67.33 148.92 51.03 Favored 'General case' 0 C--N 1.31 -1.118 0 C-N-CA 123.789 0.836 . . . . 0.0 112.822 178.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 17.3 tppt? -124.6 118.75 27.23 Favored 'General case' 0 N--CA 1.422 -1.84 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.191 176.231 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.521 ' CD1' HG21 ' A' ' 35' ' ' ILE . 5.1 mm -119.96 136.38 57.25 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 179.372 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -142.09 146.47 35.45 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 81.1 m-70 -79.34 132.71 36.52 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 4.7 t -162.41 163.73 27.58 Favored 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 -175.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -99.34 112.94 25.02 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 174.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 35.5 t80 -105.86 134.45 48.96 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-N 115.945 -0.571 . . . . 0.0 109.667 179.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -115.64 118.8 38.66 Favored Pre-proline 0 C--N 1.301 -1.542 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 176.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -63.88 143.98 87.14 Favored 'Trans proline' 0 C--O 1.251 1.174 0 C-N-CA 123.207 2.604 . . . . 0.0 114.36 -178.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 26.6 tptp -81.5 124.8 29.78 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-N 114.713 -1.131 . . . . 0.0 108.846 176.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 36.3 mmt180 . . . . . 0 C--N 1.286 -2.173 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 176.334 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 . . . . . 0 N--CA 1.47 0.56 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 223' ' ' ARG . . . . . . . . . . . . 0.312 46.7 mtp180 73.67 51.94 0.12 Allowed 'General case' 0 CA--C 1.482 -1.646 0 N-CA-C 114.703 1.372 . . . . 0.0 114.703 176.112 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 224' ' ' PHE . . . . . . . . . . . . . 49.9 m-85 -117.23 165.71 13.12 Favored 'General case' 0 C--N 1.265 -3.075 0 CA-C-N 113.462 -1.699 . . . . 0.0 109.454 177.382 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 225' ' ' ALA . . . . . . . . . . . . . . . -108.7 39.68 1.96 Allowed 'General case' 0 C--N 1.304 -1.401 0 CA-C-O 121.348 0.594 . . . . 0.0 110.538 -173.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 4.2 mp -103.17 129.56 54.78 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 C-N-CA 120.685 -0.406 . . . . 0.0 109.936 179.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 227' ' ' MET . . . . . . . . . . . . . 27.8 ptm -89.11 149.31 42.87 Favored Pre-proline 0 C--N 1.307 -1.251 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 177.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 228' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -63.62 151.04 86.92 Favored 'Trans proline' 0 C--O 1.244 0.806 0 C-N-CA 123.443 2.762 . . . . 0.0 113.564 -177.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . -77.79 174.92 54.68 Favored Glycine 0 C--O 1.246 0.869 0 CA-C-N 115.432 -0.804 . . . . 0.0 112.546 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 17.6 m -76.3 -17.06 59.62 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -176.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 231' ' ' ARG . . . . . 0.524 ' HB2' ' OG ' ' A' ' 52' ' ' SER . 9.8 mmm180 -79.82 -8.27 59.18 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 120.794 0.33 . . . . 0.0 111.324 179.63 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 232' ' ' TRP . . . . . . . . . . . . . 24.5 t90 -72.02 128.62 36.29 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-O 122.125 0.964 . . . . 0.0 111.383 179.078 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 233' ' ' ASP . . . . . 0.458 ' O ' ' N ' ' B' ' 235' ' ' VAL . 16.7 t70 -123.33 140.2 53.25 Favored 'General case' 0 C--N 1.265 -3.106 0 N-CA-C 101.586 -3.487 . . . . 0.0 101.586 173.409 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -36.9 61.12 0.0 OUTLIER Glycine 0 N--CA 1.501 3.024 0 C-N-CA 128.622 3.011 . . . . 0.0 116.72 -179.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 235' ' ' VAL . . . . . 0.458 ' N ' ' O ' ' B' ' 233' ' ' ASP . 55.9 t -112.4 126.31 69.78 Favored 'Isoleucine or valine' 0 C--N 1.253 -3.621 0 C-N-CA 128.132 2.573 . . . . 0.0 107.781 175.579 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 236' ' ' HIS . . . . . . . . . . . . . 57.5 t-80 -105.3 115.72 30.74 Favored 'General case' 0 C--N 1.288 -2.082 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 178.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 237' ' ' ARG . . . . . . . . . . . . . 38.0 mmt180 -124.8 109.71 13.41 Favored 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 120.158 -0.617 . . . . 0.0 110.187 177.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 238' ' ' SER . . . . . . . . . . . . . 45.9 t -129.98 143.77 50.97 Favored 'General case' 0 C--N 1.292 -1.896 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.411 179.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 239' ' ' ASN . . . . . 0.465 ' HB2' ' O ' ' A' ' 91' ' ' ASN . 17.2 t-20 -74.08 -17.49 60.95 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 176.569 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 240' ' ' GLY . . . . . 0.457 ' O ' ' HG2' ' B' ' 244' ' ' LYS . . . 106.73 36.64 2.55 Favored Glycine 0 N--CA 1.416 -2.664 0 CA-C-N 114.69 -1.141 . . . . 0.0 110.489 -177.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 49.7 p90 -75.95 -35.94 59.51 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -178.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -66.35 -38.74 88.3 Favored 'General case' 0 CA--C 1.5 -0.979 0 CA-C-N 116.727 -0.215 . . . . 0.0 111.04 -176.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -60.51 -35.16 75.28 Favored 'General case' 0 C--O 1.202 -1.396 0 O-C-N 123.597 0.561 . . . . 0.0 110.483 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 244' ' ' LYS . . . . . 0.457 ' HG2' ' O ' ' B' ' 240' ' ' GLY . 70.4 mmtt -67.14 -41.82 85.44 Favored 'General case' 0 CA--C 1.509 -0.628 0 CA-C-O 121.662 0.744 . . . . 0.0 109.137 -178.091 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 245' ' ' TRP . . . . . . . . . . . . . 45.3 m0 -68.93 -41.07 78.61 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 114.853 -1.067 . . . . 0.0 109.58 179.107 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 246' ' ' PHE . . . . . 0.529 ' O ' ' HG2' ' B' ' 249' ' ' GLN . 5.2 t80 -65.86 -37.86 87.3 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.777 179.155 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -68.02 -33.33 74.4 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.556 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.9 -21.05 21.58 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 120.669 -0.413 . . . . 0.0 111.946 -177.607 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 249' ' ' GLN . . . . . 0.529 ' HG2' ' O ' ' B' ' 246' ' ' PHE . 3.0 pt20 -75.42 2.29 11.79 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.092 0.472 . . . . 0.0 111.287 -178.056 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 250' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -56.91 -38.57 73.03 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.319 178.077 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -139.57 113.55 8.76 Favored 'General case' 0 N--CA 1.439 -0.987 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 175.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 252' ' ' ILE . . . . . . . . . . . . . 27.8 pt -102.54 -37.48 4.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 -172.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -108.87 -18.07 13.78 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-O 121.846 0.832 . . . . 0.0 110.048 -175.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 254' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -84.51 -174.12 5.1 Favored 'General case' 0 C--N 1.29 -2.018 0 CA-C-N 114.205 -1.361 . . . . 0.0 112.054 -176.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 255' ' ' LYS . . . . . . . . . . . . . 2.0 pptp? -57.24 130.99 48.65 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-N 115.103 -0.953 . . . . 0.0 111.502 178.2 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 256' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt . . . . . 0 C--N 1.305 -1.361 0 CA-C-O 118.965 -0.541 . . . . 0.0 110.653 -175.636 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 49.3 t-20 . . . . . 0 C--O 1.244 0.808 0 CA-C-O 121.615 0.722 . . . . 0.0 109.616 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -76.9 -23.98 52.52 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 115.151 -0.931 . . . . 0.0 112.018 -173.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 40.5 m-85 -87.24 6.39 33.42 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-O 121.716 0.769 . . . . 0.0 112.856 -173.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.427 ' C ' ' H ' ' A' ' 30' ' ' ASN . 75.8 mmtt -95.97 -39.51 9.74 Favored 'General case' 0 C--N 1.284 -2.244 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 174.509 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.422 ' C ' ' H ' ' A' ' 31' ' ' ALA 0.264 14.8 m-20 65.89 -12.52 0.17 Allowed 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 126.141 1.776 . . . . 0.0 114.859 178.44 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.427 ' H ' ' C ' ' A' ' 28' ' ' LYS . 47.3 m-80 -79.77 29.83 0.26 Allowed 'General case' 0 C--N 1.303 -1.442 0 C-N-CA 123.593 0.757 . . . . 0.0 110.716 178.013 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.459 ' HB3' ' NE2' ' A' ' 82' ' ' GLN . . . -99.31 2.16 45.19 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.971 -176.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -103.68 144.65 31.17 Favored 'General case' 0 N--CA 1.429 -1.518 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.831 -174.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 25.1 pt -141.37 157.05 21.7 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.742 0 CA-C-N 115.476 -0.783 . . . . 0.0 109.462 178.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 16.5 t80 -108.81 123.04 48.42 Favored 'General case' 0 N--CA 1.411 -2.378 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 176.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.495 HG21 ' CD1' ' A' ' 104' ' ' ILE . 12.0 mt -107.83 126.97 64.26 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.931 0 N-CA-C 105.792 -1.929 . . . . 0.0 105.792 176.518 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -129.01 165.4 21.8 Favored Glycine 0 N--CA 1.418 -2.556 0 N-CA-C 112.041 -0.424 . . . . 0.0 112.041 -177.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 8.3 t30 63.57 51.97 2.39 Favored 'General case' 0 C--N 1.314 -0.951 0 C-N-CA 125.146 1.378 . . . . 0.0 109.876 -177.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.4 HD21 ' HA ' ' A' ' 74' ' ' PHE . 3.1 mm? -78.37 161.2 27.34 Favored 'General case' 0 CA--C 1.502 -0.884 0 CA-C-N 113.99 -1.459 . . . . 0.0 111.482 178.499 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.458 ' CG ' ' HG2' ' A' ' 41' ' ' GLU . 49.8 t-20 -98.12 145.5 26.51 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 174.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.558 ' HD2' ' N ' ' A' ' 41' ' ' GLU . 7.4 ppt_? -58.79 -27.13 64.73 Favored 'General case' 0 C--N 1.31 -1.137 0 C-N-CA 123.543 0.737 . . . . 0.0 111.924 179.592 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.558 ' N ' ' HD2' ' A' ' 40' ' ' ARG . 11.4 pt-20 -85.59 -11.82 53.04 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.543 -176.366 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.439 ' HG ' ' HB3' ' A' ' 39' ' ' ASN . 79.0 mt -84.21 118.73 24.34 Favored 'General case' 0 CA--C 1.492 -1.279 0 CA-C-O 121.474 0.654 . . . . 0.0 111.09 -176.695 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 46.6 p -107.82 173.92 6.11 Favored 'General case' 0 N--CA 1.414 -2.273 0 CA-C-N 114.417 -1.265 . . . . 0.0 109.445 -178.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.437 ' HG3' ' HB2' ' A' ' 62' ' ' LEU . 1.7 mp0 -54.92 -41.37 70.93 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 123.871 0.868 . . . . 0.0 109.759 178.757 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.17 -43.28 98.56 Favored Glycine 0 N--CA 1.439 -1.126 0 CA-C-N 115.545 -0.752 . . . . 0.0 112.894 -179.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -68.1 -45.29 74.13 Favored 'General case' 0 CA--C 1.513 -0.444 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 -179.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 37.9 mt -58.55 -44.12 88.61 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.488 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.707 178.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 43.8 mt -59.37 -44.7 92.68 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 89.4 m -61.66 -46.26 90.48 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 120.804 0.335 . . . . 0.0 111.619 178.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.471 HG11 ' HG3' ' B' ' 237' ' ' ARG . 84.6 t -63.18 -49.47 83.09 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.379 179.61 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -69.43 -23.08 63.63 Favored 'General case' 0 N--CA 1.433 -1.318 0 C-N-CA 123.583 0.753 . . . . 0.0 112.868 -177.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.462 ' OG ' ' HB2' ' B' ' 231' ' ' ARG . 72.6 m -68.57 -20.1 64.51 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 111.917 0.34 . . . . 0.0 111.917 176.655 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -63.47 -28.0 69.66 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-O 122.029 0.919 . . . . 0.0 109.007 173.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 50.9 m-85 -96.3 -2.87 45.0 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.262 -174.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 148.21 -152.96 24.96 Favored Glycine 0 N--CA 1.42 -2.432 0 C-N-CA 119.975 -1.107 . . . . 0.0 112.015 178.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 61.8 t -107.52 111.01 63.06 Favored Pre-proline 0 C--N 1.296 -1.742 0 CA-C-O 120.717 0.294 . . . . 0.0 110.948 -177.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.442 ' HB3' HD22 ' A' ' 77' ' ' LEU . 58.7 Cg_endo -74.74 145.49 32.6 Favored 'Trans proline' 0 N--CA 1.45 -1.081 0 C-N-CA 122.719 2.279 . . . . 0.0 110.041 174.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.403 ' CG2' ' HG3' ' A' ' 78' ' ' LYS . 34.4 m -116.45 -24.97 3.3 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 C-N-CA 119.674 -0.81 . . . . 0.0 111.463 177.5 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -158.36 147.57 19.26 Favored 'General case' 0 C--O 1.249 1.07 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 12.5 p -145.78 132.47 14.53 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-O 121.002 0.429 . . . . 0.0 110.432 -179.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 84.2 mt -120.62 126.85 75.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 177.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.437 ' HB2' ' HG3' ' A' ' 44' ' ' GLU . 0.2 OUTLIER -100.3 122.73 43.54 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 105.753 -1.944 . . . . 0.0 105.753 175.533 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 15.4 m -82.13 116.8 21.86 Favored 'General case' 0 N--CA 1.406 -2.648 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 178.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 84.3 mtt180 -127.57 153.33 46.52 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-O 121.43 0.634 . . . . 0.0 110.82 -175.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -83.99 122.59 28.96 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 106.349 -1.723 . . . . 0.0 106.349 174.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -61.37 -22.15 64.7 Favored 'General case' 0 C--N 1.29 -2.016 0 C-N-CA 124.018 0.927 . . . . 0.0 112.939 -175.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 22.6 m-80 -82.6 -46.0 13.87 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-O 121.074 0.464 . . . . 0.0 110.868 -177.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 54.6 p -88.79 -23.73 22.79 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.424 -176.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.62 8.72 86.25 Favored Glycine 0 N--CA 1.446 -0.692 0 N-CA-C 110.891 -0.883 . . . . 0.0 110.891 -177.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.432 ' OE2' ' HD3' ' A' ' 40' ' ' ARG . 40.2 mt-10 -108.35 167.15 10.23 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-O 120.701 0.286 . . . . 0.0 110.241 -176.151 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 44.9 t -63.13 149.76 44.46 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-O 121.799 0.809 . . . . 0.0 111.029 -178.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -87.48 -2.9 58.94 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.111 176.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 100.19 17.65 24.19 Favored Glycine 0 N--CA 1.429 -1.781 0 CA-C-N 115.475 -0.784 . . . . 0.0 112.536 178.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.4 ' HA ' HD21 ' A' ' 38' ' ' LEU . 36.4 p90 -160.86 156.83 25.63 Favored 'General case' 0 C--O 1.244 0.801 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 177.38 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -152.81 175.98 12.29 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-O 120.789 0.328 . . . . 0.0 110.995 179.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -134.88 143.18 46.82 Favored 'General case' 0 C--N 1.317 -0.813 0 C-N-CA 123.989 0.915 . . . . 0.0 110.425 -177.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.442 HD22 ' HB3' ' A' ' 57' ' ' PRO . 10.0 tt -150.07 140.59 22.48 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 175.571 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.403 ' HG3' ' CG2' ' A' ' 58' ' ' VAL . 20.8 ptmt -122.56 144.18 49.26 Favored 'General case' 0 C--O 1.255 1.394 0 CA-C-O 121.02 0.438 . . . . 0.0 109.951 179.61 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -108.9 164.58 12.27 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.539 -178.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -74.59 -25.64 59.39 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 114.822 -1.081 . . . . 0.0 109.736 175.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -127.77 136.76 51.93 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.073 -175.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.459 ' NE2' ' HB3' ' A' ' 31' ' ' ALA . 22.5 mp0 -69.74 -19.9 63.53 Favored 'General case' 0 C--N 1.313 -1.022 0 N-CA-C 113.191 0.811 . . . . 0.0 113.191 177.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 90.9 mtm180 -68.24 -34.64 76.6 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-O 122.261 1.029 . . . . 0.0 109.592 174.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 67.2 m -65.21 -37.37 87.08 Favored 'General case' 0 C--N 1.286 -2.173 0 CA-C-N 114.702 -1.135 . . . . 0.0 112.226 178.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.441 ' O ' HG21 ' A' ' 89' ' ' VAL . 77.3 p -64.93 -45.62 85.05 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 120.438 -0.505 . . . . 0.0 110.577 -178.455 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 6.7 pt -64.8 -38.63 83.2 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.093 177.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.539 HD12 ' HB2' ' B' ' 224' ' ' PHE . 13.2 mt -58.87 -43.6 90.92 Favored 'General case' 0 C--O 1.242 0.696 0 O-C-N 123.296 0.372 . . . . 0.0 111.006 176.248 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.406 ' O ' ' HB2' ' A' ' 92' ' ' LEU . . . -70.84 -46.75 62.16 Favored 'General case' 0 N--CA 1.435 -1.204 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.208 -178.626 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.441 HG21 ' O ' ' A' ' 85' ' ' THR . 78.2 t -56.73 -47.05 83.2 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.581 0 CA-C-O 121.446 0.641 . . . . 0.0 110.739 179.229 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -59.02 -39.16 81.06 Favored 'General case' 0 C--N 1.295 -1.78 0 C-N-CA 125.221 1.408 . . . . 0.0 112.518 -176.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 48.9 m-80 -98.49 -22.5 15.98 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 113.798 1.036 . . . . 0.0 113.798 -175.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.416 ' HB2' HG13 ' A' ' 104' ' ' ILE . 18.6 mt -94.92 -30.05 14.35 Favored 'General case' 0 C--N 1.293 -1.889 0 C-N-CA 120.685 -0.406 . . . . 0.0 111.435 -174.284 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 50.2 t-20 -65.64 124.25 21.87 Favored 'General case' 0 N--CA 1.434 -1.265 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 176.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 84.38 -0.33 89.32 Favored Glycine 0 C--N 1.3 -1.468 0 C-N-CA 119.888 -1.148 . . . . 0.0 113.1 -179.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -92.24 136.8 32.9 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -95.57 120.06 35.17 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-O 121.061 0.458 . . . . 0.0 112.069 -176.127 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 55.3 mt -126.89 141.69 45.49 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 N-CA-C 106.565 -1.643 . . . . 0.0 106.565 174.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 60.08 19.79 52.18 Favored Glycine 0 CA--C 1.527 0.836 0 O-C-N 122.929 0.143 . . . . 0.0 113.275 -179.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 85.89 12.14 72.13 Favored Glycine 0 N--CA 1.438 -1.184 0 C-N-CA 121.497 -0.383 . . . . 0.0 113.07 -179.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.432 ' NH1' ' HA ' ' A' ' 39' ' ' ASN . 17.4 ptp180 -137.87 149.69 46.49 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 117.861 0.831 . . . . 0.0 110.719 178.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -83.7 126.18 32.63 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-O 120.64 0.257 . . . . 0.0 110.84 -178.136 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.406 HD22 ' HA ' ' A' ' 102' ' ' LEU . 12.1 mt -76.24 143.75 40.79 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-O 121.705 0.764 . . . . 0.0 112.629 178.024 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 5.3 tppp? -115.73 119.4 35.92 Favored 'General case' 0 N--CA 1.416 -2.146 0 CA-C-N 114.875 -1.057 . . . . 0.0 109.159 176.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.495 ' CD1' HG21 ' A' ' 35' ' ' ILE . 5.0 mm -121.42 135.99 59.8 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 178.777 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -144.05 150.46 38.23 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 177.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -75.17 144.13 42.88 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 177.213 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 12.3 t -163.21 165.98 23.78 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 106.7 -1.593 . . . . 0.0 106.7 -178.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -109.9 110.91 22.03 Favored 'General case' 0 N--CA 1.428 -1.536 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 171.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 16.5 t80 -106.28 135.95 46.86 Favored 'General case' 0 C--N 1.288 -2.074 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 -178.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.402 ' HA ' ' HD2' ' A' ' 111' ' ' PRO . 16.8 mmm180 -117.55 115.26 37.61 Favored Pre-proline 0 C--N 1.301 -1.542 0 C-N-CA 119.552 -0.859 . . . . 0.0 109.68 176.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' A' ' 110' ' ' ARG . 58.3 Cg_endo -70.95 153.42 63.48 Favored 'Trans proline' 0 C--O 1.25 1.079 0 C-N-CA 123.061 2.508 . . . . 0.0 111.142 177.26 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.504 ' C ' ' HD3' ' A' ' 112' ' ' LYS . 10.4 tmtt? -108.69 122.4 47.04 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 107.189 -1.411 . . . . 0.0 107.189 176.656 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 31.3 mmm180 . . . . . 0 C--N 1.295 -1.779 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 178.044 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 49.6 t-20 . . . . . 0 CA--C 1.545 0.786 0 CA-C-O 120.532 0.206 . . . . 0.0 110.932 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 223' ' ' ARG . . . . . . . . . . . . 0.466 18.7 ttm180 59.84 54.25 4.41 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 118.927 2.936 . . . . 0.0 118.927 171.07 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 224' ' ' PHE . . . . . 0.539 ' HB2' HD12 ' A' ' 87' ' ' LEU . 17.2 m-85 -96.48 165.78 12.01 Favored 'General case' 0 C--N 1.287 -2.139 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 176.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 225' ' ' ALA . . . . . . . . . . . . . . . -110.62 68.45 0.67 Allowed 'General case' 0 C--N 1.306 -1.322 0 CA-C-O 121.587 0.708 . . . . 0.0 111.488 -173.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 4.4 mp -118.83 131.88 70.34 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 227' ' ' MET . . . . . . . . . . . . . 26.7 ptt? -67.67 147.93 98.61 Favored Pre-proline 0 C--N 1.321 -0.657 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.061 179.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 228' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -78.56 150.65 24.89 Favored 'Trans proline' 0 C--O 1.253 1.23 0 C-N-CA 123.057 2.505 . . . . 0.0 112.393 -179.38 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . -73.04 167.04 54.37 Favored Glycine 0 C--N 1.315 -0.603 0 CA-C-N 116.003 -0.544 . . . . 0.0 112.52 178.137 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 21.6 t -70.5 -13.89 62.3 Favored 'General case' 0 C--N 1.317 -0.825 0 C-N-CA 123.228 0.611 . . . . 0.0 111.332 -177.183 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 231' ' ' ARG . . . . . 0.462 ' HB2' ' OG ' ' A' ' 52' ' ' SER . 31.5 mmt180 -78.94 -9.02 59.38 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.658 -0.246 . . . . 0.0 111.041 179.628 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 232' ' ' TRP . . . . . . . . . . . . . 19.2 t90 -77.34 129.47 35.88 Favored 'General case' 0 N--CA 1.427 -1.603 0 CA-C-O 122.29 1.043 . . . . 0.0 111.319 -179.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 233' ' ' ASP . . . . . 0.429 ' O ' ' N ' ' B' ' 235' ' ' VAL . 9.4 t70 -123.35 136.15 54.52 Favored 'General case' 0 C--N 1.265 -3.093 0 N-CA-C 100.926 -3.731 . . . . 0.0 100.926 175.321 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -39.82 62.45 0.0 OUTLIER Glycine 0 N--CA 1.498 2.778 0 C-N-CA 128.4 2.905 . . . . 0.0 116.87 -177.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 235' ' ' VAL . . . . . 0.429 ' N ' ' O ' ' B' ' 233' ' ' ASP . 47.5 t -111.38 118.23 56.98 Favored 'Isoleucine or valine' 0 C--N 1.251 -3.682 0 C-N-CA 127.71 2.404 . . . . 0.0 107.48 176.743 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 236' ' ' HIS . . . . . . . . . . . . . 56.7 t-80 -86.15 114.7 23.21 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 -175.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 237' ' ' ARG . . . . . 0.471 ' HG3' HG11 ' A' ' 50' ' ' VAL . 39.1 mmt180 -126.45 108.25 11.01 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 120.038 -0.665 . . . . 0.0 111.982 -178.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 238' ' ' SER . . . . . . . . . . . . . 59.2 p -147.62 152.29 37.65 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 176.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 239' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -68.0 134.91 51.49 Favored 'General case' 0 C--O 1.251 1.141 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 178.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 240' ' ' GLY . . . . . 0.502 ' O ' ' HE2' ' B' ' 244' ' ' LYS . . . -149.33 43.58 0.76 Allowed Glycine 0 C--O 1.19 -2.644 0 C-N-CA 119.605 -1.283 . . . . 0.0 112.622 -177.181 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 26.2 p90 -76.51 -33.82 58.6 Favored 'General case' 0 C--N 1.29 -2.001 0 CA-C-N 117.531 0.665 . . . . 0.0 111.094 178.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -66.79 -38.84 87.31 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.722 -178.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -62.15 -35.2 78.06 Favored 'General case' 0 C--O 1.21 -0.989 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.83 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 244' ' ' LYS . . . . . 0.502 ' HE2' ' O ' ' B' ' 240' ' ' GLY . 68.9 mmtt -65.61 -44.04 87.77 Favored 'General case' 0 CA--C 1.502 -0.884 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 -177.128 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 245' ' ' TRP . . . . . 0.459 ' O ' ' HB3' ' B' ' 249' ' ' GLN . 39.6 m0 -61.82 -43.23 99.27 Favored 'General case' 0 C--O 1.208 -1.107 0 CA-C-N 115.075 -0.966 . . . . 0.0 109.315 178.566 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 246' ' ' PHE . . . . . 0.562 ' HA ' ' NE2' ' B' ' 249' ' ' GLN . 4.5 t80 -66.94 -32.44 73.69 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.405 179.037 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -77.41 -39.88 45.51 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.301 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.23 -12.78 36.98 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 -175.686 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 249' ' ' GLN . . . . . 0.562 ' NE2' ' HA ' ' B' ' 246' ' ' PHE . 3.2 pt20 -66.27 -8.51 25.27 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 120.946 0.403 . . . . 0.0 111.038 -178.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 250' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -68.04 -28.58 67.51 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 177.074 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . 0.423 ' HB3' ' HB2' ' B' ' 254' ' ' GLU . 42.7 mt-10 -86.19 114.52 23.09 Favored 'General case' 0 N--CA 1.421 -1.905 0 CA-C-N 114.145 -1.388 . . . . 0.0 107.552 177.403 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 252' ' ' ILE . . . . . . . . . . . . . 41.2 pt -118.5 -25.92 2.72 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -174.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -105.61 -15.65 14.92 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 -177.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 254' ' ' GLU . . . . . 0.423 ' HB2' ' HB3' ' B' ' 251' ' ' GLU . 11.7 mp0 -59.49 172.75 0.62 Allowed 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 125.585 1.554 . . . . 0.0 114.722 -177.065 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 255' ' ' LYS . . . . . . . . . . . . . 53.3 mttp -86.81 -40.49 14.9 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 114.453 -1.249 . . . . 0.0 111.24 -174.081 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 256' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt . . . . . 0 C--N 1.298 -1.654 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.934 -177.394 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 16.4 m120 . . . . . 0 C--O 1.242 0.707 0 CA-C-O 121.358 0.599 . . . . 0.0 109.826 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -83.96 -1.06 53.9 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -176.365 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -88.3 2.38 52.57 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 122.497 1.141 . . . . 0.0 110.64 176.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 47.5 mmtm -122.18 -63.65 1.27 Allowed 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 104.758 -2.312 . . . . 0.0 104.758 170.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.407 ' C ' ' H ' ' A' ' 31' ' ' ALA . 12.0 t0 52.21 35.84 17.81 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 113.51 -1.677 . . . . 0.0 110.79 177.315 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -80.73 31.17 0.3 Allowed 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 114.292 -1.322 . . . . 0.0 110.246 -179.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.407 ' H ' ' C ' ' A' ' 29' ' ' ASP . . . -96.23 22.87 7.16 Favored 'General case' 0 C--N 1.307 -1.251 0 C-N-CA 123.95 0.9 . . . . 0.0 111.711 -174.232 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 13.2 m-30 -93.85 144.83 25.08 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 120.196 -0.602 . . . . 0.0 110.359 -176.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 23.6 pt -142.64 161.01 18.8 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.096 175.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 65.2 t80 -111.52 123.28 49.9 Favored 'General case' 0 N--CA 1.413 -2.305 0 CA-C-N 114.742 -1.117 . . . . 0.0 108.049 178.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 13.1 mt -108.39 127.26 64.88 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.047 0 N-CA-C 105.975 -1.861 . . . . 0.0 105.975 175.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -124.44 156.36 18.5 Favored Glycine 0 N--CA 1.42 -2.374 0 N-CA-C 111.802 -0.519 . . . . 0.0 111.802 -177.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 64.3 t30 67.07 57.57 0.6 Allowed 'General case' 0 C--N 1.314 -0.946 0 C-N-CA 125.4 1.48 . . . . 0.0 110.682 -177.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -82.96 143.91 30.35 Favored 'General case' 0 CA--C 1.485 -1.553 0 CA-C-N 114.426 -1.261 . . . . 0.0 110.002 176.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 38.4 t-20 -79.32 144.92 33.78 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 176.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.57 ' HD2' ' N ' ' A' ' 41' ' ' GLU . 0.8 OUTLIER -59.4 -24.69 63.66 Favored 'General case' 0 C--N 1.302 -1.458 0 C-N-CA 123.471 0.709 . . . . 0.0 112.23 179.528 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.57 ' N ' ' HD2' ' A' ' 40' ' ' ARG . 11.4 pt-20 -89.0 -14.32 36.82 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.609 -177.386 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 54.0 mt -75.51 132.09 40.53 Favored 'General case' 0 CA--C 1.5 -0.974 0 CA-C-O 121.548 0.69 . . . . 0.0 111.781 -176.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 42.0 p -114.81 172.7 6.88 Favored 'General case' 0 N--CA 1.418 -2.03 0 CA-C-N 114.725 -1.125 . . . . 0.0 111.046 -177.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -56.19 -42.46 77.17 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 123.707 0.803 . . . . 0.0 110.503 179.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -59.99 -38.27 93.96 Favored Glycine 0 C--O 1.24 0.484 0 CA-C-N 115.497 -0.774 . . . . 0.0 112.541 -179.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 49.9 m-20 -67.19 -49.61 63.99 Favored 'General case' 0 CA--C 1.494 -1.198 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 47.0 mt -58.87 -46.35 91.21 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 CA-C-N 115.131 -0.94 . . . . 0.0 110.706 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 40.9 mt -59.81 -43.7 94.35 Favored 'General case' 0 CA--C 1.499 -1.017 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.605 -178.224 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 85.6 m -63.36 -46.43 86.58 Favored 'General case' 0 C--N 1.313 -1.016 0 O-C-N 123.408 0.443 . . . . 0.0 111.165 -178.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 97.2 t -66.22 -49.77 73.51 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.368 -178.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -64.99 -19.89 66.22 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 123.974 0.909 . . . . 0.0 112.767 -178.132 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.51 ' OG ' ' HB2' ' B' ' 231' ' ' ARG . 60.2 m -72.97 -23.59 60.68 Favored 'General case' 0 N--CA 1.439 -0.989 0 N-CA-C 112.319 0.489 . . . . 0.0 112.319 176.657 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 50.2 tt0 -67.83 -20.52 65.17 Favored 'General case' 0 CA--C 1.56 1.349 0 CA-C-O 121.726 0.775 . . . . 0.0 110.115 177.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.462 ' OH ' ' HG ' ' A' ' 92' ' ' LEU . 41.3 m-85 -97.02 -10.2 26.62 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.608 -178.41 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 156.5 -159.12 29.25 Favored Glycine 0 N--CA 1.43 -1.747 0 C-N-CA 119.951 -1.118 . . . . 0.0 112.29 -179.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 77.5 t -103.58 110.17 63.34 Favored Pre-proline 0 C--N 1.306 -1.318 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 -176.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.443 ' HB3' HD22 ' A' ' 77' ' ' LEU . 99.0 Cg_endo -80.01 137.12 12.12 Favored 'Trans proline' 0 C--O 1.247 0.954 0 C-N-CA 123.034 2.489 . . . . 0.0 110.914 176.203 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 28.4 m -113.49 -20.06 6.4 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 -178.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.449 ' HB3' ' HG2' ' A' ' 78' ' ' LYS . 37.8 t70 -159.88 145.34 15.42 Favored 'General case' 0 C--O 1.249 1.038 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 14.3 p -144.68 134.43 19.17 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 86.1 mt -120.47 118.14 55.64 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.774 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 176.239 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -92.13 116.48 28.98 Favored 'General case' 0 C--N 1.28 -2.441 0 N-CA-C 104.677 -2.342 . . . . 0.0 104.677 175.728 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 33.6 m -79.77 115.93 19.65 Favored 'General case' 0 N--CA 1.414 -2.239 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 179.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 72.0 mtp180 -125.51 145.32 50.15 Favored 'General case' 0 CA--C 1.483 -1.617 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 -176.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -90.05 111.72 22.92 Favored 'General case' 0 C--N 1.289 -2.055 0 N-CA-C 106.017 -1.845 . . . . 0.0 106.017 178.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -61.05 -16.36 42.8 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 -175.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 22.1 m-80 -80.86 -44.5 18.29 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 -178.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 60.9 p -85.81 -24.36 26.83 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-O 121.166 0.508 . . . . 0.0 109.823 -179.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.81 9.93 86.64 Favored Glycine 0 N--CA 1.44 -1.082 0 N-CA-C 110.859 -0.897 . . . . 0.0 110.859 -178.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -115.94 167.92 10.53 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-O 120.726 0.298 . . . . 0.0 110.418 -175.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 43.3 t -61.7 144.26 54.88 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.849 175.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 -74.35 -17.88 60.76 Favored 'General case' 0 N--CA 1.432 -1.343 0 CA-C-O 121.556 0.693 . . . . 0.0 111.338 175.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 107.28 15.88 14.75 Favored Glycine 0 N--CA 1.427 -1.913 0 CA-C-N 115.386 -0.824 . . . . 0.0 112.472 -179.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 30.0 p90 -157.41 159.12 37.04 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 177.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -151.63 172.5 15.97 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-O 120.863 0.363 . . . . 0.0 110.582 179.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -130.75 142.66 50.42 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 123.762 0.825 . . . . 0.0 109.539 -179.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.443 HD22 ' HB3' ' A' ' 57' ' ' PRO . 10.2 tt -148.11 140.96 24.72 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 176.167 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.449 ' HG2' ' HB3' ' A' ' 59' ' ' ASP . 21.9 ptmt -123.82 144.3 49.81 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-O 121.356 0.598 . . . . 0.0 109.673 178.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -104.77 165.68 10.9 Favored 'General case' 0 C--N 1.282 -2.331 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.833 -178.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -77.31 -30.65 54.21 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 115.384 -0.825 . . . . 0.0 108.967 174.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.439 ' OD1' ' HB2' ' A' ' 83' ' ' ARG . 12.5 t70 -119.91 137.56 53.96 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 -176.437 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 26.0 mp0 -69.49 -25.71 64.19 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 113.377 0.88 . . . . 0.0 113.377 -177.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.439 ' HB2' ' OD1' ' A' ' 81' ' ' ASP . 0.1 OUTLIER -67.35 -33.34 75.03 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-O 122.014 0.911 . . . . 0.0 110.291 -179.342 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.45 ' OG ' HG22 ' B' ' 226' ' ' ILE . 51.5 m -59.39 -36.99 76.84 Favored 'General case' 0 C--N 1.281 -2.372 0 CA-C-N 115.307 -0.861 . . . . 0.0 111.657 175.295 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.405 ' O ' HG21 ' A' ' 89' ' ' VAL . 50.3 p -62.58 -45.3 93.55 Favored 'General case' 0 C--O 1.213 -0.823 0 C-N-CA 120.524 -0.47 . . . . 0.0 110.818 -178.17 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 3.3 pt -66.34 -38.72 82.43 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.479 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.498 179.147 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.589 HD22 ' CD1' ' B' ' 224' ' ' PHE . 38.4 mt -59.63 -44.1 93.6 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.236 175.513 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.508 ' O ' ' HB2' ' A' ' 92' ' ' LEU . . . -72.08 -47.13 53.66 Favored 'General case' 0 N--CA 1.437 -1.112 0 CA-C-N 115.992 -0.549 . . . . 0.0 112.313 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.405 HG21 ' O ' ' A' ' 85' ' ' THR . 77.0 t -57.49 -49.12 81.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 -177.547 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -67.71 -38.94 84.3 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.783 -173.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -92.91 -20.27 20.82 Favored 'General case' 0 C--N 1.297 -1.701 0 CA-C-N 115.864 -0.607 . . . . 0.0 112.378 -172.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.508 ' HB2' ' O ' ' A' ' 88' ' ' ALA . 6.6 mt -93.19 -30.29 15.29 Favored 'General case' 0 C--N 1.315 -0.919 0 O-C-N 122.346 -0.221 . . . . 0.0 111.568 178.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 31.9 t-20 -59.25 124.2 19.22 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 179.043 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 88.86 -1.21 83.2 Favored Glycine 0 N--CA 1.442 -0.947 0 C-N-CA 121.064 -0.589 . . . . 0.0 113.417 177.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 67.3 t80 -86.51 141.75 28.85 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 117.579 0.69 . . . . 0.0 110.096 -179.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.415 ' HD2' ' N ' ' A' ' 96' ' ' LYS . 0.2 OUTLIER -98.05 116.15 29.69 Favored 'General case' 0 C--O 1.248 0.997 0 CA-C-O 121.153 0.502 . . . . 0.0 112.11 -177.137 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 58.1 mt -124.12 141.53 43.98 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 174.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 60.37 18.38 49.98 Favored Glycine 0 CA--C 1.521 0.438 0 N-CA-C 113.76 0.264 . . . . 0.0 113.76 179.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 83.88 14.31 72.91 Favored Glycine 0 N--CA 1.438 -1.223 0 C-N-CA 120.786 -0.721 . . . . 0.0 113.017 -178.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 17.5 ptp180 -136.78 150.12 48.18 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 117.696 0.748 . . . . 0.0 110.081 177.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -87.87 121.89 30.84 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 120.592 0.234 . . . . 0.0 111.368 -178.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 11.4 mt -73.02 145.63 46.51 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-O 121.675 0.75 . . . . 0.0 112.769 179.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 17.4 tptm -121.33 122.17 39.26 Favored 'General case' 0 N--CA 1.413 -2.303 0 CA-C-N 115.017 -0.992 . . . . 0.0 108.783 174.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 5.1 mm -116.17 135.09 57.47 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.018 0 N-CA-C 105.358 -2.09 . . . . 0.0 105.358 176.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -141.51 151.94 43.72 Favored 'General case' 0 C--N 1.285 -2.218 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 -176.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 75.2 m-70 -83.86 138.24 33.29 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 9.8 t -157.79 168.5 27.03 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 -178.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -110.16 113.04 25.41 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 106.317 -1.735 . . . . 0.0 106.317 169.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 56.8 t80 -105.55 136.88 44.32 Favored 'General case' 0 C--N 1.287 -2.12 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.703 -175.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 7.9 mpt_? -109.24 113.47 58.72 Favored Pre-proline 0 C--N 1.31 -1.117 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 175.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -73.09 147.03 42.21 Favored 'Trans proline' 0 C--O 1.248 1.011 0 C-N-CA 123.393 2.729 . . . . 0.0 115.424 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.456 ' C ' ' HD3' ' A' ' 112' ' ' LYS . 7.6 tmtm? -121.39 129.43 53.03 Favored 'General case' 0 N--CA 1.419 -1.987 0 N-CA-C 104.209 -2.515 . . . . 0.0 104.209 168.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 8.3 mmm180 . . . . . 0 C--N 1.291 -1.942 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 -178.782 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 46.6 t-20 . . . . . 0 C--O 1.206 -1.19 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 223' ' ' ARG . . . . . . . . . . . . 0.277 12.0 ptm180 65.16 19.51 11.77 Favored 'General case' 0 N--CA 1.504 2.266 0 C-N-CA 126.472 1.909 . . . . 0.0 115.39 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 224' ' ' PHE . . . . . 0.589 ' CD1' HD22 ' A' ' 87' ' ' LEU . 12.7 m-85 -96.08 166.28 11.83 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 175.819 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 225' ' ' ALA . . . . . . . . . . . . . . . -127.89 33.32 4.8 Favored 'General case' 0 C--N 1.311 -1.1 0 C-N-CA 120.43 -0.508 . . . . 0.0 111.843 -176.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 226' ' ' ILE . . . . . 0.45 HG22 ' OG ' ' A' ' 84' ' ' SER . 4.5 mp -81.74 126.22 39.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 175.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 227' ' ' MET . . . . . . . . . . . . . 22.4 ptp -71.39 144.84 89.76 Favored Pre-proline 0 C--N 1.31 -1.115 0 O-C-N 123.608 0.568 . . . . 0.0 110.098 -178.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 228' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -68.56 147.59 70.77 Favored 'Trans proline' 0 C--N 1.317 -1.087 0 C-N-CA 123.284 2.656 . . . . 0.0 112.25 178.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . -68.46 167.64 43.79 Favored Glycine 0 N--CA 1.443 -0.839 0 CA-C-N 115.663 -0.699 . . . . 0.0 113.073 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 40.9 m -74.85 -12.92 60.49 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -176.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 231' ' ' ARG . . . . . 0.51 ' HB2' ' OG ' ' A' ' 52' ' ' SER . 27.8 mmt180 -78.93 -11.74 60.01 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 178.136 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 232' ' ' TRP . . . . . . . . . . . . . 23.1 t90 -71.15 121.68 18.76 Favored 'General case' 0 N--CA 1.435 -1.198 0 CA-C-O 122.108 0.956 . . . . 0.0 112.184 -177.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 233' ' ' ASP . . . . . 0.426 ' O ' ' N ' ' B' ' 235' ' ' VAL . 29.9 t70 -114.94 144.62 43.28 Favored 'General case' 0 C--N 1.273 -2.742 0 N-CA-C 101.791 -3.411 . . . . 0.0 101.791 171.548 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -43.77 56.28 0.0 OUTLIER Glycine 0 N--CA 1.506 3.333 0 C-N-CA 128.295 2.855 . . . . 0.0 116.973 -176.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 235' ' ' VAL . . . . . 0.426 ' N ' ' O ' ' B' ' 233' ' ' ASP . 47.7 t -111.35 125.44 68.67 Favored 'Isoleucine or valine' 0 C--N 1.248 -3.833 0 C-N-CA 128.371 2.669 . . . . 0.0 107.695 178.42 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 236' ' ' HIS . . . . . . . . . . . . . 81.2 t60 -112.15 120.21 41.01 Favored 'General case' 0 C--N 1.292 -1.933 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 -178.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 237' ' ' ARG . . . . . . . . . . . . . 35.3 mmt180 -126.35 110.14 13.03 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 238' ' ' SER . . . . . . . . . . . . . 73.4 m -146.37 129.49 16.54 Favored 'General case' 0 C--N 1.288 -2.084 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 239' ' ' ASN . . . . . . . . . . . . . 46.9 t30 -78.8 154.11 30.17 Favored 'General case' 0 N--CA 1.424 -1.752 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 173.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 240' ' ' GLY . . . . . 0.423 ' O ' ' HG2' ' B' ' 244' ' ' LYS . . . 112.53 35.27 1.76 Allowed Glycine 0 N--CA 1.417 -2.581 0 C-N-CA 120.165 -1.017 . . . . 0.0 110.77 -175.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 14.6 p90 -76.97 -34.35 57.57 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-O 121.015 0.436 . . . . 0.0 111.403 177.046 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -61.27 -42.39 98.56 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 123.761 0.824 . . . . 0.0 109.972 -177.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -64.26 -34.34 77.89 Favored 'General case' 0 C--O 1.198 -1.65 0 CA-C-N 115.459 -0.791 . . . . 0.0 112.218 -179.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 244' ' ' LYS . . . . . 0.423 ' HG2' ' O ' ' B' ' 240' ' ' GLY . 74.2 mmtt -62.42 -42.87 99.76 Favored 'General case' 0 C--N 1.316 -0.879 0 C-N-CA 122.788 0.435 . . . . 0.0 111.625 -175.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 245' ' ' TRP . . . . . . . . . . . . . 6.9 m0 -69.86 -37.5 76.13 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 121.734 0.778 . . . . 0.0 109.17 178.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 246' ' ' PHE . . . . . 0.537 ' O ' ' HG2' ' B' ' 249' ' ' GLN . 5.1 t80 -65.23 -40.71 94.42 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 114.909 -1.042 . . . . 0.0 110.31 177.545 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -67.06 -22.11 65.87 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 115.781 -0.645 . . . . 0.0 112.142 -179.03 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -100.68 -25.7 14.06 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 120.156 -0.618 . . . . 0.0 112.381 178.723 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 249' ' ' GLN . . . . . 0.537 ' HG2' ' O ' ' B' ' 246' ' ' PHE . 3.2 pt20 -69.77 -11.98 61.27 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-O 121.126 0.488 . . . . 0.0 110.504 -177.26 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 250' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -58.67 -23.06 58.62 Favored 'General case' 0 N--CA 1.482 1.142 0 CA-C-N 114.692 -1.14 . . . . 0.0 111.832 179.415 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -121.22 130.39 53.67 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 178.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 252' ' ' ILE . . . . . . . . . . . . . 32.8 pt -92.45 -36.81 8.02 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 -176.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -97.84 -25.85 14.89 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-O 121.865 0.84 . . . . 0.0 110.494 -175.046 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 254' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -101.42 149.86 23.62 Favored 'General case' 0 N--CA 1.409 -2.479 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.17 -173.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 255' ' ' LYS . . . . . . . . . . . . . 12.5 ptmm? -122.06 -20.42 6.29 Favored 'General case' 0 C--N 1.281 -2.378 0 CA-C-N 114.457 -1.247 . . . . 0.0 110.132 -178.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 256' ' ' LYS . . . . . . . . . . . . . 88.3 tttt . . . . . 0 N--CA 1.452 -0.341 0 O-C-N 124.806 1.317 . . . . 0.0 108.408 -172.073 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 . . . . . 0 CA--C 1.497 -1.087 0 N-CA-C 104.822 -2.288 . . . . 0.0 104.822 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -72.62 -17.52 61.67 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 114.513 1.301 . . . . 0.0 114.513 -156.233 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -96.61 -3.41 42.95 Favored 'General case' 0 C--N 1.282 -2.335 0 CA-C-O 121.382 0.611 . . . . 0.0 111.663 -174.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.61 ' HB3' ' OD1' ' A' ' 30' ' ' ASN . 14.4 mmmm -139.71 -57.51 0.57 Allowed 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.607 -178.777 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . 0.271 53.0 m-20 48.76 55.41 9.18 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 124.715 1.206 . . . . 0.0 114.241 -173.743 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.61 ' OD1' ' HB3' ' A' ' 28' ' ' LYS . 14.3 m120 -105.71 28.95 7.0 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 106.784 -1.562 . . . . 0.0 106.784 174.231 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -89.67 -4.89 57.55 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 114.607 -1.179 . . . . 0.0 112.102 -174.016 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.453 ' HH ' ' NH1' ' A' ' 110' ' ' ARG . 17.4 m-85 -107.89 145.11 34.18 Favored 'General case' 0 C--N 1.317 -0.846 0 C-N-CA 120.876 -0.33 . . . . 0.0 110.178 -174.813 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 30.5 pt -139.55 156.78 26.73 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 CA-C-O 120.986 0.422 . . . . 0.0 110.524 177.028 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 28.5 t80 -107.41 122.83 47.4 Favored 'General case' 0 N--CA 1.423 -1.796 0 CA-C-N 114.671 -1.149 . . . . 0.0 108.364 177.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.418 HG21 ' CD1' ' A' ' 104' ' ' ILE . 7.7 mt -108.77 128.17 64.73 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.977 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 176.51 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -129.66 173.92 19.55 Favored Glycine 0 C--N 1.287 -2.154 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.976 -178.221 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 19.5 m120 65.82 24.2 11.37 Favored 'General case' 0 CA--C 1.512 -0.517 0 C-N-CA 125.123 1.369 . . . . 0.0 111.922 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -58.27 140.77 52.67 Favored 'General case' 0 CA--C 1.495 -1.154 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 -178.357 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.495 ' CG ' ' HG2' ' A' ' 41' ' ' GLU . 49.8 t-20 -71.5 142.64 50.14 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 172.298 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.491 ' HD2' ' N ' ' A' ' 41' ' ' GLU . 7.5 ppt_? -58.99 -22.94 61.32 Favored 'General case' 0 C--N 1.303 -1.43 0 C-N-CA 123.869 0.867 . . . . 0.0 112.62 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.495 ' HG2' ' CG ' ' A' ' 39' ' ' ASN . 12.8 pt-20 -87.19 -14.8 40.15 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.85 -176.175 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.425 ' HG ' ' HB3' ' A' ' 39' ' ' ASN . 79.6 mt -76.42 126.13 30.44 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.564 0.697 . . . . 0.0 112.598 -174.747 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 66.8 p -109.26 173.71 6.2 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 114.071 -1.422 . . . . 0.0 109.538 -177.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.7 mp0 -57.56 -42.31 82.76 Favored 'General case' 0 C--O 1.211 -0.933 0 C-N-CA 123.616 0.766 . . . . 0.0 109.92 178.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.43 -37.41 93.15 Favored Glycine 0 N--CA 1.446 -0.649 0 O-C-N 123.618 0.574 . . . . 0.0 112.814 -179.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 32.5 m-20 -67.42 -49.76 62.37 Favored 'General case' 0 CA--C 1.501 -0.934 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 179.306 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 51.4 mt -60.25 -45.78 95.72 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.777 0 CA-C-N 114.748 -1.115 . . . . 0.0 110.682 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 41.4 mt -59.96 -45.24 93.31 Favored 'General case' 0 CA--C 1.496 -1.099 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.322 -178.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 87.8 m -61.88 -45.72 92.52 Favored 'General case' 0 C--N 1.313 -1.018 0 O-C-N 123.595 0.56 . . . . 0.0 111.585 -178.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 98.9 t -66.79 -50.19 67.63 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.489 -179.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -62.49 -25.66 68.13 Favored 'General case' 0 N--CA 1.433 -1.276 0 C-N-CA 123.883 0.873 . . . . 0.0 112.381 -178.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 65.9 m -67.07 -20.22 65.79 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.287 176.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -70.07 -20.71 63.21 Favored 'General case' 0 CA--C 1.555 1.158 0 CA-C-O 121.302 0.572 . . . . 0.0 109.721 176.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 41.5 m-85 -97.51 -19.98 18.03 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-O 121.03 0.443 . . . . 0.0 111.59 -175.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 167.92 -159.49 32.75 Favored Glycine 0 N--CA 1.42 -2.379 0 N-CA-C 110.825 -0.91 . . . . 0.0 110.825 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 59.1 t -102.66 110.83 64.02 Favored Pre-proline 0 C--N 1.296 -1.746 0 O-C-N 123.471 0.159 . . . . 0.0 111.062 -177.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.415 ' HB3' HD22 ' A' ' 77' ' ' LEU . 92.7 Cg_endo -77.39 140.75 19.61 Favored 'Trans proline' 0 N--CA 1.451 -1.018 0 C-N-CA 122.849 2.366 . . . . 0.0 110.18 175.469 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 31.2 m -116.39 -19.08 6.63 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 C-N-CA 120.0 -0.68 . . . . 0.0 112.167 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.444 ' HB3' ' HG2' ' A' ' 78' ' ' LYS . 36.0 t70 -161.26 141.41 10.83 Favored 'General case' 0 C--O 1.242 0.682 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 -179.804 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 14.4 p -141.71 133.96 28.22 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 178.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 91.6 mt -120.46 125.37 74.07 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 177.443 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -100.77 134.18 44.13 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 178.203 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 22.3 t -92.62 131.52 37.65 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 176.256 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 68.7 mtt85 -134.59 142.0 46.81 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-O 120.879 0.371 . . . . 0.0 111.233 -177.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -74.32 126.86 31.58 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 107.775 -1.195 . . . . 0.0 107.775 176.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -61.41 -24.13 66.3 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 112.705 0.632 . . . . 0.0 112.705 -176.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 23.0 m-80 -82.97 -50.22 8.78 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-O 121.27 0.557 . . . . 0.0 110.608 -176.08 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 74.6 p -85.62 -24.14 27.24 Favored 'General case' 0 C--N 1.312 -1.046 0 C-N-CA 120.253 -0.579 . . . . 0.0 111.267 -174.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.63 3.2 78.21 Favored Glycine 0 N--CA 1.439 -1.142 0 N-CA-C 111.359 -0.697 . . . . 0.0 111.359 -177.185 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -103.84 164.23 11.82 Favored 'General case' 0 N--CA 1.428 -1.545 0 CA-C-O 121.057 0.456 . . . . 0.0 110.796 -176.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 13.7 m -58.85 132.02 52.7 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 114.792 -1.095 . . . . 0.0 111.438 -177.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 15.7 mm-40 -63.7 -21.76 66.56 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.557 1.143 . . . . 0.0 111.692 178.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 110.2 8.29 25.61 Favored Glycine 0 N--CA 1.421 -2.35 0 C-N-CA 119.88 -1.153 . . . . 0.0 112.269 -179.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 40.8 p90 -148.82 153.36 38.0 Favored 'General case' 0 C--O 1.252 1.194 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 177.125 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -149.52 172.83 14.36 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-O 120.915 0.388 . . . . 0.0 110.874 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -130.3 139.41 50.73 Favored 'General case' 0 C--N 1.303 -1.424 0 C-N-CA 124.161 0.984 . . . . 0.0 109.617 -179.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.415 HD22 ' HB3' ' A' ' 57' ' ' PRO . 9.9 tt -146.01 140.76 27.07 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 175.587 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.444 ' HG2' ' HB3' ' A' ' 59' ' ' ASP . 20.8 ptmt -124.37 144.27 50.12 Favored 'General case' 0 C--O 1.256 1.433 0 CA-C-O 121.259 0.552 . . . . 0.0 109.787 179.344 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 66.3 m-85 -108.16 164.31 12.41 Favored 'General case' 0 C--N 1.29 -1.983 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.719 179.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -77.99 -33.59 51.24 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 174.304 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -109.8 130.09 55.56 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.94 -176.163 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.604 ' NE2' ' H ' ' A' ' 30' ' ' ASN . 83.7 mt-30 -71.02 -20.37 62.4 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 -178.095 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 88.1 mtm180 -68.03 -34.1 75.85 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-O 121.946 0.879 . . . . 0.0 108.654 174.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.492 ' OG ' HG22 ' B' ' 226' ' ' ILE . 61.9 m -63.59 -37.11 86.07 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 115.078 -0.964 . . . . 0.0 112.511 178.299 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.434 ' O ' HG21 ' A' ' 89' ' ' VAL . 80.7 p -65.31 -45.84 82.72 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 120.325 -0.55 . . . . 0.0 110.476 -177.303 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 3.4 pt -64.83 -39.23 84.96 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.884 177.179 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.486 HD12 ' HB2' ' B' ' 224' ' ' PHE . 19.9 mt -59.65 -44.54 93.51 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.653 176.393 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.468 ' O ' ' HB2' ' A' ' 92' ' ' LEU . . . -71.48 -45.88 61.32 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.035 -177.329 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.434 HG21 ' O ' ' A' ' 85' ' ' THR . 70.2 t -56.65 -49.02 79.7 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.797 0 CA-C-O 121.057 0.456 . . . . 0.0 110.95 178.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -63.25 -39.15 93.79 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 115.366 -0.834 . . . . 0.0 112.034 -175.062 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 63.3 t30 -96.42 -20.09 18.7 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.431 -171.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.468 ' HB2' ' O ' ' A' ' 88' ' ' ALA . 10.3 mt -96.59 -31.24 12.84 Favored 'General case' 0 CA--C 1.494 -1.176 0 CA-C-O 120.909 0.385 . . . . 0.0 111.655 -178.236 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 56.1 t30 -65.44 125.82 26.34 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.981 -177.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 88.13 -1.15 84.51 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 121.341 -0.457 . . . . 0.0 112.883 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 67.7 t80 -90.12 137.78 32.06 Favored 'General case' 0 C--N 1.32 -0.689 0 O-C-N 122.378 -0.483 . . . . 0.0 110.069 -178.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -92.45 116.74 29.25 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 121.56 0.695 . . . . 0.0 111.806 -176.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.583 ' HB ' HH21 ' A' ' 100' ' ' ARG . 62.7 mt -127.34 140.36 49.33 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 175.621 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 62.88 19.27 60.83 Favored Glycine 0 C--N 1.307 -1.066 0 C-N-CA 121.387 -0.435 . . . . 0.0 112.869 -179.007 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 91.72 -9.55 76.65 Favored Glycine 0 N--CA 1.438 -1.182 0 C-N-CA 121.218 -0.515 . . . . 0.0 112.953 -178.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.583 HH21 ' HB ' ' A' ' 97' ' ' ILE . 0.0 OUTLIER -125.54 146.88 49.47 Favored 'General case' 0 N--CA 1.418 -2.049 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 -175.764 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -79.8 136.54 36.75 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.692 -176.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.419 ' HG ' ' NH2' ' A' ' 100' ' ' ARG . 11.0 mt -82.47 148.39 28.17 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 115.457 -0.792 . . . . 0.0 112.445 176.253 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 4.3 tppp? -124.27 119.96 30.82 Favored 'General case' 0 N--CA 1.423 -1.825 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 174.271 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.418 ' CD1' HG21 ' A' ' 35' ' ' ILE . 4.6 mm -122.09 135.12 63.25 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 N-CA-C 107.108 -1.441 . . . . 0.0 107.108 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -143.63 158.82 43.38 Favored 'General case' 0 C--N 1.291 -1.947 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 178.335 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 38.3 m-70 -83.63 141.76 31.29 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 177.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 9.3 t -156.04 161.78 40.39 Favored 'General case' 0 C--N 1.285 -2.216 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 -178.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 26.0 p90 -109.88 110.35 21.28 Favored 'General case' 0 C--N 1.297 -1.674 0 C-N-CA 118.592 -1.243 . . . . 0.0 108.879 172.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 62.3 t80 -108.54 139.31 43.48 Favored 'General case' 0 C--N 1.294 -1.819 0 CA-C-N 115.351 -0.841 . . . . 0.0 110.98 -178.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.453 ' NH1' ' HH ' ' A' ' 32' ' ' TYR . 26.9 mmt180 -120.88 115.58 31.89 Favored Pre-proline 0 C--N 1.301 -1.506 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 172.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -61.97 138.83 75.78 Favored 'Trans proline' 0 C--O 1.24 0.61 0 C-N-CA 123.584 2.856 . . . . 0.0 113.232 -178.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.401 ' C ' ' HD3' ' A' ' 112' ' ' LYS . 10.8 tmtt? -82.69 124.32 30.1 Favored 'General case' 0 N--CA 1.432 -1.354 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 178.023 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 9.7 mmm180 . . . . . 0 C--N 1.302 -1.499 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 179.448 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 12.6 t-20 . . . . . 0 CA--C 1.545 0.758 0 CA-C-O 121.511 0.672 . . . . 0.0 109.846 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 223' ' ' ARG . . . . . . . . . . . . 0.549 10.7 mtp180 75.2 52.12 0.07 Allowed 'General case' 0 CA--C 1.501 -0.928 0 N-CA-C 118.737 2.866 . . . . 0.0 118.737 176.647 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 224' ' ' PHE . . . . . 0.486 ' HB2' HD12 ' A' ' 87' ' ' LEU . 32.2 m-85 -116.2 165.27 13.35 Favored 'General case' 0 C--N 1.283 -2.296 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 173.453 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 225' ' ' ALA . . . . . . . . . . . . . . . -125.96 83.28 2.15 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-O 121.64 0.733 . . . . 0.0 110.479 -178.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 226' ' ' ILE . . . . . 0.492 HG22 ' OG ' ' A' ' 84' ' ' SER . 3.8 mp -120.73 132.61 69.82 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 CA-C-N 115.011 -0.995 . . . . 0.0 108.843 178.778 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 227' ' ' MET . . . . . . . . . . . . . 24.8 mmt -59.53 140.19 88.91 Favored Pre-proline 0 C--N 1.323 -0.577 0 O-C-N 124.061 0.851 . . . . 0.0 111.405 179.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 228' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -71.18 156.01 60.08 Favored 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 122.555 2.17 . . . . 0.0 111.444 179.119 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . -74.38 168.9 54.33 Favored Glycine 0 C--N 1.307 -1.041 0 CA-C-N 116.167 -0.47 . . . . 0.0 112.642 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 22.6 t -77.41 -15.21 59.47 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-O 120.954 0.407 . . . . 0.0 110.315 -178.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 13.6 mmp_? -80.83 -5.2 56.97 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 121.974 -0.454 . . . . 0.0 111.192 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 232' ' ' TRP . . . . . . . . . . . . . 19.2 t90 -70.94 127.02 31.19 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-O 122.659 1.219 . . . . 0.0 111.878 -178.076 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 233' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -118.09 145.5 44.8 Favored 'General case' 0 C--N 1.271 -2.833 0 N-CA-C 101.059 -3.682 . . . . 0.0 101.059 172.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -49.78 57.76 0.0 OUTLIER Glycine 0 N--CA 1.497 2.749 0 C-N-CA 127.211 2.339 . . . . 0.0 116.175 -177.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 235' ' ' VAL . . . . . . . . . . . . . 39.7 t -103.13 133.82 45.93 Favored 'Isoleucine or valine' 0 C--N 1.247 -3.884 0 C-N-CA 128.295 2.638 . . . . 0.0 106.589 176.323 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 236' ' ' HIS . . . . . . . . . . . . . 48.6 t-80 -111.92 113.35 25.61 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 178.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 237' ' ' ARG . . . . . . . . . . . . . 35.2 mmt180 -126.46 106.96 9.83 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 109.246 -0.649 . . . . 0.0 109.246 176.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 238' ' ' SER . . . . . . . . . . . . . 75.7 m -147.28 129.19 15.36 Favored 'General case' 0 C--N 1.298 -1.667 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.936 179.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 239' ' ' ASN . . . . . . . . . . . . . 57.5 t30 -105.34 165.77 10.88 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 -179.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 240' ' ' GLY . . . . . 0.415 ' O ' ' HG2' ' B' ' 244' ' ' LYS . . . 92.23 9.68 61.71 Favored Glycine 0 C--O 1.201 -1.928 0 C-N-CA 120.979 -0.629 . . . . 0.0 111.603 179.755 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -76.14 -33.56 59.42 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-O 120.899 0.38 . . . . 0.0 110.709 179.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -60.89 -43.84 97.92 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.106 -178.347 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -62.08 -34.62 76.64 Favored 'General case' 0 C--O 1.206 -1.219 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.307 179.189 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 244' ' ' LYS . . . . . 0.415 ' HG2' ' O ' ' B' ' 240' ' ' GLY . 72.9 mmtt -64.76 -45.52 86.05 Favored 'General case' 0 CA--C 1.508 -0.653 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 -179.268 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 245' ' ' TRP . . . . . . . . . . . . . 49.3 m0 -66.03 -42.45 89.59 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.26 178.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 246' ' ' PHE . . . . . 0.515 ' HA ' ' CD ' ' B' ' 249' ' ' GLN . 6.0 t80 -63.88 -36.95 85.62 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.246 179.743 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -70.33 -32.37 70.07 Favored 'General case' 0 C--N 1.292 -1.923 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.687 -179.244 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.46 -19.94 20.78 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -177.529 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 249' ' ' GLN . . . . . 0.515 ' CD ' ' HA ' ' B' ' 246' ' ' PHE . 2.9 pt20 -74.11 2.79 8.14 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.093 0.557 . . . . 0.0 110.71 -177.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 250' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -57.93 -30.62 66.09 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.373 178.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -84.59 120.89 26.88 Favored 'General case' 0 N--CA 1.437 -1.106 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.195 179.358 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 252' ' ' ILE . . . . . . . . . . . . . 37.6 pt -101.63 -28.65 3.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.759 -175.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -107.45 -26.52 10.91 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-O 121.573 0.701 . . . . 0.0 110.123 -178.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 254' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -91.3 173.84 7.71 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-N 115.306 -0.861 . . . . 0.0 108.68 -179.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 255' ' ' LYS . . . . . . . . . . . . . 9.2 ptpp? -71.35 156.54 39.38 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 122.89 0.476 . . . . 0.0 110.137 178.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 256' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.431 -1.4 0 CA-C-O 120.691 0.281 . . . . 0.0 111.157 -178.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 15.9 m120 . . . . . 0 CA--C 1.51 -0.593 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -66.89 -27.44 67.51 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.391 0.615 . . . . 0.0 111.961 -170.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -88.98 13.7 12.26 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 113.291 0.849 . . . . 0.0 113.291 -173.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.619 ' HB3' ' OD1' ' A' ' 30' ' ' ASN . 13.6 mmmm -101.02 -43.46 6.03 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 173.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 23.2 t70 74.07 13.24 4.08 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-O 122.666 1.222 . . . . 0.0 110.747 177.245 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.619 ' OD1' ' HB3' ' A' ' 28' ' ' LYS . 15.4 m120 -89.96 24.65 2.36 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 114.448 -1.251 . . . . 0.0 109.636 -178.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -87.22 -0.04 56.1 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.341 -179.352 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -108.69 145.33 35.2 Favored 'General case' 0 N--CA 1.434 -1.248 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.868 -176.137 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 28.4 pt -136.86 160.36 36.85 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.753 177.233 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 34.4 t80 -112.8 124.12 51.88 Favored 'General case' 0 N--CA 1.413 -2.31 0 CA-C-N 115.26 -0.882 . . . . 0.0 108.831 177.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.448 HG21 ' CD1' ' A' ' 104' ' ' ILE . 10.4 mt -108.55 127.75 64.73 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.036 0 N-CA-C 106.846 -1.539 . . . . 0.0 106.846 176.136 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -130.07 160.99 23.05 Favored Glycine 0 N--CA 1.425 -2.04 0 N-CA-C 112.02 -0.432 . . . . 0.0 112.02 -179.094 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 66.4 t30 70.39 41.27 1.02 Allowed 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.82 1.648 . . . . 0.0 110.604 -179.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -69.39 151.73 45.78 Favored 'General case' 0 CA--C 1.499 -0.987 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.864 175.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.412 ' HB3' ' HG ' ' A' ' 42' ' ' LEU . 45.9 t-20 -84.66 149.94 25.48 Favored 'General case' 0 C--N 1.284 -2.273 0 N-CA-C 106.344 -1.724 . . . . 0.0 106.344 175.758 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.517 ' HD2' ' C ' ' A' ' 40' ' ' ARG . 5.8 ppt_? -59.1 -24.45 62.97 Favored 'General case' 0 C--N 1.307 -1.242 0 C-N-CA 123.354 0.662 . . . . 0.0 111.025 178.606 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.429 ' N ' ' HD2' ' A' ' 40' ' ' ARG . 13.8 pt-20 -95.39 0.11 53.13 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.825 -0.625 . . . . 0.0 112.317 -175.81 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.412 ' HG ' ' HB3' ' A' ' 39' ' ' ASN . 68.6 mt -89.81 121.69 32.18 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-O 121.132 0.492 . . . . 0.0 110.407 179.503 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 70.6 p -108.43 174.44 5.87 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-N 114.674 -1.148 . . . . 0.0 110.279 -176.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.423 ' CG ' ' HB2' ' A' ' 62' ' ' LEU . 33.6 mt-10 -55.15 -40.87 71.09 Favored 'General case' 0 C--O 1.212 -0.914 0 O-C-N 123.616 0.572 . . . . 0.0 109.689 176.622 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -59.76 -39.83 95.84 Favored Glycine 0 C--O 1.243 0.7 0 CA-C-N 116.079 -0.51 . . . . 0.0 112.738 179.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -66.82 -49.65 65.1 Favored 'General case' 0 CA--C 1.499 -1.017 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 179.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 47.2 mt -60.07 -46.68 94.01 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.808 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.842 -179.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 47.5 mt -60.07 -42.49 94.67 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 116.592 -0.277 . . . . 0.0 111.705 -177.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 90.8 m -63.98 -46.28 85.32 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 120.869 0.366 . . . . 0.0 111.256 -179.134 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 95.7 t -66.98 -48.63 78.91 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.692 -178.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -64.88 -23.08 67.12 Favored 'General case' 0 N--CA 1.426 -1.636 0 CA-C-N 115.28 -0.873 . . . . 0.0 112.416 -178.413 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.468 ' HA ' ' O ' ' A' ' 55' ' ' GLY . 61.5 m -72.3 -20.8 61.44 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 176.64 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -71.46 -22.18 61.86 Favored 'General case' 0 C--O 1.246 0.894 0 C-N-CA 119.859 -0.736 . . . . 0.0 109.596 177.275 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -92.0 -22.82 19.77 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.818 -178.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.468 ' O ' ' HA ' ' A' ' 52' ' ' SER . . . 169.79 -164.47 37.91 Favored Glycine 0 N--CA 1.427 -1.965 0 N-CA-C 110.927 -0.869 . . . . 0.0 110.927 -179.588 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 54.8 t -99.03 111.0 59.82 Favored Pre-proline 0 C--N 1.302 -1.498 0 CA-C-N 116.548 0.174 . . . . 0.0 111.039 -176.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.426 ' HB3' HD22 ' A' ' 77' ' ' LEU . 85.9 Cg_endo -78.13 141.77 18.84 Favored 'Trans proline' 0 C--O 1.246 0.895 0 C-N-CA 122.975 2.45 . . . . 0.0 110.627 175.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 29.7 m -120.53 -15.38 7.43 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 C-N-CA 120.264 -0.575 . . . . 0.0 112.132 179.226 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.477 ' HB3' ' HG2' ' A' ' 78' ' ' LYS . 28.3 t70 -163.27 135.92 5.4 Favored 'General case' 0 C--O 1.244 0.799 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 -176.835 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 14.4 p -143.97 136.88 23.71 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 90.2 mt -120.92 121.63 65.62 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.799 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 177.234 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.423 ' HB2' ' CG ' ' A' ' 44' ' ' GLU . 0.1 OUTLIER -100.2 113.54 26.28 Favored 'General case' 0 N--CA 1.42 -1.93 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 175.267 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 13.6 m -78.32 117.91 20.01 Favored 'General case' 0 C--N 1.274 -2.693 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 178.406 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 84.2 mtm180 -114.28 148.63 37.18 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-O 121.052 0.454 . . . . 0.0 110.125 179.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -82.67 117.57 22.7 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.725 178.019 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -61.42 -23.04 65.55 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.599 -0.728 . . . . 0.0 112.717 -177.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 19.3 m-80 -79.79 -50.05 11.11 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 120.897 0.379 . . . . 0.0 109.993 -175.435 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 38.3 p -87.12 -23.59 24.82 Favored 'General case' 0 C--O 1.249 1.035 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 -176.276 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.07 20.09 77.93 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 111.29 -0.724 . . . . 0.0 111.29 -177.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -123.2 172.83 8.31 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 -178.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 19.7 m -60.02 147.32 39.53 Favored 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 122.763 0.425 . . . . 0.0 111.44 179.215 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 12.9 mm-40 -79.24 -10.25 59.77 Favored 'General case' 0 CA--C 1.502 -0.878 0 C-N-CA 123.233 0.613 . . . . 0.0 112.456 178.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 96.54 2.99 59.9 Favored Glycine 0 N--CA 1.426 -2.031 0 C-N-CA 119.651 -1.261 . . . . 0.0 112.113 -179.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 34.5 p90 -145.65 151.58 38.28 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 178.294 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -149.49 170.16 19.24 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 123.266 0.354 . . . . 0.0 110.529 -179.217 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -131.5 140.12 49.46 Favored 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 123.649 0.78 . . . . 0.0 109.427 -178.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.426 HD22 ' HB3' ' A' ' 57' ' ' PRO . 9.9 tt -147.33 140.45 25.19 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 177.183 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.477 ' HG2' ' HB3' ' A' ' 59' ' ' ASP . 18.7 ptmt -124.0 144.43 49.83 Favored 'General case' 0 C--O 1.259 1.567 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 178.122 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 58.7 m-85 -106.9 164.89 11.75 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.956 -178.32 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -77.83 -25.73 49.01 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 114.813 -1.085 . . . . 0.0 109.293 176.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -124.1 130.39 52.48 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 -179.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -69.3 -21.05 63.89 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 113.137 0.792 . . . . 0.0 113.137 -177.262 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 89.6 mtm180 -63.64 -33.13 74.95 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-O 122.352 1.073 . . . . 0.0 110.109 177.374 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.423 ' OG ' HG22 ' B' ' 226' ' ' ILE . 48.9 m -63.53 -36.98 85.59 Favored 'General case' 0 C--N 1.282 -2.335 0 CA-C-N 114.628 -1.169 . . . . 0.0 112.22 178.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.402 ' O ' HG21 ' A' ' 89' ' ' VAL . 81.8 p -64.74 -45.05 88.11 Favored 'General case' 0 C--O 1.219 -0.501 0 C-N-CA 120.279 -0.568 . . . . 0.0 110.525 -177.015 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 3.3 pt -63.89 -39.45 85.46 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.103 177.225 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 29.2 mt -60.32 -43.61 96.21 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 120.902 0.382 . . . . 0.0 111.011 175.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.456 ' O ' ' HB2' ' A' ' 92' ' ' LEU . . . -71.47 -47.16 57.37 Favored 'General case' 0 C--O 1.211 -0.959 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.67 -178.64 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.402 HG21 ' O ' ' A' ' 85' ' ' THR . 79.5 t -57.21 -48.7 81.72 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.492 0 CA-C-O 120.915 0.388 . . . . 0.0 111.006 -179.44 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -68.38 -31.9 71.6 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 115.509 -0.769 . . . . 0.0 112.466 -173.413 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -97.56 -20.77 17.48 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 -176.302 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.456 ' HB2' ' O ' ' A' ' 88' ' ' ALA . 9.6 mt -93.43 -28.56 16.06 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-O 120.574 0.226 . . . . 0.0 111.07 -179.15 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -60.26 124.74 21.22 Favored 'General case' 0 C--O 1.244 0.79 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 178.056 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 83.86 -1.07 89.23 Favored Glycine 0 C--N 1.306 -1.128 0 C-N-CA 120.499 -0.858 . . . . 0.0 113.447 177.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.414 ' CE2' ' HD2' ' B' ' 237' ' ' ARG . 86.4 t80 -85.3 134.4 34.12 Favored 'General case' 0 N--CA 1.443 -0.825 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 178.688 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 11.1 mptt -92.88 118.87 31.6 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.229 -176.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 54.1 mt -121.72 141.16 43.33 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 N-CA-C 105.257 -2.127 . . . . 0.0 105.257 172.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 58.92 22.48 54.77 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 121.191 -0.528 . . . . 0.0 112.821 -179.04 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 82.21 7.41 87.77 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 121.492 -0.385 . . . . 0.0 113.546 -179.435 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 16.7 ptp180 -129.52 141.04 51.08 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 117.688 0.744 . . . . 0.0 110.894 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -79.61 122.08 26.07 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.012 0.434 . . . . 0.0 111.387 -179.215 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 9.5 mt -68.7 141.23 55.35 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.671 177.2 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -113.98 116.01 28.55 Favored 'General case' 0 N--CA 1.409 -2.517 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 176.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.448 ' CD1' HG21 ' A' ' 35' ' ' ILE . 4.8 mm -116.65 136.11 54.78 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.861 0 N-CA-C 106.423 -1.695 . . . . 0.0 106.423 178.417 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -144.0 151.85 40.26 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.331 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -80.63 135.6 36.08 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-O 120.975 0.417 . . . . 0.0 110.223 177.648 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 6.5 t -153.64 168.35 26.52 Favored 'General case' 0 C--N 1.291 -1.972 0 N-CA-C 107.427 -1.324 . . . . 0.0 107.427 -177.065 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -108.91 110.82 22.24 Favored 'General case' 0 N--CA 1.421 -1.888 0 N-CA-C 105.208 -2.145 . . . . 0.0 105.208 169.143 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 84.9 t80 -106.93 132.64 52.65 Favored 'General case' 0 C--N 1.291 -1.967 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 178.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 12.5 tpp180 -111.14 113.13 54.72 Favored Pre-proline 0 C--N 1.294 -1.822 0 N-CA-C 106.689 -1.597 . . . . 0.0 106.689 175.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -71.13 149.24 57.83 Favored 'Trans proline' 0 C--O 1.25 1.077 0 C-N-CA 123.013 2.475 . . . . 0.0 115.551 -178.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 25.1 tptp -121.01 118.88 30.95 Favored 'General case' 0 N--CA 1.42 -1.968 0 CA-C-N 112.994 -1.912 . . . . 0.0 106.793 172.074 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 23.5 mmt180 . . . . . 0 C--N 1.28 -2.44 0 N-CA-C 107.019 -1.474 . . . . 0.0 107.019 179.948 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 . . . . . 0 N--CA 1.48 1.058 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 223' ' ' ARG . . . . . . . . . . . . 0.277 30.1 mtp180 67.01 50.75 1.01 Allowed 'General case' 0 CA--C 1.505 -0.761 0 CA-C-O 122.871 1.32 . . . . 0.0 114.233 175.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 224' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -109.49 166.88 10.54 Favored 'General case' 0 C--N 1.268 -2.95 0 CA-C-N 112.495 -2.139 . . . . 0.0 106.806 175.327 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 225' ' ' ALA . . . . . . . . . . . . . . . -126.34 81.68 2.02 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-O 121.279 0.561 . . . . 0.0 110.91 -179.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 226' ' ' ILE . . . . . 0.423 HG22 ' OG ' ' A' ' 84' ' ' SER . 4.2 mp -125.93 132.76 70.3 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.211 177.518 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 227' ' ' MET . . . . . . . . . . . . . 86.8 mtp -71.2 133.54 85.54 Favored Pre-proline 0 C--N 1.315 -0.903 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 176.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 228' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -64.27 160.89 36.59 Favored 'Trans proline' 0 C--O 1.24 0.622 0 C-N-CA 123.43 2.753 . . . . 0.0 113.455 -177.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . -77.19 167.48 54.25 Favored Glycine 0 N--CA 1.439 -1.128 0 CA-C-N 115.155 -0.929 . . . . 0.0 113.429 -178.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 6.5 m -77.42 -17.58 57.99 Favored 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 123.14 0.576 . . . . 0.0 111.635 -175.169 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 7.9 mmp_? -87.29 -0.46 56.77 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.196 0.522 . . . . 0.0 110.995 -176.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 232' ' ' TRP . . . . . . . . . . . . . 21.1 t90 -76.93 127.82 33.41 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-O 122.307 1.051 . . . . 0.0 112.206 -178.063 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 233' ' ' ASP . . . . . 0.418 ' O ' ' N ' ' B' ' 235' ' ' VAL . 23.9 t70 -122.07 147.1 46.53 Favored 'General case' 0 C--N 1.277 -2.585 0 N-CA-C 102.82 -3.029 . . . . 0.0 102.82 171.705 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -45.62 56.0 0.0 OUTLIER Glycine 0 N--CA 1.505 3.272 0 C-N-CA 128.372 2.891 . . . . 0.0 117.139 -175.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 235' ' ' VAL . . . . . 0.418 ' N ' ' O ' ' B' ' 233' ' ' ASP . 52.3 t -110.83 127.52 67.86 Favored 'Isoleucine or valine' 1 C--N 1.244 -4.02 0 C-N-CA 128.237 2.615 . . . . 0.0 106.996 177.516 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 236' ' ' HIS . . . . . . . . . . . . . 57.4 t60 -112.05 122.24 47.2 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 179.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 237' ' ' ARG . . . . . 0.414 ' HD2' ' CE2' ' A' ' 95' ' ' PHE . 28.4 mmt180 -127.25 110.34 12.76 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-O 121.115 0.483 . . . . 0.0 110.877 178.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 238' ' ' SER . . . . . . . . . . . . . 77.8 p -146.82 141.85 27.08 Favored 'General case' 0 C--N 1.284 -2.259 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 174.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 239' ' ' ASN . . . . . . . . . . . . . 34.2 p30 -75.87 18.92 0.23 Allowed 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 178.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 240' ' ' GLY . . . . . . . . . . . . . . . -105.82 48.8 0.93 Allowed Glycine 0 N--CA 1.417 -2.604 0 N-CA-C 108.443 -1.863 . . . . 0.0 108.443 173.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 22.7 p90 -77.09 -33.34 56.99 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 179.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -61.27 -45.34 94.89 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.226 0.536 . . . . 0.0 112.089 -177.094 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -60.46 -34.74 74.46 Favored 'General case' 0 C--O 1.204 -1.307 0 CA-C-N 115.166 -0.924 . . . . 0.0 111.411 -179.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -63.97 -42.46 97.24 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 -178.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 245' ' ' TRP . . . . . . . . . . . . . 23.7 m0 -66.23 -38.43 87.89 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.329 0.585 . . . . 0.0 109.954 178.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 246' ' ' PHE . . . . . 0.627 ' O ' ' HG2' ' B' ' 249' ' ' GLN . 3.1 t80 -67.96 -32.89 73.63 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.433 176.302 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -74.93 -38.96 61.65 Favored 'General case' 0 C--N 1.294 -1.839 0 O-C-N 121.948 -0.47 . . . . 0.0 111.023 179.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.35 -14.57 55.08 Favored 'General case' 0 CA--C 1.504 -0.8 0 CA-C-O 121.045 0.45 . . . . 0.0 111.758 -175.235 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 249' ' ' GLN . . . . . 0.627 ' HG2' ' O ' ' B' ' 246' ' ' PHE . 3.0 pt20 -75.22 2.4 11.07 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 121.698 0.761 . . . . 0.0 110.332 -179.068 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 250' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -67.24 -25.83 66.28 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.21 176.235 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -64.29 115.88 5.48 Favored 'General case' 0 N--CA 1.437 -1.118 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.134 178.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 252' ' ' ILE . . . . . . . . . . . . . 16.3 pt -99.67 -27.63 3.52 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.317 0 CA-C-N 113.783 -1.553 . . . . 0.0 110.944 -174.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 10.6 p30 -121.01 -26.32 5.17 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.908 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 254' ' ' GLU . . . . . 0.59 ' OE1' ' HG2' ' B' ' 255' ' ' LYS . 4.7 mm-40 -84.45 172.19 11.92 Favored 'General case' 0 N--CA 1.428 -1.571 0 N-CA-C 114.089 1.144 . . . . 0.0 114.089 -177.322 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 255' ' ' LYS . . . . . 0.59 ' HG2' ' OE1' ' B' ' 254' ' ' GLU . 7.8 ptpp? -107.82 105.54 15.41 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 114.631 -1.168 . . . . 0.0 112.679 -172.537 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 256' ' ' LYS . . . . . . . . . . . . . 89.5 mttt . . . . . 0 C--N 1.302 -1.496 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 173.902 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 . . . . . 0 N--CA 1.465 0.298 0 CA-C-O 121.029 0.442 . . . . 0.0 109.884 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -76.36 -9.82 58.93 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 113.026 0.751 . . . . 0.0 113.026 -172.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 56.4 m-85 -96.28 10.13 38.9 Favored 'General case' 0 C--N 1.289 -2.034 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.303 -177.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 48.6 mmtm -125.98 160.86 28.91 Favored 'General case' 0 N--CA 1.437 -1.1 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.846 179.052 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.428 ' C ' ' H ' ' A' ' 31' ' ' ALA . 15.5 p-10 -115.54 22.36 13.24 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-O 122.179 0.99 . . . . 0.0 109.152 178.425 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -75.21 30.24 0.1 Allowed 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 125.594 1.558 . . . . 0.0 110.833 179.457 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.428 ' H ' ' C ' ' A' ' 29' ' ' ASP . . . -100.7 16.22 25.64 Favored 'General case' 0 C--N 1.306 -1.283 0 C-N-CA 122.646 0.378 . . . . 0.0 110.644 -175.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.423 ' HE2' ' NH1' ' A' ' 110' ' ' ARG . 9.9 m-30 -104.85 145.23 30.67 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.89 -175.63 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 22.8 pt -140.82 158.4 23.69 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 CA-C-O 121.137 0.494 . . . . 0.0 110.628 178.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 61.8 t80 -105.26 118.91 37.74 Favored 'General case' 0 N--CA 1.412 -2.374 0 CA-C-N 114.504 -1.226 . . . . 0.0 108.057 177.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.468 HG21 ' CD1' ' A' ' 104' ' ' ILE . 10.9 mt -108.41 127.53 64.7 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.18 0 N-CA-C 105.427 -2.064 . . . . 0.0 105.427 173.359 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -132.31 170.86 21.71 Favored Glycine 0 C--N 1.269 -3.18 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 71.74 32.84 1.87 Allowed 'General case' 0 N--CA 1.471 0.604 0 O-C-N 124.485 0.756 . . . . 0.0 109.873 -178.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -66.19 143.02 57.51 Favored 'General case' 0 CA--C 1.492 -1.267 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.465 177.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 61.2 t30 -83.49 156.5 22.83 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.061 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.446 ' HB2' ' OE2' ' A' ' 70' ' ' GLU . 18.4 ptt180 -58.01 -28.92 64.88 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 123.701 0.801 . . . . 0.0 112.664 -177.188 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -107.48 4.76 26.51 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 113.74 1.015 . . . . 0.0 113.74 -172.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 61.3 mt -84.56 121.69 27.97 Favored 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 120.348 -0.541 . . . . 0.0 110.776 178.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 69.6 p -107.58 173.47 6.31 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-N 115.096 -0.956 . . . . 0.0 109.675 -179.236 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.409 ' CG ' ' HB2' ' A' ' 62' ' ' LEU . 52.3 mt-10 -55.3 -38.97 69.34 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 123.46 0.704 . . . . 0.0 111.652 179.497 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -65.6 -37.98 94.17 Favored Glycine 0 N--CA 1.44 -1.078 0 CA-C-N 116.076 -0.511 . . . . 0.0 113.105 -178.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -67.25 -43.95 80.64 Favored 'General case' 0 CA--C 1.505 -0.773 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 -178.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 35.9 mt -60.77 -45.51 97.71 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.421 0 CA-C-N 114.922 -1.035 . . . . 0.0 110.593 178.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 50.0 mt -59.64 -44.85 93.35 Favored 'General case' 0 C--O 1.207 -1.135 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.704 -176.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 96.4 m -60.63 -46.05 91.76 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 179.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.429 HG11 ' HG2' ' B' ' 237' ' ' ARG . 85.5 t -65.95 -48.44 81.84 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 CA-C-O 121.099 0.476 . . . . 0.0 110.679 179.251 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -66.27 -24.39 66.56 Favored 'General case' 0 N--CA 1.431 -1.39 0 CA-C-N 115.595 -0.73 . . . . 0.0 112.331 -178.004 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.406 ' HA ' ' O ' ' A' ' 55' ' ' GLY . 73.3 m -68.59 -19.8 64.48 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.958 176.3 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -70.29 -25.3 63.27 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 119.553 -0.859 . . . . 0.0 108.953 175.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -93.01 -7.55 45.51 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-N 115.877 -0.602 . . . . 0.0 112.069 -175.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.406 ' O ' ' HA ' ' A' ' 52' ' ' SER . . . 152.39 -159.63 28.5 Favored Glycine 0 N--CA 1.419 -2.48 0 C-N-CA 120.699 -0.762 . . . . 0.0 111.304 178.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 98.8 t -99.83 110.9 60.69 Favored Pre-proline 0 C--N 1.298 -1.634 0 O-C-N 123.382 0.107 . . . . 0.0 110.95 -178.075 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.43 ' HB3' HD22 ' A' ' 77' ' ' LEU . 92.1 Cg_endo -79.68 137.26 12.68 Favored 'Trans proline' 0 N--CA 1.452 -0.926 0 C-N-CA 122.779 2.319 . . . . 0.0 110.16 175.694 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 27.0 m -114.39 -20.41 6.06 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 C-N-CA 119.624 -0.83 . . . . 0.0 112.038 -178.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.454 ' HB3' ' HG2' ' A' ' 78' ' ' LYS . 37.5 t70 -157.24 138.24 13.45 Favored 'General case' 0 CA--C 1.499 -0.992 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.411 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 13.6 p -139.68 134.32 38.28 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 O-C-N 123.674 0.609 . . . . 0.0 109.379 178.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.414 ' CD1' ' HB3' ' A' ' 111' ' ' PRO . 84.5 mt -121.9 126.91 75.16 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.051 177.023 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.409 ' HB2' ' CG ' ' A' ' 44' ' ' GLU . 0.1 OUTLIER -105.99 112.46 25.51 Favored 'General case' 0 N--CA 1.424 -1.763 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 173.54 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 24.2 m -79.23 119.54 22.46 Favored 'General case' 0 C--N 1.281 -2.387 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 177.208 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 81.8 mtp180 -110.15 127.74 55.08 Favored 'General case' 0 C--N 1.307 -1.274 0 O-C-N 121.992 -0.442 . . . . 0.0 111.89 -175.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -69.38 123.33 20.95 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.916 178.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -61.5 -25.7 67.44 Favored 'General case' 0 C--N 1.307 -1.249 0 C-N-CA 124.286 1.035 . . . . 0.0 113.135 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 32.8 m-80 -79.1 -49.94 11.83 Favored 'General case' 0 CA--C 1.512 -0.514 0 CA-C-O 121.308 0.575 . . . . 0.0 110.432 -175.332 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 48.7 p -84.8 -24.65 28.61 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.472 -177.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.94 12.85 71.82 Favored Glycine 0 N--CA 1.44 -1.039 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.505 -178.113 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.446 ' OE2' ' HB2' ' A' ' 40' ' ' ARG . 40.9 mt-10 -107.63 -84.31 0.53 Allowed 'General case' 0 N--CA 1.435 -1.215 0 O-C-N 122.421 -0.458 . . . . 0.0 109.856 -176.626 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 71.9 p -146.23 157.08 43.79 Favored 'General case' 0 N--CA 1.421 -1.917 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 -178.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 28.8 mm-40 -77.72 -18.05 56.96 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-O 121.167 0.508 . . . . 0.0 110.383 175.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 98.33 1.38 58.03 Favored Glycine 0 N--CA 1.43 -1.739 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.89 -177.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 37.3 p90 -140.53 151.72 44.99 Favored 'General case' 0 N--CA 1.432 -1.335 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 178.329 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -146.49 172.25 13.83 Favored 'General case' 0 N--CA 1.42 -1.927 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 178.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 8.0 t80 -135.07 143.76 46.85 Favored 'General case' 0 C--N 1.293 -1.857 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.047 -177.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.43 HD22 ' HB3' ' A' ' 57' ' ' PRO . 9.7 tt -149.83 140.52 22.63 Favored 'General case' 0 N--CA 1.434 -1.244 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 175.696 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.454 ' HG2' ' HB3' ' A' ' 59' ' ' ASP . 21.1 ptmt -123.34 144.44 49.45 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 178.33 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.402 ' HH ' ' CB ' ' A' ' 88' ' ' ALA . 70.1 m-85 -105.79 165.15 11.39 Favored 'General case' 0 C--N 1.289 -2.037 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.067 -177.641 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -75.08 -31.52 61.23 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 114.702 -1.136 . . . . 0.0 108.918 173.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.428 ' O ' ' HB2' ' A' ' 84' ' ' SER . 8.8 t70 -119.88 134.11 55.35 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 -178.31 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -70.62 -20.42 62.74 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 -179.118 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 87.0 mtm180 -67.91 -33.3 74.44 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-O 122.44 1.114 . . . . 0.0 109.239 175.1 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.485 ' OG ' HG22 ' B' ' 226' ' ' ILE . 50.3 m -62.27 -37.13 84.28 Favored 'General case' 0 C--N 1.285 -2.222 0 CA-C-N 114.6 -1.182 . . . . 0.0 112.323 177.016 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.453 ' O ' HG21 ' A' ' 89' ' ' VAL . 78.7 p -65.2 -45.49 84.58 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 120.208 -0.597 . . . . 0.0 110.179 -177.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 5.6 pt -64.72 -38.11 81.84 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.492 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.099 177.222 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.524 HD12 ' HB2' ' B' ' 224' ' ' PHE . 12.0 mt -59.09 -44.69 91.94 Favored 'General case' 0 CA--C 1.502 -0.87 0 CA-C-O 120.944 0.402 . . . . 0.0 111.089 175.472 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.536 ' O ' ' HB2' ' A' ' 92' ' ' LEU . . . -71.4 -40.93 70.22 Favored 'General case' 0 N--CA 1.427 -1.59 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.303 -178.351 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.453 HG21 ' O ' ' A' ' 85' ' ' THR . 86.0 t -62.2 -49.4 84.19 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-O 120.889 0.376 . . . . 0.0 110.671 178.21 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -66.07 -35.75 81.37 Favored 'General case' 0 C--N 1.302 -1.468 0 C-N-CA 123.59 0.756 . . . . 0.0 112.13 -175.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.584 ' HA ' ' OD1' ' B' ' 239' ' ' ASN . 4.8 m-20 -87.74 -29.22 21.23 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -177.361 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.536 ' HB2' ' O ' ' A' ' 88' ' ' ALA . 10.1 mt -97.68 -26.56 14.71 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 112.84 0.682 . . . . 0.0 112.84 -173.648 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -60.38 125.1 22.4 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 109.551 -0.536 . . . . 0.0 109.551 -179.557 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 81.44 -1.12 86.65 Favored Glycine 0 N--CA 1.441 -0.987 0 C-N-CA 120.986 -0.626 . . . . 0.0 113.649 177.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 59.4 t80 -85.67 138.16 32.32 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 117.611 0.706 . . . . 0.0 109.122 -178.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 11.7 mptt -92.47 117.2 29.7 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 -176.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 56.6 mt -126.08 141.99 44.08 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 N-CA-C 105.253 -2.129 . . . . 0.0 105.253 173.019 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 60.58 19.98 55.23 Favored Glycine 0 CA--C 1.525 0.687 0 C-N-CA 121.598 -0.334 . . . . 0.0 113.595 179.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 84.33 10.61 79.74 Favored Glycine 0 N--CA 1.441 -0.989 0 C-N-CA 121.292 -0.48 . . . . 0.0 112.539 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 12.9 ptp180 -135.82 145.9 46.95 Favored 'General case' 0 N--CA 1.439 -0.996 0 O-C-N 122.435 -0.45 . . . . 0.0 111.511 -179.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -84.38 118.07 24.01 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.015 -177.543 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 10.3 mt -65.73 139.28 58.35 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-O 121.653 0.739 . . . . 0.0 112.49 179.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 60.2 tptt -109.98 115.47 29.84 Favored 'General case' 0 N--CA 1.413 -2.275 0 CA-C-N 115.106 -0.952 . . . . 0.0 108.456 178.12 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.468 ' CD1' HG21 ' A' ' 35' ' ' ILE . 5.0 mm -121.34 131.31 73.35 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.898 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 178.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -143.91 155.09 43.95 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 -179.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -83.55 132.08 34.94 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 117.994 0.361 . . . . 0.0 110.716 177.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 5.8 t -153.86 159.78 41.93 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 107.848 -1.168 . . . . 0.0 107.848 -176.304 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -99.71 112.64 24.85 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 169.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 32.3 t80 -105.0 138.29 41.43 Favored 'General case' 0 C--N 1.29 -2.021 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.363 -176.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.423 ' NH1' ' HE2' ' A' ' 32' ' ' TYR . 33.7 mmt180 -117.85 114.5 37.43 Favored Pre-proline 0 C--N 1.309 -1.172 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 176.359 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.414 ' HB3' ' CD1' ' A' ' 61' ' ' ILE . 68.5 Cg_endo -73.67 149.37 43.34 Favored 'Trans proline' 0 C--N 1.325 -0.675 0 C-N-CA 124.07 3.18 . . . . 0.0 114.35 -178.021 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 26.6 tptp -106.15 119.67 39.83 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 173.332 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 37.4 mmt180 . . . . . 0 C--N 1.29 -1.98 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 179.586 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 42.5 t30 . . . . . 0 CA--C 1.533 0.319 0 N-CA-C 111.825 0.305 . . . . 0.0 111.825 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 223' ' ' ARG . . . . . . . . . . . . . 47.7 ttp180 56.81 51.61 10.6 Favored 'General case' 0 CA--C 1.559 1.3 0 N-CA-C 115.175 1.546 . . . . 0.0 115.175 169.421 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 224' ' ' PHE . . . . . 0.524 ' HB2' HD12 ' A' ' 87' ' ' LEU . 8.7 m-85 -96.77 166.97 11.39 Favored 'General case' 0 C--N 1.271 -2.827 0 CA-C-N 115.427 -0.806 . . . . 0.0 108.944 175.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 225' ' ' ALA . . . . . . . . . . . . . . . -115.2 80.05 1.37 Allowed 'General case' 0 C--N 1.31 -1.145 0 CA-C-O 121.608 0.718 . . . . 0.0 110.385 -176.5 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 226' ' ' ILE . . . . . 0.485 HG22 ' OG ' ' A' ' 84' ' ' SER . 4.2 mp -126.11 138.79 53.48 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 177.177 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 227' ' ' MET . . . . . . . . . . . . . 91.1 mtp -67.49 133.16 92.89 Favored Pre-proline 0 C--N 1.312 -1.022 0 O-C-N 123.528 0.518 . . . . 0.0 110.12 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 228' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -68.67 158.78 56.35 Favored 'Trans proline' 0 N--CA 1.452 -0.96 0 C-N-CA 122.761 2.307 . . . . 0.0 112.25 179.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . -75.6 163.55 53.71 Favored Glycine 0 N--CA 1.437 -1.25 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.329 179.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 14.6 m -77.79 -14.36 59.61 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 123.103 0.561 . . . . 0.0 110.974 -178.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 27.9 mmt180 -81.82 0.26 40.18 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 121.461 0.648 . . . . 0.0 109.952 -178.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 232' ' ' TRP . . . . . . . . . . . . . 22.8 t90 -81.82 130.5 35.09 Favored 'General case' 0 N--CA 1.427 -1.593 0 CA-C-O 122.228 1.013 . . . . 0.0 111.441 -177.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 233' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -117.86 147.74 42.78 Favored 'General case' 0 C--N 1.273 -2.758 0 N-CA-C 101.201 -3.629 . . . . 0.0 101.201 171.457 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -46.39 48.74 0.0 OUTLIER Glycine 0 N--CA 1.511 3.679 0 C-N-CA 128.248 2.832 . . . . 0.0 118.213 -175.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 235' ' ' VAL . . . . . . . . . . . . . 51.9 t -88.46 131.89 34.8 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.322 0 C-N-CA 127.996 2.518 . . . . 0.0 106.993 175.111 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 236' ' ' HIS . . . . . . . . . . . . . 81.5 t60 -109.68 108.56 18.99 Favored 'General case' 0 C--N 1.288 -2.074 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 175.253 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 237' ' ' ARG . . . . . 0.429 ' HG2' HG11 ' A' ' 50' ' ' VAL . 6.5 tpp180 -126.0 107.09 10.11 Favored 'General case' 0 C--N 1.288 -2.08 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 -176.646 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 238' ' ' SER . . . . . . . . . . . . . 50.7 p -148.95 154.14 38.97 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.965 -175.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 239' ' ' ASN . . . . . 0.584 ' OD1' ' HA ' ' A' ' 91' ' ' ASN . 8.6 m120 -50.44 -31.19 14.38 Favored 'General case' 0 N--CA 1.503 2.177 0 C-N-CA 123.988 0.915 . . . . 0.0 111.643 177.779 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 240' ' ' GLY . . . . . . . . . . . . . . . 117.66 20.66 4.54 Favored Glycine 0 C--O 1.2 -1.972 0 C-N-CA 120.67 -0.776 . . . . 0.0 111.165 -175.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 26.8 p90 -76.38 -34.55 58.87 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -179.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -63.61 -42.42 98.23 Favored 'General case' 0 C--O 1.219 -0.543 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.843 -174.048 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -61.16 -34.36 74.9 Favored 'General case' 0 CA--C 1.509 -0.623 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.397 178.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -67.15 -47.52 70.8 Favored 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 -179.029 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 245' ' ' TRP . . . . . . . . . . . . . 49.2 m0 -65.3 -40.15 93.43 Favored 'General case' 0 C--O 1.208 -1.089 0 CA-C-N 114.77 -1.105 . . . . 0.0 109.83 179.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 246' ' ' PHE . . . . . 0.468 ' O ' ' HG2' ' B' ' 249' ' ' GLN . 3.1 t80 -66.18 -30.75 71.28 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 124.091 0.956 . . . . 0.0 110.892 179.318 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -78.13 -39.87 39.86 Favored 'General case' 0 C--N 1.294 -1.836 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.24 178.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 248' ' ' LYS . . . . . 0.476 ' HB2' ' HZ2' ' B' ' 248' ' ' LYS . 0.0 OUTLIER -87.89 -11.7 46.92 Favored 'General case' 0 CA--C 1.51 -0.584 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -175.915 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 249' ' ' GLN . . . . . 0.468 ' HG2' ' O ' ' B' ' 246' ' ' PHE . 3.2 pt20 -74.46 2.74 8.84 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.635 -179.234 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 250' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -57.42 -35.89 70.66 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.433 177.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -88.95 107.46 19.03 Favored 'General case' 0 N--CA 1.421 -1.89 0 CA-C-O 122.179 0.99 . . . . 0.0 110.239 177.286 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 252' ' ' ILE . . . . . . . . . . . . . 9.2 pt -116.88 -34.3 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.281 -2.4 0 CA-C-N 114.27 -1.332 . . . . 0.0 110.998 -179.206 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -115.4 -26.44 7.56 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 -178.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 254' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -63.25 148.98 46.67 Favored 'General case' 0 N--CA 1.432 -1.353 0 CA-C-N 114.631 -1.168 . . . . 0.0 110.181 -175.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 255' ' ' LYS . . . . . . . . . . . . . 45.9 mmtm -93.44 142.04 27.78 Favored 'General case' 0 C--N 1.286 -2.184 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.077 -175.013 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 256' ' ' LYS . . . . . . . . . . . . . 11.3 ptpt . . . . . 0 C--N 1.287 -2.123 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.553 -176.547 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 . . . . . 0 CA--C 1.51 -0.58 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 63.2 mm-40 -93.05 -20.13 20.85 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.529 -177.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 63.6 m-85 -94.75 2.77 55.55 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 112.932 0.715 . . . . 0.0 112.932 -171.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.0 mmmp? -133.08 176.08 8.82 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 18.7 p-10 -124.29 6.12 8.43 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 -175.388 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -80.89 27.67 0.38 Allowed 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 -179.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -94.85 -1.89 51.84 Favored 'General case' 0 CA--C 1.509 -0.614 0 O-C-N 121.937 -0.477 . . . . 0.0 111.563 -178.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.417 ' HH ' ' NH1' ' A' ' 110' ' ' ARG . 17.5 m-85 -108.0 145.39 33.98 Favored 'General case' 0 C--N 1.311 -1.088 0 C-N-CA 120.816 -0.354 . . . . 0.0 110.32 -174.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 24.2 pt -142.74 161.97 18.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.984 178.085 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 63.1 t80 -111.55 122.72 48.59 Favored 'General case' 0 N--CA 1.42 -1.975 0 C-N-CA 124.655 1.182 . . . . 0.0 108.485 178.522 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.447 HG21 ' CD1' ' A' ' 104' ' ' ILE . 9.9 mt -108.85 128.32 64.74 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.933 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 175.018 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -130.15 168.74 21.34 Favored Glycine 0 C--N 1.288 -2.112 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 -179.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 72.75 27.46 2.23 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 124.766 1.226 . . . . 0.0 110.788 -177.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -62.84 143.2 57.8 Favored 'General case' 0 CA--C 1.499 -0.993 0 CA-C-O 121.407 0.622 . . . . 0.0 112.474 179.541 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.43 ' HB3' ' HG ' ' A' ' 42' ' ' LEU . 47.5 t-20 -85.38 147.11 26.67 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 175.707 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.02 -17.3 56.83 Favored 'General case' 0 C--N 1.299 -1.592 0 C-N-CA 123.949 0.9 . . . . 0.0 112.899 178.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -98.88 0.52 44.34 Favored 'General case' 0 C--O 1.244 0.768 0 CA-C-O 121.035 0.445 . . . . 0.0 111.253 -179.475 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.43 ' HG ' ' HB3' ' A' ' 39' ' ' ASN . 77.5 mt -90.68 120.35 31.67 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-O 121.637 0.732 . . . . 0.0 110.062 179.128 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 72.1 p -102.95 173.22 6.41 Favored 'General case' 0 C--N 1.29 -2.005 0 CA-C-N 114.382 -1.281 . . . . 0.0 108.973 -177.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -56.13 -39.07 71.69 Favored 'General case' 0 C--O 1.209 -1.057 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 175.431 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -59.25 -40.07 95.39 Favored Glycine 0 N--CA 1.444 -0.827 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.948 -178.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -67.04 -49.14 66.17 Favored 'General case' 0 CA--C 1.496 -1.109 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 48.4 mt -58.45 -46.44 89.55 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.762 0 CA-C-N 114.866 -1.061 . . . . 0.0 110.304 179.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 44.4 mt -59.71 -45.5 91.95 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.843 -178.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 98.2 m -62.63 -45.46 92.73 Favored 'General case' 0 N--CA 1.442 -0.869 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 179.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.486 HG11 ' HG3' ' B' ' 237' ' ' ARG . 91.3 t -65.89 -47.91 83.83 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.192 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.505 -178.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -66.45 -24.44 66.44 Favored 'General case' 0 N--CA 1.428 -1.564 0 CA-C-N 115.412 -0.813 . . . . 0.0 112.354 -178.27 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.499 ' OG ' ' HB2' ' B' ' 231' ' ' ARG . 62.3 m -68.09 -18.07 64.56 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 176.724 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -69.92 -26.78 64.31 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 119.546 -0.862 . . . . 0.0 109.226 176.165 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 -89.61 -23.26 21.98 Favored 'General case' 0 CA--C 1.505 -0.774 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.845 -175.032 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.419 ' O ' ' HA ' ' A' ' 52' ' ' SER . . . 170.41 -155.74 25.58 Favored Glycine 0 N--CA 1.418 -2.558 0 N-CA-C 110.577 -1.009 . . . . 0.0 110.577 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 49.0 t -104.46 105.57 50.47 Favored Pre-proline 0 C--N 1.289 -2.04 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 -177.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.449 ' HB3' HD22 ' A' ' 77' ' ' LEU . 64.0 Cg_endo -74.74 136.4 20.93 Favored 'Trans proline' 0 N--CA 1.447 -1.263 0 C-N-CA 121.793 1.662 . . . . 0.0 109.522 175.495 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 26.8 m -111.66 -25.54 3.47 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 C-N-CA 120.354 -0.538 . . . . 0.0 111.693 -178.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.457 ' HB3' ' HG2' ' A' ' 78' ' ' LYS . 27.9 t70 -152.92 145.38 24.11 Favored 'General case' 0 CA--C 1.491 -1.295 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 14.6 p -145.96 135.47 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.799 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 179.321 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 92.7 mt -120.51 123.91 71.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 175.607 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -97.11 114.52 26.19 Favored 'General case' 0 N--CA 1.422 -1.844 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 176.46 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 9.2 m -75.25 117.85 17.52 Favored 'General case' 0 C--N 1.276 -2.594 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 178.244 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 25.9 mtp180 -128.26 146.45 50.74 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-O 120.991 0.424 . . . . 0.0 110.991 -176.143 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -95.2 113.87 25.6 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.178 177.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -62.1 -21.12 64.73 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 -177.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 22.6 m-80 -78.1 -44.14 27.01 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.345 0.593 . . . . 0.0 109.813 -176.414 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 44.8 p -90.35 -24.12 20.91 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-O 121.444 0.64 . . . . 0.0 111.236 -179.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 80.86 10.21 85.36 Favored Glycine 0 N--CA 1.442 -0.914 0 CA-C-N 115.978 -0.555 . . . . 0.0 112.354 178.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -114.99 -177.33 3.1 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 -178.27 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 25.1 m -71.92 154.31 41.29 Favored 'General case' 0 N--CA 1.424 -1.731 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.557 175.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 12.4 mm-40 -83.3 1.91 38.71 Favored 'General case' 0 C--N 1.307 -1.258 0 C-N-CA 122.95 0.5 . . . . 0.0 111.794 178.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 85.81 6.74 82.29 Favored Glycine 0 N--CA 1.427 -1.939 0 C-N-CA 120.951 -0.643 . . . . 0.0 112.11 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -148.03 156.87 43.12 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 178.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -154.5 171.79 18.83 Favored 'General case' 0 C--N 1.307 -1.252 0 O-C-N 123.741 0.651 . . . . 0.0 110.295 178.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -128.33 140.94 51.6 Favored 'General case' 0 C--N 1.31 -1.125 0 C-N-CA 123.71 0.804 . . . . 0.0 110.222 -178.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.449 HD22 ' HB3' ' A' ' 57' ' ' PRO . 9.8 tt -147.06 140.72 25.68 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 175.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.457 ' HG2' ' HB3' ' A' ' 59' ' ' ASP . 21.6 ptmt -123.93 144.84 49.54 Favored 'General case' 0 C--O 1.259 1.59 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 178.645 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 59.0 m-85 -106.78 164.59 11.98 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-O 121.39 0.614 . . . . 0.0 112.232 -178.284 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -71.98 -34.3 68.83 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 114.053 -1.431 . . . . 0.0 109.093 175.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -124.65 135.01 52.71 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.403 -179.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -70.55 -20.09 62.83 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 114.316 1.228 . . . . 0.0 114.316 -177.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 87.5 mtm180 -61.27 -33.92 74.34 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 122.378 1.085 . . . . 0.0 109.475 173.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 50.6 m -66.02 -36.6 83.7 Favored 'General case' 0 C--N 1.288 -2.068 0 CA-C-N 114.777 -1.101 . . . . 0.0 112.662 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 71.3 p -63.46 -45.09 92.4 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 120.34 -0.544 . . . . 0.0 110.995 -177.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 3.9 pt -65.63 -38.54 82.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.048 177.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.452 HD22 ' HB2' ' B' ' 224' ' ' PHE . 16.1 mt -59.34 -43.74 92.73 Favored 'General case' 0 CA--C 1.502 -0.878 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.439 175.4 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.51 ' O ' ' HB2' ' A' ' 92' ' ' LEU . . . -69.93 -44.97 68.5 Favored 'General case' 0 N--CA 1.425 -1.678 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.648 -178.648 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 71.2 t -59.69 -44.27 93.24 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.898 0 CA-C-O 121.189 0.519 . . . . 0.0 111.229 177.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -63.15 -39.1 93.7 Favored 'General case' 0 C--N 1.291 -1.94 0 C-N-CA 124.095 0.958 . . . . 0.0 112.612 -177.403 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 50.8 t-20 -93.44 -33.27 13.89 Favored 'General case' 0 C--N 1.292 -1.924 0 CA-C-O 121.196 0.522 . . . . 0.0 111.355 -175.01 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.51 ' HB2' ' O ' ' A' ' 88' ' ' ALA . 12.9 mt -88.37 -28.13 21.17 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 112.597 0.591 . . . . 0.0 112.597 -171.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -64.26 123.83 20.14 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 81.89 -0.57 88.25 Favored Glycine 0 CA--C 1.535 1.321 0 C-N-CA 120.979 -0.629 . . . . 0.0 113.763 179.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -85.11 141.76 30.0 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -179.091 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.56 119.74 34.59 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 112.832 0.678 . . . . 0.0 112.832 -176.34 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 52.2 mt -127.56 141.25 46.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 N-CA-C 105.415 -2.069 . . . . 0.0 105.415 172.107 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 61.22 20.74 58.72 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 121.135 -0.555 . . . . 0.0 113.567 179.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 82.1 10.05 84.37 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 121.159 -0.543 . . . . 0.0 112.835 -178.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 12.7 ptp180 -134.81 143.68 47.2 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 117.128 0.464 . . . . 0.0 111.564 -179.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -81.33 121.16 25.86 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.508 -179.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 10.5 mt -70.03 138.7 52.37 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 179.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 24.2 tptm -106.4 116.2 31.51 Favored 'General case' 0 N--CA 1.415 -2.193 0 CA-C-N 115.181 -0.918 . . . . 0.0 108.575 177.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.447 ' CD1' HG21 ' A' ' 35' ' ' ILE . 5.8 mm -118.76 135.9 57.68 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.096 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 177.686 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -143.48 152.96 42.13 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 -178.105 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 47.3 m-70 -84.16 135.01 34.55 Favored 'General case' 0 C--N 1.289 -2.055 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 176.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 5.9 t -154.49 163.49 40.12 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 106.024 -1.843 . . . . 0.0 106.024 -178.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -110.16 110.61 21.52 Favored 'General case' 0 N--CA 1.422 -1.829 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 171.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 26.5 t80 -106.96 140.72 39.32 Favored 'General case' 0 C--N 1.285 -2.213 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 -179.186 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.417 ' NH1' ' HH ' ' A' ' 32' ' ' TYR . 10.8 mmm180 -120.26 115.54 32.8 Favored Pre-proline 0 C--N 1.297 -1.715 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 175.253 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -64.26 136.54 51.93 Favored 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 122.484 2.123 . . . . 0.0 112.837 -179.316 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 26.5 tptp -113.64 123.72 50.61 Favored 'General case' 0 N--CA 1.421 -1.876 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 175.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 34.0 mmt180 . . . . . 0 C--N 1.283 -2.3 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 178.717 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 . . . . . 0 N--CA 1.477 0.908 0 N-CA-C 111.368 0.136 . . . . 0.0 111.368 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 223' ' ' ARG . . . . . . . . . . . . . 9.7 ptm180 53.74 43.54 30.9 Favored 'General case' 0 N--CA 1.504 2.24 0 C-N-CA 126.68 1.992 . . . . 0.0 116.292 173.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 224' ' ' PHE . . . . . 0.452 ' HB2' HD22 ' A' ' 87' ' ' LEU . 32.8 m-85 -99.66 165.13 11.76 Favored 'General case' 0 C--N 1.28 -2.418 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 173.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 225' ' ' ALA . . . . . . . . . . . . . . . -127.05 84.74 2.29 Favored 'General case' 0 C--N 1.297 -1.698 0 CA-C-O 121.412 0.625 . . . . 0.0 110.274 -179.342 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 4.2 mp -126.02 132.07 71.02 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 176.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 227' ' ' MET . . . . . . . . . . . . . 93.1 mmm -72.35 137.92 81.18 Favored Pre-proline 0 C--N 1.317 -0.833 0 O-C-N 123.621 0.576 . . . . 0.0 110.337 178.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 228' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -63.16 160.81 32.78 Favored 'Trans proline' 0 CA--C 1.536 0.623 0 C-N-CA 123.752 2.968 . . . . 0.0 114.615 -174.28 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . -80.1 171.11 54.23 Favored Glycine 0 N--CA 1.442 -0.938 0 CA-C-N 115.077 -0.965 . . . . 0.0 113.438 -178.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 7.9 m -72.15 -15.7 61.97 Favored 'General case' 0 C--N 1.307 -1.261 0 C-N-CA 124.318 1.047 . . . . 0.0 111.772 -175.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 231' ' ' ARG . . . . . 0.499 ' HB2' ' OG ' ' A' ' 52' ' ' SER . 9.9 mmm180 -93.34 -0.03 56.76 Favored 'General case' 0 C--N 1.313 -1.007 0 O-C-N 122.175 -0.328 . . . . 0.0 110.946 -174.56 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 232' ' ' TRP . . . . . . . . . . . . . 21.2 t90 -75.15 127.41 33.14 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-O 122.655 1.216 . . . . 0.0 112.419 -176.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 233' ' ' ASP . . . . . 0.447 ' O ' ' N ' ' B' ' 235' ' ' VAL . 22.3 t70 -123.95 144.17 49.95 Favored 'General case' 0 C--N 1.263 -3.161 0 N-CA-C 102.424 -3.176 . . . . 0.0 102.424 174.444 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -42.12 63.74 0.0 OUTLIER Glycine 0 N--CA 1.49 2.276 0 C-N-CA 128.415 2.912 . . . . 0.0 116.375 -178.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 235' ' ' VAL . . . . . 0.447 ' N ' ' O ' ' B' ' 233' ' ' ASP . 55.5 t -110.64 127.99 67.29 Favored 'Isoleucine or valine' 0 C--N 1.247 -3.868 0 C-N-CA 127.627 2.371 . . . . 0.0 107.099 176.623 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 236' ' ' HIS . . . . . . . . . . . . . 33.2 t-80 -109.34 117.93 35.34 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 -176.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 237' ' ' ARG . . . . . 0.486 ' HG3' HG11 ' A' ' 50' ' ' VAL . 33.8 mmt180 -114.08 110.38 19.93 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 177.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 238' ' ' SER . . . . . . . . . . . . . 20.9 t -125.11 116.7 22.49 Favored 'General case' 0 C--N 1.29 -1.993 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.196 -178.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 239' ' ' ASN . . . . . . . . . . . . . 28.1 p-10 -82.36 16.58 2.0 Allowed 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.42 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 240' ' ' GLY . . . . . 0.433 ' O ' ' HG2' ' B' ' 244' ' ' LYS . . . -85.06 53.75 4.84 Favored Glycine 0 N--CA 1.426 -1.98 0 N-CA-C 110.204 -1.158 . . . . 0.0 110.204 177.024 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 37.8 p90 -75.18 -33.72 61.48 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -176.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -61.57 -45.33 94.6 Favored 'General case' 0 CA--C 1.507 -0.703 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.52 -178.033 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -62.28 -34.31 76.32 Favored 'General case' 0 C--O 1.212 -0.892 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.266 -179.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 244' ' ' LYS . . . . . 0.433 ' HG2' ' O ' ' B' ' 240' ' ' GLY . 71.6 mmtt -64.87 -47.79 76.59 Favored 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 -179.028 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 245' ' ' TRP . . . . . . . . . . . . . 37.8 m0 -66.14 -37.28 85.3 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.677 178.079 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 246' ' ' PHE . . . . . 0.551 ' O ' ' HG2' ' B' ' 249' ' ' GLN . 2.5 t80 -66.89 -30.36 70.5 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.809 176.612 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -77.7 -40.02 42.74 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.954 179.379 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.36 -19.26 43.09 Favored 'General case' 0 CA--C 1.506 -0.718 0 CA-C-O 120.84 0.352 . . . . 0.0 111.678 -175.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 249' ' ' GLN . . . . . 0.551 ' HG2' ' O ' ' B' ' 246' ' ' PHE . 3.0 pt20 -70.44 -0.56 8.58 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.739 -178.268 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 250' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -57.78 -32.18 67.27 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.992 177.2 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -89.83 106.56 18.55 Favored 'General case' 0 N--CA 1.428 -1.542 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 176.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 252' ' ' ILE . . . . . . . . . . . . . 37.9 pt -92.8 -33.93 5.69 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.851 0 CA-C-N 115.028 -0.987 . . . . 0.0 112.316 -174.004 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -89.26 -11.45 43.53 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-O 121.349 0.595 . . . . 0.0 110.745 -176.123 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 254' ' ' GLU . . . . . 0.429 ' OE1' ' HG2' ' B' ' 255' ' ' LYS . 0.2 OUTLIER -100.14 155.08 17.94 Favored 'General case' 0 C--N 1.287 -2.126 0 CA-C-N 114.971 -1.013 . . . . 0.0 111.16 -177.024 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 255' ' ' LYS . . . . . 0.429 ' HG2' ' OE1' ' B' ' 254' ' ' GLU . 0.1 OUTLIER -102.39 34.42 2.77 Favored 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 124.563 1.145 . . . . 0.0 111.548 -174.285 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 256' ' ' LYS . . . . . . . . . . . . . 44.0 mmtm . . . . . 0 C--N 1.311 -1.109 0 O-C-N 124.24 0.963 . . . . 0.0 111.976 179.302 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 . . . . . 0 CA--C 1.505 -0.785 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.501 ' HB2' ' CD1' ' A' ' 27' ' ' TYR . 2.4 mp0 -83.11 -44.28 15.3 Favored 'General case' 0 N--CA 1.414 -2.247 0 CA-C-O 121.782 0.801 . . . . 0.0 110.898 -176.302 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.501 ' CD1' ' HB2' ' A' ' 26' ' ' GLU . 88.7 m-85 -91.6 27.57 1.98 Allowed 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 114.737 -1.119 . . . . 0.0 113.229 -168.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -131.45 167.94 18.48 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 175.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.471 ' C ' ' H ' ' A' ' 31' ' ' ALA . 22.4 m-20 -125.39 21.2 7.94 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-O 121.567 0.698 . . . . 0.0 110.109 -178.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -77.2 15.34 0.74 Allowed 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.852 179.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.471 ' H ' ' C ' ' A' ' 29' ' ' ASP . . . -86.04 -15.38 41.52 Favored 'General case' 0 N--CA 1.44 -0.953 0 C-N-CA 123.886 0.875 . . . . 0.0 110.46 -179.657 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 16.3 m-85 -99.72 145.18 27.95 Favored 'General case' 0 N--CA 1.433 -1.283 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 -177.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 24.7 pt -140.1 156.44 24.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 CA-C-O 121.157 0.504 . . . . 0.0 110.636 175.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 49.0 t80 -106.87 123.73 48.58 Favored 'General case' 0 N--CA 1.408 -2.564 0 CA-C-N 114.396 -1.275 . . . . 0.0 107.607 177.168 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.407 HG21 ' CD1' ' A' ' 104' ' ' ILE . 8.3 mt -107.89 127.57 63.88 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.55 0 N-CA-C 105.831 -1.915 . . . . 0.0 105.831 175.224 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -126.61 164.06 20.31 Favored Glycine 0 C--N 1.272 -2.975 0 N-CA-C 110.612 -0.995 . . . . 0.0 110.612 -179.076 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 70.94 39.9 0.97 Allowed 'General case' 0 CA--C 1.506 -0.74 0 C-N-CA 124.18 0.992 . . . . 0.0 110.715 -177.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.4 HD21 ' HA ' ' A' ' 74' ' ' PHE . 4.4 mm? -73.44 151.81 40.98 Favored 'General case' 0 CA--C 1.497 -1.07 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.867 176.007 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.45 ' HB3' ' HG ' ' A' ' 42' ' ' LEU . 50.2 t-20 -96.14 147.98 23.17 Favored 'General case' 0 C--N 1.286 -2.188 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 177.657 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.403 HH11 ' HD3' ' A' ' 40' ' ' ARG . 0.3 OUTLIER -63.39 -19.41 64.65 Favored 'General case' 0 C--N 1.298 -1.672 0 C-N-CA 123.326 0.651 . . . . 0.0 111.985 179.944 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.427 ' HG2' ' CG ' ' A' ' 39' ' ' ASN . 12.9 pt-20 -91.93 -3.54 55.81 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.903 -179.179 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.45 ' HG ' ' HB3' ' A' ' 39' ' ' ASN . 78.3 mt -91.09 124.03 35.0 Favored 'General case' 0 CA--C 1.504 -0.818 0 CA-C-O 121.117 0.485 . . . . 0.0 110.285 -179.63 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 67.2 p -109.72 173.78 6.17 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 114.705 -1.134 . . . . 0.0 109.409 -178.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.517 ' CG ' ' HB2' ' A' ' 62' ' ' LEU . 51.9 mt-10 -55.66 -38.91 70.2 Favored 'General case' 0 C--N 1.328 -0.333 0 O-C-N 123.47 0.481 . . . . 0.0 110.293 178.354 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -59.96 -43.11 98.43 Favored Glycine 0 C--O 1.24 0.483 0 CA-C-N 115.928 -0.578 . . . . 0.0 113.105 179.266 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -61.68 -49.17 77.57 Favored 'General case' 0 CA--C 1.499 -0.981 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 41.7 mt -60.86 -46.07 96.97 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.931 0 CA-C-N 114.833 -1.076 . . . . 0.0 110.63 -179.529 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 36.1 mt -60.07 -45.73 91.91 Favored 'General case' 0 CA--C 1.491 -1.293 0 C-N-CA 122.511 0.325 . . . . 0.0 111.81 -176.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 97.5 m -62.88 -45.32 93.1 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 123.39 0.431 . . . . 0.0 111.751 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 76.6 t -67.28 -45.51 85.94 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.92 -179.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -66.96 -22.8 65.91 Favored 'General case' 0 N--CA 1.435 -1.184 0 C-N-CA 123.483 0.713 . . . . 0.0 111.941 -179.355 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.597 ' OG ' ' HB2' ' B' ' 231' ' ' ARG . 73.2 m -71.73 -16.54 62.22 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 116.177 -0.465 . . . . 0.0 112.141 176.139 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -73.53 -20.75 60.57 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 175.319 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.442 ' CE1' ' HB2' ' A' ' 91' ' ' ASN . 68.3 m-85 -97.76 -5.1 35.71 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-N 115.898 -0.592 . . . . 0.0 112.315 -176.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 151.7 -153.65 25.07 Favored Glycine 0 N--CA 1.423 -2.2 0 C-N-CA 120.511 -0.852 . . . . 0.0 111.317 179.212 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 99.5 t -106.61 104.51 51.26 Favored Pre-proline 0 C--N 1.305 -1.364 0 CA-C-O 120.469 0.176 . . . . 0.0 111.28 -177.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.411 ' HB3' HD22 ' A' ' 77' ' ' LEU . 87.8 Cg_endo -76.8 140.09 20.4 Favored 'Trans proline' 0 C--O 1.24 0.61 0 C-N-CA 123.011 2.474 . . . . 0.0 110.141 175.342 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 34.1 m -117.78 -26.04 2.77 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 C-N-CA 119.815 -0.754 . . . . 0.0 111.84 -179.35 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.518 ' HB3' ' HG2' ' A' ' 78' ' ' LYS . 30.5 t70 -149.52 136.48 19.65 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 -173.434 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 14.3 p -145.96 134.1 16.05 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.051 0 O-C-N 123.548 0.53 . . . . 0.0 110.165 -178.361 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 97.3 mt -121.37 120.15 61.12 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 175.173 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.517 ' HB2' ' CG ' ' A' ' 44' ' ' GLU . 0.1 OUTLIER -91.43 115.56 28.14 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 105.957 -1.868 . . . . 0.0 105.957 173.409 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 13.2 m -72.62 116.68 13.38 Favored 'General case' 0 N--CA 1.411 -2.379 0 N-CA-C 107.535 -1.284 . . . . 0.0 107.535 177.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 75.8 mtm180 -134.04 145.81 49.77 Favored 'General case' 0 C--N 1.287 -2.133 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 -174.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -87.61 119.26 27.73 Favored 'General case' 0 C--N 1.29 -1.989 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 177.245 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -60.2 -24.43 64.8 Favored 'General case' 0 C--N 1.311 -1.085 0 C-N-CA 123.432 0.693 . . . . 0.0 112.463 -176.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 35.5 m-80 -79.43 -50.4 10.86 Favored 'General case' 0 CA--C 1.507 -0.702 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.877 -175.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 50.3 p -87.1 -23.34 24.93 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-O 121.369 0.604 . . . . 0.0 111.632 -176.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 79.8 1.59 87.29 Favored Glycine 0 N--CA 1.439 -1.149 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.273 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -98.06 169.61 9.5 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-O 121.195 0.521 . . . . 0.0 109.873 -177.052 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 17.6 m -74.53 141.16 44.86 Favored 'General case' 0 C--N 1.294 -1.821 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.24 178.18 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 15.6 mm-40 -70.71 -17.0 62.83 Favored 'General case' 0 C--N 1.317 -0.831 0 C-N-CA 123.346 0.658 . . . . 0.0 112.154 -179.201 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 102.35 8.59 43.54 Favored Glycine 0 N--CA 1.431 -1.644 0 C-N-CA 120.27 -0.967 . . . . 0.0 111.636 179.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.4 ' HA ' HD21 ' A' ' 38' ' ' LEU . 34.9 p90 -148.78 159.86 43.75 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 177.044 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -156.07 172.73 17.9 Favored 'General case' 0 C--N 1.308 -1.231 0 O-C-N 123.581 0.551 . . . . 0.0 110.561 178.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -130.22 141.37 50.64 Favored 'General case' 0 C--N 1.308 -1.235 0 C-N-CA 123.723 0.809 . . . . 0.0 110.089 -179.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.411 HD22 ' HB3' ' A' ' 57' ' ' PRO . 9.4 tt -149.21 140.85 23.48 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 175.104 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.518 ' HG2' ' HB3' ' A' ' 59' ' ' ASP . 16.5 ptmt -125.93 144.28 50.75 Favored 'General case' 0 N--CA 1.431 -1.425 0 CA-C-O 121.421 0.629 . . . . 0.0 109.821 176.51 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.419 ' HH ' ' CB ' ' A' ' 88' ' ' ALA . 32.6 m-85 -102.6 165.08 11.28 Favored 'General case' 0 C--N 1.283 -2.291 0 CA-C-N 115.164 -0.926 . . . . 0.0 109.362 179.518 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -76.95 -21.49 54.7 Favored 'General case' 0 N--CA 1.428 -1.563 0 C-N-CA 119.997 -0.681 . . . . 0.0 110.07 174.052 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -123.59 132.56 53.91 Favored 'General case' 0 N--CA 1.443 -0.815 0 C-N-CA 120.424 -0.51 . . . . 0.0 110.399 179.164 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -70.47 -19.87 62.91 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 -179.318 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 86.5 mtm180 -66.11 -33.66 76.29 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-O 122.166 0.984 . . . . 0.0 108.978 174.093 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 48.7 m -67.97 -36.98 80.98 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-N 114.86 -1.063 . . . . 0.0 112.208 177.531 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.458 ' O ' HG21 ' A' ' 89' ' ' VAL . 73.1 p -64.96 -45.3 86.27 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 120.244 -0.583 . . . . 0.0 110.9 -177.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 7.1 pt -63.25 -38.69 82.79 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.466 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.161 177.178 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.6 mt -59.23 -43.83 92.35 Favored 'General case' 0 CA--C 1.502 -0.893 0 O-C-N 123.785 0.678 . . . . 0.0 111.423 177.267 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.446 ' O ' ' HB2' ' A' ' 92' ' ' LEU . . . -69.09 -46.53 67.53 Favored 'General case' 0 N--CA 1.424 -1.728 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.745 -179.418 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.458 HG21 ' O ' ' A' ' 85' ' ' THR . 92.7 t -56.64 -46.39 82.81 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.745 0 CA-C-O 121.648 0.737 . . . . 0.0 110.569 178.136 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -58.87 -40.14 83.44 Favored 'General case' 0 C--N 1.292 -1.926 0 C-N-CA 125.843 1.657 . . . . 0.0 112.329 -175.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.442 ' HB2' ' CE1' ' A' ' 54' ' ' TYR . 47.0 m-80 -98.46 -27.88 13.86 Favored 'General case' 0 C--N 1.294 -1.846 0 N-CA-C 113.129 0.788 . . . . 0.0 113.129 -175.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.446 ' HB2' ' O ' ' A' ' 88' ' ' ALA . 15.5 mt -90.07 -30.73 17.51 Favored 'General case' 0 CA--C 1.471 -2.091 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.706 -171.796 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -65.98 124.74 23.35 Favored 'General case' 0 N--CA 1.425 -1.685 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 88.75 -5.48 84.57 Favored Glycine 0 C--N 1.308 -1.003 0 C-N-CA 121.167 -0.539 . . . . 0.0 112.65 -178.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 53.6 t80 -88.69 139.75 30.15 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 -179.041 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 12.3 mptt -95.87 118.18 32.01 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-O 120.92 0.391 . . . . 0.0 111.649 -176.292 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 53.0 mt -121.33 140.73 44.52 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 173.081 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 57.22 27.22 57.43 Favored Glycine 0 C--O 1.22 -0.756 0 C-N-CA 121.327 -0.463 . . . . 0.0 112.567 -179.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 88.07 -5.81 84.34 Favored Glycine 0 CA--C 1.536 1.376 0 N-CA-C 114.541 0.577 . . . . 0.0 114.541 179.028 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 16.8 ptp180 -126.34 149.89 48.89 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 118.16 0.98 . . . . 0.0 111.901 -177.039 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -84.84 116.8 23.5 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.525 -175.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 12.9 mt -66.51 141.4 57.89 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-O 121.76 0.791 . . . . 0.0 112.797 178.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 4.3 tppp? -117.2 116.59 27.58 Favored 'General case' 0 N--CA 1.411 -2.419 0 CA-C-N 114.67 -1.15 . . . . 0.0 108.123 176.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.407 ' CD1' HG21 ' A' ' 35' ' ' ILE . 4.1 mm -115.64 133.64 61.36 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.931 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 -179.69 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -143.6 150.89 39.47 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 -179.405 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 41.7 m-70 -79.42 131.63 36.14 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-O 121.132 0.492 . . . . 0.0 110.33 177.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 15.1 t -143.77 156.38 44.48 Favored 'General case' 0 C--N 1.288 -2.068 0 N-CA-C 106.072 -1.825 . . . . 0.0 106.072 -179.445 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 30.3 p90 -101.13 109.17 21.02 Favored 'General case' 0 N--CA 1.42 -1.944 0 C-N-CA 117.173 -1.811 . . . . 0.0 107.08 169.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 42.8 t80 -108.19 144.5 35.53 Favored 'General case' 0 C--N 1.29 -2.008 0 CA-C-N 114.87 -1.059 . . . . 0.0 108.647 -178.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.42 ' HA ' ' HD2' ' A' ' 111' ' ' PRO . 39.8 mmt180 -120.34 113.32 33.84 Favored Pre-proline 0 C--N 1.298 -1.645 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 173.783 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.42 ' HD2' ' HA ' ' A' ' 110' ' ' ARG . 55.3 Cg_endo -69.33 146.54 63.17 Favored 'Trans proline' 0 C--N 1.326 -0.644 0 C-N-CA 124.07 3.18 . . . . 0.0 114.6 -179.822 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.486 ' C ' ' HD3' ' A' ' 112' ' ' LYS . 10.9 tmtt? -120.62 125.5 47.91 Favored 'General case' 0 N--CA 1.426 -1.639 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 173.474 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 39.7 mmt180 . . . . . 0 C--N 1.305 -1.36 0 CA-C-O 118.947 -0.549 . . . . 0.0 110.303 177.755 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 6.7 m120 . . . . . 0 CA--C 1.502 -0.873 0 CA-C-O 119.59 -0.243 . . . . 0.0 110.637 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 223' ' ' ARG . . . . . . . . . . . . . 11.5 ptm180 57.56 34.03 24.03 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 126.457 1.903 . . . . 0.0 114.641 178.44 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 224' ' ' PHE . . . . . . . . . . . . . 44.9 m-85 -96.74 165.25 12.22 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 175.491 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 225' ' ' ALA . . . . . . . . . . . . . . . -117.79 21.68 12.76 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 112.851 0.685 . . . . 0.0 112.851 -173.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 4.6 mp -75.18 130.86 35.84 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 C-N-CA 120.031 -0.668 . . . . 0.0 110.022 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 227' ' ' MET . . . . . . . . . . . . . 26.3 ptm -71.56 151.72 93.77 Favored Pre-proline 0 C--N 1.318 -0.778 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.387 178.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 228' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -70.94 157.28 58.53 Favored 'Trans proline' 0 C--O 1.245 0.865 0 C-N-CA 123.225 2.617 . . . . 0.0 112.991 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . -84.37 173.44 49.85 Favored Glycine 0 C--N 1.317 -0.51 0 CA-C-N 115.704 -0.68 . . . . 0.0 113.089 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 24.8 m -77.71 -14.3 59.65 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -175.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 231' ' ' ARG . . . . . 0.597 ' HB2' ' OG ' ' A' ' 52' ' ' SER . 3.1 mmp_? -80.16 -7.15 58.8 Favored 'General case' 0 C--N 1.326 -0.43 0 O-C-N 121.964 -0.46 . . . . 0.0 110.365 177.657 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 232' ' ' TRP . . . . . . . . . . . . . 22.8 t90 -73.1 127.17 31.8 Favored 'General case' 0 CA--C 1.5 -0.966 0 CA-C-O 122.355 1.074 . . . . 0.0 111.819 -178.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 233' ' ' ASP . . . . . 0.431 ' O ' ' N ' ' B' ' 235' ' ' VAL . 26.9 t70 -123.23 146.47 47.81 Favored 'General case' 0 C--N 1.269 -2.92 0 N-CA-C 102.436 -3.172 . . . . 0.0 102.436 173.511 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -41.59 65.86 0.0 OUTLIER Glycine 0 N--CA 1.48 1.611 0 C-N-CA 128.101 2.763 . . . . 0.0 116.129 -179.472 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 235' ' ' VAL . . . . . 0.431 ' N ' ' O ' ' B' ' 233' ' ' ASP . 53.7 t -111.16 132.27 60.12 Favored 'Isoleucine or valine' 0 C--N 1.253 -3.597 0 C-N-CA 128.107 2.563 . . . . 0.0 106.279 174.412 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 236' ' ' HIS . . . . . . . . . . . . . 58.0 t-80 -112.68 120.69 42.4 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 237' ' ' ARG . . . . . . . . . . . . . 6.7 mmp_? -112.68 144.71 41.73 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 174.059 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 238' ' ' SER . . . . . . . . . . . . . 26.6 t -146.26 131.15 18.12 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 174.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 239' ' ' ASN . . . . . 0.431 ' HB3' ' HA ' ' A' ' 91' ' ' ASN . 28.1 p-10 -72.01 92.73 1.32 Allowed 'General case' 0 CA--C 1.512 -0.514 0 CA-C-O 122.153 0.977 . . . . 0.0 110.77 -179.743 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 240' ' ' GLY . . . . . 0.42 ' O ' ' HG2' ' B' ' 244' ' ' LYS . . . 78.23 81.7 0.66 Allowed Glycine 0 N--CA 1.412 -2.93 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -176.072 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 10.0 p90 -75.42 -32.85 60.84 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 178.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -60.5 -42.38 96.24 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.148 0.499 . . . . 0.0 110.285 -179.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -64.79 -35.42 81.03 Favored 'General case' 0 C--O 1.202 -1.439 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.677 179.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 244' ' ' LYS . . . . . 0.42 ' HG2' ' O ' ' B' ' 240' ' ' GLY . 39.6 mmtm -60.78 -47.46 86.23 Favored 'General case' 0 C--O 1.242 0.665 0 CA-C-O 121.29 0.567 . . . . 0.0 109.865 -178.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 245' ' ' TRP . . . . . . . . . . . . . 19.4 m0 -63.55 -41.05 98.45 Favored 'General case' 0 N--CA 1.437 -1.096 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.225 179.174 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 246' ' ' PHE . . . . . 0.464 ' HA ' ' HG2' ' B' ' 249' ' ' GLN . 3.6 t80 -68.14 -34.35 76.19 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.348 179.271 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -70.19 -35.35 73.89 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.699 -178.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.41 -21.73 22.89 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 120.357 -0.537 . . . . 0.0 111.789 -178.18 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 249' ' ' GLN . . . . . 0.464 ' HG2' ' HA ' ' B' ' 246' ' ' PHE . 3.5 pt20 -78.31 2.24 19.17 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.386 0.612 . . . . 0.0 110.402 -179.494 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 250' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -57.28 -31.93 66.1 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 114.892 -1.049 . . . . 0.0 112.864 178.917 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -77.18 142.66 39.53 Favored 'General case' 0 N--CA 1.433 -1.28 0 CA-C-O 121.986 0.898 . . . . 0.0 113.292 -176.768 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 252' ' ' ILE . . . . . . . . . . . . . 34.3 pt -130.67 -32.01 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 CA-C-N 114.487 -1.233 . . . . 0.0 113.078 -171.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -110.79 -23.05 11.25 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 121.624 0.726 . . . . 0.0 110.296 -175.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 254' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -72.21 166.06 23.16 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-N 114.038 -1.437 . . . . 0.0 114.117 -173.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 255' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -81.01 122.37 27.21 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 114.574 -1.194 . . . . 0.0 109.655 -176.233 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 256' ' ' LYS . . . . . . . . . . . . . 52.6 mttm . . . . . 0 C--N 1.295 -1.79 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 -177.821 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 15.3 m120 . . . . . 0 CA--C 1.499 -1.008 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -70.4 -27.15 64.07 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.63 0.729 . . . . 0.0 110.2 -179.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 49.7 m-85 -81.99 13.75 3.17 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 114.999 -1.0 . . . . 0.0 111.776 -177.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -138.75 152.24 47.78 Favored 'General case' 0 N--CA 1.425 -1.686 0 N-CA-C 105.555 -2.017 . . . . 0.0 105.555 174.222 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.411 ' C ' ' H ' ' A' ' 31' ' ' ALA . 10.9 m-20 -116.08 22.18 13.15 Favored 'General case' 0 C--N 1.286 -2.19 0 CA-C-O 122.37 1.081 . . . . 0.0 109.294 179.361 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -76.73 18.95 0.3 Allowed 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 113.783 -1.553 . . . . 0.0 111.545 -176.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.411 ' H ' ' C ' ' A' ' 29' ' ' ASP . . . -94.48 -12.52 27.54 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.949 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -100.31 145.23 28.38 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 -177.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 23.1 pt -141.06 159.81 23.12 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 CA-C-O 121.025 0.44 . . . . 0.0 110.953 175.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 45.0 t80 -109.42 122.49 47.49 Favored 'General case' 0 N--CA 1.421 -1.901 0 CA-C-N 114.485 -1.234 . . . . 0.0 108.206 177.533 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.401 HG21 ' CD1' ' A' ' 104' ' ' ILE . 8.2 mt -108.56 128.0 64.55 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.164 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 174.562 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -129.98 165.6 22.33 Favored Glycine 0 C--N 1.283 -2.415 0 N-CA-C 110.832 -0.907 . . . . 0.0 110.832 -179.571 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 71.13 35.16 1.67 Allowed 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.865 1.266 . . . . 0.0 110.667 -177.359 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -68.47 152.77 44.93 Favored 'General case' 0 CA--C 1.497 -1.085 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.25 176.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.404 ' HB3' ' HG ' ' A' ' 42' ' ' LEU . 39.7 t-20 -91.63 151.94 20.47 Favored 'General case' 0 C--N 1.29 -1.988 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 176.55 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.505 ' HD3' ' OE1' ' A' ' 70' ' ' GLU . 1.0 OUTLIER -64.16 -17.21 63.27 Favored 'General case' 0 C--N 1.307 -1.253 0 C-N-CA 122.997 0.519 . . . . 0.0 111.734 179.837 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -97.27 3.55 51.26 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.107 -178.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.404 ' HG ' ' HB3' ' A' ' 39' ' ' ASN . 86.3 mt -98.46 117.33 32.64 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-O 121.589 0.709 . . . . 0.0 111.029 -179.128 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 68.2 p -107.23 174.74 5.76 Favored 'General case' 0 C--N 1.293 -1.866 0 CA-C-N 114.346 -1.297 . . . . 0.0 109.186 -179.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -54.46 -41.34 69.35 Favored 'General case' 0 C--O 1.209 -1.032 0 C-N-CA 123.19 0.596 . . . . 0.0 110.158 178.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.27 -39.47 96.08 Favored Glycine 0 CA--C 1.526 0.742 0 O-C-N 123.26 0.35 . . . . 0.0 112.901 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -66.8 -48.02 70.27 Favored 'General case' 0 CA--C 1.499 -1.004 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 179.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 42.0 mt -60.26 -46.36 94.92 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.782 0 CA-C-N 114.844 -1.071 . . . . 0.0 110.762 178.453 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 52.3 mt -59.77 -38.59 82.27 Favored 'General case' 0 CA--C 1.486 -1.502 0 C-N-CA 122.86 0.464 . . . . 0.0 111.525 -177.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 62.1 m -64.38 -46.79 81.83 Favored 'General case' 0 N--CA 1.433 -1.281 0 O-C-N 123.615 0.572 . . . . 0.0 110.716 -179.115 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 89.6 t -67.72 -47.91 78.0 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.624 -179.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -65.02 -25.07 67.69 Favored 'General case' 0 N--CA 1.435 -1.196 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.881 -177.145 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 59.8 m -67.59 -22.17 65.38 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.239 -0.437 . . . . 0.0 112.031 176.325 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -64.91 -28.94 69.88 Favored 'General case' 0 CA--C 1.559 1.322 0 CA-C-O 121.485 0.66 . . . . 0.0 109.917 175.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 49.1 m-85 -91.3 -18.24 24.65 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-O 121.24 0.543 . . . . 0.0 112.097 -175.204 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 165.19 -160.49 33.83 Favored Glycine 0 N--CA 1.419 -2.457 0 N-CA-C 111.011 -0.836 . . . . 0.0 111.011 179.484 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 62.2 t -100.2 110.8 60.92 Favored Pre-proline 0 C--N 1.294 -1.833 0 N-CA-C 110.347 -0.242 . . . . 0.0 110.347 -178.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.446 ' HB3' HD22 ' A' ' 77' ' ' LEU . 73.2 Cg_endo -76.05 141.07 23.33 Favored 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 122.645 2.23 . . . . 0.0 109.764 175.075 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 33.7 m -119.9 -13.57 9.1 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 C-N-CA 120.117 -0.633 . . . . 0.0 112.188 -179.275 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.42 ' HB3' ' HG2' ' A' ' 78' ' ' LYS . 33.2 t70 -164.09 136.85 5.07 Favored 'General case' 0 CA--C 1.501 -0.911 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.219 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 13.0 p -144.72 133.36 17.83 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 O-C-N 123.729 0.643 . . . . 0.0 110.01 -179.172 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.432 ' CD1' ' HB3' ' A' ' 111' ' ' PRO . 94.1 mt -121.9 128.98 75.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 176.019 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -99.36 117.28 33.45 Favored 'General case' 0 N--CA 1.419 -1.99 0 N-CA-C 105.364 -2.088 . . . . 0.0 105.364 173.394 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 62.8 m -78.61 117.82 20.14 Favored 'General case' 0 C--N 1.275 -2.655 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 176.131 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 85.8 mtt180 -125.19 130.89 53.04 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 -175.401 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -69.17 116.76 9.99 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 177.55 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -61.77 -18.07 58.43 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 113.934 1.087 . . . . 0.0 113.934 -177.251 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 23.5 m-80 -81.66 -46.42 14.37 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 -177.58 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 33.9 p -85.76 -23.96 27.07 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.411 -179.253 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 69.94 19.36 75.26 Favored Glycine 0 N--CA 1.445 -0.73 0 CA-C-N 115.583 -0.735 . . . . 0.0 113.091 176.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.505 ' OE1' ' HD3' ' A' ' 40' ' ' ARG . 17.1 mm-40 -111.41 -78.76 0.58 Allowed 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 117.059 0.429 . . . . 0.0 111.363 -177.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 34.3 t -158.1 168.34 27.36 Favored 'General case' 0 N--CA 1.441 -0.914 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 -178.258 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 13.4 mm-40 -102.84 -7.29 21.7 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 172.172 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 87.21 4.23 81.44 Favored Glycine 0 N--CA 1.433 -1.514 0 C-N-CA 120.221 -0.99 . . . . 0.0 112.344 -179.393 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 31.5 p90 -142.1 155.34 45.35 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 177.509 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -149.75 171.84 16.07 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-O 120.94 0.4 . . . . 0.0 110.88 -179.375 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -130.3 140.85 50.63 Favored 'General case' 0 C--N 1.31 -1.118 0 C-N-CA 123.854 0.861 . . . . 0.0 109.963 -178.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.446 HD22 ' HB3' ' A' ' 57' ' ' PRO . 9.8 tt -149.94 140.55 22.55 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 175.532 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.42 ' HG2' ' HB3' ' A' ' 59' ' ' ASP . 16.9 ptmt -125.05 144.56 50.34 Favored 'General case' 0 N--CA 1.433 -1.276 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 177.781 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 61.3 m-85 -104.48 164.94 11.39 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-O 121.614 0.721 . . . . 0.0 112.321 -177.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -75.86 -30.74 59.0 Favored 'General case' 0 N--CA 1.437 -1.089 0 CA-C-N 114.33 -1.304 . . . . 0.0 109.4 175.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -122.01 133.22 54.81 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 -179.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -70.06 -19.93 63.26 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 114.254 1.205 . . . . 0.0 114.254 -177.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 88.4 mtm180 -65.8 -33.21 75.33 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-O 122.299 1.047 . . . . 0.0 109.863 174.135 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.498 ' OG ' HG22 ' B' ' 226' ' ' ILE . 66.2 m -63.27 -36.77 84.78 Favored 'General case' 0 C--N 1.288 -2.101 0 CA-C-N 114.985 -1.007 . . . . 0.0 112.947 178.852 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 77.2 p -64.2 -45.54 87.85 Favored 'General case' 0 C--O 1.224 -0.25 0 C-N-CA 120.229 -0.588 . . . . 0.0 110.779 -177.554 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 5.2 pt -64.94 -38.86 83.85 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.309 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.837 177.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.459 HD12 ' HB2' ' B' ' 224' ' ' PHE . 6.4 mt -58.55 -43.53 89.32 Favored 'General case' 0 CA--C 1.505 -0.779 0 O-C-N 123.812 0.695 . . . . 0.0 110.668 177.719 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.496 ' O ' ' HB2' ' A' ' 92' ' ' LEU . . . -71.97 -43.76 64.65 Favored 'General case' 0 N--CA 1.42 -1.933 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.708 179.536 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 79.3 t -58.85 -49.04 84.35 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.751 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -71.18 -27.8 63.79 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -172.488 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.481 ' HA ' ' OD1' ' B' ' 239' ' ' ASN . 8.8 t30 -96.58 -25.62 15.54 Favored 'General case' 0 C--N 1.296 -1.759 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.761 -177.367 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.496 ' HB2' ' O ' ' A' ' 88' ' ' ALA . 12.1 mt -95.33 -22.66 17.61 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 122.052 -0.405 . . . . 0.0 111.471 -178.049 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -65.21 124.93 23.46 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 177.361 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 81.79 -0.99 87.59 Favored Glycine 0 C--O 1.243 0.666 0 C-N-CA 120.882 -0.675 . . . . 0.0 113.143 177.564 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 62.0 t80 -85.35 144.1 28.25 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 -178.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 11.8 mptt -99.88 118.78 37.05 Favored 'General case' 0 N--CA 1.44 -0.955 0 CA-C-O 121.336 0.589 . . . . 0.0 112.512 -176.396 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 58.6 mt -127.59 141.46 46.32 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.188 0 N-CA-C 105.842 -1.91 . . . . 0.0 105.842 173.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 61.1 20.06 57.66 Favored Glycine 0 CA--C 1.519 0.312 0 C-N-CA 121.143 -0.551 . . . . 0.0 112.373 -177.406 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 78.13 7.49 87.65 Favored Glycine 0 N--CA 1.436 -1.362 0 CA-C-N 115.834 -0.183 . . . . 0.0 113.217 -178.011 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 16.7 ptp180 -124.78 147.95 48.4 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 117.534 0.667 . . . . 0.0 110.405 -179.555 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -87.7 116.32 25.75 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 116.585 -0.28 . . . . 0.0 111.587 -175.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 12.7 mt -65.84 144.62 56.72 Favored 'General case' 0 C--O 1.252 1.186 0 CA-C-O 121.875 0.845 . . . . 0.0 113.103 179.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 29.2 tptp -118.72 115.47 24.55 Favored 'General case' 0 N--CA 1.416 -2.148 0 CA-C-N 114.806 -1.088 . . . . 0.0 108.216 176.076 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.401 ' CD1' HG21 ' A' ' 35' ' ' ILE . 4.7 mm -114.69 134.46 57.61 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.966 0 N-CA-C 105.859 -1.904 . . . . 0.0 105.859 178.328 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -143.12 151.99 41.32 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -176.138 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 56.2 m-70 -83.34 130.48 35.06 Favored 'General case' 0 C--N 1.295 -1.804 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 177.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 7.3 t -147.28 163.42 36.45 Favored 'General case' 0 C--N 1.291 -1.973 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 -178.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 46.5 m-85 -110.13 111.03 22.11 Favored 'General case' 0 N--CA 1.42 -1.96 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 171.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 63.7 t80 -107.73 139.13 42.77 Favored 'General case' 0 C--N 1.294 -1.819 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.783 -176.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 6.2 mpt_? -116.91 114.99 39.07 Favored Pre-proline 0 C--N 1.306 -1.325 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 170.386 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.432 ' HB3' ' CD1' ' A' ' 61' ' ' ILE . 49.0 Cg_endo -68.67 140.67 47.66 Favored 'Trans proline' 0 C--N 1.323 -0.769 0 C-N-CA 122.929 2.42 . . . . 0.0 114.525 -178.064 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -107.0 112.35 25.26 Favored 'General case' 0 N--CA 1.423 -1.812 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 170.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 31.0 mmm180 . . . . . 0 C--N 1.286 -2.176 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 -178.849 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 . . . . . 0 N--CA 1.466 0.363 0 CA-C-O 120.426 0.155 . . . . 0.0 110.899 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 223' ' ' ARG . . . . . . . . . . . . . 10.5 ptm180 51.9 46.53 26.42 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 127.049 2.139 . . . . 0.0 116.264 176.134 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 224' ' ' PHE . . . . . 0.459 ' HB2' HD12 ' A' ' 87' ' ' LEU . 63.4 m-85 -100.62 165.57 11.33 Favored 'General case' 0 C--N 1.289 -2.055 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 172.406 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 225' ' ' ALA . . . . . . . . . . . . . . . -124.88 83.85 2.21 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-O 121.672 0.748 . . . . 0.0 110.923 -177.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 226' ' ' ILE . . . . . 0.498 HG22 ' OG ' ' A' ' 84' ' ' SER . 4.0 mp -123.35 137.49 56.49 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.799 0 CA-C-N 115.177 -0.92 . . . . 0.0 108.89 178.113 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 227' ' ' MET . . . . . . . . . . . . . 65.8 mtt -61.92 134.2 94.13 Favored Pre-proline 0 C--N 1.322 -0.626 0 O-C-N 123.466 0.479 . . . . 0.0 111.516 -179.161 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 228' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -72.34 140.28 33.36 Favored 'Trans proline' 0 C--O 1.251 1.138 0 C-N-CA 123.13 2.554 . . . . 0.0 112.703 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . -65.65 164.01 39.16 Favored Glycine 0 C--N 1.317 -0.526 0 CA-C-N 115.573 -0.739 . . . . 0.0 113.372 -179.528 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 14.6 m -72.06 -18.08 61.96 Favored 'General case' 0 C--N 1.31 -1.149 0 C-N-CA 123.331 0.652 . . . . 0.0 112.375 -175.172 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 13.6 mmm180 -82.06 -3.45 54.67 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.92 0.391 . . . . 0.0 111.146 -177.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 232' ' ' TRP . . . . . . . . . . . . . 24.9 t90 -72.04 123.52 22.97 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-O 122.405 1.097 . . . . 0.0 111.502 179.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 233' ' ' ASP . . . . . 0.437 ' O ' ' N ' ' B' ' 235' ' ' VAL . 8.4 t70 -113.14 144.48 42.59 Favored 'General case' 0 C--N 1.276 -2.617 0 N-CA-C 101.095 -3.669 . . . . 0.0 101.095 171.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -48.4 61.22 0.0 OUTLIER Glycine 0 N--CA 1.487 2.059 0 C-N-CA 127.361 2.41 . . . . 0.0 115.836 -178.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 235' ' ' VAL . . . . . 0.437 ' N ' ' O ' ' B' ' 233' ' ' ASP . 38.8 t -109.17 122.21 63.45 Favored 'Isoleucine or valine' 0 C--N 1.251 -3.712 0 C-N-CA 129.003 2.921 . . . . 0.0 106.89 176.554 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 236' ' ' HIS . . . . . . . . . . . . . 51.0 t-80 -105.24 119.45 39.1 Favored 'General case' 0 C--N 1.292 -1.928 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 -179.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 237' ' ' ARG . . . . . . . . . . . . . 48.6 mmt-85 -126.54 109.41 12.12 Favored 'General case' 0 C--O 1.198 -1.657 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.001 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 238' ' ' SER . . . . . . . . . . . . . 40.0 t -142.91 126.75 17.14 Favored 'General case' 0 C--N 1.285 -2.235 0 O-C-N 121.921 -0.487 . . . . 0.0 110.2 -176.062 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 239' ' ' ASN . . . . . 0.481 ' OD1' ' HA ' ' A' ' 91' ' ' ASN . 35.5 p-10 -87.21 75.68 9.33 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 123.047 1.403 . . . . 0.0 110.992 178.706 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 240' ' ' GLY . . . . . 0.465 ' O ' ' HG2' ' B' ' 244' ' ' LYS . . . -138.84 30.96 2.43 Favored Glycine 0 N--CA 1.423 -2.199 0 CA-C-N 114.117 -1.401 . . . . 0.0 109.857 177.865 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 20.8 p90 -76.27 -38.12 56.63 Favored 'General case' 0 C--N 1.293 -1.868 0 C-N-CA 123.768 0.827 . . . . 0.0 112.318 179.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -60.71 -42.78 97.93 Favored 'General case' 0 C--O 1.243 0.741 0 C-N-CA 122.353 0.261 . . . . 0.0 111.281 -177.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -62.0 -34.99 77.2 Favored 'General case' 0 C--O 1.211 -0.935 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.476 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 244' ' ' LYS . . . . . 0.465 ' HG2' ' O ' ' B' ' 240' ' ' GLY . 43.9 mmtm -64.45 -47.85 77.52 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-O 121.133 0.492 . . . . 0.0 110.523 -177.718 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 245' ' ' TRP . . . . . . . . . . . . . 13.6 m0 -65.8 -39.12 90.6 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.225 178.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 246' ' ' PHE . . . . . 0.485 ' O ' ' HG2' ' B' ' 249' ' ' GLN . 2.7 t80 -64.97 -37.12 86.61 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.634 178.181 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -68.49 -35.42 77.5 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.591 -179.536 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.33 -16.71 28.67 Favored 'General case' 0 CA--C 1.509 -0.6 0 N-CA-C 111.887 0.329 . . . . 0.0 111.887 -177.782 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 249' ' ' GLN . . . . . 0.485 ' HG2' ' O ' ' B' ' 246' ' ' PHE . 3.2 pt20 -81.07 2.8 25.64 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-O 120.839 0.352 . . . . 0.0 110.456 -179.299 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 250' ' ' ASN . . . . . 0.434 ' OD1' ' HG3' ' B' ' 251' ' ' GLU . 7.9 p30 -52.37 -39.69 61.09 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.514 178.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . 0.434 ' HG3' ' OD1' ' B' ' 250' ' ' ASN . 46.2 mt-10 -133.66 121.36 21.88 Favored 'General case' 0 N--CA 1.435 -1.205 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 174.43 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 252' ' ' ILE . . . . . . . . . . . . . 38.1 pt -96.91 -34.34 4.91 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -174.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -100.46 -17.76 17.02 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-O 121.969 0.89 . . . . 0.0 109.58 -178.471 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 254' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -98.59 -172.31 2.29 Favored 'General case' 0 C--N 1.293 -1.88 0 CA-C-N 114.35 -1.295 . . . . 0.0 108.409 179.637 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 255' ' ' LYS . . . . . . . . . . . . . 20.1 pttm -51.92 141.61 17.32 Favored 'General case' 0 C--N 1.312 -1.032 0 C-N-CA 124.613 1.165 . . . . 0.0 111.708 178.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 256' ' ' LYS . . . . . . . . . . . . . 21.9 pttp . . . . . 0 C--N 1.304 -1.371 0 CA-C-O 118.134 -0.936 . . . . 0.0 110.541 -179.037 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 50.5 t30 . . . . . 0 CA--C 1.514 -0.411 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -69.01 -12.22 61.49 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-O 121.966 0.889 . . . . 0.0 112.235 -173.076 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 -87.0 11.55 13.39 Favored 'General case' 0 C--N 1.293 -1.864 0 CA-C-N 114.427 -1.261 . . . . 0.0 110.734 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 56.2 mttp -127.1 171.88 11.01 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 173.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -117.28 26.69 9.58 Favored 'General case' 0 CA--C 1.491 -1.294 0 CA-C-O 121.974 0.892 . . . . 0.0 109.648 -178.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -78.07 -0.27 27.39 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-N 114.596 -1.184 . . . . 0.0 111.477 -175.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.452 ' HA ' HG22 ' A' ' 85' ' ' THR . . . -82.24 -15.64 52.38 Favored 'General case' 0 CA--C 1.503 -0.847 0 CA-C-O 120.869 0.366 . . . . 0.0 110.322 179.235 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 57.5 m-85 -102.13 144.49 30.62 Favored 'General case' 0 N--CA 1.429 -1.496 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 -178.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 27.5 pt -143.24 162.55 16.85 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 CA-C-O 121.458 0.646 . . . . 0.0 110.869 -179.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -114.45 125.88 54.33 Favored 'General case' 0 N--CA 1.412 -2.359 0 CA-C-N 114.085 -1.416 . . . . 0.0 108.123 175.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 10.2 mt -108.51 127.53 64.85 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.998 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 176.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -125.68 164.2 19.35 Favored Glycine 0 C--N 1.279 -2.596 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 -179.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 66.9 m-20 71.46 45.0 0.49 Allowed 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 125.346 1.458 . . . . 0.0 110.219 -177.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.405 HD21 ' HA ' ' A' ' 74' ' ' PHE . 4.2 mm? -76.21 144.63 40.31 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.281 177.08 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 42.8 t-20 -83.88 147.23 27.64 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 176.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.518 ' C ' ' HD2' ' A' ' 40' ' ' ARG . 6.6 ppt_? -59.2 -22.02 60.36 Favored 'General case' 0 C--N 1.311 -1.068 0 C-N-CA 123.78 0.832 . . . . 0.0 111.921 -179.73 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.442 ' N ' ' HD2' ' A' ' 40' ' ' ARG . 12.9 pt-20 -92.8 -10.99 34.9 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.818 -176.207 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 71.6 mt -79.86 132.5 36.12 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.214 0.531 . . . . 0.0 111.504 -176.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 35.1 p -119.86 173.73 6.87 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 114.852 -1.067 . . . . 0.0 110.44 -178.317 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 -55.35 -39.31 69.88 Favored 'General case' 0 C--O 1.221 -0.417 0 C-N-CA 123.2 0.6 . . . . 0.0 111.05 179.33 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.95 -38.58 95.69 Favored Glycine 0 N--CA 1.448 -0.559 0 CA-C-N 116.013 -0.54 . . . . 0.0 112.597 -179.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -67.08 -49.51 64.8 Favored 'General case' 0 CA--C 1.492 -1.273 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 37.7 mt -60.43 -47.12 93.89 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.931 0 CA-C-N 114.791 -1.095 . . . . 0.0 110.78 -179.246 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 36.7 mt -59.68 -42.36 92.78 Favored 'General case' 0 CA--C 1.494 -1.179 0 CA-C-N 116.572 -0.285 . . . . 0.0 111.714 -176.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 68.8 m -65.66 -46.02 80.73 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 123.541 0.526 . . . . 0.0 111.649 -178.235 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 58.4 t -67.69 -45.74 84.12 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-O 121.42 0.629 . . . . 0.0 110.39 -178.127 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -64.63 -25.3 67.9 Favored 'General case' 0 N--CA 1.431 -1.387 0 CA-C-N 115.082 -0.963 . . . . 0.0 111.921 -179.452 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.576 ' OG ' ' HB2' ' B' ' 231' ' ' ARG . 66.9 m -70.23 -19.43 63.14 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 176.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -72.54 -20.9 61.26 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-O 121.669 0.747 . . . . 0.0 109.68 176.209 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.406 ' CE1' ' HB2' ' A' ' 91' ' ' ASN . 60.1 m-85 -94.65 -19.98 19.97 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.853 -178.663 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.427 ' O ' ' HA ' ' A' ' 52' ' ' SER . . . 167.17 -152.91 22.06 Favored Glycine 0 N--CA 1.424 -2.139 0 C-N-CA 120.741 -0.742 . . . . 0.0 111.403 179.017 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 87.7 t -105.58 110.57 64.38 Favored Pre-proline 0 C--N 1.295 -1.766 0 N-CA-C 110.307 -0.257 . . . . 0.0 110.307 -177.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.422 ' HB3' HD22 ' A' ' 77' ' ' LEU . 73.9 Cg_endo -78.24 135.99 14.01 Favored 'Trans proline' 0 N--CA 1.44 -1.65 0 C-N-CA 121.846 1.697 . . . . 0.0 109.2 174.685 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 35.8 m -113.18 -19.95 6.51 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 C-N-CA 119.726 -0.789 . . . . 0.0 111.57 -177.33 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.435 ' HB3' ' HG2' ' A' ' 78' ' ' LYS . 36.1 t70 -159.34 140.68 12.95 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 179.801 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 13.1 p -143.67 136.31 23.99 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 O-C-N 123.793 0.683 . . . . 0.0 109.868 -179.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.422 HD12 ' HB3' ' A' ' 111' ' ' PRO . 99.1 mt -122.37 125.82 73.32 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 C-N-CA 123.112 0.565 . . . . 0.0 109.503 173.19 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -98.71 118.64 35.9 Favored 'General case' 0 N--CA 1.419 -1.998 0 N-CA-C 104.963 -2.236 . . . . 0.0 104.963 173.252 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 17.8 m -81.03 116.52 21.02 Favored 'General case' 0 N--CA 1.408 -2.561 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 179.349 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 64.8 mtm180 -128.54 141.15 51.46 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 -178.132 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -69.7 120.6 15.71 Favored 'General case' 0 C--N 1.296 -1.755 0 O-C-N 123.913 0.758 . . . . 0.0 109.206 178.603 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -61.44 -18.69 60.07 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 113.615 0.968 . . . . 0.0 113.615 -177.159 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 22.9 m-80 -82.18 -47.74 12.13 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-O 121.05 0.452 . . . . 0.0 110.625 -176.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 60.2 p -91.76 -23.46 19.74 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.393 -177.319 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.43 12.95 83.87 Favored Glycine 0 N--CA 1.444 -0.813 0 N-CA-C 111.693 -0.563 . . . . 0.0 111.693 -177.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -113.71 158.48 20.85 Favored 'General case' 0 C--N 1.323 -0.551 0 O-C-N 122.682 -0.305 . . . . 0.0 110.409 -177.015 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 38.8 t -51.61 140.33 18.68 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 124.084 0.953 . . . . 0.0 112.089 179.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -83.32 -2.77 56.51 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.446 177.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 95.54 11.69 55.1 Favored Glycine 0 N--CA 1.421 -2.335 0 CA-C-N 115.494 -0.775 . . . . 0.0 112.604 179.078 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.405 ' HA ' HD21 ' A' ' 38' ' ' LEU . 33.0 p90 -152.43 157.52 41.33 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 177.936 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -153.25 172.64 16.67 Favored 'General case' 0 N--CA 1.427 -1.583 0 O-C-N 123.509 0.506 . . . . 0.0 110.2 179.31 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -132.15 144.62 50.81 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 123.761 0.825 . . . . 0.0 110.053 -178.428 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.422 HD22 ' HB3' ' A' ' 57' ' ' PRO . 9.9 tt -153.78 140.72 19.23 Favored 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 175.634 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.435 ' HG2' ' HB3' ' A' ' 59' ' ' ASP . 18.8 ptmt -123.91 144.1 49.97 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 177.578 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.411 ' CD1' HG23 ' A' ' 85' ' ' THR . 39.9 m-85 -102.5 165.04 11.32 Favored 'General case' 0 C--N 1.29 -2.013 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.611 -178.348 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -73.48 -35.32 65.66 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 114.702 -1.136 . . . . 0.0 109.133 175.402 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -124.78 137.59 54.31 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.806 -178.045 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -70.19 -20.08 63.14 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -179.49 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 80.8 mtm180 -65.08 -34.55 78.68 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 122.219 1.009 . . . . 0.0 109.478 174.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.455 ' OG ' HG22 ' B' ' 226' ' ' ILE . 60.3 m -67.43 -37.41 82.97 Favored 'General case' 0 C--N 1.292 -1.92 0 CA-C-N 114.821 -1.082 . . . . 0.0 112.185 178.369 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.47 ' O ' HG21 ' A' ' 89' ' ' VAL . 71.1 p -65.45 -45.12 85.02 Favored 'General case' 0 C--O 1.217 -0.635 0 C-N-CA 120.249 -0.58 . . . . 0.0 110.685 -177.792 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 3.7 pt -63.26 -39.2 84.36 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.317 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.075 177.409 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 30.0 mt -59.79 -43.24 94.5 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 123.44 0.463 . . . . 0.0 110.911 174.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.414 ' O ' ' HB2' ' A' ' 92' ' ' LEU . . . -68.99 -46.5 67.9 Favored 'General case' 0 C--O 1.203 -1.374 0 CA-C-N 115.712 -0.677 . . . . 0.0 110.928 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.47 HG21 ' O ' ' A' ' 85' ' ' THR . 85.9 t -58.88 -48.93 84.78 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.062 0 CA-C-O 120.712 0.291 . . . . 0.0 110.954 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -67.36 -29.77 69.39 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 -174.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.467 ' HA ' ' OD1' ' B' ' 239' ' ' ASN . 11.0 m120 -97.98 -21.02 17.06 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 113.684 0.994 . . . . 0.0 113.684 -178.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.414 ' HB2' ' O ' ' A' ' 88' ' ' ALA . 14.0 mt -98.92 -31.42 11.84 Favored 'General case' 0 CA--C 1.495 -1.172 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -176.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 52.6 t30 -66.39 124.98 24.21 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 85.21 -1.81 88.48 Favored Glycine 0 C--N 1.306 -1.128 0 C-N-CA 121.411 -0.423 . . . . 0.0 112.909 -179.151 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.527 ' CE2' ' HG3' ' B' ' 237' ' ' ARG . 64.1 t80 -90.09 137.85 32.0 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 179.468 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -93.38 119.5 32.57 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-O 120.914 0.388 . . . . 0.0 111.712 -177.213 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 35.4 mt -118.35 142.45 33.01 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 173.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 71.58 -84.67 0.44 Allowed Glycine 0 N--CA 1.438 -1.195 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 -174.257 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -161.99 17.72 0.16 Allowed Glycine 0 N--CA 1.427 -1.955 0 N-CA-C 110.199 -1.161 . . . . 0.0 110.199 175.268 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 16.6 ptp180 -137.23 149.79 47.41 Favored 'General case' 0 N--CA 1.445 -0.719 0 O-C-N 122.798 -0.236 . . . . 0.0 110.532 -175.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -87.36 122.97 31.82 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.789 -177.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 14.8 mt -66.92 148.24 52.2 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-O 121.745 0.783 . . . . 0.0 112.923 179.013 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 54.3 tptt -121.94 116.47 24.42 Favored 'General case' 0 N--CA 1.418 -2.025 0 CA-C-N 114.911 -1.04 . . . . 0.0 108.824 175.131 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 3.9 mm -116.39 136.09 54.51 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.868 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -143.81 150.57 38.73 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 178.139 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 74.4 m-70 -83.34 137.8 33.81 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 178.057 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 9.0 t -158.62 155.38 28.12 Favored 'General case' 0 C--N 1.291 -1.959 0 N-CA-C 106.247 -1.76 . . . . 0.0 106.247 -177.215 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -93.82 111.83 23.59 Favored 'General case' 0 N--CA 1.435 -1.2 0 C-N-CA 117.571 -1.651 . . . . 0.0 108.057 172.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 30.5 t80 -106.5 135.96 47.09 Favored 'General case' 0 C--N 1.294 -1.845 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.676 -179.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 86.3 mmt-85 -122.5 124.61 26.72 Favored Pre-proline 0 C--N 1.298 -1.648 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 171.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.422 ' HB3' HD12 ' A' ' 61' ' ' ILE . 73.8 Cg_endo -74.83 145.22 31.89 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 122.622 2.215 . . . . 0.0 113.773 -178.605 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.444 ' C ' ' HD3' ' A' ' 112' ' ' LYS . 11.6 tmtt? -98.62 129.92 45.14 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 174.443 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.425 ' N ' ' HD3' ' A' ' 112' ' ' LYS . 98.8 mtt180 . . . . . 0 C--N 1.305 -1.338 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 179.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 50.5 t-20 . . . . . 0 C--O 1.204 -1.327 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 223' ' ' ARG . . . . . . . . . . . . 0.25 10.5 ptm180 68.37 17.94 9.15 Favored 'General case' 0 N--CA 1.495 1.803 0 C-N-CA 127.795 2.438 . . . . 0.0 114.476 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 224' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -96.99 159.41 14.93 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 176.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 225' ' ' ALA . . . . . . . . . . . . . . . -131.82 86.83 2.38 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 -179.507 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 226' ' ' ILE . . . . . 0.455 HG22 ' OG ' ' A' ' 84' ' ' SER . 4.3 mp -127.47 128.21 69.63 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.238 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.295 178.16 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 227' ' ' MET . . . . . . . . . . . . . 90.5 mmm -66.81 137.95 95.09 Favored Pre-proline 0 C--N 1.321 -0.656 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.561 177.156 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 228' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -66.25 157.18 61.31 Favored 'Trans proline' 0 C--O 1.248 0.975 0 C-N-CA 122.938 2.425 . . . . 0.0 113.183 -178.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . -73.36 170.34 52.43 Favored Glycine 0 N--CA 1.439 -1.127 0 CA-C-N 115.412 -0.813 . . . . 0.0 112.237 179.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 20.9 m -77.44 -18.24 57.37 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-O 121.101 0.477 . . . . 0.0 111.23 -177.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 231' ' ' ARG . . . . . 0.576 ' HB2' ' OG ' ' A' ' 52' ' ' SER . 37.9 mmt180 -79.64 -8.16 59.03 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.583 -178.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 232' ' ' TRP . . . . . . . . . . . . . 21.6 t90 -73.54 122.96 23.04 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-O 122.279 1.038 . . . . 0.0 113.05 -176.078 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 233' ' ' ASP . . . . . 0.451 ' O ' ' N ' ' B' ' 235' ' ' VAL . 12.2 t70 -120.47 137.52 54.3 Favored 'General case' 0 C--N 1.276 -2.622 0 N-CA-C 100.773 -3.788 . . . . 0.0 100.773 172.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -36.54 54.61 0.0 OUTLIER Glycine 0 N--CA 1.513 3.833 0 C-N-CA 128.979 3.18 . . . . 0.0 118.257 -175.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 235' ' ' VAL . . . . . 0.451 ' N ' ' O ' ' B' ' 233' ' ' ASP . 50.1 t -104.35 121.92 56.64 Favored 'Isoleucine or valine' 0 C--N 1.25 -3.736 0 C-N-CA 127.602 2.361 . . . . 0.0 107.526 176.528 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 236' ' ' HIS . . . . . 0.417 ' C ' ' HD2' ' B' ' 237' ' ' ARG . 34.9 t-80 -112.06 115.83 29.54 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 123.867 0.73 . . . . 0.0 110.118 -177.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 237' ' ' ARG . . . . . 0.527 ' HG3' ' CE2' ' A' ' 95' ' ' PHE . 2.1 mpt_? -119.07 109.5 15.98 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-O 121.215 0.531 . . . . 0.0 110.217 176.692 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 238' ' ' SER . . . . . . . . . . . . . 47.8 t -140.61 130.16 24.08 Favored 'General case' 0 N--CA 1.417 -2.09 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 179.515 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 239' ' ' ASN . . . . . 0.467 ' OD1' ' HA ' ' A' ' 91' ' ' ASN . 27.1 p-10 -89.26 -170.98 3.07 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 175.236 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 240' ' ' GLY . . . . . 0.401 ' O ' ' HG2' ' B' ' 244' ' ' LYS . . . 134.59 -11.19 4.61 Favored Glycine 0 C--O 1.198 -2.098 0 N-CA-C 110.88 -0.888 . . . . 0.0 110.88 -179.787 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 39.9 p90 -77.26 -34.18 55.83 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-O 120.932 0.396 . . . . 0.0 111.694 177.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -62.79 -41.65 99.36 Favored 'General case' 0 C--O 1.243 0.74 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.459 -174.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -62.98 -35.29 79.69 Favored 'General case' 0 C--O 1.21 -1.002 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.581 -178.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 244' ' ' LYS . . . . . 0.401 ' HG2' ' O ' ' B' ' 240' ' ' GLY . 69.8 mmtt -65.95 -42.99 89.28 Favored 'General case' 0 N--CA 1.439 -1.021 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 -177.381 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 245' ' ' TRP . . . . . . . . . . . . . 46.1 m0 -65.44 -41.99 92.87 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.695 178.182 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 246' ' ' PHE . . . . . 0.466 ' O ' ' HG2' ' B' ' 249' ' ' GLN . 3.0 t80 -66.53 -30.23 70.5 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 121.803 0.811 . . . . 0.0 110.949 178.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -77.44 -39.39 46.99 Favored 'General case' 0 C--N 1.295 -1.786 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.384 178.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.83 -15.33 39.5 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.083 0.468 . . . . 0.0 111.793 -175.117 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 249' ' ' GLN . . . . . 0.466 ' HG2' ' O ' ' B' ' 246' ' ' PHE . 3.9 pt20 -71.46 1.77 5.94 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.804 -179.169 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 250' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -65.34 -29.2 69.91 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 176.014 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -78.29 112.18 15.02 Favored 'General case' 0 N--CA 1.426 -1.642 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 176.4 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 252' ' ' ILE . . . . . . . . . . . . . 29.4 pt -103.51 -34.23 3.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.812 -172.164 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -100.67 -15.52 17.71 Favored 'General case' 0 CA--C 1.497 -1.077 0 CA-C-O 122.224 1.011 . . . . 0.0 108.668 179.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 254' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -98.38 -169.82 1.86 Allowed 'General case' 0 N--CA 1.417 -2.097 0 CA-C-N 113.843 -1.526 . . . . 0.0 110.493 177.415 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 255' ' ' LYS . . . . . . . . . . . . . 14.5 pttm -56.31 103.0 0.09 Allowed 'General case' 0 C--N 1.296 -1.732 0 C-N-CA 125.149 1.38 . . . . 0.0 114.33 -178.175 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 256' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt . . . . . 0 C--N 1.296 -1.758 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 174.341 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 32.0 t30 . . . . . 0 CA--C 1.509 -0.611 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 68.4 mm-40 -120.04 -42.2 2.61 Favored 'General case' 0 N--CA 1.427 -1.59 0 CA-C-N 116.078 -0.51 . . . . 0.0 112.13 -176.533 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -132.52 8.13 4.22 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 113.832 1.049 . . . . 0.0 113.832 -169.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.414 ' HB2' ' OE1' ' A' ' 82' ' ' GLN . 75.0 mmtt -134.15 -177.1 4.43 Favored 'General case' 0 C--N 1.295 -1.771 0 C-N-CA 120.006 -0.678 . . . . 0.0 111.336 -174.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -127.44 10.24 6.71 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-O 121.787 0.803 . . . . 0.0 109.665 176.131 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -81.06 30.54 0.32 Allowed 'General case' 0 N--CA 1.481 1.09 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.805 -178.317 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -94.64 -1.58 52.91 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.415 -178.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 16.9 m-85 -111.9 145.01 40.29 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 -175.013 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 28.3 pt -138.65 157.03 29.78 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.172 176.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 56.7 t80 -106.72 121.7 44.89 Favored 'General case' 0 N--CA 1.41 -2.429 0 CA-C-N 114.619 -1.173 . . . . 0.0 107.978 177.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 10.8 mt -108.38 128.03 64.26 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.18 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 175.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -130.25 173.35 19.99 Favored Glycine 0 C--N 1.28 -2.583 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 179.599 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 69.98 31.03 3.47 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.312 0.645 . . . . 0.0 111.16 -178.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -68.55 155.14 40.54 Favored 'General case' 0 CA--C 1.503 -0.85 0 CA-C-O 121.955 0.883 . . . . 0.0 112.231 178.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.483 ' HB3' ' HG ' ' A' ' 42' ' ' LEU . 54.5 t-20 -95.38 146.52 24.33 Favored 'General case' 0 C--N 1.288 -2.104 0 N-CA-C 105.955 -1.868 . . . . 0.0 105.955 174.541 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.484 ' C ' ' HD2' ' A' ' 40' ' ' ARG . 7.2 ppt_? -61.83 -23.01 65.98 Favored 'General case' 0 C--N 1.298 -1.654 0 C-N-CA 123.396 0.678 . . . . 0.0 111.435 179.087 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.442 ' HG2' ' CG ' ' A' ' 39' ' ' ASN . 12.7 pt-20 -88.9 -1.18 57.97 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-O 120.857 0.361 . . . . 0.0 111.33 -178.657 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.483 ' HG ' ' HB3' ' A' ' 39' ' ' ASN . 87.3 mt -91.48 124.63 35.79 Favored 'General case' 0 N--CA 1.432 -1.353 0 CA-C-O 121.618 0.723 . . . . 0.0 110.464 179.792 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 68.0 p -113.66 174.57 5.86 Favored 'General case' 0 C--N 1.286 -2.168 0 CA-C-N 114.213 -1.358 . . . . 0.0 108.82 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.3 mp0 -55.29 -41.4 72.24 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 123.423 0.689 . . . . 0.0 110.739 -179.553 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -61.54 -38.35 95.66 Favored Glycine 0 C--O 1.241 0.557 0 CA-C-N 116.168 -0.469 . . . . 0.0 113.207 -179.127 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -67.4 -48.44 67.34 Favored 'General case' 0 CA--C 1.503 -0.853 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 51.4 mt -59.08 -44.77 92.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 CA-C-N 114.595 -1.184 . . . . 0.0 110.788 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 48.2 mt -59.36 -45.47 91.31 Favored 'General case' 0 CA--C 1.502 -0.891 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.538 -178.394 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 98.0 m -62.11 -45.83 91.73 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.462 HG12 ' HG3' ' B' ' 237' ' ' ARG . 98.7 t -65.39 -49.19 79.91 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 CA-C-O 121.246 0.545 . . . . 0.0 110.41 -179.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -66.17 -24.04 66.57 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 123.885 0.874 . . . . 0.0 113.04 -178.121 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.45 ' OG ' ' HB2' ' B' ' 231' ' ' ARG . 63.0 m -70.59 -17.91 62.9 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 177.072 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -68.56 -25.12 64.74 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 119.683 -0.807 . . . . 0.0 109.285 176.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -92.6 -15.96 26.23 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.114 -175.575 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.408 ' O ' ' HA ' ' A' ' 52' ' ' SER . . . 160.9 -158.61 30.2 Favored Glycine 0 N--CA 1.421 -2.353 0 C-N-CA 120.501 -0.857 . . . . 0.0 111.132 -179.556 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 57.5 t -102.26 111.02 64.0 Favored Pre-proline 0 C--N 1.302 -1.485 0 N-CA-C 111.798 0.296 . . . . 0.0 111.798 -175.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.443 ' HB3' HD22 ' A' ' 77' ' ' LEU . 87.1 Cg_endo -79.05 140.12 15.62 Favored 'Trans proline' 0 N--CA 1.449 -1.131 0 C-N-CA 122.96 2.44 . . . . 0.0 110.354 175.243 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 26.9 m -114.85 -21.95 5.04 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 C-N-CA 120.102 -0.639 . . . . 0.0 111.95 179.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -158.43 145.02 17.38 Favored 'General case' 0 C--O 1.247 0.944 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 -179.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 13.1 p -146.18 133.02 14.43 Favored 'Isoleucine or valine' 0 C--O 1.245 0.819 0 CA-C-O 121.5 0.667 . . . . 0.0 110.356 179.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 95.5 mt -121.06 126.98 75.82 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 177.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -99.55 122.04 42.05 Favored 'General case' 0 C--N 1.292 -1.902 0 N-CA-C 105.469 -2.049 . . . . 0.0 105.469 175.314 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 7.0 t -85.04 123.56 30.72 Favored 'General case' 0 N--CA 1.418 -2.062 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 179.198 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 73.4 mtt85 -119.5 141.17 49.43 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-O 120.901 0.381 . . . . 0.0 111.038 -179.368 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -76.07 124.35 27.26 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.942 -179.282 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -60.87 -25.5 66.72 Favored 'General case' 0 C--N 1.297 -1.705 0 CA-C-N 114.465 -1.243 . . . . 0.0 112.472 -178.293 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 25.0 m-80 -83.09 -51.38 7.58 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.083 0.468 . . . . 0.0 111.502 -176.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 47.2 p -86.63 -24.31 25.37 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 116.057 -0.519 . . . . 0.0 112.36 -174.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 81.79 -1.06 87.38 Favored Glycine 0 C--N 1.308 -0.987 0 N-CA-C 111.545 -0.622 . . . . 0.0 111.545 -177.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 36.3 mm-40 -101.04 176.44 5.26 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 110.238 -0.282 . . . . 0.0 110.238 -178.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 40.1 t -59.5 147.27 37.37 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.715 176.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 17.1 mm-40 -79.44 -7.44 58.4 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 123.759 0.823 . . . . 0.0 110.303 176.074 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 92.54 5.59 64.89 Favored Glycine 0 N--CA 1.425 -2.058 0 C-N-CA 120.594 -0.813 . . . . 0.0 111.651 -178.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 31.4 p90 -143.56 152.79 41.86 Favored 'General case' 0 N--CA 1.435 -1.181 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 178.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -148.12 171.97 15.03 Favored 'General case' 0 N--CA 1.427 -1.606 0 O-C-N 123.362 0.414 . . . . 0.0 110.165 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -130.37 139.99 50.62 Favored 'General case' 0 C--N 1.298 -1.655 0 C-N-CA 124.024 0.929 . . . . 0.0 109.952 -178.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.443 HD22 ' HB3' ' A' ' 57' ' ' PRO . 10.3 tt -146.93 140.85 25.95 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 175.739 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -125.04 144.3 50.47 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 178.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 55.8 m-85 -108.49 164.59 12.21 Favored 'General case' 0 C--N 1.29 -2.013 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.614 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -79.0 -35.49 42.78 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 174.165 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -106.49 123.73 48.53 Favored 'General case' 0 N--CA 1.439 -0.999 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 -177.451 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.414 ' OE1' ' HB2' ' A' ' 28' ' ' LYS . 96.7 mt-30 -69.47 -19.3 63.76 Favored 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 113.391 0.886 . . . . 0.0 113.391 -178.518 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 90.6 mtm180 -66.19 -33.24 75.31 Favored 'General case' 0 C--N 1.302 -1.5 0 CA-C-O 121.914 0.864 . . . . 0.0 109.261 173.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 56.9 m -65.33 -37.15 86.23 Favored 'General case' 0 N--CA 1.426 -1.639 0 CA-C-N 115.29 -0.868 . . . . 0.0 112.43 178.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.447 ' O ' HG21 ' A' ' 89' ' ' VAL . 64.9 p -62.73 -45.66 91.69 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 121.061 0.457 . . . . 0.0 110.741 -177.819 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 4.3 pt -66.17 -37.93 80.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.831 177.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.43 HD12 ' HB2' ' B' ' 224' ' ' PHE . 14.0 mt -59.41 -44.12 92.89 Favored 'General case' 0 CA--C 1.509 -0.62 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.641 175.26 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.482 ' O ' ' HB2' ' A' ' 92' ' ' LEU . . . -70.16 -45.51 66.61 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.848 -178.313 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.447 HG21 ' O ' ' A' ' 85' ' ' THR . 87.7 t -56.55 -47.79 81.43 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.967 0 CA-C-O 121.43 0.634 . . . . 0.0 111.119 178.47 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -62.08 -33.74 74.98 Favored 'General case' 0 C--N 1.297 -1.695 0 C-N-CA 125.042 1.337 . . . . 0.0 112.722 -176.337 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -98.44 -30.86 12.3 Favored 'General case' 0 C--N 1.293 -1.874 0 CA-C-N 116.145 -0.479 . . . . 0.0 112.232 -175.55 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.482 ' HB2' ' O ' ' A' ' 88' ' ' ALA . 12.5 mt -93.8 -30.16 14.99 Favored 'General case' 0 CA--C 1.482 -1.648 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 -170.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 57.4 t30 -66.12 125.04 24.26 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 179.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 83.61 -0.69 89.48 Favored Glycine 0 CA--C 1.535 1.287 0 C-N-CA 120.424 -0.893 . . . . 0.0 112.502 -177.48 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 67.8 t80 -89.36 138.42 31.46 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -178.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.46 ' HA ' ' O ' ' A' ' 100' ' ' ARG . 0.3 OUTLIER -92.51 118.52 31.06 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 -175.824 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 55.0 mt -127.64 142.08 44.63 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.259 0 N-CA-C 106.193 -1.78 . . . . 0.0 106.193 172.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 58.47 21.88 50.18 Favored Glycine 0 CA--C 1.524 0.656 0 C-N-CA 121.63 -0.319 . . . . 0.0 113.514 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 87.25 10.75 70.66 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 121.647 -0.311 . . . . 0.0 113.483 179.07 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.46 ' O ' ' HA ' ' A' ' 96' ' ' LYS . 13.6 ptp180 -140.56 148.66 41.33 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 117.985 0.892 . . . . 0.0 111.889 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -82.83 118.02 23.12 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.956 -179.374 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 12.7 mt -65.88 149.56 50.0 Favored 'General case' 0 C--N 1.309 -1.189 0 C-N-CA 124.134 0.974 . . . . 0.0 113.611 178.666 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 55.3 tptt -116.09 120.16 38.15 Favored 'General case' 0 N--CA 1.423 -1.801 0 CA-C-N 114.964 -1.016 . . . . 0.0 108.734 174.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 4.8 mm -121.44 135.36 61.85 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 178.35 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -143.57 153.25 42.37 Favored 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 109.273 -0.639 . . . . 0.0 109.273 -179.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -83.54 137.7 33.74 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 177.645 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 12.3 t -155.16 156.48 35.81 Favored 'General case' 0 N--CA 1.425 -1.724 0 N-CA-C 107.929 -1.138 . . . . 0.0 107.929 -177.117 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 7.7 p90 -97.67 109.86 22.53 Favored 'General case' 0 N--CA 1.423 -1.808 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 168.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 29.1 t80 -108.2 135.49 49.44 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-N 115.055 -0.975 . . . . 0.0 110.207 -178.175 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 5.3 mpt_? -118.82 117.88 33.6 Favored Pre-proline 0 C--N 1.29 -1.982 0 N-CA-C 109.171 -0.678 . . . . 0.0 109.171 172.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -61.73 140.56 86.72 Favored 'Trans proline' 0 C--O 1.241 0.627 0 C-N-CA 123.307 2.671 . . . . 0.0 113.783 -178.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 3.6 tmmm? -120.35 128.17 53.01 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 104.915 -2.254 . . . . 0.0 104.915 175.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 35.6 mmt180 . . . . . 0 C--N 1.297 -1.682 0 C-N-CA 120.236 -0.585 . . . . 0.0 110.125 -175.003 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 46.6 t30 . . . . . 0 N--CA 1.472 0.669 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 223' ' ' ARG . . . . . . . . . . . . . 11.7 ptm180 51.66 49.05 21.67 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 116.461 2.023 . . . . 0.0 116.461 173.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 224' ' ' PHE . . . . . 0.43 ' HB2' HD12 ' A' ' 87' ' ' LEU . 85.1 m-85 -106.25 165.42 11.26 Favored 'General case' 0 C--N 1.281 -2.403 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 173.402 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 225' ' ' ALA . . . . . . . . . . . . . . . -132.6 86.14 2.29 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-O 121.235 0.54 . . . . 0.0 110.432 179.523 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 3.7 mp -120.38 141.13 42.1 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.265 0 CA-C-N 115.101 -0.954 . . . . 0.0 109.348 178.582 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 227' ' ' MET . . . . . . . . . . . . . 68.6 mtt -69.29 139.08 89.52 Favored Pre-proline 0 N--CA 1.452 -0.341 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.354 177.568 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 228' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -69.09 159.0 55.67 Favored 'Trans proline' 0 C--O 1.243 0.726 0 C-N-CA 122.739 2.293 . . . . 0.0 112.893 -178.485 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . -75.3 168.76 54.79 Favored Glycine 0 N--CA 1.441 -0.98 0 CA-C-N 115.442 -0.799 . . . . 0.0 112.749 -179.685 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 9.4 t -77.61 -14.44 59.64 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 121.293 0.568 . . . . 0.0 110.305 -177.511 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 231' ' ' ARG . . . . . 0.45 ' HB2' ' OG ' ' A' ' 52' ' ' SER . 37.2 mmt180 -86.75 -3.93 59.11 Favored 'General case' 0 C--N 1.321 -0.644 0 O-C-N 122.139 -0.351 . . . . 0.0 111.08 -179.178 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 232' ' ' TRP . . . . . . . . . . . . . 21.7 t90 -74.77 128.25 35.12 Favored 'General case' 0 CA--C 1.497 -1.064 0 CA-C-O 122.385 1.088 . . . . 0.0 111.7 -179.142 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 233' ' ' ASP . . . . . 0.422 ' O ' ' N ' ' B' ' 235' ' ' VAL . 37.3 t70 -124.42 147.42 48.29 Favored 'General case' 0 C--N 1.263 -3.158 0 N-CA-C 103.038 -2.949 . . . . 0.0 103.038 172.671 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -40.01 60.71 0.0 OUTLIER Glycine 0 N--CA 1.501 3.022 0 C-N-CA 128.702 3.049 . . . . 0.0 116.93 -178.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 235' ' ' VAL . . . . . 0.422 ' N ' ' O ' ' B' ' 233' ' ' ASP . 59.1 t -106.34 133.85 49.63 Favored 'Isoleucine or valine' 0 C--N 1.256 -3.46 0 C-N-CA 127.898 2.479 . . . . 0.0 106.61 175.649 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 236' ' ' HIS . . . . . . . . . . . . . 41.1 t-80 -112.17 113.45 25.71 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 123.635 0.584 . . . . 0.0 109.449 -177.008 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 237' ' ' ARG . . . . . 0.462 ' HG3' HG12 ' A' ' 50' ' ' VAL . 40.2 mmt180 -114.64 110.84 20.38 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-O 121.264 0.554 . . . . 0.0 111.019 179.266 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 238' ' ' SER . . . . . . . . . . . . . 48.9 m -127.3 125.18 40.4 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-O 120.931 0.396 . . . . 0.0 111.152 179.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 239' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -60.28 116.19 4.07 Favored 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 123.848 0.859 . . . . 0.0 110.838 -176.027 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 240' ' ' GLY . . . . . 0.585 ' O ' ' HG2' ' B' ' 243' ' ' GLU . . . 80.85 39.57 13.39 Favored Glycine 0 C--O 1.194 -2.374 0 N-CA-C 111.309 -0.716 . . . . 0.0 111.309 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 17.7 p90 -55.76 -33.81 64.67 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -179.018 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -65.06 -40.9 95.38 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 111.885 0.328 . . . . 0.0 111.885 -176.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 243' ' ' GLU . . . . . 0.585 ' HG2' ' O ' ' B' ' 240' ' ' GLY . 11.4 pt-20 -66.31 -34.87 78.96 Favored 'General case' 0 C--O 1.207 -1.178 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 178.33 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 244' ' ' LYS . . . . . 0.553 ' HG2' ' O ' ' B' ' 240' ' ' GLY . 70.4 mmtt -66.0 -43.55 87.41 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 121.088 0.471 . . . . 0.0 110.555 -177.267 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 245' ' ' TRP . . . . . . . . . . . . . 46.7 m0 -63.94 -41.95 97.46 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.653 0.739 . . . . 0.0 109.358 178.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 246' ' ' PHE . . . . . 0.605 ' O ' ' HG2' ' B' ' 249' ' ' GLN . 1.7 t80 -68.46 -27.59 66.29 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 114.326 -1.306 . . . . 0.0 111.633 178.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -76.77 -39.64 50.98 Favored 'General case' 0 C--N 1.287 -2.12 0 O-C-N 121.907 -0.496 . . . . 0.0 111.597 -177.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 248' ' ' LYS . . . . . 0.41 ' C ' ' H ' ' B' ' 250' ' ' ASN . 2.6 pptp? -85.89 -14.75 43.9 Favored 'General case' 0 CA--C 1.507 -0.675 0 C-N-CA 120.231 -0.588 . . . . 0.0 112.328 -173.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 249' ' ' GLN . . . . . 0.605 ' HG2' ' O ' ' B' ' 246' ' ' PHE . 3.5 pt20 -67.75 -0.6 4.25 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.755 -176.867 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 250' ' ' ASN . . . . . 0.41 ' H ' ' C ' ' B' ' 248' ' ' LYS . 6.7 p30 -74.97 -20.78 59.52 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.975 177.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 27.0 mm-40 -64.83 146.49 54.81 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 115.136 -0.938 . . . . 0.0 113.193 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 252' ' ' ILE . . . . . . . . . . . . . 23.9 pt -97.71 -26.33 3.95 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 CA-C-N 115.045 -0.98 . . . . 0.0 111.118 177.179 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -85.22 -27.98 25.72 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 121.466 0.651 . . . . 0.0 109.696 178.19 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 254' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -99.67 169.68 9.1 Favored 'General case' 0 N--CA 1.422 -1.868 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.703 176.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 255' ' ' LYS . . . . . . . . . . . . . 14.6 ptmm? -94.26 171.26 8.94 Favored 'General case' 0 C--N 1.291 -1.943 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.468 -175.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 256' ' ' LYS . . . . . 0.459 ' HA ' ' HB2' ' B' ' 249' ' ' GLN . 28.5 ttpp . . . . . 0 N--CA 1.428 -1.539 0 CA-C-N 114.827 -1.079 . . . . 0.0 108.853 175.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 . . . . . 0 CA--C 1.51 -0.563 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.595 ' HG2' ' CD1' ' A' ' 27' ' ' TYR . 0.3 OUTLIER -83.2 -4.9 58.87 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 113.718 1.007 . . . . 0.0 113.718 -174.955 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.595 ' CD1' ' HG2' ' A' ' 26' ' ' GLU . 62.2 m-85 -114.03 23.58 12.82 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-O 121.578 0.704 . . . . 0.0 111.016 178.865 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -122.91 148.75 45.1 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 174.07 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.436 ' C ' ' H ' ' A' ' 31' ' ' ALA . 11.9 p-10 -102.56 7.95 39.95 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 -172.611 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -80.49 23.66 0.5 Allowed 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 121.133 0.492 . . . . 0.0 109.814 175.251 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.448 ' HB3' ' NE2' ' A' ' 82' ' ' GLN . . . -100.35 1.98 42.02 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.874 -174.398 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 -99.13 144.5 28.2 Favored 'General case' 0 C--N 1.315 -0.929 0 C-N-CA 120.309 -0.556 . . . . 0.0 109.866 -175.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 33.6 pt -138.14 157.04 31.49 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 CA-C-O 121.107 0.479 . . . . 0.0 110.616 178.096 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 38.9 t80 -107.74 121.07 43.97 Favored 'General case' 0 N--CA 1.417 -2.091 0 CA-C-N 114.728 -1.124 . . . . 0.0 108.444 178.469 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.42 HG21 ' CD1' ' A' ' 104' ' ' ILE . 9.9 mt -108.58 127.79 64.75 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.882 0 N-CA-C 106.714 -1.587 . . . . 0.0 106.714 175.694 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -130.5 163.7 23.14 Favored Glycine 0 C--N 1.284 -2.32 0 N-CA-C 111.232 -0.747 . . . . 0.0 111.232 -179.478 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 67.2 m-20 73.73 38.68 0.59 Allowed 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.743 1.617 . . . . 0.0 110.219 -178.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -68.69 144.69 54.35 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.451 -0.795 . . . . 0.0 112.29 178.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 41.4 t-20 -89.34 151.5 22.04 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 177.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.504 ' HD2' ' N ' ' A' ' 41' ' ' GLU . 5.3 ppt_? -59.56 -26.42 65.36 Favored 'General case' 0 C--N 1.31 -1.135 0 C-N-CA 123.103 0.561 . . . . 0.0 111.828 177.745 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.504 ' N ' ' HD2' ' A' ' 40' ' ' ARG . 10.4 pt-20 -89.55 0.89 56.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.897 -177.655 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 80.8 mt -97.32 111.87 23.93 Favored 'General case' 0 CA--C 1.494 -1.177 0 CA-C-O 121.59 0.709 . . . . 0.0 111.211 -178.551 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 82.2 p -103.51 174.53 5.83 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-N 114.344 -1.298 . . . . 0.0 109.451 -178.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.456 ' HG3' ' HB2' ' A' ' 62' ' ' LEU . 2.0 mp0 -54.62 -40.66 69.16 Favored 'General case' 0 C--O 1.216 -0.676 0 C-N-CA 123.599 0.76 . . . . 0.0 109.586 177.738 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -59.48 -41.63 97.23 Favored Glycine 0 N--CA 1.445 -0.75 0 O-C-N 123.659 0.6 . . . . 0.0 113.163 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -66.69 -49.13 67.09 Favored 'General case' 0 CA--C 1.497 -1.071 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 -179.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 52.6 mt -58.37 -45.88 89.42 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.926 0 CA-C-N 114.992 -1.003 . . . . 0.0 110.493 179.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 35.0 mt -60.55 -45.71 92.87 Favored 'General case' 0 CA--C 1.5 -0.963 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 -177.365 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 80.2 m -62.92 -45.59 91.78 Favored 'General case' 0 N--CA 1.439 -1.016 0 O-C-N 123.308 0.38 . . . . 0.0 111.563 179.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.405 HG11 ' HG3' ' B' ' 237' ' ' ARG . 77.4 t -65.79 -47.18 86.66 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.157 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.036 -179.156 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -67.43 -22.95 65.49 Favored 'General case' 0 N--CA 1.429 -1.496 0 C-N-CA 123.624 0.77 . . . . 0.0 112.144 -178.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.408 ' OG ' ' HB2' ' B' ' 231' ' ' ARG . 68.3 m -69.13 -16.92 63.77 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.937 175.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -67.02 -26.63 66.87 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-O 121.246 0.546 . . . . 0.0 109.659 175.206 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.477 ' HH ' ' HB2' ' B' ' 237' ' ' ARG . 54.4 m-85 -95.73 -15.19 22.78 Favored 'General case' 0 CA--C 1.505 -0.784 0 CA-C-O 121.245 0.545 . . . . 0.0 112.392 -173.222 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 160.1 -152.19 22.96 Favored Glycine 0 N--CA 1.413 -2.849 0 N-CA-C 110.245 -1.142 . . . . 0.0 110.245 -179.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 65.3 t -104.74 109.21 62.7 Favored Pre-proline 0 C--N 1.288 -2.068 0 O-C-N 123.554 0.208 . . . . 0.0 110.466 -176.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.427 ' HB3' HD22 ' A' ' 77' ' ' LEU . 73.2 Cg_endo -77.57 135.58 14.74 Favored 'Trans proline' 0 N--CA 1.435 -1.966 0 C-N-CA 121.525 1.483 . . . . 0.0 108.595 174.259 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.402 ' CG2' ' HG3' ' A' ' 78' ' ' LYS . 35.2 m -109.85 -23.21 4.58 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 C-N-CA 119.309 -0.956 . . . . 0.0 111.81 -177.753 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -158.68 142.94 15.67 Favored 'General case' 0 CA--C 1.503 -0.836 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 14.6 p -140.79 135.12 33.72 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 178.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 86.4 mt -120.72 123.06 69.5 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.311 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 176.242 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.456 ' HB2' ' HG3' ' A' ' 44' ' ' GLU . 0.1 OUTLIER -98.61 119.64 37.69 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 177.298 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 28.3 m -83.91 116.79 22.95 Favored 'General case' 0 N--CA 1.404 -2.772 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 176.235 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 58.9 mtt180 -123.35 131.94 53.82 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 -175.625 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -66.37 127.05 30.77 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 175.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -60.77 -20.37 61.28 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 113.583 0.957 . . . . 0.0 113.583 -176.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 31.5 m-80 -81.04 -49.0 11.44 Favored 'General case' 0 CA--C 1.497 -1.065 0 C-N-CA 120.134 -0.626 . . . . 0.0 109.811 -177.492 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 72.3 p -88.35 -24.6 23.07 Favored 'General case' 0 C--N 1.312 -1.034 0 C-N-CA 120.22 -0.592 . . . . 0.0 111.528 -176.347 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 67.9 6.78 46.47 Favored Glycine 0 CA--C 1.527 0.798 0 CA-C-N 116.163 -0.471 . . . . 0.0 112.439 -178.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -90.74 -74.49 0.49 Allowed 'General case' 0 C--O 1.216 -0.708 0 CA-C-O 120.901 0.381 . . . . 0.0 111.503 -173.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 36.2 t -166.64 161.95 16.13 Favored 'General case' 0 N--CA 1.428 -1.536 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 -178.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -99.94 0.06 40.44 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 172.453 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 94.8 8.35 59.38 Favored Glycine 0 N--CA 1.427 -1.962 0 CA-C-N 114.96 -1.018 . . . . 0.0 112.472 178.582 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 37.2 p90 -150.09 154.99 39.05 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 179.258 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -150.1 170.47 18.83 Favored 'General case' 0 N--CA 1.427 -1.595 0 CA-C-O 120.925 0.393 . . . . 0.0 110.264 178.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -128.9 142.2 51.03 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.404 -179.021 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.427 HD22 ' HB3' ' A' ' 57' ' ' PRO . 9.8 tt -148.99 140.9 23.72 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 175.696 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.402 ' HG3' ' CG2' ' A' ' 58' ' ' VAL . 20.8 ptmt -122.66 144.02 49.41 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 178.665 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.42 ' HH ' ' CB ' ' A' ' 88' ' ' ALA . 45.8 m-85 -104.65 164.88 11.44 Favored 'General case' 0 C--N 1.29 -1.992 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.575 -179.233 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -71.15 -37.49 72.26 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 114.824 -1.08 . . . . 0.0 108.607 175.062 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -125.28 143.63 50.87 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.298 0.57 . . . . 0.0 111.74 -179.019 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.448 ' NE2' ' HB3' ' A' ' 31' ' ' ALA . 20.8 mp0 -69.93 -24.0 63.29 Favored 'General case' 0 C--N 1.312 -1.061 0 C-N-CA 124.91 1.284 . . . . 0.0 112.94 -177.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 56.1 mtm180 -67.88 -34.63 77.04 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-O 122.083 0.944 . . . . 0.0 109.592 175.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.448 ' OG ' HG22 ' B' ' 226' ' ' ILE . 48.6 m -66.04 -37.71 86.55 Favored 'General case' 0 C--N 1.286 -2.177 0 CA-C-N 114.808 -1.087 . . . . 0.0 111.619 175.798 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.5 ' O ' HG21 ' A' ' 89' ' ' VAL . 71.6 p -66.02 -45.33 81.87 Favored 'General case' 0 C--O 1.221 -0.402 0 C-N-CA 120.134 -0.626 . . . . 0.0 110.52 -178.058 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 8.3 pt -64.79 -37.39 80.03 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 C-N-CA 122.481 0.312 . . . . 0.0 111.111 177.521 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 9.7 mt -58.51 -44.08 89.35 Favored 'General case' 0 CA--C 1.504 -0.822 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.203 175.034 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.452 ' O ' ' HB2' ' A' ' 92' ' ' LEU . . . -71.56 -46.67 58.78 Favored 'General case' 0 N--CA 1.434 -1.269 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.953 -179.27 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.5 HG21 ' O ' ' A' ' 85' ' ' THR . 86.5 t -56.79 -49.9 76.83 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.201 0 CA-C-O 120.844 0.354 . . . . 0.0 111.429 -178.375 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -73.53 -28.65 62.0 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 112.751 0.649 . . . . 0.0 112.751 -173.127 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -87.76 -31.79 19.46 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-O 121.011 0.434 . . . . 0.0 110.572 -177.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.452 ' HB2' ' O ' ' A' ' 88' ' ' ALA . 10.0 mt -94.26 -30.32 14.62 Favored 'General case' 0 CA--C 1.501 -0.922 0 CA-C-N 116.03 -0.532 . . . . 0.0 112.386 -173.703 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 46.1 t30 -65.74 125.24 24.68 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 179.09 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 88.47 -7.73 80.91 Favored Glycine 0 N--CA 1.436 -1.35 0 CA-C-N 115.599 -0.728 . . . . 0.0 112.268 -178.048 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -81.94 138.96 34.88 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 -178.124 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.403 ' HA ' ' O ' ' A' ' 100' ' ' ARG . 11.7 mptt -99.2 125.12 44.72 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-O 121.14 0.495 . . . . 0.0 111.68 -177.295 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 58.7 mt -127.69 141.39 46.51 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 N-CA-C 105.761 -1.94 . . . . 0.0 105.761 173.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 64.17 7.42 24.65 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 121.12 -0.562 . . . . 0.0 114.311 179.173 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 97.22 0.13 59.93 Favored Glycine 0 N--CA 1.436 -1.312 0 C-N-CA 121.118 -0.563 . . . . 0.0 112.492 -176.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.403 ' O ' ' HA ' ' A' ' 96' ' ' LYS . 17.3 ptp180 -124.29 151.56 44.09 Favored 'General case' 0 C--N 1.317 -0.806 0 O-C-N 122.233 -0.569 . . . . 0.0 110.997 -179.493 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -89.73 120.03 30.65 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.513 -176.351 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 11.7 mt -68.7 145.15 54.11 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-O 121.71 0.766 . . . . 0.0 112.343 177.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 50.1 tptt -120.96 116.66 25.53 Favored 'General case' 0 N--CA 1.417 -2.106 0 CA-C-N 114.822 -1.081 . . . . 0.0 109.184 176.348 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.42 ' CD1' HG21 ' A' ' 35' ' ' ILE . 4.7 mm -119.37 134.31 63.38 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 179.574 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -144.89 157.74 44.05 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 177.417 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 2.8 m80 -81.96 131.63 35.25 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-O 121.236 0.541 . . . . 0.0 112.122 177.019 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 13.3 t -146.35 162.86 37.25 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 -177.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -110.25 110.91 21.91 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 107.046 -1.465 . . . . 0.0 107.046 171.057 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 74.4 t80 -107.2 138.98 42.36 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.228 -179.063 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.435 ' HD2' ' N ' ' A' ' 110' ' ' ARG . 4.2 mpt_? -115.25 115.42 42.66 Favored Pre-proline 0 C--N 1.312 -1.065 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 173.817 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -63.2 141.43 82.49 Favored 'Trans proline' 0 C--O 1.243 0.726 0 C-N-CA 123.318 2.679 . . . . 0.0 115.101 -177.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.444 ' C ' ' HD3' ' A' ' 112' ' ' LYS . 12.0 tmtt? -121.09 131.83 54.51 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 105.398 -2.075 . . . . 0.0 105.398 172.701 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.403 ' N ' ' HD3' ' A' ' 112' ' ' LYS . 28.7 mmt180 . . . . . 0 C--N 1.303 -1.418 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 179.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 64.7 t30 . . . . . 0 C--O 1.208 -1.121 0 N-CA-C 111.7 0.259 . . . . 0.0 111.7 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 223' ' ' ARG . . . . . . . . . . . . . 7.5 ptp180 86.53 8.95 0.24 Allowed 'General case' 0 N--CA 1.524 3.267 0 C-N-CA 126.461 1.904 . . . . 0.0 114.131 173.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 224' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -112.48 163.97 13.83 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -179.302 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 225' ' ' ALA . . . . . . . . . . . . . . . -131.63 81.61 1.99 Allowed 'General case' 0 C--N 1.31 -1.141 0 CA-C-O 121.25 0.547 . . . . 0.0 110.53 178.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 226' ' ' ILE . . . . . 0.448 HG22 ' OG ' ' A' ' 84' ' ' SER . 4.1 mp -121.66 137.73 54.33 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 176.563 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 227' ' ' MET . . . . . . . . . . . . . 65.9 mtt -69.22 137.64 89.25 Favored Pre-proline 0 C--N 1.311 -1.077 0 O-C-N 123.706 0.629 . . . . 0.0 110.135 179.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 228' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -67.43 154.03 75.0 Favored 'Trans proline' 0 C--O 1.248 1.023 0 C-N-CA 122.787 2.324 . . . . 0.0 112.269 179.606 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . -73.11 168.98 53.4 Favored Glycine 0 C--N 1.314 -0.668 0 CA-C-N 115.558 -0.747 . . . . 0.0 112.879 -179.65 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 23.4 m -76.67 -13.93 60.01 Favored 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 123.236 0.614 . . . . 0.0 112.157 -175.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 231' ' ' ARG . . . . . 0.408 ' HB2' ' OG ' ' A' ' 52' ' ' SER . 19.7 mmt180 -87.16 -0.05 56.08 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.954 0.406 . . . . 0.0 110.095 -178.313 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 232' ' ' TRP . . . . . . . . . . . . . 21.0 t90 -77.63 126.47 30.93 Favored 'General case' 0 N--CA 1.433 -1.3 0 CA-C-O 122.428 1.109 . . . . 0.0 112.392 -176.399 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 233' ' ' ASP . . . . . 0.447 ' O ' ' N ' ' B' ' 235' ' ' VAL . 26.1 t70 -121.84 144.3 48.91 Favored 'General case' 0 C--N 1.264 -3.117 0 N-CA-C 101.829 -3.397 . . . . 0.0 101.829 171.775 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -38.27 66.64 0.0 OUTLIER Glycine 0 N--CA 1.487 2.05 0 C-N-CA 128.065 2.745 . . . . 0.0 116.113 -178.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 235' ' ' VAL . . . . . 0.447 ' N ' ' O ' ' B' ' 233' ' ' ASP . 76.9 t -111.53 122.59 66.19 Favored 'Isoleucine or valine' 0 C--N 1.255 -3.536 0 C-N-CA 126.684 1.994 . . . . 0.0 107.887 175.265 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 236' ' ' HIS . . . . . . . . . . . . . 59.8 t-80 -112.78 122.5 47.85 Favored 'General case' 0 C--N 1.282 -2.327 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 178.19 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 237' ' ' ARG . . . . . 0.477 ' HB2' ' HH ' ' A' ' 54' ' ' TYR . 4.9 mmp_? -110.28 115.79 30.33 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 176.267 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 238' ' ' SER . . . . . 0.408 ' HB2' ' HB3' ' B' ' 241' ' ' PHE . 17.8 m -92.25 114.07 26.51 Favored 'General case' 0 C--N 1.283 -2.301 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -176.79 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 239' ' ' ASN . . . . . . . . . . . . . 17.5 p-10 -63.72 111.05 2.25 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.68 173.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 240' ' ' GLY . . . . . 0.501 ' O ' ' HG2' ' B' ' 244' ' ' LYS . . . 74.04 53.04 7.31 Favored Glycine 0 C--O 1.199 -2.077 0 N-CA-C 110.456 -1.058 . . . . 0.0 110.456 -178.158 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 241' ' ' PHE . . . . . 0.408 ' HB3' ' HB2' ' B' ' 238' ' ' SER . 51.1 p90 -64.42 -34.01 77.2 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 -176.825 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -63.8 -42.44 97.72 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 112.003 0.371 . . . . 0.0 112.003 -174.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 243' ' ' GLU . . . . . 0.474 ' HG2' ' O ' ' B' ' 240' ' ' GLY . 11.1 pt-20 -63.13 -34.7 78.19 Favored 'General case' 0 C--O 1.208 -1.08 0 N-CA-C 110.466 -0.198 . . . . 0.0 110.466 178.325 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 244' ' ' LYS . . . . . 0.501 ' HG2' ' O ' ' B' ' 240' ' ' GLY . 68.8 mmtt -67.72 -44.58 77.32 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 -179.046 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 245' ' ' TRP . . . . . . . . . . . . . 50.9 m0 -62.55 -41.52 98.95 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.725 178.036 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 246' ' ' PHE . . . . . 0.493 ' O ' ' HG2' ' B' ' 249' ' ' GLN . 5.1 t80 -65.53 -36.25 83.26 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.902 177.793 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -71.69 -35.67 70.34 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.206 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.19 -15.34 36.27 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 120.991 0.424 . . . . 0.0 111.704 -178.67 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 249' ' ' GLN . . . . . 0.493 ' HG2' ' O ' ' B' ' 246' ' ' PHE . 2.9 pt20 -81.53 2.96 26.69 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-O 120.982 0.42 . . . . 0.0 110.326 179.5 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 250' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -54.01 -27.83 34.33 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.911 177.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . 0.418 ' HB3' ' HB2' ' B' ' 254' ' ' GLU . 45.5 mt-10 -80.58 110.52 16.13 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 176.039 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 252' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -112.72 -33.98 2.2 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 CA-C-N 115.843 -0.617 . . . . 0.0 112.165 -173.475 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -118.89 -6.26 10.55 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 -178.099 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 254' ' ' GLU . . . . . 0.418 ' HB2' ' HB3' ' B' ' 251' ' ' GLU . 16.8 mp0 -75.03 -169.92 1.02 Allowed 'General case' 0 C--N 1.294 -1.829 0 CA-C-N 112.549 -2.114 . . . . 0.0 111.957 -179.177 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 255' ' ' LYS . . . . . . . . . . . . . 58.0 mttm -83.44 96.97 8.73 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.857 -176.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 256' ' ' LYS . . . . . . . . . . . . . 24.5 ttmm . . . . . 0 C--N 1.296 -1.727 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 179.694 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 17.4 m120 . . . . . 0 CA--C 1.507 -0.676 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -72.85 -18.9 61.4 Favored 'General case' 0 CA--C 1.507 -0.7 0 CA-C-O 121.787 0.803 . . . . 0.0 110.779 -178.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -81.19 1.55 31.58 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 114.664 -1.153 . . . . 0.0 111.83 -177.283 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -121.3 144.34 48.69 Favored 'General case' 0 CA--C 1.483 -1.598 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 175.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -99.77 15.98 25.14 Favored 'General case' 0 C--N 1.277 -2.568 0 CA-C-O 122.914 1.34 . . . . 0.0 108.175 -179.256 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -79.93 5.72 13.15 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-N 112.709 -2.041 . . . . 0.0 109.724 -177.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -92.57 13.41 19.94 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.786 -174.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 11.3 m-30 -93.24 144.95 24.81 Favored 'General case' 0 C--N 1.309 -1.183 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.524 -176.603 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 21.4 pt -142.81 165.84 15.76 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.981 0 C-N-CA 123.291 0.636 . . . . 0.0 110.152 175.265 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.405 ' HB2' HG22 ' A' ' 107' ' ' THR . 54.7 t80 -116.2 126.4 53.59 Favored 'General case' 0 N--CA 1.413 -2.28 0 CA-C-N 114.776 -1.102 . . . . 0.0 109.114 178.217 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.442 HG21 ' CD1' ' A' ' 104' ' ' ILE . 9.1 mt -110.74 127.98 67.42 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.016 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 175.601 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -127.65 165.61 20.66 Favored Glycine 0 C--N 1.281 -2.494 0 N-CA-C 111.346 -0.701 . . . . 0.0 111.346 -178.486 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 66.39 41.52 3.26 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.708 1.203 . . . . 0.0 110.824 -176.506 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.406 HD21 ' HA ' ' A' ' 74' ' ' PHE . 4.1 mm? -68.56 146.57 52.97 Favored 'General case' 0 CA--C 1.496 -1.122 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.489 177.375 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.452 ' ND2' ' HA3' ' A' ' 98' ' ' GLY . 61.1 t30 -89.84 147.84 23.54 Favored 'General case' 0 C--N 1.291 -1.945 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 178.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.476 ' C ' ' HD2' ' A' ' 40' ' ' ARG . 2.3 ppt_? -58.87 -21.75 57.8 Favored 'General case' 0 C--N 1.318 -0.772 0 O-C-N 123.623 0.577 . . . . 0.0 112.494 -175.353 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.402 ' HG2' ' ND2' ' A' ' 39' ' ' ASN . 13.4 pt-20 -99.86 -1.01 38.54 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.383 -175.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 81.3 mt -87.71 118.54 27.28 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-O 121.33 0.586 . . . . 0.0 110.459 178.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 77.0 p -105.31 174.09 6.03 Favored 'General case' 0 C--N 1.291 -1.943 0 CA-C-N 114.816 -1.084 . . . . 0.0 108.864 -178.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.497 ' CG ' ' HB2' ' A' ' 62' ' ' LEU . 70.2 mt-10 -56.38 -37.67 70.41 Favored 'General case' 0 C--O 1.216 -0.67 0 N-CA-C 109.954 -0.388 . . . . 0.0 109.954 177.598 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -61.62 -37.46 94.25 Favored Glycine 0 N--CA 1.445 -0.758 0 CA-C-N 115.722 -0.672 . . . . 0.0 113.113 179.529 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -67.26 -49.02 65.98 Favored 'General case' 0 CA--C 1.488 -1.432 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.279 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 46.7 mt -59.17 -45.67 92.62 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.14 0 CA-C-N 114.557 -1.202 . . . . 0.0 110.597 179.129 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 42.8 mt -59.65 -43.53 93.88 Favored 'General case' 0 CA--C 1.489 -1.369 0 C-N-CA 122.249 0.22 . . . . 0.0 111.137 -178.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 72.3 m -63.26 -46.6 86.09 Favored 'General case' 0 C--N 1.309 -1.157 0 O-C-N 123.531 0.519 . . . . 0.0 111.137 -178.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.459 HG11 ' HG3' ' B' ' 237' ' ' ARG . 93.5 t -67.55 -46.89 82.18 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.702 -178.805 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -68.54 -20.09 64.53 Favored 'General case' 0 N--CA 1.424 -1.751 0 CA-C-N 115.141 -0.936 . . . . 0.0 112.537 -177.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.423 ' HA ' ' O ' ' A' ' 55' ' ' GLY . 59.1 m -71.1 -22.44 62.09 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 176.179 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -73.27 -20.69 60.77 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 119.164 -1.015 . . . . 0.0 109.97 176.233 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 62.0 m-85 -92.97 -11.01 34.32 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-O 121.232 0.539 . . . . 0.0 111.865 -179.208 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.423 ' O ' ' HA ' ' A' ' 52' ' ' SER . . . 156.96 -164.04 32.57 Favored Glycine 0 N--CA 1.424 -2.108 0 N-CA-C 110.954 -0.858 . . . . 0.0 110.954 179.091 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 80.9 t -96.31 109.75 49.04 Favored Pre-proline 0 C--N 1.299 -1.623 0 N-CA-C 110.078 -0.342 . . . . 0.0 110.078 -179.301 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.4 ' HB3' HD22 ' A' ' 77' ' ' LEU . 86.9 Cg_endo -79.41 136.87 12.8 Favored 'Trans proline' 0 N--CA 1.443 -1.442 0 C-N-CA 122.461 2.108 . . . . 0.0 109.301 176.14 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 33.8 m -110.84 -24.11 4.14 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 C-N-CA 119.2 -1.0 . . . . 0.0 111.67 -178.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.446 ' HB3' ' HG2' ' A' ' 78' ' ' LYS . 27.4 t70 -155.03 142.29 19.45 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -179.467 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 14.4 p -143.58 136.94 24.85 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 179.411 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 90.8 mt -121.88 121.17 63.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 175.08 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.497 ' HB2' ' CG ' ' A' ' 44' ' ' GLU . 0.2 OUTLIER -95.89 116.82 29.49 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 106.245 -1.761 . . . . 0.0 106.245 172.544 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 44.3 m -77.21 116.32 17.74 Favored 'General case' 0 N--CA 1.419 -1.998 0 N-CA-C 107.37 -1.345 . . . . 0.0 107.37 176.2 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 21.1 mtp180 -117.24 128.21 54.86 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-O 120.819 0.342 . . . . 0.0 110.332 -175.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -67.61 127.37 32.49 Favored 'General case' 0 CA--C 1.489 -1.376 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.283 178.031 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -60.95 -29.69 69.78 Favored 'General case' 0 C--N 1.295 -1.766 0 C-N-CA 123.943 0.897 . . . . 0.0 112.595 -178.571 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 28.1 m-80 -79.92 -46.58 16.51 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 120.942 0.401 . . . . 0.0 110.782 -172.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 48.7 p -85.3 -24.49 27.68 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-O 121.402 0.62 . . . . 0.0 109.887 -179.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.71 7.53 61.68 Favored Glycine 0 N--CA 1.442 -0.962 0 CA-C-N 115.414 -0.812 . . . . 0.0 112.357 -178.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.439 ' OE2' ' HD3' ' A' ' 40' ' ' ARG . 36.7 mt-10 -106.03 -70.29 0.79 Allowed 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -173.886 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 32.0 t -157.4 159.26 37.2 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 -178.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 18.3 mm-40 -92.22 -16.07 26.69 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 173.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 94.73 12.76 55.25 Favored Glycine 0 N--CA 1.427 -1.962 0 C-N-CA 120.44 -0.886 . . . . 0.0 112.164 -177.416 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.406 ' HA ' HD21 ' A' ' 38' ' ' LEU . 33.4 p90 -151.59 153.32 34.27 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 176.397 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -150.11 175.71 11.49 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-O 120.836 0.351 . . . . 0.0 110.818 -179.44 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -136.5 144.12 44.15 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 123.576 0.75 . . . . 0.0 110.003 -177.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.4 HD22 ' HB3' ' A' ' 57' ' ' PRO . 10.2 tt -150.38 141.59 23.17 Favored 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 176.065 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.446 ' HG2' ' HB3' ' A' ' 59' ' ' ASP . 22.0 ptmt -124.03 144.34 49.89 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-O 121.294 0.569 . . . . 0.0 109.516 178.584 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -107.6 165.92 11.06 Favored 'General case' 0 C--N 1.286 -2.177 0 CA-C-N 115.406 -0.815 . . . . 0.0 111.683 -178.019 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -75.32 -29.05 59.9 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 115.002 -0.999 . . . . 0.0 108.77 172.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -119.63 136.72 54.27 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 -176.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 19.8 mp0 -69.77 -27.61 65.07 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.449 ' O ' HG12 ' A' ' 86' ' ' ILE . 90.0 mtm180 -65.61 -33.85 76.87 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 122.301 1.048 . . . . 0.0 110.032 179.0 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.452 ' OG ' HG22 ' B' ' 226' ' ' ILE . 51.6 m -58.53 -37.14 75.02 Favored 'General case' 0 C--N 1.281 -2.379 0 CA-C-N 114.781 -1.1 . . . . 0.0 111.734 176.237 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.429 ' O ' HG21 ' A' ' 89' ' ' VAL . 43.9 p -63.33 -45.07 92.95 Favored 'General case' 0 C--N 1.347 0.487 0 C-N-CA 120.452 -0.499 . . . . 0.0 110.731 -178.482 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.449 HG12 ' O ' ' A' ' 83' ' ' ARG . 4.1 pt -66.64 -38.15 81.01 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.508 178.894 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 13.6 mt -59.4 -44.25 92.84 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 123.38 0.425 . . . . 0.0 111.28 175.437 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -71.74 -46.42 58.57 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.212 -178.586 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.429 HG21 ' O ' ' A' ' 85' ' ' THR . 69.6 t -56.93 -44.09 81.78 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.104 0 CA-C-O 121.297 0.57 . . . . 0.0 111.09 178.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -63.69 -41.53 98.13 Favored 'General case' 0 C--N 1.29 -1.996 0 C-N-CA 123.291 0.637 . . . . 0.0 112.239 -176.064 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 40.0 m-80 -90.28 -29.73 17.96 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-N 115.632 -0.713 . . . . 0.0 112.869 -173.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 15.2 mt -93.37 -31.18 14.74 Favored 'General case' 0 CA--C 1.486 -1.502 0 N-CA-C 112.257 0.466 . . . . 0.0 112.257 -172.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -66.32 124.6 23.13 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.039 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 89.19 -2.59 83.76 Favored Glycine 0 C--N 1.308 -1.004 0 C-N-CA 121.33 -0.462 . . . . 0.0 112.269 -178.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 37.2 t80 -89.23 134.98 33.82 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 -179.096 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.462 ' HA ' ' O ' ' A' ' 100' ' ' ARG . 12.1 mptt -95.42 116.38 28.72 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-O 120.914 0.388 . . . . 0.0 111.826 -177.67 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 60.6 mt -119.3 141.45 39.23 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 N-CA-C 104.946 -2.242 . . . . 0.0 104.946 172.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.452 ' HA3' ' ND2' ' A' ' 39' ' ' ASN . . . 58.19 28.02 60.92 Favored Glycine 0 C--N 1.317 -0.496 0 C-N-CA 121.331 -0.461 . . . . 0.0 112.646 -178.775 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 79.99 -5.84 61.19 Favored Glycine 0 CA--C 1.529 0.907 0 CA-C-O 119.933 -0.37 . . . . 0.0 113.863 -179.447 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.462 ' O ' ' HA ' ' A' ' 96' ' ' LYS . 16.6 ptp180 -116.43 149.71 39.0 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 117.721 0.76 . . . . 0.0 111.198 -176.311 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -88.44 117.2 27.2 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.537 -175.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 10.4 mt -65.71 136.07 55.78 Favored 'General case' 0 CA--C 1.494 -1.191 0 CA-C-O 121.491 0.663 . . . . 0.0 111.961 178.503 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 27.4 tptp -113.6 116.29 29.26 Favored 'General case' 0 N--CA 1.41 -2.45 0 CA-C-N 115.218 -0.901 . . . . 0.0 108.633 176.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.442 ' CD1' HG21 ' A' ' 35' ' ' ILE . 5.3 mm -111.02 142.32 23.75 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.192 0 N-CA-C 106.265 -1.754 . . . . 0.0 106.265 177.858 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -144.6 151.66 39.36 Favored 'General case' 0 C--N 1.29 -1.995 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 178.564 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 69.7 m-70 -83.42 130.53 35.04 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 175.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.405 HG22 ' HB2' ' A' ' 34' ' ' TYR . 6.2 t -153.79 165.19 36.79 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 -177.839 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -107.6 112.28 24.93 Favored 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 105.604 -1.999 . . . . 0.0 105.604 168.214 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 25.8 t80 -104.84 132.41 51.11 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 -175.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 19.4 mmm180 -117.4 115.28 37.88 Favored Pre-proline 0 C--N 1.295 -1.777 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 178.685 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -68.42 137.55 39.95 Favored 'Trans proline' 0 C--N 1.322 -0.855 0 C-N-CA 123.404 2.736 . . . . 0.0 114.222 -176.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 27.5 tptp -98.58 119.52 37.45 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.461 177.482 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 28.3 mmt180 . . . . . 0 C--N 1.3 -1.546 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 177.18 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 51.4 t-20 . . . . . 0 C--O 1.219 -0.531 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 223' ' ' ARG . . . . . . . . . . . . 0.258 9.8 ptm180 69.62 22.08 6.38 Favored 'General case' 0 N--CA 1.498 1.942 0 C-N-CA 127.95 2.5 . . . . 0.0 114.942 177.429 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 224' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -97.01 163.85 12.77 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 122.029 -0.419 . . . . 0.0 109.973 177.58 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 225' ' ' ALA . . . . . . . . . . . . . . . -137.05 84.58 2.07 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-O 121.85 0.833 . . . . 0.0 110.447 179.104 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 226' ' ' ILE . . . . . 0.452 HG22 ' OG ' ' A' ' 84' ' ' SER . 3.9 mp -124.0 137.49 56.86 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 177.369 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 227' ' ' MET . . . . . . . . . . . . . 67.5 mtt -70.24 133.55 87.47 Favored Pre-proline 0 C--N 1.309 -1.162 0 O-C-N 123.427 0.454 . . . . 0.0 110.306 178.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 228' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -68.05 154.36 72.77 Favored 'Trans proline' 0 C--O 1.245 0.851 0 C-N-CA 122.785 2.323 . . . . 0.0 112.272 -179.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . -72.44 168.2 52.85 Favored Glycine 0 N--CA 1.44 -1.04 0 CA-C-N 115.557 -0.747 . . . . 0.0 113.035 -179.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 5.0 p -77.44 -23.52 50.51 Favored 'General case' 0 C--N 1.298 -1.646 0 C-N-CA 123.431 0.692 . . . . 0.0 112.354 -177.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 1.8 mmp_? -79.33 1.88 23.5 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.729 -176.127 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 232' ' ' TRP . . . . . 0.406 ' HB2' ' CB ' ' A' ' 52' ' ' SER . 24.4 t90 -79.33 123.37 27.41 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 122.031 0.919 . . . . 0.0 111.908 -178.83 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 233' ' ' ASP . . . . . 0.442 ' O ' ' N ' ' B' ' 235' ' ' VAL . 12.8 t70 -113.2 149.35 33.83 Favored 'General case' 0 C--N 1.284 -2.271 0 N-CA-C 102.645 -3.094 . . . . 0.0 102.645 172.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -48.54 59.47 0.0 OUTLIER Glycine 0 N--CA 1.491 2.331 0 C-N-CA 127.53 2.49 . . . . 0.0 115.884 -178.101 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 235' ' ' VAL . . . . . 0.442 ' N ' ' O ' ' B' ' 233' ' ' ASP . 55.6 t -111.59 123.6 67.57 Favored 'Isoleucine or valine' 0 C--N 1.25 -3.725 0 C-N-CA 128.884 2.874 . . . . 0.0 106.194 175.007 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 236' ' ' HIS . . . . . . . . . . . . . 47.5 t60 -110.81 125.02 53.13 Favored 'General case' 0 C--N 1.28 -2.425 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.352 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 237' ' ' ARG . . . . . 0.459 ' HG3' HG11 ' A' ' 50' ' ' VAL . 31.6 mmt180 -127.45 109.59 11.9 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-O 121.132 0.491 . . . . 0.0 109.792 178.643 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 238' ' ' SER . . . . . . . . . . . . . 21.1 t -129.26 154.12 47.12 Favored 'General case' 0 C--N 1.285 -2.202 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 -178.573 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 239' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -27.74 104.33 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 126.123 1.769 . . . . 0.0 112.509 -176.481 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 240' ' ' GLY . . . . . 0.578 ' O ' ' HG2' ' B' ' 244' ' ' LYS . . . -68.56 -39.05 86.98 Favored Glycine 0 C--O 1.191 -2.546 0 CA-C-N 115.059 -0.973 . . . . 0.0 112.083 -177.126 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -61.89 -33.08 73.56 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 116.914 0.357 . . . . 0.0 111.618 -179.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -60.34 -44.88 95.11 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.307 -175.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 243' ' ' GLU . . . . . 0.45 ' HG2' ' O ' ' B' ' 240' ' ' GLY . 9.8 pt-20 -67.59 -35.46 79.03 Favored 'General case' 0 C--O 1.201 -1.472 0 C-N-CA 120.799 -0.36 . . . . 0.0 110.543 179.532 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 244' ' ' LYS . . . . . 0.578 ' HG2' ' O ' ' B' ' 240' ' ' GLY . 67.7 mmtt -68.1 -42.15 80.73 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-O 121.004 0.431 . . . . 0.0 110.408 -176.497 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 245' ' ' TRP . . . . . . . . . . . . . 50.9 m0 -63.39 -43.04 98.72 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 178.545 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 246' ' ' PHE . . . . . 0.413 ' HA ' ' CD ' ' B' ' 249' ' ' GLN . 5.5 t80 -67.14 -33.21 74.94 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 114.866 -1.061 . . . . 0.0 110.869 178.237 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -77.21 -21.4 53.92 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.98 -177.412 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.33 -30.04 13.64 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 119.934 -0.706 . . . . 0.0 110.806 179.255 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 249' ' ' GLN . . . . . 0.413 ' CD ' ' HA ' ' B' ' 246' ' ' PHE . 3.7 pt20 -68.52 -12.19 60.9 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.074 -176.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 250' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -57.39 -30.13 64.65 Favored 'General case' 0 N--CA 1.482 1.153 0 CA-C-N 115.538 -0.755 . . . . 0.0 112.093 177.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -117.39 166.85 11.83 Favored 'General case' 0 N--CA 1.414 -2.261 0 CA-C-N 115.412 -0.813 . . . . 0.0 112.836 -175.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 252' ' ' ILE . . . . . . . . . . . . . 32.3 pt -126.26 -27.66 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 CA-C-N 113.879 -1.51 . . . . 0.0 109.8 176.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -125.99 -34.0 2.62 Favored 'General case' 0 C--O 1.221 -0.397 0 N-CA-C 113.356 0.872 . . . . 0.0 113.356 -175.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 254' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -77.03 165.98 23.91 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 113.963 1.098 . . . . 0.0 113.963 -179.097 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 255' ' ' LYS . . . . . . . . . . . . . 56.8 mttp -97.54 75.89 2.5 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 114.22 1.192 . . . . 0.0 114.22 -167.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 256' ' ' LYS . . . . . . . . . . . . . 1.9 ttpm? . . . . . 0 C--O 1.253 1.239 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 171.209 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.512 ' HB2' ' NE2' ' A' ' 82' ' ' GLN . . . . . . . . 0 N--CA 1.452 -0.357 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -108.9 145.67 35.01 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 115.056 -0.974 . . . . 0.0 109.049 -173.305 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 26.7 pt -142.57 163.1 18.14 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 CA-C-O 121.408 0.623 . . . . 0.0 111.045 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.424 ' HB2' HG21 ' A' ' 107' ' ' THR . 17.7 t80 -114.52 127.07 55.61 Favored 'General case' 0 N--CA 1.415 -2.188 0 CA-C-N 114.383 -1.281 . . . . 0.0 108.787 176.778 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.485 HG23 ' CD1' ' A' ' 104' ' ' ILE . 9.5 mt -110.09 127.79 66.75 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.795 0 N-CA-C 107.335 -1.358 . . . . 0.0 107.335 177.613 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -127.43 165.69 20.45 Favored Glycine 0 C--N 1.284 -2.314 0 N-CA-C 110.607 -0.997 . . . . 0.0 110.607 179.455 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 71.7 m-20 72.18 40.58 0.69 Allowed 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.742 1.217 . . . . 0.0 110.038 -178.716 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.521 HD11 HD11 ' A' ' 47' ' ' ILE . 3.9 mm? -72.71 144.84 47.53 Favored 'General case' 0 CA--C 1.495 -1.153 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.551 178.804 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.461 ' HB3' ' HG ' ' A' ' 42' ' ' LEU . 42.0 t-20 -83.13 146.09 28.85 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 106.549 -1.649 . . . . 0.0 106.549 176.673 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.525 ' HD2' ' N ' ' A' ' 41' ' ' GLU . 5.8 ppt_? -60.76 -19.22 58.74 Favored 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 123.3 0.64 . . . . 0.0 112.051 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.525 ' N ' ' HD2' ' A' ' 40' ' ' ARG . 8.9 pt-20 -99.99 5.66 45.13 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.965 -178.046 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.461 ' HG ' ' HB3' ' A' ' 39' ' ' ASN . 71.1 mt -96.51 126.22 41.54 Favored 'General case' 0 C--N 1.309 -1.179 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.701 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 12.5 t -117.67 175.84 5.46 Favored 'General case' 0 N--CA 1.428 -1.53 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.18 -179.31 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.421 ' CG ' ' HB2' ' A' ' 62' ' ' LEU . 42.1 mt-10 -54.39 -39.62 67.41 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 123.743 0.817 . . . . 0.0 111.401 -176.014 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.87 -37.73 94.21 Favored Glycine 0 CA--C 1.521 0.417 0 C-N-CA 121.317 -0.468 . . . . 0.0 113.402 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -67.12 -49.17 65.84 Favored 'General case' 0 CA--C 1.499 -0.995 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.521 HD11 HD11 ' A' ' 38' ' ' LEU . 38.6 mt -61.01 -45.3 98.83 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.902 0 CA-C-N 114.861 -1.063 . . . . 0.0 110.854 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 38.1 mt -60.07 -45.75 91.86 Favored 'General case' 0 CA--C 1.494 -1.186 0 N-CA-C 111.676 0.25 . . . . 0.0 111.676 -176.552 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.479 HG23 ' H ' ' B' ' 233' ' ' ASP . 100.0 m -62.77 -45.59 91.99 Favored 'General case' 0 C--N 1.307 -1.263 0 O-C-N 123.551 0.532 . . . . 0.0 111.913 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.43 ' O ' ' HG2' ' A' ' 53' ' ' GLU . 54.6 t -66.13 -49.12 78.66 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.633 -179.794 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.462 ' HA ' ' HD2' ' A' ' 54' ' ' TYR . 3.7 m-85 -65.21 -23.03 66.97 Favored 'General case' 0 N--CA 1.425 -1.697 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.409 -178.124 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.491 ' OG ' ' HB2' ' B' ' 231' ' ' ARG . 58.7 m -69.35 -22.03 63.78 Favored 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 177.099 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.43 ' HG2' ' O ' ' A' ' 50' ' ' VAL . 7.8 pt-20 -73.52 -20.21 60.72 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 117.642 -1.623 . . . . 0.0 110.4 177.326 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.462 ' HD2' ' HA ' ' A' ' 51' ' ' PHE . 48.0 m-85 -92.36 -10.3 38.69 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-O 121.225 0.536 . . . . 0.0 111.135 -178.327 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 157.21 -154.9 25.93 Favored Glycine 0 N--CA 1.422 -2.296 0 C-N-CA 120.323 -0.941 . . . . 0.0 111.721 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 87.2 t -104.52 111.14 65.15 Favored Pre-proline 0 C--N 1.3 -1.557 0 N-CA-C 111.245 0.091 . . . . 0.0 111.245 -177.468 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.481 ' HB3' HD21 ' A' ' 77' ' ' LEU . 95.6 Cg_endo -79.84 137.34 12.52 Favored 'Trans proline' 0 N--CA 1.449 -1.133 0 C-N-CA 122.652 2.234 . . . . 0.0 109.676 175.325 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 30.7 m -111.76 -33.56 2.25 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 C-N-CA 119.355 -0.938 . . . . 0.0 111.553 179.552 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.467 ' HB3' ' HG2' ' A' ' 78' ' ' LYS . 29.3 t70 -146.13 145.59 30.55 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 -179.793 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 14.5 p -143.65 135.33 23.04 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.482 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 99.3 mt -121.05 118.76 57.26 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 175.055 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.431 HD12 ' HG3' ' A' ' 64' ' ' ARG . 0.1 OUTLIER -98.1 114.4 26.57 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 106.014 -1.847 . . . . 0.0 106.014 174.781 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 43.7 m -76.85 116.59 17.66 Favored 'General case' 0 N--CA 1.404 -2.773 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 178.356 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.431 ' HG3' HD12 ' A' ' 62' ' ' LEU . 34.1 mtm180 . . . . . 0 C--N 1.294 -1.811 0 CA-C-N 115.336 -0.847 . . . . 0.0 108.83 -176.552 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 . . . . . 0 CA--C 1.518 -0.265 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 84.71 8.95 82.07 Favored Glycine 0 C--N 1.308 -0.975 0 C-N-CA 120.926 -0.654 . . . . 0.0 113.569 179.579 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 36.7 p90 -154.98 157.79 38.21 Favored 'General case' 0 N--CA 1.436 -1.139 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 178.879 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -153.11 176.23 12.14 Favored 'General case' 0 N--CA 1.436 -1.143 0 O-C-N 123.556 0.535 . . . . 0.0 110.321 179.0 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -137.04 146.26 45.03 Favored 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 123.966 0.906 . . . . 0.0 109.856 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.481 HD21 ' HB3' ' A' ' 57' ' ' PRO . 10.0 tt -152.28 140.6 20.5 Favored 'General case' 0 N--CA 1.436 -1.143 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 175.128 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.467 ' HG2' ' HB3' ' A' ' 59' ' ' ASP . 18.8 ptmt -123.15 144.35 49.4 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 178.465 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 69.8 m-85 -102.47 164.88 11.42 Favored 'General case' 0 C--N 1.281 -2.378 0 CA-C-N 115.21 -0.905 . . . . 0.0 111.368 -178.451 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -79.1 -26.63 42.92 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 114.436 -1.256 . . . . 0.0 108.521 175.421 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -122.99 132.37 54.11 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.249 -175.209 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.512 ' NE2' ' HB2' ' A' ' 31' ' ' ALA . 15.9 mp0 -64.03 -30.33 71.41 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 179.547 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.88 -33.29 74.44 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-O 122.348 1.071 . . . . 0.0 110.353 -179.279 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 48.8 m -58.04 -36.47 72.8 Favored 'General case' 0 C--N 1.278 -2.511 0 CA-C-N 114.965 -1.016 . . . . 0.0 111.452 175.416 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.432 ' O ' HG23 ' A' ' 89' ' ' VAL . 36.9 p -63.91 -45.21 90.29 Favored 'General case' 0 C--O 1.213 -0.858 0 C-N-CA 120.332 -0.547 . . . . 0.0 110.9 -178.743 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 3.2 pt -64.94 -38.52 82.98 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.6 0 C-N-CA 122.391 0.276 . . . . 0.0 110.793 178.691 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 16.1 mt -59.09 -44.31 91.92 Favored 'General case' 0 CA--C 1.509 -0.601 0 O-C-N 123.659 0.599 . . . . 0.0 110.61 175.763 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.41 ' O ' ' HB2' ' A' ' 92' ' ' LEU . . . -72.92 -47.67 43.74 Favored 'General case' 0 N--CA 1.435 -1.195 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 179.464 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.471 HG22 HG22 ' A' ' 104' ' ' ILE . 72.4 t -59.26 -48.99 85.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 N-CA-C 112.127 0.418 . . . . 0.0 112.127 -176.325 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -73.27 -27.14 61.4 Favored 'General case' 0 C--N 1.294 -1.824 0 CA-C-O 121.466 0.65 . . . . 0.0 111.893 -172.09 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -91.59 -31.51 15.87 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.945 -177.379 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.443 ' HB2' HG13 ' A' ' 104' ' ' ILE . 9.9 mt -91.69 -29.7 16.7 Favored 'General case' 0 C--N 1.313 -1.006 0 C-N-CA 122.509 0.324 . . . . 0.0 111.566 -174.743 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 51.5 t-20 -65.49 124.72 23.06 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.254 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 86.9 -5.54 84.88 Favored Glycine 0 N--CA 1.435 -1.412 0 C-N-CA 121.256 -0.497 . . . . 0.0 112.568 179.213 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -85.7 139.04 31.69 Favored 'General case' 0 N--CA 1.44 -0.96 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 -178.781 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.494 ' HE3' ' HB2' ' A' ' 101' ' ' ALA . 11.7 mptt -94.6 119.18 32.85 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-O 121.056 0.455 . . . . 0.0 111.652 -176.41 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.431 HD12 HD12 ' A' ' 102' ' ' LEU . 54.2 mt -126.03 141.34 45.97 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 N-CA-C 106.144 -1.798 . . . . 0.0 106.144 174.162 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.431 ' HA3' HD22 ' A' ' 39' ' ' ASN . . . 59.22 21.23 53.02 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 121.539 -0.363 . . . . 0.0 113.345 -179.38 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 85.04 6.84 84.44 Favored Glycine 0 N--CA 1.435 -1.406 0 C-N-CA 121.27 -0.49 . . . . 0.0 113.335 -179.425 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 19.3 ptp180 -132.15 146.77 52.26 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 117.772 0.786 . . . . 0.0 111.668 179.538 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.494 ' HB2' ' HE3' ' A' ' 96' ' ' LYS . . . -80.1 118.03 21.45 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.59 -178.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.431 HD12 HD12 ' A' ' 97' ' ' ILE . 11.6 mt -70.76 144.64 50.84 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-O 121.604 0.716 . . . . 0.0 112.702 178.649 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 23.4 tptm -118.14 116.96 27.9 Favored 'General case' 0 N--CA 1.419 -1.981 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.141 177.292 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.485 ' CD1' HG23 ' A' ' 35' ' ' ILE . 5.7 mm -117.86 138.32 48.92 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 179.022 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -143.36 150.64 39.42 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 179.524 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 82.7 m-70 -83.23 133.81 34.98 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 178.621 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.424 HG21 ' HB2' ' A' ' 34' ' ' TYR . 7.3 t -154.66 152.95 30.57 Favored 'General case' 0 N--CA 1.423 -1.777 0 N-CA-C 107.262 -1.385 . . . . 0.0 107.262 -178.848 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 41.5 p90 -91.74 112.24 24.08 Favored 'General case' 0 N--CA 1.429 -1.517 0 N-CA-C 106.474 -1.676 . . . . 0.0 106.474 171.706 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 43.8 t80 . . . . . 0 C--N 1.28 -2.425 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 -179.441 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 4.6 mp . . . . . 0 N--CA 1.45 -0.473 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 227' ' ' MET . . . . . . . . . . . . . 65.6 mtt -81.85 135.08 49.08 Favored Pre-proline 0 C--N 1.305 -1.36 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.727 -178.835 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 228' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -57.2 148.64 68.79 Favored 'Trans proline' 0 C--O 1.255 1.341 0 C-N-CA 123.692 2.928 . . . . 0.0 114.419 -177.582 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . -74.07 170.87 52.93 Favored Glycine 0 N--CA 1.44 -1.05 0 CA-C-N 114.71 -1.132 . . . . 0.0 112.972 -179.154 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 18.9 m -77.71 -14.17 59.69 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 -172.772 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 231' ' ' ARG . . . . . 0.491 ' HB2' ' OG ' ' A' ' 52' ' ' SER . 10.7 mmm180 -84.93 -1.63 56.9 Favored 'General case' 0 C--N 1.32 -0.703 0 O-C-N 121.84 -0.537 . . . . 0.0 110.347 -179.229 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 232' ' ' TRP . . . . . . . . . . . . . 22.8 t90 -76.95 125.19 28.89 Favored 'General case' 0 N--CA 1.436 -1.161 0 CA-C-O 122.496 1.141 . . . . 0.0 112.599 -176.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 233' ' ' ASP . . . . . 0.479 ' H ' HG23 ' A' ' 49' ' ' THR . 16.0 t70 -120.59 148.19 44.21 Favored 'General case' 0 C--N 1.271 -2.846 0 N-CA-C 102.326 -3.213 . . . . 0.0 102.326 172.665 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.502 3.072 0 C-N-CA 128.312 2.863 . . . . 0.0 116.526 -176.939 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 240' ' ' GLY . . . . . 0.405 ' O ' ' HG2' ' B' ' 243' ' ' GLU . . . . . . . . 0 N--CA 1.426 -1.999 0 N-CA-C 110.624 -0.991 . . . . 0.0 110.624 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 20.7 p90 -76.29 -32.68 58.92 Favored 'General case' 0 C--N 1.297 -1.701 0 CA-C-O 121.045 0.45 . . . . 0.0 109.863 175.601 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -60.54 -39.23 87.15 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.934 -178.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 243' ' ' GLU . . . . . 0.405 ' HG2' ' O ' ' B' ' 240' ' ' GLY . 9.3 pt-20 -65.52 -34.99 79.55 Favored 'General case' 0 C--O 1.208 -1.128 0 C-N-CA 121.158 -0.217 . . . . 0.0 111.094 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 68.3 mmtt -68.0 -39.87 83.14 Favored 'General case' 0 CA--C 1.509 -0.616 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 -178.245 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 245' ' ' TRP . . . . . . . . . . . . . 51.0 m0 -65.95 -43.56 87.6 Favored 'General case' 0 N--CA 1.438 -1.044 0 CA-C-N 114.795 -1.093 . . . . 0.0 109.492 176.775 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 246' ' ' PHE . . . . . 0.528 ' O ' ' HG2' ' B' ' 249' ' ' GLN . 2.4 t80 -61.98 -39.85 93.59 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.215 178.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.96 -33.71 76.33 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.928 -178.563 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.69 -17.37 20.38 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -178.101 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 249' ' ' GLN . . . . . 0.528 ' HG2' ' O ' ' B' ' 246' ' ' PHE . 10.4 pt20 -80.04 3.44 20.24 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 177.798 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 250' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -51.45 -28.76 14.01 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.873 1.269 . . . . 0.0 112.094 -179.529 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 251' ' ' GLU . . . . . 0.415 ' HG3' ' HB3' ' B' ' 254' ' ' GLU . 8.4 mm-40 -58.59 150.48 22.93 Favored 'General case' 0 N--CA 1.426 -1.63 0 N-CA-C 115.272 1.582 . . . . 0.0 115.272 -179.427 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 252' ' ' ILE . . . . . . . . . . . . . 31.7 pt -110.17 -29.32 2.49 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 CA-C-N 113.829 -1.532 . . . . 0.0 109.905 -178.423 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -115.82 -34.71 4.71 Favored 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 120.233 -0.587 . . . . 0.0 110.511 -178.046 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 254' ' ' GLU . . . . . 0.415 ' HB3' ' HG3' ' B' ' 251' ' ' GLU . 5.2 tt0 . . . . . 0 N--CA 1.436 -1.15 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.777 -174.202 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.568 ' HA ' HG21 ' A' ' 85' ' ' THR . . . . . . . . 0 N--CA 1.438 -1.032 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 -100.95 144.54 29.77 Favored 'General case' 0 N--CA 1.436 -1.14 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 -177.397 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 26.9 pt -142.85 156.68 17.96 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 CA-C-O 121.151 0.5 . . . . 0.0 110.224 178.793 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.408 ' HB2' HG21 ' A' ' 107' ' ' THR . 20.4 t80 -108.45 124.32 50.22 Favored 'General case' 0 C--N 1.285 -2.229 0 CA-C-N 114.566 -1.197 . . . . 0.0 108.624 177.043 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.437 HG23 ' CD1' ' A' ' 104' ' ' ILE . 10.3 mt -108.28 127.52 64.51 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.935 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 175.908 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -124.65 157.91 19.05 Favored Glycine 0 C--N 1.279 -2.599 0 N-CA-C 111.155 -0.778 . . . . 0.0 111.155 -179.249 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 50.6 m-20 68.35 70.12 0.31 Allowed 'General case' 0 C--N 1.31 -1.133 0 C-N-CA 125.745 1.618 . . . . 0.0 109.908 -177.778 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.402 HD11 HD11 ' A' ' 47' ' ' ILE . 2.9 mm? -100.6 141.47 33.41 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 115.114 -0.948 . . . . 0.0 111.846 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.449 ' HB2' ' NH1' ' A' ' 100' ' ' ARG . 39.1 t-20 -76.41 144.21 40.15 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 174.73 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.434 ' HD2' ' C ' ' A' ' 40' ' ' ARG . 0.9 OUTLIER -59.46 -26.24 65.06 Favored 'General case' 0 C--N 1.312 -1.061 0 C-N-CA 123.278 0.631 . . . . 0.0 111.665 179.057 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.401 ' HG2' ' CG ' ' A' ' 39' ' ' ASN . 13.0 pt-20 -85.98 -0.89 56.63 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.383 -0.372 . . . . 0.0 111.767 -176.917 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.433 ' HG ' ' HB3' ' A' ' 39' ' ' ASN . 87.6 mt -94.3 127.38 40.13 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-O 121.081 0.467 . . . . 0.0 110.882 -179.649 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 63.2 p -116.52 175.03 5.75 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-N 115.072 -0.967 . . . . 0.0 108.678 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.401 ' HG3' ' HB2' ' A' ' 62' ' ' LEU . 5.8 mp0 -54.2 -40.6 67.74 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 122.716 0.406 . . . . 0.0 110.983 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -59.07 -38.08 92.51 Favored Glycine 0 N--CA 1.449 -0.498 0 CA-C-N 116.384 -0.371 . . . . 0.0 113.183 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -68.05 -49.23 62.64 Favored 'General case' 0 CA--C 1.496 -1.096 0 CA-C-O 121.022 0.439 . . . . 0.0 109.852 179.499 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.402 HD11 HD11 ' A' ' 38' ' ' LEU . 26.3 mt -60.31 -41.04 85.69 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.559 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.639 179.651 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 57.1 mt -59.52 -42.44 92.25 Favored 'General case' 0 C--O 1.206 -1.189 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.095 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 90.7 m -61.47 -46.01 91.86 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 120.842 0.353 . . . . 0.0 111.458 179.427 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 97.8 t -67.1 -49.04 76.86 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.77 -179.204 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.453 ' HA ' ' HD2' ' A' ' 54' ' ' TYR . 3.3 m-85 -67.89 -24.15 65.19 Favored 'General case' 0 N--CA 1.426 -1.627 0 CA-C-N 115.423 -0.808 . . . . 0.0 112.558 -176.365 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.466 ' OG ' ' HB2' ' B' ' 231' ' ' ARG . 66.1 m -68.93 -19.56 64.19 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 116.188 -0.46 . . . . 0.0 112.059 176.344 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -67.08 -29.13 68.82 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 176.347 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.453 ' HD2' ' HA ' ' A' ' 51' ' ' PHE . 75.6 m-85 -89.93 -23.2 21.65 Favored 'General case' 0 N--CA 1.441 -0.897 0 CA-C-N 115.899 -0.591 . . . . 0.0 112.245 -174.58 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 171.54 -152.57 18.1 Favored Glycine 0 N--CA 1.426 -1.985 0 N-CA-C 111.312 -0.715 . . . . 0.0 111.312 179.672 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 86.7 t -106.62 112.87 63.48 Favored Pre-proline 0 C--N 1.297 -1.674 0 CA-C-O 120.793 0.33 . . . . 0.0 110.376 -178.344 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.487 ' HB3' HD21 ' A' ' 77' ' ' LEU . 88.6 Cg_endo -80.47 136.78 11.29 Favored 'Trans proline' 0 N--CA 1.442 -1.543 0 C-N-CA 122.371 2.047 . . . . 0.0 110.439 176.287 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 28.4 m -111.17 -28.32 2.63 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 C-N-CA 120.022 -0.671 . . . . 0.0 111.469 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.435 ' HB3' ' HG2' ' A' ' 78' ' ' LYS . 26.2 t70 -152.16 145.05 24.41 Favored 'General case' 0 CA--C 1.498 -1.043 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 178.771 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 10.7 p -145.95 135.45 17.53 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 123.775 0.672 . . . . 0.0 110.006 -178.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 94.1 mt -121.38 121.94 66.0 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 175.698 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.401 ' HB2' ' HG3' ' A' ' 44' ' ' GLU . 0.2 OUTLIER -98.24 117.94 33.76 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 104.988 -2.226 . . . . 0.0 104.988 174.162 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 69.8 m -71.66 116.09 11.62 Favored 'General case' 0 N--CA 1.405 -2.681 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 177.83 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 43.3 mtm180 . . . . . 0 C--N 1.295 -1.786 0 CA-C-N 115.34 -0.845 . . . . 0.0 108.844 -177.347 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 . . . . . 0 N--CA 1.449 -0.485 0 CA-C-O 121.675 0.75 . . . . 0.0 109.779 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 90.78 15.73 55.98 Favored Glycine 0 N--CA 1.426 -1.995 0 CA-C-N 114.915 -1.039 . . . . 0.0 112.993 176.316 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 33.7 p90 -155.35 163.1 40.55 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 177.233 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -155.6 176.14 12.99 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-O 121.095 0.474 . . . . 0.0 111.228 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -137.64 146.0 43.38 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 124.334 1.054 . . . . 0.0 109.965 179.617 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.487 HD21 ' HB3' ' A' ' 57' ' ' PRO . 9.8 tt -151.88 140.86 21.13 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 175.517 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.435 ' HG2' ' HB3' ' A' ' 59' ' ' ASP . 20.1 ptmt -121.76 144.09 49.0 Favored 'General case' 0 C--O 1.257 1.482 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 178.162 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 50.2 m-85 -103.89 164.72 11.51 Favored 'General case' 0 C--N 1.288 -2.072 0 CA-C-N 115.595 -0.729 . . . . 0.0 111.688 -178.595 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -69.77 -39.52 76.62 Favored 'General case' 0 N--CA 1.429 -1.522 0 CA-C-N 114.388 -1.278 . . . . 0.0 108.665 174.358 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.41 ' OD2' ' HB2' ' A' ' 83' ' ' ARG . 26.6 t70 -124.13 140.0 53.39 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.932 -176.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 -69.46 -19.75 63.76 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 115.187 1.551 . . . . 0.0 115.187 -178.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.41 ' HB2' ' OD2' ' A' ' 81' ' ' ASP . 0.0 OUTLIER -67.23 -33.91 76.34 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-O 122.175 0.988 . . . . 0.0 109.743 173.382 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.46 ' OG ' HG21 ' B' ' 226' ' ' ILE . 45.8 m -65.31 -36.91 85.5 Favored 'General case' 0 C--N 1.289 -2.062 0 CA-C-N 115.06 -0.973 . . . . 0.0 112.199 177.652 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.568 HG21 ' HA ' ' A' ' 31' ' ' ALA . 68.6 p -64.7 -45.59 85.96 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 120.26 -0.576 . . . . 0.0 110.841 -177.749 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 5.3 pt -63.51 -38.65 82.78 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.249 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.754 176.623 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 19.5 mt -58.79 -43.86 90.57 Favored 'General case' 0 C--O 1.247 0.969 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.302 176.912 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -71.53 -46.8 58.6 Favored 'General case' 0 N--CA 1.438 -1.067 0 CA-C-N 115.573 -0.739 . . . . 0.0 111.56 -179.177 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.45 HG22 HG22 ' A' ' 104' ' ' ILE . 75.8 t -57.88 -48.07 84.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-O 121.072 0.463 . . . . 0.0 111.113 -179.344 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -62.09 -32.83 73.43 Favored 'General case' 0 C--N 1.296 -1.744 0 CA-C-N 115.047 -0.979 . . . . 0.0 112.003 -173.725 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 36.7 m-80 -97.98 -25.08 15.1 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 113.367 0.877 . . . . 0.0 113.367 -178.462 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 15.4 mt -96.33 -31.29 12.96 Favored 'General case' 0 CA--C 1.484 -1.568 0 CA-C-O 120.898 0.38 . . . . 0.0 111.875 -172.749 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 57.7 t30 -66.51 125.28 25.21 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 -179.412 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 82.94 -1.12 89.15 Favored Glycine 0 N--CA 1.444 -0.821 0 O-C-N 123.414 0.446 . . . . 0.0 112.556 179.496 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 82.7 t80 -88.05 143.75 26.9 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 -178.907 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.426 ' HE3' ' HB2' ' A' ' 101' ' ' ALA . 11.5 mptt -96.9 118.7 33.91 Favored 'General case' 0 N--CA 1.436 -1.151 0 CA-C-O 121.088 0.47 . . . . 0.0 111.27 -177.143 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 53.1 mt -124.53 141.73 43.69 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 N-CA-C 105.098 -2.186 . . . . 0.0 105.098 173.916 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 56.93 29.27 58.82 Favored Glycine 0 C--O 1.22 -0.727 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.702 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 76.55 2.1 73.67 Favored Glycine 0 CA--C 1.537 1.455 0 C-N-CA 121.71 -0.281 . . . . 0.0 113.8 -179.092 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.449 ' NH1' ' HB2' ' A' ' 39' ' ' ASN . 0.2 OUTLIER -124.37 143.77 50.41 Favored 'General case' 0 C--N 1.316 -0.868 0 O-C-N 122.176 -0.603 . . . . 0.0 111.543 -177.125 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.426 ' HB2' ' HE3' ' A' ' 96' ' ' LYS . . . -87.23 118.45 26.65 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.644 -177.252 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 11.9 mt -70.22 147.92 49.23 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 115.431 -0.804 . . . . 0.0 112.513 179.301 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 59.3 tptt -120.83 116.23 24.8 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 175.177 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.45 HG22 HG22 ' A' ' 89' ' ' VAL . 4.7 mm -119.41 131.01 73.25 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.809 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 179.326 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -144.01 151.02 39.14 Favored 'General case' 0 C--N 1.285 -2.202 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 179.52 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 28.8 m-70 -78.68 135.03 37.07 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 178.361 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.408 HG21 ' HB2' ' A' ' 34' ' ' TYR . 12.0 t -149.59 161.51 42.03 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 106.199 -1.778 . . . . 0.0 106.199 -177.692 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -103.62 110.15 22.11 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 174.151 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 28.1 t80 . . . . . 0 C--N 1.294 -1.835 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.389 -176.426 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 226' ' ' ILE . . . . . 0.46 HG21 ' OG ' ' A' ' 84' ' ' SER . 4.2 mp . . . . . 0 CA--C 1.503 -0.832 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 227' ' ' MET . . . . . . . . . . . . . 26.6 mmt -78.65 144.3 64.74 Favored Pre-proline 0 C--N 1.295 -1.802 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.721 178.792 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 228' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -68.57 160.64 48.51 Favored 'Trans proline' 0 C--O 1.248 0.984 0 C-N-CA 123.211 2.607 . . . . 0.0 113.673 -176.448 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . -82.77 172.86 52.22 Favored Glycine 0 N--CA 1.442 -0.927 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.991 178.77 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 14.8 m -74.76 -17.49 60.63 Favored 'General case' 0 C--N 1.307 -1.248 0 C-N-CA 123.29 0.636 . . . . 0.0 112.502 -175.559 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 231' ' ' ARG . . . . . 0.466 ' HB2' ' OG ' ' A' ' 52' ' ' SER . 23.0 mmm180 -79.75 -11.48 59.84 Favored 'General case' 0 CA--C 1.5 -0.949 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -179.768 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 232' ' ' TRP . . . . . . . . . . . . . 21.3 t90 -69.28 121.55 17.07 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-O 122.334 1.064 . . . . 0.0 111.922 -178.642 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 233' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -116.77 149.11 40.46 Favored 'General case' 0 C--N 1.278 -2.543 0 N-CA-C 102.486 -3.154 . . . . 0.0 102.486 171.858 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.501 2.998 0 C-N-CA 128.114 2.769 . . . . 0.0 116.919 -177.987 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 240' ' ' GLY . . . . . 0.471 ' O ' ' HG2' ' B' ' 244' ' ' LYS . . . . . . . . 0 N--CA 1.431 -1.672 0 N-CA-C 109.03 -1.628 . . . . 0.0 109.03 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 22.9 p90 -73.2 -33.26 65.28 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 -176.948 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -59.66 -47.43 85.63 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 120.731 -0.388 . . . . 0.0 111.362 -177.824 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -61.36 -34.99 76.22 Favored 'General case' 0 C--O 1.21 -1.015 0 O-C-N 123.659 0.599 . . . . 0.0 112.045 -179.101 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 244' ' ' LYS . . . . . 0.471 ' HG2' ' O ' ' B' ' 240' ' ' GLY . 43.6 mmtm -64.33 -48.39 75.77 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.248 0.547 . . . . 0.0 110.186 -178.37 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 245' ' ' TRP . . . . . . . . . . . . . 24.9 m0 -67.29 -37.69 83.83 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.103 179.627 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 246' ' ' PHE . . . . . 0.504 ' O ' ' HG2' ' B' ' 249' ' ' GLN . 2.4 t80 -65.04 -35.21 80.43 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.554 177.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -70.5 -36.33 73.72 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.656 -178.808 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.5 -14.09 36.03 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 120.974 0.416 . . . . 0.0 111.703 -177.63 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 249' ' ' GLN . . . . . 0.504 ' HG2' ' O ' ' B' ' 246' ' ' PHE . 10.3 pt20 -84.79 3.74 36.23 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 109.192 -0.669 . . . . 0.0 109.192 177.007 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 250' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -50.35 -32.09 16.38 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 114.788 -1.096 . . . . 0.0 111.938 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -64.7 123.76 20.16 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.578 -178.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 252' ' ' ILE . . . . . . . . . . . . . 27.5 pt -98.63 -31.98 3.76 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 CA-C-O 121.274 0.559 . . . . 0.0 111.937 -177.666 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -89.86 -16.9 29.12 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-O 121.584 0.706 . . . . 0.0 109.71 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 254' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 . . . . . 0 C--N 1.293 -1.888 0 CA-C-N 114.691 -1.14 . . . . 0.0 108.799 179.888 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.737 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 12.6 m-85 -108.24 144.89 35.1 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.217 -175.454 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 26.4 pt -139.47 155.51 25.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 CA-C-O 121.3 0.572 . . . . 0.0 110.374 176.613 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 50.9 t80 -106.38 123.1 47.54 Favored 'General case' 0 N--CA 1.411 -2.396 0 CA-C-N 114.31 -1.314 . . . . 0.0 107.772 177.468 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.441 HG23 ' CD1' ' A' ' 104' ' ' ILE . 8.1 mt -108.67 127.9 64.8 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.098 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 175.878 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -129.97 164.38 22.68 Favored Glycine 0 C--N 1.278 -2.685 0 N-CA-C 110.806 -0.918 . . . . 0.0 110.806 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 72.67 34.16 1.24 Allowed 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.92 1.288 . . . . 0.0 110.982 -179.114 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.41 HD11 HD11 ' A' ' 47' ' ' ILE . 4.1 mm? -64.57 146.33 54.78 Favored 'General case' 0 CA--C 1.497 -1.064 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.031 176.703 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.479 ' HB3' ' HG ' ' A' ' 42' ' ' LEU . 60.7 t30 -84.27 139.6 32.23 Favored 'General case' 0 C--N 1.289 -2.062 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 176.571 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.424 ' HD2' ' C ' ' A' ' 40' ' ' ARG . 6.9 ppt_? -58.53 -16.83 17.15 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 113.556 0.947 . . . . 0.0 113.556 -174.744 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -100.85 0.24 38.19 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -178.654 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.479 ' HG ' ' HB3' ' A' ' 39' ' ' ASN . 57.4 mt -80.94 128.66 33.93 Favored 'General case' 0 C--O 1.245 0.823 0 CA-C-O 121.235 0.541 . . . . 0.0 111.223 178.743 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 72.4 p -108.37 173.07 6.48 Favored 'General case' 0 N--CA 1.425 -1.708 0 CA-C-N 114.657 -1.156 . . . . 0.0 109.977 -177.823 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.58 ' HG3' ' HB2' ' A' ' 62' ' ' LEU . 2.3 mp0 -56.0 -43.1 77.36 Favored 'General case' 0 C--N 1.316 -0.886 0 C-N-CA 124.061 0.944 . . . . 0.0 110.824 178.361 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -62.62 -35.38 91.75 Favored Glycine 0 C--O 1.24 0.525 0 CA-C-N 115.867 -0.606 . . . . 0.0 112.557 -179.632 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 39.2 m-20 -64.84 -48.99 72.35 Favored 'General case' 0 CA--C 1.49 -1.337 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 178.86 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.41 HD11 HD11 ' A' ' 38' ' ' LEU . 52.5 mt -61.54 -48.03 90.64 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.856 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.402 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 40.1 mt -59.98 -42.44 94.19 Favored 'General case' 0 CA--C 1.494 -1.189 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.805 -176.389 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.432 HG23 ' H ' ' B' ' 233' ' ' ASP . 90.0 m -63.55 -45.9 88.38 Favored 'General case' 0 C--N 1.309 -1.191 0 O-C-N 123.456 0.473 . . . . 0.0 111.225 -179.095 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 98.1 t -67.69 -46.33 82.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.769 -178.725 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -66.12 -24.33 66.66 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.952 -178.899 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.532 ' OG ' ' HB2' ' B' ' 231' ' ' ARG . 70.2 m -70.81 -19.1 62.71 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.943 175.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -72.64 -27.2 61.99 Favored 'General case' 0 CA--C 1.551 1.009 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 177.676 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 58.3 m-85 -89.98 -16.45 29.84 Favored 'General case' 0 CA--C 1.511 -0.539 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.888 -177.586 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.419 ' O ' ' HA ' ' A' ' 52' ' ' SER . . . 163.13 -153.47 24.01 Favored Glycine 0 N--CA 1.417 -2.615 0 C-N-CA 120.325 -0.94 . . . . 0.0 111.738 178.795 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 59.7 t -105.23 107.65 59.5 Favored Pre-proline 0 C--N 1.294 -1.83 0 CA-C-N 116.105 -0.048 . . . . 0.0 110.92 -176.765 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.491 ' HB3' HD21 ' A' ' 77' ' ' LEU . 97.5 Cg_endo -78.51 136.97 14.31 Favored 'Trans proline' 0 N--CA 1.448 -1.161 0 C-N-CA 122.698 2.266 . . . . 0.0 110.194 176.126 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 35.5 m -112.86 -27.39 2.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 C-N-CA 119.84 -0.744 . . . . 0.0 111.601 -178.893 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.52 ' HB3' ' HG2' ' A' ' 78' ' ' LYS . 38.8 t70 -152.01 144.33 24.02 Favored 'General case' 0 CA--C 1.5 -0.952 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -179.197 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 13.0 p -145.38 134.73 17.88 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 179.357 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 91.2 mt -121.07 121.75 65.81 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 175.616 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.58 ' HB2' ' HG3' ' A' ' 44' ' ' GLU . 0.1 OUTLIER -94.58 115.91 28.13 Favored 'General case' 0 N--CA 1.422 -1.872 0 N-CA-C 105.838 -1.912 . . . . 0.0 105.838 176.039 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 11.3 m -76.89 116.93 18.0 Favored 'General case' 0 N--CA 1.409 -2.485 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 178.505 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.401 HH11 ' HD3' ' A' ' 64' ' ' ARG . 53.8 mtt180 . . . . . 0 C--N 1.298 -1.651 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.752 -177.256 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 14.1 mm-40 . . . . . 0 CA--C 1.507 -0.7 0 CA-C-O 121.055 0.455 . . . . 0.0 112.056 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 113.44 7.2 20.96 Favored Glycine 0 N--CA 1.427 -1.953 0 C-N-CA 119.888 -1.148 . . . . 0.0 111.423 -175.794 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 31.4 p90 -151.02 156.76 41.79 Favored 'General case' 0 N--CA 1.427 -1.584 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 178.223 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -154.64 174.6 14.76 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 123.647 0.592 . . . . 0.0 110.09 178.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -132.17 141.16 49.0 Favored 'General case' 0 C--N 1.305 -1.362 0 C-N-CA 123.605 0.762 . . . . 0.0 110.076 -178.791 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.491 HD21 ' HB3' ' A' ' 57' ' ' PRO . 9.7 tt -148.08 140.72 24.57 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 175.372 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.52 ' HG2' ' HB3' ' A' ' 59' ' ' ASP . 21.2 ptmt -123.55 144.5 49.53 Favored 'General case' 0 C--O 1.258 1.551 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 178.882 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 59.2 m-85 -105.83 164.42 11.95 Favored 'General case' 0 C--N 1.288 -2.079 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.011 -179.116 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -80.15 -33.84 38.14 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 114.88 -1.055 . . . . 0.0 108.763 175.191 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -111.96 129.31 56.23 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -177.398 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -70.03 -20.42 63.25 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 113.883 1.068 . . . . 0.0 113.883 -178.764 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.76 -33.39 75.52 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 122.193 0.997 . . . . 0.0 109.448 174.791 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.4 ' OG ' ' HA3' ' A' ' 55' ' ' GLY . 63.7 m -64.13 -37.06 86.1 Favored 'General case' 0 C--N 1.292 -1.906 0 CA-C-N 115.184 -0.916 . . . . 0.0 112.901 178.445 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 68.6 p -64.68 -45.45 86.64 Favored 'General case' 0 C--N 1.346 0.43 0 C-N-CA 120.469 -0.493 . . . . 0.0 110.818 -177.369 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 4.0 pt -65.08 -39.1 84.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.759 177.879 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 12.2 mt -59.47 -43.51 93.22 Favored 'General case' 0 CA--C 1.505 -0.784 0 O-C-N 123.35 0.406 . . . . 0.0 111.703 176.028 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -69.35 -45.99 68.09 Favored 'General case' 0 N--CA 1.428 -1.555 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.739 -178.862 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.439 HG22 HG22 ' A' ' 104' ' ' ILE . 86.8 t -58.76 -45.28 91.3 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.134 0 CA-C-O 121.21 0.529 . . . . 0.0 110.643 177.822 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -58.91 -37.63 77.07 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 125.103 1.361 . . . . 0.0 112.321 -178.655 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 41.5 m-80 -98.17 -26.67 14.48 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 -176.002 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.465 ' HB2' HG13 ' A' ' 104' ' ' ILE . 19.0 mt -96.13 -30.82 13.31 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -172.489 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -65.84 123.92 21.09 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 88.48 -12.2 65.78 Favored Glycine 0 CA--C 1.53 1.012 0 CA-C-N 116.026 -0.534 . . . . 0.0 112.422 -178.066 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 73.4 t80 -79.73 138.0 37.19 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 -176.285 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.45 ' HE2' ' HB2' ' A' ' 101' ' ' ALA . 0.3 OUTLIER -95.66 123.28 39.15 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 112.111 0.411 . . . . 0.0 112.111 -177.035 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 59.4 mt -128.15 142.12 44.65 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 N-CA-C 105.737 -1.949 . . . . 0.0 105.737 173.818 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 64.14 14.32 55.99 Favored Glycine 0 C--N 1.319 -0.416 0 C-N-CA 121.262 -0.494 . . . . 0.0 112.701 -178.051 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 90.31 -1.18 79.25 Favored Glycine 0 N--CA 1.43 -1.73 0 CA-C-O 119.923 -0.376 . . . . 0.0 112.731 -178.524 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.443 ' O ' ' HA ' ' A' ' 96' ' ' LYS . 11.4 ptp180 -124.22 151.34 44.22 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 117.714 0.757 . . . . 0.0 111.96 -177.955 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.45 ' HB2' ' HE2' ' A' ' 96' ' ' LYS . . . -86.54 116.35 24.62 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -175.39 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 11.9 mt -65.61 148.72 51.27 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.469 -0.787 . . . . 0.0 112.56 178.096 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 57.7 tptt -122.12 118.06 27.76 Favored 'General case' 0 N--CA 1.422 -1.846 0 CA-C-N 115.14 -0.936 . . . . 0.0 108.663 175.879 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.465 HG13 ' HB2' ' A' ' 92' ' ' LEU . 4.3 mm -117.61 135.4 58.13 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 N-CA-C 107.143 -1.428 . . . . 0.0 107.143 178.515 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -143.94 149.71 37.24 Favored 'General case' 0 C--N 1.285 -2.229 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 -178.016 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 45.2 m-70 -81.56 131.17 35.26 Favored 'General case' 0 C--N 1.29 -1.981 0 N-CA-C 109.487 -0.561 . . . . 0.0 109.487 178.128 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 12.5 t -145.35 165.82 27.37 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 -177.565 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -110.16 109.77 20.4 Favored 'General case' 0 N--CA 1.428 -1.568 0 N-CA-C 106.649 -1.611 . . . . 0.0 106.649 174.45 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 35.6 t80 . . . . . 0 C--N 1.305 -1.341 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.719 -176.984 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 4.1 mp . . . . . 0 N--CA 1.448 -0.544 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 227' ' ' MET . . . . . . . . . . . . . 91.4 mtp -70.35 137.7 86.51 Favored Pre-proline 0 C--N 1.313 -0.994 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 177.691 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 228' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -64.75 157.02 58.33 Favored 'Trans proline' 0 C--O 1.251 1.166 0 C-N-CA 123.398 2.732 . . . . 0.0 113.489 -176.593 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . -74.75 168.68 54.63 Favored Glycine 0 N--CA 1.435 -1.409 0 CA-C-N 115.122 -0.945 . . . . 0.0 111.83 178.289 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 15.0 m -75.04 -16.8 60.58 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 111.856 0.317 . . . . 0.0 111.856 -175.55 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 231' ' ' ARG . . . . . 0.532 ' HB2' ' OG ' ' A' ' 52' ' ' SER . 26.6 mmt180 -79.2 -10.21 59.76 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.933 0.397 . . . . 0.0 110.261 -177.627 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 232' ' ' TRP . . . . . . . . . . . . . 25.4 t90 -70.13 130.07 41.1 Favored 'General case' 0 N--CA 1.432 -1.329 0 CA-C-O 122.481 1.134 . . . . 0.0 112.059 -178.753 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 233' ' ' ASP . . . . . 0.432 ' H ' HG23 ' A' ' 49' ' ' THR . 22.8 t70 -124.03 139.45 53.93 Favored 'General case' 0 C--N 1.269 -2.906 0 N-CA-C 101.934 -3.358 . . . . 0.0 101.934 171.464 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.508 3.437 0 C-N-CA 128.747 3.07 . . . . 0.0 117.926 -177.626 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 240' ' ' GLY . . . . . 0.473 ' O ' ' HG2' ' B' ' 243' ' ' GLU . . . . . . . . 0 N--CA 1.403 -3.505 0 N-CA-C 110.39 -1.084 . . . . 0.0 110.39 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 29.3 p90 -77.26 -36.71 54.18 Favored 'General case' 0 C--N 1.294 -1.829 0 CA-C-O 121.477 0.656 . . . . 0.0 110.857 176.79 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 242' ' ' GLU . . . . . 0.512 ' HA ' ' CE3' ' B' ' 245' ' ' TRP . 42.4 tt0 -67.55 -38.95 84.91 Favored 'General case' 0 C--O 1.251 1.145 0 CA-C-N 115.093 -0.958 . . . . 0.0 111.657 -178.504 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 243' ' ' GLU . . . . . 0.473 ' HG2' ' O ' ' B' ' 240' ' ' GLY . 12.2 pt-20 -58.3 -35.02 71.19 Favored 'General case' 0 C--O 1.212 -0.9 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.229 178.911 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 244' ' ' LYS . . . . . 0.432 ' HE2' ' O ' ' B' ' 240' ' ' GLY . 72.2 mmtt -62.79 -46.17 89.25 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.598 -176.916 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 245' ' ' TRP . . . . . 0.512 ' CE3' ' HA ' ' B' ' 242' ' ' GLU . 11.8 m0 -63.98 -40.65 96.86 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.675 179.308 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 246' ' ' PHE . . . . . 0.588 ' O ' ' HG2' ' B' ' 249' ' ' GLN . 2.5 t80 -66.64 -31.12 71.59 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.075 179.069 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -77.54 -39.91 44.39 Favored 'General case' 0 C--N 1.29 -2.004 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.079 178.762 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.47 -13.28 55.05 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-O 121.395 0.617 . . . . 0.0 111.606 -175.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 249' ' ' GLN . . . . . 0.588 ' HG2' ' O ' ' B' ' 246' ' ' PHE . 11.1 pt20 -74.48 2.68 9.01 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.597 -179.635 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 250' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -61.24 -31.08 70.88 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 174.894 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 251' ' ' GLU . . . . . 0.433 ' HG3' ' HB3' ' B' ' 254' ' ' GLU . 2.6 mm-40 -91.63 158.32 16.48 Favored 'General case' 0 N--CA 1.414 -2.263 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.439 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 252' ' ' ILE . . . . . . . . . . . . . 35.0 pt -108.11 -29.17 2.62 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 CA-C-N 114.927 -1.033 . . . . 0.0 110.265 -176.829 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -120.04 -32.39 4.2 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.918 0.389 . . . . 0.0 110.85 -175.313 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 254' ' ' GLU . . . . . 0.433 ' HB3' ' HG3' ' B' ' 251' ' ' GLU . 7.0 tp10 . . . . . 0 N--CA 1.43 -1.431 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 -170.584 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.532 0 N-CA-C 111.748 0.277 . . . . 0.0 111.748 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 16.9 m-30 -93.92 145.39 24.67 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 120.933 -0.307 . . . . 0.0 110.598 -176.849 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 26.4 pt -143.8 162.26 15.83 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 C-N-CA 123.229 0.612 . . . . 0.0 110.233 176.444 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.469 ' HB2' HG21 ' A' ' 107' ' ' THR . 29.8 t80 -114.46 124.5 52.08 Favored 'General case' 0 N--CA 1.421 -1.913 0 C-N-CA 124.355 1.062 . . . . 0.0 108.616 177.743 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 7.5 mt -109.6 127.72 66.19 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.976 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 175.074 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -127.88 164.37 21.25 Favored Glycine 0 C--N 1.281 -2.501 0 N-CA-C 110.622 -0.991 . . . . 0.0 110.622 -179.166 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 16.9 m120 71.38 36.93 1.23 Allowed 'General case' 0 CA--C 1.503 -0.83 0 C-N-CA 124.177 0.991 . . . . 0.0 111.082 -177.881 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.469 HD11 HD11 ' A' ' 47' ' ' ILE . 4.1 mm? -69.79 153.87 42.75 Favored 'General case' 0 CA--C 1.499 -0.984 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.105 176.781 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.482 ' HB3' ' HG ' ' A' ' 42' ' ' LEU . 38.2 t-20 -92.07 152.96 19.69 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 175.837 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.404 ' HD2' ' C ' ' A' ' 40' ' ' ARG . 0.9 OUTLIER -67.38 -23.59 65.59 Favored 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 122.535 0.334 . . . . 0.0 110.41 -179.162 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -90.55 -10.97 41.51 Favored 'General case' 0 C--O 1.224 -0.259 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.291 -178.132 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.482 ' HG ' ' HB3' ' A' ' 39' ' ' ASN . 55.3 mt -77.43 120.38 22.34 Favored 'General case' 0 CA--C 1.495 -1.171 0 CA-C-O 121.596 0.712 . . . . 0.0 110.947 -178.218 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 73.0 p -102.07 173.49 6.36 Favored 'General case' 0 C--N 1.287 -2.142 0 CA-C-N 114.508 -1.224 . . . . 0.0 109.771 -177.215 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.441 ' HG3' ' HB2' ' A' ' 62' ' ' LEU . 1.3 mp0 -64.07 -34.61 78.43 Favored 'General case' 0 C--O 1.205 -1.276 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 177.973 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -59.31 -39.26 94.45 Favored Glycine 0 N--CA 1.443 -0.854 0 O-C-N 123.969 0.793 . . . . 0.0 111.438 178.19 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -67.54 -50.09 60.26 Favored 'General case' 0 CA--C 1.496 -1.107 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 177.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.469 HD11 HD11 ' A' ' 38' ' ' LEU . 46.3 mt -60.1 -47.22 92.79 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 CA-C-N 115.19 -0.913 . . . . 0.0 111.085 -178.157 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 41.4 mt -60.46 -45.45 93.66 Favored 'General case' 0 CA--C 1.49 -1.342 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.204 -176.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 90.4 m -63.08 -45.66 91.06 Favored 'General case' 0 N--CA 1.432 -1.356 0 O-C-N 123.74 0.65 . . . . 0.0 111.507 -178.573 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 98.2 t -67.48 -48.17 78.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.831 -179.182 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.407 ' HA ' ' HD2' ' A' ' 54' ' ' TYR . 3.5 m-85 -63.82 -25.37 68.15 Favored 'General case' 0 N--CA 1.438 -1.064 0 C-N-CA 123.769 0.827 . . . . 0.0 112.208 -179.06 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.555 ' OG ' ' HB2' ' B' ' 231' ' ' ARG . 62.8 m -67.75 -19.86 65.17 Favored 'General case' 0 N--CA 1.439 -1.011 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 176.873 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -66.03 -32.0 73.22 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-O 121.803 0.811 . . . . 0.0 109.305 174.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.407 ' HD2' ' HA ' ' A' ' 51' ' ' PHE . 57.2 m-85 -88.89 -22.78 22.96 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.56 -0.746 . . . . 0.0 111.691 -173.439 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.475 ' O ' ' HA ' ' A' ' 52' ' ' SER . . . 173.7 -162.49 33.37 Favored Glycine 0 N--CA 1.428 -1.872 0 C-N-CA 120.633 -0.794 . . . . 0.0 111.795 178.303 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 59.4 t -100.43 110.57 60.54 Favored Pre-proline 0 C--N 1.304 -1.395 0 N-CA-C 110.511 -0.181 . . . . 0.0 110.511 -178.594 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.544 ' HB3' HD21 ' A' ' 77' ' ' LEU . 97.1 Cg_endo -79.69 136.67 12.29 Favored 'Trans proline' 0 N--CA 1.45 -1.049 0 C-N-CA 122.535 2.157 . . . . 0.0 110.603 177.502 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 35.0 m -111.35 -28.22 2.64 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 C-N-CA 119.786 -0.765 . . . . 0.0 111.834 -178.887 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.502 ' HB3' ' HG2' ' A' ' 78' ' ' LYS . 36.3 t70 -151.23 141.86 22.68 Favored 'General case' 0 CA--C 1.504 -0.789 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 -179.48 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 13.8 p -142.33 133.52 25.25 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 O-C-N 123.609 0.568 . . . . 0.0 109.809 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 83.4 mt -120.54 118.5 56.77 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.213 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 177.495 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.441 ' HB2' ' HG3' ' A' ' 44' ' ' GLU . 0.1 OUTLIER -97.5 117.39 31.66 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 106.765 -1.569 . . . . 0.0 106.765 177.923 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 22.4 m -77.69 120.23 22.34 Favored 'General case' 0 C--N 1.29 -2.0 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 178.447 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 72.0 mtm180 . . . . . 0 C--N 1.306 -1.31 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.785 -175.076 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 . . . . . 0 N--CA 1.468 0.466 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 91.7 8.31 63.89 Favored Glycine 0 N--CA 1.44 -1.041 0 C-N-CA 120.85 -0.69 . . . . 0.0 113.535 177.87 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.41 ' HA ' HD23 ' A' ' 38' ' ' LEU . 32.6 p90 -152.77 157.72 41.22 Favored 'General case' 0 C--O 1.248 1.025 0 CA-C-N 117.566 0.683 . . . . 0.0 109.251 178.71 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -153.12 173.15 15.85 Favored 'General case' 0 N--CA 1.433 -1.322 0 O-C-N 123.569 0.543 . . . . 0.0 110.763 178.909 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -132.36 142.74 49.44 Favored 'General case' 0 C--N 1.306 -1.291 0 C-N-CA 124.17 0.988 . . . . 0.0 109.584 -178.549 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.544 HD21 ' HB3' ' A' ' 57' ' ' PRO . 9.8 tt -149.71 140.73 22.92 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 176.608 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.502 ' HG2' ' HB3' ' A' ' 59' ' ' ASP . 22.2 ptmt -123.46 144.25 49.64 Favored 'General case' 0 C--O 1.253 1.278 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 178.497 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -105.28 165.5 11.07 Favored 'General case' 0 C--N 1.29 -2.0 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.97 -178.903 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -73.62 -27.07 61.09 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.354 175.305 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -131.13 141.19 50.09 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 120.714 0.292 . . . . 0.0 110.606 -178.541 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 25.2 mp0 -70.08 -21.27 63.16 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 123.971 0.908 . . . . 0.0 113.279 -178.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 89.5 mtm180 -65.3 -34.46 78.39 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-O 122.313 1.054 . . . . 0.0 109.512 176.759 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.463 ' OG ' HG21 ' B' ' 226' ' ' ILE . 53.3 m -65.59 -36.85 84.95 Favored 'General case' 0 C--N 1.282 -2.33 0 CA-C-N 114.561 -1.199 . . . . 0.0 112.288 177.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 63.8 p -65.38 -44.94 85.98 Favored 'General case' 0 C--N 1.344 0.356 0 C-N-CA 120.168 -0.613 . . . . 0.0 110.875 -177.347 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.403 ' H ' HG12 ' A' ' 86' ' ' ILE . 3.5 pt -63.5 -38.91 83.46 Favored 'Isoleucine or valine' 0 C--O 1.243 0.731 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.036 177.058 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 49.2 mt -60.4 -44.04 96.08 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.385 176.211 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.453 ' O ' ' HB2' ' A' ' 92' ' ' LEU . . . -71.81 -46.61 57.59 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.838 -179.264 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.447 HG22 HG22 ' A' ' 104' ' ' ILE . 53.3 t -56.47 -48.89 79.42 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.902 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -178.004 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -62.24 -43.88 97.83 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -173.584 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -93.33 -19.98 20.82 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-N 115.758 -0.656 . . . . 0.0 112.373 -170.709 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.453 ' HB2' ' O ' ' A' ' 88' ' ' ALA . 9.8 mt -92.6 -27.85 17.09 Favored 'General case' 0 CA--C 1.491 -1.313 0 CA-C-O 120.824 0.345 . . . . 0.0 111.142 179.397 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -65.6 124.48 22.47 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 178.254 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 88.32 -1.09 84.11 Favored Glycine 0 N--CA 1.434 -1.493 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.435 -178.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -79.36 129.87 34.89 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 -179.2 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.456 ' HE3' ' HB2' ' A' ' 101' ' ' ALA . 11.9 mptt -90.06 115.63 27.47 Favored 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 120.602 -0.439 . . . . 0.0 110.245 179.264 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 54.1 mt -122.19 141.31 43.13 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 N-CA-C 105.803 -1.925 . . . . 0.0 105.803 174.419 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.409 ' HA3' HD22 ' A' ' 39' ' ' ASN . . . 57.32 21.9 42.19 Favored Glycine 0 CA--C 1.523 0.579 0 C-N-CA 121.79 -0.243 . . . . 0.0 113.411 -179.783 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 85.8 7.53 81.13 Favored Glycine 0 N--CA 1.437 -1.29 0 C-N-CA 121.149 -0.548 . . . . 0.0 113.59 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 18.6 ptp180 -132.01 139.25 48.54 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 117.726 0.763 . . . . 0.0 110.622 -179.145 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.456 ' HB2' ' HE3' ' A' ' 96' ' ' LYS . . . -81.25 119.83 24.13 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.756 -177.951 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 12.1 mt -66.47 146.73 54.21 Favored 'General case' 0 CA--C 1.501 -0.917 0 O-C-N 124.114 0.884 . . . . 0.0 112.737 178.478 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 28.6 tptp -120.44 118.82 31.29 Favored 'General case' 0 N--CA 1.421 -1.906 0 CA-C-N 115.222 -0.899 . . . . 0.0 108.922 174.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.447 HG22 HG22 ' A' ' 89' ' ' VAL . 3.2 mm -115.13 139.04 43.42 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.867 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 178.192 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -145.32 150.65 36.99 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 178.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 56.4 m-70 -83.64 130.71 34.98 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 176.803 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.469 HG21 ' HB2' ' A' ' 34' ' ' TYR . 5.4 t -148.79 163.55 37.05 Favored 'General case' 0 C--N 1.29 -1.98 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 -176.148 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -109.73 111.77 23.43 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 172.305 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 36.3 t80 . . . . . 0 C--N 1.286 -2.159 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.083 -173.527 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 226' ' ' ILE . . . . . 0.463 HG21 ' OG ' ' A' ' 84' ' ' SER . 3.7 mp . . . . . 0 N--CA 1.433 -1.314 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 227' ' ' MET . . . . . . . . . . . . . 63.6 mtt -68.42 137.43 91.14 Favored Pre-proline 0 C--N 1.31 -1.12 0 O-C-N 124.016 0.822 . . . . 0.0 109.681 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 228' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -67.94 146.39 71.34 Favored 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 122.196 1.931 . . . . 0.0 111.206 178.68 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . -66.1 161.08 44.9 Favored Glycine 0 N--CA 1.44 -1.037 0 CA-C-N 116.084 -0.507 . . . . 0.0 112.363 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 23.2 m -74.6 -12.67 60.51 Favored 'General case' 0 C--N 1.298 -1.654 0 C-N-CA 123.037 0.535 . . . . 0.0 111.794 -177.497 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 231' ' ' ARG . . . . . 0.555 ' HB2' ' OG ' ' A' ' 52' ' ' SER . 4.0 mmp_? -79.0 -14.53 59.14 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.044 0.45 . . . . 0.0 109.992 178.491 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 232' ' ' TRP . . . . . 0.409 ' HB2' ' CB ' ' A' ' 52' ' ' SER . 28.9 t90 -72.12 122.88 21.73 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.984 -0.553 . . . . 0.0 112.052 -176.095 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 233' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -126.63 106.02 9.12 Favored 'General case' 0 C--O 1.207 -1.169 0 CA-C-O 118.665 -0.684 . . . . 0.0 110.057 177.661 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.491 0 N-CA-C 115.9 1.12 . . . . 0.0 115.9 176.241 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 240' ' ' GLY . . . . . 0.408 ' O ' ' HG2' ' B' ' 244' ' ' LYS . . . . . . . . 0 N--CA 1.406 -3.339 0 N-CA-C 108.751 -1.74 . . . . 0.0 108.751 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 28.9 p90 -76.37 -35.53 58.61 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-O 120.84 0.352 . . . . 0.0 111.923 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 242' ' ' GLU . . . . . 0.47 ' HA ' ' CE3' ' B' ' 245' ' ' TRP . 44.2 tt0 -67.33 -42.07 84.2 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.576 -176.608 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -57.95 -34.02 69.46 Favored 'General case' 0 C--O 1.22 -0.47 0 C-N-CA 123.105 0.562 . . . . 0.0 111.541 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 244' ' ' LYS . . . . . 0.408 ' HG2' ' O ' ' B' ' 240' ' ' GLY . 71.7 mmtt -62.03 -45.96 91.25 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.394 -178.791 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 245' ' ' TRP . . . . . 0.47 ' CE3' ' HA ' ' B' ' 242' ' ' GLU . 11.2 m0 -69.6 -39.05 77.5 Favored 'General case' 0 CA--C 1.505 -0.756 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.425 178.778 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 246' ' ' PHE . . . . . 0.493 ' O ' ' HG2' ' B' ' 249' ' ' GLN . 6.1 t80 -62.12 -33.4 74.38 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.973 179.492 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -76.43 -30.85 57.57 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.632 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 248' ' ' LYS . . . . . 0.572 ' O ' ' HG2' ' B' ' 251' ' ' GLU . 0.0 OUTLIER -97.15 -12.61 22.89 Favored 'General case' 0 C--O 1.203 -1.378 0 O-C-N 121.895 -0.503 . . . . 0.0 112.11 -176.488 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 249' ' ' GLN . . . . . 0.493 ' HG2' ' O ' ' B' ' 246' ' ' PHE . 12.9 pt20 -70.17 2.51 3.61 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.137 0.575 . . . . 0.0 112.548 -176.327 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 250' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -63.64 -30.14 71.29 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.516 176.579 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 251' ' ' GLU . . . . . 0.572 ' HG2' ' O ' ' B' ' 248' ' ' LYS . 11.3 pt-20 -75.18 108.35 7.88 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-O 122.502 1.144 . . . . 0.0 111.067 -179.743 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 252' ' ' ILE . . . . . . . . . . . . . 30.4 pt -110.07 -34.28 2.48 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.334 0 CA-C-N 114.183 -1.372 . . . . 0.0 111.01 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -101.47 -26.01 13.72 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 178.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 254' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 . . . . . 0 N--CA 1.42 -1.945 0 CA-C-N 115.131 -0.94 . . . . 0.0 108.589 -176.28 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.406 ' O ' ' HA ' ' A' ' 78' ' ' LYS . . . . . . . . 0 CA--C 1.514 -0.407 0 N-CA-C 111.772 0.286 . . . . 0.0 111.772 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -95.93 145.83 25.08 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.064 -175.856 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 21.2 pt -140.79 160.64 23.86 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 C-N-CA 122.709 0.404 . . . . 0.0 110.175 175.014 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.452 ' HB2' HG21 ' A' ' 107' ' ' THR . 61.6 t80 -110.81 125.9 54.07 Favored 'General case' 0 N--CA 1.409 -2.508 0 CA-C-N 115.272 -0.876 . . . . 0.0 108.757 178.372 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.428 HG23 ' CD1' ' A' ' 104' ' ' ILE . 8.0 mt -110.76 129.07 66.61 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.935 0 N-CA-C 107.297 -1.371 . . . . 0.0 107.297 176.454 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -129.65 166.16 21.94 Favored Glycine 0 C--N 1.283 -2.394 0 N-CA-C 110.318 -1.113 . . . . 0.0 110.318 179.409 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 70.02 38.35 1.56 Allowed 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 125.055 1.342 . . . . 0.0 111.389 -178.314 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -70.21 154.05 42.37 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.405 0.621 . . . . 0.0 111.687 177.296 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.471 ' HB3' ' HG ' ' A' ' 42' ' ' LEU . 45.2 t-20 -90.47 150.24 21.88 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 176.438 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 7.3 ppt_? -62.91 -21.62 66.16 Favored 'General case' 0 C--N 1.314 -0.937 0 C-N-CA 122.991 0.516 . . . . 0.0 111.29 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -94.89 -0.74 53.74 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 115.965 -0.562 . . . . 0.0 111.73 -178.097 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.471 ' HG ' ' HB3' ' A' ' 39' ' ' ASN . 68.9 mt -89.95 124.33 34.63 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-O 121.365 0.602 . . . . 0.0 110.762 -179.667 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 75.8 p -108.78 174.25 5.96 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.241 -179.172 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.426 ' HG2' ' HB2' ' A' ' 62' ' ' LEU . 40.4 mt-10 -54.79 -41.17 70.24 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 123.667 0.787 . . . . 0.0 110.131 177.533 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -64.19 -38.87 96.52 Favored Glycine 0 N--CA 1.444 -0.828 0 CA-C-N 115.492 -0.777 . . . . 0.0 113.027 -178.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -65.96 -47.06 75.86 Favored 'General case' 0 CA--C 1.496 -1.125 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 -179.386 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 44.6 mt -58.5 -45.14 90.22 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.632 179.066 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.434 ' HG ' HG11 ' A' ' 60' ' ' VAL . 45.1 mt -59.09 -45.83 89.85 Favored 'General case' 0 C--O 1.209 -1.031 0 CA-C-O 119.481 -0.295 . . . . 0.0 111.428 -179.41 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.486 HG23 ' H ' ' B' ' 233' ' ' ASP . 99.0 m -61.53 -45.54 93.74 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -179.76 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 64.3 t -65.52 -47.8 85.21 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 CA-C-O 121.349 0.595 . . . . 0.0 110.708 -179.262 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -67.1 -23.04 65.8 Favored 'General case' 0 N--CA 1.436 -1.169 0 C-N-CA 124.022 0.929 . . . . 0.0 111.88 -179.136 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.456 ' OG ' ' HB2' ' B' ' 231' ' ' ARG . 65.9 m -69.7 -19.85 63.56 Favored 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 176.826 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -75.9 -25.47 56.08 Favored 'General case' 0 C--O 1.247 0.947 0 C-N-CA 118.247 -1.381 . . . . 0.0 108.853 177.326 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -88.04 -22.68 24.07 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.603 -176.86 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 175.73 -156.67 22.26 Favored Glycine 0 N--CA 1.425 -2.07 0 C-N-CA 120.624 -0.798 . . . . 0.0 111.562 177.437 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.53 ' HB ' ' HG2' ' A' ' 80' ' ' GLU . 94.5 t -106.46 102.56 41.65 Favored Pre-proline 0 C--N 1.3 -1.559 0 CA-C-O 120.851 0.357 . . . . 0.0 110.341 -178.962 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.587 ' HB3' HD21 ' A' ' 77' ' ' LEU . 89.7 Cg_endo -77.81 136.86 15.46 Favored 'Trans proline' 0 C--O 1.252 1.206 0 C-N-CA 122.534 2.156 . . . . 0.0 110.167 177.281 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 34.0 m -113.9 -18.47 7.51 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 C-N-CA 120.221 -0.592 . . . . 0.0 112.274 -177.804 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.534 ' HB3' ' HG2' ' A' ' 78' ' ' LYS . 20.3 t70 -160.14 139.13 10.69 Favored 'General case' 0 C--O 1.242 0.7 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 -178.494 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.434 HG11 ' HG ' ' A' ' 48' ' ' LEU . 12.7 p -140.62 137.59 35.83 Favored 'Isoleucine or valine' 0 C--O 1.245 0.845 0 O-C-N 123.35 0.406 . . . . 0.0 110.056 179.441 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 90.4 mt -121.33 124.76 72.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 C-N-CA 123.391 0.676 . . . . 0.0 109.394 175.035 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.426 ' HB2' ' HG2' ' A' ' 44' ' ' GLU . 0.1 OUTLIER -100.12 121.06 40.83 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 106.056 -1.831 . . . . 0.0 106.056 175.501 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 20.4 m -79.91 117.37 20.71 Favored 'General case' 0 C--N 1.284 -2.249 0 N-CA-C 107.016 -1.476 . . . . 0.0 107.016 175.054 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 57.8 mtp180 . . . . . 0 C--N 1.3 -1.559 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.573 -172.959 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 16.0 mm-40 . . . . . 0 CA--C 1.509 -0.616 0 CA-C-O 120.876 0.37 . . . . 0.0 111.709 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 87.63 8.1 74.19 Favored Glycine 0 N--CA 1.431 -1.655 0 C-N-CA 120.186 -1.007 . . . . 0.0 112.48 -177.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 32.1 p90 -149.27 155.41 40.53 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 177.85 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -154.19 176.11 12.66 Favored 'General case' 0 C--N 1.316 -0.852 0 O-C-N 123.403 0.439 . . . . 0.0 111.0 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -132.82 144.02 49.94 Favored 'General case' 0 C--N 1.314 -0.971 0 C-N-CA 124.376 1.07 . . . . 0.0 109.975 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.587 HD21 ' HB3' ' A' ' 57' ' ' PRO . 9.9 tt -150.3 141.46 23.11 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 176.485 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.534 ' HG2' ' HB3' ' A' ' 59' ' ' ASP . 21.8 ptmt -123.3 143.8 49.84 Favored 'General case' 0 C--O 1.256 1.401 0 CA-C-O 121.215 0.531 . . . . 0.0 109.983 178.279 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 68.7 m-85 -106.67 165.41 11.32 Favored 'General case' 0 C--N 1.293 -1.88 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.822 179.615 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.53 ' HG2' ' HB ' ' A' ' 56' ' ' VAL . 6.9 pt-20 -76.49 -23.92 53.78 Favored 'General case' 0 C--N 1.315 -0.918 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.318 175.561 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -133.58 144.94 49.62 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 119.497 -0.881 . . . . 0.0 111.891 177.662 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 25.0 mp0 -69.41 -20.82 63.8 Favored 'General case' 0 C--N 1.309 -1.177 0 C-N-CA 124.32 1.048 . . . . 0.0 113.239 -177.648 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 76.2 mtm180 -62.74 -35.42 79.71 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 122.092 0.949 . . . . 0.0 109.976 176.521 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 49.5 m -69.11 -37.32 78.3 Favored 'General case' 0 C--N 1.286 -2.184 0 CA-C-N 114.905 -1.043 . . . . 0.0 112.951 178.878 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 72.1 p -62.66 -45.28 93.55 Favored 'General case' 0 C--N 1.344 0.336 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.456 -177.556 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.425 ' H ' HG12 ' A' ' 86' ' ' ILE . 3.3 pt -65.71 -39.9 86.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.197 178.23 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 49.0 mt -60.31 -43.6 96.2 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 120.852 0.358 . . . . 0.0 111.319 176.008 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.419 ' O ' ' HB2' ' A' ' 92' ' ' LEU . . . -71.29 -46.47 60.74 Favored 'General case' 0 N--CA 1.433 -1.3 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.339 -178.498 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.456 HG22 HG22 ' A' ' 104' ' ' ILE . 66.9 t -57.56 -49.29 80.96 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.906 0 CA-C-O 121.054 0.454 . . . . 0.0 111.083 179.519 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -64.88 -34.66 78.93 Favored 'General case' 0 C--N 1.295 -1.798 0 C-N-CA 124.029 0.932 . . . . 0.0 111.779 -174.606 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -93.42 -28.53 16.08 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 -176.235 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.481 ' HB2' HG13 ' A' ' 104' ' ' ILE . 13.9 mt -92.84 -30.46 15.44 Favored 'General case' 0 CA--C 1.488 -1.405 0 N-CA-C 111.797 0.295 . . . . 0.0 111.797 -175.046 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -66.41 124.76 23.63 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 177.548 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 85.95 -0.72 87.81 Favored Glycine 0 CA--C 1.535 1.328 0 C-N-CA 120.496 -0.859 . . . . 0.0 112.325 -177.552 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 21.7 t80 -89.23 133.5 34.41 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 -179.738 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -96.13 123.8 39.89 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-O 121.093 0.473 . . . . 0.0 111.647 -178.084 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 55.0 mt -127.74 141.32 46.73 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 N-CA-C 105.581 -2.007 . . . . 0.0 105.581 173.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 58.22 24.58 55.59 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 121.544 -0.36 . . . . 0.0 113.344 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 81.8 3.11 90.69 Favored Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 121.673 -0.299 . . . . 0.0 113.132 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.406 ' NH1' ' HA ' ' A' ' 39' ' ' ASN . 19.4 ptp180 -125.06 144.96 50.14 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 117.271 0.535 . . . . 0.0 110.978 -178.037 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -85.71 117.7 24.75 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.372 -177.476 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 11.9 mt -66.4 147.04 53.87 Favored 'General case' 0 C--O 1.25 1.118 0 CA-C-O 121.57 0.7 . . . . 0.0 112.566 178.717 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 60.1 tptt -119.19 117.97 30.08 Favored 'General case' 0 N--CA 1.416 -2.149 0 CA-C-N 114.777 -1.101 . . . . 0.0 108.046 176.886 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.481 HG13 ' HB2' ' A' ' 92' ' ' LEU . 4.9 mm -119.89 136.2 57.74 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.052 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 179.081 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -143.31 151.24 40.27 Favored 'General case' 0 C--N 1.283 -2.323 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 -179.476 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 79.9 m-70 -80.98 131.33 35.31 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 179.139 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.452 HG21 ' HB2' ' A' ' 34' ' ' TYR . 5.9 t -151.34 160.46 43.77 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 105.724 -1.954 . . . . 0.0 105.724 -178.698 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -110.64 110.01 20.53 Favored 'General case' 0 N--CA 1.422 -1.866 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 172.551 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 76.1 t80 . . . . . 0 C--N 1.291 -1.946 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.756 -178.748 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 3.9 mp . . . . . 0 C--O 1.25 1.083 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 227' ' ' MET . . . . . . . . . . . . . 18.9 ptp -66.93 154.1 92.98 Favored Pre-proline 0 C--N 1.318 -0.79 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.16 178.61 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 228' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -73.4 145.02 37.48 Favored 'Trans proline' 0 N--CA 1.44 -1.634 0 C-N-CA 122.17 1.913 . . . . 0.0 111.565 175.756 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . -67.92 166.58 43.55 Favored Glycine 0 N--CA 1.437 -1.274 0 CA-C-N 115.497 -0.774 . . . . 0.0 112.59 179.166 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 16.2 m -74.74 -14.51 60.73 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-O 121.022 0.439 . . . . 0.0 111.738 -175.274 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 231' ' ' ARG . . . . . 0.456 ' HB2' ' OG ' ' A' ' 52' ' ' SER . 39.7 mmt180 -84.83 -3.45 58.66 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.018 0.437 . . . . 0.0 110.409 -179.113 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 232' ' ' TRP . . . . . . . . . . . . . 22.1 t90 -76.29 128.62 35.26 Favored 'General case' 0 CA--C 1.5 -0.975 0 CA-C-O 122.31 1.053 . . . . 0.0 111.846 -179.312 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 233' ' ' ASP . . . . . 0.486 ' H ' HG23 ' A' ' 49' ' ' THR . 29.7 t70 -124.17 142.87 50.86 Favored 'General case' 0 C--N 1.269 -2.896 0 N-CA-C 101.978 -3.342 . . . . 0.0 101.978 172.17 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.251 0 C-N-CA 128.207 2.813 . . . . 0.0 116.249 -179.988 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 240' ' ' GLY . . . . . 0.595 ' O ' ' HG2' ' B' ' 244' ' ' LYS . . . . . . . . 0 C--O 1.187 -2.832 0 CA-C-O 120.122 -0.266 . . . . 0.0 112.512 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 47.1 p90 -75.44 -33.82 60.92 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 117.667 0.734 . . . . 0.0 110.952 -179.437 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -63.45 -39.72 95.21 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.894 -175.781 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -67.29 -35.74 80.1 Favored 'General case' 0 C--O 1.21 -0.979 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.249 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 244' ' ' LYS . . . . . 0.595 ' HG2' ' O ' ' B' ' 240' ' ' GLY . 68.9 mmtt -67.05 -45.74 76.49 Favored 'General case' 0 CA--C 1.507 -0.675 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 -176.249 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 245' ' ' TRP . . . . . . . . . . . . . 46.7 m0 -64.44 -37.54 87.87 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.059 -179.338 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 246' ' ' PHE . . . . . 0.559 ' O ' ' HG2' ' B' ' 249' ' ' GLN . 2.9 t80 -70.65 -30.44 67.07 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.086 176.852 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -78.59 -40.66 34.01 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 178.447 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.65 -15.96 52.91 Favored 'General case' 0 CA--C 1.501 -0.917 0 CA-C-O 121.158 0.504 . . . . 0.0 111.497 -175.351 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 249' ' ' GLN . . . . . 0.559 ' HG2' ' O ' ' B' ' 246' ' ' PHE . 11.5 pt20 -70.3 -0.31 7.85 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.703 -178.352 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 250' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -64.04 -30.13 71.22 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 175.758 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -85.59 111.62 20.22 Favored 'General case' 0 N--CA 1.429 -1.521 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 176.653 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 252' ' ' ILE . . . . . . . . . . . . . 34.6 pt -109.77 -24.15 4.15 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 CA-C-N 114.985 -1.007 . . . . 0.0 113.639 -170.135 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -116.83 -19.89 9.69 Favored 'General case' 0 C--N 1.31 -1.114 0 C-N-CA 120.01 -0.676 . . . . 0.0 112.362 -176.545 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 254' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.565 1.55 0 C-N-CA 123.766 0.826 . . . . 0.0 111.966 -173.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.506 -0.747 0 CA-C-O 120.725 0.298 . . . . 0.0 110.263 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -109.93 145.65 36.53 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.127 -175.84 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 27.5 pt -138.21 156.68 30.84 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.453 176.109 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 34.3 t80 -106.67 123.02 47.5 Favored 'General case' 0 N--CA 1.414 -2.228 0 CA-C-N 114.91 -1.041 . . . . 0.0 108.264 177.666 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.468 HG23 ' CD1' ' A' ' 104' ' ' ILE . 8.7 mt -108.43 127.69 64.6 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.07 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 175.256 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -123.29 160.45 17.81 Favored Glycine 0 C--N 1.283 -2.366 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 -179.146 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 68.52 48.35 0.84 Allowed 'General case' 0 CA--C 1.491 -1.325 0 C-N-CA 125.112 1.365 . . . . 0.0 111.807 -174.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.534 HD11 HD11 ' A' ' 47' ' ' ILE . 4.0 mm? -72.65 145.46 47.25 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 115.078 -0.965 . . . . 0.0 110.78 175.387 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -96.89 144.86 26.43 Favored 'General case' 0 C--N 1.286 -2.18 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 179.675 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.5 ' HD2' ' N ' ' A' ' 41' ' ' GLU . 7.0 ppt_? -58.36 -21.3 49.44 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -176.594 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.5 ' N ' ' HD2' ' A' ' 40' ' ' ARG . 12.2 pt-20 -98.18 5.77 48.16 Favored 'General case' 0 C--N 1.318 -0.773 0 C-N-CA 120.464 -0.495 . . . . 0.0 111.518 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 75.6 mt -95.16 113.62 25.33 Favored 'General case' 0 N--CA 1.435 -1.206 0 CA-C-O 121.579 0.704 . . . . 0.0 109.955 175.249 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 58.8 p -102.98 174.86 5.68 Favored 'General case' 0 C--N 1.286 -2.159 0 CA-C-N 114.507 -1.224 . . . . 0.0 109.785 -179.105 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -54.65 -43.33 72.27 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 177.706 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -59.6 -41.97 97.56 Favored Glycine 0 CA--C 1.529 0.924 0 CA-C-N 115.603 -0.726 . . . . 0.0 113.51 178.513 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -63.94 -49.05 74.12 Favored 'General case' 0 CA--C 1.506 -0.743 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.534 HD11 HD11 ' A' ' 38' ' ' LEU . 46.8 mt -58.86 -44.31 90.31 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.892 -179.566 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.411 ' HG ' HG11 ' A' ' 60' ' ' VAL . 41.8 mt -59.27 -45.79 90.26 Favored 'General case' 0 CA--C 1.497 -1.093 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.66 -177.005 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.435 HG23 ' H ' ' B' ' 233' ' ' ASP . 92.0 m -61.05 -45.96 92.64 Favored 'General case' 0 C--N 1.307 -1.278 0 O-C-N 123.379 0.425 . . . . 0.0 112.116 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 99.3 t -66.07 -46.59 87.54 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-O 121.219 0.533 . . . . 0.0 110.8 -179.531 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -68.74 -20.87 64.4 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 115.57 -0.741 . . . . 0.0 112.185 -178.588 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.463 ' OG ' ' HB2' ' B' ' 231' ' ' ARG . 73.7 m -71.61 -19.38 62.13 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.771 176.265 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -69.58 -28.97 66.42 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 175.523 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 54.5 m-85 -95.21 -3.83 46.99 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.698 -174.613 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 156.49 -155.48 26.37 Favored Glycine 0 N--CA 1.423 -2.174 0 C-N-CA 119.67 -1.252 . . . . 0.0 112.749 177.095 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 60.8 t -108.07 103.99 52.0 Favored Pre-proline 0 C--N 1.305 -1.334 0 N-CA-C 110.475 -0.194 . . . . 0.0 110.475 -178.376 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.525 ' HB3' HD21 ' A' ' 77' ' ' LEU . 88.0 Cg_endo -79.43 138.93 14.2 Favored 'Trans proline' 0 N--CA 1.451 -0.979 0 C-N-CA 122.799 2.333 . . . . 0.0 110.775 177.602 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 33.1 m -114.71 -22.84 4.51 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 C-N-CA 119.605 -0.838 . . . . 0.0 112.548 -179.491 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.532 ' HB3' ' HG2' ' A' ' 78' ' ' LYS . 31.4 t70 -155.75 143.39 19.58 Favored 'General case' 0 CA--C 1.504 -0.8 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 -178.861 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.411 HG11 ' HG ' ' A' ' 48' ' ' LEU . 14.6 p -146.1 132.48 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.116 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 -179.402 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 90.3 mt -120.9 128.15 76.03 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 177.498 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -103.09 127.29 50.41 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 177.806 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.563 ' OG ' ' HB2' ' A' ' 72' ' ' GLN . 97.6 p -89.27 117.74 28.45 Favored 'General case' 0 N--CA 1.422 -1.867 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 178.549 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 19.4 mtp180 . . . . . 0 N--CA 1.423 -1.788 0 C-N-CA 119.41 -0.916 . . . . 0.0 109.856 179.46 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.563 ' HB2' ' OG ' ' A' ' 63' ' ' SER . 18.8 mm-40 . . . . . 0 N--CA 1.445 -0.684 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 86.44 16.73 61.71 Favored Glycine 0 N--CA 1.423 -2.208 0 CA-C-N 115.09 -0.959 . . . . 0.0 112.946 178.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -145.15 157.7 44.02 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 176.258 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -151.15 168.79 23.6 Favored 'General case' 0 C--N 1.292 -1.924 0 CA-C-O 120.999 0.428 . . . . 0.0 110.258 177.058 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -126.06 137.59 53.64 Favored 'General case' 0 C--N 1.292 -1.902 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.834 -177.742 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.525 HD21 ' HB3' ' A' ' 57' ' ' PRO . 9.9 tt -144.73 140.59 28.65 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 174.432 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.532 ' HG2' ' HB3' ' A' ' 59' ' ' ASP . 20.5 ptmt -124.7 144.8 50.02 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.107 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 -105.43 164.43 11.87 Favored 'General case' 0 C--N 1.284 -2.266 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.226 -178.774 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -71.86 -27.17 62.7 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-N 114.794 -1.094 . . . . 0.0 108.654 175.19 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.626 ' OD1' ' HG2' ' A' ' 83' ' ' ARG . 8.4 t70 -132.45 139.63 48.09 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.49 -179.304 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -69.88 -20.65 63.38 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 -179.087 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.626 ' HG2' ' OD1' ' A' ' 81' ' ' ASP . 22.8 mmm180 -62.62 -34.45 77.05 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 122.2 1.0 . . . . 0.0 109.712 174.486 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.455 ' HA ' HD12 ' A' ' 87' ' ' LEU . 52.7 m -68.96 -37.02 78.58 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 114.865 -1.061 . . . . 0.0 113.559 179.303 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.509 ' O ' HG23 ' A' ' 89' ' ' VAL . 76.2 p -61.2 -45.0 96.37 Favored 'General case' 0 C--N 1.342 0.276 0 C-N-CA 120.473 -0.491 . . . . 0.0 110.418 -177.125 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.43 ' H ' HG12 ' A' ' 86' ' ' ILE . 3.1 pt -64.46 -39.06 84.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.562 177.28 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.455 HD12 ' HA ' ' A' ' 84' ' ' SER . 40.8 mt -58.8 -44.03 90.69 Favored 'General case' 0 N--CA 1.478 0.925 0 O-C-N 123.763 0.664 . . . . 0.0 111.254 178.083 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.446 ' HB1' HD12 ' A' ' 92' ' ' LEU . . . -71.16 -41.12 70.82 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.393 -178.548 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.509 HG23 ' O ' ' A' ' 85' ' ' THR . 68.9 t -57.86 -45.73 87.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -58.5 -44.61 89.48 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 121.814 0.816 . . . . 0.0 111.347 -175.269 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -97.46 -20.31 17.85 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-N 114.744 -1.116 . . . . 0.0 113.296 -168.625 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.47 ' HB2' HG13 ' A' ' 104' ' ' ILE . 20.8 mt -95.15 -30.96 13.76 Favored 'General case' 0 C--N 1.285 -2.221 0 C-N-CA 119.615 -0.834 . . . . 0.0 110.705 -178.01 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 60.4 t30 -66.44 124.24 22.23 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 87.51 -1.22 85.71 Favored Glycine 0 C--N 1.304 -1.197 0 C-N-CA 121.107 -0.568 . . . . 0.0 113.021 -178.774 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -90.32 135.83 33.43 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.436 ' HA ' ' HA ' ' A' ' 101' ' ' ALA . 10.9 mptt -95.6 123.17 39.02 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-O 121.242 0.544 . . . . 0.0 111.397 -176.228 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 52.0 mt -126.36 141.37 46.08 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 N-CA-C 106.237 -1.764 . . . . 0.0 106.237 174.35 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 56.8 22.32 40.26 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 114.102 0.401 . . . . 0.0 114.102 178.478 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 85.52 14.07 69.04 Favored Glycine 0 N--CA 1.439 -1.116 0 C-N-CA 120.784 -0.722 . . . . 0.0 113.579 179.576 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 12.1 ptp180 -140.25 146.46 38.65 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 117.456 0.628 . . . . 0.0 110.838 177.643 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.436 ' HA ' ' HA ' ' A' ' 96' ' ' LYS . . . -88.58 119.76 29.34 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.731 -175.394 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.416 HD23 ' HA ' ' A' ' 102' ' ' LEU . 13.2 mt -65.53 138.56 58.14 Favored 'General case' 0 CA--C 1.488 -1.415 0 CA-C-O 121.646 0.736 . . . . 0.0 112.35 179.407 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 58.0 tptt -114.65 115.85 27.77 Favored 'General case' 0 C--N 1.279 -2.491 0 CA-C-N 114.822 -1.081 . . . . 0.0 108.392 177.539 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.47 HG13 ' HB2' ' A' ' 92' ' ' LEU . 4.1 mm -118.44 129.9 74.07 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -143.96 151.65 40.03 Favored 'General case' 0 C--N 1.289 -2.063 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 84.1 m-70 -79.67 140.16 37.14 Favored 'General case' 0 C--N 1.298 -1.663 0 C-N-CA 120.124 -0.63 . . . . 0.0 109.779 179.021 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 13.5 t -149.34 162.98 39.0 Favored 'General case' 0 C--N 1.279 -2.469 0 N-CA-C 106.094 -1.817 . . . . 0.0 106.094 -178.656 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -109.69 109.42 20.14 Favored 'General case' 0 N--CA 1.424 -1.767 0 N-CA-C 106.065 -1.828 . . . . 0.0 106.065 173.329 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 58.0 t80 . . . . . 0 C--N 1.289 -2.062 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.843 -177.788 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 4.6 mp . . . . . 0 N--CA 1.439 -0.995 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 227' ' ' MET . . . . . . . . . . . . . 73.0 mtm -77.24 140.13 65.23 Favored Pre-proline 0 C--N 1.318 -0.783 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.983 -178.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 228' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -61.7 144.32 97.16 Favored 'Trans proline' 0 C--O 1.243 0.733 0 C-N-CA 123.31 2.674 . . . . 0.0 113.412 -178.355 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . -68.69 172.11 36.54 Favored Glycine 0 C--O 1.242 0.625 0 CA-C-N 115.082 -0.963 . . . . 0.0 113.854 -178.286 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 23.0 t -77.02 -13.98 59.89 Favored 'General case' 0 C--N 1.314 -0.978 0 C-N-CA 123.011 0.524 . . . . 0.0 111.46 -176.211 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 231' ' ' ARG . . . . . 0.463 ' HB2' ' OG ' ' A' ' 52' ' ' SER . 31.7 mmt180 -84.94 -3.85 58.9 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.922 -0.311 . . . . 0.0 110.449 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 232' ' ' TRP . . . . . . . . . . . . . 21.5 t90 -78.96 131.94 36.51 Favored 'General case' 0 N--CA 1.433 -1.314 0 CA-C-O 122.333 1.063 . . . . 0.0 111.966 -178.045 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 233' ' ' ASP . . . . . 0.435 ' H ' HG23 ' A' ' 49' ' ' THR . 25.0 t70 -122.08 137.94 54.63 Favored 'General case' 0 C--N 1.267 -2.982 0 N-CA-C 101.388 -3.56 . . . . 0.0 101.388 168.193 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.413 0 C-N-CA 128.193 2.806 . . . . 0.0 116.093 179.96 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 240' ' ' GLY . . . . . 0.472 ' O ' ' HG2' ' B' ' 244' ' ' LYS . . . . . . . . 0 C--O 1.202 -1.869 0 N-CA-C 112.113 -0.395 . . . . 0.0 112.113 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 29.7 p90 -76.79 -34.48 57.97 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 112.705 0.632 . . . . 0.0 112.705 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -64.73 -39.16 93.17 Favored 'General case' 0 CA--C 1.504 -0.789 0 C-N-CA 122.899 0.479 . . . . 0.0 110.731 -175.913 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -63.47 -35.01 79.02 Favored 'General case' 0 C--O 1.197 -1.685 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.372 -179.304 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 244' ' ' LYS . . . . . 0.472 ' HG2' ' O ' ' B' ' 240' ' ' GLY . 70.1 mmtt -65.8 -41.95 91.31 Favored 'General case' 0 N--CA 1.439 -0.986 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 -178.934 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 245' ' ' TRP . . . . . . . . . . . . . 44.5 m0 -64.72 -40.81 95.98 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.265 -0.88 . . . . 0.0 109.635 179.235 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 246' ' ' PHE . . . . . 0.67 ' O ' ' HG2' ' B' ' 249' ' ' GLN . 3.0 t80 -72.01 -31.57 66.33 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.577 177.927 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -74.4 -38.48 63.09 Favored 'General case' 0 C--N 1.294 -1.819 0 O-C-N 121.671 -0.643 . . . . 0.0 111.246 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.47 -14.01 55.77 Favored 'General case' 0 CA--C 1.508 -0.64 0 CA-C-O 121.118 0.485 . . . . 0.0 111.635 -176.731 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 249' ' ' GLN . . . . . 0.67 ' HG2' ' O ' ' B' ' 246' ' ' PHE . 11.3 pt20 -77.89 -1.16 30.43 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.578 -178.703 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 250' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -53.15 -39.16 63.34 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.078 -179.456 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -131.39 108.24 9.48 Favored 'General case' 0 N--CA 1.432 -1.326 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 174.032 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 252' ' ' ILE . . . . . . . . . . . . . 28.3 pt -86.83 -31.57 6.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 CA-C-N 114.973 -1.012 . . . . 0.0 112.71 -173.09 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -92.25 -20.25 21.34 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-O 121.416 0.627 . . . . 0.0 111.075 -175.074 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 254' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.295 -1.763 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.198 -175.293 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.435 -1.213 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -95.01 145.21 25.1 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 -175.427 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 26.1 pt -141.01 162.17 22.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-O 121.029 0.442 . . . . 0.0 111.033 175.777 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 66.5 t80 -109.84 121.78 46.02 Favored 'General case' 0 N--CA 1.415 -2.21 0 CA-C-N 114.702 -1.136 . . . . 0.0 108.436 178.642 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 9.4 mt -109.15 127.94 65.45 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.963 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 174.86 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -130.52 168.12 21.79 Favored Glycine 0 C--N 1.29 -2.008 0 N-CA-C 111.305 -0.718 . . . . 0.0 111.305 -178.463 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 68.25 33.73 4.18 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.663 1.185 . . . . 0.0 110.503 -176.606 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.525 HD11 HD11 ' A' ' 47' ' ' ILE . 4.0 mm? -65.8 151.67 46.1 Favored 'General case' 0 CA--C 1.5 -0.969 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.606 178.083 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.489 HD22 ' HA3' ' A' ' 98' ' ' GLY . 39.2 t-20 -90.85 148.81 22.25 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 176.234 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.404 HH11 ' HB3' ' A' ' 41' ' ' GLU . 0.6 OUTLIER -64.76 -17.12 63.88 Favored 'General case' 0 C--N 1.297 -1.7 0 C-N-CA 123.765 0.826 . . . . 0.0 113.149 -179.001 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.404 ' HB3' HH11 ' A' ' 40' ' ' ARG . 10.2 pt-20 -92.91 -13.64 28.64 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.555 179.162 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.401 HD12 ' H ' ' A' ' 39' ' ' ASN . 74.8 mt -78.83 123.25 27.03 Favored 'General case' 0 CA--C 1.504 -0.82 0 CA-C-O 121.564 0.697 . . . . 0.0 111.809 -176.778 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 10.7 t -114.22 174.15 6.09 Favored 'General case' 0 C--N 1.293 -1.876 0 CA-C-N 114.737 -1.12 . . . . 0.0 108.965 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.418 ' CG ' ' HB2' ' A' ' 62' ' ' LEU . 52.3 mt-10 -55.42 -45.1 76.76 Favored 'General case' 0 C--O 1.214 -0.782 0 C-N-CA 124.016 0.927 . . . . 0.0 110.62 -176.47 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -59.35 -39.0 94.18 Favored Glycine 0 C--O 1.244 0.731 0 CA-C-N 116.117 -0.492 . . . . 0.0 113.466 -178.713 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -67.64 -48.44 66.71 Favored 'General case' 0 C--O 1.243 0.745 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 -179.492 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.525 HD11 HD11 ' A' ' 38' ' ' LEU . 36.2 mt -58.22 -46.21 88.76 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.318 0 CA-C-N 114.924 -1.035 . . . . 0.0 110.291 178.471 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 44.6 mt -59.21 -40.26 85.25 Favored 'General case' 0 CA--C 1.492 -1.259 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.397 -178.33 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.408 HG23 ' H ' ' B' ' 233' ' ' ASP . 84.3 m -65.16 -46.22 81.72 Favored 'General case' 0 N--CA 1.431 -1.381 0 O-C-N 123.502 0.501 . . . . 0.0 110.977 -178.511 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 57.6 t -67.53 -48.01 78.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.42 -178.72 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.42 ' HD2' ' HH ' ' A' ' 79' ' ' TYR . 6.1 m-85 -64.84 -21.27 66.76 Favored 'General case' 0 N--CA 1.436 -1.17 0 C-N-CA 124.408 1.083 . . . . 0.0 112.545 -179.442 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.463 ' CB ' ' HB2' ' B' ' 232' ' ' TRP . 51.2 m -71.65 -20.75 61.91 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 176.736 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -74.26 -24.55 59.3 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 118.022 -1.471 . . . . 0.0 109.523 174.691 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 -89.85 -8.81 51.13 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.221 0.534 . . . . 0.0 111.434 -175.563 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 158.99 -163.21 33.13 Favored Glycine 0 N--CA 1.425 -2.075 0 N-CA-C 110.981 -0.848 . . . . 0.0 110.981 177.673 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 60.1 t -101.33 109.37 58.62 Favored Pre-proline 0 C--N 1.297 -1.713 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 -179.097 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.511 ' HB3' HD21 ' A' ' 77' ' ' LEU . 79.0 Cg_endo -77.53 137.08 16.14 Favored 'Trans proline' 0 N--CA 1.445 -1.375 0 C-N-CA 122.17 1.914 . . . . 0.0 109.701 176.73 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 35.0 m -111.48 -26.54 3.09 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 C-N-CA 119.46 -0.896 . . . . 0.0 111.992 -178.833 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.477 ' HB3' ' HG2' ' A' ' 78' ' ' LYS . 10.5 t70 -155.06 144.43 21.18 Favored 'General case' 0 C--O 1.247 0.946 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 -179.062 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 14.6 p -146.34 138.17 19.34 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 O-C-N 123.415 0.447 . . . . 0.0 110.103 -178.486 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 98.4 mt -121.31 126.21 74.69 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 174.347 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.418 ' HB2' ' CG ' ' A' ' 44' ' ' GLU . 0.1 OUTLIER -98.58 115.77 29.36 Favored 'General case' 0 N--CA 1.425 -1.677 0 N-CA-C 106.222 -1.77 . . . . 0.0 106.222 171.396 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 6.8 m -74.96 117.24 16.59 Favored 'General case' 0 N--CA 1.412 -2.344 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 178.576 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 66.9 mtm180 . . . . . 0 C--N 1.299 -1.63 0 CA-C-O 121.269 0.557 . . . . 0.0 111.189 -176.181 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 . . . . . 0 CA--C 1.518 -0.275 0 CA-C-O 120.909 0.385 . . . . 0.0 111.668 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 83.44 11.14 80.81 Favored Glycine 0 N--CA 1.435 -1.405 0 C-N-CA 121.126 -0.559 . . . . 0.0 113.336 178.015 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 38.3 p90 -154.06 159.49 41.57 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 177.13 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -154.12 171.94 18.33 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 123.917 0.761 . . . . 0.0 109.77 178.216 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -131.12 141.45 50.13 Favored 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 123.61 0.764 . . . . 0.0 109.903 -178.893 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.511 HD21 ' HB3' ' A' ' 57' ' ' PRO . 10.0 tt -148.86 141.48 24.43 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 176.784 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.477 ' HG2' ' HB3' ' A' ' 59' ' ' ASP . 21.5 ptmt -124.11 143.98 50.15 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 178.465 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.42 ' HH ' ' HD2' ' A' ' 51' ' ' PHE . 74.5 m-85 -103.84 165.66 10.9 Favored 'General case' 0 C--N 1.288 -2.071 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.724 -178.289 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -75.13 -39.43 60.5 Favored 'General case' 0 N--CA 1.425 -1.715 0 CA-C-N 114.956 -1.02 . . . . 0.0 108.381 174.861 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -116.84 144.14 44.85 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 121.378 0.609 . . . . 0.0 111.364 179.758 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 21.4 mp0 -69.83 -28.78 65.98 Favored 'General case' 0 C--N 1.311 -1.086 0 C-N-CA 124.063 0.945 . . . . 0.0 113.15 -177.575 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.1 -33.88 76.77 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 122.142 0.972 . . . . 0.0 110.343 177.092 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 50.5 m -60.88 -37.34 81.84 Favored 'General case' 0 C--N 1.284 -2.258 0 CA-C-N 115.106 -0.952 . . . . 0.0 112.029 176.182 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.436 ' O ' HG23 ' A' ' 89' ' ' VAL . 59.5 p -63.7 -45.3 90.64 Favored 'General case' 0 C--N 1.347 0.488 0 C-N-CA 120.507 -0.477 . . . . 0.0 110.836 -177.759 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 4.0 pt -66.13 -38.24 81.54 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.687 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.408 179.279 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 13.5 mt -59.66 -44.4 93.58 Favored 'General case' 0 CA--C 1.511 -0.547 0 O-C-N 123.284 0.365 . . . . 0.0 111.751 175.558 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.424 ' O ' ' HB2' ' A' ' 92' ' ' LEU . . . -69.72 -43.98 71.24 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.106 -179.533 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.475 HG22 HG22 ' A' ' 104' ' ' ILE . 85.3 t -60.99 -45.44 98.52 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-O 121.488 0.661 . . . . 0.0 110.98 178.798 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -65.76 -37.3 85.96 Favored 'General case' 0 C--N 1.284 -2.262 0 C-N-CA 124.196 0.998 . . . . 0.0 111.828 -176.696 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -91.62 -28.09 17.72 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 112.94 0.719 . . . . 0.0 112.94 -176.188 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.439 ' HB2' HG13 ' A' ' 104' ' ' ILE . 14.8 mt -97.06 -28.91 13.93 Favored 'General case' 0 CA--C 1.491 -1.305 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -173.117 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -65.56 125.26 24.65 Favored 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 120.03 -0.668 . . . . 0.0 109.465 -178.891 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 88.53 -8.36 79.26 Favored Glycine 0 C--N 1.31 -0.876 0 CA-C-N 115.643 -0.708 . . . . 0.0 112.501 -178.611 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -81.17 137.59 35.9 Favored 'General case' 0 CA--C 1.516 -0.332 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 -178.543 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.4 ' HD2' ' N ' ' A' ' 96' ' ' LYS . 11.2 mptt -95.51 122.86 38.69 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-O 120.969 0.414 . . . . 0.0 111.571 -175.885 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 54.5 mt -127.02 141.37 46.44 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 N-CA-C 105.734 -1.95 . . . . 0.0 105.734 172.633 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.489 ' HA3' HD22 ' A' ' 39' ' ' ASN . . . 56.84 26.83 55.23 Favored Glycine 0 CA--C 1.521 0.438 0 O-C-N 123.035 0.209 . . . . 0.0 113.395 -179.309 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 79.5 8.19 87.93 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 121.296 -0.478 . . . . 0.0 113.786 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 15.8 ptp180 -131.2 142.08 50.14 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 117.87 0.835 . . . . 0.0 110.321 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -82.83 120.31 25.48 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.686 -177.117 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 11.4 mt -65.78 143.96 57.17 Favored 'General case' 0 C--O 1.249 1.047 0 CA-C-O 121.858 0.837 . . . . 0.0 112.683 179.197 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 22.7 tptm -116.59 118.7 33.33 Favored 'General case' 0 N--CA 1.418 -2.056 0 CA-C-N 114.771 -1.104 . . . . 0.0 108.548 175.713 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.475 HG22 HG22 ' A' ' 89' ' ' VAL . 4.4 mm -117.63 136.01 56.19 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.185 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 178.254 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -143.43 152.66 41.81 Favored 'General case' 0 C--N 1.287 -2.151 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -178.451 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 74.4 m-70 -83.81 131.96 34.86 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 178.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 5.8 t -156.27 161.73 40.2 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 -177.706 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 41.7 m-85 -109.91 109.21 19.76 Favored 'General case' 0 N--CA 1.42 -1.963 0 C-N-CA 118.351 -1.34 . . . . 0.0 107.466 169.655 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 25.5 t80 . . . . . 0 C--N 1.277 -2.546 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 -179.915 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 4.0 mp . . . . . 0 C--O 1.246 0.871 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 227' ' ' MET . . . . . . . . . . . . . 26.1 ptt? -69.71 151.03 96.59 Favored Pre-proline 0 C--N 1.318 -0.797 0 O-C-N 123.485 0.491 . . . . 0.0 110.077 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 228' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -71.7 161.2 45.93 Favored 'Trans proline' 0 C--O 1.252 1.176 0 C-N-CA 123.141 2.561 . . . . 0.0 114.327 -175.27 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . -83.66 173.28 51.01 Favored Glycine 0 N--CA 1.436 -1.326 0 CA-C-N 114.736 -1.12 . . . . 0.0 112.318 177.851 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 9.6 m -74.35 -14.49 60.89 Favored 'General case' 0 C--N 1.306 -1.288 0 C-N-CA 123.456 0.703 . . . . 0.0 112.369 -174.021 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 38.9 mmt180 -91.41 -6.22 53.16 Favored 'General case' 0 C--N 1.318 -0.791 0 C-N-CA 120.076 -0.65 . . . . 0.0 111.693 -177.004 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 232' ' ' TRP . . . . . 0.463 ' HB2' ' CB ' ' A' ' 52' ' ' SER . 21.0 t90 -76.4 121.11 22.57 Favored 'General case' 0 CA--C 1.497 -1.062 0 CA-C-O 122.45 1.119 . . . . 0.0 112.324 -178.732 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 233' ' ' ASP . . . . . 0.408 ' H ' HG23 ' A' ' 49' ' ' THR . 24.7 t70 -118.04 148.68 42.02 Favored 'General case' 0 N--CA 1.407 -2.623 0 N-CA-C 102.541 -3.133 . . . . 0.0 102.541 171.546 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.208 0 C-N-CA 127.967 2.699 . . . . 0.0 116.418 -176.987 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 240' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.418 -2.547 0 N-CA-C 111.568 -0.613 . . . . 0.0 111.568 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 35.0 p90 -76.96 -33.51 57.66 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-O 121.481 0.657 . . . . 0.0 110.273 174.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -67.23 -39.45 86.21 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.518 -176.449 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -60.13 -34.35 73.4 Favored 'General case' 0 C--O 1.202 -1.43 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.826 177.831 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -62.09 -37.81 86.48 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 122.817 0.447 . . . . 0.0 109.96 -179.147 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 245' ' ' TRP . . . . . 0.519 ' O ' ' HG3' ' B' ' 248' ' ' LYS . 36.8 m0 -69.6 -39.73 77.07 Favored 'General case' 0 C--O 1.242 0.702 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.551 178.887 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 246' ' ' PHE . . . . . 0.742 ' O ' ' HG2' ' B' ' 249' ' ' GLN . 2.8 t80 -70.2 -33.05 71.23 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 114.879 -1.055 . . . . 0.0 110.812 177.874 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -73.15 -31.01 64.0 Favored 'General case' 0 C--N 1.285 -2.237 0 O-C-N 121.817 -0.552 . . . . 0.0 110.663 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 248' ' ' LYS . . . . . 0.519 ' HG3' ' O ' ' B' ' 245' ' ' TRP . 2.2 pptp? -87.22 -12.1 47.81 Favored 'General case' 0 C--O 1.221 -0.414 0 CA-C-O 120.86 0.362 . . . . 0.0 111.594 -177.259 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 249' ' ' GLN . . . . . 0.742 ' HG2' ' O ' ' B' ' 246' ' ' PHE . 10.8 pt20 -79.33 2.99 19.54 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.002 -178.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 250' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -56.98 -36.99 70.99 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.267 176.517 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -116.27 152.92 32.86 Favored 'General case' 0 N--CA 1.411 -2.379 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 175.596 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 252' ' ' ILE . . . . . . . . . . . . . 28.5 pt -128.79 -28.21 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 -173.164 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -117.32 -24.7 7.32 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-O 121.061 0.457 . . . . 0.0 109.806 -174.583 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 254' ' ' GLU . . . . . . . . . . . . . 48.4 mp0 . . . . . 0 N--CA 1.438 -1.032 0 C-N-CA 126.084 1.754 . . . . 0.0 114.622 -172.754 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.24 0.6 0 N-CA-C 112.33 0.492 . . . . 0.0 112.33 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -108.25 145.85 33.71 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-O 121.124 0.488 . . . . 0.0 111.548 -173.06 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 26.7 pt -138.23 154.99 28.61 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.503 175.879 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -106.81 122.86 47.22 Favored 'General case' 0 C--N 1.286 -2.158 0 CA-C-N 114.67 -1.15 . . . . 0.0 108.802 176.009 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.532 HG23 ' CD1' ' A' ' 104' ' ' ILE . 11.5 mt -107.97 127.04 64.43 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 N-CA-C 106.182 -1.784 . . . . 0.0 106.182 176.543 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -129.07 167.94 20.96 Favored Glycine 0 C--N 1.28 -2.566 0 N-CA-C 110.357 -1.097 . . . . 0.0 110.357 179.03 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 75.7 30.32 0.79 Allowed 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.644 1.178 . . . . 0.0 111.179 -179.056 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.455 HD11 HD11 ' A' ' 47' ' ' ILE . 4.1 mm? -66.94 154.54 40.83 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.639 -0.71 . . . . 0.0 112.047 178.826 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.422 ' HB3' ' HG ' ' A' ' 42' ' ' LEU . 42.8 t-20 -95.03 146.06 24.52 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 106.225 -1.768 . . . . 0.0 106.225 174.728 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 8.0 ppt_? -60.52 -23.31 64.47 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 122.96 0.504 . . . . 0.0 112.332 178.734 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.4 ' HG2' ' CG ' ' A' ' 39' ' ' ASN . 11.2 pt-20 -88.61 -9.53 51.86 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.798 -178.521 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.422 ' HG ' ' HB3' ' A' ' 39' ' ' ASN . 67.1 mt -80.99 125.96 30.79 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 121.188 0.518 . . . . 0.0 110.874 -177.872 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 66.9 p -107.31 173.36 6.36 Favored 'General case' 0 C--N 1.293 -1.867 0 CA-C-N 114.885 -1.052 . . . . 0.0 110.063 -178.252 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.8 mp0 -57.66 -40.54 79.59 Favored 'General case' 0 N--CA 1.433 -1.282 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.449 177.005 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -59.42 -38.49 93.54 Favored Glycine 0 N--CA 1.445 -0.716 0 O-C-N 123.681 0.613 . . . . 0.0 112.629 179.119 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -67.25 -49.19 65.36 Favored 'General case' 0 CA--C 1.499 -1.002 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 179.115 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.455 HD11 HD11 ' A' ' 38' ' ' LEU . 54.4 mt -59.73 -47.39 91.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.074 -0.966 . . . . 0.0 110.616 179.436 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 49.4 mt -59.72 -44.55 93.68 Favored 'General case' 0 CA--C 1.49 -1.345 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.468 -177.138 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.453 HG23 ' H ' ' B' ' 233' ' ' ASP . 62.5 m -61.69 -46.27 90.41 Favored 'General case' 0 C--N 1.31 -1.13 0 O-C-N 123.454 0.471 . . . . 0.0 111.636 -178.553 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 86.8 t -67.3 -47.59 80.73 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.777 -178.755 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.409 ' HD2' ' HH ' ' A' ' 79' ' ' TYR . 3.7 m-85 -65.92 -23.82 66.7 Favored 'General case' 0 N--CA 1.435 -1.177 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.725 -179.235 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.533 ' OG ' ' HB2' ' B' ' 231' ' ' ARG . 70.0 m -70.69 -18.53 62.82 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 176.255 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -76.06 -28.96 57.82 Favored 'General case' 0 C--O 1.249 1.051 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 176.726 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 51.7 m-85 -86.23 -23.19 26.52 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.279 -176.709 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 177.4 -155.89 18.81 Favored Glycine 0 N--CA 1.43 -1.74 0 C-N-CA 120.4 -0.905 . . . . 0.0 112.546 177.325 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 69.3 t -107.66 108.66 61.84 Favored Pre-proline 0 C--N 1.303 -1.438 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 -179.617 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.402 ' HB3' HD21 ' A' ' 77' ' ' LEU . 73.8 Cg_endo -76.24 137.0 18.57 Favored 'Trans proline' 0 N--CA 1.439 -1.686 0 C-N-CA 122.175 1.917 . . . . 0.0 109.905 177.796 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 35.4 m -113.45 -23.83 4.14 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.864 0 C-N-CA 119.699 -0.8 . . . . 0.0 111.146 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.48 ' HB3' ' HG2' ' A' ' 78' ' ' LYS . 32.7 t70 -158.02 142.87 16.46 Favored 'General case' 0 C--O 1.244 0.812 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 178.93 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 14.1 p -140.57 135.95 35.41 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.238 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 178.167 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 78.7 mt -121.3 128.47 75.95 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 176.294 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -102.02 120.96 41.26 Favored 'General case' 0 C--N 1.29 -1.984 0 N-CA-C 105.742 -1.947 . . . . 0.0 105.742 175.251 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 15.7 m -80.98 117.6 21.74 Favored 'General case' 0 N--CA 1.415 -2.192 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 70.0 mtt85 . . . . . 0 C--N 1.299 -1.603 0 CA-C-O 120.981 0.42 . . . . 0.0 111.298 -178.072 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 . . . . . 0 N--CA 1.446 -0.672 0 CA-C-O 120.949 0.404 . . . . 0.0 111.828 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 90.3 13.01 60.73 Favored Glycine 0 N--CA 1.429 -1.769 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.027 179.323 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.426 ' HA ' HD23 ' A' ' 38' ' ' LEU . 45.6 p90 -154.08 158.85 41.09 Favored 'General case' 0 N--CA 1.431 -1.396 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 177.745 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -152.14 176.44 11.55 Favored 'General case' 0 N--CA 1.438 -1.043 0 O-C-N 123.568 0.543 . . . . 0.0 110.085 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -136.64 144.71 44.17 Favored 'General case' 0 C--N 1.306 -1.324 0 C-N-CA 123.292 0.637 . . . . 0.0 110.037 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.402 HD21 ' HB3' ' A' ' 57' ' ' PRO . 9.9 tt -149.28 140.68 23.27 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 176.451 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.48 ' HG2' ' HB3' ' A' ' 59' ' ' ASP . 22.0 ptmt -122.93 144.57 49.15 Favored 'General case' 0 C--O 1.257 1.486 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.409 ' HH ' ' HD2' ' A' ' 51' ' ' PHE . 86.2 m-85 -108.96 165.24 11.73 Favored 'General case' 0 C--N 1.29 -2.021 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.34 -177.781 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -68.4 -38.09 80.95 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 114.703 -1.135 . . . . 0.0 108.786 174.384 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -126.23 145.9 50.21 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-O 121.324 0.583 . . . . 0.0 111.967 -178.574 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 20.0 mp0 -67.1 -29.28 68.99 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 124.495 1.118 . . . . 0.0 112.271 -178.39 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 58.3 mtm180 -61.06 -33.81 73.89 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-O 122.145 0.974 . . . . 0.0 111.692 178.228 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 51.1 m -64.27 -37.34 87.14 Favored 'General case' 0 C--N 1.28 -2.424 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.541 174.493 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.419 ' O ' HG23 ' A' ' 89' ' ' VAL . 52.6 p -63.18 -44.75 94.51 Favored 'General case' 0 C--O 1.22 -0.496 0 C-N-CA 120.424 -0.51 . . . . 0.0 110.432 -178.15 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 5.4 pt -65.86 -39.21 84.05 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 C-N-CA 122.49 0.316 . . . . 0.0 111.459 179.32 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 18.7 mt -60.21 -43.94 95.54 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 123.662 0.601 . . . . 0.0 110.903 175.489 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.402 ' HB1' HD12 ' A' ' 92' ' ' LEU . . . -71.69 -46.47 58.7 Favored 'General case' 0 N--CA 1.435 -1.189 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.757 -178.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 85' ' ' THR . 72.4 t -57.03 -48.29 82.06 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.71 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -179.42 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -63.63 -37.17 86.31 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-O 120.951 0.405 . . . . 0.0 111.437 -175.226 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -93.02 -21.09 19.95 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 -174.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.507 ' HB2' HG13 ' A' ' 104' ' ' ILE . 20.4 mt -99.3 -28.89 13.1 Favored 'General case' 0 C--N 1.291 -1.976 0 C-N-CA 120.455 -0.498 . . . . 0.0 111.506 -176.361 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -66.28 124.6 23.11 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 177.283 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 83.18 -0.59 89.65 Favored Glycine 0 C--N 1.304 -1.242 0 C-N-CA 121.099 -0.572 . . . . 0.0 112.608 -179.248 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 69.4 t80 -85.2 131.66 34.4 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 -178.433 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -90.62 119.42 30.85 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-O 121.172 0.51 . . . . 0.0 112.241 -176.955 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 48.5 mt -127.67 141.35 46.64 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 N-CA-C 105.866 -1.902 . . . . 0.0 105.866 172.464 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 60.34 18.24 49.3 Favored Glycine 0 CA--C 1.526 0.774 0 C-N-CA 121.41 -0.424 . . . . 0.0 113.939 178.315 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 85.44 11.26 75.43 Favored Glycine 0 N--CA 1.437 -1.266 0 C-N-CA 121.058 -0.592 . . . . 0.0 112.721 -179.042 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 16.1 ptp180 -135.5 145.3 46.96 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 117.115 0.458 . . . . 0.0 110.913 179.523 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -87.49 120.58 28.94 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.067 -177.115 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 12.4 mt -67.33 148.92 51.03 Favored 'General case' 0 C--N 1.31 -1.118 0 C-N-CA 123.789 0.836 . . . . 0.0 112.822 178.769 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 17.3 tppt? -124.6 118.75 27.23 Favored 'General case' 0 N--CA 1.422 -1.84 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.191 176.231 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.532 ' CD1' HG23 ' A' ' 35' ' ' ILE . 5.1 mm -119.96 136.38 57.25 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 179.372 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -142.09 146.47 35.45 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 81.1 m-70 -79.34 132.71 36.52 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.278 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 4.7 t -162.41 163.73 27.58 Favored 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 -175.217 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -99.34 112.94 25.02 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 174.771 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 35.5 t80 . . . . . 0 C--N 1.297 -1.696 0 CA-C-N 115.945 -0.571 . . . . 0.0 109.667 179.785 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 4.2 mp . . . . . 0 N--CA 1.434 -1.229 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 227' ' ' MET . . . . . . . . . . . . . 27.8 ptm -89.11 149.31 42.87 Favored Pre-proline 0 C--N 1.307 -1.251 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 177.033 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 228' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -63.62 151.04 86.92 Favored 'Trans proline' 0 C--O 1.244 0.806 0 C-N-CA 123.443 2.762 . . . . 0.0 113.564 -177.588 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . -77.79 174.92 54.68 Favored Glycine 0 C--O 1.246 0.869 0 CA-C-N 115.432 -0.804 . . . . 0.0 112.546 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 17.6 m -76.3 -17.06 59.62 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -176.333 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 231' ' ' ARG . . . . . 0.533 ' HB2' ' OG ' ' A' ' 52' ' ' SER . 9.8 mmm180 -79.82 -8.27 59.18 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 120.794 0.33 . . . . 0.0 111.324 179.63 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 232' ' ' TRP . . . . . . . . . . . . . 24.5 t90 -72.02 128.62 36.29 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-O 122.125 0.964 . . . . 0.0 111.383 179.078 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 233' ' ' ASP . . . . . 0.453 ' H ' HG23 ' A' ' 49' ' ' THR . 16.7 t70 -123.33 140.2 53.25 Favored 'General case' 0 C--N 1.265 -3.106 0 N-CA-C 101.586 -3.487 . . . . 0.0 101.586 173.409 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.501 3.024 0 C-N-CA 128.622 3.011 . . . . 0.0 116.72 -179.447 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 240' ' ' GLY . . . . . 0.494 ' O ' ' HG2' ' B' ' 244' ' ' LYS . . . . . . . . 0 N--CA 1.416 -2.664 0 N-CA-C 110.489 -1.045 . . . . 0.0 110.489 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 49.7 p90 -75.95 -35.94 59.51 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -178.148 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -66.35 -38.74 88.3 Favored 'General case' 0 CA--C 1.5 -0.979 0 CA-C-N 116.727 -0.215 . . . . 0.0 111.04 -176.005 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -60.51 -35.16 75.28 Favored 'General case' 0 C--O 1.202 -1.396 0 O-C-N 123.597 0.561 . . . . 0.0 110.483 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 244' ' ' LYS . . . . . 0.494 ' HG2' ' O ' ' B' ' 240' ' ' GLY . 70.4 mmtt -67.14 -41.82 85.44 Favored 'General case' 0 CA--C 1.509 -0.628 0 CA-C-O 121.662 0.744 . . . . 0.0 109.137 -178.091 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 245' ' ' TRP . . . . . . . . . . . . . 45.3 m0 -68.93 -41.07 78.61 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 114.853 -1.067 . . . . 0.0 109.58 179.107 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 246' ' ' PHE . . . . . 0.548 ' O ' ' HG2' ' B' ' 249' ' ' GLN . 5.2 t80 -65.86 -37.86 87.3 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.777 179.155 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -68.02 -33.33 74.4 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.556 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.9 -21.05 21.58 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 120.669 -0.413 . . . . 0.0 111.946 -177.607 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 249' ' ' GLN . . . . . 0.548 ' HG2' ' O ' ' B' ' 246' ' ' PHE . 12.6 pt20 -75.42 2.29 11.79 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.092 0.472 . . . . 0.0 111.287 -178.056 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 250' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -56.91 -38.57 73.03 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.319 178.077 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -139.57 113.55 8.76 Favored 'General case' 0 N--CA 1.439 -0.987 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 175.755 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 252' ' ' ILE . . . . . . . . . . . . . 27.8 pt -102.54 -37.48 4.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 -172.288 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -108.87 -18.07 13.78 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-O 121.846 0.832 . . . . 0.0 110.048 -175.877 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 254' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 . . . . . 0 C--N 1.29 -2.018 0 CA-C-N 114.205 -1.361 . . . . 0.0 112.054 -176.476 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.464 ' HB2' ' NE2' ' A' ' 82' ' ' GLN . . . . . . . . 0 N--CA 1.435 -1.181 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -103.68 144.65 31.17 Favored 'General case' 0 N--CA 1.429 -1.518 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.831 -174.336 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 25.1 pt -141.37 157.05 21.7 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.742 0 CA-C-N 115.476 -0.783 . . . . 0.0 109.462 178.803 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.422 ' HB2' HG21 ' A' ' 107' ' ' THR . 16.5 t80 -108.81 123.04 48.42 Favored 'General case' 0 N--CA 1.411 -2.378 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 176.806 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.505 HG23 ' CD1' ' A' ' 104' ' ' ILE . 12.0 mt -107.83 126.97 64.26 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.931 0 N-CA-C 105.792 -1.929 . . . . 0.0 105.792 176.518 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -129.01 165.4 21.8 Favored Glycine 0 N--CA 1.418 -2.556 0 N-CA-C 112.041 -0.424 . . . . 0.0 112.041 -177.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 63.57 51.97 2.39 Favored 'General case' 0 C--N 1.314 -0.951 0 C-N-CA 125.146 1.378 . . . . 0.0 109.876 -177.672 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.408 HD11 HD11 ' A' ' 47' ' ' ILE . 3.1 mm? -78.37 161.2 27.34 Favored 'General case' 0 CA--C 1.502 -0.884 0 CA-C-N 113.99 -1.459 . . . . 0.0 111.482 178.499 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.493 ' HB3' ' HG ' ' A' ' 42' ' ' LEU . 49.8 t-20 -98.12 145.5 26.51 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 174.947 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.552 ' HD2' ' N ' ' A' ' 41' ' ' GLU . 7.4 ppt_? -58.79 -27.13 64.73 Favored 'General case' 0 C--N 1.31 -1.137 0 C-N-CA 123.543 0.737 . . . . 0.0 111.924 179.592 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.552 ' N ' ' HD2' ' A' ' 40' ' ' ARG . 11.4 pt-20 -85.59 -11.82 53.04 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.543 -176.366 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.493 ' HG ' ' HB3' ' A' ' 39' ' ' ASN . 79.0 mt -84.21 118.73 24.34 Favored 'General case' 0 CA--C 1.492 -1.279 0 CA-C-O 121.474 0.654 . . . . 0.0 111.09 -176.695 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 46.6 p -107.82 173.92 6.11 Favored 'General case' 0 N--CA 1.414 -2.273 0 CA-C-N 114.417 -1.265 . . . . 0.0 109.445 -178.433 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.479 ' HG3' ' HB2' ' A' ' 62' ' ' LEU . 1.7 mp0 -54.92 -41.37 70.93 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 123.871 0.868 . . . . 0.0 109.759 178.757 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.17 -43.28 98.56 Favored Glycine 0 N--CA 1.439 -1.126 0 CA-C-N 115.545 -0.752 . . . . 0.0 112.894 -179.219 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -68.1 -45.29 74.13 Favored 'General case' 0 CA--C 1.513 -0.444 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 -179.539 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.408 HD11 HD11 ' A' ' 38' ' ' LEU . 37.9 mt -58.55 -44.12 88.61 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.488 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.707 178.571 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 43.8 mt -59.37 -44.7 92.68 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.51 HG23 ' H ' ' B' ' 233' ' ' ASP . 89.4 m -61.66 -46.26 90.48 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 120.804 0.335 . . . . 0.0 111.619 178.844 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 84.6 t -63.18 -49.47 83.09 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.379 179.61 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.427 ' HA ' ' HD2' ' A' ' 54' ' ' TYR . 4.1 m-85 -69.43 -23.08 63.63 Favored 'General case' 0 N--CA 1.433 -1.318 0 C-N-CA 123.583 0.753 . . . . 0.0 112.868 -177.257 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.472 ' OG ' ' HB2' ' B' ' 231' ' ' ARG . 72.6 m -68.57 -20.1 64.51 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 111.917 0.34 . . . . 0.0 111.917 176.655 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -63.47 -28.0 69.66 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-O 122.029 0.919 . . . . 0.0 109.007 173.46 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.427 ' HD2' ' HA ' ' A' ' 51' ' ' PHE . 50.9 m-85 -96.3 -2.87 45.0 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.262 -174.452 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 148.21 -152.96 24.96 Favored Glycine 0 N--CA 1.42 -2.432 0 C-N-CA 119.975 -1.107 . . . . 0.0 112.015 178.687 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 61.8 t -107.52 111.01 63.06 Favored Pre-proline 0 C--N 1.296 -1.742 0 CA-C-O 120.717 0.294 . . . . 0.0 110.948 -177.66 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.493 ' HB3' HD21 ' A' ' 77' ' ' LEU . 58.7 Cg_endo -74.74 145.49 32.6 Favored 'Trans proline' 0 N--CA 1.45 -1.081 0 C-N-CA 122.719 2.279 . . . . 0.0 110.041 174.913 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.416 ' CG2' ' HG3' ' A' ' 78' ' ' LYS . 34.4 m -116.45 -24.97 3.3 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 C-N-CA 119.674 -0.81 . . . . 0.0 111.463 177.5 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -158.36 147.57 19.26 Favored 'General case' 0 C--O 1.249 1.07 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.548 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 12.5 p -145.78 132.47 14.53 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-O 121.002 0.429 . . . . 0.0 110.432 -179.147 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 84.2 mt -120.62 126.85 75.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 177.7 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.479 ' HB2' ' HG3' ' A' ' 44' ' ' GLU . 0.2 OUTLIER -100.3 122.73 43.54 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 105.753 -1.944 . . . . 0.0 105.753 175.533 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 15.4 m -82.13 116.8 21.86 Favored 'General case' 0 N--CA 1.406 -2.648 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 178.453 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 84.3 mtt180 . . . . . 0 C--N 1.303 -1.418 0 CA-C-O 121.43 0.634 . . . . 0.0 110.82 -175.543 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 . . . . . 0 N--CA 1.435 -1.194 0 CA-C-O 121.433 0.635 . . . . 0.0 110.111 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 100.19 17.65 24.19 Favored Glycine 0 N--CA 1.429 -1.781 0 CA-C-N 115.475 -0.784 . . . . 0.0 112.536 178.446 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -160.86 156.83 25.63 Favored 'General case' 0 C--O 1.244 0.801 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 177.38 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -152.81 175.98 12.29 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-O 120.789 0.328 . . . . 0.0 110.995 179.553 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -134.88 143.18 46.82 Favored 'General case' 0 C--N 1.317 -0.813 0 C-N-CA 123.989 0.915 . . . . 0.0 110.425 -177.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.493 HD21 ' HB3' ' A' ' 57' ' ' PRO . 10.0 tt -150.07 140.59 22.48 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 175.571 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.416 ' HG3' ' CG2' ' A' ' 58' ' ' VAL . 20.8 ptmt -122.56 144.18 49.26 Favored 'General case' 0 C--O 1.255 1.394 0 CA-C-O 121.02 0.438 . . . . 0.0 109.951 179.61 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -108.9 164.58 12.27 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.539 -178.389 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -74.59 -25.64 59.39 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 114.822 -1.081 . . . . 0.0 109.736 175.349 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -127.77 136.76 51.93 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.073 -175.323 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.464 ' NE2' ' HB2' ' A' ' 31' ' ' ALA . 22.5 mp0 -69.74 -19.9 63.53 Favored 'General case' 0 C--N 1.313 -1.022 0 N-CA-C 113.191 0.811 . . . . 0.0 113.191 177.893 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 90.9 mtm180 -68.24 -34.64 76.6 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-O 122.261 1.029 . . . . 0.0 109.592 174.62 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 67.2 m -65.21 -37.37 87.08 Favored 'General case' 0 C--N 1.286 -2.173 0 CA-C-N 114.702 -1.135 . . . . 0.0 112.226 178.269 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.46 ' O ' HG23 ' A' ' 89' ' ' VAL . 77.3 p -64.93 -45.62 85.05 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 120.438 -0.505 . . . . 0.0 110.577 -178.455 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 6.7 pt -64.8 -38.63 83.2 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.093 177.892 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 13.2 mt -58.87 -43.6 90.92 Favored 'General case' 0 C--O 1.242 0.696 0 O-C-N 123.296 0.372 . . . . 0.0 111.006 176.248 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.412 ' HB1' HD12 ' A' ' 92' ' ' LEU . . . -70.84 -46.75 62.16 Favored 'General case' 0 N--CA 1.435 -1.204 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.208 -178.626 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 85' ' ' THR . 78.2 t -56.73 -47.05 83.2 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.581 0 CA-C-O 121.446 0.641 . . . . 0.0 110.739 179.229 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -59.02 -39.16 81.06 Favored 'General case' 0 C--N 1.295 -1.78 0 C-N-CA 125.221 1.408 . . . . 0.0 112.518 -176.597 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 48.9 m-80 -98.49 -22.5 15.98 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 113.798 1.036 . . . . 0.0 113.798 -175.648 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.515 ' HB2' HG13 ' A' ' 104' ' ' ILE . 18.6 mt -94.92 -30.05 14.35 Favored 'General case' 0 C--N 1.293 -1.889 0 C-N-CA 120.685 -0.406 . . . . 0.0 111.435 -174.284 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 50.2 t-20 -65.64 124.25 21.87 Favored 'General case' 0 N--CA 1.434 -1.265 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 176.198 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 84.38 -0.33 89.32 Favored Glycine 0 C--N 1.3 -1.468 0 C-N-CA 119.888 -1.148 . . . . 0.0 113.1 -179.646 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -92.24 136.8 32.9 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -95.57 120.06 35.17 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-O 121.061 0.458 . . . . 0.0 112.069 -176.127 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 55.3 mt -126.89 141.69 45.49 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 N-CA-C 106.565 -1.643 . . . . 0.0 106.565 174.25 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 60.08 19.79 52.18 Favored Glycine 0 CA--C 1.527 0.836 0 O-C-N 122.929 0.143 . . . . 0.0 113.275 -179.607 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 85.89 12.14 72.13 Favored Glycine 0 N--CA 1.438 -1.184 0 C-N-CA 121.497 -0.383 . . . . 0.0 113.07 -179.573 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.448 ' NH1' ' HA ' ' A' ' 39' ' ' ASN . 17.4 ptp180 -137.87 149.69 46.49 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 117.861 0.831 . . . . 0.0 110.719 178.91 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -83.7 126.18 32.63 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-O 120.64 0.257 . . . . 0.0 110.84 -178.136 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.414 ' HA ' HD23 ' A' ' 102' ' ' LEU . 12.1 mt -76.24 143.75 40.79 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-O 121.705 0.764 . . . . 0.0 112.629 178.024 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 5.3 tppp? -115.73 119.4 35.92 Favored 'General case' 0 N--CA 1.416 -2.146 0 CA-C-N 114.875 -1.057 . . . . 0.0 109.159 176.395 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.515 HG13 ' HB2' ' A' ' 92' ' ' LEU . 5.0 mm -121.42 135.99 59.8 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 178.777 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -144.05 150.46 38.23 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 177.856 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -75.17 144.13 42.88 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 177.213 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.422 HG21 ' HB2' ' A' ' 34' ' ' TYR . 12.3 t -163.21 165.98 23.78 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 106.7 -1.593 . . . . 0.0 106.7 -178.823 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -109.9 110.91 22.03 Favored 'General case' 0 N--CA 1.428 -1.536 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 171.174 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 16.5 t80 . . . . . 0 C--N 1.288 -2.074 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 -178.884 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 4.4 mp . . . . . 0 N--CA 1.442 -0.853 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 227' ' ' MET . . . . . . . . . . . . . 26.7 ptt? -67.67 147.93 98.61 Favored Pre-proline 0 C--N 1.321 -0.657 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.061 179.658 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 228' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -78.56 150.65 24.89 Favored 'Trans proline' 0 C--O 1.253 1.23 0 C-N-CA 123.057 2.505 . . . . 0.0 112.393 -179.38 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . -73.04 167.04 54.37 Favored Glycine 0 C--N 1.315 -0.603 0 CA-C-N 116.003 -0.544 . . . . 0.0 112.52 178.137 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 21.6 t -70.5 -13.89 62.3 Favored 'General case' 0 C--N 1.317 -0.825 0 C-N-CA 123.228 0.611 . . . . 0.0 111.332 -177.183 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 231' ' ' ARG . . . . . 0.472 ' HB2' ' OG ' ' A' ' 52' ' ' SER . 31.5 mmt180 -78.94 -9.02 59.38 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.658 -0.246 . . . . 0.0 111.041 179.628 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 232' ' ' TRP . . . . . 0.414 ' HB2' ' CB ' ' A' ' 52' ' ' SER . 19.2 t90 -77.34 129.47 35.88 Favored 'General case' 0 N--CA 1.427 -1.603 0 CA-C-O 122.29 1.043 . . . . 0.0 111.319 -179.487 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 233' ' ' ASP . . . . . 0.51 ' H ' HG23 ' A' ' 49' ' ' THR . 9.4 t70 -123.35 136.15 54.52 Favored 'General case' 0 C--N 1.265 -3.093 0 N-CA-C 100.926 -3.731 . . . . 0.0 100.926 175.321 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 2.778 0 C-N-CA 128.4 2.905 . . . . 0.0 116.87 -177.222 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 240' ' ' GLY . . . . . 0.513 ' O ' ' HE2' ' B' ' 244' ' ' LYS . . . . . . . . 0 C--O 1.19 -2.644 0 N-CA-C 112.622 -0.191 . . . . 0.0 112.622 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 26.2 p90 -76.51 -33.82 58.6 Favored 'General case' 0 C--N 1.29 -2.001 0 CA-C-N 117.531 0.665 . . . . 0.0 111.094 178.113 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -66.79 -38.84 87.31 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.722 -178.249 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -62.15 -35.2 78.06 Favored 'General case' 0 C--O 1.21 -0.989 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.83 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 244' ' ' LYS . . . . . 0.513 ' HE2' ' O ' ' B' ' 240' ' ' GLY . 68.9 mmtt -65.61 -44.04 87.77 Favored 'General case' 0 CA--C 1.502 -0.884 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 -177.128 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 245' ' ' TRP . . . . . 0.426 ' O ' ' HB3' ' B' ' 249' ' ' GLN . 39.6 m0 -61.82 -43.23 99.27 Favored 'General case' 0 C--O 1.208 -1.107 0 CA-C-N 115.075 -0.966 . . . . 0.0 109.315 178.566 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 246' ' ' PHE . . . . . 0.49 ' O ' ' HG2' ' B' ' 249' ' ' GLN . 4.5 t80 -66.94 -32.44 73.69 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.405 179.037 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -77.41 -39.88 45.51 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.301 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.23 -12.78 36.98 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 -175.686 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 249' ' ' GLN . . . . . 0.49 ' HG2' ' O ' ' B' ' 246' ' ' PHE . 13.1 pt20 -66.27 -8.51 25.27 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 120.946 0.403 . . . . 0.0 111.038 -178.822 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 250' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -68.04 -28.58 67.51 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 177.074 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 251' ' ' GLU . . . . . 0.554 ' HB3' ' HB2' ' B' ' 254' ' ' GLU . 42.7 mt-10 -86.19 114.52 23.09 Favored 'General case' 0 N--CA 1.421 -1.905 0 CA-C-N 114.145 -1.388 . . . . 0.0 107.552 177.403 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 252' ' ' ILE . . . . . . . . . . . . . 41.2 pt -118.5 -25.92 2.72 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -174.53 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -105.61 -15.65 14.92 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 -177.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 254' ' ' GLU . . . . . 0.554 ' HB2' ' HB3' ' B' ' 251' ' ' GLU . 11.7 mp0 . . . . . 0 C--N 1.303 -1.42 0 C-N-CA 125.585 1.554 . . . . 0.0 114.722 -177.065 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.741 0 N-CA-C 111.711 0.263 . . . . 0.0 111.711 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 13.2 m-30 -93.85 144.83 25.08 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 120.196 -0.602 . . . . 0.0 110.359 -176.301 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 23.6 pt -142.64 161.01 18.8 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.096 175.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.424 ' HB2' HG21 ' A' ' 107' ' ' THR . 65.2 t80 -111.52 123.28 49.9 Favored 'General case' 0 N--CA 1.413 -2.305 0 CA-C-N 114.742 -1.117 . . . . 0.0 108.049 178.469 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 13.1 mt -108.39 127.26 64.88 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.047 0 N-CA-C 105.975 -1.861 . . . . 0.0 105.975 175.232 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -124.44 156.36 18.5 Favored Glycine 0 N--CA 1.42 -2.374 0 N-CA-C 111.802 -0.519 . . . . 0.0 111.802 -177.089 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.422 HD21 ' HB2' ' A' ' 100' ' ' ARG . 64.3 t30 67.07 57.57 0.6 Allowed 'General case' 0 C--N 1.314 -0.946 0 C-N-CA 125.4 1.48 . . . . 0.0 110.682 -177.669 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.427 HD11 HD11 ' A' ' 47' ' ' ILE . 3.1 mm? -82.96 143.91 30.35 Favored 'General case' 0 CA--C 1.485 -1.553 0 CA-C-N 114.426 -1.261 . . . . 0.0 110.002 176.588 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.445 HD22 ' HA3' ' A' ' 98' ' ' GLY . 38.4 t-20 -79.32 144.92 33.78 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 176.629 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.562 ' HD2' ' N ' ' A' ' 41' ' ' GLU . 0.8 OUTLIER -59.4 -24.69 63.66 Favored 'General case' 0 C--N 1.302 -1.458 0 C-N-CA 123.471 0.709 . . . . 0.0 112.23 179.528 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.562 ' N ' ' HD2' ' A' ' 40' ' ' ARG . 11.4 pt-20 -89.0 -14.32 36.82 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.609 -177.386 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.423 ' HG ' ' HB3' ' A' ' 39' ' ' ASN . 54.0 mt -75.51 132.09 40.53 Favored 'General case' 0 CA--C 1.5 -0.974 0 CA-C-O 121.548 0.69 . . . . 0.0 111.781 -176.228 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 42.0 p -114.81 172.7 6.88 Favored 'General case' 0 N--CA 1.418 -2.03 0 CA-C-N 114.725 -1.125 . . . . 0.0 111.046 -177.117 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -56.19 -42.46 77.17 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 123.707 0.803 . . . . 0.0 110.503 179.481 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -59.99 -38.27 93.96 Favored Glycine 0 C--O 1.24 0.484 0 CA-C-N 115.497 -0.774 . . . . 0.0 112.541 -179.358 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 49.9 m-20 -67.19 -49.61 63.99 Favored 'General case' 0 CA--C 1.494 -1.198 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.427 HD11 HD11 ' A' ' 38' ' ' LEU . 47.0 mt -58.87 -46.35 91.21 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 CA-C-N 115.131 -0.94 . . . . 0.0 110.706 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 40.9 mt -59.81 -43.7 94.35 Favored 'General case' 0 CA--C 1.499 -1.017 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.605 -178.224 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.436 HG23 ' H ' ' B' ' 233' ' ' ASP . 85.6 m -63.36 -46.43 86.58 Favored 'General case' 0 C--N 1.313 -1.016 0 O-C-N 123.408 0.443 . . . . 0.0 111.165 -178.589 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 97.2 t -66.22 -49.77 73.51 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.368 -178.355 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.447 ' HA ' ' HD2' ' A' ' 54' ' ' TYR . 4.8 m-85 -64.99 -19.89 66.22 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 123.974 0.909 . . . . 0.0 112.767 -178.132 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.514 ' OG ' ' HB2' ' B' ' 231' ' ' ARG . 60.2 m -72.97 -23.59 60.68 Favored 'General case' 0 N--CA 1.439 -0.989 0 N-CA-C 112.319 0.489 . . . . 0.0 112.319 176.657 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 50.2 tt0 -67.83 -20.52 65.17 Favored 'General case' 0 CA--C 1.56 1.349 0 CA-C-O 121.726 0.775 . . . . 0.0 110.115 177.877 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.458 ' OH ' ' HG ' ' A' ' 92' ' ' LEU . 41.3 m-85 -97.02 -10.2 26.62 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.608 -178.41 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 156.5 -159.12 29.25 Favored Glycine 0 N--CA 1.43 -1.747 0 C-N-CA 119.951 -1.118 . . . . 0.0 112.29 -179.574 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 77.5 t -103.58 110.17 63.34 Favored Pre-proline 0 C--N 1.306 -1.318 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 -176.367 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.512 ' HB3' HD21 ' A' ' 77' ' ' LEU . 99.0 Cg_endo -80.01 137.12 12.12 Favored 'Trans proline' 0 C--O 1.247 0.954 0 C-N-CA 123.034 2.489 . . . . 0.0 110.914 176.203 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 28.4 m -113.49 -20.06 6.4 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 -178.612 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.515 ' HB3' ' HG2' ' A' ' 78' ' ' LYS . 37.8 t70 -159.88 145.34 15.42 Favored 'General case' 0 C--O 1.249 1.038 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 14.3 p -144.68 134.43 19.17 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.595 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 86.1 mt -120.47 118.14 55.64 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.774 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 176.239 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -92.13 116.48 28.98 Favored 'General case' 0 C--N 1.28 -2.441 0 N-CA-C 104.677 -2.342 . . . . 0.0 104.677 175.728 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 33.6 m -79.77 115.93 19.65 Favored 'General case' 0 N--CA 1.414 -2.239 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 179.355 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 72.0 mtp180 . . . . . 0 CA--C 1.483 -1.617 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 -176.419 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 . . . . . 0 N--CA 1.432 -1.343 0 CA-C-O 121.556 0.693 . . . . 0.0 111.338 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 107.28 15.88 14.75 Favored Glycine 0 N--CA 1.427 -1.913 0 CA-C-N 115.386 -0.824 . . . . 0.0 112.472 -179.276 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 30.0 p90 -157.41 159.12 37.04 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 177.274 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -151.63 172.5 15.97 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-O 120.863 0.363 . . . . 0.0 110.582 179.532 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -130.75 142.66 50.42 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 123.762 0.825 . . . . 0.0 109.539 -179.248 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.512 HD21 ' HB3' ' A' ' 57' ' ' PRO . 10.2 tt -148.11 140.96 24.72 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 176.167 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.515 ' HG2' ' HB3' ' A' ' 59' ' ' ASP . 21.9 ptmt -123.82 144.3 49.81 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-O 121.356 0.598 . . . . 0.0 109.673 178.939 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -104.77 165.68 10.9 Favored 'General case' 0 C--N 1.282 -2.331 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.833 -178.812 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -77.31 -30.65 54.21 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 115.384 -0.825 . . . . 0.0 108.967 174.55 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.436 ' OD1' ' HB2' ' A' ' 83' ' ' ARG . 12.5 t70 -119.91 137.56 53.96 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 -176.437 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 26.0 mp0 -69.49 -25.71 64.19 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 113.377 0.88 . . . . 0.0 113.377 -177.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.436 ' HB2' ' OD1' ' A' ' 81' ' ' ASP . 0.1 OUTLIER -67.35 -33.34 75.03 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-O 122.014 0.911 . . . . 0.0 110.291 -179.342 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.461 ' OG ' HG21 ' B' ' 226' ' ' ILE . 51.5 m -59.39 -36.99 76.84 Favored 'General case' 0 C--N 1.281 -2.372 0 CA-C-N 115.307 -0.861 . . . . 0.0 111.657 175.295 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.429 ' O ' HG23 ' A' ' 89' ' ' VAL . 50.3 p -62.58 -45.3 93.55 Favored 'General case' 0 C--O 1.213 -0.823 0 C-N-CA 120.524 -0.47 . . . . 0.0 110.818 -178.17 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.418 ' H ' HG12 ' A' ' 86' ' ' ILE . 3.3 pt -66.34 -38.72 82.43 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.479 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.498 179.147 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 38.4 mt -59.63 -44.1 93.6 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.236 175.513 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.489 ' O ' ' HB2' ' A' ' 92' ' ' LEU . . . -72.08 -47.13 53.66 Favored 'General case' 0 N--CA 1.437 -1.112 0 CA-C-N 115.992 -0.549 . . . . 0.0 112.313 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.463 HG22 HG22 ' A' ' 104' ' ' ILE . 77.0 t -57.49 -49.12 81.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 -177.547 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -67.71 -38.94 84.3 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.783 -173.295 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -92.91 -20.27 20.82 Favored 'General case' 0 C--N 1.297 -1.701 0 CA-C-N 115.864 -0.607 . . . . 0.0 112.378 -172.128 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.489 ' HB2' ' O ' ' A' ' 88' ' ' ALA . 6.6 mt -93.19 -30.29 15.29 Favored 'General case' 0 C--N 1.315 -0.919 0 O-C-N 122.346 -0.221 . . . . 0.0 111.568 178.952 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 31.9 t-20 -59.25 124.2 19.22 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 179.043 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 88.86 -1.21 83.2 Favored Glycine 0 N--CA 1.442 -0.947 0 C-N-CA 121.064 -0.589 . . . . 0.0 113.417 177.43 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 67.3 t80 -86.51 141.75 28.85 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 117.579 0.69 . . . . 0.0 110.096 -179.35 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.425 ' HD2' ' N ' ' A' ' 96' ' ' LYS . 0.2 OUTLIER -98.05 116.15 29.69 Favored 'General case' 0 C--O 1.248 0.997 0 CA-C-O 121.153 0.502 . . . . 0.0 112.11 -177.137 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 58.1 mt -124.12 141.53 43.98 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 174.843 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.445 ' HA3' HD22 ' A' ' 39' ' ' ASN . . . 60.37 18.38 49.98 Favored Glycine 0 CA--C 1.521 0.438 0 N-CA-C 113.76 0.264 . . . . 0.0 113.76 179.461 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 83.88 14.31 72.91 Favored Glycine 0 N--CA 1.438 -1.223 0 C-N-CA 120.786 -0.721 . . . . 0.0 113.017 -178.571 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.422 ' HB2' HD21 ' A' ' 37' ' ' ASN . 17.5 ptp180 -136.78 150.12 48.18 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 117.696 0.748 . . . . 0.0 110.081 177.756 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -87.87 121.89 30.84 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 120.592 0.234 . . . . 0.0 111.368 -178.473 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 11.4 mt -73.02 145.63 46.51 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-O 121.675 0.75 . . . . 0.0 112.769 179.241 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 17.4 tptm -121.33 122.17 39.26 Favored 'General case' 0 N--CA 1.413 -2.303 0 CA-C-N 115.017 -0.992 . . . . 0.0 108.783 174.815 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.463 HG22 HG22 ' A' ' 89' ' ' VAL . 5.1 mm -116.17 135.09 57.47 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.018 0 N-CA-C 105.358 -2.09 . . . . 0.0 105.358 176.428 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -141.51 151.94 43.72 Favored 'General case' 0 C--N 1.285 -2.218 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 -176.705 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 75.2 m-70 -83.86 138.24 33.29 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.424 HG21 ' HB2' ' A' ' 34' ' ' TYR . 9.8 t -157.79 168.5 27.03 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 -178.461 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -110.16 113.04 25.41 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 106.317 -1.735 . . . . 0.0 106.317 169.792 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 56.8 t80 . . . . . 0 C--N 1.287 -2.12 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.703 -175.188 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 226' ' ' ILE . . . . . 0.461 HG21 ' OG ' ' A' ' 84' ' ' SER . 4.5 mp . . . . . 0 C--O 1.243 0.723 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 227' ' ' MET . . . . . . . . . . . . . 22.4 ptp -71.39 144.84 89.76 Favored Pre-proline 0 C--N 1.31 -1.115 0 O-C-N 123.608 0.568 . . . . 0.0 110.098 -178.558 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 228' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -68.56 147.59 70.77 Favored 'Trans proline' 0 C--N 1.317 -1.087 0 C-N-CA 123.284 2.656 . . . . 0.0 112.25 178.915 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . -68.46 167.64 43.79 Favored Glycine 0 N--CA 1.443 -0.839 0 CA-C-N 115.663 -0.699 . . . . 0.0 113.073 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 40.9 m -74.85 -12.92 60.49 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -176.886 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 231' ' ' ARG . . . . . 0.514 ' HB2' ' OG ' ' A' ' 52' ' ' SER . 27.8 mmt180 -78.93 -11.74 60.01 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 178.136 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 232' ' ' TRP . . . . . . . . . . . . . 23.1 t90 -71.15 121.68 18.76 Favored 'General case' 0 N--CA 1.435 -1.198 0 CA-C-O 122.108 0.956 . . . . 0.0 112.184 -177.252 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 233' ' ' ASP . . . . . 0.436 ' H ' HG23 ' A' ' 49' ' ' THR . 29.9 t70 -114.94 144.62 43.28 Favored 'General case' 0 C--N 1.273 -2.742 0 N-CA-C 101.791 -3.411 . . . . 0.0 101.791 171.548 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.506 3.333 0 C-N-CA 128.295 2.855 . . . . 0.0 116.973 -176.146 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 240' ' ' GLY . . . . . 0.473 ' O ' ' HG2' ' B' ' 244' ' ' LYS . . . . . . . . 0 N--CA 1.417 -2.581 0 N-CA-C 110.77 -0.932 . . . . 0.0 110.77 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 14.6 p90 -76.97 -34.35 57.57 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-O 121.015 0.436 . . . . 0.0 111.403 177.046 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -61.27 -42.39 98.56 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 123.761 0.824 . . . . 0.0 109.972 -177.603 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -64.26 -34.34 77.89 Favored 'General case' 0 C--O 1.198 -1.65 0 CA-C-N 115.459 -0.791 . . . . 0.0 112.218 -179.336 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 244' ' ' LYS . . . . . 0.473 ' HG2' ' O ' ' B' ' 240' ' ' GLY . 74.2 mmtt -62.42 -42.87 99.76 Favored 'General case' 0 C--N 1.316 -0.879 0 C-N-CA 122.788 0.435 . . . . 0.0 111.625 -175.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 245' ' ' TRP . . . . . . . . . . . . . 6.9 m0 -69.86 -37.5 76.13 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 121.734 0.778 . . . . 0.0 109.17 178.863 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 246' ' ' PHE . . . . . 0.553 ' O ' ' HG2' ' B' ' 249' ' ' GLN . 5.1 t80 -65.23 -40.71 94.42 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 114.909 -1.042 . . . . 0.0 110.31 177.545 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -67.06 -22.11 65.87 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 115.781 -0.645 . . . . 0.0 112.142 -179.03 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -100.68 -25.7 14.06 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 120.156 -0.618 . . . . 0.0 112.381 178.723 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 249' ' ' GLN . . . . . 0.553 ' HG2' ' O ' ' B' ' 246' ' ' PHE . 12.2 pt20 -69.77 -11.98 61.27 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-O 121.126 0.488 . . . . 0.0 110.504 -177.26 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 250' ' ' ASN . . . . . . . . . . . . . 22.7 p-10 -58.67 -23.06 58.62 Favored 'General case' 0 N--CA 1.482 1.142 0 CA-C-N 114.692 -1.14 . . . . 0.0 111.832 179.415 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -121.22 130.39 53.67 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 178.821 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 252' ' ' ILE . . . . . . . . . . . . . 32.8 pt -92.45 -36.81 8.02 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 -176.379 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -97.84 -25.85 14.89 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-O 121.865 0.84 . . . . 0.0 110.494 -175.046 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 254' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 . . . . . 0 N--CA 1.409 -2.479 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.17 -173.273 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.411 ' HA ' HG21 ' A' ' 85' ' ' THR . . . . . . . . 0 N--CA 1.447 -0.619 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -107.89 145.11 34.18 Favored 'General case' 0 C--N 1.317 -0.846 0 C-N-CA 120.876 -0.33 . . . . 0.0 110.178 -174.813 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 30.5 pt -139.55 156.78 26.73 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 CA-C-O 120.986 0.422 . . . . 0.0 110.524 177.028 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 28.5 t80 -107.41 122.83 47.4 Favored 'General case' 0 N--CA 1.423 -1.796 0 CA-C-N 114.671 -1.149 . . . . 0.0 108.364 177.963 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.425 HG23 ' CD1' ' A' ' 104' ' ' ILE . 7.7 mt -108.77 128.17 64.73 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.977 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 176.51 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -129.66 173.92 19.55 Favored Glycine 0 C--N 1.287 -2.154 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.976 -178.221 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 19.5 m120 65.82 24.2 11.37 Favored 'General case' 0 CA--C 1.512 -0.517 0 C-N-CA 125.123 1.369 . . . . 0.0 111.922 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -58.27 140.77 52.67 Favored 'General case' 0 CA--C 1.495 -1.154 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 -178.357 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.508 ' CG ' ' HG2' ' A' ' 41' ' ' GLU . 49.8 t-20 -71.5 142.64 50.14 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 172.298 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.485 ' HD2' ' N ' ' A' ' 41' ' ' GLU . 7.5 ppt_? -58.99 -22.94 61.32 Favored 'General case' 0 C--N 1.303 -1.43 0 C-N-CA 123.869 0.867 . . . . 0.0 112.62 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.508 ' HG2' ' CG ' ' A' ' 39' ' ' ASN . 12.8 pt-20 -87.19 -14.8 40.15 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.85 -176.175 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.469 ' HG ' ' HB3' ' A' ' 39' ' ' ASN . 79.6 mt -76.42 126.13 30.44 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.564 0.697 . . . . 0.0 112.598 -174.747 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 66.8 p -109.26 173.71 6.2 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 114.071 -1.422 . . . . 0.0 109.538 -177.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.7 mp0 -57.56 -42.31 82.76 Favored 'General case' 0 C--O 1.211 -0.933 0 C-N-CA 123.616 0.766 . . . . 0.0 109.92 178.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.43 -37.41 93.15 Favored Glycine 0 N--CA 1.446 -0.649 0 O-C-N 123.618 0.574 . . . . 0.0 112.814 -179.762 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 32.5 m-20 -67.42 -49.76 62.37 Favored 'General case' 0 CA--C 1.501 -0.934 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 179.306 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 51.4 mt -60.25 -45.78 95.72 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.777 0 CA-C-N 114.748 -1.115 . . . . 0.0 110.682 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 41.4 mt -59.96 -45.24 93.31 Favored 'General case' 0 CA--C 1.496 -1.099 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.322 -178.288 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.464 HG23 ' H ' ' B' ' 233' ' ' ASP . 87.8 m -61.88 -45.72 92.52 Favored 'General case' 0 C--N 1.313 -1.018 0 O-C-N 123.595 0.56 . . . . 0.0 111.585 -178.724 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 98.9 t -66.79 -50.19 67.63 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.489 -179.638 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.487 ' HA ' ' HD2' ' A' ' 54' ' ' TYR . 4.3 m-85 -62.49 -25.66 68.13 Favored 'General case' 0 N--CA 1.433 -1.276 0 C-N-CA 123.883 0.873 . . . . 0.0 112.381 -178.553 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 65.9 m -67.07 -20.22 65.79 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.287 176.29 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -70.07 -20.71 63.21 Favored 'General case' 0 CA--C 1.555 1.158 0 CA-C-O 121.302 0.572 . . . . 0.0 109.721 176.848 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.487 ' HD2' ' HA ' ' A' ' 51' ' ' PHE . 41.5 m-85 -97.51 -19.98 18.03 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-O 121.03 0.443 . . . . 0.0 111.59 -175.674 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 167.92 -159.49 32.75 Favored Glycine 0 N--CA 1.42 -2.379 0 N-CA-C 110.825 -0.91 . . . . 0.0 110.825 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 59.1 t -102.66 110.83 64.02 Favored Pre-proline 0 C--N 1.296 -1.746 0 O-C-N 123.471 0.159 . . . . 0.0 111.062 -177.922 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.511 ' HB3' HD21 ' A' ' 77' ' ' LEU . 92.7 Cg_endo -77.39 140.75 19.61 Favored 'Trans proline' 0 N--CA 1.451 -1.018 0 C-N-CA 122.849 2.366 . . . . 0.0 110.18 175.469 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 31.2 m -116.39 -19.08 6.63 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 C-N-CA 120.0 -0.68 . . . . 0.0 112.167 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.487 ' HB3' ' HG2' ' A' ' 78' ' ' LYS . 36.0 t70 -161.26 141.41 10.83 Favored 'General case' 0 C--O 1.242 0.682 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 -179.804 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 14.4 p -141.71 133.96 28.22 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 178.524 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 91.6 mt -120.46 125.37 74.07 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 177.443 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -100.77 134.18 44.13 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 178.203 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 22.3 t -92.62 131.52 37.65 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 176.256 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 68.7 mtt85 . . . . . 0 C--N 1.307 -1.249 0 CA-C-O 120.879 0.371 . . . . 0.0 111.233 -177.742 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 15.7 mm-40 . . . . . 0 N--CA 1.478 0.973 0 CA-C-O 121.324 0.583 . . . . 0.0 111.692 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 110.2 8.29 25.61 Favored Glycine 0 N--CA 1.421 -2.35 0 C-N-CA 119.88 -1.153 . . . . 0.0 112.269 -179.699 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 40.8 p90 -148.82 153.36 38.0 Favored 'General case' 0 C--O 1.252 1.194 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 177.125 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -149.52 172.83 14.36 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-O 120.915 0.388 . . . . 0.0 110.874 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -130.3 139.41 50.73 Favored 'General case' 0 C--N 1.303 -1.424 0 C-N-CA 124.161 0.984 . . . . 0.0 109.617 -179.274 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.511 HD21 ' HB3' ' A' ' 57' ' ' PRO . 9.9 tt -146.01 140.76 27.07 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 175.587 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.487 ' HG2' ' HB3' ' A' ' 59' ' ' ASP . 20.8 ptmt -124.37 144.27 50.12 Favored 'General case' 0 C--O 1.256 1.433 0 CA-C-O 121.259 0.552 . . . . 0.0 109.787 179.344 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 66.3 m-85 -108.16 164.31 12.41 Favored 'General case' 0 C--N 1.29 -1.983 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.719 179.578 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -77.99 -33.59 51.24 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 174.304 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -109.8 130.09 55.56 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.94 -176.163 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 83.7 mt-30 -71.02 -20.37 62.4 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 -178.095 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 88.1 mtm180 -68.03 -34.1 75.85 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-O 121.946 0.879 . . . . 0.0 108.654 174.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.501 ' OG ' HG21 ' B' ' 226' ' ' ILE . 61.9 m -63.59 -37.11 86.07 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 115.078 -0.964 . . . . 0.0 112.511 178.299 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.447 ' O ' HG23 ' A' ' 89' ' ' VAL . 80.7 p -65.31 -45.84 82.72 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 120.325 -0.55 . . . . 0.0 110.476 -177.303 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.412 ' H ' HG12 ' A' ' 86' ' ' ILE . 3.4 pt -64.83 -39.23 84.96 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.884 177.179 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.408 HD12 ' HA ' ' A' ' 84' ' ' SER . 19.9 mt -59.65 -44.54 93.51 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.653 176.393 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.452 ' O ' ' HB2' ' A' ' 92' ' ' LEU . . . -71.48 -45.88 61.32 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.035 -177.329 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.453 HG22 HG22 ' A' ' 104' ' ' ILE . 70.2 t -56.65 -49.02 79.7 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.797 0 CA-C-O 121.057 0.456 . . . . 0.0 110.95 178.992 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -63.25 -39.15 93.79 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 115.366 -0.834 . . . . 0.0 112.034 -175.062 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.479 HD22 ' HE1' ' A' ' 54' ' ' TYR . 63.3 t30 -96.42 -20.09 18.7 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.431 -171.748 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.452 ' HB2' ' O ' ' A' ' 88' ' ' ALA . 10.3 mt -96.59 -31.24 12.84 Favored 'General case' 0 CA--C 1.494 -1.176 0 CA-C-O 120.909 0.385 . . . . 0.0 111.655 -178.236 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 56.1 t30 -65.44 125.82 26.34 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.981 -177.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 88.13 -1.15 84.51 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 121.341 -0.457 . . . . 0.0 112.883 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 67.7 t80 -90.12 137.78 32.06 Favored 'General case' 0 C--N 1.32 -0.689 0 O-C-N 122.378 -0.483 . . . . 0.0 110.069 -178.423 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -92.45 116.74 29.25 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 121.56 0.695 . . . . 0.0 111.806 -176.963 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.62 ' HB ' HH21 ' A' ' 100' ' ' ARG . 62.7 mt -127.34 140.36 49.33 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 175.621 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 62.88 19.27 60.83 Favored Glycine 0 C--N 1.307 -1.066 0 C-N-CA 121.387 -0.435 . . . . 0.0 112.869 -179.007 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 91.72 -9.55 76.65 Favored Glycine 0 N--CA 1.438 -1.182 0 C-N-CA 121.218 -0.515 . . . . 0.0 112.953 -178.679 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.62 HH21 ' HB ' ' A' ' 97' ' ' ILE . 0.0 OUTLIER -125.54 146.88 49.47 Favored 'General case' 0 N--CA 1.418 -2.049 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 -175.764 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -79.8 136.54 36.75 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.692 -176.566 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.428 ' HG ' HH22 ' A' ' 100' ' ' ARG . 11.0 mt -82.47 148.39 28.17 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 115.457 -0.792 . . . . 0.0 112.445 176.253 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 4.3 tppp? -124.27 119.96 30.82 Favored 'General case' 0 N--CA 1.423 -1.825 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 174.271 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.453 HG22 HG22 ' A' ' 89' ' ' VAL . 4.6 mm -122.09 135.12 63.25 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 N-CA-C 107.108 -1.441 . . . . 0.0 107.108 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -143.63 158.82 43.38 Favored 'General case' 0 C--N 1.291 -1.947 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 178.335 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 38.3 m-70 -83.63 141.76 31.29 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 177.753 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 9.3 t -156.04 161.78 40.39 Favored 'General case' 0 C--N 1.285 -2.216 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 -178.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 26.0 p90 -109.88 110.35 21.28 Favored 'General case' 0 C--N 1.297 -1.674 0 C-N-CA 118.592 -1.243 . . . . 0.0 108.879 172.412 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 62.3 t80 . . . . . 0 C--N 1.294 -1.819 0 CA-C-N 115.351 -0.841 . . . . 0.0 110.98 -178.79 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 226' ' ' ILE . . . . . 0.501 HG21 ' OG ' ' A' ' 84' ' ' SER . 3.8 mp . . . . . 0 N--CA 1.44 -0.947 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 227' ' ' MET . . . . . . . . . . . . . 24.8 mmt -59.53 140.19 88.91 Favored Pre-proline 0 C--N 1.323 -0.577 0 O-C-N 124.061 0.851 . . . . 0.0 111.405 179.815 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 228' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -71.18 156.01 60.08 Favored 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 122.555 2.17 . . . . 0.0 111.444 179.119 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . -74.38 168.9 54.33 Favored Glycine 0 C--N 1.307 -1.041 0 CA-C-N 116.167 -0.47 . . . . 0.0 112.642 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 22.6 t -77.41 -15.21 59.47 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-O 120.954 0.407 . . . . 0.0 110.315 -178.606 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 13.6 mmp_? -80.83 -5.2 56.97 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 121.974 -0.454 . . . . 0.0 111.192 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 232' ' ' TRP . . . . . . . . . . . . . 19.2 t90 -70.94 127.02 31.19 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-O 122.659 1.219 . . . . 0.0 111.878 -178.076 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 233' ' ' ASP . . . . . 0.464 ' H ' HG23 ' A' ' 49' ' ' THR . 11.8 t70 -118.09 145.5 44.8 Favored 'General case' 0 C--N 1.271 -2.833 0 N-CA-C 101.059 -3.682 . . . . 0.0 101.059 172.579 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.749 0 C-N-CA 127.211 2.339 . . . . 0.0 116.175 -177.912 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 240' ' ' GLY . . . . . 0.483 ' O ' ' HG2' ' B' ' 244' ' ' LYS . . . . . . . . 0 C--O 1.201 -1.928 0 N-CA-C 111.603 -0.599 . . . . 0.0 111.603 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -76.14 -33.56 59.42 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-O 120.899 0.38 . . . . 0.0 110.709 179.684 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -60.89 -43.84 97.92 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.106 -178.347 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -62.08 -34.62 76.64 Favored 'General case' 0 C--O 1.206 -1.219 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.307 179.189 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 244' ' ' LYS . . . . . 0.483 ' HG2' ' O ' ' B' ' 240' ' ' GLY . 72.9 mmtt -64.76 -45.52 86.05 Favored 'General case' 0 CA--C 1.508 -0.653 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 -179.268 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 245' ' ' TRP . . . . . . . . . . . . . 49.3 m0 -66.03 -42.45 89.59 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.26 178.506 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 246' ' ' PHE . . . . . 0.52 ' HA ' ' CD ' ' B' ' 249' ' ' GLN . 6.0 t80 -63.88 -36.95 85.62 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.246 179.743 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -70.33 -32.37 70.07 Favored 'General case' 0 C--N 1.292 -1.923 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.687 -179.244 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.46 -19.94 20.78 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -177.529 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 249' ' ' GLN . . . . . 0.52 ' CD ' ' HA ' ' B' ' 246' ' ' PHE . 12.6 pt20 -74.11 2.79 8.14 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.093 0.557 . . . . 0.0 110.71 -177.977 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 250' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -57.93 -30.62 66.09 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.373 178.521 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -84.59 120.89 26.88 Favored 'General case' 0 N--CA 1.437 -1.106 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.195 179.358 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 252' ' ' ILE . . . . . . . . . . . . . 37.6 pt -101.63 -28.65 3.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.759 -175.943 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -107.45 -26.52 10.91 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-O 121.573 0.701 . . . . 0.0 110.123 -178.701 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 254' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.292 -1.907 0 CA-C-N 115.306 -0.861 . . . . 0.0 108.68 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.515 -0.366 0 CA-C-O 120.633 0.254 . . . . 0.0 110.341 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -108.69 145.33 35.2 Favored 'General case' 0 N--CA 1.434 -1.248 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.868 -176.137 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 28.4 pt -136.86 160.36 36.85 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.753 177.233 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.49 ' HB2' HG21 ' A' ' 107' ' ' THR . 34.4 t80 -112.8 124.12 51.88 Favored 'General case' 0 N--CA 1.413 -2.31 0 CA-C-N 115.26 -0.882 . . . . 0.0 108.831 177.76 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.458 HG23 ' CD1' ' A' ' 104' ' ' ILE . 10.4 mt -108.55 127.75 64.73 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.036 0 N-CA-C 106.846 -1.539 . . . . 0.0 106.846 176.136 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -130.07 160.99 23.05 Favored Glycine 0 N--CA 1.425 -2.04 0 N-CA-C 112.02 -0.432 . . . . 0.0 112.02 -179.094 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 66.4 t30 70.39 41.27 1.02 Allowed 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.82 1.648 . . . . 0.0 110.604 -179.232 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -69.39 151.73 45.78 Favored 'General case' 0 CA--C 1.499 -0.987 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.864 175.831 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.469 ' HB3' ' HG ' ' A' ' 42' ' ' LEU . 45.9 t-20 -84.66 149.94 25.48 Favored 'General case' 0 C--N 1.284 -2.273 0 N-CA-C 106.344 -1.724 . . . . 0.0 106.344 175.758 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.507 ' HD2' ' C ' ' A' ' 40' ' ' ARG . 5.8 ppt_? -59.1 -24.45 62.97 Favored 'General case' 0 C--N 1.307 -1.242 0 C-N-CA 123.354 0.662 . . . . 0.0 111.025 178.606 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.403 ' N ' ' HD2' ' A' ' 40' ' ' ARG . 13.8 pt-20 -95.39 0.11 53.13 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.825 -0.625 . . . . 0.0 112.317 -175.81 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.469 ' HG ' ' HB3' ' A' ' 39' ' ' ASN . 68.6 mt -89.81 121.69 32.18 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-O 121.132 0.492 . . . . 0.0 110.407 179.503 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 70.6 p -108.43 174.44 5.87 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-N 114.674 -1.148 . . . . 0.0 110.279 -176.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.44 ' CG ' ' HB2' ' A' ' 62' ' ' LEU . 33.6 mt-10 -55.15 -40.87 71.09 Favored 'General case' 0 C--O 1.212 -0.914 0 O-C-N 123.616 0.572 . . . . 0.0 109.689 176.622 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -59.76 -39.83 95.84 Favored Glycine 0 C--O 1.243 0.7 0 CA-C-N 116.079 -0.51 . . . . 0.0 112.738 179.744 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -66.82 -49.65 65.1 Favored 'General case' 0 CA--C 1.499 -1.017 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 179.261 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 47.2 mt -60.07 -46.68 94.01 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.808 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.842 -179.643 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 47.5 mt -60.07 -42.49 94.67 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 116.592 -0.277 . . . . 0.0 111.705 -177.974 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 90.8 m -63.98 -46.28 85.32 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 120.869 0.366 . . . . 0.0 111.256 -179.134 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 95.7 t -66.98 -48.63 78.91 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.692 -178.923 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.433 ' HA ' ' HD2' ' A' ' 54' ' ' TYR . 4.6 m-85 -64.88 -23.08 67.12 Favored 'General case' 0 N--CA 1.426 -1.636 0 CA-C-N 115.28 -0.873 . . . . 0.0 112.416 -178.413 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.477 ' HA ' ' O ' ' A' ' 55' ' ' GLY . 61.5 m -72.3 -20.8 61.44 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 176.64 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -71.46 -22.18 61.86 Favored 'General case' 0 C--O 1.246 0.894 0 C-N-CA 119.859 -0.736 . . . . 0.0 109.596 177.275 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.433 ' HD2' ' HA ' ' A' ' 51' ' ' PHE . 73.7 m-85 -92.0 -22.82 19.77 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.818 -178.538 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.477 ' O ' ' HA ' ' A' ' 52' ' ' SER . . . 169.79 -164.47 37.91 Favored Glycine 0 N--CA 1.427 -1.965 0 N-CA-C 110.927 -0.869 . . . . 0.0 110.927 -179.588 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 54.8 t -99.03 111.0 59.82 Favored Pre-proline 0 C--N 1.302 -1.498 0 CA-C-N 116.548 0.174 . . . . 0.0 111.039 -176.84 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.46 ' HB3' HD21 ' A' ' 77' ' ' LEU . 85.9 Cg_endo -78.13 141.77 18.84 Favored 'Trans proline' 0 C--O 1.246 0.895 0 C-N-CA 122.975 2.45 . . . . 0.0 110.627 175.84 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 29.7 m -120.53 -15.38 7.43 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 C-N-CA 120.264 -0.575 . . . . 0.0 112.132 179.226 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.565 ' HB3' ' HG2' ' A' ' 78' ' ' LYS . 28.3 t70 -163.27 135.92 5.4 Favored 'General case' 0 C--O 1.244 0.799 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 -176.835 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 14.4 p -143.97 136.88 23.71 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 90.2 mt -120.92 121.63 65.62 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.799 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 177.234 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.44 ' HB2' ' CG ' ' A' ' 44' ' ' GLU . 0.1 OUTLIER -100.2 113.54 26.28 Favored 'General case' 0 N--CA 1.42 -1.93 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 175.267 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 13.6 m -78.32 117.91 20.01 Favored 'General case' 0 C--N 1.274 -2.693 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 178.406 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 84.2 mtm180 . . . . . 0 C--N 1.301 -1.514 0 CA-C-O 121.052 0.454 . . . . 0.0 110.125 179.353 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 12.9 mm-40 . . . . . 0 CA--C 1.502 -0.878 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 96.54 2.99 59.9 Favored Glycine 0 N--CA 1.426 -2.031 0 C-N-CA 119.651 -1.261 . . . . 0.0 112.113 -179.616 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 34.5 p90 -145.65 151.58 38.28 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 178.294 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -149.49 170.16 19.24 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 123.266 0.354 . . . . 0.0 110.529 -179.217 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -131.5 140.12 49.46 Favored 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 123.649 0.78 . . . . 0.0 109.427 -178.63 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.46 HD21 ' HB3' ' A' ' 57' ' ' PRO . 9.9 tt -147.33 140.45 25.19 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 177.183 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.565 ' HG2' ' HB3' ' A' ' 59' ' ' ASP . 18.7 ptmt -124.0 144.43 49.83 Favored 'General case' 0 C--O 1.259 1.567 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 178.122 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.415 ' HH ' ' HD2' ' A' ' 51' ' ' PHE . 58.7 m-85 -106.9 164.89 11.75 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.956 -178.32 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -77.83 -25.73 49.01 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 114.813 -1.085 . . . . 0.0 109.293 176.616 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -124.1 130.39 52.48 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 -179.812 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -69.3 -21.05 63.89 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 113.137 0.792 . . . . 0.0 113.137 -177.262 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 89.6 mtm180 -63.64 -33.13 74.95 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-O 122.352 1.073 . . . . 0.0 110.109 177.374 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.435 ' OG ' HG21 ' B' ' 226' ' ' ILE . 48.9 m -63.53 -36.98 85.59 Favored 'General case' 0 C--N 1.282 -2.335 0 CA-C-N 114.628 -1.169 . . . . 0.0 112.22 178.859 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.421 ' O ' HG23 ' A' ' 89' ' ' VAL . 81.8 p -64.74 -45.05 88.11 Favored 'General case' 0 C--O 1.219 -0.501 0 C-N-CA 120.279 -0.568 . . . . 0.0 110.525 -177.015 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.425 ' H ' HG12 ' A' ' 86' ' ' ILE . 3.3 pt -63.89 -39.45 85.46 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.103 177.225 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 29.2 mt -60.32 -43.61 96.21 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 120.902 0.382 . . . . 0.0 111.011 175.363 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.423 ' O ' ' HB2' ' A' ' 92' ' ' LEU . . . -71.47 -47.16 57.37 Favored 'General case' 0 C--O 1.211 -0.959 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.67 -178.64 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.449 HG22 HG22 ' A' ' 104' ' ' ILE . 79.5 t -57.21 -48.7 81.72 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.492 0 CA-C-O 120.915 0.388 . . . . 0.0 111.006 -179.44 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -68.38 -31.9 71.6 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 115.509 -0.769 . . . . 0.0 112.466 -173.413 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -97.56 -20.77 17.48 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 -176.302 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.461 ' HB2' HG13 ' A' ' 104' ' ' ILE . 9.6 mt -93.43 -28.56 16.06 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-O 120.574 0.226 . . . . 0.0 111.07 -179.15 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -60.26 124.74 21.22 Favored 'General case' 0 C--O 1.244 0.79 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 178.056 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 83.86 -1.07 89.23 Favored Glycine 0 C--N 1.306 -1.128 0 C-N-CA 120.499 -0.858 . . . . 0.0 113.447 177.542 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 86.4 t80 -85.3 134.4 34.12 Favored 'General case' 0 N--CA 1.443 -0.825 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 178.688 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.409 ' HA ' ' HA ' ' A' ' 101' ' ' ALA . 11.1 mptt -92.88 118.87 31.6 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.229 -176.925 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 54.1 mt -121.72 141.16 43.33 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 N-CA-C 105.257 -2.127 . . . . 0.0 105.257 172.577 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.413 ' HA3' HD22 ' A' ' 39' ' ' ASN . . . 58.92 22.48 54.77 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 121.191 -0.528 . . . . 0.0 112.821 -179.04 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 82.21 7.41 87.77 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 121.492 -0.385 . . . . 0.0 113.546 -179.435 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 16.7 ptp180 -129.52 141.04 51.08 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 117.688 0.744 . . . . 0.0 110.894 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.409 ' HA ' ' HA ' ' A' ' 96' ' ' LYS . . . -79.61 122.08 26.07 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.012 0.434 . . . . 0.0 111.387 -179.215 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 9.5 mt -68.7 141.23 55.35 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.671 177.2 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -113.98 116.01 28.55 Favored 'General case' 0 N--CA 1.409 -2.517 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 176.244 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.461 HG13 ' HB2' ' A' ' 92' ' ' LEU . 4.8 mm -116.65 136.11 54.78 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.861 0 N-CA-C 106.423 -1.695 . . . . 0.0 106.423 178.417 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -144.0 151.85 40.26 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.331 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -80.63 135.6 36.08 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-O 120.975 0.417 . . . . 0.0 110.223 177.648 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.49 HG21 ' HB2' ' A' ' 34' ' ' TYR . 6.5 t -153.64 168.35 26.52 Favored 'General case' 0 C--N 1.291 -1.972 0 N-CA-C 107.427 -1.324 . . . . 0.0 107.427 -177.065 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -108.91 110.82 22.24 Favored 'General case' 0 N--CA 1.421 -1.888 0 N-CA-C 105.208 -2.145 . . . . 0.0 105.208 169.143 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 84.9 t80 . . . . . 0 C--N 1.291 -1.967 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 178.879 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 226' ' ' ILE . . . . . 0.435 HG21 ' OG ' ' A' ' 84' ' ' SER . 4.2 mp . . . . . 0 N--CA 1.451 -0.421 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 227' ' ' MET . . . . . . . . . . . . . 86.8 mtp -71.2 133.54 85.54 Favored Pre-proline 0 C--N 1.315 -0.903 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 176.568 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 228' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -64.27 160.89 36.59 Favored 'Trans proline' 0 C--O 1.24 0.622 0 C-N-CA 123.43 2.753 . . . . 0.0 113.455 -177.609 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . -77.19 167.48 54.25 Favored Glycine 0 N--CA 1.439 -1.128 0 CA-C-N 115.155 -0.929 . . . . 0.0 113.429 -178.328 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 6.5 m -77.42 -17.58 57.99 Favored 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 123.14 0.576 . . . . 0.0 111.635 -175.169 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 7.9 mmp_? -87.29 -0.46 56.77 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.196 0.522 . . . . 0.0 110.995 -176.167 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 232' ' ' TRP . . . . . . . . . . . . . 21.1 t90 -76.93 127.82 33.41 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-O 122.307 1.051 . . . . 0.0 112.206 -178.063 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 233' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -122.07 147.1 46.53 Favored 'General case' 0 C--N 1.277 -2.585 0 N-CA-C 102.82 -3.029 . . . . 0.0 102.82 171.705 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.505 3.272 0 C-N-CA 128.372 2.891 . . . . 0.0 117.139 -175.654 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 240' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.417 -2.604 0 N-CA-C 108.443 -1.863 . . . . 0.0 108.443 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 22.7 p90 -77.09 -33.34 56.99 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 179.777 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -61.27 -45.34 94.89 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.226 0.536 . . . . 0.0 112.089 -177.094 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -60.46 -34.74 74.46 Favored 'General case' 0 C--O 1.204 -1.307 0 CA-C-N 115.166 -0.924 . . . . 0.0 111.411 -179.328 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -63.97 -42.46 97.24 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 -178.938 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 245' ' ' TRP . . . . . 0.451 ' HA ' ' HG3' ' B' ' 248' ' ' LYS . 23.7 m0 -66.23 -38.43 87.89 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.329 0.585 . . . . 0.0 109.954 178.354 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 246' ' ' PHE . . . . . 0.653 ' O ' ' HG2' ' B' ' 249' ' ' GLN . 3.1 t80 -67.96 -32.89 73.63 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.433 176.302 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -74.93 -38.96 61.65 Favored 'General case' 0 C--N 1.294 -1.839 0 O-C-N 121.948 -0.47 . . . . 0.0 111.023 179.399 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 248' ' ' LYS . . . . . 0.451 ' HG3' ' HA ' ' B' ' 245' ' ' TRP . 0.0 OUTLIER -82.35 -14.57 55.08 Favored 'General case' 0 CA--C 1.504 -0.8 0 CA-C-O 121.045 0.45 . . . . 0.0 111.758 -175.235 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 249' ' ' GLN . . . . . 0.653 ' HG2' ' O ' ' B' ' 246' ' ' PHE . 10.1 pt20 -75.22 2.4 11.07 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 121.698 0.761 . . . . 0.0 110.332 -179.068 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 250' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -67.24 -25.83 66.28 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.21 176.235 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -64.29 115.88 5.48 Favored 'General case' 0 N--CA 1.437 -1.118 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.134 178.681 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 252' ' ' ILE . . . . . . . . . . . . . 16.3 pt -99.67 -27.63 3.52 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.317 0 CA-C-N 113.783 -1.553 . . . . 0.0 110.944 -174.963 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 10.6 p30 -121.01 -26.32 5.17 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.908 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 254' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 . . . . . 0 N--CA 1.428 -1.571 0 N-CA-C 114.089 1.144 . . . . 0.0 114.089 -177.322 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.439 ' HA ' HG21 ' A' ' 85' ' ' THR . . . . . . . . 0 N--CA 1.441 -0.878 0 CA-C-O 120.579 0.228 . . . . 0.0 110.644 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 9.9 m-30 -104.85 145.23 30.67 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.89 -175.63 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 22.8 pt -140.82 158.4 23.69 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 CA-C-O 121.137 0.494 . . . . 0.0 110.628 178.795 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.442 ' HB2' HG21 ' A' ' 107' ' ' THR . 61.8 t80 -105.26 118.91 37.74 Favored 'General case' 0 N--CA 1.412 -2.374 0 CA-C-N 114.504 -1.226 . . . . 0.0 108.057 177.771 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.475 HG23 ' CD1' ' A' ' 104' ' ' ILE . 10.9 mt -108.41 127.53 64.7 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.18 0 N-CA-C 105.427 -2.064 . . . . 0.0 105.427 173.359 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -132.31 170.86 21.71 Favored Glycine 0 C--N 1.269 -3.18 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 71.74 32.84 1.87 Allowed 'General case' 0 N--CA 1.471 0.604 0 O-C-N 124.485 0.756 . . . . 0.0 109.873 -178.822 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.5 HD11 HD11 ' A' ' 47' ' ' ILE . 4.0 mm? -66.19 143.02 57.51 Favored 'General case' 0 CA--C 1.492 -1.267 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.465 177.768 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.426 ' HB3' ' HG ' ' A' ' 42' ' ' LEU . 61.2 t30 -83.49 156.5 22.83 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.061 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 18.4 ptt180 -58.01 -28.92 64.88 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 123.701 0.801 . . . . 0.0 112.664 -177.188 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -107.48 4.76 26.51 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 113.74 1.015 . . . . 0.0 113.74 -172.944 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.426 ' HG ' ' HB3' ' A' ' 39' ' ' ASN . 61.3 mt -84.56 121.69 27.97 Favored 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 120.348 -0.541 . . . . 0.0 110.776 178.775 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 69.6 p -107.58 173.47 6.31 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-N 115.096 -0.956 . . . . 0.0 109.675 -179.236 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.432 ' HG3' ' HB2' ' A' ' 62' ' ' LEU . 52.3 mt-10 -55.3 -38.97 69.34 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 123.46 0.704 . . . . 0.0 111.652 179.497 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -65.6 -37.98 94.17 Favored Glycine 0 N--CA 1.44 -1.078 0 CA-C-N 116.076 -0.511 . . . . 0.0 113.105 -178.693 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -67.25 -43.95 80.64 Favored 'General case' 0 CA--C 1.505 -0.773 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 -178.881 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.5 HD11 HD11 ' A' ' 38' ' ' LEU . 35.9 mt -60.77 -45.51 97.71 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.421 0 CA-C-N 114.922 -1.035 . . . . 0.0 110.593 178.587 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 50.0 mt -59.64 -44.85 93.35 Favored 'General case' 0 C--O 1.207 -1.135 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.704 -176.86 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.45 HG23 ' H ' ' B' ' 233' ' ' ASP . 96.4 m -60.63 -46.05 91.76 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 179.809 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 85.5 t -65.95 -48.44 81.84 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 CA-C-O 121.099 0.476 . . . . 0.0 110.679 179.251 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.425 ' HA ' ' HD2' ' A' ' 54' ' ' TYR . 5.4 m-85 -66.27 -24.39 66.56 Favored 'General case' 0 N--CA 1.431 -1.39 0 CA-C-N 115.595 -0.73 . . . . 0.0 112.331 -178.004 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.407 ' HA ' ' O ' ' A' ' 55' ' ' GLY . 73.3 m -68.59 -19.8 64.48 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.958 176.3 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -70.29 -25.3 63.27 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 119.553 -0.859 . . . . 0.0 108.953 175.938 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.425 ' HD2' ' HA ' ' A' ' 51' ' ' PHE . 37.0 m-85 -93.01 -7.55 45.51 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-N 115.877 -0.602 . . . . 0.0 112.069 -175.711 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.407 ' O ' ' HA ' ' A' ' 52' ' ' SER . . . 152.39 -159.63 28.5 Favored Glycine 0 N--CA 1.419 -2.48 0 C-N-CA 120.699 -0.762 . . . . 0.0 111.304 178.968 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 98.8 t -99.83 110.9 60.69 Favored Pre-proline 0 C--N 1.298 -1.634 0 O-C-N 123.382 0.107 . . . . 0.0 110.95 -178.075 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.532 ' HB3' HD21 ' A' ' 77' ' ' LEU . 92.1 Cg_endo -79.68 137.26 12.68 Favored 'Trans proline' 0 N--CA 1.452 -0.926 0 C-N-CA 122.779 2.319 . . . . 0.0 110.16 175.694 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 27.0 m -114.39 -20.41 6.06 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 C-N-CA 119.624 -0.83 . . . . 0.0 112.038 -178.595 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.519 ' HB3' ' HG2' ' A' ' 78' ' ' LYS . 37.5 t70 -157.24 138.24 13.45 Favored 'General case' 0 CA--C 1.499 -0.992 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.411 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 13.6 p -139.68 134.32 38.28 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 O-C-N 123.674 0.609 . . . . 0.0 109.379 178.619 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 84.5 mt -121.9 126.91 75.16 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.051 177.023 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.432 ' HB2' ' HG3' ' A' ' 44' ' ' GLU . 0.1 OUTLIER -105.99 112.46 25.51 Favored 'General case' 0 N--CA 1.424 -1.763 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 173.54 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 24.2 m -79.23 119.54 22.46 Favored 'General case' 0 C--N 1.281 -2.387 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 177.208 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 81.8 mtp180 . . . . . 0 C--N 1.307 -1.274 0 O-C-N 121.992 -0.442 . . . . 0.0 111.89 -175.951 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 28.8 mm-40 . . . . . 0 CA--C 1.506 -0.723 0 CA-C-O 121.167 0.508 . . . . 0.0 110.383 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 98.33 1.38 58.03 Favored Glycine 0 N--CA 1.43 -1.739 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.89 -177.841 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 37.3 p90 -140.53 151.72 44.99 Favored 'General case' 0 N--CA 1.432 -1.335 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 178.329 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -146.49 172.25 13.83 Favored 'General case' 0 N--CA 1.42 -1.927 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 178.43 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 8.0 t80 -135.07 143.76 46.85 Favored 'General case' 0 C--N 1.293 -1.857 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.047 -177.732 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.532 HD21 ' HB3' ' A' ' 57' ' ' PRO . 9.7 tt -149.83 140.52 22.63 Favored 'General case' 0 N--CA 1.434 -1.244 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 175.696 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.519 ' HG2' ' HB3' ' A' ' 59' ' ' ASP . 21.1 ptmt -123.34 144.44 49.45 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 178.33 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 70.1 m-85 -105.79 165.15 11.39 Favored 'General case' 0 C--N 1.289 -2.037 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.067 -177.641 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -75.08 -31.52 61.23 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 114.702 -1.136 . . . . 0.0 108.918 173.459 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.404 ' O ' ' HB2' ' A' ' 84' ' ' SER . 8.8 t70 -119.88 134.11 55.35 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 -178.31 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -70.62 -20.42 62.74 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 -179.118 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 87.0 mtm180 -67.91 -33.3 74.44 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-O 122.44 1.114 . . . . 0.0 109.239 175.1 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.49 ' OG ' HG21 ' B' ' 226' ' ' ILE . 50.3 m -62.27 -37.13 84.28 Favored 'General case' 0 C--N 1.285 -2.222 0 CA-C-N 114.6 -1.182 . . . . 0.0 112.323 177.016 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.479 ' O ' HG23 ' A' ' 89' ' ' VAL . 78.7 p -65.2 -45.49 84.58 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 120.208 -0.597 . . . . 0.0 110.179 -177.998 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.422 ' H ' HG12 ' A' ' 86' ' ' ILE . 5.6 pt -64.72 -38.11 81.84 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.492 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.099 177.222 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 12.0 mt -59.09 -44.69 91.94 Favored 'General case' 0 CA--C 1.502 -0.87 0 CA-C-O 120.944 0.402 . . . . 0.0 111.089 175.472 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.505 ' O ' ' HB2' ' A' ' 92' ' ' LEU . . . -71.4 -40.93 70.22 Favored 'General case' 0 N--CA 1.427 -1.59 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.303 -178.351 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.482 HG22 HG22 ' A' ' 104' ' ' ILE . 86.0 t -62.2 -49.4 84.19 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-O 120.889 0.376 . . . . 0.0 110.671 178.21 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -66.07 -35.75 81.37 Favored 'General case' 0 C--N 1.302 -1.468 0 C-N-CA 123.59 0.756 . . . . 0.0 112.13 -175.428 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -87.74 -29.22 21.23 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -177.361 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.505 ' HB2' ' O ' ' A' ' 88' ' ' ALA . 10.1 mt -97.68 -26.56 14.71 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 112.84 0.682 . . . . 0.0 112.84 -173.648 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -60.38 125.1 22.4 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 109.551 -0.536 . . . . 0.0 109.551 -179.557 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 81.44 -1.12 86.65 Favored Glycine 0 N--CA 1.441 -0.987 0 C-N-CA 120.986 -0.626 . . . . 0.0 113.649 177.888 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 59.4 t80 -85.67 138.16 32.32 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 117.611 0.706 . . . . 0.0 109.122 -178.567 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.424 ' HE3' ' HB2' ' A' ' 101' ' ' ALA . 11.7 mptt -92.47 117.2 29.7 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 -176.506 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 56.6 mt -126.08 141.99 44.08 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 N-CA-C 105.253 -2.129 . . . . 0.0 105.253 173.019 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 60.58 19.98 55.23 Favored Glycine 0 CA--C 1.525 0.687 0 C-N-CA 121.598 -0.334 . . . . 0.0 113.595 179.794 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 84.33 10.61 79.74 Favored Glycine 0 N--CA 1.441 -0.989 0 C-N-CA 121.292 -0.48 . . . . 0.0 112.539 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 12.9 ptp180 -135.82 145.9 46.95 Favored 'General case' 0 N--CA 1.439 -0.996 0 O-C-N 122.435 -0.45 . . . . 0.0 111.511 -179.744 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.424 ' HB2' ' HE3' ' A' ' 96' ' ' LYS . . . -84.38 118.07 24.01 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.015 -177.543 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 10.3 mt -65.73 139.28 58.35 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-O 121.653 0.739 . . . . 0.0 112.49 179.671 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 60.2 tptt -109.98 115.47 29.84 Favored 'General case' 0 N--CA 1.413 -2.275 0 CA-C-N 115.106 -0.952 . . . . 0.0 108.456 178.12 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.482 HG22 HG22 ' A' ' 89' ' ' VAL . 5.0 mm -121.34 131.31 73.35 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.898 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 178.98 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -143.91 155.09 43.95 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 -179.349 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -83.55 132.08 34.94 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 117.994 0.361 . . . . 0.0 110.716 177.941 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.442 HG21 ' HB2' ' A' ' 34' ' ' TYR . 5.8 t -153.86 159.78 41.93 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 107.848 -1.168 . . . . 0.0 107.848 -176.304 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -99.71 112.64 24.85 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 169.629 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 32.3 t80 . . . . . 0 C--N 1.29 -2.021 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.363 -176.874 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 226' ' ' ILE . . . . . 0.49 HG21 ' OG ' ' A' ' 84' ' ' SER . 4.2 mp . . . . . 0 CA--C 1.501 -0.927 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 227' ' ' MET . . . . . . . . . . . . . 91.1 mtp -67.49 133.16 92.89 Favored Pre-proline 0 C--N 1.312 -1.022 0 O-C-N 123.528 0.518 . . . . 0.0 110.12 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 228' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -68.67 158.78 56.35 Favored 'Trans proline' 0 N--CA 1.452 -0.96 0 C-N-CA 122.761 2.307 . . . . 0.0 112.25 179.695 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . -75.6 163.55 53.71 Favored Glycine 0 N--CA 1.437 -1.25 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.329 179.784 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 14.6 m -77.79 -14.36 59.61 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 123.103 0.561 . . . . 0.0 110.974 -178.581 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 27.9 mmt180 -81.82 0.26 40.18 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 121.461 0.648 . . . . 0.0 109.952 -178.371 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 232' ' ' TRP . . . . . . . . . . . . . 22.8 t90 -81.82 130.5 35.09 Favored 'General case' 0 N--CA 1.427 -1.593 0 CA-C-O 122.228 1.013 . . . . 0.0 111.441 -177.883 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 233' ' ' ASP . . . . . 0.45 ' H ' HG23 ' A' ' 49' ' ' THR . 17.3 t70 -117.86 147.74 42.78 Favored 'General case' 0 C--N 1.273 -2.758 0 N-CA-C 101.201 -3.629 . . . . 0.0 101.201 171.457 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.511 3.679 0 C-N-CA 128.248 2.832 . . . . 0.0 118.213 -175.447 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 240' ' ' GLY . . . . . 0.436 ' O ' ' HG2' ' B' ' 244' ' ' LYS . . . . . . . . 0 C--O 1.2 -1.972 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 26.8 p90 -76.38 -34.55 58.87 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -179.536 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -63.61 -42.42 98.23 Favored 'General case' 0 C--O 1.219 -0.543 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.843 -174.048 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -61.16 -34.36 74.9 Favored 'General case' 0 CA--C 1.509 -0.623 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.397 178.479 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 244' ' ' LYS . . . . . 0.436 ' HG2' ' O ' ' B' ' 240' ' ' GLY . 71.0 mmtt -67.15 -47.52 70.8 Favored 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 -179.029 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 245' ' ' TRP . . . . . . . . . . . . . 49.2 m0 -65.3 -40.15 93.43 Favored 'General case' 0 C--O 1.208 -1.089 0 CA-C-N 114.77 -1.105 . . . . 0.0 109.83 179.765 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 246' ' ' PHE . . . . . 0.486 ' O ' ' HG2' ' B' ' 249' ' ' GLN . 3.1 t80 -66.18 -30.75 71.28 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 124.091 0.956 . . . . 0.0 110.892 179.318 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -78.13 -39.87 39.86 Favored 'General case' 0 C--N 1.294 -1.836 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.24 178.784 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.89 -11.7 46.92 Favored 'General case' 0 CA--C 1.51 -0.584 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -175.915 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 249' ' ' GLN . . . . . 0.486 ' HG2' ' O ' ' B' ' 246' ' ' PHE . 12.4 pt20 -74.46 2.74 8.84 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.635 -179.234 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 250' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -57.42 -35.89 70.66 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.433 177.766 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -88.95 107.46 19.03 Favored 'General case' 0 N--CA 1.421 -1.89 0 CA-C-O 122.179 0.99 . . . . 0.0 110.239 177.286 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 252' ' ' ILE . . . . . . . . . . . . . 9.2 pt -116.88 -34.3 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.281 -2.4 0 CA-C-N 114.27 -1.332 . . . . 0.0 110.998 -179.206 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -115.4 -26.44 7.56 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 -178.841 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 254' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 . . . . . 0 N--CA 1.432 -1.353 0 CA-C-N 114.631 -1.168 . . . . 0.0 110.181 -175.518 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.509 -0.614 0 N-CA-C 111.563 0.209 . . . . 0.0 111.563 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -108.0 145.39 33.98 Favored 'General case' 0 C--N 1.311 -1.088 0 C-N-CA 120.816 -0.354 . . . . 0.0 110.32 -174.837 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 24.2 pt -142.74 161.97 18.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.984 178.085 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.414 ' HB2' HG21 ' A' ' 107' ' ' THR . 63.1 t80 -111.55 122.72 48.59 Favored 'General case' 0 N--CA 1.42 -1.975 0 C-N-CA 124.655 1.182 . . . . 0.0 108.485 178.522 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.456 HG23 ' CD1' ' A' ' 104' ' ' ILE . 9.9 mt -108.85 128.32 64.74 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.933 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 175.018 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -130.15 168.74 21.34 Favored Glycine 0 C--N 1.288 -2.112 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 -179.578 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.404 ' O ' ' HD3' ' A' ' 100' ' ' ARG . 83.5 m-20 72.75 27.46 2.23 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 124.766 1.226 . . . . 0.0 110.788 -177.781 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.401 HD11 HD11 ' A' ' 47' ' ' ILE . 4.3 mm? -62.84 143.2 57.8 Favored 'General case' 0 CA--C 1.499 -0.993 0 CA-C-O 121.407 0.622 . . . . 0.0 112.474 179.541 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.5 ' HB3' ' HG ' ' A' ' 42' ' ' LEU . 47.5 t-20 -85.38 147.11 26.67 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 175.707 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.02 -17.3 56.83 Favored 'General case' 0 C--N 1.299 -1.592 0 C-N-CA 123.949 0.9 . . . . 0.0 112.899 178.978 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -98.88 0.52 44.34 Favored 'General case' 0 C--O 1.244 0.768 0 CA-C-O 121.035 0.445 . . . . 0.0 111.253 -179.475 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.5 ' HG ' ' HB3' ' A' ' 39' ' ' ASN . 77.5 mt -90.68 120.35 31.67 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-O 121.637 0.732 . . . . 0.0 110.062 179.128 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 72.1 p -102.95 173.22 6.41 Favored 'General case' 0 C--N 1.29 -2.005 0 CA-C-N 114.382 -1.281 . . . . 0.0 108.973 -177.862 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.432 ' HG3' ' HB2' ' A' ' 62' ' ' LEU . 2.7 mp0 -56.13 -39.07 71.69 Favored 'General case' 0 C--O 1.209 -1.057 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 175.431 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -59.25 -40.07 95.39 Favored Glycine 0 N--CA 1.444 -0.827 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.948 -178.673 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -67.04 -49.14 66.17 Favored 'General case' 0 CA--C 1.496 -1.109 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.571 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.401 HD11 HD11 ' A' ' 38' ' ' LEU . 48.4 mt -58.45 -46.44 89.55 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.762 0 CA-C-N 114.866 -1.061 . . . . 0.0 110.304 179.601 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 44.4 mt -59.71 -45.5 91.95 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.843 -178.525 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.475 HG23 ' H ' ' B' ' 233' ' ' ASP . 98.2 m -62.63 -45.46 92.73 Favored 'General case' 0 N--CA 1.442 -0.869 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 179.606 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 91.3 t -65.89 -47.91 83.83 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.192 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.505 -178.938 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.496 ' HA ' ' HD2' ' A' ' 54' ' ' TYR . 3.7 m-85 -66.45 -24.44 66.44 Favored 'General case' 0 N--CA 1.428 -1.564 0 CA-C-N 115.412 -0.813 . . . . 0.0 112.354 -178.27 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.499 ' OG ' ' HB2' ' B' ' 231' ' ' ARG . 62.3 m -68.09 -18.07 64.56 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 176.724 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -69.92 -26.78 64.31 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 119.546 -0.862 . . . . 0.0 109.226 176.165 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.496 ' HD2' ' HA ' ' A' ' 51' ' ' PHE . 61.9 m-85 -89.61 -23.26 21.98 Favored 'General case' 0 CA--C 1.505 -0.774 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.845 -175.032 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.419 ' O ' ' HA ' ' A' ' 52' ' ' SER . . . 170.41 -155.74 25.58 Favored Glycine 0 N--CA 1.418 -2.558 0 N-CA-C 110.577 -1.009 . . . . 0.0 110.577 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.417 HG22 ' HA2' ' B' ' 229' ' ' GLY . 49.0 t -104.46 105.57 50.47 Favored Pre-proline 0 C--N 1.289 -2.04 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 -177.476 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.601 ' HB3' HD21 ' A' ' 77' ' ' LEU . 64.0 Cg_endo -74.74 136.4 20.93 Favored 'Trans proline' 0 N--CA 1.447 -1.263 0 C-N-CA 121.793 1.662 . . . . 0.0 109.522 175.495 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 26.8 m -111.66 -25.54 3.47 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 C-N-CA 120.354 -0.538 . . . . 0.0 111.693 -178.45 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.507 ' HB3' ' HG2' ' A' ' 78' ' ' LYS . 27.9 t70 -152.92 145.38 24.11 Favored 'General case' 0 CA--C 1.491 -1.295 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 14.6 p -145.96 135.47 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.799 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 179.321 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 92.7 mt -120.51 123.91 71.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 175.607 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.432 ' HB2' ' HG3' ' A' ' 44' ' ' GLU . 0.1 OUTLIER -97.11 114.52 26.19 Favored 'General case' 0 N--CA 1.422 -1.844 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 176.46 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 9.2 m -75.25 117.85 17.52 Favored 'General case' 0 C--N 1.276 -2.594 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 178.244 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 25.9 mtp180 . . . . . 0 C--N 1.305 -1.334 0 CA-C-O 120.991 0.424 . . . . 0.0 110.991 -176.143 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 12.4 mm-40 . . . . . 0 CA--C 1.511 -0.526 0 CA-C-O 121.067 0.461 . . . . 0.0 111.794 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 85.81 6.74 82.29 Favored Glycine 0 N--CA 1.427 -1.939 0 C-N-CA 120.951 -0.643 . . . . 0.0 112.11 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -148.03 156.87 43.12 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 178.922 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -154.5 171.79 18.83 Favored 'General case' 0 C--N 1.307 -1.252 0 O-C-N 123.741 0.651 . . . . 0.0 110.295 178.939 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -128.33 140.94 51.6 Favored 'General case' 0 C--N 1.31 -1.125 0 C-N-CA 123.71 0.804 . . . . 0.0 110.222 -178.52 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.601 HD21 ' HB3' ' A' ' 57' ' ' PRO . 9.8 tt -147.06 140.72 25.68 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 175.867 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.507 ' HG2' ' HB3' ' A' ' 59' ' ' ASP . 21.6 ptmt -123.93 144.84 49.54 Favored 'General case' 0 C--O 1.259 1.59 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 178.645 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 59.0 m-85 -106.78 164.59 11.98 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-O 121.39 0.614 . . . . 0.0 112.232 -178.284 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -71.98 -34.3 68.83 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 114.053 -1.431 . . . . 0.0 109.093 175.81 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -124.65 135.01 52.71 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.403 -179.717 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -70.55 -20.09 62.83 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 114.316 1.228 . . . . 0.0 114.316 -177.409 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 87.5 mtm180 -61.27 -33.92 74.34 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 122.378 1.085 . . . . 0.0 109.475 173.747 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 50.6 m -66.02 -36.6 83.7 Favored 'General case' 0 C--N 1.288 -2.068 0 CA-C-N 114.777 -1.101 . . . . 0.0 112.662 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 71.3 p -63.46 -45.09 92.4 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 120.34 -0.544 . . . . 0.0 110.995 -177.931 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 3.9 pt -65.63 -38.54 82.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.048 177.536 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 16.1 mt -59.34 -43.74 92.73 Favored 'General case' 0 CA--C 1.502 -0.878 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.439 175.4 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.485 ' O ' ' HB2' ' A' ' 92' ' ' LEU . . . -69.93 -44.97 68.5 Favored 'General case' 0 N--CA 1.425 -1.678 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.648 -178.648 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.499 HG22 HG22 ' A' ' 104' ' ' ILE . 71.2 t -59.69 -44.27 93.24 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.898 0 CA-C-O 121.189 0.519 . . . . 0.0 111.229 177.927 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -63.15 -39.1 93.7 Favored 'General case' 0 C--N 1.291 -1.94 0 C-N-CA 124.095 0.958 . . . . 0.0 112.612 -177.403 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.416 ' HB3' ' CE1' ' A' ' 54' ' ' TYR . 50.8 t-20 -93.44 -33.27 13.89 Favored 'General case' 0 C--N 1.292 -1.924 0 CA-C-O 121.196 0.522 . . . . 0.0 111.355 -175.01 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.485 ' HB2' ' O ' ' A' ' 88' ' ' ALA . 12.9 mt -88.37 -28.13 21.17 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 112.597 0.591 . . . . 0.0 112.597 -171.995 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -64.26 123.83 20.14 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 81.89 -0.57 88.25 Favored Glycine 0 CA--C 1.535 1.321 0 C-N-CA 120.979 -0.629 . . . . 0.0 113.763 179.631 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.402 ' O ' ' HA ' ' A' ' 101' ' ' ALA . 68.3 t80 -85.11 141.76 30.0 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -179.091 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.56 119.74 34.59 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 112.832 0.678 . . . . 0.0 112.832 -176.34 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 52.2 mt -127.56 141.25 46.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 N-CA-C 105.415 -2.069 . . . . 0.0 105.415 172.107 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 61.22 20.74 58.72 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 121.135 -0.555 . . . . 0.0 113.567 179.762 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 82.1 10.05 84.37 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 121.159 -0.543 . . . . 0.0 112.835 -178.963 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.404 ' HD3' ' O ' ' A' ' 37' ' ' ASN . 12.7 ptp180 -134.81 143.68 47.2 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 117.128 0.464 . . . . 0.0 111.564 -179.762 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.402 ' HA ' ' O ' ' A' ' 95' ' ' PHE . . . -81.33 121.16 25.86 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.508 -179.836 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 10.5 mt -70.03 138.7 52.37 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 179.626 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 24.2 tptm -106.4 116.2 31.51 Favored 'General case' 0 N--CA 1.415 -2.193 0 CA-C-N 115.181 -0.918 . . . . 0.0 108.575 177.557 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.499 HG22 HG22 ' A' ' 89' ' ' VAL . 5.8 mm -118.76 135.9 57.68 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.096 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 177.686 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -143.48 152.96 42.13 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 -178.105 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' HIS . . . . . 0.401 ' CD2' HG21 ' A' ' 89' ' ' VAL . 47.3 m-70 -84.16 135.01 34.55 Favored 'General case' 0 C--N 1.289 -2.055 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 176.551 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.414 HG21 ' HB2' ' A' ' 34' ' ' TYR . 5.9 t -154.49 163.49 40.12 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 106.024 -1.843 . . . . 0.0 106.024 -178.752 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -110.16 110.61 21.52 Favored 'General case' 0 N--CA 1.422 -1.829 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 171.957 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 26.5 t80 . . . . . 0 C--N 1.285 -2.213 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 -179.186 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 4.2 mp . . . . . 0 C--O 1.249 1.035 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 227' ' ' MET . . . . . . . . . . . . . 93.1 mmm -72.35 137.92 81.18 Favored Pre-proline 0 C--N 1.317 -0.833 0 O-C-N 123.621 0.576 . . . . 0.0 110.337 178.915 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 228' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -63.16 160.81 32.78 Favored 'Trans proline' 0 CA--C 1.536 0.623 0 C-N-CA 123.752 2.968 . . . . 0.0 114.615 -174.28 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 229' ' ' GLY . . . . . 0.417 ' HA2' HG22 ' A' ' 56' ' ' VAL . . . -80.1 171.11 54.23 Favored Glycine 0 N--CA 1.442 -0.938 0 CA-C-N 115.077 -0.965 . . . . 0.0 113.438 -178.834 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 7.9 m -72.15 -15.7 61.97 Favored 'General case' 0 C--N 1.307 -1.261 0 C-N-CA 124.318 1.047 . . . . 0.0 111.772 -175.928 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 231' ' ' ARG . . . . . 0.499 ' HB2' ' OG ' ' A' ' 52' ' ' SER . 9.9 mmm180 -93.34 -0.03 56.76 Favored 'General case' 0 C--N 1.313 -1.007 0 O-C-N 122.175 -0.328 . . . . 0.0 110.946 -174.56 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 232' ' ' TRP . . . . . . . . . . . . . 21.2 t90 -75.15 127.41 33.14 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-O 122.655 1.216 . . . . 0.0 112.419 -176.779 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 233' ' ' ASP . . . . . 0.475 ' H ' HG23 ' A' ' 49' ' ' THR . 22.3 t70 -123.95 144.17 49.95 Favored 'General case' 0 C--N 1.263 -3.161 0 N-CA-C 102.424 -3.176 . . . . 0.0 102.424 174.444 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.276 0 C-N-CA 128.415 2.912 . . . . 0.0 116.375 -178.239 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 240' ' ' GLY . . . . . 0.5 ' O ' ' HG2' ' B' ' 244' ' ' LYS . . . . . . . . 0 N--CA 1.426 -1.98 0 N-CA-C 110.204 -1.158 . . . . 0.0 110.204 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 37.8 p90 -75.18 -33.72 61.48 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -176.794 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -61.57 -45.33 94.6 Favored 'General case' 0 CA--C 1.507 -0.703 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.52 -178.033 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -62.28 -34.31 76.32 Favored 'General case' 0 C--O 1.212 -0.892 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.266 -179.564 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 244' ' ' LYS . . . . . 0.5 ' HG2' ' O ' ' B' ' 240' ' ' GLY . 71.6 mmtt -64.87 -47.79 76.59 Favored 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 -179.028 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 245' ' ' TRP . . . . . 0.47 ' HA ' ' HG3' ' B' ' 248' ' ' LYS . 37.8 m0 -66.14 -37.28 85.3 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.677 178.079 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 246' ' ' PHE . . . . . 0.566 ' O ' ' HG2' ' B' ' 249' ' ' GLN . 2.5 t80 -66.89 -30.36 70.5 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.809 176.612 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -77.7 -40.02 42.74 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.954 179.379 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 248' ' ' LYS . . . . . 0.47 ' HG3' ' HA ' ' B' ' 245' ' ' TRP . 0.0 OUTLIER -81.36 -19.26 43.09 Favored 'General case' 0 CA--C 1.506 -0.718 0 CA-C-O 120.84 0.352 . . . . 0.0 111.678 -175.908 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 249' ' ' GLN . . . . . 0.566 ' HG2' ' O ' ' B' ' 246' ' ' PHE . 11.6 pt20 -70.44 -0.56 8.58 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.739 -178.268 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 250' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -57.78 -32.18 67.27 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.992 177.2 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -89.83 106.56 18.55 Favored 'General case' 0 N--CA 1.428 -1.542 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 176.441 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 252' ' ' ILE . . . . . . . . . . . . . 37.9 pt -92.8 -33.93 5.69 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.851 0 CA-C-N 115.028 -0.987 . . . . 0.0 112.316 -174.004 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -89.26 -11.45 43.53 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-O 121.349 0.595 . . . . 0.0 110.745 -176.123 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 254' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.287 -2.126 0 CA-C-N 114.971 -1.013 . . . . 0.0 111.16 -177.024 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.415 ' HA ' HG21 ' A' ' 85' ' ' THR . . . . . . . . 0 N--CA 1.44 -0.953 0 CA-C-O 120.567 0.223 . . . . 0.0 110.46 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 16.3 m-85 -99.72 145.18 27.95 Favored 'General case' 0 N--CA 1.433 -1.283 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 -177.696 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 24.7 pt -140.1 156.44 24.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 CA-C-O 121.157 0.504 . . . . 0.0 110.636 175.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 49.0 t80 -106.87 123.73 48.58 Favored 'General case' 0 N--CA 1.408 -2.564 0 CA-C-N 114.396 -1.275 . . . . 0.0 107.607 177.168 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.416 HG23 ' CD1' ' A' ' 104' ' ' ILE . 8.3 mt -107.89 127.57 63.88 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.55 0 N-CA-C 105.831 -1.915 . . . . 0.0 105.831 175.224 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -126.61 164.06 20.31 Favored Glycine 0 C--N 1.272 -2.975 0 N-CA-C 110.612 -0.995 . . . . 0.0 110.612 -179.076 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 70.94 39.9 0.97 Allowed 'General case' 0 CA--C 1.506 -0.74 0 C-N-CA 124.18 0.992 . . . . 0.0 110.715 -177.553 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.493 HD11 HD11 ' A' ' 47' ' ' ILE . 4.4 mm? -73.44 151.81 40.98 Favored 'General case' 0 CA--C 1.497 -1.07 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.867 176.007 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.506 ' HB3' ' HG ' ' A' ' 42' ' ' LEU . 50.2 t-20 -96.14 147.98 23.17 Favored 'General case' 0 C--N 1.286 -2.188 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 177.657 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.41 HH11 ' HD3' ' A' ' 40' ' ' ARG . 0.3 OUTLIER -63.39 -19.41 64.65 Favored 'General case' 0 C--N 1.298 -1.672 0 C-N-CA 123.326 0.651 . . . . 0.0 111.985 179.944 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.441 ' HG2' ' CG ' ' A' ' 39' ' ' ASN . 12.9 pt-20 -91.93 -3.54 55.81 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.903 -179.179 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.506 ' HG ' ' HB3' ' A' ' 39' ' ' ASN . 78.3 mt -91.09 124.03 35.0 Favored 'General case' 0 CA--C 1.504 -0.818 0 CA-C-O 121.117 0.485 . . . . 0.0 110.285 -179.63 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 67.2 p -109.72 173.78 6.17 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 114.705 -1.134 . . . . 0.0 109.409 -178.418 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.533 ' CG ' ' HB2' ' A' ' 62' ' ' LEU . 51.9 mt-10 -55.66 -38.91 70.2 Favored 'General case' 0 C--N 1.328 -0.333 0 O-C-N 123.47 0.481 . . . . 0.0 110.293 178.354 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -59.96 -43.11 98.43 Favored Glycine 0 C--O 1.24 0.483 0 CA-C-N 115.928 -0.578 . . . . 0.0 113.105 179.266 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -61.68 -49.17 77.57 Favored 'General case' 0 CA--C 1.499 -0.981 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.493 HD11 HD11 ' A' ' 38' ' ' LEU . 41.7 mt -60.86 -46.07 96.97 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.931 0 CA-C-N 114.833 -1.076 . . . . 0.0 110.63 -179.529 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 36.1 mt -60.07 -45.73 91.91 Favored 'General case' 0 CA--C 1.491 -1.293 0 C-N-CA 122.511 0.325 . . . . 0.0 111.81 -176.503 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.493 HG23 ' H ' ' B' ' 233' ' ' ASP . 97.5 m -62.88 -45.32 93.1 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 123.39 0.431 . . . . 0.0 111.751 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 76.6 t -67.28 -45.51 85.94 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.92 -179.645 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -66.96 -22.8 65.91 Favored 'General case' 0 N--CA 1.435 -1.184 0 C-N-CA 123.483 0.713 . . . . 0.0 111.941 -179.355 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.6 ' OG ' ' HB2' ' B' ' 231' ' ' ARG . 73.2 m -71.73 -16.54 62.22 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 116.177 -0.465 . . . . 0.0 112.141 176.139 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -73.53 -20.75 60.57 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 175.319 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.459 ' CE1' ' HB2' ' A' ' 91' ' ' ASN . 68.3 m-85 -97.76 -5.1 35.71 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-N 115.898 -0.592 . . . . 0.0 112.315 -176.864 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 151.7 -153.65 25.07 Favored Glycine 0 N--CA 1.423 -2.2 0 C-N-CA 120.511 -0.852 . . . . 0.0 111.317 179.212 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.461 ' HB ' ' HG2' ' A' ' 80' ' ' GLU . 99.5 t -106.61 104.51 51.26 Favored Pre-proline 0 C--N 1.305 -1.364 0 CA-C-O 120.469 0.176 . . . . 0.0 111.28 -177.466 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.555 ' HB3' HD21 ' A' ' 77' ' ' LEU . 87.8 Cg_endo -76.8 140.09 20.4 Favored 'Trans proline' 0 C--O 1.24 0.61 0 C-N-CA 123.011 2.474 . . . . 0.0 110.141 175.342 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 34.1 m -117.78 -26.04 2.77 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 C-N-CA 119.815 -0.754 . . . . 0.0 111.84 -179.35 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.617 ' HB3' ' HG2' ' A' ' 78' ' ' LYS . 30.5 t70 -149.52 136.48 19.65 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 -173.434 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 14.3 p -145.96 134.1 16.05 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.051 0 O-C-N 123.548 0.53 . . . . 0.0 110.165 -178.361 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 97.3 mt -121.37 120.15 61.12 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 175.173 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.533 ' HB2' ' CG ' ' A' ' 44' ' ' GLU . 0.1 OUTLIER -91.43 115.56 28.14 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 105.957 -1.868 . . . . 0.0 105.957 173.409 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 13.2 m -72.62 116.68 13.38 Favored 'General case' 0 N--CA 1.411 -2.379 0 N-CA-C 107.535 -1.284 . . . . 0.0 107.535 177.636 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 75.8 mtm180 . . . . . 0 C--N 1.287 -2.133 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 -174.753 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 15.6 mm-40 . . . . . 0 CA--C 1.516 -0.328 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 102.35 8.59 43.54 Favored Glycine 0 N--CA 1.431 -1.644 0 C-N-CA 120.27 -0.967 . . . . 0.0 111.636 179.785 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 34.9 p90 -148.78 159.86 43.75 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 177.044 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -156.07 172.73 17.9 Favored 'General case' 0 C--N 1.308 -1.231 0 O-C-N 123.581 0.551 . . . . 0.0 110.561 178.436 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -130.22 141.37 50.64 Favored 'General case' 0 C--N 1.308 -1.235 0 C-N-CA 123.723 0.809 . . . . 0.0 110.089 -179.517 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.555 HD21 ' HB3' ' A' ' 57' ' ' PRO . 9.4 tt -149.21 140.85 23.48 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 175.104 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.617 ' HG2' ' HB3' ' A' ' 59' ' ' ASP . 16.5 ptmt -125.93 144.28 50.75 Favored 'General case' 0 N--CA 1.431 -1.425 0 CA-C-O 121.421 0.629 . . . . 0.0 109.821 176.51 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -102.6 165.08 11.28 Favored 'General case' 0 C--N 1.283 -2.291 0 CA-C-N 115.164 -0.926 . . . . 0.0 109.362 179.518 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.461 ' HG2' ' HB ' ' A' ' 56' ' ' VAL . 8.2 pt-20 -76.95 -21.49 54.7 Favored 'General case' 0 N--CA 1.428 -1.563 0 C-N-CA 119.997 -0.681 . . . . 0.0 110.07 174.052 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -123.59 132.56 53.91 Favored 'General case' 0 N--CA 1.443 -0.815 0 C-N-CA 120.424 -0.51 . . . . 0.0 110.399 179.164 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -70.47 -19.87 62.91 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 -179.318 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 86.5 mtm180 -66.11 -33.66 76.29 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-O 122.166 0.984 . . . . 0.0 108.978 174.093 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 48.7 m -67.97 -36.98 80.98 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-N 114.86 -1.063 . . . . 0.0 112.208 177.531 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.478 ' O ' HG23 ' A' ' 89' ' ' VAL . 73.1 p -64.96 -45.3 86.27 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 120.244 -0.583 . . . . 0.0 110.9 -177.886 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 7.1 pt -63.25 -38.69 82.79 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.466 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.161 177.178 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.6 mt -59.23 -43.83 92.35 Favored 'General case' 0 CA--C 1.502 -0.893 0 O-C-N 123.785 0.678 . . . . 0.0 111.423 177.267 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.429 ' HB1' HD12 ' A' ' 92' ' ' LEU . . . -69.09 -46.53 67.53 Favored 'General case' 0 N--CA 1.424 -1.728 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.745 -179.418 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.478 HG23 ' O ' ' A' ' 85' ' ' THR . 92.7 t -56.64 -46.39 82.81 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.745 0 CA-C-O 121.648 0.737 . . . . 0.0 110.569 178.136 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -58.87 -40.14 83.44 Favored 'General case' 0 C--N 1.292 -1.926 0 C-N-CA 125.843 1.657 . . . . 0.0 112.329 -175.522 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.459 ' HB2' ' CE1' ' A' ' 54' ' ' TYR . 47.0 m-80 -98.46 -27.88 13.86 Favored 'General case' 0 C--N 1.294 -1.846 0 N-CA-C 113.129 0.788 . . . . 0.0 113.129 -175.96 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.429 HD12 ' HB1' ' A' ' 88' ' ' ALA . 15.5 mt -90.07 -30.73 17.51 Favored 'General case' 0 CA--C 1.471 -2.091 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.706 -171.796 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -65.98 124.74 23.35 Favored 'General case' 0 N--CA 1.425 -1.685 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.805 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 88.75 -5.48 84.57 Favored Glycine 0 C--N 1.308 -1.003 0 C-N-CA 121.167 -0.539 . . . . 0.0 112.65 -178.666 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 53.6 t80 -88.69 139.75 30.15 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 -179.041 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.457 ' HE3' ' HB2' ' A' ' 101' ' ' ALA . 12.3 mptt -95.87 118.18 32.01 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-O 120.92 0.391 . . . . 0.0 111.649 -176.292 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 53.0 mt -121.33 140.73 44.52 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 173.081 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 57.22 27.22 57.43 Favored Glycine 0 C--O 1.22 -0.756 0 C-N-CA 121.327 -0.463 . . . . 0.0 112.567 -179.582 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 88.07 -5.81 84.34 Favored Glycine 0 CA--C 1.536 1.376 0 N-CA-C 114.541 0.577 . . . . 0.0 114.541 179.028 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 16.8 ptp180 -126.34 149.89 48.89 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 118.16 0.98 . . . . 0.0 111.901 -177.039 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.457 ' HB2' ' HE3' ' A' ' 96' ' ' LYS . . . -84.84 116.8 23.5 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.525 -175.725 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.441 HD23 ' HA ' ' A' ' 102' ' ' LEU . 12.9 mt -66.51 141.4 57.89 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-O 121.76 0.791 . . . . 0.0 112.797 178.538 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 4.3 tppp? -117.2 116.59 27.58 Favored 'General case' 0 N--CA 1.411 -2.419 0 CA-C-N 114.67 -1.15 . . . . 0.0 108.123 176.583 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.435 HG22 HG22 ' A' ' 89' ' ' VAL . 4.1 mm -115.64 133.64 61.36 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.931 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 -179.69 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -143.6 150.89 39.47 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 -179.405 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 41.7 m-70 -79.42 131.63 36.14 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-O 121.132 0.492 . . . . 0.0 110.33 177.678 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 15.1 t -143.77 156.38 44.48 Favored 'General case' 0 C--N 1.288 -2.068 0 N-CA-C 106.072 -1.825 . . . . 0.0 106.072 -179.445 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 30.3 p90 -101.13 109.17 21.02 Favored 'General case' 0 N--CA 1.42 -1.944 0 C-N-CA 117.173 -1.811 . . . . 0.0 107.08 169.718 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 42.8 t80 . . . . . 0 C--N 1.29 -2.008 0 CA-C-N 114.87 -1.059 . . . . 0.0 108.647 -178.876 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 4.6 mp . . . . . 0 C--O 1.241 0.619 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 227' ' ' MET . . . . . . . . . . . . . 26.3 ptm -71.56 151.72 93.77 Favored Pre-proline 0 C--N 1.318 -0.778 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.387 178.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 228' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -70.94 157.28 58.53 Favored 'Trans proline' 0 C--O 1.245 0.865 0 C-N-CA 123.225 2.617 . . . . 0.0 112.991 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . -84.37 173.44 49.85 Favored Glycine 0 C--N 1.317 -0.51 0 CA-C-N 115.704 -0.68 . . . . 0.0 113.089 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 24.8 m -77.71 -14.3 59.65 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -175.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 231' ' ' ARG . . . . . 0.6 ' HB2' ' OG ' ' A' ' 52' ' ' SER . 3.1 mmp_? -80.16 -7.15 58.8 Favored 'General case' 0 C--N 1.326 -0.43 0 O-C-N 121.964 -0.46 . . . . 0.0 110.365 177.657 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 232' ' ' TRP . . . . . . . . . . . . . 22.8 t90 -73.1 127.17 31.8 Favored 'General case' 0 CA--C 1.5 -0.966 0 CA-C-O 122.355 1.074 . . . . 0.0 111.819 -178.754 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 233' ' ' ASP . . . . . 0.493 ' H ' HG23 ' A' ' 49' ' ' THR . 26.9 t70 -123.23 146.47 47.81 Favored 'General case' 0 C--N 1.269 -2.92 0 N-CA-C 102.436 -3.172 . . . . 0.0 102.436 173.511 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.611 0 C-N-CA 128.101 2.763 . . . . 0.0 116.129 -179.472 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 240' ' ' GLY . . . . . 0.49 ' O ' ' HG2' ' B' ' 244' ' ' LYS . . . . . . . . 0 N--CA 1.412 -2.93 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 10.0 p90 -75.42 -32.85 60.84 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 178.582 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -60.5 -42.38 96.24 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.148 0.499 . . . . 0.0 110.285 -179.579 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -64.79 -35.42 81.03 Favored 'General case' 0 C--O 1.202 -1.439 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.677 179.668 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 244' ' ' LYS . . . . . 0.49 ' HG2' ' O ' ' B' ' 240' ' ' GLY . 39.6 mmtm -60.78 -47.46 86.23 Favored 'General case' 0 C--O 1.242 0.665 0 CA-C-O 121.29 0.567 . . . . 0.0 109.865 -178.87 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 245' ' ' TRP . . . . . . . . . . . . . 19.4 m0 -63.55 -41.05 98.45 Favored 'General case' 0 N--CA 1.437 -1.096 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.225 179.174 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 246' ' ' PHE . . . . . 0.524 ' HA ' ' HG2' ' B' ' 249' ' ' GLN . 3.6 t80 -68.14 -34.35 76.19 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.348 179.271 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -70.19 -35.35 73.89 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.699 -178.587 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.41 -21.73 22.89 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 120.357 -0.537 . . . . 0.0 111.789 -178.18 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 249' ' ' GLN . . . . . 0.524 ' HG2' ' HA ' ' B' ' 246' ' ' PHE . 13.5 pt20 -78.31 2.24 19.17 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.386 0.612 . . . . 0.0 110.402 -179.494 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 250' ' ' ASN . . . . . . . . . . . . . 20.4 p-10 -57.28 -31.93 66.1 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 114.892 -1.049 . . . . 0.0 112.864 178.917 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -77.18 142.66 39.53 Favored 'General case' 0 N--CA 1.433 -1.28 0 CA-C-O 121.986 0.898 . . . . 0.0 113.292 -176.768 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 252' ' ' ILE . . . . . . . . . . . . . 34.3 pt -130.67 -32.01 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 CA-C-N 114.487 -1.233 . . . . 0.0 113.078 -171.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -110.79 -23.05 11.25 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 121.624 0.726 . . . . 0.0 110.296 -175.65 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 254' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 . . . . . 0 C--N 1.295 -1.787 0 CA-C-N 114.038 -1.437 . . . . 0.0 114.117 -173.868 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.437 -1.081 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -100.31 145.23 28.38 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 -177.919 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 23.1 pt -141.06 159.81 23.12 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 CA-C-O 121.025 0.44 . . . . 0.0 110.953 175.691 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 45.0 t80 -109.42 122.49 47.49 Favored 'General case' 0 N--CA 1.421 -1.901 0 CA-C-N 114.485 -1.234 . . . . 0.0 108.206 177.533 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.411 HG23 ' CD1' ' A' ' 104' ' ' ILE . 8.2 mt -108.56 128.0 64.55 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.164 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 174.562 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -129.98 165.6 22.33 Favored Glycine 0 C--N 1.283 -2.415 0 N-CA-C 110.832 -0.907 . . . . 0.0 110.832 -179.571 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 71.13 35.16 1.67 Allowed 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.865 1.266 . . . . 0.0 110.667 -177.359 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.421 HD11 HD11 ' A' ' 47' ' ' ILE . 4.5 mm? -68.47 152.77 44.93 Favored 'General case' 0 CA--C 1.497 -1.085 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.25 176.928 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.445 ' HB3' ' HG ' ' A' ' 42' ' ' LEU . 39.7 t-20 -91.63 151.94 20.47 Favored 'General case' 0 C--N 1.29 -1.988 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 176.55 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -64.16 -17.21 63.27 Favored 'General case' 0 C--N 1.307 -1.253 0 C-N-CA 122.997 0.519 . . . . 0.0 111.734 179.837 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -97.27 3.55 51.26 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.107 -178.565 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.445 ' HG ' ' HB3' ' A' ' 39' ' ' ASN . 86.3 mt -98.46 117.33 32.64 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-O 121.589 0.709 . . . . 0.0 111.029 -179.128 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 68.2 p -107.23 174.74 5.76 Favored 'General case' 0 C--N 1.293 -1.866 0 CA-C-N 114.346 -1.297 . . . . 0.0 109.186 -179.635 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -54.46 -41.34 69.35 Favored 'General case' 0 C--O 1.209 -1.032 0 C-N-CA 123.19 0.596 . . . . 0.0 110.158 178.391 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.27 -39.47 96.08 Favored Glycine 0 CA--C 1.526 0.742 0 O-C-N 123.26 0.35 . . . . 0.0 112.901 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -66.8 -48.02 70.27 Favored 'General case' 0 CA--C 1.499 -1.004 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 179.81 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.421 HD11 HD11 ' A' ' 38' ' ' LEU . 42.0 mt -60.26 -46.36 94.92 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.782 0 CA-C-N 114.844 -1.071 . . . . 0.0 110.762 178.453 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 52.3 mt -59.77 -38.59 82.27 Favored 'General case' 0 CA--C 1.486 -1.502 0 C-N-CA 122.86 0.464 . . . . 0.0 111.525 -177.678 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.465 HG23 ' H ' ' B' ' 233' ' ' ASP . 62.1 m -64.38 -46.79 81.83 Favored 'General case' 0 N--CA 1.433 -1.281 0 O-C-N 123.615 0.572 . . . . 0.0 110.716 -179.115 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 89.6 t -67.72 -47.91 78.0 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.624 -179.581 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.464 ' HA ' ' HD2' ' A' ' 54' ' ' TYR . 3.7 m-85 -65.02 -25.07 67.69 Favored 'General case' 0 N--CA 1.435 -1.196 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.881 -177.145 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 59.8 m -67.59 -22.17 65.38 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.239 -0.437 . . . . 0.0 112.031 176.325 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -64.91 -28.94 69.88 Favored 'General case' 0 CA--C 1.559 1.322 0 CA-C-O 121.485 0.66 . . . . 0.0 109.917 175.729 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.464 ' HD2' ' HA ' ' A' ' 51' ' ' PHE . 49.1 m-85 -91.3 -18.24 24.65 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-O 121.24 0.543 . . . . 0.0 112.097 -175.204 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 165.19 -160.49 33.83 Favored Glycine 0 N--CA 1.419 -2.457 0 N-CA-C 111.011 -0.836 . . . . 0.0 111.011 179.484 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 62.2 t -100.2 110.8 60.92 Favored Pre-proline 0 C--N 1.294 -1.833 0 N-CA-C 110.347 -0.242 . . . . 0.0 110.347 -178.832 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.51 ' HB3' HD21 ' A' ' 77' ' ' LEU . 73.2 Cg_endo -76.05 141.07 23.33 Favored 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 122.645 2.23 . . . . 0.0 109.764 175.075 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 33.7 m -119.9 -13.57 9.1 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 C-N-CA 120.117 -0.633 . . . . 0.0 112.188 -179.275 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.496 ' HB3' ' HG2' ' A' ' 78' ' ' LYS . 33.2 t70 -164.09 136.85 5.07 Favored 'General case' 0 CA--C 1.501 -0.911 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.219 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 13.0 p -144.72 133.36 17.83 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 O-C-N 123.729 0.643 . . . . 0.0 110.01 -179.172 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 94.1 mt -121.9 128.98 75.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 176.019 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -99.36 117.28 33.45 Favored 'General case' 0 N--CA 1.419 -1.99 0 N-CA-C 105.364 -2.088 . . . . 0.0 105.364 173.394 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 62.8 m -78.61 117.82 20.14 Favored 'General case' 0 C--N 1.275 -2.655 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 176.131 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 85.8 mtt180 . . . . . 0 C--N 1.304 -1.394 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 -175.401 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 13.4 mm-40 . . . . . 0 CA--C 1.504 -0.815 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 87.21 4.23 81.44 Favored Glycine 0 N--CA 1.433 -1.514 0 C-N-CA 120.221 -0.99 . . . . 0.0 112.344 -179.393 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 31.5 p90 -142.1 155.34 45.35 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 177.509 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -149.75 171.84 16.07 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-O 120.94 0.4 . . . . 0.0 110.88 -179.375 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -130.3 140.85 50.63 Favored 'General case' 0 C--N 1.31 -1.118 0 C-N-CA 123.854 0.861 . . . . 0.0 109.963 -178.76 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.51 HD21 ' HB3' ' A' ' 57' ' ' PRO . 9.8 tt -149.94 140.55 22.55 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 175.532 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.496 ' HG2' ' HB3' ' A' ' 59' ' ' ASP . 16.9 ptmt -125.05 144.56 50.34 Favored 'General case' 0 N--CA 1.433 -1.276 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 177.781 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 61.3 m-85 -104.48 164.94 11.39 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-O 121.614 0.721 . . . . 0.0 112.321 -177.74 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -75.86 -30.74 59.0 Favored 'General case' 0 N--CA 1.437 -1.089 0 CA-C-N 114.33 -1.304 . . . . 0.0 109.4 175.671 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -122.01 133.22 54.81 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 -179.593 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -70.06 -19.93 63.26 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 114.254 1.205 . . . . 0.0 114.254 -177.805 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 88.4 mtm180 -65.8 -33.21 75.33 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-O 122.299 1.047 . . . . 0.0 109.863 174.135 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.502 ' OG ' HG21 ' B' ' 226' ' ' ILE . 66.2 m -63.27 -36.77 84.78 Favored 'General case' 0 C--N 1.288 -2.101 0 CA-C-N 114.985 -1.007 . . . . 0.0 112.947 178.852 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.447 ' O ' HG23 ' A' ' 89' ' ' VAL . 77.2 p -64.2 -45.54 87.85 Favored 'General case' 0 C--O 1.224 -0.25 0 C-N-CA 120.229 -0.588 . . . . 0.0 110.779 -177.554 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 5.2 pt -64.94 -38.86 83.85 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.309 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.837 177.77 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.462 HD12 ' HA ' ' A' ' 84' ' ' SER . 6.4 mt -58.55 -43.53 89.32 Favored 'General case' 0 CA--C 1.505 -0.779 0 O-C-N 123.812 0.695 . . . . 0.0 110.668 177.719 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.472 ' O ' ' HB2' ' A' ' 92' ' ' LEU . . . -71.97 -43.76 64.65 Favored 'General case' 0 N--CA 1.42 -1.933 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.708 179.536 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.469 HG22 HG22 ' A' ' 104' ' ' ILE . 79.3 t -58.85 -49.04 84.35 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.751 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -71.18 -27.8 63.79 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -172.488 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -96.58 -25.62 15.54 Favored 'General case' 0 C--N 1.296 -1.759 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.761 -177.367 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.472 ' HB2' ' O ' ' A' ' 88' ' ' ALA . 12.1 mt -95.33 -22.66 17.61 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 122.052 -0.405 . . . . 0.0 111.471 -178.049 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -65.21 124.93 23.46 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 177.361 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 81.79 -0.99 87.59 Favored Glycine 0 C--O 1.243 0.666 0 C-N-CA 120.882 -0.675 . . . . 0.0 113.143 177.564 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 62.0 t80 -85.35 144.1 28.25 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 -178.719 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 11.8 mptt -99.88 118.78 37.05 Favored 'General case' 0 N--CA 1.44 -0.955 0 CA-C-O 121.336 0.589 . . . . 0.0 112.512 -176.396 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 58.6 mt -127.59 141.46 46.32 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.188 0 N-CA-C 105.842 -1.91 . . . . 0.0 105.842 173.723 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 61.1 20.06 57.66 Favored Glycine 0 CA--C 1.519 0.312 0 C-N-CA 121.143 -0.551 . . . . 0.0 112.373 -177.406 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 78.13 7.49 87.65 Favored Glycine 0 N--CA 1.436 -1.362 0 CA-C-N 115.834 -0.183 . . . . 0.0 113.217 -178.011 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 16.7 ptp180 -124.78 147.95 48.4 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 117.534 0.667 . . . . 0.0 110.405 -179.555 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -87.7 116.32 25.75 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 116.585 -0.28 . . . . 0.0 111.587 -175.631 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 12.7 mt -65.84 144.62 56.72 Favored 'General case' 0 C--O 1.252 1.186 0 CA-C-O 121.875 0.845 . . . . 0.0 113.103 179.679 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 29.2 tptp -118.72 115.47 24.55 Favored 'General case' 0 N--CA 1.416 -2.148 0 CA-C-N 114.806 -1.088 . . . . 0.0 108.216 176.076 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.469 HG22 HG22 ' A' ' 89' ' ' VAL . 4.7 mm -114.69 134.46 57.61 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.966 0 N-CA-C 105.859 -1.904 . . . . 0.0 105.859 178.328 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -143.12 151.99 41.32 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -176.138 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 56.2 m-70 -83.34 130.48 35.06 Favored 'General case' 0 C--N 1.295 -1.804 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 177.492 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 7.3 t -147.28 163.42 36.45 Favored 'General case' 0 C--N 1.291 -1.973 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 -178.936 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 46.5 m-85 -110.13 111.03 22.11 Favored 'General case' 0 N--CA 1.42 -1.96 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 171.913 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 63.7 t80 . . . . . 0 C--N 1.294 -1.819 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.783 -176.41 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' 226' ' ' ILE . . . . . 0.502 HG21 ' OG ' ' A' ' 84' ' ' SER . 4.0 mp . . . . . 0 N--CA 1.437 -1.087 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 227' ' ' MET . . . . . . . . . . . . . 65.8 mtt -61.92 134.2 94.13 Favored Pre-proline 0 C--N 1.322 -0.626 0 O-C-N 123.466 0.479 . . . . 0.0 111.516 -179.161 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 228' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -72.34 140.28 33.36 Favored 'Trans proline' 0 C--O 1.251 1.138 0 C-N-CA 123.13 2.554 . . . . 0.0 112.703 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . -65.65 164.01 39.16 Favored Glycine 0 C--N 1.317 -0.526 0 CA-C-N 115.573 -0.739 . . . . 0.0 113.372 -179.528 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 14.6 m -72.06 -18.08 61.96 Favored 'General case' 0 C--N 1.31 -1.149 0 C-N-CA 123.331 0.652 . . . . 0.0 112.375 -175.172 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 13.6 mmm180 -82.06 -3.45 54.67 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.92 0.391 . . . . 0.0 111.146 -177.733 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 232' ' ' TRP . . . . . . . . . . . . . 24.9 t90 -72.04 123.52 22.97 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-O 122.405 1.097 . . . . 0.0 111.502 179.639 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 233' ' ' ASP . . . . . 0.465 ' H ' HG23 ' A' ' 49' ' ' THR . 8.4 t70 -113.14 144.48 42.59 Favored 'General case' 0 C--N 1.276 -2.617 0 N-CA-C 101.095 -3.669 . . . . 0.0 101.095 171.819 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.059 0 C-N-CA 127.361 2.41 . . . . 0.0 115.836 -178.795 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' 240' ' ' GLY . . . . . 0.52 ' O ' ' HG2' ' B' ' 244' ' ' LYS . . . . . . . . 0 N--CA 1.423 -2.199 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 20.8 p90 -76.27 -38.12 56.63 Favored 'General case' 0 C--N 1.293 -1.868 0 C-N-CA 123.768 0.827 . . . . 0.0 112.318 179.684 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -60.71 -42.78 97.93 Favored 'General case' 0 C--O 1.243 0.741 0 C-N-CA 122.353 0.261 . . . . 0.0 111.281 -177.886 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -62.0 -34.99 77.2 Favored 'General case' 0 C--O 1.211 -0.935 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.476 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 244' ' ' LYS . . . . . 0.52 ' HG2' ' O ' ' B' ' 240' ' ' GLY . 43.9 mmtm -64.45 -47.85 77.52 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-O 121.133 0.492 . . . . 0.0 110.523 -177.718 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 245' ' ' TRP . . . . . . . . . . . . . 13.6 m0 -65.8 -39.12 90.6 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.225 178.701 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 246' ' ' PHE . . . . . 0.504 ' O ' ' HG2' ' B' ' 249' ' ' GLN . 2.7 t80 -64.97 -37.12 86.61 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.634 178.181 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -68.49 -35.42 77.5 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.591 -179.536 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.33 -16.71 28.67 Favored 'General case' 0 CA--C 1.509 -0.6 0 N-CA-C 111.887 0.329 . . . . 0.0 111.887 -177.782 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 249' ' ' GLN . . . . . 0.504 ' HG2' ' O ' ' B' ' 246' ' ' PHE . 11.8 pt20 -81.07 2.8 25.64 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-O 120.839 0.352 . . . . 0.0 110.456 -179.299 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 250' ' ' ASN . . . . . 0.436 ' OD1' ' HG3' ' B' ' 251' ' ' GLU . 7.9 p30 -52.37 -39.69 61.09 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.514 178.915 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 251' ' ' GLU . . . . . 0.436 ' HG3' ' OD1' ' B' ' 250' ' ' ASN . 46.2 mt-10 -133.66 121.36 21.88 Favored 'General case' 0 N--CA 1.435 -1.205 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 174.43 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 252' ' ' ILE . . . . . . . . . . . . . 38.1 pt -96.91 -34.34 4.91 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -174.844 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -100.46 -17.76 17.02 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-O 121.969 0.89 . . . . 0.0 109.58 -178.471 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 254' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.293 -1.88 0 CA-C-N 114.35 -1.295 . . . . 0.0 108.409 179.637 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.491 ' HA ' HG21 ' A' ' 85' ' ' THR . . . . . . . . 0 CA--C 1.503 -0.847 0 CA-C-O 120.869 0.366 . . . . 0.0 110.322 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 57.5 m-85 -102.13 144.49 30.62 Favored 'General case' 0 N--CA 1.429 -1.496 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 -178.978 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 27.5 pt -143.24 162.55 16.85 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 CA-C-O 121.458 0.646 . . . . 0.0 110.869 -179.741 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.414 ' HB2' HG21 ' A' ' 107' ' ' THR . 8.2 t80 -114.45 125.88 54.33 Favored 'General case' 0 N--CA 1.412 -2.359 0 CA-C-N 114.085 -1.416 . . . . 0.0 108.123 175.963 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 10.2 mt -108.51 127.53 64.85 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.998 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 176.848 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -125.68 164.2 19.35 Favored Glycine 0 C--N 1.279 -2.596 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 -179.663 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 66.9 m-20 71.46 45.0 0.49 Allowed 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 125.346 1.458 . . . . 0.0 110.219 -177.648 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.483 HD11 HD11 ' A' ' 47' ' ' ILE . 4.2 mm? -76.21 144.63 40.31 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.281 177.08 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.436 ' HB3' ' HG ' ' A' ' 42' ' ' LEU . 42.8 t-20 -83.88 147.23 27.64 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 176.827 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.513 ' HD2' ' C ' ' A' ' 40' ' ' ARG . 6.6 ppt_? -59.2 -22.02 60.36 Favored 'General case' 0 C--N 1.311 -1.068 0 C-N-CA 123.78 0.832 . . . . 0.0 111.921 -179.73 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.422 ' N ' ' HD2' ' A' ' 40' ' ' ARG . 12.9 pt-20 -92.8 -10.99 34.9 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.818 -176.207 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.436 ' HG ' ' HB3' ' A' ' 39' ' ' ASN . 71.6 mt -79.86 132.5 36.12 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.214 0.531 . . . . 0.0 111.504 -176.973 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 35.1 p -119.86 173.73 6.87 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 114.852 -1.067 . . . . 0.0 110.44 -178.317 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 -55.35 -39.31 69.88 Favored 'General case' 0 C--O 1.221 -0.417 0 C-N-CA 123.2 0.6 . . . . 0.0 111.05 179.33 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.95 -38.58 95.69 Favored Glycine 0 N--CA 1.448 -0.559 0 CA-C-N 116.013 -0.54 . . . . 0.0 112.597 -179.663 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.408 ' O ' HG23 ' A' ' 50' ' ' VAL . 21.8 m-20 -67.08 -49.51 64.8 Favored 'General case' 0 CA--C 1.492 -1.273 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.483 HD11 HD11 ' A' ' 38' ' ' LEU . 37.7 mt -60.43 -47.12 93.89 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.931 0 CA-C-N 114.791 -1.095 . . . . 0.0 110.78 -179.246 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 36.7 mt -59.68 -42.36 92.78 Favored 'General case' 0 CA--C 1.494 -1.179 0 CA-C-N 116.572 -0.285 . . . . 0.0 111.714 -176.926 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.419 HG23 ' H ' ' B' ' 233' ' ' ASP . 68.8 m -65.66 -46.02 80.73 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 123.541 0.526 . . . . 0.0 111.649 -178.235 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.408 HG23 ' O ' ' A' ' 46' ' ' ASP . 58.4 t -67.69 -45.74 84.12 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-O 121.42 0.629 . . . . 0.0 110.39 -178.127 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.414 ' HA ' ' HD2' ' A' ' 54' ' ' TYR . 4.5 m-85 -64.63 -25.3 67.9 Favored 'General case' 0 N--CA 1.431 -1.387 0 CA-C-N 115.082 -0.963 . . . . 0.0 111.921 -179.452 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.57 ' OG ' ' HB2' ' B' ' 231' ' ' ARG . 66.9 m -70.23 -19.43 63.14 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 176.923 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -72.54 -20.9 61.26 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-O 121.669 0.747 . . . . 0.0 109.68 176.209 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.438 ' CE1' ' HB2' ' A' ' 91' ' ' ASN . 60.1 m-85 -94.65 -19.98 19.97 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.853 -178.663 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.436 ' O ' ' HA ' ' A' ' 52' ' ' SER . . . 167.17 -152.91 22.06 Favored Glycine 0 N--CA 1.424 -2.139 0 C-N-CA 120.741 -0.742 . . . . 0.0 111.403 179.017 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 87.7 t -105.58 110.57 64.38 Favored Pre-proline 0 C--N 1.295 -1.766 0 N-CA-C 110.307 -0.257 . . . . 0.0 110.307 -177.848 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.526 ' HB3' HD21 ' A' ' 77' ' ' LEU . 73.9 Cg_endo -78.24 135.99 14.01 Favored 'Trans proline' 0 N--CA 1.44 -1.65 0 C-N-CA 121.846 1.697 . . . . 0.0 109.2 174.685 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 35.8 m -113.18 -19.95 6.51 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 C-N-CA 119.726 -0.789 . . . . 0.0 111.57 -177.33 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.501 ' HB3' ' HG2' ' A' ' 78' ' ' LYS . 36.1 t70 -159.34 140.68 12.95 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 179.801 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 13.1 p -143.67 136.31 23.99 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 O-C-N 123.793 0.683 . . . . 0.0 109.868 -179.722 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 99.1 mt -122.37 125.82 73.32 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 C-N-CA 123.112 0.565 . . . . 0.0 109.503 173.19 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -98.71 118.64 35.9 Favored 'General case' 0 N--CA 1.419 -1.998 0 N-CA-C 104.963 -2.236 . . . . 0.0 104.963 173.252 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 17.8 m -81.03 116.52 21.02 Favored 'General case' 0 N--CA 1.408 -2.561 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 179.349 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 64.8 mtm180 . . . . . 0 C--N 1.299 -1.614 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 -178.132 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 . . . . . 0 N--CA 1.442 -0.84 0 CA-C-O 121.345 0.593 . . . . 0.0 110.446 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 95.54 11.69 55.1 Favored Glycine 0 N--CA 1.421 -2.335 0 CA-C-N 115.494 -0.775 . . . . 0.0 112.604 179.078 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 33.0 p90 -152.43 157.52 41.33 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 177.936 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -153.25 172.64 16.67 Favored 'General case' 0 N--CA 1.427 -1.583 0 O-C-N 123.509 0.506 . . . . 0.0 110.2 179.31 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -132.15 144.62 50.81 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 123.761 0.825 . . . . 0.0 110.053 -178.428 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.526 HD21 ' HB3' ' A' ' 57' ' ' PRO . 9.9 tt -153.78 140.72 19.23 Favored 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 175.634 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.501 ' HG2' ' HB3' ' A' ' 59' ' ' ASP . 18.8 ptmt -123.91 144.1 49.97 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 177.578 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.409 ' CD1' HG22 ' A' ' 85' ' ' THR . 39.9 m-85 -102.5 165.04 11.32 Favored 'General case' 0 C--N 1.29 -2.013 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.611 -178.348 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -73.48 -35.32 65.66 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 114.702 -1.136 . . . . 0.0 109.133 175.402 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -124.78 137.59 54.31 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.806 -178.045 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -70.19 -20.08 63.14 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -179.49 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 80.8 mtm180 -65.08 -34.55 78.68 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 122.219 1.009 . . . . 0.0 109.478 174.948 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.462 ' OG ' HG21 ' B' ' 226' ' ' ILE . 60.3 m -67.43 -37.41 82.97 Favored 'General case' 0 C--N 1.292 -1.92 0 CA-C-N 114.821 -1.082 . . . . 0.0 112.185 178.369 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.491 HG21 ' HA ' ' A' ' 31' ' ' ALA . 71.1 p -65.45 -45.12 85.02 Favored 'General case' 0 C--O 1.217 -0.635 0 C-N-CA 120.249 -0.58 . . . . 0.0 110.685 -177.792 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 3.7 pt -63.26 -39.2 84.36 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.317 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.075 177.409 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 30.0 mt -59.79 -43.24 94.5 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 123.44 0.463 . . . . 0.0 110.911 174.959 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -68.99 -46.5 67.9 Favored 'General case' 0 C--O 1.203 -1.374 0 CA-C-N 115.712 -0.677 . . . . 0.0 110.928 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.49 HG23 ' O ' ' A' ' 85' ' ' THR . 85.9 t -58.88 -48.93 84.78 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.062 0 CA-C-O 120.712 0.291 . . . . 0.0 110.954 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -67.36 -29.77 69.39 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 -174.759 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.438 ' HB2' ' CE1' ' A' ' 54' ' ' TYR . 90.6 m-20 -97.98 -21.02 17.06 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 113.684 0.994 . . . . 0.0 113.684 -178.885 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 14.0 mt -98.92 -31.42 11.84 Favored 'General case' 0 CA--C 1.495 -1.172 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -176.948 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 52.6 t30 -66.39 124.98 24.21 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 85.21 -1.81 88.48 Favored Glycine 0 C--N 1.306 -1.128 0 C-N-CA 121.411 -0.423 . . . . 0.0 112.909 -179.151 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 64.1 t80 -90.09 137.85 32.0 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 179.468 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.421 ' HA ' ' HA ' ' A' ' 101' ' ' ALA . 0.4 OUTLIER -93.38 119.5 32.57 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-O 120.914 0.388 . . . . 0.0 111.712 -177.213 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 35.4 mt -118.35 142.45 33.01 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 173.78 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 71.58 -84.67 0.44 Allowed Glycine 0 N--CA 1.438 -1.195 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 -174.257 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -161.99 17.72 0.16 Allowed Glycine 0 N--CA 1.427 -1.955 0 N-CA-C 110.199 -1.161 . . . . 0.0 110.199 175.268 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 16.6 ptp180 -137.23 149.79 47.41 Favored 'General case' 0 N--CA 1.445 -0.719 0 O-C-N 122.798 -0.236 . . . . 0.0 110.532 -175.974 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.421 ' HA ' ' HA ' ' A' ' 96' ' ' LYS . . . -87.36 122.97 31.82 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.789 -177.832 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 14.8 mt -66.92 148.24 52.2 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-O 121.745 0.783 . . . . 0.0 112.923 179.013 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 54.3 tptt -121.94 116.47 24.42 Favored 'General case' 0 N--CA 1.418 -2.025 0 CA-C-N 114.911 -1.04 . . . . 0.0 108.824 175.131 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 3.9 mm -116.39 136.09 54.51 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.868 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -143.81 150.57 38.73 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 178.139 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 74.4 m-70 -83.34 137.8 33.81 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 178.057 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.414 HG21 ' HB2' ' A' ' 34' ' ' TYR . 9.0 t -158.62 155.38 28.12 Favored 'General case' 0 C--N 1.291 -1.959 0 N-CA-C 106.247 -1.76 . . . . 0.0 106.247 -177.215 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -93.82 111.83 23.59 Favored 'General case' 0 N--CA 1.435 -1.2 0 C-N-CA 117.571 -1.651 . . . . 0.0 108.057 172.76 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 30.5 t80 . . . . . 0 C--N 1.294 -1.845 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.676 -179.653 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' 226' ' ' ILE . . . . . 0.462 HG21 ' OG ' ' A' ' 84' ' ' SER . 4.3 mp . . . . . 0 C--O 1.245 0.855 0 CA-C-O 120.658 0.266 . . . . 0.0 110.295 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 227' ' ' MET . . . . . . . . . . . . . 90.5 mmm -66.81 137.95 95.09 Favored Pre-proline 0 C--N 1.321 -0.656 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.561 177.156 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 228' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -66.25 157.18 61.31 Favored 'Trans proline' 0 C--O 1.248 0.975 0 C-N-CA 122.938 2.425 . . . . 0.0 113.183 -178.217 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . -73.36 170.34 52.43 Favored Glycine 0 N--CA 1.439 -1.127 0 CA-C-N 115.412 -0.813 . . . . 0.0 112.237 179.474 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 20.9 m -77.44 -18.24 57.37 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-O 121.101 0.477 . . . . 0.0 111.23 -177.882 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 231' ' ' ARG . . . . . 0.57 ' HB2' ' OG ' ' A' ' 52' ' ' SER . 37.9 mmt180 -79.64 -8.16 59.03 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.583 -178.908 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 232' ' ' TRP . . . . . . . . . . . . . 21.6 t90 -73.54 122.96 23.04 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-O 122.279 1.038 . . . . 0.0 113.05 -176.078 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 233' ' ' ASP . . . . . 0.419 ' H ' HG23 ' A' ' 49' ' ' THR . 12.2 t70 -120.47 137.52 54.3 Favored 'General case' 0 C--N 1.276 -2.622 0 N-CA-C 100.773 -3.788 . . . . 0.0 100.773 172.918 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.513 3.833 0 C-N-CA 128.979 3.18 . . . . 0.0 118.257 -175.674 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' 240' ' ' GLY . . . . . 0.445 ' O ' ' HG2' ' B' ' 244' ' ' LYS . . . . . . . . 0 C--O 1.198 -2.098 0 N-CA-C 110.88 -0.888 . . . . 0.0 110.88 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 39.9 p90 -77.26 -34.18 55.83 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-O 120.932 0.396 . . . . 0.0 111.694 177.859 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -62.79 -41.65 99.36 Favored 'General case' 0 C--O 1.243 0.74 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.459 -174.911 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -62.98 -35.29 79.69 Favored 'General case' 0 C--O 1.21 -1.002 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.581 -178.664 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 244' ' ' LYS . . . . . 0.445 ' HG2' ' O ' ' B' ' 240' ' ' GLY . 69.8 mmtt -65.95 -42.99 89.28 Favored 'General case' 0 N--CA 1.439 -1.021 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 -177.381 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 245' ' ' TRP . . . . . . . . . . . . . 46.1 m0 -65.44 -41.99 92.87 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.695 178.182 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 246' ' ' PHE . . . . . 0.486 ' O ' ' HG2' ' B' ' 249' ' ' GLN . 3.0 t80 -66.53 -30.23 70.5 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 121.803 0.811 . . . . 0.0 110.949 178.975 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -77.44 -39.39 46.99 Favored 'General case' 0 C--N 1.295 -1.786 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.384 178.809 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.83 -15.33 39.5 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.083 0.468 . . . . 0.0 111.793 -175.117 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 249' ' ' GLN . . . . . 0.486 ' HG2' ' O ' ' B' ' 246' ' ' PHE . 13.3 pt20 -71.46 1.77 5.94 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.804 -179.169 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 250' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -65.34 -29.2 69.91 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 176.014 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -78.29 112.18 15.02 Favored 'General case' 0 N--CA 1.426 -1.642 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 176.4 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 252' ' ' ILE . . . . . . . . . . . . . 29.4 pt -103.51 -34.23 3.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.812 -172.164 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -100.67 -15.52 17.71 Favored 'General case' 0 CA--C 1.497 -1.077 0 CA-C-O 122.224 1.011 . . . . 0.0 108.668 179.757 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 254' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 . . . . . 0 N--CA 1.417 -2.097 0 CA-C-N 113.843 -1.526 . . . . 0.0 110.493 177.415 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.512 -0.508 0 N-CA-C 110.415 -0.217 . . . . 0.0 110.415 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 16.9 m-85 -111.9 145.01 40.29 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 -175.013 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 28.3 pt -138.65 157.03 29.78 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.172 176.731 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 56.7 t80 -106.72 121.7 44.89 Favored 'General case' 0 N--CA 1.41 -2.429 0 CA-C-N 114.619 -1.173 . . . . 0.0 107.978 177.712 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.407 HG23 ' CD1' ' A' ' 104' ' ' ILE . 10.8 mt -108.38 128.03 64.26 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.18 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 175.567 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -130.25 173.35 19.99 Favored Glycine 0 C--N 1.28 -2.583 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 179.599 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 69.98 31.03 3.47 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.312 0.645 . . . . 0.0 111.16 -178.647 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -68.55 155.14 40.54 Favored 'General case' 0 CA--C 1.503 -0.85 0 CA-C-O 121.955 0.883 . . . . 0.0 112.231 178.919 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.523 ' HB3' ' HG ' ' A' ' 42' ' ' LEU . 54.5 t-20 -95.38 146.52 24.33 Favored 'General case' 0 C--N 1.288 -2.104 0 N-CA-C 105.955 -1.868 . . . . 0.0 105.955 174.541 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.478 ' HD2' ' C ' ' A' ' 40' ' ' ARG . 7.2 ppt_? -61.83 -23.01 65.98 Favored 'General case' 0 C--N 1.298 -1.654 0 C-N-CA 123.396 0.678 . . . . 0.0 111.435 179.087 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.465 ' HG2' ' CG ' ' A' ' 39' ' ' ASN . 12.7 pt-20 -88.9 -1.18 57.97 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-O 120.857 0.361 . . . . 0.0 111.33 -178.657 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.523 ' HG ' ' HB3' ' A' ' 39' ' ' ASN . 87.3 mt -91.48 124.63 35.79 Favored 'General case' 0 N--CA 1.432 -1.353 0 CA-C-O 121.618 0.723 . . . . 0.0 110.464 179.792 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 68.0 p -113.66 174.57 5.86 Favored 'General case' 0 C--N 1.286 -2.168 0 CA-C-N 114.213 -1.358 . . . . 0.0 108.82 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.3 mp0 -55.29 -41.4 72.24 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 123.423 0.689 . . . . 0.0 110.739 -179.553 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -61.54 -38.35 95.66 Favored Glycine 0 C--O 1.241 0.557 0 CA-C-N 116.168 -0.469 . . . . 0.0 113.207 -179.127 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -67.4 -48.44 67.34 Favored 'General case' 0 CA--C 1.503 -0.853 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 51.4 mt -59.08 -44.77 92.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 CA-C-N 114.595 -1.184 . . . . 0.0 110.788 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 48.2 mt -59.36 -45.47 91.31 Favored 'General case' 0 CA--C 1.502 -0.891 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.538 -178.394 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.448 HG23 ' H ' ' B' ' 233' ' ' ASP . 98.0 m -62.11 -45.83 91.73 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -179.839 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 98.7 t -65.39 -49.19 79.91 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 CA-C-O 121.246 0.545 . . . . 0.0 110.41 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.469 ' HD2' ' HH ' ' A' ' 79' ' ' TYR . 5.3 m-85 -66.17 -24.04 66.57 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 123.885 0.874 . . . . 0.0 113.04 -178.121 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.454 ' OG ' ' HB2' ' B' ' 231' ' ' ARG . 63.0 m -70.59 -17.91 62.9 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 177.072 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -68.56 -25.12 64.74 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 119.683 -0.807 . . . . 0.0 109.285 176.493 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.468 ' HD2' ' HA ' ' A' ' 51' ' ' PHE . 64.5 m-85 -92.6 -15.96 26.23 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.114 -175.575 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.407 ' O ' ' HA ' ' A' ' 52' ' ' SER . . . 160.9 -158.61 30.2 Favored Glycine 0 N--CA 1.421 -2.353 0 C-N-CA 120.501 -0.857 . . . . 0.0 111.132 -179.556 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 57.5 t -102.26 111.02 64.0 Favored Pre-proline 0 C--N 1.302 -1.485 0 N-CA-C 111.798 0.296 . . . . 0.0 111.798 -175.995 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.5 ' HB3' HD21 ' A' ' 77' ' ' LEU . 87.1 Cg_endo -79.05 140.12 15.62 Favored 'Trans proline' 0 N--CA 1.449 -1.131 0 C-N-CA 122.96 2.44 . . . . 0.0 110.354 175.243 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 26.9 m -114.85 -21.95 5.04 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 C-N-CA 120.102 -0.639 . . . . 0.0 111.95 179.607 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.409 ' HB3' ' HG2' ' A' ' 78' ' ' LYS . 17.6 t70 -158.43 145.02 17.38 Favored 'General case' 0 C--O 1.247 0.944 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 -179.752 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 13.1 p -146.18 133.02 14.43 Favored 'Isoleucine or valine' 0 C--O 1.245 0.819 0 CA-C-O 121.5 0.667 . . . . 0.0 110.356 179.779 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 95.5 mt -121.06 126.98 75.82 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 177.647 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -99.55 122.04 42.05 Favored 'General case' 0 C--N 1.292 -1.902 0 N-CA-C 105.469 -2.049 . . . . 0.0 105.469 175.314 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 7.0 t -85.04 123.56 30.72 Favored 'General case' 0 N--CA 1.418 -2.062 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 179.198 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 73.4 mtt85 . . . . . 0 C--N 1.295 -1.777 0 CA-C-O 120.901 0.381 . . . . 0.0 111.038 -179.368 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 17.1 mm-40 . . . . . 0 CA--C 1.511 -0.546 0 CA-C-O 121.108 0.48 . . . . 0.0 110.303 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 92.54 5.59 64.89 Favored Glycine 0 N--CA 1.425 -2.058 0 C-N-CA 120.594 -0.813 . . . . 0.0 111.651 -178.767 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 31.4 p90 -143.56 152.79 41.86 Favored 'General case' 0 N--CA 1.435 -1.181 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 178.56 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -148.12 171.97 15.03 Favored 'General case' 0 N--CA 1.427 -1.606 0 O-C-N 123.362 0.414 . . . . 0.0 110.165 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -130.37 139.99 50.62 Favored 'General case' 0 C--N 1.298 -1.655 0 C-N-CA 124.024 0.929 . . . . 0.0 109.952 -178.5 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.5 HD21 ' HB3' ' A' ' 57' ' ' PRO . 10.3 tt -146.93 140.85 25.95 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 175.739 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.409 ' HG2' ' HB3' ' A' ' 59' ' ' ASP . 21.7 ptmt -125.04 144.3 50.47 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 178.905 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.469 ' HH ' ' HD2' ' A' ' 51' ' ' PHE . 55.8 m-85 -108.49 164.59 12.21 Favored 'General case' 0 C--N 1.29 -2.013 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.614 -179.875 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -79.0 -35.49 42.78 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 174.165 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -106.49 123.73 48.53 Favored 'General case' 0 N--CA 1.439 -0.999 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 -177.451 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -69.47 -19.3 63.76 Favored 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 113.391 0.886 . . . . 0.0 113.391 -178.518 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 90.6 mtm180 -66.19 -33.24 75.31 Favored 'General case' 0 C--N 1.302 -1.5 0 CA-C-O 121.914 0.864 . . . . 0.0 109.261 173.895 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 56.9 m -65.33 -37.15 86.23 Favored 'General case' 0 N--CA 1.426 -1.639 0 CA-C-N 115.29 -0.868 . . . . 0.0 112.43 178.909 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.49 ' O ' HG23 ' A' ' 89' ' ' VAL . 64.9 p -62.73 -45.66 91.69 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 121.061 0.457 . . . . 0.0 110.741 -177.819 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 4.3 pt -66.17 -37.93 80.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.831 177.807 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 14.0 mt -59.41 -44.12 92.89 Favored 'General case' 0 CA--C 1.509 -0.62 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.641 175.26 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.485 ' HB1' HD12 ' A' ' 92' ' ' LEU . . . -70.16 -45.51 66.61 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.848 -178.313 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.49 HG23 ' O ' ' A' ' 85' ' ' THR . 87.7 t -56.55 -47.79 81.43 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.967 0 CA-C-O 121.43 0.634 . . . . 0.0 111.119 178.47 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -62.08 -33.74 74.98 Favored 'General case' 0 C--N 1.297 -1.695 0 C-N-CA 125.042 1.337 . . . . 0.0 112.722 -176.337 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.402 ' HB3' ' CE1' ' A' ' 54' ' ' TYR . 14.8 t-20 -98.44 -30.86 12.3 Favored 'General case' 0 C--N 1.293 -1.874 0 CA-C-N 116.145 -0.479 . . . . 0.0 112.232 -175.55 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.485 HD12 ' HB1' ' A' ' 88' ' ' ALA . 12.5 mt -93.8 -30.16 14.99 Favored 'General case' 0 CA--C 1.482 -1.648 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 -170.977 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 57.4 t30 -66.12 125.04 24.26 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 179.742 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 83.61 -0.69 89.48 Favored Glycine 0 CA--C 1.535 1.287 0 C-N-CA 120.424 -0.893 . . . . 0.0 112.502 -177.48 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 67.8 t80 -89.36 138.42 31.46 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -178.925 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.452 ' HA ' ' O ' ' A' ' 100' ' ' ARG . 0.3 OUTLIER -92.51 118.52 31.06 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 -175.824 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 55.0 mt -127.64 142.08 44.63 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.259 0 N-CA-C 106.193 -1.78 . . . . 0.0 106.193 172.814 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 58.47 21.88 50.18 Favored Glycine 0 CA--C 1.524 0.656 0 C-N-CA 121.63 -0.319 . . . . 0.0 113.514 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 87.25 10.75 70.66 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 121.647 -0.311 . . . . 0.0 113.483 179.07 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.452 ' O ' ' HA ' ' A' ' 96' ' ' LYS . 13.6 ptp180 -140.56 148.66 41.33 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 117.985 0.892 . . . . 0.0 111.889 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -82.83 118.02 23.12 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.956 -179.374 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 12.7 mt -65.88 149.56 50.0 Favored 'General case' 0 C--N 1.309 -1.189 0 C-N-CA 124.134 0.974 . . . . 0.0 113.611 178.666 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 55.3 tptt -116.09 120.16 38.15 Favored 'General case' 0 N--CA 1.423 -1.801 0 CA-C-N 114.964 -1.016 . . . . 0.0 108.734 174.678 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.448 HG22 HG22 ' A' ' 89' ' ' VAL . 4.8 mm -121.44 135.36 61.85 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 178.35 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -143.57 153.25 42.37 Favored 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 109.273 -0.639 . . . . 0.0 109.273 -179.412 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -83.54 137.7 33.74 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 177.645 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 12.3 t -155.16 156.48 35.81 Favored 'General case' 0 N--CA 1.425 -1.724 0 N-CA-C 107.929 -1.138 . . . . 0.0 107.929 -177.117 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 7.7 p90 -97.67 109.86 22.53 Favored 'General case' 0 N--CA 1.423 -1.808 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 168.637 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 29.1 t80 . . . . . 0 C--N 1.296 -1.746 0 CA-C-N 115.055 -0.975 . . . . 0.0 110.207 -178.175 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 3.7 mp . . . . . 0 C--O 1.24 0.562 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' 227' ' ' MET . . . . . . . . . . . . . 68.6 mtt -69.29 139.08 89.52 Favored Pre-proline 0 N--CA 1.452 -0.341 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.354 177.568 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 228' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -69.09 159.0 55.67 Favored 'Trans proline' 0 C--O 1.243 0.726 0 C-N-CA 122.739 2.293 . . . . 0.0 112.893 -178.485 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . -75.3 168.76 54.79 Favored Glycine 0 N--CA 1.441 -0.98 0 CA-C-N 115.442 -0.799 . . . . 0.0 112.749 -179.685 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 9.4 t -77.61 -14.44 59.64 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 121.293 0.568 . . . . 0.0 110.305 -177.511 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 231' ' ' ARG . . . . . 0.454 ' HB2' ' OG ' ' A' ' 52' ' ' SER . 37.2 mmt180 -86.75 -3.93 59.11 Favored 'General case' 0 C--N 1.321 -0.644 0 O-C-N 122.139 -0.351 . . . . 0.0 111.08 -179.178 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 232' ' ' TRP . . . . . . . . . . . . . 21.7 t90 -74.77 128.25 35.12 Favored 'General case' 0 CA--C 1.497 -1.064 0 CA-C-O 122.385 1.088 . . . . 0.0 111.7 -179.142 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 233' ' ' ASP . . . . . 0.448 ' H ' HG23 ' A' ' 49' ' ' THR . 37.3 t70 -124.42 147.42 48.29 Favored 'General case' 0 C--N 1.263 -3.158 0 N-CA-C 103.038 -2.949 . . . . 0.0 103.038 172.671 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.501 3.022 0 C-N-CA 128.702 3.049 . . . . 0.0 116.93 -178.993 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' 240' ' ' GLY . . . . . 0.613 ' O ' ' HG2' ' B' ' 243' ' ' GLU . . . . . . . . 0 C--O 1.194 -2.374 0 N-CA-C 111.309 -0.716 . . . . 0.0 111.309 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 17.7 p90 -55.76 -33.81 64.67 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -179.018 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -65.06 -40.9 95.38 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 111.885 0.328 . . . . 0.0 111.885 -176.768 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 243' ' ' GLU . . . . . 0.613 ' HG2' ' O ' ' B' ' 240' ' ' GLY . 11.4 pt-20 -66.31 -34.87 78.96 Favored 'General case' 0 C--O 1.207 -1.178 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 178.33 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 244' ' ' LYS . . . . . 0.583 ' HG2' ' O ' ' B' ' 240' ' ' GLY . 70.4 mmtt -66.0 -43.55 87.41 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 121.088 0.471 . . . . 0.0 110.555 -177.267 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 245' ' ' TRP . . . . . . . . . . . . . 46.7 m0 -63.94 -41.95 97.46 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.653 0.739 . . . . 0.0 109.358 178.536 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 246' ' ' PHE . . . . . 0.62 ' O ' ' HG2' ' B' ' 249' ' ' GLN . 1.7 t80 -68.46 -27.59 66.29 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 114.326 -1.306 . . . . 0.0 111.633 178.957 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -76.77 -39.64 50.98 Favored 'General case' 0 C--N 1.287 -2.12 0 O-C-N 121.907 -0.496 . . . . 0.0 111.597 -177.865 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 2.6 pptp? -85.89 -14.75 43.9 Favored 'General case' 0 CA--C 1.507 -0.675 0 C-N-CA 120.231 -0.588 . . . . 0.0 112.328 -173.943 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 249' ' ' GLN . . . . . 0.62 ' HG2' ' O ' ' B' ' 246' ' ' PHE . 13.8 pt20 -67.75 -0.6 4.25 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.755 -176.867 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 250' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -74.97 -20.78 59.52 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.975 177.941 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 27.0 mm-40 -64.83 146.49 54.81 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 115.136 -0.938 . . . . 0.0 113.193 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 252' ' ' ILE . . . . . . . . . . . . . 23.9 pt -97.71 -26.33 3.95 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 CA-C-N 115.045 -0.98 . . . . 0.0 111.118 177.179 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -85.22 -27.98 25.72 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 121.466 0.651 . . . . 0.0 109.696 178.19 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 254' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 . . . . . 0 N--CA 1.422 -1.868 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.703 176.909 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.487 ' HA ' HG21 ' A' ' 85' ' ' THR . . . . . . . . 0 N--CA 1.444 -0.734 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 -99.13 144.5 28.2 Favored 'General case' 0 C--N 1.315 -0.929 0 C-N-CA 120.309 -0.556 . . . . 0.0 109.866 -175.901 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 33.6 pt -138.14 157.04 31.49 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 CA-C-O 121.107 0.479 . . . . 0.0 110.616 178.096 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 38.9 t80 -107.74 121.07 43.97 Favored 'General case' 0 N--CA 1.417 -2.091 0 CA-C-N 114.728 -1.124 . . . . 0.0 108.444 178.469 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.427 HG23 ' CD1' ' A' ' 104' ' ' ILE . 9.9 mt -108.58 127.79 64.75 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.882 0 N-CA-C 106.714 -1.587 . . . . 0.0 106.714 175.694 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -130.5 163.7 23.14 Favored Glycine 0 C--N 1.284 -2.32 0 N-CA-C 111.232 -0.747 . . . . 0.0 111.232 -179.478 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 67.2 m-20 73.73 38.68 0.59 Allowed 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.743 1.617 . . . . 0.0 110.219 -178.593 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.435 HD11 HD11 ' A' ' 47' ' ' ILE . 4.2 mm? -68.69 144.69 54.35 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.451 -0.795 . . . . 0.0 112.29 178.819 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.469 HD22 ' HA3' ' A' ' 98' ' ' GLY . 41.4 t-20 -89.34 151.5 22.04 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 177.476 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.507 ' HD2' ' N ' ' A' ' 41' ' ' GLU . 5.3 ppt_? -59.56 -26.42 65.36 Favored 'General case' 0 C--N 1.31 -1.135 0 C-N-CA 123.103 0.561 . . . . 0.0 111.828 177.745 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.507 ' N ' ' HD2' ' A' ' 40' ' ' ARG . 10.4 pt-20 -89.55 0.89 56.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.897 -177.655 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 80.8 mt -97.32 111.87 23.93 Favored 'General case' 0 CA--C 1.494 -1.177 0 CA-C-O 121.59 0.709 . . . . 0.0 111.211 -178.551 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 82.2 p -103.51 174.53 5.83 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-N 114.344 -1.298 . . . . 0.0 109.451 -178.59 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.498 ' HG3' ' HB2' ' A' ' 62' ' ' LEU . 2.0 mp0 -54.62 -40.66 69.16 Favored 'General case' 0 C--O 1.216 -0.676 0 C-N-CA 123.599 0.76 . . . . 0.0 109.586 177.738 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -59.48 -41.63 97.23 Favored Glycine 0 N--CA 1.445 -0.75 0 O-C-N 123.659 0.6 . . . . 0.0 113.163 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -66.69 -49.13 67.09 Favored 'General case' 0 CA--C 1.497 -1.071 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 -179.689 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.435 HD11 HD11 ' A' ' 38' ' ' LEU . 52.6 mt -58.37 -45.88 89.42 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.926 0 CA-C-N 114.992 -1.003 . . . . 0.0 110.493 179.735 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 35.0 mt -60.55 -45.71 92.87 Favored 'General case' 0 CA--C 1.5 -0.963 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 -177.365 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.491 HG23 ' H ' ' B' ' 233' ' ' ASP . 80.2 m -62.92 -45.59 91.78 Favored 'General case' 0 N--CA 1.439 -1.016 0 O-C-N 123.308 0.38 . . . . 0.0 111.563 179.313 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 77.4 t -65.79 -47.18 86.66 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.157 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.036 -179.156 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.444 ' HA ' ' HD2' ' A' ' 54' ' ' TYR . 3.8 m-85 -67.43 -22.95 65.49 Favored 'General case' 0 N--CA 1.429 -1.496 0 C-N-CA 123.624 0.77 . . . . 0.0 112.144 -178.924 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.408 ' OG ' ' HB2' ' B' ' 231' ' ' ARG . 68.3 m -69.13 -16.92 63.77 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.937 175.941 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -67.02 -26.63 66.87 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-O 121.246 0.546 . . . . 0.0 109.659 175.206 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.444 ' HD2' ' HA ' ' A' ' 51' ' ' PHE . 54.4 m-85 -95.73 -15.19 22.78 Favored 'General case' 0 CA--C 1.505 -0.784 0 CA-C-O 121.245 0.545 . . . . 0.0 112.392 -173.222 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 160.1 -152.19 22.96 Favored Glycine 0 N--CA 1.413 -2.849 0 N-CA-C 110.245 -1.142 . . . . 0.0 110.245 -179.616 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 65.3 t -104.74 109.21 62.7 Favored Pre-proline 0 C--N 1.288 -2.068 0 O-C-N 123.554 0.208 . . . . 0.0 110.466 -176.701 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.548 ' HB3' HD21 ' A' ' 77' ' ' LEU . 73.2 Cg_endo -77.57 135.58 14.74 Favored 'Trans proline' 0 N--CA 1.435 -1.966 0 C-N-CA 121.525 1.483 . . . . 0.0 108.595 174.259 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.422 ' CG2' ' HG3' ' A' ' 78' ' ' LYS . 35.2 m -109.85 -23.21 4.58 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 C-N-CA 119.309 -0.956 . . . . 0.0 111.81 -177.753 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.44 ' HB3' ' HG2' ' A' ' 78' ' ' LYS . 25.8 t70 -158.68 142.94 15.67 Favored 'General case' 0 CA--C 1.503 -0.836 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 14.6 p -140.79 135.12 33.72 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 178.807 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 86.4 mt -120.72 123.06 69.5 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.311 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 176.242 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.498 ' HB2' ' HG3' ' A' ' 44' ' ' GLU . 0.1 OUTLIER -98.61 119.64 37.69 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 177.298 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 28.3 m -83.91 116.79 22.95 Favored 'General case' 0 N--CA 1.404 -2.772 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 176.235 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 58.9 mtt180 . . . . . 0 C--N 1.304 -1.374 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 -175.625 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 . . . . . 0 CA--C 1.506 -0.721 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 94.8 8.35 59.38 Favored Glycine 0 N--CA 1.427 -1.962 0 CA-C-N 114.96 -1.018 . . . . 0.0 112.472 178.582 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 37.2 p90 -150.09 154.99 39.05 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 179.258 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -150.1 170.47 18.83 Favored 'General case' 0 N--CA 1.427 -1.595 0 CA-C-O 120.925 0.393 . . . . 0.0 110.264 178.874 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -128.9 142.2 51.03 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.404 -179.021 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.548 HD21 ' HB3' ' A' ' 57' ' ' PRO . 9.8 tt -148.99 140.9 23.72 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 175.696 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.44 ' HG2' ' HB3' ' A' ' 59' ' ' ASP . 20.8 ptmt -122.66 144.02 49.41 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 178.665 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 45.8 m-85 -104.65 164.88 11.44 Favored 'General case' 0 C--N 1.29 -1.992 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.575 -179.233 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -71.15 -37.49 72.26 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 114.824 -1.08 . . . . 0.0 108.607 175.062 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -125.28 143.63 50.87 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.298 0.57 . . . . 0.0 111.74 -179.019 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.454 ' NE2' ' HB2' ' A' ' 31' ' ' ALA . 20.8 mp0 -69.93 -24.0 63.29 Favored 'General case' 0 C--N 1.312 -1.061 0 C-N-CA 124.91 1.284 . . . . 0.0 112.94 -177.964 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 56.1 mtm180 -67.88 -34.63 77.04 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-O 122.083 0.944 . . . . 0.0 109.592 175.804 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.455 ' OG ' HG21 ' B' ' 226' ' ' ILE . 48.6 m -66.04 -37.71 86.55 Favored 'General case' 0 C--N 1.286 -2.177 0 CA-C-N 114.808 -1.087 . . . . 0.0 111.619 175.798 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.512 ' O ' HG23 ' A' ' 89' ' ' VAL . 71.6 p -66.02 -45.33 81.87 Favored 'General case' 0 C--O 1.221 -0.402 0 C-N-CA 120.134 -0.626 . . . . 0.0 110.52 -178.058 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 8.3 pt -64.79 -37.39 80.03 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 C-N-CA 122.481 0.312 . . . . 0.0 111.111 177.521 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 9.7 mt -58.51 -44.08 89.35 Favored 'General case' 0 CA--C 1.504 -0.822 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.203 175.034 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.432 ' O ' ' HB2' ' A' ' 92' ' ' LEU . . . -71.56 -46.67 58.78 Favored 'General case' 0 N--CA 1.434 -1.269 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.953 -179.27 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.512 HG23 ' O ' ' A' ' 85' ' ' THR . 86.5 t -56.79 -49.9 76.83 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.201 0 CA-C-O 120.844 0.354 . . . . 0.0 111.429 -178.375 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -73.53 -28.65 62.0 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 112.751 0.649 . . . . 0.0 112.751 -173.127 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 -87.76 -31.79 19.46 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-O 121.011 0.434 . . . . 0.0 110.572 -177.485 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.432 ' HB2' ' O ' ' A' ' 88' ' ' ALA . 10.0 mt -94.26 -30.32 14.62 Favored 'General case' 0 CA--C 1.501 -0.922 0 CA-C-N 116.03 -0.532 . . . . 0.0 112.386 -173.703 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 46.1 t30 -65.74 125.24 24.68 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 179.09 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 88.47 -7.73 80.91 Favored Glycine 0 N--CA 1.436 -1.35 0 CA-C-N 115.599 -0.728 . . . . 0.0 112.268 -178.048 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -81.94 138.96 34.88 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 -178.124 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.524 ' HE3' ' HB2' ' A' ' 101' ' ' ALA . 11.7 mptt -99.2 125.12 44.72 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-O 121.14 0.495 . . . . 0.0 111.68 -177.295 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 58.7 mt -127.69 141.39 46.51 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 N-CA-C 105.761 -1.94 . . . . 0.0 105.761 173.972 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.469 ' HA3' HD22 ' A' ' 39' ' ' ASN . . . 64.17 7.42 24.65 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 121.12 -0.562 . . . . 0.0 114.311 179.173 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 97.22 0.13 59.93 Favored Glycine 0 N--CA 1.436 -1.312 0 C-N-CA 121.118 -0.563 . . . . 0.0 112.492 -176.97 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 17.3 ptp180 -124.29 151.56 44.09 Favored 'General case' 0 C--N 1.317 -0.806 0 O-C-N 122.233 -0.569 . . . . 0.0 110.997 -179.493 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.524 ' HB2' ' HE3' ' A' ' 96' ' ' LYS . . . -89.73 120.03 30.65 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.513 -176.351 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 11.7 mt -68.7 145.15 54.11 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-O 121.71 0.766 . . . . 0.0 112.343 177.685 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.41 ' HE3' ' HB2' ' A' ' 105' ' ' ASP . 50.1 tptt -120.96 116.66 25.53 Favored 'General case' 0 N--CA 1.417 -2.106 0 CA-C-N 114.822 -1.081 . . . . 0.0 109.184 176.348 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.427 ' CD1' HG23 ' A' ' 35' ' ' ILE . 4.7 mm -119.37 134.31 63.38 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 179.574 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.41 ' HB2' ' HE3' ' A' ' 103' ' ' LYS . 27.5 t70 -144.89 157.74 44.05 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 177.417 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 2.8 m80 -81.96 131.63 35.25 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-O 121.236 0.541 . . . . 0.0 112.122 177.019 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 13.3 t -146.35 162.86 37.25 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 -177.718 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -110.25 110.91 21.91 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 107.046 -1.465 . . . . 0.0 107.046 171.057 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 74.4 t80 . . . . . 0 C--N 1.294 -1.827 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.228 -179.063 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B ' 226' ' ' ILE . . . . . 0.455 HG21 ' OG ' ' A' ' 84' ' ' SER . 4.1 mp . . . . . 0 C--O 1.251 1.156 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 227' ' ' MET . . . . . . . . . . . . . 65.9 mtt -69.22 137.64 89.25 Favored Pre-proline 0 C--N 1.311 -1.077 0 O-C-N 123.706 0.629 . . . . 0.0 110.135 179.717 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 228' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -67.43 154.03 75.0 Favored 'Trans proline' 0 C--O 1.248 1.023 0 C-N-CA 122.787 2.324 . . . . 0.0 112.269 179.606 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . -73.11 168.98 53.4 Favored Glycine 0 C--N 1.314 -0.668 0 CA-C-N 115.558 -0.747 . . . . 0.0 112.879 -179.65 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 23.4 m -76.67 -13.93 60.01 Favored 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 123.236 0.614 . . . . 0.0 112.157 -175.543 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 231' ' ' ARG . . . . . 0.408 ' HB2' ' OG ' ' A' ' 52' ' ' SER . 19.7 mmt180 -87.16 -0.05 56.08 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.954 0.406 . . . . 0.0 110.095 -178.313 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 232' ' ' TRP . . . . . . . . . . . . . 21.0 t90 -77.63 126.47 30.93 Favored 'General case' 0 N--CA 1.433 -1.3 0 CA-C-O 122.428 1.109 . . . . 0.0 112.392 -176.399 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 233' ' ' ASP . . . . . 0.491 ' H ' HG23 ' A' ' 49' ' ' THR . 26.1 t70 -121.84 144.3 48.91 Favored 'General case' 0 C--N 1.264 -3.117 0 N-CA-C 101.829 -3.397 . . . . 0.0 101.829 171.775 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.05 0 C-N-CA 128.065 2.745 . . . . 0.0 116.113 -178.976 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B ' 240' ' ' GLY . . . . . 0.536 ' O ' ' HG2' ' B' ' 244' ' ' LYS . . . . . . . . 0 C--O 1.199 -2.077 0 N-CA-C 110.456 -1.058 . . . . 0.0 110.456 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 51.1 p90 -64.42 -34.01 77.2 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 -176.825 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -63.8 -42.44 97.72 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 112.003 0.371 . . . . 0.0 112.003 -174.4 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 243' ' ' GLU . . . . . 0.494 ' HG2' ' O ' ' B' ' 240' ' ' GLY . 11.1 pt-20 -63.13 -34.7 78.19 Favored 'General case' 0 C--O 1.208 -1.08 0 N-CA-C 110.466 -0.198 . . . . 0.0 110.466 178.325 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 244' ' ' LYS . . . . . 0.536 ' HG2' ' O ' ' B' ' 240' ' ' GLY . 68.8 mmtt -67.72 -44.58 77.32 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 -179.046 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 245' ' ' TRP . . . . . . . . . . . . . 50.9 m0 -62.55 -41.52 98.95 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.725 178.036 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 246' ' ' PHE . . . . . 0.514 ' O ' ' HG2' ' B' ' 249' ' ' GLN . 5.1 t80 -65.53 -36.25 83.26 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.902 177.793 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -71.69 -35.67 70.34 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.206 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.19 -15.34 36.27 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 120.991 0.424 . . . . 0.0 111.704 -178.67 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 249' ' ' GLN . . . . . 0.514 ' HG2' ' O ' ' B' ' 246' ' ' PHE . 11.8 pt20 -81.53 2.96 26.69 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-O 120.982 0.42 . . . . 0.0 110.326 179.5 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 250' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -54.01 -27.83 34.33 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.911 177.767 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 251' ' ' GLU . . . . . 0.648 ' HB3' ' HB2' ' B' ' 254' ' ' GLU . 45.5 mt-10 -80.58 110.52 16.13 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 176.039 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 252' ' ' ILE . . . . . 0.645 HD13 ' H ' ' B' ' 252' ' ' ILE . 0.2 OUTLIER -112.72 -33.98 2.2 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 CA-C-N 115.843 -0.617 . . . . 0.0 112.165 -173.475 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -118.89 -6.26 10.55 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 -178.099 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 254' ' ' GLU . . . . . 0.648 ' HB2' ' HB3' ' B' ' 251' ' ' GLU . 16.8 mp0 . . . . . 0 C--N 1.294 -1.829 0 CA-C-N 112.549 -2.114 . . . . 0.0 111.957 -179.177 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.589 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 11.3 m-30 -93.24 144.95 24.81 Favored 'General case' 0 C--N 1.309 -1.183 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.524 -176.603 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 21.4 pt -142.81 165.84 15.76 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.981 0 C-N-CA 123.291 0.636 . . . . 0.0 110.152 175.265 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.532 ' HB2' HG21 ' A' ' 107' ' ' THR . 54.7 t80 -116.2 126.4 53.59 Favored 'General case' 0 N--CA 1.413 -2.28 0 CA-C-N 114.776 -1.102 . . . . 0.0 109.114 178.217 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.453 HG23 ' CD1' ' A' ' 104' ' ' ILE . 9.1 mt -110.74 127.98 67.42 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.016 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 175.601 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -127.65 165.61 20.66 Favored Glycine 0 C--N 1.281 -2.494 0 N-CA-C 111.346 -0.701 . . . . 0.0 111.346 -178.486 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 66.39 41.52 3.26 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.708 1.203 . . . . 0.0 110.824 -176.506 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.477 HD11 HD11 ' A' ' 47' ' ' ILE . 4.1 mm? -68.56 146.57 52.97 Favored 'General case' 0 CA--C 1.496 -1.122 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.489 177.375 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.472 ' ND2' ' HA3' ' A' ' 98' ' ' GLY . 61.1 t30 -89.84 147.84 23.54 Favored 'General case' 0 C--N 1.291 -1.945 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 178.889 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.474 ' HD2' ' C ' ' A' ' 40' ' ' ARG . 2.3 ppt_? -58.87 -21.75 57.8 Favored 'General case' 0 C--N 1.318 -0.772 0 O-C-N 123.623 0.577 . . . . 0.0 112.494 -175.353 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.41 ' HG2' ' ND2' ' A' ' 39' ' ' ASN . 13.4 pt-20 -99.86 -1.01 38.54 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.383 -175.908 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.435 HD12 ' H ' ' A' ' 39' ' ' ASN . 81.3 mt -87.71 118.54 27.28 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-O 121.33 0.586 . . . . 0.0 110.459 178.992 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 77.0 p -105.31 174.09 6.03 Favored 'General case' 0 C--N 1.291 -1.943 0 CA-C-N 114.816 -1.084 . . . . 0.0 108.864 -178.983 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.519 ' CG ' ' HB2' ' A' ' 62' ' ' LEU . 70.2 mt-10 -56.38 -37.67 70.41 Favored 'General case' 0 C--O 1.216 -0.67 0 N-CA-C 109.954 -0.388 . . . . 0.0 109.954 177.598 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -61.62 -37.46 94.25 Favored Glycine 0 N--CA 1.445 -0.758 0 CA-C-N 115.722 -0.672 . . . . 0.0 113.113 179.529 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -67.26 -49.02 65.98 Favored 'General case' 0 CA--C 1.488 -1.432 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.279 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.477 HD11 HD11 ' A' ' 38' ' ' LEU . 46.7 mt -59.17 -45.67 92.62 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.14 0 CA-C-N 114.557 -1.202 . . . . 0.0 110.597 179.129 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.433 ' HG ' HG11 ' A' ' 60' ' ' VAL . 42.8 mt -59.65 -43.53 93.88 Favored 'General case' 0 CA--C 1.489 -1.369 0 C-N-CA 122.249 0.22 . . . . 0.0 111.137 -178.702 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.494 HG23 ' H ' ' B' ' 233' ' ' ASP . 72.3 m -63.26 -46.6 86.09 Favored 'General case' 0 C--N 1.309 -1.157 0 O-C-N 123.531 0.519 . . . . 0.0 111.137 -178.594 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 93.5 t -67.55 -46.89 82.18 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.702 -178.805 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.435 ' HA ' ' HD2' ' A' ' 54' ' ' TYR . 4.0 m-85 -68.54 -20.09 64.53 Favored 'General case' 0 N--CA 1.424 -1.751 0 CA-C-N 115.141 -0.936 . . . . 0.0 112.537 -177.861 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.43 ' CB ' ' HB2' ' B' ' 232' ' ' TRP . 59.1 m -71.1 -22.44 62.09 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 176.179 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -73.27 -20.69 60.77 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 119.164 -1.015 . . . . 0.0 109.97 176.233 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.435 ' HD2' ' HA ' ' A' ' 51' ' ' PHE . 62.0 m-85 -92.97 -11.01 34.32 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-O 121.232 0.539 . . . . 0.0 111.865 -179.208 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.417 ' O ' ' HA ' ' A' ' 52' ' ' SER . . . 156.96 -164.04 32.57 Favored Glycine 0 N--CA 1.424 -2.108 0 N-CA-C 110.954 -0.858 . . . . 0.0 110.954 179.091 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 80.9 t -96.31 109.75 49.04 Favored Pre-proline 0 C--N 1.299 -1.623 0 N-CA-C 110.078 -0.342 . . . . 0.0 110.078 -179.301 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.505 ' HB3' HD21 ' A' ' 77' ' ' LEU . 86.9 Cg_endo -79.41 136.87 12.8 Favored 'Trans proline' 0 N--CA 1.443 -1.442 0 C-N-CA 122.461 2.108 . . . . 0.0 109.301 176.14 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 33.8 m -110.84 -24.11 4.14 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 C-N-CA 119.2 -1.0 . . . . 0.0 111.67 -178.922 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.51 ' HB3' ' HG2' ' A' ' 78' ' ' LYS . 27.4 t70 -155.03 142.29 19.45 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -179.467 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.433 HG11 ' HG ' ' A' ' 48' ' ' LEU . 14.4 p -143.58 136.94 24.85 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 179.411 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 90.8 mt -121.88 121.17 63.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 175.08 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.519 ' HB2' ' CG ' ' A' ' 44' ' ' GLU . 0.2 OUTLIER -95.89 116.82 29.49 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 106.245 -1.761 . . . . 0.0 106.245 172.544 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 44.3 m -77.21 116.32 17.74 Favored 'General case' 0 N--CA 1.419 -1.998 0 N-CA-C 107.37 -1.345 . . . . 0.0 107.37 176.2 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 21.1 mtp180 . . . . . 0 C--N 1.307 -1.28 0 CA-C-O 120.819 0.342 . . . . 0.0 110.332 -175.854 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 18.3 mm-40 . . . . . 0 CA--C 1.504 -0.818 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 94.73 12.76 55.25 Favored Glycine 0 N--CA 1.427 -1.962 0 C-N-CA 120.44 -0.886 . . . . 0.0 112.164 -177.416 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 33.4 p90 -151.59 153.32 34.27 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 176.397 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -150.11 175.71 11.49 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-O 120.836 0.351 . . . . 0.0 110.818 -179.44 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -136.5 144.12 44.15 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 123.576 0.75 . . . . 0.0 110.003 -177.979 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.505 HD21 ' HB3' ' A' ' 57' ' ' PRO . 10.2 tt -150.38 141.59 23.17 Favored 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 176.065 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.51 ' HG2' ' HB3' ' A' ' 59' ' ' ASP . 22.0 ptmt -124.03 144.34 49.89 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-O 121.294 0.569 . . . . 0.0 109.516 178.584 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -107.6 165.92 11.06 Favored 'General case' 0 C--N 1.286 -2.177 0 CA-C-N 115.406 -0.815 . . . . 0.0 111.683 -178.019 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -75.32 -29.05 59.9 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 115.002 -0.999 . . . . 0.0 108.77 172.536 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -119.63 136.72 54.27 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 -176.787 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 19.8 mp0 -69.77 -27.61 65.07 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.467 ' O ' HG12 ' A' ' 86' ' ' ILE . 90.0 mtm180 -65.61 -33.85 76.87 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 122.301 1.048 . . . . 0.0 110.032 179.0 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.45 ' OG ' HG21 ' B' ' 226' ' ' ILE . 51.6 m -58.53 -37.14 75.02 Favored 'General case' 0 C--N 1.281 -2.379 0 CA-C-N 114.781 -1.1 . . . . 0.0 111.734 176.237 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.462 ' O ' HG23 ' A' ' 89' ' ' VAL . 43.9 p -63.33 -45.07 92.95 Favored 'General case' 0 C--N 1.347 0.487 0 C-N-CA 120.452 -0.499 . . . . 0.0 110.731 -178.482 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.467 HG12 ' O ' ' A' ' 83' ' ' ARG . 4.1 pt -66.64 -38.15 81.01 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.508 178.894 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 13.6 mt -59.4 -44.25 92.84 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 123.38 0.425 . . . . 0.0 111.28 175.437 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -71.74 -46.42 58.57 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.212 -178.586 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 85' ' ' THR . 69.6 t -56.93 -44.09 81.78 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.104 0 CA-C-O 121.297 0.57 . . . . 0.0 111.09 178.981 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -63.69 -41.53 98.13 Favored 'General case' 0 C--N 1.29 -1.996 0 C-N-CA 123.291 0.637 . . . . 0.0 112.239 -176.064 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 40.0 m-80 -90.28 -29.73 17.96 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-N 115.632 -0.713 . . . . 0.0 112.869 -173.944 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 15.2 mt -93.37 -31.18 14.74 Favored 'General case' 0 CA--C 1.486 -1.502 0 N-CA-C 112.257 0.466 . . . . 0.0 112.257 -172.631 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.417 ' OD1' ' HD2' ' A' ' 103' ' ' LYS . 56.9 t30 -66.32 124.6 23.13 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.039 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 89.19 -2.59 83.76 Favored Glycine 0 C--N 1.308 -1.004 0 C-N-CA 121.33 -0.462 . . . . 0.0 112.269 -178.895 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 37.2 t80 -89.23 134.98 33.82 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 -179.096 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.448 ' HA ' ' O ' ' A' ' 100' ' ' ARG . 12.1 mptt -95.42 116.38 28.72 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-O 120.914 0.388 . . . . 0.0 111.826 -177.67 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 60.6 mt -119.3 141.45 39.23 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 N-CA-C 104.946 -2.242 . . . . 0.0 104.946 172.856 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.472 ' HA3' ' ND2' ' A' ' 39' ' ' ASN . . . 58.19 28.02 60.92 Favored Glycine 0 C--N 1.317 -0.496 0 C-N-CA 121.331 -0.461 . . . . 0.0 112.646 -178.775 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 79.99 -5.84 61.19 Favored Glycine 0 CA--C 1.529 0.907 0 CA-C-O 119.933 -0.37 . . . . 0.0 113.863 -179.447 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.448 ' O ' ' HA ' ' A' ' 96' ' ' LYS . 16.6 ptp180 -116.43 149.71 39.0 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 117.721 0.76 . . . . 0.0 111.198 -176.311 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -88.44 117.2 27.2 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.537 -175.646 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.423 HD23 ' HA ' ' A' ' 102' ' ' LEU . 10.4 mt -65.71 136.07 55.78 Favored 'General case' 0 CA--C 1.494 -1.191 0 CA-C-O 121.491 0.663 . . . . 0.0 111.961 178.503 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.417 ' HD2' ' OD1' ' A' ' 93' ' ' ASN . 27.4 tptp -113.6 116.29 29.26 Favored 'General case' 0 N--CA 1.41 -2.45 0 CA-C-N 115.218 -0.901 . . . . 0.0 108.633 176.885 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.453 ' CD1' HG23 ' A' ' 35' ' ' ILE . 5.3 mm -111.02 142.32 23.75 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.192 0 N-CA-C 106.265 -1.754 . . . . 0.0 106.265 177.858 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -144.6 151.66 39.36 Favored 'General case' 0 C--N 1.29 -1.995 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 178.564 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 69.7 m-70 -83.42 130.53 35.04 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 175.998 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.532 HG21 ' HB2' ' A' ' 34' ' ' TYR . 6.2 t -153.79 165.19 36.79 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 -177.839 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -107.6 112.28 24.93 Favored 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 105.604 -1.999 . . . . 0.0 105.604 168.214 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 25.8 t80 . . . . . 0 C--N 1.295 -1.769 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 -175.943 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' B' B ' 226' ' ' ILE . . . . . 0.45 HG21 ' OG ' ' A' ' 84' ' ' SER . 3.9 mp . . . . . 0 N--CA 1.433 -1.32 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 227' ' ' MET . . . . . . . . . . . . . 67.5 mtt -70.24 133.55 87.47 Favored Pre-proline 0 C--N 1.309 -1.162 0 O-C-N 123.427 0.454 . . . . 0.0 110.306 178.523 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 228' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -68.05 154.36 72.77 Favored 'Trans proline' 0 C--O 1.245 0.851 0 C-N-CA 122.785 2.323 . . . . 0.0 112.272 -179.836 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . -72.44 168.2 52.85 Favored Glycine 0 N--CA 1.44 -1.04 0 CA-C-N 115.557 -0.747 . . . . 0.0 113.035 -179.731 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 5.0 p -77.44 -23.52 50.51 Favored 'General case' 0 C--N 1.298 -1.646 0 C-N-CA 123.431 0.692 . . . . 0.0 112.354 -177.889 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 1.8 mmp_? -79.33 1.88 23.5 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.729 -176.127 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 232' ' ' TRP . . . . . 0.43 ' HB2' ' CB ' ' A' ' 52' ' ' SER . 24.4 t90 -79.33 123.37 27.41 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 122.031 0.919 . . . . 0.0 111.908 -178.83 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 233' ' ' ASP . . . . . 0.494 ' H ' HG23 ' A' ' 49' ' ' THR . 12.8 t70 -113.2 149.35 33.83 Favored 'General case' 0 C--N 1.284 -2.271 0 N-CA-C 102.645 -3.094 . . . . 0.0 102.645 172.948 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.331 0 C-N-CA 127.53 2.49 . . . . 0.0 115.884 -178.101 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' B' B ' 240' ' ' GLY . . . . . 0.606 ' O ' ' HG2' ' B' ' 244' ' ' LYS . . . . . . . . 0 C--O 1.191 -2.546 0 N-CA-C 112.083 -0.407 . . . . 0.0 112.083 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -61.89 -33.08 73.56 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 116.914 0.357 . . . . 0.0 111.618 -179.815 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -60.34 -44.88 95.11 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.307 -175.799 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 243' ' ' GLU . . . . . 0.473 ' HG2' ' O ' ' B' ' 240' ' ' GLY . 9.8 pt-20 -67.59 -35.46 79.03 Favored 'General case' 0 C--O 1.201 -1.472 0 C-N-CA 120.799 -0.36 . . . . 0.0 110.543 179.532 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 244' ' ' LYS . . . . . 0.606 ' HG2' ' O ' ' B' ' 240' ' ' GLY . 67.7 mmtt -68.1 -42.15 80.73 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-O 121.004 0.431 . . . . 0.0 110.408 -176.497 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 245' ' ' TRP . . . . . . . . . . . . . 50.9 m0 -63.39 -43.04 98.72 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 178.545 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 246' ' ' PHE . . . . . 0.425 ' O ' ' HG2' ' B' ' 249' ' ' GLN . 5.5 t80 -67.14 -33.21 74.94 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 114.866 -1.061 . . . . 0.0 110.869 178.237 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -77.21 -21.4 53.92 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.98 -177.412 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.33 -30.04 13.64 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 119.934 -0.706 . . . . 0.0 110.806 179.255 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 249' ' ' GLN . . . . . 0.425 ' HG2' ' O ' ' B' ' 246' ' ' PHE . 13.6 pt20 -68.52 -12.19 60.9 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.074 -176.889 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 250' ' ' ASN . . . . . . . . . . . . . 20.6 p-10 -57.39 -30.13 64.65 Favored 'General case' 0 N--CA 1.482 1.153 0 CA-C-N 115.538 -0.755 . . . . 0.0 112.093 177.968 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -117.39 166.85 11.83 Favored 'General case' 0 N--CA 1.414 -2.261 0 CA-C-N 115.412 -0.813 . . . . 0.0 112.836 -175.826 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 252' ' ' ILE . . . . . . . . . . . . . 32.3 pt -126.26 -27.66 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 CA-C-N 113.879 -1.51 . . . . 0.0 109.8 176.898 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -125.99 -34.0 2.62 Favored 'General case' 0 C--O 1.221 -0.397 0 N-CA-C 113.356 0.872 . . . . 0.0 113.356 -175.908 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 254' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 . . . . . 0 C--N 1.309 -1.153 0 N-CA-C 113.963 1.098 . . . . 0.0 113.963 -179.097 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 50.8 t-20 . . . . . 0 C--O 1.234 0.288 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -86.35 -30.89 21.85 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-O 121.426 0.631 . . . . 0.0 111.222 -177.295 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 33.7 m-85 -88.23 66.9 8.62 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-O 123.348 1.547 . . . . 0.0 112.287 -177.478 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 30.1 mmmt -121.72 169.98 10.19 Favored 'General case' 0 C--N 1.277 -2.575 0 CA-C-N 112.303 -2.226 . . . . 0.0 107.352 174.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -98.86 23.24 9.09 Favored 'General case' 0 C--N 1.292 -1.898 0 CA-C-O 122.407 1.099 . . . . 0.0 109.326 -178.604 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -83.87 9.43 12.1 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 114.204 -1.362 . . . . 0.0 109.106 178.016 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.512 ' HB2' ' NE2' ' A' ' 82' ' ' GLN . . . -98.05 0.92 47.1 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.284 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -108.9 145.67 35.01 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 115.056 -0.974 . . . . 0.0 109.049 -173.305 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 26.7 pt -142.57 163.1 18.14 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 CA-C-O 121.408 0.623 . . . . 0.0 111.045 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.424 ' HB2' HG21 ' A' ' 107' ' ' THR . 17.7 t80 -114.52 127.07 55.61 Favored 'General case' 0 N--CA 1.415 -2.188 0 CA-C-N 114.383 -1.281 . . . . 0.0 108.787 176.778 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.485 HG23 ' CD1' ' A' ' 104' ' ' ILE . 9.5 mt -110.09 127.79 66.75 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.795 0 N-CA-C 107.335 -1.358 . . . . 0.0 107.335 177.613 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -127.43 165.69 20.45 Favored Glycine 0 C--N 1.284 -2.314 0 N-CA-C 110.607 -0.997 . . . . 0.0 110.607 179.455 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 71.7 m-20 72.18 40.58 0.69 Allowed 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.742 1.217 . . . . 0.0 110.038 -178.716 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.521 HD11 HD11 ' A' ' 47' ' ' ILE . 3.9 mm? -72.71 144.84 47.53 Favored 'General case' 0 CA--C 1.495 -1.153 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.551 178.804 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.461 ' HB3' ' HG ' ' A' ' 42' ' ' LEU . 42.0 t-20 -83.13 146.09 28.85 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 106.549 -1.649 . . . . 0.0 106.549 176.673 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.525 ' HD2' ' N ' ' A' ' 41' ' ' GLU . 5.8 ppt_? -60.76 -19.22 58.74 Favored 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 123.3 0.64 . . . . 0.0 112.051 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.525 ' N ' ' HD2' ' A' ' 40' ' ' ARG . 8.9 pt-20 -99.99 5.66 45.13 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.965 -178.046 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.461 ' HG ' ' HB3' ' A' ' 39' ' ' ASN . 71.1 mt -96.51 126.22 41.54 Favored 'General case' 0 C--N 1.309 -1.179 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.701 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 12.5 t -117.67 175.84 5.46 Favored 'General case' 0 N--CA 1.428 -1.53 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.18 -179.31 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.421 ' CG ' ' HB2' ' A' ' 62' ' ' LEU . 42.1 mt-10 -54.39 -39.62 67.41 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 123.743 0.817 . . . . 0.0 111.401 -176.014 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.87 -37.73 94.21 Favored Glycine 0 CA--C 1.521 0.417 0 C-N-CA 121.317 -0.468 . . . . 0.0 113.402 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -67.12 -49.17 65.84 Favored 'General case' 0 CA--C 1.499 -0.995 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.521 HD11 HD11 ' A' ' 38' ' ' LEU . 38.6 mt -61.01 -45.3 98.83 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.902 0 CA-C-N 114.861 -1.063 . . . . 0.0 110.854 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 38.1 mt -60.07 -45.75 91.86 Favored 'General case' 0 CA--C 1.494 -1.186 0 N-CA-C 111.676 0.25 . . . . 0.0 111.676 -176.552 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.479 HG23 ' H ' ' B' ' 233' ' ' ASP . 100.0 m -62.77 -45.59 91.99 Favored 'General case' 0 C--N 1.307 -1.263 0 O-C-N 123.551 0.532 . . . . 0.0 111.913 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.652 HG13 ' HG3' ' B' ' 237' ' ' ARG . 54.6 t -66.13 -49.12 78.66 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.633 -179.794 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.462 ' HA ' ' HD2' ' A' ' 54' ' ' TYR . 3.7 m-85 -65.21 -23.03 66.97 Favored 'General case' 0 N--CA 1.425 -1.697 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.409 -178.124 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.491 ' OG ' ' HB2' ' B' ' 231' ' ' ARG . 58.7 m -69.35 -22.03 63.78 Favored 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 177.099 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.43 ' HG2' ' O ' ' A' ' 50' ' ' VAL . 7.8 pt-20 -73.52 -20.21 60.72 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 117.642 -1.623 . . . . 0.0 110.4 177.326 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.462 ' HD2' ' HA ' ' A' ' 51' ' ' PHE . 48.0 m-85 -92.36 -10.3 38.69 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-O 121.225 0.536 . . . . 0.0 111.135 -178.327 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 157.21 -154.9 25.93 Favored Glycine 0 N--CA 1.422 -2.296 0 C-N-CA 120.323 -0.941 . . . . 0.0 111.721 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 87.2 t -104.52 111.14 65.15 Favored Pre-proline 0 C--N 1.3 -1.557 0 N-CA-C 111.245 0.091 . . . . 0.0 111.245 -177.468 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.481 ' HB3' HD21 ' A' ' 77' ' ' LEU . 95.6 Cg_endo -79.84 137.34 12.52 Favored 'Trans proline' 0 N--CA 1.449 -1.133 0 C-N-CA 122.652 2.234 . . . . 0.0 109.676 175.325 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 30.7 m -111.76 -33.56 2.25 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 C-N-CA 119.355 -0.938 . . . . 0.0 111.553 179.552 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.467 ' HB3' ' HG2' ' A' ' 78' ' ' LYS . 29.3 t70 -146.13 145.59 30.55 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 -179.793 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 14.5 p -143.65 135.33 23.04 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.482 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 99.3 mt -121.05 118.76 57.26 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 175.055 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.431 HD12 ' HG3' ' A' ' 64' ' ' ARG . 0.1 OUTLIER -98.1 114.4 26.57 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 106.014 -1.847 . . . . 0.0 106.014 174.781 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 43.7 m -76.85 116.59 17.66 Favored 'General case' 0 N--CA 1.404 -2.773 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 178.356 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.431 ' HG3' HD12 ' A' ' 62' ' ' LEU . 34.1 mtm180 -128.45 138.97 52.56 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-N 115.336 -0.847 . . . . 0.0 108.83 -176.552 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -79.92 125.91 30.33 Favored 'General case' 0 C--N 1.292 -1.926 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.453 -177.549 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -61.3 -24.52 66.48 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 -178.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 22.7 m-80 -81.68 -47.46 12.94 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-O 121.154 0.502 . . . . 0.0 110.662 -174.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 39.2 p -90.03 -24.16 21.27 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.986 -177.403 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.41 6.16 86.3 Favored Glycine 0 N--CA 1.439 -1.115 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.714 -177.428 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -111.88 163.93 13.66 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 110.346 -0.242 . . . . 0.0 110.346 -176.712 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 6.1 m -56.37 143.76 33.24 Favored 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 124.85 1.26 . . . . 0.0 111.419 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -87.84 10.93 16.95 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -177.72 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 84.71 8.95 82.07 Favored Glycine 0 C--N 1.308 -0.975 0 C-N-CA 120.926 -0.654 . . . . 0.0 113.569 179.579 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 36.7 p90 -154.98 157.79 38.21 Favored 'General case' 0 N--CA 1.436 -1.139 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 178.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -153.11 176.23 12.14 Favored 'General case' 0 N--CA 1.436 -1.143 0 O-C-N 123.556 0.535 . . . . 0.0 110.321 179.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -137.04 146.26 45.03 Favored 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 123.966 0.906 . . . . 0.0 109.856 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.481 HD21 ' HB3' ' A' ' 57' ' ' PRO . 10.0 tt -152.28 140.6 20.5 Favored 'General case' 0 N--CA 1.436 -1.143 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 175.128 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.467 ' HG2' ' HB3' ' A' ' 59' ' ' ASP . 18.8 ptmt -123.15 144.35 49.4 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 178.465 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 69.8 m-85 -102.47 164.88 11.42 Favored 'General case' 0 C--N 1.281 -2.378 0 CA-C-N 115.21 -0.905 . . . . 0.0 111.368 -178.451 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -79.1 -26.63 42.92 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 114.436 -1.256 . . . . 0.0 108.521 175.421 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -122.99 132.37 54.11 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.249 -175.209 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.512 ' NE2' ' HB2' ' A' ' 31' ' ' ALA . 15.9 mp0 -64.03 -30.33 71.41 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 179.547 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.88 -33.29 74.44 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-O 122.348 1.071 . . . . 0.0 110.353 -179.279 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 48.8 m -58.04 -36.47 72.8 Favored 'General case' 0 C--N 1.278 -2.511 0 CA-C-N 114.965 -1.016 . . . . 0.0 111.452 175.416 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.432 ' O ' HG23 ' A' ' 89' ' ' VAL . 36.9 p -63.91 -45.21 90.29 Favored 'General case' 0 C--O 1.213 -0.858 0 C-N-CA 120.332 -0.547 . . . . 0.0 110.9 -178.743 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 3.2 pt -64.94 -38.52 82.98 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.6 0 C-N-CA 122.391 0.276 . . . . 0.0 110.793 178.691 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.538 HD11 ' HB2' ' B' ' 224' ' ' PHE . 16.1 mt -59.09 -44.31 91.92 Favored 'General case' 0 CA--C 1.509 -0.601 0 O-C-N 123.659 0.599 . . . . 0.0 110.61 175.763 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.41 ' O ' ' HB2' ' A' ' 92' ' ' LEU . . . -72.92 -47.67 43.74 Favored 'General case' 0 N--CA 1.435 -1.195 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 179.464 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.471 HG22 HG22 ' A' ' 104' ' ' ILE . 72.4 t -59.26 -48.99 85.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 N-CA-C 112.127 0.418 . . . . 0.0 112.127 -176.325 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -73.27 -27.14 61.4 Favored 'General case' 0 C--N 1.294 -1.824 0 CA-C-O 121.466 0.65 . . . . 0.0 111.893 -172.09 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.441 ' HA ' HD22 ' B' ' 239' ' ' ASN . 6.6 t30 -91.59 -31.51 15.87 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.945 -177.379 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.443 ' HB2' HG13 ' A' ' 104' ' ' ILE . 9.9 mt -91.69 -29.7 16.7 Favored 'General case' 0 C--N 1.313 -1.006 0 C-N-CA 122.509 0.324 . . . . 0.0 111.566 -174.743 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 51.5 t-20 -65.49 124.72 23.06 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.254 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 86.9 -5.54 84.88 Favored Glycine 0 N--CA 1.435 -1.412 0 C-N-CA 121.256 -0.497 . . . . 0.0 112.568 179.213 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -85.7 139.04 31.69 Favored 'General case' 0 N--CA 1.44 -0.96 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 -178.781 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.494 ' HE3' ' HB2' ' A' ' 101' ' ' ALA . 11.7 mptt -94.6 119.18 32.85 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-O 121.056 0.455 . . . . 0.0 111.652 -176.41 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.431 HD12 HD12 ' A' ' 102' ' ' LEU . 54.2 mt -126.03 141.34 45.97 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 N-CA-C 106.144 -1.798 . . . . 0.0 106.144 174.162 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.431 ' HA3' HD22 ' A' ' 39' ' ' ASN . . . 59.22 21.23 53.02 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 121.539 -0.363 . . . . 0.0 113.345 -179.38 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 85.04 6.84 84.44 Favored Glycine 0 N--CA 1.435 -1.406 0 C-N-CA 121.27 -0.49 . . . . 0.0 113.335 -179.425 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 19.3 ptp180 -132.15 146.77 52.26 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 117.772 0.786 . . . . 0.0 111.668 179.538 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.494 ' HB2' ' HE3' ' A' ' 96' ' ' LYS . . . -80.1 118.03 21.45 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.59 -178.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.431 HD12 HD12 ' A' ' 97' ' ' ILE . 11.6 mt -70.76 144.64 50.84 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-O 121.604 0.716 . . . . 0.0 112.702 178.649 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 23.4 tptm -118.14 116.96 27.9 Favored 'General case' 0 N--CA 1.419 -1.981 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.141 177.292 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.485 ' CD1' HG23 ' A' ' 35' ' ' ILE . 5.7 mm -117.86 138.32 48.92 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 179.022 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -143.36 150.64 39.42 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 179.524 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 82.7 m-70 -83.23 133.81 34.98 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 178.621 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.424 HG21 ' HB2' ' A' ' 34' ' ' TYR . 7.3 t -154.66 152.95 30.57 Favored 'General case' 0 N--CA 1.423 -1.777 0 N-CA-C 107.262 -1.385 . . . . 0.0 107.262 -178.848 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 41.5 p90 -91.74 112.24 24.08 Favored 'General case' 0 N--CA 1.429 -1.517 0 N-CA-C 106.474 -1.676 . . . . 0.0 106.474 171.706 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 43.8 t80 -105.81 135.56 47.02 Favored 'General case' 0 C--N 1.28 -2.425 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 -179.441 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 18.1 mmm180 -120.46 115.55 32.51 Favored Pre-proline 0 C--N 1.289 -2.042 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 174.615 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -71.28 153.28 61.78 Favored 'Trans proline' 0 C--O 1.246 0.907 0 C-N-CA 123.518 2.812 . . . . 0.0 114.689 -176.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.436 ' HD3' ' C ' ' A' ' 112' ' ' LYS . 12.7 tmtt? -108.91 134.08 52.06 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 105.747 -1.946 . . . . 0.0 105.747 174.406 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 35.7 mmt180 . . . . . 0 C--N 1.303 -1.44 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 -179.147 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 . . . . . 0 N--CA 1.479 0.989 0 N-CA-C 113.461 0.912 . . . . 0.0 113.461 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 223' ' ' ARG . . . . . . . . . . . . 0.417 53.3 mtp180 70.69 51.49 0.33 Allowed 'General case' 0 CA--C 1.501 -0.938 0 N-CA-C 117.192 2.293 . . . . 0.0 117.192 178.26 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 224' ' ' PHE . . . . . 0.538 ' HB2' HD11 ' A' ' 87' ' ' LEU . 30.2 m-85 -105.99 166.0 10.81 Favored 'General case' 0 C--N 1.273 -2.719 0 CA-C-N 114.792 -1.095 . . . . 0.0 109.569 176.419 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 225' ' ' ALA . . . . . . . . . . . . . . . -107.17 22.25 16.28 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 111.957 0.355 . . . . 0.0 111.957 -172.398 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 4.6 mp -83.46 132.17 32.07 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 178.596 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 227' ' ' MET . . . . . . . . . . . . . 65.6 mtt -81.85 135.08 49.08 Favored Pre-proline 0 C--N 1.305 -1.36 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.727 -178.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 228' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -57.2 148.64 68.79 Favored 'Trans proline' 0 C--O 1.255 1.341 0 C-N-CA 123.692 2.928 . . . . 0.0 114.419 -177.582 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . -74.07 170.87 52.93 Favored Glycine 0 N--CA 1.44 -1.05 0 CA-C-N 114.71 -1.132 . . . . 0.0 112.972 -179.154 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 18.9 m -77.71 -14.17 59.69 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 -172.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 231' ' ' ARG . . . . . 0.491 ' HB2' ' OG ' ' A' ' 52' ' ' SER . 10.7 mmm180 -84.93 -1.63 56.9 Favored 'General case' 0 C--N 1.32 -0.703 0 O-C-N 121.84 -0.537 . . . . 0.0 110.347 -179.229 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 232' ' ' TRP . . . . . . . . . . . . . 22.8 t90 -76.95 125.19 28.89 Favored 'General case' 0 N--CA 1.436 -1.161 0 CA-C-O 122.496 1.141 . . . . 0.0 112.599 -176.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 233' ' ' ASP . . . . . 0.479 ' H ' HG23 ' A' ' 49' ' ' THR . 16.0 t70 -120.59 148.19 44.21 Favored 'General case' 0 C--N 1.271 -2.846 0 N-CA-C 102.326 -3.213 . . . . 0.0 102.326 172.665 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -43.25 60.47 0.0 OUTLIER Glycine 0 N--CA 1.502 3.072 0 C-N-CA 128.312 2.863 . . . . 0.0 116.526 -176.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 235' ' ' VAL . . . . . 0.467 ' N ' ' O ' ' B' ' 233' ' ' ASP . 75.7 t -111.29 118.93 58.61 Favored 'Isoleucine or valine' 0 C--N 1.25 -3.741 0 C-N-CA 127.309 2.244 . . . . 0.0 107.634 176.526 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 236' ' ' HIS . . . . . . . . . . . . . 15.5 t-80 -113.38 107.88 16.46 Favored 'General case' 0 C--N 1.282 -2.347 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.474 179.211 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 237' ' ' ARG . . . . . 0.652 ' HG3' HG13 ' A' ' 50' ' ' VAL . 3.3 mmp_? -108.4 114.96 29.21 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 104.957 -2.238 . . . . 0.0 104.957 173.762 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 238' ' ' SER . . . . . . . . . . . . . 23.8 t -131.31 134.15 46.06 Favored 'General case' 0 C--N 1.275 -2.657 0 C-N-CA 119.982 -0.687 . . . . 0.0 112.504 -175.141 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 239' ' ' ASN . . . . . 0.441 HD22 ' HA ' ' A' ' 91' ' ' ASN . 39.4 p30 -72.59 174.76 7.08 Favored 'General case' 0 C--O 1.244 0.799 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.325 174.737 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 240' ' ' GLY . . . . . 0.405 ' O ' ' HG2' ' B' ' 243' ' ' GLU . . . 76.57 35.37 41.46 Favored Glycine 0 N--CA 1.426 -1.999 0 C-N-CA 119.549 -1.31 . . . . 0.0 110.624 -179.201 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 20.7 p90 -76.29 -32.68 58.92 Favored 'General case' 0 C--N 1.297 -1.701 0 CA-C-O 121.045 0.45 . . . . 0.0 109.863 175.601 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -60.54 -39.23 87.15 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.934 -178.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 243' ' ' GLU . . . . . 0.405 ' HG2' ' O ' ' B' ' 240' ' ' GLY . 9.3 pt-20 -65.52 -34.99 79.55 Favored 'General case' 0 C--O 1.208 -1.128 0 C-N-CA 121.158 -0.217 . . . . 0.0 111.094 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 68.3 mmtt -68.0 -39.87 83.14 Favored 'General case' 0 CA--C 1.509 -0.616 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 -178.245 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 245' ' ' TRP . . . . . . . . . . . . . 51.0 m0 -65.95 -43.56 87.6 Favored 'General case' 0 N--CA 1.438 -1.044 0 CA-C-N 114.795 -1.093 . . . . 0.0 109.492 176.775 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 246' ' ' PHE . . . . . 0.528 ' O ' ' HG2' ' B' ' 249' ' ' GLN . 2.4 t80 -61.98 -39.85 93.59 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.215 178.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.96 -33.71 76.33 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.928 -178.563 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.69 -17.37 20.38 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -178.101 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 249' ' ' GLN . . . . . 0.528 ' HG2' ' O ' ' B' ' 246' ' ' PHE . 10.4 pt20 -80.04 3.44 20.24 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 177.798 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 250' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -51.45 -28.76 14.01 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.873 1.269 . . . . 0.0 112.094 -179.529 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 251' ' ' GLU . . . . . 0.415 ' HG3' ' HB3' ' B' ' 254' ' ' GLU . 8.4 mm-40 -58.59 150.48 22.93 Favored 'General case' 0 N--CA 1.426 -1.63 0 N-CA-C 115.272 1.582 . . . . 0.0 115.272 -179.427 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 252' ' ' ILE . . . . . . . . . . . . . 31.7 pt -110.17 -29.32 2.49 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 CA-C-N 113.829 -1.532 . . . . 0.0 109.905 -178.423 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -115.82 -34.71 4.71 Favored 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 120.233 -0.587 . . . . 0.0 110.511 -178.046 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 254' ' ' GLU . . . . . 0.424 ' HG2' ' H ' ' B' ' 255' ' ' LYS . 5.2 tt0 -83.67 -174.37 5.25 Favored 'General case' 0 N--CA 1.436 -1.15 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.777 -174.202 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 255' ' ' LYS . . . . . 0.424 ' H ' ' HG2' ' B' ' 254' ' ' GLU . 24.9 pttm -48.59 139.11 9.77 Favored 'General case' 0 C--O 1.241 0.651 0 C-N-CA 125.142 1.377 . . . . 0.0 112.122 178.47 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 256' ' ' LYS . . . . . . . . . . . . . 43.3 mmtm . . . . . 0 C--N 1.302 -1.468 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 179.743 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 50.7 t-20 . . . . . 0 N--CA 1.451 -0.415 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 29.4 mm-40 -85.67 -23.44 27.44 Favored 'General case' 0 C--N 1.314 -0.944 0 C-N-CA 122.845 0.458 . . . . 0.0 111.3 -176.181 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 56.6 m-85 -88.07 6.07 37.99 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.593 -0.73 . . . . 0.0 112.099 -172.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -127.82 163.35 24.58 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 176.109 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.406 ' C ' ' H ' ' A' ' 31' ' ' ALA . 7.8 m-20 -121.77 19.65 11.02 Favored 'General case' 0 C--N 1.291 -1.96 0 CA-C-O 121.965 0.888 . . . . 0.0 108.659 -175.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -76.59 11.03 1.79 Allowed 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 114.747 -1.115 . . . . 0.0 109.92 -178.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.568 ' HA ' HG21 ' A' ' 85' ' ' THR . . . -84.55 -11.33 56.26 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-N 115.272 -0.877 . . . . 0.0 109.401 178.764 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 -100.95 144.54 29.77 Favored 'General case' 0 N--CA 1.436 -1.14 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 -177.397 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 26.9 pt -142.85 156.68 17.96 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 CA-C-O 121.151 0.5 . . . . 0.0 110.224 178.793 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.408 ' HB2' HG21 ' A' ' 107' ' ' THR . 20.4 t80 -108.45 124.32 50.22 Favored 'General case' 0 C--N 1.285 -2.229 0 CA-C-N 114.566 -1.197 . . . . 0.0 108.624 177.043 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.437 HG23 ' CD1' ' A' ' 104' ' ' ILE . 10.3 mt -108.28 127.52 64.51 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.935 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 175.908 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -124.65 157.91 19.05 Favored Glycine 0 C--N 1.279 -2.599 0 N-CA-C 111.155 -0.778 . . . . 0.0 111.155 -179.249 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 50.6 m-20 68.35 70.12 0.31 Allowed 'General case' 0 C--N 1.31 -1.133 0 C-N-CA 125.745 1.618 . . . . 0.0 109.908 -177.778 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.402 HD11 HD11 ' A' ' 47' ' ' ILE . 2.9 mm? -100.6 141.47 33.41 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 115.114 -0.948 . . . . 0.0 111.846 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.449 ' HB2' ' NH1' ' A' ' 100' ' ' ARG . 39.1 t-20 -76.41 144.21 40.15 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 174.73 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.434 ' HD2' ' C ' ' A' ' 40' ' ' ARG . 0.9 OUTLIER -59.46 -26.24 65.06 Favored 'General case' 0 C--N 1.312 -1.061 0 C-N-CA 123.278 0.631 . . . . 0.0 111.665 179.057 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.401 ' HG2' ' CG ' ' A' ' 39' ' ' ASN . 13.0 pt-20 -85.98 -0.89 56.63 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.383 -0.372 . . . . 0.0 111.767 -176.917 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.433 ' HG ' ' HB3' ' A' ' 39' ' ' ASN . 87.6 mt -94.3 127.38 40.13 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-O 121.081 0.467 . . . . 0.0 110.882 -179.649 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 63.2 p -116.52 175.03 5.75 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-N 115.072 -0.967 . . . . 0.0 108.678 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.401 ' HG3' ' HB2' ' A' ' 62' ' ' LEU . 5.8 mp0 -54.2 -40.6 67.74 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 122.716 0.406 . . . . 0.0 110.983 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -59.07 -38.08 92.51 Favored Glycine 0 N--CA 1.449 -0.498 0 CA-C-N 116.384 -0.371 . . . . 0.0 113.183 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -68.05 -49.23 62.64 Favored 'General case' 0 CA--C 1.496 -1.096 0 CA-C-O 121.022 0.439 . . . . 0.0 109.852 179.499 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.402 HD11 HD11 ' A' ' 38' ' ' LEU . 26.3 mt -60.31 -41.04 85.69 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.559 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.639 179.651 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 57.1 mt -59.52 -42.44 92.25 Favored 'General case' 0 C--O 1.206 -1.189 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.095 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 90.7 m -61.47 -46.01 91.86 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 120.842 0.353 . . . . 0.0 111.458 179.427 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.589 HG13 ' HG3' ' B' ' 237' ' ' ARG . 97.8 t -67.1 -49.04 76.86 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.77 -179.204 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.453 ' HA ' ' HD2' ' A' ' 54' ' ' TYR . 3.3 m-85 -67.89 -24.15 65.19 Favored 'General case' 0 N--CA 1.426 -1.627 0 CA-C-N 115.423 -0.808 . . . . 0.0 112.558 -176.365 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.466 ' OG ' ' HB2' ' B' ' 231' ' ' ARG . 66.1 m -68.93 -19.56 64.19 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 116.188 -0.46 . . . . 0.0 112.059 176.344 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -67.08 -29.13 68.82 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 176.347 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.453 ' HD2' ' HA ' ' A' ' 51' ' ' PHE . 75.6 m-85 -89.93 -23.2 21.65 Favored 'General case' 0 N--CA 1.441 -0.897 0 CA-C-N 115.899 -0.591 . . . . 0.0 112.245 -174.58 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 171.54 -152.57 18.1 Favored Glycine 0 N--CA 1.426 -1.985 0 N-CA-C 111.312 -0.715 . . . . 0.0 111.312 179.672 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 86.7 t -106.62 112.87 63.48 Favored Pre-proline 0 C--N 1.297 -1.674 0 CA-C-O 120.793 0.33 . . . . 0.0 110.376 -178.344 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.487 ' HB3' HD21 ' A' ' 77' ' ' LEU . 88.6 Cg_endo -80.47 136.78 11.29 Favored 'Trans proline' 0 N--CA 1.442 -1.543 0 C-N-CA 122.371 2.047 . . . . 0.0 110.439 176.287 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 28.4 m -111.17 -28.32 2.63 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 C-N-CA 120.022 -0.671 . . . . 0.0 111.469 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.435 ' HB3' ' HG2' ' A' ' 78' ' ' LYS . 26.2 t70 -152.16 145.05 24.41 Favored 'General case' 0 CA--C 1.498 -1.043 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 178.771 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 10.7 p -145.95 135.45 17.53 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 123.775 0.672 . . . . 0.0 110.006 -178.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 94.1 mt -121.38 121.94 66.0 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 175.698 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.401 ' HB2' ' HG3' ' A' ' 44' ' ' GLU . 0.2 OUTLIER -98.24 117.94 33.76 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 104.988 -2.226 . . . . 0.0 104.988 174.162 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 69.8 m -71.66 116.09 11.62 Favored 'General case' 0 N--CA 1.405 -2.681 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 177.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 43.3 mtm180 -130.21 130.59 44.85 Favored 'General case' 0 C--N 1.295 -1.786 0 CA-C-N 115.34 -0.845 . . . . 0.0 108.844 -177.347 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -79.63 126.44 30.91 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.861 -177.081 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -61.67 -27.42 68.67 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 179.69 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 25.7 m-80 -79.77 -49.84 11.44 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 121.184 0.516 . . . . 0.0 110.511 -173.488 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 39.5 p -85.75 -24.35 26.94 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 115.646 -0.707 . . . . 0.0 111.542 -177.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.2 20.88 79.36 Favored Glycine 0 N--CA 1.443 -0.845 0 N-CA-C 110.686 -0.965 . . . . 0.0 110.686 -176.725 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -121.39 174.1 6.95 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 -177.273 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.422 ' HB3' ' HA ' ' A' ' 40' ' ' ARG . 48.3 t -67.95 146.2 53.81 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 178.132 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -83.2 -2.06 54.59 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 121.675 0.75 . . . . 0.0 109.779 177.833 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 90.78 15.73 55.98 Favored Glycine 0 N--CA 1.426 -1.995 0 CA-C-N 114.915 -1.039 . . . . 0.0 112.993 176.316 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 33.7 p90 -155.35 163.1 40.55 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 177.233 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -155.6 176.14 12.99 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-O 121.095 0.474 . . . . 0.0 111.228 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -137.64 146.0 43.38 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 124.334 1.054 . . . . 0.0 109.965 179.617 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.487 HD21 ' HB3' ' A' ' 57' ' ' PRO . 9.8 tt -151.88 140.86 21.13 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 175.517 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.435 ' HG2' ' HB3' ' A' ' 59' ' ' ASP . 20.1 ptmt -121.76 144.09 49.0 Favored 'General case' 0 C--O 1.257 1.482 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 178.162 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 50.2 m-85 -103.89 164.72 11.51 Favored 'General case' 0 C--N 1.288 -2.072 0 CA-C-N 115.595 -0.729 . . . . 0.0 111.688 -178.595 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -69.77 -39.52 76.62 Favored 'General case' 0 N--CA 1.429 -1.522 0 CA-C-N 114.388 -1.278 . . . . 0.0 108.665 174.358 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.41 ' OD2' ' HB2' ' A' ' 83' ' ' ARG . 26.6 t70 -124.13 140.0 53.39 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.932 -176.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 -69.46 -19.75 63.76 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 115.187 1.551 . . . . 0.0 115.187 -178.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.41 ' HB2' ' OD2' ' A' ' 81' ' ' ASP . 0.0 OUTLIER -67.23 -33.91 76.34 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-O 122.175 0.988 . . . . 0.0 109.743 173.382 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.46 ' OG ' HG21 ' B' ' 226' ' ' ILE . 45.8 m -65.31 -36.91 85.5 Favored 'General case' 0 C--N 1.289 -2.062 0 CA-C-N 115.06 -0.973 . . . . 0.0 112.199 177.652 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.568 HG21 ' HA ' ' A' ' 31' ' ' ALA . 68.6 p -64.7 -45.59 85.96 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 120.26 -0.576 . . . . 0.0 110.841 -177.749 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 5.3 pt -63.51 -38.65 82.78 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.249 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.754 176.623 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.665 HD21 ' CD1' ' B' ' 224' ' ' PHE . 19.5 mt -58.79 -43.86 90.57 Favored 'General case' 0 C--O 1.247 0.969 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.302 176.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -71.53 -46.8 58.6 Favored 'General case' 0 N--CA 1.438 -1.067 0 CA-C-N 115.573 -0.739 . . . . 0.0 111.56 -179.177 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.45 HG22 HG22 ' A' ' 104' ' ' ILE . 75.8 t -57.88 -48.07 84.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-O 121.072 0.463 . . . . 0.0 111.113 -179.344 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -62.09 -32.83 73.43 Favored 'General case' 0 C--N 1.296 -1.744 0 CA-C-N 115.047 -0.979 . . . . 0.0 112.003 -173.725 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 36.7 m-80 -97.98 -25.08 15.1 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 113.367 0.877 . . . . 0.0 113.367 -178.462 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 15.4 mt -96.33 -31.29 12.96 Favored 'General case' 0 CA--C 1.484 -1.568 0 CA-C-O 120.898 0.38 . . . . 0.0 111.875 -172.749 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 57.7 t30 -66.51 125.28 25.21 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 -179.412 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 82.94 -1.12 89.15 Favored Glycine 0 N--CA 1.444 -0.821 0 O-C-N 123.414 0.446 . . . . 0.0 112.556 179.496 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 82.7 t80 -88.05 143.75 26.9 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 -178.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.426 ' HE3' ' HB2' ' A' ' 101' ' ' ALA . 11.5 mptt -96.9 118.7 33.91 Favored 'General case' 0 N--CA 1.436 -1.151 0 CA-C-O 121.088 0.47 . . . . 0.0 111.27 -177.143 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 53.1 mt -124.53 141.73 43.69 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 N-CA-C 105.098 -2.186 . . . . 0.0 105.098 173.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 56.93 29.27 58.82 Favored Glycine 0 C--O 1.22 -0.727 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.702 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 76.55 2.1 73.67 Favored Glycine 0 CA--C 1.537 1.455 0 C-N-CA 121.71 -0.281 . . . . 0.0 113.8 -179.092 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.449 ' NH1' ' HB2' ' A' ' 39' ' ' ASN . 0.2 OUTLIER -124.37 143.77 50.41 Favored 'General case' 0 C--N 1.316 -0.868 0 O-C-N 122.176 -0.603 . . . . 0.0 111.543 -177.125 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.426 ' HB2' ' HE3' ' A' ' 96' ' ' LYS . . . -87.23 118.45 26.65 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.644 -177.252 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 11.9 mt -70.22 147.92 49.23 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 115.431 -0.804 . . . . 0.0 112.513 179.301 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 59.3 tptt -120.83 116.23 24.8 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 175.177 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.45 HG22 HG22 ' A' ' 89' ' ' VAL . 4.7 mm -119.41 131.01 73.25 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.809 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 179.326 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -144.01 151.02 39.14 Favored 'General case' 0 C--N 1.285 -2.202 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 179.52 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 28.8 m-70 -78.68 135.03 37.07 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 178.361 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.408 HG21 ' HB2' ' A' ' 34' ' ' TYR . 12.0 t -149.59 161.51 42.03 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 106.199 -1.778 . . . . 0.0 106.199 -177.692 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -103.62 110.15 22.11 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 174.151 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 28.1 t80 -107.82 133.08 52.72 Favored 'General case' 0 C--N 1.294 -1.835 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.389 -176.426 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 21.9 mmm180 -121.11 118.28 30.29 Favored Pre-proline 0 C--N 1.297 -1.705 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 173.384 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -65.0 139.32 61.0 Favored 'Trans proline' 0 C--O 1.252 1.202 0 C-N-CA 123.577 2.851 . . . . 0.0 113.644 -178.177 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.468 ' HD3' ' C ' ' A' ' 112' ' ' LYS . 11.2 tmtt? -91.46 123.91 35.24 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 178.088 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 . . . . . 0 C--N 1.303 -1.418 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.173 179.538 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 222' ' ' ASN . . . . . 0.561 ' HB3' ' CD2' ' A' ' 87' ' ' LEU . 62.8 t30 . . . . . 0 N--CA 1.477 0.921 0 CA-C-O 120.447 0.165 . . . . 0.0 111.437 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 223' ' ' ARG . . . . . . . . . . . . . 3.1 mmp_? 80.08 24.88 0.38 Allowed 'General case' 0 N--CA 1.505 2.3 0 C-N-CA 124.916 1.286 . . . . 0.0 112.477 174.321 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 224' ' ' PHE . . . . . 0.665 ' CD1' HD21 ' A' ' 87' ' ' LEU . 12.6 m-85 -115.37 166.06 12.29 Favored 'General case' 0 C--N 1.28 -2.442 0 CA-C-N 114.386 -1.279 . . . . 0.0 108.714 176.78 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 225' ' ' ALA . . . . . . . . . . . . . . . -114.32 17.78 17.33 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-O 120.801 0.334 . . . . 0.0 111.682 -173.457 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 226' ' ' ILE . . . . . 0.46 HG21 ' OG ' ' A' ' 84' ' ' SER . 4.2 mp -77.85 127.04 38.57 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.112 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 -179.664 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 227' ' ' MET . . . . . . . . . . . . . 26.6 mmt -78.65 144.3 64.74 Favored Pre-proline 0 C--N 1.295 -1.802 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.721 178.792 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 228' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -68.57 160.64 48.51 Favored 'Trans proline' 0 C--O 1.248 0.984 0 C-N-CA 123.211 2.607 . . . . 0.0 113.673 -176.448 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . -82.77 172.86 52.22 Favored Glycine 0 N--CA 1.442 -0.927 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.991 178.77 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 14.8 m -74.76 -17.49 60.63 Favored 'General case' 0 C--N 1.307 -1.248 0 C-N-CA 123.29 0.636 . . . . 0.0 112.502 -175.559 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 231' ' ' ARG . . . . . 0.466 ' HB2' ' OG ' ' A' ' 52' ' ' SER . 23.0 mmm180 -79.75 -11.48 59.84 Favored 'General case' 0 CA--C 1.5 -0.949 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -179.768 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 232' ' ' TRP . . . . . . . . . . . . . 21.3 t90 -69.28 121.55 17.07 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-O 122.334 1.064 . . . . 0.0 111.922 -178.642 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 233' ' ' ASP . . . . . 0.446 ' O ' ' N ' ' B' ' 235' ' ' VAL . 30.3 t70 -116.77 149.11 40.46 Favored 'General case' 0 C--N 1.278 -2.543 0 N-CA-C 102.486 -3.154 . . . . 0.0 102.486 171.858 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -45.06 56.68 0.0 OUTLIER Glycine 0 N--CA 1.501 2.998 0 C-N-CA 128.114 2.769 . . . . 0.0 116.919 -177.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 235' ' ' VAL . . . . . 0.446 ' N ' ' O ' ' B' ' 233' ' ' ASP . 52.1 t -104.97 131.32 54.41 Favored 'Isoleucine or valine' 0 C--N 1.251 -3.678 0 C-N-CA 128.115 2.566 . . . . 0.0 106.926 176.255 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 236' ' ' HIS . . . . . . . . . . . . . 45.0 t60 -112.25 115.92 29.58 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 -178.514 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 237' ' ' ARG . . . . . 0.589 ' HG3' HG13 ' A' ' 50' ' ' VAL . 39.0 mmt180 -127.09 109.24 11.67 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 177.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 238' ' ' SER . . . . . . . . . . . . . 27.4 t -146.51 143.13 28.71 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 116.726 -0.215 . . . . 0.0 110.523 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 239' ' ' ASN . . . . . . . . . . . . . 27.2 p-10 -75.17 -22.86 57.78 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 121.482 0.658 . . . . 0.0 110.298 179.308 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 240' ' ' GLY . . . . . 0.471 ' O ' ' HG2' ' B' ' 244' ' ' LYS . . . -96.5 60.74 1.25 Allowed Glycine 0 N--CA 1.431 -1.672 0 N-CA-C 109.03 -1.628 . . . . 0.0 109.03 176.382 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 22.9 p90 -73.2 -33.26 65.28 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 -176.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -59.66 -47.43 85.63 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 120.731 -0.388 . . . . 0.0 111.362 -177.824 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -61.36 -34.99 76.22 Favored 'General case' 0 C--O 1.21 -1.015 0 O-C-N 123.659 0.599 . . . . 0.0 112.045 -179.101 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 244' ' ' LYS . . . . . 0.471 ' HG2' ' O ' ' B' ' 240' ' ' GLY . 43.6 mmtm -64.33 -48.39 75.77 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.248 0.547 . . . . 0.0 110.186 -178.37 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 245' ' ' TRP . . . . . . . . . . . . . 24.9 m0 -67.29 -37.69 83.83 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.103 179.627 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 246' ' ' PHE . . . . . 0.504 ' O ' ' HG2' ' B' ' 249' ' ' GLN . 2.4 t80 -65.04 -35.21 80.43 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.554 177.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -70.5 -36.33 73.72 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.656 -178.808 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.5 -14.09 36.03 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 120.974 0.416 . . . . 0.0 111.703 -177.63 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 249' ' ' GLN . . . . . 0.504 ' HG2' ' O ' ' B' ' 246' ' ' PHE . 10.3 pt20 -84.79 3.74 36.23 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 109.192 -0.669 . . . . 0.0 109.192 177.007 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 250' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -50.35 -32.09 16.38 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 114.788 -1.096 . . . . 0.0 111.938 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -64.7 123.76 20.16 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.578 -178.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 252' ' ' ILE . . . . . . . . . . . . . 27.5 pt -98.63 -31.98 3.76 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 CA-C-O 121.274 0.559 . . . . 0.0 111.937 -177.666 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -89.86 -16.9 29.12 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-O 121.584 0.706 . . . . 0.0 109.71 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 254' ' ' GLU . . . . . 0.588 ' OE1' ' HG3' ' B' ' 255' ' ' LYS . 1.2 tm-20 -105.58 -170.99 1.83 Allowed 'General case' 0 C--N 1.293 -1.888 0 CA-C-N 114.691 -1.14 . . . . 0.0 108.799 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 255' ' ' LYS . . . . . 0.588 ' HG3' ' OE1' ' B' ' 254' ' ' GLU . 0.0 OUTLIER -75.72 176.02 8.11 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 114.55 1.315 . . . . 0.0 114.55 -178.25 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 256' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt . . . . . 0 C--N 1.31 -1.141 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 -179.113 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.488 HD21 ' HA ' ' A' ' 29' ' ' ASP . 34.4 t30 . . . . . 0 CA--C 1.497 -1.083 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 33.9 mm-40 -115.66 -50.58 2.7 Favored 'General case' 0 N--CA 1.428 -1.526 0 C-N-CA 120.248 -0.581 . . . . 0.0 109.676 174.639 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -137.08 17.4 3.0 Favored 'General case' 0 C--O 1.241 0.606 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 -176.139 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.48 ' HB2' HE22 ' A' ' 82' ' ' GLN . 95.5 mttt -94.54 -42.61 8.74 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-O 121.651 0.738 . . . . 0.0 110.19 179.735 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.488 ' HA ' HD21 ' A' ' 25' ' ' ASN . 79.4 m-20 60.72 18.54 8.64 Favored 'General case' 0 C--O 1.213 -0.829 0 C-N-CA 125.771 1.628 . . . . 0.0 113.257 179.469 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 57.9 t30 -89.39 19.69 4.3 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 114.08 -1.418 . . . . 0.0 108.964 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -96.86 -5.14 38.9 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 114.67 -1.15 . . . . 0.0 108.768 178.284 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 12.6 m-85 -108.24 144.89 35.1 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.217 -175.454 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 26.4 pt -139.47 155.51 25.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 CA-C-O 121.3 0.572 . . . . 0.0 110.374 176.613 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 50.9 t80 -106.38 123.1 47.54 Favored 'General case' 0 N--CA 1.411 -2.396 0 CA-C-N 114.31 -1.314 . . . . 0.0 107.772 177.468 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.441 HG23 ' CD1' ' A' ' 104' ' ' ILE . 8.1 mt -108.67 127.9 64.8 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.098 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 175.878 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -129.97 164.38 22.68 Favored Glycine 0 C--N 1.278 -2.685 0 N-CA-C 110.806 -0.918 . . . . 0.0 110.806 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 72.67 34.16 1.24 Allowed 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.92 1.288 . . . . 0.0 110.982 -179.114 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.41 HD11 HD11 ' A' ' 47' ' ' ILE . 4.1 mm? -64.57 146.33 54.78 Favored 'General case' 0 CA--C 1.497 -1.064 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.031 176.703 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.479 ' HB3' ' HG ' ' A' ' 42' ' ' LEU . 60.7 t30 -84.27 139.6 32.23 Favored 'General case' 0 C--N 1.289 -2.062 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 176.571 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.424 ' HD2' ' C ' ' A' ' 40' ' ' ARG . 6.9 ppt_? -58.53 -16.83 17.15 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 113.556 0.947 . . . . 0.0 113.556 -174.744 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -100.85 0.24 38.19 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -178.654 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.479 ' HG ' ' HB3' ' A' ' 39' ' ' ASN . 57.4 mt -80.94 128.66 33.93 Favored 'General case' 0 C--O 1.245 0.823 0 CA-C-O 121.235 0.541 . . . . 0.0 111.223 178.743 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 72.4 p -108.37 173.07 6.48 Favored 'General case' 0 N--CA 1.425 -1.708 0 CA-C-N 114.657 -1.156 . . . . 0.0 109.977 -177.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.58 ' HG3' ' HB2' ' A' ' 62' ' ' LEU . 2.3 mp0 -56.0 -43.1 77.36 Favored 'General case' 0 C--N 1.316 -0.886 0 C-N-CA 124.061 0.944 . . . . 0.0 110.824 178.361 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -62.62 -35.38 91.75 Favored Glycine 0 C--O 1.24 0.525 0 CA-C-N 115.867 -0.606 . . . . 0.0 112.557 -179.632 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 39.2 m-20 -64.84 -48.99 72.35 Favored 'General case' 0 CA--C 1.49 -1.337 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 178.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.41 HD11 HD11 ' A' ' 38' ' ' LEU . 52.5 mt -61.54 -48.03 90.64 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.856 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.402 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 40.1 mt -59.98 -42.44 94.19 Favored 'General case' 0 CA--C 1.494 -1.189 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.805 -176.389 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.432 HG23 ' H ' ' B' ' 233' ' ' ASP . 90.0 m -63.55 -45.9 88.38 Favored 'General case' 0 C--N 1.309 -1.191 0 O-C-N 123.456 0.473 . . . . 0.0 111.225 -179.095 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.418 HG13 ' HG3' ' B' ' 237' ' ' ARG . 98.1 t -67.69 -46.33 82.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.769 -178.725 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -66.12 -24.33 66.66 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.952 -178.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.532 ' OG ' ' HB2' ' B' ' 231' ' ' ARG . 70.2 m -70.81 -19.1 62.71 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.943 175.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -72.64 -27.2 61.99 Favored 'General case' 0 CA--C 1.551 1.009 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 177.676 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 58.3 m-85 -89.98 -16.45 29.84 Favored 'General case' 0 CA--C 1.511 -0.539 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.888 -177.586 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.419 ' O ' ' HA ' ' A' ' 52' ' ' SER . . . 163.13 -153.47 24.01 Favored Glycine 0 N--CA 1.417 -2.615 0 C-N-CA 120.325 -0.94 . . . . 0.0 111.738 178.795 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 59.7 t -105.23 107.65 59.5 Favored Pre-proline 0 C--N 1.294 -1.83 0 CA-C-N 116.105 -0.048 . . . . 0.0 110.92 -176.765 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.491 ' HB3' HD21 ' A' ' 77' ' ' LEU . 97.5 Cg_endo -78.51 136.97 14.31 Favored 'Trans proline' 0 N--CA 1.448 -1.161 0 C-N-CA 122.698 2.266 . . . . 0.0 110.194 176.126 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 35.5 m -112.86 -27.39 2.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 C-N-CA 119.84 -0.744 . . . . 0.0 111.601 -178.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.52 ' HB3' ' HG2' ' A' ' 78' ' ' LYS . 38.8 t70 -152.01 144.33 24.02 Favored 'General case' 0 CA--C 1.5 -0.952 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -179.197 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 13.0 p -145.38 134.73 17.88 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 179.357 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 91.2 mt -121.07 121.75 65.81 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 175.616 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.58 ' HB2' ' HG3' ' A' ' 44' ' ' GLU . 0.1 OUTLIER -94.58 115.91 28.13 Favored 'General case' 0 N--CA 1.422 -1.872 0 N-CA-C 105.838 -1.912 . . . . 0.0 105.838 176.039 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 11.3 m -76.89 116.93 18.0 Favored 'General case' 0 N--CA 1.409 -2.485 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 178.505 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.401 HH11 ' HD3' ' A' ' 64' ' ' ARG . 53.8 mtt180 -128.45 154.23 46.29 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.752 -177.256 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -88.94 115.03 26.2 Favored 'General case' 0 C--N 1.284 -2.25 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 173.661 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -62.0 -16.44 51.48 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 114.341 1.237 . . . . 0.0 114.341 -175.669 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 20.1 m-80 -81.65 -49.4 10.54 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-O 121.505 0.669 . . . . 0.0 109.501 -176.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 41.7 p -85.72 -23.27 27.43 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 115.373 -0.831 . . . . 0.0 110.984 -179.187 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.29 7.48 86.92 Favored Glycine 0 N--CA 1.446 -0.653 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.691 -179.467 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -105.72 163.43 12.7 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-O 121.16 0.505 . . . . 0.0 111.129 -175.582 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 14.5 m -63.4 139.54 58.78 Favored 'General case' 0 N--CA 1.425 -1.693 0 CA-C-N 114.579 -1.191 . . . . 0.0 109.932 178.368 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 14.1 mm-40 -74.51 -24.24 58.96 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 116.104 -0.498 . . . . 0.0 112.056 -179.269 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 113.44 7.2 20.96 Favored Glycine 0 N--CA 1.427 -1.953 0 C-N-CA 119.888 -1.148 . . . . 0.0 111.423 -175.794 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 31.4 p90 -151.02 156.76 41.79 Favored 'General case' 0 N--CA 1.427 -1.584 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 178.223 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -154.64 174.6 14.76 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 123.647 0.592 . . . . 0.0 110.09 178.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -132.17 141.16 49.0 Favored 'General case' 0 C--N 1.305 -1.362 0 C-N-CA 123.605 0.762 . . . . 0.0 110.076 -178.791 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.491 HD21 ' HB3' ' A' ' 57' ' ' PRO . 9.7 tt -148.08 140.72 24.57 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 175.372 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.52 ' HG2' ' HB3' ' A' ' 59' ' ' ASP . 21.2 ptmt -123.55 144.5 49.53 Favored 'General case' 0 C--O 1.258 1.551 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 178.882 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 59.2 m-85 -105.83 164.42 11.95 Favored 'General case' 0 C--N 1.288 -2.079 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.011 -179.116 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -80.15 -33.84 38.14 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 114.88 -1.055 . . . . 0.0 108.763 175.191 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -111.96 129.31 56.23 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -177.398 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.48 HE22 ' HB2' ' A' ' 28' ' ' LYS . 91.7 mt-30 -70.03 -20.42 63.25 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 113.883 1.068 . . . . 0.0 113.883 -178.764 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.76 -33.39 75.52 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 122.193 0.997 . . . . 0.0 109.448 174.791 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.4 ' OG ' ' HA3' ' A' ' 55' ' ' GLY . 63.7 m -64.13 -37.06 86.1 Favored 'General case' 0 C--N 1.292 -1.906 0 CA-C-N 115.184 -0.916 . . . . 0.0 112.901 178.445 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 68.6 p -64.68 -45.45 86.64 Favored 'General case' 0 C--N 1.346 0.43 0 C-N-CA 120.469 -0.493 . . . . 0.0 110.818 -177.369 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 4.0 pt -65.08 -39.1 84.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.759 177.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.424 HD11 ' HB2' ' B' ' 224' ' ' PHE . 12.2 mt -59.47 -43.51 93.22 Favored 'General case' 0 CA--C 1.505 -0.784 0 O-C-N 123.35 0.406 . . . . 0.0 111.703 176.028 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -69.35 -45.99 68.09 Favored 'General case' 0 N--CA 1.428 -1.555 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.739 -178.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.439 HG22 HG22 ' A' ' 104' ' ' ILE . 86.8 t -58.76 -45.28 91.3 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.134 0 CA-C-O 121.21 0.529 . . . . 0.0 110.643 177.822 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -58.91 -37.63 77.07 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 125.103 1.361 . . . . 0.0 112.321 -178.655 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.441 ' HA ' ' HB3' ' B' ' 239' ' ' ASN . 41.5 m-80 -98.17 -26.67 14.48 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 -176.002 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.465 ' HB2' HG13 ' A' ' 104' ' ' ILE . 19.0 mt -96.13 -30.82 13.31 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -172.489 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -65.84 123.92 21.09 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 88.48 -12.2 65.78 Favored Glycine 0 CA--C 1.53 1.012 0 CA-C-N 116.026 -0.534 . . . . 0.0 112.422 -178.066 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 73.4 t80 -79.73 138.0 37.19 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 -176.285 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.45 ' HE2' ' HB2' ' A' ' 101' ' ' ALA . 0.3 OUTLIER -95.66 123.28 39.15 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 112.111 0.411 . . . . 0.0 112.111 -177.035 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 59.4 mt -128.15 142.12 44.65 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 N-CA-C 105.737 -1.949 . . . . 0.0 105.737 173.818 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 64.14 14.32 55.99 Favored Glycine 0 C--N 1.319 -0.416 0 C-N-CA 121.262 -0.494 . . . . 0.0 112.701 -178.051 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 90.31 -1.18 79.25 Favored Glycine 0 N--CA 1.43 -1.73 0 CA-C-O 119.923 -0.376 . . . . 0.0 112.731 -178.524 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.443 ' O ' ' HA ' ' A' ' 96' ' ' LYS . 11.4 ptp180 -124.22 151.34 44.22 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 117.714 0.757 . . . . 0.0 111.96 -177.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.45 ' HB2' ' HE2' ' A' ' 96' ' ' LYS . . . -86.54 116.35 24.62 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -175.39 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 11.9 mt -65.61 148.72 51.27 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.469 -0.787 . . . . 0.0 112.56 178.096 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 57.7 tptt -122.12 118.06 27.76 Favored 'General case' 0 N--CA 1.422 -1.846 0 CA-C-N 115.14 -0.936 . . . . 0.0 108.663 175.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.465 HG13 ' HB2' ' A' ' 92' ' ' LEU . 4.3 mm -117.61 135.4 58.13 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 N-CA-C 107.143 -1.428 . . . . 0.0 107.143 178.515 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -143.94 149.71 37.24 Favored 'General case' 0 C--N 1.285 -2.229 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 -178.016 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 45.2 m-70 -81.56 131.17 35.26 Favored 'General case' 0 C--N 1.29 -1.981 0 N-CA-C 109.487 -0.561 . . . . 0.0 109.487 178.128 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 12.5 t -145.35 165.82 27.37 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 -177.565 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -110.16 109.77 20.4 Favored 'General case' 0 N--CA 1.428 -1.568 0 N-CA-C 106.649 -1.611 . . . . 0.0 106.649 174.45 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 35.6 t80 -108.62 134.7 51.01 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.719 -176.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 4.4 mpt_? -121.16 114.26 32.16 Favored Pre-proline 0 C--N 1.309 -1.189 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 172.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -81.44 152.76 17.93 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 122.89 2.394 . . . . 0.0 114.998 -177.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.478 ' HD3' ' N ' ' A' ' 113' ' ' ARG . 11.7 tmtt? -120.92 134.06 55.29 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 104.943 -2.243 . . . . 0.0 104.943 172.371 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.478 ' N ' ' HD3' ' A' ' 112' ' ' LYS . 28.4 mmt180 . . . . . 0 C--N 1.299 -1.617 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 36.4 t30 . . . . . 0 N--CA 1.469 0.492 0 N-CA-C 110.495 -0.187 . . . . 0.0 110.495 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 223' ' ' ARG . . . . . . . . . . . . 0.252 12.4 ptm180 53.59 50.17 17.81 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 116.898 2.184 . . . . 0.0 116.898 173.75 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 224' ' ' PHE . . . . . 0.424 ' HB2' HD11 ' A' ' 87' ' ' LEU . 56.5 m-85 -104.82 165.55 10.99 Favored 'General case' 0 C--N 1.273 -2.734 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.685 173.853 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 225' ' ' ALA . . . . . . . . . . . . . . . -128.44 81.79 2.05 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-O 121.007 0.432 . . . . 0.0 110.959 179.703 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 4.1 mp -125.4 129.09 73.0 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 177.834 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 227' ' ' MET . . . . . . . . . . . . . 91.4 mtp -70.35 137.7 86.51 Favored Pre-proline 0 C--N 1.313 -0.994 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 177.691 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 228' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -64.75 157.02 58.33 Favored 'Trans proline' 0 C--O 1.251 1.166 0 C-N-CA 123.398 2.732 . . . . 0.0 113.489 -176.593 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . -74.75 168.68 54.63 Favored Glycine 0 N--CA 1.435 -1.409 0 CA-C-N 115.122 -0.945 . . . . 0.0 111.83 178.289 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 15.0 m -75.04 -16.8 60.58 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 111.856 0.317 . . . . 0.0 111.856 -175.55 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 231' ' ' ARG . . . . . 0.532 ' HB2' ' OG ' ' A' ' 52' ' ' SER . 26.6 mmt180 -79.2 -10.21 59.76 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.933 0.397 . . . . 0.0 110.261 -177.627 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 232' ' ' TRP . . . . . . . . . . . . . 25.4 t90 -70.13 130.07 41.1 Favored 'General case' 0 N--CA 1.432 -1.329 0 CA-C-O 122.481 1.134 . . . . 0.0 112.059 -178.753 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 233' ' ' ASP . . . . . 0.453 ' O ' ' N ' ' B' ' 235' ' ' VAL . 22.8 t70 -124.03 139.45 53.93 Favored 'General case' 0 C--N 1.269 -2.906 0 N-CA-C 101.934 -3.358 . . . . 0.0 101.934 171.464 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -35.56 56.28 0.0 OUTLIER Glycine 0 N--CA 1.508 3.437 0 C-N-CA 128.747 3.07 . . . . 0.0 117.926 -177.626 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 235' ' ' VAL . . . . . 0.453 ' N ' ' O ' ' B' ' 233' ' ' ASP . 55.3 t -111.4 120.22 61.49 Favored 'Isoleucine or valine' 0 C--N 1.249 -3.783 0 C-N-CA 127.655 2.382 . . . . 0.0 107.664 176.633 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 236' ' ' HIS . . . . . . . . . . . . . 40.3 t-80 -107.0 116.7 32.38 Favored 'General case' 0 C--N 1.291 -1.965 0 CA-C-O 121.056 0.455 . . . . 0.0 109.823 -178.469 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 237' ' ' ARG . . . . . 0.418 ' HG3' HG13 ' A' ' 50' ' ' VAL . 38.4 mmt180 -126.89 120.36 29.0 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 177.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 238' ' ' SER . . . . . . . . . . . . . 55.0 m -146.53 153.53 40.5 Favored 'General case' 0 C--N 1.282 -2.365 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 178.645 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 239' ' ' ASN . . . . . 0.441 ' HB3' ' HA ' ' A' ' 91' ' ' ASN . 24.7 p-10 -61.78 88.41 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.837 0 CA-C-O 122.477 1.132 . . . . 0.0 112.271 -178.052 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 240' ' ' GLY . . . . . 0.473 ' O ' ' HG2' ' B' ' 243' ' ' GLU . . . -133.41 37.81 1.94 Allowed Glycine 0 N--CA 1.403 -3.505 0 CA-C-N 113.742 -1.572 . . . . 0.0 110.39 178.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 29.3 p90 -77.26 -36.71 54.18 Favored 'General case' 0 C--N 1.294 -1.829 0 CA-C-O 121.477 0.656 . . . . 0.0 110.857 176.79 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 242' ' ' GLU . . . . . 0.512 ' HA ' ' CE3' ' B' ' 245' ' ' TRP . 42.4 tt0 -67.55 -38.95 84.91 Favored 'General case' 0 C--O 1.251 1.145 0 CA-C-N 115.093 -0.958 . . . . 0.0 111.657 -178.504 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 243' ' ' GLU . . . . . 0.473 ' HG2' ' O ' ' B' ' 240' ' ' GLY . 12.2 pt-20 -58.3 -35.02 71.19 Favored 'General case' 0 C--O 1.212 -0.9 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.229 178.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 244' ' ' LYS . . . . . 0.432 ' HE2' ' O ' ' B' ' 240' ' ' GLY . 72.2 mmtt -62.79 -46.17 89.25 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.598 -176.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 245' ' ' TRP . . . . . 0.512 ' CE3' ' HA ' ' B' ' 242' ' ' GLU . 11.8 m0 -63.98 -40.65 96.86 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.675 179.308 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 246' ' ' PHE . . . . . 0.588 ' O ' ' HG2' ' B' ' 249' ' ' GLN . 2.5 t80 -66.64 -31.12 71.59 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.075 179.069 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -77.54 -39.91 44.39 Favored 'General case' 0 C--N 1.29 -2.004 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.079 178.762 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.47 -13.28 55.05 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-O 121.395 0.617 . . . . 0.0 111.606 -175.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 249' ' ' GLN . . . . . 0.588 ' HG2' ' O ' ' B' ' 246' ' ' PHE . 11.1 pt20 -74.48 2.68 9.01 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.597 -179.635 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 250' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -61.24 -31.08 70.88 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 174.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 251' ' ' GLU . . . . . 0.433 ' HG3' ' HB3' ' B' ' 254' ' ' GLU . 2.6 mm-40 -91.63 158.32 16.48 Favored 'General case' 0 N--CA 1.414 -2.263 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.439 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 252' ' ' ILE . . . . . . . . . . . . . 35.0 pt -108.11 -29.17 2.62 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 CA-C-N 114.927 -1.033 . . . . 0.0 110.265 -176.829 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -120.04 -32.39 4.2 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.918 0.389 . . . . 0.0 110.85 -175.313 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 254' ' ' GLU . . . . . 0.433 ' HB3' ' HG3' ' B' ' 251' ' ' GLU . 7.0 tp10 -77.09 155.18 32.62 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 -170.584 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 255' ' ' LYS . . . . . . . . . . . . . 35.5 mtmm -62.23 -74.78 0.08 Allowed 'General case' 0 C--N 1.315 -0.922 0 C-N-CA 125.436 1.495 . . . . 0.0 113.946 -174.279 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 256' ' ' LYS . . . . . . . . . . . . . 86.4 tttt . . . . . 0 C--N 1.296 -1.744 0 CA-C-O 118.873 -0.584 . . . . 0.0 109.595 -176.149 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 10.1 t30 . . . . . 0 CA--C 1.512 -0.494 0 CA-C-O 121.239 0.542 . . . . 0.0 109.714 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.481 ' HG2' ' CD1' ' A' ' 27' ' ' TYR . 1.4 pm0 -146.46 16.51 1.31 Allowed 'General case' 0 N--CA 1.413 -2.31 0 CA-C-N 114.955 -1.021 . . . . 0.0 111.959 -178.017 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.481 ' CD1' ' HG2' ' A' ' 26' ' ' GLU . 19.9 m-85 -113.43 6.49 17.2 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.134 0.492 . . . . 0.0 112.246 -177.283 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -96.19 -69.97 0.73 Allowed 'General case' 0 C--N 1.302 -1.481 0 CA-C-O 121.393 0.616 . . . . 0.0 109.629 178.589 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 56.12 21.23 4.99 Favored 'General case' 0 C--O 1.215 -0.759 0 C-N-CA 125.446 1.498 . . . . 0.0 114.98 177.204 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -89.79 12.65 16.5 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 171.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -92.13 22.43 4.4 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 114.809 -1.087 . . . . 0.0 111.748 -173.38 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 16.9 m-30 -93.92 145.39 24.67 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 120.933 -0.307 . . . . 0.0 110.598 -176.849 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 26.4 pt -143.8 162.26 15.83 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 C-N-CA 123.229 0.612 . . . . 0.0 110.233 176.444 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.469 ' HB2' HG21 ' A' ' 107' ' ' THR . 29.8 t80 -114.46 124.5 52.08 Favored 'General case' 0 N--CA 1.421 -1.913 0 C-N-CA 124.355 1.062 . . . . 0.0 108.616 177.743 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 7.5 mt -109.6 127.72 66.19 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.976 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 175.074 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -127.88 164.37 21.25 Favored Glycine 0 C--N 1.281 -2.501 0 N-CA-C 110.622 -0.991 . . . . 0.0 110.622 -179.166 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 16.9 m120 71.38 36.93 1.23 Allowed 'General case' 0 CA--C 1.503 -0.83 0 C-N-CA 124.177 0.991 . . . . 0.0 111.082 -177.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.469 HD11 HD11 ' A' ' 47' ' ' ILE . 4.1 mm? -69.79 153.87 42.75 Favored 'General case' 0 CA--C 1.499 -0.984 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.105 176.781 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.482 ' HB3' ' HG ' ' A' ' 42' ' ' LEU . 38.2 t-20 -92.07 152.96 19.69 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 175.837 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.447 ' HD3' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -67.38 -23.59 65.59 Favored 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 122.535 0.334 . . . . 0.0 110.41 -179.162 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -90.55 -10.97 41.51 Favored 'General case' 0 C--O 1.224 -0.259 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.291 -178.132 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.482 ' HG ' ' HB3' ' A' ' 39' ' ' ASN . 55.3 mt -77.43 120.38 22.34 Favored 'General case' 0 CA--C 1.495 -1.171 0 CA-C-O 121.596 0.712 . . . . 0.0 110.947 -178.218 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 73.0 p -102.07 173.49 6.36 Favored 'General case' 0 C--N 1.287 -2.142 0 CA-C-N 114.508 -1.224 . . . . 0.0 109.771 -177.215 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.441 ' HG3' ' HB2' ' A' ' 62' ' ' LEU . 1.3 mp0 -64.07 -34.61 78.43 Favored 'General case' 0 C--O 1.205 -1.276 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 177.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -59.31 -39.26 94.45 Favored Glycine 0 N--CA 1.443 -0.854 0 O-C-N 123.969 0.793 . . . . 0.0 111.438 178.19 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -67.54 -50.09 60.26 Favored 'General case' 0 CA--C 1.496 -1.107 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 177.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.469 HD11 HD11 ' A' ' 38' ' ' LEU . 46.3 mt -60.1 -47.22 92.79 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 CA-C-N 115.19 -0.913 . . . . 0.0 111.085 -178.157 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 41.4 mt -60.46 -45.45 93.66 Favored 'General case' 0 CA--C 1.49 -1.342 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.204 -176.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 90.4 m -63.08 -45.66 91.06 Favored 'General case' 0 N--CA 1.432 -1.356 0 O-C-N 123.74 0.65 . . . . 0.0 111.507 -178.573 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.566 HG13 ' HG3' ' B' ' 237' ' ' ARG . 98.2 t -67.48 -48.17 78.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.831 -179.182 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.407 ' HA ' ' HD2' ' A' ' 54' ' ' TYR . 3.5 m-85 -63.82 -25.37 68.15 Favored 'General case' 0 N--CA 1.438 -1.064 0 C-N-CA 123.769 0.827 . . . . 0.0 112.208 -179.06 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.555 ' OG ' ' HB2' ' B' ' 231' ' ' ARG . 62.8 m -67.75 -19.86 65.17 Favored 'General case' 0 N--CA 1.439 -1.011 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 176.873 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -66.03 -32.0 73.22 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-O 121.803 0.811 . . . . 0.0 109.305 174.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.407 ' HD2' ' HA ' ' A' ' 51' ' ' PHE . 57.2 m-85 -88.89 -22.78 22.96 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.56 -0.746 . . . . 0.0 111.691 -173.439 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.475 ' O ' ' HA ' ' A' ' 52' ' ' SER . . . 173.7 -162.49 33.37 Favored Glycine 0 N--CA 1.428 -1.872 0 C-N-CA 120.633 -0.794 . . . . 0.0 111.795 178.303 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 59.4 t -100.43 110.57 60.54 Favored Pre-proline 0 C--N 1.304 -1.395 0 N-CA-C 110.511 -0.181 . . . . 0.0 110.511 -178.594 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.544 ' HB3' HD21 ' A' ' 77' ' ' LEU . 97.1 Cg_endo -79.69 136.67 12.29 Favored 'Trans proline' 0 N--CA 1.45 -1.049 0 C-N-CA 122.535 2.157 . . . . 0.0 110.603 177.502 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 35.0 m -111.35 -28.22 2.64 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 C-N-CA 119.786 -0.765 . . . . 0.0 111.834 -178.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.502 ' HB3' ' HG2' ' A' ' 78' ' ' LYS . 36.3 t70 -151.23 141.86 22.68 Favored 'General case' 0 CA--C 1.504 -0.789 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 -179.48 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 13.8 p -142.33 133.52 25.25 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 O-C-N 123.609 0.568 . . . . 0.0 109.809 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 83.4 mt -120.54 118.5 56.77 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.213 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 177.495 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.441 ' HB2' ' HG3' ' A' ' 44' ' ' GLU . 0.1 OUTLIER -97.5 117.39 31.66 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 106.765 -1.569 . . . . 0.0 106.765 177.923 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 22.4 m -77.69 120.23 22.34 Favored 'General case' 0 C--N 1.29 -2.0 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 178.447 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 72.0 mtm180 -131.91 137.78 48.13 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.785 -175.076 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -70.35 128.73 37.2 Favored 'General case' 0 CA--C 1.499 -0.988 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.561 179.132 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -61.02 -29.39 69.68 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 115.416 -0.811 . . . . 0.0 112.692 -178.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 25.6 m-80 -81.83 -50.13 9.56 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-O 120.979 0.418 . . . . 0.0 111.5 -172.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 53.0 p -88.8 -23.79 22.77 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.756 -176.671 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 80.68 -1.63 82.28 Favored Glycine 0 N--CA 1.438 -1.201 0 N-CA-C 111.479 -0.648 . . . . 0.0 111.479 -176.741 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.447 ' OE2' ' HD3' ' A' ' 40' ' ' ARG . 5.5 mm-40 -91.4 168.32 11.64 Favored 'General case' 0 CA--C 1.503 -0.832 0 C-N-CA 122.842 0.457 . . . . 0.0 111.043 -174.637 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 13.1 m -68.11 145.16 54.65 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.88 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -86.06 6.05 30.73 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 -178.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 91.7 8.31 63.89 Favored Glycine 0 N--CA 1.44 -1.041 0 C-N-CA 120.85 -0.69 . . . . 0.0 113.535 177.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.41 ' HA ' HD23 ' A' ' 38' ' ' LEU . 32.6 p90 -152.77 157.72 41.22 Favored 'General case' 0 C--O 1.248 1.025 0 CA-C-N 117.566 0.683 . . . . 0.0 109.251 178.71 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -153.12 173.15 15.85 Favored 'General case' 0 N--CA 1.433 -1.322 0 O-C-N 123.569 0.543 . . . . 0.0 110.763 178.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -132.36 142.74 49.44 Favored 'General case' 0 C--N 1.306 -1.291 0 C-N-CA 124.17 0.988 . . . . 0.0 109.584 -178.549 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.544 HD21 ' HB3' ' A' ' 57' ' ' PRO . 9.8 tt -149.71 140.73 22.92 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 176.608 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.502 ' HG2' ' HB3' ' A' ' 59' ' ' ASP . 22.2 ptmt -123.46 144.25 49.64 Favored 'General case' 0 C--O 1.253 1.278 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 178.497 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -105.28 165.5 11.07 Favored 'General case' 0 C--N 1.29 -2.0 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.97 -178.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -73.62 -27.07 61.09 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.354 175.305 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -131.13 141.19 50.09 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 120.714 0.292 . . . . 0.0 110.606 -178.541 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 25.2 mp0 -70.08 -21.27 63.16 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 123.971 0.908 . . . . 0.0 113.279 -178.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 89.5 mtm180 -65.3 -34.46 78.39 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-O 122.313 1.054 . . . . 0.0 109.512 176.759 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.463 ' OG ' HG21 ' B' ' 226' ' ' ILE . 53.3 m -65.59 -36.85 84.95 Favored 'General case' 0 C--N 1.282 -2.33 0 CA-C-N 114.561 -1.199 . . . . 0.0 112.288 177.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 63.8 p -65.38 -44.94 85.98 Favored 'General case' 0 C--N 1.344 0.356 0 C-N-CA 120.168 -0.613 . . . . 0.0 110.875 -177.347 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.403 ' H ' HG12 ' A' ' 86' ' ' ILE . 3.5 pt -63.5 -38.91 83.46 Favored 'Isoleucine or valine' 0 C--O 1.243 0.731 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.036 177.058 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.551 HD21 ' CD1' ' B' ' 224' ' ' PHE . 49.2 mt -60.4 -44.04 96.08 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.385 176.211 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.453 ' O ' ' HB2' ' A' ' 92' ' ' LEU . . . -71.81 -46.61 57.59 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.838 -179.264 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.447 HG22 HG22 ' A' ' 104' ' ' ILE . 53.3 t -56.47 -48.89 79.42 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.902 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -178.004 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -62.24 -43.88 97.83 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -173.584 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -93.33 -19.98 20.82 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-N 115.758 -0.656 . . . . 0.0 112.373 -170.709 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.453 ' HB2' ' O ' ' A' ' 88' ' ' ALA . 9.8 mt -92.6 -27.85 17.09 Favored 'General case' 0 CA--C 1.491 -1.313 0 CA-C-O 120.824 0.345 . . . . 0.0 111.142 179.397 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -65.6 124.48 22.47 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 178.254 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 88.32 -1.09 84.11 Favored Glycine 0 N--CA 1.434 -1.493 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.435 -178.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -79.36 129.87 34.89 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 -179.2 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.456 ' HE3' ' HB2' ' A' ' 101' ' ' ALA . 11.9 mptt -90.06 115.63 27.47 Favored 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 120.602 -0.439 . . . . 0.0 110.245 179.264 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 54.1 mt -122.19 141.31 43.13 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 N-CA-C 105.803 -1.925 . . . . 0.0 105.803 174.419 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.409 ' HA3' HD22 ' A' ' 39' ' ' ASN . . . 57.32 21.9 42.19 Favored Glycine 0 CA--C 1.523 0.579 0 C-N-CA 121.79 -0.243 . . . . 0.0 113.411 -179.783 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 85.8 7.53 81.13 Favored Glycine 0 N--CA 1.437 -1.29 0 C-N-CA 121.149 -0.548 . . . . 0.0 113.59 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 18.6 ptp180 -132.01 139.25 48.54 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 117.726 0.763 . . . . 0.0 110.622 -179.145 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.456 ' HB2' ' HE3' ' A' ' 96' ' ' LYS . . . -81.25 119.83 24.13 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.756 -177.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 12.1 mt -66.47 146.73 54.21 Favored 'General case' 0 CA--C 1.501 -0.917 0 O-C-N 124.114 0.884 . . . . 0.0 112.737 178.478 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 28.6 tptp -120.44 118.82 31.29 Favored 'General case' 0 N--CA 1.421 -1.906 0 CA-C-N 115.222 -0.899 . . . . 0.0 108.922 174.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.447 HG22 HG22 ' A' ' 89' ' ' VAL . 3.2 mm -115.13 139.04 43.42 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.867 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 178.192 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -145.32 150.65 36.99 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 178.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 56.4 m-70 -83.64 130.71 34.98 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 176.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.469 HG21 ' HB2' ' A' ' 34' ' ' TYR . 5.4 t -148.79 163.55 37.05 Favored 'General case' 0 C--N 1.29 -1.98 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 -176.148 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -109.73 111.77 23.43 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 172.305 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 36.3 t80 -105.18 138.76 40.88 Favored 'General case' 0 C--N 1.286 -2.159 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.083 -173.527 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.448 ' HD3' ' N ' ' A' ' 110' ' ' ARG . 0.4 OUTLIER -113.24 113.36 48.89 Favored Pre-proline 0 C--N 1.309 -1.184 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 176.623 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.96 146.76 53.59 Favored 'Trans proline' 0 C--N 1.333 -0.26 0 C-N-CA 123.369 2.712 . . . . 0.0 114.136 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 25.8 tptp -110.53 120.87 43.83 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 174.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 36.8 mmt180 . . . . . 0 C--N 1.295 -1.762 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 -178.971 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 . . . . . 0 CA--C 1.488 -1.409 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 223' ' ' ARG . . . . . . . . . . . . . 10.6 ptm180 65.05 16.94 10.85 Favored 'General case' 0 N--CA 1.505 2.291 0 C-N-CA 126.731 2.012 . . . . 0.0 114.118 -179.269 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 224' ' ' PHE . . . . . 0.551 ' CD1' HD21 ' A' ' 87' ' ' LEU . 58.6 m-85 -96.35 164.68 12.54 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 175.133 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 225' ' ' ALA . . . . . . . . . . . . . . . -138.81 81.21 1.83 Allowed 'General case' 0 C--N 1.291 -1.964 0 CA-C-O 121.399 0.618 . . . . 0.0 109.365 179.444 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 226' ' ' ILE . . . . . 0.463 HG21 ' OG ' ' A' ' 84' ' ' SER . 3.7 mp -116.11 136.02 54.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 176.852 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 227' ' ' MET . . . . . . . . . . . . . 63.6 mtt -68.42 137.43 91.14 Favored Pre-proline 0 C--N 1.31 -1.12 0 O-C-N 124.016 0.822 . . . . 0.0 109.681 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 228' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -67.94 146.39 71.34 Favored 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 122.196 1.931 . . . . 0.0 111.206 178.68 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . -66.1 161.08 44.9 Favored Glycine 0 N--CA 1.44 -1.037 0 CA-C-N 116.084 -0.507 . . . . 0.0 112.363 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 23.2 m -74.6 -12.67 60.51 Favored 'General case' 0 C--N 1.298 -1.654 0 C-N-CA 123.037 0.535 . . . . 0.0 111.794 -177.497 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 231' ' ' ARG . . . . . 0.555 ' HB2' ' OG ' ' A' ' 52' ' ' SER . 4.0 mmp_? -79.0 -14.53 59.14 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.044 0.45 . . . . 0.0 109.992 178.491 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 232' ' ' TRP . . . . . 0.409 ' HB2' ' CB ' ' A' ' 52' ' ' SER . 28.9 t90 -72.12 122.88 21.73 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.984 -0.553 . . . . 0.0 112.052 -176.095 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 233' ' ' ASP . . . . . 0.715 ' O ' HG23 ' B' ' 235' ' ' VAL . 25.7 t70 -126.63 106.02 9.12 Favored 'General case' 0 C--O 1.207 -1.169 0 CA-C-O 118.665 -0.684 . . . . 0.0 110.057 177.661 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . 35.79 39.3 0.26 Allowed Glycine 0 N--CA 1.493 2.491 0 N-CA-C 115.9 1.12 . . . . 0.0 115.9 176.241 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 235' ' ' VAL . . . . . 0.715 HG23 ' O ' ' B' ' 233' ' ' ASP . 64.6 t -106.05 127.21 61.36 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 CA-C-N 117.22 0.51 . . . . 0.0 110.935 -175.326 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 236' ' ' HIS . . . . . . . . . . . . . 66.5 t-80 -112.99 115.04 27.77 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 107.597 -1.261 . . . . 0.0 107.597 172.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 237' ' ' ARG . . . . . 0.566 ' HG3' HG13 ' A' ' 50' ' ' VAL . 40.7 mmt180 -126.77 109.96 12.59 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-O 121.111 0.481 . . . . 0.0 110.557 178.539 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 238' ' ' SER . . . . . . . . . . . . . 69.3 m -145.13 115.79 7.7 Favored 'General case' 0 C--N 1.295 -1.789 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.361 177.183 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 239' ' ' ASN . . . . . . . . . . . . . 33.0 t30 -80.79 -35.49 33.02 Favored 'General case' 0 CA--C 1.502 -0.868 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 174.794 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 240' ' ' GLY . . . . . 0.408 ' O ' ' HG2' ' B' ' 244' ' ' LYS . . . -98.1 63.47 0.87 Allowed Glycine 0 N--CA 1.406 -3.339 0 N-CA-C 108.751 -1.74 . . . . 0.0 108.751 176.285 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 28.9 p90 -76.37 -35.53 58.61 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-O 120.84 0.352 . . . . 0.0 111.923 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 242' ' ' GLU . . . . . 0.47 ' HA ' ' CE3' ' B' ' 245' ' ' TRP . 44.2 tt0 -67.33 -42.07 84.2 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.576 -176.608 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -57.95 -34.02 69.46 Favored 'General case' 0 C--O 1.22 -0.47 0 C-N-CA 123.105 0.562 . . . . 0.0 111.541 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 244' ' ' LYS . . . . . 0.408 ' HG2' ' O ' ' B' ' 240' ' ' GLY . 71.7 mmtt -62.03 -45.96 91.25 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.394 -178.791 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 245' ' ' TRP . . . . . 0.47 ' CE3' ' HA ' ' B' ' 242' ' ' GLU . 11.2 m0 -69.6 -39.05 77.5 Favored 'General case' 0 CA--C 1.505 -0.756 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.425 178.778 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 246' ' ' PHE . . . . . 0.493 ' O ' ' HG2' ' B' ' 249' ' ' GLN . 6.1 t80 -62.12 -33.4 74.38 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.973 179.492 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -76.43 -30.85 57.57 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.632 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 248' ' ' LYS . . . . . 0.572 ' O ' ' HG2' ' B' ' 251' ' ' GLU . 0.0 OUTLIER -97.15 -12.61 22.89 Favored 'General case' 0 C--O 1.203 -1.378 0 O-C-N 121.895 -0.503 . . . . 0.0 112.11 -176.488 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 249' ' ' GLN . . . . . 0.493 ' HG2' ' O ' ' B' ' 246' ' ' PHE . 12.9 pt20 -70.17 2.51 3.61 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.137 0.575 . . . . 0.0 112.548 -176.327 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 250' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -63.64 -30.14 71.29 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.516 176.579 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 251' ' ' GLU . . . . . 0.572 ' HG2' ' O ' ' B' ' 248' ' ' LYS . 11.3 pt-20 -75.18 108.35 7.88 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-O 122.502 1.144 . . . . 0.0 111.067 -179.743 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 252' ' ' ILE . . . . . . . . . . . . . 30.4 pt -110.07 -34.28 2.48 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.334 0 CA-C-N 114.183 -1.372 . . . . 0.0 111.01 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -101.47 -26.01 13.72 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 178.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 254' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 -84.29 154.97 22.64 Favored 'General case' 0 N--CA 1.42 -1.945 0 CA-C-N 115.131 -0.94 . . . . 0.0 108.589 -176.28 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 255' ' ' LYS . . . . . . . . . . . . . 61.4 pttt -63.9 116.0 5.4 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-O 121.886 0.851 . . . . 0.0 113.268 -175.085 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 256' ' ' LYS . . . . . 0.41 ' HA ' ' OE2' ' B' ' 251' ' ' GLU . 39.6 ttmt . . . . . 0 N--CA 1.425 -1.684 0 CA-C-N 114.494 -1.23 . . . . 0.0 108.218 179.095 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 35.8 m-80 . . . . . 0 N--CA 1.48 1.032 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -75.35 -11.84 60.14 Favored 'General case' 0 CA--C 1.51 -0.586 0 CA-C-O 121.411 0.624 . . . . 0.0 111.13 -178.24 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 54.0 m-85 -90.79 8.43 34.76 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-O 121.851 0.834 . . . . 0.0 110.967 179.529 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -128.82 151.56 49.46 Favored 'General case' 0 N--CA 1.429 -1.516 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 174.424 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -123.22 20.02 9.81 Favored 'General case' 0 C--N 1.281 -2.384 0 CA-C-O 123.282 1.515 . . . . 0.0 107.192 174.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.401 ' HB2' ' HG2' ' A' ' 82' ' ' GLN . 1.5 m-20 -84.95 21.67 1.55 Allowed 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 112.964 -1.926 . . . . 0.0 109.343 -178.266 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.406 ' O ' ' HA ' ' A' ' 78' ' ' LYS . . . -91.07 3.5 54.6 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.772 -174.446 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -95.93 145.83 25.08 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.064 -175.856 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 21.2 pt -140.79 160.64 23.86 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 C-N-CA 122.709 0.404 . . . . 0.0 110.175 175.014 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.452 ' HB2' HG21 ' A' ' 107' ' ' THR . 61.6 t80 -110.81 125.9 54.07 Favored 'General case' 0 N--CA 1.409 -2.508 0 CA-C-N 115.272 -0.876 . . . . 0.0 108.757 178.372 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.428 HG23 ' CD1' ' A' ' 104' ' ' ILE . 8.0 mt -110.76 129.07 66.61 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.935 0 N-CA-C 107.297 -1.371 . . . . 0.0 107.297 176.454 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -129.65 166.16 21.94 Favored Glycine 0 C--N 1.283 -2.394 0 N-CA-C 110.318 -1.113 . . . . 0.0 110.318 179.409 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 70.02 38.35 1.56 Allowed 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 125.055 1.342 . . . . 0.0 111.389 -178.314 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -70.21 154.05 42.37 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.405 0.621 . . . . 0.0 111.687 177.296 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.471 ' HB3' ' HG ' ' A' ' 42' ' ' LEU . 45.2 t-20 -90.47 150.24 21.88 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 176.438 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.497 ' HD3' ' OE2' ' A' ' 70' ' ' GLU . 7.3 ppt_? -62.91 -21.62 66.16 Favored 'General case' 0 C--N 1.314 -0.937 0 C-N-CA 122.991 0.516 . . . . 0.0 111.29 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -94.89 -0.74 53.74 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 115.965 -0.562 . . . . 0.0 111.73 -178.097 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.471 ' HG ' ' HB3' ' A' ' 39' ' ' ASN . 68.9 mt -89.95 124.33 34.63 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-O 121.365 0.602 . . . . 0.0 110.762 -179.667 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 75.8 p -108.78 174.25 5.96 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.241 -179.172 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.426 ' HG2' ' HB2' ' A' ' 62' ' ' LEU . 40.4 mt-10 -54.79 -41.17 70.24 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 123.667 0.787 . . . . 0.0 110.131 177.533 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -64.19 -38.87 96.52 Favored Glycine 0 N--CA 1.444 -0.828 0 CA-C-N 115.492 -0.777 . . . . 0.0 113.027 -178.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -65.96 -47.06 75.86 Favored 'General case' 0 CA--C 1.496 -1.125 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 -179.386 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 44.6 mt -58.5 -45.14 90.22 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.632 179.066 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.434 ' HG ' HG11 ' A' ' 60' ' ' VAL . 45.1 mt -59.09 -45.83 89.85 Favored 'General case' 0 C--O 1.209 -1.031 0 CA-C-O 119.481 -0.295 . . . . 0.0 111.428 -179.41 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.486 HG23 ' H ' ' B' ' 233' ' ' ASP . 99.0 m -61.53 -45.54 93.74 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -179.76 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.611 HG13 ' HG3' ' B' ' 237' ' ' ARG . 64.3 t -65.52 -47.8 85.21 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 CA-C-O 121.349 0.595 . . . . 0.0 110.708 -179.262 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -67.1 -23.04 65.8 Favored 'General case' 0 N--CA 1.436 -1.169 0 C-N-CA 124.022 0.929 . . . . 0.0 111.88 -179.136 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.456 ' OG ' ' HB2' ' B' ' 231' ' ' ARG . 65.9 m -69.7 -19.85 63.56 Favored 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 176.826 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -75.9 -25.47 56.08 Favored 'General case' 0 C--O 1.247 0.947 0 C-N-CA 118.247 -1.381 . . . . 0.0 108.853 177.326 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -88.04 -22.68 24.07 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.603 -176.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 175.73 -156.67 22.26 Favored Glycine 0 N--CA 1.425 -2.07 0 C-N-CA 120.624 -0.798 . . . . 0.0 111.562 177.437 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.53 ' HB ' ' HG2' ' A' ' 80' ' ' GLU . 94.5 t -106.46 102.56 41.65 Favored Pre-proline 0 C--N 1.3 -1.559 0 CA-C-O 120.851 0.357 . . . . 0.0 110.341 -178.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.587 ' HB3' HD21 ' A' ' 77' ' ' LEU . 89.7 Cg_endo -77.81 136.86 15.46 Favored 'Trans proline' 0 C--O 1.252 1.206 0 C-N-CA 122.534 2.156 . . . . 0.0 110.167 177.281 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 34.0 m -113.9 -18.47 7.51 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 C-N-CA 120.221 -0.592 . . . . 0.0 112.274 -177.804 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.534 ' HB3' ' HG2' ' A' ' 78' ' ' LYS . 20.3 t70 -160.14 139.13 10.69 Favored 'General case' 0 C--O 1.242 0.7 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 -178.494 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.434 HG11 ' HG ' ' A' ' 48' ' ' LEU . 12.7 p -140.62 137.59 35.83 Favored 'Isoleucine or valine' 0 C--O 1.245 0.845 0 O-C-N 123.35 0.406 . . . . 0.0 110.056 179.441 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 90.4 mt -121.33 124.76 72.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 C-N-CA 123.391 0.676 . . . . 0.0 109.394 175.035 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.426 ' HB2' ' HG2' ' A' ' 44' ' ' GLU . 0.1 OUTLIER -100.12 121.06 40.83 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 106.056 -1.831 . . . . 0.0 106.056 175.501 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 20.4 m -79.91 117.37 20.71 Favored 'General case' 0 C--N 1.284 -2.249 0 N-CA-C 107.016 -1.476 . . . . 0.0 107.016 175.054 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.442 ' HA ' ' HA ' ' A' ' 71' ' ' SER . 57.8 mtp180 -118.02 133.15 56.18 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.573 -172.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -65.03 123.47 19.56 Favored 'General case' 0 CA--C 1.497 -1.08 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.843 177.743 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -61.62 -25.09 67.14 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 115.379 -0.828 . . . . 0.0 112.379 -178.52 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 34.5 m-80 -81.7 -50.57 9.14 Favored 'General case' 0 CA--C 1.504 -0.794 0 CA-C-O 121.061 0.458 . . . . 0.0 111.176 -175.606 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 62.9 p -86.32 -23.97 26.06 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.63 -176.843 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.76 -0.12 78.62 Favored Glycine 0 N--CA 1.445 -0.716 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.118 -179.474 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.497 ' OE2' ' HD3' ' A' ' 40' ' ' ARG . 37.6 mt-10 -91.33 -89.77 0.17 Allowed 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -173.401 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.442 ' HA ' ' HA ' ' A' ' 64' ' ' ARG . 50.8 m -148.28 160.72 42.68 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 -176.122 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 16.0 mm-40 -99.11 -3.07 35.43 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 122.955 0.502 . . . . 0.0 111.709 176.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 87.63 8.1 74.19 Favored Glycine 0 N--CA 1.431 -1.655 0 C-N-CA 120.186 -1.007 . . . . 0.0 112.48 -177.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 32.1 p90 -149.27 155.41 40.53 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 177.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -154.19 176.11 12.66 Favored 'General case' 0 C--N 1.316 -0.852 0 O-C-N 123.403 0.439 . . . . 0.0 111.0 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -132.82 144.02 49.94 Favored 'General case' 0 C--N 1.314 -0.971 0 C-N-CA 124.376 1.07 . . . . 0.0 109.975 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.587 HD21 ' HB3' ' A' ' 57' ' ' PRO . 9.9 tt -150.3 141.46 23.11 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 176.485 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.534 ' HG2' ' HB3' ' A' ' 59' ' ' ASP . 21.8 ptmt -123.3 143.8 49.84 Favored 'General case' 0 C--O 1.256 1.401 0 CA-C-O 121.215 0.531 . . . . 0.0 109.983 178.279 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 68.7 m-85 -106.67 165.41 11.32 Favored 'General case' 0 C--N 1.293 -1.88 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.822 179.615 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.53 ' HG2' ' HB ' ' A' ' 56' ' ' VAL . 6.9 pt-20 -76.49 -23.92 53.78 Favored 'General case' 0 C--N 1.315 -0.918 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.318 175.561 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -133.58 144.94 49.62 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 119.497 -0.881 . . . . 0.0 111.891 177.662 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.401 ' HG2' ' HB2' ' A' ' 30' ' ' ASN . 25.0 mp0 -69.41 -20.82 63.8 Favored 'General case' 0 C--N 1.309 -1.177 0 C-N-CA 124.32 1.048 . . . . 0.0 113.239 -177.648 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 76.2 mtm180 -62.74 -35.42 79.71 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 122.092 0.949 . . . . 0.0 109.976 176.521 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 49.5 m -69.11 -37.32 78.3 Favored 'General case' 0 C--N 1.286 -2.184 0 CA-C-N 114.905 -1.043 . . . . 0.0 112.951 178.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 72.1 p -62.66 -45.28 93.55 Favored 'General case' 0 C--N 1.344 0.336 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.456 -177.556 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.425 ' H ' HG12 ' A' ' 86' ' ' ILE . 3.3 pt -65.71 -39.9 86.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.197 178.23 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.483 HD21 ' CD1' ' B' ' 224' ' ' PHE . 49.0 mt -60.31 -43.6 96.2 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 120.852 0.358 . . . . 0.0 111.319 176.008 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.419 ' O ' ' HB2' ' A' ' 92' ' ' LEU . . . -71.29 -46.47 60.74 Favored 'General case' 0 N--CA 1.433 -1.3 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.339 -178.498 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.456 HG22 HG22 ' A' ' 104' ' ' ILE . 66.9 t -57.56 -49.29 80.96 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.906 0 CA-C-O 121.054 0.454 . . . . 0.0 111.083 179.519 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -64.88 -34.66 78.93 Favored 'General case' 0 C--N 1.295 -1.798 0 C-N-CA 124.029 0.932 . . . . 0.0 111.779 -174.606 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -93.42 -28.53 16.08 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 -176.235 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.481 ' HB2' HG13 ' A' ' 104' ' ' ILE . 13.9 mt -92.84 -30.46 15.44 Favored 'General case' 0 CA--C 1.488 -1.405 0 N-CA-C 111.797 0.295 . . . . 0.0 111.797 -175.046 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -66.41 124.76 23.63 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 177.548 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 85.95 -0.72 87.81 Favored Glycine 0 CA--C 1.535 1.328 0 C-N-CA 120.496 -0.859 . . . . 0.0 112.325 -177.552 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 21.7 t80 -89.23 133.5 34.41 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 -179.738 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -96.13 123.8 39.89 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-O 121.093 0.473 . . . . 0.0 111.647 -178.084 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 55.0 mt -127.74 141.32 46.73 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 N-CA-C 105.581 -2.007 . . . . 0.0 105.581 173.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 58.22 24.58 55.59 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 121.544 -0.36 . . . . 0.0 113.344 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 81.8 3.11 90.69 Favored Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 121.673 -0.299 . . . . 0.0 113.132 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.406 ' NH1' ' HA ' ' A' ' 39' ' ' ASN . 19.4 ptp180 -125.06 144.96 50.14 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 117.271 0.535 . . . . 0.0 110.978 -178.037 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -85.71 117.7 24.75 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.372 -177.476 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 11.9 mt -66.4 147.04 53.87 Favored 'General case' 0 C--O 1.25 1.118 0 CA-C-O 121.57 0.7 . . . . 0.0 112.566 178.717 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 60.1 tptt -119.19 117.97 30.08 Favored 'General case' 0 N--CA 1.416 -2.149 0 CA-C-N 114.777 -1.101 . . . . 0.0 108.046 176.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.481 HG13 ' HB2' ' A' ' 92' ' ' LEU . 4.9 mm -119.89 136.2 57.74 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.052 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 179.081 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -143.31 151.24 40.27 Favored 'General case' 0 C--N 1.283 -2.323 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 -179.476 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 79.9 m-70 -80.98 131.33 35.31 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 179.139 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.452 HG21 ' HB2' ' A' ' 34' ' ' TYR . 5.9 t -151.34 160.46 43.77 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 105.724 -1.954 . . . . 0.0 105.724 -178.698 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -110.64 110.01 20.53 Favored 'General case' 0 N--CA 1.422 -1.866 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 172.551 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 76.1 t80 -107.39 131.54 54.15 Favored 'General case' 0 C--N 1.291 -1.946 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.756 -178.748 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 5.3 mpt_? -115.08 114.48 43.52 Favored Pre-proline 0 C--N 1.29 -2.016 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 174.151 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -71.64 137.19 29.7 Favored 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 121.861 1.707 . . . . 0.0 110.926 179.496 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 26.6 tptp -82.91 114.66 21.35 Favored 'General case' 0 N--CA 1.418 -2.035 0 C-N-CA 119.41 -0.916 . . . . 0.0 109.855 -179.468 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 38.9 mmt180 . . . . . 0 C--N 1.282 -2.365 0 N-CA-C 105.949 -1.871 . . . . 0.0 105.949 178.039 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 40.3 t-20 . . . . . 0 C--O 1.197 -1.682 0 CA-C-O 120.553 0.216 . . . . 0.0 110.685 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 223' ' ' ARG . . . . . . . . . . . . . 3.7 mmp_? 75.13 7.19 4.18 Favored 'General case' 0 N--CA 1.513 2.722 0 C-N-CA 125.072 1.349 . . . . 0.0 113.721 173.636 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 224' ' ' PHE . . . . . 0.483 ' CD1' HD21 ' A' ' 87' ' ' LEU . 52.9 m-85 -99.52 165.29 11.71 Favored 'General case' 0 C--N 1.275 -2.652 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 225' ' ' ALA . . . . . . . . . . . . . . . -132.68 79.49 1.85 Allowed 'General case' 0 C--N 1.302 -1.483 0 CA-C-O 121.198 0.523 . . . . 0.0 110.396 178.827 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 3.9 mp -117.33 134.05 62.14 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.188 0 CA-C-N 115.298 -0.864 . . . . 0.0 108.882 176.75 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 227' ' ' MET . . . . . . . . . . . . . 18.9 ptp -66.93 154.1 92.98 Favored Pre-proline 0 C--N 1.318 -0.79 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.16 178.61 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 228' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -73.4 145.02 37.48 Favored 'Trans proline' 0 N--CA 1.44 -1.634 0 C-N-CA 122.17 1.913 . . . . 0.0 111.565 175.756 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . -67.92 166.58 43.55 Favored Glycine 0 N--CA 1.437 -1.274 0 CA-C-N 115.497 -0.774 . . . . 0.0 112.59 179.166 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 16.2 m -74.74 -14.51 60.73 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-O 121.022 0.439 . . . . 0.0 111.738 -175.274 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 231' ' ' ARG . . . . . 0.456 ' HB2' ' OG ' ' A' ' 52' ' ' SER . 39.7 mmt180 -84.83 -3.45 58.66 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.018 0.437 . . . . 0.0 110.409 -179.113 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 232' ' ' TRP . . . . . . . . . . . . . 22.1 t90 -76.29 128.62 35.26 Favored 'General case' 0 CA--C 1.5 -0.975 0 CA-C-O 122.31 1.053 . . . . 0.0 111.846 -179.312 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 233' ' ' ASP . . . . . 0.486 ' H ' HG23 ' A' ' 49' ' ' THR . 29.7 t70 -124.17 142.87 50.86 Favored 'General case' 0 C--N 1.269 -2.896 0 N-CA-C 101.978 -3.342 . . . . 0.0 101.978 172.17 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -37.38 66.1 0.0 OUTLIER Glycine 0 N--CA 1.49 2.251 0 C-N-CA 128.207 2.813 . . . . 0.0 116.249 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 235' ' ' VAL . . . . . 0.444 ' N ' ' O ' ' B' ' 233' ' ' ASP . 58.9 t -111.81 121.56 64.53 Favored 'Isoleucine or valine' 0 C--N 1.25 -3.753 0 C-N-CA 127.714 2.406 . . . . 0.0 106.366 174.12 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 236' ' ' HIS . . . . . . . . . . . . . 56.8 t60 -95.85 116.07 28.36 Favored 'General case' 0 C--N 1.296 -1.755 0 O-C-N 123.37 0.418 . . . . 0.0 109.966 -175.527 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 237' ' ' ARG . . . . . 0.611 ' HG3' HG13 ' A' ' 50' ' ' VAL . 41.3 mmt180 -120.62 110.21 16.16 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 177.361 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 238' ' ' SER . . . . . . . . . . . . . 13.9 t -126.24 124.96 41.58 Favored 'General case' 0 C--N 1.289 -2.038 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 239' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -63.02 142.26 58.45 Favored 'General case' 0 C--O 1.25 1.108 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.615 -177.2 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 240' ' ' GLY . . . . . 0.595 ' O ' ' HG2' ' B' ' 244' ' ' LYS . . . 66.66 46.26 77.42 Favored Glycine 0 C--O 1.187 -2.832 0 CA-C-N 114.701 -1.136 . . . . 0.0 112.512 177.353 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 47.1 p90 -75.44 -33.82 60.92 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 117.667 0.734 . . . . 0.0 110.952 -179.437 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -63.45 -39.72 95.21 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.894 -175.781 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -67.29 -35.74 80.1 Favored 'General case' 0 C--O 1.21 -0.979 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.249 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 244' ' ' LYS . . . . . 0.595 ' HG2' ' O ' ' B' ' 240' ' ' GLY . 68.9 mmtt -67.05 -45.74 76.49 Favored 'General case' 0 CA--C 1.507 -0.675 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 -176.249 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 245' ' ' TRP . . . . . . . . . . . . . 46.7 m0 -64.44 -37.54 87.87 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.059 -179.338 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 246' ' ' PHE . . . . . 0.559 ' O ' ' HG2' ' B' ' 249' ' ' GLN . 2.9 t80 -70.65 -30.44 67.07 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.086 176.852 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -78.59 -40.66 34.01 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 178.447 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.65 -15.96 52.91 Favored 'General case' 0 CA--C 1.501 -0.917 0 CA-C-O 121.158 0.504 . . . . 0.0 111.497 -175.351 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 249' ' ' GLN . . . . . 0.559 ' HG2' ' O ' ' B' ' 246' ' ' PHE . 11.5 pt20 -70.3 -0.31 7.85 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.703 -178.352 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 250' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -64.04 -30.13 71.22 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 175.758 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -85.59 111.62 20.22 Favored 'General case' 0 N--CA 1.429 -1.521 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 176.653 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 252' ' ' ILE . . . . . . . . . . . . . 34.6 pt -109.77 -24.15 4.15 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 CA-C-N 114.985 -1.007 . . . . 0.0 113.639 -170.135 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -116.83 -19.89 9.69 Favored 'General case' 0 C--N 1.31 -1.114 0 C-N-CA 120.01 -0.676 . . . . 0.0 112.362 -176.545 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 254' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.09 163.16 6.34 Favored 'General case' 0 CA--C 1.565 1.55 0 C-N-CA 123.766 0.826 . . . . 0.0 111.966 -173.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 255' ' ' LYS . . . . . 0.421 ' O ' ' HG3' ' B' ' 256' ' ' LYS . 31.4 mtmm -70.94 95.57 1.19 Allowed 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 124.458 1.103 . . . . 0.0 111.019 -174.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 256' ' ' LYS . . . . . 0.421 ' HG3' ' O ' ' B' ' 255' ' ' LYS . 7.4 mtmm . . . . . 0 C--N 1.316 -0.856 0 C-N-CA 124.835 1.254 . . . . 0.0 109.152 179.723 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 17.2 m120 . . . . . 0 CA--C 1.491 -1.298 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -95.92 -10.55 28.46 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-O 121.225 0.536 . . . . 0.0 111.403 -177.09 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 20.6 m-85 -88.57 -4.36 58.6 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-O 122.024 0.916 . . . . 0.0 110.816 -179.067 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 61.0 mttp -120.03 152.34 37.66 Favored 'General case' 0 C--N 1.29 -2.0 0 CA-C-N 114.711 -1.131 . . . . 0.0 108.919 178.796 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -115.6 22.72 12.92 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-O 123.332 1.539 . . . . 0.0 107.054 179.118 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -77.9 24.79 0.22 Allowed 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 113.279 -1.782 . . . . 0.0 111.85 -175.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -88.35 -7.45 56.66 Favored 'General case' 0 CA--C 1.506 -0.747 0 CA-C-O 120.725 0.298 . . . . 0.0 110.263 -178.455 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -109.93 145.65 36.53 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.127 -175.84 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 27.5 pt -138.21 156.68 30.84 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.453 176.109 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 34.3 t80 -106.67 123.02 47.5 Favored 'General case' 0 N--CA 1.414 -2.228 0 CA-C-N 114.91 -1.041 . . . . 0.0 108.264 177.666 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.468 HG23 ' CD1' ' A' ' 104' ' ' ILE . 8.7 mt -108.43 127.69 64.6 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.07 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 175.256 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -123.29 160.45 17.81 Favored Glycine 0 C--N 1.283 -2.366 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 -179.146 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 68.52 48.35 0.84 Allowed 'General case' 0 CA--C 1.491 -1.325 0 C-N-CA 125.112 1.365 . . . . 0.0 111.807 -174.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.534 HD11 HD11 ' A' ' 47' ' ' ILE . 4.0 mm? -72.65 145.46 47.25 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 115.078 -0.965 . . . . 0.0 110.78 175.387 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -96.89 144.86 26.43 Favored 'General case' 0 C--N 1.286 -2.18 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 179.675 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.5 ' HD2' ' N ' ' A' ' 41' ' ' GLU . 7.0 ppt_? -58.36 -21.3 49.44 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -176.594 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.5 ' N ' ' HD2' ' A' ' 40' ' ' ARG . 12.2 pt-20 -98.18 5.77 48.16 Favored 'General case' 0 C--N 1.318 -0.773 0 C-N-CA 120.464 -0.495 . . . . 0.0 111.518 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 75.6 mt -95.16 113.62 25.33 Favored 'General case' 0 N--CA 1.435 -1.206 0 CA-C-O 121.579 0.704 . . . . 0.0 109.955 175.249 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 58.8 p -102.98 174.86 5.68 Favored 'General case' 0 C--N 1.286 -2.159 0 CA-C-N 114.507 -1.224 . . . . 0.0 109.785 -179.105 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -54.65 -43.33 72.27 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 177.706 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -59.6 -41.97 97.56 Favored Glycine 0 CA--C 1.529 0.924 0 CA-C-N 115.603 -0.726 . . . . 0.0 113.51 178.513 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -63.94 -49.05 74.12 Favored 'General case' 0 CA--C 1.506 -0.743 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.534 HD11 HD11 ' A' ' 38' ' ' LEU . 46.8 mt -58.86 -44.31 90.31 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.892 -179.566 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.411 ' HG ' HG11 ' A' ' 60' ' ' VAL . 41.8 mt -59.27 -45.79 90.26 Favored 'General case' 0 CA--C 1.497 -1.093 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.66 -177.005 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.435 HG23 ' H ' ' B' ' 233' ' ' ASP . 92.0 m -61.05 -45.96 92.64 Favored 'General case' 0 C--N 1.307 -1.278 0 O-C-N 123.379 0.425 . . . . 0.0 112.116 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.636 HG13 ' HG3' ' B' ' 237' ' ' ARG . 99.3 t -66.07 -46.59 87.54 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-O 121.219 0.533 . . . . 0.0 110.8 -179.531 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -68.74 -20.87 64.4 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 115.57 -0.741 . . . . 0.0 112.185 -178.588 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.463 ' OG ' ' HB2' ' B' ' 231' ' ' ARG . 73.7 m -71.61 -19.38 62.13 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.771 176.265 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -69.58 -28.97 66.42 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 175.523 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 54.5 m-85 -95.21 -3.83 46.99 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.698 -174.613 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 156.49 -155.48 26.37 Favored Glycine 0 N--CA 1.423 -2.174 0 C-N-CA 119.67 -1.252 . . . . 0.0 112.749 177.095 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 60.8 t -108.07 103.99 52.0 Favored Pre-proline 0 C--N 1.305 -1.334 0 N-CA-C 110.475 -0.194 . . . . 0.0 110.475 -178.376 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.525 ' HB3' HD21 ' A' ' 77' ' ' LEU . 88.0 Cg_endo -79.43 138.93 14.2 Favored 'Trans proline' 0 N--CA 1.451 -0.979 0 C-N-CA 122.799 2.333 . . . . 0.0 110.775 177.602 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 33.1 m -114.71 -22.84 4.51 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 C-N-CA 119.605 -0.838 . . . . 0.0 112.548 -179.491 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.532 ' HB3' ' HG2' ' A' ' 78' ' ' LYS . 31.4 t70 -155.75 143.39 19.58 Favored 'General case' 0 CA--C 1.504 -0.8 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 -178.861 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.411 HG11 ' HG ' ' A' ' 48' ' ' LEU . 14.6 p -146.1 132.48 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.116 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 -179.402 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 90.3 mt -120.9 128.15 76.03 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 177.498 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -103.09 127.29 50.41 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 177.806 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.563 ' OG ' ' HB2' ' A' ' 72' ' ' GLN . 97.6 p -89.27 117.74 28.45 Favored 'General case' 0 N--CA 1.422 -1.867 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 178.549 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.423 ' HA ' ' HA ' ' A' ' 71' ' ' SER . 19.4 mtp180 -119.77 123.02 42.7 Favored 'General case' 0 N--CA 1.423 -1.788 0 C-N-CA 119.41 -0.916 . . . . 0.0 109.856 179.46 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -66.33 119.84 12.27 Favored 'General case' 0 C--N 1.296 -1.76 0 CA-C-N 114.505 -1.225 . . . . 0.0 111.427 -178.029 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -61.93 -23.65 66.48 Favored 'General case' 0 C--N 1.326 -0.43 0 O-C-N 123.682 0.614 . . . . 0.0 112.519 -178.031 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 28.8 m-80 -76.13 -50.59 14.22 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.328 -176.681 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 61.5 p -87.91 -24.1 23.73 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-N 116.295 -0.411 . . . . 0.0 112.042 -176.596 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 68.56 16.35 69.58 Favored Glycine 0 CA--C 1.522 0.496 0 N-CA-C 111.316 -0.714 . . . . 0.0 111.316 -177.06 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 44.8 mm-40 -106.95 -76.7 0.61 Allowed 'General case' 0 N--CA 1.437 -1.092 0 CA-C-O 120.829 0.347 . . . . 0.0 111.178 -176.195 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.423 ' HA ' ' HA ' ' A' ' 64' ' ' ARG . 23.0 t -168.27 158.92 10.33 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 -176.826 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.563 ' HB2' ' OG ' ' A' ' 63' ' ' SER . 18.8 mm-40 -90.83 -12.64 35.73 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 171.86 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 86.44 16.73 61.71 Favored Glycine 0 N--CA 1.423 -2.208 0 CA-C-N 115.09 -0.959 . . . . 0.0 112.946 178.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -145.15 157.7 44.02 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 176.258 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -151.15 168.79 23.6 Favored 'General case' 0 C--N 1.292 -1.924 0 CA-C-O 120.999 0.428 . . . . 0.0 110.258 177.058 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -126.06 137.59 53.64 Favored 'General case' 0 C--N 1.292 -1.902 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.834 -177.742 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.525 HD21 ' HB3' ' A' ' 57' ' ' PRO . 9.9 tt -144.73 140.59 28.65 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 174.432 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.532 ' HG2' ' HB3' ' A' ' 59' ' ' ASP . 20.5 ptmt -124.7 144.8 50.02 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.107 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 -105.43 164.43 11.87 Favored 'General case' 0 C--N 1.284 -2.266 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.226 -178.774 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -71.86 -27.17 62.7 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-N 114.794 -1.094 . . . . 0.0 108.654 175.19 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.626 ' OD1' ' HG2' ' A' ' 83' ' ' ARG . 8.4 t70 -132.45 139.63 48.09 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.49 -179.304 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -69.88 -20.65 63.38 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 -179.087 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.626 ' HG2' ' OD1' ' A' ' 81' ' ' ASP . 22.8 mmm180 -62.62 -34.45 77.05 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 122.2 1.0 . . . . 0.0 109.712 174.486 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.455 ' HA ' HD12 ' A' ' 87' ' ' LEU . 52.7 m -68.96 -37.02 78.58 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 114.865 -1.061 . . . . 0.0 113.559 179.303 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.509 ' O ' HG23 ' A' ' 89' ' ' VAL . 76.2 p -61.2 -45.0 96.37 Favored 'General case' 0 C--N 1.342 0.276 0 C-N-CA 120.473 -0.491 . . . . 0.0 110.418 -177.125 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.43 ' H ' HG12 ' A' ' 86' ' ' ILE . 3.1 pt -64.46 -39.06 84.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.562 177.28 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.698 HD11 ' HB2' ' B' ' 224' ' ' PHE . 40.8 mt -58.8 -44.03 90.69 Favored 'General case' 0 N--CA 1.478 0.925 0 O-C-N 123.763 0.664 . . . . 0.0 111.254 178.083 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.446 ' HB1' HD12 ' A' ' 92' ' ' LEU . . . -71.16 -41.12 70.82 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.393 -178.548 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.509 HG23 ' O ' ' A' ' 85' ' ' THR . 68.9 t -57.86 -45.73 87.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -58.5 -44.61 89.48 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 121.814 0.816 . . . . 0.0 111.347 -175.269 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -97.46 -20.31 17.85 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-N 114.744 -1.116 . . . . 0.0 113.296 -168.625 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.47 ' HB2' HG13 ' A' ' 104' ' ' ILE . 20.8 mt -95.15 -30.96 13.76 Favored 'General case' 0 C--N 1.285 -2.221 0 C-N-CA 119.615 -0.834 . . . . 0.0 110.705 -178.01 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 60.4 t30 -66.44 124.24 22.23 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 87.51 -1.22 85.71 Favored Glycine 0 C--N 1.304 -1.197 0 C-N-CA 121.107 -0.568 . . . . 0.0 113.021 -178.774 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -90.32 135.83 33.43 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.436 ' HA ' ' HA ' ' A' ' 101' ' ' ALA . 10.9 mptt -95.6 123.17 39.02 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-O 121.242 0.544 . . . . 0.0 111.397 -176.228 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 52.0 mt -126.36 141.37 46.08 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 N-CA-C 106.237 -1.764 . . . . 0.0 106.237 174.35 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 56.8 22.32 40.26 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 114.102 0.401 . . . . 0.0 114.102 178.478 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 85.52 14.07 69.04 Favored Glycine 0 N--CA 1.439 -1.116 0 C-N-CA 120.784 -0.722 . . . . 0.0 113.579 179.576 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 12.1 ptp180 -140.25 146.46 38.65 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 117.456 0.628 . . . . 0.0 110.838 177.643 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.436 ' HA ' ' HA ' ' A' ' 96' ' ' LYS . . . -88.58 119.76 29.34 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.731 -175.394 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.416 HD23 ' HA ' ' A' ' 102' ' ' LEU . 13.2 mt -65.53 138.56 58.14 Favored 'General case' 0 CA--C 1.488 -1.415 0 CA-C-O 121.646 0.736 . . . . 0.0 112.35 179.407 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 58.0 tptt -114.65 115.85 27.77 Favored 'General case' 0 C--N 1.279 -2.491 0 CA-C-N 114.822 -1.081 . . . . 0.0 108.392 177.539 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.47 HG13 ' HB2' ' A' ' 92' ' ' LEU . 4.1 mm -118.44 129.9 74.07 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -143.96 151.65 40.03 Favored 'General case' 0 C--N 1.289 -2.063 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 84.1 m-70 -79.67 140.16 37.14 Favored 'General case' 0 C--N 1.298 -1.663 0 C-N-CA 120.124 -0.63 . . . . 0.0 109.779 179.021 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 13.5 t -149.34 162.98 39.0 Favored 'General case' 0 C--N 1.279 -2.469 0 N-CA-C 106.094 -1.817 . . . . 0.0 106.094 -178.656 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -109.69 109.42 20.14 Favored 'General case' 0 N--CA 1.424 -1.767 0 N-CA-C 106.065 -1.828 . . . . 0.0 106.065 173.329 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 58.0 t80 -107.96 144.67 34.91 Favored 'General case' 0 C--N 1.289 -2.062 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.843 -177.788 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.415 ' HA ' ' HD2' ' A' ' 111' ' ' PRO . 7.9 tpp180 -120.45 113.66 33.51 Favored Pre-proline 0 C--N 1.292 -1.891 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 174.144 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.415 ' HD2' ' HA ' ' A' ' 110' ' ' ARG . 29.0 Cg_endo -62.83 137.06 60.89 Favored 'Trans proline' 0 C--O 1.249 1.026 0 C-N-CA 123.326 2.684 . . . . 0.0 113.768 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 16.5 tppt? -117.63 128.24 54.74 Favored 'General case' 0 N--CA 1.418 -2.034 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 176.8 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 34.8 mmt180 . . . . . 0 C--N 1.292 -1.926 0 CA-C-O 118.97 -0.538 . . . . 0.0 109.976 -176.719 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 7.4 t30 . . . . . 0 N--CA 1.467 0.407 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 223' ' ' ARG . . . . . . . . . . . . . 7.0 ttm180 63.34 52.84 2.3 Favored 'General case' 0 C--N 1.352 0.676 0 CA-C-O 122.482 1.134 . . . . 0.0 113.422 173.14 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 224' ' ' PHE . . . . . 0.698 ' HB2' HD11 ' A' ' 87' ' ' LEU . 4.3 m-30 -96.43 169.45 9.91 Favored 'General case' 0 C--N 1.298 -1.635 0 CA-C-N 113.779 -1.555 . . . . 0.0 109.978 -177.846 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 225' ' ' ALA . . . . . . . . . . . . . . . -87.77 28.26 1.04 Allowed 'General case' 0 C--N 1.309 -1.154 0 C-N-CA 123.045 0.538 . . . . 0.0 111.861 -170.547 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 4.6 mp -92.25 131.76 38.45 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 -179.285 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 227' ' ' MET . . . . . . . . . . . . . 73.0 mtm -77.24 140.13 65.23 Favored Pre-proline 0 C--N 1.318 -0.783 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.983 -178.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 228' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -61.7 144.32 97.16 Favored 'Trans proline' 0 C--O 1.243 0.733 0 C-N-CA 123.31 2.674 . . . . 0.0 113.412 -178.355 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . -68.69 172.11 36.54 Favored Glycine 0 C--O 1.242 0.625 0 CA-C-N 115.082 -0.963 . . . . 0.0 113.854 -178.286 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 23.0 t -77.02 -13.98 59.89 Favored 'General case' 0 C--N 1.314 -0.978 0 C-N-CA 123.011 0.524 . . . . 0.0 111.46 -176.211 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 231' ' ' ARG . . . . . 0.463 ' HB2' ' OG ' ' A' ' 52' ' ' SER . 31.7 mmt180 -84.94 -3.85 58.9 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.922 -0.311 . . . . 0.0 110.449 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 232' ' ' TRP . . . . . . . . . . . . . 21.5 t90 -78.96 131.94 36.51 Favored 'General case' 0 N--CA 1.433 -1.314 0 CA-C-O 122.333 1.063 . . . . 0.0 111.966 -178.045 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 233' ' ' ASP . . . . . 0.458 ' O ' ' N ' ' B' ' 235' ' ' VAL . 25.0 t70 -122.08 137.94 54.63 Favored 'General case' 0 C--N 1.267 -2.982 0 N-CA-C 101.388 -3.56 . . . . 0.0 101.388 168.193 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -37.87 63.8 0.0 OUTLIER Glycine 0 N--CA 1.492 2.413 0 C-N-CA 128.193 2.806 . . . . 0.0 116.093 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 235' ' ' VAL . . . . . 0.5 HG12 ' HG2' ' B' ' 237' ' ' ARG . 39.5 t -102.9 124.04 56.69 Favored 'Isoleucine or valine' 0 C--N 1.25 -3.745 0 C-N-CA 127.594 2.358 . . . . 0.0 106.875 176.04 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 236' ' ' HIS . . . . . . . . . . . . . 43.2 t60 -99.11 109.85 22.51 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 -177.444 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 237' ' ' ARG . . . . . 0.636 ' HG3' HG13 ' A' ' 50' ' ' VAL . 34.4 mmt180 -121.58 109.16 14.45 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-O 121.742 0.782 . . . . 0.0 110.925 177.623 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 238' ' ' SER . . . . . . . . . . . . . 40.5 m -129.08 135.33 48.76 Favored 'General case' 0 C--N 1.294 -1.824 0 CA-C-N 115.363 -0.835 . . . . 0.0 108.78 177.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 239' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 -64.13 -49.16 73.27 Favored 'General case' 0 C--N 1.31 -1.122 0 O-C-N 124.046 0.841 . . . . 0.0 110.683 -174.308 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 240' ' ' GLY . . . . . 0.472 ' O ' ' HG2' ' B' ' 244' ' ' LYS . . . 157.06 -35.02 0.56 Allowed Glycine 0 C--O 1.202 -1.869 0 C-N-CA 120.174 -1.012 . . . . 0.0 112.113 177.602 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 29.7 p90 -76.79 -34.48 57.97 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 112.705 0.632 . . . . 0.0 112.705 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -64.73 -39.16 93.17 Favored 'General case' 0 CA--C 1.504 -0.789 0 C-N-CA 122.899 0.479 . . . . 0.0 110.731 -175.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -63.47 -35.01 79.02 Favored 'General case' 0 C--O 1.197 -1.685 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.372 -179.304 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 244' ' ' LYS . . . . . 0.472 ' HG2' ' O ' ' B' ' 240' ' ' GLY . 70.1 mmtt -65.8 -41.95 91.31 Favored 'General case' 0 N--CA 1.439 -0.986 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 -178.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 245' ' ' TRP . . . . . . . . . . . . . 44.5 m0 -64.72 -40.81 95.98 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.265 -0.88 . . . . 0.0 109.635 179.235 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 246' ' ' PHE . . . . . 0.67 ' O ' ' HG2' ' B' ' 249' ' ' GLN . 3.0 t80 -72.01 -31.57 66.33 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.577 177.927 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -74.4 -38.48 63.09 Favored 'General case' 0 C--N 1.294 -1.819 0 O-C-N 121.671 -0.643 . . . . 0.0 111.246 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.47 -14.01 55.77 Favored 'General case' 0 CA--C 1.508 -0.64 0 CA-C-O 121.118 0.485 . . . . 0.0 111.635 -176.731 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 249' ' ' GLN . . . . . 0.67 ' HG2' ' O ' ' B' ' 246' ' ' PHE . 11.3 pt20 -77.89 -1.16 30.43 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.578 -178.703 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 250' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -53.15 -39.16 63.34 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.078 -179.456 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -131.39 108.24 9.48 Favored 'General case' 0 N--CA 1.432 -1.326 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 174.032 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 252' ' ' ILE . . . . . . . . . . . . . 28.3 pt -86.83 -31.57 6.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 CA-C-N 114.973 -1.012 . . . . 0.0 112.71 -173.09 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -92.25 -20.25 21.34 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-O 121.416 0.627 . . . . 0.0 111.075 -175.074 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 254' ' ' GLU . . . . . 0.423 ' CD ' ' H ' ' B' ' 255' ' ' LYS . 0.5 OUTLIER -85.5 161.01 19.55 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.198 -175.293 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 255' ' ' LYS . . . . . 0.423 ' H ' ' CD ' ' B' ' 254' ' ' GLU . 28.8 mtmm -88.39 -9.67 51.89 Favored 'General case' 0 C--N 1.31 -1.149 0 C-N-CA 124.775 1.23 . . . . 0.0 112.042 -172.282 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 256' ' ' LYS . . . . . . . . . . . . . 7.7 ptpp? . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.672 -0.68 . . . . 0.0 111.367 179.2 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 20.2 m120 . . . . . 0 CA--C 1.505 -0.783 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.439 ' H ' ' CD ' ' A' ' 26' ' ' GLU . 1.6 mp0 -65.64 -32.83 74.61 Favored 'General case' 0 C--N 1.316 -0.874 0 C-N-CA 124.777 1.231 . . . . 0.0 110.616 -178.11 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -88.74 17.28 5.69 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-N 113.913 -1.494 . . . . 0.0 112.37 -172.481 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -134.51 150.08 50.75 Favored 'General case' 0 CA--C 1.485 -1.54 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 177.185 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 39.6 m-20 -112.51 8.82 19.45 Favored 'General case' 0 C--N 1.291 -1.945 0 CA-C-O 122.3 1.048 . . . . 0.0 108.427 177.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.502 ' HA ' ' CE2' ' A' ' 108' ' ' PHE . 1.9 m-20 -75.5 30.37 0.1 Allowed 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 125.746 1.618 . . . . 0.0 111.396 -176.125 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -104.58 12.86 32.58 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.978 -172.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -95.01 145.21 25.1 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 -175.427 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 26.1 pt -141.01 162.17 22.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-O 121.029 0.442 . . . . 0.0 111.033 175.777 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 66.5 t80 -109.84 121.78 46.02 Favored 'General case' 0 N--CA 1.415 -2.21 0 CA-C-N 114.702 -1.136 . . . . 0.0 108.436 178.642 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 9.4 mt -109.15 127.94 65.45 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.963 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 174.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -130.52 168.12 21.79 Favored Glycine 0 C--N 1.29 -2.008 0 N-CA-C 111.305 -0.718 . . . . 0.0 111.305 -178.463 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 68.25 33.73 4.18 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.663 1.185 . . . . 0.0 110.503 -176.606 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.525 HD11 HD11 ' A' ' 47' ' ' ILE . 4.0 mm? -65.8 151.67 46.1 Favored 'General case' 0 CA--C 1.5 -0.969 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.606 178.083 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.489 HD22 ' HA3' ' A' ' 98' ' ' GLY . 39.2 t-20 -90.85 148.81 22.25 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 176.234 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.404 HH11 ' HB3' ' A' ' 41' ' ' GLU . 0.6 OUTLIER -64.76 -17.12 63.88 Favored 'General case' 0 C--N 1.297 -1.7 0 C-N-CA 123.765 0.826 . . . . 0.0 113.149 -179.001 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.404 ' HB3' HH11 ' A' ' 40' ' ' ARG . 10.2 pt-20 -92.91 -13.64 28.64 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.555 179.162 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.401 HD12 ' H ' ' A' ' 39' ' ' ASN . 74.8 mt -78.83 123.25 27.03 Favored 'General case' 0 CA--C 1.504 -0.82 0 CA-C-O 121.564 0.697 . . . . 0.0 111.809 -176.778 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 10.7 t -114.22 174.15 6.09 Favored 'General case' 0 C--N 1.293 -1.876 0 CA-C-N 114.737 -1.12 . . . . 0.0 108.965 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.418 ' CG ' ' HB2' ' A' ' 62' ' ' LEU . 52.3 mt-10 -55.42 -45.1 76.76 Favored 'General case' 0 C--O 1.214 -0.782 0 C-N-CA 124.016 0.927 . . . . 0.0 110.62 -176.47 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -59.35 -39.0 94.18 Favored Glycine 0 C--O 1.244 0.731 0 CA-C-N 116.117 -0.492 . . . . 0.0 113.466 -178.713 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -67.64 -48.44 66.71 Favored 'General case' 0 C--O 1.243 0.745 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 -179.492 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.525 HD11 HD11 ' A' ' 38' ' ' LEU . 36.2 mt -58.22 -46.21 88.76 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.318 0 CA-C-N 114.924 -1.035 . . . . 0.0 110.291 178.471 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 44.6 mt -59.21 -40.26 85.25 Favored 'General case' 0 CA--C 1.492 -1.259 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.397 -178.33 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.408 HG23 ' H ' ' B' ' 233' ' ' ASP . 84.3 m -65.16 -46.22 81.72 Favored 'General case' 0 N--CA 1.431 -1.381 0 O-C-N 123.502 0.501 . . . . 0.0 110.977 -178.511 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 57.6 t -67.53 -48.01 78.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.42 -178.72 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.42 ' HD2' ' HH ' ' A' ' 79' ' ' TYR . 6.1 m-85 -64.84 -21.27 66.76 Favored 'General case' 0 N--CA 1.436 -1.17 0 C-N-CA 124.408 1.083 . . . . 0.0 112.545 -179.442 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.463 ' CB ' ' HB2' ' B' ' 232' ' ' TRP . 51.2 m -71.65 -20.75 61.91 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 176.736 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -74.26 -24.55 59.3 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 118.022 -1.471 . . . . 0.0 109.523 174.691 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 -89.85 -8.81 51.13 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.221 0.534 . . . . 0.0 111.434 -175.563 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 158.99 -163.21 33.13 Favored Glycine 0 N--CA 1.425 -2.075 0 N-CA-C 110.981 -0.848 . . . . 0.0 110.981 177.673 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 60.1 t -101.33 109.37 58.62 Favored Pre-proline 0 C--N 1.297 -1.713 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 -179.097 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.511 ' HB3' HD21 ' A' ' 77' ' ' LEU . 79.0 Cg_endo -77.53 137.08 16.14 Favored 'Trans proline' 0 N--CA 1.445 -1.375 0 C-N-CA 122.17 1.914 . . . . 0.0 109.701 176.73 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 35.0 m -111.48 -26.54 3.09 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 C-N-CA 119.46 -0.896 . . . . 0.0 111.992 -178.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.477 ' HB3' ' HG2' ' A' ' 78' ' ' LYS . 10.5 t70 -155.06 144.43 21.18 Favored 'General case' 0 C--O 1.247 0.946 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 -179.062 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 14.6 p -146.34 138.17 19.34 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 O-C-N 123.415 0.447 . . . . 0.0 110.103 -178.486 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.46 HD11 ' HB3' ' A' ' 111' ' ' PRO . 98.4 mt -121.31 126.21 74.69 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 174.347 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.418 ' HB2' ' CG ' ' A' ' 44' ' ' GLU . 0.1 OUTLIER -98.58 115.77 29.36 Favored 'General case' 0 N--CA 1.425 -1.677 0 N-CA-C 106.222 -1.77 . . . . 0.0 106.222 171.396 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 6.8 m -74.96 117.24 16.59 Favored 'General case' 0 N--CA 1.412 -2.344 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 178.576 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 66.9 mtm180 -131.74 142.69 49.85 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-O 121.269 0.557 . . . . 0.0 111.189 -176.181 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -77.99 131.51 37.42 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 114.607 -1.178 . . . . 0.0 110.356 -179.649 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -61.68 -29.26 69.97 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 115.349 -0.841 . . . . 0.0 112.545 179.46 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 29.9 m-80 -81.84 -50.67 8.94 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 121.371 0.605 . . . . 0.0 111.314 -172.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 58.2 p -86.46 -24.65 25.55 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-O 121.401 0.62 . . . . 0.0 111.131 -176.628 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.48 6.03 83.47 Favored Glycine 0 N--CA 1.44 -1.091 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 -175.337 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -104.32 166.6 10.3 Favored 'General case' 0 N--CA 1.436 -1.13 0 CA-C-O 121.042 0.448 . . . . 0.0 110.875 -175.792 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 8.2 m -62.47 141.32 58.45 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 114.969 -1.014 . . . . 0.0 110.461 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 -84.98 12.89 6.71 Favored 'General case' 0 C--N 1.315 -0.899 0 C-N-CA 123.168 0.587 . . . . 0.0 111.668 -178.849 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 83.44 11.14 80.81 Favored Glycine 0 N--CA 1.435 -1.405 0 C-N-CA 121.126 -0.559 . . . . 0.0 113.336 178.015 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 38.3 p90 -154.06 159.49 41.57 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 177.13 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -154.12 171.94 18.33 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 123.917 0.761 . . . . 0.0 109.77 178.216 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -131.12 141.45 50.13 Favored 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 123.61 0.764 . . . . 0.0 109.903 -178.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.511 HD21 ' HB3' ' A' ' 57' ' ' PRO . 10.0 tt -148.86 141.48 24.43 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 176.784 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.477 ' HG2' ' HB3' ' A' ' 59' ' ' ASP . 21.5 ptmt -124.11 143.98 50.15 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 178.465 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.42 ' HH ' ' HD2' ' A' ' 51' ' ' PHE . 74.5 m-85 -103.84 165.66 10.9 Favored 'General case' 0 C--N 1.288 -2.071 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.724 -178.289 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -75.13 -39.43 60.5 Favored 'General case' 0 N--CA 1.425 -1.715 0 CA-C-N 114.956 -1.02 . . . . 0.0 108.381 174.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -116.84 144.14 44.85 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 121.378 0.609 . . . . 0.0 111.364 179.758 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 21.4 mp0 -69.83 -28.78 65.98 Favored 'General case' 0 C--N 1.311 -1.086 0 C-N-CA 124.063 0.945 . . . . 0.0 113.15 -177.575 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.1 -33.88 76.77 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 122.142 0.972 . . . . 0.0 110.343 177.092 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 50.5 m -60.88 -37.34 81.84 Favored 'General case' 0 C--N 1.284 -2.258 0 CA-C-N 115.106 -0.952 . . . . 0.0 112.029 176.182 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.436 ' O ' HG23 ' A' ' 89' ' ' VAL . 59.5 p -63.7 -45.3 90.64 Favored 'General case' 0 C--N 1.347 0.488 0 C-N-CA 120.507 -0.477 . . . . 0.0 110.836 -177.759 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 4.0 pt -66.13 -38.24 81.54 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.687 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.408 179.279 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.464 HD11 ' HB2' ' B' ' 224' ' ' PHE . 13.5 mt -59.66 -44.4 93.58 Favored 'General case' 0 CA--C 1.511 -0.547 0 O-C-N 123.284 0.365 . . . . 0.0 111.751 175.558 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.424 ' O ' ' HB2' ' A' ' 92' ' ' LEU . . . -69.72 -43.98 71.24 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.106 -179.533 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.475 HG22 HG22 ' A' ' 104' ' ' ILE . 85.3 t -60.99 -45.44 98.52 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-O 121.488 0.661 . . . . 0.0 110.98 178.798 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.404 ' OD2' ' HB2' ' B' ' 222' ' ' ASN . 33.4 t70 -65.76 -37.3 85.96 Favored 'General case' 0 C--N 1.284 -2.262 0 C-N-CA 124.196 0.998 . . . . 0.0 111.828 -176.696 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.439 ' O ' ' HB3' ' B' ' 239' ' ' ASN . 4.3 m-20 -91.62 -28.09 17.72 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 112.94 0.719 . . . . 0.0 112.94 -176.188 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.439 ' HB2' HG13 ' A' ' 104' ' ' ILE . 14.8 mt -97.06 -28.91 13.93 Favored 'General case' 0 CA--C 1.491 -1.305 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -173.117 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -65.56 125.26 24.65 Favored 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 120.03 -0.668 . . . . 0.0 109.465 -178.891 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 88.53 -8.36 79.26 Favored Glycine 0 C--N 1.31 -0.876 0 CA-C-N 115.643 -0.708 . . . . 0.0 112.501 -178.611 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -81.17 137.59 35.9 Favored 'General case' 0 CA--C 1.516 -0.332 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 -178.543 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.4 ' HD2' ' N ' ' A' ' 96' ' ' LYS . 11.2 mptt -95.51 122.86 38.69 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-O 120.969 0.414 . . . . 0.0 111.571 -175.885 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 54.5 mt -127.02 141.37 46.44 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 N-CA-C 105.734 -1.95 . . . . 0.0 105.734 172.633 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.489 ' HA3' HD22 ' A' ' 39' ' ' ASN . . . 56.84 26.83 55.23 Favored Glycine 0 CA--C 1.521 0.438 0 O-C-N 123.035 0.209 . . . . 0.0 113.395 -179.309 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 79.5 8.19 87.93 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 121.296 -0.478 . . . . 0.0 113.786 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 15.8 ptp180 -131.2 142.08 50.14 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 117.87 0.835 . . . . 0.0 110.321 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -82.83 120.31 25.48 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.686 -177.117 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 11.4 mt -65.78 143.96 57.17 Favored 'General case' 0 C--O 1.249 1.047 0 CA-C-O 121.858 0.837 . . . . 0.0 112.683 179.197 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 22.7 tptm -116.59 118.7 33.33 Favored 'General case' 0 N--CA 1.418 -2.056 0 CA-C-N 114.771 -1.104 . . . . 0.0 108.548 175.713 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.475 HG22 HG22 ' A' ' 89' ' ' VAL . 4.4 mm -117.63 136.01 56.19 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.185 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 178.254 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -143.43 152.66 41.81 Favored 'General case' 0 C--N 1.287 -2.151 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -178.451 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 74.4 m-70 -83.81 131.96 34.86 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 178.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 5.8 t -156.27 161.73 40.2 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 -177.706 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.502 ' CE2' ' HA ' ' A' ' 30' ' ' ASN . 41.7 m-85 -109.91 109.21 19.76 Favored 'General case' 0 N--CA 1.42 -1.963 0 C-N-CA 118.351 -1.34 . . . . 0.0 107.466 169.655 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 25.5 t80 -107.18 135.63 48.38 Favored 'General case' 0 C--N 1.277 -2.546 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -112.06 113.48 51.99 Favored Pre-proline 0 C--N 1.291 -1.955 0 C-N-CA 118.971 -1.091 . . . . 0.0 109.595 177.004 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.46 ' HB3' HD11 ' A' ' 61' ' ' ILE . 55.7 Cg_endo -70.42 148.84 61.7 Favored 'Trans proline' 0 C--O 1.245 0.835 0 C-N-CA 123.63 2.887 . . . . 0.0 113.91 -179.154 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 27.3 tptp -120.83 118.02 28.89 Favored 'General case' 0 N--CA 1.427 -1.584 0 CA-C-N 115.063 -0.971 . . . . 0.0 108.505 172.812 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 33.5 mmt180 . . . . . 0 C--N 1.285 -2.236 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 177.722 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 222' ' ' ASN . . . . . 0.404 ' HB2' ' OD2' ' A' ' 90' ' ' ASP . 44.7 t-20 . . . . . 0 CA--C 1.538 0.518 0 N-CA-C 111.333 0.123 . . . . 0.0 111.333 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 223' ' ' ARG . . . . . . . . . . . . 0.277 11.6 ptm180 58.51 49.94 9.91 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 117.325 2.343 . . . . 0.0 117.325 173.333 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 224' ' ' PHE . . . . . 0.464 ' HB2' HD11 ' A' ' 87' ' ' LEU . 71.3 m-85 -108.83 167.02 10.38 Favored 'General case' 0 C--N 1.272 -2.787 0 C-N-CA 123.926 0.89 . . . . 0.0 109.774 176.199 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 225' ' ' ALA . . . . . . . . . . . . . . . -129.59 75.47 1.65 Allowed 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 121.302 0.572 . . . . 0.0 110.462 177.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 4.0 mp -114.14 131.03 67.3 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 175.605 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 227' ' ' MET . . . . . . . . . . . . . 26.1 ptt? -69.71 151.03 96.59 Favored Pre-proline 0 C--N 1.318 -0.797 0 O-C-N 123.485 0.491 . . . . 0.0 110.077 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 228' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -71.7 161.2 45.93 Favored 'Trans proline' 0 C--O 1.252 1.176 0 C-N-CA 123.141 2.561 . . . . 0.0 114.327 -175.27 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . -83.66 173.28 51.01 Favored Glycine 0 N--CA 1.436 -1.326 0 CA-C-N 114.736 -1.12 . . . . 0.0 112.318 177.851 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 9.6 m -74.35 -14.49 60.89 Favored 'General case' 0 C--N 1.306 -1.288 0 C-N-CA 123.456 0.703 . . . . 0.0 112.369 -174.021 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 38.9 mmt180 -91.41 -6.22 53.16 Favored 'General case' 0 C--N 1.318 -0.791 0 C-N-CA 120.076 -0.65 . . . . 0.0 111.693 -177.004 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 232' ' ' TRP . . . . . 0.463 ' HB2' ' CB ' ' A' ' 52' ' ' SER . 21.0 t90 -76.4 121.11 22.57 Favored 'General case' 0 CA--C 1.497 -1.062 0 CA-C-O 122.45 1.119 . . . . 0.0 112.324 -178.732 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 233' ' ' ASP . . . . . 0.449 ' O ' ' N ' ' B' ' 235' ' ' VAL . 24.7 t70 -118.04 148.68 42.02 Favored 'General case' 0 N--CA 1.407 -2.623 0 N-CA-C 102.541 -3.133 . . . . 0.0 102.541 171.546 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -46.26 60.19 0.0 OUTLIER Glycine 0 N--CA 1.489 2.208 0 C-N-CA 127.967 2.699 . . . . 0.0 116.418 -176.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 235' ' ' VAL . . . . . 0.46 HG12 ' HG2' ' B' ' 237' ' ' ARG . 54.5 t -103.32 124.16 57.31 Favored 'Isoleucine or valine' 0 C--N 1.253 -3.608 0 C-N-CA 127.59 2.356 . . . . 0.0 107.302 175.532 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 236' ' ' HIS . . . . . . . . . . . . . 41.0 t60 -101.51 106.76 17.91 Favored 'General case' 0 N--CA 1.418 -2.047 0 CA-C-O 121.35 0.595 . . . . 0.0 109.664 -177.798 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 237' ' ' ARG . . . . . 0.46 ' HG2' HG12 ' B' ' 235' ' ' VAL . 38.7 mmt180 -128.31 111.84 13.8 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 105.361 -2.088 . . . . 0.0 105.361 172.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 238' ' ' SER . . . . . . . . . . . . . 10.5 t -145.03 151.74 39.02 Favored 'General case' 0 C--N 1.28 -2.452 0 C-N-CA 119.097 -1.041 . . . . 0.0 111.275 -175.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 239' ' ' ASN . . . . . 0.439 ' HB3' ' O ' ' A' ' 91' ' ' ASN . 28.8 p-10 -84.79 163.61 19.0 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.92 -178.643 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 240' ' ' GLY . . . . . . . . . . . . . . . 123.66 80.17 0.47 Allowed Glycine 0 N--CA 1.418 -2.547 0 C-N-CA 120.174 -1.012 . . . . 0.0 111.568 178.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 35.0 p90 -76.96 -33.51 57.66 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-O 121.481 0.657 . . . . 0.0 110.273 174.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -67.23 -39.45 86.21 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.518 -176.449 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -60.13 -34.35 73.4 Favored 'General case' 0 C--O 1.202 -1.43 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.826 177.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -62.09 -37.81 86.48 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 122.817 0.447 . . . . 0.0 109.96 -179.147 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 245' ' ' TRP . . . . . 0.519 ' O ' ' HG3' ' B' ' 248' ' ' LYS . 36.8 m0 -69.6 -39.73 77.07 Favored 'General case' 0 C--O 1.242 0.702 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.551 178.887 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 246' ' ' PHE . . . . . 0.742 ' O ' ' HG2' ' B' ' 249' ' ' GLN . 2.8 t80 -70.2 -33.05 71.23 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 114.879 -1.055 . . . . 0.0 110.812 177.874 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -73.15 -31.01 64.0 Favored 'General case' 0 C--N 1.285 -2.237 0 O-C-N 121.817 -0.552 . . . . 0.0 110.663 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 248' ' ' LYS . . . . . 0.519 ' HG3' ' O ' ' B' ' 245' ' ' TRP . 2.2 pptp? -87.22 -12.1 47.81 Favored 'General case' 0 C--O 1.221 -0.414 0 CA-C-O 120.86 0.362 . . . . 0.0 111.594 -177.259 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 249' ' ' GLN . . . . . 0.742 ' HG2' ' O ' ' B' ' 246' ' ' PHE . 10.8 pt20 -79.33 2.99 19.54 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.002 -178.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 250' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -56.98 -36.99 70.99 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.267 176.517 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -116.27 152.92 32.86 Favored 'General case' 0 N--CA 1.411 -2.379 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 175.596 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 252' ' ' ILE . . . . . . . . . . . . . 28.5 pt -128.79 -28.21 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 -173.164 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -117.32 -24.7 7.32 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-O 121.061 0.457 . . . . 0.0 109.806 -174.583 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 254' ' ' GLU . . . . . . . . . . . . . 48.4 mp0 -51.49 148.18 5.42 Favored 'General case' 0 N--CA 1.438 -1.032 0 C-N-CA 126.084 1.754 . . . . 0.0 114.622 -172.754 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 255' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -61.48 122.95 16.49 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 113.763 -1.562 . . . . 0.0 112.715 -178.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 256' ' ' LYS . . . . . . . . . . . . . 66.5 mttm . . . . . 0 C--N 1.306 -1.312 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 176.364 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.455 ' N ' ' HA ' ' A' ' 81' ' ' ASP . 88.2 m-20 . . . . . 0 CA--C 1.508 -0.65 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.545 ' HG3' ' CD1' ' A' ' 27' ' ' TYR . 13.2 pt-20 -81.24 -17.05 50.84 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -172.36 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.545 ' CD1' ' HG3' ' A' ' 26' ' ' GLU . 26.4 m-85 -93.85 8.41 41.3 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-O 121.653 0.74 . . . . 0.0 109.958 179.563 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -108.33 135.24 49.97 Favored 'General case' 0 N--CA 1.426 -1.633 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.502 177.72 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -90.41 -4.33 57.1 Favored 'General case' 0 C--N 1.275 -2.653 0 CA-C-N 114.329 -1.305 . . . . 0.0 111.858 -170.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 41.8 m-80 -83.15 30.86 0.45 Allowed 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.592 178.814 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -97.36 9.15 43.07 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 112.33 0.492 . . . . 0.0 112.33 -175.578 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -108.25 145.85 33.71 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-O 121.124 0.488 . . . . 0.0 111.548 -173.06 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 26.7 pt -138.23 154.99 28.61 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.503 175.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -106.81 122.86 47.22 Favored 'General case' 0 C--N 1.286 -2.158 0 CA-C-N 114.67 -1.15 . . . . 0.0 108.802 176.009 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.532 HG23 ' CD1' ' A' ' 104' ' ' ILE . 11.5 mt -107.97 127.04 64.43 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 N-CA-C 106.182 -1.784 . . . . 0.0 106.182 176.543 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -129.07 167.94 20.96 Favored Glycine 0 C--N 1.28 -2.566 0 N-CA-C 110.357 -1.097 . . . . 0.0 110.357 179.03 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 75.7 30.32 0.79 Allowed 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.644 1.178 . . . . 0.0 111.179 -179.056 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.455 HD11 HD11 ' A' ' 47' ' ' ILE . 4.1 mm? -66.94 154.54 40.83 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.639 -0.71 . . . . 0.0 112.047 178.826 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.422 ' HB3' ' HG ' ' A' ' 42' ' ' LEU . 42.8 t-20 -95.03 146.06 24.52 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 106.225 -1.768 . . . . 0.0 106.225 174.728 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.63 ' HA ' ' OG ' ' A' ' 71' ' ' SER . 8.0 ppt_? -60.52 -23.31 64.47 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 122.96 0.504 . . . . 0.0 112.332 178.734 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.4 ' HG2' ' CG ' ' A' ' 39' ' ' ASN . 11.2 pt-20 -88.61 -9.53 51.86 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.798 -178.521 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.422 ' HG ' ' HB3' ' A' ' 39' ' ' ASN . 67.1 mt -80.99 125.96 30.79 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 121.188 0.518 . . . . 0.0 110.874 -177.872 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 66.9 p -107.31 173.36 6.36 Favored 'General case' 0 C--N 1.293 -1.867 0 CA-C-N 114.885 -1.052 . . . . 0.0 110.063 -178.252 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.8 mp0 -57.66 -40.54 79.59 Favored 'General case' 0 N--CA 1.433 -1.282 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.449 177.005 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -59.42 -38.49 93.54 Favored Glycine 0 N--CA 1.445 -0.716 0 O-C-N 123.681 0.613 . . . . 0.0 112.629 179.119 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -67.25 -49.19 65.36 Favored 'General case' 0 CA--C 1.499 -1.002 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 179.115 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.455 HD11 HD11 ' A' ' 38' ' ' LEU . 54.4 mt -59.73 -47.39 91.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.074 -0.966 . . . . 0.0 110.616 179.436 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 49.4 mt -59.72 -44.55 93.68 Favored 'General case' 0 CA--C 1.49 -1.345 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.468 -177.138 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.453 HG23 ' H ' ' B' ' 233' ' ' ASP . 62.5 m -61.69 -46.27 90.41 Favored 'General case' 0 C--N 1.31 -1.13 0 O-C-N 123.454 0.471 . . . . 0.0 111.636 -178.553 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.435 HG13 ' HG3' ' B' ' 237' ' ' ARG . 86.8 t -67.3 -47.59 80.73 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.777 -178.755 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.409 ' HD2' ' HH ' ' A' ' 79' ' ' TYR . 3.7 m-85 -65.92 -23.82 66.7 Favored 'General case' 0 N--CA 1.435 -1.177 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.725 -179.235 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.533 ' OG ' ' HB2' ' B' ' 231' ' ' ARG . 70.0 m -70.69 -18.53 62.82 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 176.255 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -76.06 -28.96 57.82 Favored 'General case' 0 C--O 1.249 1.051 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 176.726 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 51.7 m-85 -86.23 -23.19 26.52 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.279 -176.709 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 177.4 -155.89 18.81 Favored Glycine 0 N--CA 1.43 -1.74 0 C-N-CA 120.4 -0.905 . . . . 0.0 112.546 177.325 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 69.3 t -107.66 108.66 61.84 Favored Pre-proline 0 C--N 1.303 -1.438 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 -179.617 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.402 ' HB3' HD21 ' A' ' 77' ' ' LEU . 73.8 Cg_endo -76.24 137.0 18.57 Favored 'Trans proline' 0 N--CA 1.439 -1.686 0 C-N-CA 122.175 1.917 . . . . 0.0 109.905 177.796 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 35.4 m -113.45 -23.83 4.14 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.864 0 C-N-CA 119.699 -0.8 . . . . 0.0 111.146 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.48 ' HB3' ' HG2' ' A' ' 78' ' ' LYS . 32.7 t70 -158.02 142.87 16.46 Favored 'General case' 0 C--O 1.244 0.812 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 178.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 14.1 p -140.57 135.95 35.41 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.238 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 178.167 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 78.7 mt -121.3 128.47 75.95 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 176.294 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -102.02 120.96 41.26 Favored 'General case' 0 C--N 1.29 -1.984 0 N-CA-C 105.742 -1.947 . . . . 0.0 105.742 175.251 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 15.7 m -80.98 117.6 21.74 Favored 'General case' 0 N--CA 1.415 -2.192 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 70.0 mtt85 -124.02 146.31 48.63 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-O 120.981 0.42 . . . . 0.0 111.298 -178.072 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -79.45 123.44 27.54 Favored 'General case' 0 N--CA 1.428 -1.547 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 177.486 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -61.02 -20.64 62.74 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 -174.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 14.9 m-80 -83.02 -45.6 13.86 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-O 120.716 0.294 . . . . 0.0 110.99 -176.543 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 65.1 p -94.24 -23.96 17.66 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.265 0.555 . . . . 0.0 111.808 -176.194 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.34 2.75 84.73 Favored Glycine 0 N--CA 1.441 -1.023 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 -175.577 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -92.24 164.25 13.61 Favored 'General case' 0 CA--C 1.49 -1.361 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 -177.67 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.63 ' OG ' ' HA ' ' A' ' 40' ' ' ARG . 53.7 p -70.84 145.52 50.23 Favored 'General case' 0 C--N 1.29 -2.005 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.776 -179.643 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 -81.87 4.15 23.45 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-O 120.949 0.404 . . . . 0.0 111.828 -178.105 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 90.3 13.01 60.73 Favored Glycine 0 N--CA 1.429 -1.769 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.027 179.323 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.426 ' HA ' HD23 ' A' ' 38' ' ' LEU . 45.6 p90 -154.08 158.85 41.09 Favored 'General case' 0 N--CA 1.431 -1.396 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 177.745 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -152.14 176.44 11.55 Favored 'General case' 0 N--CA 1.438 -1.043 0 O-C-N 123.568 0.543 . . . . 0.0 110.085 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -136.64 144.71 44.17 Favored 'General case' 0 C--N 1.306 -1.324 0 C-N-CA 123.292 0.637 . . . . 0.0 110.037 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.402 HD21 ' HB3' ' A' ' 57' ' ' PRO . 9.9 tt -149.28 140.68 23.27 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 176.451 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.48 ' HG2' ' HB3' ' A' ' 59' ' ' ASP . 22.0 ptmt -122.93 144.57 49.15 Favored 'General case' 0 C--O 1.257 1.486 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.409 ' HH ' ' HD2' ' A' ' 51' ' ' PHE . 86.2 m-85 -108.96 165.24 11.73 Favored 'General case' 0 C--N 1.29 -2.021 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.34 -177.781 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -68.4 -38.09 80.95 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 114.703 -1.135 . . . . 0.0 108.786 174.384 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.455 ' HA ' ' N ' ' A' ' 25' ' ' ASN . 12.3 t70 -126.23 145.9 50.21 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-O 121.324 0.583 . . . . 0.0 111.967 -178.574 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 20.0 mp0 -67.1 -29.28 68.99 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 124.495 1.118 . . . . 0.0 112.271 -178.39 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 58.3 mtm180 -61.06 -33.81 73.89 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-O 122.145 0.974 . . . . 0.0 111.692 178.228 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 51.1 m -64.27 -37.34 87.14 Favored 'General case' 0 C--N 1.28 -2.424 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.541 174.493 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.419 ' O ' HG23 ' A' ' 89' ' ' VAL . 52.6 p -63.18 -44.75 94.51 Favored 'General case' 0 C--O 1.22 -0.496 0 C-N-CA 120.424 -0.51 . . . . 0.0 110.432 -178.15 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 5.4 pt -65.86 -39.21 84.05 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 C-N-CA 122.49 0.316 . . . . 0.0 111.459 179.32 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.457 HD11 ' HB2' ' B' ' 224' ' ' PHE . 18.7 mt -60.21 -43.94 95.54 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 123.662 0.601 . . . . 0.0 110.903 175.489 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.402 ' HB1' HD12 ' A' ' 92' ' ' LEU . . . -71.69 -46.47 58.7 Favored 'General case' 0 N--CA 1.435 -1.189 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.757 -178.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 85' ' ' THR . 72.4 t -57.03 -48.29 82.06 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.71 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -179.42 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -63.63 -37.17 86.31 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-O 120.951 0.405 . . . . 0.0 111.437 -175.226 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.442 ' O ' ' HB2' ' B' ' 239' ' ' ASN . 85.4 m-20 -93.02 -21.09 19.95 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 -174.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.507 ' HB2' HG13 ' A' ' 104' ' ' ILE . 20.4 mt -99.3 -28.89 13.1 Favored 'General case' 0 C--N 1.291 -1.976 0 C-N-CA 120.455 -0.498 . . . . 0.0 111.506 -176.361 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -66.28 124.6 23.11 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 177.283 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 83.18 -0.59 89.65 Favored Glycine 0 C--N 1.304 -1.242 0 C-N-CA 121.099 -0.572 . . . . 0.0 112.608 -179.248 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 69.4 t80 -85.2 131.66 34.4 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 -178.433 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -90.62 119.42 30.85 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-O 121.172 0.51 . . . . 0.0 112.241 -176.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 48.5 mt -127.67 141.35 46.64 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 N-CA-C 105.866 -1.902 . . . . 0.0 105.866 172.464 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 60.34 18.24 49.3 Favored Glycine 0 CA--C 1.526 0.774 0 C-N-CA 121.41 -0.424 . . . . 0.0 113.939 178.315 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 85.44 11.26 75.43 Favored Glycine 0 N--CA 1.437 -1.266 0 C-N-CA 121.058 -0.592 . . . . 0.0 112.721 -179.042 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 16.1 ptp180 -135.5 145.3 46.96 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 117.115 0.458 . . . . 0.0 110.913 179.523 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -87.49 120.58 28.94 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.067 -177.115 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 12.4 mt -67.33 148.92 51.03 Favored 'General case' 0 C--N 1.31 -1.118 0 C-N-CA 123.789 0.836 . . . . 0.0 112.822 178.769 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 17.3 tppt? -124.6 118.75 27.23 Favored 'General case' 0 N--CA 1.422 -1.84 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.191 176.231 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.532 ' CD1' HG23 ' A' ' 35' ' ' ILE . 5.1 mm -119.96 136.38 57.25 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 179.372 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -142.09 146.47 35.45 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 81.1 m-70 -79.34 132.71 36.52 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.278 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 4.7 t -162.41 163.73 27.58 Favored 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 -175.217 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -99.34 112.94 25.02 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 174.771 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 35.5 t80 -105.86 134.45 48.96 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-N 115.945 -0.571 . . . . 0.0 109.667 179.785 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -115.64 118.8 38.66 Favored Pre-proline 0 C--N 1.301 -1.542 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 176.171 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -63.88 143.98 87.14 Favored 'Trans proline' 0 C--O 1.251 1.174 0 C-N-CA 123.207 2.604 . . . . 0.0 114.36 -178.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 26.6 tptp -81.5 124.8 29.78 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-N 114.713 -1.131 . . . . 0.0 108.846 176.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 36.3 mmt180 . . . . . 0 C--N 1.286 -2.173 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 176.334 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 222' ' ' ASN . . . . . 0.402 ' HB2' HD23 ' A' ' 87' ' ' LEU . 2.7 m-20 . . . . . 0 N--CA 1.47 0.56 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 223' ' ' ARG . . . . . . . . . . . . 0.312 46.7 mtp180 73.67 51.94 0.12 Allowed 'General case' 0 CA--C 1.482 -1.646 0 N-CA-C 114.703 1.372 . . . . 0.0 114.703 176.112 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 224' ' ' PHE . . . . . 0.457 ' HB2' HD11 ' A' ' 87' ' ' LEU . 49.9 m-85 -117.23 165.71 13.12 Favored 'General case' 0 C--N 1.265 -3.075 0 CA-C-N 113.462 -1.699 . . . . 0.0 109.454 177.382 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 225' ' ' ALA . . . . . . . . . . . . . . . -108.7 39.68 1.96 Allowed 'General case' 0 C--N 1.304 -1.401 0 CA-C-O 121.348 0.594 . . . . 0.0 110.538 -173.155 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 4.2 mp -103.17 129.56 54.78 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 C-N-CA 120.685 -0.406 . . . . 0.0 109.936 179.297 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 227' ' ' MET . . . . . . . . . . . . . 27.8 ptm -89.11 149.31 42.87 Favored Pre-proline 0 C--N 1.307 -1.251 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 177.033 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 228' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -63.62 151.04 86.92 Favored 'Trans proline' 0 C--O 1.244 0.806 0 C-N-CA 123.443 2.762 . . . . 0.0 113.564 -177.588 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . -77.79 174.92 54.68 Favored Glycine 0 C--O 1.246 0.869 0 CA-C-N 115.432 -0.804 . . . . 0.0 112.546 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 17.6 m -76.3 -17.06 59.62 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -176.333 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 231' ' ' ARG . . . . . 0.533 ' HB2' ' OG ' ' A' ' 52' ' ' SER . 9.8 mmm180 -79.82 -8.27 59.18 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 120.794 0.33 . . . . 0.0 111.324 179.63 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 232' ' ' TRP . . . . . . . . . . . . . 24.5 t90 -72.02 128.62 36.29 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-O 122.125 0.964 . . . . 0.0 111.383 179.078 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 233' ' ' ASP . . . . . 0.458 ' O ' ' N ' ' B' ' 235' ' ' VAL . 16.7 t70 -123.33 140.2 53.25 Favored 'General case' 0 C--N 1.265 -3.106 0 N-CA-C 101.586 -3.487 . . . . 0.0 101.586 173.409 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -36.9 61.12 0.0 OUTLIER Glycine 0 N--CA 1.501 3.024 0 C-N-CA 128.622 3.011 . . . . 0.0 116.72 -179.447 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 235' ' ' VAL . . . . . 0.477 HG12 ' HG2' ' B' ' 237' ' ' ARG . 55.9 t -112.4 126.31 69.78 Favored 'Isoleucine or valine' 0 C--N 1.253 -3.621 0 C-N-CA 128.132 2.573 . . . . 0.0 107.781 175.579 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 236' ' ' HIS . . . . . . . . . . . . . 57.5 t-80 -105.3 115.72 30.74 Favored 'General case' 0 C--N 1.288 -2.082 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 178.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 237' ' ' ARG . . . . . 0.477 ' HG2' HG12 ' B' ' 235' ' ' VAL . 38.0 mmt180 -124.8 109.71 13.41 Favored 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 120.158 -0.617 . . . . 0.0 110.187 177.504 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 238' ' ' SER . . . . . . . . . . . . . 45.9 t -129.98 143.77 50.97 Favored 'General case' 0 C--N 1.292 -1.896 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.411 179.073 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 239' ' ' ASN . . . . . 0.442 ' HB2' ' O ' ' A' ' 91' ' ' ASN . 17.2 t-20 -74.08 -17.49 60.95 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 176.569 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 240' ' ' GLY . . . . . 0.494 ' O ' ' HG2' ' B' ' 244' ' ' LYS . . . 106.73 36.64 2.55 Favored Glycine 0 N--CA 1.416 -2.664 0 CA-C-N 114.69 -1.141 . . . . 0.0 110.489 -177.841 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 49.7 p90 -75.95 -35.94 59.51 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -178.148 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -66.35 -38.74 88.3 Favored 'General case' 0 CA--C 1.5 -0.979 0 CA-C-N 116.727 -0.215 . . . . 0.0 111.04 -176.005 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -60.51 -35.16 75.28 Favored 'General case' 0 C--O 1.202 -1.396 0 O-C-N 123.597 0.561 . . . . 0.0 110.483 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 244' ' ' LYS . . . . . 0.494 ' HG2' ' O ' ' B' ' 240' ' ' GLY . 70.4 mmtt -67.14 -41.82 85.44 Favored 'General case' 0 CA--C 1.509 -0.628 0 CA-C-O 121.662 0.744 . . . . 0.0 109.137 -178.091 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 245' ' ' TRP . . . . . . . . . . . . . 45.3 m0 -68.93 -41.07 78.61 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 114.853 -1.067 . . . . 0.0 109.58 179.107 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 246' ' ' PHE . . . . . 0.548 ' O ' ' HG2' ' B' ' 249' ' ' GLN . 5.2 t80 -65.86 -37.86 87.3 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.777 179.155 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -68.02 -33.33 74.4 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.556 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.9 -21.05 21.58 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 120.669 -0.413 . . . . 0.0 111.946 -177.607 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 249' ' ' GLN . . . . . 0.548 ' HG2' ' O ' ' B' ' 246' ' ' PHE . 12.6 pt20 -75.42 2.29 11.79 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.092 0.472 . . . . 0.0 111.287 -178.056 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 250' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -56.91 -38.57 73.03 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.319 178.077 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -139.57 113.55 8.76 Favored 'General case' 0 N--CA 1.439 -0.987 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 175.755 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 252' ' ' ILE . . . . . . . . . . . . . 27.8 pt -102.54 -37.48 4.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 -172.288 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -108.87 -18.07 13.78 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-O 121.846 0.832 . . . . 0.0 110.048 -175.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 254' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -84.51 -174.12 5.1 Favored 'General case' 0 C--N 1.29 -2.018 0 CA-C-N 114.205 -1.361 . . . . 0.0 112.054 -176.476 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 255' ' ' LYS . . . . . 0.411 ' HD2' ' O ' ' B' ' 255' ' ' LYS . 2.0 pptp? -57.24 130.99 48.65 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-N 115.103 -0.953 . . . . 0.0 111.502 178.2 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 256' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt . . . . . 0 C--N 1.305 -1.361 0 CA-C-O 118.965 -0.541 . . . . 0.0 110.653 -175.636 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 49.3 t-20 . . . . . 0 C--O 1.244 0.808 0 CA-C-O 121.615 0.722 . . . . 0.0 109.616 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -76.9 -23.98 52.52 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 115.151 -0.931 . . . . 0.0 112.018 -173.372 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 40.5 m-85 -87.24 6.39 33.42 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-O 121.716 0.769 . . . . 0.0 112.856 -173.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -95.97 -39.51 9.74 Favored 'General case' 0 C--N 1.284 -2.244 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 174.509 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . 0.264 14.8 m-20 65.89 -12.52 0.17 Allowed 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 126.141 1.776 . . . . 0.0 114.859 178.44 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 47.3 m-80 -79.77 29.83 0.26 Allowed 'General case' 0 C--N 1.303 -1.442 0 C-N-CA 123.593 0.757 . . . . 0.0 110.716 178.013 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.454 ' HA ' HG21 ' A' ' 85' ' ' THR . . . -99.31 2.16 45.19 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.971 -176.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -103.68 144.65 31.17 Favored 'General case' 0 N--CA 1.429 -1.518 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.831 -174.336 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 25.1 pt -141.37 157.05 21.7 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.742 0 CA-C-N 115.476 -0.783 . . . . 0.0 109.462 178.803 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.422 ' HB2' HG21 ' A' ' 107' ' ' THR . 16.5 t80 -108.81 123.04 48.42 Favored 'General case' 0 N--CA 1.411 -2.378 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 176.806 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.505 HG23 ' CD1' ' A' ' 104' ' ' ILE . 12.0 mt -107.83 126.97 64.26 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.931 0 N-CA-C 105.792 -1.929 . . . . 0.0 105.792 176.518 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -129.01 165.4 21.8 Favored Glycine 0 N--CA 1.418 -2.556 0 N-CA-C 112.041 -0.424 . . . . 0.0 112.041 -177.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 63.57 51.97 2.39 Favored 'General case' 0 C--N 1.314 -0.951 0 C-N-CA 125.146 1.378 . . . . 0.0 109.876 -177.672 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.408 HD11 HD11 ' A' ' 47' ' ' ILE . 3.1 mm? -78.37 161.2 27.34 Favored 'General case' 0 CA--C 1.502 -0.884 0 CA-C-N 113.99 -1.459 . . . . 0.0 111.482 178.499 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.493 ' HB3' ' HG ' ' A' ' 42' ' ' LEU . 49.8 t-20 -98.12 145.5 26.51 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 174.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.552 ' HD2' ' N ' ' A' ' 41' ' ' GLU . 7.4 ppt_? -58.79 -27.13 64.73 Favored 'General case' 0 C--N 1.31 -1.137 0 C-N-CA 123.543 0.737 . . . . 0.0 111.924 179.592 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.552 ' N ' ' HD2' ' A' ' 40' ' ' ARG . 11.4 pt-20 -85.59 -11.82 53.04 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.543 -176.366 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.493 ' HG ' ' HB3' ' A' ' 39' ' ' ASN . 79.0 mt -84.21 118.73 24.34 Favored 'General case' 0 CA--C 1.492 -1.279 0 CA-C-O 121.474 0.654 . . . . 0.0 111.09 -176.695 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 46.6 p -107.82 173.92 6.11 Favored 'General case' 0 N--CA 1.414 -2.273 0 CA-C-N 114.417 -1.265 . . . . 0.0 109.445 -178.433 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.479 ' HG3' ' HB2' ' A' ' 62' ' ' LEU . 1.7 mp0 -54.92 -41.37 70.93 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 123.871 0.868 . . . . 0.0 109.759 178.757 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.17 -43.28 98.56 Favored Glycine 0 N--CA 1.439 -1.126 0 CA-C-N 115.545 -0.752 . . . . 0.0 112.894 -179.219 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -68.1 -45.29 74.13 Favored 'General case' 0 CA--C 1.513 -0.444 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 -179.539 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.408 HD11 HD11 ' A' ' 38' ' ' LEU . 37.9 mt -58.55 -44.12 88.61 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.488 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.707 178.571 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 43.8 mt -59.37 -44.7 92.68 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.51 HG23 ' H ' ' B' ' 233' ' ' ASP . 89.4 m -61.66 -46.26 90.48 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 120.804 0.335 . . . . 0.0 111.619 178.844 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.556 HG13 ' HG3' ' B' ' 237' ' ' ARG . 84.6 t -63.18 -49.47 83.09 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.379 179.61 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.427 ' HA ' ' HD2' ' A' ' 54' ' ' TYR . 4.1 m-85 -69.43 -23.08 63.63 Favored 'General case' 0 N--CA 1.433 -1.318 0 C-N-CA 123.583 0.753 . . . . 0.0 112.868 -177.257 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.472 ' OG ' ' HB2' ' B' ' 231' ' ' ARG . 72.6 m -68.57 -20.1 64.51 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 111.917 0.34 . . . . 0.0 111.917 176.655 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -63.47 -28.0 69.66 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-O 122.029 0.919 . . . . 0.0 109.007 173.46 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.427 ' HD2' ' HA ' ' A' ' 51' ' ' PHE . 50.9 m-85 -96.3 -2.87 45.0 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.262 -174.452 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 148.21 -152.96 24.96 Favored Glycine 0 N--CA 1.42 -2.432 0 C-N-CA 119.975 -1.107 . . . . 0.0 112.015 178.687 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 61.8 t -107.52 111.01 63.06 Favored Pre-proline 0 C--N 1.296 -1.742 0 CA-C-O 120.717 0.294 . . . . 0.0 110.948 -177.66 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.493 ' HB3' HD21 ' A' ' 77' ' ' LEU . 58.7 Cg_endo -74.74 145.49 32.6 Favored 'Trans proline' 0 N--CA 1.45 -1.081 0 C-N-CA 122.719 2.279 . . . . 0.0 110.041 174.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.416 ' CG2' ' HG3' ' A' ' 78' ' ' LYS . 34.4 m -116.45 -24.97 3.3 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 C-N-CA 119.674 -0.81 . . . . 0.0 111.463 177.5 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -158.36 147.57 19.26 Favored 'General case' 0 C--O 1.249 1.07 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.548 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 12.5 p -145.78 132.47 14.53 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-O 121.002 0.429 . . . . 0.0 110.432 -179.147 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 84.2 mt -120.62 126.85 75.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 177.7 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.479 ' HB2' ' HG3' ' A' ' 44' ' ' GLU . 0.2 OUTLIER -100.3 122.73 43.54 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 105.753 -1.944 . . . . 0.0 105.753 175.533 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 15.4 m -82.13 116.8 21.86 Favored 'General case' 0 N--CA 1.406 -2.648 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 178.453 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 84.3 mtt180 -127.57 153.33 46.52 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-O 121.43 0.634 . . . . 0.0 110.82 -175.543 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -83.99 122.59 28.96 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 106.349 -1.723 . . . . 0.0 106.349 174.751 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -61.37 -22.15 64.7 Favored 'General case' 0 C--N 1.29 -2.016 0 C-N-CA 124.018 0.927 . . . . 0.0 112.939 -175.163 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 22.6 m-80 -82.6 -46.0 13.87 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-O 121.074 0.464 . . . . 0.0 110.868 -177.345 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 54.6 p -88.79 -23.73 22.79 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.424 -176.294 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.62 8.72 86.25 Favored Glycine 0 N--CA 1.446 -0.692 0 N-CA-C 110.891 -0.883 . . . . 0.0 110.891 -177.683 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.424 ' OE2' ' HD3' ' A' ' 40' ' ' ARG . 40.2 mt-10 -108.35 167.15 10.23 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-O 120.701 0.286 . . . . 0.0 110.241 -176.151 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 44.9 t -63.13 149.76 44.46 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-O 121.799 0.809 . . . . 0.0 111.029 -178.714 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -87.48 -2.9 58.94 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.111 176.714 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 100.19 17.65 24.19 Favored Glycine 0 N--CA 1.429 -1.781 0 CA-C-N 115.475 -0.784 . . . . 0.0 112.536 178.446 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -160.86 156.83 25.63 Favored 'General case' 0 C--O 1.244 0.801 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 177.38 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -152.81 175.98 12.29 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-O 120.789 0.328 . . . . 0.0 110.995 179.553 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -134.88 143.18 46.82 Favored 'General case' 0 C--N 1.317 -0.813 0 C-N-CA 123.989 0.915 . . . . 0.0 110.425 -177.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.493 HD21 ' HB3' ' A' ' 57' ' ' PRO . 10.0 tt -150.07 140.59 22.48 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 175.571 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.416 ' HG3' ' CG2' ' A' ' 58' ' ' VAL . 20.8 ptmt -122.56 144.18 49.26 Favored 'General case' 0 C--O 1.255 1.394 0 CA-C-O 121.02 0.438 . . . . 0.0 109.951 179.61 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -108.9 164.58 12.27 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.539 -178.389 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -74.59 -25.64 59.39 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 114.822 -1.081 . . . . 0.0 109.736 175.349 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -127.77 136.76 51.93 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.073 -175.323 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -69.74 -19.9 63.53 Favored 'General case' 0 C--N 1.313 -1.022 0 N-CA-C 113.191 0.811 . . . . 0.0 113.191 177.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 90.9 mtm180 -68.24 -34.64 76.6 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-O 122.261 1.029 . . . . 0.0 109.592 174.62 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 67.2 m -65.21 -37.37 87.08 Favored 'General case' 0 C--N 1.286 -2.173 0 CA-C-N 114.702 -1.135 . . . . 0.0 112.226 178.269 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.46 ' O ' HG23 ' A' ' 89' ' ' VAL . 77.3 p -64.93 -45.62 85.05 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 120.438 -0.505 . . . . 0.0 110.577 -178.455 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 6.7 pt -64.8 -38.63 83.2 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.093 177.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.674 HD11 ' HB2' ' B' ' 224' ' ' PHE . 13.2 mt -58.87 -43.6 90.92 Favored 'General case' 0 C--O 1.242 0.696 0 O-C-N 123.296 0.372 . . . . 0.0 111.006 176.248 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.412 ' HB1' HD12 ' A' ' 92' ' ' LEU . . . -70.84 -46.75 62.16 Favored 'General case' 0 N--CA 1.435 -1.204 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.208 -178.626 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 85' ' ' THR . 78.2 t -56.73 -47.05 83.2 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.581 0 CA-C-O 121.446 0.641 . . . . 0.0 110.739 179.229 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -59.02 -39.16 81.06 Favored 'General case' 0 C--N 1.295 -1.78 0 C-N-CA 125.221 1.408 . . . . 0.0 112.518 -176.597 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 48.9 m-80 -98.49 -22.5 15.98 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 113.798 1.036 . . . . 0.0 113.798 -175.648 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.515 ' HB2' HG13 ' A' ' 104' ' ' ILE . 18.6 mt -94.92 -30.05 14.35 Favored 'General case' 0 C--N 1.293 -1.889 0 C-N-CA 120.685 -0.406 . . . . 0.0 111.435 -174.284 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 50.2 t-20 -65.64 124.25 21.87 Favored 'General case' 0 N--CA 1.434 -1.265 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 176.198 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 84.38 -0.33 89.32 Favored Glycine 0 C--N 1.3 -1.468 0 C-N-CA 119.888 -1.148 . . . . 0.0 113.1 -179.646 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -92.24 136.8 32.9 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -95.57 120.06 35.17 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-O 121.061 0.458 . . . . 0.0 112.069 -176.127 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 55.3 mt -126.89 141.69 45.49 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 N-CA-C 106.565 -1.643 . . . . 0.0 106.565 174.25 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 60.08 19.79 52.18 Favored Glycine 0 CA--C 1.527 0.836 0 O-C-N 122.929 0.143 . . . . 0.0 113.275 -179.607 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 85.89 12.14 72.13 Favored Glycine 0 N--CA 1.438 -1.184 0 C-N-CA 121.497 -0.383 . . . . 0.0 113.07 -179.573 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.448 ' NH1' ' HA ' ' A' ' 39' ' ' ASN . 17.4 ptp180 -137.87 149.69 46.49 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 117.861 0.831 . . . . 0.0 110.719 178.91 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -83.7 126.18 32.63 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-O 120.64 0.257 . . . . 0.0 110.84 -178.136 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.414 ' HA ' HD23 ' A' ' 102' ' ' LEU . 12.1 mt -76.24 143.75 40.79 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-O 121.705 0.764 . . . . 0.0 112.629 178.024 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 5.3 tppp? -115.73 119.4 35.92 Favored 'General case' 0 N--CA 1.416 -2.146 0 CA-C-N 114.875 -1.057 . . . . 0.0 109.159 176.395 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.515 HG13 ' HB2' ' A' ' 92' ' ' LEU . 5.0 mm -121.42 135.99 59.8 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 178.777 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -144.05 150.46 38.23 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 177.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -75.17 144.13 42.88 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 177.213 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.422 HG21 ' HB2' ' A' ' 34' ' ' TYR . 12.3 t -163.21 165.98 23.78 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 106.7 -1.593 . . . . 0.0 106.7 -178.823 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -109.9 110.91 22.03 Favored 'General case' 0 N--CA 1.428 -1.536 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 171.174 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 16.5 t80 -106.28 135.95 46.86 Favored 'General case' 0 C--N 1.288 -2.074 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 -178.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 16.8 mmm180 -117.55 115.26 37.61 Favored Pre-proline 0 C--N 1.301 -1.542 0 C-N-CA 119.552 -0.859 . . . . 0.0 109.68 176.713 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -70.95 153.42 63.48 Favored 'Trans proline' 0 C--O 1.25 1.079 0 C-N-CA 123.061 2.508 . . . . 0.0 111.142 177.26 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.504 ' HD3' ' C ' ' A' ' 112' ' ' LYS . 10.4 tmtt? -108.69 122.4 47.04 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 107.189 -1.411 . . . . 0.0 107.189 176.656 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 31.3 mmm180 . . . . . 0 C--N 1.295 -1.779 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 178.044 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 49.6 t-20 . . . . . 0 CA--C 1.545 0.786 0 CA-C-O 120.532 0.206 . . . . 0.0 110.932 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 223' ' ' ARG . . . . . . . . . . . . 0.466 18.7 ttm180 59.84 54.25 4.41 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 118.927 2.936 . . . . 0.0 118.927 171.07 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 224' ' ' PHE . . . . . 0.674 ' HB2' HD11 ' A' ' 87' ' ' LEU . 17.2 m-85 -96.48 165.78 12.01 Favored 'General case' 0 C--N 1.287 -2.139 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 176.903 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 225' ' ' ALA . . . . . . . . . . . . . . . -110.62 68.45 0.67 Allowed 'General case' 0 C--N 1.306 -1.322 0 CA-C-O 121.587 0.708 . . . . 0.0 111.488 -173.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 4.4 mp -118.83 131.88 70.34 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.853 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 227' ' ' MET . . . . . . . . . . . . . 26.7 ptt? -67.67 147.93 98.61 Favored Pre-proline 0 C--N 1.321 -0.657 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.061 179.658 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 228' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -78.56 150.65 24.89 Favored 'Trans proline' 0 C--O 1.253 1.23 0 C-N-CA 123.057 2.505 . . . . 0.0 112.393 -179.38 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . -73.04 167.04 54.37 Favored Glycine 0 C--N 1.315 -0.603 0 CA-C-N 116.003 -0.544 . . . . 0.0 112.52 178.137 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 21.6 t -70.5 -13.89 62.3 Favored 'General case' 0 C--N 1.317 -0.825 0 C-N-CA 123.228 0.611 . . . . 0.0 111.332 -177.183 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 231' ' ' ARG . . . . . 0.472 ' HB2' ' OG ' ' A' ' 52' ' ' SER . 31.5 mmt180 -78.94 -9.02 59.38 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.658 -0.246 . . . . 0.0 111.041 179.628 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 232' ' ' TRP . . . . . 0.414 ' HB2' ' CB ' ' A' ' 52' ' ' SER . 19.2 t90 -77.34 129.47 35.88 Favored 'General case' 0 N--CA 1.427 -1.603 0 CA-C-O 122.29 1.043 . . . . 0.0 111.319 -179.487 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 233' ' ' ASP . . . . . 0.51 ' H ' HG23 ' A' ' 49' ' ' THR . 9.4 t70 -123.35 136.15 54.52 Favored 'General case' 0 C--N 1.265 -3.093 0 N-CA-C 100.926 -3.731 . . . . 0.0 100.926 175.321 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -39.82 62.45 0.0 OUTLIER Glycine 0 N--CA 1.498 2.778 0 C-N-CA 128.4 2.905 . . . . 0.0 116.87 -177.222 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 235' ' ' VAL . . . . . 0.47 HG12 ' HG2' ' B' ' 237' ' ' ARG . 47.5 t -111.38 118.23 56.98 Favored 'Isoleucine or valine' 0 C--N 1.251 -3.682 0 C-N-CA 127.71 2.404 . . . . 0.0 107.48 176.743 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 236' ' ' HIS . . . . . . . . . . . . . 73.4 t60 -86.15 114.7 23.21 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 -175.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 237' ' ' ARG . . . . . 0.556 ' HG3' HG13 ' A' ' 50' ' ' VAL . 39.1 mmt180 -126.45 108.25 11.01 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 120.038 -0.665 . . . . 0.0 111.982 -178.842 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 238' ' ' SER . . . . . . . . . . . . . 59.2 p -147.62 152.29 37.65 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 176.234 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 239' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -68.0 134.91 51.49 Favored 'General case' 0 C--O 1.251 1.141 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 178.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 240' ' ' GLY . . . . . 0.513 ' O ' ' HE2' ' B' ' 244' ' ' LYS . . . -149.33 43.58 0.76 Allowed Glycine 0 C--O 1.19 -2.644 0 C-N-CA 119.605 -1.283 . . . . 0.0 112.622 -177.181 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 26.2 p90 -76.51 -33.82 58.6 Favored 'General case' 0 C--N 1.29 -2.001 0 CA-C-N 117.531 0.665 . . . . 0.0 111.094 178.113 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -66.79 -38.84 87.31 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.722 -178.249 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -62.15 -35.2 78.06 Favored 'General case' 0 C--O 1.21 -0.989 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.83 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 244' ' ' LYS . . . . . 0.513 ' HE2' ' O ' ' B' ' 240' ' ' GLY . 68.9 mmtt -65.61 -44.04 87.77 Favored 'General case' 0 CA--C 1.502 -0.884 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 -177.128 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 245' ' ' TRP . . . . . 0.426 ' O ' ' HB3' ' B' ' 249' ' ' GLN . 39.6 m0 -61.82 -43.23 99.27 Favored 'General case' 0 C--O 1.208 -1.107 0 CA-C-N 115.075 -0.966 . . . . 0.0 109.315 178.566 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 246' ' ' PHE . . . . . 0.49 ' O ' ' HG2' ' B' ' 249' ' ' GLN . 4.5 t80 -66.94 -32.44 73.69 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.405 179.037 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -77.41 -39.88 45.51 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.301 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.23 -12.78 36.98 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 -175.686 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 249' ' ' GLN . . . . . 0.49 ' HG2' ' O ' ' B' ' 246' ' ' PHE . 13.1 pt20 -66.27 -8.51 25.27 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 120.946 0.403 . . . . 0.0 111.038 -178.822 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 250' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -68.04 -28.58 67.51 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 177.074 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 251' ' ' GLU . . . . . 0.554 ' HB3' ' HB2' ' B' ' 254' ' ' GLU . 42.7 mt-10 -86.19 114.52 23.09 Favored 'General case' 0 N--CA 1.421 -1.905 0 CA-C-N 114.145 -1.388 . . . . 0.0 107.552 177.403 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 252' ' ' ILE . . . . . . . . . . . . . 41.2 pt -118.5 -25.92 2.72 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -174.53 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -105.61 -15.65 14.92 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 -177.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 254' ' ' GLU . . . . . 0.554 ' HB2' ' HB3' ' B' ' 251' ' ' GLU . 11.7 mp0 -59.49 172.75 0.62 Allowed 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 125.585 1.554 . . . . 0.0 114.722 -177.065 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 255' ' ' LYS . . . . . . . . . . . . . 53.3 mttp -86.81 -40.49 14.9 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 114.453 -1.249 . . . . 0.0 111.24 -174.081 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 256' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt . . . . . 0 C--N 1.298 -1.654 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.934 -177.394 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 16.4 m120 . . . . . 0 C--O 1.242 0.707 0 CA-C-O 121.358 0.599 . . . . 0.0 109.826 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.403 ' H ' ' CD ' ' A' ' 26' ' ' GLU . 0.5 OUTLIER -83.96 -1.06 53.9 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -176.365 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -88.3 2.38 52.57 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 122.497 1.141 . . . . 0.0 110.64 176.277 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 47.5 mmtm -122.18 -63.65 1.27 Allowed 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 104.758 -2.312 . . . . 0.0 104.758 170.353 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.4 ' C ' ' H ' ' A' ' 31' ' ' ALA . 12.0 t0 52.21 35.84 17.81 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 113.51 -1.677 . . . . 0.0 110.79 177.315 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -80.73 31.17 0.3 Allowed 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 114.292 -1.322 . . . . 0.0 110.246 -179.418 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.4 ' H ' ' C ' ' A' ' 29' ' ' ASP . . . -96.23 22.87 7.16 Favored 'General case' 0 C--N 1.307 -1.251 0 C-N-CA 123.95 0.9 . . . . 0.0 111.711 -174.232 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 13.2 m-30 -93.85 144.83 25.08 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 120.196 -0.602 . . . . 0.0 110.359 -176.301 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 23.6 pt -142.64 161.01 18.8 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.096 175.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.424 ' HB2' HG21 ' A' ' 107' ' ' THR . 65.2 t80 -111.52 123.28 49.9 Favored 'General case' 0 N--CA 1.413 -2.305 0 CA-C-N 114.742 -1.117 . . . . 0.0 108.049 178.469 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 13.1 mt -108.39 127.26 64.88 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.047 0 N-CA-C 105.975 -1.861 . . . . 0.0 105.975 175.232 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -124.44 156.36 18.5 Favored Glycine 0 N--CA 1.42 -2.374 0 N-CA-C 111.802 -0.519 . . . . 0.0 111.802 -177.089 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.422 HD21 ' HB2' ' A' ' 100' ' ' ARG . 64.3 t30 67.07 57.57 0.6 Allowed 'General case' 0 C--N 1.314 -0.946 0 C-N-CA 125.4 1.48 . . . . 0.0 110.682 -177.669 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.427 HD11 HD11 ' A' ' 47' ' ' ILE . 3.1 mm? -82.96 143.91 30.35 Favored 'General case' 0 CA--C 1.485 -1.553 0 CA-C-N 114.426 -1.261 . . . . 0.0 110.002 176.588 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.445 HD22 ' HA3' ' A' ' 98' ' ' GLY . 38.4 t-20 -79.32 144.92 33.78 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 176.629 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.562 ' HD2' ' N ' ' A' ' 41' ' ' GLU . 0.8 OUTLIER -59.4 -24.69 63.66 Favored 'General case' 0 C--N 1.302 -1.458 0 C-N-CA 123.471 0.709 . . . . 0.0 112.23 179.528 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.562 ' N ' ' HD2' ' A' ' 40' ' ' ARG . 11.4 pt-20 -89.0 -14.32 36.82 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.609 -177.386 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.423 ' HG ' ' HB3' ' A' ' 39' ' ' ASN . 54.0 mt -75.51 132.09 40.53 Favored 'General case' 0 CA--C 1.5 -0.974 0 CA-C-O 121.548 0.69 . . . . 0.0 111.781 -176.228 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 42.0 p -114.81 172.7 6.88 Favored 'General case' 0 N--CA 1.418 -2.03 0 CA-C-N 114.725 -1.125 . . . . 0.0 111.046 -177.117 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -56.19 -42.46 77.17 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 123.707 0.803 . . . . 0.0 110.503 179.481 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -59.99 -38.27 93.96 Favored Glycine 0 C--O 1.24 0.484 0 CA-C-N 115.497 -0.774 . . . . 0.0 112.541 -179.358 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 49.9 m-20 -67.19 -49.61 63.99 Favored 'General case' 0 CA--C 1.494 -1.198 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.427 HD11 HD11 ' A' ' 38' ' ' LEU . 47.0 mt -58.87 -46.35 91.21 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 CA-C-N 115.131 -0.94 . . . . 0.0 110.706 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 40.9 mt -59.81 -43.7 94.35 Favored 'General case' 0 CA--C 1.499 -1.017 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.605 -178.224 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.436 HG23 ' H ' ' B' ' 233' ' ' ASP . 85.6 m -63.36 -46.43 86.58 Favored 'General case' 0 C--N 1.313 -1.016 0 O-C-N 123.408 0.443 . . . . 0.0 111.165 -178.589 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.407 HG13 ' HG3' ' B' ' 237' ' ' ARG . 97.2 t -66.22 -49.77 73.51 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.368 -178.355 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.447 ' HA ' ' HD2' ' A' ' 54' ' ' TYR . 4.8 m-85 -64.99 -19.89 66.22 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 123.974 0.909 . . . . 0.0 112.767 -178.132 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.514 ' OG ' ' HB2' ' B' ' 231' ' ' ARG . 60.2 m -72.97 -23.59 60.68 Favored 'General case' 0 N--CA 1.439 -0.989 0 N-CA-C 112.319 0.489 . . . . 0.0 112.319 176.657 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 50.2 tt0 -67.83 -20.52 65.17 Favored 'General case' 0 CA--C 1.56 1.349 0 CA-C-O 121.726 0.775 . . . . 0.0 110.115 177.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.458 ' OH ' ' HG ' ' A' ' 92' ' ' LEU . 41.3 m-85 -97.02 -10.2 26.62 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.608 -178.41 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 156.5 -159.12 29.25 Favored Glycine 0 N--CA 1.43 -1.747 0 C-N-CA 119.951 -1.118 . . . . 0.0 112.29 -179.574 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 77.5 t -103.58 110.17 63.34 Favored Pre-proline 0 C--N 1.306 -1.318 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 -176.367 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.512 ' HB3' HD21 ' A' ' 77' ' ' LEU . 99.0 Cg_endo -80.01 137.12 12.12 Favored 'Trans proline' 0 C--O 1.247 0.954 0 C-N-CA 123.034 2.489 . . . . 0.0 110.914 176.203 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 28.4 m -113.49 -20.06 6.4 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 -178.612 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.515 ' HB3' ' HG2' ' A' ' 78' ' ' LYS . 37.8 t70 -159.88 145.34 15.42 Favored 'General case' 0 C--O 1.249 1.038 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 14.3 p -144.68 134.43 19.17 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.595 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 86.1 mt -120.47 118.14 55.64 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.774 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 176.239 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -92.13 116.48 28.98 Favored 'General case' 0 C--N 1.28 -2.441 0 N-CA-C 104.677 -2.342 . . . . 0.0 104.677 175.728 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 33.6 m -79.77 115.93 19.65 Favored 'General case' 0 N--CA 1.414 -2.239 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 179.355 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 72.0 mtp180 -125.51 145.32 50.15 Favored 'General case' 0 CA--C 1.483 -1.617 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 -176.419 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -90.05 111.72 22.92 Favored 'General case' 0 C--N 1.289 -2.055 0 N-CA-C 106.017 -1.845 . . . . 0.0 106.017 178.113 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -61.05 -16.36 42.8 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 -175.105 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 22.1 m-80 -80.86 -44.5 18.29 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 -178.5 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 60.9 p -85.81 -24.36 26.83 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-O 121.166 0.508 . . . . 0.0 109.823 -179.246 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.81 9.93 86.64 Favored Glycine 0 N--CA 1.44 -1.082 0 N-CA-C 110.859 -0.897 . . . . 0.0 110.859 -178.654 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -115.94 167.92 10.53 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-O 120.726 0.298 . . . . 0.0 110.418 -175.245 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 43.3 t -61.7 144.26 54.88 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.849 175.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 -74.35 -17.88 60.76 Favored 'General case' 0 N--CA 1.432 -1.343 0 CA-C-O 121.556 0.693 . . . . 0.0 111.338 175.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 107.28 15.88 14.75 Favored Glycine 0 N--CA 1.427 -1.913 0 CA-C-N 115.386 -0.824 . . . . 0.0 112.472 -179.276 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 30.0 p90 -157.41 159.12 37.04 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 177.274 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -151.63 172.5 15.97 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-O 120.863 0.363 . . . . 0.0 110.582 179.532 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -130.75 142.66 50.42 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 123.762 0.825 . . . . 0.0 109.539 -179.248 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.512 HD21 ' HB3' ' A' ' 57' ' ' PRO . 10.2 tt -148.11 140.96 24.72 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 176.167 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.515 ' HG2' ' HB3' ' A' ' 59' ' ' ASP . 21.9 ptmt -123.82 144.3 49.81 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-O 121.356 0.598 . . . . 0.0 109.673 178.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -104.77 165.68 10.9 Favored 'General case' 0 C--N 1.282 -2.331 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.833 -178.812 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -77.31 -30.65 54.21 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 115.384 -0.825 . . . . 0.0 108.967 174.55 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.436 ' OD1' ' HB2' ' A' ' 83' ' ' ARG . 12.5 t70 -119.91 137.56 53.96 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 -176.437 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 26.0 mp0 -69.49 -25.71 64.19 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 113.377 0.88 . . . . 0.0 113.377 -177.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.436 ' HB2' ' OD1' ' A' ' 81' ' ' ASP . 0.1 OUTLIER -67.35 -33.34 75.03 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-O 122.014 0.911 . . . . 0.0 110.291 -179.342 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.461 ' OG ' HG21 ' B' ' 226' ' ' ILE . 51.5 m -59.39 -36.99 76.84 Favored 'General case' 0 C--N 1.281 -2.372 0 CA-C-N 115.307 -0.861 . . . . 0.0 111.657 175.295 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.429 ' O ' HG23 ' A' ' 89' ' ' VAL . 50.3 p -62.58 -45.3 93.55 Favored 'General case' 0 C--O 1.213 -0.823 0 C-N-CA 120.524 -0.47 . . . . 0.0 110.818 -178.17 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.418 ' H ' HG12 ' A' ' 86' ' ' ILE . 3.3 pt -66.34 -38.72 82.43 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.479 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.498 179.147 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.617 HD21 ' CD1' ' B' ' 224' ' ' PHE . 38.4 mt -59.63 -44.1 93.6 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.236 175.513 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.489 ' O ' ' HB2' ' A' ' 92' ' ' LEU . . . -72.08 -47.13 53.66 Favored 'General case' 0 N--CA 1.437 -1.112 0 CA-C-N 115.992 -0.549 . . . . 0.0 112.313 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.463 HG22 HG22 ' A' ' 104' ' ' ILE . 77.0 t -57.49 -49.12 81.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 -177.547 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -67.71 -38.94 84.3 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.783 -173.295 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -92.91 -20.27 20.82 Favored 'General case' 0 C--N 1.297 -1.701 0 CA-C-N 115.864 -0.607 . . . . 0.0 112.378 -172.128 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.489 ' HB2' ' O ' ' A' ' 88' ' ' ALA . 6.6 mt -93.19 -30.29 15.29 Favored 'General case' 0 C--N 1.315 -0.919 0 O-C-N 122.346 -0.221 . . . . 0.0 111.568 178.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 31.9 t-20 -59.25 124.2 19.22 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 179.043 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 88.86 -1.21 83.2 Favored Glycine 0 N--CA 1.442 -0.947 0 C-N-CA 121.064 -0.589 . . . . 0.0 113.417 177.43 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 67.3 t80 -86.51 141.75 28.85 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 117.579 0.69 . . . . 0.0 110.096 -179.35 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.425 ' HD2' ' N ' ' A' ' 96' ' ' LYS . 0.2 OUTLIER -98.05 116.15 29.69 Favored 'General case' 0 C--O 1.248 0.997 0 CA-C-O 121.153 0.502 . . . . 0.0 112.11 -177.137 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 58.1 mt -124.12 141.53 43.98 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 174.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.445 ' HA3' HD22 ' A' ' 39' ' ' ASN . . . 60.37 18.38 49.98 Favored Glycine 0 CA--C 1.521 0.438 0 N-CA-C 113.76 0.264 . . . . 0.0 113.76 179.461 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 83.88 14.31 72.91 Favored Glycine 0 N--CA 1.438 -1.223 0 C-N-CA 120.786 -0.721 . . . . 0.0 113.017 -178.571 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.422 ' HB2' HD21 ' A' ' 37' ' ' ASN . 17.5 ptp180 -136.78 150.12 48.18 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 117.696 0.748 . . . . 0.0 110.081 177.756 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -87.87 121.89 30.84 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 120.592 0.234 . . . . 0.0 111.368 -178.473 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 11.4 mt -73.02 145.63 46.51 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-O 121.675 0.75 . . . . 0.0 112.769 179.241 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 17.4 tptm -121.33 122.17 39.26 Favored 'General case' 0 N--CA 1.413 -2.303 0 CA-C-N 115.017 -0.992 . . . . 0.0 108.783 174.815 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.463 HG22 HG22 ' A' ' 89' ' ' VAL . 5.1 mm -116.17 135.09 57.47 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.018 0 N-CA-C 105.358 -2.09 . . . . 0.0 105.358 176.428 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -141.51 151.94 43.72 Favored 'General case' 0 C--N 1.285 -2.218 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 -176.705 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 75.2 m-70 -83.86 138.24 33.29 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.424 HG21 ' HB2' ' A' ' 34' ' ' TYR . 9.8 t -157.79 168.5 27.03 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 -178.461 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -110.16 113.04 25.41 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 106.317 -1.735 . . . . 0.0 106.317 169.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 56.8 t80 -105.55 136.88 44.32 Favored 'General case' 0 C--N 1.287 -2.12 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.703 -175.188 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 7.9 mpt_? -109.24 113.47 58.72 Favored Pre-proline 0 C--N 1.31 -1.117 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 175.364 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -73.09 147.03 42.21 Favored 'Trans proline' 0 C--O 1.248 1.011 0 C-N-CA 123.393 2.729 . . . . 0.0 115.424 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.441 ' HD3' ' C ' ' A' ' 112' ' ' LYS . 7.6 tmtm? -121.39 129.43 53.03 Favored 'General case' 0 N--CA 1.419 -1.987 0 N-CA-C 104.209 -2.515 . . . . 0.0 104.209 168.84 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 8.3 mmm180 . . . . . 0 C--N 1.291 -1.942 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 -178.782 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 46.6 t-20 . . . . . 0 C--O 1.206 -1.19 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 223' ' ' ARG . . . . . . . . . . . . 0.277 12.0 ptm180 65.16 19.51 11.77 Favored 'General case' 0 N--CA 1.504 2.266 0 C-N-CA 126.472 1.909 . . . . 0.0 115.39 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 224' ' ' PHE . . . . . 0.617 ' CD1' HD21 ' A' ' 87' ' ' LEU . 12.7 m-85 -96.08 166.28 11.83 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 175.819 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 225' ' ' ALA . . . . . . . . . . . . . . . -127.89 33.32 4.8 Favored 'General case' 0 C--N 1.311 -1.1 0 C-N-CA 120.43 -0.508 . . . . 0.0 111.843 -176.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 226' ' ' ILE . . . . . 0.461 HG21 ' OG ' ' A' ' 84' ' ' SER . 4.5 mp -81.74 126.22 39.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 175.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 227' ' ' MET . . . . . . . . . . . . . 22.4 ptp -71.39 144.84 89.76 Favored Pre-proline 0 C--N 1.31 -1.115 0 O-C-N 123.608 0.568 . . . . 0.0 110.098 -178.558 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 228' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -68.56 147.59 70.77 Favored 'Trans proline' 0 C--N 1.317 -1.087 0 C-N-CA 123.284 2.656 . . . . 0.0 112.25 178.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . -68.46 167.64 43.79 Favored Glycine 0 N--CA 1.443 -0.839 0 CA-C-N 115.663 -0.699 . . . . 0.0 113.073 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 40.9 m -74.85 -12.92 60.49 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -176.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 231' ' ' ARG . . . . . 0.514 ' HB2' ' OG ' ' A' ' 52' ' ' SER . 27.8 mmt180 -78.93 -11.74 60.01 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 178.136 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 232' ' ' TRP . . . . . . . . . . . . . 23.1 t90 -71.15 121.68 18.76 Favored 'General case' 0 N--CA 1.435 -1.198 0 CA-C-O 122.108 0.956 . . . . 0.0 112.184 -177.252 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 233' ' ' ASP . . . . . 0.436 ' H ' HG23 ' A' ' 49' ' ' THR . 29.9 t70 -114.94 144.62 43.28 Favored 'General case' 0 C--N 1.273 -2.742 0 N-CA-C 101.791 -3.411 . . . . 0.0 101.791 171.548 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -43.77 56.28 0.0 OUTLIER Glycine 0 N--CA 1.506 3.333 0 C-N-CA 128.295 2.855 . . . . 0.0 116.973 -176.146 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 235' ' ' VAL . . . . . 0.429 ' N ' ' O ' ' B' ' 233' ' ' ASP . 47.7 t -111.35 125.44 68.67 Favored 'Isoleucine or valine' 0 C--N 1.248 -3.833 0 C-N-CA 128.371 2.669 . . . . 0.0 107.695 178.42 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 236' ' ' HIS . . . . . . . . . . . . . 81.2 t60 -112.15 120.21 41.01 Favored 'General case' 0 C--N 1.292 -1.933 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 -178.782 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 237' ' ' ARG . . . . . 0.407 ' HG3' HG13 ' A' ' 50' ' ' VAL . 35.3 mmt180 -126.35 110.14 13.03 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 238' ' ' SER . . . . . . . . . . . . . 73.4 m -146.37 129.49 16.54 Favored 'General case' 0 C--N 1.288 -2.084 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 239' ' ' ASN . . . . . . . . . . . . . 46.9 t30 -78.8 154.11 30.17 Favored 'General case' 0 N--CA 1.424 -1.752 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 173.412 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 240' ' ' GLY . . . . . 0.473 ' O ' ' HG2' ' B' ' 244' ' ' LYS . . . 112.53 35.27 1.76 Allowed Glycine 0 N--CA 1.417 -2.581 0 C-N-CA 120.165 -1.017 . . . . 0.0 110.77 -175.831 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 14.6 p90 -76.97 -34.35 57.57 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-O 121.015 0.436 . . . . 0.0 111.403 177.046 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -61.27 -42.39 98.56 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 123.761 0.824 . . . . 0.0 109.972 -177.603 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -64.26 -34.34 77.89 Favored 'General case' 0 C--O 1.198 -1.65 0 CA-C-N 115.459 -0.791 . . . . 0.0 112.218 -179.336 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 244' ' ' LYS . . . . . 0.473 ' HG2' ' O ' ' B' ' 240' ' ' GLY . 74.2 mmtt -62.42 -42.87 99.76 Favored 'General case' 0 C--N 1.316 -0.879 0 C-N-CA 122.788 0.435 . . . . 0.0 111.625 -175.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 245' ' ' TRP . . . . . . . . . . . . . 6.9 m0 -69.86 -37.5 76.13 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 121.734 0.778 . . . . 0.0 109.17 178.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 246' ' ' PHE . . . . . 0.553 ' O ' ' HG2' ' B' ' 249' ' ' GLN . 5.1 t80 -65.23 -40.71 94.42 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 114.909 -1.042 . . . . 0.0 110.31 177.545 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -67.06 -22.11 65.87 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 115.781 -0.645 . . . . 0.0 112.142 -179.03 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -100.68 -25.7 14.06 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 120.156 -0.618 . . . . 0.0 112.381 178.723 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 249' ' ' GLN . . . . . 0.553 ' HG2' ' O ' ' B' ' 246' ' ' PHE . 12.2 pt20 -69.77 -11.98 61.27 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-O 121.126 0.488 . . . . 0.0 110.504 -177.26 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 250' ' ' ASN . . . . . . . . . . . . . 22.7 p-10 -58.67 -23.06 58.62 Favored 'General case' 0 N--CA 1.482 1.142 0 CA-C-N 114.692 -1.14 . . . . 0.0 111.832 179.415 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -121.22 130.39 53.67 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 178.821 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 252' ' ' ILE . . . . . . . . . . . . . 32.8 pt -92.45 -36.81 8.02 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 -176.379 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -97.84 -25.85 14.89 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-O 121.865 0.84 . . . . 0.0 110.494 -175.046 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 254' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -101.42 149.86 23.62 Favored 'General case' 0 N--CA 1.409 -2.479 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.17 -173.273 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 255' ' ' LYS . . . . . . . . . . . . . 12.5 ptmm? -122.06 -20.42 6.29 Favored 'General case' 0 C--N 1.281 -2.378 0 CA-C-N 114.457 -1.247 . . . . 0.0 110.132 -178.793 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 256' ' ' LYS . . . . . . . . . . . . . 88.3 tttt . . . . . 0 N--CA 1.452 -0.341 0 O-C-N 124.806 1.317 . . . . 0.0 108.408 -172.073 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.635 ' N ' HD21 ' A' ' 25' ' ' ASN . 0.4 OUTLIER . . . . . 0 CA--C 1.497 -1.087 0 N-CA-C 104.822 -2.288 . . . . 0.0 104.822 . . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -72.62 -17.52 61.67 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 114.513 1.301 . . . . 0.0 114.513 -156.233 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -96.61 -3.41 42.95 Favored 'General case' 0 C--N 1.282 -2.335 0 CA-C-O 121.382 0.611 . . . . 0.0 111.663 -174.753 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.616 ' HB3' ' OD1' ' A' ' 30' ' ' ASN . 14.4 mmmm -139.71 -57.51 0.57 Allowed 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.607 -178.777 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . 0.271 53.0 m-20 48.76 55.41 9.18 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 124.715 1.206 . . . . 0.0 114.241 -173.743 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.616 ' OD1' ' HB3' ' A' ' 28' ' ' LYS . 14.3 m120 -105.71 28.95 7.0 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 106.784 -1.562 . . . . 0.0 106.784 174.231 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.411 ' HA ' HG21 ' A' ' 85' ' ' THR . . . -89.67 -4.89 57.55 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 114.607 -1.179 . . . . 0.0 112.102 -174.016 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -107.89 145.11 34.18 Favored 'General case' 0 C--N 1.317 -0.846 0 C-N-CA 120.876 -0.33 . . . . 0.0 110.178 -174.813 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 30.5 pt -139.55 156.78 26.73 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 CA-C-O 120.986 0.422 . . . . 0.0 110.524 177.028 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 28.5 t80 -107.41 122.83 47.4 Favored 'General case' 0 N--CA 1.423 -1.796 0 CA-C-N 114.671 -1.149 . . . . 0.0 108.364 177.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.425 HG23 ' CD1' ' A' ' 104' ' ' ILE . 7.7 mt -108.77 128.17 64.73 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.977 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 176.51 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -129.66 173.92 19.55 Favored Glycine 0 C--N 1.287 -2.154 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.976 -178.221 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 19.5 m120 65.82 24.2 11.37 Favored 'General case' 0 CA--C 1.512 -0.517 0 C-N-CA 125.123 1.369 . . . . 0.0 111.922 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -58.27 140.77 52.67 Favored 'General case' 0 CA--C 1.495 -1.154 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 -178.357 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.508 ' CG ' ' HG2' ' A' ' 41' ' ' GLU . 49.8 t-20 -71.5 142.64 50.14 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 172.298 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.485 ' HD2' ' N ' ' A' ' 41' ' ' GLU . 7.5 ppt_? -58.99 -22.94 61.32 Favored 'General case' 0 C--N 1.303 -1.43 0 C-N-CA 123.869 0.867 . . . . 0.0 112.62 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.508 ' HG2' ' CG ' ' A' ' 39' ' ' ASN . 12.8 pt-20 -87.19 -14.8 40.15 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.85 -176.175 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.469 ' HG ' ' HB3' ' A' ' 39' ' ' ASN . 79.6 mt -76.42 126.13 30.44 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.564 0.697 . . . . 0.0 112.598 -174.747 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 66.8 p -109.26 173.71 6.2 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 114.071 -1.422 . . . . 0.0 109.538 -177.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.7 mp0 -57.56 -42.31 82.76 Favored 'General case' 0 C--O 1.211 -0.933 0 C-N-CA 123.616 0.766 . . . . 0.0 109.92 178.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.43 -37.41 93.15 Favored Glycine 0 N--CA 1.446 -0.649 0 O-C-N 123.618 0.574 . . . . 0.0 112.814 -179.762 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 32.5 m-20 -67.42 -49.76 62.37 Favored 'General case' 0 CA--C 1.501 -0.934 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 179.306 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 51.4 mt -60.25 -45.78 95.72 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.777 0 CA-C-N 114.748 -1.115 . . . . 0.0 110.682 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 41.4 mt -59.96 -45.24 93.31 Favored 'General case' 0 CA--C 1.496 -1.099 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.322 -178.288 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.464 HG23 ' H ' ' B' ' 233' ' ' ASP . 87.8 m -61.88 -45.72 92.52 Favored 'General case' 0 C--N 1.313 -1.018 0 O-C-N 123.595 0.56 . . . . 0.0 111.585 -178.724 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.489 HG13 ' HG3' ' B' ' 237' ' ' ARG . 98.9 t -66.79 -50.19 67.63 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.489 -179.638 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.487 ' HA ' ' HD2' ' A' ' 54' ' ' TYR . 4.3 m-85 -62.49 -25.66 68.13 Favored 'General case' 0 N--CA 1.433 -1.276 0 C-N-CA 123.883 0.873 . . . . 0.0 112.381 -178.553 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 65.9 m -67.07 -20.22 65.79 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.287 176.29 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -70.07 -20.71 63.21 Favored 'General case' 0 CA--C 1.555 1.158 0 CA-C-O 121.302 0.572 . . . . 0.0 109.721 176.848 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.487 ' HD2' ' HA ' ' A' ' 51' ' ' PHE . 41.5 m-85 -97.51 -19.98 18.03 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-O 121.03 0.443 . . . . 0.0 111.59 -175.674 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 167.92 -159.49 32.75 Favored Glycine 0 N--CA 1.42 -2.379 0 N-CA-C 110.825 -0.91 . . . . 0.0 110.825 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 59.1 t -102.66 110.83 64.02 Favored Pre-proline 0 C--N 1.296 -1.746 0 O-C-N 123.471 0.159 . . . . 0.0 111.062 -177.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.511 ' HB3' HD21 ' A' ' 77' ' ' LEU . 92.7 Cg_endo -77.39 140.75 19.61 Favored 'Trans proline' 0 N--CA 1.451 -1.018 0 C-N-CA 122.849 2.366 . . . . 0.0 110.18 175.469 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 31.2 m -116.39 -19.08 6.63 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 C-N-CA 120.0 -0.68 . . . . 0.0 112.167 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.487 ' HB3' ' HG2' ' A' ' 78' ' ' LYS . 36.0 t70 -161.26 141.41 10.83 Favored 'General case' 0 C--O 1.242 0.682 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 -179.804 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 14.4 p -141.71 133.96 28.22 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 178.524 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 91.6 mt -120.46 125.37 74.07 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 177.443 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -100.77 134.18 44.13 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 178.203 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 22.3 t -92.62 131.52 37.65 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 176.256 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 68.7 mtt85 -134.59 142.0 46.81 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-O 120.879 0.371 . . . . 0.0 111.233 -177.742 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -74.32 126.86 31.58 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 107.775 -1.195 . . . . 0.0 107.775 176.778 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -61.41 -24.13 66.3 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 112.705 0.632 . . . . 0.0 112.705 -176.679 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 23.0 m-80 -82.97 -50.22 8.78 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-O 121.27 0.557 . . . . 0.0 110.608 -176.08 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 74.6 p -85.62 -24.14 27.24 Favored 'General case' 0 C--N 1.312 -1.046 0 C-N-CA 120.253 -0.579 . . . . 0.0 111.267 -174.551 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.63 3.2 78.21 Favored Glycine 0 N--CA 1.439 -1.142 0 N-CA-C 111.359 -0.697 . . . . 0.0 111.359 -177.185 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -103.84 164.23 11.82 Favored 'General case' 0 N--CA 1.428 -1.545 0 CA-C-O 121.057 0.456 . . . . 0.0 110.796 -176.413 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 13.7 m -58.85 132.02 52.7 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 114.792 -1.095 . . . . 0.0 111.438 -177.277 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 15.7 mm-40 -63.7 -21.76 66.56 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.557 1.143 . . . . 0.0 111.692 178.516 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 110.2 8.29 25.61 Favored Glycine 0 N--CA 1.421 -2.35 0 C-N-CA 119.88 -1.153 . . . . 0.0 112.269 -179.699 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 40.8 p90 -148.82 153.36 38.0 Favored 'General case' 0 C--O 1.252 1.194 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 177.125 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -149.52 172.83 14.36 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-O 120.915 0.388 . . . . 0.0 110.874 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -130.3 139.41 50.73 Favored 'General case' 0 C--N 1.303 -1.424 0 C-N-CA 124.161 0.984 . . . . 0.0 109.617 -179.274 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.511 HD21 ' HB3' ' A' ' 57' ' ' PRO . 9.9 tt -146.01 140.76 27.07 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 175.587 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.487 ' HG2' ' HB3' ' A' ' 59' ' ' ASP . 20.8 ptmt -124.37 144.27 50.12 Favored 'General case' 0 C--O 1.256 1.433 0 CA-C-O 121.259 0.552 . . . . 0.0 109.787 179.344 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 66.3 m-85 -108.16 164.31 12.41 Favored 'General case' 0 C--N 1.29 -1.983 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.719 179.578 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -77.99 -33.59 51.24 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 174.304 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -109.8 130.09 55.56 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.94 -176.163 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.474 HE22 ' CB ' ' A' ' 28' ' ' LYS . 21.3 mt-30 -71.02 -20.37 62.4 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 -178.095 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 88.1 mtm180 -68.03 -34.1 75.85 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-O 121.946 0.879 . . . . 0.0 108.654 174.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.501 ' OG ' HG21 ' B' ' 226' ' ' ILE . 61.9 m -63.59 -37.11 86.07 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 115.078 -0.964 . . . . 0.0 112.511 178.299 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.447 ' O ' HG23 ' A' ' 89' ' ' VAL . 80.7 p -65.31 -45.84 82.72 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 120.325 -0.55 . . . . 0.0 110.476 -177.303 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.412 ' H ' HG12 ' A' ' 86' ' ' ILE . 3.4 pt -64.83 -39.23 84.96 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.884 177.179 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.604 HD11 ' HB2' ' B' ' 224' ' ' PHE . 19.9 mt -59.65 -44.54 93.51 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.653 176.393 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.452 ' O ' ' HB2' ' A' ' 92' ' ' LEU . . . -71.48 -45.88 61.32 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.035 -177.329 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.453 HG22 HG22 ' A' ' 104' ' ' ILE . 70.2 t -56.65 -49.02 79.7 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.797 0 CA-C-O 121.057 0.456 . . . . 0.0 110.95 178.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -63.25 -39.15 93.79 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 115.366 -0.834 . . . . 0.0 112.034 -175.062 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.479 HD22 ' HE1' ' A' ' 54' ' ' TYR . 63.3 t30 -96.42 -20.09 18.7 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.431 -171.748 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.452 ' HB2' ' O ' ' A' ' 88' ' ' ALA . 10.3 mt -96.59 -31.24 12.84 Favored 'General case' 0 CA--C 1.494 -1.176 0 CA-C-O 120.909 0.385 . . . . 0.0 111.655 -178.236 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 56.1 t30 -65.44 125.82 26.34 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.981 -177.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 88.13 -1.15 84.51 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 121.341 -0.457 . . . . 0.0 112.883 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.424 ' HB2' ' HB2' ' B' ' 239' ' ' ASN . 67.7 t80 -90.12 137.78 32.06 Favored 'General case' 0 C--N 1.32 -0.689 0 O-C-N 122.378 -0.483 . . . . 0.0 110.069 -178.423 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -92.45 116.74 29.25 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 121.56 0.695 . . . . 0.0 111.806 -176.963 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.62 ' HB ' HH21 ' A' ' 100' ' ' ARG . 62.7 mt -127.34 140.36 49.33 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 175.621 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 62.88 19.27 60.83 Favored Glycine 0 C--N 1.307 -1.066 0 C-N-CA 121.387 -0.435 . . . . 0.0 112.869 -179.007 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 91.72 -9.55 76.65 Favored Glycine 0 N--CA 1.438 -1.182 0 C-N-CA 121.218 -0.515 . . . . 0.0 112.953 -178.679 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.62 HH21 ' HB ' ' A' ' 97' ' ' ILE . 0.0 OUTLIER -125.54 146.88 49.47 Favored 'General case' 0 N--CA 1.418 -2.049 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 -175.764 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -79.8 136.54 36.75 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.692 -176.566 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.428 ' HG ' HH22 ' A' ' 100' ' ' ARG . 11.0 mt -82.47 148.39 28.17 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 115.457 -0.792 . . . . 0.0 112.445 176.253 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 4.3 tppp? -124.27 119.96 30.82 Favored 'General case' 0 N--CA 1.423 -1.825 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 174.271 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.453 HG22 HG22 ' A' ' 89' ' ' VAL . 4.6 mm -122.09 135.12 63.25 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 N-CA-C 107.108 -1.441 . . . . 0.0 107.108 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -143.63 158.82 43.38 Favored 'General case' 0 C--N 1.291 -1.947 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 178.335 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 38.3 m-70 -83.63 141.76 31.29 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 177.753 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 9.3 t -156.04 161.78 40.39 Favored 'General case' 0 C--N 1.285 -2.216 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 -178.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 26.0 p90 -109.88 110.35 21.28 Favored 'General case' 0 C--N 1.297 -1.674 0 C-N-CA 118.592 -1.243 . . . . 0.0 108.879 172.412 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 62.3 t80 -108.54 139.31 43.48 Favored 'General case' 0 C--N 1.294 -1.819 0 CA-C-N 115.351 -0.841 . . . . 0.0 110.98 -178.79 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.425 ' HA ' ' HD2' ' A' ' 111' ' ' PRO . 26.9 mmt180 -120.88 115.58 31.89 Favored Pre-proline 0 C--N 1.301 -1.506 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 172.912 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.425 ' HD2' ' HA ' ' A' ' 110' ' ' ARG . 36.3 Cg_endo -61.97 138.83 75.78 Favored 'Trans proline' 0 C--O 1.24 0.61 0 C-N-CA 123.584 2.856 . . . . 0.0 113.232 -178.522 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.402 ' C ' ' HD3' ' A' ' 112' ' ' LYS . 10.8 tmtt? -82.69 124.32 30.1 Favored 'General case' 0 N--CA 1.432 -1.354 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 178.023 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 9.7 mmm180 . . . . . 0 C--N 1.302 -1.499 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 179.448 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 12.6 t-20 . . . . . 0 CA--C 1.545 0.758 0 CA-C-O 121.511 0.672 . . . . 0.0 109.846 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 223' ' ' ARG . . . . . . . . . . . . 0.549 10.7 mtp180 75.2 52.12 0.07 Allowed 'General case' 0 CA--C 1.501 -0.928 0 N-CA-C 118.737 2.866 . . . . 0.0 118.737 176.647 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 224' ' ' PHE . . . . . 0.604 ' HB2' HD11 ' A' ' 87' ' ' LEU . 32.2 m-85 -116.2 165.27 13.35 Favored 'General case' 0 C--N 1.283 -2.296 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 173.453 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 225' ' ' ALA . . . . . . . . . . . . . . . -125.96 83.28 2.15 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-O 121.64 0.733 . . . . 0.0 110.479 -178.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 226' ' ' ILE . . . . . 0.501 HG21 ' OG ' ' A' ' 84' ' ' SER . 3.8 mp -120.73 132.61 69.82 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 CA-C-N 115.011 -0.995 . . . . 0.0 108.843 178.778 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 227' ' ' MET . . . . . . . . . . . . . 24.8 mmt -59.53 140.19 88.91 Favored Pre-proline 0 C--N 1.323 -0.577 0 O-C-N 124.061 0.851 . . . . 0.0 111.405 179.815 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 228' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -71.18 156.01 60.08 Favored 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 122.555 2.17 . . . . 0.0 111.444 179.119 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . -74.38 168.9 54.33 Favored Glycine 0 C--N 1.307 -1.041 0 CA-C-N 116.167 -0.47 . . . . 0.0 112.642 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 22.6 t -77.41 -15.21 59.47 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-O 120.954 0.407 . . . . 0.0 110.315 -178.606 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 13.6 mmp_? -80.83 -5.2 56.97 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 121.974 -0.454 . . . . 0.0 111.192 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 232' ' ' TRP . . . . . . . . . . . . . 19.2 t90 -70.94 127.02 31.19 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-O 122.659 1.219 . . . . 0.0 111.878 -178.076 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 233' ' ' ASP . . . . . 0.464 ' H ' HG23 ' A' ' 49' ' ' THR . 11.8 t70 -118.09 145.5 44.8 Favored 'General case' 0 C--N 1.271 -2.833 0 N-CA-C 101.059 -3.682 . . . . 0.0 101.059 172.579 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -49.78 57.76 0.0 OUTLIER Glycine 0 N--CA 1.497 2.749 0 C-N-CA 127.211 2.339 . . . . 0.0 116.175 -177.912 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 235' ' ' VAL . . . . . 0.448 HG12 ' HG2' ' B' ' 237' ' ' ARG . 39.7 t -103.13 133.82 45.93 Favored 'Isoleucine or valine' 0 C--N 1.247 -3.884 0 C-N-CA 128.295 2.638 . . . . 0.0 106.589 176.323 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 236' ' ' HIS . . . . . . . . . . . . . 48.6 t-80 -111.92 113.35 25.61 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 178.245 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 237' ' ' ARG . . . . . 0.489 ' HG3' HG13 ' A' ' 50' ' ' VAL . 35.2 mmt180 -126.46 106.96 9.83 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 109.246 -0.649 . . . . 0.0 109.246 176.529 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 238' ' ' SER . . . . . . . . . . . . . 75.7 m -147.28 129.19 15.36 Favored 'General case' 0 C--N 1.298 -1.667 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.936 179.639 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 239' ' ' ASN . . . . . 0.424 ' HB2' ' HB2' ' A' ' 95' ' ' PHE . 57.5 t30 -105.34 165.77 10.88 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 -179.773 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 240' ' ' GLY . . . . . 0.483 ' O ' ' HG2' ' B' ' 244' ' ' LYS . . . 92.23 9.68 61.71 Favored Glycine 0 C--O 1.201 -1.928 0 C-N-CA 120.979 -0.629 . . . . 0.0 111.603 179.755 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -76.14 -33.56 59.42 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-O 120.899 0.38 . . . . 0.0 110.709 179.684 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -60.89 -43.84 97.92 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.106 -178.347 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -62.08 -34.62 76.64 Favored 'General case' 0 C--O 1.206 -1.219 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.307 179.189 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 244' ' ' LYS . . . . . 0.483 ' HG2' ' O ' ' B' ' 240' ' ' GLY . 72.9 mmtt -64.76 -45.52 86.05 Favored 'General case' 0 CA--C 1.508 -0.653 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 -179.268 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 245' ' ' TRP . . . . . . . . . . . . . 49.3 m0 -66.03 -42.45 89.59 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.26 178.506 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 246' ' ' PHE . . . . . 0.52 ' HA ' ' CD ' ' B' ' 249' ' ' GLN . 6.0 t80 -63.88 -36.95 85.62 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.246 179.743 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -70.33 -32.37 70.07 Favored 'General case' 0 C--N 1.292 -1.923 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.687 -179.244 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.46 -19.94 20.78 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -177.529 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 249' ' ' GLN . . . . . 0.52 ' CD ' ' HA ' ' B' ' 246' ' ' PHE . 12.6 pt20 -74.11 2.79 8.14 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.093 0.557 . . . . 0.0 110.71 -177.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 250' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -57.93 -30.62 66.09 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.373 178.521 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -84.59 120.89 26.88 Favored 'General case' 0 N--CA 1.437 -1.106 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.195 179.358 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 252' ' ' ILE . . . . . . . . . . . . . 37.6 pt -101.63 -28.65 3.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.759 -175.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -107.45 -26.52 10.91 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-O 121.573 0.701 . . . . 0.0 110.123 -178.701 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 254' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -91.3 173.84 7.71 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-N 115.306 -0.861 . . . . 0.0 108.68 -179.843 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 255' ' ' LYS . . . . . . . . . . . . . 9.2 ptpp? -71.35 156.54 39.38 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 122.89 0.476 . . . . 0.0 110.137 178.6 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 256' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.431 -1.4 0 CA-C-O 120.691 0.281 . . . . 0.0 111.157 -178.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.433 ' HB2' HE22 ' A' ' 82' ' ' GLN . 15.9 m120 . . . . . 0 CA--C 1.51 -0.593 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -66.89 -27.44 67.51 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.391 0.615 . . . . 0.0 111.961 -170.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -88.98 13.7 12.26 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 113.291 0.849 . . . . 0.0 113.291 -173.785 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.614 ' HB3' ' OD1' ' A' ' 30' ' ' ASN . 13.6 mmmm -101.02 -43.46 6.03 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 173.89 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 23.2 t70 74.07 13.24 4.08 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-O 122.666 1.222 . . . . 0.0 110.747 177.245 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.614 ' OD1' ' HB3' ' A' ' 28' ' ' LYS . 15.4 m120 -89.96 24.65 2.36 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 114.448 -1.251 . . . . 0.0 109.636 -178.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -87.22 -0.04 56.1 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.341 -179.352 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -108.69 145.33 35.2 Favored 'General case' 0 N--CA 1.434 -1.248 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.868 -176.137 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 28.4 pt -136.86 160.36 36.85 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.753 177.233 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.49 ' HB2' HG21 ' A' ' 107' ' ' THR . 34.4 t80 -112.8 124.12 51.88 Favored 'General case' 0 N--CA 1.413 -2.31 0 CA-C-N 115.26 -0.882 . . . . 0.0 108.831 177.76 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.458 HG23 ' CD1' ' A' ' 104' ' ' ILE . 10.4 mt -108.55 127.75 64.73 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.036 0 N-CA-C 106.846 -1.539 . . . . 0.0 106.846 176.136 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -130.07 160.99 23.05 Favored Glycine 0 N--CA 1.425 -2.04 0 N-CA-C 112.02 -0.432 . . . . 0.0 112.02 -179.094 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 66.4 t30 70.39 41.27 1.02 Allowed 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.82 1.648 . . . . 0.0 110.604 -179.232 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -69.39 151.73 45.78 Favored 'General case' 0 CA--C 1.499 -0.987 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.864 175.831 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.469 ' HB3' ' HG ' ' A' ' 42' ' ' LEU . 45.9 t-20 -84.66 149.94 25.48 Favored 'General case' 0 C--N 1.284 -2.273 0 N-CA-C 106.344 -1.724 . . . . 0.0 106.344 175.758 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.507 ' HD2' ' C ' ' A' ' 40' ' ' ARG . 5.8 ppt_? -59.1 -24.45 62.97 Favored 'General case' 0 C--N 1.307 -1.242 0 C-N-CA 123.354 0.662 . . . . 0.0 111.025 178.606 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.403 ' N ' ' HD2' ' A' ' 40' ' ' ARG . 13.8 pt-20 -95.39 0.11 53.13 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.825 -0.625 . . . . 0.0 112.317 -175.81 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.469 ' HG ' ' HB3' ' A' ' 39' ' ' ASN . 68.6 mt -89.81 121.69 32.18 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-O 121.132 0.492 . . . . 0.0 110.407 179.503 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 70.6 p -108.43 174.44 5.87 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-N 114.674 -1.148 . . . . 0.0 110.279 -176.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.44 ' CG ' ' HB2' ' A' ' 62' ' ' LEU . 33.6 mt-10 -55.15 -40.87 71.09 Favored 'General case' 0 C--O 1.212 -0.914 0 O-C-N 123.616 0.572 . . . . 0.0 109.689 176.622 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -59.76 -39.83 95.84 Favored Glycine 0 C--O 1.243 0.7 0 CA-C-N 116.079 -0.51 . . . . 0.0 112.738 179.744 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -66.82 -49.65 65.1 Favored 'General case' 0 CA--C 1.499 -1.017 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 179.261 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 47.2 mt -60.07 -46.68 94.01 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.808 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.842 -179.643 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 47.5 mt -60.07 -42.49 94.67 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 116.592 -0.277 . . . . 0.0 111.705 -177.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 90.8 m -63.98 -46.28 85.32 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 120.869 0.366 . . . . 0.0 111.256 -179.134 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.501 HG13 ' HG3' ' B' ' 237' ' ' ARG . 95.7 t -66.98 -48.63 78.91 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.692 -178.923 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.433 ' HA ' ' HD2' ' A' ' 54' ' ' TYR . 4.6 m-85 -64.88 -23.08 67.12 Favored 'General case' 0 N--CA 1.426 -1.636 0 CA-C-N 115.28 -0.873 . . . . 0.0 112.416 -178.413 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.477 ' HA ' ' O ' ' A' ' 55' ' ' GLY . 61.5 m -72.3 -20.8 61.44 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 176.64 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -71.46 -22.18 61.86 Favored 'General case' 0 C--O 1.246 0.894 0 C-N-CA 119.859 -0.736 . . . . 0.0 109.596 177.275 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.433 ' HD2' ' HA ' ' A' ' 51' ' ' PHE . 73.7 m-85 -92.0 -22.82 19.77 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.818 -178.538 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.477 ' O ' ' HA ' ' A' ' 52' ' ' SER . . . 169.79 -164.47 37.91 Favored Glycine 0 N--CA 1.427 -1.965 0 N-CA-C 110.927 -0.869 . . . . 0.0 110.927 -179.588 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 54.8 t -99.03 111.0 59.82 Favored Pre-proline 0 C--N 1.302 -1.498 0 CA-C-N 116.548 0.174 . . . . 0.0 111.039 -176.84 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.46 ' HB3' HD21 ' A' ' 77' ' ' LEU . 85.9 Cg_endo -78.13 141.77 18.84 Favored 'Trans proline' 0 C--O 1.246 0.895 0 C-N-CA 122.975 2.45 . . . . 0.0 110.627 175.84 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 29.7 m -120.53 -15.38 7.43 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 C-N-CA 120.264 -0.575 . . . . 0.0 112.132 179.226 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.565 ' HB3' ' HG2' ' A' ' 78' ' ' LYS . 28.3 t70 -163.27 135.92 5.4 Favored 'General case' 0 C--O 1.244 0.799 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 -176.835 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 14.4 p -143.97 136.88 23.71 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.416 ' CD1' ' HB3' ' A' ' 111' ' ' PRO . 90.2 mt -120.92 121.63 65.62 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.799 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 177.234 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.44 ' HB2' ' CG ' ' A' ' 44' ' ' GLU . 0.1 OUTLIER -100.2 113.54 26.28 Favored 'General case' 0 N--CA 1.42 -1.93 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 175.267 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 13.6 m -78.32 117.91 20.01 Favored 'General case' 0 C--N 1.274 -2.693 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 178.406 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 84.2 mtm180 -114.28 148.63 37.18 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-O 121.052 0.454 . . . . 0.0 110.125 179.353 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -82.67 117.57 22.7 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.725 178.019 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -61.42 -23.04 65.55 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.599 -0.728 . . . . 0.0 112.717 -177.829 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 19.3 m-80 -79.79 -50.05 11.11 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 120.897 0.379 . . . . 0.0 109.993 -175.435 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 38.3 p -87.12 -23.59 24.82 Favored 'General case' 0 C--O 1.249 1.035 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 -176.276 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.07 20.09 77.93 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 111.29 -0.724 . . . . 0.0 111.29 -177.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -123.2 172.83 8.31 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 -178.804 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 19.7 m -60.02 147.32 39.53 Favored 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 122.763 0.425 . . . . 0.0 111.44 179.215 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 12.9 mm-40 -79.24 -10.25 59.77 Favored 'General case' 0 CA--C 1.502 -0.878 0 C-N-CA 123.233 0.613 . . . . 0.0 112.456 178.654 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 96.54 2.99 59.9 Favored Glycine 0 N--CA 1.426 -2.031 0 C-N-CA 119.651 -1.261 . . . . 0.0 112.113 -179.616 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 34.5 p90 -145.65 151.58 38.28 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 178.294 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -149.49 170.16 19.24 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 123.266 0.354 . . . . 0.0 110.529 -179.217 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -131.5 140.12 49.46 Favored 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 123.649 0.78 . . . . 0.0 109.427 -178.63 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.46 HD21 ' HB3' ' A' ' 57' ' ' PRO . 9.9 tt -147.33 140.45 25.19 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 177.183 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.565 ' HG2' ' HB3' ' A' ' 59' ' ' ASP . 18.7 ptmt -124.0 144.43 49.83 Favored 'General case' 0 C--O 1.259 1.567 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 178.122 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.415 ' HH ' ' HD2' ' A' ' 51' ' ' PHE . 58.7 m-85 -106.9 164.89 11.75 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.956 -178.32 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -77.83 -25.73 49.01 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 114.813 -1.085 . . . . 0.0 109.293 176.616 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -124.1 130.39 52.48 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 -179.812 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.433 HE22 ' HB2' ' A' ' 25' ' ' ASN . 38.6 mt-30 -69.3 -21.05 63.89 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 113.137 0.792 . . . . 0.0 113.137 -177.262 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 89.6 mtm180 -63.64 -33.13 74.95 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-O 122.352 1.073 . . . . 0.0 110.109 177.374 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.435 ' OG ' HG21 ' B' ' 226' ' ' ILE . 48.9 m -63.53 -36.98 85.59 Favored 'General case' 0 C--N 1.282 -2.335 0 CA-C-N 114.628 -1.169 . . . . 0.0 112.22 178.859 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.421 ' O ' HG23 ' A' ' 89' ' ' VAL . 81.8 p -64.74 -45.05 88.11 Favored 'General case' 0 C--O 1.219 -0.501 0 C-N-CA 120.279 -0.568 . . . . 0.0 110.525 -177.015 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.425 ' H ' HG12 ' A' ' 86' ' ' ILE . 3.3 pt -63.89 -39.45 85.46 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.103 177.225 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 29.2 mt -60.32 -43.61 96.21 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 120.902 0.382 . . . . 0.0 111.011 175.363 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.423 ' O ' ' HB2' ' A' ' 92' ' ' LEU . . . -71.47 -47.16 57.37 Favored 'General case' 0 C--O 1.211 -0.959 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.67 -178.64 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.449 HG22 HG22 ' A' ' 104' ' ' ILE . 79.5 t -57.21 -48.7 81.72 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.492 0 CA-C-O 120.915 0.388 . . . . 0.0 111.006 -179.44 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -68.38 -31.9 71.6 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 115.509 -0.769 . . . . 0.0 112.466 -173.413 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -97.56 -20.77 17.48 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 -176.302 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.461 ' HB2' HG13 ' A' ' 104' ' ' ILE . 9.6 mt -93.43 -28.56 16.06 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-O 120.574 0.226 . . . . 0.0 111.07 -179.15 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -60.26 124.74 21.22 Favored 'General case' 0 C--O 1.244 0.79 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 178.056 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 83.86 -1.07 89.23 Favored Glycine 0 C--N 1.306 -1.128 0 C-N-CA 120.499 -0.858 . . . . 0.0 113.447 177.542 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.463 ' CE2' ' HD2' ' B' ' 237' ' ' ARG . 86.4 t80 -85.3 134.4 34.12 Favored 'General case' 0 N--CA 1.443 -0.825 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 178.688 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.409 ' HA ' ' HA ' ' A' ' 101' ' ' ALA . 11.1 mptt -92.88 118.87 31.6 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.229 -176.925 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 54.1 mt -121.72 141.16 43.33 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 N-CA-C 105.257 -2.127 . . . . 0.0 105.257 172.577 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.413 ' HA3' HD22 ' A' ' 39' ' ' ASN . . . 58.92 22.48 54.77 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 121.191 -0.528 . . . . 0.0 112.821 -179.04 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 82.21 7.41 87.77 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 121.492 -0.385 . . . . 0.0 113.546 -179.435 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 16.7 ptp180 -129.52 141.04 51.08 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 117.688 0.744 . . . . 0.0 110.894 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.409 ' HA ' ' HA ' ' A' ' 96' ' ' LYS . . . -79.61 122.08 26.07 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.012 0.434 . . . . 0.0 111.387 -179.215 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 9.5 mt -68.7 141.23 55.35 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.671 177.2 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -113.98 116.01 28.55 Favored 'General case' 0 N--CA 1.409 -2.517 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 176.244 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.461 HG13 ' HB2' ' A' ' 92' ' ' LEU . 4.8 mm -116.65 136.11 54.78 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.861 0 N-CA-C 106.423 -1.695 . . . . 0.0 106.423 178.417 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -144.0 151.85 40.26 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.331 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -80.63 135.6 36.08 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-O 120.975 0.417 . . . . 0.0 110.223 177.648 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.49 HG21 ' HB2' ' A' ' 34' ' ' TYR . 6.5 t -153.64 168.35 26.52 Favored 'General case' 0 C--N 1.291 -1.972 0 N-CA-C 107.427 -1.324 . . . . 0.0 107.427 -177.065 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -108.91 110.82 22.24 Favored 'General case' 0 N--CA 1.421 -1.888 0 N-CA-C 105.208 -2.145 . . . . 0.0 105.208 169.143 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 84.9 t80 -106.93 132.64 52.65 Favored 'General case' 0 C--N 1.291 -1.967 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 178.879 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 12.5 tpp180 -111.14 113.13 54.72 Favored Pre-proline 0 C--N 1.294 -1.822 0 N-CA-C 106.689 -1.597 . . . . 0.0 106.689 175.901 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.416 ' HB3' ' CD1' ' A' ' 61' ' ' ILE . 47.4 Cg_endo -71.13 149.24 57.83 Favored 'Trans proline' 0 C--O 1.25 1.077 0 C-N-CA 123.013 2.475 . . . . 0.0 115.551 -178.839 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 25.1 tptp -121.01 118.88 30.95 Favored 'General case' 0 N--CA 1.42 -1.968 0 CA-C-N 112.994 -1.912 . . . . 0.0 106.793 172.074 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 23.5 mmt180 . . . . . 0 C--N 1.28 -2.44 0 N-CA-C 107.019 -1.474 . . . . 0.0 107.019 179.948 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 . . . . . 0 N--CA 1.48 1.058 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 223' ' ' ARG . . . . . . . . . . . . 0.277 30.1 mtp180 67.01 50.75 1.01 Allowed 'General case' 0 CA--C 1.505 -0.761 0 CA-C-O 122.871 1.32 . . . . 0.0 114.233 175.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 224' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -109.49 166.88 10.54 Favored 'General case' 0 C--N 1.268 -2.95 0 CA-C-N 112.495 -2.139 . . . . 0.0 106.806 175.327 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 225' ' ' ALA . . . . . . . . . . . . . . . -126.34 81.68 2.02 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-O 121.279 0.561 . . . . 0.0 110.91 -179.224 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 226' ' ' ILE . . . . . 0.435 HG21 ' OG ' ' A' ' 84' ' ' SER . 4.2 mp -125.93 132.76 70.3 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.211 177.518 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 227' ' ' MET . . . . . . . . . . . . . 86.8 mtp -71.2 133.54 85.54 Favored Pre-proline 0 C--N 1.315 -0.903 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 176.568 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 228' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -64.27 160.89 36.59 Favored 'Trans proline' 0 C--O 1.24 0.622 0 C-N-CA 123.43 2.753 . . . . 0.0 113.455 -177.609 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . -77.19 167.48 54.25 Favored Glycine 0 N--CA 1.439 -1.128 0 CA-C-N 115.155 -0.929 . . . . 0.0 113.429 -178.328 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 6.5 m -77.42 -17.58 57.99 Favored 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 123.14 0.576 . . . . 0.0 111.635 -175.169 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 7.9 mmp_? -87.29 -0.46 56.77 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.196 0.522 . . . . 0.0 110.995 -176.167 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 232' ' ' TRP . . . . . . . . . . . . . 21.1 t90 -76.93 127.82 33.41 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-O 122.307 1.051 . . . . 0.0 112.206 -178.063 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 233' ' ' ASP . . . . . 0.418 ' O ' ' N ' ' B' ' 235' ' ' VAL . 23.9 t70 -122.07 147.1 46.53 Favored 'General case' 0 C--N 1.277 -2.585 0 N-CA-C 102.82 -3.029 . . . . 0.0 102.82 171.705 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -45.62 56.0 0.0 OUTLIER Glycine 0 N--CA 1.505 3.272 0 C-N-CA 128.372 2.891 . . . . 0.0 117.139 -175.654 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 235' ' ' VAL . . . . . 0.418 ' N ' ' O ' ' B' ' 233' ' ' ASP . 52.3 t -110.83 127.52 67.86 Favored 'Isoleucine or valine' 1 C--N 1.244 -4.02 0 C-N-CA 128.237 2.615 . . . . 0.0 106.996 177.516 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 236' ' ' HIS . . . . . . . . . . . . . 57.4 t60 -112.05 122.24 47.2 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 179.578 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 237' ' ' ARG . . . . . 0.501 ' HG3' HG13 ' A' ' 50' ' ' VAL . 28.4 mmt180 -127.25 110.34 12.76 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-O 121.115 0.483 . . . . 0.0 110.877 178.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 238' ' ' SER . . . . . . . . . . . . . 77.8 p -146.82 141.85 27.08 Favored 'General case' 0 C--N 1.284 -2.259 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 174.855 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 239' ' ' ASN . . . . . . . . . . . . . 34.2 p30 -75.87 18.92 0.23 Allowed 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 178.675 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 240' ' ' GLY . . . . . . . . . . . . . . . -105.82 48.8 0.93 Allowed Glycine 0 N--CA 1.417 -2.604 0 N-CA-C 108.443 -1.863 . . . . 0.0 108.443 173.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 22.7 p90 -77.09 -33.34 56.99 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 179.777 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -61.27 -45.34 94.89 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.226 0.536 . . . . 0.0 112.089 -177.094 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -60.46 -34.74 74.46 Favored 'General case' 0 C--O 1.204 -1.307 0 CA-C-N 115.166 -0.924 . . . . 0.0 111.411 -179.328 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -63.97 -42.46 97.24 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 -178.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 245' ' ' TRP . . . . . 0.451 ' HA ' ' HG3' ' B' ' 248' ' ' LYS . 23.7 m0 -66.23 -38.43 87.89 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.329 0.585 . . . . 0.0 109.954 178.354 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 246' ' ' PHE . . . . . 0.653 ' O ' ' HG2' ' B' ' 249' ' ' GLN . 3.1 t80 -67.96 -32.89 73.63 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.433 176.302 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -74.93 -38.96 61.65 Favored 'General case' 0 C--N 1.294 -1.839 0 O-C-N 121.948 -0.47 . . . . 0.0 111.023 179.399 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 248' ' ' LYS . . . . . 0.451 ' HG3' ' HA ' ' B' ' 245' ' ' TRP . 0.0 OUTLIER -82.35 -14.57 55.08 Favored 'General case' 0 CA--C 1.504 -0.8 0 CA-C-O 121.045 0.45 . . . . 0.0 111.758 -175.235 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 249' ' ' GLN . . . . . 0.653 ' HG2' ' O ' ' B' ' 246' ' ' PHE . 10.1 pt20 -75.22 2.4 11.07 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 121.698 0.761 . . . . 0.0 110.332 -179.068 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 250' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -67.24 -25.83 66.28 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.21 176.235 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -64.29 115.88 5.48 Favored 'General case' 0 N--CA 1.437 -1.118 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.134 178.681 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 252' ' ' ILE . . . . . . . . . . . . . 16.3 pt -99.67 -27.63 3.52 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.317 0 CA-C-N 113.783 -1.553 . . . . 0.0 110.944 -174.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 10.6 p30 -121.01 -26.32 5.17 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.908 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 254' ' ' GLU . . . . . 0.603 ' OE1' ' HG2' ' B' ' 255' ' ' LYS . 4.7 mm-40 -84.45 172.19 11.92 Favored 'General case' 0 N--CA 1.428 -1.571 0 N-CA-C 114.089 1.144 . . . . 0.0 114.089 -177.322 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 255' ' ' LYS . . . . . 0.603 ' HG2' ' OE1' ' B' ' 254' ' ' GLU . 7.8 ptpp? -107.82 105.54 15.41 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 114.631 -1.168 . . . . 0.0 112.679 -172.537 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 256' ' ' LYS . . . . . . . . . . . . . 89.5 mttt . . . . . 0 C--N 1.302 -1.496 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 173.902 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 . . . . . 0 N--CA 1.465 0.298 0 CA-C-O 121.029 0.442 . . . . 0.0 109.884 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -76.36 -9.82 58.93 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 113.026 0.751 . . . . 0.0 113.026 -172.655 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 56.4 m-85 -96.28 10.13 38.9 Favored 'General case' 0 C--N 1.289 -2.034 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.303 -177.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 48.6 mmtm -125.98 160.86 28.91 Favored 'General case' 0 N--CA 1.437 -1.1 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.846 179.052 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 15.5 p-10 -115.54 22.36 13.24 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-O 122.179 0.99 . . . . 0.0 109.152 178.425 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -75.21 30.24 0.1 Allowed 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 125.594 1.558 . . . . 0.0 110.833 179.457 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.439 ' HA ' HG21 ' A' ' 85' ' ' THR . . . -100.7 16.22 25.64 Favored 'General case' 0 C--N 1.306 -1.283 0 C-N-CA 122.646 0.378 . . . . 0.0 110.644 -175.955 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.427 ' HE2' ' NH1' ' A' ' 110' ' ' ARG . 9.9 m-30 -104.85 145.23 30.67 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.89 -175.63 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 22.8 pt -140.82 158.4 23.69 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 CA-C-O 121.137 0.494 . . . . 0.0 110.628 178.795 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.442 ' HB2' HG21 ' A' ' 107' ' ' THR . 61.8 t80 -105.26 118.91 37.74 Favored 'General case' 0 N--CA 1.412 -2.374 0 CA-C-N 114.504 -1.226 . . . . 0.0 108.057 177.771 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.475 HG23 ' CD1' ' A' ' 104' ' ' ILE . 10.9 mt -108.41 127.53 64.7 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.18 0 N-CA-C 105.427 -2.064 . . . . 0.0 105.427 173.359 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -132.31 170.86 21.71 Favored Glycine 0 C--N 1.269 -3.18 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 71.74 32.84 1.87 Allowed 'General case' 0 N--CA 1.471 0.604 0 O-C-N 124.485 0.756 . . . . 0.0 109.873 -178.822 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.5 HD11 HD11 ' A' ' 47' ' ' ILE . 4.0 mm? -66.19 143.02 57.51 Favored 'General case' 0 CA--C 1.492 -1.267 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.465 177.768 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.426 ' HB3' ' HG ' ' A' ' 42' ' ' LEU . 61.2 t30 -83.49 156.5 22.83 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.061 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.458 ' HB2' ' OE2' ' A' ' 70' ' ' GLU . 18.4 ptt180 -58.01 -28.92 64.88 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 123.701 0.801 . . . . 0.0 112.664 -177.188 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -107.48 4.76 26.51 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 113.74 1.015 . . . . 0.0 113.74 -172.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.426 ' HG ' ' HB3' ' A' ' 39' ' ' ASN . 61.3 mt -84.56 121.69 27.97 Favored 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 120.348 -0.541 . . . . 0.0 110.776 178.775 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 69.6 p -107.58 173.47 6.31 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-N 115.096 -0.956 . . . . 0.0 109.675 -179.236 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.432 ' HG3' ' HB2' ' A' ' 62' ' ' LEU . 52.3 mt-10 -55.3 -38.97 69.34 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 123.46 0.704 . . . . 0.0 111.652 179.497 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -65.6 -37.98 94.17 Favored Glycine 0 N--CA 1.44 -1.078 0 CA-C-N 116.076 -0.511 . . . . 0.0 113.105 -178.693 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -67.25 -43.95 80.64 Favored 'General case' 0 CA--C 1.505 -0.773 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 -178.881 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.5 HD11 HD11 ' A' ' 38' ' ' LEU . 35.9 mt -60.77 -45.51 97.71 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.421 0 CA-C-N 114.922 -1.035 . . . . 0.0 110.593 178.587 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 50.0 mt -59.64 -44.85 93.35 Favored 'General case' 0 C--O 1.207 -1.135 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.704 -176.86 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.45 HG23 ' H ' ' B' ' 233' ' ' ASP . 96.4 m -60.63 -46.05 91.76 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 179.809 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.63 HG13 ' HG2' ' B' ' 237' ' ' ARG . 85.5 t -65.95 -48.44 81.84 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 CA-C-O 121.099 0.476 . . . . 0.0 110.679 179.251 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.425 ' HA ' ' HD2' ' A' ' 54' ' ' TYR . 5.4 m-85 -66.27 -24.39 66.56 Favored 'General case' 0 N--CA 1.431 -1.39 0 CA-C-N 115.595 -0.73 . . . . 0.0 112.331 -178.004 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.407 ' HA ' ' O ' ' A' ' 55' ' ' GLY . 73.3 m -68.59 -19.8 64.48 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.958 176.3 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -70.29 -25.3 63.27 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 119.553 -0.859 . . . . 0.0 108.953 175.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.425 ' HD2' ' HA ' ' A' ' 51' ' ' PHE . 37.0 m-85 -93.01 -7.55 45.51 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-N 115.877 -0.602 . . . . 0.0 112.069 -175.711 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.407 ' O ' ' HA ' ' A' ' 52' ' ' SER . . . 152.39 -159.63 28.5 Favored Glycine 0 N--CA 1.419 -2.48 0 C-N-CA 120.699 -0.762 . . . . 0.0 111.304 178.968 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 98.8 t -99.83 110.9 60.69 Favored Pre-proline 0 C--N 1.298 -1.634 0 O-C-N 123.382 0.107 . . . . 0.0 110.95 -178.075 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.532 ' HB3' HD21 ' A' ' 77' ' ' LEU . 92.1 Cg_endo -79.68 137.26 12.68 Favored 'Trans proline' 0 N--CA 1.452 -0.926 0 C-N-CA 122.779 2.319 . . . . 0.0 110.16 175.694 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 27.0 m -114.39 -20.41 6.06 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 C-N-CA 119.624 -0.83 . . . . 0.0 112.038 -178.595 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.519 ' HB3' ' HG2' ' A' ' 78' ' ' LYS . 37.5 t70 -157.24 138.24 13.45 Favored 'General case' 0 CA--C 1.499 -0.992 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.411 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 13.6 p -139.68 134.32 38.28 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 O-C-N 123.674 0.609 . . . . 0.0 109.379 178.619 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.444 ' CD1' ' HB3' ' A' ' 111' ' ' PRO . 84.5 mt -121.9 126.91 75.16 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.051 177.023 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.432 ' HB2' ' HG3' ' A' ' 44' ' ' GLU . 0.1 OUTLIER -105.99 112.46 25.51 Favored 'General case' 0 N--CA 1.424 -1.763 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 173.54 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 24.2 m -79.23 119.54 22.46 Favored 'General case' 0 C--N 1.281 -2.387 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 177.208 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.412 ' HA ' ' HA ' ' A' ' 71' ' ' SER . 81.8 mtp180 -110.15 127.74 55.08 Favored 'General case' 0 C--N 1.307 -1.274 0 O-C-N 121.992 -0.442 . . . . 0.0 111.89 -175.951 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.448 ' HA ' HE21 ' A' ' 72' ' ' GLN . 13.5 t70 -69.38 123.33 20.95 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.916 178.469 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -61.5 -25.7 67.44 Favored 'General case' 0 C--N 1.307 -1.249 0 C-N-CA 124.286 1.035 . . . . 0.0 113.135 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 32.8 m-80 -79.1 -49.94 11.83 Favored 'General case' 0 CA--C 1.512 -0.514 0 CA-C-O 121.308 0.575 . . . . 0.0 110.432 -175.332 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 48.7 p -84.8 -24.65 28.61 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.472 -177.718 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.94 12.85 71.82 Favored Glycine 0 N--CA 1.44 -1.039 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.505 -178.113 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.458 ' OE2' ' HB2' ' A' ' 40' ' ' ARG . 40.9 mt-10 -107.63 -84.31 0.53 Allowed 'General case' 0 N--CA 1.435 -1.215 0 O-C-N 122.421 -0.458 . . . . 0.0 109.856 -176.626 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.412 ' HA ' ' HA ' ' A' ' 64' ' ' ARG . 71.9 p -146.23 157.08 43.79 Favored 'General case' 0 N--CA 1.421 -1.917 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 -178.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.448 HE21 ' HA ' ' A' ' 65' ' ' ASP . 28.8 mm-40 -77.72 -18.05 56.96 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-O 121.167 0.508 . . . . 0.0 110.383 175.673 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 98.33 1.38 58.03 Favored Glycine 0 N--CA 1.43 -1.739 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.89 -177.841 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 37.3 p90 -140.53 151.72 44.99 Favored 'General case' 0 N--CA 1.432 -1.335 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 178.329 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -146.49 172.25 13.83 Favored 'General case' 0 N--CA 1.42 -1.927 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 178.43 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 8.0 t80 -135.07 143.76 46.85 Favored 'General case' 0 C--N 1.293 -1.857 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.047 -177.732 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.532 HD21 ' HB3' ' A' ' 57' ' ' PRO . 9.7 tt -149.83 140.52 22.63 Favored 'General case' 0 N--CA 1.434 -1.244 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 175.696 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.519 ' HG2' ' HB3' ' A' ' 59' ' ' ASP . 21.1 ptmt -123.34 144.44 49.45 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 178.33 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 70.1 m-85 -105.79 165.15 11.39 Favored 'General case' 0 C--N 1.289 -2.037 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.067 -177.641 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -75.08 -31.52 61.23 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 114.702 -1.136 . . . . 0.0 108.918 173.459 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.404 ' O ' ' HB2' ' A' ' 84' ' ' SER . 8.8 t70 -119.88 134.11 55.35 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 -178.31 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -70.62 -20.42 62.74 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 -179.118 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 87.0 mtm180 -67.91 -33.3 74.44 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-O 122.44 1.114 . . . . 0.0 109.239 175.1 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.49 ' OG ' HG21 ' B' ' 226' ' ' ILE . 50.3 m -62.27 -37.13 84.28 Favored 'General case' 0 C--N 1.285 -2.222 0 CA-C-N 114.6 -1.182 . . . . 0.0 112.323 177.016 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.479 ' O ' HG23 ' A' ' 89' ' ' VAL . 78.7 p -65.2 -45.49 84.58 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 120.208 -0.597 . . . . 0.0 110.179 -177.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.422 ' H ' HG12 ' A' ' 86' ' ' ILE . 5.6 pt -64.72 -38.11 81.84 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.492 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.099 177.222 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.656 HD11 ' HB2' ' B' ' 224' ' ' PHE . 12.0 mt -59.09 -44.69 91.94 Favored 'General case' 0 CA--C 1.502 -0.87 0 CA-C-O 120.944 0.402 . . . . 0.0 111.089 175.472 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.505 ' O ' ' HB2' ' A' ' 92' ' ' LEU . . . -71.4 -40.93 70.22 Favored 'General case' 0 N--CA 1.427 -1.59 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.303 -178.351 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.482 HG22 HG22 ' A' ' 104' ' ' ILE . 86.0 t -62.2 -49.4 84.19 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-O 120.889 0.376 . . . . 0.0 110.671 178.21 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -66.07 -35.75 81.37 Favored 'General case' 0 C--N 1.302 -1.468 0 C-N-CA 123.59 0.756 . . . . 0.0 112.13 -175.428 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.583 ' HA ' ' OD1' ' B' ' 239' ' ' ASN . 4.8 m-20 -87.74 -29.22 21.23 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -177.361 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.505 ' HB2' ' O ' ' A' ' 88' ' ' ALA . 10.1 mt -97.68 -26.56 14.71 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 112.84 0.682 . . . . 0.0 112.84 -173.648 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -60.38 125.1 22.4 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 109.551 -0.536 . . . . 0.0 109.551 -179.557 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 81.44 -1.12 86.65 Favored Glycine 0 N--CA 1.441 -0.987 0 C-N-CA 120.986 -0.626 . . . . 0.0 113.649 177.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 59.4 t80 -85.67 138.16 32.32 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 117.611 0.706 . . . . 0.0 109.122 -178.567 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.424 ' HE3' ' HB2' ' A' ' 101' ' ' ALA . 11.7 mptt -92.47 117.2 29.7 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 -176.506 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 56.6 mt -126.08 141.99 44.08 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 N-CA-C 105.253 -2.129 . . . . 0.0 105.253 173.019 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 60.58 19.98 55.23 Favored Glycine 0 CA--C 1.525 0.687 0 C-N-CA 121.598 -0.334 . . . . 0.0 113.595 179.794 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 84.33 10.61 79.74 Favored Glycine 0 N--CA 1.441 -0.989 0 C-N-CA 121.292 -0.48 . . . . 0.0 112.539 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 12.9 ptp180 -135.82 145.9 46.95 Favored 'General case' 0 N--CA 1.439 -0.996 0 O-C-N 122.435 -0.45 . . . . 0.0 111.511 -179.744 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.424 ' HB2' ' HE3' ' A' ' 96' ' ' LYS . . . -84.38 118.07 24.01 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.015 -177.543 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 10.3 mt -65.73 139.28 58.35 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-O 121.653 0.739 . . . . 0.0 112.49 179.671 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 60.2 tptt -109.98 115.47 29.84 Favored 'General case' 0 N--CA 1.413 -2.275 0 CA-C-N 115.106 -0.952 . . . . 0.0 108.456 178.12 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.482 HG22 HG22 ' A' ' 89' ' ' VAL . 5.0 mm -121.34 131.31 73.35 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.898 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 178.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -143.91 155.09 43.95 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 -179.349 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -83.55 132.08 34.94 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 117.994 0.361 . . . . 0.0 110.716 177.941 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.442 HG21 ' HB2' ' A' ' 34' ' ' TYR . 5.8 t -153.86 159.78 41.93 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 107.848 -1.168 . . . . 0.0 107.848 -176.304 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -99.71 112.64 24.85 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 169.629 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 32.3 t80 -105.0 138.29 41.43 Favored 'General case' 0 C--N 1.29 -2.021 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.363 -176.874 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.427 ' NH1' ' HE2' ' A' ' 32' ' ' TYR . 33.7 mmt180 -117.85 114.5 37.43 Favored Pre-proline 0 C--N 1.309 -1.172 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 176.359 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.444 ' HB3' ' CD1' ' A' ' 61' ' ' ILE . 68.5 Cg_endo -73.67 149.37 43.34 Favored 'Trans proline' 0 C--N 1.325 -0.675 0 C-N-CA 124.07 3.18 . . . . 0.0 114.35 -178.021 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 26.6 tptp -106.15 119.67 39.83 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 173.332 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 37.4 mmt180 . . . . . 0 C--N 1.29 -1.98 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 179.586 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 42.5 t30 . . . . . 0 CA--C 1.533 0.319 0 N-CA-C 111.825 0.305 . . . . 0.0 111.825 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 223' ' ' ARG . . . . . . . . . . . . . 47.7 ttp180 56.81 51.61 10.6 Favored 'General case' 0 CA--C 1.559 1.3 0 N-CA-C 115.175 1.546 . . . . 0.0 115.175 169.421 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 224' ' ' PHE . . . . . 0.656 ' HB2' HD11 ' A' ' 87' ' ' LEU . 8.7 m-85 -96.77 166.97 11.39 Favored 'General case' 0 C--N 1.271 -2.827 0 CA-C-N 115.427 -0.806 . . . . 0.0 108.944 175.948 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 225' ' ' ALA . . . . . . . . . . . . . . . -115.2 80.05 1.37 Allowed 'General case' 0 C--N 1.31 -1.145 0 CA-C-O 121.608 0.718 . . . . 0.0 110.385 -176.5 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 226' ' ' ILE . . . . . 0.49 HG21 ' OG ' ' A' ' 84' ' ' SER . 4.2 mp -126.11 138.79 53.48 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 177.177 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 227' ' ' MET . . . . . . . . . . . . . 91.1 mtp -67.49 133.16 92.89 Favored Pre-proline 0 C--N 1.312 -1.022 0 O-C-N 123.528 0.518 . . . . 0.0 110.12 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 228' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -68.67 158.78 56.35 Favored 'Trans proline' 0 N--CA 1.452 -0.96 0 C-N-CA 122.761 2.307 . . . . 0.0 112.25 179.695 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . -75.6 163.55 53.71 Favored Glycine 0 N--CA 1.437 -1.25 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.329 179.784 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 14.6 m -77.79 -14.36 59.61 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 123.103 0.561 . . . . 0.0 110.974 -178.581 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 27.9 mmt180 -81.82 0.26 40.18 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 121.461 0.648 . . . . 0.0 109.952 -178.371 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 232' ' ' TRP . . . . . . . . . . . . . 22.8 t90 -81.82 130.5 35.09 Favored 'General case' 0 N--CA 1.427 -1.593 0 CA-C-O 122.228 1.013 . . . . 0.0 111.441 -177.883 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 233' ' ' ASP . . . . . 0.45 ' H ' HG23 ' A' ' 49' ' ' THR . 17.3 t70 -117.86 147.74 42.78 Favored 'General case' 0 C--N 1.273 -2.758 0 N-CA-C 101.201 -3.629 . . . . 0.0 101.201 171.457 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -46.39 48.74 0.0 OUTLIER Glycine 0 N--CA 1.511 3.679 0 C-N-CA 128.248 2.832 . . . . 0.0 118.213 -175.447 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 235' ' ' VAL . . . . . 0.405 ' N ' ' O ' ' B' ' 233' ' ' ASP . 51.9 t -88.46 131.89 34.8 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.322 0 C-N-CA 127.996 2.518 . . . . 0.0 106.993 175.111 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 236' ' ' HIS . . . . . . . . . . . . . 81.5 t60 -109.68 108.56 18.99 Favored 'General case' 0 C--N 1.288 -2.074 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 175.253 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 237' ' ' ARG . . . . . 0.63 ' HG2' HG13 ' A' ' 50' ' ' VAL . 6.5 tpp180 -126.0 107.09 10.11 Favored 'General case' 0 C--N 1.288 -2.08 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 -176.646 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 238' ' ' SER . . . . . . . . . . . . . 50.7 p -148.95 154.14 38.97 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.965 -175.497 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 239' ' ' ASN . . . . . 0.583 ' OD1' ' HA ' ' A' ' 91' ' ' ASN . 8.6 m120 -50.44 -31.19 14.38 Favored 'General case' 0 N--CA 1.503 2.177 0 C-N-CA 123.988 0.915 . . . . 0.0 111.643 177.779 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 240' ' ' GLY . . . . . 0.436 ' O ' ' HG2' ' B' ' 244' ' ' LYS . . . 117.66 20.66 4.54 Favored Glycine 0 C--O 1.2 -1.972 0 C-N-CA 120.67 -0.776 . . . . 0.0 111.165 -175.754 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 26.8 p90 -76.38 -34.55 58.87 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -179.536 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -63.61 -42.42 98.23 Favored 'General case' 0 C--O 1.219 -0.543 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.843 -174.048 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -61.16 -34.36 74.9 Favored 'General case' 0 CA--C 1.509 -0.623 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.397 178.479 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 244' ' ' LYS . . . . . 0.436 ' HG2' ' O ' ' B' ' 240' ' ' GLY . 71.0 mmtt -67.15 -47.52 70.8 Favored 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 -179.029 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 245' ' ' TRP . . . . . . . . . . . . . 49.2 m0 -65.3 -40.15 93.43 Favored 'General case' 0 C--O 1.208 -1.089 0 CA-C-N 114.77 -1.105 . . . . 0.0 109.83 179.765 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 246' ' ' PHE . . . . . 0.486 ' O ' ' HG2' ' B' ' 249' ' ' GLN . 3.1 t80 -66.18 -30.75 71.28 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 124.091 0.956 . . . . 0.0 110.892 179.318 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -78.13 -39.87 39.86 Favored 'General case' 0 C--N 1.294 -1.836 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.24 178.784 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.89 -11.7 46.92 Favored 'General case' 0 CA--C 1.51 -0.584 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -175.915 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 249' ' ' GLN . . . . . 0.486 ' HG2' ' O ' ' B' ' 246' ' ' PHE . 12.4 pt20 -74.46 2.74 8.84 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.635 -179.234 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 250' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -57.42 -35.89 70.66 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.433 177.766 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -88.95 107.46 19.03 Favored 'General case' 0 N--CA 1.421 -1.89 0 CA-C-O 122.179 0.99 . . . . 0.0 110.239 177.286 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 252' ' ' ILE . . . . . . . . . . . . . 9.2 pt -116.88 -34.3 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.281 -2.4 0 CA-C-N 114.27 -1.332 . . . . 0.0 110.998 -179.206 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -115.4 -26.44 7.56 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 -178.841 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 254' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -63.25 148.98 46.67 Favored 'General case' 0 N--CA 1.432 -1.353 0 CA-C-N 114.631 -1.168 . . . . 0.0 110.181 -175.518 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 255' ' ' LYS . . . . . . . . . . . . . 45.9 mmtm -93.44 142.04 27.78 Favored 'General case' 0 C--N 1.286 -2.184 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.077 -175.013 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 256' ' ' LYS . . . . . . . . . . . . . 11.3 ptpt . . . . . 0 C--N 1.287 -2.123 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.553 -176.547 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 . . . . . 0 CA--C 1.51 -0.58 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 63.2 mm-40 -93.05 -20.13 20.85 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.529 -177.448 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 63.6 m-85 -94.75 2.77 55.55 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 112.932 0.715 . . . . 0.0 112.932 -171.514 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.0 mmmp? -133.08 176.08 8.82 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 18.7 p-10 -124.29 6.12 8.43 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 -175.388 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -80.89 27.67 0.38 Allowed 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 -179.466 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -94.85 -1.89 51.84 Favored 'General case' 0 CA--C 1.509 -0.614 0 O-C-N 121.937 -0.477 . . . . 0.0 111.563 -178.69 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -108.0 145.39 33.98 Favored 'General case' 0 C--N 1.311 -1.088 0 C-N-CA 120.816 -0.354 . . . . 0.0 110.32 -174.837 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 24.2 pt -142.74 161.97 18.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.984 178.085 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.414 ' HB2' HG21 ' A' ' 107' ' ' THR . 63.1 t80 -111.55 122.72 48.59 Favored 'General case' 0 N--CA 1.42 -1.975 0 C-N-CA 124.655 1.182 . . . . 0.0 108.485 178.522 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.456 HG23 ' CD1' ' A' ' 104' ' ' ILE . 9.9 mt -108.85 128.32 64.74 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.933 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 175.018 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -130.15 168.74 21.34 Favored Glycine 0 C--N 1.288 -2.112 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 -179.578 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.404 ' O ' ' HD3' ' A' ' 100' ' ' ARG . 83.5 m-20 72.75 27.46 2.23 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 124.766 1.226 . . . . 0.0 110.788 -177.781 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.401 HD11 HD11 ' A' ' 47' ' ' ILE . 4.3 mm? -62.84 143.2 57.8 Favored 'General case' 0 CA--C 1.499 -0.993 0 CA-C-O 121.407 0.622 . . . . 0.0 112.474 179.541 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.5 ' HB3' ' HG ' ' A' ' 42' ' ' LEU . 47.5 t-20 -85.38 147.11 26.67 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 175.707 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.02 -17.3 56.83 Favored 'General case' 0 C--N 1.299 -1.592 0 C-N-CA 123.949 0.9 . . . . 0.0 112.899 178.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -98.88 0.52 44.34 Favored 'General case' 0 C--O 1.244 0.768 0 CA-C-O 121.035 0.445 . . . . 0.0 111.253 -179.475 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.5 ' HG ' ' HB3' ' A' ' 39' ' ' ASN . 77.5 mt -90.68 120.35 31.67 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-O 121.637 0.732 . . . . 0.0 110.062 179.128 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 72.1 p -102.95 173.22 6.41 Favored 'General case' 0 C--N 1.29 -2.005 0 CA-C-N 114.382 -1.281 . . . . 0.0 108.973 -177.862 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.432 ' HG3' ' HB2' ' A' ' 62' ' ' LEU . 2.7 mp0 -56.13 -39.07 71.69 Favored 'General case' 0 C--O 1.209 -1.057 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 175.431 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -59.25 -40.07 95.39 Favored Glycine 0 N--CA 1.444 -0.827 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.948 -178.673 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -67.04 -49.14 66.17 Favored 'General case' 0 CA--C 1.496 -1.109 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.571 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.401 HD11 HD11 ' A' ' 38' ' ' LEU . 48.4 mt -58.45 -46.44 89.55 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.762 0 CA-C-N 114.866 -1.061 . . . . 0.0 110.304 179.601 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 44.4 mt -59.71 -45.5 91.95 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.843 -178.525 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.475 HG23 ' H ' ' B' ' 233' ' ' ASP . 98.2 m -62.63 -45.46 92.73 Favored 'General case' 0 N--CA 1.442 -0.869 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 179.606 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.588 HG13 ' HG3' ' B' ' 237' ' ' ARG . 91.3 t -65.89 -47.91 83.83 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.192 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.505 -178.938 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.496 ' HA ' ' HD2' ' A' ' 54' ' ' TYR . 3.7 m-85 -66.45 -24.44 66.44 Favored 'General case' 0 N--CA 1.428 -1.564 0 CA-C-N 115.412 -0.813 . . . . 0.0 112.354 -178.27 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.499 ' OG ' ' HB2' ' B' ' 231' ' ' ARG . 62.3 m -68.09 -18.07 64.56 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 176.724 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -69.92 -26.78 64.31 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 119.546 -0.862 . . . . 0.0 109.226 176.165 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.496 ' HD2' ' HA ' ' A' ' 51' ' ' PHE . 61.9 m-85 -89.61 -23.26 21.98 Favored 'General case' 0 CA--C 1.505 -0.774 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.845 -175.032 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.419 ' O ' ' HA ' ' A' ' 52' ' ' SER . . . 170.41 -155.74 25.58 Favored Glycine 0 N--CA 1.418 -2.558 0 N-CA-C 110.577 -1.009 . . . . 0.0 110.577 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.417 HG22 ' HA2' ' B' ' 229' ' ' GLY . 49.0 t -104.46 105.57 50.47 Favored Pre-proline 0 C--N 1.289 -2.04 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 -177.476 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.601 ' HB3' HD21 ' A' ' 77' ' ' LEU . 64.0 Cg_endo -74.74 136.4 20.93 Favored 'Trans proline' 0 N--CA 1.447 -1.263 0 C-N-CA 121.793 1.662 . . . . 0.0 109.522 175.495 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 26.8 m -111.66 -25.54 3.47 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 C-N-CA 120.354 -0.538 . . . . 0.0 111.693 -178.45 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.507 ' HB3' ' HG2' ' A' ' 78' ' ' LYS . 27.9 t70 -152.92 145.38 24.11 Favored 'General case' 0 CA--C 1.491 -1.295 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 14.6 p -145.96 135.47 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.799 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 179.321 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 92.7 mt -120.51 123.91 71.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 175.607 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.432 ' HB2' ' HG3' ' A' ' 44' ' ' GLU . 0.1 OUTLIER -97.11 114.52 26.19 Favored 'General case' 0 N--CA 1.422 -1.844 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 176.46 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 9.2 m -75.25 117.85 17.52 Favored 'General case' 0 C--N 1.276 -2.594 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 178.244 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 25.9 mtp180 -128.26 146.45 50.74 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-O 120.991 0.424 . . . . 0.0 110.991 -176.143 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -95.2 113.87 25.6 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.178 177.524 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -62.1 -21.12 64.73 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 -177.701 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 22.6 m-80 -78.1 -44.14 27.01 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.345 0.593 . . . . 0.0 109.813 -176.414 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 44.8 p -90.35 -24.12 20.91 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-O 121.444 0.64 . . . . 0.0 111.236 -179.644 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 80.86 10.21 85.36 Favored Glycine 0 N--CA 1.442 -0.914 0 CA-C-N 115.978 -0.555 . . . . 0.0 112.354 178.72 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -114.99 -177.33 3.1 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 -178.27 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 25.1 m -71.92 154.31 41.29 Favored 'General case' 0 N--CA 1.424 -1.731 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.557 175.502 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 12.4 mm-40 -83.3 1.91 38.71 Favored 'General case' 0 C--N 1.307 -1.258 0 C-N-CA 122.95 0.5 . . . . 0.0 111.794 178.836 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 85.81 6.74 82.29 Favored Glycine 0 N--CA 1.427 -1.939 0 C-N-CA 120.951 -0.643 . . . . 0.0 112.11 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -148.03 156.87 43.12 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 178.922 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -154.5 171.79 18.83 Favored 'General case' 0 C--N 1.307 -1.252 0 O-C-N 123.741 0.651 . . . . 0.0 110.295 178.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -128.33 140.94 51.6 Favored 'General case' 0 C--N 1.31 -1.125 0 C-N-CA 123.71 0.804 . . . . 0.0 110.222 -178.52 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.601 HD21 ' HB3' ' A' ' 57' ' ' PRO . 9.8 tt -147.06 140.72 25.68 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 175.867 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.507 ' HG2' ' HB3' ' A' ' 59' ' ' ASP . 21.6 ptmt -123.93 144.84 49.54 Favored 'General case' 0 C--O 1.259 1.59 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 178.645 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 59.0 m-85 -106.78 164.59 11.98 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-O 121.39 0.614 . . . . 0.0 112.232 -178.284 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -71.98 -34.3 68.83 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 114.053 -1.431 . . . . 0.0 109.093 175.81 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -124.65 135.01 52.71 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.403 -179.717 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -70.55 -20.09 62.83 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 114.316 1.228 . . . . 0.0 114.316 -177.409 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 87.5 mtm180 -61.27 -33.92 74.34 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 122.378 1.085 . . . . 0.0 109.475 173.747 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 50.6 m -66.02 -36.6 83.7 Favored 'General case' 0 C--N 1.288 -2.068 0 CA-C-N 114.777 -1.101 . . . . 0.0 112.662 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 71.3 p -63.46 -45.09 92.4 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 120.34 -0.544 . . . . 0.0 110.995 -177.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 3.9 pt -65.63 -38.54 82.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.048 177.536 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.477 HD11 ' HB2' ' B' ' 224' ' ' PHE . 16.1 mt -59.34 -43.74 92.73 Favored 'General case' 0 CA--C 1.502 -0.878 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.439 175.4 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.485 ' O ' ' HB2' ' A' ' 92' ' ' LEU . . . -69.93 -44.97 68.5 Favored 'General case' 0 N--CA 1.425 -1.678 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.648 -178.648 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.499 HG22 HG22 ' A' ' 104' ' ' ILE . 71.2 t -59.69 -44.27 93.24 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.898 0 CA-C-O 121.189 0.519 . . . . 0.0 111.229 177.927 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -63.15 -39.1 93.7 Favored 'General case' 0 C--N 1.291 -1.94 0 C-N-CA 124.095 0.958 . . . . 0.0 112.612 -177.403 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.431 ' HA ' ' HB3' ' B' ' 239' ' ' ASN . 50.8 t-20 -93.44 -33.27 13.89 Favored 'General case' 0 C--N 1.292 -1.924 0 CA-C-O 121.196 0.522 . . . . 0.0 111.355 -175.01 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.485 ' HB2' ' O ' ' A' ' 88' ' ' ALA . 12.9 mt -88.37 -28.13 21.17 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 112.597 0.591 . . . . 0.0 112.597 -171.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -64.26 123.83 20.14 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 81.89 -0.57 88.25 Favored Glycine 0 CA--C 1.535 1.321 0 C-N-CA 120.979 -0.629 . . . . 0.0 113.763 179.631 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.402 ' O ' ' HA ' ' A' ' 101' ' ' ALA . 68.3 t80 -85.11 141.76 30.0 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -179.091 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.56 119.74 34.59 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 112.832 0.678 . . . . 0.0 112.832 -176.34 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 52.2 mt -127.56 141.25 46.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 N-CA-C 105.415 -2.069 . . . . 0.0 105.415 172.107 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 61.22 20.74 58.72 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 121.135 -0.555 . . . . 0.0 113.567 179.762 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 82.1 10.05 84.37 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 121.159 -0.543 . . . . 0.0 112.835 -178.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.404 ' HD3' ' O ' ' A' ' 37' ' ' ASN . 12.7 ptp180 -134.81 143.68 47.2 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 117.128 0.464 . . . . 0.0 111.564 -179.762 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.402 ' HA ' ' O ' ' A' ' 95' ' ' PHE . . . -81.33 121.16 25.86 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.508 -179.836 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 10.5 mt -70.03 138.7 52.37 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 179.626 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 24.2 tptm -106.4 116.2 31.51 Favored 'General case' 0 N--CA 1.415 -2.193 0 CA-C-N 115.181 -0.918 . . . . 0.0 108.575 177.557 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.499 HG22 HG22 ' A' ' 89' ' ' VAL . 5.8 mm -118.76 135.9 57.68 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.096 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 177.686 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -143.48 152.96 42.13 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 -178.105 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' HIS . . . . . 0.401 ' CD2' HG21 ' A' ' 89' ' ' VAL . 47.3 m-70 -84.16 135.01 34.55 Favored 'General case' 0 C--N 1.289 -2.055 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 176.551 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.414 HG21 ' HB2' ' A' ' 34' ' ' TYR . 5.9 t -154.49 163.49 40.12 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 106.024 -1.843 . . . . 0.0 106.024 -178.752 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -110.16 110.61 21.52 Favored 'General case' 0 N--CA 1.422 -1.829 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 171.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 26.5 t80 -106.96 140.72 39.32 Favored 'General case' 0 C--N 1.285 -2.213 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 -179.186 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.429 ' HA ' ' HD2' ' A' ' 111' ' ' PRO . 10.8 mmm180 -120.26 115.54 32.8 Favored Pre-proline 0 C--N 1.297 -1.715 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 175.253 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.429 ' HD2' ' HA ' ' A' ' 110' ' ' ARG . 39.3 Cg_endo -64.26 136.54 51.93 Favored 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 122.484 2.123 . . . . 0.0 112.837 -179.316 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 26.5 tptp -113.64 123.72 50.61 Favored 'General case' 0 N--CA 1.421 -1.876 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 175.76 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 34.0 mmt180 . . . . . 0 C--N 1.283 -2.3 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 178.717 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 . . . . . 0 N--CA 1.477 0.908 0 N-CA-C 111.368 0.136 . . . . 0.0 111.368 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 223' ' ' ARG . . . . . . . . . . . . . 9.7 ptm180 53.74 43.54 30.9 Favored 'General case' 0 N--CA 1.504 2.24 0 C-N-CA 126.68 1.992 . . . . 0.0 116.292 173.62 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 224' ' ' PHE . . . . . 0.477 ' HB2' HD11 ' A' ' 87' ' ' LEU . 32.8 m-85 -99.66 165.13 11.76 Favored 'General case' 0 C--N 1.28 -2.418 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 173.852 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 225' ' ' ALA . . . . . . . . . . . . . . . -127.05 84.74 2.29 Favored 'General case' 0 C--N 1.297 -1.698 0 CA-C-O 121.412 0.625 . . . . 0.0 110.274 -179.342 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 4.2 mp -126.02 132.07 71.02 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 176.616 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 227' ' ' MET . . . . . . . . . . . . . 93.1 mmm -72.35 137.92 81.18 Favored Pre-proline 0 C--N 1.317 -0.833 0 O-C-N 123.621 0.576 . . . . 0.0 110.337 178.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 228' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -63.16 160.81 32.78 Favored 'Trans proline' 0 CA--C 1.536 0.623 0 C-N-CA 123.752 2.968 . . . . 0.0 114.615 -174.28 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 229' ' ' GLY . . . . . 0.417 ' HA2' HG22 ' A' ' 56' ' ' VAL . . . -80.1 171.11 54.23 Favored Glycine 0 N--CA 1.442 -0.938 0 CA-C-N 115.077 -0.965 . . . . 0.0 113.438 -178.834 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 7.9 m -72.15 -15.7 61.97 Favored 'General case' 0 C--N 1.307 -1.261 0 C-N-CA 124.318 1.047 . . . . 0.0 111.772 -175.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 231' ' ' ARG . . . . . 0.499 ' HB2' ' OG ' ' A' ' 52' ' ' SER . 9.9 mmm180 -93.34 -0.03 56.76 Favored 'General case' 0 C--N 1.313 -1.007 0 O-C-N 122.175 -0.328 . . . . 0.0 110.946 -174.56 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 232' ' ' TRP . . . . . . . . . . . . . 21.2 t90 -75.15 127.41 33.14 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-O 122.655 1.216 . . . . 0.0 112.419 -176.779 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 233' ' ' ASP . . . . . 0.475 ' H ' HG23 ' A' ' 49' ' ' THR . 22.3 t70 -123.95 144.17 49.95 Favored 'General case' 0 C--N 1.263 -3.161 0 N-CA-C 102.424 -3.176 . . . . 0.0 102.424 174.444 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -42.12 63.74 0.0 OUTLIER Glycine 0 N--CA 1.49 2.276 0 C-N-CA 128.415 2.912 . . . . 0.0 116.375 -178.239 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 235' ' ' VAL . . . . . 0.447 ' N ' ' O ' ' B' ' 233' ' ' ASP . 55.5 t -110.64 127.99 67.29 Favored 'Isoleucine or valine' 0 C--N 1.247 -3.868 0 C-N-CA 127.627 2.371 . . . . 0.0 107.099 176.623 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 236' ' ' HIS . . . . . . . . . . . . . 85.2 t60 -109.34 117.93 35.34 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 -176.776 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 237' ' ' ARG . . . . . 0.588 ' HG3' HG13 ' A' ' 50' ' ' VAL . 33.8 mmt180 -114.08 110.38 19.93 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 177.92 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 238' ' ' SER . . . . . . . . . . . . . 20.9 t -125.11 116.7 22.49 Favored 'General case' 0 C--N 1.29 -1.993 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.196 -178.768 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 239' ' ' ASN . . . . . 0.431 ' HB3' ' HA ' ' A' ' 91' ' ' ASN . 28.1 p-10 -82.36 16.58 2.0 Allowed 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.42 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 240' ' ' GLY . . . . . 0.5 ' O ' ' HG2' ' B' ' 244' ' ' LYS . . . -85.06 53.75 4.84 Favored Glycine 0 N--CA 1.426 -1.98 0 N-CA-C 110.204 -1.158 . . . . 0.0 110.204 177.024 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 37.8 p90 -75.18 -33.72 61.48 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -176.794 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -61.57 -45.33 94.6 Favored 'General case' 0 CA--C 1.507 -0.703 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.52 -178.033 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -62.28 -34.31 76.32 Favored 'General case' 0 C--O 1.212 -0.892 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.266 -179.564 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 244' ' ' LYS . . . . . 0.5 ' HG2' ' O ' ' B' ' 240' ' ' GLY . 71.6 mmtt -64.87 -47.79 76.59 Favored 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 -179.028 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 245' ' ' TRP . . . . . 0.47 ' HA ' ' HG3' ' B' ' 248' ' ' LYS . 37.8 m0 -66.14 -37.28 85.3 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.677 178.079 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 246' ' ' PHE . . . . . 0.566 ' O ' ' HG2' ' B' ' 249' ' ' GLN . 2.5 t80 -66.89 -30.36 70.5 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.809 176.612 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -77.7 -40.02 42.74 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.954 179.379 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 248' ' ' LYS . . . . . 0.47 ' HG3' ' HA ' ' B' ' 245' ' ' TRP . 0.0 OUTLIER -81.36 -19.26 43.09 Favored 'General case' 0 CA--C 1.506 -0.718 0 CA-C-O 120.84 0.352 . . . . 0.0 111.678 -175.908 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 249' ' ' GLN . . . . . 0.566 ' HG2' ' O ' ' B' ' 246' ' ' PHE . 11.6 pt20 -70.44 -0.56 8.58 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.739 -178.268 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 250' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -57.78 -32.18 67.27 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.992 177.2 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -89.83 106.56 18.55 Favored 'General case' 0 N--CA 1.428 -1.542 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 176.441 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 252' ' ' ILE . . . . . . . . . . . . . 37.9 pt -92.8 -33.93 5.69 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.851 0 CA-C-N 115.028 -0.987 . . . . 0.0 112.316 -174.004 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -89.26 -11.45 43.53 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-O 121.349 0.595 . . . . 0.0 110.745 -176.123 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 254' ' ' GLU . . . . . 0.438 ' OE1' ' HG2' ' B' ' 255' ' ' LYS . 0.2 OUTLIER -100.14 155.08 17.94 Favored 'General case' 0 C--N 1.287 -2.126 0 CA-C-N 114.971 -1.013 . . . . 0.0 111.16 -177.024 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 255' ' ' LYS . . . . . 0.438 ' HG2' ' OE1' ' B' ' 254' ' ' GLU . 0.1 OUTLIER -102.39 34.42 2.77 Favored 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 124.563 1.145 . . . . 0.0 111.548 -174.285 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 256' ' ' LYS . . . . . . . . . . . . . 44.0 mmtm . . . . . 0 C--N 1.311 -1.109 0 O-C-N 124.24 0.963 . . . . 0.0 111.976 179.302 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.54 ' N ' HD21 ' A' ' 25' ' ' ASN . 0.6 OUTLIER . . . . . 0 CA--C 1.505 -0.785 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 . . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.516 ' HB2' ' CD1' ' A' ' 27' ' ' TYR . 2.4 mp0 -83.11 -44.28 15.3 Favored 'General case' 0 N--CA 1.414 -2.247 0 CA-C-O 121.782 0.801 . . . . 0.0 110.898 -176.302 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.516 ' CD1' ' HB2' ' A' ' 26' ' ' GLU . 88.7 m-85 -91.6 27.57 1.98 Allowed 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 114.737 -1.119 . . . . 0.0 113.229 -168.949 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -131.45 167.94 18.48 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 175.511 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.407 ' C ' ' H ' ' A' ' 31' ' ' ALA . 22.4 m-20 -125.39 21.2 7.94 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-O 121.567 0.698 . . . . 0.0 110.109 -178.799 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -77.2 15.34 0.74 Allowed 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.852 179.219 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.415 ' HA ' HG21 ' A' ' 85' ' ' THR . . . -86.04 -15.38 41.52 Favored 'General case' 0 N--CA 1.44 -0.953 0 C-N-CA 123.886 0.875 . . . . 0.0 110.46 -179.657 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 16.3 m-85 -99.72 145.18 27.95 Favored 'General case' 0 N--CA 1.433 -1.283 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 -177.696 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 24.7 pt -140.1 156.44 24.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 CA-C-O 121.157 0.504 . . . . 0.0 110.636 175.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 49.0 t80 -106.87 123.73 48.58 Favored 'General case' 0 N--CA 1.408 -2.564 0 CA-C-N 114.396 -1.275 . . . . 0.0 107.607 177.168 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.416 HG23 ' CD1' ' A' ' 104' ' ' ILE . 8.3 mt -107.89 127.57 63.88 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.55 0 N-CA-C 105.831 -1.915 . . . . 0.0 105.831 175.224 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -126.61 164.06 20.31 Favored Glycine 0 C--N 1.272 -2.975 0 N-CA-C 110.612 -0.995 . . . . 0.0 110.612 -179.076 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 70.94 39.9 0.97 Allowed 'General case' 0 CA--C 1.506 -0.74 0 C-N-CA 124.18 0.992 . . . . 0.0 110.715 -177.553 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.493 HD11 HD11 ' A' ' 47' ' ' ILE . 4.4 mm? -73.44 151.81 40.98 Favored 'General case' 0 CA--C 1.497 -1.07 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.867 176.007 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.506 ' HB3' ' HG ' ' A' ' 42' ' ' LEU . 50.2 t-20 -96.14 147.98 23.17 Favored 'General case' 0 C--N 1.286 -2.188 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 177.657 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.41 HH11 ' HD3' ' A' ' 40' ' ' ARG . 0.3 OUTLIER -63.39 -19.41 64.65 Favored 'General case' 0 C--N 1.298 -1.672 0 C-N-CA 123.326 0.651 . . . . 0.0 111.985 179.944 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.441 ' HG2' ' CG ' ' A' ' 39' ' ' ASN . 12.9 pt-20 -91.93 -3.54 55.81 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.903 -179.179 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.506 ' HG ' ' HB3' ' A' ' 39' ' ' ASN . 78.3 mt -91.09 124.03 35.0 Favored 'General case' 0 CA--C 1.504 -0.818 0 CA-C-O 121.117 0.485 . . . . 0.0 110.285 -179.63 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 67.2 p -109.72 173.78 6.17 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 114.705 -1.134 . . . . 0.0 109.409 -178.418 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.533 ' CG ' ' HB2' ' A' ' 62' ' ' LEU . 51.9 mt-10 -55.66 -38.91 70.2 Favored 'General case' 0 C--N 1.328 -0.333 0 O-C-N 123.47 0.481 . . . . 0.0 110.293 178.354 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -59.96 -43.11 98.43 Favored Glycine 0 C--O 1.24 0.483 0 CA-C-N 115.928 -0.578 . . . . 0.0 113.105 179.266 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -61.68 -49.17 77.57 Favored 'General case' 0 CA--C 1.499 -0.981 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.493 HD11 HD11 ' A' ' 38' ' ' LEU . 41.7 mt -60.86 -46.07 96.97 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.931 0 CA-C-N 114.833 -1.076 . . . . 0.0 110.63 -179.529 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 36.1 mt -60.07 -45.73 91.91 Favored 'General case' 0 CA--C 1.491 -1.293 0 C-N-CA 122.511 0.325 . . . . 0.0 111.81 -176.503 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.493 HG23 ' H ' ' B' ' 233' ' ' ASP . 97.5 m -62.88 -45.32 93.1 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 123.39 0.431 . . . . 0.0 111.751 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.447 HG13 ' HD2' ' B' ' 237' ' ' ARG . 76.6 t -67.28 -45.51 85.94 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.92 -179.645 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -66.96 -22.8 65.91 Favored 'General case' 0 N--CA 1.435 -1.184 0 C-N-CA 123.483 0.713 . . . . 0.0 111.941 -179.355 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.6 ' OG ' ' HB2' ' B' ' 231' ' ' ARG . 73.2 m -71.73 -16.54 62.22 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 116.177 -0.465 . . . . 0.0 112.141 176.139 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -73.53 -20.75 60.57 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 175.319 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.459 ' CE1' ' HB2' ' A' ' 91' ' ' ASN . 68.3 m-85 -97.76 -5.1 35.71 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-N 115.898 -0.592 . . . . 0.0 112.315 -176.864 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 151.7 -153.65 25.07 Favored Glycine 0 N--CA 1.423 -2.2 0 C-N-CA 120.511 -0.852 . . . . 0.0 111.317 179.212 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.461 ' HB ' ' HG2' ' A' ' 80' ' ' GLU . 99.5 t -106.61 104.51 51.26 Favored Pre-proline 0 C--N 1.305 -1.364 0 CA-C-O 120.469 0.176 . . . . 0.0 111.28 -177.466 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.555 ' HB3' HD21 ' A' ' 77' ' ' LEU . 87.8 Cg_endo -76.8 140.09 20.4 Favored 'Trans proline' 0 C--O 1.24 0.61 0 C-N-CA 123.011 2.474 . . . . 0.0 110.141 175.342 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 34.1 m -117.78 -26.04 2.77 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 C-N-CA 119.815 -0.754 . . . . 0.0 111.84 -179.35 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.617 ' HB3' ' HG2' ' A' ' 78' ' ' LYS . 30.5 t70 -149.52 136.48 19.65 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 -173.434 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 14.3 p -145.96 134.1 16.05 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.051 0 O-C-N 123.548 0.53 . . . . 0.0 110.165 -178.361 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 97.3 mt -121.37 120.15 61.12 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 175.173 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.533 ' HB2' ' CG ' ' A' ' 44' ' ' GLU . 0.1 OUTLIER -91.43 115.56 28.14 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 105.957 -1.868 . . . . 0.0 105.957 173.409 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 13.2 m -72.62 116.68 13.38 Favored 'General case' 0 N--CA 1.411 -2.379 0 N-CA-C 107.535 -1.284 . . . . 0.0 107.535 177.636 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 75.8 mtm180 -134.04 145.81 49.77 Favored 'General case' 0 C--N 1.287 -2.133 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 -174.753 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -87.61 119.26 27.73 Favored 'General case' 0 C--N 1.29 -1.989 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 177.245 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -60.2 -24.43 64.8 Favored 'General case' 0 C--N 1.311 -1.085 0 C-N-CA 123.432 0.693 . . . . 0.0 112.463 -176.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 35.5 m-80 -79.43 -50.4 10.86 Favored 'General case' 0 CA--C 1.507 -0.702 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.877 -175.725 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 50.3 p -87.1 -23.34 24.93 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-O 121.369 0.604 . . . . 0.0 111.632 -176.605 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 79.8 1.59 87.29 Favored Glycine 0 N--CA 1.439 -1.149 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.273 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -98.06 169.61 9.5 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-O 121.195 0.521 . . . . 0.0 109.873 -177.052 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 17.6 m -74.53 141.16 44.86 Favored 'General case' 0 C--N 1.294 -1.821 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.24 178.18 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 15.6 mm-40 -70.71 -17.0 62.83 Favored 'General case' 0 C--N 1.317 -0.831 0 C-N-CA 123.346 0.658 . . . . 0.0 112.154 -179.201 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 102.35 8.59 43.54 Favored Glycine 0 N--CA 1.431 -1.644 0 C-N-CA 120.27 -0.967 . . . . 0.0 111.636 179.785 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 34.9 p90 -148.78 159.86 43.75 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 177.044 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -156.07 172.73 17.9 Favored 'General case' 0 C--N 1.308 -1.231 0 O-C-N 123.581 0.551 . . . . 0.0 110.561 178.436 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -130.22 141.37 50.64 Favored 'General case' 0 C--N 1.308 -1.235 0 C-N-CA 123.723 0.809 . . . . 0.0 110.089 -179.517 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.555 HD21 ' HB3' ' A' ' 57' ' ' PRO . 9.4 tt -149.21 140.85 23.48 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 175.104 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.617 ' HG2' ' HB3' ' A' ' 59' ' ' ASP . 16.5 ptmt -125.93 144.28 50.75 Favored 'General case' 0 N--CA 1.431 -1.425 0 CA-C-O 121.421 0.629 . . . . 0.0 109.821 176.51 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -102.6 165.08 11.28 Favored 'General case' 0 C--N 1.283 -2.291 0 CA-C-N 115.164 -0.926 . . . . 0.0 109.362 179.518 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.461 ' HG2' ' HB ' ' A' ' 56' ' ' VAL . 8.2 pt-20 -76.95 -21.49 54.7 Favored 'General case' 0 N--CA 1.428 -1.563 0 C-N-CA 119.997 -0.681 . . . . 0.0 110.07 174.052 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -123.59 132.56 53.91 Favored 'General case' 0 N--CA 1.443 -0.815 0 C-N-CA 120.424 -0.51 . . . . 0.0 110.399 179.164 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -70.47 -19.87 62.91 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 -179.318 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 86.5 mtm180 -66.11 -33.66 76.29 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-O 122.166 0.984 . . . . 0.0 108.978 174.093 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 48.7 m -67.97 -36.98 80.98 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-N 114.86 -1.063 . . . . 0.0 112.208 177.531 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.478 ' O ' HG23 ' A' ' 89' ' ' VAL . 73.1 p -64.96 -45.3 86.27 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 120.244 -0.583 . . . . 0.0 110.9 -177.886 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 7.1 pt -63.25 -38.69 82.79 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.466 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.161 177.178 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.448 HD11 ' HB2' ' B' ' 224' ' ' PHE . 5.6 mt -59.23 -43.83 92.35 Favored 'General case' 0 CA--C 1.502 -0.893 0 O-C-N 123.785 0.678 . . . . 0.0 111.423 177.267 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.429 ' HB1' HD12 ' A' ' 92' ' ' LEU . . . -69.09 -46.53 67.53 Favored 'General case' 0 N--CA 1.424 -1.728 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.745 -179.418 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.478 HG23 ' O ' ' A' ' 85' ' ' THR . 92.7 t -56.64 -46.39 82.81 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.745 0 CA-C-O 121.648 0.737 . . . . 0.0 110.569 178.136 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -58.87 -40.14 83.44 Favored 'General case' 0 C--N 1.292 -1.926 0 C-N-CA 125.843 1.657 . . . . 0.0 112.329 -175.522 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.471 ' HA ' ' HB3' ' B' ' 239' ' ' ASN . 47.0 m-80 -98.46 -27.88 13.86 Favored 'General case' 0 C--N 1.294 -1.846 0 N-CA-C 113.129 0.788 . . . . 0.0 113.129 -175.96 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.429 HD12 ' HB1' ' A' ' 88' ' ' ALA . 15.5 mt -90.07 -30.73 17.51 Favored 'General case' 0 CA--C 1.471 -2.091 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.706 -171.796 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -65.98 124.74 23.35 Favored 'General case' 0 N--CA 1.425 -1.685 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.805 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 88.75 -5.48 84.57 Favored Glycine 0 C--N 1.308 -1.003 0 C-N-CA 121.167 -0.539 . . . . 0.0 112.65 -178.666 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 53.6 t80 -88.69 139.75 30.15 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 -179.041 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.457 ' HE3' ' HB2' ' A' ' 101' ' ' ALA . 12.3 mptt -95.87 118.18 32.01 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-O 120.92 0.391 . . . . 0.0 111.649 -176.292 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 53.0 mt -121.33 140.73 44.52 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 173.081 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 57.22 27.22 57.43 Favored Glycine 0 C--O 1.22 -0.756 0 C-N-CA 121.327 -0.463 . . . . 0.0 112.567 -179.582 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 88.07 -5.81 84.34 Favored Glycine 0 CA--C 1.536 1.376 0 N-CA-C 114.541 0.577 . . . . 0.0 114.541 179.028 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 16.8 ptp180 -126.34 149.89 48.89 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 118.16 0.98 . . . . 0.0 111.901 -177.039 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.457 ' HB2' ' HE3' ' A' ' 96' ' ' LYS . . . -84.84 116.8 23.5 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.525 -175.725 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.441 HD23 ' HA ' ' A' ' 102' ' ' LEU . 12.9 mt -66.51 141.4 57.89 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-O 121.76 0.791 . . . . 0.0 112.797 178.538 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 4.3 tppp? -117.2 116.59 27.58 Favored 'General case' 0 N--CA 1.411 -2.419 0 CA-C-N 114.67 -1.15 . . . . 0.0 108.123 176.583 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.435 HG22 HG22 ' A' ' 89' ' ' VAL . 4.1 mm -115.64 133.64 61.36 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.931 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 -179.69 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -143.6 150.89 39.47 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 -179.405 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 41.7 m-70 -79.42 131.63 36.14 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-O 121.132 0.492 . . . . 0.0 110.33 177.678 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 15.1 t -143.77 156.38 44.48 Favored 'General case' 0 C--N 1.288 -2.068 0 N-CA-C 106.072 -1.825 . . . . 0.0 106.072 -179.445 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 30.3 p90 -101.13 109.17 21.02 Favored 'General case' 0 N--CA 1.42 -1.944 0 C-N-CA 117.173 -1.811 . . . . 0.0 107.08 169.718 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 42.8 t80 -108.19 144.5 35.53 Favored 'General case' 0 C--N 1.29 -2.008 0 CA-C-N 114.87 -1.059 . . . . 0.0 108.647 -178.876 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.403 ' HA ' ' HD2' ' A' ' 111' ' ' PRO . 39.8 mmt180 -120.34 113.32 33.84 Favored Pre-proline 0 C--N 1.298 -1.645 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 173.783 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.403 ' HD2' ' HA ' ' A' ' 110' ' ' ARG . 55.3 Cg_endo -69.33 146.54 63.17 Favored 'Trans proline' 0 C--N 1.326 -0.644 0 C-N-CA 124.07 3.18 . . . . 0.0 114.6 -179.822 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.478 ' HD3' ' C ' ' A' ' 112' ' ' LYS . 10.9 tmtt? -120.62 125.5 47.91 Favored 'General case' 0 N--CA 1.426 -1.639 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 173.474 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 39.7 mmt180 . . . . . 0 C--N 1.305 -1.36 0 CA-C-O 118.947 -0.549 . . . . 0.0 110.303 177.755 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 6.7 m120 . . . . . 0 CA--C 1.502 -0.873 0 CA-C-O 119.59 -0.243 . . . . 0.0 110.637 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 223' ' ' ARG . . . . . . . . . . . . . 11.5 ptm180 57.56 34.03 24.03 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 126.457 1.903 . . . . 0.0 114.641 178.44 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 224' ' ' PHE . . . . . 0.448 ' HB2' HD11 ' A' ' 87' ' ' LEU . 44.9 m-85 -96.74 165.25 12.22 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 175.491 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 225' ' ' ALA . . . . . . . . . . . . . . . -117.79 21.68 12.76 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 112.851 0.685 . . . . 0.0 112.851 -173.604 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 4.6 mp -75.18 130.86 35.84 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 C-N-CA 120.031 -0.668 . . . . 0.0 110.022 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 227' ' ' MET . . . . . . . . . . . . . 26.3 ptm -71.56 151.72 93.77 Favored Pre-proline 0 C--N 1.318 -0.778 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.387 178.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 228' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -70.94 157.28 58.53 Favored 'Trans proline' 0 C--O 1.245 0.865 0 C-N-CA 123.225 2.617 . . . . 0.0 112.991 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . -84.37 173.44 49.85 Favored Glycine 0 C--N 1.317 -0.51 0 CA-C-N 115.704 -0.68 . . . . 0.0 113.089 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 24.8 m -77.71 -14.3 59.65 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -175.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 231' ' ' ARG . . . . . 0.6 ' HB2' ' OG ' ' A' ' 52' ' ' SER . 3.1 mmp_? -80.16 -7.15 58.8 Favored 'General case' 0 C--N 1.326 -0.43 0 O-C-N 121.964 -0.46 . . . . 0.0 110.365 177.657 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 232' ' ' TRP . . . . . . . . . . . . . 22.8 t90 -73.1 127.17 31.8 Favored 'General case' 0 CA--C 1.5 -0.966 0 CA-C-O 122.355 1.074 . . . . 0.0 111.819 -178.754 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 233' ' ' ASP . . . . . 0.493 ' H ' HG23 ' A' ' 49' ' ' THR . 26.9 t70 -123.23 146.47 47.81 Favored 'General case' 0 C--N 1.269 -2.92 0 N-CA-C 102.436 -3.172 . . . . 0.0 102.436 173.511 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -41.59 65.86 0.0 OUTLIER Glycine 0 N--CA 1.48 1.611 0 C-N-CA 128.101 2.763 . . . . 0.0 116.129 -179.472 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 235' ' ' VAL . . . . . 0.441 ' N ' ' O ' ' B' ' 233' ' ' ASP . 53.7 t -111.16 132.27 60.12 Favored 'Isoleucine or valine' 0 C--N 1.253 -3.597 0 C-N-CA 128.107 2.563 . . . . 0.0 106.279 174.412 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 236' ' ' HIS . . . . . . . . . . . . . 58.0 t-80 -112.68 120.69 42.4 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.686 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 237' ' ' ARG . . . . . 0.447 ' HD2' HG13 ' A' ' 50' ' ' VAL . 6.7 mmp_? -112.68 144.71 41.73 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 174.059 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 238' ' ' SER . . . . . . . . . . . . . 26.6 t -146.26 131.15 18.12 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 174.875 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 239' ' ' ASN . . . . . 0.471 ' HB3' ' HA ' ' A' ' 91' ' ' ASN . 28.1 p-10 -72.01 92.73 1.32 Allowed 'General case' 0 CA--C 1.512 -0.514 0 CA-C-O 122.153 0.977 . . . . 0.0 110.77 -179.743 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 240' ' ' GLY . . . . . 0.49 ' O ' ' HG2' ' B' ' 244' ' ' LYS . . . 78.23 81.7 0.66 Allowed Glycine 0 N--CA 1.412 -2.93 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -176.072 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 10.0 p90 -75.42 -32.85 60.84 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 178.582 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -60.5 -42.38 96.24 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.148 0.499 . . . . 0.0 110.285 -179.579 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -64.79 -35.42 81.03 Favored 'General case' 0 C--O 1.202 -1.439 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.677 179.668 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 244' ' ' LYS . . . . . 0.49 ' HG2' ' O ' ' B' ' 240' ' ' GLY . 39.6 mmtm -60.78 -47.46 86.23 Favored 'General case' 0 C--O 1.242 0.665 0 CA-C-O 121.29 0.567 . . . . 0.0 109.865 -178.87 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 245' ' ' TRP . . . . . . . . . . . . . 19.4 m0 -63.55 -41.05 98.45 Favored 'General case' 0 N--CA 1.437 -1.096 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.225 179.174 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 246' ' ' PHE . . . . . 0.524 ' HA ' ' HG2' ' B' ' 249' ' ' GLN . 3.6 t80 -68.14 -34.35 76.19 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.348 179.271 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -70.19 -35.35 73.89 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.699 -178.587 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.41 -21.73 22.89 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 120.357 -0.537 . . . . 0.0 111.789 -178.18 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 249' ' ' GLN . . . . . 0.524 ' HG2' ' HA ' ' B' ' 246' ' ' PHE . 13.5 pt20 -78.31 2.24 19.17 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.386 0.612 . . . . 0.0 110.402 -179.494 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 250' ' ' ASN . . . . . . . . . . . . . 20.4 p-10 -57.28 -31.93 66.1 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 114.892 -1.049 . . . . 0.0 112.864 178.917 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -77.18 142.66 39.53 Favored 'General case' 0 N--CA 1.433 -1.28 0 CA-C-O 121.986 0.898 . . . . 0.0 113.292 -176.768 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 252' ' ' ILE . . . . . . . . . . . . . 34.3 pt -130.67 -32.01 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 CA-C-N 114.487 -1.233 . . . . 0.0 113.078 -171.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -110.79 -23.05 11.25 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 121.624 0.726 . . . . 0.0 110.296 -175.65 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 254' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -72.21 166.06 23.16 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-N 114.038 -1.437 . . . . 0.0 114.117 -173.868 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 255' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -81.01 122.37 27.21 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 114.574 -1.194 . . . . 0.0 109.655 -176.233 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 256' ' ' LYS . . . . . . . . . . . . . 52.6 mttm . . . . . 0 C--N 1.295 -1.79 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 -177.821 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 . . . . . 0 CA--C 1.499 -1.008 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -70.4 -27.15 64.07 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.63 0.729 . . . . 0.0 110.2 -179.585 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 49.7 m-85 -81.99 13.75 3.17 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 114.999 -1.0 . . . . 0.0 111.776 -177.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -138.75 152.24 47.78 Favored 'General case' 0 N--CA 1.425 -1.686 0 N-CA-C 105.555 -2.017 . . . . 0.0 105.555 174.222 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -116.08 22.18 13.15 Favored 'General case' 0 C--N 1.286 -2.19 0 CA-C-O 122.37 1.081 . . . . 0.0 109.294 179.361 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -76.73 18.95 0.3 Allowed 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 113.783 -1.553 . . . . 0.0 111.545 -176.816 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -94.48 -12.52 27.54 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.949 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -100.31 145.23 28.38 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 -177.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 23.1 pt -141.06 159.81 23.12 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 CA-C-O 121.025 0.44 . . . . 0.0 110.953 175.691 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 45.0 t80 -109.42 122.49 47.49 Favored 'General case' 0 N--CA 1.421 -1.901 0 CA-C-N 114.485 -1.234 . . . . 0.0 108.206 177.533 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.411 HG23 ' CD1' ' A' ' 104' ' ' ILE . 8.2 mt -108.56 128.0 64.55 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.164 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 174.562 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -129.98 165.6 22.33 Favored Glycine 0 C--N 1.283 -2.415 0 N-CA-C 110.832 -0.907 . . . . 0.0 110.832 -179.571 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 71.13 35.16 1.67 Allowed 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.865 1.266 . . . . 0.0 110.667 -177.359 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.421 HD11 HD11 ' A' ' 47' ' ' ILE . 4.5 mm? -68.47 152.77 44.93 Favored 'General case' 0 CA--C 1.497 -1.085 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.25 176.928 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.445 ' HB3' ' HG ' ' A' ' 42' ' ' LEU . 39.7 t-20 -91.63 151.94 20.47 Favored 'General case' 0 C--N 1.29 -1.988 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 176.55 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.517 ' HD3' ' OE1' ' A' ' 70' ' ' GLU . 1.0 OUTLIER -64.16 -17.21 63.27 Favored 'General case' 0 C--N 1.307 -1.253 0 C-N-CA 122.997 0.519 . . . . 0.0 111.734 179.837 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -97.27 3.55 51.26 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.107 -178.565 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.445 ' HG ' ' HB3' ' A' ' 39' ' ' ASN . 86.3 mt -98.46 117.33 32.64 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-O 121.589 0.709 . . . . 0.0 111.029 -179.128 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 68.2 p -107.23 174.74 5.76 Favored 'General case' 0 C--N 1.293 -1.866 0 CA-C-N 114.346 -1.297 . . . . 0.0 109.186 -179.635 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -54.46 -41.34 69.35 Favored 'General case' 0 C--O 1.209 -1.032 0 C-N-CA 123.19 0.596 . . . . 0.0 110.158 178.391 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.27 -39.47 96.08 Favored Glycine 0 CA--C 1.526 0.742 0 O-C-N 123.26 0.35 . . . . 0.0 112.901 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -66.8 -48.02 70.27 Favored 'General case' 0 CA--C 1.499 -1.004 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 179.81 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.421 HD11 HD11 ' A' ' 38' ' ' LEU . 42.0 mt -60.26 -46.36 94.92 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.782 0 CA-C-N 114.844 -1.071 . . . . 0.0 110.762 178.453 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 52.3 mt -59.77 -38.59 82.27 Favored 'General case' 0 CA--C 1.486 -1.502 0 C-N-CA 122.86 0.464 . . . . 0.0 111.525 -177.678 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.465 HG23 ' H ' ' B' ' 233' ' ' ASP . 62.1 m -64.38 -46.79 81.83 Favored 'General case' 0 N--CA 1.433 -1.281 0 O-C-N 123.615 0.572 . . . . 0.0 110.716 -179.115 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.547 HG13 ' HG3' ' B' ' 237' ' ' ARG . 89.6 t -67.72 -47.91 78.0 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.624 -179.581 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.464 ' HA ' ' HD2' ' A' ' 54' ' ' TYR . 3.7 m-85 -65.02 -25.07 67.69 Favored 'General case' 0 N--CA 1.435 -1.196 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.881 -177.145 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 59.8 m -67.59 -22.17 65.38 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.239 -0.437 . . . . 0.0 112.031 176.325 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -64.91 -28.94 69.88 Favored 'General case' 0 CA--C 1.559 1.322 0 CA-C-O 121.485 0.66 . . . . 0.0 109.917 175.729 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.464 ' HD2' ' HA ' ' A' ' 51' ' ' PHE . 49.1 m-85 -91.3 -18.24 24.65 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-O 121.24 0.543 . . . . 0.0 112.097 -175.204 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 165.19 -160.49 33.83 Favored Glycine 0 N--CA 1.419 -2.457 0 N-CA-C 111.011 -0.836 . . . . 0.0 111.011 179.484 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 62.2 t -100.2 110.8 60.92 Favored Pre-proline 0 C--N 1.294 -1.833 0 N-CA-C 110.347 -0.242 . . . . 0.0 110.347 -178.832 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.51 ' HB3' HD21 ' A' ' 77' ' ' LEU . 73.2 Cg_endo -76.05 141.07 23.33 Favored 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 122.645 2.23 . . . . 0.0 109.764 175.075 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 33.7 m -119.9 -13.57 9.1 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 C-N-CA 120.117 -0.633 . . . . 0.0 112.188 -179.275 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.496 ' HB3' ' HG2' ' A' ' 78' ' ' LYS . 33.2 t70 -164.09 136.85 5.07 Favored 'General case' 0 CA--C 1.501 -0.911 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.219 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 13.0 p -144.72 133.36 17.83 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 O-C-N 123.729 0.643 . . . . 0.0 110.01 -179.172 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.462 ' CD1' ' HB3' ' A' ' 111' ' ' PRO . 94.1 mt -121.9 128.98 75.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 176.019 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -99.36 117.28 33.45 Favored 'General case' 0 N--CA 1.419 -1.99 0 N-CA-C 105.364 -2.088 . . . . 0.0 105.364 173.394 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 62.8 m -78.61 117.82 20.14 Favored 'General case' 0 C--N 1.275 -2.655 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 176.131 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.431 ' HA ' ' HA ' ' A' ' 71' ' ' SER . 85.8 mtt180 -125.19 130.89 53.04 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 -175.401 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -69.17 116.76 9.99 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 177.55 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -61.77 -18.07 58.43 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 113.934 1.087 . . . . 0.0 113.934 -177.251 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 23.5 m-80 -81.66 -46.42 14.37 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 -177.58 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 33.9 p -85.76 -23.96 27.07 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.411 -179.253 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 69.94 19.36 75.26 Favored Glycine 0 N--CA 1.445 -0.73 0 CA-C-N 115.583 -0.735 . . . . 0.0 113.091 176.823 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.517 ' OE1' ' HD3' ' A' ' 40' ' ' ARG . 17.1 mm-40 -111.41 -78.76 0.58 Allowed 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 117.059 0.429 . . . . 0.0 111.363 -177.914 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.431 ' HA ' ' HA ' ' A' ' 64' ' ' ARG . 34.3 t -158.1 168.34 27.36 Favored 'General case' 0 N--CA 1.441 -0.914 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 -178.258 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 13.4 mm-40 -102.84 -7.29 21.7 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 172.172 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 87.21 4.23 81.44 Favored Glycine 0 N--CA 1.433 -1.514 0 C-N-CA 120.221 -0.99 . . . . 0.0 112.344 -179.393 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 31.5 p90 -142.1 155.34 45.35 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 177.509 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -149.75 171.84 16.07 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-O 120.94 0.4 . . . . 0.0 110.88 -179.375 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -130.3 140.85 50.63 Favored 'General case' 0 C--N 1.31 -1.118 0 C-N-CA 123.854 0.861 . . . . 0.0 109.963 -178.76 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.51 HD21 ' HB3' ' A' ' 57' ' ' PRO . 9.8 tt -149.94 140.55 22.55 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 175.532 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.496 ' HG2' ' HB3' ' A' ' 59' ' ' ASP . 16.9 ptmt -125.05 144.56 50.34 Favored 'General case' 0 N--CA 1.433 -1.276 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 177.781 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 61.3 m-85 -104.48 164.94 11.39 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-O 121.614 0.721 . . . . 0.0 112.321 -177.74 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -75.86 -30.74 59.0 Favored 'General case' 0 N--CA 1.437 -1.089 0 CA-C-N 114.33 -1.304 . . . . 0.0 109.4 175.671 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -122.01 133.22 54.81 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 -179.593 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -70.06 -19.93 63.26 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 114.254 1.205 . . . . 0.0 114.254 -177.805 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 88.4 mtm180 -65.8 -33.21 75.33 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-O 122.299 1.047 . . . . 0.0 109.863 174.135 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.502 ' OG ' HG21 ' B' ' 226' ' ' ILE . 66.2 m -63.27 -36.77 84.78 Favored 'General case' 0 C--N 1.288 -2.101 0 CA-C-N 114.985 -1.007 . . . . 0.0 112.947 178.852 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.447 ' O ' HG23 ' A' ' 89' ' ' VAL . 77.2 p -64.2 -45.54 87.85 Favored 'General case' 0 C--O 1.224 -0.25 0 C-N-CA 120.229 -0.588 . . . . 0.0 110.779 -177.554 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 5.2 pt -64.94 -38.86 83.85 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.309 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.837 177.77 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.569 HD11 ' HB2' ' B' ' 224' ' ' PHE . 6.4 mt -58.55 -43.53 89.32 Favored 'General case' 0 CA--C 1.505 -0.779 0 O-C-N 123.812 0.695 . . . . 0.0 110.668 177.719 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.472 ' O ' ' HB2' ' A' ' 92' ' ' LEU . . . -71.97 -43.76 64.65 Favored 'General case' 0 N--CA 1.42 -1.933 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.708 179.536 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.469 HG22 HG22 ' A' ' 104' ' ' ILE . 79.3 t -58.85 -49.04 84.35 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.751 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -71.18 -27.8 63.79 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -172.488 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.49 ' HA ' ' OD1' ' B' ' 239' ' ' ASN . 8.8 t30 -96.58 -25.62 15.54 Favored 'General case' 0 C--N 1.296 -1.759 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.761 -177.367 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.472 ' HB2' ' O ' ' A' ' 88' ' ' ALA . 12.1 mt -95.33 -22.66 17.61 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 122.052 -0.405 . . . . 0.0 111.471 -178.049 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -65.21 124.93 23.46 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 177.361 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 81.79 -0.99 87.59 Favored Glycine 0 C--O 1.243 0.666 0 C-N-CA 120.882 -0.675 . . . . 0.0 113.143 177.564 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 62.0 t80 -85.35 144.1 28.25 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 -178.719 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 11.8 mptt -99.88 118.78 37.05 Favored 'General case' 0 N--CA 1.44 -0.955 0 CA-C-O 121.336 0.589 . . . . 0.0 112.512 -176.396 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 58.6 mt -127.59 141.46 46.32 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.188 0 N-CA-C 105.842 -1.91 . . . . 0.0 105.842 173.723 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 61.1 20.06 57.66 Favored Glycine 0 CA--C 1.519 0.312 0 C-N-CA 121.143 -0.551 . . . . 0.0 112.373 -177.406 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 78.13 7.49 87.65 Favored Glycine 0 N--CA 1.436 -1.362 0 CA-C-N 115.834 -0.183 . . . . 0.0 113.217 -178.011 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 16.7 ptp180 -124.78 147.95 48.4 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 117.534 0.667 . . . . 0.0 110.405 -179.555 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -87.7 116.32 25.75 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 116.585 -0.28 . . . . 0.0 111.587 -175.631 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 12.7 mt -65.84 144.62 56.72 Favored 'General case' 0 C--O 1.252 1.186 0 CA-C-O 121.875 0.845 . . . . 0.0 113.103 179.679 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 29.2 tptp -118.72 115.47 24.55 Favored 'General case' 0 N--CA 1.416 -2.148 0 CA-C-N 114.806 -1.088 . . . . 0.0 108.216 176.076 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.469 HG22 HG22 ' A' ' 89' ' ' VAL . 4.7 mm -114.69 134.46 57.61 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.966 0 N-CA-C 105.859 -1.904 . . . . 0.0 105.859 178.328 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -143.12 151.99 41.32 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -176.138 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 56.2 m-70 -83.34 130.48 35.06 Favored 'General case' 0 C--N 1.295 -1.804 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 177.492 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 7.3 t -147.28 163.42 36.45 Favored 'General case' 0 C--N 1.291 -1.973 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 -178.936 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 46.5 m-85 -110.13 111.03 22.11 Favored 'General case' 0 N--CA 1.42 -1.96 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 171.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 63.7 t80 -107.73 139.13 42.77 Favored 'General case' 0 C--N 1.294 -1.819 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.783 -176.41 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 6.2 mpt_? -116.91 114.99 39.07 Favored Pre-proline 0 C--N 1.306 -1.325 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 170.386 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.462 ' HB3' ' CD1' ' A' ' 61' ' ' ILE . 49.0 Cg_endo -68.67 140.67 47.66 Favored 'Trans proline' 0 C--N 1.323 -0.769 0 C-N-CA 122.929 2.42 . . . . 0.0 114.525 -178.064 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -107.0 112.35 25.26 Favored 'General case' 0 N--CA 1.423 -1.812 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 170.645 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 31.0 mmm180 . . . . . 0 C--N 1.286 -2.176 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 -178.849 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 . . . . . 0 N--CA 1.466 0.363 0 CA-C-O 120.426 0.155 . . . . 0.0 110.899 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 223' ' ' ARG . . . . . . . . . . . . . 10.5 ptm180 51.9 46.53 26.42 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 127.049 2.139 . . . . 0.0 116.264 176.134 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 224' ' ' PHE . . . . . 0.569 ' HB2' HD11 ' A' ' 87' ' ' LEU . 63.4 m-85 -100.62 165.57 11.33 Favored 'General case' 0 C--N 1.289 -2.055 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 172.406 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 225' ' ' ALA . . . . . . . . . . . . . . . -124.88 83.85 2.21 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-O 121.672 0.748 . . . . 0.0 110.923 -177.69 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 226' ' ' ILE . . . . . 0.502 HG21 ' OG ' ' A' ' 84' ' ' SER . 4.0 mp -123.35 137.49 56.49 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.799 0 CA-C-N 115.177 -0.92 . . . . 0.0 108.89 178.113 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 227' ' ' MET . . . . . . . . . . . . . 65.8 mtt -61.92 134.2 94.13 Favored Pre-proline 0 C--N 1.322 -0.626 0 O-C-N 123.466 0.479 . . . . 0.0 111.516 -179.161 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 228' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -72.34 140.28 33.36 Favored 'Trans proline' 0 C--O 1.251 1.138 0 C-N-CA 123.13 2.554 . . . . 0.0 112.703 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . -65.65 164.01 39.16 Favored Glycine 0 C--N 1.317 -0.526 0 CA-C-N 115.573 -0.739 . . . . 0.0 113.372 -179.528 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 14.6 m -72.06 -18.08 61.96 Favored 'General case' 0 C--N 1.31 -1.149 0 C-N-CA 123.331 0.652 . . . . 0.0 112.375 -175.172 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 13.6 mmm180 -82.06 -3.45 54.67 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.92 0.391 . . . . 0.0 111.146 -177.733 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 232' ' ' TRP . . . . . . . . . . . . . 24.9 t90 -72.04 123.52 22.97 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-O 122.405 1.097 . . . . 0.0 111.502 179.639 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 233' ' ' ASP . . . . . 0.465 ' H ' HG23 ' A' ' 49' ' ' THR . 8.4 t70 -113.14 144.48 42.59 Favored 'General case' 0 C--N 1.276 -2.617 0 N-CA-C 101.095 -3.669 . . . . 0.0 101.095 171.819 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -48.4 61.22 0.0 OUTLIER Glycine 0 N--CA 1.487 2.059 0 C-N-CA 127.361 2.41 . . . . 0.0 115.836 -178.795 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 235' ' ' VAL . . . . . 0.437 ' N ' ' O ' ' B' ' 233' ' ' ASP . 38.8 t -109.17 122.21 63.45 Favored 'Isoleucine or valine' 0 C--N 1.251 -3.712 0 C-N-CA 129.003 2.921 . . . . 0.0 106.89 176.554 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 236' ' ' HIS . . . . . . . . . . . . . 51.0 t-80 -105.24 119.45 39.1 Favored 'General case' 0 C--N 1.292 -1.928 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 -179.709 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 237' ' ' ARG . . . . . 0.547 ' HG3' HG13 ' A' ' 50' ' ' VAL . 48.6 mmt-85 -126.54 109.41 12.12 Favored 'General case' 0 C--O 1.198 -1.657 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.001 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 238' ' ' SER . . . . . . . . . . . . . 40.0 t -142.91 126.75 17.14 Favored 'General case' 0 C--N 1.285 -2.235 0 O-C-N 121.921 -0.487 . . . . 0.0 110.2 -176.062 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 239' ' ' ASN . . . . . 0.49 ' OD1' ' HA ' ' A' ' 91' ' ' ASN . 35.5 p-10 -87.21 75.68 9.33 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 123.047 1.403 . . . . 0.0 110.992 178.706 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 240' ' ' GLY . . . . . 0.52 ' O ' ' HG2' ' B' ' 244' ' ' LYS . . . -138.84 30.96 2.43 Favored Glycine 0 N--CA 1.423 -2.199 0 CA-C-N 114.117 -1.401 . . . . 0.0 109.857 177.865 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 20.8 p90 -76.27 -38.12 56.63 Favored 'General case' 0 C--N 1.293 -1.868 0 C-N-CA 123.768 0.827 . . . . 0.0 112.318 179.684 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -60.71 -42.78 97.93 Favored 'General case' 0 C--O 1.243 0.741 0 C-N-CA 122.353 0.261 . . . . 0.0 111.281 -177.886 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -62.0 -34.99 77.2 Favored 'General case' 0 C--O 1.211 -0.935 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.476 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 244' ' ' LYS . . . . . 0.52 ' HG2' ' O ' ' B' ' 240' ' ' GLY . 43.9 mmtm -64.45 -47.85 77.52 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-O 121.133 0.492 . . . . 0.0 110.523 -177.718 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 245' ' ' TRP . . . . . . . . . . . . . 13.6 m0 -65.8 -39.12 90.6 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.225 178.701 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 246' ' ' PHE . . . . . 0.504 ' O ' ' HG2' ' B' ' 249' ' ' GLN . 2.7 t80 -64.97 -37.12 86.61 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.634 178.181 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -68.49 -35.42 77.5 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.591 -179.536 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.33 -16.71 28.67 Favored 'General case' 0 CA--C 1.509 -0.6 0 N-CA-C 111.887 0.329 . . . . 0.0 111.887 -177.782 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 249' ' ' GLN . . . . . 0.504 ' HG2' ' O ' ' B' ' 246' ' ' PHE . 11.8 pt20 -81.07 2.8 25.64 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-O 120.839 0.352 . . . . 0.0 110.456 -179.299 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 250' ' ' ASN . . . . . 0.436 ' OD1' ' HG3' ' B' ' 251' ' ' GLU . 7.9 p30 -52.37 -39.69 61.09 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.514 178.915 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 251' ' ' GLU . . . . . 0.436 ' HG3' ' OD1' ' B' ' 250' ' ' ASN . 46.2 mt-10 -133.66 121.36 21.88 Favored 'General case' 0 N--CA 1.435 -1.205 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 174.43 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 252' ' ' ILE . . . . . . . . . . . . . 38.1 pt -96.91 -34.34 4.91 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -174.844 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -100.46 -17.76 17.02 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-O 121.969 0.89 . . . . 0.0 109.58 -178.471 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 254' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -98.59 -172.31 2.29 Favored 'General case' 0 C--N 1.293 -1.88 0 CA-C-N 114.35 -1.295 . . . . 0.0 108.409 179.637 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 255' ' ' LYS . . . . . . . . . . . . . 20.1 pttm -51.92 141.61 17.32 Favored 'General case' 0 C--N 1.312 -1.032 0 C-N-CA 124.613 1.165 . . . . 0.0 111.708 178.909 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 256' ' ' LYS . . . . . . . . . . . . . 21.9 pttp . . . . . 0 C--N 1.304 -1.371 0 CA-C-O 118.134 -0.936 . . . . 0.0 110.541 -179.037 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 50.5 t30 . . . . . 0 CA--C 1.514 -0.411 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -69.01 -12.22 61.49 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-O 121.966 0.889 . . . . 0.0 112.235 -173.076 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 -87.0 11.55 13.39 Favored 'General case' 0 C--N 1.293 -1.864 0 CA-C-N 114.427 -1.261 . . . . 0.0 110.734 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 56.2 mttp -127.1 171.88 11.01 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 173.86 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -117.28 26.69 9.58 Favored 'General case' 0 CA--C 1.491 -1.294 0 CA-C-O 121.974 0.892 . . . . 0.0 109.648 -178.68 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -78.07 -0.27 27.39 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-N 114.596 -1.184 . . . . 0.0 111.477 -175.619 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.491 ' HA ' HG21 ' A' ' 85' ' ' THR . . . -82.24 -15.64 52.38 Favored 'General case' 0 CA--C 1.503 -0.847 0 CA-C-O 120.869 0.366 . . . . 0.0 110.322 179.235 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 57.5 m-85 -102.13 144.49 30.62 Favored 'General case' 0 N--CA 1.429 -1.496 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 -178.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 27.5 pt -143.24 162.55 16.85 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 CA-C-O 121.458 0.646 . . . . 0.0 110.869 -179.741 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.414 ' HB2' HG21 ' A' ' 107' ' ' THR . 8.2 t80 -114.45 125.88 54.33 Favored 'General case' 0 N--CA 1.412 -2.359 0 CA-C-N 114.085 -1.416 . . . . 0.0 108.123 175.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 10.2 mt -108.51 127.53 64.85 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.998 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 176.848 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -125.68 164.2 19.35 Favored Glycine 0 C--N 1.279 -2.596 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 -179.663 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 66.9 m-20 71.46 45.0 0.49 Allowed 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 125.346 1.458 . . . . 0.0 110.219 -177.648 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.483 HD11 HD11 ' A' ' 47' ' ' ILE . 4.2 mm? -76.21 144.63 40.31 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.281 177.08 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.436 ' HB3' ' HG ' ' A' ' 42' ' ' LEU . 42.8 t-20 -83.88 147.23 27.64 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 176.827 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.513 ' HD2' ' C ' ' A' ' 40' ' ' ARG . 6.6 ppt_? -59.2 -22.02 60.36 Favored 'General case' 0 C--N 1.311 -1.068 0 C-N-CA 123.78 0.832 . . . . 0.0 111.921 -179.73 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.422 ' N ' ' HD2' ' A' ' 40' ' ' ARG . 12.9 pt-20 -92.8 -10.99 34.9 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.818 -176.207 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.436 ' HG ' ' HB3' ' A' ' 39' ' ' ASN . 71.6 mt -79.86 132.5 36.12 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.214 0.531 . . . . 0.0 111.504 -176.973 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 35.1 p -119.86 173.73 6.87 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 114.852 -1.067 . . . . 0.0 110.44 -178.317 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 -55.35 -39.31 69.88 Favored 'General case' 0 C--O 1.221 -0.417 0 C-N-CA 123.2 0.6 . . . . 0.0 111.05 179.33 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.95 -38.58 95.69 Favored Glycine 0 N--CA 1.448 -0.559 0 CA-C-N 116.013 -0.54 . . . . 0.0 112.597 -179.663 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.408 ' O ' HG23 ' A' ' 50' ' ' VAL . 21.8 m-20 -67.08 -49.51 64.8 Favored 'General case' 0 CA--C 1.492 -1.273 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.483 HD11 HD11 ' A' ' 38' ' ' LEU . 37.7 mt -60.43 -47.12 93.89 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.931 0 CA-C-N 114.791 -1.095 . . . . 0.0 110.78 -179.246 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 36.7 mt -59.68 -42.36 92.78 Favored 'General case' 0 CA--C 1.494 -1.179 0 CA-C-N 116.572 -0.285 . . . . 0.0 111.714 -176.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.419 HG23 ' H ' ' B' ' 233' ' ' ASP . 68.8 m -65.66 -46.02 80.73 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 123.541 0.526 . . . . 0.0 111.649 -178.235 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.408 HG23 ' O ' ' A' ' 46' ' ' ASP . 58.4 t -67.69 -45.74 84.12 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-O 121.42 0.629 . . . . 0.0 110.39 -178.127 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.414 ' HA ' ' HD2' ' A' ' 54' ' ' TYR . 4.5 m-85 -64.63 -25.3 67.9 Favored 'General case' 0 N--CA 1.431 -1.387 0 CA-C-N 115.082 -0.963 . . . . 0.0 111.921 -179.452 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.57 ' OG ' ' HB2' ' B' ' 231' ' ' ARG . 66.9 m -70.23 -19.43 63.14 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 176.923 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -72.54 -20.9 61.26 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-O 121.669 0.747 . . . . 0.0 109.68 176.209 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.438 ' CE1' ' HB2' ' A' ' 91' ' ' ASN . 60.1 m-85 -94.65 -19.98 19.97 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.853 -178.663 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.436 ' O ' ' HA ' ' A' ' 52' ' ' SER . . . 167.17 -152.91 22.06 Favored Glycine 0 N--CA 1.424 -2.139 0 C-N-CA 120.741 -0.742 . . . . 0.0 111.403 179.017 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 87.7 t -105.58 110.57 64.38 Favored Pre-proline 0 C--N 1.295 -1.766 0 N-CA-C 110.307 -0.257 . . . . 0.0 110.307 -177.848 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.526 ' HB3' HD21 ' A' ' 77' ' ' LEU . 73.9 Cg_endo -78.24 135.99 14.01 Favored 'Trans proline' 0 N--CA 1.44 -1.65 0 C-N-CA 121.846 1.697 . . . . 0.0 109.2 174.685 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 35.8 m -113.18 -19.95 6.51 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 C-N-CA 119.726 -0.789 . . . . 0.0 111.57 -177.33 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.501 ' HB3' ' HG2' ' A' ' 78' ' ' LYS . 36.1 t70 -159.34 140.68 12.95 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 179.801 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 13.1 p -143.67 136.31 23.99 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 O-C-N 123.793 0.683 . . . . 0.0 109.868 -179.722 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.521 HD11 ' HB3' ' A' ' 111' ' ' PRO . 99.1 mt -122.37 125.82 73.32 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 C-N-CA 123.112 0.565 . . . . 0.0 109.503 173.19 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -98.71 118.64 35.9 Favored 'General case' 0 N--CA 1.419 -1.998 0 N-CA-C 104.963 -2.236 . . . . 0.0 104.963 173.252 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 17.8 m -81.03 116.52 21.02 Favored 'General case' 0 N--CA 1.408 -2.561 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 179.349 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.406 ' HG2' ' HA ' ' A' ' 71' ' ' SER . 64.8 mtm180 -128.54 141.15 51.46 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 -178.132 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -69.7 120.6 15.71 Favored 'General case' 0 C--N 1.296 -1.755 0 O-C-N 123.913 0.758 . . . . 0.0 109.206 178.603 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -61.44 -18.69 60.07 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 113.615 0.968 . . . . 0.0 113.615 -177.159 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 22.9 m-80 -82.18 -47.74 12.13 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-O 121.05 0.452 . . . . 0.0 110.625 -176.787 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 60.2 p -91.76 -23.46 19.74 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.393 -177.319 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.43 12.95 83.87 Favored Glycine 0 N--CA 1.444 -0.813 0 N-CA-C 111.693 -0.563 . . . . 0.0 111.693 -177.744 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -113.71 158.48 20.85 Favored 'General case' 0 C--N 1.323 -0.551 0 O-C-N 122.682 -0.305 . . . . 0.0 110.409 -177.015 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.406 ' HA ' ' HG2' ' A' ' 64' ' ' ARG . 38.8 t -51.61 140.33 18.68 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 124.084 0.953 . . . . 0.0 112.089 179.688 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -83.32 -2.77 56.51 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.446 177.78 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 95.54 11.69 55.1 Favored Glycine 0 N--CA 1.421 -2.335 0 CA-C-N 115.494 -0.775 . . . . 0.0 112.604 179.078 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 33.0 p90 -152.43 157.52 41.33 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 177.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -153.25 172.64 16.67 Favored 'General case' 0 N--CA 1.427 -1.583 0 O-C-N 123.509 0.506 . . . . 0.0 110.2 179.31 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -132.15 144.62 50.81 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 123.761 0.825 . . . . 0.0 110.053 -178.428 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.526 HD21 ' HB3' ' A' ' 57' ' ' PRO . 9.9 tt -153.78 140.72 19.23 Favored 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 175.634 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.501 ' HG2' ' HB3' ' A' ' 59' ' ' ASP . 18.8 ptmt -123.91 144.1 49.97 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 177.578 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.409 ' CD1' HG22 ' A' ' 85' ' ' THR . 39.9 m-85 -102.5 165.04 11.32 Favored 'General case' 0 C--N 1.29 -2.013 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.611 -178.348 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -73.48 -35.32 65.66 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 114.702 -1.136 . . . . 0.0 109.133 175.402 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -124.78 137.59 54.31 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.806 -178.045 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -70.19 -20.08 63.14 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -179.49 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 80.8 mtm180 -65.08 -34.55 78.68 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 122.219 1.009 . . . . 0.0 109.478 174.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.462 ' OG ' HG21 ' B' ' 226' ' ' ILE . 60.3 m -67.43 -37.41 82.97 Favored 'General case' 0 C--N 1.292 -1.92 0 CA-C-N 114.821 -1.082 . . . . 0.0 112.185 178.369 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.491 HG21 ' HA ' ' A' ' 31' ' ' ALA . 71.1 p -65.45 -45.12 85.02 Favored 'General case' 0 C--O 1.217 -0.635 0 C-N-CA 120.249 -0.58 . . . . 0.0 110.685 -177.792 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 3.7 pt -63.26 -39.2 84.36 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.317 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.075 177.409 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.466 HD21 ' CD1' ' B' ' 224' ' ' PHE . 30.0 mt -59.79 -43.24 94.5 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 123.44 0.463 . . . . 0.0 110.911 174.959 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -68.99 -46.5 67.9 Favored 'General case' 0 C--O 1.203 -1.374 0 CA-C-N 115.712 -0.677 . . . . 0.0 110.928 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.49 HG23 ' O ' ' A' ' 85' ' ' THR . 85.9 t -58.88 -48.93 84.78 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.062 0 CA-C-O 120.712 0.291 . . . . 0.0 110.954 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -67.36 -29.77 69.39 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 -174.759 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.473 ' HA ' ' OD1' ' B' ' 239' ' ' ASN . 11.0 m120 -97.98 -21.02 17.06 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 113.684 0.994 . . . . 0.0 113.684 -178.885 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 14.0 mt -98.92 -31.42 11.84 Favored 'General case' 0 CA--C 1.495 -1.172 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -176.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 52.6 t30 -66.39 124.98 24.21 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 85.21 -1.81 88.48 Favored Glycine 0 C--N 1.306 -1.128 0 C-N-CA 121.411 -0.423 . . . . 0.0 112.909 -179.151 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.538 ' CE2' ' HG3' ' B' ' 237' ' ' ARG . 64.1 t80 -90.09 137.85 32.0 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 179.468 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.421 ' HA ' ' HA ' ' A' ' 101' ' ' ALA . 0.4 OUTLIER -93.38 119.5 32.57 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-O 120.914 0.388 . . . . 0.0 111.712 -177.213 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 35.4 mt -118.35 142.45 33.01 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 173.78 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 71.58 -84.67 0.44 Allowed Glycine 0 N--CA 1.438 -1.195 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 -174.257 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -161.99 17.72 0.16 Allowed Glycine 0 N--CA 1.427 -1.955 0 N-CA-C 110.199 -1.161 . . . . 0.0 110.199 175.268 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 16.6 ptp180 -137.23 149.79 47.41 Favored 'General case' 0 N--CA 1.445 -0.719 0 O-C-N 122.798 -0.236 . . . . 0.0 110.532 -175.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.421 ' HA ' ' HA ' ' A' ' 96' ' ' LYS . . . -87.36 122.97 31.82 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.789 -177.832 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 14.8 mt -66.92 148.24 52.2 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-O 121.745 0.783 . . . . 0.0 112.923 179.013 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 54.3 tptt -121.94 116.47 24.42 Favored 'General case' 0 N--CA 1.418 -2.025 0 CA-C-N 114.911 -1.04 . . . . 0.0 108.824 175.131 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 3.9 mm -116.39 136.09 54.51 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.868 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -143.81 150.57 38.73 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 178.139 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 74.4 m-70 -83.34 137.8 33.81 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 178.057 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.414 HG21 ' HB2' ' A' ' 34' ' ' TYR . 9.0 t -158.62 155.38 28.12 Favored 'General case' 0 C--N 1.291 -1.959 0 N-CA-C 106.247 -1.76 . . . . 0.0 106.247 -177.215 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -93.82 111.83 23.59 Favored 'General case' 0 N--CA 1.435 -1.2 0 C-N-CA 117.571 -1.651 . . . . 0.0 108.057 172.76 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 30.5 t80 -106.5 135.96 47.09 Favored 'General case' 0 C--N 1.294 -1.845 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.676 -179.653 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 86.3 mmt-85 -122.5 124.61 26.72 Favored Pre-proline 0 C--N 1.298 -1.648 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 171.867 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.521 ' HB3' HD11 ' A' ' 61' ' ' ILE . 73.8 Cg_endo -74.83 145.22 31.89 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 122.622 2.215 . . . . 0.0 113.773 -178.605 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.446 ' HD3' ' C ' ' A' ' 112' ' ' LYS . 11.6 tmtt? -98.62 129.92 45.14 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 174.443 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.424 ' N ' ' HD3' ' A' ' 112' ' ' LYS . 98.8 mtt180 . . . . . 0 C--N 1.305 -1.338 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 179.849 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 50.5 t-20 . . . . . 0 C--O 1.204 -1.327 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 223' ' ' ARG . . . . . . . . . . . . 0.25 10.5 ptm180 68.37 17.94 9.15 Favored 'General case' 0 N--CA 1.495 1.803 0 C-N-CA 127.795 2.438 . . . . 0.0 114.476 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 224' ' ' PHE . . . . . 0.466 ' CD1' HD21 ' A' ' 87' ' ' LEU . 66.9 m-85 -96.99 159.41 14.93 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 176.682 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 225' ' ' ALA . . . . . . . . . . . . . . . -131.82 86.83 2.38 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 -179.507 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 226' ' ' ILE . . . . . 0.462 HG21 ' OG ' ' A' ' 84' ' ' SER . 4.3 mp -127.47 128.21 69.63 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.238 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.295 178.16 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 227' ' ' MET . . . . . . . . . . . . . 90.5 mmm -66.81 137.95 95.09 Favored Pre-proline 0 C--N 1.321 -0.656 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.561 177.156 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 228' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -66.25 157.18 61.31 Favored 'Trans proline' 0 C--O 1.248 0.975 0 C-N-CA 122.938 2.425 . . . . 0.0 113.183 -178.217 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . -73.36 170.34 52.43 Favored Glycine 0 N--CA 1.439 -1.127 0 CA-C-N 115.412 -0.813 . . . . 0.0 112.237 179.474 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 20.9 m -77.44 -18.24 57.37 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-O 121.101 0.477 . . . . 0.0 111.23 -177.882 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 231' ' ' ARG . . . . . 0.57 ' HB2' ' OG ' ' A' ' 52' ' ' SER . 37.9 mmt180 -79.64 -8.16 59.03 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.583 -178.908 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 232' ' ' TRP . . . . . . . . . . . . . 21.6 t90 -73.54 122.96 23.04 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-O 122.279 1.038 . . . . 0.0 113.05 -176.078 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 233' ' ' ASP . . . . . 0.451 ' O ' ' N ' ' B' ' 235' ' ' VAL . 12.2 t70 -120.47 137.52 54.3 Favored 'General case' 0 C--N 1.276 -2.622 0 N-CA-C 100.773 -3.788 . . . . 0.0 100.773 172.918 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -36.54 54.61 0.0 OUTLIER Glycine 0 N--CA 1.513 3.833 0 C-N-CA 128.979 3.18 . . . . 0.0 118.257 -175.674 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 235' ' ' VAL . . . . . 0.451 ' N ' ' O ' ' B' ' 233' ' ' ASP . 50.1 t -104.35 121.92 56.64 Favored 'Isoleucine or valine' 0 C--N 1.25 -3.736 0 C-N-CA 127.602 2.361 . . . . 0.0 107.526 176.528 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 236' ' ' HIS . . . . . 0.422 ' C ' ' HD2' ' B' ' 237' ' ' ARG . 34.9 t-80 -112.06 115.83 29.54 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 123.867 0.73 . . . . 0.0 110.118 -177.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 237' ' ' ARG . . . . . 0.538 ' HG3' ' CE2' ' A' ' 95' ' ' PHE . 2.1 mpt_? -119.07 109.5 15.98 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-O 121.215 0.531 . . . . 0.0 110.217 176.692 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 238' ' ' SER . . . . . . . . . . . . . 47.8 t -140.61 130.16 24.08 Favored 'General case' 0 N--CA 1.417 -2.09 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 179.515 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 239' ' ' ASN . . . . . 0.473 ' OD1' ' HA ' ' A' ' 91' ' ' ASN . 27.1 p-10 -89.26 -170.98 3.07 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 175.236 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 240' ' ' GLY . . . . . 0.445 ' O ' ' HG2' ' B' ' 244' ' ' LYS . . . 134.59 -11.19 4.61 Favored Glycine 0 C--O 1.198 -2.098 0 N-CA-C 110.88 -0.888 . . . . 0.0 110.88 -179.787 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 39.9 p90 -77.26 -34.18 55.83 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-O 120.932 0.396 . . . . 0.0 111.694 177.859 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -62.79 -41.65 99.36 Favored 'General case' 0 C--O 1.243 0.74 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.459 -174.911 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -62.98 -35.29 79.69 Favored 'General case' 0 C--O 1.21 -1.002 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.581 -178.664 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 244' ' ' LYS . . . . . 0.445 ' HG2' ' O ' ' B' ' 240' ' ' GLY . 69.8 mmtt -65.95 -42.99 89.28 Favored 'General case' 0 N--CA 1.439 -1.021 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 -177.381 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 245' ' ' TRP . . . . . . . . . . . . . 46.1 m0 -65.44 -41.99 92.87 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.695 178.182 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 246' ' ' PHE . . . . . 0.486 ' O ' ' HG2' ' B' ' 249' ' ' GLN . 3.0 t80 -66.53 -30.23 70.5 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 121.803 0.811 . . . . 0.0 110.949 178.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -77.44 -39.39 46.99 Favored 'General case' 0 C--N 1.295 -1.786 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.384 178.809 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.83 -15.33 39.5 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.083 0.468 . . . . 0.0 111.793 -175.117 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 249' ' ' GLN . . . . . 0.486 ' HG2' ' O ' ' B' ' 246' ' ' PHE . 13.3 pt20 -71.46 1.77 5.94 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.804 -179.169 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 250' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -65.34 -29.2 69.91 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 176.014 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -78.29 112.18 15.02 Favored 'General case' 0 N--CA 1.426 -1.642 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 176.4 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 252' ' ' ILE . . . . . . . . . . . . . 29.4 pt -103.51 -34.23 3.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.812 -172.164 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -100.67 -15.52 17.71 Favored 'General case' 0 CA--C 1.497 -1.077 0 CA-C-O 122.224 1.011 . . . . 0.0 108.668 179.757 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 254' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -98.38 -169.82 1.86 Allowed 'General case' 0 N--CA 1.417 -2.097 0 CA-C-N 113.843 -1.526 . . . . 0.0 110.493 177.415 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 255' ' ' LYS . . . . . . . . . . . . . 14.5 pttm -56.31 103.0 0.09 Allowed 'General case' 0 C--N 1.296 -1.732 0 C-N-CA 125.149 1.38 . . . . 0.0 114.33 -178.175 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 256' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt . . . . . 0 C--N 1.296 -1.758 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 174.341 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 32.0 t30 . . . . . 0 CA--C 1.509 -0.611 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 68.4 mm-40 -120.04 -42.2 2.61 Favored 'General case' 0 N--CA 1.427 -1.59 0 CA-C-N 116.078 -0.51 . . . . 0.0 112.13 -176.533 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -132.52 8.13 4.22 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 113.832 1.049 . . . . 0.0 113.832 -169.62 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.431 ' HB2' HE22 ' A' ' 82' ' ' GLN . 75.0 mmtt -134.15 -177.1 4.43 Favored 'General case' 0 C--N 1.295 -1.771 0 C-N-CA 120.006 -0.678 . . . . 0.0 111.336 -174.995 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -127.44 10.24 6.71 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-O 121.787 0.803 . . . . 0.0 109.665 176.131 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -81.06 30.54 0.32 Allowed 'General case' 0 N--CA 1.481 1.09 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.805 -178.317 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -94.64 -1.58 52.91 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.415 -178.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 16.9 m-85 -111.9 145.01 40.29 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 -175.013 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 28.3 pt -138.65 157.03 29.78 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.172 176.731 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 56.7 t80 -106.72 121.7 44.89 Favored 'General case' 0 N--CA 1.41 -2.429 0 CA-C-N 114.619 -1.173 . . . . 0.0 107.978 177.712 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.407 HG23 ' CD1' ' A' ' 104' ' ' ILE . 10.8 mt -108.38 128.03 64.26 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.18 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 175.567 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -130.25 173.35 19.99 Favored Glycine 0 C--N 1.28 -2.583 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 179.599 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 69.98 31.03 3.47 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.312 0.645 . . . . 0.0 111.16 -178.647 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -68.55 155.14 40.54 Favored 'General case' 0 CA--C 1.503 -0.85 0 CA-C-O 121.955 0.883 . . . . 0.0 112.231 178.919 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.523 ' HB3' ' HG ' ' A' ' 42' ' ' LEU . 54.5 t-20 -95.38 146.52 24.33 Favored 'General case' 0 C--N 1.288 -2.104 0 N-CA-C 105.955 -1.868 . . . . 0.0 105.955 174.541 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.478 ' HD2' ' C ' ' A' ' 40' ' ' ARG . 7.2 ppt_? -61.83 -23.01 65.98 Favored 'General case' 0 C--N 1.298 -1.654 0 C-N-CA 123.396 0.678 . . . . 0.0 111.435 179.087 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.465 ' HG2' ' CG ' ' A' ' 39' ' ' ASN . 12.7 pt-20 -88.9 -1.18 57.97 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-O 120.857 0.361 . . . . 0.0 111.33 -178.657 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.523 ' HG ' ' HB3' ' A' ' 39' ' ' ASN . 87.3 mt -91.48 124.63 35.79 Favored 'General case' 0 N--CA 1.432 -1.353 0 CA-C-O 121.618 0.723 . . . . 0.0 110.464 179.792 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 68.0 p -113.66 174.57 5.86 Favored 'General case' 0 C--N 1.286 -2.168 0 CA-C-N 114.213 -1.358 . . . . 0.0 108.82 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.3 mp0 -55.29 -41.4 72.24 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 123.423 0.689 . . . . 0.0 110.739 -179.553 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -61.54 -38.35 95.66 Favored Glycine 0 C--O 1.241 0.557 0 CA-C-N 116.168 -0.469 . . . . 0.0 113.207 -179.127 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -67.4 -48.44 67.34 Favored 'General case' 0 CA--C 1.503 -0.853 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 51.4 mt -59.08 -44.77 92.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 CA-C-N 114.595 -1.184 . . . . 0.0 110.788 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 48.2 mt -59.36 -45.47 91.31 Favored 'General case' 0 CA--C 1.502 -0.891 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.538 -178.394 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.448 HG23 ' H ' ' B' ' 233' ' ' ASP . 98.0 m -62.11 -45.83 91.73 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -179.839 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.586 HG13 ' HG3' ' B' ' 237' ' ' ARG . 98.7 t -65.39 -49.19 79.91 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 CA-C-O 121.246 0.545 . . . . 0.0 110.41 -179.908 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.469 ' HD2' ' HH ' ' A' ' 79' ' ' TYR . 5.3 m-85 -66.17 -24.04 66.57 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 123.885 0.874 . . . . 0.0 113.04 -178.121 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.454 ' OG ' ' HB2' ' B' ' 231' ' ' ARG . 63.0 m -70.59 -17.91 62.9 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 177.072 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -68.56 -25.12 64.74 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 119.683 -0.807 . . . . 0.0 109.285 176.493 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.468 ' HD2' ' HA ' ' A' ' 51' ' ' PHE . 64.5 m-85 -92.6 -15.96 26.23 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.114 -175.575 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.407 ' O ' ' HA ' ' A' ' 52' ' ' SER . . . 160.9 -158.61 30.2 Favored Glycine 0 N--CA 1.421 -2.353 0 C-N-CA 120.501 -0.857 . . . . 0.0 111.132 -179.556 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 57.5 t -102.26 111.02 64.0 Favored Pre-proline 0 C--N 1.302 -1.485 0 N-CA-C 111.798 0.296 . . . . 0.0 111.798 -175.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.5 ' HB3' HD21 ' A' ' 77' ' ' LEU . 87.1 Cg_endo -79.05 140.12 15.62 Favored 'Trans proline' 0 N--CA 1.449 -1.131 0 C-N-CA 122.96 2.44 . . . . 0.0 110.354 175.243 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 26.9 m -114.85 -21.95 5.04 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 C-N-CA 120.102 -0.639 . . . . 0.0 111.95 179.607 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.409 ' HB3' ' HG2' ' A' ' 78' ' ' LYS . 17.6 t70 -158.43 145.02 17.38 Favored 'General case' 0 C--O 1.247 0.944 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 -179.752 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 13.1 p -146.18 133.02 14.43 Favored 'Isoleucine or valine' 0 C--O 1.245 0.819 0 CA-C-O 121.5 0.667 . . . . 0.0 110.356 179.779 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.419 HD11 ' HB3' ' A' ' 111' ' ' PRO . 95.5 mt -121.06 126.98 75.82 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 177.647 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -99.55 122.04 42.05 Favored 'General case' 0 C--N 1.292 -1.902 0 N-CA-C 105.469 -2.049 . . . . 0.0 105.469 175.314 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 7.0 t -85.04 123.56 30.72 Favored 'General case' 0 N--CA 1.418 -2.062 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 179.198 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 73.4 mtt85 -119.5 141.17 49.43 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-O 120.901 0.381 . . . . 0.0 111.038 -179.368 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -76.07 124.35 27.26 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.942 -179.282 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -60.87 -25.5 66.72 Favored 'General case' 0 C--N 1.297 -1.705 0 CA-C-N 114.465 -1.243 . . . . 0.0 112.472 -178.293 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 25.0 m-80 -83.09 -51.38 7.58 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.083 0.468 . . . . 0.0 111.502 -176.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 47.2 p -86.63 -24.31 25.37 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 116.057 -0.519 . . . . 0.0 112.36 -174.875 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 81.79 -1.06 87.38 Favored Glycine 0 C--N 1.308 -0.987 0 N-CA-C 111.545 -0.622 . . . . 0.0 111.545 -177.4 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 36.3 mm-40 -101.04 176.44 5.26 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 110.238 -0.282 . . . . 0.0 110.238 -178.742 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 40.1 t -59.5 147.27 37.37 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.715 176.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 17.1 mm-40 -79.44 -7.44 58.4 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 123.759 0.823 . . . . 0.0 110.303 176.074 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 92.54 5.59 64.89 Favored Glycine 0 N--CA 1.425 -2.058 0 C-N-CA 120.594 -0.813 . . . . 0.0 111.651 -178.767 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 31.4 p90 -143.56 152.79 41.86 Favored 'General case' 0 N--CA 1.435 -1.181 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 178.56 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -148.12 171.97 15.03 Favored 'General case' 0 N--CA 1.427 -1.606 0 O-C-N 123.362 0.414 . . . . 0.0 110.165 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -130.37 139.99 50.62 Favored 'General case' 0 C--N 1.298 -1.655 0 C-N-CA 124.024 0.929 . . . . 0.0 109.952 -178.5 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.5 HD21 ' HB3' ' A' ' 57' ' ' PRO . 10.3 tt -146.93 140.85 25.95 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 175.739 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.409 ' HG2' ' HB3' ' A' ' 59' ' ' ASP . 21.7 ptmt -125.04 144.3 50.47 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 178.905 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.469 ' HH ' ' HD2' ' A' ' 51' ' ' PHE . 55.8 m-85 -108.49 164.59 12.21 Favored 'General case' 0 C--N 1.29 -2.013 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.614 -179.875 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -79.0 -35.49 42.78 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 174.165 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -106.49 123.73 48.53 Favored 'General case' 0 N--CA 1.439 -0.999 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 -177.451 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.431 HE22 ' HB2' ' A' ' 28' ' ' LYS . 96.7 mt-30 -69.47 -19.3 63.76 Favored 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 113.391 0.886 . . . . 0.0 113.391 -178.518 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 90.6 mtm180 -66.19 -33.24 75.31 Favored 'General case' 0 C--N 1.302 -1.5 0 CA-C-O 121.914 0.864 . . . . 0.0 109.261 173.895 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 56.9 m -65.33 -37.15 86.23 Favored 'General case' 0 N--CA 1.426 -1.639 0 CA-C-N 115.29 -0.868 . . . . 0.0 112.43 178.909 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.49 ' O ' HG23 ' A' ' 89' ' ' VAL . 64.9 p -62.73 -45.66 91.69 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 121.061 0.457 . . . . 0.0 110.741 -177.819 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 4.3 pt -66.17 -37.93 80.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.831 177.807 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.507 HD11 ' HB2' ' B' ' 224' ' ' PHE . 14.0 mt -59.41 -44.12 92.89 Favored 'General case' 0 CA--C 1.509 -0.62 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.641 175.26 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.485 ' HB1' HD12 ' A' ' 92' ' ' LEU . . . -70.16 -45.51 66.61 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.848 -178.313 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.49 HG23 ' O ' ' A' ' 85' ' ' THR . 87.7 t -56.55 -47.79 81.43 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.967 0 CA-C-O 121.43 0.634 . . . . 0.0 111.119 178.47 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -62.08 -33.74 74.98 Favored 'General case' 0 C--N 1.297 -1.695 0 C-N-CA 125.042 1.337 . . . . 0.0 112.722 -176.337 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.402 ' HB3' ' CE1' ' A' ' 54' ' ' TYR . 14.8 t-20 -98.44 -30.86 12.3 Favored 'General case' 0 C--N 1.293 -1.874 0 CA-C-N 116.145 -0.479 . . . . 0.0 112.232 -175.55 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.485 HD12 ' HB1' ' A' ' 88' ' ' ALA . 12.5 mt -93.8 -30.16 14.99 Favored 'General case' 0 CA--C 1.482 -1.648 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 -170.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 57.4 t30 -66.12 125.04 24.26 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 179.742 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 83.61 -0.69 89.48 Favored Glycine 0 CA--C 1.535 1.287 0 C-N-CA 120.424 -0.893 . . . . 0.0 112.502 -177.48 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 67.8 t80 -89.36 138.42 31.46 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -178.925 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.452 ' HA ' ' O ' ' A' ' 100' ' ' ARG . 0.3 OUTLIER -92.51 118.52 31.06 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 -175.824 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 55.0 mt -127.64 142.08 44.63 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.259 0 N-CA-C 106.193 -1.78 . . . . 0.0 106.193 172.814 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 58.47 21.88 50.18 Favored Glycine 0 CA--C 1.524 0.656 0 C-N-CA 121.63 -0.319 . . . . 0.0 113.514 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 87.25 10.75 70.66 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 121.647 -0.311 . . . . 0.0 113.483 179.07 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.452 ' O ' ' HA ' ' A' ' 96' ' ' LYS . 13.6 ptp180 -140.56 148.66 41.33 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 117.985 0.892 . . . . 0.0 111.889 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -82.83 118.02 23.12 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.956 -179.374 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 12.7 mt -65.88 149.56 50.0 Favored 'General case' 0 C--N 1.309 -1.189 0 C-N-CA 124.134 0.974 . . . . 0.0 113.611 178.666 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 55.3 tptt -116.09 120.16 38.15 Favored 'General case' 0 N--CA 1.423 -1.801 0 CA-C-N 114.964 -1.016 . . . . 0.0 108.734 174.678 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.448 HG22 HG22 ' A' ' 89' ' ' VAL . 4.8 mm -121.44 135.36 61.85 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 178.35 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -143.57 153.25 42.37 Favored 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 109.273 -0.639 . . . . 0.0 109.273 -179.412 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -83.54 137.7 33.74 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 177.645 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 12.3 t -155.16 156.48 35.81 Favored 'General case' 0 N--CA 1.425 -1.724 0 N-CA-C 107.929 -1.138 . . . . 0.0 107.929 -177.117 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 7.7 p90 -97.67 109.86 22.53 Favored 'General case' 0 N--CA 1.423 -1.808 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 168.637 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 29.1 t80 -108.2 135.49 49.44 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-N 115.055 -0.975 . . . . 0.0 110.207 -178.175 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.408 ' HA ' ' HD2' ' A' ' 111' ' ' PRO . 5.3 mpt_? -118.82 117.88 33.6 Favored Pre-proline 0 C--N 1.29 -1.982 0 N-CA-C 109.171 -0.678 . . . . 0.0 109.171 172.567 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.419 ' HB3' HD11 ' A' ' 61' ' ' ILE . 35.5 Cg_endo -61.73 140.56 86.72 Favored 'Trans proline' 0 C--O 1.241 0.627 0 C-N-CA 123.307 2.671 . . . . 0.0 113.783 -178.825 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 3.6 tmmm? -120.35 128.17 53.01 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 104.915 -2.254 . . . . 0.0 104.915 175.481 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 35.6 mmt180 . . . . . 0 C--N 1.297 -1.682 0 C-N-CA 120.236 -0.585 . . . . 0.0 110.125 -175.003 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 46.6 t30 . . . . . 0 N--CA 1.472 0.669 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 223' ' ' ARG . . . . . . . . . . . . . 11.7 ptm180 51.66 49.05 21.67 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 116.461 2.023 . . . . 0.0 116.461 173.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 224' ' ' PHE . . . . . 0.507 ' HB2' HD11 ' A' ' 87' ' ' LEU . 85.1 m-85 -106.25 165.42 11.26 Favored 'General case' 0 C--N 1.281 -2.403 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 173.402 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 225' ' ' ALA . . . . . . . . . . . . . . . -132.6 86.14 2.29 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-O 121.235 0.54 . . . . 0.0 110.432 179.523 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 3.7 mp -120.38 141.13 42.1 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.265 0 CA-C-N 115.101 -0.954 . . . . 0.0 109.348 178.582 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 227' ' ' MET . . . . . . . . . . . . . 68.6 mtt -69.29 139.08 89.52 Favored Pre-proline 0 N--CA 1.452 -0.341 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.354 177.568 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 228' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -69.09 159.0 55.67 Favored 'Trans proline' 0 C--O 1.243 0.726 0 C-N-CA 122.739 2.293 . . . . 0.0 112.893 -178.485 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . -75.3 168.76 54.79 Favored Glycine 0 N--CA 1.441 -0.98 0 CA-C-N 115.442 -0.799 . . . . 0.0 112.749 -179.685 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 9.4 t -77.61 -14.44 59.64 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 121.293 0.568 . . . . 0.0 110.305 -177.511 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 231' ' ' ARG . . . . . 0.454 ' HB2' ' OG ' ' A' ' 52' ' ' SER . 37.2 mmt180 -86.75 -3.93 59.11 Favored 'General case' 0 C--N 1.321 -0.644 0 O-C-N 122.139 -0.351 . . . . 0.0 111.08 -179.178 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 232' ' ' TRP . . . . . . . . . . . . . 21.7 t90 -74.77 128.25 35.12 Favored 'General case' 0 CA--C 1.497 -1.064 0 CA-C-O 122.385 1.088 . . . . 0.0 111.7 -179.142 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 233' ' ' ASP . . . . . 0.448 ' H ' HG23 ' A' ' 49' ' ' THR . 37.3 t70 -124.42 147.42 48.29 Favored 'General case' 0 C--N 1.263 -3.158 0 N-CA-C 103.038 -2.949 . . . . 0.0 103.038 172.671 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -40.01 60.71 0.0 OUTLIER Glycine 0 N--CA 1.501 3.022 0 C-N-CA 128.702 3.049 . . . . 0.0 116.93 -178.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 235' ' ' VAL . . . . . 0.447 ' N ' ' O ' ' B' ' 233' ' ' ASP . 59.1 t -106.34 133.85 49.63 Favored 'Isoleucine or valine' 0 C--N 1.256 -3.46 0 C-N-CA 127.898 2.479 . . . . 0.0 106.61 175.649 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 236' ' ' HIS . . . . . . . . . . . . . 83.9 t60 -112.17 113.45 25.71 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 123.635 0.584 . . . . 0.0 109.449 -177.008 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 237' ' ' ARG . . . . . 0.586 ' HG3' HG13 ' A' ' 50' ' ' VAL . 40.2 mmt180 -114.64 110.84 20.38 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-O 121.264 0.554 . . . . 0.0 111.019 179.266 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 238' ' ' SER . . . . . . . . . . . . . 48.9 m -127.3 125.18 40.4 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-O 120.931 0.396 . . . . 0.0 111.152 179.311 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 239' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -60.28 116.19 4.07 Favored 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 123.848 0.859 . . . . 0.0 110.838 -176.027 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 240' ' ' GLY . . . . . 0.613 ' O ' ' HG2' ' B' ' 243' ' ' GLU . . . 80.85 39.57 13.39 Favored Glycine 0 C--O 1.194 -2.374 0 N-CA-C 111.309 -0.716 . . . . 0.0 111.309 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 17.7 p90 -55.76 -33.81 64.67 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -179.018 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -65.06 -40.9 95.38 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 111.885 0.328 . . . . 0.0 111.885 -176.768 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 243' ' ' GLU . . . . . 0.613 ' HG2' ' O ' ' B' ' 240' ' ' GLY . 11.4 pt-20 -66.31 -34.87 78.96 Favored 'General case' 0 C--O 1.207 -1.178 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 178.33 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 244' ' ' LYS . . . . . 0.583 ' HG2' ' O ' ' B' ' 240' ' ' GLY . 70.4 mmtt -66.0 -43.55 87.41 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 121.088 0.471 . . . . 0.0 110.555 -177.267 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 245' ' ' TRP . . . . . . . . . . . . . 46.7 m0 -63.94 -41.95 97.46 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.653 0.739 . . . . 0.0 109.358 178.536 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 246' ' ' PHE . . . . . 0.62 ' O ' ' HG2' ' B' ' 249' ' ' GLN . 1.7 t80 -68.46 -27.59 66.29 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 114.326 -1.306 . . . . 0.0 111.633 178.957 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -76.77 -39.64 50.98 Favored 'General case' 0 C--N 1.287 -2.12 0 O-C-N 121.907 -0.496 . . . . 0.0 111.597 -177.865 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 2.6 pptp? -85.89 -14.75 43.9 Favored 'General case' 0 CA--C 1.507 -0.675 0 C-N-CA 120.231 -0.588 . . . . 0.0 112.328 -173.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 249' ' ' GLN . . . . . 0.62 ' HG2' ' O ' ' B' ' 246' ' ' PHE . 13.8 pt20 -67.75 -0.6 4.25 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.755 -176.867 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 250' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -74.97 -20.78 59.52 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.975 177.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 27.0 mm-40 -64.83 146.49 54.81 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 115.136 -0.938 . . . . 0.0 113.193 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 252' ' ' ILE . . . . . . . . . . . . . 23.9 pt -97.71 -26.33 3.95 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 CA-C-N 115.045 -0.98 . . . . 0.0 111.118 177.179 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -85.22 -27.98 25.72 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 121.466 0.651 . . . . 0.0 109.696 178.19 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 254' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -99.67 169.68 9.1 Favored 'General case' 0 N--CA 1.422 -1.868 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.703 176.909 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 255' ' ' LYS . . . . . . . . . . . . . 14.6 ptmm? -94.26 171.26 8.94 Favored 'General case' 0 C--N 1.291 -1.943 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.468 -175.878 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 256' ' ' LYS . . . . . 0.548 ' HA ' ' HB2' ' B' ' 249' ' ' GLN . 28.5 ttpp . . . . . 0 N--CA 1.428 -1.539 0 CA-C-N 114.827 -1.079 . . . . 0.0 108.853 175.649 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 . . . . . 0 CA--C 1.51 -0.563 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.627 ' HG2' ' CD1' ' A' ' 27' ' ' TYR . 0.3 OUTLIER -83.2 -4.9 58.87 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 113.718 1.007 . . . . 0.0 113.718 -174.955 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.627 ' CD1' ' HG2' ' A' ' 26' ' ' GLU . 62.2 m-85 -114.03 23.58 12.82 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-O 121.578 0.704 . . . . 0.0 111.016 178.865 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -122.91 148.75 45.1 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 174.07 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -102.56 7.95 39.95 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 -172.611 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.46 ' HB2' ' HG2' ' A' ' 82' ' ' GLN . 88.0 m-20 -80.49 23.66 0.5 Allowed 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 121.133 0.492 . . . . 0.0 109.814 175.251 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.487 ' HA ' HG21 ' A' ' 85' ' ' THR . . . -100.35 1.98 42.02 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.874 -174.398 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 -99.13 144.5 28.2 Favored 'General case' 0 C--N 1.315 -0.929 0 C-N-CA 120.309 -0.556 . . . . 0.0 109.866 -175.901 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 33.6 pt -138.14 157.04 31.49 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 CA-C-O 121.107 0.479 . . . . 0.0 110.616 178.096 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 38.9 t80 -107.74 121.07 43.97 Favored 'General case' 0 N--CA 1.417 -2.091 0 CA-C-N 114.728 -1.124 . . . . 0.0 108.444 178.469 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.427 HG23 ' CD1' ' A' ' 104' ' ' ILE . 9.9 mt -108.58 127.79 64.75 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.882 0 N-CA-C 106.714 -1.587 . . . . 0.0 106.714 175.694 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -130.5 163.7 23.14 Favored Glycine 0 C--N 1.284 -2.32 0 N-CA-C 111.232 -0.747 . . . . 0.0 111.232 -179.478 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 67.2 m-20 73.73 38.68 0.59 Allowed 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.743 1.617 . . . . 0.0 110.219 -178.593 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.435 HD11 HD11 ' A' ' 47' ' ' ILE . 4.2 mm? -68.69 144.69 54.35 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.451 -0.795 . . . . 0.0 112.29 178.819 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.469 HD22 ' HA3' ' A' ' 98' ' ' GLY . 41.4 t-20 -89.34 151.5 22.04 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 177.476 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.507 ' HD2' ' N ' ' A' ' 41' ' ' GLU . 5.3 ppt_? -59.56 -26.42 65.36 Favored 'General case' 0 C--N 1.31 -1.135 0 C-N-CA 123.103 0.561 . . . . 0.0 111.828 177.745 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.507 ' N ' ' HD2' ' A' ' 40' ' ' ARG . 10.4 pt-20 -89.55 0.89 56.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.897 -177.655 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 80.8 mt -97.32 111.87 23.93 Favored 'General case' 0 CA--C 1.494 -1.177 0 CA-C-O 121.59 0.709 . . . . 0.0 111.211 -178.551 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 82.2 p -103.51 174.53 5.83 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-N 114.344 -1.298 . . . . 0.0 109.451 -178.59 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.498 ' HG3' ' HB2' ' A' ' 62' ' ' LEU . 2.0 mp0 -54.62 -40.66 69.16 Favored 'General case' 0 C--O 1.216 -0.676 0 C-N-CA 123.599 0.76 . . . . 0.0 109.586 177.738 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -59.48 -41.63 97.23 Favored Glycine 0 N--CA 1.445 -0.75 0 O-C-N 123.659 0.6 . . . . 0.0 113.163 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -66.69 -49.13 67.09 Favored 'General case' 0 CA--C 1.497 -1.071 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 -179.689 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.435 HD11 HD11 ' A' ' 38' ' ' LEU . 52.6 mt -58.37 -45.88 89.42 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.926 0 CA-C-N 114.992 -1.003 . . . . 0.0 110.493 179.735 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 35.0 mt -60.55 -45.71 92.87 Favored 'General case' 0 CA--C 1.5 -0.963 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 -177.365 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.491 HG23 ' H ' ' B' ' 233' ' ' ASP . 80.2 m -62.92 -45.59 91.78 Favored 'General case' 0 N--CA 1.439 -1.016 0 O-C-N 123.308 0.38 . . . . 0.0 111.563 179.313 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.484 HG13 ' HG3' ' B' ' 237' ' ' ARG . 77.4 t -65.79 -47.18 86.66 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.157 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.036 -179.156 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.444 ' HA ' ' HD2' ' A' ' 54' ' ' TYR . 3.8 m-85 -67.43 -22.95 65.49 Favored 'General case' 0 N--CA 1.429 -1.496 0 C-N-CA 123.624 0.77 . . . . 0.0 112.144 -178.924 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.408 ' OG ' ' HB2' ' B' ' 231' ' ' ARG . 68.3 m -69.13 -16.92 63.77 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.937 175.941 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -67.02 -26.63 66.87 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-O 121.246 0.546 . . . . 0.0 109.659 175.206 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.444 ' HD2' ' HA ' ' A' ' 51' ' ' PHE . 54.4 m-85 -95.73 -15.19 22.78 Favored 'General case' 0 CA--C 1.505 -0.784 0 CA-C-O 121.245 0.545 . . . . 0.0 112.392 -173.222 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 160.1 -152.19 22.96 Favored Glycine 0 N--CA 1.413 -2.849 0 N-CA-C 110.245 -1.142 . . . . 0.0 110.245 -179.616 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 65.3 t -104.74 109.21 62.7 Favored Pre-proline 0 C--N 1.288 -2.068 0 O-C-N 123.554 0.208 . . . . 0.0 110.466 -176.701 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.548 ' HB3' HD21 ' A' ' 77' ' ' LEU . 73.2 Cg_endo -77.57 135.58 14.74 Favored 'Trans proline' 0 N--CA 1.435 -1.966 0 C-N-CA 121.525 1.483 . . . . 0.0 108.595 174.259 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.422 ' CG2' ' HG3' ' A' ' 78' ' ' LYS . 35.2 m -109.85 -23.21 4.58 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 C-N-CA 119.309 -0.956 . . . . 0.0 111.81 -177.753 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.44 ' HB3' ' HG2' ' A' ' 78' ' ' LYS . 25.8 t70 -158.68 142.94 15.67 Favored 'General case' 0 CA--C 1.503 -0.836 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 14.6 p -140.79 135.12 33.72 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 178.807 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 86.4 mt -120.72 123.06 69.5 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.311 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 176.242 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.498 ' HB2' ' HG3' ' A' ' 44' ' ' GLU . 0.1 OUTLIER -98.61 119.64 37.69 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 177.298 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 28.3 m -83.91 116.79 22.95 Favored 'General case' 0 N--CA 1.404 -2.772 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 176.235 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 58.9 mtt180 -123.35 131.94 53.82 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 -175.625 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -66.37 127.05 30.77 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 175.697 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -60.77 -20.37 61.28 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 113.583 0.957 . . . . 0.0 113.583 -176.766 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 31.5 m-80 -81.04 -49.0 11.44 Favored 'General case' 0 CA--C 1.497 -1.065 0 C-N-CA 120.134 -0.626 . . . . 0.0 109.811 -177.492 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 72.3 p -88.35 -24.6 23.07 Favored 'General case' 0 C--N 1.312 -1.034 0 C-N-CA 120.22 -0.592 . . . . 0.0 111.528 -176.347 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 67.9 6.78 46.47 Favored Glycine 0 CA--C 1.527 0.798 0 CA-C-N 116.163 -0.471 . . . . 0.0 112.439 -178.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -90.74 -74.49 0.49 Allowed 'General case' 0 C--O 1.216 -0.708 0 CA-C-O 120.901 0.381 . . . . 0.0 111.503 -173.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 36.2 t -166.64 161.95 16.13 Favored 'General case' 0 N--CA 1.428 -1.536 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 -178.597 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -99.94 0.06 40.44 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 172.453 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 94.8 8.35 59.38 Favored Glycine 0 N--CA 1.427 -1.962 0 CA-C-N 114.96 -1.018 . . . . 0.0 112.472 178.582 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 37.2 p90 -150.09 154.99 39.05 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 179.258 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -150.1 170.47 18.83 Favored 'General case' 0 N--CA 1.427 -1.595 0 CA-C-O 120.925 0.393 . . . . 0.0 110.264 178.874 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -128.9 142.2 51.03 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.404 -179.021 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.548 HD21 ' HB3' ' A' ' 57' ' ' PRO . 9.8 tt -148.99 140.9 23.72 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 175.696 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.44 ' HG2' ' HB3' ' A' ' 59' ' ' ASP . 20.8 ptmt -122.66 144.02 49.41 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 178.665 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 45.8 m-85 -104.65 164.88 11.44 Favored 'General case' 0 C--N 1.29 -1.992 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.575 -179.233 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -71.15 -37.49 72.26 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 114.824 -1.08 . . . . 0.0 108.607 175.062 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -125.28 143.63 50.87 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.298 0.57 . . . . 0.0 111.74 -179.019 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.46 ' HG2' ' HB2' ' A' ' 30' ' ' ASN . 20.8 mp0 -69.93 -24.0 63.29 Favored 'General case' 0 C--N 1.312 -1.061 0 C-N-CA 124.91 1.284 . . . . 0.0 112.94 -177.964 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 56.1 mtm180 -67.88 -34.63 77.04 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-O 122.083 0.944 . . . . 0.0 109.592 175.804 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.455 ' OG ' HG21 ' B' ' 226' ' ' ILE . 48.6 m -66.04 -37.71 86.55 Favored 'General case' 0 C--N 1.286 -2.177 0 CA-C-N 114.808 -1.087 . . . . 0.0 111.619 175.798 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.512 ' O ' HG23 ' A' ' 89' ' ' VAL . 71.6 p -66.02 -45.33 81.87 Favored 'General case' 0 C--O 1.221 -0.402 0 C-N-CA 120.134 -0.626 . . . . 0.0 110.52 -178.058 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 8.3 pt -64.79 -37.39 80.03 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 C-N-CA 122.481 0.312 . . . . 0.0 111.111 177.521 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.434 HD23 ' HB3' ' B' ' 222' ' ' ASN . 9.7 mt -58.51 -44.08 89.35 Favored 'General case' 0 CA--C 1.504 -0.822 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.203 175.034 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.432 ' O ' ' HB2' ' A' ' 92' ' ' LEU . . . -71.56 -46.67 58.78 Favored 'General case' 0 N--CA 1.434 -1.269 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.953 -179.27 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.512 HG23 ' O ' ' A' ' 85' ' ' THR . 86.5 t -56.79 -49.9 76.83 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.201 0 CA-C-O 120.844 0.354 . . . . 0.0 111.429 -178.375 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -73.53 -28.65 62.0 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 112.751 0.649 . . . . 0.0 112.751 -173.127 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.504 ' ND2' ' HB3' ' B' ' 239' ' ' ASN . 12.8 t-20 -87.76 -31.79 19.46 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-O 121.011 0.434 . . . . 0.0 110.572 -177.485 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.432 ' HB2' ' O ' ' A' ' 88' ' ' ALA . 10.0 mt -94.26 -30.32 14.62 Favored 'General case' 0 CA--C 1.501 -0.922 0 CA-C-N 116.03 -0.532 . . . . 0.0 112.386 -173.703 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 46.1 t30 -65.74 125.24 24.68 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 179.09 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 88.47 -7.73 80.91 Favored Glycine 0 N--CA 1.436 -1.35 0 CA-C-N 115.599 -0.728 . . . . 0.0 112.268 -178.048 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -81.94 138.96 34.88 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 -178.124 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.524 ' HE3' ' HB2' ' A' ' 101' ' ' ALA . 11.7 mptt -99.2 125.12 44.72 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-O 121.14 0.495 . . . . 0.0 111.68 -177.295 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 58.7 mt -127.69 141.39 46.51 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 N-CA-C 105.761 -1.94 . . . . 0.0 105.761 173.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.469 ' HA3' HD22 ' A' ' 39' ' ' ASN . . . 64.17 7.42 24.65 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 121.12 -0.562 . . . . 0.0 114.311 179.173 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 97.22 0.13 59.93 Favored Glycine 0 N--CA 1.436 -1.312 0 C-N-CA 121.118 -0.563 . . . . 0.0 112.492 -176.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 17.3 ptp180 -124.29 151.56 44.09 Favored 'General case' 0 C--N 1.317 -0.806 0 O-C-N 122.233 -0.569 . . . . 0.0 110.997 -179.493 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.524 ' HB2' ' HE3' ' A' ' 96' ' ' LYS . . . -89.73 120.03 30.65 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.513 -176.351 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 11.7 mt -68.7 145.15 54.11 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-O 121.71 0.766 . . . . 0.0 112.343 177.685 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.41 ' HE3' ' HB2' ' A' ' 105' ' ' ASP . 50.1 tptt -120.96 116.66 25.53 Favored 'General case' 0 N--CA 1.417 -2.106 0 CA-C-N 114.822 -1.081 . . . . 0.0 109.184 176.348 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.427 ' CD1' HG23 ' A' ' 35' ' ' ILE . 4.7 mm -119.37 134.31 63.38 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 179.574 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.41 ' HB2' ' HE3' ' A' ' 103' ' ' LYS . 27.5 t70 -144.89 157.74 44.05 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 177.417 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 2.8 m80 -81.96 131.63 35.25 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-O 121.236 0.541 . . . . 0.0 112.122 177.019 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 13.3 t -146.35 162.86 37.25 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 -177.718 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -110.25 110.91 21.91 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 107.046 -1.465 . . . . 0.0 107.046 171.057 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 74.4 t80 -107.2 138.98 42.36 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.228 -179.063 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.441 ' N ' ' HD2' ' A' ' 110' ' ' ARG . 4.2 mpt_? -115.25 115.42 42.66 Favored Pre-proline 0 C--N 1.312 -1.065 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 173.817 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -63.2 141.43 82.49 Favored 'Trans proline' 0 C--O 1.243 0.726 0 C-N-CA 123.318 2.679 . . . . 0.0 115.101 -177.855 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.445 ' HD3' ' C ' ' A' ' 112' ' ' LYS . 12.0 tmtt? -121.09 131.83 54.51 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 105.398 -2.075 . . . . 0.0 105.398 172.701 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 28.7 mmt180 . . . . . 0 C--N 1.303 -1.418 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 179.699 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 222' ' ' ASN . . . . . 0.434 ' HB3' HD23 ' A' ' 87' ' ' LEU . 64.7 t30 . . . . . 0 C--O 1.208 -1.121 0 N-CA-C 111.7 0.259 . . . . 0.0 111.7 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 223' ' ' ARG . . . . . . . . . . . . . 7.5 ptp180 86.53 8.95 0.24 Allowed 'General case' 0 N--CA 1.524 3.267 0 C-N-CA 126.461 1.904 . . . . 0.0 114.131 173.674 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 224' ' ' PHE . . . . . 0.432 ' HB2' HD11 ' A' ' 87' ' ' LEU . 38.0 m-85 -112.48 163.97 13.83 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -179.302 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 225' ' ' ALA . . . . . . . . . . . . . . . -131.63 81.61 1.99 Allowed 'General case' 0 C--N 1.31 -1.141 0 CA-C-O 121.25 0.547 . . . . 0.0 110.53 178.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 226' ' ' ILE . . . . . 0.455 HG21 ' OG ' ' A' ' 84' ' ' SER . 4.1 mp -121.66 137.73 54.33 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 176.563 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 227' ' ' MET . . . . . . . . . . . . . 65.9 mtt -69.22 137.64 89.25 Favored Pre-proline 0 C--N 1.311 -1.077 0 O-C-N 123.706 0.629 . . . . 0.0 110.135 179.717 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 228' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -67.43 154.03 75.0 Favored 'Trans proline' 0 C--O 1.248 1.023 0 C-N-CA 122.787 2.324 . . . . 0.0 112.269 179.606 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . -73.11 168.98 53.4 Favored Glycine 0 C--N 1.314 -0.668 0 CA-C-N 115.558 -0.747 . . . . 0.0 112.879 -179.65 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 23.4 m -76.67 -13.93 60.01 Favored 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 123.236 0.614 . . . . 0.0 112.157 -175.543 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 231' ' ' ARG . . . . . 0.408 ' HB2' ' OG ' ' A' ' 52' ' ' SER . 19.7 mmt180 -87.16 -0.05 56.08 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.954 0.406 . . . . 0.0 110.095 -178.313 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 232' ' ' TRP . . . . . . . . . . . . . 21.0 t90 -77.63 126.47 30.93 Favored 'General case' 0 N--CA 1.433 -1.3 0 CA-C-O 122.428 1.109 . . . . 0.0 112.392 -176.399 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 233' ' ' ASP . . . . . 0.491 ' H ' HG23 ' A' ' 49' ' ' THR . 26.1 t70 -121.84 144.3 48.91 Favored 'General case' 0 C--N 1.264 -3.117 0 N-CA-C 101.829 -3.397 . . . . 0.0 101.829 171.775 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -38.27 66.64 0.0 OUTLIER Glycine 0 N--CA 1.487 2.05 0 C-N-CA 128.065 2.745 . . . . 0.0 116.113 -178.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 235' ' ' VAL . . . . . 0.454 ' N ' ' O ' ' B' ' 233' ' ' ASP . 76.9 t -111.53 122.59 66.19 Favored 'Isoleucine or valine' 0 C--N 1.255 -3.536 0 C-N-CA 126.684 1.994 . . . . 0.0 107.887 175.265 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 236' ' ' HIS . . . . . . . . . . . . . 59.8 t-80 -112.78 122.5 47.85 Favored 'General case' 0 C--N 1.282 -2.327 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 178.19 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 237' ' ' ARG . . . . . 0.484 ' HG3' HG13 ' A' ' 50' ' ' VAL . 4.9 mmp_? -110.28 115.79 30.33 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 176.267 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 238' ' ' SER . . . . . 0.48 ' HB2' ' HB3' ' B' ' 241' ' ' PHE . 17.8 m -92.25 114.07 26.51 Favored 'General case' 0 C--N 1.283 -2.301 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -176.79 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 239' ' ' ASN . . . . . 0.504 ' HB3' ' ND2' ' A' ' 91' ' ' ASN . 17.5 p-10 -63.72 111.05 2.25 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.68 173.869 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 240' ' ' GLY . . . . . 0.536 ' O ' ' HG2' ' B' ' 244' ' ' LYS . . . 74.04 53.04 7.31 Favored Glycine 0 C--O 1.199 -2.077 0 N-CA-C 110.456 -1.058 . . . . 0.0 110.456 -178.158 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 241' ' ' PHE . . . . . 0.48 ' HB3' ' HB2' ' B' ' 238' ' ' SER . 51.1 p90 -64.42 -34.01 77.2 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 -176.825 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -63.8 -42.44 97.72 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 112.003 0.371 . . . . 0.0 112.003 -174.4 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 243' ' ' GLU . . . . . 0.494 ' HG2' ' O ' ' B' ' 240' ' ' GLY . 11.1 pt-20 -63.13 -34.7 78.19 Favored 'General case' 0 C--O 1.208 -1.08 0 N-CA-C 110.466 -0.198 . . . . 0.0 110.466 178.325 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 244' ' ' LYS . . . . . 0.536 ' HG2' ' O ' ' B' ' 240' ' ' GLY . 68.8 mmtt -67.72 -44.58 77.32 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 -179.046 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 245' ' ' TRP . . . . . . . . . . . . . 50.9 m0 -62.55 -41.52 98.95 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.725 178.036 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 246' ' ' PHE . . . . . 0.514 ' O ' ' HG2' ' B' ' 249' ' ' GLN . 5.1 t80 -65.53 -36.25 83.26 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.902 177.793 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -71.69 -35.67 70.34 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.206 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.19 -15.34 36.27 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 120.991 0.424 . . . . 0.0 111.704 -178.67 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 249' ' ' GLN . . . . . 0.514 ' HG2' ' O ' ' B' ' 246' ' ' PHE . 11.8 pt20 -81.53 2.96 26.69 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-O 120.982 0.42 . . . . 0.0 110.326 179.5 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 250' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -54.01 -27.83 34.33 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.911 177.767 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 251' ' ' GLU . . . . . 0.648 ' HB3' ' HB2' ' B' ' 254' ' ' GLU . 45.5 mt-10 -80.58 110.52 16.13 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 176.039 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 252' ' ' ILE . . . . . 0.645 HD13 ' H ' ' B' ' 252' ' ' ILE . 0.2 OUTLIER -112.72 -33.98 2.2 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 CA-C-N 115.843 -0.617 . . . . 0.0 112.165 -173.475 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -118.89 -6.26 10.55 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 -178.099 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 254' ' ' GLU . . . . . 0.648 ' HB2' ' HB3' ' B' ' 251' ' ' GLU . 16.8 mp0 -75.03 -169.92 1.02 Allowed 'General case' 0 C--N 1.294 -1.829 0 CA-C-N 112.549 -2.114 . . . . 0.0 111.957 -179.177 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 255' ' ' LYS . . . . . . . . . . . . . 58.0 mttm -83.44 96.97 8.73 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.857 -176.778 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 256' ' ' LYS . . . . . . . . . . . . . 24.5 ttmm . . . . . 0 C--N 1.296 -1.727 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 179.694 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 17.4 m120 . . . . . 0 CA--C 1.507 -0.676 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -72.85 -18.9 61.4 Favored 'General case' 0 CA--C 1.507 -0.7 0 CA-C-O 121.787 0.803 . . . . 0.0 110.779 -178.68 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -81.19 1.55 31.58 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 114.664 -1.153 . . . . 0.0 111.83 -177.283 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -121.3 144.34 48.69 Favored 'General case' 0 CA--C 1.483 -1.598 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 175.807 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -99.77 15.98 25.14 Favored 'General case' 0 C--N 1.277 -2.568 0 CA-C-O 122.914 1.34 . . . . 0.0 108.175 -179.256 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -79.93 5.72 13.15 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-N 112.709 -2.041 . . . . 0.0 109.724 -177.764 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -92.57 13.41 19.94 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.786 -174.617 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 11.3 m-30 -93.24 144.95 24.81 Favored 'General case' 0 C--N 1.309 -1.183 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.524 -176.603 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 21.4 pt -142.81 165.84 15.76 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.981 0 C-N-CA 123.291 0.636 . . . . 0.0 110.152 175.265 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.532 ' HB2' HG21 ' A' ' 107' ' ' THR . 54.7 t80 -116.2 126.4 53.59 Favored 'General case' 0 N--CA 1.413 -2.28 0 CA-C-N 114.776 -1.102 . . . . 0.0 109.114 178.217 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.453 HG23 ' CD1' ' A' ' 104' ' ' ILE . 9.1 mt -110.74 127.98 67.42 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.016 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 175.601 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -127.65 165.61 20.66 Favored Glycine 0 C--N 1.281 -2.494 0 N-CA-C 111.346 -0.701 . . . . 0.0 111.346 -178.486 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 66.39 41.52 3.26 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.708 1.203 . . . . 0.0 110.824 -176.506 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.477 HD11 HD11 ' A' ' 47' ' ' ILE . 4.1 mm? -68.56 146.57 52.97 Favored 'General case' 0 CA--C 1.496 -1.122 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.489 177.375 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.472 ' ND2' ' HA3' ' A' ' 98' ' ' GLY . 61.1 t30 -89.84 147.84 23.54 Favored 'General case' 0 C--N 1.291 -1.945 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 178.889 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.474 ' HD2' ' C ' ' A' ' 40' ' ' ARG . 2.3 ppt_? -58.87 -21.75 57.8 Favored 'General case' 0 C--N 1.318 -0.772 0 O-C-N 123.623 0.577 . . . . 0.0 112.494 -175.353 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.41 ' HG2' ' ND2' ' A' ' 39' ' ' ASN . 13.4 pt-20 -99.86 -1.01 38.54 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.383 -175.908 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.435 HD12 ' H ' ' A' ' 39' ' ' ASN . 81.3 mt -87.71 118.54 27.28 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-O 121.33 0.586 . . . . 0.0 110.459 178.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 77.0 p -105.31 174.09 6.03 Favored 'General case' 0 C--N 1.291 -1.943 0 CA-C-N 114.816 -1.084 . . . . 0.0 108.864 -178.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.519 ' CG ' ' HB2' ' A' ' 62' ' ' LEU . 70.2 mt-10 -56.38 -37.67 70.41 Favored 'General case' 0 C--O 1.216 -0.67 0 N-CA-C 109.954 -0.388 . . . . 0.0 109.954 177.598 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -61.62 -37.46 94.25 Favored Glycine 0 N--CA 1.445 -0.758 0 CA-C-N 115.722 -0.672 . . . . 0.0 113.113 179.529 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -67.26 -49.02 65.98 Favored 'General case' 0 CA--C 1.488 -1.432 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.279 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.477 HD11 HD11 ' A' ' 38' ' ' LEU . 46.7 mt -59.17 -45.67 92.62 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.14 0 CA-C-N 114.557 -1.202 . . . . 0.0 110.597 179.129 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.433 ' HG ' HG11 ' A' ' 60' ' ' VAL . 42.8 mt -59.65 -43.53 93.88 Favored 'General case' 0 CA--C 1.489 -1.369 0 C-N-CA 122.249 0.22 . . . . 0.0 111.137 -178.702 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.494 HG23 ' H ' ' B' ' 233' ' ' ASP . 72.3 m -63.26 -46.6 86.09 Favored 'General case' 0 C--N 1.309 -1.157 0 O-C-N 123.531 0.519 . . . . 0.0 111.137 -178.594 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.761 HG13 ' HG3' ' B' ' 237' ' ' ARG . 93.5 t -67.55 -46.89 82.18 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.702 -178.805 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.435 ' HA ' ' HD2' ' A' ' 54' ' ' TYR . 4.0 m-85 -68.54 -20.09 64.53 Favored 'General case' 0 N--CA 1.424 -1.751 0 CA-C-N 115.141 -0.936 . . . . 0.0 112.537 -177.861 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.43 ' CB ' ' HB2' ' B' ' 232' ' ' TRP . 59.1 m -71.1 -22.44 62.09 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 176.179 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -73.27 -20.69 60.77 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 119.164 -1.015 . . . . 0.0 109.97 176.233 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.435 ' HD2' ' HA ' ' A' ' 51' ' ' PHE . 62.0 m-85 -92.97 -11.01 34.32 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-O 121.232 0.539 . . . . 0.0 111.865 -179.208 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.417 ' O ' ' HA ' ' A' ' 52' ' ' SER . . . 156.96 -164.04 32.57 Favored Glycine 0 N--CA 1.424 -2.108 0 N-CA-C 110.954 -0.858 . . . . 0.0 110.954 179.091 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 80.9 t -96.31 109.75 49.04 Favored Pre-proline 0 C--N 1.299 -1.623 0 N-CA-C 110.078 -0.342 . . . . 0.0 110.078 -179.301 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.505 ' HB3' HD21 ' A' ' 77' ' ' LEU . 86.9 Cg_endo -79.41 136.87 12.8 Favored 'Trans proline' 0 N--CA 1.443 -1.442 0 C-N-CA 122.461 2.108 . . . . 0.0 109.301 176.14 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 33.8 m -110.84 -24.11 4.14 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 C-N-CA 119.2 -1.0 . . . . 0.0 111.67 -178.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.51 ' HB3' ' HG2' ' A' ' 78' ' ' LYS . 27.4 t70 -155.03 142.29 19.45 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -179.467 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.433 HG11 ' HG ' ' A' ' 48' ' ' LEU . 14.4 p -143.58 136.94 24.85 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 179.411 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 90.8 mt -121.88 121.17 63.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 175.08 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.519 ' HB2' ' CG ' ' A' ' 44' ' ' GLU . 0.2 OUTLIER -95.89 116.82 29.49 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 106.245 -1.761 . . . . 0.0 106.245 172.544 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 44.3 m -77.21 116.32 17.74 Favored 'General case' 0 N--CA 1.419 -1.998 0 N-CA-C 107.37 -1.345 . . . . 0.0 107.37 176.2 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.414 ' HA ' ' HA ' ' A' ' 71' ' ' SER . 21.1 mtp180 -117.24 128.21 54.86 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-O 120.819 0.342 . . . . 0.0 110.332 -175.854 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -67.61 127.37 32.49 Favored 'General case' 0 CA--C 1.489 -1.376 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.283 178.031 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -60.95 -29.69 69.78 Favored 'General case' 0 C--N 1.295 -1.766 0 C-N-CA 123.943 0.897 . . . . 0.0 112.595 -178.571 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 28.1 m-80 -79.92 -46.58 16.51 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 120.942 0.401 . . . . 0.0 110.782 -172.895 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 48.7 p -85.3 -24.49 27.68 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-O 121.402 0.62 . . . . 0.0 109.887 -179.689 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.71 7.53 61.68 Favored Glycine 0 N--CA 1.442 -0.962 0 CA-C-N 115.414 -0.812 . . . . 0.0 112.357 -178.857 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.454 ' OE2' ' HD3' ' A' ' 40' ' ' ARG . 36.7 mt-10 -106.03 -70.29 0.79 Allowed 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -173.886 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.414 ' HA ' ' HA ' ' A' ' 64' ' ' ARG . 32.0 t -157.4 159.26 37.2 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 -178.819 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 18.3 mm-40 -92.22 -16.07 26.69 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 173.0 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 94.73 12.76 55.25 Favored Glycine 0 N--CA 1.427 -1.962 0 C-N-CA 120.44 -0.886 . . . . 0.0 112.164 -177.416 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 33.4 p90 -151.59 153.32 34.27 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 176.397 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -150.11 175.71 11.49 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-O 120.836 0.351 . . . . 0.0 110.818 -179.44 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -136.5 144.12 44.15 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 123.576 0.75 . . . . 0.0 110.003 -177.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.505 HD21 ' HB3' ' A' ' 57' ' ' PRO . 10.2 tt -150.38 141.59 23.17 Favored 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 176.065 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.51 ' HG2' ' HB3' ' A' ' 59' ' ' ASP . 22.0 ptmt -124.03 144.34 49.89 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-O 121.294 0.569 . . . . 0.0 109.516 178.584 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -107.6 165.92 11.06 Favored 'General case' 0 C--N 1.286 -2.177 0 CA-C-N 115.406 -0.815 . . . . 0.0 111.683 -178.019 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -75.32 -29.05 59.9 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 115.002 -0.999 . . . . 0.0 108.77 172.536 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -119.63 136.72 54.27 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 -176.787 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 19.8 mp0 -69.77 -27.61 65.07 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.467 ' O ' HG12 ' A' ' 86' ' ' ILE . 90.0 mtm180 -65.61 -33.85 76.87 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 122.301 1.048 . . . . 0.0 110.032 179.0 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.45 ' OG ' HG21 ' B' ' 226' ' ' ILE . 51.6 m -58.53 -37.14 75.02 Favored 'General case' 0 C--N 1.281 -2.379 0 CA-C-N 114.781 -1.1 . . . . 0.0 111.734 176.237 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.462 ' O ' HG23 ' A' ' 89' ' ' VAL . 43.9 p -63.33 -45.07 92.95 Favored 'General case' 0 C--N 1.347 0.487 0 C-N-CA 120.452 -0.499 . . . . 0.0 110.731 -178.482 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.467 HG12 ' O ' ' A' ' 83' ' ' ARG . 4.1 pt -66.64 -38.15 81.01 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.508 178.894 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 13.6 mt -59.4 -44.25 92.84 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 123.38 0.425 . . . . 0.0 111.28 175.437 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -71.74 -46.42 58.57 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.212 -178.586 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 85' ' ' THR . 69.6 t -56.93 -44.09 81.78 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.104 0 CA-C-O 121.297 0.57 . . . . 0.0 111.09 178.981 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -63.69 -41.53 98.13 Favored 'General case' 0 C--N 1.29 -1.996 0 C-N-CA 123.291 0.637 . . . . 0.0 112.239 -176.064 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 40.0 m-80 -90.28 -29.73 17.96 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-N 115.632 -0.713 . . . . 0.0 112.869 -173.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 15.2 mt -93.37 -31.18 14.74 Favored 'General case' 0 CA--C 1.486 -1.502 0 N-CA-C 112.257 0.466 . . . . 0.0 112.257 -172.631 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.417 ' OD1' ' HD2' ' A' ' 103' ' ' LYS . 56.9 t30 -66.32 124.6 23.13 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.039 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 89.19 -2.59 83.76 Favored Glycine 0 C--N 1.308 -1.004 0 C-N-CA 121.33 -0.462 . . . . 0.0 112.269 -178.895 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 37.2 t80 -89.23 134.98 33.82 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 -179.096 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.448 ' HA ' ' O ' ' A' ' 100' ' ' ARG . 12.1 mptt -95.42 116.38 28.72 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-O 120.914 0.388 . . . . 0.0 111.826 -177.67 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 60.6 mt -119.3 141.45 39.23 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 N-CA-C 104.946 -2.242 . . . . 0.0 104.946 172.856 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.472 ' HA3' ' ND2' ' A' ' 39' ' ' ASN . . . 58.19 28.02 60.92 Favored Glycine 0 C--N 1.317 -0.496 0 C-N-CA 121.331 -0.461 . . . . 0.0 112.646 -178.775 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 79.99 -5.84 61.19 Favored Glycine 0 CA--C 1.529 0.907 0 CA-C-O 119.933 -0.37 . . . . 0.0 113.863 -179.447 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.448 ' O ' ' HA ' ' A' ' 96' ' ' LYS . 16.6 ptp180 -116.43 149.71 39.0 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 117.721 0.76 . . . . 0.0 111.198 -176.311 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -88.44 117.2 27.2 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.537 -175.646 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.423 HD23 ' HA ' ' A' ' 102' ' ' LEU . 10.4 mt -65.71 136.07 55.78 Favored 'General case' 0 CA--C 1.494 -1.191 0 CA-C-O 121.491 0.663 . . . . 0.0 111.961 178.503 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.417 ' HD2' ' OD1' ' A' ' 93' ' ' ASN . 27.4 tptp -113.6 116.29 29.26 Favored 'General case' 0 N--CA 1.41 -2.45 0 CA-C-N 115.218 -0.901 . . . . 0.0 108.633 176.885 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.453 ' CD1' HG23 ' A' ' 35' ' ' ILE . 5.3 mm -111.02 142.32 23.75 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.192 0 N-CA-C 106.265 -1.754 . . . . 0.0 106.265 177.858 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -144.6 151.66 39.36 Favored 'General case' 0 C--N 1.29 -1.995 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 178.564 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 69.7 m-70 -83.42 130.53 35.04 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 175.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.532 HG21 ' HB2' ' A' ' 34' ' ' TYR . 6.2 t -153.79 165.19 36.79 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 -177.839 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -107.6 112.28 24.93 Favored 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 105.604 -1.999 . . . . 0.0 105.604 168.214 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 25.8 t80 -104.84 132.41 51.11 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 -175.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 19.4 mmm180 -117.4 115.28 37.88 Favored Pre-proline 0 C--N 1.295 -1.777 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 178.685 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -68.42 137.55 39.95 Favored 'Trans proline' 0 C--N 1.322 -0.855 0 C-N-CA 123.404 2.736 . . . . 0.0 114.222 -176.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 27.5 tptp -98.58 119.52 37.45 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.461 177.482 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 28.3 mmt180 . . . . . 0 C--N 1.3 -1.546 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 177.18 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 51.4 t-20 . . . . . 0 C--O 1.219 -0.531 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 223' ' ' ARG . . . . . . . . . . . . 0.258 9.8 ptm180 69.62 22.08 6.38 Favored 'General case' 0 N--CA 1.498 1.942 0 C-N-CA 127.95 2.5 . . . . 0.0 114.942 177.429 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 224' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -97.01 163.85 12.77 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 122.029 -0.419 . . . . 0.0 109.973 177.58 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 225' ' ' ALA . . . . . . . . . . . . . . . -137.05 84.58 2.07 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-O 121.85 0.833 . . . . 0.0 110.447 179.104 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 226' ' ' ILE . . . . . 0.45 HG21 ' OG ' ' A' ' 84' ' ' SER . 3.9 mp -124.0 137.49 56.86 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 177.369 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 227' ' ' MET . . . . . . . . . . . . . 67.5 mtt -70.24 133.55 87.47 Favored Pre-proline 0 C--N 1.309 -1.162 0 O-C-N 123.427 0.454 . . . . 0.0 110.306 178.523 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 228' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -68.05 154.36 72.77 Favored 'Trans proline' 0 C--O 1.245 0.851 0 C-N-CA 122.785 2.323 . . . . 0.0 112.272 -179.836 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . -72.44 168.2 52.85 Favored Glycine 0 N--CA 1.44 -1.04 0 CA-C-N 115.557 -0.747 . . . . 0.0 113.035 -179.731 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 5.0 p -77.44 -23.52 50.51 Favored 'General case' 0 C--N 1.298 -1.646 0 C-N-CA 123.431 0.692 . . . . 0.0 112.354 -177.889 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 1.8 mmp_? -79.33 1.88 23.5 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.729 -176.127 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 232' ' ' TRP . . . . . 0.43 ' HB2' ' CB ' ' A' ' 52' ' ' SER . 24.4 t90 -79.33 123.37 27.41 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 122.031 0.919 . . . . 0.0 111.908 -178.83 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 233' ' ' ASP . . . . . 0.494 ' H ' HG23 ' A' ' 49' ' ' THR . 12.8 t70 -113.2 149.35 33.83 Favored 'General case' 0 C--N 1.284 -2.271 0 N-CA-C 102.645 -3.094 . . . . 0.0 102.645 172.948 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -48.54 59.47 0.0 OUTLIER Glycine 0 N--CA 1.491 2.331 0 C-N-CA 127.53 2.49 . . . . 0.0 115.884 -178.101 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 235' ' ' VAL . . . . . 0.442 ' N ' ' O ' ' B' ' 233' ' ' ASP . 55.6 t -111.59 123.6 67.57 Favored 'Isoleucine or valine' 0 C--N 1.25 -3.725 0 C-N-CA 128.884 2.874 . . . . 0.0 106.194 175.007 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 236' ' ' HIS . . . . . . . . . . . . . 47.5 t60 -110.81 125.02 53.13 Favored 'General case' 0 C--N 1.28 -2.425 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.352 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 237' ' ' ARG . . . . . 0.761 ' HG3' HG13 ' A' ' 50' ' ' VAL . 31.6 mmt180 -127.45 109.59 11.9 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-O 121.132 0.491 . . . . 0.0 109.792 178.643 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 238' ' ' SER . . . . . . . . . . . . . 21.1 t -129.26 154.12 47.12 Favored 'General case' 0 C--N 1.285 -2.202 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 -178.573 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 239' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -27.74 104.33 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 126.123 1.769 . . . . 0.0 112.509 -176.481 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 240' ' ' GLY . . . . . 0.606 ' O ' ' HG2' ' B' ' 244' ' ' LYS . . . -68.56 -39.05 86.98 Favored Glycine 0 C--O 1.191 -2.546 0 CA-C-N 115.059 -0.973 . . . . 0.0 112.083 -177.126 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -61.89 -33.08 73.56 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 116.914 0.357 . . . . 0.0 111.618 -179.815 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -60.34 -44.88 95.11 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.307 -175.799 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 243' ' ' GLU . . . . . 0.473 ' HG2' ' O ' ' B' ' 240' ' ' GLY . 9.8 pt-20 -67.59 -35.46 79.03 Favored 'General case' 0 C--O 1.201 -1.472 0 C-N-CA 120.799 -0.36 . . . . 0.0 110.543 179.532 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 244' ' ' LYS . . . . . 0.606 ' HG2' ' O ' ' B' ' 240' ' ' GLY . 67.7 mmtt -68.1 -42.15 80.73 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-O 121.004 0.431 . . . . 0.0 110.408 -176.497 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 245' ' ' TRP . . . . . . . . . . . . . 50.9 m0 -63.39 -43.04 98.72 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 178.545 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 246' ' ' PHE . . . . . 0.425 ' O ' ' HG2' ' B' ' 249' ' ' GLN . 5.5 t80 -67.14 -33.21 74.94 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 114.866 -1.061 . . . . 0.0 110.869 178.237 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -77.21 -21.4 53.92 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.98 -177.412 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.33 -30.04 13.64 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 119.934 -0.706 . . . . 0.0 110.806 179.255 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 249' ' ' GLN . . . . . 0.425 ' HG2' ' O ' ' B' ' 246' ' ' PHE . 13.6 pt20 -68.52 -12.19 60.9 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.074 -176.889 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 250' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -57.39 -30.13 64.65 Favored 'General case' 0 N--CA 1.482 1.153 0 CA-C-N 115.538 -0.755 . . . . 0.0 112.093 177.968 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -117.39 166.85 11.83 Favored 'General case' 0 N--CA 1.414 -2.261 0 CA-C-N 115.412 -0.813 . . . . 0.0 112.836 -175.826 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 252' ' ' ILE . . . . . . . . . . . . . 32.3 pt -126.26 -27.66 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 CA-C-N 113.879 -1.51 . . . . 0.0 109.8 176.898 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -125.99 -34.0 2.62 Favored 'General case' 0 C--O 1.221 -0.397 0 N-CA-C 113.356 0.872 . . . . 0.0 113.356 -175.908 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 254' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -77.03 165.98 23.91 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 113.963 1.098 . . . . 0.0 113.963 -179.097 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 255' ' ' LYS . . . . . . . . . . . . . 56.8 mttp -97.54 75.89 2.5 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 114.22 1.192 . . . . 0.0 114.22 -167.736 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 256' ' ' LYS . . . . . . . . . . . . . 1.9 ttpm? . . . . . 0 C--O 1.253 1.239 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 171.209 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.512 ' HB2' ' NE2' ' A' ' 82' ' ' GLN . . . . . . . . 0 N--CA 1.452 -0.357 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -108.9 145.67 35.01 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 115.056 -0.974 . . . . 0.0 109.049 -173.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 26.7 pt -142.57 163.1 18.14 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 CA-C-O 121.408 0.623 . . . . 0.0 111.045 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.424 ' HB2' HG21 ' A' ' 107' ' ' THR . 17.7 t80 -114.52 127.07 55.61 Favored 'General case' 0 N--CA 1.415 -2.188 0 CA-C-N 114.383 -1.281 . . . . 0.0 108.787 176.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.485 HG23 ' CD1' ' A' ' 104' ' ' ILE . 9.5 mt -110.09 127.79 66.75 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.795 0 N-CA-C 107.335 -1.358 . . . . 0.0 107.335 177.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -127.43 165.69 20.45 Favored Glycine 0 C--N 1.284 -2.314 0 N-CA-C 110.607 -0.997 . . . . 0.0 110.607 179.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 71.7 m-20 72.18 40.58 0.69 Allowed 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.742 1.217 . . . . 0.0 110.038 -178.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.521 HD11 HD11 ' A' ' 47' ' ' ILE . 3.9 mm? -72.71 144.84 47.53 Favored 'General case' 0 CA--C 1.495 -1.153 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.551 178.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.461 ' HB3' ' HG ' ' A' ' 42' ' ' LEU . 42.0 t-20 -83.13 146.09 28.85 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 106.549 -1.649 . . . . 0.0 106.549 176.673 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.525 ' HD2' ' N ' ' A' ' 41' ' ' GLU . 5.8 ppt_? -60.76 -19.22 58.74 Favored 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 123.3 0.64 . . . . 0.0 112.051 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.525 ' N ' ' HD2' ' A' ' 40' ' ' ARG . 8.9 pt-20 -99.99 5.66 45.13 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.965 -178.046 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.461 ' HG ' ' HB3' ' A' ' 39' ' ' ASN . 71.1 mt -96.51 126.22 41.54 Favored 'General case' 0 C--N 1.309 -1.179 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.701 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 12.5 t -117.67 175.84 5.46 Favored 'General case' 0 N--CA 1.428 -1.53 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.18 -179.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.421 ' CG ' ' HB2' ' A' ' 62' ' ' LEU . 42.1 mt-10 -54.39 -39.62 67.41 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 123.743 0.817 . . . . 0.0 111.401 -176.014 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.87 -37.73 94.21 Favored Glycine 0 CA--C 1.521 0.417 0 C-N-CA 121.317 -0.468 . . . . 0.0 113.402 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -67.12 -49.17 65.84 Favored 'General case' 0 CA--C 1.499 -0.995 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.521 HD11 HD11 ' A' ' 38' ' ' LEU . 38.6 mt -61.01 -45.3 98.83 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.902 0 CA-C-N 114.861 -1.063 . . . . 0.0 110.854 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 38.1 mt -60.07 -45.75 91.86 Favored 'General case' 0 CA--C 1.494 -1.186 0 N-CA-C 111.676 0.25 . . . . 0.0 111.676 -176.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.479 HG23 ' H ' ' B' ' 233' ' ' ASP . 100.0 m -62.77 -45.59 91.99 Favored 'General case' 0 C--N 1.307 -1.263 0 O-C-N 123.551 0.532 . . . . 0.0 111.913 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.43 ' O ' ' HG2' ' A' ' 53' ' ' GLU . 54.6 t -66.13 -49.12 78.66 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.633 -179.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.462 ' HA ' ' HD2' ' A' ' 54' ' ' TYR . 3.7 m-85 -65.21 -23.03 66.97 Favored 'General case' 0 N--CA 1.425 -1.697 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.409 -178.124 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.491 ' OG ' ' HB2' ' B' ' 231' ' ' ARG . 58.7 m -69.35 -22.03 63.78 Favored 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 177.099 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.43 ' HG2' ' O ' ' A' ' 50' ' ' VAL . 7.8 pt-20 -73.52 -20.21 60.72 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 117.642 -1.623 . . . . 0.0 110.4 177.326 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.462 ' HD2' ' HA ' ' A' ' 51' ' ' PHE . 48.0 m-85 -92.36 -10.3 38.69 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-O 121.225 0.536 . . . . 0.0 111.135 -178.327 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 157.21 -154.9 25.93 Favored Glycine 0 N--CA 1.422 -2.296 0 C-N-CA 120.323 -0.941 . . . . 0.0 111.721 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 87.2 t -104.52 111.14 65.15 Favored Pre-proline 0 C--N 1.3 -1.557 0 N-CA-C 111.245 0.091 . . . . 0.0 111.245 -177.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.481 ' HB3' HD21 ' A' ' 77' ' ' LEU . 95.6 Cg_endo -79.84 137.34 12.52 Favored 'Trans proline' 0 N--CA 1.449 -1.133 0 C-N-CA 122.652 2.234 . . . . 0.0 109.676 175.325 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 30.7 m -111.76 -33.56 2.25 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 C-N-CA 119.355 -0.938 . . . . 0.0 111.553 179.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.467 ' HB3' ' HG2' ' A' ' 78' ' ' LYS . 29.3 t70 -146.13 145.59 30.55 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 -179.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 14.5 p -143.65 135.33 23.04 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.482 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 99.3 mt -121.05 118.76 57.26 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 175.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.431 HD12 ' HG3' ' A' ' 64' ' ' ARG . 0.1 OUTLIER -98.1 114.4 26.57 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 106.014 -1.847 . . . . 0.0 106.014 174.781 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 43.7 m -76.85 116.59 17.66 Favored 'General case' 0 N--CA 1.404 -2.773 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 178.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.431 ' HG3' HD12 ' A' ' 62' ' ' LEU . 34.1 mtm180 . . . . . 0 C--N 1.294 -1.811 0 CA-C-N 115.336 -0.847 . . . . 0.0 108.83 -176.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 . . . . . 0 CA--C 1.518 -0.265 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 84.71 8.95 82.07 Favored Glycine 0 C--N 1.308 -0.975 0 C-N-CA 120.926 -0.654 . . . . 0.0 113.569 179.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 36.7 p90 -154.98 157.79 38.21 Favored 'General case' 0 N--CA 1.436 -1.139 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 178.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -153.11 176.23 12.14 Favored 'General case' 0 N--CA 1.436 -1.143 0 O-C-N 123.556 0.535 . . . . 0.0 110.321 179.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -137.04 146.26 45.03 Favored 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 123.966 0.906 . . . . 0.0 109.856 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.481 HD21 ' HB3' ' A' ' 57' ' ' PRO . 10.0 tt -152.28 140.6 20.5 Favored 'General case' 0 N--CA 1.436 -1.143 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 175.128 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.467 ' HG2' ' HB3' ' A' ' 59' ' ' ASP . 18.8 ptmt -123.15 144.35 49.4 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 178.465 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 69.8 m-85 -102.47 164.88 11.42 Favored 'General case' 0 C--N 1.281 -2.378 0 CA-C-N 115.21 -0.905 . . . . 0.0 111.368 -178.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -79.1 -26.63 42.92 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 114.436 -1.256 . . . . 0.0 108.521 175.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -122.99 132.37 54.11 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.249 -175.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.512 ' NE2' ' HB2' ' A' ' 31' ' ' ALA . 15.9 mp0 -64.03 -30.33 71.41 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 179.547 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.88 -33.29 74.44 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-O 122.348 1.071 . . . . 0.0 110.353 -179.279 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 48.8 m -58.04 -36.47 72.8 Favored 'General case' 0 C--N 1.278 -2.511 0 CA-C-N 114.965 -1.016 . . . . 0.0 111.452 175.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.432 ' O ' HG23 ' A' ' 89' ' ' VAL . 36.9 p -63.91 -45.21 90.29 Favored 'General case' 0 C--O 1.213 -0.858 0 C-N-CA 120.332 -0.547 . . . . 0.0 110.9 -178.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 3.2 pt -64.94 -38.52 82.98 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.6 0 C-N-CA 122.391 0.276 . . . . 0.0 110.793 178.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 16.1 mt -59.09 -44.31 91.92 Favored 'General case' 0 CA--C 1.509 -0.601 0 O-C-N 123.659 0.599 . . . . 0.0 110.61 175.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.41 ' O ' ' HB2' ' A' ' 92' ' ' LEU . . . -72.92 -47.67 43.74 Favored 'General case' 0 N--CA 1.435 -1.195 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 179.464 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.471 HG22 HG22 ' A' ' 104' ' ' ILE . 72.4 t -59.26 -48.99 85.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 N-CA-C 112.127 0.418 . . . . 0.0 112.127 -176.325 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -73.27 -27.14 61.4 Favored 'General case' 0 C--N 1.294 -1.824 0 CA-C-O 121.466 0.65 . . . . 0.0 111.893 -172.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -91.59 -31.51 15.87 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.945 -177.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.443 ' HB2' HG13 ' A' ' 104' ' ' ILE . 9.9 mt -91.69 -29.7 16.7 Favored 'General case' 0 C--N 1.313 -1.006 0 C-N-CA 122.509 0.324 . . . . 0.0 111.566 -174.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 51.5 t-20 -65.49 124.72 23.06 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 86.9 -5.54 84.88 Favored Glycine 0 N--CA 1.435 -1.412 0 C-N-CA 121.256 -0.497 . . . . 0.0 112.568 179.213 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -85.7 139.04 31.69 Favored 'General case' 0 N--CA 1.44 -0.96 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 -178.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.494 ' HE3' ' HB2' ' A' ' 101' ' ' ALA . 11.7 mptt -94.6 119.18 32.85 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-O 121.056 0.455 . . . . 0.0 111.652 -176.41 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.431 HD12 HD12 ' A' ' 102' ' ' LEU . 54.2 mt -126.03 141.34 45.97 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 N-CA-C 106.144 -1.798 . . . . 0.0 106.144 174.162 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.431 ' HA3' HD22 ' A' ' 39' ' ' ASN . . . 59.22 21.23 53.02 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 121.539 -0.363 . . . . 0.0 113.345 -179.38 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 85.04 6.84 84.44 Favored Glycine 0 N--CA 1.435 -1.406 0 C-N-CA 121.27 -0.49 . . . . 0.0 113.335 -179.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 19.3 ptp180 -132.15 146.77 52.26 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 117.772 0.786 . . . . 0.0 111.668 179.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.494 ' HB2' ' HE3' ' A' ' 96' ' ' LYS . . . -80.1 118.03 21.45 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.59 -178.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.431 HD12 HD12 ' A' ' 97' ' ' ILE . 11.6 mt -70.76 144.64 50.84 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-O 121.604 0.716 . . . . 0.0 112.702 178.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 23.4 tptm -118.14 116.96 27.9 Favored 'General case' 0 N--CA 1.419 -1.981 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.141 177.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.485 ' CD1' HG23 ' A' ' 35' ' ' ILE . 5.7 mm -117.86 138.32 48.92 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 179.022 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -143.36 150.64 39.42 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 179.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 82.7 m-70 -83.23 133.81 34.98 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 178.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.424 HG21 ' HB2' ' A' ' 34' ' ' TYR . 7.3 t -154.66 152.95 30.57 Favored 'General case' 0 N--CA 1.423 -1.777 0 N-CA-C 107.262 -1.385 . . . . 0.0 107.262 -178.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 41.5 p90 -91.74 112.24 24.08 Favored 'General case' 0 N--CA 1.429 -1.517 0 N-CA-C 106.474 -1.676 . . . . 0.0 106.474 171.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 43.8 t80 . . . . . 0 C--N 1.28 -2.425 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 -179.441 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 4.6 mp . . . . . 0 N--CA 1.45 -0.473 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 227' ' ' MET . . . . . . . . . . . . . 65.6 mtt -81.85 135.08 49.08 Favored Pre-proline 0 C--N 1.305 -1.36 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.727 -178.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 228' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -57.2 148.64 68.79 Favored 'Trans proline' 0 C--O 1.255 1.341 0 C-N-CA 123.692 2.928 . . . . 0.0 114.419 -177.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . -74.07 170.87 52.93 Favored Glycine 0 N--CA 1.44 -1.05 0 CA-C-N 114.71 -1.132 . . . . 0.0 112.972 -179.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 18.9 m -77.71 -14.17 59.69 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 -172.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 231' ' ' ARG . . . . . 0.491 ' HB2' ' OG ' ' A' ' 52' ' ' SER . 10.7 mmm180 -84.93 -1.63 56.9 Favored 'General case' 0 C--N 1.32 -0.703 0 O-C-N 121.84 -0.537 . . . . 0.0 110.347 -179.229 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 232' ' ' TRP . . . . . . . . . . . . . 22.8 t90 -76.95 125.19 28.89 Favored 'General case' 0 N--CA 1.436 -1.161 0 CA-C-O 122.496 1.141 . . . . 0.0 112.599 -176.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 233' ' ' ASP . . . . . 0.479 ' H ' HG23 ' A' ' 49' ' ' THR . 16.0 t70 -120.59 148.19 44.21 Favored 'General case' 0 C--N 1.271 -2.846 0 N-CA-C 102.326 -3.213 . . . . 0.0 102.326 172.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.502 3.072 0 C-N-CA 128.312 2.863 . . . . 0.0 116.526 -176.939 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 240' ' ' GLY . . . . . 0.405 ' O ' ' HG2' ' B' ' 243' ' ' GLU . . . . . . . . 0 N--CA 1.426 -1.999 0 N-CA-C 110.624 -0.991 . . . . 0.0 110.624 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 20.7 p90 -76.29 -32.68 58.92 Favored 'General case' 0 C--N 1.297 -1.701 0 CA-C-O 121.045 0.45 . . . . 0.0 109.863 175.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -60.54 -39.23 87.15 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.934 -178.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 243' ' ' GLU . . . . . 0.405 ' HG2' ' O ' ' B' ' 240' ' ' GLY . 9.3 pt-20 -65.52 -34.99 79.55 Favored 'General case' 0 C--O 1.208 -1.128 0 C-N-CA 121.158 -0.217 . . . . 0.0 111.094 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 68.3 mmtt -68.0 -39.87 83.14 Favored 'General case' 0 CA--C 1.509 -0.616 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 -178.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 245' ' ' TRP . . . . . . . . . . . . . 51.0 m0 -65.95 -43.56 87.6 Favored 'General case' 0 N--CA 1.438 -1.044 0 CA-C-N 114.795 -1.093 . . . . 0.0 109.492 176.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 246' ' ' PHE . . . . . 0.528 ' O ' ' HG2' ' B' ' 249' ' ' GLN . 2.4 t80 -61.98 -39.85 93.59 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.215 178.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.96 -33.71 76.33 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.928 -178.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.69 -17.37 20.38 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -178.101 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 249' ' ' GLN . . . . . 0.528 ' HG2' ' O ' ' B' ' 246' ' ' PHE . 2.2 pt20 -80.04 3.44 20.24 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 177.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 250' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -51.45 -28.76 14.01 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.873 1.269 . . . . 0.0 112.094 -179.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 251' ' ' GLU . . . . . 0.415 ' HG3' ' HB3' ' B' ' 254' ' ' GLU . 8.4 mm-40 -58.59 150.48 22.93 Favored 'General case' 0 N--CA 1.426 -1.63 0 N-CA-C 115.272 1.582 . . . . 0.0 115.272 -179.427 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 252' ' ' ILE . . . . . . . . . . . . . 31.7 pt -110.17 -29.32 2.49 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 CA-C-N 113.829 -1.532 . . . . 0.0 109.905 -178.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -115.82 -34.71 4.71 Favored 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 120.233 -0.587 . . . . 0.0 110.511 -178.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 254' ' ' GLU . . . . . 0.415 ' HB3' ' HG3' ' B' ' 251' ' ' GLU . 5.2 tt0 . . . . . 0 N--CA 1.436 -1.15 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.777 -174.202 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.568 ' HA ' HG21 ' A' ' 85' ' ' THR . . . . . . . . 0 N--CA 1.438 -1.032 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 -100.95 144.54 29.77 Favored 'General case' 0 N--CA 1.436 -1.14 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 -177.397 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 26.9 pt -142.85 156.68 17.96 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 CA-C-O 121.151 0.5 . . . . 0.0 110.224 178.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.408 ' HB2' HG21 ' A' ' 107' ' ' THR . 20.4 t80 -108.45 124.32 50.22 Favored 'General case' 0 C--N 1.285 -2.229 0 CA-C-N 114.566 -1.197 . . . . 0.0 108.624 177.043 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.437 HG23 ' CD1' ' A' ' 104' ' ' ILE . 10.3 mt -108.28 127.52 64.51 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.935 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 175.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -124.65 157.91 19.05 Favored Glycine 0 C--N 1.279 -2.599 0 N-CA-C 111.155 -0.778 . . . . 0.0 111.155 -179.249 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 50.6 m-20 68.35 70.12 0.31 Allowed 'General case' 0 C--N 1.31 -1.133 0 C-N-CA 125.745 1.618 . . . . 0.0 109.908 -177.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.402 HD11 HD11 ' A' ' 47' ' ' ILE . 2.9 mm? -100.6 141.47 33.41 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 115.114 -0.948 . . . . 0.0 111.846 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.449 ' HB2' ' NH1' ' A' ' 100' ' ' ARG . 39.1 t-20 -76.41 144.21 40.15 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 174.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.434 ' C ' ' HD2' ' A' ' 40' ' ' ARG . 0.9 OUTLIER -59.46 -26.24 65.06 Favored 'General case' 0 C--N 1.312 -1.061 0 C-N-CA 123.278 0.631 . . . . 0.0 111.665 179.057 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.401 ' HG2' ' CG ' ' A' ' 39' ' ' ASN . 13.0 pt-20 -85.98 -0.89 56.63 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.383 -0.372 . . . . 0.0 111.767 -176.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.433 ' HG ' ' HB3' ' A' ' 39' ' ' ASN . 87.6 mt -94.3 127.38 40.13 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-O 121.081 0.467 . . . . 0.0 110.882 -179.649 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 63.2 p -116.52 175.03 5.75 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-N 115.072 -0.967 . . . . 0.0 108.678 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.401 ' HG3' ' HB2' ' A' ' 62' ' ' LEU . 5.8 mp0 -54.2 -40.6 67.74 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 122.716 0.406 . . . . 0.0 110.983 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -59.07 -38.08 92.51 Favored Glycine 0 N--CA 1.449 -0.498 0 CA-C-N 116.384 -0.371 . . . . 0.0 113.183 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -68.05 -49.23 62.64 Favored 'General case' 0 CA--C 1.496 -1.096 0 CA-C-O 121.022 0.439 . . . . 0.0 109.852 179.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.402 HD11 HD11 ' A' ' 38' ' ' LEU . 26.3 mt -60.31 -41.04 85.69 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.559 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.639 179.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 57.1 mt -59.52 -42.44 92.25 Favored 'General case' 0 C--O 1.206 -1.189 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.095 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 90.7 m -61.47 -46.01 91.86 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 120.842 0.353 . . . . 0.0 111.458 179.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 97.8 t -67.1 -49.04 76.86 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.77 -179.204 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.453 ' HA ' ' HD2' ' A' ' 54' ' ' TYR . 3.3 m-85 -67.89 -24.15 65.19 Favored 'General case' 0 N--CA 1.426 -1.627 0 CA-C-N 115.423 -0.808 . . . . 0.0 112.558 -176.365 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.466 ' OG ' ' HB2' ' B' ' 231' ' ' ARG . 66.1 m -68.93 -19.56 64.19 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 116.188 -0.46 . . . . 0.0 112.059 176.344 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -67.08 -29.13 68.82 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 176.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.453 ' HD2' ' HA ' ' A' ' 51' ' ' PHE . 75.6 m-85 -89.93 -23.2 21.65 Favored 'General case' 0 N--CA 1.441 -0.897 0 CA-C-N 115.899 -0.591 . . . . 0.0 112.245 -174.58 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 171.54 -152.57 18.1 Favored Glycine 0 N--CA 1.426 -1.985 0 N-CA-C 111.312 -0.715 . . . . 0.0 111.312 179.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 86.7 t -106.62 112.87 63.48 Favored Pre-proline 0 C--N 1.297 -1.674 0 CA-C-O 120.793 0.33 . . . . 0.0 110.376 -178.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.487 ' HB3' HD21 ' A' ' 77' ' ' LEU . 88.6 Cg_endo -80.47 136.78 11.29 Favored 'Trans proline' 0 N--CA 1.442 -1.543 0 C-N-CA 122.371 2.047 . . . . 0.0 110.439 176.287 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 28.4 m -111.17 -28.32 2.63 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 C-N-CA 120.022 -0.671 . . . . 0.0 111.469 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.435 ' HB3' ' HG2' ' A' ' 78' ' ' LYS . 26.2 t70 -152.16 145.05 24.41 Favored 'General case' 0 CA--C 1.498 -1.043 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 178.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 10.7 p -145.95 135.45 17.53 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 123.775 0.672 . . . . 0.0 110.006 -178.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 94.1 mt -121.38 121.94 66.0 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 175.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.401 ' HB2' ' HG3' ' A' ' 44' ' ' GLU . 0.2 OUTLIER -98.24 117.94 33.76 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 104.988 -2.226 . . . . 0.0 104.988 174.162 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 69.8 m -71.66 116.09 11.62 Favored 'General case' 0 N--CA 1.405 -2.681 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 177.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 43.3 mtm180 . . . . . 0 C--N 1.295 -1.786 0 CA-C-N 115.34 -0.845 . . . . 0.0 108.844 -177.347 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 . . . . . 0 N--CA 1.449 -0.485 0 CA-C-O 121.675 0.75 . . . . 0.0 109.779 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 90.78 15.73 55.98 Favored Glycine 0 N--CA 1.426 -1.995 0 CA-C-N 114.915 -1.039 . . . . 0.0 112.993 176.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 33.7 p90 -155.35 163.1 40.55 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 177.233 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -155.6 176.14 12.99 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-O 121.095 0.474 . . . . 0.0 111.228 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -137.64 146.0 43.38 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 124.334 1.054 . . . . 0.0 109.965 179.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.487 HD21 ' HB3' ' A' ' 57' ' ' PRO . 9.8 tt -151.88 140.86 21.13 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 175.517 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.435 ' HG2' ' HB3' ' A' ' 59' ' ' ASP . 20.1 ptmt -121.76 144.09 49.0 Favored 'General case' 0 C--O 1.257 1.482 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 178.162 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 50.2 m-85 -103.89 164.72 11.51 Favored 'General case' 0 C--N 1.288 -2.072 0 CA-C-N 115.595 -0.729 . . . . 0.0 111.688 -178.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -69.77 -39.52 76.62 Favored 'General case' 0 N--CA 1.429 -1.522 0 CA-C-N 114.388 -1.278 . . . . 0.0 108.665 174.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.41 ' OD2' ' HB2' ' A' ' 83' ' ' ARG . 26.6 t70 -124.13 140.0 53.39 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.932 -176.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 -69.46 -19.75 63.76 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 115.187 1.551 . . . . 0.0 115.187 -178.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.41 ' HB2' ' OD2' ' A' ' 81' ' ' ASP . 0.0 OUTLIER -67.23 -33.91 76.34 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-O 122.175 0.988 . . . . 0.0 109.743 173.382 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.46 ' OG ' HG21 ' B' ' 226' ' ' ILE . 45.8 m -65.31 -36.91 85.5 Favored 'General case' 0 C--N 1.289 -2.062 0 CA-C-N 115.06 -0.973 . . . . 0.0 112.199 177.652 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.568 HG21 ' HA ' ' A' ' 31' ' ' ALA . 68.6 p -64.7 -45.59 85.96 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 120.26 -0.576 . . . . 0.0 110.841 -177.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 5.3 pt -63.51 -38.65 82.78 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.249 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.754 176.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 19.5 mt -58.79 -43.86 90.57 Favored 'General case' 0 C--O 1.247 0.969 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.302 176.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -71.53 -46.8 58.6 Favored 'General case' 0 N--CA 1.438 -1.067 0 CA-C-N 115.573 -0.739 . . . . 0.0 111.56 -179.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.45 HG22 HG22 ' A' ' 104' ' ' ILE . 75.8 t -57.88 -48.07 84.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-O 121.072 0.463 . . . . 0.0 111.113 -179.344 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -62.09 -32.83 73.43 Favored 'General case' 0 C--N 1.296 -1.744 0 CA-C-N 115.047 -0.979 . . . . 0.0 112.003 -173.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 36.7 m-80 -97.98 -25.08 15.1 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 113.367 0.877 . . . . 0.0 113.367 -178.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 15.4 mt -96.33 -31.29 12.96 Favored 'General case' 0 CA--C 1.484 -1.568 0 CA-C-O 120.898 0.38 . . . . 0.0 111.875 -172.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 57.7 t30 -66.51 125.28 25.21 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 -179.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 82.94 -1.12 89.15 Favored Glycine 0 N--CA 1.444 -0.821 0 O-C-N 123.414 0.446 . . . . 0.0 112.556 179.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 82.7 t80 -88.05 143.75 26.9 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 -178.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.426 ' HE3' ' HB2' ' A' ' 101' ' ' ALA . 11.5 mptt -96.9 118.7 33.91 Favored 'General case' 0 N--CA 1.436 -1.151 0 CA-C-O 121.088 0.47 . . . . 0.0 111.27 -177.143 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 53.1 mt -124.53 141.73 43.69 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 N-CA-C 105.098 -2.186 . . . . 0.0 105.098 173.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 56.93 29.27 58.82 Favored Glycine 0 C--O 1.22 -0.727 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.702 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 76.55 2.1 73.67 Favored Glycine 0 CA--C 1.537 1.455 0 C-N-CA 121.71 -0.281 . . . . 0.0 113.8 -179.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.449 ' NH1' ' HB2' ' A' ' 39' ' ' ASN . 0.2 OUTLIER -124.37 143.77 50.41 Favored 'General case' 0 C--N 1.316 -0.868 0 O-C-N 122.176 -0.603 . . . . 0.0 111.543 -177.125 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.426 ' HB2' ' HE3' ' A' ' 96' ' ' LYS . . . -87.23 118.45 26.65 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.644 -177.252 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 11.9 mt -70.22 147.92 49.23 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 115.431 -0.804 . . . . 0.0 112.513 179.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 59.3 tptt -120.83 116.23 24.8 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 175.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.45 HG22 HG22 ' A' ' 89' ' ' VAL . 4.7 mm -119.41 131.01 73.25 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.809 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 179.326 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -144.01 151.02 39.14 Favored 'General case' 0 C--N 1.285 -2.202 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 179.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 28.8 m-70 -78.68 135.03 37.07 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 178.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.408 HG21 ' HB2' ' A' ' 34' ' ' TYR . 12.0 t -149.59 161.51 42.03 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 106.199 -1.778 . . . . 0.0 106.199 -177.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -103.62 110.15 22.11 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 174.151 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 28.1 t80 . . . . . 0 C--N 1.294 -1.835 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.389 -176.426 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 226' ' ' ILE . . . . . 0.46 HG21 ' OG ' ' A' ' 84' ' ' SER . 4.2 mp . . . . . 0 CA--C 1.503 -0.832 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 227' ' ' MET . . . . . . . . . . . . . 26.6 mmt -78.65 144.3 64.74 Favored Pre-proline 0 C--N 1.295 -1.802 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.721 178.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 228' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -68.57 160.64 48.51 Favored 'Trans proline' 0 C--O 1.248 0.984 0 C-N-CA 123.211 2.607 . . . . 0.0 113.673 -176.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . -82.77 172.86 52.22 Favored Glycine 0 N--CA 1.442 -0.927 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.991 178.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 14.8 m -74.76 -17.49 60.63 Favored 'General case' 0 C--N 1.307 -1.248 0 C-N-CA 123.29 0.636 . . . . 0.0 112.502 -175.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 231' ' ' ARG . . . . . 0.466 ' HB2' ' OG ' ' A' ' 52' ' ' SER . 23.0 mmm180 -79.75 -11.48 59.84 Favored 'General case' 0 CA--C 1.5 -0.949 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -179.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 232' ' ' TRP . . . . . . . . . . . . . 21.3 t90 -69.28 121.55 17.07 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-O 122.334 1.064 . . . . 0.0 111.922 -178.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 233' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -116.77 149.11 40.46 Favored 'General case' 0 C--N 1.278 -2.543 0 N-CA-C 102.486 -3.154 . . . . 0.0 102.486 171.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.501 2.998 0 C-N-CA 128.114 2.769 . . . . 0.0 116.919 -177.987 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 240' ' ' GLY . . . . . 0.471 ' O ' ' HG2' ' B' ' 244' ' ' LYS . . . . . . . . 0 N--CA 1.431 -1.672 0 N-CA-C 109.03 -1.628 . . . . 0.0 109.03 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 22.9 p90 -73.2 -33.26 65.28 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 -176.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -59.66 -47.43 85.63 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 120.731 -0.388 . . . . 0.0 111.362 -177.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -61.36 -34.99 76.22 Favored 'General case' 0 C--O 1.21 -1.015 0 O-C-N 123.659 0.599 . . . . 0.0 112.045 -179.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 244' ' ' LYS . . . . . 0.471 ' HG2' ' O ' ' B' ' 240' ' ' GLY . 43.6 mmtm -64.33 -48.39 75.77 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.248 0.547 . . . . 0.0 110.186 -178.37 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 245' ' ' TRP . . . . . . . . . . . . . 24.9 m0 -67.29 -37.69 83.83 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.103 179.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 246' ' ' PHE . . . . . 0.504 ' O ' ' HG2' ' B' ' 249' ' ' GLN . 2.4 t80 -65.04 -35.21 80.43 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.554 177.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -70.5 -36.33 73.72 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.656 -178.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.5 -14.09 36.03 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 120.974 0.416 . . . . 0.0 111.703 -177.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 249' ' ' GLN . . . . . 0.504 ' HG2' ' O ' ' B' ' 246' ' ' PHE . 2.6 pt20 -84.79 3.74 36.23 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 109.192 -0.669 . . . . 0.0 109.192 177.007 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 250' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -50.35 -32.09 16.38 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 114.788 -1.096 . . . . 0.0 111.938 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -64.7 123.76 20.16 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.578 -178.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 252' ' ' ILE . . . . . . . . . . . . . 27.5 pt -98.63 -31.98 3.76 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 CA-C-O 121.274 0.559 . . . . 0.0 111.937 -177.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -89.86 -16.9 29.12 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-O 121.584 0.706 . . . . 0.0 109.71 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 254' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 . . . . . 0 C--N 1.293 -1.888 0 CA-C-N 114.691 -1.14 . . . . 0.0 108.799 179.888 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.737 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 12.6 m-85 -108.24 144.89 35.1 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.217 -175.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 26.4 pt -139.47 155.51 25.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 CA-C-O 121.3 0.572 . . . . 0.0 110.374 176.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 50.9 t80 -106.38 123.1 47.54 Favored 'General case' 0 N--CA 1.411 -2.396 0 CA-C-N 114.31 -1.314 . . . . 0.0 107.772 177.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.441 HG23 ' CD1' ' A' ' 104' ' ' ILE . 8.1 mt -108.67 127.9 64.8 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.098 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 175.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -129.97 164.38 22.68 Favored Glycine 0 C--N 1.278 -2.685 0 N-CA-C 110.806 -0.918 . . . . 0.0 110.806 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 72.67 34.16 1.24 Allowed 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.92 1.288 . . . . 0.0 110.982 -179.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.41 HD11 HD11 ' A' ' 47' ' ' ILE . 4.1 mm? -64.57 146.33 54.78 Favored 'General case' 0 CA--C 1.497 -1.064 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.031 176.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.479 ' HB3' ' HG ' ' A' ' 42' ' ' LEU . 60.7 t30 -84.27 139.6 32.23 Favored 'General case' 0 C--N 1.289 -2.062 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 176.571 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.424 ' C ' ' HD2' ' A' ' 40' ' ' ARG . 6.9 ppt_? -58.53 -16.83 17.15 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 113.556 0.947 . . . . 0.0 113.556 -174.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -100.85 0.24 38.19 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -178.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.479 ' HG ' ' HB3' ' A' ' 39' ' ' ASN . 57.4 mt -80.94 128.66 33.93 Favored 'General case' 0 C--O 1.245 0.823 0 CA-C-O 121.235 0.541 . . . . 0.0 111.223 178.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 72.4 p -108.37 173.07 6.48 Favored 'General case' 0 N--CA 1.425 -1.708 0 CA-C-N 114.657 -1.156 . . . . 0.0 109.977 -177.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.58 ' HG3' ' HB2' ' A' ' 62' ' ' LEU . 2.3 mp0 -56.0 -43.1 77.36 Favored 'General case' 0 C--N 1.316 -0.886 0 C-N-CA 124.061 0.944 . . . . 0.0 110.824 178.361 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -62.62 -35.38 91.75 Favored Glycine 0 C--O 1.24 0.525 0 CA-C-N 115.867 -0.606 . . . . 0.0 112.557 -179.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 39.2 m-20 -64.84 -48.99 72.35 Favored 'General case' 0 CA--C 1.49 -1.337 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 178.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.41 HD11 HD11 ' A' ' 38' ' ' LEU . 52.5 mt -61.54 -48.03 90.64 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.856 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.402 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 40.1 mt -59.98 -42.44 94.19 Favored 'General case' 0 CA--C 1.494 -1.189 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.805 -176.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.432 HG23 ' H ' ' B' ' 233' ' ' ASP . 90.0 m -63.55 -45.9 88.38 Favored 'General case' 0 C--N 1.309 -1.191 0 O-C-N 123.456 0.473 . . . . 0.0 111.225 -179.095 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 98.1 t -67.69 -46.33 82.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.769 -178.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -66.12 -24.33 66.66 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.952 -178.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.532 ' OG ' ' HB2' ' B' ' 231' ' ' ARG . 70.2 m -70.81 -19.1 62.71 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.943 175.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -72.64 -27.2 61.99 Favored 'General case' 0 CA--C 1.551 1.009 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 177.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 58.3 m-85 -89.98 -16.45 29.84 Favored 'General case' 0 CA--C 1.511 -0.539 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.888 -177.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.419 ' O ' ' HA ' ' A' ' 52' ' ' SER . . . 163.13 -153.47 24.01 Favored Glycine 0 N--CA 1.417 -2.615 0 C-N-CA 120.325 -0.94 . . . . 0.0 111.738 178.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 59.7 t -105.23 107.65 59.5 Favored Pre-proline 0 C--N 1.294 -1.83 0 CA-C-N 116.105 -0.048 . . . . 0.0 110.92 -176.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.491 ' HB3' HD21 ' A' ' 77' ' ' LEU . 97.5 Cg_endo -78.51 136.97 14.31 Favored 'Trans proline' 0 N--CA 1.448 -1.161 0 C-N-CA 122.698 2.266 . . . . 0.0 110.194 176.126 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 35.5 m -112.86 -27.39 2.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 C-N-CA 119.84 -0.744 . . . . 0.0 111.601 -178.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.52 ' HB3' ' HG2' ' A' ' 78' ' ' LYS . 38.8 t70 -152.01 144.33 24.02 Favored 'General case' 0 CA--C 1.5 -0.952 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -179.197 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 13.0 p -145.38 134.73 17.88 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 179.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 91.2 mt -121.07 121.75 65.81 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 175.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.58 ' HB2' ' HG3' ' A' ' 44' ' ' GLU . 0.1 OUTLIER -94.58 115.91 28.13 Favored 'General case' 0 N--CA 1.422 -1.872 0 N-CA-C 105.838 -1.912 . . . . 0.0 105.838 176.039 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 11.3 m -76.89 116.93 18.0 Favored 'General case' 0 N--CA 1.409 -2.485 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 178.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.401 HH11 ' HD3' ' A' ' 64' ' ' ARG . 53.8 mtt180 . . . . . 0 C--N 1.298 -1.651 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.752 -177.256 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 14.1 mm-40 . . . . . 0 CA--C 1.507 -0.7 0 CA-C-O 121.055 0.455 . . . . 0.0 112.056 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 113.44 7.2 20.96 Favored Glycine 0 N--CA 1.427 -1.953 0 C-N-CA 119.888 -1.148 . . . . 0.0 111.423 -175.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 31.4 p90 -151.02 156.76 41.79 Favored 'General case' 0 N--CA 1.427 -1.584 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 178.223 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -154.64 174.6 14.76 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 123.647 0.592 . . . . 0.0 110.09 178.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -132.17 141.16 49.0 Favored 'General case' 0 C--N 1.305 -1.362 0 C-N-CA 123.605 0.762 . . . . 0.0 110.076 -178.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.491 HD21 ' HB3' ' A' ' 57' ' ' PRO . 9.7 tt -148.08 140.72 24.57 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 175.372 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.52 ' HG2' ' HB3' ' A' ' 59' ' ' ASP . 21.2 ptmt -123.55 144.5 49.53 Favored 'General case' 0 C--O 1.258 1.551 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 178.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 59.2 m-85 -105.83 164.42 11.95 Favored 'General case' 0 C--N 1.288 -2.079 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.011 -179.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -80.15 -33.84 38.14 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 114.88 -1.055 . . . . 0.0 108.763 175.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -111.96 129.31 56.23 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -177.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -70.03 -20.42 63.25 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 113.883 1.068 . . . . 0.0 113.883 -178.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.76 -33.39 75.52 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 122.193 0.997 . . . . 0.0 109.448 174.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.4 ' OG ' ' HA3' ' A' ' 55' ' ' GLY . 63.7 m -64.13 -37.06 86.1 Favored 'General case' 0 C--N 1.292 -1.906 0 CA-C-N 115.184 -0.916 . . . . 0.0 112.901 178.445 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 68.6 p -64.68 -45.45 86.64 Favored 'General case' 0 C--N 1.346 0.43 0 C-N-CA 120.469 -0.493 . . . . 0.0 110.818 -177.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 4.0 pt -65.08 -39.1 84.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.759 177.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 12.2 mt -59.47 -43.51 93.22 Favored 'General case' 0 CA--C 1.505 -0.784 0 O-C-N 123.35 0.406 . . . . 0.0 111.703 176.028 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -69.35 -45.99 68.09 Favored 'General case' 0 N--CA 1.428 -1.555 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.739 -178.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.439 HG22 HG22 ' A' ' 104' ' ' ILE . 86.8 t -58.76 -45.28 91.3 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.134 0 CA-C-O 121.21 0.529 . . . . 0.0 110.643 177.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -58.91 -37.63 77.07 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 125.103 1.361 . . . . 0.0 112.321 -178.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 41.5 m-80 -98.17 -26.67 14.48 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 -176.002 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.465 ' HB2' HG13 ' A' ' 104' ' ' ILE . 19.0 mt -96.13 -30.82 13.31 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -172.489 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -65.84 123.92 21.09 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 88.48 -12.2 65.78 Favored Glycine 0 CA--C 1.53 1.012 0 CA-C-N 116.026 -0.534 . . . . 0.0 112.422 -178.066 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 73.4 t80 -79.73 138.0 37.19 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 -176.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.45 ' HE2' ' HB2' ' A' ' 101' ' ' ALA . 0.3 OUTLIER -95.66 123.28 39.15 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 112.111 0.411 . . . . 0.0 112.111 -177.035 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 59.4 mt -128.15 142.12 44.65 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 N-CA-C 105.737 -1.949 . . . . 0.0 105.737 173.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 64.14 14.32 55.99 Favored Glycine 0 C--N 1.319 -0.416 0 C-N-CA 121.262 -0.494 . . . . 0.0 112.701 -178.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 90.31 -1.18 79.25 Favored Glycine 0 N--CA 1.43 -1.73 0 CA-C-O 119.923 -0.376 . . . . 0.0 112.731 -178.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.443 ' O ' ' HA ' ' A' ' 96' ' ' LYS . 11.4 ptp180 -124.22 151.34 44.22 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 117.714 0.757 . . . . 0.0 111.96 -177.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.45 ' HB2' ' HE2' ' A' ' 96' ' ' LYS . . . -86.54 116.35 24.62 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -175.39 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 11.9 mt -65.61 148.72 51.27 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.469 -0.787 . . . . 0.0 112.56 178.096 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 57.7 tptt -122.12 118.06 27.76 Favored 'General case' 0 N--CA 1.422 -1.846 0 CA-C-N 115.14 -0.936 . . . . 0.0 108.663 175.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.465 HG13 ' HB2' ' A' ' 92' ' ' LEU . 4.3 mm -117.61 135.4 58.13 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 N-CA-C 107.143 -1.428 . . . . 0.0 107.143 178.515 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -143.94 149.71 37.24 Favored 'General case' 0 C--N 1.285 -2.229 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 -178.016 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 45.2 m-70 -81.56 131.17 35.26 Favored 'General case' 0 C--N 1.29 -1.981 0 N-CA-C 109.487 -0.561 . . . . 0.0 109.487 178.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 12.5 t -145.35 165.82 27.37 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 -177.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -110.16 109.77 20.4 Favored 'General case' 0 N--CA 1.428 -1.568 0 N-CA-C 106.649 -1.611 . . . . 0.0 106.649 174.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 35.6 t80 . . . . . 0 C--N 1.305 -1.341 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.719 -176.984 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 4.1 mp . . . . . 0 N--CA 1.448 -0.544 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 227' ' ' MET . . . . . . . . . . . . . 91.4 mtp -70.35 137.7 86.51 Favored Pre-proline 0 C--N 1.313 -0.994 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 177.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 228' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -64.75 157.02 58.33 Favored 'Trans proline' 0 C--O 1.251 1.166 0 C-N-CA 123.398 2.732 . . . . 0.0 113.489 -176.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . -74.75 168.68 54.63 Favored Glycine 0 N--CA 1.435 -1.409 0 CA-C-N 115.122 -0.945 . . . . 0.0 111.83 178.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 15.0 m -75.04 -16.8 60.58 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 111.856 0.317 . . . . 0.0 111.856 -175.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 231' ' ' ARG . . . . . 0.532 ' HB2' ' OG ' ' A' ' 52' ' ' SER . 26.6 mmt180 -79.2 -10.21 59.76 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.933 0.397 . . . . 0.0 110.261 -177.627 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 232' ' ' TRP . . . . . . . . . . . . . 25.4 t90 -70.13 130.07 41.1 Favored 'General case' 0 N--CA 1.432 -1.329 0 CA-C-O 122.481 1.134 . . . . 0.0 112.059 -178.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 233' ' ' ASP . . . . . 0.432 ' H ' HG23 ' A' ' 49' ' ' THR . 22.8 t70 -124.03 139.45 53.93 Favored 'General case' 0 C--N 1.269 -2.906 0 N-CA-C 101.934 -3.358 . . . . 0.0 101.934 171.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.508 3.437 0 C-N-CA 128.747 3.07 . . . . 0.0 117.926 -177.626 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 240' ' ' GLY . . . . . 0.473 ' O ' ' HG2' ' B' ' 243' ' ' GLU . . . . . . . . 0 N--CA 1.403 -3.505 0 N-CA-C 110.39 -1.084 . . . . 0.0 110.39 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 29.3 p90 -77.26 -36.71 54.18 Favored 'General case' 0 C--N 1.294 -1.829 0 CA-C-O 121.477 0.656 . . . . 0.0 110.857 176.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 242' ' ' GLU . . . . . 0.512 ' HA ' ' CE3' ' B' ' 245' ' ' TRP . 42.4 tt0 -67.55 -38.95 84.91 Favored 'General case' 0 C--O 1.251 1.145 0 CA-C-N 115.093 -0.958 . . . . 0.0 111.657 -178.504 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 243' ' ' GLU . . . . . 0.473 ' HG2' ' O ' ' B' ' 240' ' ' GLY . 12.2 pt-20 -58.3 -35.02 71.19 Favored 'General case' 0 C--O 1.212 -0.9 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.229 178.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 244' ' ' LYS . . . . . 0.432 ' HE2' ' O ' ' B' ' 240' ' ' GLY . 72.2 mmtt -62.79 -46.17 89.25 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.598 -176.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 245' ' ' TRP . . . . . 0.512 ' CE3' ' HA ' ' B' ' 242' ' ' GLU . 11.8 m0 -63.98 -40.65 96.86 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.675 179.308 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 246' ' ' PHE . . . . . 0.588 ' O ' ' HG2' ' B' ' 249' ' ' GLN . 2.5 t80 -66.64 -31.12 71.59 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.075 179.069 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -77.54 -39.91 44.39 Favored 'General case' 0 C--N 1.29 -2.004 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.079 178.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.47 -13.28 55.05 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-O 121.395 0.617 . . . . 0.0 111.606 -175.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 249' ' ' GLN . . . . . 0.588 ' HG2' ' O ' ' B' ' 246' ' ' PHE . 3.2 pt20 -74.48 2.68 9.01 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.597 -179.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 250' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -61.24 -31.08 70.88 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 174.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 251' ' ' GLU . . . . . 0.433 ' HG3' ' HB3' ' B' ' 254' ' ' GLU . 2.6 mm-40 -91.63 158.32 16.48 Favored 'General case' 0 N--CA 1.414 -2.263 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.439 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 252' ' ' ILE . . . . . . . . . . . . . 35.0 pt -108.11 -29.17 2.62 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 CA-C-N 114.927 -1.033 . . . . 0.0 110.265 -176.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -120.04 -32.39 4.2 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.918 0.389 . . . . 0.0 110.85 -175.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 254' ' ' GLU . . . . . 0.433 ' HB3' ' HG3' ' B' ' 251' ' ' GLU . 7.0 tp10 . . . . . 0 N--CA 1.43 -1.431 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 -170.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.532 0 N-CA-C 111.748 0.277 . . . . 0.0 111.748 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 16.9 m-30 -93.92 145.39 24.67 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 120.933 -0.307 . . . . 0.0 110.598 -176.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 26.4 pt -143.8 162.26 15.83 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 C-N-CA 123.229 0.612 . . . . 0.0 110.233 176.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.469 ' HB2' HG21 ' A' ' 107' ' ' THR . 29.8 t80 -114.46 124.5 52.08 Favored 'General case' 0 N--CA 1.421 -1.913 0 C-N-CA 124.355 1.062 . . . . 0.0 108.616 177.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 7.5 mt -109.6 127.72 66.19 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.976 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 175.074 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -127.88 164.37 21.25 Favored Glycine 0 C--N 1.281 -2.501 0 N-CA-C 110.622 -0.991 . . . . 0.0 110.622 -179.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 16.9 m120 71.38 36.93 1.23 Allowed 'General case' 0 CA--C 1.503 -0.83 0 C-N-CA 124.177 0.991 . . . . 0.0 111.082 -177.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.469 HD11 HD11 ' A' ' 47' ' ' ILE . 4.1 mm? -69.79 153.87 42.75 Favored 'General case' 0 CA--C 1.499 -0.984 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.105 176.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.482 ' HB3' ' HG ' ' A' ' 42' ' ' LEU . 38.2 t-20 -92.07 152.96 19.69 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 175.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.404 ' HD2' ' C ' ' A' ' 40' ' ' ARG . 0.9 OUTLIER -67.38 -23.59 65.59 Favored 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 122.535 0.334 . . . . 0.0 110.41 -179.162 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -90.55 -10.97 41.51 Favored 'General case' 0 C--O 1.224 -0.259 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.291 -178.132 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.482 ' HG ' ' HB3' ' A' ' 39' ' ' ASN . 55.3 mt -77.43 120.38 22.34 Favored 'General case' 0 CA--C 1.495 -1.171 0 CA-C-O 121.596 0.712 . . . . 0.0 110.947 -178.218 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 73.0 p -102.07 173.49 6.36 Favored 'General case' 0 C--N 1.287 -2.142 0 CA-C-N 114.508 -1.224 . . . . 0.0 109.771 -177.215 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.441 ' HG3' ' HB2' ' A' ' 62' ' ' LEU . 1.3 mp0 -64.07 -34.61 78.43 Favored 'General case' 0 C--O 1.205 -1.276 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 177.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -59.31 -39.26 94.45 Favored Glycine 0 N--CA 1.443 -0.854 0 O-C-N 123.969 0.793 . . . . 0.0 111.438 178.19 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -67.54 -50.09 60.26 Favored 'General case' 0 CA--C 1.496 -1.107 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 177.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.469 HD11 HD11 ' A' ' 38' ' ' LEU . 46.3 mt -60.1 -47.22 92.79 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 CA-C-N 115.19 -0.913 . . . . 0.0 111.085 -178.157 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 41.4 mt -60.46 -45.45 93.66 Favored 'General case' 0 CA--C 1.49 -1.342 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.204 -176.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 90.4 m -63.08 -45.66 91.06 Favored 'General case' 0 N--CA 1.432 -1.356 0 O-C-N 123.74 0.65 . . . . 0.0 111.507 -178.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 98.2 t -67.48 -48.17 78.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.831 -179.182 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.407 ' HA ' ' HD2' ' A' ' 54' ' ' TYR . 3.5 m-85 -63.82 -25.37 68.15 Favored 'General case' 0 N--CA 1.438 -1.064 0 C-N-CA 123.769 0.827 . . . . 0.0 112.208 -179.06 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.555 ' OG ' ' HB2' ' B' ' 231' ' ' ARG . 62.8 m -67.75 -19.86 65.17 Favored 'General case' 0 N--CA 1.439 -1.011 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 176.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -66.03 -32.0 73.22 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-O 121.803 0.811 . . . . 0.0 109.305 174.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.407 ' HD2' ' HA ' ' A' ' 51' ' ' PHE . 57.2 m-85 -88.89 -22.78 22.96 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.56 -0.746 . . . . 0.0 111.691 -173.439 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.475 ' O ' ' HA ' ' A' ' 52' ' ' SER . . . 173.7 -162.49 33.37 Favored Glycine 0 N--CA 1.428 -1.872 0 C-N-CA 120.633 -0.794 . . . . 0.0 111.795 178.303 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 59.4 t -100.43 110.57 60.54 Favored Pre-proline 0 C--N 1.304 -1.395 0 N-CA-C 110.511 -0.181 . . . . 0.0 110.511 -178.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.544 ' HB3' HD21 ' A' ' 77' ' ' LEU . 97.1 Cg_endo -79.69 136.67 12.29 Favored 'Trans proline' 0 N--CA 1.45 -1.049 0 C-N-CA 122.535 2.157 . . . . 0.0 110.603 177.502 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 35.0 m -111.35 -28.22 2.64 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 C-N-CA 119.786 -0.765 . . . . 0.0 111.834 -178.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.502 ' HB3' ' HG2' ' A' ' 78' ' ' LYS . 36.3 t70 -151.23 141.86 22.68 Favored 'General case' 0 CA--C 1.504 -0.789 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 -179.48 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 13.8 p -142.33 133.52 25.25 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 O-C-N 123.609 0.568 . . . . 0.0 109.809 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 83.4 mt -120.54 118.5 56.77 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.213 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 177.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.441 ' HB2' ' HG3' ' A' ' 44' ' ' GLU . 0.1 OUTLIER -97.5 117.39 31.66 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 106.765 -1.569 . . . . 0.0 106.765 177.923 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 22.4 m -77.69 120.23 22.34 Favored 'General case' 0 C--N 1.29 -2.0 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 178.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 72.0 mtm180 . . . . . 0 C--N 1.306 -1.31 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.785 -175.076 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 . . . . . 0 N--CA 1.468 0.466 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 91.7 8.31 63.89 Favored Glycine 0 N--CA 1.44 -1.041 0 C-N-CA 120.85 -0.69 . . . . 0.0 113.535 177.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.41 ' HA ' HD23 ' A' ' 38' ' ' LEU . 32.6 p90 -152.77 157.72 41.22 Favored 'General case' 0 C--O 1.248 1.025 0 CA-C-N 117.566 0.683 . . . . 0.0 109.251 178.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -153.12 173.15 15.85 Favored 'General case' 0 N--CA 1.433 -1.322 0 O-C-N 123.569 0.543 . . . . 0.0 110.763 178.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -132.36 142.74 49.44 Favored 'General case' 0 C--N 1.306 -1.291 0 C-N-CA 124.17 0.988 . . . . 0.0 109.584 -178.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.544 HD21 ' HB3' ' A' ' 57' ' ' PRO . 9.8 tt -149.71 140.73 22.92 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 176.608 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.502 ' HG2' ' HB3' ' A' ' 59' ' ' ASP . 22.2 ptmt -123.46 144.25 49.64 Favored 'General case' 0 C--O 1.253 1.278 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 178.497 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -105.28 165.5 11.07 Favored 'General case' 0 C--N 1.29 -2.0 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.97 -178.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -73.62 -27.07 61.09 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.354 175.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -131.13 141.19 50.09 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 120.714 0.292 . . . . 0.0 110.606 -178.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 25.2 mp0 -70.08 -21.27 63.16 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 123.971 0.908 . . . . 0.0 113.279 -178.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 89.5 mtm180 -65.3 -34.46 78.39 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-O 122.313 1.054 . . . . 0.0 109.512 176.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.463 ' OG ' HG21 ' B' ' 226' ' ' ILE . 53.3 m -65.59 -36.85 84.95 Favored 'General case' 0 C--N 1.282 -2.33 0 CA-C-N 114.561 -1.199 . . . . 0.0 112.288 177.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 63.8 p -65.38 -44.94 85.98 Favored 'General case' 0 C--N 1.344 0.356 0 C-N-CA 120.168 -0.613 . . . . 0.0 110.875 -177.347 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.403 ' H ' HG12 ' A' ' 86' ' ' ILE . 3.5 pt -63.5 -38.91 83.46 Favored 'Isoleucine or valine' 0 C--O 1.243 0.731 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.036 177.058 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 49.2 mt -60.4 -44.04 96.08 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.385 176.211 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.453 ' O ' ' HB2' ' A' ' 92' ' ' LEU . . . -71.81 -46.61 57.59 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.838 -179.264 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.447 HG22 HG22 ' A' ' 104' ' ' ILE . 53.3 t -56.47 -48.89 79.42 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.902 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -178.004 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -62.24 -43.88 97.83 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -173.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -93.33 -19.98 20.82 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-N 115.758 -0.656 . . . . 0.0 112.373 -170.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.453 ' HB2' ' O ' ' A' ' 88' ' ' ALA . 9.8 mt -92.6 -27.85 17.09 Favored 'General case' 0 CA--C 1.491 -1.313 0 CA-C-O 120.824 0.345 . . . . 0.0 111.142 179.397 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -65.6 124.48 22.47 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 178.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 88.32 -1.09 84.11 Favored Glycine 0 N--CA 1.434 -1.493 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.435 -178.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -79.36 129.87 34.89 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 -179.2 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.456 ' HE3' ' HB2' ' A' ' 101' ' ' ALA . 11.9 mptt -90.06 115.63 27.47 Favored 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 120.602 -0.439 . . . . 0.0 110.245 179.264 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 54.1 mt -122.19 141.31 43.13 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 N-CA-C 105.803 -1.925 . . . . 0.0 105.803 174.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.409 ' HA3' HD22 ' A' ' 39' ' ' ASN . . . 57.32 21.9 42.19 Favored Glycine 0 CA--C 1.523 0.579 0 C-N-CA 121.79 -0.243 . . . . 0.0 113.411 -179.783 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 85.8 7.53 81.13 Favored Glycine 0 N--CA 1.437 -1.29 0 C-N-CA 121.149 -0.548 . . . . 0.0 113.59 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 18.6 ptp180 -132.01 139.25 48.54 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 117.726 0.763 . . . . 0.0 110.622 -179.145 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.456 ' HB2' ' HE3' ' A' ' 96' ' ' LYS . . . -81.25 119.83 24.13 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.756 -177.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 12.1 mt -66.47 146.73 54.21 Favored 'General case' 0 CA--C 1.501 -0.917 0 O-C-N 124.114 0.884 . . . . 0.0 112.737 178.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 28.6 tptp -120.44 118.82 31.29 Favored 'General case' 0 N--CA 1.421 -1.906 0 CA-C-N 115.222 -0.899 . . . . 0.0 108.922 174.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.447 HG22 HG22 ' A' ' 89' ' ' VAL . 3.2 mm -115.13 139.04 43.42 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.867 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 178.192 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -145.32 150.65 36.99 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 178.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 56.4 m-70 -83.64 130.71 34.98 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 176.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.469 HG21 ' HB2' ' A' ' 34' ' ' TYR . 5.4 t -148.79 163.55 37.05 Favored 'General case' 0 C--N 1.29 -1.98 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 -176.148 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -109.73 111.77 23.43 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 172.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 36.3 t80 . . . . . 0 C--N 1.286 -2.159 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.083 -173.527 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 226' ' ' ILE . . . . . 0.463 HG21 ' OG ' ' A' ' 84' ' ' SER . 3.7 mp . . . . . 0 N--CA 1.433 -1.314 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 227' ' ' MET . . . . . . . . . . . . . 63.6 mtt -68.42 137.43 91.14 Favored Pre-proline 0 C--N 1.31 -1.12 0 O-C-N 124.016 0.822 . . . . 0.0 109.681 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 228' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -67.94 146.39 71.34 Favored 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 122.196 1.931 . . . . 0.0 111.206 178.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . -66.1 161.08 44.9 Favored Glycine 0 N--CA 1.44 -1.037 0 CA-C-N 116.084 -0.507 . . . . 0.0 112.363 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 23.2 m -74.6 -12.67 60.51 Favored 'General case' 0 C--N 1.298 -1.654 0 C-N-CA 123.037 0.535 . . . . 0.0 111.794 -177.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 231' ' ' ARG . . . . . 0.555 ' HB2' ' OG ' ' A' ' 52' ' ' SER . 4.0 mmp_? -79.0 -14.53 59.14 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.044 0.45 . . . . 0.0 109.992 178.491 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 232' ' ' TRP . . . . . 0.409 ' HB2' ' CB ' ' A' ' 52' ' ' SER . 28.9 t90 -72.12 122.88 21.73 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.984 -0.553 . . . . 0.0 112.052 -176.095 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 233' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -126.63 106.02 9.12 Favored 'General case' 0 C--O 1.207 -1.169 0 CA-C-O 118.665 -0.684 . . . . 0.0 110.057 177.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.491 0 N-CA-C 115.9 1.12 . . . . 0.0 115.9 176.241 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 240' ' ' GLY . . . . . 0.408 ' O ' ' HG2' ' B' ' 244' ' ' LYS . . . . . . . . 0 N--CA 1.406 -3.339 0 N-CA-C 108.751 -1.74 . . . . 0.0 108.751 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 28.9 p90 -76.37 -35.53 58.61 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-O 120.84 0.352 . . . . 0.0 111.923 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 242' ' ' GLU . . . . . 0.47 ' HA ' ' CE3' ' B' ' 245' ' ' TRP . 44.2 tt0 -67.33 -42.07 84.2 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.576 -176.608 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -57.95 -34.02 69.46 Favored 'General case' 0 C--O 1.22 -0.47 0 C-N-CA 123.105 0.562 . . . . 0.0 111.541 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 244' ' ' LYS . . . . . 0.408 ' HG2' ' O ' ' B' ' 240' ' ' GLY . 71.7 mmtt -62.03 -45.96 91.25 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.394 -178.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 245' ' ' TRP . . . . . 0.47 ' CE3' ' HA ' ' B' ' 242' ' ' GLU . 11.2 m0 -69.6 -39.05 77.5 Favored 'General case' 0 CA--C 1.505 -0.756 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.425 178.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 246' ' ' PHE . . . . . 0.493 ' O ' ' HG2' ' B' ' 249' ' ' GLN . 6.1 t80 -62.12 -33.4 74.38 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.973 179.492 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -76.43 -30.85 57.57 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.632 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 248' ' ' LYS . . . . . 0.572 ' O ' ' HG2' ' B' ' 251' ' ' GLU . 0.0 OUTLIER -97.15 -12.61 22.89 Favored 'General case' 0 C--O 1.203 -1.378 0 O-C-N 121.895 -0.503 . . . . 0.0 112.11 -176.488 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 249' ' ' GLN . . . . . 0.493 ' HG2' ' O ' ' B' ' 246' ' ' PHE . 3.0 pt20 -70.17 2.51 3.61 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.137 0.575 . . . . 0.0 112.548 -176.327 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 250' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -63.64 -30.14 71.29 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.516 176.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 251' ' ' GLU . . . . . 0.572 ' HG2' ' O ' ' B' ' 248' ' ' LYS . 11.3 pt-20 -75.18 108.35 7.88 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-O 122.502 1.144 . . . . 0.0 111.067 -179.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 252' ' ' ILE . . . . . . . . . . . . . 30.4 pt -110.07 -34.28 2.48 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.334 0 CA-C-N 114.183 -1.372 . . . . 0.0 111.01 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -101.47 -26.01 13.72 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 178.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 254' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 . . . . . 0 N--CA 1.42 -1.945 0 CA-C-N 115.131 -0.94 . . . . 0.0 108.589 -176.28 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.406 ' O ' ' HA ' ' A' ' 78' ' ' LYS . . . . . . . . 0 CA--C 1.514 -0.407 0 N-CA-C 111.772 0.286 . . . . 0.0 111.772 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -95.93 145.83 25.08 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.064 -175.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 21.2 pt -140.79 160.64 23.86 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 C-N-CA 122.709 0.404 . . . . 0.0 110.175 175.014 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.452 ' HB2' HG21 ' A' ' 107' ' ' THR . 61.6 t80 -110.81 125.9 54.07 Favored 'General case' 0 N--CA 1.409 -2.508 0 CA-C-N 115.272 -0.876 . . . . 0.0 108.757 178.372 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.428 HG23 ' CD1' ' A' ' 104' ' ' ILE . 8.0 mt -110.76 129.07 66.61 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.935 0 N-CA-C 107.297 -1.371 . . . . 0.0 107.297 176.454 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -129.65 166.16 21.94 Favored Glycine 0 C--N 1.283 -2.394 0 N-CA-C 110.318 -1.113 . . . . 0.0 110.318 179.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 70.02 38.35 1.56 Allowed 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 125.055 1.342 . . . . 0.0 111.389 -178.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -70.21 154.05 42.37 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.405 0.621 . . . . 0.0 111.687 177.296 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.471 ' HB3' ' HG ' ' A' ' 42' ' ' LEU . 45.2 t-20 -90.47 150.24 21.88 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 176.438 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 7.3 ppt_? -62.91 -21.62 66.16 Favored 'General case' 0 C--N 1.314 -0.937 0 C-N-CA 122.991 0.516 . . . . 0.0 111.29 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -94.89 -0.74 53.74 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 115.965 -0.562 . . . . 0.0 111.73 -178.097 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.471 ' HG ' ' HB3' ' A' ' 39' ' ' ASN . 68.9 mt -89.95 124.33 34.63 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-O 121.365 0.602 . . . . 0.0 110.762 -179.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 75.8 p -108.78 174.25 5.96 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.241 -179.172 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.426 ' HG2' ' HB2' ' A' ' 62' ' ' LEU . 40.4 mt-10 -54.79 -41.17 70.24 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 123.667 0.787 . . . . 0.0 110.131 177.533 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -64.19 -38.87 96.52 Favored Glycine 0 N--CA 1.444 -0.828 0 CA-C-N 115.492 -0.777 . . . . 0.0 113.027 -178.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -65.96 -47.06 75.86 Favored 'General case' 0 CA--C 1.496 -1.125 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 -179.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 44.6 mt -58.5 -45.14 90.22 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.632 179.066 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.434 ' HG ' HG11 ' A' ' 60' ' ' VAL . 45.1 mt -59.09 -45.83 89.85 Favored 'General case' 0 C--O 1.209 -1.031 0 CA-C-O 119.481 -0.295 . . . . 0.0 111.428 -179.41 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.486 HG23 ' H ' ' B' ' 233' ' ' ASP . 99.0 m -61.53 -45.54 93.74 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -179.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 64.3 t -65.52 -47.8 85.21 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 CA-C-O 121.349 0.595 . . . . 0.0 110.708 -179.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -67.1 -23.04 65.8 Favored 'General case' 0 N--CA 1.436 -1.169 0 C-N-CA 124.022 0.929 . . . . 0.0 111.88 -179.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.456 ' OG ' ' HB2' ' B' ' 231' ' ' ARG . 65.9 m -69.7 -19.85 63.56 Favored 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 176.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -75.9 -25.47 56.08 Favored 'General case' 0 C--O 1.247 0.947 0 C-N-CA 118.247 -1.381 . . . . 0.0 108.853 177.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -88.04 -22.68 24.07 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.603 -176.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 175.73 -156.67 22.26 Favored Glycine 0 N--CA 1.425 -2.07 0 C-N-CA 120.624 -0.798 . . . . 0.0 111.562 177.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.53 ' HB ' ' HG2' ' A' ' 80' ' ' GLU . 94.5 t -106.46 102.56 41.65 Favored Pre-proline 0 C--N 1.3 -1.559 0 CA-C-O 120.851 0.357 . . . . 0.0 110.341 -178.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.587 ' HB3' HD21 ' A' ' 77' ' ' LEU . 89.7 Cg_endo -77.81 136.86 15.46 Favored 'Trans proline' 0 C--O 1.252 1.206 0 C-N-CA 122.534 2.156 . . . . 0.0 110.167 177.281 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 34.0 m -113.9 -18.47 7.51 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 C-N-CA 120.221 -0.592 . . . . 0.0 112.274 -177.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.534 ' HB3' ' HG2' ' A' ' 78' ' ' LYS . 20.3 t70 -160.14 139.13 10.69 Favored 'General case' 0 C--O 1.242 0.7 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 -178.494 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.434 HG11 ' HG ' ' A' ' 48' ' ' LEU . 12.7 p -140.62 137.59 35.83 Favored 'Isoleucine or valine' 0 C--O 1.245 0.845 0 O-C-N 123.35 0.406 . . . . 0.0 110.056 179.441 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 90.4 mt -121.33 124.76 72.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 C-N-CA 123.391 0.676 . . . . 0.0 109.394 175.035 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.426 ' HB2' ' HG2' ' A' ' 44' ' ' GLU . 0.1 OUTLIER -100.12 121.06 40.83 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 106.056 -1.831 . . . . 0.0 106.056 175.501 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 20.4 m -79.91 117.37 20.71 Favored 'General case' 0 C--N 1.284 -2.249 0 N-CA-C 107.016 -1.476 . . . . 0.0 107.016 175.054 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 57.8 mtp180 . . . . . 0 C--N 1.3 -1.559 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.573 -172.959 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 16.0 mm-40 . . . . . 0 CA--C 1.509 -0.616 0 CA-C-O 120.876 0.37 . . . . 0.0 111.709 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 87.63 8.1 74.19 Favored Glycine 0 N--CA 1.431 -1.655 0 C-N-CA 120.186 -1.007 . . . . 0.0 112.48 -177.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 32.1 p90 -149.27 155.41 40.53 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 177.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -154.19 176.11 12.66 Favored 'General case' 0 C--N 1.316 -0.852 0 O-C-N 123.403 0.439 . . . . 0.0 111.0 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -132.82 144.02 49.94 Favored 'General case' 0 C--N 1.314 -0.971 0 C-N-CA 124.376 1.07 . . . . 0.0 109.975 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.587 HD21 ' HB3' ' A' ' 57' ' ' PRO . 9.9 tt -150.3 141.46 23.11 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 176.485 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.534 ' HG2' ' HB3' ' A' ' 59' ' ' ASP . 21.8 ptmt -123.3 143.8 49.84 Favored 'General case' 0 C--O 1.256 1.401 0 CA-C-O 121.215 0.531 . . . . 0.0 109.983 178.279 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 68.7 m-85 -106.67 165.41 11.32 Favored 'General case' 0 C--N 1.293 -1.88 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.822 179.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.53 ' HG2' ' HB ' ' A' ' 56' ' ' VAL . 6.9 pt-20 -76.49 -23.92 53.78 Favored 'General case' 0 C--N 1.315 -0.918 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.318 175.561 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -133.58 144.94 49.62 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 119.497 -0.881 . . . . 0.0 111.891 177.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 25.0 mp0 -69.41 -20.82 63.8 Favored 'General case' 0 C--N 1.309 -1.177 0 C-N-CA 124.32 1.048 . . . . 0.0 113.239 -177.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 76.2 mtm180 -62.74 -35.42 79.71 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 122.092 0.949 . . . . 0.0 109.976 176.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 49.5 m -69.11 -37.32 78.3 Favored 'General case' 0 C--N 1.286 -2.184 0 CA-C-N 114.905 -1.043 . . . . 0.0 112.951 178.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 72.1 p -62.66 -45.28 93.55 Favored 'General case' 0 C--N 1.344 0.336 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.456 -177.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.425 ' H ' HG12 ' A' ' 86' ' ' ILE . 3.3 pt -65.71 -39.9 86.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.197 178.23 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 49.0 mt -60.31 -43.6 96.2 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 120.852 0.358 . . . . 0.0 111.319 176.008 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.419 ' O ' ' HB2' ' A' ' 92' ' ' LEU . . . -71.29 -46.47 60.74 Favored 'General case' 0 N--CA 1.433 -1.3 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.339 -178.498 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.456 HG22 HG22 ' A' ' 104' ' ' ILE . 66.9 t -57.56 -49.29 80.96 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.906 0 CA-C-O 121.054 0.454 . . . . 0.0 111.083 179.519 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -64.88 -34.66 78.93 Favored 'General case' 0 C--N 1.295 -1.798 0 C-N-CA 124.029 0.932 . . . . 0.0 111.779 -174.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -93.42 -28.53 16.08 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 -176.235 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.481 ' HB2' HG13 ' A' ' 104' ' ' ILE . 13.9 mt -92.84 -30.46 15.44 Favored 'General case' 0 CA--C 1.488 -1.405 0 N-CA-C 111.797 0.295 . . . . 0.0 111.797 -175.046 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -66.41 124.76 23.63 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 177.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 85.95 -0.72 87.81 Favored Glycine 0 CA--C 1.535 1.328 0 C-N-CA 120.496 -0.859 . . . . 0.0 112.325 -177.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 21.7 t80 -89.23 133.5 34.41 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 -179.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -96.13 123.8 39.89 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-O 121.093 0.473 . . . . 0.0 111.647 -178.084 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 55.0 mt -127.74 141.32 46.73 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 N-CA-C 105.581 -2.007 . . . . 0.0 105.581 173.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 58.22 24.58 55.59 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 121.544 -0.36 . . . . 0.0 113.344 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 81.8 3.11 90.69 Favored Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 121.673 -0.299 . . . . 0.0 113.132 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.406 ' NH1' ' HA ' ' A' ' 39' ' ' ASN . 19.4 ptp180 -125.06 144.96 50.14 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 117.271 0.535 . . . . 0.0 110.978 -178.037 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -85.71 117.7 24.75 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.372 -177.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 11.9 mt -66.4 147.04 53.87 Favored 'General case' 0 C--O 1.25 1.118 0 CA-C-O 121.57 0.7 . . . . 0.0 112.566 178.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 60.1 tptt -119.19 117.97 30.08 Favored 'General case' 0 N--CA 1.416 -2.149 0 CA-C-N 114.777 -1.101 . . . . 0.0 108.046 176.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.481 HG13 ' HB2' ' A' ' 92' ' ' LEU . 4.9 mm -119.89 136.2 57.74 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.052 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 179.081 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -143.31 151.24 40.27 Favored 'General case' 0 C--N 1.283 -2.323 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 -179.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 79.9 m-70 -80.98 131.33 35.31 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 179.139 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.452 HG21 ' HB2' ' A' ' 34' ' ' TYR . 5.9 t -151.34 160.46 43.77 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 105.724 -1.954 . . . . 0.0 105.724 -178.698 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -110.64 110.01 20.53 Favored 'General case' 0 N--CA 1.422 -1.866 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 172.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 76.1 t80 . . . . . 0 C--N 1.291 -1.946 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.756 -178.748 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 3.9 mp . . . . . 0 C--O 1.25 1.083 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 227' ' ' MET . . . . . . . . . . . . . 18.9 ptp -66.93 154.1 92.98 Favored Pre-proline 0 C--N 1.318 -0.79 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.16 178.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 228' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -73.4 145.02 37.48 Favored 'Trans proline' 0 N--CA 1.44 -1.634 0 C-N-CA 122.17 1.913 . . . . 0.0 111.565 175.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . -67.92 166.58 43.55 Favored Glycine 0 N--CA 1.437 -1.274 0 CA-C-N 115.497 -0.774 . . . . 0.0 112.59 179.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 16.2 m -74.74 -14.51 60.73 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-O 121.022 0.439 . . . . 0.0 111.738 -175.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 231' ' ' ARG . . . . . 0.456 ' HB2' ' OG ' ' A' ' 52' ' ' SER . 39.7 mmt180 -84.83 -3.45 58.66 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.018 0.437 . . . . 0.0 110.409 -179.113 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 232' ' ' TRP . . . . . . . . . . . . . 22.1 t90 -76.29 128.62 35.26 Favored 'General case' 0 CA--C 1.5 -0.975 0 CA-C-O 122.31 1.053 . . . . 0.0 111.846 -179.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 233' ' ' ASP . . . . . 0.486 ' H ' HG23 ' A' ' 49' ' ' THR . 29.7 t70 -124.17 142.87 50.86 Favored 'General case' 0 C--N 1.269 -2.896 0 N-CA-C 101.978 -3.342 . . . . 0.0 101.978 172.17 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.251 0 C-N-CA 128.207 2.813 . . . . 0.0 116.249 -179.988 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 240' ' ' GLY . . . . . 0.595 ' O ' ' HG2' ' B' ' 244' ' ' LYS . . . . . . . . 0 C--O 1.187 -2.832 0 CA-C-O 120.122 -0.266 . . . . 0.0 112.512 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 47.1 p90 -75.44 -33.82 60.92 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 117.667 0.734 . . . . 0.0 110.952 -179.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -63.45 -39.72 95.21 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.894 -175.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -67.29 -35.74 80.1 Favored 'General case' 0 C--O 1.21 -0.979 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.249 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 244' ' ' LYS . . . . . 0.595 ' HG2' ' O ' ' B' ' 240' ' ' GLY . 68.9 mmtt -67.05 -45.74 76.49 Favored 'General case' 0 CA--C 1.507 -0.675 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 -176.249 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 245' ' ' TRP . . . . . . . . . . . . . 46.7 m0 -64.44 -37.54 87.87 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.059 -179.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 246' ' ' PHE . . . . . 0.559 ' O ' ' HG2' ' B' ' 249' ' ' GLN . 2.9 t80 -70.65 -30.44 67.07 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.086 176.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -78.59 -40.66 34.01 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 178.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.65 -15.96 52.91 Favored 'General case' 0 CA--C 1.501 -0.917 0 CA-C-O 121.158 0.504 . . . . 0.0 111.497 -175.351 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 249' ' ' GLN . . . . . 0.559 ' HG2' ' O ' ' B' ' 246' ' ' PHE . 3.1 pt20 -70.3 -0.31 7.85 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.703 -178.352 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 250' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -64.04 -30.13 71.22 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 175.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -85.59 111.62 20.22 Favored 'General case' 0 N--CA 1.429 -1.521 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 176.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 252' ' ' ILE . . . . . . . . . . . . . 34.6 pt -109.77 -24.15 4.15 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 CA-C-N 114.985 -1.007 . . . . 0.0 113.639 -170.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -116.83 -19.89 9.69 Favored 'General case' 0 C--N 1.31 -1.114 0 C-N-CA 120.01 -0.676 . . . . 0.0 112.362 -176.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 254' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.565 1.55 0 C-N-CA 123.766 0.826 . . . . 0.0 111.966 -173.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.506 -0.747 0 CA-C-O 120.725 0.298 . . . . 0.0 110.263 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -109.93 145.65 36.53 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.127 -175.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 27.5 pt -138.21 156.68 30.84 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.453 176.109 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 34.3 t80 -106.67 123.02 47.5 Favored 'General case' 0 N--CA 1.414 -2.228 0 CA-C-N 114.91 -1.041 . . . . 0.0 108.264 177.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.468 HG23 ' CD1' ' A' ' 104' ' ' ILE . 8.7 mt -108.43 127.69 64.6 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.07 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 175.256 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -123.29 160.45 17.81 Favored Glycine 0 C--N 1.283 -2.366 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 -179.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 68.52 48.35 0.84 Allowed 'General case' 0 CA--C 1.491 -1.325 0 C-N-CA 125.112 1.365 . . . . 0.0 111.807 -174.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.534 HD11 HD11 ' A' ' 47' ' ' ILE . 4.0 mm? -72.65 145.46 47.25 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 115.078 -0.965 . . . . 0.0 110.78 175.387 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -96.89 144.86 26.43 Favored 'General case' 0 C--N 1.286 -2.18 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 179.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.5 ' HD2' ' N ' ' A' ' 41' ' ' GLU . 7.0 ppt_? -58.36 -21.3 49.44 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -176.594 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.5 ' N ' ' HD2' ' A' ' 40' ' ' ARG . 12.2 pt-20 -98.18 5.77 48.16 Favored 'General case' 0 C--N 1.318 -0.773 0 C-N-CA 120.464 -0.495 . . . . 0.0 111.518 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 75.6 mt -95.16 113.62 25.33 Favored 'General case' 0 N--CA 1.435 -1.206 0 CA-C-O 121.579 0.704 . . . . 0.0 109.955 175.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 58.8 p -102.98 174.86 5.68 Favored 'General case' 0 C--N 1.286 -2.159 0 CA-C-N 114.507 -1.224 . . . . 0.0 109.785 -179.105 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -54.65 -43.33 72.27 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 177.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -59.6 -41.97 97.56 Favored Glycine 0 CA--C 1.529 0.924 0 CA-C-N 115.603 -0.726 . . . . 0.0 113.51 178.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -63.94 -49.05 74.12 Favored 'General case' 0 CA--C 1.506 -0.743 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.534 HD11 HD11 ' A' ' 38' ' ' LEU . 46.8 mt -58.86 -44.31 90.31 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.892 -179.566 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.411 ' HG ' HG11 ' A' ' 60' ' ' VAL . 41.8 mt -59.27 -45.79 90.26 Favored 'General case' 0 CA--C 1.497 -1.093 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.66 -177.005 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.435 HG23 ' H ' ' B' ' 233' ' ' ASP . 92.0 m -61.05 -45.96 92.64 Favored 'General case' 0 C--N 1.307 -1.278 0 O-C-N 123.379 0.425 . . . . 0.0 112.116 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 99.3 t -66.07 -46.59 87.54 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-O 121.219 0.533 . . . . 0.0 110.8 -179.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -68.74 -20.87 64.4 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 115.57 -0.741 . . . . 0.0 112.185 -178.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.463 ' OG ' ' HB2' ' B' ' 231' ' ' ARG . 73.7 m -71.61 -19.38 62.13 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.771 176.265 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -69.58 -28.97 66.42 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 175.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 54.5 m-85 -95.21 -3.83 46.99 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.698 -174.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 156.49 -155.48 26.37 Favored Glycine 0 N--CA 1.423 -2.174 0 C-N-CA 119.67 -1.252 . . . . 0.0 112.749 177.095 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 60.8 t -108.07 103.99 52.0 Favored Pre-proline 0 C--N 1.305 -1.334 0 N-CA-C 110.475 -0.194 . . . . 0.0 110.475 -178.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.525 ' HB3' HD21 ' A' ' 77' ' ' LEU . 88.0 Cg_endo -79.43 138.93 14.2 Favored 'Trans proline' 0 N--CA 1.451 -0.979 0 C-N-CA 122.799 2.333 . . . . 0.0 110.775 177.602 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 33.1 m -114.71 -22.84 4.51 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 C-N-CA 119.605 -0.838 . . . . 0.0 112.548 -179.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.532 ' HB3' ' HG2' ' A' ' 78' ' ' LYS . 31.4 t70 -155.75 143.39 19.58 Favored 'General case' 0 CA--C 1.504 -0.8 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 -178.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.411 HG11 ' HG ' ' A' ' 48' ' ' LEU . 14.6 p -146.1 132.48 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.116 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 -179.402 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 90.3 mt -120.9 128.15 76.03 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 177.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -103.09 127.29 50.41 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 177.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.563 ' OG ' ' HB2' ' A' ' 72' ' ' GLN . 97.6 p -89.27 117.74 28.45 Favored 'General case' 0 N--CA 1.422 -1.867 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 178.549 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 19.4 mtp180 . . . . . 0 N--CA 1.423 -1.788 0 C-N-CA 119.41 -0.916 . . . . 0.0 109.856 179.46 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.563 ' HB2' ' OG ' ' A' ' 63' ' ' SER . 18.8 mm-40 . . . . . 0 N--CA 1.445 -0.684 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 86.44 16.73 61.71 Favored Glycine 0 N--CA 1.423 -2.208 0 CA-C-N 115.09 -0.959 . . . . 0.0 112.946 178.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -145.15 157.7 44.02 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 176.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -151.15 168.79 23.6 Favored 'General case' 0 C--N 1.292 -1.924 0 CA-C-O 120.999 0.428 . . . . 0.0 110.258 177.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -126.06 137.59 53.64 Favored 'General case' 0 C--N 1.292 -1.902 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.834 -177.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.525 HD21 ' HB3' ' A' ' 57' ' ' PRO . 9.9 tt -144.73 140.59 28.65 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 174.432 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.532 ' HG2' ' HB3' ' A' ' 59' ' ' ASP . 20.5 ptmt -124.7 144.8 50.02 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.107 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 -105.43 164.43 11.87 Favored 'General case' 0 C--N 1.284 -2.266 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.226 -178.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -71.86 -27.17 62.7 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-N 114.794 -1.094 . . . . 0.0 108.654 175.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.626 ' OD1' ' HG2' ' A' ' 83' ' ' ARG . 8.4 t70 -132.45 139.63 48.09 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.49 -179.304 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -69.88 -20.65 63.38 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 -179.087 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.626 ' HG2' ' OD1' ' A' ' 81' ' ' ASP . 22.8 mmm180 -62.62 -34.45 77.05 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 122.2 1.0 . . . . 0.0 109.712 174.486 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.455 ' HA ' HD12 ' A' ' 87' ' ' LEU . 52.7 m -68.96 -37.02 78.58 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 114.865 -1.061 . . . . 0.0 113.559 179.303 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.509 ' O ' HG23 ' A' ' 89' ' ' VAL . 76.2 p -61.2 -45.0 96.37 Favored 'General case' 0 C--N 1.342 0.276 0 C-N-CA 120.473 -0.491 . . . . 0.0 110.418 -177.125 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.43 ' H ' HG12 ' A' ' 86' ' ' ILE . 3.1 pt -64.46 -39.06 84.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.562 177.28 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.455 HD12 ' HA ' ' A' ' 84' ' ' SER . 40.8 mt -58.8 -44.03 90.69 Favored 'General case' 0 N--CA 1.478 0.925 0 O-C-N 123.763 0.664 . . . . 0.0 111.254 178.083 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.446 ' HB1' HD12 ' A' ' 92' ' ' LEU . . . -71.16 -41.12 70.82 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.393 -178.548 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.509 HG23 ' O ' ' A' ' 85' ' ' THR . 68.9 t -57.86 -45.73 87.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -58.5 -44.61 89.48 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 121.814 0.816 . . . . 0.0 111.347 -175.269 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -97.46 -20.31 17.85 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-N 114.744 -1.116 . . . . 0.0 113.296 -168.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.47 ' HB2' HG13 ' A' ' 104' ' ' ILE . 20.8 mt -95.15 -30.96 13.76 Favored 'General case' 0 C--N 1.285 -2.221 0 C-N-CA 119.615 -0.834 . . . . 0.0 110.705 -178.01 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 60.4 t30 -66.44 124.24 22.23 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 87.51 -1.22 85.71 Favored Glycine 0 C--N 1.304 -1.197 0 C-N-CA 121.107 -0.568 . . . . 0.0 113.021 -178.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -90.32 135.83 33.43 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.436 ' HA ' ' HA ' ' A' ' 101' ' ' ALA . 10.9 mptt -95.6 123.17 39.02 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-O 121.242 0.544 . . . . 0.0 111.397 -176.228 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 52.0 mt -126.36 141.37 46.08 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 N-CA-C 106.237 -1.764 . . . . 0.0 106.237 174.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 56.8 22.32 40.26 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 114.102 0.401 . . . . 0.0 114.102 178.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 85.52 14.07 69.04 Favored Glycine 0 N--CA 1.439 -1.116 0 C-N-CA 120.784 -0.722 . . . . 0.0 113.579 179.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 12.1 ptp180 -140.25 146.46 38.65 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 117.456 0.628 . . . . 0.0 110.838 177.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.436 ' HA ' ' HA ' ' A' ' 96' ' ' LYS . . . -88.58 119.76 29.34 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.731 -175.394 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.416 ' HA ' HD23 ' A' ' 102' ' ' LEU . 13.2 mt -65.53 138.56 58.14 Favored 'General case' 0 CA--C 1.488 -1.415 0 CA-C-O 121.646 0.736 . . . . 0.0 112.35 179.407 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 58.0 tptt -114.65 115.85 27.77 Favored 'General case' 0 C--N 1.279 -2.491 0 CA-C-N 114.822 -1.081 . . . . 0.0 108.392 177.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.47 HG13 ' HB2' ' A' ' 92' ' ' LEU . 4.1 mm -118.44 129.9 74.07 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -143.96 151.65 40.03 Favored 'General case' 0 C--N 1.289 -2.063 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 84.1 m-70 -79.67 140.16 37.14 Favored 'General case' 0 C--N 1.298 -1.663 0 C-N-CA 120.124 -0.63 . . . . 0.0 109.779 179.021 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 13.5 t -149.34 162.98 39.0 Favored 'General case' 0 C--N 1.279 -2.469 0 N-CA-C 106.094 -1.817 . . . . 0.0 106.094 -178.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -109.69 109.42 20.14 Favored 'General case' 0 N--CA 1.424 -1.767 0 N-CA-C 106.065 -1.828 . . . . 0.0 106.065 173.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 58.0 t80 . . . . . 0 C--N 1.289 -2.062 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.843 -177.788 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 4.6 mp . . . . . 0 N--CA 1.439 -0.995 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 227' ' ' MET . . . . . . . . . . . . . 73.0 mtm -77.24 140.13 65.23 Favored Pre-proline 0 C--N 1.318 -0.783 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.983 -178.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 228' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -61.7 144.32 97.16 Favored 'Trans proline' 0 C--O 1.243 0.733 0 C-N-CA 123.31 2.674 . . . . 0.0 113.412 -178.355 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . -68.69 172.11 36.54 Favored Glycine 0 C--O 1.242 0.625 0 CA-C-N 115.082 -0.963 . . . . 0.0 113.854 -178.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 23.0 t -77.02 -13.98 59.89 Favored 'General case' 0 C--N 1.314 -0.978 0 C-N-CA 123.011 0.524 . . . . 0.0 111.46 -176.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 231' ' ' ARG . . . . . 0.463 ' HB2' ' OG ' ' A' ' 52' ' ' SER . 31.7 mmt180 -84.94 -3.85 58.9 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.922 -0.311 . . . . 0.0 110.449 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 232' ' ' TRP . . . . . . . . . . . . . 21.5 t90 -78.96 131.94 36.51 Favored 'General case' 0 N--CA 1.433 -1.314 0 CA-C-O 122.333 1.063 . . . . 0.0 111.966 -178.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 233' ' ' ASP . . . . . 0.435 ' H ' HG23 ' A' ' 49' ' ' THR . 25.0 t70 -122.08 137.94 54.63 Favored 'General case' 0 C--N 1.267 -2.982 0 N-CA-C 101.388 -3.56 . . . . 0.0 101.388 168.193 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.413 0 C-N-CA 128.193 2.806 . . . . 0.0 116.093 179.96 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 240' ' ' GLY . . . . . 0.472 ' O ' ' HG2' ' B' ' 244' ' ' LYS . . . . . . . . 0 C--O 1.202 -1.869 0 N-CA-C 112.113 -0.395 . . . . 0.0 112.113 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 29.7 p90 -76.79 -34.48 57.97 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 112.705 0.632 . . . . 0.0 112.705 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -64.73 -39.16 93.17 Favored 'General case' 0 CA--C 1.504 -0.789 0 C-N-CA 122.899 0.479 . . . . 0.0 110.731 -175.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -63.47 -35.01 79.02 Favored 'General case' 0 C--O 1.197 -1.685 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.372 -179.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 244' ' ' LYS . . . . . 0.472 ' HG2' ' O ' ' B' ' 240' ' ' GLY . 70.1 mmtt -65.8 -41.95 91.31 Favored 'General case' 0 N--CA 1.439 -0.986 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 -178.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 245' ' ' TRP . . . . . . . . . . . . . 44.5 m0 -64.72 -40.81 95.98 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.265 -0.88 . . . . 0.0 109.635 179.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 246' ' ' PHE . . . . . 0.67 ' O ' ' HG2' ' B' ' 249' ' ' GLN . 3.0 t80 -72.01 -31.57 66.33 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.577 177.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -74.4 -38.48 63.09 Favored 'General case' 0 C--N 1.294 -1.819 0 O-C-N 121.671 -0.643 . . . . 0.0 111.246 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.47 -14.01 55.77 Favored 'General case' 0 CA--C 1.508 -0.64 0 CA-C-O 121.118 0.485 . . . . 0.0 111.635 -176.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 249' ' ' GLN . . . . . 0.67 ' HG2' ' O ' ' B' ' 246' ' ' PHE . 3.3 pt20 -77.89 -1.16 30.43 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.578 -178.703 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 250' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -53.15 -39.16 63.34 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.078 -179.456 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -131.39 108.24 9.48 Favored 'General case' 0 N--CA 1.432 -1.326 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 174.032 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 252' ' ' ILE . . . . . . . . . . . . . 28.3 pt -86.83 -31.57 6.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 CA-C-N 114.973 -1.012 . . . . 0.0 112.71 -173.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -92.25 -20.25 21.34 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-O 121.416 0.627 . . . . 0.0 111.075 -175.074 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 254' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.295 -1.763 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.198 -175.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.435 -1.213 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -95.01 145.21 25.1 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 -175.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 26.1 pt -141.01 162.17 22.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-O 121.029 0.442 . . . . 0.0 111.033 175.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 66.5 t80 -109.84 121.78 46.02 Favored 'General case' 0 N--CA 1.415 -2.21 0 CA-C-N 114.702 -1.136 . . . . 0.0 108.436 178.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 9.4 mt -109.15 127.94 65.45 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.963 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 174.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -130.52 168.12 21.79 Favored Glycine 0 C--N 1.29 -2.008 0 N-CA-C 111.305 -0.718 . . . . 0.0 111.305 -178.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 68.25 33.73 4.18 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.663 1.185 . . . . 0.0 110.503 -176.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.525 HD11 HD11 ' A' ' 47' ' ' ILE . 4.0 mm? -65.8 151.67 46.1 Favored 'General case' 0 CA--C 1.5 -0.969 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.606 178.083 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.489 HD22 ' HA3' ' A' ' 98' ' ' GLY . 39.2 t-20 -90.85 148.81 22.25 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 176.234 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.404 HH11 ' HB3' ' A' ' 41' ' ' GLU . 0.6 OUTLIER -64.76 -17.12 63.88 Favored 'General case' 0 C--N 1.297 -1.7 0 C-N-CA 123.765 0.826 . . . . 0.0 113.149 -179.001 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.404 ' HB3' HH11 ' A' ' 40' ' ' ARG . 10.2 pt-20 -92.91 -13.64 28.64 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.555 179.162 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.401 HD12 ' H ' ' A' ' 39' ' ' ASN . 74.8 mt -78.83 123.25 27.03 Favored 'General case' 0 CA--C 1.504 -0.82 0 CA-C-O 121.564 0.697 . . . . 0.0 111.809 -176.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 10.7 t -114.22 174.15 6.09 Favored 'General case' 0 C--N 1.293 -1.876 0 CA-C-N 114.737 -1.12 . . . . 0.0 108.965 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.418 ' CG ' ' HB2' ' A' ' 62' ' ' LEU . 52.3 mt-10 -55.42 -45.1 76.76 Favored 'General case' 0 C--O 1.214 -0.782 0 C-N-CA 124.016 0.927 . . . . 0.0 110.62 -176.47 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -59.35 -39.0 94.18 Favored Glycine 0 C--O 1.244 0.731 0 CA-C-N 116.117 -0.492 . . . . 0.0 113.466 -178.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -67.64 -48.44 66.71 Favored 'General case' 0 C--O 1.243 0.745 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 -179.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.525 HD11 HD11 ' A' ' 38' ' ' LEU . 36.2 mt -58.22 -46.21 88.76 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.318 0 CA-C-N 114.924 -1.035 . . . . 0.0 110.291 178.471 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 44.6 mt -59.21 -40.26 85.25 Favored 'General case' 0 CA--C 1.492 -1.259 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.397 -178.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.408 HG23 ' H ' ' B' ' 233' ' ' ASP . 84.3 m -65.16 -46.22 81.72 Favored 'General case' 0 N--CA 1.431 -1.381 0 O-C-N 123.502 0.501 . . . . 0.0 110.977 -178.511 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 57.6 t -67.53 -48.01 78.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.42 -178.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.42 ' HD2' ' HH ' ' A' ' 79' ' ' TYR . 6.1 m-85 -64.84 -21.27 66.76 Favored 'General case' 0 N--CA 1.436 -1.17 0 C-N-CA 124.408 1.083 . . . . 0.0 112.545 -179.442 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.463 ' CB ' ' HB2' ' B' ' 232' ' ' TRP . 51.2 m -71.65 -20.75 61.91 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 176.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -74.26 -24.55 59.3 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 118.022 -1.471 . . . . 0.0 109.523 174.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 -89.85 -8.81 51.13 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.221 0.534 . . . . 0.0 111.434 -175.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 158.99 -163.21 33.13 Favored Glycine 0 N--CA 1.425 -2.075 0 N-CA-C 110.981 -0.848 . . . . 0.0 110.981 177.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 60.1 t -101.33 109.37 58.62 Favored Pre-proline 0 C--N 1.297 -1.713 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 -179.097 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.511 ' HB3' HD21 ' A' ' 77' ' ' LEU . 79.0 Cg_endo -77.53 137.08 16.14 Favored 'Trans proline' 0 N--CA 1.445 -1.375 0 C-N-CA 122.17 1.914 . . . . 0.0 109.701 176.73 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 35.0 m -111.48 -26.54 3.09 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 C-N-CA 119.46 -0.896 . . . . 0.0 111.992 -178.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.477 ' HB3' ' HG2' ' A' ' 78' ' ' LYS . 10.5 t70 -155.06 144.43 21.18 Favored 'General case' 0 C--O 1.247 0.946 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 -179.062 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 14.6 p -146.34 138.17 19.34 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 O-C-N 123.415 0.447 . . . . 0.0 110.103 -178.486 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 98.4 mt -121.31 126.21 74.69 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 174.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.418 ' HB2' ' CG ' ' A' ' 44' ' ' GLU . 0.1 OUTLIER -98.58 115.77 29.36 Favored 'General case' 0 N--CA 1.425 -1.677 0 N-CA-C 106.222 -1.77 . . . . 0.0 106.222 171.396 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 6.8 m -74.96 117.24 16.59 Favored 'General case' 0 N--CA 1.412 -2.344 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 178.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 66.9 mtm180 . . . . . 0 C--N 1.299 -1.63 0 CA-C-O 121.269 0.557 . . . . 0.0 111.189 -176.181 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 . . . . . 0 CA--C 1.518 -0.275 0 CA-C-O 120.909 0.385 . . . . 0.0 111.668 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 83.44 11.14 80.81 Favored Glycine 0 N--CA 1.435 -1.405 0 C-N-CA 121.126 -0.559 . . . . 0.0 113.336 178.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 38.3 p90 -154.06 159.49 41.57 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 177.13 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -154.12 171.94 18.33 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 123.917 0.761 . . . . 0.0 109.77 178.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -131.12 141.45 50.13 Favored 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 123.61 0.764 . . . . 0.0 109.903 -178.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.511 HD21 ' HB3' ' A' ' 57' ' ' PRO . 10.0 tt -148.86 141.48 24.43 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 176.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.477 ' HG2' ' HB3' ' A' ' 59' ' ' ASP . 21.5 ptmt -124.11 143.98 50.15 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 178.465 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.42 ' HH ' ' HD2' ' A' ' 51' ' ' PHE . 74.5 m-85 -103.84 165.66 10.9 Favored 'General case' 0 C--N 1.288 -2.071 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.724 -178.289 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -75.13 -39.43 60.5 Favored 'General case' 0 N--CA 1.425 -1.715 0 CA-C-N 114.956 -1.02 . . . . 0.0 108.381 174.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -116.84 144.14 44.85 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 121.378 0.609 . . . . 0.0 111.364 179.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 21.4 mp0 -69.83 -28.78 65.98 Favored 'General case' 0 C--N 1.311 -1.086 0 C-N-CA 124.063 0.945 . . . . 0.0 113.15 -177.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.1 -33.88 76.77 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 122.142 0.972 . . . . 0.0 110.343 177.092 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 50.5 m -60.88 -37.34 81.84 Favored 'General case' 0 C--N 1.284 -2.258 0 CA-C-N 115.106 -0.952 . . . . 0.0 112.029 176.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.436 ' O ' HG23 ' A' ' 89' ' ' VAL . 59.5 p -63.7 -45.3 90.64 Favored 'General case' 0 C--N 1.347 0.488 0 C-N-CA 120.507 -0.477 . . . . 0.0 110.836 -177.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 4.0 pt -66.13 -38.24 81.54 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.687 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.408 179.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 13.5 mt -59.66 -44.4 93.58 Favored 'General case' 0 CA--C 1.511 -0.547 0 O-C-N 123.284 0.365 . . . . 0.0 111.751 175.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.424 ' O ' ' HB2' ' A' ' 92' ' ' LEU . . . -69.72 -43.98 71.24 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.106 -179.533 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.475 HG22 HG22 ' A' ' 104' ' ' ILE . 85.3 t -60.99 -45.44 98.52 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-O 121.488 0.661 . . . . 0.0 110.98 178.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -65.76 -37.3 85.96 Favored 'General case' 0 C--N 1.284 -2.262 0 C-N-CA 124.196 0.998 . . . . 0.0 111.828 -176.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -91.62 -28.09 17.72 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 112.94 0.719 . . . . 0.0 112.94 -176.188 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.439 ' HB2' HG13 ' A' ' 104' ' ' ILE . 14.8 mt -97.06 -28.91 13.93 Favored 'General case' 0 CA--C 1.491 -1.305 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -173.117 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -65.56 125.26 24.65 Favored 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 120.03 -0.668 . . . . 0.0 109.465 -178.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 88.53 -8.36 79.26 Favored Glycine 0 C--N 1.31 -0.876 0 CA-C-N 115.643 -0.708 . . . . 0.0 112.501 -178.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -81.17 137.59 35.9 Favored 'General case' 0 CA--C 1.516 -0.332 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 -178.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.4 ' HD2' ' N ' ' A' ' 96' ' ' LYS . 11.2 mptt -95.51 122.86 38.69 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-O 120.969 0.414 . . . . 0.0 111.571 -175.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 54.5 mt -127.02 141.37 46.44 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 N-CA-C 105.734 -1.95 . . . . 0.0 105.734 172.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.489 ' HA3' HD22 ' A' ' 39' ' ' ASN . . . 56.84 26.83 55.23 Favored Glycine 0 CA--C 1.521 0.438 0 O-C-N 123.035 0.209 . . . . 0.0 113.395 -179.309 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 79.5 8.19 87.93 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 121.296 -0.478 . . . . 0.0 113.786 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 15.8 ptp180 -131.2 142.08 50.14 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 117.87 0.835 . . . . 0.0 110.321 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -82.83 120.31 25.48 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.686 -177.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 11.4 mt -65.78 143.96 57.17 Favored 'General case' 0 C--O 1.249 1.047 0 CA-C-O 121.858 0.837 . . . . 0.0 112.683 179.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 22.7 tptm -116.59 118.7 33.33 Favored 'General case' 0 N--CA 1.418 -2.056 0 CA-C-N 114.771 -1.104 . . . . 0.0 108.548 175.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.475 HG22 HG22 ' A' ' 89' ' ' VAL . 4.4 mm -117.63 136.01 56.19 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.185 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 178.254 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -143.43 152.66 41.81 Favored 'General case' 0 C--N 1.287 -2.151 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -178.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 74.4 m-70 -83.81 131.96 34.86 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 178.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 5.8 t -156.27 161.73 40.2 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 -177.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 41.7 m-85 -109.91 109.21 19.76 Favored 'General case' 0 N--CA 1.42 -1.963 0 C-N-CA 118.351 -1.34 . . . . 0.0 107.466 169.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 25.5 t80 . . . . . 0 C--N 1.277 -2.546 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 -179.915 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 4.0 mp . . . . . 0 C--O 1.246 0.871 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 227' ' ' MET . . . . . . . . . . . . . 26.1 ptt? -69.71 151.03 96.59 Favored Pre-proline 0 C--N 1.318 -0.797 0 O-C-N 123.485 0.491 . . . . 0.0 110.077 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 228' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -71.7 161.2 45.93 Favored 'Trans proline' 0 C--O 1.252 1.176 0 C-N-CA 123.141 2.561 . . . . 0.0 114.327 -175.27 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . -83.66 173.28 51.01 Favored Glycine 0 N--CA 1.436 -1.326 0 CA-C-N 114.736 -1.12 . . . . 0.0 112.318 177.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 9.6 m -74.35 -14.49 60.89 Favored 'General case' 0 C--N 1.306 -1.288 0 C-N-CA 123.456 0.703 . . . . 0.0 112.369 -174.021 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 38.9 mmt180 -91.41 -6.22 53.16 Favored 'General case' 0 C--N 1.318 -0.791 0 C-N-CA 120.076 -0.65 . . . . 0.0 111.693 -177.004 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 232' ' ' TRP . . . . . 0.463 ' HB2' ' CB ' ' A' ' 52' ' ' SER . 21.0 t90 -76.4 121.11 22.57 Favored 'General case' 0 CA--C 1.497 -1.062 0 CA-C-O 122.45 1.119 . . . . 0.0 112.324 -178.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 233' ' ' ASP . . . . . 0.408 ' H ' HG23 ' A' ' 49' ' ' THR . 24.7 t70 -118.04 148.68 42.02 Favored 'General case' 0 N--CA 1.407 -2.623 0 N-CA-C 102.541 -3.133 . . . . 0.0 102.541 171.546 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.208 0 C-N-CA 127.967 2.699 . . . . 0.0 116.418 -176.987 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 240' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.418 -2.547 0 N-CA-C 111.568 -0.613 . . . . 0.0 111.568 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 35.0 p90 -76.96 -33.51 57.66 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-O 121.481 0.657 . . . . 0.0 110.273 174.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -67.23 -39.45 86.21 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.518 -176.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -60.13 -34.35 73.4 Favored 'General case' 0 C--O 1.202 -1.43 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.826 177.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -62.09 -37.81 86.48 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 122.817 0.447 . . . . 0.0 109.96 -179.147 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 245' ' ' TRP . . . . . 0.519 ' O ' ' HG3' ' B' ' 248' ' ' LYS . 36.8 m0 -69.6 -39.73 77.07 Favored 'General case' 0 C--O 1.242 0.702 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.551 178.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 246' ' ' PHE . . . . . 0.742 ' O ' ' HG2' ' B' ' 249' ' ' GLN . 2.8 t80 -70.2 -33.05 71.23 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 114.879 -1.055 . . . . 0.0 110.812 177.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -73.15 -31.01 64.0 Favored 'General case' 0 C--N 1.285 -2.237 0 O-C-N 121.817 -0.552 . . . . 0.0 110.663 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 248' ' ' LYS . . . . . 0.519 ' HG3' ' O ' ' B' ' 245' ' ' TRP . 2.2 pptp? -87.22 -12.1 47.81 Favored 'General case' 0 C--O 1.221 -0.414 0 CA-C-O 120.86 0.362 . . . . 0.0 111.594 -177.259 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 249' ' ' GLN . . . . . 0.742 ' HG2' ' O ' ' B' ' 246' ' ' PHE . 2.9 pt20 -79.33 2.99 19.54 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.002 -178.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 250' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -56.98 -36.99 70.99 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.267 176.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -116.27 152.92 32.86 Favored 'General case' 0 N--CA 1.411 -2.379 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 175.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 252' ' ' ILE . . . . . . . . . . . . . 28.5 pt -128.79 -28.21 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 -173.164 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -117.32 -24.7 7.32 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-O 121.061 0.457 . . . . 0.0 109.806 -174.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 254' ' ' GLU . . . . . . . . . . . . . 48.4 mp0 . . . . . 0 N--CA 1.438 -1.032 0 C-N-CA 126.084 1.754 . . . . 0.0 114.622 -172.754 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.24 0.6 0 N-CA-C 112.33 0.492 . . . . 0.0 112.33 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -108.25 145.85 33.71 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-O 121.124 0.488 . . . . 0.0 111.548 -173.06 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 26.7 pt -138.23 154.99 28.61 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.503 175.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -106.81 122.86 47.22 Favored 'General case' 0 C--N 1.286 -2.158 0 CA-C-N 114.67 -1.15 . . . . 0.0 108.802 176.009 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.532 HG23 ' CD1' ' A' ' 104' ' ' ILE . 11.5 mt -107.97 127.04 64.43 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 N-CA-C 106.182 -1.784 . . . . 0.0 106.182 176.543 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -129.07 167.94 20.96 Favored Glycine 0 C--N 1.28 -2.566 0 N-CA-C 110.357 -1.097 . . . . 0.0 110.357 179.03 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 75.7 30.32 0.79 Allowed 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.644 1.178 . . . . 0.0 111.179 -179.056 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.455 HD11 HD11 ' A' ' 47' ' ' ILE . 4.1 mm? -66.94 154.54 40.83 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.639 -0.71 . . . . 0.0 112.047 178.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.422 ' HB3' ' HG ' ' A' ' 42' ' ' LEU . 42.8 t-20 -95.03 146.06 24.52 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 106.225 -1.768 . . . . 0.0 106.225 174.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 8.0 ppt_? -60.52 -23.31 64.47 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 122.96 0.504 . . . . 0.0 112.332 178.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.4 ' HG2' ' CG ' ' A' ' 39' ' ' ASN . 11.2 pt-20 -88.61 -9.53 51.86 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.798 -178.521 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.422 ' HG ' ' HB3' ' A' ' 39' ' ' ASN . 67.1 mt -80.99 125.96 30.79 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 121.188 0.518 . . . . 0.0 110.874 -177.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 66.9 p -107.31 173.36 6.36 Favored 'General case' 0 C--N 1.293 -1.867 0 CA-C-N 114.885 -1.052 . . . . 0.0 110.063 -178.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.8 mp0 -57.66 -40.54 79.59 Favored 'General case' 0 N--CA 1.433 -1.282 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.449 177.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -59.42 -38.49 93.54 Favored Glycine 0 N--CA 1.445 -0.716 0 O-C-N 123.681 0.613 . . . . 0.0 112.629 179.119 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -67.25 -49.19 65.36 Favored 'General case' 0 CA--C 1.499 -1.002 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 179.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.455 HD11 HD11 ' A' ' 38' ' ' LEU . 54.4 mt -59.73 -47.39 91.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.074 -0.966 . . . . 0.0 110.616 179.436 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 49.4 mt -59.72 -44.55 93.68 Favored 'General case' 0 CA--C 1.49 -1.345 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.468 -177.138 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.453 HG23 ' H ' ' B' ' 233' ' ' ASP . 62.5 m -61.69 -46.27 90.41 Favored 'General case' 0 C--N 1.31 -1.13 0 O-C-N 123.454 0.471 . . . . 0.0 111.636 -178.553 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 86.8 t -67.3 -47.59 80.73 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.777 -178.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.409 ' HD2' ' HH ' ' A' ' 79' ' ' TYR . 3.7 m-85 -65.92 -23.82 66.7 Favored 'General case' 0 N--CA 1.435 -1.177 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.725 -179.235 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.533 ' OG ' ' HB2' ' B' ' 231' ' ' ARG . 70.0 m -70.69 -18.53 62.82 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 176.255 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -76.06 -28.96 57.82 Favored 'General case' 0 C--O 1.249 1.051 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 176.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 51.7 m-85 -86.23 -23.19 26.52 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.279 -176.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 177.4 -155.89 18.81 Favored Glycine 0 N--CA 1.43 -1.74 0 C-N-CA 120.4 -0.905 . . . . 0.0 112.546 177.325 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 69.3 t -107.66 108.66 61.84 Favored Pre-proline 0 C--N 1.303 -1.438 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 -179.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.402 ' HB3' HD21 ' A' ' 77' ' ' LEU . 73.8 Cg_endo -76.24 137.0 18.57 Favored 'Trans proline' 0 N--CA 1.439 -1.686 0 C-N-CA 122.175 1.917 . . . . 0.0 109.905 177.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 35.4 m -113.45 -23.83 4.14 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.864 0 C-N-CA 119.699 -0.8 . . . . 0.0 111.146 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.48 ' HB3' ' HG2' ' A' ' 78' ' ' LYS . 32.7 t70 -158.02 142.87 16.46 Favored 'General case' 0 C--O 1.244 0.812 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 178.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 14.1 p -140.57 135.95 35.41 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.238 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 178.167 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 78.7 mt -121.3 128.47 75.95 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 176.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -102.02 120.96 41.26 Favored 'General case' 0 C--N 1.29 -1.984 0 N-CA-C 105.742 -1.947 . . . . 0.0 105.742 175.251 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 15.7 m -80.98 117.6 21.74 Favored 'General case' 0 N--CA 1.415 -2.192 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 70.0 mtt85 . . . . . 0 C--N 1.299 -1.603 0 CA-C-O 120.981 0.42 . . . . 0.0 111.298 -178.072 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 . . . . . 0 N--CA 1.446 -0.672 0 CA-C-O 120.949 0.404 . . . . 0.0 111.828 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 90.3 13.01 60.73 Favored Glycine 0 N--CA 1.429 -1.769 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.027 179.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.426 ' HA ' HD23 ' A' ' 38' ' ' LEU . 45.6 p90 -154.08 158.85 41.09 Favored 'General case' 0 N--CA 1.431 -1.396 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 177.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -152.14 176.44 11.55 Favored 'General case' 0 N--CA 1.438 -1.043 0 O-C-N 123.568 0.543 . . . . 0.0 110.085 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -136.64 144.71 44.17 Favored 'General case' 0 C--N 1.306 -1.324 0 C-N-CA 123.292 0.637 . . . . 0.0 110.037 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.402 HD21 ' HB3' ' A' ' 57' ' ' PRO . 9.9 tt -149.28 140.68 23.27 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 176.451 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.48 ' HG2' ' HB3' ' A' ' 59' ' ' ASP . 22.0 ptmt -122.93 144.57 49.15 Favored 'General case' 0 C--O 1.257 1.486 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.409 ' HH ' ' HD2' ' A' ' 51' ' ' PHE . 86.2 m-85 -108.96 165.24 11.73 Favored 'General case' 0 C--N 1.29 -2.021 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.34 -177.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -68.4 -38.09 80.95 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 114.703 -1.135 . . . . 0.0 108.786 174.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -126.23 145.9 50.21 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-O 121.324 0.583 . . . . 0.0 111.967 -178.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 20.0 mp0 -67.1 -29.28 68.99 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 124.495 1.118 . . . . 0.0 112.271 -178.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 58.3 mtm180 -61.06 -33.81 73.89 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-O 122.145 0.974 . . . . 0.0 111.692 178.228 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 51.1 m -64.27 -37.34 87.14 Favored 'General case' 0 C--N 1.28 -2.424 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.541 174.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.419 ' O ' HG23 ' A' ' 89' ' ' VAL . 52.6 p -63.18 -44.75 94.51 Favored 'General case' 0 C--O 1.22 -0.496 0 C-N-CA 120.424 -0.51 . . . . 0.0 110.432 -178.15 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 5.4 pt -65.86 -39.21 84.05 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 C-N-CA 122.49 0.316 . . . . 0.0 111.459 179.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 18.7 mt -60.21 -43.94 95.54 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 123.662 0.601 . . . . 0.0 110.903 175.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.402 ' HB1' HD12 ' A' ' 92' ' ' LEU . . . -71.69 -46.47 58.7 Favored 'General case' 0 N--CA 1.435 -1.189 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.757 -178.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 85' ' ' THR . 72.4 t -57.03 -48.29 82.06 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.71 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -179.42 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -63.63 -37.17 86.31 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-O 120.951 0.405 . . . . 0.0 111.437 -175.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -93.02 -21.09 19.95 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 -174.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.507 ' HB2' HG13 ' A' ' 104' ' ' ILE . 20.4 mt -99.3 -28.89 13.1 Favored 'General case' 0 C--N 1.291 -1.976 0 C-N-CA 120.455 -0.498 . . . . 0.0 111.506 -176.361 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -66.28 124.6 23.11 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 177.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 83.18 -0.59 89.65 Favored Glycine 0 C--N 1.304 -1.242 0 C-N-CA 121.099 -0.572 . . . . 0.0 112.608 -179.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 69.4 t80 -85.2 131.66 34.4 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 -178.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -90.62 119.42 30.85 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-O 121.172 0.51 . . . . 0.0 112.241 -176.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 48.5 mt -127.67 141.35 46.64 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 N-CA-C 105.866 -1.902 . . . . 0.0 105.866 172.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 60.34 18.24 49.3 Favored Glycine 0 CA--C 1.526 0.774 0 C-N-CA 121.41 -0.424 . . . . 0.0 113.939 178.315 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 85.44 11.26 75.43 Favored Glycine 0 N--CA 1.437 -1.266 0 C-N-CA 121.058 -0.592 . . . . 0.0 112.721 -179.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 16.1 ptp180 -135.5 145.3 46.96 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 117.115 0.458 . . . . 0.0 110.913 179.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -87.49 120.58 28.94 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.067 -177.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 12.4 mt -67.33 148.92 51.03 Favored 'General case' 0 C--N 1.31 -1.118 0 C-N-CA 123.789 0.836 . . . . 0.0 112.822 178.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 17.3 tppt? -124.6 118.75 27.23 Favored 'General case' 0 N--CA 1.422 -1.84 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.191 176.231 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.532 ' CD1' HG23 ' A' ' 35' ' ' ILE . 5.1 mm -119.96 136.38 57.25 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 179.372 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -142.09 146.47 35.45 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 81.1 m-70 -79.34 132.71 36.52 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.278 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 4.7 t -162.41 163.73 27.58 Favored 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 -175.217 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -99.34 112.94 25.02 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 174.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 35.5 t80 . . . . . 0 C--N 1.297 -1.696 0 CA-C-N 115.945 -0.571 . . . . 0.0 109.667 179.785 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 4.2 mp . . . . . 0 N--CA 1.434 -1.229 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 227' ' ' MET . . . . . . . . . . . . . 27.8 ptm -89.11 149.31 42.87 Favored Pre-proline 0 C--N 1.307 -1.251 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 177.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 228' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -63.62 151.04 86.92 Favored 'Trans proline' 0 C--O 1.244 0.806 0 C-N-CA 123.443 2.762 . . . . 0.0 113.564 -177.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . -77.79 174.92 54.68 Favored Glycine 0 C--O 1.246 0.869 0 CA-C-N 115.432 -0.804 . . . . 0.0 112.546 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 17.6 m -76.3 -17.06 59.62 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -176.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 231' ' ' ARG . . . . . 0.533 ' HB2' ' OG ' ' A' ' 52' ' ' SER . 9.8 mmm180 -79.82 -8.27 59.18 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 120.794 0.33 . . . . 0.0 111.324 179.63 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 232' ' ' TRP . . . . . . . . . . . . . 24.5 t90 -72.02 128.62 36.29 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-O 122.125 0.964 . . . . 0.0 111.383 179.078 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 233' ' ' ASP . . . . . 0.453 ' H ' HG23 ' A' ' 49' ' ' THR . 16.7 t70 -123.33 140.2 53.25 Favored 'General case' 0 C--N 1.265 -3.106 0 N-CA-C 101.586 -3.487 . . . . 0.0 101.586 173.409 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.501 3.024 0 C-N-CA 128.622 3.011 . . . . 0.0 116.72 -179.447 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 240' ' ' GLY . . . . . 0.494 ' O ' ' HG2' ' B' ' 244' ' ' LYS . . . . . . . . 0 N--CA 1.416 -2.664 0 N-CA-C 110.489 -1.045 . . . . 0.0 110.489 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 49.7 p90 -75.95 -35.94 59.51 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -178.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -66.35 -38.74 88.3 Favored 'General case' 0 CA--C 1.5 -0.979 0 CA-C-N 116.727 -0.215 . . . . 0.0 111.04 -176.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -60.51 -35.16 75.28 Favored 'General case' 0 C--O 1.202 -1.396 0 O-C-N 123.597 0.561 . . . . 0.0 110.483 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 244' ' ' LYS . . . . . 0.494 ' HG2' ' O ' ' B' ' 240' ' ' GLY . 70.4 mmtt -67.14 -41.82 85.44 Favored 'General case' 0 CA--C 1.509 -0.628 0 CA-C-O 121.662 0.744 . . . . 0.0 109.137 -178.091 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 245' ' ' TRP . . . . . . . . . . . . . 45.3 m0 -68.93 -41.07 78.61 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 114.853 -1.067 . . . . 0.0 109.58 179.107 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 246' ' ' PHE . . . . . 0.548 ' O ' ' HG2' ' B' ' 249' ' ' GLN . 5.2 t80 -65.86 -37.86 87.3 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.777 179.155 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -68.02 -33.33 74.4 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.556 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.9 -21.05 21.58 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 120.669 -0.413 . . . . 0.0 111.946 -177.607 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 249' ' ' GLN . . . . . 0.548 ' HG2' ' O ' ' B' ' 246' ' ' PHE . 3.0 pt20 -75.42 2.29 11.79 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.092 0.472 . . . . 0.0 111.287 -178.056 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 250' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -56.91 -38.57 73.03 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.319 178.077 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -139.57 113.55 8.76 Favored 'General case' 0 N--CA 1.439 -0.987 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 175.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 252' ' ' ILE . . . . . . . . . . . . . 27.8 pt -102.54 -37.48 4.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 -172.288 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -108.87 -18.07 13.78 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-O 121.846 0.832 . . . . 0.0 110.048 -175.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 254' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 . . . . . 0 C--N 1.29 -2.018 0 CA-C-N 114.205 -1.361 . . . . 0.0 112.054 -176.476 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.464 ' HB2' ' NE2' ' A' ' 82' ' ' GLN . . . . . . . . 0 N--CA 1.435 -1.181 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -103.68 144.65 31.17 Favored 'General case' 0 N--CA 1.429 -1.518 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.831 -174.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 25.1 pt -141.37 157.05 21.7 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.742 0 CA-C-N 115.476 -0.783 . . . . 0.0 109.462 178.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.422 ' HB2' HG21 ' A' ' 107' ' ' THR . 16.5 t80 -108.81 123.04 48.42 Favored 'General case' 0 N--CA 1.411 -2.378 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 176.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.505 HG23 ' CD1' ' A' ' 104' ' ' ILE . 12.0 mt -107.83 126.97 64.26 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.931 0 N-CA-C 105.792 -1.929 . . . . 0.0 105.792 176.518 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -129.01 165.4 21.8 Favored Glycine 0 N--CA 1.418 -2.556 0 N-CA-C 112.041 -0.424 . . . . 0.0 112.041 -177.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 8.3 t30 63.57 51.97 2.39 Favored 'General case' 0 C--N 1.314 -0.951 0 C-N-CA 125.146 1.378 . . . . 0.0 109.876 -177.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.408 HD11 HD11 ' A' ' 47' ' ' ILE . 3.1 mm? -78.37 161.2 27.34 Favored 'General case' 0 CA--C 1.502 -0.884 0 CA-C-N 113.99 -1.459 . . . . 0.0 111.482 178.499 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.493 ' HB3' ' HG ' ' A' ' 42' ' ' LEU . 49.8 t-20 -98.12 145.5 26.51 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 174.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.552 ' HD2' ' N ' ' A' ' 41' ' ' GLU . 7.4 ppt_? -58.79 -27.13 64.73 Favored 'General case' 0 C--N 1.31 -1.137 0 C-N-CA 123.543 0.737 . . . . 0.0 111.924 179.592 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.552 ' N ' ' HD2' ' A' ' 40' ' ' ARG . 11.4 pt-20 -85.59 -11.82 53.04 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.543 -176.366 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.493 ' HG ' ' HB3' ' A' ' 39' ' ' ASN . 79.0 mt -84.21 118.73 24.34 Favored 'General case' 0 CA--C 1.492 -1.279 0 CA-C-O 121.474 0.654 . . . . 0.0 111.09 -176.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 46.6 p -107.82 173.92 6.11 Favored 'General case' 0 N--CA 1.414 -2.273 0 CA-C-N 114.417 -1.265 . . . . 0.0 109.445 -178.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.479 ' HG3' ' HB2' ' A' ' 62' ' ' LEU . 1.7 mp0 -54.92 -41.37 70.93 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 123.871 0.868 . . . . 0.0 109.759 178.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.17 -43.28 98.56 Favored Glycine 0 N--CA 1.439 -1.126 0 CA-C-N 115.545 -0.752 . . . . 0.0 112.894 -179.219 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -68.1 -45.29 74.13 Favored 'General case' 0 CA--C 1.513 -0.444 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 -179.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.408 HD11 HD11 ' A' ' 38' ' ' LEU . 37.9 mt -58.55 -44.12 88.61 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.488 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.707 178.571 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 43.8 mt -59.37 -44.7 92.68 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.51 HG23 ' H ' ' B' ' 233' ' ' ASP . 89.4 m -61.66 -46.26 90.48 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 120.804 0.335 . . . . 0.0 111.619 178.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 84.6 t -63.18 -49.47 83.09 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.379 179.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.427 ' HA ' ' HD2' ' A' ' 54' ' ' TYR . 4.1 m-85 -69.43 -23.08 63.63 Favored 'General case' 0 N--CA 1.433 -1.318 0 C-N-CA 123.583 0.753 . . . . 0.0 112.868 -177.257 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.472 ' OG ' ' HB2' ' B' ' 231' ' ' ARG . 72.6 m -68.57 -20.1 64.51 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 111.917 0.34 . . . . 0.0 111.917 176.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -63.47 -28.0 69.66 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-O 122.029 0.919 . . . . 0.0 109.007 173.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.427 ' HD2' ' HA ' ' A' ' 51' ' ' PHE . 50.9 m-85 -96.3 -2.87 45.0 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.262 -174.452 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 148.21 -152.96 24.96 Favored Glycine 0 N--CA 1.42 -2.432 0 C-N-CA 119.975 -1.107 . . . . 0.0 112.015 178.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 61.8 t -107.52 111.01 63.06 Favored Pre-proline 0 C--N 1.296 -1.742 0 CA-C-O 120.717 0.294 . . . . 0.0 110.948 -177.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.493 ' HB3' HD21 ' A' ' 77' ' ' LEU . 58.7 Cg_endo -74.74 145.49 32.6 Favored 'Trans proline' 0 N--CA 1.45 -1.081 0 C-N-CA 122.719 2.279 . . . . 0.0 110.041 174.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.416 ' CG2' ' HG3' ' A' ' 78' ' ' LYS . 34.4 m -116.45 -24.97 3.3 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 C-N-CA 119.674 -0.81 . . . . 0.0 111.463 177.5 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -158.36 147.57 19.26 Favored 'General case' 0 C--O 1.249 1.07 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 12.5 p -145.78 132.47 14.53 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-O 121.002 0.429 . . . . 0.0 110.432 -179.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 84.2 mt -120.62 126.85 75.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 177.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.479 ' HB2' ' HG3' ' A' ' 44' ' ' GLU . 0.2 OUTLIER -100.3 122.73 43.54 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 105.753 -1.944 . . . . 0.0 105.753 175.533 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 15.4 m -82.13 116.8 21.86 Favored 'General case' 0 N--CA 1.406 -2.648 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 178.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 84.3 mtt180 . . . . . 0 C--N 1.303 -1.418 0 CA-C-O 121.43 0.634 . . . . 0.0 110.82 -175.543 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 . . . . . 0 N--CA 1.435 -1.194 0 CA-C-O 121.433 0.635 . . . . 0.0 110.111 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 100.19 17.65 24.19 Favored Glycine 0 N--CA 1.429 -1.781 0 CA-C-N 115.475 -0.784 . . . . 0.0 112.536 178.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -160.86 156.83 25.63 Favored 'General case' 0 C--O 1.244 0.801 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 177.38 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -152.81 175.98 12.29 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-O 120.789 0.328 . . . . 0.0 110.995 179.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -134.88 143.18 46.82 Favored 'General case' 0 C--N 1.317 -0.813 0 C-N-CA 123.989 0.915 . . . . 0.0 110.425 -177.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.493 HD21 ' HB3' ' A' ' 57' ' ' PRO . 10.0 tt -150.07 140.59 22.48 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 175.571 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.416 ' HG3' ' CG2' ' A' ' 58' ' ' VAL . 20.8 ptmt -122.56 144.18 49.26 Favored 'General case' 0 C--O 1.255 1.394 0 CA-C-O 121.02 0.438 . . . . 0.0 109.951 179.61 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -108.9 164.58 12.27 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.539 -178.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -74.59 -25.64 59.39 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 114.822 -1.081 . . . . 0.0 109.736 175.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -127.77 136.76 51.93 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.073 -175.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.464 ' NE2' ' HB2' ' A' ' 31' ' ' ALA . 22.5 mp0 -69.74 -19.9 63.53 Favored 'General case' 0 C--N 1.313 -1.022 0 N-CA-C 113.191 0.811 . . . . 0.0 113.191 177.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 90.9 mtm180 -68.24 -34.64 76.6 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-O 122.261 1.029 . . . . 0.0 109.592 174.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 67.2 m -65.21 -37.37 87.08 Favored 'General case' 0 C--N 1.286 -2.173 0 CA-C-N 114.702 -1.135 . . . . 0.0 112.226 178.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.46 ' O ' HG23 ' A' ' 89' ' ' VAL . 77.3 p -64.93 -45.62 85.05 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 120.438 -0.505 . . . . 0.0 110.577 -178.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 6.7 pt -64.8 -38.63 83.2 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.093 177.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 13.2 mt -58.87 -43.6 90.92 Favored 'General case' 0 C--O 1.242 0.696 0 O-C-N 123.296 0.372 . . . . 0.0 111.006 176.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.412 ' HB1' HD12 ' A' ' 92' ' ' LEU . . . -70.84 -46.75 62.16 Favored 'General case' 0 N--CA 1.435 -1.204 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.208 -178.626 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 85' ' ' THR . 78.2 t -56.73 -47.05 83.2 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.581 0 CA-C-O 121.446 0.641 . . . . 0.0 110.739 179.229 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -59.02 -39.16 81.06 Favored 'General case' 0 C--N 1.295 -1.78 0 C-N-CA 125.221 1.408 . . . . 0.0 112.518 -176.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 48.9 m-80 -98.49 -22.5 15.98 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 113.798 1.036 . . . . 0.0 113.798 -175.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.515 ' HB2' HG13 ' A' ' 104' ' ' ILE . 18.6 mt -94.92 -30.05 14.35 Favored 'General case' 0 C--N 1.293 -1.889 0 C-N-CA 120.685 -0.406 . . . . 0.0 111.435 -174.284 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 50.2 t-20 -65.64 124.25 21.87 Favored 'General case' 0 N--CA 1.434 -1.265 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 176.198 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 84.38 -0.33 89.32 Favored Glycine 0 C--N 1.3 -1.468 0 C-N-CA 119.888 -1.148 . . . . 0.0 113.1 -179.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -92.24 136.8 32.9 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -95.57 120.06 35.17 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-O 121.061 0.458 . . . . 0.0 112.069 -176.127 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 55.3 mt -126.89 141.69 45.49 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 N-CA-C 106.565 -1.643 . . . . 0.0 106.565 174.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 60.08 19.79 52.18 Favored Glycine 0 CA--C 1.527 0.836 0 O-C-N 122.929 0.143 . . . . 0.0 113.275 -179.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 85.89 12.14 72.13 Favored Glycine 0 N--CA 1.438 -1.184 0 C-N-CA 121.497 -0.383 . . . . 0.0 113.07 -179.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.448 ' NH1' ' HA ' ' A' ' 39' ' ' ASN . 17.4 ptp180 -137.87 149.69 46.49 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 117.861 0.831 . . . . 0.0 110.719 178.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -83.7 126.18 32.63 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-O 120.64 0.257 . . . . 0.0 110.84 -178.136 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.414 ' HA ' HD23 ' A' ' 102' ' ' LEU . 12.1 mt -76.24 143.75 40.79 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-O 121.705 0.764 . . . . 0.0 112.629 178.024 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 5.3 tppp? -115.73 119.4 35.92 Favored 'General case' 0 N--CA 1.416 -2.146 0 CA-C-N 114.875 -1.057 . . . . 0.0 109.159 176.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.515 HG13 ' HB2' ' A' ' 92' ' ' LEU . 5.0 mm -121.42 135.99 59.8 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 178.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -144.05 150.46 38.23 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 177.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -75.17 144.13 42.88 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 177.213 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.422 HG21 ' HB2' ' A' ' 34' ' ' TYR . 12.3 t -163.21 165.98 23.78 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 106.7 -1.593 . . . . 0.0 106.7 -178.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -109.9 110.91 22.03 Favored 'General case' 0 N--CA 1.428 -1.536 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 171.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 16.5 t80 . . . . . 0 C--N 1.288 -2.074 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 -178.884 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 4.4 mp . . . . . 0 N--CA 1.442 -0.853 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 227' ' ' MET . . . . . . . . . . . . . 26.7 ptt? -67.67 147.93 98.61 Favored Pre-proline 0 C--N 1.321 -0.657 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.061 179.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 228' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -78.56 150.65 24.89 Favored 'Trans proline' 0 C--O 1.253 1.23 0 C-N-CA 123.057 2.505 . . . . 0.0 112.393 -179.38 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . -73.04 167.04 54.37 Favored Glycine 0 C--N 1.315 -0.603 0 CA-C-N 116.003 -0.544 . . . . 0.0 112.52 178.137 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 21.6 t -70.5 -13.89 62.3 Favored 'General case' 0 C--N 1.317 -0.825 0 C-N-CA 123.228 0.611 . . . . 0.0 111.332 -177.183 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 231' ' ' ARG . . . . . 0.472 ' HB2' ' OG ' ' A' ' 52' ' ' SER . 31.5 mmt180 -78.94 -9.02 59.38 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.658 -0.246 . . . . 0.0 111.041 179.628 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 232' ' ' TRP . . . . . 0.414 ' HB2' ' CB ' ' A' ' 52' ' ' SER . 19.2 t90 -77.34 129.47 35.88 Favored 'General case' 0 N--CA 1.427 -1.603 0 CA-C-O 122.29 1.043 . . . . 0.0 111.319 -179.487 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 233' ' ' ASP . . . . . 0.51 ' H ' HG23 ' A' ' 49' ' ' THR . 9.4 t70 -123.35 136.15 54.52 Favored 'General case' 0 C--N 1.265 -3.093 0 N-CA-C 100.926 -3.731 . . . . 0.0 100.926 175.321 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 2.778 0 C-N-CA 128.4 2.905 . . . . 0.0 116.87 -177.222 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 240' ' ' GLY . . . . . 0.513 ' O ' ' HE2' ' B' ' 244' ' ' LYS . . . . . . . . 0 C--O 1.19 -2.644 0 N-CA-C 112.622 -0.191 . . . . 0.0 112.622 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 26.2 p90 -76.51 -33.82 58.6 Favored 'General case' 0 C--N 1.29 -2.001 0 CA-C-N 117.531 0.665 . . . . 0.0 111.094 178.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -66.79 -38.84 87.31 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.722 -178.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -62.15 -35.2 78.06 Favored 'General case' 0 C--O 1.21 -0.989 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.83 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 244' ' ' LYS . . . . . 0.513 ' HE2' ' O ' ' B' ' 240' ' ' GLY . 68.9 mmtt -65.61 -44.04 87.77 Favored 'General case' 0 CA--C 1.502 -0.884 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 -177.128 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 245' ' ' TRP . . . . . 0.426 ' O ' ' HB3' ' B' ' 249' ' ' GLN . 39.6 m0 -61.82 -43.23 99.27 Favored 'General case' 0 C--O 1.208 -1.107 0 CA-C-N 115.075 -0.966 . . . . 0.0 109.315 178.566 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 246' ' ' PHE . . . . . 0.555 ' HA ' ' NE2' ' B' ' 249' ' ' GLN . 4.5 t80 -66.94 -32.44 73.69 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.405 179.037 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -77.41 -39.88 45.51 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.301 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.23 -12.78 36.98 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 -175.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 249' ' ' GLN . . . . . 0.555 ' NE2' ' HA ' ' B' ' 246' ' ' PHE . 3.2 pt20 -66.27 -8.51 25.27 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 120.946 0.403 . . . . 0.0 111.038 -178.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 250' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -68.04 -28.58 67.51 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 177.074 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 251' ' ' GLU . . . . . 0.554 ' HB3' ' HB2' ' B' ' 254' ' ' GLU . 42.7 mt-10 -86.19 114.52 23.09 Favored 'General case' 0 N--CA 1.421 -1.905 0 CA-C-N 114.145 -1.388 . . . . 0.0 107.552 177.403 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 252' ' ' ILE . . . . . . . . . . . . . 41.2 pt -118.5 -25.92 2.72 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -174.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -105.61 -15.65 14.92 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 -177.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 254' ' ' GLU . . . . . 0.554 ' HB2' ' HB3' ' B' ' 251' ' ' GLU . 11.7 mp0 . . . . . 0 C--N 1.303 -1.42 0 C-N-CA 125.585 1.554 . . . . 0.0 114.722 -177.065 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.741 0 N-CA-C 111.711 0.263 . . . . 0.0 111.711 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 13.2 m-30 -93.85 144.83 25.08 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 120.196 -0.602 . . . . 0.0 110.359 -176.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 23.6 pt -142.64 161.01 18.8 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.096 175.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.424 ' HB2' HG21 ' A' ' 107' ' ' THR . 65.2 t80 -111.52 123.28 49.9 Favored 'General case' 0 N--CA 1.413 -2.305 0 CA-C-N 114.742 -1.117 . . . . 0.0 108.049 178.469 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 13.1 mt -108.39 127.26 64.88 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.047 0 N-CA-C 105.975 -1.861 . . . . 0.0 105.975 175.232 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -124.44 156.36 18.5 Favored Glycine 0 N--CA 1.42 -2.374 0 N-CA-C 111.802 -0.519 . . . . 0.0 111.802 -177.089 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.422 HD21 ' HB2' ' A' ' 100' ' ' ARG . 64.3 t30 67.07 57.57 0.6 Allowed 'General case' 0 C--N 1.314 -0.946 0 C-N-CA 125.4 1.48 . . . . 0.0 110.682 -177.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.427 HD11 HD11 ' A' ' 47' ' ' ILE . 3.1 mm? -82.96 143.91 30.35 Favored 'General case' 0 CA--C 1.485 -1.553 0 CA-C-N 114.426 -1.261 . . . . 0.0 110.002 176.588 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.445 HD22 ' HA3' ' A' ' 98' ' ' GLY . 38.4 t-20 -79.32 144.92 33.78 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 176.629 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.562 ' HD2' ' N ' ' A' ' 41' ' ' GLU . 0.8 OUTLIER -59.4 -24.69 63.66 Favored 'General case' 0 C--N 1.302 -1.458 0 C-N-CA 123.471 0.709 . . . . 0.0 112.23 179.528 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.562 ' N ' ' HD2' ' A' ' 40' ' ' ARG . 11.4 pt-20 -89.0 -14.32 36.82 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.609 -177.386 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.423 ' HG ' ' HB3' ' A' ' 39' ' ' ASN . 54.0 mt -75.51 132.09 40.53 Favored 'General case' 0 CA--C 1.5 -0.974 0 CA-C-O 121.548 0.69 . . . . 0.0 111.781 -176.228 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 42.0 p -114.81 172.7 6.88 Favored 'General case' 0 N--CA 1.418 -2.03 0 CA-C-N 114.725 -1.125 . . . . 0.0 111.046 -177.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -56.19 -42.46 77.17 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 123.707 0.803 . . . . 0.0 110.503 179.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -59.99 -38.27 93.96 Favored Glycine 0 C--O 1.24 0.484 0 CA-C-N 115.497 -0.774 . . . . 0.0 112.541 -179.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 49.9 m-20 -67.19 -49.61 63.99 Favored 'General case' 0 CA--C 1.494 -1.198 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.427 HD11 HD11 ' A' ' 38' ' ' LEU . 47.0 mt -58.87 -46.35 91.21 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 CA-C-N 115.131 -0.94 . . . . 0.0 110.706 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 40.9 mt -59.81 -43.7 94.35 Favored 'General case' 0 CA--C 1.499 -1.017 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.605 -178.224 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.436 HG23 ' H ' ' B' ' 233' ' ' ASP . 85.6 m -63.36 -46.43 86.58 Favored 'General case' 0 C--N 1.313 -1.016 0 O-C-N 123.408 0.443 . . . . 0.0 111.165 -178.589 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 97.2 t -66.22 -49.77 73.51 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.368 -178.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.447 ' HA ' ' HD2' ' A' ' 54' ' ' TYR . 4.8 m-85 -64.99 -19.89 66.22 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 123.974 0.909 . . . . 0.0 112.767 -178.132 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.514 ' OG ' ' HB2' ' B' ' 231' ' ' ARG . 60.2 m -72.97 -23.59 60.68 Favored 'General case' 0 N--CA 1.439 -0.989 0 N-CA-C 112.319 0.489 . . . . 0.0 112.319 176.657 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 50.2 tt0 -67.83 -20.52 65.17 Favored 'General case' 0 CA--C 1.56 1.349 0 CA-C-O 121.726 0.775 . . . . 0.0 110.115 177.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.458 ' OH ' ' HG ' ' A' ' 92' ' ' LEU . 41.3 m-85 -97.02 -10.2 26.62 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.608 -178.41 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 156.5 -159.12 29.25 Favored Glycine 0 N--CA 1.43 -1.747 0 C-N-CA 119.951 -1.118 . . . . 0.0 112.29 -179.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 77.5 t -103.58 110.17 63.34 Favored Pre-proline 0 C--N 1.306 -1.318 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 -176.367 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.512 ' HB3' HD21 ' A' ' 77' ' ' LEU . 99.0 Cg_endo -80.01 137.12 12.12 Favored 'Trans proline' 0 C--O 1.247 0.954 0 C-N-CA 123.034 2.489 . . . . 0.0 110.914 176.203 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 28.4 m -113.49 -20.06 6.4 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 -178.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.515 ' HB3' ' HG2' ' A' ' 78' ' ' LYS . 37.8 t70 -159.88 145.34 15.42 Favored 'General case' 0 C--O 1.249 1.038 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 14.3 p -144.68 134.43 19.17 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 86.1 mt -120.47 118.14 55.64 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.774 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 176.239 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -92.13 116.48 28.98 Favored 'General case' 0 C--N 1.28 -2.441 0 N-CA-C 104.677 -2.342 . . . . 0.0 104.677 175.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 33.6 m -79.77 115.93 19.65 Favored 'General case' 0 N--CA 1.414 -2.239 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 179.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 72.0 mtp180 . . . . . 0 CA--C 1.483 -1.617 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 -176.419 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 . . . . . 0 N--CA 1.432 -1.343 0 CA-C-O 121.556 0.693 . . . . 0.0 111.338 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 107.28 15.88 14.75 Favored Glycine 0 N--CA 1.427 -1.913 0 CA-C-N 115.386 -0.824 . . . . 0.0 112.472 -179.276 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 30.0 p90 -157.41 159.12 37.04 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 177.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -151.63 172.5 15.97 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-O 120.863 0.363 . . . . 0.0 110.582 179.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -130.75 142.66 50.42 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 123.762 0.825 . . . . 0.0 109.539 -179.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.512 HD21 ' HB3' ' A' ' 57' ' ' PRO . 10.2 tt -148.11 140.96 24.72 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 176.167 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.515 ' HG2' ' HB3' ' A' ' 59' ' ' ASP . 21.9 ptmt -123.82 144.3 49.81 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-O 121.356 0.598 . . . . 0.0 109.673 178.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -104.77 165.68 10.9 Favored 'General case' 0 C--N 1.282 -2.331 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.833 -178.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -77.31 -30.65 54.21 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 115.384 -0.825 . . . . 0.0 108.967 174.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.436 ' OD1' ' HB2' ' A' ' 83' ' ' ARG . 12.5 t70 -119.91 137.56 53.96 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 -176.437 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 26.0 mp0 -69.49 -25.71 64.19 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 113.377 0.88 . . . . 0.0 113.377 -177.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.436 ' HB2' ' OD1' ' A' ' 81' ' ' ASP . 0.1 OUTLIER -67.35 -33.34 75.03 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-O 122.014 0.911 . . . . 0.0 110.291 -179.342 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.461 ' OG ' HG21 ' B' ' 226' ' ' ILE . 51.5 m -59.39 -36.99 76.84 Favored 'General case' 0 C--N 1.281 -2.372 0 CA-C-N 115.307 -0.861 . . . . 0.0 111.657 175.295 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.429 ' O ' HG23 ' A' ' 89' ' ' VAL . 50.3 p -62.58 -45.3 93.55 Favored 'General case' 0 C--O 1.213 -0.823 0 C-N-CA 120.524 -0.47 . . . . 0.0 110.818 -178.17 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.418 ' H ' HG12 ' A' ' 86' ' ' ILE . 3.3 pt -66.34 -38.72 82.43 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.479 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.498 179.147 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 38.4 mt -59.63 -44.1 93.6 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.236 175.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.489 ' O ' ' HB2' ' A' ' 92' ' ' LEU . . . -72.08 -47.13 53.66 Favored 'General case' 0 N--CA 1.437 -1.112 0 CA-C-N 115.992 -0.549 . . . . 0.0 112.313 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.463 HG22 HG22 ' A' ' 104' ' ' ILE . 77.0 t -57.49 -49.12 81.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 -177.547 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -67.71 -38.94 84.3 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.783 -173.295 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -92.91 -20.27 20.82 Favored 'General case' 0 C--N 1.297 -1.701 0 CA-C-N 115.864 -0.607 . . . . 0.0 112.378 -172.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.489 ' HB2' ' O ' ' A' ' 88' ' ' ALA . 6.6 mt -93.19 -30.29 15.29 Favored 'General case' 0 C--N 1.315 -0.919 0 O-C-N 122.346 -0.221 . . . . 0.0 111.568 178.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 31.9 t-20 -59.25 124.2 19.22 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 179.043 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 88.86 -1.21 83.2 Favored Glycine 0 N--CA 1.442 -0.947 0 C-N-CA 121.064 -0.589 . . . . 0.0 113.417 177.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 67.3 t80 -86.51 141.75 28.85 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 117.579 0.69 . . . . 0.0 110.096 -179.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.425 ' HD2' ' N ' ' A' ' 96' ' ' LYS . 0.2 OUTLIER -98.05 116.15 29.69 Favored 'General case' 0 C--O 1.248 0.997 0 CA-C-O 121.153 0.502 . . . . 0.0 112.11 -177.137 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 58.1 mt -124.12 141.53 43.98 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 174.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.445 ' HA3' HD22 ' A' ' 39' ' ' ASN . . . 60.37 18.38 49.98 Favored Glycine 0 CA--C 1.521 0.438 0 N-CA-C 113.76 0.264 . . . . 0.0 113.76 179.461 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 83.88 14.31 72.91 Favored Glycine 0 N--CA 1.438 -1.223 0 C-N-CA 120.786 -0.721 . . . . 0.0 113.017 -178.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.422 ' HB2' HD21 ' A' ' 37' ' ' ASN . 17.5 ptp180 -136.78 150.12 48.18 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 117.696 0.748 . . . . 0.0 110.081 177.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -87.87 121.89 30.84 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 120.592 0.234 . . . . 0.0 111.368 -178.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 11.4 mt -73.02 145.63 46.51 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-O 121.675 0.75 . . . . 0.0 112.769 179.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 17.4 tptm -121.33 122.17 39.26 Favored 'General case' 0 N--CA 1.413 -2.303 0 CA-C-N 115.017 -0.992 . . . . 0.0 108.783 174.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.463 HG22 HG22 ' A' ' 89' ' ' VAL . 5.1 mm -116.17 135.09 57.47 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.018 0 N-CA-C 105.358 -2.09 . . . . 0.0 105.358 176.428 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -141.51 151.94 43.72 Favored 'General case' 0 C--N 1.285 -2.218 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 -176.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 75.2 m-70 -83.86 138.24 33.29 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.424 HG21 ' HB2' ' A' ' 34' ' ' TYR . 9.8 t -157.79 168.5 27.03 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 -178.461 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -110.16 113.04 25.41 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 106.317 -1.735 . . . . 0.0 106.317 169.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 56.8 t80 . . . . . 0 C--N 1.287 -2.12 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.703 -175.188 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 226' ' ' ILE . . . . . 0.461 HG21 ' OG ' ' A' ' 84' ' ' SER . 4.5 mp . . . . . 0 C--O 1.243 0.723 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 227' ' ' MET . . . . . . . . . . . . . 22.4 ptp -71.39 144.84 89.76 Favored Pre-proline 0 C--N 1.31 -1.115 0 O-C-N 123.608 0.568 . . . . 0.0 110.098 -178.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 228' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -68.56 147.59 70.77 Favored 'Trans proline' 0 C--N 1.317 -1.087 0 C-N-CA 123.284 2.656 . . . . 0.0 112.25 178.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . -68.46 167.64 43.79 Favored Glycine 0 N--CA 1.443 -0.839 0 CA-C-N 115.663 -0.699 . . . . 0.0 113.073 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 40.9 m -74.85 -12.92 60.49 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -176.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 231' ' ' ARG . . . . . 0.514 ' HB2' ' OG ' ' A' ' 52' ' ' SER . 27.8 mmt180 -78.93 -11.74 60.01 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 178.136 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 232' ' ' TRP . . . . . . . . . . . . . 23.1 t90 -71.15 121.68 18.76 Favored 'General case' 0 N--CA 1.435 -1.198 0 CA-C-O 122.108 0.956 . . . . 0.0 112.184 -177.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 233' ' ' ASP . . . . . 0.436 ' H ' HG23 ' A' ' 49' ' ' THR . 29.9 t70 -114.94 144.62 43.28 Favored 'General case' 0 C--N 1.273 -2.742 0 N-CA-C 101.791 -3.411 . . . . 0.0 101.791 171.548 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.506 3.333 0 C-N-CA 128.295 2.855 . . . . 0.0 116.973 -176.146 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 240' ' ' GLY . . . . . 0.473 ' O ' ' HG2' ' B' ' 244' ' ' LYS . . . . . . . . 0 N--CA 1.417 -2.581 0 N-CA-C 110.77 -0.932 . . . . 0.0 110.77 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 14.6 p90 -76.97 -34.35 57.57 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-O 121.015 0.436 . . . . 0.0 111.403 177.046 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -61.27 -42.39 98.56 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 123.761 0.824 . . . . 0.0 109.972 -177.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -64.26 -34.34 77.89 Favored 'General case' 0 C--O 1.198 -1.65 0 CA-C-N 115.459 -0.791 . . . . 0.0 112.218 -179.336 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 244' ' ' LYS . . . . . 0.473 ' HG2' ' O ' ' B' ' 240' ' ' GLY . 74.2 mmtt -62.42 -42.87 99.76 Favored 'General case' 0 C--N 1.316 -0.879 0 C-N-CA 122.788 0.435 . . . . 0.0 111.625 -175.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 245' ' ' TRP . . . . . . . . . . . . . 6.9 m0 -69.86 -37.5 76.13 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 121.734 0.778 . . . . 0.0 109.17 178.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 246' ' ' PHE . . . . . 0.553 ' O ' ' HG2' ' B' ' 249' ' ' GLN . 5.1 t80 -65.23 -40.71 94.42 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 114.909 -1.042 . . . . 0.0 110.31 177.545 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -67.06 -22.11 65.87 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 115.781 -0.645 . . . . 0.0 112.142 -179.03 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -100.68 -25.7 14.06 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 120.156 -0.618 . . . . 0.0 112.381 178.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 249' ' ' GLN . . . . . 0.553 ' HG2' ' O ' ' B' ' 246' ' ' PHE . 3.2 pt20 -69.77 -11.98 61.27 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-O 121.126 0.488 . . . . 0.0 110.504 -177.26 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 250' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -58.67 -23.06 58.62 Favored 'General case' 0 N--CA 1.482 1.142 0 CA-C-N 114.692 -1.14 . . . . 0.0 111.832 179.415 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -121.22 130.39 53.67 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 178.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 252' ' ' ILE . . . . . . . . . . . . . 32.8 pt -92.45 -36.81 8.02 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 -176.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -97.84 -25.85 14.89 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-O 121.865 0.84 . . . . 0.0 110.494 -175.046 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 254' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 . . . . . 0 N--CA 1.409 -2.479 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.17 -173.273 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.411 ' HA ' HG21 ' A' ' 85' ' ' THR . . . . . . . . 0 N--CA 1.447 -0.619 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -107.89 145.11 34.18 Favored 'General case' 0 C--N 1.317 -0.846 0 C-N-CA 120.876 -0.33 . . . . 0.0 110.178 -174.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 30.5 pt -139.55 156.78 26.73 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 CA-C-O 120.986 0.422 . . . . 0.0 110.524 177.028 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 28.5 t80 -107.41 122.83 47.4 Favored 'General case' 0 N--CA 1.423 -1.796 0 CA-C-N 114.671 -1.149 . . . . 0.0 108.364 177.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.425 HG23 ' CD1' ' A' ' 104' ' ' ILE . 7.7 mt -108.77 128.17 64.73 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.977 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 176.51 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -129.66 173.92 19.55 Favored Glycine 0 C--N 1.287 -2.154 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.976 -178.221 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 19.5 m120 65.82 24.2 11.37 Favored 'General case' 0 CA--C 1.512 -0.517 0 C-N-CA 125.123 1.369 . . . . 0.0 111.922 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -58.27 140.77 52.67 Favored 'General case' 0 CA--C 1.495 -1.154 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 -178.357 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.508 ' CG ' ' HG2' ' A' ' 41' ' ' GLU . 49.8 t-20 -71.5 142.64 50.14 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 172.298 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.485 ' HD2' ' N ' ' A' ' 41' ' ' GLU . 7.5 ppt_? -58.99 -22.94 61.32 Favored 'General case' 0 C--N 1.303 -1.43 0 C-N-CA 123.869 0.867 . . . . 0.0 112.62 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.508 ' HG2' ' CG ' ' A' ' 39' ' ' ASN . 12.8 pt-20 -87.19 -14.8 40.15 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.85 -176.175 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.469 ' HG ' ' HB3' ' A' ' 39' ' ' ASN . 79.6 mt -76.42 126.13 30.44 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.564 0.697 . . . . 0.0 112.598 -174.747 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 66.8 p -109.26 173.71 6.2 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 114.071 -1.422 . . . . 0.0 109.538 -177.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.7 mp0 -57.56 -42.31 82.76 Favored 'General case' 0 C--O 1.211 -0.933 0 C-N-CA 123.616 0.766 . . . . 0.0 109.92 178.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.43 -37.41 93.15 Favored Glycine 0 N--CA 1.446 -0.649 0 O-C-N 123.618 0.574 . . . . 0.0 112.814 -179.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 32.5 m-20 -67.42 -49.76 62.37 Favored 'General case' 0 CA--C 1.501 -0.934 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 179.306 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 51.4 mt -60.25 -45.78 95.72 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.777 0 CA-C-N 114.748 -1.115 . . . . 0.0 110.682 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 41.4 mt -59.96 -45.24 93.31 Favored 'General case' 0 CA--C 1.496 -1.099 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.322 -178.288 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.464 HG23 ' H ' ' B' ' 233' ' ' ASP . 87.8 m -61.88 -45.72 92.52 Favored 'General case' 0 C--N 1.313 -1.018 0 O-C-N 123.595 0.56 . . . . 0.0 111.585 -178.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 98.9 t -66.79 -50.19 67.63 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.489 -179.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.487 ' HA ' ' HD2' ' A' ' 54' ' ' TYR . 4.3 m-85 -62.49 -25.66 68.13 Favored 'General case' 0 N--CA 1.433 -1.276 0 C-N-CA 123.883 0.873 . . . . 0.0 112.381 -178.553 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 65.9 m -67.07 -20.22 65.79 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.287 176.29 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -70.07 -20.71 63.21 Favored 'General case' 0 CA--C 1.555 1.158 0 CA-C-O 121.302 0.572 . . . . 0.0 109.721 176.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.487 ' HD2' ' HA ' ' A' ' 51' ' ' PHE . 41.5 m-85 -97.51 -19.98 18.03 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-O 121.03 0.443 . . . . 0.0 111.59 -175.674 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 167.92 -159.49 32.75 Favored Glycine 0 N--CA 1.42 -2.379 0 N-CA-C 110.825 -0.91 . . . . 0.0 110.825 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 59.1 t -102.66 110.83 64.02 Favored Pre-proline 0 C--N 1.296 -1.746 0 O-C-N 123.471 0.159 . . . . 0.0 111.062 -177.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.511 ' HB3' HD21 ' A' ' 77' ' ' LEU . 92.7 Cg_endo -77.39 140.75 19.61 Favored 'Trans proline' 0 N--CA 1.451 -1.018 0 C-N-CA 122.849 2.366 . . . . 0.0 110.18 175.469 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 31.2 m -116.39 -19.08 6.63 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 C-N-CA 120.0 -0.68 . . . . 0.0 112.167 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.487 ' HB3' ' HG2' ' A' ' 78' ' ' LYS . 36.0 t70 -161.26 141.41 10.83 Favored 'General case' 0 C--O 1.242 0.682 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 -179.804 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 14.4 p -141.71 133.96 28.22 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 178.524 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 91.6 mt -120.46 125.37 74.07 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 177.443 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -100.77 134.18 44.13 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 178.203 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 22.3 t -92.62 131.52 37.65 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 176.256 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 68.7 mtt85 . . . . . 0 C--N 1.307 -1.249 0 CA-C-O 120.879 0.371 . . . . 0.0 111.233 -177.742 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 15.7 mm-40 . . . . . 0 N--CA 1.478 0.973 0 CA-C-O 121.324 0.583 . . . . 0.0 111.692 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 110.2 8.29 25.61 Favored Glycine 0 N--CA 1.421 -2.35 0 C-N-CA 119.88 -1.153 . . . . 0.0 112.269 -179.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 40.8 p90 -148.82 153.36 38.0 Favored 'General case' 0 C--O 1.252 1.194 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 177.125 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -149.52 172.83 14.36 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-O 120.915 0.388 . . . . 0.0 110.874 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -130.3 139.41 50.73 Favored 'General case' 0 C--N 1.303 -1.424 0 C-N-CA 124.161 0.984 . . . . 0.0 109.617 -179.274 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.511 HD21 ' HB3' ' A' ' 57' ' ' PRO . 9.9 tt -146.01 140.76 27.07 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 175.587 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.487 ' HG2' ' HB3' ' A' ' 59' ' ' ASP . 20.8 ptmt -124.37 144.27 50.12 Favored 'General case' 0 C--O 1.256 1.433 0 CA-C-O 121.259 0.552 . . . . 0.0 109.787 179.344 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 66.3 m-85 -108.16 164.31 12.41 Favored 'General case' 0 C--N 1.29 -1.983 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.719 179.578 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -77.99 -33.59 51.24 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 174.304 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -109.8 130.09 55.56 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.94 -176.163 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 83.7 mt-30 -71.02 -20.37 62.4 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 -178.095 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 88.1 mtm180 -68.03 -34.1 75.85 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-O 121.946 0.879 . . . . 0.0 108.654 174.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.501 ' OG ' HG21 ' B' ' 226' ' ' ILE . 61.9 m -63.59 -37.11 86.07 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 115.078 -0.964 . . . . 0.0 112.511 178.299 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.447 ' O ' HG23 ' A' ' 89' ' ' VAL . 80.7 p -65.31 -45.84 82.72 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 120.325 -0.55 . . . . 0.0 110.476 -177.303 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.412 ' H ' HG12 ' A' ' 86' ' ' ILE . 3.4 pt -64.83 -39.23 84.96 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.884 177.179 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.408 HD12 ' HA ' ' A' ' 84' ' ' SER . 19.9 mt -59.65 -44.54 93.51 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.653 176.393 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.452 ' O ' ' HB2' ' A' ' 92' ' ' LEU . . . -71.48 -45.88 61.32 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.035 -177.329 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.453 HG22 HG22 ' A' ' 104' ' ' ILE . 70.2 t -56.65 -49.02 79.7 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.797 0 CA-C-O 121.057 0.456 . . . . 0.0 110.95 178.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -63.25 -39.15 93.79 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 115.366 -0.834 . . . . 0.0 112.034 -175.062 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.479 HD22 ' HE1' ' A' ' 54' ' ' TYR . 63.3 t30 -96.42 -20.09 18.7 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.431 -171.748 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.452 ' HB2' ' O ' ' A' ' 88' ' ' ALA . 10.3 mt -96.59 -31.24 12.84 Favored 'General case' 0 CA--C 1.494 -1.176 0 CA-C-O 120.909 0.385 . . . . 0.0 111.655 -178.236 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 56.1 t30 -65.44 125.82 26.34 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.981 -177.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 88.13 -1.15 84.51 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 121.341 -0.457 . . . . 0.0 112.883 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 67.7 t80 -90.12 137.78 32.06 Favored 'General case' 0 C--N 1.32 -0.689 0 O-C-N 122.378 -0.483 . . . . 0.0 110.069 -178.423 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -92.45 116.74 29.25 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 121.56 0.695 . . . . 0.0 111.806 -176.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.62 ' HB ' HH21 ' A' ' 100' ' ' ARG . 62.7 mt -127.34 140.36 49.33 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 175.621 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 62.88 19.27 60.83 Favored Glycine 0 C--N 1.307 -1.066 0 C-N-CA 121.387 -0.435 . . . . 0.0 112.869 -179.007 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 91.72 -9.55 76.65 Favored Glycine 0 N--CA 1.438 -1.182 0 C-N-CA 121.218 -0.515 . . . . 0.0 112.953 -178.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.62 HH21 ' HB ' ' A' ' 97' ' ' ILE . 0.0 OUTLIER -125.54 146.88 49.47 Favored 'General case' 0 N--CA 1.418 -2.049 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 -175.764 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -79.8 136.54 36.75 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.692 -176.566 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.428 ' HG ' HH22 ' A' ' 100' ' ' ARG . 11.0 mt -82.47 148.39 28.17 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 115.457 -0.792 . . . . 0.0 112.445 176.253 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 4.3 tppp? -124.27 119.96 30.82 Favored 'General case' 0 N--CA 1.423 -1.825 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 174.271 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.453 HG22 HG22 ' A' ' 89' ' ' VAL . 4.6 mm -122.09 135.12 63.25 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 N-CA-C 107.108 -1.441 . . . . 0.0 107.108 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -143.63 158.82 43.38 Favored 'General case' 0 C--N 1.291 -1.947 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 178.335 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 38.3 m-70 -83.63 141.76 31.29 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 177.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 9.3 t -156.04 161.78 40.39 Favored 'General case' 0 C--N 1.285 -2.216 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 -178.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 26.0 p90 -109.88 110.35 21.28 Favored 'General case' 0 C--N 1.297 -1.674 0 C-N-CA 118.592 -1.243 . . . . 0.0 108.879 172.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 62.3 t80 . . . . . 0 C--N 1.294 -1.819 0 CA-C-N 115.351 -0.841 . . . . 0.0 110.98 -178.79 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 226' ' ' ILE . . . . . 0.501 HG21 ' OG ' ' A' ' 84' ' ' SER . 3.8 mp . . . . . 0 N--CA 1.44 -0.947 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 227' ' ' MET . . . . . . . . . . . . . 24.8 mmt -59.53 140.19 88.91 Favored Pre-proline 0 C--N 1.323 -0.577 0 O-C-N 124.061 0.851 . . . . 0.0 111.405 179.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 228' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -71.18 156.01 60.08 Favored 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 122.555 2.17 . . . . 0.0 111.444 179.119 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . -74.38 168.9 54.33 Favored Glycine 0 C--N 1.307 -1.041 0 CA-C-N 116.167 -0.47 . . . . 0.0 112.642 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 22.6 t -77.41 -15.21 59.47 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-O 120.954 0.407 . . . . 0.0 110.315 -178.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 13.6 mmp_? -80.83 -5.2 56.97 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 121.974 -0.454 . . . . 0.0 111.192 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 232' ' ' TRP . . . . . . . . . . . . . 19.2 t90 -70.94 127.02 31.19 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-O 122.659 1.219 . . . . 0.0 111.878 -178.076 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 233' ' ' ASP . . . . . 0.464 ' H ' HG23 ' A' ' 49' ' ' THR . 11.8 t70 -118.09 145.5 44.8 Favored 'General case' 0 C--N 1.271 -2.833 0 N-CA-C 101.059 -3.682 . . . . 0.0 101.059 172.579 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.749 0 C-N-CA 127.211 2.339 . . . . 0.0 116.175 -177.912 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 240' ' ' GLY . . . . . 0.483 ' O ' ' HG2' ' B' ' 244' ' ' LYS . . . . . . . . 0 C--O 1.201 -1.928 0 N-CA-C 111.603 -0.599 . . . . 0.0 111.603 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -76.14 -33.56 59.42 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-O 120.899 0.38 . . . . 0.0 110.709 179.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -60.89 -43.84 97.92 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.106 -178.347 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -62.08 -34.62 76.64 Favored 'General case' 0 C--O 1.206 -1.219 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.307 179.189 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 244' ' ' LYS . . . . . 0.483 ' HG2' ' O ' ' B' ' 240' ' ' GLY . 72.9 mmtt -64.76 -45.52 86.05 Favored 'General case' 0 CA--C 1.508 -0.653 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 -179.268 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 245' ' ' TRP . . . . . . . . . . . . . 49.3 m0 -66.03 -42.45 89.59 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.26 178.506 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 246' ' ' PHE . . . . . 0.52 ' HA ' ' CD ' ' B' ' 249' ' ' GLN . 6.0 t80 -63.88 -36.95 85.62 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.246 179.743 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -70.33 -32.37 70.07 Favored 'General case' 0 C--N 1.292 -1.923 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.687 -179.244 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.46 -19.94 20.78 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -177.529 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 249' ' ' GLN . . . . . 0.52 ' CD ' ' HA ' ' B' ' 246' ' ' PHE . 2.9 pt20 -74.11 2.79 8.14 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.093 0.557 . . . . 0.0 110.71 -177.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 250' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -57.93 -30.62 66.09 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.373 178.521 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -84.59 120.89 26.88 Favored 'General case' 0 N--CA 1.437 -1.106 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.195 179.358 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 252' ' ' ILE . . . . . . . . . . . . . 37.6 pt -101.63 -28.65 3.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.759 -175.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -107.45 -26.52 10.91 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-O 121.573 0.701 . . . . 0.0 110.123 -178.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 254' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.292 -1.907 0 CA-C-N 115.306 -0.861 . . . . 0.0 108.68 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.515 -0.366 0 CA-C-O 120.633 0.254 . . . . 0.0 110.341 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -108.69 145.33 35.2 Favored 'General case' 0 N--CA 1.434 -1.248 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.868 -176.137 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 28.4 pt -136.86 160.36 36.85 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.753 177.233 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.49 ' HB2' HG21 ' A' ' 107' ' ' THR . 34.4 t80 -112.8 124.12 51.88 Favored 'General case' 0 N--CA 1.413 -2.31 0 CA-C-N 115.26 -0.882 . . . . 0.0 108.831 177.76 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.458 HG23 ' CD1' ' A' ' 104' ' ' ILE . 10.4 mt -108.55 127.75 64.73 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.036 0 N-CA-C 106.846 -1.539 . . . . 0.0 106.846 176.136 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -130.07 160.99 23.05 Favored Glycine 0 N--CA 1.425 -2.04 0 N-CA-C 112.02 -0.432 . . . . 0.0 112.02 -179.094 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 66.4 t30 70.39 41.27 1.02 Allowed 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.82 1.648 . . . . 0.0 110.604 -179.232 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -69.39 151.73 45.78 Favored 'General case' 0 CA--C 1.499 -0.987 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.864 175.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.469 ' HB3' ' HG ' ' A' ' 42' ' ' LEU . 45.9 t-20 -84.66 149.94 25.48 Favored 'General case' 0 C--N 1.284 -2.273 0 N-CA-C 106.344 -1.724 . . . . 0.0 106.344 175.758 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.507 ' C ' ' HD2' ' A' ' 40' ' ' ARG . 5.8 ppt_? -59.1 -24.45 62.97 Favored 'General case' 0 C--N 1.307 -1.242 0 C-N-CA 123.354 0.662 . . . . 0.0 111.025 178.606 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.403 ' N ' ' HD2' ' A' ' 40' ' ' ARG . 13.8 pt-20 -95.39 0.11 53.13 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.825 -0.625 . . . . 0.0 112.317 -175.81 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.469 ' HG ' ' HB3' ' A' ' 39' ' ' ASN . 68.6 mt -89.81 121.69 32.18 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-O 121.132 0.492 . . . . 0.0 110.407 179.503 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 70.6 p -108.43 174.44 5.87 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-N 114.674 -1.148 . . . . 0.0 110.279 -176.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.44 ' CG ' ' HB2' ' A' ' 62' ' ' LEU . 33.6 mt-10 -55.15 -40.87 71.09 Favored 'General case' 0 C--O 1.212 -0.914 0 O-C-N 123.616 0.572 . . . . 0.0 109.689 176.622 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -59.76 -39.83 95.84 Favored Glycine 0 C--O 1.243 0.7 0 CA-C-N 116.079 -0.51 . . . . 0.0 112.738 179.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -66.82 -49.65 65.1 Favored 'General case' 0 CA--C 1.499 -1.017 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 179.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 47.2 mt -60.07 -46.68 94.01 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.808 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.842 -179.643 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 47.5 mt -60.07 -42.49 94.67 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 116.592 -0.277 . . . . 0.0 111.705 -177.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 90.8 m -63.98 -46.28 85.32 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 120.869 0.366 . . . . 0.0 111.256 -179.134 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 95.7 t -66.98 -48.63 78.91 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.692 -178.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.433 ' HA ' ' HD2' ' A' ' 54' ' ' TYR . 4.6 m-85 -64.88 -23.08 67.12 Favored 'General case' 0 N--CA 1.426 -1.636 0 CA-C-N 115.28 -0.873 . . . . 0.0 112.416 -178.413 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.477 ' HA ' ' O ' ' A' ' 55' ' ' GLY . 61.5 m -72.3 -20.8 61.44 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 176.64 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -71.46 -22.18 61.86 Favored 'General case' 0 C--O 1.246 0.894 0 C-N-CA 119.859 -0.736 . . . . 0.0 109.596 177.275 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.433 ' HD2' ' HA ' ' A' ' 51' ' ' PHE . 73.7 m-85 -92.0 -22.82 19.77 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.818 -178.538 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.477 ' O ' ' HA ' ' A' ' 52' ' ' SER . . . 169.79 -164.47 37.91 Favored Glycine 0 N--CA 1.427 -1.965 0 N-CA-C 110.927 -0.869 . . . . 0.0 110.927 -179.588 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 54.8 t -99.03 111.0 59.82 Favored Pre-proline 0 C--N 1.302 -1.498 0 CA-C-N 116.548 0.174 . . . . 0.0 111.039 -176.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.46 ' HB3' HD21 ' A' ' 77' ' ' LEU . 85.9 Cg_endo -78.13 141.77 18.84 Favored 'Trans proline' 0 C--O 1.246 0.895 0 C-N-CA 122.975 2.45 . . . . 0.0 110.627 175.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 29.7 m -120.53 -15.38 7.43 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 C-N-CA 120.264 -0.575 . . . . 0.0 112.132 179.226 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.565 ' HB3' ' HG2' ' A' ' 78' ' ' LYS . 28.3 t70 -163.27 135.92 5.4 Favored 'General case' 0 C--O 1.244 0.799 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 -176.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 14.4 p -143.97 136.88 23.71 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 90.2 mt -120.92 121.63 65.62 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.799 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 177.234 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.44 ' HB2' ' CG ' ' A' ' 44' ' ' GLU . 0.1 OUTLIER -100.2 113.54 26.28 Favored 'General case' 0 N--CA 1.42 -1.93 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 175.267 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 13.6 m -78.32 117.91 20.01 Favored 'General case' 0 C--N 1.274 -2.693 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 178.406 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 84.2 mtm180 . . . . . 0 C--N 1.301 -1.514 0 CA-C-O 121.052 0.454 . . . . 0.0 110.125 179.353 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 12.9 mm-40 . . . . . 0 CA--C 1.502 -0.878 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 96.54 2.99 59.9 Favored Glycine 0 N--CA 1.426 -2.031 0 C-N-CA 119.651 -1.261 . . . . 0.0 112.113 -179.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 34.5 p90 -145.65 151.58 38.28 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 178.294 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -149.49 170.16 19.24 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 123.266 0.354 . . . . 0.0 110.529 -179.217 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -131.5 140.12 49.46 Favored 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 123.649 0.78 . . . . 0.0 109.427 -178.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.46 HD21 ' HB3' ' A' ' 57' ' ' PRO . 9.9 tt -147.33 140.45 25.19 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 177.183 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.565 ' HG2' ' HB3' ' A' ' 59' ' ' ASP . 18.7 ptmt -124.0 144.43 49.83 Favored 'General case' 0 C--O 1.259 1.567 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 178.122 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.415 ' HH ' ' HD2' ' A' ' 51' ' ' PHE . 58.7 m-85 -106.9 164.89 11.75 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.956 -178.32 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -77.83 -25.73 49.01 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 114.813 -1.085 . . . . 0.0 109.293 176.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -124.1 130.39 52.48 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 -179.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -69.3 -21.05 63.89 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 113.137 0.792 . . . . 0.0 113.137 -177.262 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 89.6 mtm180 -63.64 -33.13 74.95 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-O 122.352 1.073 . . . . 0.0 110.109 177.374 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.435 ' OG ' HG21 ' B' ' 226' ' ' ILE . 48.9 m -63.53 -36.98 85.59 Favored 'General case' 0 C--N 1.282 -2.335 0 CA-C-N 114.628 -1.169 . . . . 0.0 112.22 178.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.421 ' O ' HG23 ' A' ' 89' ' ' VAL . 81.8 p -64.74 -45.05 88.11 Favored 'General case' 0 C--O 1.219 -0.501 0 C-N-CA 120.279 -0.568 . . . . 0.0 110.525 -177.015 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.425 ' H ' HG12 ' A' ' 86' ' ' ILE . 3.3 pt -63.89 -39.45 85.46 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.103 177.225 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 29.2 mt -60.32 -43.61 96.21 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 120.902 0.382 . . . . 0.0 111.011 175.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.423 ' O ' ' HB2' ' A' ' 92' ' ' LEU . . . -71.47 -47.16 57.37 Favored 'General case' 0 C--O 1.211 -0.959 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.67 -178.64 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.449 HG22 HG22 ' A' ' 104' ' ' ILE . 79.5 t -57.21 -48.7 81.72 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.492 0 CA-C-O 120.915 0.388 . . . . 0.0 111.006 -179.44 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -68.38 -31.9 71.6 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 115.509 -0.769 . . . . 0.0 112.466 -173.413 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -97.56 -20.77 17.48 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 -176.302 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.461 ' HB2' HG13 ' A' ' 104' ' ' ILE . 9.6 mt -93.43 -28.56 16.06 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-O 120.574 0.226 . . . . 0.0 111.07 -179.15 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -60.26 124.74 21.22 Favored 'General case' 0 C--O 1.244 0.79 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 178.056 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 83.86 -1.07 89.23 Favored Glycine 0 C--N 1.306 -1.128 0 C-N-CA 120.499 -0.858 . . . . 0.0 113.447 177.542 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 86.4 t80 -85.3 134.4 34.12 Favored 'General case' 0 N--CA 1.443 -0.825 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 178.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.409 ' HA ' ' HA ' ' A' ' 101' ' ' ALA . 11.1 mptt -92.88 118.87 31.6 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.229 -176.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 54.1 mt -121.72 141.16 43.33 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 N-CA-C 105.257 -2.127 . . . . 0.0 105.257 172.577 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.413 ' HA3' HD22 ' A' ' 39' ' ' ASN . . . 58.92 22.48 54.77 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 121.191 -0.528 . . . . 0.0 112.821 -179.04 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 82.21 7.41 87.77 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 121.492 -0.385 . . . . 0.0 113.546 -179.435 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 16.7 ptp180 -129.52 141.04 51.08 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 117.688 0.744 . . . . 0.0 110.894 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.409 ' HA ' ' HA ' ' A' ' 96' ' ' LYS . . . -79.61 122.08 26.07 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.012 0.434 . . . . 0.0 111.387 -179.215 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 9.5 mt -68.7 141.23 55.35 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.671 177.2 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -113.98 116.01 28.55 Favored 'General case' 0 N--CA 1.409 -2.517 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 176.244 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.461 HG13 ' HB2' ' A' ' 92' ' ' LEU . 4.8 mm -116.65 136.11 54.78 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.861 0 N-CA-C 106.423 -1.695 . . . . 0.0 106.423 178.417 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -144.0 151.85 40.26 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.331 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -80.63 135.6 36.08 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-O 120.975 0.417 . . . . 0.0 110.223 177.648 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.49 HG21 ' HB2' ' A' ' 34' ' ' TYR . 6.5 t -153.64 168.35 26.52 Favored 'General case' 0 C--N 1.291 -1.972 0 N-CA-C 107.427 -1.324 . . . . 0.0 107.427 -177.065 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -108.91 110.82 22.24 Favored 'General case' 0 N--CA 1.421 -1.888 0 N-CA-C 105.208 -2.145 . . . . 0.0 105.208 169.143 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 84.9 t80 . . . . . 0 C--N 1.291 -1.967 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 178.879 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 226' ' ' ILE . . . . . 0.435 HG21 ' OG ' ' A' ' 84' ' ' SER . 4.2 mp . . . . . 0 N--CA 1.451 -0.421 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 227' ' ' MET . . . . . . . . . . . . . 86.8 mtp -71.2 133.54 85.54 Favored Pre-proline 0 C--N 1.315 -0.903 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 176.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 228' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -64.27 160.89 36.59 Favored 'Trans proline' 0 C--O 1.24 0.622 0 C-N-CA 123.43 2.753 . . . . 0.0 113.455 -177.609 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . -77.19 167.48 54.25 Favored Glycine 0 N--CA 1.439 -1.128 0 CA-C-N 115.155 -0.929 . . . . 0.0 113.429 -178.328 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 6.5 m -77.42 -17.58 57.99 Favored 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 123.14 0.576 . . . . 0.0 111.635 -175.169 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 7.9 mmp_? -87.29 -0.46 56.77 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.196 0.522 . . . . 0.0 110.995 -176.167 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 232' ' ' TRP . . . . . . . . . . . . . 21.1 t90 -76.93 127.82 33.41 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-O 122.307 1.051 . . . . 0.0 112.206 -178.063 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 233' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -122.07 147.1 46.53 Favored 'General case' 0 C--N 1.277 -2.585 0 N-CA-C 102.82 -3.029 . . . . 0.0 102.82 171.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.505 3.272 0 C-N-CA 128.372 2.891 . . . . 0.0 117.139 -175.654 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 240' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.417 -2.604 0 N-CA-C 108.443 -1.863 . . . . 0.0 108.443 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 22.7 p90 -77.09 -33.34 56.99 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 179.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -61.27 -45.34 94.89 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.226 0.536 . . . . 0.0 112.089 -177.094 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -60.46 -34.74 74.46 Favored 'General case' 0 C--O 1.204 -1.307 0 CA-C-N 115.166 -0.924 . . . . 0.0 111.411 -179.328 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -63.97 -42.46 97.24 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 -178.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 245' ' ' TRP . . . . . 0.451 ' HA ' ' HG3' ' B' ' 248' ' ' LYS . 23.7 m0 -66.23 -38.43 87.89 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.329 0.585 . . . . 0.0 109.954 178.354 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 246' ' ' PHE . . . . . 0.653 ' O ' ' HG2' ' B' ' 249' ' ' GLN . 3.1 t80 -67.96 -32.89 73.63 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.433 176.302 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -74.93 -38.96 61.65 Favored 'General case' 0 C--N 1.294 -1.839 0 O-C-N 121.948 -0.47 . . . . 0.0 111.023 179.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 248' ' ' LYS . . . . . 0.451 ' HG3' ' HA ' ' B' ' 245' ' ' TRP . 0.0 OUTLIER -82.35 -14.57 55.08 Favored 'General case' 0 CA--C 1.504 -0.8 0 CA-C-O 121.045 0.45 . . . . 0.0 111.758 -175.235 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 249' ' ' GLN . . . . . 0.653 ' HG2' ' O ' ' B' ' 246' ' ' PHE . 3.0 pt20 -75.22 2.4 11.07 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 121.698 0.761 . . . . 0.0 110.332 -179.068 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 250' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -67.24 -25.83 66.28 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.21 176.235 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -64.29 115.88 5.48 Favored 'General case' 0 N--CA 1.437 -1.118 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.134 178.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 252' ' ' ILE . . . . . . . . . . . . . 16.3 pt -99.67 -27.63 3.52 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.317 0 CA-C-N 113.783 -1.553 . . . . 0.0 110.944 -174.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 10.6 p30 -121.01 -26.32 5.17 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.908 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 254' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 . . . . . 0 N--CA 1.428 -1.571 0 N-CA-C 114.089 1.144 . . . . 0.0 114.089 -177.322 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.439 ' HA ' HG21 ' A' ' 85' ' ' THR . . . . . . . . 0 N--CA 1.441 -0.878 0 CA-C-O 120.579 0.228 . . . . 0.0 110.644 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 9.9 m-30 -104.85 145.23 30.67 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.89 -175.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 22.8 pt -140.82 158.4 23.69 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 CA-C-O 121.137 0.494 . . . . 0.0 110.628 178.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.442 ' HB2' HG21 ' A' ' 107' ' ' THR . 61.8 t80 -105.26 118.91 37.74 Favored 'General case' 0 N--CA 1.412 -2.374 0 CA-C-N 114.504 -1.226 . . . . 0.0 108.057 177.771 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.475 HG23 ' CD1' ' A' ' 104' ' ' ILE . 10.9 mt -108.41 127.53 64.7 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.18 0 N-CA-C 105.427 -2.064 . . . . 0.0 105.427 173.359 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -132.31 170.86 21.71 Favored Glycine 0 C--N 1.269 -3.18 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 71.74 32.84 1.87 Allowed 'General case' 0 N--CA 1.471 0.604 0 O-C-N 124.485 0.756 . . . . 0.0 109.873 -178.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.5 HD11 HD11 ' A' ' 47' ' ' ILE . 4.0 mm? -66.19 143.02 57.51 Favored 'General case' 0 CA--C 1.492 -1.267 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.465 177.768 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.426 ' HB3' ' HG ' ' A' ' 42' ' ' LEU . 61.2 t30 -83.49 156.5 22.83 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.061 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 18.4 ptt180 -58.01 -28.92 64.88 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 123.701 0.801 . . . . 0.0 112.664 -177.188 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -107.48 4.76 26.51 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 113.74 1.015 . . . . 0.0 113.74 -172.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.426 ' HG ' ' HB3' ' A' ' 39' ' ' ASN . 61.3 mt -84.56 121.69 27.97 Favored 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 120.348 -0.541 . . . . 0.0 110.776 178.775 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 69.6 p -107.58 173.47 6.31 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-N 115.096 -0.956 . . . . 0.0 109.675 -179.236 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.432 ' HG3' ' HB2' ' A' ' 62' ' ' LEU . 52.3 mt-10 -55.3 -38.97 69.34 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 123.46 0.704 . . . . 0.0 111.652 179.497 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -65.6 -37.98 94.17 Favored Glycine 0 N--CA 1.44 -1.078 0 CA-C-N 116.076 -0.511 . . . . 0.0 113.105 -178.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -67.25 -43.95 80.64 Favored 'General case' 0 CA--C 1.505 -0.773 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 -178.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.5 HD11 HD11 ' A' ' 38' ' ' LEU . 35.9 mt -60.77 -45.51 97.71 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.421 0 CA-C-N 114.922 -1.035 . . . . 0.0 110.593 178.587 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 50.0 mt -59.64 -44.85 93.35 Favored 'General case' 0 C--O 1.207 -1.135 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.704 -176.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.45 HG23 ' H ' ' B' ' 233' ' ' ASP . 96.4 m -60.63 -46.05 91.76 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 179.809 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 85.5 t -65.95 -48.44 81.84 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 CA-C-O 121.099 0.476 . . . . 0.0 110.679 179.251 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.425 ' HA ' ' HD2' ' A' ' 54' ' ' TYR . 5.4 m-85 -66.27 -24.39 66.56 Favored 'General case' 0 N--CA 1.431 -1.39 0 CA-C-N 115.595 -0.73 . . . . 0.0 112.331 -178.004 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.407 ' HA ' ' O ' ' A' ' 55' ' ' GLY . 73.3 m -68.59 -19.8 64.48 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.958 176.3 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -70.29 -25.3 63.27 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 119.553 -0.859 . . . . 0.0 108.953 175.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.425 ' HD2' ' HA ' ' A' ' 51' ' ' PHE . 37.0 m-85 -93.01 -7.55 45.51 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-N 115.877 -0.602 . . . . 0.0 112.069 -175.711 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.407 ' O ' ' HA ' ' A' ' 52' ' ' SER . . . 152.39 -159.63 28.5 Favored Glycine 0 N--CA 1.419 -2.48 0 C-N-CA 120.699 -0.762 . . . . 0.0 111.304 178.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 98.8 t -99.83 110.9 60.69 Favored Pre-proline 0 C--N 1.298 -1.634 0 O-C-N 123.382 0.107 . . . . 0.0 110.95 -178.075 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.532 ' HB3' HD21 ' A' ' 77' ' ' LEU . 92.1 Cg_endo -79.68 137.26 12.68 Favored 'Trans proline' 0 N--CA 1.452 -0.926 0 C-N-CA 122.779 2.319 . . . . 0.0 110.16 175.694 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 27.0 m -114.39 -20.41 6.06 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 C-N-CA 119.624 -0.83 . . . . 0.0 112.038 -178.595 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.519 ' HB3' ' HG2' ' A' ' 78' ' ' LYS . 37.5 t70 -157.24 138.24 13.45 Favored 'General case' 0 CA--C 1.499 -0.992 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.411 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 13.6 p -139.68 134.32 38.28 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 O-C-N 123.674 0.609 . . . . 0.0 109.379 178.619 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 84.5 mt -121.9 126.91 75.16 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.051 177.023 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.432 ' HB2' ' HG3' ' A' ' 44' ' ' GLU . 0.1 OUTLIER -105.99 112.46 25.51 Favored 'General case' 0 N--CA 1.424 -1.763 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 173.54 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 24.2 m -79.23 119.54 22.46 Favored 'General case' 0 C--N 1.281 -2.387 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 177.208 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 81.8 mtp180 . . . . . 0 C--N 1.307 -1.274 0 O-C-N 121.992 -0.442 . . . . 0.0 111.89 -175.951 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 28.8 mm-40 . . . . . 0 CA--C 1.506 -0.723 0 CA-C-O 121.167 0.508 . . . . 0.0 110.383 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 98.33 1.38 58.03 Favored Glycine 0 N--CA 1.43 -1.739 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.89 -177.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 37.3 p90 -140.53 151.72 44.99 Favored 'General case' 0 N--CA 1.432 -1.335 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 178.329 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -146.49 172.25 13.83 Favored 'General case' 0 N--CA 1.42 -1.927 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 178.43 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 8.0 t80 -135.07 143.76 46.85 Favored 'General case' 0 C--N 1.293 -1.857 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.047 -177.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.532 HD21 ' HB3' ' A' ' 57' ' ' PRO . 9.7 tt -149.83 140.52 22.63 Favored 'General case' 0 N--CA 1.434 -1.244 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 175.696 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.519 ' HG2' ' HB3' ' A' ' 59' ' ' ASP . 21.1 ptmt -123.34 144.44 49.45 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 178.33 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 70.1 m-85 -105.79 165.15 11.39 Favored 'General case' 0 C--N 1.289 -2.037 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.067 -177.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -75.08 -31.52 61.23 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 114.702 -1.136 . . . . 0.0 108.918 173.459 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.404 ' O ' ' HB2' ' A' ' 84' ' ' SER . 8.8 t70 -119.88 134.11 55.35 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 -178.31 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -70.62 -20.42 62.74 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 -179.118 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 87.0 mtm180 -67.91 -33.3 74.44 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-O 122.44 1.114 . . . . 0.0 109.239 175.1 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.49 ' OG ' HG21 ' B' ' 226' ' ' ILE . 50.3 m -62.27 -37.13 84.28 Favored 'General case' 0 C--N 1.285 -2.222 0 CA-C-N 114.6 -1.182 . . . . 0.0 112.323 177.016 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.479 ' O ' HG23 ' A' ' 89' ' ' VAL . 78.7 p -65.2 -45.49 84.58 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 120.208 -0.597 . . . . 0.0 110.179 -177.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.422 ' H ' HG12 ' A' ' 86' ' ' ILE . 5.6 pt -64.72 -38.11 81.84 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.492 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.099 177.222 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 12.0 mt -59.09 -44.69 91.94 Favored 'General case' 0 CA--C 1.502 -0.87 0 CA-C-O 120.944 0.402 . . . . 0.0 111.089 175.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.505 ' O ' ' HB2' ' A' ' 92' ' ' LEU . . . -71.4 -40.93 70.22 Favored 'General case' 0 N--CA 1.427 -1.59 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.303 -178.351 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.482 HG22 HG22 ' A' ' 104' ' ' ILE . 86.0 t -62.2 -49.4 84.19 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-O 120.889 0.376 . . . . 0.0 110.671 178.21 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -66.07 -35.75 81.37 Favored 'General case' 0 C--N 1.302 -1.468 0 C-N-CA 123.59 0.756 . . . . 0.0 112.13 -175.428 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -87.74 -29.22 21.23 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -177.361 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.505 ' HB2' ' O ' ' A' ' 88' ' ' ALA . 10.1 mt -97.68 -26.56 14.71 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 112.84 0.682 . . . . 0.0 112.84 -173.648 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -60.38 125.1 22.4 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 109.551 -0.536 . . . . 0.0 109.551 -179.557 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 81.44 -1.12 86.65 Favored Glycine 0 N--CA 1.441 -0.987 0 C-N-CA 120.986 -0.626 . . . . 0.0 113.649 177.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 59.4 t80 -85.67 138.16 32.32 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 117.611 0.706 . . . . 0.0 109.122 -178.567 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.424 ' HE3' ' HB2' ' A' ' 101' ' ' ALA . 11.7 mptt -92.47 117.2 29.7 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 -176.506 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 56.6 mt -126.08 141.99 44.08 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 N-CA-C 105.253 -2.129 . . . . 0.0 105.253 173.019 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 60.58 19.98 55.23 Favored Glycine 0 CA--C 1.525 0.687 0 C-N-CA 121.598 -0.334 . . . . 0.0 113.595 179.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 84.33 10.61 79.74 Favored Glycine 0 N--CA 1.441 -0.989 0 C-N-CA 121.292 -0.48 . . . . 0.0 112.539 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 12.9 ptp180 -135.82 145.9 46.95 Favored 'General case' 0 N--CA 1.439 -0.996 0 O-C-N 122.435 -0.45 . . . . 0.0 111.511 -179.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.424 ' HB2' ' HE3' ' A' ' 96' ' ' LYS . . . -84.38 118.07 24.01 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.015 -177.543 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 10.3 mt -65.73 139.28 58.35 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-O 121.653 0.739 . . . . 0.0 112.49 179.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 60.2 tptt -109.98 115.47 29.84 Favored 'General case' 0 N--CA 1.413 -2.275 0 CA-C-N 115.106 -0.952 . . . . 0.0 108.456 178.12 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.482 HG22 HG22 ' A' ' 89' ' ' VAL . 5.0 mm -121.34 131.31 73.35 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.898 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 178.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -143.91 155.09 43.95 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 -179.349 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -83.55 132.08 34.94 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 117.994 0.361 . . . . 0.0 110.716 177.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.442 HG21 ' HB2' ' A' ' 34' ' ' TYR . 5.8 t -153.86 159.78 41.93 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 107.848 -1.168 . . . . 0.0 107.848 -176.304 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -99.71 112.64 24.85 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 169.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 32.3 t80 . . . . . 0 C--N 1.29 -2.021 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.363 -176.874 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 226' ' ' ILE . . . . . 0.49 HG21 ' OG ' ' A' ' 84' ' ' SER . 4.2 mp . . . . . 0 CA--C 1.501 -0.927 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 227' ' ' MET . . . . . . . . . . . . . 91.1 mtp -67.49 133.16 92.89 Favored Pre-proline 0 C--N 1.312 -1.022 0 O-C-N 123.528 0.518 . . . . 0.0 110.12 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 228' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -68.67 158.78 56.35 Favored 'Trans proline' 0 N--CA 1.452 -0.96 0 C-N-CA 122.761 2.307 . . . . 0.0 112.25 179.695 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . -75.6 163.55 53.71 Favored Glycine 0 N--CA 1.437 -1.25 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.329 179.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 14.6 m -77.79 -14.36 59.61 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 123.103 0.561 . . . . 0.0 110.974 -178.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 27.9 mmt180 -81.82 0.26 40.18 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 121.461 0.648 . . . . 0.0 109.952 -178.371 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 232' ' ' TRP . . . . . . . . . . . . . 22.8 t90 -81.82 130.5 35.09 Favored 'General case' 0 N--CA 1.427 -1.593 0 CA-C-O 122.228 1.013 . . . . 0.0 111.441 -177.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 233' ' ' ASP . . . . . 0.45 ' H ' HG23 ' A' ' 49' ' ' THR . 17.3 t70 -117.86 147.74 42.78 Favored 'General case' 0 C--N 1.273 -2.758 0 N-CA-C 101.201 -3.629 . . . . 0.0 101.201 171.457 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.511 3.679 0 C-N-CA 128.248 2.832 . . . . 0.0 118.213 -175.447 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 240' ' ' GLY . . . . . 0.436 ' O ' ' HG2' ' B' ' 244' ' ' LYS . . . . . . . . 0 C--O 1.2 -1.972 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 26.8 p90 -76.38 -34.55 58.87 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -179.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -63.61 -42.42 98.23 Favored 'General case' 0 C--O 1.219 -0.543 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.843 -174.048 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -61.16 -34.36 74.9 Favored 'General case' 0 CA--C 1.509 -0.623 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.397 178.479 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 244' ' ' LYS . . . . . 0.436 ' HG2' ' O ' ' B' ' 240' ' ' GLY . 71.0 mmtt -67.15 -47.52 70.8 Favored 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 -179.029 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 245' ' ' TRP . . . . . . . . . . . . . 49.2 m0 -65.3 -40.15 93.43 Favored 'General case' 0 C--O 1.208 -1.089 0 CA-C-N 114.77 -1.105 . . . . 0.0 109.83 179.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 246' ' ' PHE . . . . . 0.486 ' O ' ' HG2' ' B' ' 249' ' ' GLN . 3.1 t80 -66.18 -30.75 71.28 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 124.091 0.956 . . . . 0.0 110.892 179.318 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -78.13 -39.87 39.86 Favored 'General case' 0 C--N 1.294 -1.836 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.24 178.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.89 -11.7 46.92 Favored 'General case' 0 CA--C 1.51 -0.584 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -175.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 249' ' ' GLN . . . . . 0.486 ' HG2' ' O ' ' B' ' 246' ' ' PHE . 3.2 pt20 -74.46 2.74 8.84 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.635 -179.234 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 250' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -57.42 -35.89 70.66 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.433 177.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -88.95 107.46 19.03 Favored 'General case' 0 N--CA 1.421 -1.89 0 CA-C-O 122.179 0.99 . . . . 0.0 110.239 177.286 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 252' ' ' ILE . . . . . . . . . . . . . 9.2 pt -116.88 -34.3 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.281 -2.4 0 CA-C-N 114.27 -1.332 . . . . 0.0 110.998 -179.206 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -115.4 -26.44 7.56 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 -178.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 254' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 . . . . . 0 N--CA 1.432 -1.353 0 CA-C-N 114.631 -1.168 . . . . 0.0 110.181 -175.518 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.509 -0.614 0 N-CA-C 111.563 0.209 . . . . 0.0 111.563 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -108.0 145.39 33.98 Favored 'General case' 0 C--N 1.311 -1.088 0 C-N-CA 120.816 -0.354 . . . . 0.0 110.32 -174.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 24.2 pt -142.74 161.97 18.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.984 178.085 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.414 ' HB2' HG21 ' A' ' 107' ' ' THR . 63.1 t80 -111.55 122.72 48.59 Favored 'General case' 0 N--CA 1.42 -1.975 0 C-N-CA 124.655 1.182 . . . . 0.0 108.485 178.522 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.456 HG23 ' CD1' ' A' ' 104' ' ' ILE . 9.9 mt -108.85 128.32 64.74 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.933 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 175.018 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -130.15 168.74 21.34 Favored Glycine 0 C--N 1.288 -2.112 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 -179.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.404 ' O ' ' HD3' ' A' ' 100' ' ' ARG . 83.5 m-20 72.75 27.46 2.23 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 124.766 1.226 . . . . 0.0 110.788 -177.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.401 HD11 HD11 ' A' ' 47' ' ' ILE . 4.3 mm? -62.84 143.2 57.8 Favored 'General case' 0 CA--C 1.499 -0.993 0 CA-C-O 121.407 0.622 . . . . 0.0 112.474 179.541 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.5 ' HB3' ' HG ' ' A' ' 42' ' ' LEU . 47.5 t-20 -85.38 147.11 26.67 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 175.707 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.02 -17.3 56.83 Favored 'General case' 0 C--N 1.299 -1.592 0 C-N-CA 123.949 0.9 . . . . 0.0 112.899 178.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -98.88 0.52 44.34 Favored 'General case' 0 C--O 1.244 0.768 0 CA-C-O 121.035 0.445 . . . . 0.0 111.253 -179.475 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.5 ' HG ' ' HB3' ' A' ' 39' ' ' ASN . 77.5 mt -90.68 120.35 31.67 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-O 121.637 0.732 . . . . 0.0 110.062 179.128 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 72.1 p -102.95 173.22 6.41 Favored 'General case' 0 C--N 1.29 -2.005 0 CA-C-N 114.382 -1.281 . . . . 0.0 108.973 -177.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.432 ' HG3' ' HB2' ' A' ' 62' ' ' LEU . 2.7 mp0 -56.13 -39.07 71.69 Favored 'General case' 0 C--O 1.209 -1.057 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 175.431 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -59.25 -40.07 95.39 Favored Glycine 0 N--CA 1.444 -0.827 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.948 -178.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -67.04 -49.14 66.17 Favored 'General case' 0 CA--C 1.496 -1.109 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.571 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.401 HD11 HD11 ' A' ' 38' ' ' LEU . 48.4 mt -58.45 -46.44 89.55 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.762 0 CA-C-N 114.866 -1.061 . . . . 0.0 110.304 179.601 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 44.4 mt -59.71 -45.5 91.95 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.843 -178.525 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.475 HG23 ' H ' ' B' ' 233' ' ' ASP . 98.2 m -62.63 -45.46 92.73 Favored 'General case' 0 N--CA 1.442 -0.869 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 179.606 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 91.3 t -65.89 -47.91 83.83 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.192 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.505 -178.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.496 ' HA ' ' HD2' ' A' ' 54' ' ' TYR . 3.7 m-85 -66.45 -24.44 66.44 Favored 'General case' 0 N--CA 1.428 -1.564 0 CA-C-N 115.412 -0.813 . . . . 0.0 112.354 -178.27 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.499 ' OG ' ' HB2' ' B' ' 231' ' ' ARG . 62.3 m -68.09 -18.07 64.56 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 176.724 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -69.92 -26.78 64.31 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 119.546 -0.862 . . . . 0.0 109.226 176.165 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.496 ' HD2' ' HA ' ' A' ' 51' ' ' PHE . 61.9 m-85 -89.61 -23.26 21.98 Favored 'General case' 0 CA--C 1.505 -0.774 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.845 -175.032 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.419 ' O ' ' HA ' ' A' ' 52' ' ' SER . . . 170.41 -155.74 25.58 Favored Glycine 0 N--CA 1.418 -2.558 0 N-CA-C 110.577 -1.009 . . . . 0.0 110.577 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.417 HG22 ' HA2' ' B' ' 229' ' ' GLY . 49.0 t -104.46 105.57 50.47 Favored Pre-proline 0 C--N 1.289 -2.04 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 -177.476 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.601 ' HB3' HD21 ' A' ' 77' ' ' LEU . 64.0 Cg_endo -74.74 136.4 20.93 Favored 'Trans proline' 0 N--CA 1.447 -1.263 0 C-N-CA 121.793 1.662 . . . . 0.0 109.522 175.495 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 26.8 m -111.66 -25.54 3.47 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 C-N-CA 120.354 -0.538 . . . . 0.0 111.693 -178.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.507 ' HB3' ' HG2' ' A' ' 78' ' ' LYS . 27.9 t70 -152.92 145.38 24.11 Favored 'General case' 0 CA--C 1.491 -1.295 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 14.6 p -145.96 135.47 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.799 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 179.321 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 92.7 mt -120.51 123.91 71.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 175.607 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.432 ' HB2' ' HG3' ' A' ' 44' ' ' GLU . 0.1 OUTLIER -97.11 114.52 26.19 Favored 'General case' 0 N--CA 1.422 -1.844 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 176.46 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 9.2 m -75.25 117.85 17.52 Favored 'General case' 0 C--N 1.276 -2.594 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 178.244 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 25.9 mtp180 . . . . . 0 C--N 1.305 -1.334 0 CA-C-O 120.991 0.424 . . . . 0.0 110.991 -176.143 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 12.4 mm-40 . . . . . 0 CA--C 1.511 -0.526 0 CA-C-O 121.067 0.461 . . . . 0.0 111.794 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 85.81 6.74 82.29 Favored Glycine 0 N--CA 1.427 -1.939 0 C-N-CA 120.951 -0.643 . . . . 0.0 112.11 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -148.03 156.87 43.12 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 178.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -154.5 171.79 18.83 Favored 'General case' 0 C--N 1.307 -1.252 0 O-C-N 123.741 0.651 . . . . 0.0 110.295 178.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -128.33 140.94 51.6 Favored 'General case' 0 C--N 1.31 -1.125 0 C-N-CA 123.71 0.804 . . . . 0.0 110.222 -178.52 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.601 HD21 ' HB3' ' A' ' 57' ' ' PRO . 9.8 tt -147.06 140.72 25.68 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 175.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.507 ' HG2' ' HB3' ' A' ' 59' ' ' ASP . 21.6 ptmt -123.93 144.84 49.54 Favored 'General case' 0 C--O 1.259 1.59 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 178.645 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 59.0 m-85 -106.78 164.59 11.98 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-O 121.39 0.614 . . . . 0.0 112.232 -178.284 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -71.98 -34.3 68.83 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 114.053 -1.431 . . . . 0.0 109.093 175.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -124.65 135.01 52.71 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.403 -179.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -70.55 -20.09 62.83 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 114.316 1.228 . . . . 0.0 114.316 -177.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 87.5 mtm180 -61.27 -33.92 74.34 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 122.378 1.085 . . . . 0.0 109.475 173.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 50.6 m -66.02 -36.6 83.7 Favored 'General case' 0 C--N 1.288 -2.068 0 CA-C-N 114.777 -1.101 . . . . 0.0 112.662 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 71.3 p -63.46 -45.09 92.4 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 120.34 -0.544 . . . . 0.0 110.995 -177.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 3.9 pt -65.63 -38.54 82.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.048 177.536 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 16.1 mt -59.34 -43.74 92.73 Favored 'General case' 0 CA--C 1.502 -0.878 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.439 175.4 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.485 ' O ' ' HB2' ' A' ' 92' ' ' LEU . . . -69.93 -44.97 68.5 Favored 'General case' 0 N--CA 1.425 -1.678 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.648 -178.648 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.499 HG22 HG22 ' A' ' 104' ' ' ILE . 71.2 t -59.69 -44.27 93.24 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.898 0 CA-C-O 121.189 0.519 . . . . 0.0 111.229 177.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -63.15 -39.1 93.7 Favored 'General case' 0 C--N 1.291 -1.94 0 C-N-CA 124.095 0.958 . . . . 0.0 112.612 -177.403 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.416 ' HB3' ' CE1' ' A' ' 54' ' ' TYR . 50.8 t-20 -93.44 -33.27 13.89 Favored 'General case' 0 C--N 1.292 -1.924 0 CA-C-O 121.196 0.522 . . . . 0.0 111.355 -175.01 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.485 ' HB2' ' O ' ' A' ' 88' ' ' ALA . 12.9 mt -88.37 -28.13 21.17 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 112.597 0.591 . . . . 0.0 112.597 -171.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -64.26 123.83 20.14 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 81.89 -0.57 88.25 Favored Glycine 0 CA--C 1.535 1.321 0 C-N-CA 120.979 -0.629 . . . . 0.0 113.763 179.631 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.402 ' O ' ' HA ' ' A' ' 101' ' ' ALA . 68.3 t80 -85.11 141.76 30.0 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -179.091 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.56 119.74 34.59 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 112.832 0.678 . . . . 0.0 112.832 -176.34 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 52.2 mt -127.56 141.25 46.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 N-CA-C 105.415 -2.069 . . . . 0.0 105.415 172.107 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 61.22 20.74 58.72 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 121.135 -0.555 . . . . 0.0 113.567 179.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 82.1 10.05 84.37 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 121.159 -0.543 . . . . 0.0 112.835 -178.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.404 ' HD3' ' O ' ' A' ' 37' ' ' ASN . 12.7 ptp180 -134.81 143.68 47.2 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 117.128 0.464 . . . . 0.0 111.564 -179.762 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.402 ' HA ' ' O ' ' A' ' 95' ' ' PHE . . . -81.33 121.16 25.86 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.508 -179.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 10.5 mt -70.03 138.7 52.37 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 179.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 24.2 tptm -106.4 116.2 31.51 Favored 'General case' 0 N--CA 1.415 -2.193 0 CA-C-N 115.181 -0.918 . . . . 0.0 108.575 177.557 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.499 HG22 HG22 ' A' ' 89' ' ' VAL . 5.8 mm -118.76 135.9 57.68 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.096 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 177.686 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -143.48 152.96 42.13 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 -178.105 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' HIS . . . . . 0.401 ' CD2' HG21 ' A' ' 89' ' ' VAL . 47.3 m-70 -84.16 135.01 34.55 Favored 'General case' 0 C--N 1.289 -2.055 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 176.551 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.414 HG21 ' HB2' ' A' ' 34' ' ' TYR . 5.9 t -154.49 163.49 40.12 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 106.024 -1.843 . . . . 0.0 106.024 -178.752 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -110.16 110.61 21.52 Favored 'General case' 0 N--CA 1.422 -1.829 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 171.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 26.5 t80 . . . . . 0 C--N 1.285 -2.213 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 -179.186 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 4.2 mp . . . . . 0 C--O 1.249 1.035 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 227' ' ' MET . . . . . . . . . . . . . 93.1 mmm -72.35 137.92 81.18 Favored Pre-proline 0 C--N 1.317 -0.833 0 O-C-N 123.621 0.576 . . . . 0.0 110.337 178.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 228' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -63.16 160.81 32.78 Favored 'Trans proline' 0 CA--C 1.536 0.623 0 C-N-CA 123.752 2.968 . . . . 0.0 114.615 -174.28 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 229' ' ' GLY . . . . . 0.417 ' HA2' HG22 ' A' ' 56' ' ' VAL . . . -80.1 171.11 54.23 Favored Glycine 0 N--CA 1.442 -0.938 0 CA-C-N 115.077 -0.965 . . . . 0.0 113.438 -178.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 7.9 m -72.15 -15.7 61.97 Favored 'General case' 0 C--N 1.307 -1.261 0 C-N-CA 124.318 1.047 . . . . 0.0 111.772 -175.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 231' ' ' ARG . . . . . 0.499 ' HB2' ' OG ' ' A' ' 52' ' ' SER . 9.9 mmm180 -93.34 -0.03 56.76 Favored 'General case' 0 C--N 1.313 -1.007 0 O-C-N 122.175 -0.328 . . . . 0.0 110.946 -174.56 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 232' ' ' TRP . . . . . . . . . . . . . 21.2 t90 -75.15 127.41 33.14 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-O 122.655 1.216 . . . . 0.0 112.419 -176.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 233' ' ' ASP . . . . . 0.475 ' H ' HG23 ' A' ' 49' ' ' THR . 22.3 t70 -123.95 144.17 49.95 Favored 'General case' 0 C--N 1.263 -3.161 0 N-CA-C 102.424 -3.176 . . . . 0.0 102.424 174.444 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.276 0 C-N-CA 128.415 2.912 . . . . 0.0 116.375 -178.239 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 240' ' ' GLY . . . . . 0.5 ' O ' ' HG2' ' B' ' 244' ' ' LYS . . . . . . . . 0 N--CA 1.426 -1.98 0 N-CA-C 110.204 -1.158 . . . . 0.0 110.204 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 37.8 p90 -75.18 -33.72 61.48 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -176.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -61.57 -45.33 94.6 Favored 'General case' 0 CA--C 1.507 -0.703 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.52 -178.033 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -62.28 -34.31 76.32 Favored 'General case' 0 C--O 1.212 -0.892 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.266 -179.564 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 244' ' ' LYS . . . . . 0.5 ' HG2' ' O ' ' B' ' 240' ' ' GLY . 71.6 mmtt -64.87 -47.79 76.59 Favored 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 -179.028 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 245' ' ' TRP . . . . . 0.47 ' HA ' ' HG3' ' B' ' 248' ' ' LYS . 37.8 m0 -66.14 -37.28 85.3 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.677 178.079 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 246' ' ' PHE . . . . . 0.566 ' O ' ' HG2' ' B' ' 249' ' ' GLN . 2.5 t80 -66.89 -30.36 70.5 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.809 176.612 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -77.7 -40.02 42.74 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.954 179.379 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 248' ' ' LYS . . . . . 0.47 ' HG3' ' HA ' ' B' ' 245' ' ' TRP . 0.0 OUTLIER -81.36 -19.26 43.09 Favored 'General case' 0 CA--C 1.506 -0.718 0 CA-C-O 120.84 0.352 . . . . 0.0 111.678 -175.908 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 249' ' ' GLN . . . . . 0.566 ' HG2' ' O ' ' B' ' 246' ' ' PHE . 3.0 pt20 -70.44 -0.56 8.58 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.739 -178.268 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 250' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -57.78 -32.18 67.27 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.992 177.2 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -89.83 106.56 18.55 Favored 'General case' 0 N--CA 1.428 -1.542 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 176.441 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 252' ' ' ILE . . . . . . . . . . . . . 37.9 pt -92.8 -33.93 5.69 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.851 0 CA-C-N 115.028 -0.987 . . . . 0.0 112.316 -174.004 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -89.26 -11.45 43.53 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-O 121.349 0.595 . . . . 0.0 110.745 -176.123 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 254' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.287 -2.126 0 CA-C-N 114.971 -1.013 . . . . 0.0 111.16 -177.024 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.415 ' HA ' HG21 ' A' ' 85' ' ' THR . . . . . . . . 0 N--CA 1.44 -0.953 0 CA-C-O 120.567 0.223 . . . . 0.0 110.46 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 16.3 m-85 -99.72 145.18 27.95 Favored 'General case' 0 N--CA 1.433 -1.283 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 -177.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 24.7 pt -140.1 156.44 24.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 CA-C-O 121.157 0.504 . . . . 0.0 110.636 175.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 49.0 t80 -106.87 123.73 48.58 Favored 'General case' 0 N--CA 1.408 -2.564 0 CA-C-N 114.396 -1.275 . . . . 0.0 107.607 177.168 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.416 HG23 ' CD1' ' A' ' 104' ' ' ILE . 8.3 mt -107.89 127.57 63.88 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.55 0 N-CA-C 105.831 -1.915 . . . . 0.0 105.831 175.224 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -126.61 164.06 20.31 Favored Glycine 0 C--N 1.272 -2.975 0 N-CA-C 110.612 -0.995 . . . . 0.0 110.612 -179.076 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 70.94 39.9 0.97 Allowed 'General case' 0 CA--C 1.506 -0.74 0 C-N-CA 124.18 0.992 . . . . 0.0 110.715 -177.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.493 HD11 HD11 ' A' ' 47' ' ' ILE . 4.4 mm? -73.44 151.81 40.98 Favored 'General case' 0 CA--C 1.497 -1.07 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.867 176.007 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.506 ' HB3' ' HG ' ' A' ' 42' ' ' LEU . 50.2 t-20 -96.14 147.98 23.17 Favored 'General case' 0 C--N 1.286 -2.188 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 177.657 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.41 HH11 ' HD3' ' A' ' 40' ' ' ARG . 0.3 OUTLIER -63.39 -19.41 64.65 Favored 'General case' 0 C--N 1.298 -1.672 0 C-N-CA 123.326 0.651 . . . . 0.0 111.985 179.944 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.441 ' HG2' ' CG ' ' A' ' 39' ' ' ASN . 12.9 pt-20 -91.93 -3.54 55.81 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.903 -179.179 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.506 ' HG ' ' HB3' ' A' ' 39' ' ' ASN . 78.3 mt -91.09 124.03 35.0 Favored 'General case' 0 CA--C 1.504 -0.818 0 CA-C-O 121.117 0.485 . . . . 0.0 110.285 -179.63 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 67.2 p -109.72 173.78 6.17 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 114.705 -1.134 . . . . 0.0 109.409 -178.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.533 ' CG ' ' HB2' ' A' ' 62' ' ' LEU . 51.9 mt-10 -55.66 -38.91 70.2 Favored 'General case' 0 C--N 1.328 -0.333 0 O-C-N 123.47 0.481 . . . . 0.0 110.293 178.354 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -59.96 -43.11 98.43 Favored Glycine 0 C--O 1.24 0.483 0 CA-C-N 115.928 -0.578 . . . . 0.0 113.105 179.266 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -61.68 -49.17 77.57 Favored 'General case' 0 CA--C 1.499 -0.981 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.493 HD11 HD11 ' A' ' 38' ' ' LEU . 41.7 mt -60.86 -46.07 96.97 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.931 0 CA-C-N 114.833 -1.076 . . . . 0.0 110.63 -179.529 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 36.1 mt -60.07 -45.73 91.91 Favored 'General case' 0 CA--C 1.491 -1.293 0 C-N-CA 122.511 0.325 . . . . 0.0 111.81 -176.503 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.493 HG23 ' H ' ' B' ' 233' ' ' ASP . 97.5 m -62.88 -45.32 93.1 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 123.39 0.431 . . . . 0.0 111.751 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 76.6 t -67.28 -45.51 85.94 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.92 -179.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -66.96 -22.8 65.91 Favored 'General case' 0 N--CA 1.435 -1.184 0 C-N-CA 123.483 0.713 . . . . 0.0 111.941 -179.355 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.6 ' OG ' ' HB2' ' B' ' 231' ' ' ARG . 73.2 m -71.73 -16.54 62.22 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 116.177 -0.465 . . . . 0.0 112.141 176.139 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -73.53 -20.75 60.57 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 175.319 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.459 ' CE1' ' HB2' ' A' ' 91' ' ' ASN . 68.3 m-85 -97.76 -5.1 35.71 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-N 115.898 -0.592 . . . . 0.0 112.315 -176.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 151.7 -153.65 25.07 Favored Glycine 0 N--CA 1.423 -2.2 0 C-N-CA 120.511 -0.852 . . . . 0.0 111.317 179.212 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.461 ' HB ' ' HG2' ' A' ' 80' ' ' GLU . 99.5 t -106.61 104.51 51.26 Favored Pre-proline 0 C--N 1.305 -1.364 0 CA-C-O 120.469 0.176 . . . . 0.0 111.28 -177.466 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.555 ' HB3' HD21 ' A' ' 77' ' ' LEU . 87.8 Cg_endo -76.8 140.09 20.4 Favored 'Trans proline' 0 C--O 1.24 0.61 0 C-N-CA 123.011 2.474 . . . . 0.0 110.141 175.342 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 34.1 m -117.78 -26.04 2.77 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 C-N-CA 119.815 -0.754 . . . . 0.0 111.84 -179.35 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.617 ' HB3' ' HG2' ' A' ' 78' ' ' LYS . 30.5 t70 -149.52 136.48 19.65 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 -173.434 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 14.3 p -145.96 134.1 16.05 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.051 0 O-C-N 123.548 0.53 . . . . 0.0 110.165 -178.361 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 97.3 mt -121.37 120.15 61.12 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 175.173 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.533 ' HB2' ' CG ' ' A' ' 44' ' ' GLU . 0.1 OUTLIER -91.43 115.56 28.14 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 105.957 -1.868 . . . . 0.0 105.957 173.409 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 13.2 m -72.62 116.68 13.38 Favored 'General case' 0 N--CA 1.411 -2.379 0 N-CA-C 107.535 -1.284 . . . . 0.0 107.535 177.636 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 75.8 mtm180 . . . . . 0 C--N 1.287 -2.133 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 -174.753 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 15.6 mm-40 . . . . . 0 CA--C 1.516 -0.328 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 102.35 8.59 43.54 Favored Glycine 0 N--CA 1.431 -1.644 0 C-N-CA 120.27 -0.967 . . . . 0.0 111.636 179.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 34.9 p90 -148.78 159.86 43.75 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 177.044 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -156.07 172.73 17.9 Favored 'General case' 0 C--N 1.308 -1.231 0 O-C-N 123.581 0.551 . . . . 0.0 110.561 178.436 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -130.22 141.37 50.64 Favored 'General case' 0 C--N 1.308 -1.235 0 C-N-CA 123.723 0.809 . . . . 0.0 110.089 -179.517 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.555 HD21 ' HB3' ' A' ' 57' ' ' PRO . 9.4 tt -149.21 140.85 23.48 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 175.104 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.617 ' HG2' ' HB3' ' A' ' 59' ' ' ASP . 16.5 ptmt -125.93 144.28 50.75 Favored 'General case' 0 N--CA 1.431 -1.425 0 CA-C-O 121.421 0.629 . . . . 0.0 109.821 176.51 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -102.6 165.08 11.28 Favored 'General case' 0 C--N 1.283 -2.291 0 CA-C-N 115.164 -0.926 . . . . 0.0 109.362 179.518 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.461 ' HG2' ' HB ' ' A' ' 56' ' ' VAL . 8.2 pt-20 -76.95 -21.49 54.7 Favored 'General case' 0 N--CA 1.428 -1.563 0 C-N-CA 119.997 -0.681 . . . . 0.0 110.07 174.052 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -123.59 132.56 53.91 Favored 'General case' 0 N--CA 1.443 -0.815 0 C-N-CA 120.424 -0.51 . . . . 0.0 110.399 179.164 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -70.47 -19.87 62.91 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 -179.318 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 86.5 mtm180 -66.11 -33.66 76.29 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-O 122.166 0.984 . . . . 0.0 108.978 174.093 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 48.7 m -67.97 -36.98 80.98 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-N 114.86 -1.063 . . . . 0.0 112.208 177.531 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.478 ' O ' HG23 ' A' ' 89' ' ' VAL . 73.1 p -64.96 -45.3 86.27 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 120.244 -0.583 . . . . 0.0 110.9 -177.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 7.1 pt -63.25 -38.69 82.79 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.466 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.161 177.178 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.6 mt -59.23 -43.83 92.35 Favored 'General case' 0 CA--C 1.502 -0.893 0 O-C-N 123.785 0.678 . . . . 0.0 111.423 177.267 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.429 ' HB1' HD12 ' A' ' 92' ' ' LEU . . . -69.09 -46.53 67.53 Favored 'General case' 0 N--CA 1.424 -1.728 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.745 -179.418 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.478 HG23 ' O ' ' A' ' 85' ' ' THR . 92.7 t -56.64 -46.39 82.81 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.745 0 CA-C-O 121.648 0.737 . . . . 0.0 110.569 178.136 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -58.87 -40.14 83.44 Favored 'General case' 0 C--N 1.292 -1.926 0 C-N-CA 125.843 1.657 . . . . 0.0 112.329 -175.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.459 ' HB2' ' CE1' ' A' ' 54' ' ' TYR . 47.0 m-80 -98.46 -27.88 13.86 Favored 'General case' 0 C--N 1.294 -1.846 0 N-CA-C 113.129 0.788 . . . . 0.0 113.129 -175.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.429 HD12 ' HB1' ' A' ' 88' ' ' ALA . 15.5 mt -90.07 -30.73 17.51 Favored 'General case' 0 CA--C 1.471 -2.091 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.706 -171.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -65.98 124.74 23.35 Favored 'General case' 0 N--CA 1.425 -1.685 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 88.75 -5.48 84.57 Favored Glycine 0 C--N 1.308 -1.003 0 C-N-CA 121.167 -0.539 . . . . 0.0 112.65 -178.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 53.6 t80 -88.69 139.75 30.15 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 -179.041 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.457 ' HE3' ' HB2' ' A' ' 101' ' ' ALA . 12.3 mptt -95.87 118.18 32.01 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-O 120.92 0.391 . . . . 0.0 111.649 -176.292 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 53.0 mt -121.33 140.73 44.52 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 173.081 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 57.22 27.22 57.43 Favored Glycine 0 C--O 1.22 -0.756 0 C-N-CA 121.327 -0.463 . . . . 0.0 112.567 -179.582 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 88.07 -5.81 84.34 Favored Glycine 0 CA--C 1.536 1.376 0 N-CA-C 114.541 0.577 . . . . 0.0 114.541 179.028 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 16.8 ptp180 -126.34 149.89 48.89 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 118.16 0.98 . . . . 0.0 111.901 -177.039 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.457 ' HB2' ' HE3' ' A' ' 96' ' ' LYS . . . -84.84 116.8 23.5 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.525 -175.725 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.441 ' HA ' HD23 ' A' ' 102' ' ' LEU . 12.9 mt -66.51 141.4 57.89 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-O 121.76 0.791 . . . . 0.0 112.797 178.538 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 4.3 tppp? -117.2 116.59 27.58 Favored 'General case' 0 N--CA 1.411 -2.419 0 CA-C-N 114.67 -1.15 . . . . 0.0 108.123 176.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.435 HG22 HG22 ' A' ' 89' ' ' VAL . 4.1 mm -115.64 133.64 61.36 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.931 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 -179.69 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -143.6 150.89 39.47 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 -179.405 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 41.7 m-70 -79.42 131.63 36.14 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-O 121.132 0.492 . . . . 0.0 110.33 177.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 15.1 t -143.77 156.38 44.48 Favored 'General case' 0 C--N 1.288 -2.068 0 N-CA-C 106.072 -1.825 . . . . 0.0 106.072 -179.445 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 30.3 p90 -101.13 109.17 21.02 Favored 'General case' 0 N--CA 1.42 -1.944 0 C-N-CA 117.173 -1.811 . . . . 0.0 107.08 169.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 42.8 t80 . . . . . 0 C--N 1.29 -2.008 0 CA-C-N 114.87 -1.059 . . . . 0.0 108.647 -178.876 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 4.6 mp . . . . . 0 C--O 1.241 0.619 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 227' ' ' MET . . . . . . . . . . . . . 26.3 ptm -71.56 151.72 93.77 Favored Pre-proline 0 C--N 1.318 -0.778 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.387 178.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 228' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -70.94 157.28 58.53 Favored 'Trans proline' 0 C--O 1.245 0.865 0 C-N-CA 123.225 2.617 . . . . 0.0 112.991 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . -84.37 173.44 49.85 Favored Glycine 0 C--N 1.317 -0.51 0 CA-C-N 115.704 -0.68 . . . . 0.0 113.089 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 24.8 m -77.71 -14.3 59.65 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -175.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 231' ' ' ARG . . . . . 0.6 ' HB2' ' OG ' ' A' ' 52' ' ' SER . 3.1 mmp_? -80.16 -7.15 58.8 Favored 'General case' 0 C--N 1.326 -0.43 0 O-C-N 121.964 -0.46 . . . . 0.0 110.365 177.657 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 232' ' ' TRP . . . . . . . . . . . . . 22.8 t90 -73.1 127.17 31.8 Favored 'General case' 0 CA--C 1.5 -0.966 0 CA-C-O 122.355 1.074 . . . . 0.0 111.819 -178.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 233' ' ' ASP . . . . . 0.493 ' H ' HG23 ' A' ' 49' ' ' THR . 26.9 t70 -123.23 146.47 47.81 Favored 'General case' 0 C--N 1.269 -2.92 0 N-CA-C 102.436 -3.172 . . . . 0.0 102.436 173.511 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.611 0 C-N-CA 128.101 2.763 . . . . 0.0 116.129 -179.472 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 240' ' ' GLY . . . . . 0.49 ' O ' ' HG2' ' B' ' 244' ' ' LYS . . . . . . . . 0 N--CA 1.412 -2.93 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 10.0 p90 -75.42 -32.85 60.84 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 178.582 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -60.5 -42.38 96.24 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.148 0.499 . . . . 0.0 110.285 -179.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -64.79 -35.42 81.03 Favored 'General case' 0 C--O 1.202 -1.439 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.677 179.668 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 244' ' ' LYS . . . . . 0.49 ' HG2' ' O ' ' B' ' 240' ' ' GLY . 39.6 mmtm -60.78 -47.46 86.23 Favored 'General case' 0 C--O 1.242 0.665 0 CA-C-O 121.29 0.567 . . . . 0.0 109.865 -178.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 245' ' ' TRP . . . . . . . . . . . . . 19.4 m0 -63.55 -41.05 98.45 Favored 'General case' 0 N--CA 1.437 -1.096 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.225 179.174 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 246' ' ' PHE . . . . . 0.524 ' HA ' ' HG2' ' B' ' 249' ' ' GLN . 3.6 t80 -68.14 -34.35 76.19 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.348 179.271 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -70.19 -35.35 73.89 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.699 -178.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.41 -21.73 22.89 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 120.357 -0.537 . . . . 0.0 111.789 -178.18 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 249' ' ' GLN . . . . . 0.524 ' HG2' ' HA ' ' B' ' 246' ' ' PHE . 3.5 pt20 -78.31 2.24 19.17 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.386 0.612 . . . . 0.0 110.402 -179.494 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 250' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -57.28 -31.93 66.1 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 114.892 -1.049 . . . . 0.0 112.864 178.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -77.18 142.66 39.53 Favored 'General case' 0 N--CA 1.433 -1.28 0 CA-C-O 121.986 0.898 . . . . 0.0 113.292 -176.768 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 252' ' ' ILE . . . . . . . . . . . . . 34.3 pt -130.67 -32.01 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 CA-C-N 114.487 -1.233 . . . . 0.0 113.078 -171.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -110.79 -23.05 11.25 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 121.624 0.726 . . . . 0.0 110.296 -175.65 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 254' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 . . . . . 0 C--N 1.295 -1.787 0 CA-C-N 114.038 -1.437 . . . . 0.0 114.117 -173.868 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.437 -1.081 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -100.31 145.23 28.38 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 -177.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 23.1 pt -141.06 159.81 23.12 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 CA-C-O 121.025 0.44 . . . . 0.0 110.953 175.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 45.0 t80 -109.42 122.49 47.49 Favored 'General case' 0 N--CA 1.421 -1.901 0 CA-C-N 114.485 -1.234 . . . . 0.0 108.206 177.533 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.411 HG23 ' CD1' ' A' ' 104' ' ' ILE . 8.2 mt -108.56 128.0 64.55 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.164 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 174.562 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -129.98 165.6 22.33 Favored Glycine 0 C--N 1.283 -2.415 0 N-CA-C 110.832 -0.907 . . . . 0.0 110.832 -179.571 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 71.13 35.16 1.67 Allowed 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.865 1.266 . . . . 0.0 110.667 -177.359 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.421 HD11 HD11 ' A' ' 47' ' ' ILE . 4.5 mm? -68.47 152.77 44.93 Favored 'General case' 0 CA--C 1.497 -1.085 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.25 176.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.445 ' HB3' ' HG ' ' A' ' 42' ' ' LEU . 39.7 t-20 -91.63 151.94 20.47 Favored 'General case' 0 C--N 1.29 -1.988 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 176.55 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -64.16 -17.21 63.27 Favored 'General case' 0 C--N 1.307 -1.253 0 C-N-CA 122.997 0.519 . . . . 0.0 111.734 179.837 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -97.27 3.55 51.26 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.107 -178.565 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.445 ' HG ' ' HB3' ' A' ' 39' ' ' ASN . 86.3 mt -98.46 117.33 32.64 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-O 121.589 0.709 . . . . 0.0 111.029 -179.128 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 68.2 p -107.23 174.74 5.76 Favored 'General case' 0 C--N 1.293 -1.866 0 CA-C-N 114.346 -1.297 . . . . 0.0 109.186 -179.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -54.46 -41.34 69.35 Favored 'General case' 0 C--O 1.209 -1.032 0 C-N-CA 123.19 0.596 . . . . 0.0 110.158 178.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.27 -39.47 96.08 Favored Glycine 0 CA--C 1.526 0.742 0 O-C-N 123.26 0.35 . . . . 0.0 112.901 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -66.8 -48.02 70.27 Favored 'General case' 0 CA--C 1.499 -1.004 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 179.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.421 HD11 HD11 ' A' ' 38' ' ' LEU . 42.0 mt -60.26 -46.36 94.92 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.782 0 CA-C-N 114.844 -1.071 . . . . 0.0 110.762 178.453 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 52.3 mt -59.77 -38.59 82.27 Favored 'General case' 0 CA--C 1.486 -1.502 0 C-N-CA 122.86 0.464 . . . . 0.0 111.525 -177.678 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.465 HG23 ' H ' ' B' ' 233' ' ' ASP . 62.1 m -64.38 -46.79 81.83 Favored 'General case' 0 N--CA 1.433 -1.281 0 O-C-N 123.615 0.572 . . . . 0.0 110.716 -179.115 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 89.6 t -67.72 -47.91 78.0 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.624 -179.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.464 ' HA ' ' HD2' ' A' ' 54' ' ' TYR . 3.7 m-85 -65.02 -25.07 67.69 Favored 'General case' 0 N--CA 1.435 -1.196 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.881 -177.145 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 59.8 m -67.59 -22.17 65.38 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.239 -0.437 . . . . 0.0 112.031 176.325 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -64.91 -28.94 69.88 Favored 'General case' 0 CA--C 1.559 1.322 0 CA-C-O 121.485 0.66 . . . . 0.0 109.917 175.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.464 ' HD2' ' HA ' ' A' ' 51' ' ' PHE . 49.1 m-85 -91.3 -18.24 24.65 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-O 121.24 0.543 . . . . 0.0 112.097 -175.204 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 165.19 -160.49 33.83 Favored Glycine 0 N--CA 1.419 -2.457 0 N-CA-C 111.011 -0.836 . . . . 0.0 111.011 179.484 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 62.2 t -100.2 110.8 60.92 Favored Pre-proline 0 C--N 1.294 -1.833 0 N-CA-C 110.347 -0.242 . . . . 0.0 110.347 -178.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.51 ' HB3' HD21 ' A' ' 77' ' ' LEU . 73.2 Cg_endo -76.05 141.07 23.33 Favored 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 122.645 2.23 . . . . 0.0 109.764 175.075 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 33.7 m -119.9 -13.57 9.1 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 C-N-CA 120.117 -0.633 . . . . 0.0 112.188 -179.275 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.496 ' HB3' ' HG2' ' A' ' 78' ' ' LYS . 33.2 t70 -164.09 136.85 5.07 Favored 'General case' 0 CA--C 1.501 -0.911 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.219 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 13.0 p -144.72 133.36 17.83 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 O-C-N 123.729 0.643 . . . . 0.0 110.01 -179.172 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 94.1 mt -121.9 128.98 75.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 176.019 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -99.36 117.28 33.45 Favored 'General case' 0 N--CA 1.419 -1.99 0 N-CA-C 105.364 -2.088 . . . . 0.0 105.364 173.394 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 62.8 m -78.61 117.82 20.14 Favored 'General case' 0 C--N 1.275 -2.655 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 176.131 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 85.8 mtt180 . . . . . 0 C--N 1.304 -1.394 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 -175.401 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 13.4 mm-40 . . . . . 0 CA--C 1.504 -0.815 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 87.21 4.23 81.44 Favored Glycine 0 N--CA 1.433 -1.514 0 C-N-CA 120.221 -0.99 . . . . 0.0 112.344 -179.393 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 31.5 p90 -142.1 155.34 45.35 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 177.509 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -149.75 171.84 16.07 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-O 120.94 0.4 . . . . 0.0 110.88 -179.375 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -130.3 140.85 50.63 Favored 'General case' 0 C--N 1.31 -1.118 0 C-N-CA 123.854 0.861 . . . . 0.0 109.963 -178.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.51 HD21 ' HB3' ' A' ' 57' ' ' PRO . 9.8 tt -149.94 140.55 22.55 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 175.532 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.496 ' HG2' ' HB3' ' A' ' 59' ' ' ASP . 16.9 ptmt -125.05 144.56 50.34 Favored 'General case' 0 N--CA 1.433 -1.276 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 177.781 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 61.3 m-85 -104.48 164.94 11.39 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-O 121.614 0.721 . . . . 0.0 112.321 -177.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -75.86 -30.74 59.0 Favored 'General case' 0 N--CA 1.437 -1.089 0 CA-C-N 114.33 -1.304 . . . . 0.0 109.4 175.671 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -122.01 133.22 54.81 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 -179.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -70.06 -19.93 63.26 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 114.254 1.205 . . . . 0.0 114.254 -177.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 88.4 mtm180 -65.8 -33.21 75.33 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-O 122.299 1.047 . . . . 0.0 109.863 174.135 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.502 ' OG ' HG21 ' B' ' 226' ' ' ILE . 66.2 m -63.27 -36.77 84.78 Favored 'General case' 0 C--N 1.288 -2.101 0 CA-C-N 114.985 -1.007 . . . . 0.0 112.947 178.852 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.447 ' O ' HG23 ' A' ' 89' ' ' VAL . 77.2 p -64.2 -45.54 87.85 Favored 'General case' 0 C--O 1.224 -0.25 0 C-N-CA 120.229 -0.588 . . . . 0.0 110.779 -177.554 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 5.2 pt -64.94 -38.86 83.85 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.309 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.837 177.77 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.462 HD12 ' HA ' ' A' ' 84' ' ' SER . 6.4 mt -58.55 -43.53 89.32 Favored 'General case' 0 CA--C 1.505 -0.779 0 O-C-N 123.812 0.695 . . . . 0.0 110.668 177.719 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.472 ' O ' ' HB2' ' A' ' 92' ' ' LEU . . . -71.97 -43.76 64.65 Favored 'General case' 0 N--CA 1.42 -1.933 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.708 179.536 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.469 HG22 HG22 ' A' ' 104' ' ' ILE . 79.3 t -58.85 -49.04 84.35 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.751 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -71.18 -27.8 63.79 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -172.488 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -96.58 -25.62 15.54 Favored 'General case' 0 C--N 1.296 -1.759 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.761 -177.367 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.472 ' HB2' ' O ' ' A' ' 88' ' ' ALA . 12.1 mt -95.33 -22.66 17.61 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 122.052 -0.405 . . . . 0.0 111.471 -178.049 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -65.21 124.93 23.46 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 177.361 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 81.79 -0.99 87.59 Favored Glycine 0 C--O 1.243 0.666 0 C-N-CA 120.882 -0.675 . . . . 0.0 113.143 177.564 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 62.0 t80 -85.35 144.1 28.25 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 -178.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 11.8 mptt -99.88 118.78 37.05 Favored 'General case' 0 N--CA 1.44 -0.955 0 CA-C-O 121.336 0.589 . . . . 0.0 112.512 -176.396 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 58.6 mt -127.59 141.46 46.32 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.188 0 N-CA-C 105.842 -1.91 . . . . 0.0 105.842 173.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 61.1 20.06 57.66 Favored Glycine 0 CA--C 1.519 0.312 0 C-N-CA 121.143 -0.551 . . . . 0.0 112.373 -177.406 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 78.13 7.49 87.65 Favored Glycine 0 N--CA 1.436 -1.362 0 CA-C-N 115.834 -0.183 . . . . 0.0 113.217 -178.011 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 16.7 ptp180 -124.78 147.95 48.4 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 117.534 0.667 . . . . 0.0 110.405 -179.555 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -87.7 116.32 25.75 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 116.585 -0.28 . . . . 0.0 111.587 -175.631 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 12.7 mt -65.84 144.62 56.72 Favored 'General case' 0 C--O 1.252 1.186 0 CA-C-O 121.875 0.845 . . . . 0.0 113.103 179.679 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 29.2 tptp -118.72 115.47 24.55 Favored 'General case' 0 N--CA 1.416 -2.148 0 CA-C-N 114.806 -1.088 . . . . 0.0 108.216 176.076 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.469 HG22 HG22 ' A' ' 89' ' ' VAL . 4.7 mm -114.69 134.46 57.61 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.966 0 N-CA-C 105.859 -1.904 . . . . 0.0 105.859 178.328 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -143.12 151.99 41.32 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -176.138 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 56.2 m-70 -83.34 130.48 35.06 Favored 'General case' 0 C--N 1.295 -1.804 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 177.492 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 7.3 t -147.28 163.42 36.45 Favored 'General case' 0 C--N 1.291 -1.973 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 -178.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 46.5 m-85 -110.13 111.03 22.11 Favored 'General case' 0 N--CA 1.42 -1.96 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 171.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 63.7 t80 . . . . . 0 C--N 1.294 -1.819 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.783 -176.41 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' 226' ' ' ILE . . . . . 0.502 HG21 ' OG ' ' A' ' 84' ' ' SER . 4.0 mp . . . . . 0 N--CA 1.437 -1.087 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 227' ' ' MET . . . . . . . . . . . . . 65.8 mtt -61.92 134.2 94.13 Favored Pre-proline 0 C--N 1.322 -0.626 0 O-C-N 123.466 0.479 . . . . 0.0 111.516 -179.161 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 228' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -72.34 140.28 33.36 Favored 'Trans proline' 0 C--O 1.251 1.138 0 C-N-CA 123.13 2.554 . . . . 0.0 112.703 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . -65.65 164.01 39.16 Favored Glycine 0 C--N 1.317 -0.526 0 CA-C-N 115.573 -0.739 . . . . 0.0 113.372 -179.528 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 14.6 m -72.06 -18.08 61.96 Favored 'General case' 0 C--N 1.31 -1.149 0 C-N-CA 123.331 0.652 . . . . 0.0 112.375 -175.172 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 13.6 mmm180 -82.06 -3.45 54.67 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.92 0.391 . . . . 0.0 111.146 -177.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 232' ' ' TRP . . . . . . . . . . . . . 24.9 t90 -72.04 123.52 22.97 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-O 122.405 1.097 . . . . 0.0 111.502 179.639 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 233' ' ' ASP . . . . . 0.465 ' H ' HG23 ' A' ' 49' ' ' THR . 8.4 t70 -113.14 144.48 42.59 Favored 'General case' 0 C--N 1.276 -2.617 0 N-CA-C 101.095 -3.669 . . . . 0.0 101.095 171.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.059 0 C-N-CA 127.361 2.41 . . . . 0.0 115.836 -178.795 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' 240' ' ' GLY . . . . . 0.52 ' O ' ' HG2' ' B' ' 244' ' ' LYS . . . . . . . . 0 N--CA 1.423 -2.199 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 20.8 p90 -76.27 -38.12 56.63 Favored 'General case' 0 C--N 1.293 -1.868 0 C-N-CA 123.768 0.827 . . . . 0.0 112.318 179.684 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -60.71 -42.78 97.93 Favored 'General case' 0 C--O 1.243 0.741 0 C-N-CA 122.353 0.261 . . . . 0.0 111.281 -177.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -62.0 -34.99 77.2 Favored 'General case' 0 C--O 1.211 -0.935 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.476 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 244' ' ' LYS . . . . . 0.52 ' HG2' ' O ' ' B' ' 240' ' ' GLY . 43.9 mmtm -64.45 -47.85 77.52 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-O 121.133 0.492 . . . . 0.0 110.523 -177.718 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 245' ' ' TRP . . . . . . . . . . . . . 13.6 m0 -65.8 -39.12 90.6 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.225 178.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 246' ' ' PHE . . . . . 0.504 ' O ' ' HG2' ' B' ' 249' ' ' GLN . 2.7 t80 -64.97 -37.12 86.61 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.634 178.181 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -68.49 -35.42 77.5 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.591 -179.536 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.33 -16.71 28.67 Favored 'General case' 0 CA--C 1.509 -0.6 0 N-CA-C 111.887 0.329 . . . . 0.0 111.887 -177.782 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 249' ' ' GLN . . . . . 0.504 ' HG2' ' O ' ' B' ' 246' ' ' PHE . 3.2 pt20 -81.07 2.8 25.64 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-O 120.839 0.352 . . . . 0.0 110.456 -179.299 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 250' ' ' ASN . . . . . 0.436 ' OD1' ' HG3' ' B' ' 251' ' ' GLU . 7.9 p30 -52.37 -39.69 61.09 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.514 178.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 251' ' ' GLU . . . . . 0.436 ' HG3' ' OD1' ' B' ' 250' ' ' ASN . 46.2 mt-10 -133.66 121.36 21.88 Favored 'General case' 0 N--CA 1.435 -1.205 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 174.43 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 252' ' ' ILE . . . . . . . . . . . . . 38.1 pt -96.91 -34.34 4.91 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -174.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -100.46 -17.76 17.02 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-O 121.969 0.89 . . . . 0.0 109.58 -178.471 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 254' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.293 -1.88 0 CA-C-N 114.35 -1.295 . . . . 0.0 108.409 179.637 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.491 ' HA ' HG21 ' A' ' 85' ' ' THR . . . . . . . . 0 CA--C 1.503 -0.847 0 CA-C-O 120.869 0.366 . . . . 0.0 110.322 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 57.5 m-85 -102.13 144.49 30.62 Favored 'General case' 0 N--CA 1.429 -1.496 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 -178.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 27.5 pt -143.24 162.55 16.85 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 CA-C-O 121.458 0.646 . . . . 0.0 110.869 -179.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.414 ' HB2' HG21 ' A' ' 107' ' ' THR . 8.2 t80 -114.45 125.88 54.33 Favored 'General case' 0 N--CA 1.412 -2.359 0 CA-C-N 114.085 -1.416 . . . . 0.0 108.123 175.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 10.2 mt -108.51 127.53 64.85 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.998 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 176.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -125.68 164.2 19.35 Favored Glycine 0 C--N 1.279 -2.596 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 -179.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 66.9 m-20 71.46 45.0 0.49 Allowed 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 125.346 1.458 . . . . 0.0 110.219 -177.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.483 HD11 HD11 ' A' ' 47' ' ' ILE . 4.2 mm? -76.21 144.63 40.31 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.281 177.08 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.436 ' HB3' ' HG ' ' A' ' 42' ' ' LEU . 42.8 t-20 -83.88 147.23 27.64 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 176.827 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.513 ' C ' ' HD2' ' A' ' 40' ' ' ARG . 6.6 ppt_? -59.2 -22.02 60.36 Favored 'General case' 0 C--N 1.311 -1.068 0 C-N-CA 123.78 0.832 . . . . 0.0 111.921 -179.73 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.422 ' N ' ' HD2' ' A' ' 40' ' ' ARG . 12.9 pt-20 -92.8 -10.99 34.9 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.818 -176.207 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.436 ' HG ' ' HB3' ' A' ' 39' ' ' ASN . 71.6 mt -79.86 132.5 36.12 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.214 0.531 . . . . 0.0 111.504 -176.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 35.1 p -119.86 173.73 6.87 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 114.852 -1.067 . . . . 0.0 110.44 -178.317 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 -55.35 -39.31 69.88 Favored 'General case' 0 C--O 1.221 -0.417 0 C-N-CA 123.2 0.6 . . . . 0.0 111.05 179.33 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.95 -38.58 95.69 Favored Glycine 0 N--CA 1.448 -0.559 0 CA-C-N 116.013 -0.54 . . . . 0.0 112.597 -179.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.408 ' O ' HG23 ' A' ' 50' ' ' VAL . 21.8 m-20 -67.08 -49.51 64.8 Favored 'General case' 0 CA--C 1.492 -1.273 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.483 HD11 HD11 ' A' ' 38' ' ' LEU . 37.7 mt -60.43 -47.12 93.89 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.931 0 CA-C-N 114.791 -1.095 . . . . 0.0 110.78 -179.246 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 36.7 mt -59.68 -42.36 92.78 Favored 'General case' 0 CA--C 1.494 -1.179 0 CA-C-N 116.572 -0.285 . . . . 0.0 111.714 -176.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.419 HG23 ' H ' ' B' ' 233' ' ' ASP . 68.8 m -65.66 -46.02 80.73 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 123.541 0.526 . . . . 0.0 111.649 -178.235 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.408 HG23 ' O ' ' A' ' 46' ' ' ASP . 58.4 t -67.69 -45.74 84.12 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-O 121.42 0.629 . . . . 0.0 110.39 -178.127 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.414 ' HA ' ' HD2' ' A' ' 54' ' ' TYR . 4.5 m-85 -64.63 -25.3 67.9 Favored 'General case' 0 N--CA 1.431 -1.387 0 CA-C-N 115.082 -0.963 . . . . 0.0 111.921 -179.452 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.57 ' OG ' ' HB2' ' B' ' 231' ' ' ARG . 66.9 m -70.23 -19.43 63.14 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 176.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -72.54 -20.9 61.26 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-O 121.669 0.747 . . . . 0.0 109.68 176.209 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.438 ' CE1' ' HB2' ' A' ' 91' ' ' ASN . 60.1 m-85 -94.65 -19.98 19.97 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.853 -178.663 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.436 ' O ' ' HA ' ' A' ' 52' ' ' SER . . . 167.17 -152.91 22.06 Favored Glycine 0 N--CA 1.424 -2.139 0 C-N-CA 120.741 -0.742 . . . . 0.0 111.403 179.017 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 87.7 t -105.58 110.57 64.38 Favored Pre-proline 0 C--N 1.295 -1.766 0 N-CA-C 110.307 -0.257 . . . . 0.0 110.307 -177.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.526 ' HB3' HD21 ' A' ' 77' ' ' LEU . 73.9 Cg_endo -78.24 135.99 14.01 Favored 'Trans proline' 0 N--CA 1.44 -1.65 0 C-N-CA 121.846 1.697 . . . . 0.0 109.2 174.685 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 35.8 m -113.18 -19.95 6.51 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 C-N-CA 119.726 -0.789 . . . . 0.0 111.57 -177.33 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.501 ' HB3' ' HG2' ' A' ' 78' ' ' LYS . 36.1 t70 -159.34 140.68 12.95 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 179.801 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 13.1 p -143.67 136.31 23.99 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 O-C-N 123.793 0.683 . . . . 0.0 109.868 -179.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 99.1 mt -122.37 125.82 73.32 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 C-N-CA 123.112 0.565 . . . . 0.0 109.503 173.19 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -98.71 118.64 35.9 Favored 'General case' 0 N--CA 1.419 -1.998 0 N-CA-C 104.963 -2.236 . . . . 0.0 104.963 173.252 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 17.8 m -81.03 116.52 21.02 Favored 'General case' 0 N--CA 1.408 -2.561 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 179.349 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 64.8 mtm180 . . . . . 0 C--N 1.299 -1.614 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 -178.132 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 . . . . . 0 N--CA 1.442 -0.84 0 CA-C-O 121.345 0.593 . . . . 0.0 110.446 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 95.54 11.69 55.1 Favored Glycine 0 N--CA 1.421 -2.335 0 CA-C-N 115.494 -0.775 . . . . 0.0 112.604 179.078 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 33.0 p90 -152.43 157.52 41.33 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 177.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -153.25 172.64 16.67 Favored 'General case' 0 N--CA 1.427 -1.583 0 O-C-N 123.509 0.506 . . . . 0.0 110.2 179.31 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -132.15 144.62 50.81 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 123.761 0.825 . . . . 0.0 110.053 -178.428 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.526 HD21 ' HB3' ' A' ' 57' ' ' PRO . 9.9 tt -153.78 140.72 19.23 Favored 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 175.634 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.501 ' HG2' ' HB3' ' A' ' 59' ' ' ASP . 18.8 ptmt -123.91 144.1 49.97 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 177.578 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.409 ' CD1' HG22 ' A' ' 85' ' ' THR . 39.9 m-85 -102.5 165.04 11.32 Favored 'General case' 0 C--N 1.29 -2.013 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.611 -178.348 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -73.48 -35.32 65.66 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 114.702 -1.136 . . . . 0.0 109.133 175.402 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -124.78 137.59 54.31 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.806 -178.045 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -70.19 -20.08 63.14 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -179.49 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 80.8 mtm180 -65.08 -34.55 78.68 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 122.219 1.009 . . . . 0.0 109.478 174.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.462 ' OG ' HG21 ' B' ' 226' ' ' ILE . 60.3 m -67.43 -37.41 82.97 Favored 'General case' 0 C--N 1.292 -1.92 0 CA-C-N 114.821 -1.082 . . . . 0.0 112.185 178.369 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.491 HG21 ' HA ' ' A' ' 31' ' ' ALA . 71.1 p -65.45 -45.12 85.02 Favored 'General case' 0 C--O 1.217 -0.635 0 C-N-CA 120.249 -0.58 . . . . 0.0 110.685 -177.792 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 3.7 pt -63.26 -39.2 84.36 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.317 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.075 177.409 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 30.0 mt -59.79 -43.24 94.5 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 123.44 0.463 . . . . 0.0 110.911 174.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -68.99 -46.5 67.9 Favored 'General case' 0 C--O 1.203 -1.374 0 CA-C-N 115.712 -0.677 . . . . 0.0 110.928 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.49 HG23 ' O ' ' A' ' 85' ' ' THR . 85.9 t -58.88 -48.93 84.78 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.062 0 CA-C-O 120.712 0.291 . . . . 0.0 110.954 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -67.36 -29.77 69.39 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 -174.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.438 ' HB2' ' CE1' ' A' ' 54' ' ' TYR . 11.0 m120 -97.98 -21.02 17.06 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 113.684 0.994 . . . . 0.0 113.684 -178.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 14.0 mt -98.92 -31.42 11.84 Favored 'General case' 0 CA--C 1.495 -1.172 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -176.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 52.6 t30 -66.39 124.98 24.21 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 85.21 -1.81 88.48 Favored Glycine 0 C--N 1.306 -1.128 0 C-N-CA 121.411 -0.423 . . . . 0.0 112.909 -179.151 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 64.1 t80 -90.09 137.85 32.0 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 179.468 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.421 ' HA ' ' HA ' ' A' ' 101' ' ' ALA . 0.4 OUTLIER -93.38 119.5 32.57 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-O 120.914 0.388 . . . . 0.0 111.712 -177.213 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 35.4 mt -118.35 142.45 33.01 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 173.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 71.58 -84.67 0.44 Allowed Glycine 0 N--CA 1.438 -1.195 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 -174.257 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -161.99 17.72 0.16 Allowed Glycine 0 N--CA 1.427 -1.955 0 N-CA-C 110.199 -1.161 . . . . 0.0 110.199 175.268 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 16.6 ptp180 -137.23 149.79 47.41 Favored 'General case' 0 N--CA 1.445 -0.719 0 O-C-N 122.798 -0.236 . . . . 0.0 110.532 -175.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.421 ' HA ' ' HA ' ' A' ' 96' ' ' LYS . . . -87.36 122.97 31.82 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.789 -177.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 14.8 mt -66.92 148.24 52.2 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-O 121.745 0.783 . . . . 0.0 112.923 179.013 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 54.3 tptt -121.94 116.47 24.42 Favored 'General case' 0 N--CA 1.418 -2.025 0 CA-C-N 114.911 -1.04 . . . . 0.0 108.824 175.131 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 3.9 mm -116.39 136.09 54.51 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.868 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -143.81 150.57 38.73 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 178.139 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 74.4 m-70 -83.34 137.8 33.81 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 178.057 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.414 HG21 ' HB2' ' A' ' 34' ' ' TYR . 9.0 t -158.62 155.38 28.12 Favored 'General case' 0 C--N 1.291 -1.959 0 N-CA-C 106.247 -1.76 . . . . 0.0 106.247 -177.215 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -93.82 111.83 23.59 Favored 'General case' 0 N--CA 1.435 -1.2 0 C-N-CA 117.571 -1.651 . . . . 0.0 108.057 172.76 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 30.5 t80 . . . . . 0 C--N 1.294 -1.845 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.676 -179.653 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B ' 226' ' ' ILE . . . . . 0.462 HG21 ' OG ' ' A' ' 84' ' ' SER . 4.3 mp . . . . . 0 C--O 1.245 0.855 0 CA-C-O 120.658 0.266 . . . . 0.0 110.295 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 227' ' ' MET . . . . . . . . . . . . . 90.5 mmm -66.81 137.95 95.09 Favored Pre-proline 0 C--N 1.321 -0.656 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.561 177.156 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 228' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -66.25 157.18 61.31 Favored 'Trans proline' 0 C--O 1.248 0.975 0 C-N-CA 122.938 2.425 . . . . 0.0 113.183 -178.217 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . -73.36 170.34 52.43 Favored Glycine 0 N--CA 1.439 -1.127 0 CA-C-N 115.412 -0.813 . . . . 0.0 112.237 179.474 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 20.9 m -77.44 -18.24 57.37 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-O 121.101 0.477 . . . . 0.0 111.23 -177.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 231' ' ' ARG . . . . . 0.57 ' HB2' ' OG ' ' A' ' 52' ' ' SER . 37.9 mmt180 -79.64 -8.16 59.03 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.583 -178.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 232' ' ' TRP . . . . . . . . . . . . . 21.6 t90 -73.54 122.96 23.04 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-O 122.279 1.038 . . . . 0.0 113.05 -176.078 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 233' ' ' ASP . . . . . 0.419 ' H ' HG23 ' A' ' 49' ' ' THR . 12.2 t70 -120.47 137.52 54.3 Favored 'General case' 0 C--N 1.276 -2.622 0 N-CA-C 100.773 -3.788 . . . . 0.0 100.773 172.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.513 3.833 0 C-N-CA 128.979 3.18 . . . . 0.0 118.257 -175.674 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B ' 240' ' ' GLY . . . . . 0.445 ' O ' ' HG2' ' B' ' 244' ' ' LYS . . . . . . . . 0 C--O 1.198 -2.098 0 N-CA-C 110.88 -0.888 . . . . 0.0 110.88 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 39.9 p90 -77.26 -34.18 55.83 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-O 120.932 0.396 . . . . 0.0 111.694 177.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -62.79 -41.65 99.36 Favored 'General case' 0 C--O 1.243 0.74 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.459 -174.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -62.98 -35.29 79.69 Favored 'General case' 0 C--O 1.21 -1.002 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.581 -178.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 244' ' ' LYS . . . . . 0.445 ' HG2' ' O ' ' B' ' 240' ' ' GLY . 69.8 mmtt -65.95 -42.99 89.28 Favored 'General case' 0 N--CA 1.439 -1.021 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 -177.381 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 245' ' ' TRP . . . . . . . . . . . . . 46.1 m0 -65.44 -41.99 92.87 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.695 178.182 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 246' ' ' PHE . . . . . 0.486 ' O ' ' HG2' ' B' ' 249' ' ' GLN . 3.0 t80 -66.53 -30.23 70.5 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 121.803 0.811 . . . . 0.0 110.949 178.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -77.44 -39.39 46.99 Favored 'General case' 0 C--N 1.295 -1.786 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.384 178.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.83 -15.33 39.5 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.083 0.468 . . . . 0.0 111.793 -175.117 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 249' ' ' GLN . . . . . 0.486 ' HG2' ' O ' ' B' ' 246' ' ' PHE . 3.9 pt20 -71.46 1.77 5.94 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.804 -179.169 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 250' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -65.34 -29.2 69.91 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 176.014 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -78.29 112.18 15.02 Favored 'General case' 0 N--CA 1.426 -1.642 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 176.4 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 252' ' ' ILE . . . . . . . . . . . . . 29.4 pt -103.51 -34.23 3.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.812 -172.164 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -100.67 -15.52 17.71 Favored 'General case' 0 CA--C 1.497 -1.077 0 CA-C-O 122.224 1.011 . . . . 0.0 108.668 179.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 254' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 . . . . . 0 N--CA 1.417 -2.097 0 CA-C-N 113.843 -1.526 . . . . 0.0 110.493 177.415 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.512 -0.508 0 N-CA-C 110.415 -0.217 . . . . 0.0 110.415 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 16.9 m-85 -111.9 145.01 40.29 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 -175.013 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 28.3 pt -138.65 157.03 29.78 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.172 176.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 56.7 t80 -106.72 121.7 44.89 Favored 'General case' 0 N--CA 1.41 -2.429 0 CA-C-N 114.619 -1.173 . . . . 0.0 107.978 177.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.407 HG23 ' CD1' ' A' ' 104' ' ' ILE . 10.8 mt -108.38 128.03 64.26 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.18 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 175.567 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -130.25 173.35 19.99 Favored Glycine 0 C--N 1.28 -2.583 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 179.599 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 69.98 31.03 3.47 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.312 0.645 . . . . 0.0 111.16 -178.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -68.55 155.14 40.54 Favored 'General case' 0 CA--C 1.503 -0.85 0 CA-C-O 121.955 0.883 . . . . 0.0 112.231 178.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.523 ' HB3' ' HG ' ' A' ' 42' ' ' LEU . 54.5 t-20 -95.38 146.52 24.33 Favored 'General case' 0 C--N 1.288 -2.104 0 N-CA-C 105.955 -1.868 . . . . 0.0 105.955 174.541 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.478 ' C ' ' HD2' ' A' ' 40' ' ' ARG . 7.2 ppt_? -61.83 -23.01 65.98 Favored 'General case' 0 C--N 1.298 -1.654 0 C-N-CA 123.396 0.678 . . . . 0.0 111.435 179.087 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.465 ' HG2' ' CG ' ' A' ' 39' ' ' ASN . 12.7 pt-20 -88.9 -1.18 57.97 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-O 120.857 0.361 . . . . 0.0 111.33 -178.657 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.523 ' HG ' ' HB3' ' A' ' 39' ' ' ASN . 87.3 mt -91.48 124.63 35.79 Favored 'General case' 0 N--CA 1.432 -1.353 0 CA-C-O 121.618 0.723 . . . . 0.0 110.464 179.792 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 68.0 p -113.66 174.57 5.86 Favored 'General case' 0 C--N 1.286 -2.168 0 CA-C-N 114.213 -1.358 . . . . 0.0 108.82 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.3 mp0 -55.29 -41.4 72.24 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 123.423 0.689 . . . . 0.0 110.739 -179.553 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -61.54 -38.35 95.66 Favored Glycine 0 C--O 1.241 0.557 0 CA-C-N 116.168 -0.469 . . . . 0.0 113.207 -179.127 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -67.4 -48.44 67.34 Favored 'General case' 0 CA--C 1.503 -0.853 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 51.4 mt -59.08 -44.77 92.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 CA-C-N 114.595 -1.184 . . . . 0.0 110.788 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 48.2 mt -59.36 -45.47 91.31 Favored 'General case' 0 CA--C 1.502 -0.891 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.538 -178.394 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.448 HG23 ' H ' ' B' ' 233' ' ' ASP . 98.0 m -62.11 -45.83 91.73 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -179.839 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 98.7 t -65.39 -49.19 79.91 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 CA-C-O 121.246 0.545 . . . . 0.0 110.41 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.469 ' HD2' ' HH ' ' A' ' 79' ' ' TYR . 5.3 m-85 -66.17 -24.04 66.57 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 123.885 0.874 . . . . 0.0 113.04 -178.121 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.454 ' OG ' ' HB2' ' B' ' 231' ' ' ARG . 63.0 m -70.59 -17.91 62.9 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 177.072 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -68.56 -25.12 64.74 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 119.683 -0.807 . . . . 0.0 109.285 176.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.468 ' HD2' ' HA ' ' A' ' 51' ' ' PHE . 64.5 m-85 -92.6 -15.96 26.23 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.114 -175.575 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.407 ' O ' ' HA ' ' A' ' 52' ' ' SER . . . 160.9 -158.61 30.2 Favored Glycine 0 N--CA 1.421 -2.353 0 C-N-CA 120.501 -0.857 . . . . 0.0 111.132 -179.556 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 57.5 t -102.26 111.02 64.0 Favored Pre-proline 0 C--N 1.302 -1.485 0 N-CA-C 111.798 0.296 . . . . 0.0 111.798 -175.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.5 ' HB3' HD21 ' A' ' 77' ' ' LEU . 87.1 Cg_endo -79.05 140.12 15.62 Favored 'Trans proline' 0 N--CA 1.449 -1.131 0 C-N-CA 122.96 2.44 . . . . 0.0 110.354 175.243 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 26.9 m -114.85 -21.95 5.04 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 C-N-CA 120.102 -0.639 . . . . 0.0 111.95 179.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.409 ' HB3' ' HG2' ' A' ' 78' ' ' LYS . 17.6 t70 -158.43 145.02 17.38 Favored 'General case' 0 C--O 1.247 0.944 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 -179.752 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 13.1 p -146.18 133.02 14.43 Favored 'Isoleucine or valine' 0 C--O 1.245 0.819 0 CA-C-O 121.5 0.667 . . . . 0.0 110.356 179.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 95.5 mt -121.06 126.98 75.82 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 177.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -99.55 122.04 42.05 Favored 'General case' 0 C--N 1.292 -1.902 0 N-CA-C 105.469 -2.049 . . . . 0.0 105.469 175.314 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 7.0 t -85.04 123.56 30.72 Favored 'General case' 0 N--CA 1.418 -2.062 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 179.198 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 73.4 mtt85 . . . . . 0 C--N 1.295 -1.777 0 CA-C-O 120.901 0.381 . . . . 0.0 111.038 -179.368 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 17.1 mm-40 . . . . . 0 CA--C 1.511 -0.546 0 CA-C-O 121.108 0.48 . . . . 0.0 110.303 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 92.54 5.59 64.89 Favored Glycine 0 N--CA 1.425 -2.058 0 C-N-CA 120.594 -0.813 . . . . 0.0 111.651 -178.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 31.4 p90 -143.56 152.79 41.86 Favored 'General case' 0 N--CA 1.435 -1.181 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 178.56 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -148.12 171.97 15.03 Favored 'General case' 0 N--CA 1.427 -1.606 0 O-C-N 123.362 0.414 . . . . 0.0 110.165 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -130.37 139.99 50.62 Favored 'General case' 0 C--N 1.298 -1.655 0 C-N-CA 124.024 0.929 . . . . 0.0 109.952 -178.5 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.5 HD21 ' HB3' ' A' ' 57' ' ' PRO . 10.3 tt -146.93 140.85 25.95 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 175.739 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.409 ' HG2' ' HB3' ' A' ' 59' ' ' ASP . 21.7 ptmt -125.04 144.3 50.47 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 178.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.469 ' HH ' ' HD2' ' A' ' 51' ' ' PHE . 55.8 m-85 -108.49 164.59 12.21 Favored 'General case' 0 C--N 1.29 -2.013 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.614 -179.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -79.0 -35.49 42.78 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 174.165 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -106.49 123.73 48.53 Favored 'General case' 0 N--CA 1.439 -0.999 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 -177.451 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -69.47 -19.3 63.76 Favored 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 113.391 0.886 . . . . 0.0 113.391 -178.518 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 90.6 mtm180 -66.19 -33.24 75.31 Favored 'General case' 0 C--N 1.302 -1.5 0 CA-C-O 121.914 0.864 . . . . 0.0 109.261 173.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 56.9 m -65.33 -37.15 86.23 Favored 'General case' 0 N--CA 1.426 -1.639 0 CA-C-N 115.29 -0.868 . . . . 0.0 112.43 178.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.49 ' O ' HG23 ' A' ' 89' ' ' VAL . 64.9 p -62.73 -45.66 91.69 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 121.061 0.457 . . . . 0.0 110.741 -177.819 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 4.3 pt -66.17 -37.93 80.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.831 177.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 14.0 mt -59.41 -44.12 92.89 Favored 'General case' 0 CA--C 1.509 -0.62 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.641 175.26 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.485 ' HB1' HD12 ' A' ' 92' ' ' LEU . . . -70.16 -45.51 66.61 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.848 -178.313 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.49 HG23 ' O ' ' A' ' 85' ' ' THR . 87.7 t -56.55 -47.79 81.43 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.967 0 CA-C-O 121.43 0.634 . . . . 0.0 111.119 178.47 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -62.08 -33.74 74.98 Favored 'General case' 0 C--N 1.297 -1.695 0 C-N-CA 125.042 1.337 . . . . 0.0 112.722 -176.337 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.402 ' HB3' ' CE1' ' A' ' 54' ' ' TYR . 14.8 t-20 -98.44 -30.86 12.3 Favored 'General case' 0 C--N 1.293 -1.874 0 CA-C-N 116.145 -0.479 . . . . 0.0 112.232 -175.55 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.485 HD12 ' HB1' ' A' ' 88' ' ' ALA . 12.5 mt -93.8 -30.16 14.99 Favored 'General case' 0 CA--C 1.482 -1.648 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 -170.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 57.4 t30 -66.12 125.04 24.26 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 179.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 83.61 -0.69 89.48 Favored Glycine 0 CA--C 1.535 1.287 0 C-N-CA 120.424 -0.893 . . . . 0.0 112.502 -177.48 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 67.8 t80 -89.36 138.42 31.46 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -178.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.452 ' HA ' ' O ' ' A' ' 100' ' ' ARG . 0.3 OUTLIER -92.51 118.52 31.06 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 -175.824 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 55.0 mt -127.64 142.08 44.63 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.259 0 N-CA-C 106.193 -1.78 . . . . 0.0 106.193 172.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 58.47 21.88 50.18 Favored Glycine 0 CA--C 1.524 0.656 0 C-N-CA 121.63 -0.319 . . . . 0.0 113.514 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 87.25 10.75 70.66 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 121.647 -0.311 . . . . 0.0 113.483 179.07 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.452 ' O ' ' HA ' ' A' ' 96' ' ' LYS . 13.6 ptp180 -140.56 148.66 41.33 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 117.985 0.892 . . . . 0.0 111.889 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -82.83 118.02 23.12 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.956 -179.374 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 12.7 mt -65.88 149.56 50.0 Favored 'General case' 0 C--N 1.309 -1.189 0 C-N-CA 124.134 0.974 . . . . 0.0 113.611 178.666 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 55.3 tptt -116.09 120.16 38.15 Favored 'General case' 0 N--CA 1.423 -1.801 0 CA-C-N 114.964 -1.016 . . . . 0.0 108.734 174.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.448 HG22 HG22 ' A' ' 89' ' ' VAL . 4.8 mm -121.44 135.36 61.85 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 178.35 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -143.57 153.25 42.37 Favored 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 109.273 -0.639 . . . . 0.0 109.273 -179.412 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -83.54 137.7 33.74 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 177.645 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 12.3 t -155.16 156.48 35.81 Favored 'General case' 0 N--CA 1.425 -1.724 0 N-CA-C 107.929 -1.138 . . . . 0.0 107.929 -177.117 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 7.7 p90 -97.67 109.86 22.53 Favored 'General case' 0 N--CA 1.423 -1.808 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 168.637 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 29.1 t80 . . . . . 0 C--N 1.296 -1.746 0 CA-C-N 115.055 -0.975 . . . . 0.0 110.207 -178.175 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 3.7 mp . . . . . 0 C--O 1.24 0.562 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' 227' ' ' MET . . . . . . . . . . . . . 68.6 mtt -69.29 139.08 89.52 Favored Pre-proline 0 N--CA 1.452 -0.341 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.354 177.568 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 228' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -69.09 159.0 55.67 Favored 'Trans proline' 0 C--O 1.243 0.726 0 C-N-CA 122.739 2.293 . . . . 0.0 112.893 -178.485 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . -75.3 168.76 54.79 Favored Glycine 0 N--CA 1.441 -0.98 0 CA-C-N 115.442 -0.799 . . . . 0.0 112.749 -179.685 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 9.4 t -77.61 -14.44 59.64 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 121.293 0.568 . . . . 0.0 110.305 -177.511 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 231' ' ' ARG . . . . . 0.454 ' HB2' ' OG ' ' A' ' 52' ' ' SER . 37.2 mmt180 -86.75 -3.93 59.11 Favored 'General case' 0 C--N 1.321 -0.644 0 O-C-N 122.139 -0.351 . . . . 0.0 111.08 -179.178 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 232' ' ' TRP . . . . . . . . . . . . . 21.7 t90 -74.77 128.25 35.12 Favored 'General case' 0 CA--C 1.497 -1.064 0 CA-C-O 122.385 1.088 . . . . 0.0 111.7 -179.142 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 233' ' ' ASP . . . . . 0.448 ' H ' HG23 ' A' ' 49' ' ' THR . 37.3 t70 -124.42 147.42 48.29 Favored 'General case' 0 C--N 1.263 -3.158 0 N-CA-C 103.038 -2.949 . . . . 0.0 103.038 172.671 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.501 3.022 0 C-N-CA 128.702 3.049 . . . . 0.0 116.93 -178.993 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' 240' ' ' GLY . . . . . 0.613 ' O ' ' HG2' ' B' ' 243' ' ' GLU . . . . . . . . 0 C--O 1.194 -2.374 0 N-CA-C 111.309 -0.716 . . . . 0.0 111.309 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 17.7 p90 -55.76 -33.81 64.67 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -179.018 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -65.06 -40.9 95.38 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 111.885 0.328 . . . . 0.0 111.885 -176.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 243' ' ' GLU . . . . . 0.613 ' HG2' ' O ' ' B' ' 240' ' ' GLY . 11.4 pt-20 -66.31 -34.87 78.96 Favored 'General case' 0 C--O 1.207 -1.178 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 178.33 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 244' ' ' LYS . . . . . 0.583 ' HG2' ' O ' ' B' ' 240' ' ' GLY . 70.4 mmtt -66.0 -43.55 87.41 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 121.088 0.471 . . . . 0.0 110.555 -177.267 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 245' ' ' TRP . . . . . . . . . . . . . 46.7 m0 -63.94 -41.95 97.46 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.653 0.739 . . . . 0.0 109.358 178.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 246' ' ' PHE . . . . . 0.62 ' O ' ' HG2' ' B' ' 249' ' ' GLN . 1.7 t80 -68.46 -27.59 66.29 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 114.326 -1.306 . . . . 0.0 111.633 178.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -76.77 -39.64 50.98 Favored 'General case' 0 C--N 1.287 -2.12 0 O-C-N 121.907 -0.496 . . . . 0.0 111.597 -177.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 2.6 pptp? -85.89 -14.75 43.9 Favored 'General case' 0 CA--C 1.507 -0.675 0 C-N-CA 120.231 -0.588 . . . . 0.0 112.328 -173.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 249' ' ' GLN . . . . . 0.62 ' HG2' ' O ' ' B' ' 246' ' ' PHE . 3.5 pt20 -67.75 -0.6 4.25 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.755 -176.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 250' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -74.97 -20.78 59.52 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.975 177.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 27.0 mm-40 -64.83 146.49 54.81 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 115.136 -0.938 . . . . 0.0 113.193 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 252' ' ' ILE . . . . . . . . . . . . . 23.9 pt -97.71 -26.33 3.95 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 CA-C-N 115.045 -0.98 . . . . 0.0 111.118 177.179 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -85.22 -27.98 25.72 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 121.466 0.651 . . . . 0.0 109.696 178.19 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 254' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 . . . . . 0 N--CA 1.422 -1.868 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.703 176.909 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.487 ' HA ' HG21 ' A' ' 85' ' ' THR . . . . . . . . 0 N--CA 1.444 -0.734 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 -99.13 144.5 28.2 Favored 'General case' 0 C--N 1.315 -0.929 0 C-N-CA 120.309 -0.556 . . . . 0.0 109.866 -175.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 33.6 pt -138.14 157.04 31.49 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 CA-C-O 121.107 0.479 . . . . 0.0 110.616 178.096 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 38.9 t80 -107.74 121.07 43.97 Favored 'General case' 0 N--CA 1.417 -2.091 0 CA-C-N 114.728 -1.124 . . . . 0.0 108.444 178.469 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.427 HG23 ' CD1' ' A' ' 104' ' ' ILE . 9.9 mt -108.58 127.79 64.75 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.882 0 N-CA-C 106.714 -1.587 . . . . 0.0 106.714 175.694 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -130.5 163.7 23.14 Favored Glycine 0 C--N 1.284 -2.32 0 N-CA-C 111.232 -0.747 . . . . 0.0 111.232 -179.478 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 67.2 m-20 73.73 38.68 0.59 Allowed 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.743 1.617 . . . . 0.0 110.219 -178.593 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.435 HD11 HD11 ' A' ' 47' ' ' ILE . 4.2 mm? -68.69 144.69 54.35 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.451 -0.795 . . . . 0.0 112.29 178.819 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.469 HD22 ' HA3' ' A' ' 98' ' ' GLY . 41.4 t-20 -89.34 151.5 22.04 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 177.476 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.507 ' HD2' ' N ' ' A' ' 41' ' ' GLU . 5.3 ppt_? -59.56 -26.42 65.36 Favored 'General case' 0 C--N 1.31 -1.135 0 C-N-CA 123.103 0.561 . . . . 0.0 111.828 177.745 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.507 ' N ' ' HD2' ' A' ' 40' ' ' ARG . 10.4 pt-20 -89.55 0.89 56.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.897 -177.655 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 80.8 mt -97.32 111.87 23.93 Favored 'General case' 0 CA--C 1.494 -1.177 0 CA-C-O 121.59 0.709 . . . . 0.0 111.211 -178.551 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 82.2 p -103.51 174.53 5.83 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-N 114.344 -1.298 . . . . 0.0 109.451 -178.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.498 ' HG3' ' HB2' ' A' ' 62' ' ' LEU . 2.0 mp0 -54.62 -40.66 69.16 Favored 'General case' 0 C--O 1.216 -0.676 0 C-N-CA 123.599 0.76 . . . . 0.0 109.586 177.738 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -59.48 -41.63 97.23 Favored Glycine 0 N--CA 1.445 -0.75 0 O-C-N 123.659 0.6 . . . . 0.0 113.163 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -66.69 -49.13 67.09 Favored 'General case' 0 CA--C 1.497 -1.071 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 -179.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.435 HD11 HD11 ' A' ' 38' ' ' LEU . 52.6 mt -58.37 -45.88 89.42 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.926 0 CA-C-N 114.992 -1.003 . . . . 0.0 110.493 179.735 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 35.0 mt -60.55 -45.71 92.87 Favored 'General case' 0 CA--C 1.5 -0.963 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 -177.365 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.491 HG23 ' H ' ' B' ' 233' ' ' ASP . 80.2 m -62.92 -45.59 91.78 Favored 'General case' 0 N--CA 1.439 -1.016 0 O-C-N 123.308 0.38 . . . . 0.0 111.563 179.313 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 77.4 t -65.79 -47.18 86.66 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.157 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.036 -179.156 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.444 ' HA ' ' HD2' ' A' ' 54' ' ' TYR . 3.8 m-85 -67.43 -22.95 65.49 Favored 'General case' 0 N--CA 1.429 -1.496 0 C-N-CA 123.624 0.77 . . . . 0.0 112.144 -178.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.408 ' OG ' ' HB2' ' B' ' 231' ' ' ARG . 68.3 m -69.13 -16.92 63.77 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.937 175.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -67.02 -26.63 66.87 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-O 121.246 0.546 . . . . 0.0 109.659 175.206 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.444 ' HD2' ' HA ' ' A' ' 51' ' ' PHE . 54.4 m-85 -95.73 -15.19 22.78 Favored 'General case' 0 CA--C 1.505 -0.784 0 CA-C-O 121.245 0.545 . . . . 0.0 112.392 -173.222 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 160.1 -152.19 22.96 Favored Glycine 0 N--CA 1.413 -2.849 0 N-CA-C 110.245 -1.142 . . . . 0.0 110.245 -179.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 65.3 t -104.74 109.21 62.7 Favored Pre-proline 0 C--N 1.288 -2.068 0 O-C-N 123.554 0.208 . . . . 0.0 110.466 -176.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.548 ' HB3' HD21 ' A' ' 77' ' ' LEU . 73.2 Cg_endo -77.57 135.58 14.74 Favored 'Trans proline' 0 N--CA 1.435 -1.966 0 C-N-CA 121.525 1.483 . . . . 0.0 108.595 174.259 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.422 ' CG2' ' HG3' ' A' ' 78' ' ' LYS . 35.2 m -109.85 -23.21 4.58 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 C-N-CA 119.309 -0.956 . . . . 0.0 111.81 -177.753 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.44 ' HB3' ' HG2' ' A' ' 78' ' ' LYS . 25.8 t70 -158.68 142.94 15.67 Favored 'General case' 0 CA--C 1.503 -0.836 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 14.6 p -140.79 135.12 33.72 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 178.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 86.4 mt -120.72 123.06 69.5 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.311 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 176.242 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.498 ' HB2' ' HG3' ' A' ' 44' ' ' GLU . 0.1 OUTLIER -98.61 119.64 37.69 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 177.298 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 28.3 m -83.91 116.79 22.95 Favored 'General case' 0 N--CA 1.404 -2.772 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 176.235 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 58.9 mtt180 . . . . . 0 C--N 1.304 -1.374 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 -175.625 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 . . . . . 0 CA--C 1.506 -0.721 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 94.8 8.35 59.38 Favored Glycine 0 N--CA 1.427 -1.962 0 CA-C-N 114.96 -1.018 . . . . 0.0 112.472 178.582 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 37.2 p90 -150.09 154.99 39.05 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 179.258 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -150.1 170.47 18.83 Favored 'General case' 0 N--CA 1.427 -1.595 0 CA-C-O 120.925 0.393 . . . . 0.0 110.264 178.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -128.9 142.2 51.03 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.404 -179.021 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.548 HD21 ' HB3' ' A' ' 57' ' ' PRO . 9.8 tt -148.99 140.9 23.72 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 175.696 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.44 ' HG2' ' HB3' ' A' ' 59' ' ' ASP . 20.8 ptmt -122.66 144.02 49.41 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 178.665 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 45.8 m-85 -104.65 164.88 11.44 Favored 'General case' 0 C--N 1.29 -1.992 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.575 -179.233 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -71.15 -37.49 72.26 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 114.824 -1.08 . . . . 0.0 108.607 175.062 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -125.28 143.63 50.87 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.298 0.57 . . . . 0.0 111.74 -179.019 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.454 ' NE2' ' HB2' ' A' ' 31' ' ' ALA . 20.8 mp0 -69.93 -24.0 63.29 Favored 'General case' 0 C--N 1.312 -1.061 0 C-N-CA 124.91 1.284 . . . . 0.0 112.94 -177.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 56.1 mtm180 -67.88 -34.63 77.04 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-O 122.083 0.944 . . . . 0.0 109.592 175.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.455 ' OG ' HG21 ' B' ' 226' ' ' ILE . 48.6 m -66.04 -37.71 86.55 Favored 'General case' 0 C--N 1.286 -2.177 0 CA-C-N 114.808 -1.087 . . . . 0.0 111.619 175.798 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.512 ' O ' HG23 ' A' ' 89' ' ' VAL . 71.6 p -66.02 -45.33 81.87 Favored 'General case' 0 C--O 1.221 -0.402 0 C-N-CA 120.134 -0.626 . . . . 0.0 110.52 -178.058 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 8.3 pt -64.79 -37.39 80.03 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 C-N-CA 122.481 0.312 . . . . 0.0 111.111 177.521 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 9.7 mt -58.51 -44.08 89.35 Favored 'General case' 0 CA--C 1.504 -0.822 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.203 175.034 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.432 ' O ' ' HB2' ' A' ' 92' ' ' LEU . . . -71.56 -46.67 58.78 Favored 'General case' 0 N--CA 1.434 -1.269 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.953 -179.27 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.512 HG23 ' O ' ' A' ' 85' ' ' THR . 86.5 t -56.79 -49.9 76.83 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.201 0 CA-C-O 120.844 0.354 . . . . 0.0 111.429 -178.375 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -73.53 -28.65 62.0 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 112.751 0.649 . . . . 0.0 112.751 -173.127 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -87.76 -31.79 19.46 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-O 121.011 0.434 . . . . 0.0 110.572 -177.485 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.432 ' HB2' ' O ' ' A' ' 88' ' ' ALA . 10.0 mt -94.26 -30.32 14.62 Favored 'General case' 0 CA--C 1.501 -0.922 0 CA-C-N 116.03 -0.532 . . . . 0.0 112.386 -173.703 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 46.1 t30 -65.74 125.24 24.68 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 179.09 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 88.47 -7.73 80.91 Favored Glycine 0 N--CA 1.436 -1.35 0 CA-C-N 115.599 -0.728 . . . . 0.0 112.268 -178.048 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -81.94 138.96 34.88 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 -178.124 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.524 ' HE3' ' HB2' ' A' ' 101' ' ' ALA . 11.7 mptt -99.2 125.12 44.72 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-O 121.14 0.495 . . . . 0.0 111.68 -177.295 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 58.7 mt -127.69 141.39 46.51 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 N-CA-C 105.761 -1.94 . . . . 0.0 105.761 173.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.469 ' HA3' HD22 ' A' ' 39' ' ' ASN . . . 64.17 7.42 24.65 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 121.12 -0.562 . . . . 0.0 114.311 179.173 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 97.22 0.13 59.93 Favored Glycine 0 N--CA 1.436 -1.312 0 C-N-CA 121.118 -0.563 . . . . 0.0 112.492 -176.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 17.3 ptp180 -124.29 151.56 44.09 Favored 'General case' 0 C--N 1.317 -0.806 0 O-C-N 122.233 -0.569 . . . . 0.0 110.997 -179.493 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.524 ' HB2' ' HE3' ' A' ' 96' ' ' LYS . . . -89.73 120.03 30.65 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.513 -176.351 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 11.7 mt -68.7 145.15 54.11 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-O 121.71 0.766 . . . . 0.0 112.343 177.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.41 ' HE3' ' HB2' ' A' ' 105' ' ' ASP . 50.1 tptt -120.96 116.66 25.53 Favored 'General case' 0 N--CA 1.417 -2.106 0 CA-C-N 114.822 -1.081 . . . . 0.0 109.184 176.348 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.427 ' CD1' HG23 ' A' ' 35' ' ' ILE . 4.7 mm -119.37 134.31 63.38 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 179.574 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.41 ' HB2' ' HE3' ' A' ' 103' ' ' LYS . 27.5 t70 -144.89 157.74 44.05 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 177.417 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 2.8 m80 -81.96 131.63 35.25 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-O 121.236 0.541 . . . . 0.0 112.122 177.019 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 13.3 t -146.35 162.86 37.25 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 -177.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -110.25 110.91 21.91 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 107.046 -1.465 . . . . 0.0 107.046 171.057 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 74.4 t80 . . . . . 0 C--N 1.294 -1.827 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.228 -179.063 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B ' 226' ' ' ILE . . . . . 0.455 HG21 ' OG ' ' A' ' 84' ' ' SER . 4.1 mp . . . . . 0 C--O 1.251 1.156 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 227' ' ' MET . . . . . . . . . . . . . 65.9 mtt -69.22 137.64 89.25 Favored Pre-proline 0 C--N 1.311 -1.077 0 O-C-N 123.706 0.629 . . . . 0.0 110.135 179.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 228' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -67.43 154.03 75.0 Favored 'Trans proline' 0 C--O 1.248 1.023 0 C-N-CA 122.787 2.324 . . . . 0.0 112.269 179.606 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . -73.11 168.98 53.4 Favored Glycine 0 C--N 1.314 -0.668 0 CA-C-N 115.558 -0.747 . . . . 0.0 112.879 -179.65 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 23.4 m -76.67 -13.93 60.01 Favored 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 123.236 0.614 . . . . 0.0 112.157 -175.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 231' ' ' ARG . . . . . 0.408 ' HB2' ' OG ' ' A' ' 52' ' ' SER . 19.7 mmt180 -87.16 -0.05 56.08 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.954 0.406 . . . . 0.0 110.095 -178.313 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 232' ' ' TRP . . . . . . . . . . . . . 21.0 t90 -77.63 126.47 30.93 Favored 'General case' 0 N--CA 1.433 -1.3 0 CA-C-O 122.428 1.109 . . . . 0.0 112.392 -176.399 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 233' ' ' ASP . . . . . 0.491 ' H ' HG23 ' A' ' 49' ' ' THR . 26.1 t70 -121.84 144.3 48.91 Favored 'General case' 0 C--N 1.264 -3.117 0 N-CA-C 101.829 -3.397 . . . . 0.0 101.829 171.775 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.05 0 C-N-CA 128.065 2.745 . . . . 0.0 116.113 -178.976 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B ' 240' ' ' GLY . . . . . 0.536 ' O ' ' HG2' ' B' ' 244' ' ' LYS . . . . . . . . 0 C--O 1.199 -2.077 0 N-CA-C 110.456 -1.058 . . . . 0.0 110.456 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 51.1 p90 -64.42 -34.01 77.2 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 -176.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -63.8 -42.44 97.72 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 112.003 0.371 . . . . 0.0 112.003 -174.4 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 243' ' ' GLU . . . . . 0.494 ' HG2' ' O ' ' B' ' 240' ' ' GLY . 11.1 pt-20 -63.13 -34.7 78.19 Favored 'General case' 0 C--O 1.208 -1.08 0 N-CA-C 110.466 -0.198 . . . . 0.0 110.466 178.325 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 244' ' ' LYS . . . . . 0.536 ' HG2' ' O ' ' B' ' 240' ' ' GLY . 68.8 mmtt -67.72 -44.58 77.32 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 -179.046 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 245' ' ' TRP . . . . . . . . . . . . . 50.9 m0 -62.55 -41.52 98.95 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.725 178.036 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 246' ' ' PHE . . . . . 0.514 ' O ' ' HG2' ' B' ' 249' ' ' GLN . 5.1 t80 -65.53 -36.25 83.26 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.902 177.793 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -71.69 -35.67 70.34 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.206 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.19 -15.34 36.27 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 120.991 0.424 . . . . 0.0 111.704 -178.67 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 249' ' ' GLN . . . . . 0.514 ' HG2' ' O ' ' B' ' 246' ' ' PHE . 2.9 pt20 -81.53 2.96 26.69 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-O 120.982 0.42 . . . . 0.0 110.326 179.5 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 250' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -54.01 -27.83 34.33 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.911 177.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 251' ' ' GLU . . . . . 0.648 ' HB3' ' HB2' ' B' ' 254' ' ' GLU . 45.5 mt-10 -80.58 110.52 16.13 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 176.039 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 252' ' ' ILE . . . . . 0.645 HD13 ' H ' ' B' ' 252' ' ' ILE . 0.2 OUTLIER -112.72 -33.98 2.2 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 CA-C-N 115.843 -0.617 . . . . 0.0 112.165 -173.475 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -118.89 -6.26 10.55 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 -178.099 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 254' ' ' GLU . . . . . 0.648 ' HB2' ' HB3' ' B' ' 251' ' ' GLU . 16.8 mp0 . . . . . 0 C--N 1.294 -1.829 0 CA-C-N 112.549 -2.114 . . . . 0.0 111.957 -179.177 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.589 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 11.3 m-30 -93.24 144.95 24.81 Favored 'General case' 0 C--N 1.309 -1.183 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.524 -176.603 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 21.4 pt -142.81 165.84 15.76 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.981 0 C-N-CA 123.291 0.636 . . . . 0.0 110.152 175.265 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.532 ' HB2' HG21 ' A' ' 107' ' ' THR . 54.7 t80 -116.2 126.4 53.59 Favored 'General case' 0 N--CA 1.413 -2.28 0 CA-C-N 114.776 -1.102 . . . . 0.0 109.114 178.217 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.453 HG23 ' CD1' ' A' ' 104' ' ' ILE . 9.1 mt -110.74 127.98 67.42 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.016 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 175.601 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -127.65 165.61 20.66 Favored Glycine 0 C--N 1.281 -2.494 0 N-CA-C 111.346 -0.701 . . . . 0.0 111.346 -178.486 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 66.39 41.52 3.26 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.708 1.203 . . . . 0.0 110.824 -176.506 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.477 HD11 HD11 ' A' ' 47' ' ' ILE . 4.1 mm? -68.56 146.57 52.97 Favored 'General case' 0 CA--C 1.496 -1.122 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.489 177.375 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.472 ' ND2' ' HA3' ' A' ' 98' ' ' GLY . 61.1 t30 -89.84 147.84 23.54 Favored 'General case' 0 C--N 1.291 -1.945 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 178.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.474 ' C ' ' HD2' ' A' ' 40' ' ' ARG . 2.3 ppt_? -58.87 -21.75 57.8 Favored 'General case' 0 C--N 1.318 -0.772 0 O-C-N 123.623 0.577 . . . . 0.0 112.494 -175.353 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.41 ' HG2' ' ND2' ' A' ' 39' ' ' ASN . 13.4 pt-20 -99.86 -1.01 38.54 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.383 -175.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.435 HD12 ' H ' ' A' ' 39' ' ' ASN . 81.3 mt -87.71 118.54 27.28 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-O 121.33 0.586 . . . . 0.0 110.459 178.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 77.0 p -105.31 174.09 6.03 Favored 'General case' 0 C--N 1.291 -1.943 0 CA-C-N 114.816 -1.084 . . . . 0.0 108.864 -178.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.519 ' CG ' ' HB2' ' A' ' 62' ' ' LEU . 70.2 mt-10 -56.38 -37.67 70.41 Favored 'General case' 0 C--O 1.216 -0.67 0 N-CA-C 109.954 -0.388 . . . . 0.0 109.954 177.598 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -61.62 -37.46 94.25 Favored Glycine 0 N--CA 1.445 -0.758 0 CA-C-N 115.722 -0.672 . . . . 0.0 113.113 179.529 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -67.26 -49.02 65.98 Favored 'General case' 0 CA--C 1.488 -1.432 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.279 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.477 HD11 HD11 ' A' ' 38' ' ' LEU . 46.7 mt -59.17 -45.67 92.62 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.14 0 CA-C-N 114.557 -1.202 . . . . 0.0 110.597 179.129 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.433 ' HG ' HG11 ' A' ' 60' ' ' VAL . 42.8 mt -59.65 -43.53 93.88 Favored 'General case' 0 CA--C 1.489 -1.369 0 C-N-CA 122.249 0.22 . . . . 0.0 111.137 -178.702 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.494 HG23 ' H ' ' B' ' 233' ' ' ASP . 72.3 m -63.26 -46.6 86.09 Favored 'General case' 0 C--N 1.309 -1.157 0 O-C-N 123.531 0.519 . . . . 0.0 111.137 -178.594 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 93.5 t -67.55 -46.89 82.18 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.702 -178.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.435 ' HA ' ' HD2' ' A' ' 54' ' ' TYR . 4.0 m-85 -68.54 -20.09 64.53 Favored 'General case' 0 N--CA 1.424 -1.751 0 CA-C-N 115.141 -0.936 . . . . 0.0 112.537 -177.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.43 ' CB ' ' HB2' ' B' ' 232' ' ' TRP . 59.1 m -71.1 -22.44 62.09 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 176.179 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -73.27 -20.69 60.77 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 119.164 -1.015 . . . . 0.0 109.97 176.233 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.435 ' HD2' ' HA ' ' A' ' 51' ' ' PHE . 62.0 m-85 -92.97 -11.01 34.32 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-O 121.232 0.539 . . . . 0.0 111.865 -179.208 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.417 ' O ' ' HA ' ' A' ' 52' ' ' SER . . . 156.96 -164.04 32.57 Favored Glycine 0 N--CA 1.424 -2.108 0 N-CA-C 110.954 -0.858 . . . . 0.0 110.954 179.091 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 80.9 t -96.31 109.75 49.04 Favored Pre-proline 0 C--N 1.299 -1.623 0 N-CA-C 110.078 -0.342 . . . . 0.0 110.078 -179.301 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.505 ' HB3' HD21 ' A' ' 77' ' ' LEU . 86.9 Cg_endo -79.41 136.87 12.8 Favored 'Trans proline' 0 N--CA 1.443 -1.442 0 C-N-CA 122.461 2.108 . . . . 0.0 109.301 176.14 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 33.8 m -110.84 -24.11 4.14 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 C-N-CA 119.2 -1.0 . . . . 0.0 111.67 -178.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.51 ' HB3' ' HG2' ' A' ' 78' ' ' LYS . 27.4 t70 -155.03 142.29 19.45 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -179.467 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.433 HG11 ' HG ' ' A' ' 48' ' ' LEU . 14.4 p -143.58 136.94 24.85 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 179.411 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 90.8 mt -121.88 121.17 63.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 175.08 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.519 ' HB2' ' CG ' ' A' ' 44' ' ' GLU . 0.2 OUTLIER -95.89 116.82 29.49 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 106.245 -1.761 . . . . 0.0 106.245 172.544 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 44.3 m -77.21 116.32 17.74 Favored 'General case' 0 N--CA 1.419 -1.998 0 N-CA-C 107.37 -1.345 . . . . 0.0 107.37 176.2 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 21.1 mtp180 . . . . . 0 C--N 1.307 -1.28 0 CA-C-O 120.819 0.342 . . . . 0.0 110.332 -175.854 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 18.3 mm-40 . . . . . 0 CA--C 1.504 -0.818 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 94.73 12.76 55.25 Favored Glycine 0 N--CA 1.427 -1.962 0 C-N-CA 120.44 -0.886 . . . . 0.0 112.164 -177.416 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 33.4 p90 -151.59 153.32 34.27 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 176.397 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -150.11 175.71 11.49 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-O 120.836 0.351 . . . . 0.0 110.818 -179.44 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -136.5 144.12 44.15 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 123.576 0.75 . . . . 0.0 110.003 -177.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.505 HD21 ' HB3' ' A' ' 57' ' ' PRO . 10.2 tt -150.38 141.59 23.17 Favored 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 176.065 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.51 ' HG2' ' HB3' ' A' ' 59' ' ' ASP . 22.0 ptmt -124.03 144.34 49.89 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-O 121.294 0.569 . . . . 0.0 109.516 178.584 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -107.6 165.92 11.06 Favored 'General case' 0 C--N 1.286 -2.177 0 CA-C-N 115.406 -0.815 . . . . 0.0 111.683 -178.019 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -75.32 -29.05 59.9 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 115.002 -0.999 . . . . 0.0 108.77 172.536 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -119.63 136.72 54.27 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 -176.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 19.8 mp0 -69.77 -27.61 65.07 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.467 ' O ' HG12 ' A' ' 86' ' ' ILE . 90.0 mtm180 -65.61 -33.85 76.87 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 122.301 1.048 . . . . 0.0 110.032 179.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.45 ' OG ' HG21 ' B' ' 226' ' ' ILE . 51.6 m -58.53 -37.14 75.02 Favored 'General case' 0 C--N 1.281 -2.379 0 CA-C-N 114.781 -1.1 . . . . 0.0 111.734 176.237 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.462 ' O ' HG23 ' A' ' 89' ' ' VAL . 43.9 p -63.33 -45.07 92.95 Favored 'General case' 0 C--N 1.347 0.487 0 C-N-CA 120.452 -0.499 . . . . 0.0 110.731 -178.482 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.467 HG12 ' O ' ' A' ' 83' ' ' ARG . 4.1 pt -66.64 -38.15 81.01 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.508 178.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 13.6 mt -59.4 -44.25 92.84 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 123.38 0.425 . . . . 0.0 111.28 175.437 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -71.74 -46.42 58.57 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.212 -178.586 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 85' ' ' THR . 69.6 t -56.93 -44.09 81.78 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.104 0 CA-C-O 121.297 0.57 . . . . 0.0 111.09 178.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -63.69 -41.53 98.13 Favored 'General case' 0 C--N 1.29 -1.996 0 C-N-CA 123.291 0.637 . . . . 0.0 112.239 -176.064 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 40.0 m-80 -90.28 -29.73 17.96 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-N 115.632 -0.713 . . . . 0.0 112.869 -173.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 15.2 mt -93.37 -31.18 14.74 Favored 'General case' 0 CA--C 1.486 -1.502 0 N-CA-C 112.257 0.466 . . . . 0.0 112.257 -172.631 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.417 ' OD1' ' HD2' ' A' ' 103' ' ' LYS . 56.9 t30 -66.32 124.6 23.13 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.039 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 89.19 -2.59 83.76 Favored Glycine 0 C--N 1.308 -1.004 0 C-N-CA 121.33 -0.462 . . . . 0.0 112.269 -178.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 37.2 t80 -89.23 134.98 33.82 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 -179.096 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.448 ' HA ' ' O ' ' A' ' 100' ' ' ARG . 12.1 mptt -95.42 116.38 28.72 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-O 120.914 0.388 . . . . 0.0 111.826 -177.67 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 60.6 mt -119.3 141.45 39.23 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 N-CA-C 104.946 -2.242 . . . . 0.0 104.946 172.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.472 ' HA3' ' ND2' ' A' ' 39' ' ' ASN . . . 58.19 28.02 60.92 Favored Glycine 0 C--N 1.317 -0.496 0 C-N-CA 121.331 -0.461 . . . . 0.0 112.646 -178.775 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 79.99 -5.84 61.19 Favored Glycine 0 CA--C 1.529 0.907 0 CA-C-O 119.933 -0.37 . . . . 0.0 113.863 -179.447 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.448 ' O ' ' HA ' ' A' ' 96' ' ' LYS . 16.6 ptp180 -116.43 149.71 39.0 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 117.721 0.76 . . . . 0.0 111.198 -176.311 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -88.44 117.2 27.2 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.537 -175.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.423 HD23 ' HA ' ' A' ' 102' ' ' LEU . 10.4 mt -65.71 136.07 55.78 Favored 'General case' 0 CA--C 1.494 -1.191 0 CA-C-O 121.491 0.663 . . . . 0.0 111.961 178.503 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.417 ' HD2' ' OD1' ' A' ' 93' ' ' ASN . 27.4 tptp -113.6 116.29 29.26 Favored 'General case' 0 N--CA 1.41 -2.45 0 CA-C-N 115.218 -0.901 . . . . 0.0 108.633 176.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.453 ' CD1' HG23 ' A' ' 35' ' ' ILE . 5.3 mm -111.02 142.32 23.75 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.192 0 N-CA-C 106.265 -1.754 . . . . 0.0 106.265 177.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -144.6 151.66 39.36 Favored 'General case' 0 C--N 1.29 -1.995 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 178.564 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 69.7 m-70 -83.42 130.53 35.04 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 175.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.532 HG21 ' HB2' ' A' ' 34' ' ' TYR . 6.2 t -153.79 165.19 36.79 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 -177.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -107.6 112.28 24.93 Favored 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 105.604 -1.999 . . . . 0.0 105.604 168.214 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 25.8 t80 . . . . . 0 C--N 1.295 -1.769 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 -175.943 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' B' B ' 226' ' ' ILE . . . . . 0.45 HG21 ' OG ' ' A' ' 84' ' ' SER . 3.9 mp . . . . . 0 N--CA 1.433 -1.32 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 227' ' ' MET . . . . . . . . . . . . . 67.5 mtt -70.24 133.55 87.47 Favored Pre-proline 0 C--N 1.309 -1.162 0 O-C-N 123.427 0.454 . . . . 0.0 110.306 178.523 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 228' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -68.05 154.36 72.77 Favored 'Trans proline' 0 C--O 1.245 0.851 0 C-N-CA 122.785 2.323 . . . . 0.0 112.272 -179.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . -72.44 168.2 52.85 Favored Glycine 0 N--CA 1.44 -1.04 0 CA-C-N 115.557 -0.747 . . . . 0.0 113.035 -179.731 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 5.0 p -77.44 -23.52 50.51 Favored 'General case' 0 C--N 1.298 -1.646 0 C-N-CA 123.431 0.692 . . . . 0.0 112.354 -177.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 1.8 mmp_? -79.33 1.88 23.5 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.729 -176.127 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 232' ' ' TRP . . . . . 0.43 ' HB2' ' CB ' ' A' ' 52' ' ' SER . 24.4 t90 -79.33 123.37 27.41 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 122.031 0.919 . . . . 0.0 111.908 -178.83 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 233' ' ' ASP . . . . . 0.494 ' H ' HG23 ' A' ' 49' ' ' THR . 12.8 t70 -113.2 149.35 33.83 Favored 'General case' 0 C--N 1.284 -2.271 0 N-CA-C 102.645 -3.094 . . . . 0.0 102.645 172.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.331 0 C-N-CA 127.53 2.49 . . . . 0.0 115.884 -178.101 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' B' B ' 240' ' ' GLY . . . . . 0.606 ' O ' ' HG2' ' B' ' 244' ' ' LYS . . . . . . . . 0 C--O 1.191 -2.546 0 N-CA-C 112.083 -0.407 . . . . 0.0 112.083 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -61.89 -33.08 73.56 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 116.914 0.357 . . . . 0.0 111.618 -179.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -60.34 -44.88 95.11 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.307 -175.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 243' ' ' GLU . . . . . 0.473 ' HG2' ' O ' ' B' ' 240' ' ' GLY . 9.8 pt-20 -67.59 -35.46 79.03 Favored 'General case' 0 C--O 1.201 -1.472 0 C-N-CA 120.799 -0.36 . . . . 0.0 110.543 179.532 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 244' ' ' LYS . . . . . 0.606 ' HG2' ' O ' ' B' ' 240' ' ' GLY . 67.7 mmtt -68.1 -42.15 80.73 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-O 121.004 0.431 . . . . 0.0 110.408 -176.497 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 245' ' ' TRP . . . . . . . . . . . . . 50.9 m0 -63.39 -43.04 98.72 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 178.545 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 246' ' ' PHE . . . . . 0.425 ' O ' ' HG2' ' B' ' 249' ' ' GLN . 5.5 t80 -67.14 -33.21 74.94 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 114.866 -1.061 . . . . 0.0 110.869 178.237 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -77.21 -21.4 53.92 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.98 -177.412 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.33 -30.04 13.64 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 119.934 -0.706 . . . . 0.0 110.806 179.255 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 249' ' ' GLN . . . . . 0.425 ' HG2' ' O ' ' B' ' 246' ' ' PHE . 3.7 pt20 -68.52 -12.19 60.9 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.074 -176.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 250' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -57.39 -30.13 64.65 Favored 'General case' 0 N--CA 1.482 1.153 0 CA-C-N 115.538 -0.755 . . . . 0.0 112.093 177.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -117.39 166.85 11.83 Favored 'General case' 0 N--CA 1.414 -2.261 0 CA-C-N 115.412 -0.813 . . . . 0.0 112.836 -175.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 252' ' ' ILE . . . . . . . . . . . . . 32.3 pt -126.26 -27.66 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 CA-C-N 113.879 -1.51 . . . . 0.0 109.8 176.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -125.99 -34.0 2.62 Favored 'General case' 0 C--O 1.221 -0.397 0 N-CA-C 113.356 0.872 . . . . 0.0 113.356 -175.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 254' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 . . . . . 0 C--N 1.309 -1.153 0 N-CA-C 113.963 1.098 . . . . 0.0 113.963 -179.097 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 50.8 t-20 . . . . . 0 C--O 1.234 0.288 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -86.35 -30.89 21.85 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-O 121.426 0.631 . . . . 0.0 111.222 -177.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 33.7 m-85 -88.23 66.9 8.62 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-O 123.348 1.547 . . . . 0.0 112.287 -177.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 30.1 mmmt -121.72 169.98 10.19 Favored 'General case' 0 C--N 1.277 -2.575 0 CA-C-N 112.303 -2.226 . . . . 0.0 107.352 174.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -98.86 23.24 9.09 Favored 'General case' 0 C--N 1.292 -1.898 0 CA-C-O 122.407 1.099 . . . . 0.0 109.326 -178.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -83.87 9.43 12.1 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 114.204 -1.362 . . . . 0.0 109.106 178.016 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.512 ' HB2' ' NE2' ' A' ' 82' ' ' GLN . . . -98.05 0.92 47.1 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.284 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -108.9 145.67 35.01 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 115.056 -0.974 . . . . 0.0 109.049 -173.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 26.7 pt -142.57 163.1 18.14 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 CA-C-O 121.408 0.623 . . . . 0.0 111.045 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.424 ' HB2' HG21 ' A' ' 107' ' ' THR . 17.7 t80 -114.52 127.07 55.61 Favored 'General case' 0 N--CA 1.415 -2.188 0 CA-C-N 114.383 -1.281 . . . . 0.0 108.787 176.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.485 HG23 ' CD1' ' A' ' 104' ' ' ILE . 9.5 mt -110.09 127.79 66.75 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.795 0 N-CA-C 107.335 -1.358 . . . . 0.0 107.335 177.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -127.43 165.69 20.45 Favored Glycine 0 C--N 1.284 -2.314 0 N-CA-C 110.607 -0.997 . . . . 0.0 110.607 179.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 71.7 m-20 72.18 40.58 0.69 Allowed 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.742 1.217 . . . . 0.0 110.038 -178.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.521 HD11 HD11 ' A' ' 47' ' ' ILE . 3.9 mm? -72.71 144.84 47.53 Favored 'General case' 0 CA--C 1.495 -1.153 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.551 178.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.461 ' HB3' ' HG ' ' A' ' 42' ' ' LEU . 42.0 t-20 -83.13 146.09 28.85 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 106.549 -1.649 . . . . 0.0 106.549 176.673 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.525 ' HD2' ' N ' ' A' ' 41' ' ' GLU . 5.8 ppt_? -60.76 -19.22 58.74 Favored 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 123.3 0.64 . . . . 0.0 112.051 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.525 ' N ' ' HD2' ' A' ' 40' ' ' ARG . 8.9 pt-20 -99.99 5.66 45.13 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.965 -178.046 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.461 ' HG ' ' HB3' ' A' ' 39' ' ' ASN . 71.1 mt -96.51 126.22 41.54 Favored 'General case' 0 C--N 1.309 -1.179 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.701 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 12.5 t -117.67 175.84 5.46 Favored 'General case' 0 N--CA 1.428 -1.53 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.18 -179.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.421 ' CG ' ' HB2' ' A' ' 62' ' ' LEU . 42.1 mt-10 -54.39 -39.62 67.41 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 123.743 0.817 . . . . 0.0 111.401 -176.014 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.87 -37.73 94.21 Favored Glycine 0 CA--C 1.521 0.417 0 C-N-CA 121.317 -0.468 . . . . 0.0 113.402 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -67.12 -49.17 65.84 Favored 'General case' 0 CA--C 1.499 -0.995 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.521 HD11 HD11 ' A' ' 38' ' ' LEU . 38.6 mt -61.01 -45.3 98.83 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.902 0 CA-C-N 114.861 -1.063 . . . . 0.0 110.854 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 38.1 mt -60.07 -45.75 91.86 Favored 'General case' 0 CA--C 1.494 -1.186 0 N-CA-C 111.676 0.25 . . . . 0.0 111.676 -176.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.479 HG23 ' H ' ' B' ' 233' ' ' ASP . 100.0 m -62.77 -45.59 91.99 Favored 'General case' 0 C--N 1.307 -1.263 0 O-C-N 123.551 0.532 . . . . 0.0 111.913 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.652 HG13 ' HG3' ' B' ' 237' ' ' ARG . 54.6 t -66.13 -49.12 78.66 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.633 -179.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.462 ' HA ' ' HD2' ' A' ' 54' ' ' TYR . 3.7 m-85 -65.21 -23.03 66.97 Favored 'General case' 0 N--CA 1.425 -1.697 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.409 -178.124 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.491 ' OG ' ' HB2' ' B' ' 231' ' ' ARG . 58.7 m -69.35 -22.03 63.78 Favored 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 177.099 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.43 ' HG2' ' O ' ' A' ' 50' ' ' VAL . 7.8 pt-20 -73.52 -20.21 60.72 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 117.642 -1.623 . . . . 0.0 110.4 177.326 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.462 ' HD2' ' HA ' ' A' ' 51' ' ' PHE . 48.0 m-85 -92.36 -10.3 38.69 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-O 121.225 0.536 . . . . 0.0 111.135 -178.327 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 157.21 -154.9 25.93 Favored Glycine 0 N--CA 1.422 -2.296 0 C-N-CA 120.323 -0.941 . . . . 0.0 111.721 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 87.2 t -104.52 111.14 65.15 Favored Pre-proline 0 C--N 1.3 -1.557 0 N-CA-C 111.245 0.091 . . . . 0.0 111.245 -177.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.481 ' HB3' HD21 ' A' ' 77' ' ' LEU . 95.6 Cg_endo -79.84 137.34 12.52 Favored 'Trans proline' 0 N--CA 1.449 -1.133 0 C-N-CA 122.652 2.234 . . . . 0.0 109.676 175.325 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 30.7 m -111.76 -33.56 2.25 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 C-N-CA 119.355 -0.938 . . . . 0.0 111.553 179.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.467 ' HB3' ' HG2' ' A' ' 78' ' ' LYS . 29.3 t70 -146.13 145.59 30.55 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 -179.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 14.5 p -143.65 135.33 23.04 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.482 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 99.3 mt -121.05 118.76 57.26 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 175.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.431 HD12 ' HG3' ' A' ' 64' ' ' ARG . 0.1 OUTLIER -98.1 114.4 26.57 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 106.014 -1.847 . . . . 0.0 106.014 174.781 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 43.7 m -76.85 116.59 17.66 Favored 'General case' 0 N--CA 1.404 -2.773 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 178.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.431 ' HG3' HD12 ' A' ' 62' ' ' LEU . 34.1 mtm180 -128.45 138.97 52.56 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-N 115.336 -0.847 . . . . 0.0 108.83 -176.552 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -79.92 125.91 30.33 Favored 'General case' 0 C--N 1.292 -1.926 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.453 -177.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -61.3 -24.52 66.48 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 -178.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 22.7 m-80 -81.68 -47.46 12.94 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-O 121.154 0.502 . . . . 0.0 110.662 -174.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 39.2 p -90.03 -24.16 21.27 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.986 -177.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.41 6.16 86.3 Favored Glycine 0 N--CA 1.439 -1.115 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.714 -177.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -111.88 163.93 13.66 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 110.346 -0.242 . . . . 0.0 110.346 -176.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 6.1 m -56.37 143.76 33.24 Favored 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 124.85 1.26 . . . . 0.0 111.419 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -87.84 10.93 16.95 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -177.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 84.71 8.95 82.07 Favored Glycine 0 C--N 1.308 -0.975 0 C-N-CA 120.926 -0.654 . . . . 0.0 113.569 179.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 36.7 p90 -154.98 157.79 38.21 Favored 'General case' 0 N--CA 1.436 -1.139 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 178.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -153.11 176.23 12.14 Favored 'General case' 0 N--CA 1.436 -1.143 0 O-C-N 123.556 0.535 . . . . 0.0 110.321 179.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -137.04 146.26 45.03 Favored 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 123.966 0.906 . . . . 0.0 109.856 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.481 HD21 ' HB3' ' A' ' 57' ' ' PRO . 10.0 tt -152.28 140.6 20.5 Favored 'General case' 0 N--CA 1.436 -1.143 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 175.128 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.467 ' HG2' ' HB3' ' A' ' 59' ' ' ASP . 18.8 ptmt -123.15 144.35 49.4 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 178.465 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 69.8 m-85 -102.47 164.88 11.42 Favored 'General case' 0 C--N 1.281 -2.378 0 CA-C-N 115.21 -0.905 . . . . 0.0 111.368 -178.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -79.1 -26.63 42.92 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 114.436 -1.256 . . . . 0.0 108.521 175.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -122.99 132.37 54.11 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.249 -175.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.512 ' NE2' ' HB2' ' A' ' 31' ' ' ALA . 15.9 mp0 -64.03 -30.33 71.41 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 179.547 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.88 -33.29 74.44 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-O 122.348 1.071 . . . . 0.0 110.353 -179.279 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 48.8 m -58.04 -36.47 72.8 Favored 'General case' 0 C--N 1.278 -2.511 0 CA-C-N 114.965 -1.016 . . . . 0.0 111.452 175.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.432 ' O ' HG23 ' A' ' 89' ' ' VAL . 36.9 p -63.91 -45.21 90.29 Favored 'General case' 0 C--O 1.213 -0.858 0 C-N-CA 120.332 -0.547 . . . . 0.0 110.9 -178.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 3.2 pt -64.94 -38.52 82.98 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.6 0 C-N-CA 122.391 0.276 . . . . 0.0 110.793 178.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.538 HD11 ' HB2' ' B' ' 224' ' ' PHE . 16.1 mt -59.09 -44.31 91.92 Favored 'General case' 0 CA--C 1.509 -0.601 0 O-C-N 123.659 0.599 . . . . 0.0 110.61 175.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.41 ' O ' ' HB2' ' A' ' 92' ' ' LEU . . . -72.92 -47.67 43.74 Favored 'General case' 0 N--CA 1.435 -1.195 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 179.464 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.471 HG22 HG22 ' A' ' 104' ' ' ILE . 72.4 t -59.26 -48.99 85.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 N-CA-C 112.127 0.418 . . . . 0.0 112.127 -176.325 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -73.27 -27.14 61.4 Favored 'General case' 0 C--N 1.294 -1.824 0 CA-C-O 121.466 0.65 . . . . 0.0 111.893 -172.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.441 ' HA ' HD22 ' B' ' 239' ' ' ASN . 6.6 t30 -91.59 -31.51 15.87 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.945 -177.379 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.443 ' HB2' HG13 ' A' ' 104' ' ' ILE . 9.9 mt -91.69 -29.7 16.7 Favored 'General case' 0 C--N 1.313 -1.006 0 C-N-CA 122.509 0.324 . . . . 0.0 111.566 -174.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 51.5 t-20 -65.49 124.72 23.06 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 86.9 -5.54 84.88 Favored Glycine 0 N--CA 1.435 -1.412 0 C-N-CA 121.256 -0.497 . . . . 0.0 112.568 179.213 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -85.7 139.04 31.69 Favored 'General case' 0 N--CA 1.44 -0.96 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 -178.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.494 ' HE3' ' HB2' ' A' ' 101' ' ' ALA . 11.7 mptt -94.6 119.18 32.85 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-O 121.056 0.455 . . . . 0.0 111.652 -176.41 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.431 HD12 HD12 ' A' ' 102' ' ' LEU . 54.2 mt -126.03 141.34 45.97 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 N-CA-C 106.144 -1.798 . . . . 0.0 106.144 174.162 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.431 ' HA3' HD22 ' A' ' 39' ' ' ASN . . . 59.22 21.23 53.02 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 121.539 -0.363 . . . . 0.0 113.345 -179.38 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 85.04 6.84 84.44 Favored Glycine 0 N--CA 1.435 -1.406 0 C-N-CA 121.27 -0.49 . . . . 0.0 113.335 -179.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 19.3 ptp180 -132.15 146.77 52.26 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 117.772 0.786 . . . . 0.0 111.668 179.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.494 ' HB2' ' HE3' ' A' ' 96' ' ' LYS . . . -80.1 118.03 21.45 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.59 -178.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.431 HD12 HD12 ' A' ' 97' ' ' ILE . 11.6 mt -70.76 144.64 50.84 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-O 121.604 0.716 . . . . 0.0 112.702 178.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 23.4 tptm -118.14 116.96 27.9 Favored 'General case' 0 N--CA 1.419 -1.981 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.141 177.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.485 ' CD1' HG23 ' A' ' 35' ' ' ILE . 5.7 mm -117.86 138.32 48.92 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 179.022 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -143.36 150.64 39.42 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 179.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 82.7 m-70 -83.23 133.81 34.98 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 178.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.424 HG21 ' HB2' ' A' ' 34' ' ' TYR . 7.3 t -154.66 152.95 30.57 Favored 'General case' 0 N--CA 1.423 -1.777 0 N-CA-C 107.262 -1.385 . . . . 0.0 107.262 -178.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 41.5 p90 -91.74 112.24 24.08 Favored 'General case' 0 N--CA 1.429 -1.517 0 N-CA-C 106.474 -1.676 . . . . 0.0 106.474 171.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 43.8 t80 -105.81 135.56 47.02 Favored 'General case' 0 C--N 1.28 -2.425 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 -179.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 18.1 mmm180 -120.46 115.55 32.51 Favored Pre-proline 0 C--N 1.289 -2.042 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 174.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -71.28 153.28 61.78 Favored 'Trans proline' 0 C--O 1.246 0.907 0 C-N-CA 123.518 2.812 . . . . 0.0 114.689 -176.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.436 ' C ' ' HD3' ' A' ' 112' ' ' LYS . 12.7 tmtt? -108.91 134.08 52.06 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 105.747 -1.946 . . . . 0.0 105.747 174.406 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 35.7 mmt180 . . . . . 0 C--N 1.303 -1.44 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 -179.147 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 . . . . . 0 N--CA 1.479 0.989 0 N-CA-C 113.461 0.912 . . . . 0.0 113.461 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 223' ' ' ARG . . . . . . . . . . . . 0.417 53.3 mtp180 70.69 51.49 0.33 Allowed 'General case' 0 CA--C 1.501 -0.938 0 N-CA-C 117.192 2.293 . . . . 0.0 117.192 178.26 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 224' ' ' PHE . . . . . 0.538 ' HB2' HD11 ' A' ' 87' ' ' LEU . 30.2 m-85 -105.99 166.0 10.81 Favored 'General case' 0 C--N 1.273 -2.719 0 CA-C-N 114.792 -1.095 . . . . 0.0 109.569 176.419 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 225' ' ' ALA . . . . . . . . . . . . . . . -107.17 22.25 16.28 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 111.957 0.355 . . . . 0.0 111.957 -172.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 4.6 mp -83.46 132.17 32.07 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 178.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 227' ' ' MET . . . . . . . . . . . . . 65.6 mtt -81.85 135.08 49.08 Favored Pre-proline 0 C--N 1.305 -1.36 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.727 -178.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 228' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -57.2 148.64 68.79 Favored 'Trans proline' 0 C--O 1.255 1.341 0 C-N-CA 123.692 2.928 . . . . 0.0 114.419 -177.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . -74.07 170.87 52.93 Favored Glycine 0 N--CA 1.44 -1.05 0 CA-C-N 114.71 -1.132 . . . . 0.0 112.972 -179.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 18.9 m -77.71 -14.17 59.69 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 -172.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 231' ' ' ARG . . . . . 0.491 ' HB2' ' OG ' ' A' ' 52' ' ' SER . 10.7 mmm180 -84.93 -1.63 56.9 Favored 'General case' 0 C--N 1.32 -0.703 0 O-C-N 121.84 -0.537 . . . . 0.0 110.347 -179.229 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 232' ' ' TRP . . . . . . . . . . . . . 22.8 t90 -76.95 125.19 28.89 Favored 'General case' 0 N--CA 1.436 -1.161 0 CA-C-O 122.496 1.141 . . . . 0.0 112.599 -176.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 233' ' ' ASP . . . . . 0.479 ' H ' HG23 ' A' ' 49' ' ' THR . 16.0 t70 -120.59 148.19 44.21 Favored 'General case' 0 C--N 1.271 -2.846 0 N-CA-C 102.326 -3.213 . . . . 0.0 102.326 172.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -43.25 60.47 0.0 OUTLIER Glycine 0 N--CA 1.502 3.072 0 C-N-CA 128.312 2.863 . . . . 0.0 116.526 -176.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 235' ' ' VAL . . . . . 0.467 ' N ' ' O ' ' B' ' 233' ' ' ASP . 75.7 t -111.29 118.93 58.61 Favored 'Isoleucine or valine' 0 C--N 1.25 -3.741 0 C-N-CA 127.309 2.244 . . . . 0.0 107.634 176.526 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 236' ' ' HIS . . . . . . . . . . . . . 15.5 t-80 -113.38 107.88 16.46 Favored 'General case' 0 C--N 1.282 -2.347 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.474 179.211 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 237' ' ' ARG . . . . . 0.652 ' HG3' HG13 ' A' ' 50' ' ' VAL . 3.3 mmp_? -108.4 114.96 29.21 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 104.957 -2.238 . . . . 0.0 104.957 173.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 238' ' ' SER . . . . . . . . . . . . . 23.8 t -131.31 134.15 46.06 Favored 'General case' 0 C--N 1.275 -2.657 0 C-N-CA 119.982 -0.687 . . . . 0.0 112.504 -175.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 239' ' ' ASN . . . . . 0.441 HD22 ' HA ' ' A' ' 91' ' ' ASN . 39.4 p30 -72.59 174.76 7.08 Favored 'General case' 0 C--O 1.244 0.799 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.325 174.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 240' ' ' GLY . . . . . 0.405 ' O ' ' HG2' ' B' ' 243' ' ' GLU . . . 76.57 35.37 41.46 Favored Glycine 0 N--CA 1.426 -1.999 0 C-N-CA 119.549 -1.31 . . . . 0.0 110.624 -179.201 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 20.7 p90 -76.29 -32.68 58.92 Favored 'General case' 0 C--N 1.297 -1.701 0 CA-C-O 121.045 0.45 . . . . 0.0 109.863 175.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -60.54 -39.23 87.15 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.934 -178.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 243' ' ' GLU . . . . . 0.405 ' HG2' ' O ' ' B' ' 240' ' ' GLY . 9.3 pt-20 -65.52 -34.99 79.55 Favored 'General case' 0 C--O 1.208 -1.128 0 C-N-CA 121.158 -0.217 . . . . 0.0 111.094 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 68.3 mmtt -68.0 -39.87 83.14 Favored 'General case' 0 CA--C 1.509 -0.616 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 -178.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 245' ' ' TRP . . . . . . . . . . . . . 51.0 m0 -65.95 -43.56 87.6 Favored 'General case' 0 N--CA 1.438 -1.044 0 CA-C-N 114.795 -1.093 . . . . 0.0 109.492 176.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 246' ' ' PHE . . . . . 0.528 ' O ' ' HG2' ' B' ' 249' ' ' GLN . 2.4 t80 -61.98 -39.85 93.59 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.215 178.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.96 -33.71 76.33 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.928 -178.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.69 -17.37 20.38 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -178.101 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 249' ' ' GLN . . . . . 0.528 ' HG2' ' O ' ' B' ' 246' ' ' PHE . 2.2 pt20 -80.04 3.44 20.24 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 177.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 250' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -51.45 -28.76 14.01 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.873 1.269 . . . . 0.0 112.094 -179.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . 0.415 ' HG3' ' HB3' ' B' ' 254' ' ' GLU . 8.4 mm-40 -58.59 150.48 22.93 Favored 'General case' 0 N--CA 1.426 -1.63 0 N-CA-C 115.272 1.582 . . . . 0.0 115.272 -179.427 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 252' ' ' ILE . . . . . . . . . . . . . 31.7 pt -110.17 -29.32 2.49 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 CA-C-N 113.829 -1.532 . . . . 0.0 109.905 -178.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -115.82 -34.71 4.71 Favored 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 120.233 -0.587 . . . . 0.0 110.511 -178.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 254' ' ' GLU . . . . . 0.424 ' HG2' ' H ' ' B' ' 255' ' ' LYS . 5.2 tt0 -83.67 -174.37 5.25 Favored 'General case' 0 N--CA 1.436 -1.15 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.777 -174.202 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 255' ' ' LYS . . . . . 0.424 ' H ' ' HG2' ' B' ' 254' ' ' GLU . 24.9 pttm -48.59 139.11 9.77 Favored 'General case' 0 C--O 1.241 0.651 0 C-N-CA 125.142 1.377 . . . . 0.0 112.122 178.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 256' ' ' LYS . . . . . . . . . . . . . 43.3 mmtm . . . . . 0 C--N 1.302 -1.468 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 179.743 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 50.7 t-20 . . . . . 0 N--CA 1.451 -0.415 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 29.4 mm-40 -85.67 -23.44 27.44 Favored 'General case' 0 C--N 1.314 -0.944 0 C-N-CA 122.845 0.458 . . . . 0.0 111.3 -176.181 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 56.6 m-85 -88.07 6.07 37.99 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.593 -0.73 . . . . 0.0 112.099 -172.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -127.82 163.35 24.58 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 176.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.406 ' C ' ' H ' ' A' ' 31' ' ' ALA . 7.8 m-20 -121.77 19.65 11.02 Favored 'General case' 0 C--N 1.291 -1.96 0 CA-C-O 121.965 0.888 . . . . 0.0 108.659 -175.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -76.59 11.03 1.79 Allowed 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 114.747 -1.115 . . . . 0.0 109.92 -178.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.568 ' HA ' HG21 ' A' ' 85' ' ' THR . . . -84.55 -11.33 56.26 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-N 115.272 -0.877 . . . . 0.0 109.401 178.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 -100.95 144.54 29.77 Favored 'General case' 0 N--CA 1.436 -1.14 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 -177.397 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 26.9 pt -142.85 156.68 17.96 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 CA-C-O 121.151 0.5 . . . . 0.0 110.224 178.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.408 ' HB2' HG21 ' A' ' 107' ' ' THR . 20.4 t80 -108.45 124.32 50.22 Favored 'General case' 0 C--N 1.285 -2.229 0 CA-C-N 114.566 -1.197 . . . . 0.0 108.624 177.043 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.437 HG23 ' CD1' ' A' ' 104' ' ' ILE . 10.3 mt -108.28 127.52 64.51 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.935 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 175.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -124.65 157.91 19.05 Favored Glycine 0 C--N 1.279 -2.599 0 N-CA-C 111.155 -0.778 . . . . 0.0 111.155 -179.249 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 50.6 m-20 68.35 70.12 0.31 Allowed 'General case' 0 C--N 1.31 -1.133 0 C-N-CA 125.745 1.618 . . . . 0.0 109.908 -177.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.402 HD11 HD11 ' A' ' 47' ' ' ILE . 2.9 mm? -100.6 141.47 33.41 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 115.114 -0.948 . . . . 0.0 111.846 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.449 ' HB2' ' NH1' ' A' ' 100' ' ' ARG . 39.1 t-20 -76.41 144.21 40.15 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 174.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.434 ' C ' ' HD2' ' A' ' 40' ' ' ARG . 0.9 OUTLIER -59.46 -26.24 65.06 Favored 'General case' 0 C--N 1.312 -1.061 0 C-N-CA 123.278 0.631 . . . . 0.0 111.665 179.057 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.401 ' HG2' ' CG ' ' A' ' 39' ' ' ASN . 13.0 pt-20 -85.98 -0.89 56.63 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.383 -0.372 . . . . 0.0 111.767 -176.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.433 ' HG ' ' HB3' ' A' ' 39' ' ' ASN . 87.6 mt -94.3 127.38 40.13 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-O 121.081 0.467 . . . . 0.0 110.882 -179.649 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 63.2 p -116.52 175.03 5.75 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-N 115.072 -0.967 . . . . 0.0 108.678 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.401 ' HG3' ' HB2' ' A' ' 62' ' ' LEU . 5.8 mp0 -54.2 -40.6 67.74 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 122.716 0.406 . . . . 0.0 110.983 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -59.07 -38.08 92.51 Favored Glycine 0 N--CA 1.449 -0.498 0 CA-C-N 116.384 -0.371 . . . . 0.0 113.183 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -68.05 -49.23 62.64 Favored 'General case' 0 CA--C 1.496 -1.096 0 CA-C-O 121.022 0.439 . . . . 0.0 109.852 179.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.402 HD11 HD11 ' A' ' 38' ' ' LEU . 26.3 mt -60.31 -41.04 85.69 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.559 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.639 179.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 57.1 mt -59.52 -42.44 92.25 Favored 'General case' 0 C--O 1.206 -1.189 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.095 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 90.7 m -61.47 -46.01 91.86 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 120.842 0.353 . . . . 0.0 111.458 179.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.589 HG13 ' HG3' ' B' ' 237' ' ' ARG . 97.8 t -67.1 -49.04 76.86 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.77 -179.204 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.453 ' HA ' ' HD2' ' A' ' 54' ' ' TYR . 3.3 m-85 -67.89 -24.15 65.19 Favored 'General case' 0 N--CA 1.426 -1.627 0 CA-C-N 115.423 -0.808 . . . . 0.0 112.558 -176.365 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.466 ' OG ' ' HB2' ' B' ' 231' ' ' ARG . 66.1 m -68.93 -19.56 64.19 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 116.188 -0.46 . . . . 0.0 112.059 176.344 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -67.08 -29.13 68.82 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 176.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.453 ' HD2' ' HA ' ' A' ' 51' ' ' PHE . 75.6 m-85 -89.93 -23.2 21.65 Favored 'General case' 0 N--CA 1.441 -0.897 0 CA-C-N 115.899 -0.591 . . . . 0.0 112.245 -174.58 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 171.54 -152.57 18.1 Favored Glycine 0 N--CA 1.426 -1.985 0 N-CA-C 111.312 -0.715 . . . . 0.0 111.312 179.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 86.7 t -106.62 112.87 63.48 Favored Pre-proline 0 C--N 1.297 -1.674 0 CA-C-O 120.793 0.33 . . . . 0.0 110.376 -178.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.487 ' HB3' HD21 ' A' ' 77' ' ' LEU . 88.6 Cg_endo -80.47 136.78 11.29 Favored 'Trans proline' 0 N--CA 1.442 -1.543 0 C-N-CA 122.371 2.047 . . . . 0.0 110.439 176.287 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 28.4 m -111.17 -28.32 2.63 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 C-N-CA 120.022 -0.671 . . . . 0.0 111.469 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.435 ' HB3' ' HG2' ' A' ' 78' ' ' LYS . 26.2 t70 -152.16 145.05 24.41 Favored 'General case' 0 CA--C 1.498 -1.043 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 178.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 10.7 p -145.95 135.45 17.53 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 123.775 0.672 . . . . 0.0 110.006 -178.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 94.1 mt -121.38 121.94 66.0 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 175.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.401 ' HB2' ' HG3' ' A' ' 44' ' ' GLU . 0.2 OUTLIER -98.24 117.94 33.76 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 104.988 -2.226 . . . . 0.0 104.988 174.162 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 69.8 m -71.66 116.09 11.62 Favored 'General case' 0 N--CA 1.405 -2.681 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 177.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 43.3 mtm180 -130.21 130.59 44.85 Favored 'General case' 0 C--N 1.295 -1.786 0 CA-C-N 115.34 -0.845 . . . . 0.0 108.844 -177.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -79.63 126.44 30.91 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.861 -177.081 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -61.67 -27.42 68.67 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 179.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 25.7 m-80 -79.77 -49.84 11.44 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 121.184 0.516 . . . . 0.0 110.511 -173.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 39.5 p -85.75 -24.35 26.94 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 115.646 -0.707 . . . . 0.0 111.542 -177.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.2 20.88 79.36 Favored Glycine 0 N--CA 1.443 -0.845 0 N-CA-C 110.686 -0.965 . . . . 0.0 110.686 -176.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -121.39 174.1 6.95 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 -177.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.422 ' HB3' ' HA ' ' A' ' 40' ' ' ARG . 48.3 t -67.95 146.2 53.81 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 178.132 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -83.2 -2.06 54.59 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 121.675 0.75 . . . . 0.0 109.779 177.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 90.78 15.73 55.98 Favored Glycine 0 N--CA 1.426 -1.995 0 CA-C-N 114.915 -1.039 . . . . 0.0 112.993 176.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 33.7 p90 -155.35 163.1 40.55 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 177.233 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -155.6 176.14 12.99 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-O 121.095 0.474 . . . . 0.0 111.228 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -137.64 146.0 43.38 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 124.334 1.054 . . . . 0.0 109.965 179.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.487 HD21 ' HB3' ' A' ' 57' ' ' PRO . 9.8 tt -151.88 140.86 21.13 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 175.517 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.435 ' HG2' ' HB3' ' A' ' 59' ' ' ASP . 20.1 ptmt -121.76 144.09 49.0 Favored 'General case' 0 C--O 1.257 1.482 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 178.162 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 50.2 m-85 -103.89 164.72 11.51 Favored 'General case' 0 C--N 1.288 -2.072 0 CA-C-N 115.595 -0.729 . . . . 0.0 111.688 -178.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -69.77 -39.52 76.62 Favored 'General case' 0 N--CA 1.429 -1.522 0 CA-C-N 114.388 -1.278 . . . . 0.0 108.665 174.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.41 ' OD2' ' HB2' ' A' ' 83' ' ' ARG . 26.6 t70 -124.13 140.0 53.39 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.932 -176.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 -69.46 -19.75 63.76 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 115.187 1.551 . . . . 0.0 115.187 -178.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.41 ' HB2' ' OD2' ' A' ' 81' ' ' ASP . 0.0 OUTLIER -67.23 -33.91 76.34 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-O 122.175 0.988 . . . . 0.0 109.743 173.382 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.46 ' OG ' HG21 ' B' ' 226' ' ' ILE . 45.8 m -65.31 -36.91 85.5 Favored 'General case' 0 C--N 1.289 -2.062 0 CA-C-N 115.06 -0.973 . . . . 0.0 112.199 177.652 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.568 HG21 ' HA ' ' A' ' 31' ' ' ALA . 68.6 p -64.7 -45.59 85.96 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 120.26 -0.576 . . . . 0.0 110.841 -177.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 5.3 pt -63.51 -38.65 82.78 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.249 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.754 176.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.665 HD21 ' CD1' ' B' ' 224' ' ' PHE . 19.5 mt -58.79 -43.86 90.57 Favored 'General case' 0 C--O 1.247 0.969 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.302 176.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -71.53 -46.8 58.6 Favored 'General case' 0 N--CA 1.438 -1.067 0 CA-C-N 115.573 -0.739 . . . . 0.0 111.56 -179.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.45 HG22 HG22 ' A' ' 104' ' ' ILE . 75.8 t -57.88 -48.07 84.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-O 121.072 0.463 . . . . 0.0 111.113 -179.344 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -62.09 -32.83 73.43 Favored 'General case' 0 C--N 1.296 -1.744 0 CA-C-N 115.047 -0.979 . . . . 0.0 112.003 -173.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 36.7 m-80 -97.98 -25.08 15.1 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 113.367 0.877 . . . . 0.0 113.367 -178.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 15.4 mt -96.33 -31.29 12.96 Favored 'General case' 0 CA--C 1.484 -1.568 0 CA-C-O 120.898 0.38 . . . . 0.0 111.875 -172.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 57.7 t30 -66.51 125.28 25.21 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 -179.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 82.94 -1.12 89.15 Favored Glycine 0 N--CA 1.444 -0.821 0 O-C-N 123.414 0.446 . . . . 0.0 112.556 179.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 82.7 t80 -88.05 143.75 26.9 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 -178.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.426 ' HE3' ' HB2' ' A' ' 101' ' ' ALA . 11.5 mptt -96.9 118.7 33.91 Favored 'General case' 0 N--CA 1.436 -1.151 0 CA-C-O 121.088 0.47 . . . . 0.0 111.27 -177.143 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 53.1 mt -124.53 141.73 43.69 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 N-CA-C 105.098 -2.186 . . . . 0.0 105.098 173.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 56.93 29.27 58.82 Favored Glycine 0 C--O 1.22 -0.727 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.702 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 76.55 2.1 73.67 Favored Glycine 0 CA--C 1.537 1.455 0 C-N-CA 121.71 -0.281 . . . . 0.0 113.8 -179.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.449 ' NH1' ' HB2' ' A' ' 39' ' ' ASN . 0.2 OUTLIER -124.37 143.77 50.41 Favored 'General case' 0 C--N 1.316 -0.868 0 O-C-N 122.176 -0.603 . . . . 0.0 111.543 -177.125 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.426 ' HB2' ' HE3' ' A' ' 96' ' ' LYS . . . -87.23 118.45 26.65 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.644 -177.252 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 11.9 mt -70.22 147.92 49.23 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 115.431 -0.804 . . . . 0.0 112.513 179.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 59.3 tptt -120.83 116.23 24.8 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 175.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.45 HG22 HG22 ' A' ' 89' ' ' VAL . 4.7 mm -119.41 131.01 73.25 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.809 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 179.326 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -144.01 151.02 39.14 Favored 'General case' 0 C--N 1.285 -2.202 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 179.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 28.8 m-70 -78.68 135.03 37.07 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 178.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.408 HG21 ' HB2' ' A' ' 34' ' ' TYR . 12.0 t -149.59 161.51 42.03 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 106.199 -1.778 . . . . 0.0 106.199 -177.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -103.62 110.15 22.11 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 174.151 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 28.1 t80 -107.82 133.08 52.72 Favored 'General case' 0 C--N 1.294 -1.835 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.389 -176.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 21.9 mmm180 -121.11 118.28 30.29 Favored Pre-proline 0 C--N 1.297 -1.705 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 173.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -65.0 139.32 61.0 Favored 'Trans proline' 0 C--O 1.252 1.202 0 C-N-CA 123.577 2.851 . . . . 0.0 113.644 -178.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.468 ' C ' ' HD3' ' A' ' 112' ' ' LYS . 11.2 tmtt? -91.46 123.91 35.24 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 178.088 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 . . . . . 0 C--N 1.303 -1.418 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.173 179.538 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 222' ' ' ASN . . . . . 0.561 ' HB3' ' CD2' ' A' ' 87' ' ' LEU . 62.8 t30 . . . . . 0 N--CA 1.477 0.921 0 CA-C-O 120.447 0.165 . . . . 0.0 111.437 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 223' ' ' ARG . . . . . . . . . . . . . 3.1 mmp_? 80.08 24.88 0.38 Allowed 'General case' 0 N--CA 1.505 2.3 0 C-N-CA 124.916 1.286 . . . . 0.0 112.477 174.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 224' ' ' PHE . . . . . 0.665 ' CD1' HD21 ' A' ' 87' ' ' LEU . 12.6 m-85 -115.37 166.06 12.29 Favored 'General case' 0 C--N 1.28 -2.442 0 CA-C-N 114.386 -1.279 . . . . 0.0 108.714 176.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 225' ' ' ALA . . . . . . . . . . . . . . . -114.32 17.78 17.33 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-O 120.801 0.334 . . . . 0.0 111.682 -173.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 226' ' ' ILE . . . . . 0.46 HG21 ' OG ' ' A' ' 84' ' ' SER . 4.2 mp -77.85 127.04 38.57 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.112 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 -179.664 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 227' ' ' MET . . . . . . . . . . . . . 26.6 mmt -78.65 144.3 64.74 Favored Pre-proline 0 C--N 1.295 -1.802 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.721 178.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 228' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -68.57 160.64 48.51 Favored 'Trans proline' 0 C--O 1.248 0.984 0 C-N-CA 123.211 2.607 . . . . 0.0 113.673 -176.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . -82.77 172.86 52.22 Favored Glycine 0 N--CA 1.442 -0.927 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.991 178.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 14.8 m -74.76 -17.49 60.63 Favored 'General case' 0 C--N 1.307 -1.248 0 C-N-CA 123.29 0.636 . . . . 0.0 112.502 -175.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 231' ' ' ARG . . . . . 0.466 ' HB2' ' OG ' ' A' ' 52' ' ' SER . 23.0 mmm180 -79.75 -11.48 59.84 Favored 'General case' 0 CA--C 1.5 -0.949 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -179.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 232' ' ' TRP . . . . . . . . . . . . . 21.3 t90 -69.28 121.55 17.07 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-O 122.334 1.064 . . . . 0.0 111.922 -178.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 233' ' ' ASP . . . . . 0.446 ' O ' ' N ' ' B' ' 235' ' ' VAL . 30.3 t70 -116.77 149.11 40.46 Favored 'General case' 0 C--N 1.278 -2.543 0 N-CA-C 102.486 -3.154 . . . . 0.0 102.486 171.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -45.06 56.68 0.0 OUTLIER Glycine 0 N--CA 1.501 2.998 0 C-N-CA 128.114 2.769 . . . . 0.0 116.919 -177.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 235' ' ' VAL . . . . . 0.446 ' N ' ' O ' ' B' ' 233' ' ' ASP . 52.1 t -104.97 131.32 54.41 Favored 'Isoleucine or valine' 0 C--N 1.251 -3.678 0 C-N-CA 128.115 2.566 . . . . 0.0 106.926 176.255 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 236' ' ' HIS . . . . . . . . . . . . . 45.0 t60 -112.25 115.92 29.58 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 -178.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 237' ' ' ARG . . . . . 0.589 ' HG3' HG13 ' A' ' 50' ' ' VAL . 39.0 mmt180 -127.09 109.24 11.67 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 177.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 238' ' ' SER . . . . . . . . . . . . . 27.4 t -146.51 143.13 28.71 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 116.726 -0.215 . . . . 0.0 110.523 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 239' ' ' ASN . . . . . . . . . . . . . 27.2 p-10 -75.17 -22.86 57.78 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 121.482 0.658 . . . . 0.0 110.298 179.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 240' ' ' GLY . . . . . 0.471 ' O ' ' HG2' ' B' ' 244' ' ' LYS . . . -96.5 60.74 1.25 Allowed Glycine 0 N--CA 1.431 -1.672 0 N-CA-C 109.03 -1.628 . . . . 0.0 109.03 176.382 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 22.9 p90 -73.2 -33.26 65.28 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 -176.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -59.66 -47.43 85.63 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 120.731 -0.388 . . . . 0.0 111.362 -177.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -61.36 -34.99 76.22 Favored 'General case' 0 C--O 1.21 -1.015 0 O-C-N 123.659 0.599 . . . . 0.0 112.045 -179.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 244' ' ' LYS . . . . . 0.471 ' HG2' ' O ' ' B' ' 240' ' ' GLY . 43.6 mmtm -64.33 -48.39 75.77 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.248 0.547 . . . . 0.0 110.186 -178.37 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 245' ' ' TRP . . . . . . . . . . . . . 24.9 m0 -67.29 -37.69 83.83 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.103 179.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 246' ' ' PHE . . . . . 0.504 ' O ' ' HG2' ' B' ' 249' ' ' GLN . 2.4 t80 -65.04 -35.21 80.43 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.554 177.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -70.5 -36.33 73.72 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.656 -178.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.5 -14.09 36.03 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 120.974 0.416 . . . . 0.0 111.703 -177.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 249' ' ' GLN . . . . . 0.504 ' HG2' ' O ' ' B' ' 246' ' ' PHE . 2.6 pt20 -84.79 3.74 36.23 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 109.192 -0.669 . . . . 0.0 109.192 177.007 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 250' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -50.35 -32.09 16.38 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 114.788 -1.096 . . . . 0.0 111.938 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -64.7 123.76 20.16 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.578 -178.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 252' ' ' ILE . . . . . . . . . . . . . 27.5 pt -98.63 -31.98 3.76 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 CA-C-O 121.274 0.559 . . . . 0.0 111.937 -177.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -89.86 -16.9 29.12 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-O 121.584 0.706 . . . . 0.0 109.71 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 254' ' ' GLU . . . . . 0.588 ' OE1' ' HG3' ' B' ' 255' ' ' LYS . 1.2 tm-20 -105.58 -170.99 1.83 Allowed 'General case' 0 C--N 1.293 -1.888 0 CA-C-N 114.691 -1.14 . . . . 0.0 108.799 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 255' ' ' LYS . . . . . 0.588 ' HG3' ' OE1' ' B' ' 254' ' ' GLU . 0.0 OUTLIER -75.72 176.02 8.11 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 114.55 1.315 . . . . 0.0 114.55 -178.25 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 256' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt . . . . . 0 C--N 1.31 -1.141 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 -179.113 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.488 HD21 ' HA ' ' A' ' 29' ' ' ASP . 34.4 t30 . . . . . 0 CA--C 1.497 -1.083 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 33.9 mm-40 -115.66 -50.58 2.7 Favored 'General case' 0 N--CA 1.428 -1.526 0 C-N-CA 120.248 -0.581 . . . . 0.0 109.676 174.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -137.08 17.4 3.0 Favored 'General case' 0 C--O 1.241 0.606 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 -176.139 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.48 ' HB2' HE22 ' A' ' 82' ' ' GLN . 95.5 mttt -94.54 -42.61 8.74 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-O 121.651 0.738 . . . . 0.0 110.19 179.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.488 ' HA ' HD21 ' A' ' 25' ' ' ASN . 79.4 m-20 60.72 18.54 8.64 Favored 'General case' 0 C--O 1.213 -0.829 0 C-N-CA 125.771 1.628 . . . . 0.0 113.257 179.469 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 57.9 t30 -89.39 19.69 4.3 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 114.08 -1.418 . . . . 0.0 108.964 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -96.86 -5.14 38.9 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 114.67 -1.15 . . . . 0.0 108.768 178.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 12.6 m-85 -108.24 144.89 35.1 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.217 -175.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 26.4 pt -139.47 155.51 25.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 CA-C-O 121.3 0.572 . . . . 0.0 110.374 176.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 50.9 t80 -106.38 123.1 47.54 Favored 'General case' 0 N--CA 1.411 -2.396 0 CA-C-N 114.31 -1.314 . . . . 0.0 107.772 177.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.441 HG23 ' CD1' ' A' ' 104' ' ' ILE . 8.1 mt -108.67 127.9 64.8 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.098 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 175.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -129.97 164.38 22.68 Favored Glycine 0 C--N 1.278 -2.685 0 N-CA-C 110.806 -0.918 . . . . 0.0 110.806 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 72.67 34.16 1.24 Allowed 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.92 1.288 . . . . 0.0 110.982 -179.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.41 HD11 HD11 ' A' ' 47' ' ' ILE . 4.1 mm? -64.57 146.33 54.78 Favored 'General case' 0 CA--C 1.497 -1.064 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.031 176.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.479 ' HB3' ' HG ' ' A' ' 42' ' ' LEU . 60.7 t30 -84.27 139.6 32.23 Favored 'General case' 0 C--N 1.289 -2.062 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 176.571 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.424 ' C ' ' HD2' ' A' ' 40' ' ' ARG . 6.9 ppt_? -58.53 -16.83 17.15 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 113.556 0.947 . . . . 0.0 113.556 -174.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -100.85 0.24 38.19 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -178.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.479 ' HG ' ' HB3' ' A' ' 39' ' ' ASN . 57.4 mt -80.94 128.66 33.93 Favored 'General case' 0 C--O 1.245 0.823 0 CA-C-O 121.235 0.541 . . . . 0.0 111.223 178.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 72.4 p -108.37 173.07 6.48 Favored 'General case' 0 N--CA 1.425 -1.708 0 CA-C-N 114.657 -1.156 . . . . 0.0 109.977 -177.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.58 ' HG3' ' HB2' ' A' ' 62' ' ' LEU . 2.3 mp0 -56.0 -43.1 77.36 Favored 'General case' 0 C--N 1.316 -0.886 0 C-N-CA 124.061 0.944 . . . . 0.0 110.824 178.361 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -62.62 -35.38 91.75 Favored Glycine 0 C--O 1.24 0.525 0 CA-C-N 115.867 -0.606 . . . . 0.0 112.557 -179.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 39.2 m-20 -64.84 -48.99 72.35 Favored 'General case' 0 CA--C 1.49 -1.337 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 178.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.41 HD11 HD11 ' A' ' 38' ' ' LEU . 52.5 mt -61.54 -48.03 90.64 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.856 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.402 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 40.1 mt -59.98 -42.44 94.19 Favored 'General case' 0 CA--C 1.494 -1.189 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.805 -176.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.432 HG23 ' H ' ' B' ' 233' ' ' ASP . 90.0 m -63.55 -45.9 88.38 Favored 'General case' 0 C--N 1.309 -1.191 0 O-C-N 123.456 0.473 . . . . 0.0 111.225 -179.095 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.418 HG13 ' HG3' ' B' ' 237' ' ' ARG . 98.1 t -67.69 -46.33 82.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.769 -178.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -66.12 -24.33 66.66 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.952 -178.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.532 ' OG ' ' HB2' ' B' ' 231' ' ' ARG . 70.2 m -70.81 -19.1 62.71 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.943 175.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -72.64 -27.2 61.99 Favored 'General case' 0 CA--C 1.551 1.009 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 177.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 58.3 m-85 -89.98 -16.45 29.84 Favored 'General case' 0 CA--C 1.511 -0.539 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.888 -177.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.419 ' O ' ' HA ' ' A' ' 52' ' ' SER . . . 163.13 -153.47 24.01 Favored Glycine 0 N--CA 1.417 -2.615 0 C-N-CA 120.325 -0.94 . . . . 0.0 111.738 178.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 59.7 t -105.23 107.65 59.5 Favored Pre-proline 0 C--N 1.294 -1.83 0 CA-C-N 116.105 -0.048 . . . . 0.0 110.92 -176.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.491 ' HB3' HD21 ' A' ' 77' ' ' LEU . 97.5 Cg_endo -78.51 136.97 14.31 Favored 'Trans proline' 0 N--CA 1.448 -1.161 0 C-N-CA 122.698 2.266 . . . . 0.0 110.194 176.126 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 35.5 m -112.86 -27.39 2.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 C-N-CA 119.84 -0.744 . . . . 0.0 111.601 -178.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.52 ' HB3' ' HG2' ' A' ' 78' ' ' LYS . 38.8 t70 -152.01 144.33 24.02 Favored 'General case' 0 CA--C 1.5 -0.952 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -179.197 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 13.0 p -145.38 134.73 17.88 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 179.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 91.2 mt -121.07 121.75 65.81 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 175.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.58 ' HB2' ' HG3' ' A' ' 44' ' ' GLU . 0.1 OUTLIER -94.58 115.91 28.13 Favored 'General case' 0 N--CA 1.422 -1.872 0 N-CA-C 105.838 -1.912 . . . . 0.0 105.838 176.039 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 11.3 m -76.89 116.93 18.0 Favored 'General case' 0 N--CA 1.409 -2.485 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 178.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.401 HH11 ' HD3' ' A' ' 64' ' ' ARG . 53.8 mtt180 -128.45 154.23 46.29 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.752 -177.256 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -88.94 115.03 26.2 Favored 'General case' 0 C--N 1.284 -2.25 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 173.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -62.0 -16.44 51.48 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 114.341 1.237 . . . . 0.0 114.341 -175.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 20.1 m-80 -81.65 -49.4 10.54 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-O 121.505 0.669 . . . . 0.0 109.501 -176.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 41.7 p -85.72 -23.27 27.43 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 115.373 -0.831 . . . . 0.0 110.984 -179.187 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.29 7.48 86.92 Favored Glycine 0 N--CA 1.446 -0.653 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.691 -179.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -105.72 163.43 12.7 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-O 121.16 0.505 . . . . 0.0 111.129 -175.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 14.5 m -63.4 139.54 58.78 Favored 'General case' 0 N--CA 1.425 -1.693 0 CA-C-N 114.579 -1.191 . . . . 0.0 109.932 178.368 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 14.1 mm-40 -74.51 -24.24 58.96 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 116.104 -0.498 . . . . 0.0 112.056 -179.269 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 113.44 7.2 20.96 Favored Glycine 0 N--CA 1.427 -1.953 0 C-N-CA 119.888 -1.148 . . . . 0.0 111.423 -175.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 31.4 p90 -151.02 156.76 41.79 Favored 'General case' 0 N--CA 1.427 -1.584 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 178.223 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -154.64 174.6 14.76 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 123.647 0.592 . . . . 0.0 110.09 178.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -132.17 141.16 49.0 Favored 'General case' 0 C--N 1.305 -1.362 0 C-N-CA 123.605 0.762 . . . . 0.0 110.076 -178.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.491 HD21 ' HB3' ' A' ' 57' ' ' PRO . 9.7 tt -148.08 140.72 24.57 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 175.372 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.52 ' HG2' ' HB3' ' A' ' 59' ' ' ASP . 21.2 ptmt -123.55 144.5 49.53 Favored 'General case' 0 C--O 1.258 1.551 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 178.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 59.2 m-85 -105.83 164.42 11.95 Favored 'General case' 0 C--N 1.288 -2.079 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.011 -179.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -80.15 -33.84 38.14 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 114.88 -1.055 . . . . 0.0 108.763 175.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -111.96 129.31 56.23 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -177.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.48 HE22 ' HB2' ' A' ' 28' ' ' LYS . 91.7 mt-30 -70.03 -20.42 63.25 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 113.883 1.068 . . . . 0.0 113.883 -178.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.76 -33.39 75.52 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 122.193 0.997 . . . . 0.0 109.448 174.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.4 ' OG ' ' HA3' ' A' ' 55' ' ' GLY . 63.7 m -64.13 -37.06 86.1 Favored 'General case' 0 C--N 1.292 -1.906 0 CA-C-N 115.184 -0.916 . . . . 0.0 112.901 178.445 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 68.6 p -64.68 -45.45 86.64 Favored 'General case' 0 C--N 1.346 0.43 0 C-N-CA 120.469 -0.493 . . . . 0.0 110.818 -177.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 4.0 pt -65.08 -39.1 84.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.759 177.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.424 HD11 ' HB2' ' B' ' 224' ' ' PHE . 12.2 mt -59.47 -43.51 93.22 Favored 'General case' 0 CA--C 1.505 -0.784 0 O-C-N 123.35 0.406 . . . . 0.0 111.703 176.028 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -69.35 -45.99 68.09 Favored 'General case' 0 N--CA 1.428 -1.555 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.739 -178.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.439 HG22 HG22 ' A' ' 104' ' ' ILE . 86.8 t -58.76 -45.28 91.3 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.134 0 CA-C-O 121.21 0.529 . . . . 0.0 110.643 177.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -58.91 -37.63 77.07 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 125.103 1.361 . . . . 0.0 112.321 -178.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.441 ' HA ' ' HB3' ' B' ' 239' ' ' ASN . 41.5 m-80 -98.17 -26.67 14.48 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 -176.002 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.465 ' HB2' HG13 ' A' ' 104' ' ' ILE . 19.0 mt -96.13 -30.82 13.31 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -172.489 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -65.84 123.92 21.09 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 88.48 -12.2 65.78 Favored Glycine 0 CA--C 1.53 1.012 0 CA-C-N 116.026 -0.534 . . . . 0.0 112.422 -178.066 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 73.4 t80 -79.73 138.0 37.19 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 -176.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.45 ' HE2' ' HB2' ' A' ' 101' ' ' ALA . 0.3 OUTLIER -95.66 123.28 39.15 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 112.111 0.411 . . . . 0.0 112.111 -177.035 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 59.4 mt -128.15 142.12 44.65 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 N-CA-C 105.737 -1.949 . . . . 0.0 105.737 173.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 64.14 14.32 55.99 Favored Glycine 0 C--N 1.319 -0.416 0 C-N-CA 121.262 -0.494 . . . . 0.0 112.701 -178.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 90.31 -1.18 79.25 Favored Glycine 0 N--CA 1.43 -1.73 0 CA-C-O 119.923 -0.376 . . . . 0.0 112.731 -178.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.443 ' O ' ' HA ' ' A' ' 96' ' ' LYS . 11.4 ptp180 -124.22 151.34 44.22 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 117.714 0.757 . . . . 0.0 111.96 -177.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.45 ' HB2' ' HE2' ' A' ' 96' ' ' LYS . . . -86.54 116.35 24.62 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -175.39 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 11.9 mt -65.61 148.72 51.27 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.469 -0.787 . . . . 0.0 112.56 178.096 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 57.7 tptt -122.12 118.06 27.76 Favored 'General case' 0 N--CA 1.422 -1.846 0 CA-C-N 115.14 -0.936 . . . . 0.0 108.663 175.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.465 HG13 ' HB2' ' A' ' 92' ' ' LEU . 4.3 mm -117.61 135.4 58.13 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 N-CA-C 107.143 -1.428 . . . . 0.0 107.143 178.515 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -143.94 149.71 37.24 Favored 'General case' 0 C--N 1.285 -2.229 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 -178.016 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 45.2 m-70 -81.56 131.17 35.26 Favored 'General case' 0 C--N 1.29 -1.981 0 N-CA-C 109.487 -0.561 . . . . 0.0 109.487 178.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 12.5 t -145.35 165.82 27.37 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 -177.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -110.16 109.77 20.4 Favored 'General case' 0 N--CA 1.428 -1.568 0 N-CA-C 106.649 -1.611 . . . . 0.0 106.649 174.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 35.6 t80 -108.62 134.7 51.01 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.719 -176.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 4.4 mpt_? -121.16 114.26 32.16 Favored Pre-proline 0 C--N 1.309 -1.189 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 172.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -81.44 152.76 17.93 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 122.89 2.394 . . . . 0.0 114.998 -177.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.478 ' HD3' ' N ' ' A' ' 113' ' ' ARG . 11.7 tmtt? -120.92 134.06 55.29 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 104.943 -2.243 . . . . 0.0 104.943 172.371 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.478 ' N ' ' HD3' ' A' ' 112' ' ' LYS . 28.4 mmt180 . . . . . 0 C--N 1.299 -1.617 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 36.4 t30 . . . . . 0 N--CA 1.469 0.492 0 N-CA-C 110.495 -0.187 . . . . 0.0 110.495 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 223' ' ' ARG . . . . . . . . . . . . 0.252 12.4 ptm180 53.59 50.17 17.81 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 116.898 2.184 . . . . 0.0 116.898 173.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 224' ' ' PHE . . . . . 0.424 ' HB2' HD11 ' A' ' 87' ' ' LEU . 56.5 m-85 -104.82 165.55 10.99 Favored 'General case' 0 C--N 1.273 -2.734 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.685 173.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 225' ' ' ALA . . . . . . . . . . . . . . . -128.44 81.79 2.05 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-O 121.007 0.432 . . . . 0.0 110.959 179.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 4.1 mp -125.4 129.09 73.0 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 177.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 227' ' ' MET . . . . . . . . . . . . . 91.4 mtp -70.35 137.7 86.51 Favored Pre-proline 0 C--N 1.313 -0.994 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 177.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 228' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -64.75 157.02 58.33 Favored 'Trans proline' 0 C--O 1.251 1.166 0 C-N-CA 123.398 2.732 . . . . 0.0 113.489 -176.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . -74.75 168.68 54.63 Favored Glycine 0 N--CA 1.435 -1.409 0 CA-C-N 115.122 -0.945 . . . . 0.0 111.83 178.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 15.0 m -75.04 -16.8 60.58 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 111.856 0.317 . . . . 0.0 111.856 -175.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 231' ' ' ARG . . . . . 0.532 ' HB2' ' OG ' ' A' ' 52' ' ' SER . 26.6 mmt180 -79.2 -10.21 59.76 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.933 0.397 . . . . 0.0 110.261 -177.627 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 232' ' ' TRP . . . . . . . . . . . . . 25.4 t90 -70.13 130.07 41.1 Favored 'General case' 0 N--CA 1.432 -1.329 0 CA-C-O 122.481 1.134 . . . . 0.0 112.059 -178.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 233' ' ' ASP . . . . . 0.453 ' O ' ' N ' ' B' ' 235' ' ' VAL . 22.8 t70 -124.03 139.45 53.93 Favored 'General case' 0 C--N 1.269 -2.906 0 N-CA-C 101.934 -3.358 . . . . 0.0 101.934 171.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -35.56 56.28 0.0 OUTLIER Glycine 0 N--CA 1.508 3.437 0 C-N-CA 128.747 3.07 . . . . 0.0 117.926 -177.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 235' ' ' VAL . . . . . 0.453 ' N ' ' O ' ' B' ' 233' ' ' ASP . 55.3 t -111.4 120.22 61.49 Favored 'Isoleucine or valine' 0 C--N 1.249 -3.783 0 C-N-CA 127.655 2.382 . . . . 0.0 107.664 176.633 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 236' ' ' HIS . . . . . . . . . . . . . 40.3 t-80 -107.0 116.7 32.38 Favored 'General case' 0 C--N 1.291 -1.965 0 CA-C-O 121.056 0.455 . . . . 0.0 109.823 -178.469 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 237' ' ' ARG . . . . . 0.418 ' HG3' HG13 ' A' ' 50' ' ' VAL . 38.4 mmt180 -126.89 120.36 29.0 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 177.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 238' ' ' SER . . . . . . . . . . . . . 55.0 m -146.53 153.53 40.5 Favored 'General case' 0 C--N 1.282 -2.365 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 178.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 239' ' ' ASN . . . . . 0.441 ' HB3' ' HA ' ' A' ' 91' ' ' ASN . 24.7 p-10 -61.78 88.41 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.837 0 CA-C-O 122.477 1.132 . . . . 0.0 112.271 -178.052 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 240' ' ' GLY . . . . . 0.473 ' O ' ' HG2' ' B' ' 243' ' ' GLU . . . -133.41 37.81 1.94 Allowed Glycine 0 N--CA 1.403 -3.505 0 CA-C-N 113.742 -1.572 . . . . 0.0 110.39 178.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 29.3 p90 -77.26 -36.71 54.18 Favored 'General case' 0 C--N 1.294 -1.829 0 CA-C-O 121.477 0.656 . . . . 0.0 110.857 176.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 242' ' ' GLU . . . . . 0.512 ' HA ' ' CE3' ' B' ' 245' ' ' TRP . 42.4 tt0 -67.55 -38.95 84.91 Favored 'General case' 0 C--O 1.251 1.145 0 CA-C-N 115.093 -0.958 . . . . 0.0 111.657 -178.504 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 243' ' ' GLU . . . . . 0.473 ' HG2' ' O ' ' B' ' 240' ' ' GLY . 12.2 pt-20 -58.3 -35.02 71.19 Favored 'General case' 0 C--O 1.212 -0.9 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.229 178.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 244' ' ' LYS . . . . . 0.432 ' HE2' ' O ' ' B' ' 240' ' ' GLY . 72.2 mmtt -62.79 -46.17 89.25 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.598 -176.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 245' ' ' TRP . . . . . 0.512 ' CE3' ' HA ' ' B' ' 242' ' ' GLU . 11.8 m0 -63.98 -40.65 96.86 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.675 179.308 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 246' ' ' PHE . . . . . 0.588 ' O ' ' HG2' ' B' ' 249' ' ' GLN . 2.5 t80 -66.64 -31.12 71.59 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.075 179.069 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -77.54 -39.91 44.39 Favored 'General case' 0 C--N 1.29 -2.004 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.079 178.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.47 -13.28 55.05 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-O 121.395 0.617 . . . . 0.0 111.606 -175.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 249' ' ' GLN . . . . . 0.588 ' HG2' ' O ' ' B' ' 246' ' ' PHE . 3.2 pt20 -74.48 2.68 9.01 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.597 -179.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 250' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -61.24 -31.08 70.88 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 174.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . 0.433 ' HG3' ' HB3' ' B' ' 254' ' ' GLU . 2.6 mm-40 -91.63 158.32 16.48 Favored 'General case' 0 N--CA 1.414 -2.263 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.439 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 252' ' ' ILE . . . . . . . . . . . . . 35.0 pt -108.11 -29.17 2.62 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 CA-C-N 114.927 -1.033 . . . . 0.0 110.265 -176.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -120.04 -32.39 4.2 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.918 0.389 . . . . 0.0 110.85 -175.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 254' ' ' GLU . . . . . 0.433 ' HB3' ' HG3' ' B' ' 251' ' ' GLU . 7.0 tp10 -77.09 155.18 32.62 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 -170.584 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 255' ' ' LYS . . . . . . . . . . . . . 35.5 mtmm -62.23 -74.78 0.08 Allowed 'General case' 0 C--N 1.315 -0.922 0 C-N-CA 125.436 1.495 . . . . 0.0 113.946 -174.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 256' ' ' LYS . . . . . . . . . . . . . 86.4 tttt . . . . . 0 C--N 1.296 -1.744 0 CA-C-O 118.873 -0.584 . . . . 0.0 109.595 -176.149 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 10.1 t30 . . . . . 0 CA--C 1.512 -0.494 0 CA-C-O 121.239 0.542 . . . . 0.0 109.714 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.481 ' HG2' ' CD1' ' A' ' 27' ' ' TYR . 1.4 pm0 -146.46 16.51 1.31 Allowed 'General case' 0 N--CA 1.413 -2.31 0 CA-C-N 114.955 -1.021 . . . . 0.0 111.959 -178.017 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.481 ' CD1' ' HG2' ' A' ' 26' ' ' GLU . 19.9 m-85 -113.43 6.49 17.2 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.134 0.492 . . . . 0.0 112.246 -177.283 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -96.19 -69.97 0.73 Allowed 'General case' 0 C--N 1.302 -1.481 0 CA-C-O 121.393 0.616 . . . . 0.0 109.629 178.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 56.12 21.23 4.99 Favored 'General case' 0 C--O 1.215 -0.759 0 C-N-CA 125.446 1.498 . . . . 0.0 114.98 177.204 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -89.79 12.65 16.5 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 171.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -92.13 22.43 4.4 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 114.809 -1.087 . . . . 0.0 111.748 -173.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 16.9 m-30 -93.92 145.39 24.67 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 120.933 -0.307 . . . . 0.0 110.598 -176.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 26.4 pt -143.8 162.26 15.83 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 C-N-CA 123.229 0.612 . . . . 0.0 110.233 176.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.469 ' HB2' HG21 ' A' ' 107' ' ' THR . 29.8 t80 -114.46 124.5 52.08 Favored 'General case' 0 N--CA 1.421 -1.913 0 C-N-CA 124.355 1.062 . . . . 0.0 108.616 177.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 7.5 mt -109.6 127.72 66.19 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.976 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 175.074 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -127.88 164.37 21.25 Favored Glycine 0 C--N 1.281 -2.501 0 N-CA-C 110.622 -0.991 . . . . 0.0 110.622 -179.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 16.9 m120 71.38 36.93 1.23 Allowed 'General case' 0 CA--C 1.503 -0.83 0 C-N-CA 124.177 0.991 . . . . 0.0 111.082 -177.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.469 HD11 HD11 ' A' ' 47' ' ' ILE . 4.1 mm? -69.79 153.87 42.75 Favored 'General case' 0 CA--C 1.499 -0.984 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.105 176.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.482 ' HB3' ' HG ' ' A' ' 42' ' ' LEU . 38.2 t-20 -92.07 152.96 19.69 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 175.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.447 ' HD3' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -67.38 -23.59 65.59 Favored 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 122.535 0.334 . . . . 0.0 110.41 -179.162 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -90.55 -10.97 41.51 Favored 'General case' 0 C--O 1.224 -0.259 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.291 -178.132 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.482 ' HG ' ' HB3' ' A' ' 39' ' ' ASN . 55.3 mt -77.43 120.38 22.34 Favored 'General case' 0 CA--C 1.495 -1.171 0 CA-C-O 121.596 0.712 . . . . 0.0 110.947 -178.218 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 73.0 p -102.07 173.49 6.36 Favored 'General case' 0 C--N 1.287 -2.142 0 CA-C-N 114.508 -1.224 . . . . 0.0 109.771 -177.215 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.441 ' HG3' ' HB2' ' A' ' 62' ' ' LEU . 1.3 mp0 -64.07 -34.61 78.43 Favored 'General case' 0 C--O 1.205 -1.276 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 177.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -59.31 -39.26 94.45 Favored Glycine 0 N--CA 1.443 -0.854 0 O-C-N 123.969 0.793 . . . . 0.0 111.438 178.19 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -67.54 -50.09 60.26 Favored 'General case' 0 CA--C 1.496 -1.107 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 177.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.469 HD11 HD11 ' A' ' 38' ' ' LEU . 46.3 mt -60.1 -47.22 92.79 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 CA-C-N 115.19 -0.913 . . . . 0.0 111.085 -178.157 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 41.4 mt -60.46 -45.45 93.66 Favored 'General case' 0 CA--C 1.49 -1.342 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.204 -176.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 90.4 m -63.08 -45.66 91.06 Favored 'General case' 0 N--CA 1.432 -1.356 0 O-C-N 123.74 0.65 . . . . 0.0 111.507 -178.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.566 HG13 ' HG3' ' B' ' 237' ' ' ARG . 98.2 t -67.48 -48.17 78.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.831 -179.182 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.407 ' HA ' ' HD2' ' A' ' 54' ' ' TYR . 3.5 m-85 -63.82 -25.37 68.15 Favored 'General case' 0 N--CA 1.438 -1.064 0 C-N-CA 123.769 0.827 . . . . 0.0 112.208 -179.06 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.555 ' OG ' ' HB2' ' B' ' 231' ' ' ARG . 62.8 m -67.75 -19.86 65.17 Favored 'General case' 0 N--CA 1.439 -1.011 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 176.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -66.03 -32.0 73.22 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-O 121.803 0.811 . . . . 0.0 109.305 174.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.407 ' HD2' ' HA ' ' A' ' 51' ' ' PHE . 57.2 m-85 -88.89 -22.78 22.96 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.56 -0.746 . . . . 0.0 111.691 -173.439 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.475 ' O ' ' HA ' ' A' ' 52' ' ' SER . . . 173.7 -162.49 33.37 Favored Glycine 0 N--CA 1.428 -1.872 0 C-N-CA 120.633 -0.794 . . . . 0.0 111.795 178.303 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 59.4 t -100.43 110.57 60.54 Favored Pre-proline 0 C--N 1.304 -1.395 0 N-CA-C 110.511 -0.181 . . . . 0.0 110.511 -178.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.544 ' HB3' HD21 ' A' ' 77' ' ' LEU . 97.1 Cg_endo -79.69 136.67 12.29 Favored 'Trans proline' 0 N--CA 1.45 -1.049 0 C-N-CA 122.535 2.157 . . . . 0.0 110.603 177.502 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 35.0 m -111.35 -28.22 2.64 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 C-N-CA 119.786 -0.765 . . . . 0.0 111.834 -178.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.502 ' HB3' ' HG2' ' A' ' 78' ' ' LYS . 36.3 t70 -151.23 141.86 22.68 Favored 'General case' 0 CA--C 1.504 -0.789 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 -179.48 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 13.8 p -142.33 133.52 25.25 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 O-C-N 123.609 0.568 . . . . 0.0 109.809 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 83.4 mt -120.54 118.5 56.77 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.213 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 177.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.441 ' HB2' ' HG3' ' A' ' 44' ' ' GLU . 0.1 OUTLIER -97.5 117.39 31.66 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 106.765 -1.569 . . . . 0.0 106.765 177.923 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 22.4 m -77.69 120.23 22.34 Favored 'General case' 0 C--N 1.29 -2.0 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 178.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 72.0 mtm180 -131.91 137.78 48.13 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.785 -175.076 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -70.35 128.73 37.2 Favored 'General case' 0 CA--C 1.499 -0.988 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.561 179.132 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -61.02 -29.39 69.68 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 115.416 -0.811 . . . . 0.0 112.692 -178.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 25.6 m-80 -81.83 -50.13 9.56 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-O 120.979 0.418 . . . . 0.0 111.5 -172.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 53.0 p -88.8 -23.79 22.77 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.756 -176.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 80.68 -1.63 82.28 Favored Glycine 0 N--CA 1.438 -1.201 0 N-CA-C 111.479 -0.648 . . . . 0.0 111.479 -176.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.447 ' OE2' ' HD3' ' A' ' 40' ' ' ARG . 5.5 mm-40 -91.4 168.32 11.64 Favored 'General case' 0 CA--C 1.503 -0.832 0 C-N-CA 122.842 0.457 . . . . 0.0 111.043 -174.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 13.1 m -68.11 145.16 54.65 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.88 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -86.06 6.05 30.73 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 -178.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 91.7 8.31 63.89 Favored Glycine 0 N--CA 1.44 -1.041 0 C-N-CA 120.85 -0.69 . . . . 0.0 113.535 177.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.41 ' HA ' HD23 ' A' ' 38' ' ' LEU . 32.6 p90 -152.77 157.72 41.22 Favored 'General case' 0 C--O 1.248 1.025 0 CA-C-N 117.566 0.683 . . . . 0.0 109.251 178.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -153.12 173.15 15.85 Favored 'General case' 0 N--CA 1.433 -1.322 0 O-C-N 123.569 0.543 . . . . 0.0 110.763 178.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -132.36 142.74 49.44 Favored 'General case' 0 C--N 1.306 -1.291 0 C-N-CA 124.17 0.988 . . . . 0.0 109.584 -178.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.544 HD21 ' HB3' ' A' ' 57' ' ' PRO . 9.8 tt -149.71 140.73 22.92 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 176.608 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.502 ' HG2' ' HB3' ' A' ' 59' ' ' ASP . 22.2 ptmt -123.46 144.25 49.64 Favored 'General case' 0 C--O 1.253 1.278 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 178.497 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -105.28 165.5 11.07 Favored 'General case' 0 C--N 1.29 -2.0 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.97 -178.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -73.62 -27.07 61.09 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.354 175.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -131.13 141.19 50.09 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 120.714 0.292 . . . . 0.0 110.606 -178.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 25.2 mp0 -70.08 -21.27 63.16 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 123.971 0.908 . . . . 0.0 113.279 -178.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 89.5 mtm180 -65.3 -34.46 78.39 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-O 122.313 1.054 . . . . 0.0 109.512 176.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.463 ' OG ' HG21 ' B' ' 226' ' ' ILE . 53.3 m -65.59 -36.85 84.95 Favored 'General case' 0 C--N 1.282 -2.33 0 CA-C-N 114.561 -1.199 . . . . 0.0 112.288 177.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 63.8 p -65.38 -44.94 85.98 Favored 'General case' 0 C--N 1.344 0.356 0 C-N-CA 120.168 -0.613 . . . . 0.0 110.875 -177.347 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.403 ' H ' HG12 ' A' ' 86' ' ' ILE . 3.5 pt -63.5 -38.91 83.46 Favored 'Isoleucine or valine' 0 C--O 1.243 0.731 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.036 177.058 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.551 HD21 ' CD1' ' B' ' 224' ' ' PHE . 49.2 mt -60.4 -44.04 96.08 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.385 176.211 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.453 ' O ' ' HB2' ' A' ' 92' ' ' LEU . . . -71.81 -46.61 57.59 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.838 -179.264 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.447 HG22 HG22 ' A' ' 104' ' ' ILE . 53.3 t -56.47 -48.89 79.42 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.902 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -178.004 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -62.24 -43.88 97.83 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -173.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -93.33 -19.98 20.82 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-N 115.758 -0.656 . . . . 0.0 112.373 -170.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.453 ' HB2' ' O ' ' A' ' 88' ' ' ALA . 9.8 mt -92.6 -27.85 17.09 Favored 'General case' 0 CA--C 1.491 -1.313 0 CA-C-O 120.824 0.345 . . . . 0.0 111.142 179.397 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -65.6 124.48 22.47 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 178.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 88.32 -1.09 84.11 Favored Glycine 0 N--CA 1.434 -1.493 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.435 -178.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -79.36 129.87 34.89 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 -179.2 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.456 ' HE3' ' HB2' ' A' ' 101' ' ' ALA . 11.9 mptt -90.06 115.63 27.47 Favored 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 120.602 -0.439 . . . . 0.0 110.245 179.264 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 54.1 mt -122.19 141.31 43.13 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 N-CA-C 105.803 -1.925 . . . . 0.0 105.803 174.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.409 ' HA3' HD22 ' A' ' 39' ' ' ASN . . . 57.32 21.9 42.19 Favored Glycine 0 CA--C 1.523 0.579 0 C-N-CA 121.79 -0.243 . . . . 0.0 113.411 -179.783 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 85.8 7.53 81.13 Favored Glycine 0 N--CA 1.437 -1.29 0 C-N-CA 121.149 -0.548 . . . . 0.0 113.59 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 18.6 ptp180 -132.01 139.25 48.54 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 117.726 0.763 . . . . 0.0 110.622 -179.145 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.456 ' HB2' ' HE3' ' A' ' 96' ' ' LYS . . . -81.25 119.83 24.13 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.756 -177.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 12.1 mt -66.47 146.73 54.21 Favored 'General case' 0 CA--C 1.501 -0.917 0 O-C-N 124.114 0.884 . . . . 0.0 112.737 178.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 28.6 tptp -120.44 118.82 31.29 Favored 'General case' 0 N--CA 1.421 -1.906 0 CA-C-N 115.222 -0.899 . . . . 0.0 108.922 174.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.447 HG22 HG22 ' A' ' 89' ' ' VAL . 3.2 mm -115.13 139.04 43.42 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.867 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 178.192 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -145.32 150.65 36.99 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 178.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 56.4 m-70 -83.64 130.71 34.98 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 176.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.469 HG21 ' HB2' ' A' ' 34' ' ' TYR . 5.4 t -148.79 163.55 37.05 Favored 'General case' 0 C--N 1.29 -1.98 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 -176.148 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -109.73 111.77 23.43 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 172.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 36.3 t80 -105.18 138.76 40.88 Favored 'General case' 0 C--N 1.286 -2.159 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.083 -173.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.448 ' HD3' ' N ' ' A' ' 110' ' ' ARG . 0.4 OUTLIER -113.24 113.36 48.89 Favored Pre-proline 0 C--N 1.309 -1.184 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 176.623 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.96 146.76 53.59 Favored 'Trans proline' 0 C--N 1.333 -0.26 0 C-N-CA 123.369 2.712 . . . . 0.0 114.136 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 25.8 tptp -110.53 120.87 43.83 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 174.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 36.8 mmt180 . . . . . 0 C--N 1.295 -1.762 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 -178.971 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 . . . . . 0 CA--C 1.488 -1.409 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 223' ' ' ARG . . . . . . . . . . . . . 10.6 ptm180 65.05 16.94 10.85 Favored 'General case' 0 N--CA 1.505 2.291 0 C-N-CA 126.731 2.012 . . . . 0.0 114.118 -179.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 224' ' ' PHE . . . . . 0.551 ' CD1' HD21 ' A' ' 87' ' ' LEU . 58.6 m-85 -96.35 164.68 12.54 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 175.133 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 225' ' ' ALA . . . . . . . . . . . . . . . -138.81 81.21 1.83 Allowed 'General case' 0 C--N 1.291 -1.964 0 CA-C-O 121.399 0.618 . . . . 0.0 109.365 179.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 226' ' ' ILE . . . . . 0.463 HG21 ' OG ' ' A' ' 84' ' ' SER . 3.7 mp -116.11 136.02 54.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 176.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 227' ' ' MET . . . . . . . . . . . . . 63.6 mtt -68.42 137.43 91.14 Favored Pre-proline 0 C--N 1.31 -1.12 0 O-C-N 124.016 0.822 . . . . 0.0 109.681 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 228' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -67.94 146.39 71.34 Favored 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 122.196 1.931 . . . . 0.0 111.206 178.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . -66.1 161.08 44.9 Favored Glycine 0 N--CA 1.44 -1.037 0 CA-C-N 116.084 -0.507 . . . . 0.0 112.363 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 23.2 m -74.6 -12.67 60.51 Favored 'General case' 0 C--N 1.298 -1.654 0 C-N-CA 123.037 0.535 . . . . 0.0 111.794 -177.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 231' ' ' ARG . . . . . 0.555 ' HB2' ' OG ' ' A' ' 52' ' ' SER . 4.0 mmp_? -79.0 -14.53 59.14 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.044 0.45 . . . . 0.0 109.992 178.491 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 232' ' ' TRP . . . . . 0.409 ' HB2' ' CB ' ' A' ' 52' ' ' SER . 28.9 t90 -72.12 122.88 21.73 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.984 -0.553 . . . . 0.0 112.052 -176.095 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 233' ' ' ASP . . . . . 0.715 ' O ' HG23 ' B' ' 235' ' ' VAL . 25.7 t70 -126.63 106.02 9.12 Favored 'General case' 0 C--O 1.207 -1.169 0 CA-C-O 118.665 -0.684 . . . . 0.0 110.057 177.661 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . 35.79 39.3 0.26 Allowed Glycine 0 N--CA 1.493 2.491 0 N-CA-C 115.9 1.12 . . . . 0.0 115.9 176.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 235' ' ' VAL . . . . . 0.715 HG23 ' O ' ' B' ' 233' ' ' ASP . 64.6 t -106.05 127.21 61.36 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 CA-C-N 117.22 0.51 . . . . 0.0 110.935 -175.326 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 236' ' ' HIS . . . . . . . . . . . . . 66.5 t-80 -112.99 115.04 27.77 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 107.597 -1.261 . . . . 0.0 107.597 172.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 237' ' ' ARG . . . . . 0.566 ' HG3' HG13 ' A' ' 50' ' ' VAL . 40.7 mmt180 -126.77 109.96 12.59 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-O 121.111 0.481 . . . . 0.0 110.557 178.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 238' ' ' SER . . . . . . . . . . . . . 69.3 m -145.13 115.79 7.7 Favored 'General case' 0 C--N 1.295 -1.789 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.361 177.183 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 239' ' ' ASN . . . . . . . . . . . . . 33.0 t30 -80.79 -35.49 33.02 Favored 'General case' 0 CA--C 1.502 -0.868 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 174.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 240' ' ' GLY . . . . . 0.408 ' O ' ' HG2' ' B' ' 244' ' ' LYS . . . -98.1 63.47 0.87 Allowed Glycine 0 N--CA 1.406 -3.339 0 N-CA-C 108.751 -1.74 . . . . 0.0 108.751 176.285 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 28.9 p90 -76.37 -35.53 58.61 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-O 120.84 0.352 . . . . 0.0 111.923 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 242' ' ' GLU . . . . . 0.47 ' HA ' ' CE3' ' B' ' 245' ' ' TRP . 44.2 tt0 -67.33 -42.07 84.2 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.576 -176.608 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -57.95 -34.02 69.46 Favored 'General case' 0 C--O 1.22 -0.47 0 C-N-CA 123.105 0.562 . . . . 0.0 111.541 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 244' ' ' LYS . . . . . 0.408 ' HG2' ' O ' ' B' ' 240' ' ' GLY . 71.7 mmtt -62.03 -45.96 91.25 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.394 -178.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 245' ' ' TRP . . . . . 0.47 ' CE3' ' HA ' ' B' ' 242' ' ' GLU . 11.2 m0 -69.6 -39.05 77.5 Favored 'General case' 0 CA--C 1.505 -0.756 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.425 178.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 246' ' ' PHE . . . . . 0.493 ' O ' ' HG2' ' B' ' 249' ' ' GLN . 6.1 t80 -62.12 -33.4 74.38 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.973 179.492 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -76.43 -30.85 57.57 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.632 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 248' ' ' LYS . . . . . 0.572 ' O ' ' HG2' ' B' ' 251' ' ' GLU . 0.0 OUTLIER -97.15 -12.61 22.89 Favored 'General case' 0 C--O 1.203 -1.378 0 O-C-N 121.895 -0.503 . . . . 0.0 112.11 -176.488 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 249' ' ' GLN . . . . . 0.493 ' HG2' ' O ' ' B' ' 246' ' ' PHE . 3.0 pt20 -70.17 2.51 3.61 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.137 0.575 . . . . 0.0 112.548 -176.327 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 250' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -63.64 -30.14 71.29 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.516 176.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . 0.572 ' HG2' ' O ' ' B' ' 248' ' ' LYS . 11.3 pt-20 -75.18 108.35 7.88 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-O 122.502 1.144 . . . . 0.0 111.067 -179.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 252' ' ' ILE . . . . . . . . . . . . . 30.4 pt -110.07 -34.28 2.48 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.334 0 CA-C-N 114.183 -1.372 . . . . 0.0 111.01 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -101.47 -26.01 13.72 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 178.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 254' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 -84.29 154.97 22.64 Favored 'General case' 0 N--CA 1.42 -1.945 0 CA-C-N 115.131 -0.94 . . . . 0.0 108.589 -176.28 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 255' ' ' LYS . . . . . . . . . . . . . 61.4 pttt -63.9 116.0 5.4 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-O 121.886 0.851 . . . . 0.0 113.268 -175.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 256' ' ' LYS . . . . . 0.41 ' HA ' ' OE2' ' B' ' 251' ' ' GLU . 39.6 ttmt . . . . . 0 N--CA 1.425 -1.684 0 CA-C-N 114.494 -1.23 . . . . 0.0 108.218 179.095 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 35.8 m-80 . . . . . 0 N--CA 1.48 1.032 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -75.35 -11.84 60.14 Favored 'General case' 0 CA--C 1.51 -0.586 0 CA-C-O 121.411 0.624 . . . . 0.0 111.13 -178.24 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 54.0 m-85 -90.79 8.43 34.76 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-O 121.851 0.834 . . . . 0.0 110.967 179.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -128.82 151.56 49.46 Favored 'General case' 0 N--CA 1.429 -1.516 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 174.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -123.22 20.02 9.81 Favored 'General case' 0 C--N 1.281 -2.384 0 CA-C-O 123.282 1.515 . . . . 0.0 107.192 174.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.401 ' HB2' ' HG2' ' A' ' 82' ' ' GLN . 1.5 m-20 -84.95 21.67 1.55 Allowed 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 112.964 -1.926 . . . . 0.0 109.343 -178.266 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.406 ' O ' ' HA ' ' A' ' 78' ' ' LYS . . . -91.07 3.5 54.6 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.772 -174.446 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -95.93 145.83 25.08 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.064 -175.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 21.2 pt -140.79 160.64 23.86 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 C-N-CA 122.709 0.404 . . . . 0.0 110.175 175.014 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.452 ' HB2' HG21 ' A' ' 107' ' ' THR . 61.6 t80 -110.81 125.9 54.07 Favored 'General case' 0 N--CA 1.409 -2.508 0 CA-C-N 115.272 -0.876 . . . . 0.0 108.757 178.372 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.428 HG23 ' CD1' ' A' ' 104' ' ' ILE . 8.0 mt -110.76 129.07 66.61 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.935 0 N-CA-C 107.297 -1.371 . . . . 0.0 107.297 176.454 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -129.65 166.16 21.94 Favored Glycine 0 C--N 1.283 -2.394 0 N-CA-C 110.318 -1.113 . . . . 0.0 110.318 179.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 70.02 38.35 1.56 Allowed 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 125.055 1.342 . . . . 0.0 111.389 -178.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -70.21 154.05 42.37 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.405 0.621 . . . . 0.0 111.687 177.296 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.471 ' HB3' ' HG ' ' A' ' 42' ' ' LEU . 45.2 t-20 -90.47 150.24 21.88 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 176.438 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.497 ' HD3' ' OE2' ' A' ' 70' ' ' GLU . 7.3 ppt_? -62.91 -21.62 66.16 Favored 'General case' 0 C--N 1.314 -0.937 0 C-N-CA 122.991 0.516 . . . . 0.0 111.29 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -94.89 -0.74 53.74 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 115.965 -0.562 . . . . 0.0 111.73 -178.097 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.471 ' HG ' ' HB3' ' A' ' 39' ' ' ASN . 68.9 mt -89.95 124.33 34.63 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-O 121.365 0.602 . . . . 0.0 110.762 -179.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 75.8 p -108.78 174.25 5.96 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.241 -179.172 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.426 ' HG2' ' HB2' ' A' ' 62' ' ' LEU . 40.4 mt-10 -54.79 -41.17 70.24 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 123.667 0.787 . . . . 0.0 110.131 177.533 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -64.19 -38.87 96.52 Favored Glycine 0 N--CA 1.444 -0.828 0 CA-C-N 115.492 -0.777 . . . . 0.0 113.027 -178.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -65.96 -47.06 75.86 Favored 'General case' 0 CA--C 1.496 -1.125 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 -179.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 44.6 mt -58.5 -45.14 90.22 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.632 179.066 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.434 ' HG ' HG11 ' A' ' 60' ' ' VAL . 45.1 mt -59.09 -45.83 89.85 Favored 'General case' 0 C--O 1.209 -1.031 0 CA-C-O 119.481 -0.295 . . . . 0.0 111.428 -179.41 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.486 HG23 ' H ' ' B' ' 233' ' ' ASP . 99.0 m -61.53 -45.54 93.74 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -179.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.611 HG13 ' HG3' ' B' ' 237' ' ' ARG . 64.3 t -65.52 -47.8 85.21 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 CA-C-O 121.349 0.595 . . . . 0.0 110.708 -179.262 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -67.1 -23.04 65.8 Favored 'General case' 0 N--CA 1.436 -1.169 0 C-N-CA 124.022 0.929 . . . . 0.0 111.88 -179.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.456 ' OG ' ' HB2' ' B' ' 231' ' ' ARG . 65.9 m -69.7 -19.85 63.56 Favored 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 176.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -75.9 -25.47 56.08 Favored 'General case' 0 C--O 1.247 0.947 0 C-N-CA 118.247 -1.381 . . . . 0.0 108.853 177.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -88.04 -22.68 24.07 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.603 -176.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 175.73 -156.67 22.26 Favored Glycine 0 N--CA 1.425 -2.07 0 C-N-CA 120.624 -0.798 . . . . 0.0 111.562 177.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.53 ' HB ' ' HG2' ' A' ' 80' ' ' GLU . 94.5 t -106.46 102.56 41.65 Favored Pre-proline 0 C--N 1.3 -1.559 0 CA-C-O 120.851 0.357 . . . . 0.0 110.341 -178.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.587 ' HB3' HD21 ' A' ' 77' ' ' LEU . 89.7 Cg_endo -77.81 136.86 15.46 Favored 'Trans proline' 0 C--O 1.252 1.206 0 C-N-CA 122.534 2.156 . . . . 0.0 110.167 177.281 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 34.0 m -113.9 -18.47 7.51 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 C-N-CA 120.221 -0.592 . . . . 0.0 112.274 -177.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.534 ' HB3' ' HG2' ' A' ' 78' ' ' LYS . 20.3 t70 -160.14 139.13 10.69 Favored 'General case' 0 C--O 1.242 0.7 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 -178.494 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.434 HG11 ' HG ' ' A' ' 48' ' ' LEU . 12.7 p -140.62 137.59 35.83 Favored 'Isoleucine or valine' 0 C--O 1.245 0.845 0 O-C-N 123.35 0.406 . . . . 0.0 110.056 179.441 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 90.4 mt -121.33 124.76 72.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 C-N-CA 123.391 0.676 . . . . 0.0 109.394 175.035 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.426 ' HB2' ' HG2' ' A' ' 44' ' ' GLU . 0.1 OUTLIER -100.12 121.06 40.83 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 106.056 -1.831 . . . . 0.0 106.056 175.501 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 20.4 m -79.91 117.37 20.71 Favored 'General case' 0 C--N 1.284 -2.249 0 N-CA-C 107.016 -1.476 . . . . 0.0 107.016 175.054 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.442 ' HA ' ' HA ' ' A' ' 71' ' ' SER . 57.8 mtp180 -118.02 133.15 56.18 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.573 -172.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -65.03 123.47 19.56 Favored 'General case' 0 CA--C 1.497 -1.08 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.843 177.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -61.62 -25.09 67.14 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 115.379 -0.828 . . . . 0.0 112.379 -178.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 34.5 m-80 -81.7 -50.57 9.14 Favored 'General case' 0 CA--C 1.504 -0.794 0 CA-C-O 121.061 0.458 . . . . 0.0 111.176 -175.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 62.9 p -86.32 -23.97 26.06 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.63 -176.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.76 -0.12 78.62 Favored Glycine 0 N--CA 1.445 -0.716 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.118 -179.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.497 ' OE2' ' HD3' ' A' ' 40' ' ' ARG . 37.6 mt-10 -91.33 -89.77 0.17 Allowed 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -173.401 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.442 ' HA ' ' HA ' ' A' ' 64' ' ' ARG . 50.8 m -148.28 160.72 42.68 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 -176.122 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 16.0 mm-40 -99.11 -3.07 35.43 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 122.955 0.502 . . . . 0.0 111.709 176.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 87.63 8.1 74.19 Favored Glycine 0 N--CA 1.431 -1.655 0 C-N-CA 120.186 -1.007 . . . . 0.0 112.48 -177.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 32.1 p90 -149.27 155.41 40.53 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 177.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -154.19 176.11 12.66 Favored 'General case' 0 C--N 1.316 -0.852 0 O-C-N 123.403 0.439 . . . . 0.0 111.0 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -132.82 144.02 49.94 Favored 'General case' 0 C--N 1.314 -0.971 0 C-N-CA 124.376 1.07 . . . . 0.0 109.975 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.587 HD21 ' HB3' ' A' ' 57' ' ' PRO . 9.9 tt -150.3 141.46 23.11 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 176.485 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.534 ' HG2' ' HB3' ' A' ' 59' ' ' ASP . 21.8 ptmt -123.3 143.8 49.84 Favored 'General case' 0 C--O 1.256 1.401 0 CA-C-O 121.215 0.531 . . . . 0.0 109.983 178.279 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 68.7 m-85 -106.67 165.41 11.32 Favored 'General case' 0 C--N 1.293 -1.88 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.822 179.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.53 ' HG2' ' HB ' ' A' ' 56' ' ' VAL . 6.9 pt-20 -76.49 -23.92 53.78 Favored 'General case' 0 C--N 1.315 -0.918 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.318 175.561 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -133.58 144.94 49.62 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 119.497 -0.881 . . . . 0.0 111.891 177.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.401 ' HG2' ' HB2' ' A' ' 30' ' ' ASN . 25.0 mp0 -69.41 -20.82 63.8 Favored 'General case' 0 C--N 1.309 -1.177 0 C-N-CA 124.32 1.048 . . . . 0.0 113.239 -177.648 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 76.2 mtm180 -62.74 -35.42 79.71 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 122.092 0.949 . . . . 0.0 109.976 176.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 49.5 m -69.11 -37.32 78.3 Favored 'General case' 0 C--N 1.286 -2.184 0 CA-C-N 114.905 -1.043 . . . . 0.0 112.951 178.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 72.1 p -62.66 -45.28 93.55 Favored 'General case' 0 C--N 1.344 0.336 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.456 -177.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.425 ' H ' HG12 ' A' ' 86' ' ' ILE . 3.3 pt -65.71 -39.9 86.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.197 178.23 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.483 HD21 ' CD1' ' B' ' 224' ' ' PHE . 49.0 mt -60.31 -43.6 96.2 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 120.852 0.358 . . . . 0.0 111.319 176.008 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.419 ' O ' ' HB2' ' A' ' 92' ' ' LEU . . . -71.29 -46.47 60.74 Favored 'General case' 0 N--CA 1.433 -1.3 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.339 -178.498 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.456 HG22 HG22 ' A' ' 104' ' ' ILE . 66.9 t -57.56 -49.29 80.96 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.906 0 CA-C-O 121.054 0.454 . . . . 0.0 111.083 179.519 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -64.88 -34.66 78.93 Favored 'General case' 0 C--N 1.295 -1.798 0 C-N-CA 124.029 0.932 . . . . 0.0 111.779 -174.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -93.42 -28.53 16.08 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 -176.235 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.481 ' HB2' HG13 ' A' ' 104' ' ' ILE . 13.9 mt -92.84 -30.46 15.44 Favored 'General case' 0 CA--C 1.488 -1.405 0 N-CA-C 111.797 0.295 . . . . 0.0 111.797 -175.046 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -66.41 124.76 23.63 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 177.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 85.95 -0.72 87.81 Favored Glycine 0 CA--C 1.535 1.328 0 C-N-CA 120.496 -0.859 . . . . 0.0 112.325 -177.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 21.7 t80 -89.23 133.5 34.41 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 -179.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -96.13 123.8 39.89 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-O 121.093 0.473 . . . . 0.0 111.647 -178.084 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 55.0 mt -127.74 141.32 46.73 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 N-CA-C 105.581 -2.007 . . . . 0.0 105.581 173.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 58.22 24.58 55.59 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 121.544 -0.36 . . . . 0.0 113.344 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 81.8 3.11 90.69 Favored Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 121.673 -0.299 . . . . 0.0 113.132 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.406 ' NH1' ' HA ' ' A' ' 39' ' ' ASN . 19.4 ptp180 -125.06 144.96 50.14 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 117.271 0.535 . . . . 0.0 110.978 -178.037 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -85.71 117.7 24.75 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.372 -177.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 11.9 mt -66.4 147.04 53.87 Favored 'General case' 0 C--O 1.25 1.118 0 CA-C-O 121.57 0.7 . . . . 0.0 112.566 178.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 60.1 tptt -119.19 117.97 30.08 Favored 'General case' 0 N--CA 1.416 -2.149 0 CA-C-N 114.777 -1.101 . . . . 0.0 108.046 176.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.481 HG13 ' HB2' ' A' ' 92' ' ' LEU . 4.9 mm -119.89 136.2 57.74 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.052 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 179.081 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -143.31 151.24 40.27 Favored 'General case' 0 C--N 1.283 -2.323 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 -179.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 79.9 m-70 -80.98 131.33 35.31 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 179.139 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.452 HG21 ' HB2' ' A' ' 34' ' ' TYR . 5.9 t -151.34 160.46 43.77 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 105.724 -1.954 . . . . 0.0 105.724 -178.698 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -110.64 110.01 20.53 Favored 'General case' 0 N--CA 1.422 -1.866 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 172.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 76.1 t80 -107.39 131.54 54.15 Favored 'General case' 0 C--N 1.291 -1.946 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.756 -178.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 5.3 mpt_? -115.08 114.48 43.52 Favored Pre-proline 0 C--N 1.29 -2.016 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 174.151 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -71.64 137.19 29.7 Favored 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 121.861 1.707 . . . . 0.0 110.926 179.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 26.6 tptp -82.91 114.66 21.35 Favored 'General case' 0 N--CA 1.418 -2.035 0 C-N-CA 119.41 -0.916 . . . . 0.0 109.855 -179.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 38.9 mmt180 . . . . . 0 C--N 1.282 -2.365 0 N-CA-C 105.949 -1.871 . . . . 0.0 105.949 178.039 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 40.3 t-20 . . . . . 0 C--O 1.197 -1.682 0 CA-C-O 120.553 0.216 . . . . 0.0 110.685 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 223' ' ' ARG . . . . . . . . . . . . . 3.7 mmp_? 75.13 7.19 4.18 Favored 'General case' 0 N--CA 1.513 2.722 0 C-N-CA 125.072 1.349 . . . . 0.0 113.721 173.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 224' ' ' PHE . . . . . 0.483 ' CD1' HD21 ' A' ' 87' ' ' LEU . 52.9 m-85 -99.52 165.29 11.71 Favored 'General case' 0 C--N 1.275 -2.652 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 225' ' ' ALA . . . . . . . . . . . . . . . -132.68 79.49 1.85 Allowed 'General case' 0 C--N 1.302 -1.483 0 CA-C-O 121.198 0.523 . . . . 0.0 110.396 178.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 3.9 mp -117.33 134.05 62.14 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.188 0 CA-C-N 115.298 -0.864 . . . . 0.0 108.882 176.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 227' ' ' MET . . . . . . . . . . . . . 18.9 ptp -66.93 154.1 92.98 Favored Pre-proline 0 C--N 1.318 -0.79 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.16 178.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 228' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -73.4 145.02 37.48 Favored 'Trans proline' 0 N--CA 1.44 -1.634 0 C-N-CA 122.17 1.913 . . . . 0.0 111.565 175.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . -67.92 166.58 43.55 Favored Glycine 0 N--CA 1.437 -1.274 0 CA-C-N 115.497 -0.774 . . . . 0.0 112.59 179.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 16.2 m -74.74 -14.51 60.73 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-O 121.022 0.439 . . . . 0.0 111.738 -175.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 231' ' ' ARG . . . . . 0.456 ' HB2' ' OG ' ' A' ' 52' ' ' SER . 39.7 mmt180 -84.83 -3.45 58.66 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.018 0.437 . . . . 0.0 110.409 -179.113 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 232' ' ' TRP . . . . . . . . . . . . . 22.1 t90 -76.29 128.62 35.26 Favored 'General case' 0 CA--C 1.5 -0.975 0 CA-C-O 122.31 1.053 . . . . 0.0 111.846 -179.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 233' ' ' ASP . . . . . 0.486 ' H ' HG23 ' A' ' 49' ' ' THR . 29.7 t70 -124.17 142.87 50.86 Favored 'General case' 0 C--N 1.269 -2.896 0 N-CA-C 101.978 -3.342 . . . . 0.0 101.978 172.17 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -37.38 66.1 0.0 OUTLIER Glycine 0 N--CA 1.49 2.251 0 C-N-CA 128.207 2.813 . . . . 0.0 116.249 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 235' ' ' VAL . . . . . 0.444 ' N ' ' O ' ' B' ' 233' ' ' ASP . 58.9 t -111.81 121.56 64.53 Favored 'Isoleucine or valine' 0 C--N 1.25 -3.753 0 C-N-CA 127.714 2.406 . . . . 0.0 106.366 174.12 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 236' ' ' HIS . . . . . . . . . . . . . 57.3 t-80 -95.85 116.07 28.36 Favored 'General case' 0 C--N 1.296 -1.755 0 O-C-N 123.37 0.418 . . . . 0.0 109.966 -175.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 237' ' ' ARG . . . . . 0.611 ' HG3' HG13 ' A' ' 50' ' ' VAL . 41.3 mmt180 -120.62 110.21 16.16 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 177.361 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 238' ' ' SER . . . . . . . . . . . . . 13.9 t -126.24 124.96 41.58 Favored 'General case' 0 C--N 1.289 -2.038 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 239' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -63.02 142.26 58.45 Favored 'General case' 0 C--O 1.25 1.108 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.615 -177.2 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 240' ' ' GLY . . . . . 0.595 ' O ' ' HG2' ' B' ' 244' ' ' LYS . . . 66.66 46.26 77.42 Favored Glycine 0 C--O 1.187 -2.832 0 CA-C-N 114.701 -1.136 . . . . 0.0 112.512 177.353 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 47.1 p90 -75.44 -33.82 60.92 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 117.667 0.734 . . . . 0.0 110.952 -179.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -63.45 -39.72 95.21 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.894 -175.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -67.29 -35.74 80.1 Favored 'General case' 0 C--O 1.21 -0.979 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.249 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 244' ' ' LYS . . . . . 0.595 ' HG2' ' O ' ' B' ' 240' ' ' GLY . 68.9 mmtt -67.05 -45.74 76.49 Favored 'General case' 0 CA--C 1.507 -0.675 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 -176.249 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 245' ' ' TRP . . . . . . . . . . . . . 46.7 m0 -64.44 -37.54 87.87 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.059 -179.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 246' ' ' PHE . . . . . 0.559 ' O ' ' HG2' ' B' ' 249' ' ' GLN . 2.9 t80 -70.65 -30.44 67.07 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.086 176.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -78.59 -40.66 34.01 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 178.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.65 -15.96 52.91 Favored 'General case' 0 CA--C 1.501 -0.917 0 CA-C-O 121.158 0.504 . . . . 0.0 111.497 -175.351 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 249' ' ' GLN . . . . . 0.559 ' HG2' ' O ' ' B' ' 246' ' ' PHE . 3.1 pt20 -70.3 -0.31 7.85 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.703 -178.352 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 250' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -64.04 -30.13 71.22 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 175.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -85.59 111.62 20.22 Favored 'General case' 0 N--CA 1.429 -1.521 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 176.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 252' ' ' ILE . . . . . . . . . . . . . 34.6 pt -109.77 -24.15 4.15 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 CA-C-N 114.985 -1.007 . . . . 0.0 113.639 -170.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -116.83 -19.89 9.69 Favored 'General case' 0 C--N 1.31 -1.114 0 C-N-CA 120.01 -0.676 . . . . 0.0 112.362 -176.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 254' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.09 163.16 6.34 Favored 'General case' 0 CA--C 1.565 1.55 0 C-N-CA 123.766 0.826 . . . . 0.0 111.966 -173.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 255' ' ' LYS . . . . . 0.421 ' O ' ' HG3' ' B' ' 256' ' ' LYS . 31.4 mtmm -70.94 95.57 1.19 Allowed 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 124.458 1.103 . . . . 0.0 111.019 -174.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 256' ' ' LYS . . . . . 0.421 ' HG3' ' O ' ' B' ' 255' ' ' LYS . 7.4 mtmm . . . . . 0 C--N 1.316 -0.856 0 C-N-CA 124.835 1.254 . . . . 0.0 109.152 179.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 17.2 m120 . . . . . 0 CA--C 1.491 -1.298 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -95.92 -10.55 28.46 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-O 121.225 0.536 . . . . 0.0 111.403 -177.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 20.6 m-85 -88.57 -4.36 58.6 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-O 122.024 0.916 . . . . 0.0 110.816 -179.067 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 61.0 mttp -120.03 152.34 37.66 Favored 'General case' 0 C--N 1.29 -2.0 0 CA-C-N 114.711 -1.131 . . . . 0.0 108.919 178.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -115.6 22.72 12.92 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-O 123.332 1.539 . . . . 0.0 107.054 179.118 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -77.9 24.79 0.22 Allowed 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 113.279 -1.782 . . . . 0.0 111.85 -175.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -88.35 -7.45 56.66 Favored 'General case' 0 CA--C 1.506 -0.747 0 CA-C-O 120.725 0.298 . . . . 0.0 110.263 -178.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -109.93 145.65 36.53 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.127 -175.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 27.5 pt -138.21 156.68 30.84 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.453 176.109 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 34.3 t80 -106.67 123.02 47.5 Favored 'General case' 0 N--CA 1.414 -2.228 0 CA-C-N 114.91 -1.041 . . . . 0.0 108.264 177.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.468 HG23 ' CD1' ' A' ' 104' ' ' ILE . 8.7 mt -108.43 127.69 64.6 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.07 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 175.256 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -123.29 160.45 17.81 Favored Glycine 0 C--N 1.283 -2.366 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 -179.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 68.52 48.35 0.84 Allowed 'General case' 0 CA--C 1.491 -1.325 0 C-N-CA 125.112 1.365 . . . . 0.0 111.807 -174.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.534 HD11 HD11 ' A' ' 47' ' ' ILE . 4.0 mm? -72.65 145.46 47.25 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 115.078 -0.965 . . . . 0.0 110.78 175.387 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -96.89 144.86 26.43 Favored 'General case' 0 C--N 1.286 -2.18 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 179.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.5 ' HD2' ' N ' ' A' ' 41' ' ' GLU . 7.0 ppt_? -58.36 -21.3 49.44 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -176.594 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.5 ' N ' ' HD2' ' A' ' 40' ' ' ARG . 12.2 pt-20 -98.18 5.77 48.16 Favored 'General case' 0 C--N 1.318 -0.773 0 C-N-CA 120.464 -0.495 . . . . 0.0 111.518 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 75.6 mt -95.16 113.62 25.33 Favored 'General case' 0 N--CA 1.435 -1.206 0 CA-C-O 121.579 0.704 . . . . 0.0 109.955 175.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 58.8 p -102.98 174.86 5.68 Favored 'General case' 0 C--N 1.286 -2.159 0 CA-C-N 114.507 -1.224 . . . . 0.0 109.785 -179.105 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -54.65 -43.33 72.27 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 177.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -59.6 -41.97 97.56 Favored Glycine 0 CA--C 1.529 0.924 0 CA-C-N 115.603 -0.726 . . . . 0.0 113.51 178.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -63.94 -49.05 74.12 Favored 'General case' 0 CA--C 1.506 -0.743 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.534 HD11 HD11 ' A' ' 38' ' ' LEU . 46.8 mt -58.86 -44.31 90.31 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.892 -179.566 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.411 ' HG ' HG11 ' A' ' 60' ' ' VAL . 41.8 mt -59.27 -45.79 90.26 Favored 'General case' 0 CA--C 1.497 -1.093 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.66 -177.005 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.435 HG23 ' H ' ' B' ' 233' ' ' ASP . 92.0 m -61.05 -45.96 92.64 Favored 'General case' 0 C--N 1.307 -1.278 0 O-C-N 123.379 0.425 . . . . 0.0 112.116 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.636 HG13 ' HG3' ' B' ' 237' ' ' ARG . 99.3 t -66.07 -46.59 87.54 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-O 121.219 0.533 . . . . 0.0 110.8 -179.531 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -68.74 -20.87 64.4 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 115.57 -0.741 . . . . 0.0 112.185 -178.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.463 ' OG ' ' HB2' ' B' ' 231' ' ' ARG . 73.7 m -71.61 -19.38 62.13 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.771 176.265 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -69.58 -28.97 66.42 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 175.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 54.5 m-85 -95.21 -3.83 46.99 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.698 -174.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 156.49 -155.48 26.37 Favored Glycine 0 N--CA 1.423 -2.174 0 C-N-CA 119.67 -1.252 . . . . 0.0 112.749 177.095 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 60.8 t -108.07 103.99 52.0 Favored Pre-proline 0 C--N 1.305 -1.334 0 N-CA-C 110.475 -0.194 . . . . 0.0 110.475 -178.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.525 ' HB3' HD21 ' A' ' 77' ' ' LEU . 88.0 Cg_endo -79.43 138.93 14.2 Favored 'Trans proline' 0 N--CA 1.451 -0.979 0 C-N-CA 122.799 2.333 . . . . 0.0 110.775 177.602 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 33.1 m -114.71 -22.84 4.51 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 C-N-CA 119.605 -0.838 . . . . 0.0 112.548 -179.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.532 ' HB3' ' HG2' ' A' ' 78' ' ' LYS . 31.4 t70 -155.75 143.39 19.58 Favored 'General case' 0 CA--C 1.504 -0.8 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 -178.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.411 HG11 ' HG ' ' A' ' 48' ' ' LEU . 14.6 p -146.1 132.48 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.116 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 -179.402 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 90.3 mt -120.9 128.15 76.03 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 177.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -103.09 127.29 50.41 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 177.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.563 ' OG ' ' HB2' ' A' ' 72' ' ' GLN . 97.6 p -89.27 117.74 28.45 Favored 'General case' 0 N--CA 1.422 -1.867 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 178.549 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.423 ' HA ' ' HA ' ' A' ' 71' ' ' SER . 19.4 mtp180 -119.77 123.02 42.7 Favored 'General case' 0 N--CA 1.423 -1.788 0 C-N-CA 119.41 -0.916 . . . . 0.0 109.856 179.46 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -66.33 119.84 12.27 Favored 'General case' 0 C--N 1.296 -1.76 0 CA-C-N 114.505 -1.225 . . . . 0.0 111.427 -178.029 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -61.93 -23.65 66.48 Favored 'General case' 0 C--N 1.326 -0.43 0 O-C-N 123.682 0.614 . . . . 0.0 112.519 -178.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 28.8 m-80 -76.13 -50.59 14.22 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.328 -176.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 61.5 p -87.91 -24.1 23.73 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-N 116.295 -0.411 . . . . 0.0 112.042 -176.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 68.56 16.35 69.58 Favored Glycine 0 CA--C 1.522 0.496 0 N-CA-C 111.316 -0.714 . . . . 0.0 111.316 -177.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 44.8 mm-40 -106.95 -76.7 0.61 Allowed 'General case' 0 N--CA 1.437 -1.092 0 CA-C-O 120.829 0.347 . . . . 0.0 111.178 -176.195 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.423 ' HA ' ' HA ' ' A' ' 64' ' ' ARG . 23.0 t -168.27 158.92 10.33 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 -176.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.563 ' HB2' ' OG ' ' A' ' 63' ' ' SER . 18.8 mm-40 -90.83 -12.64 35.73 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 171.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 86.44 16.73 61.71 Favored Glycine 0 N--CA 1.423 -2.208 0 CA-C-N 115.09 -0.959 . . . . 0.0 112.946 178.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -145.15 157.7 44.02 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 176.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -151.15 168.79 23.6 Favored 'General case' 0 C--N 1.292 -1.924 0 CA-C-O 120.999 0.428 . . . . 0.0 110.258 177.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -126.06 137.59 53.64 Favored 'General case' 0 C--N 1.292 -1.902 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.834 -177.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.525 HD21 ' HB3' ' A' ' 57' ' ' PRO . 9.9 tt -144.73 140.59 28.65 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 174.432 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.532 ' HG2' ' HB3' ' A' ' 59' ' ' ASP . 20.5 ptmt -124.7 144.8 50.02 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.107 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 -105.43 164.43 11.87 Favored 'General case' 0 C--N 1.284 -2.266 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.226 -178.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -71.86 -27.17 62.7 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-N 114.794 -1.094 . . . . 0.0 108.654 175.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.626 ' OD1' ' HG2' ' A' ' 83' ' ' ARG . 8.4 t70 -132.45 139.63 48.09 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.49 -179.304 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -69.88 -20.65 63.38 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 -179.087 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.626 ' HG2' ' OD1' ' A' ' 81' ' ' ASP . 22.8 mmm180 -62.62 -34.45 77.05 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 122.2 1.0 . . . . 0.0 109.712 174.486 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.455 ' HA ' HD12 ' A' ' 87' ' ' LEU . 52.7 m -68.96 -37.02 78.58 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 114.865 -1.061 . . . . 0.0 113.559 179.303 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.509 ' O ' HG23 ' A' ' 89' ' ' VAL . 76.2 p -61.2 -45.0 96.37 Favored 'General case' 0 C--N 1.342 0.276 0 C-N-CA 120.473 -0.491 . . . . 0.0 110.418 -177.125 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.43 ' H ' HG12 ' A' ' 86' ' ' ILE . 3.1 pt -64.46 -39.06 84.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.562 177.28 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.698 HD11 ' HB2' ' B' ' 224' ' ' PHE . 40.8 mt -58.8 -44.03 90.69 Favored 'General case' 0 N--CA 1.478 0.925 0 O-C-N 123.763 0.664 . . . . 0.0 111.254 178.083 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.446 ' HB1' HD12 ' A' ' 92' ' ' LEU . . . -71.16 -41.12 70.82 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.393 -178.548 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.509 HG23 ' O ' ' A' ' 85' ' ' THR . 68.9 t -57.86 -45.73 87.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -58.5 -44.61 89.48 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 121.814 0.816 . . . . 0.0 111.347 -175.269 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -97.46 -20.31 17.85 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-N 114.744 -1.116 . . . . 0.0 113.296 -168.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.47 ' HB2' HG13 ' A' ' 104' ' ' ILE . 20.8 mt -95.15 -30.96 13.76 Favored 'General case' 0 C--N 1.285 -2.221 0 C-N-CA 119.615 -0.834 . . . . 0.0 110.705 -178.01 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 60.4 t30 -66.44 124.24 22.23 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 87.51 -1.22 85.71 Favored Glycine 0 C--N 1.304 -1.197 0 C-N-CA 121.107 -0.568 . . . . 0.0 113.021 -178.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -90.32 135.83 33.43 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.436 ' HA ' ' HA ' ' A' ' 101' ' ' ALA . 10.9 mptt -95.6 123.17 39.02 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-O 121.242 0.544 . . . . 0.0 111.397 -176.228 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 52.0 mt -126.36 141.37 46.08 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 N-CA-C 106.237 -1.764 . . . . 0.0 106.237 174.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 56.8 22.32 40.26 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 114.102 0.401 . . . . 0.0 114.102 178.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 85.52 14.07 69.04 Favored Glycine 0 N--CA 1.439 -1.116 0 C-N-CA 120.784 -0.722 . . . . 0.0 113.579 179.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 12.1 ptp180 -140.25 146.46 38.65 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 117.456 0.628 . . . . 0.0 110.838 177.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.436 ' HA ' ' HA ' ' A' ' 96' ' ' LYS . . . -88.58 119.76 29.34 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.731 -175.394 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.416 ' HA ' HD23 ' A' ' 102' ' ' LEU . 13.2 mt -65.53 138.56 58.14 Favored 'General case' 0 CA--C 1.488 -1.415 0 CA-C-O 121.646 0.736 . . . . 0.0 112.35 179.407 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 58.0 tptt -114.65 115.85 27.77 Favored 'General case' 0 C--N 1.279 -2.491 0 CA-C-N 114.822 -1.081 . . . . 0.0 108.392 177.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.47 HG13 ' HB2' ' A' ' 92' ' ' LEU . 4.1 mm -118.44 129.9 74.07 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -143.96 151.65 40.03 Favored 'General case' 0 C--N 1.289 -2.063 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 84.1 m-70 -79.67 140.16 37.14 Favored 'General case' 0 C--N 1.298 -1.663 0 C-N-CA 120.124 -0.63 . . . . 0.0 109.779 179.021 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 13.5 t -149.34 162.98 39.0 Favored 'General case' 0 C--N 1.279 -2.469 0 N-CA-C 106.094 -1.817 . . . . 0.0 106.094 -178.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -109.69 109.42 20.14 Favored 'General case' 0 N--CA 1.424 -1.767 0 N-CA-C 106.065 -1.828 . . . . 0.0 106.065 173.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 58.0 t80 -107.96 144.67 34.91 Favored 'General case' 0 C--N 1.289 -2.062 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.843 -177.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.415 ' HA ' ' HD2' ' A' ' 111' ' ' PRO . 7.9 tpp180 -120.45 113.66 33.51 Favored Pre-proline 0 C--N 1.292 -1.891 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 174.144 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.415 ' HD2' ' HA ' ' A' ' 110' ' ' ARG . 29.0 Cg_endo -62.83 137.06 60.89 Favored 'Trans proline' 0 C--O 1.249 1.026 0 C-N-CA 123.326 2.684 . . . . 0.0 113.768 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 16.5 tppt? -117.63 128.24 54.74 Favored 'General case' 0 N--CA 1.418 -2.034 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 176.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 34.8 mmt180 . . . . . 0 C--N 1.292 -1.926 0 CA-C-O 118.97 -0.538 . . . . 0.0 109.976 -176.719 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 . . . . . 0 N--CA 1.467 0.407 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 223' ' ' ARG . . . . . . . . . . . . . 7.0 ttm180 63.34 52.84 2.3 Favored 'General case' 0 C--N 1.352 0.676 0 CA-C-O 122.482 1.134 . . . . 0.0 113.422 173.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 224' ' ' PHE . . . . . 0.698 ' HB2' HD11 ' A' ' 87' ' ' LEU . 4.3 m-30 -96.43 169.45 9.91 Favored 'General case' 0 C--N 1.298 -1.635 0 CA-C-N 113.779 -1.555 . . . . 0.0 109.978 -177.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 225' ' ' ALA . . . . . . . . . . . . . . . -87.77 28.26 1.04 Allowed 'General case' 0 C--N 1.309 -1.154 0 C-N-CA 123.045 0.538 . . . . 0.0 111.861 -170.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 4.6 mp -92.25 131.76 38.45 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 -179.285 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 227' ' ' MET . . . . . . . . . . . . . 73.0 mtm -77.24 140.13 65.23 Favored Pre-proline 0 C--N 1.318 -0.783 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.983 -178.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 228' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -61.7 144.32 97.16 Favored 'Trans proline' 0 C--O 1.243 0.733 0 C-N-CA 123.31 2.674 . . . . 0.0 113.412 -178.355 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . -68.69 172.11 36.54 Favored Glycine 0 C--O 1.242 0.625 0 CA-C-N 115.082 -0.963 . . . . 0.0 113.854 -178.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 23.0 t -77.02 -13.98 59.89 Favored 'General case' 0 C--N 1.314 -0.978 0 C-N-CA 123.011 0.524 . . . . 0.0 111.46 -176.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 231' ' ' ARG . . . . . 0.463 ' HB2' ' OG ' ' A' ' 52' ' ' SER . 31.7 mmt180 -84.94 -3.85 58.9 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.922 -0.311 . . . . 0.0 110.449 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 232' ' ' TRP . . . . . . . . . . . . . 21.5 t90 -78.96 131.94 36.51 Favored 'General case' 0 N--CA 1.433 -1.314 0 CA-C-O 122.333 1.063 . . . . 0.0 111.966 -178.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 233' ' ' ASP . . . . . 0.458 ' O ' ' N ' ' B' ' 235' ' ' VAL . 25.0 t70 -122.08 137.94 54.63 Favored 'General case' 0 C--N 1.267 -2.982 0 N-CA-C 101.388 -3.56 . . . . 0.0 101.388 168.193 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -37.87 63.8 0.0 OUTLIER Glycine 0 N--CA 1.492 2.413 0 C-N-CA 128.193 2.806 . . . . 0.0 116.093 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 235' ' ' VAL . . . . . 0.5 HG12 ' HG2' ' B' ' 237' ' ' ARG . 39.5 t -102.9 124.04 56.69 Favored 'Isoleucine or valine' 0 C--N 1.25 -3.745 0 C-N-CA 127.594 2.358 . . . . 0.0 106.875 176.04 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 236' ' ' HIS . . . . . . . . . . . . . 59.3 t-80 -99.11 109.85 22.51 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 -177.444 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 237' ' ' ARG . . . . . 0.636 ' HG3' HG13 ' A' ' 50' ' ' VAL . 34.4 mmt180 -121.58 109.16 14.45 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-O 121.742 0.782 . . . . 0.0 110.925 177.623 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 238' ' ' SER . . . . . . . . . . . . . 40.5 m -129.08 135.33 48.76 Favored 'General case' 0 C--N 1.294 -1.824 0 CA-C-N 115.363 -0.835 . . . . 0.0 108.78 177.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 239' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 -64.13 -49.16 73.27 Favored 'General case' 0 C--N 1.31 -1.122 0 O-C-N 124.046 0.841 . . . . 0.0 110.683 -174.308 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 240' ' ' GLY . . . . . 0.472 ' O ' ' HG2' ' B' ' 244' ' ' LYS . . . 157.06 -35.02 0.56 Allowed Glycine 0 C--O 1.202 -1.869 0 C-N-CA 120.174 -1.012 . . . . 0.0 112.113 177.602 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 29.7 p90 -76.79 -34.48 57.97 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 112.705 0.632 . . . . 0.0 112.705 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -64.73 -39.16 93.17 Favored 'General case' 0 CA--C 1.504 -0.789 0 C-N-CA 122.899 0.479 . . . . 0.0 110.731 -175.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -63.47 -35.01 79.02 Favored 'General case' 0 C--O 1.197 -1.685 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.372 -179.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 244' ' ' LYS . . . . . 0.472 ' HG2' ' O ' ' B' ' 240' ' ' GLY . 70.1 mmtt -65.8 -41.95 91.31 Favored 'General case' 0 N--CA 1.439 -0.986 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 -178.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 245' ' ' TRP . . . . . . . . . . . . . 44.5 m0 -64.72 -40.81 95.98 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.265 -0.88 . . . . 0.0 109.635 179.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 246' ' ' PHE . . . . . 0.67 ' O ' ' HG2' ' B' ' 249' ' ' GLN . 3.0 t80 -72.01 -31.57 66.33 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.577 177.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -74.4 -38.48 63.09 Favored 'General case' 0 C--N 1.294 -1.819 0 O-C-N 121.671 -0.643 . . . . 0.0 111.246 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.47 -14.01 55.77 Favored 'General case' 0 CA--C 1.508 -0.64 0 CA-C-O 121.118 0.485 . . . . 0.0 111.635 -176.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 249' ' ' GLN . . . . . 0.67 ' HG2' ' O ' ' B' ' 246' ' ' PHE . 3.3 pt20 -77.89 -1.16 30.43 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.578 -178.703 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 250' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -53.15 -39.16 63.34 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.078 -179.456 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -131.39 108.24 9.48 Favored 'General case' 0 N--CA 1.432 -1.326 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 174.032 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 252' ' ' ILE . . . . . . . . . . . . . 28.3 pt -86.83 -31.57 6.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 CA-C-N 114.973 -1.012 . . . . 0.0 112.71 -173.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -92.25 -20.25 21.34 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-O 121.416 0.627 . . . . 0.0 111.075 -175.074 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 254' ' ' GLU . . . . . 0.423 ' CD ' ' H ' ' B' ' 255' ' ' LYS . 0.5 OUTLIER -85.5 161.01 19.55 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.198 -175.293 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 255' ' ' LYS . . . . . 0.423 ' H ' ' CD ' ' B' ' 254' ' ' GLU . 28.8 mtmm -88.39 -9.67 51.89 Favored 'General case' 0 C--N 1.31 -1.149 0 C-N-CA 124.775 1.23 . . . . 0.0 112.042 -172.282 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 256' ' ' LYS . . . . . . . . . . . . . 7.7 ptpp? . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.672 -0.68 . . . . 0.0 111.367 179.2 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 20.2 m120 . . . . . 0 CA--C 1.505 -0.783 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.439 ' CD ' ' H ' ' A' ' 26' ' ' GLU . 1.6 mp0 -65.64 -32.83 74.61 Favored 'General case' 0 C--N 1.316 -0.874 0 C-N-CA 124.777 1.231 . . . . 0.0 110.616 -178.11 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -88.74 17.28 5.69 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-N 113.913 -1.494 . . . . 0.0 112.37 -172.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -134.51 150.08 50.75 Favored 'General case' 0 CA--C 1.485 -1.54 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 177.185 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 39.6 m-20 -112.51 8.82 19.45 Favored 'General case' 0 C--N 1.291 -1.945 0 CA-C-O 122.3 1.048 . . . . 0.0 108.427 177.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.502 ' HA ' ' CE2' ' A' ' 108' ' ' PHE . 1.9 m-20 -75.5 30.37 0.1 Allowed 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 125.746 1.618 . . . . 0.0 111.396 -176.125 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -104.58 12.86 32.58 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.978 -172.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -95.01 145.21 25.1 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 -175.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 26.1 pt -141.01 162.17 22.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-O 121.029 0.442 . . . . 0.0 111.033 175.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 66.5 t80 -109.84 121.78 46.02 Favored 'General case' 0 N--CA 1.415 -2.21 0 CA-C-N 114.702 -1.136 . . . . 0.0 108.436 178.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 9.4 mt -109.15 127.94 65.45 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.963 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 174.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -130.52 168.12 21.79 Favored Glycine 0 C--N 1.29 -2.008 0 N-CA-C 111.305 -0.718 . . . . 0.0 111.305 -178.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 68.25 33.73 4.18 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.663 1.185 . . . . 0.0 110.503 -176.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.525 HD11 HD11 ' A' ' 47' ' ' ILE . 4.0 mm? -65.8 151.67 46.1 Favored 'General case' 0 CA--C 1.5 -0.969 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.606 178.083 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.489 HD22 ' HA3' ' A' ' 98' ' ' GLY . 39.2 t-20 -90.85 148.81 22.25 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 176.234 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.404 HH11 ' HB3' ' A' ' 41' ' ' GLU . 0.6 OUTLIER -64.76 -17.12 63.88 Favored 'General case' 0 C--N 1.297 -1.7 0 C-N-CA 123.765 0.826 . . . . 0.0 113.149 -179.001 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.404 ' HB3' HH11 ' A' ' 40' ' ' ARG . 10.2 pt-20 -92.91 -13.64 28.64 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.555 179.162 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.401 HD12 ' H ' ' A' ' 39' ' ' ASN . 74.8 mt -78.83 123.25 27.03 Favored 'General case' 0 CA--C 1.504 -0.82 0 CA-C-O 121.564 0.697 . . . . 0.0 111.809 -176.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 10.7 t -114.22 174.15 6.09 Favored 'General case' 0 C--N 1.293 -1.876 0 CA-C-N 114.737 -1.12 . . . . 0.0 108.965 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.418 ' CG ' ' HB2' ' A' ' 62' ' ' LEU . 52.3 mt-10 -55.42 -45.1 76.76 Favored 'General case' 0 C--O 1.214 -0.782 0 C-N-CA 124.016 0.927 . . . . 0.0 110.62 -176.47 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -59.35 -39.0 94.18 Favored Glycine 0 C--O 1.244 0.731 0 CA-C-N 116.117 -0.492 . . . . 0.0 113.466 -178.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -67.64 -48.44 66.71 Favored 'General case' 0 C--O 1.243 0.745 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 -179.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.525 HD11 HD11 ' A' ' 38' ' ' LEU . 36.2 mt -58.22 -46.21 88.76 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.318 0 CA-C-N 114.924 -1.035 . . . . 0.0 110.291 178.471 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 44.6 mt -59.21 -40.26 85.25 Favored 'General case' 0 CA--C 1.492 -1.259 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.397 -178.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.408 HG23 ' H ' ' B' ' 233' ' ' ASP . 84.3 m -65.16 -46.22 81.72 Favored 'General case' 0 N--CA 1.431 -1.381 0 O-C-N 123.502 0.501 . . . . 0.0 110.977 -178.511 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 57.6 t -67.53 -48.01 78.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.42 -178.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.42 ' HD2' ' HH ' ' A' ' 79' ' ' TYR . 6.1 m-85 -64.84 -21.27 66.76 Favored 'General case' 0 N--CA 1.436 -1.17 0 C-N-CA 124.408 1.083 . . . . 0.0 112.545 -179.442 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.463 ' CB ' ' HB2' ' B' ' 232' ' ' TRP . 51.2 m -71.65 -20.75 61.91 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 176.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -74.26 -24.55 59.3 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 118.022 -1.471 . . . . 0.0 109.523 174.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 -89.85 -8.81 51.13 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.221 0.534 . . . . 0.0 111.434 -175.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 158.99 -163.21 33.13 Favored Glycine 0 N--CA 1.425 -2.075 0 N-CA-C 110.981 -0.848 . . . . 0.0 110.981 177.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 60.1 t -101.33 109.37 58.62 Favored Pre-proline 0 C--N 1.297 -1.713 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 -179.097 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.511 ' HB3' HD21 ' A' ' 77' ' ' LEU . 79.0 Cg_endo -77.53 137.08 16.14 Favored 'Trans proline' 0 N--CA 1.445 -1.375 0 C-N-CA 122.17 1.914 . . . . 0.0 109.701 176.73 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 35.0 m -111.48 -26.54 3.09 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 C-N-CA 119.46 -0.896 . . . . 0.0 111.992 -178.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.477 ' HB3' ' HG2' ' A' ' 78' ' ' LYS . 10.5 t70 -155.06 144.43 21.18 Favored 'General case' 0 C--O 1.247 0.946 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 -179.062 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 14.6 p -146.34 138.17 19.34 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 O-C-N 123.415 0.447 . . . . 0.0 110.103 -178.486 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.46 HD11 ' HB3' ' A' ' 111' ' ' PRO . 98.4 mt -121.31 126.21 74.69 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 174.347 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.418 ' HB2' ' CG ' ' A' ' 44' ' ' GLU . 0.1 OUTLIER -98.58 115.77 29.36 Favored 'General case' 0 N--CA 1.425 -1.677 0 N-CA-C 106.222 -1.77 . . . . 0.0 106.222 171.396 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 6.8 m -74.96 117.24 16.59 Favored 'General case' 0 N--CA 1.412 -2.344 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 178.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 66.9 mtm180 -131.74 142.69 49.85 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-O 121.269 0.557 . . . . 0.0 111.189 -176.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -77.99 131.51 37.42 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 114.607 -1.178 . . . . 0.0 110.356 -179.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -61.68 -29.26 69.97 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 115.349 -0.841 . . . . 0.0 112.545 179.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 29.9 m-80 -81.84 -50.67 8.94 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 121.371 0.605 . . . . 0.0 111.314 -172.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 58.2 p -86.46 -24.65 25.55 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-O 121.401 0.62 . . . . 0.0 111.131 -176.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.48 6.03 83.47 Favored Glycine 0 N--CA 1.44 -1.091 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 -175.337 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -104.32 166.6 10.3 Favored 'General case' 0 N--CA 1.436 -1.13 0 CA-C-O 121.042 0.448 . . . . 0.0 110.875 -175.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 8.2 m -62.47 141.32 58.45 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 114.969 -1.014 . . . . 0.0 110.461 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 -84.98 12.89 6.71 Favored 'General case' 0 C--N 1.315 -0.899 0 C-N-CA 123.168 0.587 . . . . 0.0 111.668 -178.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 83.44 11.14 80.81 Favored Glycine 0 N--CA 1.435 -1.405 0 C-N-CA 121.126 -0.559 . . . . 0.0 113.336 178.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 38.3 p90 -154.06 159.49 41.57 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 177.13 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -154.12 171.94 18.33 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 123.917 0.761 . . . . 0.0 109.77 178.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -131.12 141.45 50.13 Favored 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 123.61 0.764 . . . . 0.0 109.903 -178.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.511 HD21 ' HB3' ' A' ' 57' ' ' PRO . 10.0 tt -148.86 141.48 24.43 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 176.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.477 ' HG2' ' HB3' ' A' ' 59' ' ' ASP . 21.5 ptmt -124.11 143.98 50.15 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 178.465 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.42 ' HH ' ' HD2' ' A' ' 51' ' ' PHE . 74.5 m-85 -103.84 165.66 10.9 Favored 'General case' 0 C--N 1.288 -2.071 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.724 -178.289 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -75.13 -39.43 60.5 Favored 'General case' 0 N--CA 1.425 -1.715 0 CA-C-N 114.956 -1.02 . . . . 0.0 108.381 174.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -116.84 144.14 44.85 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 121.378 0.609 . . . . 0.0 111.364 179.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 21.4 mp0 -69.83 -28.78 65.98 Favored 'General case' 0 C--N 1.311 -1.086 0 C-N-CA 124.063 0.945 . . . . 0.0 113.15 -177.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.1 -33.88 76.77 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 122.142 0.972 . . . . 0.0 110.343 177.092 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 50.5 m -60.88 -37.34 81.84 Favored 'General case' 0 C--N 1.284 -2.258 0 CA-C-N 115.106 -0.952 . . . . 0.0 112.029 176.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.436 ' O ' HG23 ' A' ' 89' ' ' VAL . 59.5 p -63.7 -45.3 90.64 Favored 'General case' 0 C--N 1.347 0.488 0 C-N-CA 120.507 -0.477 . . . . 0.0 110.836 -177.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 4.0 pt -66.13 -38.24 81.54 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.687 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.408 179.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.464 HD11 ' HB2' ' B' ' 224' ' ' PHE . 13.5 mt -59.66 -44.4 93.58 Favored 'General case' 0 CA--C 1.511 -0.547 0 O-C-N 123.284 0.365 . . . . 0.0 111.751 175.558 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.424 ' O ' ' HB2' ' A' ' 92' ' ' LEU . . . -69.72 -43.98 71.24 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.106 -179.533 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.475 HG22 HG22 ' A' ' 104' ' ' ILE . 85.3 t -60.99 -45.44 98.52 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-O 121.488 0.661 . . . . 0.0 110.98 178.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.404 ' OD2' ' HB2' ' B' ' 222' ' ' ASN . 33.4 t70 -65.76 -37.3 85.96 Favored 'General case' 0 C--N 1.284 -2.262 0 C-N-CA 124.196 0.998 . . . . 0.0 111.828 -176.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.439 ' O ' ' HB3' ' B' ' 239' ' ' ASN . 4.3 m-20 -91.62 -28.09 17.72 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 112.94 0.719 . . . . 0.0 112.94 -176.188 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.439 ' HB2' HG13 ' A' ' 104' ' ' ILE . 14.8 mt -97.06 -28.91 13.93 Favored 'General case' 0 CA--C 1.491 -1.305 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -173.117 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -65.56 125.26 24.65 Favored 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 120.03 -0.668 . . . . 0.0 109.465 -178.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 88.53 -8.36 79.26 Favored Glycine 0 C--N 1.31 -0.876 0 CA-C-N 115.643 -0.708 . . . . 0.0 112.501 -178.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -81.17 137.59 35.9 Favored 'General case' 0 CA--C 1.516 -0.332 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 -178.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.4 ' HD2' ' N ' ' A' ' 96' ' ' LYS . 11.2 mptt -95.51 122.86 38.69 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-O 120.969 0.414 . . . . 0.0 111.571 -175.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 54.5 mt -127.02 141.37 46.44 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 N-CA-C 105.734 -1.95 . . . . 0.0 105.734 172.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.489 ' HA3' HD22 ' A' ' 39' ' ' ASN . . . 56.84 26.83 55.23 Favored Glycine 0 CA--C 1.521 0.438 0 O-C-N 123.035 0.209 . . . . 0.0 113.395 -179.309 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 79.5 8.19 87.93 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 121.296 -0.478 . . . . 0.0 113.786 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 15.8 ptp180 -131.2 142.08 50.14 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 117.87 0.835 . . . . 0.0 110.321 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -82.83 120.31 25.48 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.686 -177.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 11.4 mt -65.78 143.96 57.17 Favored 'General case' 0 C--O 1.249 1.047 0 CA-C-O 121.858 0.837 . . . . 0.0 112.683 179.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 22.7 tptm -116.59 118.7 33.33 Favored 'General case' 0 N--CA 1.418 -2.056 0 CA-C-N 114.771 -1.104 . . . . 0.0 108.548 175.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.475 HG22 HG22 ' A' ' 89' ' ' VAL . 4.4 mm -117.63 136.01 56.19 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.185 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 178.254 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -143.43 152.66 41.81 Favored 'General case' 0 C--N 1.287 -2.151 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -178.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 74.4 m-70 -83.81 131.96 34.86 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 178.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 5.8 t -156.27 161.73 40.2 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 -177.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.502 ' CE2' ' HA ' ' A' ' 30' ' ' ASN . 41.7 m-85 -109.91 109.21 19.76 Favored 'General case' 0 N--CA 1.42 -1.963 0 C-N-CA 118.351 -1.34 . . . . 0.0 107.466 169.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 25.5 t80 -107.18 135.63 48.38 Favored 'General case' 0 C--N 1.277 -2.546 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -112.06 113.48 51.99 Favored Pre-proline 0 C--N 1.291 -1.955 0 C-N-CA 118.971 -1.091 . . . . 0.0 109.595 177.004 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.46 ' HB3' HD11 ' A' ' 61' ' ' ILE . 55.7 Cg_endo -70.42 148.84 61.7 Favored 'Trans proline' 0 C--O 1.245 0.835 0 C-N-CA 123.63 2.887 . . . . 0.0 113.91 -179.154 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 27.3 tptp -120.83 118.02 28.89 Favored 'General case' 0 N--CA 1.427 -1.584 0 CA-C-N 115.063 -0.971 . . . . 0.0 108.505 172.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 33.5 mmt180 . . . . . 0 C--N 1.285 -2.236 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 177.722 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 222' ' ' ASN . . . . . 0.404 ' HB2' ' OD2' ' A' ' 90' ' ' ASP . 44.7 t-20 . . . . . 0 CA--C 1.538 0.518 0 N-CA-C 111.333 0.123 . . . . 0.0 111.333 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 223' ' ' ARG . . . . . . . . . . . . 0.277 11.6 ptm180 58.51 49.94 9.91 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 117.325 2.343 . . . . 0.0 117.325 173.333 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 224' ' ' PHE . . . . . 0.464 ' HB2' HD11 ' A' ' 87' ' ' LEU . 71.3 m-85 -108.83 167.02 10.38 Favored 'General case' 0 C--N 1.272 -2.787 0 C-N-CA 123.926 0.89 . . . . 0.0 109.774 176.199 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 225' ' ' ALA . . . . . . . . . . . . . . . -129.59 75.47 1.65 Allowed 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 121.302 0.572 . . . . 0.0 110.462 177.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 4.0 mp -114.14 131.03 67.3 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 175.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 227' ' ' MET . . . . . . . . . . . . . 26.1 ptt? -69.71 151.03 96.59 Favored Pre-proline 0 C--N 1.318 -0.797 0 O-C-N 123.485 0.491 . . . . 0.0 110.077 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 228' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -71.7 161.2 45.93 Favored 'Trans proline' 0 C--O 1.252 1.176 0 C-N-CA 123.141 2.561 . . . . 0.0 114.327 -175.27 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . -83.66 173.28 51.01 Favored Glycine 0 N--CA 1.436 -1.326 0 CA-C-N 114.736 -1.12 . . . . 0.0 112.318 177.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 9.6 m -74.35 -14.49 60.89 Favored 'General case' 0 C--N 1.306 -1.288 0 C-N-CA 123.456 0.703 . . . . 0.0 112.369 -174.021 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 38.9 mmt180 -91.41 -6.22 53.16 Favored 'General case' 0 C--N 1.318 -0.791 0 C-N-CA 120.076 -0.65 . . . . 0.0 111.693 -177.004 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 232' ' ' TRP . . . . . 0.463 ' HB2' ' CB ' ' A' ' 52' ' ' SER . 21.0 t90 -76.4 121.11 22.57 Favored 'General case' 0 CA--C 1.497 -1.062 0 CA-C-O 122.45 1.119 . . . . 0.0 112.324 -178.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 233' ' ' ASP . . . . . 0.449 ' O ' ' N ' ' B' ' 235' ' ' VAL . 24.7 t70 -118.04 148.68 42.02 Favored 'General case' 0 N--CA 1.407 -2.623 0 N-CA-C 102.541 -3.133 . . . . 0.0 102.541 171.546 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -46.26 60.19 0.0 OUTLIER Glycine 0 N--CA 1.489 2.208 0 C-N-CA 127.967 2.699 . . . . 0.0 116.418 -176.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 235' ' ' VAL . . . . . 0.46 HG12 ' HG2' ' B' ' 237' ' ' ARG . 54.5 t -103.32 124.16 57.31 Favored 'Isoleucine or valine' 0 C--N 1.253 -3.608 0 C-N-CA 127.59 2.356 . . . . 0.0 107.302 175.532 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 236' ' ' HIS . . . . . . . . . . . . . 41.0 t60 -101.51 106.76 17.91 Favored 'General case' 0 N--CA 1.418 -2.047 0 CA-C-O 121.35 0.595 . . . . 0.0 109.664 -177.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 237' ' ' ARG . . . . . 0.46 ' HG2' HG12 ' B' ' 235' ' ' VAL . 38.7 mmt180 -128.31 111.84 13.8 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 105.361 -2.088 . . . . 0.0 105.361 172.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 238' ' ' SER . . . . . . . . . . . . . 10.5 t -145.03 151.74 39.02 Favored 'General case' 0 C--N 1.28 -2.452 0 C-N-CA 119.097 -1.041 . . . . 0.0 111.275 -175.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 239' ' ' ASN . . . . . 0.439 ' HB3' ' O ' ' A' ' 91' ' ' ASN . 28.8 p-10 -84.79 163.61 19.0 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.92 -178.643 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 240' ' ' GLY . . . . . . . . . . . . . . . 123.66 80.17 0.47 Allowed Glycine 0 N--CA 1.418 -2.547 0 C-N-CA 120.174 -1.012 . . . . 0.0 111.568 178.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 35.0 p90 -76.96 -33.51 57.66 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-O 121.481 0.657 . . . . 0.0 110.273 174.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -67.23 -39.45 86.21 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.518 -176.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -60.13 -34.35 73.4 Favored 'General case' 0 C--O 1.202 -1.43 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.826 177.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -62.09 -37.81 86.48 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 122.817 0.447 . . . . 0.0 109.96 -179.147 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 245' ' ' TRP . . . . . 0.519 ' O ' ' HG3' ' B' ' 248' ' ' LYS . 36.8 m0 -69.6 -39.73 77.07 Favored 'General case' 0 C--O 1.242 0.702 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.551 178.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 246' ' ' PHE . . . . . 0.742 ' O ' ' HG2' ' B' ' 249' ' ' GLN . 2.8 t80 -70.2 -33.05 71.23 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 114.879 -1.055 . . . . 0.0 110.812 177.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -73.15 -31.01 64.0 Favored 'General case' 0 C--N 1.285 -2.237 0 O-C-N 121.817 -0.552 . . . . 0.0 110.663 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 248' ' ' LYS . . . . . 0.519 ' HG3' ' O ' ' B' ' 245' ' ' TRP . 2.2 pptp? -87.22 -12.1 47.81 Favored 'General case' 0 C--O 1.221 -0.414 0 CA-C-O 120.86 0.362 . . . . 0.0 111.594 -177.259 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 249' ' ' GLN . . . . . 0.742 ' HG2' ' O ' ' B' ' 246' ' ' PHE . 2.9 pt20 -79.33 2.99 19.54 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.002 -178.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 250' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -56.98 -36.99 70.99 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.267 176.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -116.27 152.92 32.86 Favored 'General case' 0 N--CA 1.411 -2.379 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 175.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 252' ' ' ILE . . . . . . . . . . . . . 28.5 pt -128.79 -28.21 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 -173.164 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -117.32 -24.7 7.32 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-O 121.061 0.457 . . . . 0.0 109.806 -174.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 254' ' ' GLU . . . . . . . . . . . . . 48.4 mp0 -51.49 148.18 5.42 Favored 'General case' 0 N--CA 1.438 -1.032 0 C-N-CA 126.084 1.754 . . . . 0.0 114.622 -172.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 255' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -61.48 122.95 16.49 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 113.763 -1.562 . . . . 0.0 112.715 -178.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 256' ' ' LYS . . . . . . . . . . . . . 66.5 mttm . . . . . 0 C--N 1.306 -1.312 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 176.364 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.455 ' N ' ' HA ' ' A' ' 81' ' ' ASP . 88.2 m-20 . . . . . 0 CA--C 1.508 -0.65 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.545 ' HG3' ' CD1' ' A' ' 27' ' ' TYR . 13.2 pt-20 -81.24 -17.05 50.84 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -172.36 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.545 ' CD1' ' HG3' ' A' ' 26' ' ' GLU . 26.4 m-85 -93.85 8.41 41.3 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-O 121.653 0.74 . . . . 0.0 109.958 179.563 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -108.33 135.24 49.97 Favored 'General case' 0 N--CA 1.426 -1.633 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.502 177.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -90.41 -4.33 57.1 Favored 'General case' 0 C--N 1.275 -2.653 0 CA-C-N 114.329 -1.305 . . . . 0.0 111.858 -170.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 41.8 m-80 -83.15 30.86 0.45 Allowed 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.592 178.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -97.36 9.15 43.07 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 112.33 0.492 . . . . 0.0 112.33 -175.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -108.25 145.85 33.71 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-O 121.124 0.488 . . . . 0.0 111.548 -173.06 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 26.7 pt -138.23 154.99 28.61 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.503 175.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -106.81 122.86 47.22 Favored 'General case' 0 C--N 1.286 -2.158 0 CA-C-N 114.67 -1.15 . . . . 0.0 108.802 176.009 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.532 HG23 ' CD1' ' A' ' 104' ' ' ILE . 11.5 mt -107.97 127.04 64.43 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 N-CA-C 106.182 -1.784 . . . . 0.0 106.182 176.543 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -129.07 167.94 20.96 Favored Glycine 0 C--N 1.28 -2.566 0 N-CA-C 110.357 -1.097 . . . . 0.0 110.357 179.03 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 75.7 30.32 0.79 Allowed 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.644 1.178 . . . . 0.0 111.179 -179.056 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.455 HD11 HD11 ' A' ' 47' ' ' ILE . 4.1 mm? -66.94 154.54 40.83 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.639 -0.71 . . . . 0.0 112.047 178.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.422 ' HB3' ' HG ' ' A' ' 42' ' ' LEU . 42.8 t-20 -95.03 146.06 24.52 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 106.225 -1.768 . . . . 0.0 106.225 174.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.63 ' HA ' ' OG ' ' A' ' 71' ' ' SER . 8.0 ppt_? -60.52 -23.31 64.47 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 122.96 0.504 . . . . 0.0 112.332 178.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.4 ' HG2' ' CG ' ' A' ' 39' ' ' ASN . 11.2 pt-20 -88.61 -9.53 51.86 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.798 -178.521 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.422 ' HG ' ' HB3' ' A' ' 39' ' ' ASN . 67.1 mt -80.99 125.96 30.79 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 121.188 0.518 . . . . 0.0 110.874 -177.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 66.9 p -107.31 173.36 6.36 Favored 'General case' 0 C--N 1.293 -1.867 0 CA-C-N 114.885 -1.052 . . . . 0.0 110.063 -178.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.8 mp0 -57.66 -40.54 79.59 Favored 'General case' 0 N--CA 1.433 -1.282 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.449 177.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -59.42 -38.49 93.54 Favored Glycine 0 N--CA 1.445 -0.716 0 O-C-N 123.681 0.613 . . . . 0.0 112.629 179.119 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -67.25 -49.19 65.36 Favored 'General case' 0 CA--C 1.499 -1.002 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 179.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.455 HD11 HD11 ' A' ' 38' ' ' LEU . 54.4 mt -59.73 -47.39 91.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.074 -0.966 . . . . 0.0 110.616 179.436 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 49.4 mt -59.72 -44.55 93.68 Favored 'General case' 0 CA--C 1.49 -1.345 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.468 -177.138 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.453 HG23 ' H ' ' B' ' 233' ' ' ASP . 62.5 m -61.69 -46.27 90.41 Favored 'General case' 0 C--N 1.31 -1.13 0 O-C-N 123.454 0.471 . . . . 0.0 111.636 -178.553 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.435 HG13 ' HG3' ' B' ' 237' ' ' ARG . 86.8 t -67.3 -47.59 80.73 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.777 -178.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.409 ' HD2' ' HH ' ' A' ' 79' ' ' TYR . 3.7 m-85 -65.92 -23.82 66.7 Favored 'General case' 0 N--CA 1.435 -1.177 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.725 -179.235 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.533 ' OG ' ' HB2' ' B' ' 231' ' ' ARG . 70.0 m -70.69 -18.53 62.82 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 176.255 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -76.06 -28.96 57.82 Favored 'General case' 0 C--O 1.249 1.051 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 176.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 51.7 m-85 -86.23 -23.19 26.52 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.279 -176.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 177.4 -155.89 18.81 Favored Glycine 0 N--CA 1.43 -1.74 0 C-N-CA 120.4 -0.905 . . . . 0.0 112.546 177.325 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 69.3 t -107.66 108.66 61.84 Favored Pre-proline 0 C--N 1.303 -1.438 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 -179.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.402 ' HB3' HD21 ' A' ' 77' ' ' LEU . 73.8 Cg_endo -76.24 137.0 18.57 Favored 'Trans proline' 0 N--CA 1.439 -1.686 0 C-N-CA 122.175 1.917 . . . . 0.0 109.905 177.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 35.4 m -113.45 -23.83 4.14 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.864 0 C-N-CA 119.699 -0.8 . . . . 0.0 111.146 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.48 ' HB3' ' HG2' ' A' ' 78' ' ' LYS . 32.7 t70 -158.02 142.87 16.46 Favored 'General case' 0 C--O 1.244 0.812 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 178.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 14.1 p -140.57 135.95 35.41 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.238 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 178.167 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 78.7 mt -121.3 128.47 75.95 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 176.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -102.02 120.96 41.26 Favored 'General case' 0 C--N 1.29 -1.984 0 N-CA-C 105.742 -1.947 . . . . 0.0 105.742 175.251 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 15.7 m -80.98 117.6 21.74 Favored 'General case' 0 N--CA 1.415 -2.192 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 70.0 mtt85 -124.02 146.31 48.63 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-O 120.981 0.42 . . . . 0.0 111.298 -178.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -79.45 123.44 27.54 Favored 'General case' 0 N--CA 1.428 -1.547 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 177.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -61.02 -20.64 62.74 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 -174.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 14.9 m-80 -83.02 -45.6 13.86 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-O 120.716 0.294 . . . . 0.0 110.99 -176.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 65.1 p -94.24 -23.96 17.66 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.265 0.555 . . . . 0.0 111.808 -176.194 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.34 2.75 84.73 Favored Glycine 0 N--CA 1.441 -1.023 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 -175.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -92.24 164.25 13.61 Favored 'General case' 0 CA--C 1.49 -1.361 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 -177.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.63 ' OG ' ' HA ' ' A' ' 40' ' ' ARG . 53.7 p -70.84 145.52 50.23 Favored 'General case' 0 C--N 1.29 -2.005 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.776 -179.643 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 -81.87 4.15 23.45 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-O 120.949 0.404 . . . . 0.0 111.828 -178.105 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 90.3 13.01 60.73 Favored Glycine 0 N--CA 1.429 -1.769 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.027 179.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.426 ' HA ' HD23 ' A' ' 38' ' ' LEU . 45.6 p90 -154.08 158.85 41.09 Favored 'General case' 0 N--CA 1.431 -1.396 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 177.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -152.14 176.44 11.55 Favored 'General case' 0 N--CA 1.438 -1.043 0 O-C-N 123.568 0.543 . . . . 0.0 110.085 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -136.64 144.71 44.17 Favored 'General case' 0 C--N 1.306 -1.324 0 C-N-CA 123.292 0.637 . . . . 0.0 110.037 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.402 HD21 ' HB3' ' A' ' 57' ' ' PRO . 9.9 tt -149.28 140.68 23.27 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 176.451 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.48 ' HG2' ' HB3' ' A' ' 59' ' ' ASP . 22.0 ptmt -122.93 144.57 49.15 Favored 'General case' 0 C--O 1.257 1.486 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.409 ' HH ' ' HD2' ' A' ' 51' ' ' PHE . 86.2 m-85 -108.96 165.24 11.73 Favored 'General case' 0 C--N 1.29 -2.021 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.34 -177.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -68.4 -38.09 80.95 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 114.703 -1.135 . . . . 0.0 108.786 174.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.455 ' HA ' ' N ' ' A' ' 25' ' ' ASN . 12.3 t70 -126.23 145.9 50.21 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-O 121.324 0.583 . . . . 0.0 111.967 -178.574 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 20.0 mp0 -67.1 -29.28 68.99 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 124.495 1.118 . . . . 0.0 112.271 -178.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 58.3 mtm180 -61.06 -33.81 73.89 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-O 122.145 0.974 . . . . 0.0 111.692 178.228 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 51.1 m -64.27 -37.34 87.14 Favored 'General case' 0 C--N 1.28 -2.424 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.541 174.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.419 ' O ' HG23 ' A' ' 89' ' ' VAL . 52.6 p -63.18 -44.75 94.51 Favored 'General case' 0 C--O 1.22 -0.496 0 C-N-CA 120.424 -0.51 . . . . 0.0 110.432 -178.15 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 5.4 pt -65.86 -39.21 84.05 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 C-N-CA 122.49 0.316 . . . . 0.0 111.459 179.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.457 HD11 ' HB2' ' B' ' 224' ' ' PHE . 18.7 mt -60.21 -43.94 95.54 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 123.662 0.601 . . . . 0.0 110.903 175.489 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.402 ' HB1' HD12 ' A' ' 92' ' ' LEU . . . -71.69 -46.47 58.7 Favored 'General case' 0 N--CA 1.435 -1.189 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.757 -178.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 85' ' ' THR . 72.4 t -57.03 -48.29 82.06 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.71 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -179.42 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -63.63 -37.17 86.31 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-O 120.951 0.405 . . . . 0.0 111.437 -175.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.442 ' O ' ' HB2' ' B' ' 239' ' ' ASN . 85.4 m-20 -93.02 -21.09 19.95 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 -174.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.507 ' HB2' HG13 ' A' ' 104' ' ' ILE . 20.4 mt -99.3 -28.89 13.1 Favored 'General case' 0 C--N 1.291 -1.976 0 C-N-CA 120.455 -0.498 . . . . 0.0 111.506 -176.361 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -66.28 124.6 23.11 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 177.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 83.18 -0.59 89.65 Favored Glycine 0 C--N 1.304 -1.242 0 C-N-CA 121.099 -0.572 . . . . 0.0 112.608 -179.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 69.4 t80 -85.2 131.66 34.4 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 -178.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -90.62 119.42 30.85 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-O 121.172 0.51 . . . . 0.0 112.241 -176.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 48.5 mt -127.67 141.35 46.64 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 N-CA-C 105.866 -1.902 . . . . 0.0 105.866 172.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 60.34 18.24 49.3 Favored Glycine 0 CA--C 1.526 0.774 0 C-N-CA 121.41 -0.424 . . . . 0.0 113.939 178.315 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 85.44 11.26 75.43 Favored Glycine 0 N--CA 1.437 -1.266 0 C-N-CA 121.058 -0.592 . . . . 0.0 112.721 -179.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 16.1 ptp180 -135.5 145.3 46.96 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 117.115 0.458 . . . . 0.0 110.913 179.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -87.49 120.58 28.94 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.067 -177.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 12.4 mt -67.33 148.92 51.03 Favored 'General case' 0 C--N 1.31 -1.118 0 C-N-CA 123.789 0.836 . . . . 0.0 112.822 178.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 17.3 tppt? -124.6 118.75 27.23 Favored 'General case' 0 N--CA 1.422 -1.84 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.191 176.231 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.532 ' CD1' HG23 ' A' ' 35' ' ' ILE . 5.1 mm -119.96 136.38 57.25 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 179.372 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -142.09 146.47 35.45 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 81.1 m-70 -79.34 132.71 36.52 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.278 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 4.7 t -162.41 163.73 27.58 Favored 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 -175.217 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -99.34 112.94 25.02 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 174.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 35.5 t80 -105.86 134.45 48.96 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-N 115.945 -0.571 . . . . 0.0 109.667 179.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -115.64 118.8 38.66 Favored Pre-proline 0 C--N 1.301 -1.542 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 176.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -63.88 143.98 87.14 Favored 'Trans proline' 0 C--O 1.251 1.174 0 C-N-CA 123.207 2.604 . . . . 0.0 114.36 -178.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 26.6 tptp -81.5 124.8 29.78 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-N 114.713 -1.131 . . . . 0.0 108.846 176.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 36.3 mmt180 . . . . . 0 C--N 1.286 -2.173 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 176.334 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 222' ' ' ASN . . . . . 0.402 ' HB2' HD23 ' A' ' 87' ' ' LEU . 2.7 m-20 . . . . . 0 N--CA 1.47 0.56 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 223' ' ' ARG . . . . . . . . . . . . 0.312 46.7 mtp180 73.67 51.94 0.12 Allowed 'General case' 0 CA--C 1.482 -1.646 0 N-CA-C 114.703 1.372 . . . . 0.0 114.703 176.112 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 224' ' ' PHE . . . . . 0.457 ' HB2' HD11 ' A' ' 87' ' ' LEU . 49.9 m-85 -117.23 165.71 13.12 Favored 'General case' 0 C--N 1.265 -3.075 0 CA-C-N 113.462 -1.699 . . . . 0.0 109.454 177.382 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 225' ' ' ALA . . . . . . . . . . . . . . . -108.7 39.68 1.96 Allowed 'General case' 0 C--N 1.304 -1.401 0 CA-C-O 121.348 0.594 . . . . 0.0 110.538 -173.155 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 4.2 mp -103.17 129.56 54.78 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 C-N-CA 120.685 -0.406 . . . . 0.0 109.936 179.297 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 227' ' ' MET . . . . . . . . . . . . . 27.8 ptm -89.11 149.31 42.87 Favored Pre-proline 0 C--N 1.307 -1.251 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 177.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 228' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -63.62 151.04 86.92 Favored 'Trans proline' 0 C--O 1.244 0.806 0 C-N-CA 123.443 2.762 . . . . 0.0 113.564 -177.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . -77.79 174.92 54.68 Favored Glycine 0 C--O 1.246 0.869 0 CA-C-N 115.432 -0.804 . . . . 0.0 112.546 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 17.6 m -76.3 -17.06 59.62 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -176.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 231' ' ' ARG . . . . . 0.533 ' HB2' ' OG ' ' A' ' 52' ' ' SER . 9.8 mmm180 -79.82 -8.27 59.18 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 120.794 0.33 . . . . 0.0 111.324 179.63 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 232' ' ' TRP . . . . . . . . . . . . . 24.5 t90 -72.02 128.62 36.29 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-O 122.125 0.964 . . . . 0.0 111.383 179.078 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 233' ' ' ASP . . . . . 0.458 ' O ' ' N ' ' B' ' 235' ' ' VAL . 16.7 t70 -123.33 140.2 53.25 Favored 'General case' 0 C--N 1.265 -3.106 0 N-CA-C 101.586 -3.487 . . . . 0.0 101.586 173.409 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -36.9 61.12 0.0 OUTLIER Glycine 0 N--CA 1.501 3.024 0 C-N-CA 128.622 3.011 . . . . 0.0 116.72 -179.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 235' ' ' VAL . . . . . 0.477 HG12 ' HG2' ' B' ' 237' ' ' ARG . 55.9 t -112.4 126.31 69.78 Favored 'Isoleucine or valine' 0 C--N 1.253 -3.621 0 C-N-CA 128.132 2.573 . . . . 0.0 107.781 175.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 236' ' ' HIS . . . . . . . . . . . . . 57.5 t-80 -105.3 115.72 30.74 Favored 'General case' 0 C--N 1.288 -2.082 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 178.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 237' ' ' ARG . . . . . 0.477 ' HG2' HG12 ' B' ' 235' ' ' VAL . 38.0 mmt180 -124.8 109.71 13.41 Favored 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 120.158 -0.617 . . . . 0.0 110.187 177.504 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 238' ' ' SER . . . . . . . . . . . . . 45.9 t -129.98 143.77 50.97 Favored 'General case' 0 C--N 1.292 -1.896 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.411 179.073 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 239' ' ' ASN . . . . . 0.442 ' HB2' ' O ' ' A' ' 91' ' ' ASN . 17.2 t-20 -74.08 -17.49 60.95 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 176.569 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 240' ' ' GLY . . . . . 0.494 ' O ' ' HG2' ' B' ' 244' ' ' LYS . . . 106.73 36.64 2.55 Favored Glycine 0 N--CA 1.416 -2.664 0 CA-C-N 114.69 -1.141 . . . . 0.0 110.489 -177.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 49.7 p90 -75.95 -35.94 59.51 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -178.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -66.35 -38.74 88.3 Favored 'General case' 0 CA--C 1.5 -0.979 0 CA-C-N 116.727 -0.215 . . . . 0.0 111.04 -176.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -60.51 -35.16 75.28 Favored 'General case' 0 C--O 1.202 -1.396 0 O-C-N 123.597 0.561 . . . . 0.0 110.483 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 244' ' ' LYS . . . . . 0.494 ' HG2' ' O ' ' B' ' 240' ' ' GLY . 70.4 mmtt -67.14 -41.82 85.44 Favored 'General case' 0 CA--C 1.509 -0.628 0 CA-C-O 121.662 0.744 . . . . 0.0 109.137 -178.091 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 245' ' ' TRP . . . . . . . . . . . . . 45.3 m0 -68.93 -41.07 78.61 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 114.853 -1.067 . . . . 0.0 109.58 179.107 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 246' ' ' PHE . . . . . 0.548 ' O ' ' HG2' ' B' ' 249' ' ' GLN . 5.2 t80 -65.86 -37.86 87.3 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.777 179.155 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -68.02 -33.33 74.4 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.556 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.9 -21.05 21.58 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 120.669 -0.413 . . . . 0.0 111.946 -177.607 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 249' ' ' GLN . . . . . 0.548 ' HG2' ' O ' ' B' ' 246' ' ' PHE . 3.0 pt20 -75.42 2.29 11.79 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.092 0.472 . . . . 0.0 111.287 -178.056 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 250' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -56.91 -38.57 73.03 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.319 178.077 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -139.57 113.55 8.76 Favored 'General case' 0 N--CA 1.439 -0.987 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 175.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 252' ' ' ILE . . . . . . . . . . . . . 27.8 pt -102.54 -37.48 4.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 -172.288 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -108.87 -18.07 13.78 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-O 121.846 0.832 . . . . 0.0 110.048 -175.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 254' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -84.51 -174.12 5.1 Favored 'General case' 0 C--N 1.29 -2.018 0 CA-C-N 114.205 -1.361 . . . . 0.0 112.054 -176.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 255' ' ' LYS . . . . . 0.411 ' HD2' ' O ' ' B' ' 255' ' ' LYS . 2.0 pptp? -57.24 130.99 48.65 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-N 115.103 -0.953 . . . . 0.0 111.502 178.2 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 256' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt . . . . . 0 C--N 1.305 -1.361 0 CA-C-O 118.965 -0.541 . . . . 0.0 110.653 -175.636 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 49.3 t-20 . . . . . 0 C--O 1.244 0.808 0 CA-C-O 121.615 0.722 . . . . 0.0 109.616 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -76.9 -23.98 52.52 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 115.151 -0.931 . . . . 0.0 112.018 -173.372 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 40.5 m-85 -87.24 6.39 33.42 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-O 121.716 0.769 . . . . 0.0 112.856 -173.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -95.97 -39.51 9.74 Favored 'General case' 0 C--N 1.284 -2.244 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 174.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . 0.264 14.8 m-20 65.89 -12.52 0.17 Allowed 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 126.141 1.776 . . . . 0.0 114.859 178.44 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 47.3 m-80 -79.77 29.83 0.26 Allowed 'General case' 0 C--N 1.303 -1.442 0 C-N-CA 123.593 0.757 . . . . 0.0 110.716 178.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.464 ' HB2' ' NE2' ' A' ' 82' ' ' GLN . . . -99.31 2.16 45.19 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.971 -176.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -103.68 144.65 31.17 Favored 'General case' 0 N--CA 1.429 -1.518 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.831 -174.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 25.1 pt -141.37 157.05 21.7 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.742 0 CA-C-N 115.476 -0.783 . . . . 0.0 109.462 178.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.422 ' HB2' HG21 ' A' ' 107' ' ' THR . 16.5 t80 -108.81 123.04 48.42 Favored 'General case' 0 N--CA 1.411 -2.378 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 176.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.505 HG23 ' CD1' ' A' ' 104' ' ' ILE . 12.0 mt -107.83 126.97 64.26 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.931 0 N-CA-C 105.792 -1.929 . . . . 0.0 105.792 176.518 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -129.01 165.4 21.8 Favored Glycine 0 N--CA 1.418 -2.556 0 N-CA-C 112.041 -0.424 . . . . 0.0 112.041 -177.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 8.3 t30 63.57 51.97 2.39 Favored 'General case' 0 C--N 1.314 -0.951 0 C-N-CA 125.146 1.378 . . . . 0.0 109.876 -177.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.408 HD11 HD11 ' A' ' 47' ' ' ILE . 3.1 mm? -78.37 161.2 27.34 Favored 'General case' 0 CA--C 1.502 -0.884 0 CA-C-N 113.99 -1.459 . . . . 0.0 111.482 178.499 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.493 ' HB3' ' HG ' ' A' ' 42' ' ' LEU . 49.8 t-20 -98.12 145.5 26.51 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 174.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.552 ' HD2' ' N ' ' A' ' 41' ' ' GLU . 7.4 ppt_? -58.79 -27.13 64.73 Favored 'General case' 0 C--N 1.31 -1.137 0 C-N-CA 123.543 0.737 . . . . 0.0 111.924 179.592 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.552 ' N ' ' HD2' ' A' ' 40' ' ' ARG . 11.4 pt-20 -85.59 -11.82 53.04 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.543 -176.366 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.493 ' HG ' ' HB3' ' A' ' 39' ' ' ASN . 79.0 mt -84.21 118.73 24.34 Favored 'General case' 0 CA--C 1.492 -1.279 0 CA-C-O 121.474 0.654 . . . . 0.0 111.09 -176.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 46.6 p -107.82 173.92 6.11 Favored 'General case' 0 N--CA 1.414 -2.273 0 CA-C-N 114.417 -1.265 . . . . 0.0 109.445 -178.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.479 ' HG3' ' HB2' ' A' ' 62' ' ' LEU . 1.7 mp0 -54.92 -41.37 70.93 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 123.871 0.868 . . . . 0.0 109.759 178.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.17 -43.28 98.56 Favored Glycine 0 N--CA 1.439 -1.126 0 CA-C-N 115.545 -0.752 . . . . 0.0 112.894 -179.219 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -68.1 -45.29 74.13 Favored 'General case' 0 CA--C 1.513 -0.444 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 -179.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.408 HD11 HD11 ' A' ' 38' ' ' LEU . 37.9 mt -58.55 -44.12 88.61 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.488 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.707 178.571 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 43.8 mt -59.37 -44.7 92.68 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.51 HG23 ' H ' ' B' ' 233' ' ' ASP . 89.4 m -61.66 -46.26 90.48 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 120.804 0.335 . . . . 0.0 111.619 178.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.556 HG13 ' HG3' ' B' ' 237' ' ' ARG . 84.6 t -63.18 -49.47 83.09 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.379 179.61 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.427 ' HA ' ' HD2' ' A' ' 54' ' ' TYR . 4.1 m-85 -69.43 -23.08 63.63 Favored 'General case' 0 N--CA 1.433 -1.318 0 C-N-CA 123.583 0.753 . . . . 0.0 112.868 -177.257 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.472 ' OG ' ' HB2' ' B' ' 231' ' ' ARG . 72.6 m -68.57 -20.1 64.51 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 111.917 0.34 . . . . 0.0 111.917 176.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -63.47 -28.0 69.66 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-O 122.029 0.919 . . . . 0.0 109.007 173.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.427 ' HD2' ' HA ' ' A' ' 51' ' ' PHE . 50.9 m-85 -96.3 -2.87 45.0 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.262 -174.452 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 148.21 -152.96 24.96 Favored Glycine 0 N--CA 1.42 -2.432 0 C-N-CA 119.975 -1.107 . . . . 0.0 112.015 178.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 61.8 t -107.52 111.01 63.06 Favored Pre-proline 0 C--N 1.296 -1.742 0 CA-C-O 120.717 0.294 . . . . 0.0 110.948 -177.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.493 ' HB3' HD21 ' A' ' 77' ' ' LEU . 58.7 Cg_endo -74.74 145.49 32.6 Favored 'Trans proline' 0 N--CA 1.45 -1.081 0 C-N-CA 122.719 2.279 . . . . 0.0 110.041 174.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.416 ' CG2' ' HG3' ' A' ' 78' ' ' LYS . 34.4 m -116.45 -24.97 3.3 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 C-N-CA 119.674 -0.81 . . . . 0.0 111.463 177.5 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -158.36 147.57 19.26 Favored 'General case' 0 C--O 1.249 1.07 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 12.5 p -145.78 132.47 14.53 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-O 121.002 0.429 . . . . 0.0 110.432 -179.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 84.2 mt -120.62 126.85 75.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 177.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.479 ' HB2' ' HG3' ' A' ' 44' ' ' GLU . 0.2 OUTLIER -100.3 122.73 43.54 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 105.753 -1.944 . . . . 0.0 105.753 175.533 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 15.4 m -82.13 116.8 21.86 Favored 'General case' 0 N--CA 1.406 -2.648 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 178.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 84.3 mtt180 -127.57 153.33 46.52 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-O 121.43 0.634 . . . . 0.0 110.82 -175.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -83.99 122.59 28.96 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 106.349 -1.723 . . . . 0.0 106.349 174.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -61.37 -22.15 64.7 Favored 'General case' 0 C--N 1.29 -2.016 0 C-N-CA 124.018 0.927 . . . . 0.0 112.939 -175.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 22.6 m-80 -82.6 -46.0 13.87 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-O 121.074 0.464 . . . . 0.0 110.868 -177.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 54.6 p -88.79 -23.73 22.79 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.424 -176.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.62 8.72 86.25 Favored Glycine 0 N--CA 1.446 -0.692 0 N-CA-C 110.891 -0.883 . . . . 0.0 110.891 -177.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.424 ' OE2' ' HD3' ' A' ' 40' ' ' ARG . 40.2 mt-10 -108.35 167.15 10.23 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-O 120.701 0.286 . . . . 0.0 110.241 -176.151 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 44.9 t -63.13 149.76 44.46 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-O 121.799 0.809 . . . . 0.0 111.029 -178.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -87.48 -2.9 58.94 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.111 176.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 100.19 17.65 24.19 Favored Glycine 0 N--CA 1.429 -1.781 0 CA-C-N 115.475 -0.784 . . . . 0.0 112.536 178.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -160.86 156.83 25.63 Favored 'General case' 0 C--O 1.244 0.801 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 177.38 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -152.81 175.98 12.29 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-O 120.789 0.328 . . . . 0.0 110.995 179.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -134.88 143.18 46.82 Favored 'General case' 0 C--N 1.317 -0.813 0 C-N-CA 123.989 0.915 . . . . 0.0 110.425 -177.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.493 HD21 ' HB3' ' A' ' 57' ' ' PRO . 10.0 tt -150.07 140.59 22.48 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 175.571 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.416 ' HG3' ' CG2' ' A' ' 58' ' ' VAL . 20.8 ptmt -122.56 144.18 49.26 Favored 'General case' 0 C--O 1.255 1.394 0 CA-C-O 121.02 0.438 . . . . 0.0 109.951 179.61 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -108.9 164.58 12.27 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.539 -178.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -74.59 -25.64 59.39 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 114.822 -1.081 . . . . 0.0 109.736 175.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -127.77 136.76 51.93 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.073 -175.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.464 ' NE2' ' HB2' ' A' ' 31' ' ' ALA . 22.5 mp0 -69.74 -19.9 63.53 Favored 'General case' 0 C--N 1.313 -1.022 0 N-CA-C 113.191 0.811 . . . . 0.0 113.191 177.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 90.9 mtm180 -68.24 -34.64 76.6 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-O 122.261 1.029 . . . . 0.0 109.592 174.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 67.2 m -65.21 -37.37 87.08 Favored 'General case' 0 C--N 1.286 -2.173 0 CA-C-N 114.702 -1.135 . . . . 0.0 112.226 178.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.46 ' O ' HG23 ' A' ' 89' ' ' VAL . 77.3 p -64.93 -45.62 85.05 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 120.438 -0.505 . . . . 0.0 110.577 -178.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 6.7 pt -64.8 -38.63 83.2 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.093 177.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.674 HD11 ' HB2' ' B' ' 224' ' ' PHE . 13.2 mt -58.87 -43.6 90.92 Favored 'General case' 0 C--O 1.242 0.696 0 O-C-N 123.296 0.372 . . . . 0.0 111.006 176.248 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.412 ' HB1' HD12 ' A' ' 92' ' ' LEU . . . -70.84 -46.75 62.16 Favored 'General case' 0 N--CA 1.435 -1.204 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.208 -178.626 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 85' ' ' THR . 78.2 t -56.73 -47.05 83.2 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.581 0 CA-C-O 121.446 0.641 . . . . 0.0 110.739 179.229 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -59.02 -39.16 81.06 Favored 'General case' 0 C--N 1.295 -1.78 0 C-N-CA 125.221 1.408 . . . . 0.0 112.518 -176.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 48.9 m-80 -98.49 -22.5 15.98 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 113.798 1.036 . . . . 0.0 113.798 -175.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.515 ' HB2' HG13 ' A' ' 104' ' ' ILE . 18.6 mt -94.92 -30.05 14.35 Favored 'General case' 0 C--N 1.293 -1.889 0 C-N-CA 120.685 -0.406 . . . . 0.0 111.435 -174.284 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 50.2 t-20 -65.64 124.25 21.87 Favored 'General case' 0 N--CA 1.434 -1.265 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 176.198 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 84.38 -0.33 89.32 Favored Glycine 0 C--N 1.3 -1.468 0 C-N-CA 119.888 -1.148 . . . . 0.0 113.1 -179.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -92.24 136.8 32.9 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -95.57 120.06 35.17 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-O 121.061 0.458 . . . . 0.0 112.069 -176.127 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 55.3 mt -126.89 141.69 45.49 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 N-CA-C 106.565 -1.643 . . . . 0.0 106.565 174.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 60.08 19.79 52.18 Favored Glycine 0 CA--C 1.527 0.836 0 O-C-N 122.929 0.143 . . . . 0.0 113.275 -179.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 85.89 12.14 72.13 Favored Glycine 0 N--CA 1.438 -1.184 0 C-N-CA 121.497 -0.383 . . . . 0.0 113.07 -179.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.448 ' NH1' ' HA ' ' A' ' 39' ' ' ASN . 17.4 ptp180 -137.87 149.69 46.49 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 117.861 0.831 . . . . 0.0 110.719 178.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -83.7 126.18 32.63 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-O 120.64 0.257 . . . . 0.0 110.84 -178.136 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.414 ' HA ' HD23 ' A' ' 102' ' ' LEU . 12.1 mt -76.24 143.75 40.79 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-O 121.705 0.764 . . . . 0.0 112.629 178.024 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 5.3 tppp? -115.73 119.4 35.92 Favored 'General case' 0 N--CA 1.416 -2.146 0 CA-C-N 114.875 -1.057 . . . . 0.0 109.159 176.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.515 HG13 ' HB2' ' A' ' 92' ' ' LEU . 5.0 mm -121.42 135.99 59.8 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 178.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -144.05 150.46 38.23 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 177.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -75.17 144.13 42.88 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 177.213 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.422 HG21 ' HB2' ' A' ' 34' ' ' TYR . 12.3 t -163.21 165.98 23.78 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 106.7 -1.593 . . . . 0.0 106.7 -178.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -109.9 110.91 22.03 Favored 'General case' 0 N--CA 1.428 -1.536 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 171.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 16.5 t80 -106.28 135.95 46.86 Favored 'General case' 0 C--N 1.288 -2.074 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 -178.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 16.8 mmm180 -117.55 115.26 37.61 Favored Pre-proline 0 C--N 1.301 -1.542 0 C-N-CA 119.552 -0.859 . . . . 0.0 109.68 176.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -70.95 153.42 63.48 Favored 'Trans proline' 0 C--O 1.25 1.079 0 C-N-CA 123.061 2.508 . . . . 0.0 111.142 177.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.504 ' C ' ' HD3' ' A' ' 112' ' ' LYS . 10.4 tmtt? -108.69 122.4 47.04 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 107.189 -1.411 . . . . 0.0 107.189 176.656 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 31.3 mmm180 . . . . . 0 C--N 1.295 -1.779 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 178.044 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 49.6 t-20 . . . . . 0 CA--C 1.545 0.786 0 CA-C-O 120.532 0.206 . . . . 0.0 110.932 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 223' ' ' ARG . . . . . . . . . . . . 0.466 18.7 ttm180 59.84 54.25 4.41 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 118.927 2.936 . . . . 0.0 118.927 171.07 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 224' ' ' PHE . . . . . 0.674 ' HB2' HD11 ' A' ' 87' ' ' LEU . 17.2 m-85 -96.48 165.78 12.01 Favored 'General case' 0 C--N 1.287 -2.139 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 176.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 225' ' ' ALA . . . . . . . . . . . . . . . -110.62 68.45 0.67 Allowed 'General case' 0 C--N 1.306 -1.322 0 CA-C-O 121.587 0.708 . . . . 0.0 111.488 -173.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 4.4 mp -118.83 131.88 70.34 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 227' ' ' MET . . . . . . . . . . . . . 26.7 ptt? -67.67 147.93 98.61 Favored Pre-proline 0 C--N 1.321 -0.657 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.061 179.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 228' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -78.56 150.65 24.89 Favored 'Trans proline' 0 C--O 1.253 1.23 0 C-N-CA 123.057 2.505 . . . . 0.0 112.393 -179.38 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . -73.04 167.04 54.37 Favored Glycine 0 C--N 1.315 -0.603 0 CA-C-N 116.003 -0.544 . . . . 0.0 112.52 178.137 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 21.6 t -70.5 -13.89 62.3 Favored 'General case' 0 C--N 1.317 -0.825 0 C-N-CA 123.228 0.611 . . . . 0.0 111.332 -177.183 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 231' ' ' ARG . . . . . 0.472 ' HB2' ' OG ' ' A' ' 52' ' ' SER . 31.5 mmt180 -78.94 -9.02 59.38 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.658 -0.246 . . . . 0.0 111.041 179.628 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 232' ' ' TRP . . . . . 0.414 ' HB2' ' CB ' ' A' ' 52' ' ' SER . 19.2 t90 -77.34 129.47 35.88 Favored 'General case' 0 N--CA 1.427 -1.603 0 CA-C-O 122.29 1.043 . . . . 0.0 111.319 -179.487 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 233' ' ' ASP . . . . . 0.51 ' H ' HG23 ' A' ' 49' ' ' THR . 9.4 t70 -123.35 136.15 54.52 Favored 'General case' 0 C--N 1.265 -3.093 0 N-CA-C 100.926 -3.731 . . . . 0.0 100.926 175.321 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -39.82 62.45 0.0 OUTLIER Glycine 0 N--CA 1.498 2.778 0 C-N-CA 128.4 2.905 . . . . 0.0 116.87 -177.222 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 235' ' ' VAL . . . . . 0.47 HG12 ' HG2' ' B' ' 237' ' ' ARG . 47.5 t -111.38 118.23 56.98 Favored 'Isoleucine or valine' 0 C--N 1.251 -3.682 0 C-N-CA 127.71 2.404 . . . . 0.0 107.48 176.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 236' ' ' HIS . . . . . . . . . . . . . 56.7 t-80 -86.15 114.7 23.21 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 -175.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 237' ' ' ARG . . . . . 0.556 ' HG3' HG13 ' A' ' 50' ' ' VAL . 39.1 mmt180 -126.45 108.25 11.01 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 120.038 -0.665 . . . . 0.0 111.982 -178.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 238' ' ' SER . . . . . . . . . . . . . 59.2 p -147.62 152.29 37.65 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 176.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 239' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -68.0 134.91 51.49 Favored 'General case' 0 C--O 1.251 1.141 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 178.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 240' ' ' GLY . . . . . 0.513 ' O ' ' HE2' ' B' ' 244' ' ' LYS . . . -149.33 43.58 0.76 Allowed Glycine 0 C--O 1.19 -2.644 0 C-N-CA 119.605 -1.283 . . . . 0.0 112.622 -177.181 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 26.2 p90 -76.51 -33.82 58.6 Favored 'General case' 0 C--N 1.29 -2.001 0 CA-C-N 117.531 0.665 . . . . 0.0 111.094 178.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -66.79 -38.84 87.31 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.722 -178.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -62.15 -35.2 78.06 Favored 'General case' 0 C--O 1.21 -0.989 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.83 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 244' ' ' LYS . . . . . 0.513 ' HE2' ' O ' ' B' ' 240' ' ' GLY . 68.9 mmtt -65.61 -44.04 87.77 Favored 'General case' 0 CA--C 1.502 -0.884 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 -177.128 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 245' ' ' TRP . . . . . 0.426 ' O ' ' HB3' ' B' ' 249' ' ' GLN . 39.6 m0 -61.82 -43.23 99.27 Favored 'General case' 0 C--O 1.208 -1.107 0 CA-C-N 115.075 -0.966 . . . . 0.0 109.315 178.566 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 246' ' ' PHE . . . . . 0.555 ' HA ' ' NE2' ' B' ' 249' ' ' GLN . 4.5 t80 -66.94 -32.44 73.69 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.405 179.037 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -77.41 -39.88 45.51 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.301 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.23 -12.78 36.98 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 -175.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 249' ' ' GLN . . . . . 0.555 ' NE2' ' HA ' ' B' ' 246' ' ' PHE . 3.2 pt20 -66.27 -8.51 25.27 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 120.946 0.403 . . . . 0.0 111.038 -178.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 250' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -68.04 -28.58 67.51 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 177.074 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . 0.554 ' HB3' ' HB2' ' B' ' 254' ' ' GLU . 42.7 mt-10 -86.19 114.52 23.09 Favored 'General case' 0 N--CA 1.421 -1.905 0 CA-C-N 114.145 -1.388 . . . . 0.0 107.552 177.403 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 252' ' ' ILE . . . . . . . . . . . . . 41.2 pt -118.5 -25.92 2.72 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -174.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -105.61 -15.65 14.92 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 -177.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 254' ' ' GLU . . . . . 0.554 ' HB2' ' HB3' ' B' ' 251' ' ' GLU . 11.7 mp0 -59.49 172.75 0.62 Allowed 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 125.585 1.554 . . . . 0.0 114.722 -177.065 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 255' ' ' LYS . . . . . . . . . . . . . 53.3 mttp -86.81 -40.49 14.9 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 114.453 -1.249 . . . . 0.0 111.24 -174.081 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 256' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt . . . . . 0 C--N 1.298 -1.654 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.934 -177.394 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 16.4 m120 . . . . . 0 C--O 1.242 0.707 0 CA-C-O 121.358 0.599 . . . . 0.0 109.826 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.403 ' H ' ' CD ' ' A' ' 26' ' ' GLU . 0.5 OUTLIER -83.96 -1.06 53.9 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -176.365 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -88.3 2.38 52.57 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 122.497 1.141 . . . . 0.0 110.64 176.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 47.5 mmtm -122.18 -63.65 1.27 Allowed 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 104.758 -2.312 . . . . 0.0 104.758 170.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.4 ' C ' ' H ' ' A' ' 31' ' ' ALA . 12.0 t0 52.21 35.84 17.81 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 113.51 -1.677 . . . . 0.0 110.79 177.315 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -80.73 31.17 0.3 Allowed 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 114.292 -1.322 . . . . 0.0 110.246 -179.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.4 ' H ' ' C ' ' A' ' 29' ' ' ASP . . . -96.23 22.87 7.16 Favored 'General case' 0 C--N 1.307 -1.251 0 C-N-CA 123.95 0.9 . . . . 0.0 111.711 -174.232 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 13.2 m-30 -93.85 144.83 25.08 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 120.196 -0.602 . . . . 0.0 110.359 -176.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 23.6 pt -142.64 161.01 18.8 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.096 175.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.424 ' HB2' HG21 ' A' ' 107' ' ' THR . 65.2 t80 -111.52 123.28 49.9 Favored 'General case' 0 N--CA 1.413 -2.305 0 CA-C-N 114.742 -1.117 . . . . 0.0 108.049 178.469 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 13.1 mt -108.39 127.26 64.88 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.047 0 N-CA-C 105.975 -1.861 . . . . 0.0 105.975 175.232 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -124.44 156.36 18.5 Favored Glycine 0 N--CA 1.42 -2.374 0 N-CA-C 111.802 -0.519 . . . . 0.0 111.802 -177.089 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.422 HD21 ' HB2' ' A' ' 100' ' ' ARG . 64.3 t30 67.07 57.57 0.6 Allowed 'General case' 0 C--N 1.314 -0.946 0 C-N-CA 125.4 1.48 . . . . 0.0 110.682 -177.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.427 HD11 HD11 ' A' ' 47' ' ' ILE . 3.1 mm? -82.96 143.91 30.35 Favored 'General case' 0 CA--C 1.485 -1.553 0 CA-C-N 114.426 -1.261 . . . . 0.0 110.002 176.588 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.445 HD22 ' HA3' ' A' ' 98' ' ' GLY . 38.4 t-20 -79.32 144.92 33.78 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 176.629 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.562 ' HD2' ' N ' ' A' ' 41' ' ' GLU . 0.8 OUTLIER -59.4 -24.69 63.66 Favored 'General case' 0 C--N 1.302 -1.458 0 C-N-CA 123.471 0.709 . . . . 0.0 112.23 179.528 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.562 ' N ' ' HD2' ' A' ' 40' ' ' ARG . 11.4 pt-20 -89.0 -14.32 36.82 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.609 -177.386 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.423 ' HG ' ' HB3' ' A' ' 39' ' ' ASN . 54.0 mt -75.51 132.09 40.53 Favored 'General case' 0 CA--C 1.5 -0.974 0 CA-C-O 121.548 0.69 . . . . 0.0 111.781 -176.228 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 42.0 p -114.81 172.7 6.88 Favored 'General case' 0 N--CA 1.418 -2.03 0 CA-C-N 114.725 -1.125 . . . . 0.0 111.046 -177.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -56.19 -42.46 77.17 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 123.707 0.803 . . . . 0.0 110.503 179.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -59.99 -38.27 93.96 Favored Glycine 0 C--O 1.24 0.484 0 CA-C-N 115.497 -0.774 . . . . 0.0 112.541 -179.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 49.9 m-20 -67.19 -49.61 63.99 Favored 'General case' 0 CA--C 1.494 -1.198 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.427 HD11 HD11 ' A' ' 38' ' ' LEU . 47.0 mt -58.87 -46.35 91.21 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 CA-C-N 115.131 -0.94 . . . . 0.0 110.706 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 40.9 mt -59.81 -43.7 94.35 Favored 'General case' 0 CA--C 1.499 -1.017 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.605 -178.224 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.436 HG23 ' H ' ' B' ' 233' ' ' ASP . 85.6 m -63.36 -46.43 86.58 Favored 'General case' 0 C--N 1.313 -1.016 0 O-C-N 123.408 0.443 . . . . 0.0 111.165 -178.589 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.407 HG13 ' HG3' ' B' ' 237' ' ' ARG . 97.2 t -66.22 -49.77 73.51 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.368 -178.355 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.447 ' HA ' ' HD2' ' A' ' 54' ' ' TYR . 4.8 m-85 -64.99 -19.89 66.22 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 123.974 0.909 . . . . 0.0 112.767 -178.132 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.514 ' OG ' ' HB2' ' B' ' 231' ' ' ARG . 60.2 m -72.97 -23.59 60.68 Favored 'General case' 0 N--CA 1.439 -0.989 0 N-CA-C 112.319 0.489 . . . . 0.0 112.319 176.657 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 50.2 tt0 -67.83 -20.52 65.17 Favored 'General case' 0 CA--C 1.56 1.349 0 CA-C-O 121.726 0.775 . . . . 0.0 110.115 177.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.458 ' OH ' ' HG ' ' A' ' 92' ' ' LEU . 41.3 m-85 -97.02 -10.2 26.62 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.608 -178.41 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 156.5 -159.12 29.25 Favored Glycine 0 N--CA 1.43 -1.747 0 C-N-CA 119.951 -1.118 . . . . 0.0 112.29 -179.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 77.5 t -103.58 110.17 63.34 Favored Pre-proline 0 C--N 1.306 -1.318 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 -176.367 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.512 ' HB3' HD21 ' A' ' 77' ' ' LEU . 99.0 Cg_endo -80.01 137.12 12.12 Favored 'Trans proline' 0 C--O 1.247 0.954 0 C-N-CA 123.034 2.489 . . . . 0.0 110.914 176.203 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 28.4 m -113.49 -20.06 6.4 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 -178.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.515 ' HB3' ' HG2' ' A' ' 78' ' ' LYS . 37.8 t70 -159.88 145.34 15.42 Favored 'General case' 0 C--O 1.249 1.038 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 14.3 p -144.68 134.43 19.17 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 86.1 mt -120.47 118.14 55.64 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.774 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 176.239 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -92.13 116.48 28.98 Favored 'General case' 0 C--N 1.28 -2.441 0 N-CA-C 104.677 -2.342 . . . . 0.0 104.677 175.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 33.6 m -79.77 115.93 19.65 Favored 'General case' 0 N--CA 1.414 -2.239 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 179.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 72.0 mtp180 -125.51 145.32 50.15 Favored 'General case' 0 CA--C 1.483 -1.617 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 -176.419 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -90.05 111.72 22.92 Favored 'General case' 0 C--N 1.289 -2.055 0 N-CA-C 106.017 -1.845 . . . . 0.0 106.017 178.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -61.05 -16.36 42.8 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 -175.105 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 22.1 m-80 -80.86 -44.5 18.29 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 -178.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 60.9 p -85.81 -24.36 26.83 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-O 121.166 0.508 . . . . 0.0 109.823 -179.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.81 9.93 86.64 Favored Glycine 0 N--CA 1.44 -1.082 0 N-CA-C 110.859 -0.897 . . . . 0.0 110.859 -178.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -115.94 167.92 10.53 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-O 120.726 0.298 . . . . 0.0 110.418 -175.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 43.3 t -61.7 144.26 54.88 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.849 175.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 -74.35 -17.88 60.76 Favored 'General case' 0 N--CA 1.432 -1.343 0 CA-C-O 121.556 0.693 . . . . 0.0 111.338 175.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 107.28 15.88 14.75 Favored Glycine 0 N--CA 1.427 -1.913 0 CA-C-N 115.386 -0.824 . . . . 0.0 112.472 -179.276 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 30.0 p90 -157.41 159.12 37.04 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 177.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -151.63 172.5 15.97 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-O 120.863 0.363 . . . . 0.0 110.582 179.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -130.75 142.66 50.42 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 123.762 0.825 . . . . 0.0 109.539 -179.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.512 HD21 ' HB3' ' A' ' 57' ' ' PRO . 10.2 tt -148.11 140.96 24.72 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 176.167 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.515 ' HG2' ' HB3' ' A' ' 59' ' ' ASP . 21.9 ptmt -123.82 144.3 49.81 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-O 121.356 0.598 . . . . 0.0 109.673 178.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -104.77 165.68 10.9 Favored 'General case' 0 C--N 1.282 -2.331 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.833 -178.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -77.31 -30.65 54.21 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 115.384 -0.825 . . . . 0.0 108.967 174.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.436 ' OD1' ' HB2' ' A' ' 83' ' ' ARG . 12.5 t70 -119.91 137.56 53.96 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 -176.437 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 26.0 mp0 -69.49 -25.71 64.19 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 113.377 0.88 . . . . 0.0 113.377 -177.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.436 ' HB2' ' OD1' ' A' ' 81' ' ' ASP . 0.1 OUTLIER -67.35 -33.34 75.03 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-O 122.014 0.911 . . . . 0.0 110.291 -179.342 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.461 ' OG ' HG21 ' B' ' 226' ' ' ILE . 51.5 m -59.39 -36.99 76.84 Favored 'General case' 0 C--N 1.281 -2.372 0 CA-C-N 115.307 -0.861 . . . . 0.0 111.657 175.295 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.429 ' O ' HG23 ' A' ' 89' ' ' VAL . 50.3 p -62.58 -45.3 93.55 Favored 'General case' 0 C--O 1.213 -0.823 0 C-N-CA 120.524 -0.47 . . . . 0.0 110.818 -178.17 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.418 ' H ' HG12 ' A' ' 86' ' ' ILE . 3.3 pt -66.34 -38.72 82.43 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.479 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.498 179.147 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.617 HD21 ' CD1' ' B' ' 224' ' ' PHE . 38.4 mt -59.63 -44.1 93.6 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.236 175.513 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.489 ' O ' ' HB2' ' A' ' 92' ' ' LEU . . . -72.08 -47.13 53.66 Favored 'General case' 0 N--CA 1.437 -1.112 0 CA-C-N 115.992 -0.549 . . . . 0.0 112.313 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.463 HG22 HG22 ' A' ' 104' ' ' ILE . 77.0 t -57.49 -49.12 81.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 -177.547 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -67.71 -38.94 84.3 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.783 -173.295 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -92.91 -20.27 20.82 Favored 'General case' 0 C--N 1.297 -1.701 0 CA-C-N 115.864 -0.607 . . . . 0.0 112.378 -172.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.489 ' HB2' ' O ' ' A' ' 88' ' ' ALA . 6.6 mt -93.19 -30.29 15.29 Favored 'General case' 0 C--N 1.315 -0.919 0 O-C-N 122.346 -0.221 . . . . 0.0 111.568 178.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 31.9 t-20 -59.25 124.2 19.22 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 179.043 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 88.86 -1.21 83.2 Favored Glycine 0 N--CA 1.442 -0.947 0 C-N-CA 121.064 -0.589 . . . . 0.0 113.417 177.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 67.3 t80 -86.51 141.75 28.85 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 117.579 0.69 . . . . 0.0 110.096 -179.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.425 ' HD2' ' N ' ' A' ' 96' ' ' LYS . 0.2 OUTLIER -98.05 116.15 29.69 Favored 'General case' 0 C--O 1.248 0.997 0 CA-C-O 121.153 0.502 . . . . 0.0 112.11 -177.137 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 58.1 mt -124.12 141.53 43.98 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 174.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.445 ' HA3' HD22 ' A' ' 39' ' ' ASN . . . 60.37 18.38 49.98 Favored Glycine 0 CA--C 1.521 0.438 0 N-CA-C 113.76 0.264 . . . . 0.0 113.76 179.461 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 83.88 14.31 72.91 Favored Glycine 0 N--CA 1.438 -1.223 0 C-N-CA 120.786 -0.721 . . . . 0.0 113.017 -178.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.422 ' HB2' HD21 ' A' ' 37' ' ' ASN . 17.5 ptp180 -136.78 150.12 48.18 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 117.696 0.748 . . . . 0.0 110.081 177.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -87.87 121.89 30.84 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 120.592 0.234 . . . . 0.0 111.368 -178.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 11.4 mt -73.02 145.63 46.51 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-O 121.675 0.75 . . . . 0.0 112.769 179.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 17.4 tptm -121.33 122.17 39.26 Favored 'General case' 0 N--CA 1.413 -2.303 0 CA-C-N 115.017 -0.992 . . . . 0.0 108.783 174.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.463 HG22 HG22 ' A' ' 89' ' ' VAL . 5.1 mm -116.17 135.09 57.47 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.018 0 N-CA-C 105.358 -2.09 . . . . 0.0 105.358 176.428 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -141.51 151.94 43.72 Favored 'General case' 0 C--N 1.285 -2.218 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 -176.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 75.2 m-70 -83.86 138.24 33.29 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.424 HG21 ' HB2' ' A' ' 34' ' ' TYR . 9.8 t -157.79 168.5 27.03 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 -178.461 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -110.16 113.04 25.41 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 106.317 -1.735 . . . . 0.0 106.317 169.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 56.8 t80 -105.55 136.88 44.32 Favored 'General case' 0 C--N 1.287 -2.12 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.703 -175.188 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 7.9 mpt_? -109.24 113.47 58.72 Favored Pre-proline 0 C--N 1.31 -1.117 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 175.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -73.09 147.03 42.21 Favored 'Trans proline' 0 C--O 1.248 1.011 0 C-N-CA 123.393 2.729 . . . . 0.0 115.424 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.441 ' C ' ' HD3' ' A' ' 112' ' ' LYS . 7.6 tmtm? -121.39 129.43 53.03 Favored 'General case' 0 N--CA 1.419 -1.987 0 N-CA-C 104.209 -2.515 . . . . 0.0 104.209 168.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 8.3 mmm180 . . . . . 0 C--N 1.291 -1.942 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 -178.782 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 46.6 t-20 . . . . . 0 C--O 1.206 -1.19 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 223' ' ' ARG . . . . . . . . . . . . 0.277 12.0 ptm180 65.16 19.51 11.77 Favored 'General case' 0 N--CA 1.504 2.266 0 C-N-CA 126.472 1.909 . . . . 0.0 115.39 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 224' ' ' PHE . . . . . 0.617 ' CD1' HD21 ' A' ' 87' ' ' LEU . 12.7 m-85 -96.08 166.28 11.83 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 175.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 225' ' ' ALA . . . . . . . . . . . . . . . -127.89 33.32 4.8 Favored 'General case' 0 C--N 1.311 -1.1 0 C-N-CA 120.43 -0.508 . . . . 0.0 111.843 -176.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 226' ' ' ILE . . . . . 0.461 HG21 ' OG ' ' A' ' 84' ' ' SER . 4.5 mp -81.74 126.22 39.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 175.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 227' ' ' MET . . . . . . . . . . . . . 22.4 ptp -71.39 144.84 89.76 Favored Pre-proline 0 C--N 1.31 -1.115 0 O-C-N 123.608 0.568 . . . . 0.0 110.098 -178.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 228' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -68.56 147.59 70.77 Favored 'Trans proline' 0 C--N 1.317 -1.087 0 C-N-CA 123.284 2.656 . . . . 0.0 112.25 178.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . -68.46 167.64 43.79 Favored Glycine 0 N--CA 1.443 -0.839 0 CA-C-N 115.663 -0.699 . . . . 0.0 113.073 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 40.9 m -74.85 -12.92 60.49 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -176.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 231' ' ' ARG . . . . . 0.514 ' HB2' ' OG ' ' A' ' 52' ' ' SER . 27.8 mmt180 -78.93 -11.74 60.01 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 178.136 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 232' ' ' TRP . . . . . . . . . . . . . 23.1 t90 -71.15 121.68 18.76 Favored 'General case' 0 N--CA 1.435 -1.198 0 CA-C-O 122.108 0.956 . . . . 0.0 112.184 -177.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 233' ' ' ASP . . . . . 0.436 ' H ' HG23 ' A' ' 49' ' ' THR . 29.9 t70 -114.94 144.62 43.28 Favored 'General case' 0 C--N 1.273 -2.742 0 N-CA-C 101.791 -3.411 . . . . 0.0 101.791 171.548 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -43.77 56.28 0.0 OUTLIER Glycine 0 N--CA 1.506 3.333 0 C-N-CA 128.295 2.855 . . . . 0.0 116.973 -176.146 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 235' ' ' VAL . . . . . 0.429 ' N ' ' O ' ' B' ' 233' ' ' ASP . 47.7 t -111.35 125.44 68.67 Favored 'Isoleucine or valine' 0 C--N 1.248 -3.833 0 C-N-CA 128.371 2.669 . . . . 0.0 107.695 178.42 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 236' ' ' HIS . . . . . . . . . . . . . 81.2 t60 -112.15 120.21 41.01 Favored 'General case' 0 C--N 1.292 -1.933 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 -178.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 237' ' ' ARG . . . . . 0.407 ' HG3' HG13 ' A' ' 50' ' ' VAL . 35.3 mmt180 -126.35 110.14 13.03 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 238' ' ' SER . . . . . . . . . . . . . 73.4 m -146.37 129.49 16.54 Favored 'General case' 0 C--N 1.288 -2.084 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 239' ' ' ASN . . . . . . . . . . . . . 46.9 t30 -78.8 154.11 30.17 Favored 'General case' 0 N--CA 1.424 -1.752 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 173.412 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 240' ' ' GLY . . . . . 0.473 ' O ' ' HG2' ' B' ' 244' ' ' LYS . . . 112.53 35.27 1.76 Allowed Glycine 0 N--CA 1.417 -2.581 0 C-N-CA 120.165 -1.017 . . . . 0.0 110.77 -175.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 14.6 p90 -76.97 -34.35 57.57 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-O 121.015 0.436 . . . . 0.0 111.403 177.046 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -61.27 -42.39 98.56 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 123.761 0.824 . . . . 0.0 109.972 -177.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -64.26 -34.34 77.89 Favored 'General case' 0 C--O 1.198 -1.65 0 CA-C-N 115.459 -0.791 . . . . 0.0 112.218 -179.336 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 244' ' ' LYS . . . . . 0.473 ' HG2' ' O ' ' B' ' 240' ' ' GLY . 74.2 mmtt -62.42 -42.87 99.76 Favored 'General case' 0 C--N 1.316 -0.879 0 C-N-CA 122.788 0.435 . . . . 0.0 111.625 -175.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 245' ' ' TRP . . . . . . . . . . . . . 6.9 m0 -69.86 -37.5 76.13 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 121.734 0.778 . . . . 0.0 109.17 178.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 246' ' ' PHE . . . . . 0.553 ' O ' ' HG2' ' B' ' 249' ' ' GLN . 5.1 t80 -65.23 -40.71 94.42 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 114.909 -1.042 . . . . 0.0 110.31 177.545 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -67.06 -22.11 65.87 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 115.781 -0.645 . . . . 0.0 112.142 -179.03 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -100.68 -25.7 14.06 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 120.156 -0.618 . . . . 0.0 112.381 178.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 249' ' ' GLN . . . . . 0.553 ' HG2' ' O ' ' B' ' 246' ' ' PHE . 3.2 pt20 -69.77 -11.98 61.27 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-O 121.126 0.488 . . . . 0.0 110.504 -177.26 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 250' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -58.67 -23.06 58.62 Favored 'General case' 0 N--CA 1.482 1.142 0 CA-C-N 114.692 -1.14 . . . . 0.0 111.832 179.415 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -121.22 130.39 53.67 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 178.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 252' ' ' ILE . . . . . . . . . . . . . 32.8 pt -92.45 -36.81 8.02 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 -176.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -97.84 -25.85 14.89 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-O 121.865 0.84 . . . . 0.0 110.494 -175.046 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 254' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -101.42 149.86 23.62 Favored 'General case' 0 N--CA 1.409 -2.479 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.17 -173.273 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 255' ' ' LYS . . . . . . . . . . . . . 12.5 ptmm? -122.06 -20.42 6.29 Favored 'General case' 0 C--N 1.281 -2.378 0 CA-C-N 114.457 -1.247 . . . . 0.0 110.132 -178.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 256' ' ' LYS . . . . . . . . . . . . . 88.3 tttt . . . . . 0 N--CA 1.452 -0.341 0 O-C-N 124.806 1.317 . . . . 0.0 108.408 -172.073 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 . . . . . 0 CA--C 1.497 -1.087 0 N-CA-C 104.822 -2.288 . . . . 0.0 104.822 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -72.62 -17.52 61.67 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 114.513 1.301 . . . . 0.0 114.513 -156.233 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -96.61 -3.41 42.95 Favored 'General case' 0 C--N 1.282 -2.335 0 CA-C-O 121.382 0.611 . . . . 0.0 111.663 -174.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.616 ' HB3' ' OD1' ' A' ' 30' ' ' ASN . 14.4 mmmm -139.71 -57.51 0.57 Allowed 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.607 -178.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . 0.271 53.0 m-20 48.76 55.41 9.18 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 124.715 1.206 . . . . 0.0 114.241 -173.743 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.647 ' H ' ' NE2' ' A' ' 82' ' ' GLN . 14.3 m120 -105.71 28.95 7.0 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 106.784 -1.562 . . . . 0.0 106.784 174.231 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.411 ' HA ' HG21 ' A' ' 85' ' ' THR . . . -89.67 -4.89 57.55 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 114.607 -1.179 . . . . 0.0 112.102 -174.016 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -107.89 145.11 34.18 Favored 'General case' 0 C--N 1.317 -0.846 0 C-N-CA 120.876 -0.33 . . . . 0.0 110.178 -174.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 30.5 pt -139.55 156.78 26.73 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 CA-C-O 120.986 0.422 . . . . 0.0 110.524 177.028 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 28.5 t80 -107.41 122.83 47.4 Favored 'General case' 0 N--CA 1.423 -1.796 0 CA-C-N 114.671 -1.149 . . . . 0.0 108.364 177.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.425 HG23 ' CD1' ' A' ' 104' ' ' ILE . 7.7 mt -108.77 128.17 64.73 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.977 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 176.51 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -129.66 173.92 19.55 Favored Glycine 0 C--N 1.287 -2.154 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.976 -178.221 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 19.5 m120 65.82 24.2 11.37 Favored 'General case' 0 CA--C 1.512 -0.517 0 C-N-CA 125.123 1.369 . . . . 0.0 111.922 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -58.27 140.77 52.67 Favored 'General case' 0 CA--C 1.495 -1.154 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 -178.357 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.508 ' CG ' ' HG2' ' A' ' 41' ' ' GLU . 49.8 t-20 -71.5 142.64 50.14 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 172.298 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.485 ' HD2' ' N ' ' A' ' 41' ' ' GLU . 7.5 ppt_? -58.99 -22.94 61.32 Favored 'General case' 0 C--N 1.303 -1.43 0 C-N-CA 123.869 0.867 . . . . 0.0 112.62 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.508 ' HG2' ' CG ' ' A' ' 39' ' ' ASN . 12.8 pt-20 -87.19 -14.8 40.15 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.85 -176.175 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.469 ' HG ' ' HB3' ' A' ' 39' ' ' ASN . 79.6 mt -76.42 126.13 30.44 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.564 0.697 . . . . 0.0 112.598 -174.747 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 66.8 p -109.26 173.71 6.2 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 114.071 -1.422 . . . . 0.0 109.538 -177.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.7 mp0 -57.56 -42.31 82.76 Favored 'General case' 0 C--O 1.211 -0.933 0 C-N-CA 123.616 0.766 . . . . 0.0 109.92 178.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.43 -37.41 93.15 Favored Glycine 0 N--CA 1.446 -0.649 0 O-C-N 123.618 0.574 . . . . 0.0 112.814 -179.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 32.5 m-20 -67.42 -49.76 62.37 Favored 'General case' 0 CA--C 1.501 -0.934 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 179.306 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 51.4 mt -60.25 -45.78 95.72 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.777 0 CA-C-N 114.748 -1.115 . . . . 0.0 110.682 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 41.4 mt -59.96 -45.24 93.31 Favored 'General case' 0 CA--C 1.496 -1.099 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.322 -178.288 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.464 HG23 ' H ' ' B' ' 233' ' ' ASP . 87.8 m -61.88 -45.72 92.52 Favored 'General case' 0 C--N 1.313 -1.018 0 O-C-N 123.595 0.56 . . . . 0.0 111.585 -178.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.489 HG13 ' HG3' ' B' ' 237' ' ' ARG . 98.9 t -66.79 -50.19 67.63 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.489 -179.638 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.487 ' HA ' ' HD2' ' A' ' 54' ' ' TYR . 4.3 m-85 -62.49 -25.66 68.13 Favored 'General case' 0 N--CA 1.433 -1.276 0 C-N-CA 123.883 0.873 . . . . 0.0 112.381 -178.553 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 65.9 m -67.07 -20.22 65.79 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.287 176.29 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -70.07 -20.71 63.21 Favored 'General case' 0 CA--C 1.555 1.158 0 CA-C-O 121.302 0.572 . . . . 0.0 109.721 176.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.487 ' HD2' ' HA ' ' A' ' 51' ' ' PHE . 41.5 m-85 -97.51 -19.98 18.03 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-O 121.03 0.443 . . . . 0.0 111.59 -175.674 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 167.92 -159.49 32.75 Favored Glycine 0 N--CA 1.42 -2.379 0 N-CA-C 110.825 -0.91 . . . . 0.0 110.825 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 59.1 t -102.66 110.83 64.02 Favored Pre-proline 0 C--N 1.296 -1.746 0 O-C-N 123.471 0.159 . . . . 0.0 111.062 -177.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.511 ' HB3' HD21 ' A' ' 77' ' ' LEU . 92.7 Cg_endo -77.39 140.75 19.61 Favored 'Trans proline' 0 N--CA 1.451 -1.018 0 C-N-CA 122.849 2.366 . . . . 0.0 110.18 175.469 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 31.2 m -116.39 -19.08 6.63 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 C-N-CA 120.0 -0.68 . . . . 0.0 112.167 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.487 ' HB3' ' HG2' ' A' ' 78' ' ' LYS . 36.0 t70 -161.26 141.41 10.83 Favored 'General case' 0 C--O 1.242 0.682 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 -179.804 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 14.4 p -141.71 133.96 28.22 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 178.524 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 91.6 mt -120.46 125.37 74.07 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 177.443 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -100.77 134.18 44.13 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 178.203 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 22.3 t -92.62 131.52 37.65 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 176.256 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 68.7 mtt85 -134.59 142.0 46.81 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-O 120.879 0.371 . . . . 0.0 111.233 -177.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -74.32 126.86 31.58 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 107.775 -1.195 . . . . 0.0 107.775 176.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -61.41 -24.13 66.3 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 112.705 0.632 . . . . 0.0 112.705 -176.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 23.0 m-80 -82.97 -50.22 8.78 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-O 121.27 0.557 . . . . 0.0 110.608 -176.08 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 74.6 p -85.62 -24.14 27.24 Favored 'General case' 0 C--N 1.312 -1.046 0 C-N-CA 120.253 -0.579 . . . . 0.0 111.267 -174.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.63 3.2 78.21 Favored Glycine 0 N--CA 1.439 -1.142 0 N-CA-C 111.359 -0.697 . . . . 0.0 111.359 -177.185 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -103.84 164.23 11.82 Favored 'General case' 0 N--CA 1.428 -1.545 0 CA-C-O 121.057 0.456 . . . . 0.0 110.796 -176.413 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 13.7 m -58.85 132.02 52.7 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 114.792 -1.095 . . . . 0.0 111.438 -177.277 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 15.7 mm-40 -63.7 -21.76 66.56 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.557 1.143 . . . . 0.0 111.692 178.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 110.2 8.29 25.61 Favored Glycine 0 N--CA 1.421 -2.35 0 C-N-CA 119.88 -1.153 . . . . 0.0 112.269 -179.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 40.8 p90 -148.82 153.36 38.0 Favored 'General case' 0 C--O 1.252 1.194 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 177.125 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -149.52 172.83 14.36 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-O 120.915 0.388 . . . . 0.0 110.874 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -130.3 139.41 50.73 Favored 'General case' 0 C--N 1.303 -1.424 0 C-N-CA 124.161 0.984 . . . . 0.0 109.617 -179.274 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.511 HD21 ' HB3' ' A' ' 57' ' ' PRO . 9.9 tt -146.01 140.76 27.07 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 175.587 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.487 ' HG2' ' HB3' ' A' ' 59' ' ' ASP . 20.8 ptmt -124.37 144.27 50.12 Favored 'General case' 0 C--O 1.256 1.433 0 CA-C-O 121.259 0.552 . . . . 0.0 109.787 179.344 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 66.3 m-85 -108.16 164.31 12.41 Favored 'General case' 0 C--N 1.29 -1.983 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.719 179.578 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -77.99 -33.59 51.24 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 174.304 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -109.8 130.09 55.56 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.94 -176.163 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.647 ' NE2' ' H ' ' A' ' 30' ' ' ASN . 83.7 mt-30 -71.02 -20.37 62.4 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 -178.095 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 88.1 mtm180 -68.03 -34.1 75.85 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-O 121.946 0.879 . . . . 0.0 108.654 174.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.501 ' OG ' HG21 ' B' ' 226' ' ' ILE . 61.9 m -63.59 -37.11 86.07 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 115.078 -0.964 . . . . 0.0 112.511 178.299 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.447 ' O ' HG23 ' A' ' 89' ' ' VAL . 80.7 p -65.31 -45.84 82.72 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 120.325 -0.55 . . . . 0.0 110.476 -177.303 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.412 ' H ' HG12 ' A' ' 86' ' ' ILE . 3.4 pt -64.83 -39.23 84.96 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.884 177.179 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.604 HD11 ' HB2' ' B' ' 224' ' ' PHE . 19.9 mt -59.65 -44.54 93.51 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.653 176.393 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.452 ' O ' ' HB2' ' A' ' 92' ' ' LEU . . . -71.48 -45.88 61.32 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.035 -177.329 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.453 HG22 HG22 ' A' ' 104' ' ' ILE . 70.2 t -56.65 -49.02 79.7 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.797 0 CA-C-O 121.057 0.456 . . . . 0.0 110.95 178.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -63.25 -39.15 93.79 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 115.366 -0.834 . . . . 0.0 112.034 -175.062 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.479 HD22 ' HE1' ' A' ' 54' ' ' TYR . 63.3 t30 -96.42 -20.09 18.7 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.431 -171.748 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.452 ' HB2' ' O ' ' A' ' 88' ' ' ALA . 10.3 mt -96.59 -31.24 12.84 Favored 'General case' 0 CA--C 1.494 -1.176 0 CA-C-O 120.909 0.385 . . . . 0.0 111.655 -178.236 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 56.1 t30 -65.44 125.82 26.34 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.981 -177.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 88.13 -1.15 84.51 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 121.341 -0.457 . . . . 0.0 112.883 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.424 ' HB2' ' HB2' ' B' ' 239' ' ' ASN . 67.7 t80 -90.12 137.78 32.06 Favored 'General case' 0 C--N 1.32 -0.689 0 O-C-N 122.378 -0.483 . . . . 0.0 110.069 -178.423 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -92.45 116.74 29.25 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 121.56 0.695 . . . . 0.0 111.806 -176.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.62 ' HB ' HH21 ' A' ' 100' ' ' ARG . 62.7 mt -127.34 140.36 49.33 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 175.621 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 62.88 19.27 60.83 Favored Glycine 0 C--N 1.307 -1.066 0 C-N-CA 121.387 -0.435 . . . . 0.0 112.869 -179.007 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 91.72 -9.55 76.65 Favored Glycine 0 N--CA 1.438 -1.182 0 C-N-CA 121.218 -0.515 . . . . 0.0 112.953 -178.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.62 HH21 ' HB ' ' A' ' 97' ' ' ILE . 0.0 OUTLIER -125.54 146.88 49.47 Favored 'General case' 0 N--CA 1.418 -2.049 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 -175.764 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -79.8 136.54 36.75 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.692 -176.566 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.428 ' HG ' HH22 ' A' ' 100' ' ' ARG . 11.0 mt -82.47 148.39 28.17 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 115.457 -0.792 . . . . 0.0 112.445 176.253 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 4.3 tppp? -124.27 119.96 30.82 Favored 'General case' 0 N--CA 1.423 -1.825 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 174.271 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.453 HG22 HG22 ' A' ' 89' ' ' VAL . 4.6 mm -122.09 135.12 63.25 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 N-CA-C 107.108 -1.441 . . . . 0.0 107.108 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -143.63 158.82 43.38 Favored 'General case' 0 C--N 1.291 -1.947 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 178.335 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 38.3 m-70 -83.63 141.76 31.29 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 177.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 9.3 t -156.04 161.78 40.39 Favored 'General case' 0 C--N 1.285 -2.216 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 -178.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 26.0 p90 -109.88 110.35 21.28 Favored 'General case' 0 C--N 1.297 -1.674 0 C-N-CA 118.592 -1.243 . . . . 0.0 108.879 172.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 62.3 t80 -108.54 139.31 43.48 Favored 'General case' 0 C--N 1.294 -1.819 0 CA-C-N 115.351 -0.841 . . . . 0.0 110.98 -178.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.425 ' HA ' ' HD2' ' A' ' 111' ' ' PRO . 26.9 mmt180 -120.88 115.58 31.89 Favored Pre-proline 0 C--N 1.301 -1.506 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 172.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.425 ' HD2' ' HA ' ' A' ' 110' ' ' ARG . 36.3 Cg_endo -61.97 138.83 75.78 Favored 'Trans proline' 0 C--O 1.24 0.61 0 C-N-CA 123.584 2.856 . . . . 0.0 113.232 -178.522 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.402 ' C ' ' HD3' ' A' ' 112' ' ' LYS . 10.8 tmtt? -82.69 124.32 30.1 Favored 'General case' 0 N--CA 1.432 -1.354 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 178.023 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 9.7 mmm180 . . . . . 0 C--N 1.302 -1.499 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 179.448 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 12.6 t-20 . . . . . 0 CA--C 1.545 0.758 0 CA-C-O 121.511 0.672 . . . . 0.0 109.846 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 223' ' ' ARG . . . . . . . . . . . . 0.549 10.7 mtp180 75.2 52.12 0.07 Allowed 'General case' 0 CA--C 1.501 -0.928 0 N-CA-C 118.737 2.866 . . . . 0.0 118.737 176.647 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 224' ' ' PHE . . . . . 0.604 ' HB2' HD11 ' A' ' 87' ' ' LEU . 32.2 m-85 -116.2 165.27 13.35 Favored 'General case' 0 C--N 1.283 -2.296 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 173.453 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 225' ' ' ALA . . . . . . . . . . . . . . . -125.96 83.28 2.15 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-O 121.64 0.733 . . . . 0.0 110.479 -178.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 226' ' ' ILE . . . . . 0.501 HG21 ' OG ' ' A' ' 84' ' ' SER . 3.8 mp -120.73 132.61 69.82 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 CA-C-N 115.011 -0.995 . . . . 0.0 108.843 178.778 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 227' ' ' MET . . . . . . . . . . . . . 24.8 mmt -59.53 140.19 88.91 Favored Pre-proline 0 C--N 1.323 -0.577 0 O-C-N 124.061 0.851 . . . . 0.0 111.405 179.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 228' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -71.18 156.01 60.08 Favored 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 122.555 2.17 . . . . 0.0 111.444 179.119 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . -74.38 168.9 54.33 Favored Glycine 0 C--N 1.307 -1.041 0 CA-C-N 116.167 -0.47 . . . . 0.0 112.642 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 22.6 t -77.41 -15.21 59.47 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-O 120.954 0.407 . . . . 0.0 110.315 -178.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 13.6 mmp_? -80.83 -5.2 56.97 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 121.974 -0.454 . . . . 0.0 111.192 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 232' ' ' TRP . . . . . . . . . . . . . 19.2 t90 -70.94 127.02 31.19 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-O 122.659 1.219 . . . . 0.0 111.878 -178.076 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 233' ' ' ASP . . . . . 0.464 ' H ' HG23 ' A' ' 49' ' ' THR . 11.8 t70 -118.09 145.5 44.8 Favored 'General case' 0 C--N 1.271 -2.833 0 N-CA-C 101.059 -3.682 . . . . 0.0 101.059 172.579 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -49.78 57.76 0.0 OUTLIER Glycine 0 N--CA 1.497 2.749 0 C-N-CA 127.211 2.339 . . . . 0.0 116.175 -177.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 235' ' ' VAL . . . . . 0.448 HG12 ' HG2' ' B' ' 237' ' ' ARG . 39.7 t -103.13 133.82 45.93 Favored 'Isoleucine or valine' 0 C--N 1.247 -3.884 0 C-N-CA 128.295 2.638 . . . . 0.0 106.589 176.323 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 236' ' ' HIS . . . . . . . . . . . . . 48.6 t-80 -111.92 113.35 25.61 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 178.245 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 237' ' ' ARG . . . . . 0.489 ' HG3' HG13 ' A' ' 50' ' ' VAL . 35.2 mmt180 -126.46 106.96 9.83 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 109.246 -0.649 . . . . 0.0 109.246 176.529 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 238' ' ' SER . . . . . . . . . . . . . 75.7 m -147.28 129.19 15.36 Favored 'General case' 0 C--N 1.298 -1.667 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.936 179.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 239' ' ' ASN . . . . . 0.424 ' HB2' ' HB2' ' A' ' 95' ' ' PHE . 57.5 t30 -105.34 165.77 10.88 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 -179.773 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 240' ' ' GLY . . . . . 0.483 ' O ' ' HG2' ' B' ' 244' ' ' LYS . . . 92.23 9.68 61.71 Favored Glycine 0 C--O 1.201 -1.928 0 C-N-CA 120.979 -0.629 . . . . 0.0 111.603 179.755 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -76.14 -33.56 59.42 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-O 120.899 0.38 . . . . 0.0 110.709 179.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -60.89 -43.84 97.92 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.106 -178.347 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -62.08 -34.62 76.64 Favored 'General case' 0 C--O 1.206 -1.219 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.307 179.189 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 244' ' ' LYS . . . . . 0.483 ' HG2' ' O ' ' B' ' 240' ' ' GLY . 72.9 mmtt -64.76 -45.52 86.05 Favored 'General case' 0 CA--C 1.508 -0.653 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 -179.268 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 245' ' ' TRP . . . . . . . . . . . . . 49.3 m0 -66.03 -42.45 89.59 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.26 178.506 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 246' ' ' PHE . . . . . 0.52 ' HA ' ' CD ' ' B' ' 249' ' ' GLN . 6.0 t80 -63.88 -36.95 85.62 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.246 179.743 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -70.33 -32.37 70.07 Favored 'General case' 0 C--N 1.292 -1.923 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.687 -179.244 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.46 -19.94 20.78 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -177.529 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 249' ' ' GLN . . . . . 0.52 ' CD ' ' HA ' ' B' ' 246' ' ' PHE . 2.9 pt20 -74.11 2.79 8.14 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.093 0.557 . . . . 0.0 110.71 -177.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 250' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -57.93 -30.62 66.09 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.373 178.521 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -84.59 120.89 26.88 Favored 'General case' 0 N--CA 1.437 -1.106 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.195 179.358 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 252' ' ' ILE . . . . . . . . . . . . . 37.6 pt -101.63 -28.65 3.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.759 -175.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -107.45 -26.52 10.91 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-O 121.573 0.701 . . . . 0.0 110.123 -178.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 254' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -91.3 173.84 7.71 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-N 115.306 -0.861 . . . . 0.0 108.68 -179.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 255' ' ' LYS . . . . . . . . . . . . . 9.2 ptpp? -71.35 156.54 39.38 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 122.89 0.476 . . . . 0.0 110.137 178.6 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 256' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.431 -1.4 0 CA-C-O 120.691 0.281 . . . . 0.0 111.157 -178.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 15.9 m120 . . . . . 0 CA--C 1.51 -0.593 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -66.89 -27.44 67.51 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.391 0.615 . . . . 0.0 111.961 -170.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -88.98 13.7 12.26 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 113.291 0.849 . . . . 0.0 113.291 -173.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.614 ' HB3' ' OD1' ' A' ' 30' ' ' ASN . 13.6 mmmm -101.02 -43.46 6.03 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 173.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 23.2 t70 74.07 13.24 4.08 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-O 122.666 1.222 . . . . 0.0 110.747 177.245 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.614 ' OD1' ' HB3' ' A' ' 28' ' ' LYS . 15.4 m120 -89.96 24.65 2.36 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 114.448 -1.251 . . . . 0.0 109.636 -178.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -87.22 -0.04 56.1 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.341 -179.352 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -108.69 145.33 35.2 Favored 'General case' 0 N--CA 1.434 -1.248 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.868 -176.137 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 28.4 pt -136.86 160.36 36.85 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.753 177.233 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.49 ' HB2' HG21 ' A' ' 107' ' ' THR . 34.4 t80 -112.8 124.12 51.88 Favored 'General case' 0 N--CA 1.413 -2.31 0 CA-C-N 115.26 -0.882 . . . . 0.0 108.831 177.76 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.458 HG23 ' CD1' ' A' ' 104' ' ' ILE . 10.4 mt -108.55 127.75 64.73 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.036 0 N-CA-C 106.846 -1.539 . . . . 0.0 106.846 176.136 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -130.07 160.99 23.05 Favored Glycine 0 N--CA 1.425 -2.04 0 N-CA-C 112.02 -0.432 . . . . 0.0 112.02 -179.094 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 66.4 t30 70.39 41.27 1.02 Allowed 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.82 1.648 . . . . 0.0 110.604 -179.232 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -69.39 151.73 45.78 Favored 'General case' 0 CA--C 1.499 -0.987 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.864 175.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.469 ' HB3' ' HG ' ' A' ' 42' ' ' LEU . 45.9 t-20 -84.66 149.94 25.48 Favored 'General case' 0 C--N 1.284 -2.273 0 N-CA-C 106.344 -1.724 . . . . 0.0 106.344 175.758 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.507 ' C ' ' HD2' ' A' ' 40' ' ' ARG . 5.8 ppt_? -59.1 -24.45 62.97 Favored 'General case' 0 C--N 1.307 -1.242 0 C-N-CA 123.354 0.662 . . . . 0.0 111.025 178.606 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.403 ' N ' ' HD2' ' A' ' 40' ' ' ARG . 13.8 pt-20 -95.39 0.11 53.13 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.825 -0.625 . . . . 0.0 112.317 -175.81 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.469 ' HG ' ' HB3' ' A' ' 39' ' ' ASN . 68.6 mt -89.81 121.69 32.18 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-O 121.132 0.492 . . . . 0.0 110.407 179.503 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 70.6 p -108.43 174.44 5.87 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-N 114.674 -1.148 . . . . 0.0 110.279 -176.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.44 ' CG ' ' HB2' ' A' ' 62' ' ' LEU . 33.6 mt-10 -55.15 -40.87 71.09 Favored 'General case' 0 C--O 1.212 -0.914 0 O-C-N 123.616 0.572 . . . . 0.0 109.689 176.622 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -59.76 -39.83 95.84 Favored Glycine 0 C--O 1.243 0.7 0 CA-C-N 116.079 -0.51 . . . . 0.0 112.738 179.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -66.82 -49.65 65.1 Favored 'General case' 0 CA--C 1.499 -1.017 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 179.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 47.2 mt -60.07 -46.68 94.01 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.808 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.842 -179.643 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 47.5 mt -60.07 -42.49 94.67 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 116.592 -0.277 . . . . 0.0 111.705 -177.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 90.8 m -63.98 -46.28 85.32 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 120.869 0.366 . . . . 0.0 111.256 -179.134 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.501 HG13 ' HG3' ' B' ' 237' ' ' ARG . 95.7 t -66.98 -48.63 78.91 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.692 -178.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.433 ' HA ' ' HD2' ' A' ' 54' ' ' TYR . 4.6 m-85 -64.88 -23.08 67.12 Favored 'General case' 0 N--CA 1.426 -1.636 0 CA-C-N 115.28 -0.873 . . . . 0.0 112.416 -178.413 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.477 ' HA ' ' O ' ' A' ' 55' ' ' GLY . 61.5 m -72.3 -20.8 61.44 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 176.64 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -71.46 -22.18 61.86 Favored 'General case' 0 C--O 1.246 0.894 0 C-N-CA 119.859 -0.736 . . . . 0.0 109.596 177.275 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.433 ' HD2' ' HA ' ' A' ' 51' ' ' PHE . 73.7 m-85 -92.0 -22.82 19.77 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.818 -178.538 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.477 ' O ' ' HA ' ' A' ' 52' ' ' SER . . . 169.79 -164.47 37.91 Favored Glycine 0 N--CA 1.427 -1.965 0 N-CA-C 110.927 -0.869 . . . . 0.0 110.927 -179.588 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 54.8 t -99.03 111.0 59.82 Favored Pre-proline 0 C--N 1.302 -1.498 0 CA-C-N 116.548 0.174 . . . . 0.0 111.039 -176.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.46 ' HB3' HD21 ' A' ' 77' ' ' LEU . 85.9 Cg_endo -78.13 141.77 18.84 Favored 'Trans proline' 0 C--O 1.246 0.895 0 C-N-CA 122.975 2.45 . . . . 0.0 110.627 175.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 29.7 m -120.53 -15.38 7.43 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 C-N-CA 120.264 -0.575 . . . . 0.0 112.132 179.226 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.565 ' HB3' ' HG2' ' A' ' 78' ' ' LYS . 28.3 t70 -163.27 135.92 5.4 Favored 'General case' 0 C--O 1.244 0.799 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 -176.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 14.4 p -143.97 136.88 23.71 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.416 ' CD1' ' HB3' ' A' ' 111' ' ' PRO . 90.2 mt -120.92 121.63 65.62 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.799 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 177.234 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.44 ' HB2' ' CG ' ' A' ' 44' ' ' GLU . 0.1 OUTLIER -100.2 113.54 26.28 Favored 'General case' 0 N--CA 1.42 -1.93 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 175.267 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 13.6 m -78.32 117.91 20.01 Favored 'General case' 0 C--N 1.274 -2.693 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 178.406 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 84.2 mtm180 -114.28 148.63 37.18 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-O 121.052 0.454 . . . . 0.0 110.125 179.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -82.67 117.57 22.7 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.725 178.019 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -61.42 -23.04 65.55 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.599 -0.728 . . . . 0.0 112.717 -177.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 19.3 m-80 -79.79 -50.05 11.11 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 120.897 0.379 . . . . 0.0 109.993 -175.435 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 38.3 p -87.12 -23.59 24.82 Favored 'General case' 0 C--O 1.249 1.035 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 -176.276 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.07 20.09 77.93 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 111.29 -0.724 . . . . 0.0 111.29 -177.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -123.2 172.83 8.31 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 -178.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 19.7 m -60.02 147.32 39.53 Favored 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 122.763 0.425 . . . . 0.0 111.44 179.215 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 12.9 mm-40 -79.24 -10.25 59.77 Favored 'General case' 0 CA--C 1.502 -0.878 0 C-N-CA 123.233 0.613 . . . . 0.0 112.456 178.654 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 96.54 2.99 59.9 Favored Glycine 0 N--CA 1.426 -2.031 0 C-N-CA 119.651 -1.261 . . . . 0.0 112.113 -179.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 34.5 p90 -145.65 151.58 38.28 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 178.294 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -149.49 170.16 19.24 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 123.266 0.354 . . . . 0.0 110.529 -179.217 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -131.5 140.12 49.46 Favored 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 123.649 0.78 . . . . 0.0 109.427 -178.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.46 HD21 ' HB3' ' A' ' 57' ' ' PRO . 9.9 tt -147.33 140.45 25.19 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 177.183 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.565 ' HG2' ' HB3' ' A' ' 59' ' ' ASP . 18.7 ptmt -124.0 144.43 49.83 Favored 'General case' 0 C--O 1.259 1.567 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 178.122 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.415 ' HH ' ' HD2' ' A' ' 51' ' ' PHE . 58.7 m-85 -106.9 164.89 11.75 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.956 -178.32 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -77.83 -25.73 49.01 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 114.813 -1.085 . . . . 0.0 109.293 176.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -124.1 130.39 52.48 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 -179.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.498 HE22 ' HB2' ' A' ' 28' ' ' LYS . 49.0 mt-30 -69.3 -21.05 63.89 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 113.137 0.792 . . . . 0.0 113.137 -177.262 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 89.6 mtm180 -63.64 -33.13 74.95 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-O 122.352 1.073 . . . . 0.0 110.109 177.374 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.435 ' OG ' HG21 ' B' ' 226' ' ' ILE . 48.9 m -63.53 -36.98 85.59 Favored 'General case' 0 C--N 1.282 -2.335 0 CA-C-N 114.628 -1.169 . . . . 0.0 112.22 178.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.421 ' O ' HG23 ' A' ' 89' ' ' VAL . 81.8 p -64.74 -45.05 88.11 Favored 'General case' 0 C--O 1.219 -0.501 0 C-N-CA 120.279 -0.568 . . . . 0.0 110.525 -177.015 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.425 ' H ' HG12 ' A' ' 86' ' ' ILE . 3.3 pt -63.89 -39.45 85.46 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.103 177.225 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 29.2 mt -60.32 -43.61 96.21 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 120.902 0.382 . . . . 0.0 111.011 175.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.423 ' O ' ' HB2' ' A' ' 92' ' ' LEU . . . -71.47 -47.16 57.37 Favored 'General case' 0 C--O 1.211 -0.959 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.67 -178.64 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.449 HG22 HG22 ' A' ' 104' ' ' ILE . 79.5 t -57.21 -48.7 81.72 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.492 0 CA-C-O 120.915 0.388 . . . . 0.0 111.006 -179.44 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -68.38 -31.9 71.6 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 115.509 -0.769 . . . . 0.0 112.466 -173.413 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -97.56 -20.77 17.48 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 -176.302 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.461 ' HB2' HG13 ' A' ' 104' ' ' ILE . 9.6 mt -93.43 -28.56 16.06 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-O 120.574 0.226 . . . . 0.0 111.07 -179.15 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -60.26 124.74 21.22 Favored 'General case' 0 C--O 1.244 0.79 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 178.056 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 83.86 -1.07 89.23 Favored Glycine 0 C--N 1.306 -1.128 0 C-N-CA 120.499 -0.858 . . . . 0.0 113.447 177.542 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.463 ' CE2' ' HD2' ' B' ' 237' ' ' ARG . 86.4 t80 -85.3 134.4 34.12 Favored 'General case' 0 N--CA 1.443 -0.825 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 178.688 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.409 ' HA ' ' HA ' ' A' ' 101' ' ' ALA . 11.1 mptt -92.88 118.87 31.6 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.229 -176.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 54.1 mt -121.72 141.16 43.33 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 N-CA-C 105.257 -2.127 . . . . 0.0 105.257 172.577 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.413 ' HA3' HD22 ' A' ' 39' ' ' ASN . . . 58.92 22.48 54.77 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 121.191 -0.528 . . . . 0.0 112.821 -179.04 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 82.21 7.41 87.77 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 121.492 -0.385 . . . . 0.0 113.546 -179.435 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 16.7 ptp180 -129.52 141.04 51.08 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 117.688 0.744 . . . . 0.0 110.894 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.409 ' HA ' ' HA ' ' A' ' 96' ' ' LYS . . . -79.61 122.08 26.07 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.012 0.434 . . . . 0.0 111.387 -179.215 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 9.5 mt -68.7 141.23 55.35 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.671 177.2 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -113.98 116.01 28.55 Favored 'General case' 0 N--CA 1.409 -2.517 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 176.244 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.461 HG13 ' HB2' ' A' ' 92' ' ' LEU . 4.8 mm -116.65 136.11 54.78 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.861 0 N-CA-C 106.423 -1.695 . . . . 0.0 106.423 178.417 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -144.0 151.85 40.26 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.331 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -80.63 135.6 36.08 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-O 120.975 0.417 . . . . 0.0 110.223 177.648 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.49 HG21 ' HB2' ' A' ' 34' ' ' TYR . 6.5 t -153.64 168.35 26.52 Favored 'General case' 0 C--N 1.291 -1.972 0 N-CA-C 107.427 -1.324 . . . . 0.0 107.427 -177.065 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -108.91 110.82 22.24 Favored 'General case' 0 N--CA 1.421 -1.888 0 N-CA-C 105.208 -2.145 . . . . 0.0 105.208 169.143 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 84.9 t80 -106.93 132.64 52.65 Favored 'General case' 0 C--N 1.291 -1.967 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 178.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 12.5 tpp180 -111.14 113.13 54.72 Favored Pre-proline 0 C--N 1.294 -1.822 0 N-CA-C 106.689 -1.597 . . . . 0.0 106.689 175.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.416 ' HB3' ' CD1' ' A' ' 61' ' ' ILE . 47.4 Cg_endo -71.13 149.24 57.83 Favored 'Trans proline' 0 C--O 1.25 1.077 0 C-N-CA 123.013 2.475 . . . . 0.0 115.551 -178.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 25.1 tptp -121.01 118.88 30.95 Favored 'General case' 0 N--CA 1.42 -1.968 0 CA-C-N 112.994 -1.912 . . . . 0.0 106.793 172.074 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 23.5 mmt180 . . . . . 0 C--N 1.28 -2.44 0 N-CA-C 107.019 -1.474 . . . . 0.0 107.019 179.948 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 . . . . . 0 N--CA 1.48 1.058 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 223' ' ' ARG . . . . . . . . . . . . 0.277 30.1 mtp180 67.01 50.75 1.01 Allowed 'General case' 0 CA--C 1.505 -0.761 0 CA-C-O 122.871 1.32 . . . . 0.0 114.233 175.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 224' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -109.49 166.88 10.54 Favored 'General case' 0 C--N 1.268 -2.95 0 CA-C-N 112.495 -2.139 . . . . 0.0 106.806 175.327 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 225' ' ' ALA . . . . . . . . . . . . . . . -126.34 81.68 2.02 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-O 121.279 0.561 . . . . 0.0 110.91 -179.224 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 226' ' ' ILE . . . . . 0.435 HG21 ' OG ' ' A' ' 84' ' ' SER . 4.2 mp -125.93 132.76 70.3 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.211 177.518 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 227' ' ' MET . . . . . . . . . . . . . 86.8 mtp -71.2 133.54 85.54 Favored Pre-proline 0 C--N 1.315 -0.903 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 176.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 228' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -64.27 160.89 36.59 Favored 'Trans proline' 0 C--O 1.24 0.622 0 C-N-CA 123.43 2.753 . . . . 0.0 113.455 -177.609 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . -77.19 167.48 54.25 Favored Glycine 0 N--CA 1.439 -1.128 0 CA-C-N 115.155 -0.929 . . . . 0.0 113.429 -178.328 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 6.5 m -77.42 -17.58 57.99 Favored 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 123.14 0.576 . . . . 0.0 111.635 -175.169 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 7.9 mmp_? -87.29 -0.46 56.77 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.196 0.522 . . . . 0.0 110.995 -176.167 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 232' ' ' TRP . . . . . . . . . . . . . 21.1 t90 -76.93 127.82 33.41 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-O 122.307 1.051 . . . . 0.0 112.206 -178.063 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 233' ' ' ASP . . . . . 0.418 ' O ' ' N ' ' B' ' 235' ' ' VAL . 23.9 t70 -122.07 147.1 46.53 Favored 'General case' 0 C--N 1.277 -2.585 0 N-CA-C 102.82 -3.029 . . . . 0.0 102.82 171.705 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -45.62 56.0 0.0 OUTLIER Glycine 0 N--CA 1.505 3.272 0 C-N-CA 128.372 2.891 . . . . 0.0 117.139 -175.654 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 235' ' ' VAL . . . . . 0.418 ' N ' ' O ' ' B' ' 233' ' ' ASP . 52.3 t -110.83 127.52 67.86 Favored 'Isoleucine or valine' 1 C--N 1.244 -4.02 0 C-N-CA 128.237 2.615 . . . . 0.0 106.996 177.516 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 236' ' ' HIS . . . . . . . . . . . . . 57.4 t60 -112.05 122.24 47.2 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 179.578 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 237' ' ' ARG . . . . . 0.501 ' HG3' HG13 ' A' ' 50' ' ' VAL . 28.4 mmt180 -127.25 110.34 12.76 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-O 121.115 0.483 . . . . 0.0 110.877 178.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 238' ' ' SER . . . . . . . . . . . . . 77.8 p -146.82 141.85 27.08 Favored 'General case' 0 C--N 1.284 -2.259 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 174.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 239' ' ' ASN . . . . . . . . . . . . . 34.2 p30 -75.87 18.92 0.23 Allowed 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 178.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 240' ' ' GLY . . . . . . . . . . . . . . . -105.82 48.8 0.93 Allowed Glycine 0 N--CA 1.417 -2.604 0 N-CA-C 108.443 -1.863 . . . . 0.0 108.443 173.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 22.7 p90 -77.09 -33.34 56.99 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 179.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -61.27 -45.34 94.89 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.226 0.536 . . . . 0.0 112.089 -177.094 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -60.46 -34.74 74.46 Favored 'General case' 0 C--O 1.204 -1.307 0 CA-C-N 115.166 -0.924 . . . . 0.0 111.411 -179.328 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -63.97 -42.46 97.24 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 -178.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 245' ' ' TRP . . . . . 0.451 ' HA ' ' HG3' ' B' ' 248' ' ' LYS . 23.7 m0 -66.23 -38.43 87.89 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.329 0.585 . . . . 0.0 109.954 178.354 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 246' ' ' PHE . . . . . 0.653 ' O ' ' HG2' ' B' ' 249' ' ' GLN . 3.1 t80 -67.96 -32.89 73.63 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.433 176.302 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -74.93 -38.96 61.65 Favored 'General case' 0 C--N 1.294 -1.839 0 O-C-N 121.948 -0.47 . . . . 0.0 111.023 179.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 248' ' ' LYS . . . . . 0.451 ' HG3' ' HA ' ' B' ' 245' ' ' TRP . 0.0 OUTLIER -82.35 -14.57 55.08 Favored 'General case' 0 CA--C 1.504 -0.8 0 CA-C-O 121.045 0.45 . . . . 0.0 111.758 -175.235 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 249' ' ' GLN . . . . . 0.653 ' HG2' ' O ' ' B' ' 246' ' ' PHE . 3.0 pt20 -75.22 2.4 11.07 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 121.698 0.761 . . . . 0.0 110.332 -179.068 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 250' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -67.24 -25.83 66.28 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.21 176.235 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -64.29 115.88 5.48 Favored 'General case' 0 N--CA 1.437 -1.118 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.134 178.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 252' ' ' ILE . . . . . . . . . . . . . 16.3 pt -99.67 -27.63 3.52 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.317 0 CA-C-N 113.783 -1.553 . . . . 0.0 110.944 -174.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 10.6 p30 -121.01 -26.32 5.17 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.908 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 254' ' ' GLU . . . . . 0.603 ' OE1' ' HG2' ' B' ' 255' ' ' LYS . 4.7 mm-40 -84.45 172.19 11.92 Favored 'General case' 0 N--CA 1.428 -1.571 0 N-CA-C 114.089 1.144 . . . . 0.0 114.089 -177.322 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 255' ' ' LYS . . . . . 0.603 ' HG2' ' OE1' ' B' ' 254' ' ' GLU . 7.8 ptpp? -107.82 105.54 15.41 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 114.631 -1.168 . . . . 0.0 112.679 -172.537 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 256' ' ' LYS . . . . . . . . . . . . . 89.5 mttt . . . . . 0 C--N 1.302 -1.496 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 173.902 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 . . . . . 0 N--CA 1.465 0.298 0 CA-C-O 121.029 0.442 . . . . 0.0 109.884 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -76.36 -9.82 58.93 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 113.026 0.751 . . . . 0.0 113.026 -172.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 56.4 m-85 -96.28 10.13 38.9 Favored 'General case' 0 C--N 1.289 -2.034 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.303 -177.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.432 ' HB2' HE22 ' A' ' 82' ' ' GLN . 48.6 mmtm -125.98 160.86 28.91 Favored 'General case' 0 N--CA 1.437 -1.1 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.846 179.052 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 15.5 p-10 -115.54 22.36 13.24 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-O 122.179 0.99 . . . . 0.0 109.152 178.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -75.21 30.24 0.1 Allowed 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 125.594 1.558 . . . . 0.0 110.833 179.457 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.439 ' HA ' HG21 ' A' ' 85' ' ' THR . . . -100.7 16.22 25.64 Favored 'General case' 0 C--N 1.306 -1.283 0 C-N-CA 122.646 0.378 . . . . 0.0 110.644 -175.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.427 ' HE2' ' NH1' ' A' ' 110' ' ' ARG . 9.9 m-30 -104.85 145.23 30.67 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.89 -175.63 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 22.8 pt -140.82 158.4 23.69 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 CA-C-O 121.137 0.494 . . . . 0.0 110.628 178.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.442 ' HB2' HG21 ' A' ' 107' ' ' THR . 61.8 t80 -105.26 118.91 37.74 Favored 'General case' 0 N--CA 1.412 -2.374 0 CA-C-N 114.504 -1.226 . . . . 0.0 108.057 177.771 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.475 HG23 ' CD1' ' A' ' 104' ' ' ILE . 10.9 mt -108.41 127.53 64.7 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.18 0 N-CA-C 105.427 -2.064 . . . . 0.0 105.427 173.359 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -132.31 170.86 21.71 Favored Glycine 0 C--N 1.269 -3.18 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 71.74 32.84 1.87 Allowed 'General case' 0 N--CA 1.471 0.604 0 O-C-N 124.485 0.756 . . . . 0.0 109.873 -178.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.5 HD11 HD11 ' A' ' 47' ' ' ILE . 4.0 mm? -66.19 143.02 57.51 Favored 'General case' 0 CA--C 1.492 -1.267 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.465 177.768 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.426 ' HB3' ' HG ' ' A' ' 42' ' ' LEU . 61.2 t30 -83.49 156.5 22.83 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.061 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.458 ' HB2' ' OE2' ' A' ' 70' ' ' GLU . 18.4 ptt180 -58.01 -28.92 64.88 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 123.701 0.801 . . . . 0.0 112.664 -177.188 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -107.48 4.76 26.51 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 113.74 1.015 . . . . 0.0 113.74 -172.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.426 ' HG ' ' HB3' ' A' ' 39' ' ' ASN . 61.3 mt -84.56 121.69 27.97 Favored 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 120.348 -0.541 . . . . 0.0 110.776 178.775 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 69.6 p -107.58 173.47 6.31 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-N 115.096 -0.956 . . . . 0.0 109.675 -179.236 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.432 ' HG3' ' HB2' ' A' ' 62' ' ' LEU . 52.3 mt-10 -55.3 -38.97 69.34 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 123.46 0.704 . . . . 0.0 111.652 179.497 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -65.6 -37.98 94.17 Favored Glycine 0 N--CA 1.44 -1.078 0 CA-C-N 116.076 -0.511 . . . . 0.0 113.105 -178.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -67.25 -43.95 80.64 Favored 'General case' 0 CA--C 1.505 -0.773 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 -178.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.5 HD11 HD11 ' A' ' 38' ' ' LEU . 35.9 mt -60.77 -45.51 97.71 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.421 0 CA-C-N 114.922 -1.035 . . . . 0.0 110.593 178.587 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 50.0 mt -59.64 -44.85 93.35 Favored 'General case' 0 C--O 1.207 -1.135 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.704 -176.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.45 HG23 ' H ' ' B' ' 233' ' ' ASP . 96.4 m -60.63 -46.05 91.76 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 179.809 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.63 HG13 ' HG2' ' B' ' 237' ' ' ARG . 85.5 t -65.95 -48.44 81.84 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 CA-C-O 121.099 0.476 . . . . 0.0 110.679 179.251 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.425 ' HA ' ' HD2' ' A' ' 54' ' ' TYR . 5.4 m-85 -66.27 -24.39 66.56 Favored 'General case' 0 N--CA 1.431 -1.39 0 CA-C-N 115.595 -0.73 . . . . 0.0 112.331 -178.004 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.407 ' HA ' ' O ' ' A' ' 55' ' ' GLY . 73.3 m -68.59 -19.8 64.48 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.958 176.3 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -70.29 -25.3 63.27 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 119.553 -0.859 . . . . 0.0 108.953 175.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.425 ' HD2' ' HA ' ' A' ' 51' ' ' PHE . 37.0 m-85 -93.01 -7.55 45.51 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-N 115.877 -0.602 . . . . 0.0 112.069 -175.711 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.407 ' O ' ' HA ' ' A' ' 52' ' ' SER . . . 152.39 -159.63 28.5 Favored Glycine 0 N--CA 1.419 -2.48 0 C-N-CA 120.699 -0.762 . . . . 0.0 111.304 178.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 98.8 t -99.83 110.9 60.69 Favored Pre-proline 0 C--N 1.298 -1.634 0 O-C-N 123.382 0.107 . . . . 0.0 110.95 -178.075 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.532 ' HB3' HD21 ' A' ' 77' ' ' LEU . 92.1 Cg_endo -79.68 137.26 12.68 Favored 'Trans proline' 0 N--CA 1.452 -0.926 0 C-N-CA 122.779 2.319 . . . . 0.0 110.16 175.694 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 27.0 m -114.39 -20.41 6.06 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 C-N-CA 119.624 -0.83 . . . . 0.0 112.038 -178.595 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.519 ' HB3' ' HG2' ' A' ' 78' ' ' LYS . 37.5 t70 -157.24 138.24 13.45 Favored 'General case' 0 CA--C 1.499 -0.992 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.411 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 13.6 p -139.68 134.32 38.28 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 O-C-N 123.674 0.609 . . . . 0.0 109.379 178.619 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.444 ' CD1' ' HB3' ' A' ' 111' ' ' PRO . 84.5 mt -121.9 126.91 75.16 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.051 177.023 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.432 ' HB2' ' HG3' ' A' ' 44' ' ' GLU . 0.1 OUTLIER -105.99 112.46 25.51 Favored 'General case' 0 N--CA 1.424 -1.763 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 173.54 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 24.2 m -79.23 119.54 22.46 Favored 'General case' 0 C--N 1.281 -2.387 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 177.208 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.412 ' HA ' ' HA ' ' A' ' 71' ' ' SER . 81.8 mtp180 -110.15 127.74 55.08 Favored 'General case' 0 C--N 1.307 -1.274 0 O-C-N 121.992 -0.442 . . . . 0.0 111.89 -175.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.448 ' HA ' HE21 ' A' ' 72' ' ' GLN . 13.5 t70 -69.38 123.33 20.95 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.916 178.469 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -61.5 -25.7 67.44 Favored 'General case' 0 C--N 1.307 -1.249 0 C-N-CA 124.286 1.035 . . . . 0.0 113.135 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 32.8 m-80 -79.1 -49.94 11.83 Favored 'General case' 0 CA--C 1.512 -0.514 0 CA-C-O 121.308 0.575 . . . . 0.0 110.432 -175.332 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 48.7 p -84.8 -24.65 28.61 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.472 -177.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.94 12.85 71.82 Favored Glycine 0 N--CA 1.44 -1.039 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.505 -178.113 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.458 ' OE2' ' HB2' ' A' ' 40' ' ' ARG . 40.9 mt-10 -107.63 -84.31 0.53 Allowed 'General case' 0 N--CA 1.435 -1.215 0 O-C-N 122.421 -0.458 . . . . 0.0 109.856 -176.626 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.412 ' HA ' ' HA ' ' A' ' 64' ' ' ARG . 71.9 p -146.23 157.08 43.79 Favored 'General case' 0 N--CA 1.421 -1.917 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 -178.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.448 HE21 ' HA ' ' A' ' 65' ' ' ASP . 28.8 mm-40 -77.72 -18.05 56.96 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-O 121.167 0.508 . . . . 0.0 110.383 175.673 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 98.33 1.38 58.03 Favored Glycine 0 N--CA 1.43 -1.739 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.89 -177.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 37.3 p90 -140.53 151.72 44.99 Favored 'General case' 0 N--CA 1.432 -1.335 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 178.329 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -146.49 172.25 13.83 Favored 'General case' 0 N--CA 1.42 -1.927 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 178.43 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 8.0 t80 -135.07 143.76 46.85 Favored 'General case' 0 C--N 1.293 -1.857 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.047 -177.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.532 HD21 ' HB3' ' A' ' 57' ' ' PRO . 9.7 tt -149.83 140.52 22.63 Favored 'General case' 0 N--CA 1.434 -1.244 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 175.696 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.519 ' HG2' ' HB3' ' A' ' 59' ' ' ASP . 21.1 ptmt -123.34 144.44 49.45 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 178.33 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 70.1 m-85 -105.79 165.15 11.39 Favored 'General case' 0 C--N 1.289 -2.037 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.067 -177.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -75.08 -31.52 61.23 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 114.702 -1.136 . . . . 0.0 108.918 173.459 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.404 ' O ' ' HB2' ' A' ' 84' ' ' SER . 8.8 t70 -119.88 134.11 55.35 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 -178.31 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.432 HE22 ' HB2' ' A' ' 28' ' ' LYS . 96.0 mt-30 -70.62 -20.42 62.74 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 -179.118 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 87.0 mtm180 -67.91 -33.3 74.44 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-O 122.44 1.114 . . . . 0.0 109.239 175.1 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.49 ' OG ' HG21 ' B' ' 226' ' ' ILE . 50.3 m -62.27 -37.13 84.28 Favored 'General case' 0 C--N 1.285 -2.222 0 CA-C-N 114.6 -1.182 . . . . 0.0 112.323 177.016 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.479 ' O ' HG23 ' A' ' 89' ' ' VAL . 78.7 p -65.2 -45.49 84.58 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 120.208 -0.597 . . . . 0.0 110.179 -177.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.422 ' H ' HG12 ' A' ' 86' ' ' ILE . 5.6 pt -64.72 -38.11 81.84 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.492 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.099 177.222 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.656 HD11 ' HB2' ' B' ' 224' ' ' PHE . 12.0 mt -59.09 -44.69 91.94 Favored 'General case' 0 CA--C 1.502 -0.87 0 CA-C-O 120.944 0.402 . . . . 0.0 111.089 175.472 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.505 ' O ' ' HB2' ' A' ' 92' ' ' LEU . . . -71.4 -40.93 70.22 Favored 'General case' 0 N--CA 1.427 -1.59 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.303 -178.351 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.482 HG22 HG22 ' A' ' 104' ' ' ILE . 86.0 t -62.2 -49.4 84.19 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-O 120.889 0.376 . . . . 0.0 110.671 178.21 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -66.07 -35.75 81.37 Favored 'General case' 0 C--N 1.302 -1.468 0 C-N-CA 123.59 0.756 . . . . 0.0 112.13 -175.428 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.583 ' HA ' ' OD1' ' B' ' 239' ' ' ASN . 4.8 m-20 -87.74 -29.22 21.23 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -177.361 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.505 ' HB2' ' O ' ' A' ' 88' ' ' ALA . 10.1 mt -97.68 -26.56 14.71 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 112.84 0.682 . . . . 0.0 112.84 -173.648 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -60.38 125.1 22.4 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 109.551 -0.536 . . . . 0.0 109.551 -179.557 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 81.44 -1.12 86.65 Favored Glycine 0 N--CA 1.441 -0.987 0 C-N-CA 120.986 -0.626 . . . . 0.0 113.649 177.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 59.4 t80 -85.67 138.16 32.32 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 117.611 0.706 . . . . 0.0 109.122 -178.567 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.424 ' HE3' ' HB2' ' A' ' 101' ' ' ALA . 11.7 mptt -92.47 117.2 29.7 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 -176.506 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 56.6 mt -126.08 141.99 44.08 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 N-CA-C 105.253 -2.129 . . . . 0.0 105.253 173.019 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 60.58 19.98 55.23 Favored Glycine 0 CA--C 1.525 0.687 0 C-N-CA 121.598 -0.334 . . . . 0.0 113.595 179.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 84.33 10.61 79.74 Favored Glycine 0 N--CA 1.441 -0.989 0 C-N-CA 121.292 -0.48 . . . . 0.0 112.539 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 12.9 ptp180 -135.82 145.9 46.95 Favored 'General case' 0 N--CA 1.439 -0.996 0 O-C-N 122.435 -0.45 . . . . 0.0 111.511 -179.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.424 ' HB2' ' HE3' ' A' ' 96' ' ' LYS . . . -84.38 118.07 24.01 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.015 -177.543 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 10.3 mt -65.73 139.28 58.35 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-O 121.653 0.739 . . . . 0.0 112.49 179.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 60.2 tptt -109.98 115.47 29.84 Favored 'General case' 0 N--CA 1.413 -2.275 0 CA-C-N 115.106 -0.952 . . . . 0.0 108.456 178.12 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.482 HG22 HG22 ' A' ' 89' ' ' VAL . 5.0 mm -121.34 131.31 73.35 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.898 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 178.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -143.91 155.09 43.95 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 -179.349 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -83.55 132.08 34.94 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 117.994 0.361 . . . . 0.0 110.716 177.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.442 HG21 ' HB2' ' A' ' 34' ' ' TYR . 5.8 t -153.86 159.78 41.93 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 107.848 -1.168 . . . . 0.0 107.848 -176.304 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -99.71 112.64 24.85 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 169.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 32.3 t80 -105.0 138.29 41.43 Favored 'General case' 0 C--N 1.29 -2.021 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.363 -176.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.427 ' NH1' ' HE2' ' A' ' 32' ' ' TYR . 33.7 mmt180 -117.85 114.5 37.43 Favored Pre-proline 0 C--N 1.309 -1.172 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 176.359 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.444 ' HB3' ' CD1' ' A' ' 61' ' ' ILE . 68.5 Cg_endo -73.67 149.37 43.34 Favored 'Trans proline' 0 C--N 1.325 -0.675 0 C-N-CA 124.07 3.18 . . . . 0.0 114.35 -178.021 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 26.6 tptp -106.15 119.67 39.83 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 173.332 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 37.4 mmt180 . . . . . 0 C--N 1.29 -1.98 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 179.586 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 42.5 t30 . . . . . 0 CA--C 1.533 0.319 0 N-CA-C 111.825 0.305 . . . . 0.0 111.825 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 223' ' ' ARG . . . . . . . . . . . . . 47.7 ttp180 56.81 51.61 10.6 Favored 'General case' 0 CA--C 1.559 1.3 0 N-CA-C 115.175 1.546 . . . . 0.0 115.175 169.421 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 224' ' ' PHE . . . . . 0.656 ' HB2' HD11 ' A' ' 87' ' ' LEU . 8.7 m-85 -96.77 166.97 11.39 Favored 'General case' 0 C--N 1.271 -2.827 0 CA-C-N 115.427 -0.806 . . . . 0.0 108.944 175.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 225' ' ' ALA . . . . . . . . . . . . . . . -115.2 80.05 1.37 Allowed 'General case' 0 C--N 1.31 -1.145 0 CA-C-O 121.608 0.718 . . . . 0.0 110.385 -176.5 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 226' ' ' ILE . . . . . 0.49 HG21 ' OG ' ' A' ' 84' ' ' SER . 4.2 mp -126.11 138.79 53.48 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 177.177 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 227' ' ' MET . . . . . . . . . . . . . 91.1 mtp -67.49 133.16 92.89 Favored Pre-proline 0 C--N 1.312 -1.022 0 O-C-N 123.528 0.518 . . . . 0.0 110.12 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 228' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -68.67 158.78 56.35 Favored 'Trans proline' 0 N--CA 1.452 -0.96 0 C-N-CA 122.761 2.307 . . . . 0.0 112.25 179.695 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . -75.6 163.55 53.71 Favored Glycine 0 N--CA 1.437 -1.25 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.329 179.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 14.6 m -77.79 -14.36 59.61 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 123.103 0.561 . . . . 0.0 110.974 -178.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 27.9 mmt180 -81.82 0.26 40.18 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 121.461 0.648 . . . . 0.0 109.952 -178.371 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 232' ' ' TRP . . . . . . . . . . . . . 22.8 t90 -81.82 130.5 35.09 Favored 'General case' 0 N--CA 1.427 -1.593 0 CA-C-O 122.228 1.013 . . . . 0.0 111.441 -177.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 233' ' ' ASP . . . . . 0.45 ' H ' HG23 ' A' ' 49' ' ' THR . 17.3 t70 -117.86 147.74 42.78 Favored 'General case' 0 C--N 1.273 -2.758 0 N-CA-C 101.201 -3.629 . . . . 0.0 101.201 171.457 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -46.39 48.74 0.0 OUTLIER Glycine 0 N--CA 1.511 3.679 0 C-N-CA 128.248 2.832 . . . . 0.0 118.213 -175.447 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 235' ' ' VAL . . . . . 0.405 ' N ' ' O ' ' B' ' 233' ' ' ASP . 51.9 t -88.46 131.89 34.8 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.322 0 C-N-CA 127.996 2.518 . . . . 0.0 106.993 175.111 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 236' ' ' HIS . . . . . . . . . . . . . 81.5 t60 -109.68 108.56 18.99 Favored 'General case' 0 C--N 1.288 -2.074 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 175.253 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 237' ' ' ARG . . . . . 0.63 ' HG2' HG13 ' A' ' 50' ' ' VAL . 6.5 tpp180 -126.0 107.09 10.11 Favored 'General case' 0 C--N 1.288 -2.08 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 -176.646 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 238' ' ' SER . . . . . . . . . . . . . 50.7 p -148.95 154.14 38.97 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.965 -175.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 239' ' ' ASN . . . . . 0.583 ' OD1' ' HA ' ' A' ' 91' ' ' ASN . 8.6 m120 -50.44 -31.19 14.38 Favored 'General case' 0 N--CA 1.503 2.177 0 C-N-CA 123.988 0.915 . . . . 0.0 111.643 177.779 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 240' ' ' GLY . . . . . 0.436 ' O ' ' HG2' ' B' ' 244' ' ' LYS . . . 117.66 20.66 4.54 Favored Glycine 0 C--O 1.2 -1.972 0 C-N-CA 120.67 -0.776 . . . . 0.0 111.165 -175.754 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 26.8 p90 -76.38 -34.55 58.87 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -179.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -63.61 -42.42 98.23 Favored 'General case' 0 C--O 1.219 -0.543 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.843 -174.048 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -61.16 -34.36 74.9 Favored 'General case' 0 CA--C 1.509 -0.623 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.397 178.479 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 244' ' ' LYS . . . . . 0.436 ' HG2' ' O ' ' B' ' 240' ' ' GLY . 71.0 mmtt -67.15 -47.52 70.8 Favored 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 -179.029 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 245' ' ' TRP . . . . . . . . . . . . . 49.2 m0 -65.3 -40.15 93.43 Favored 'General case' 0 C--O 1.208 -1.089 0 CA-C-N 114.77 -1.105 . . . . 0.0 109.83 179.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 246' ' ' PHE . . . . . 0.486 ' O ' ' HG2' ' B' ' 249' ' ' GLN . 3.1 t80 -66.18 -30.75 71.28 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 124.091 0.956 . . . . 0.0 110.892 179.318 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -78.13 -39.87 39.86 Favored 'General case' 0 C--N 1.294 -1.836 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.24 178.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.89 -11.7 46.92 Favored 'General case' 0 CA--C 1.51 -0.584 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -175.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 249' ' ' GLN . . . . . 0.486 ' HG2' ' O ' ' B' ' 246' ' ' PHE . 3.2 pt20 -74.46 2.74 8.84 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.635 -179.234 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 250' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -57.42 -35.89 70.66 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.433 177.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -88.95 107.46 19.03 Favored 'General case' 0 N--CA 1.421 -1.89 0 CA-C-O 122.179 0.99 . . . . 0.0 110.239 177.286 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 252' ' ' ILE . . . . . . . . . . . . . 9.2 pt -116.88 -34.3 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.281 -2.4 0 CA-C-N 114.27 -1.332 . . . . 0.0 110.998 -179.206 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -115.4 -26.44 7.56 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 -178.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 254' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -63.25 148.98 46.67 Favored 'General case' 0 N--CA 1.432 -1.353 0 CA-C-N 114.631 -1.168 . . . . 0.0 110.181 -175.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 255' ' ' LYS . . . . . . . . . . . . . 45.9 mmtm -93.44 142.04 27.78 Favored 'General case' 0 C--N 1.286 -2.184 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.077 -175.013 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 256' ' ' LYS . . . . . . . . . . . . . 11.3 ptpt . . . . . 0 C--N 1.287 -2.123 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.553 -176.547 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 . . . . . 0 CA--C 1.51 -0.58 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 63.2 mm-40 -93.05 -20.13 20.85 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.529 -177.448 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 63.6 m-85 -94.75 2.77 55.55 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 112.932 0.715 . . . . 0.0 112.932 -171.514 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.0 mmmp? -133.08 176.08 8.82 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 18.7 p-10 -124.29 6.12 8.43 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 -175.388 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -80.89 27.67 0.38 Allowed 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 -179.466 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -94.85 -1.89 51.84 Favored 'General case' 0 CA--C 1.509 -0.614 0 O-C-N 121.937 -0.477 . . . . 0.0 111.563 -178.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -108.0 145.39 33.98 Favored 'General case' 0 C--N 1.311 -1.088 0 C-N-CA 120.816 -0.354 . . . . 0.0 110.32 -174.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 24.2 pt -142.74 161.97 18.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.984 178.085 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.414 ' HB2' HG21 ' A' ' 107' ' ' THR . 63.1 t80 -111.55 122.72 48.59 Favored 'General case' 0 N--CA 1.42 -1.975 0 C-N-CA 124.655 1.182 . . . . 0.0 108.485 178.522 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.456 HG23 ' CD1' ' A' ' 104' ' ' ILE . 9.9 mt -108.85 128.32 64.74 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.933 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 175.018 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -130.15 168.74 21.34 Favored Glycine 0 C--N 1.288 -2.112 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 -179.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.404 ' O ' ' HD3' ' A' ' 100' ' ' ARG . 83.5 m-20 72.75 27.46 2.23 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 124.766 1.226 . . . . 0.0 110.788 -177.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.401 HD11 HD11 ' A' ' 47' ' ' ILE . 4.3 mm? -62.84 143.2 57.8 Favored 'General case' 0 CA--C 1.499 -0.993 0 CA-C-O 121.407 0.622 . . . . 0.0 112.474 179.541 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.5 ' HB3' ' HG ' ' A' ' 42' ' ' LEU . 47.5 t-20 -85.38 147.11 26.67 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 175.707 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.02 -17.3 56.83 Favored 'General case' 0 C--N 1.299 -1.592 0 C-N-CA 123.949 0.9 . . . . 0.0 112.899 178.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -98.88 0.52 44.34 Favored 'General case' 0 C--O 1.244 0.768 0 CA-C-O 121.035 0.445 . . . . 0.0 111.253 -179.475 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.5 ' HG ' ' HB3' ' A' ' 39' ' ' ASN . 77.5 mt -90.68 120.35 31.67 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-O 121.637 0.732 . . . . 0.0 110.062 179.128 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 72.1 p -102.95 173.22 6.41 Favored 'General case' 0 C--N 1.29 -2.005 0 CA-C-N 114.382 -1.281 . . . . 0.0 108.973 -177.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.432 ' HG3' ' HB2' ' A' ' 62' ' ' LEU . 2.7 mp0 -56.13 -39.07 71.69 Favored 'General case' 0 C--O 1.209 -1.057 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 175.431 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -59.25 -40.07 95.39 Favored Glycine 0 N--CA 1.444 -0.827 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.948 -178.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -67.04 -49.14 66.17 Favored 'General case' 0 CA--C 1.496 -1.109 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.571 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.401 HD11 HD11 ' A' ' 38' ' ' LEU . 48.4 mt -58.45 -46.44 89.55 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.762 0 CA-C-N 114.866 -1.061 . . . . 0.0 110.304 179.601 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 44.4 mt -59.71 -45.5 91.95 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.843 -178.525 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.475 HG23 ' H ' ' B' ' 233' ' ' ASP . 98.2 m -62.63 -45.46 92.73 Favored 'General case' 0 N--CA 1.442 -0.869 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 179.606 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.588 HG13 ' HG3' ' B' ' 237' ' ' ARG . 91.3 t -65.89 -47.91 83.83 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.192 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.505 -178.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.496 ' HA ' ' HD2' ' A' ' 54' ' ' TYR . 3.7 m-85 -66.45 -24.44 66.44 Favored 'General case' 0 N--CA 1.428 -1.564 0 CA-C-N 115.412 -0.813 . . . . 0.0 112.354 -178.27 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.499 ' OG ' ' HB2' ' B' ' 231' ' ' ARG . 62.3 m -68.09 -18.07 64.56 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 176.724 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -69.92 -26.78 64.31 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 119.546 -0.862 . . . . 0.0 109.226 176.165 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.496 ' HD2' ' HA ' ' A' ' 51' ' ' PHE . 61.9 m-85 -89.61 -23.26 21.98 Favored 'General case' 0 CA--C 1.505 -0.774 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.845 -175.032 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.419 ' O ' ' HA ' ' A' ' 52' ' ' SER . . . 170.41 -155.74 25.58 Favored Glycine 0 N--CA 1.418 -2.558 0 N-CA-C 110.577 -1.009 . . . . 0.0 110.577 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.417 HG22 ' HA2' ' B' ' 229' ' ' GLY . 49.0 t -104.46 105.57 50.47 Favored Pre-proline 0 C--N 1.289 -2.04 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 -177.476 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.601 ' HB3' HD21 ' A' ' 77' ' ' LEU . 64.0 Cg_endo -74.74 136.4 20.93 Favored 'Trans proline' 0 N--CA 1.447 -1.263 0 C-N-CA 121.793 1.662 . . . . 0.0 109.522 175.495 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 26.8 m -111.66 -25.54 3.47 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 C-N-CA 120.354 -0.538 . . . . 0.0 111.693 -178.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.507 ' HB3' ' HG2' ' A' ' 78' ' ' LYS . 27.9 t70 -152.92 145.38 24.11 Favored 'General case' 0 CA--C 1.491 -1.295 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 14.6 p -145.96 135.47 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.799 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 179.321 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 92.7 mt -120.51 123.91 71.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 175.607 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.432 ' HB2' ' HG3' ' A' ' 44' ' ' GLU . 0.1 OUTLIER -97.11 114.52 26.19 Favored 'General case' 0 N--CA 1.422 -1.844 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 176.46 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 9.2 m -75.25 117.85 17.52 Favored 'General case' 0 C--N 1.276 -2.594 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 178.244 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 25.9 mtp180 -128.26 146.45 50.74 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-O 120.991 0.424 . . . . 0.0 110.991 -176.143 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -95.2 113.87 25.6 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.178 177.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -62.1 -21.12 64.73 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 -177.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 22.6 m-80 -78.1 -44.14 27.01 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.345 0.593 . . . . 0.0 109.813 -176.414 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 44.8 p -90.35 -24.12 20.91 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-O 121.444 0.64 . . . . 0.0 111.236 -179.644 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 80.86 10.21 85.36 Favored Glycine 0 N--CA 1.442 -0.914 0 CA-C-N 115.978 -0.555 . . . . 0.0 112.354 178.72 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -114.99 -177.33 3.1 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 -178.27 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 25.1 m -71.92 154.31 41.29 Favored 'General case' 0 N--CA 1.424 -1.731 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.557 175.502 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 12.4 mm-40 -83.3 1.91 38.71 Favored 'General case' 0 C--N 1.307 -1.258 0 C-N-CA 122.95 0.5 . . . . 0.0 111.794 178.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 85.81 6.74 82.29 Favored Glycine 0 N--CA 1.427 -1.939 0 C-N-CA 120.951 -0.643 . . . . 0.0 112.11 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -148.03 156.87 43.12 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 178.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -154.5 171.79 18.83 Favored 'General case' 0 C--N 1.307 -1.252 0 O-C-N 123.741 0.651 . . . . 0.0 110.295 178.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -128.33 140.94 51.6 Favored 'General case' 0 C--N 1.31 -1.125 0 C-N-CA 123.71 0.804 . . . . 0.0 110.222 -178.52 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.601 HD21 ' HB3' ' A' ' 57' ' ' PRO . 9.8 tt -147.06 140.72 25.68 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 175.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.507 ' HG2' ' HB3' ' A' ' 59' ' ' ASP . 21.6 ptmt -123.93 144.84 49.54 Favored 'General case' 0 C--O 1.259 1.59 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 178.645 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 59.0 m-85 -106.78 164.59 11.98 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-O 121.39 0.614 . . . . 0.0 112.232 -178.284 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -71.98 -34.3 68.83 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 114.053 -1.431 . . . . 0.0 109.093 175.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -124.65 135.01 52.71 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.403 -179.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -70.55 -20.09 62.83 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 114.316 1.228 . . . . 0.0 114.316 -177.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 87.5 mtm180 -61.27 -33.92 74.34 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 122.378 1.085 . . . . 0.0 109.475 173.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 50.6 m -66.02 -36.6 83.7 Favored 'General case' 0 C--N 1.288 -2.068 0 CA-C-N 114.777 -1.101 . . . . 0.0 112.662 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 71.3 p -63.46 -45.09 92.4 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 120.34 -0.544 . . . . 0.0 110.995 -177.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 3.9 pt -65.63 -38.54 82.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.048 177.536 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.477 HD11 ' HB2' ' B' ' 224' ' ' PHE . 16.1 mt -59.34 -43.74 92.73 Favored 'General case' 0 CA--C 1.502 -0.878 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.439 175.4 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.485 ' O ' ' HB2' ' A' ' 92' ' ' LEU . . . -69.93 -44.97 68.5 Favored 'General case' 0 N--CA 1.425 -1.678 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.648 -178.648 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.499 HG22 HG22 ' A' ' 104' ' ' ILE . 71.2 t -59.69 -44.27 93.24 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.898 0 CA-C-O 121.189 0.519 . . . . 0.0 111.229 177.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -63.15 -39.1 93.7 Favored 'General case' 0 C--N 1.291 -1.94 0 C-N-CA 124.095 0.958 . . . . 0.0 112.612 -177.403 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.431 ' HA ' ' HB3' ' B' ' 239' ' ' ASN . 50.8 t-20 -93.44 -33.27 13.89 Favored 'General case' 0 C--N 1.292 -1.924 0 CA-C-O 121.196 0.522 . . . . 0.0 111.355 -175.01 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.485 ' HB2' ' O ' ' A' ' 88' ' ' ALA . 12.9 mt -88.37 -28.13 21.17 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 112.597 0.591 . . . . 0.0 112.597 -171.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -64.26 123.83 20.14 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 81.89 -0.57 88.25 Favored Glycine 0 CA--C 1.535 1.321 0 C-N-CA 120.979 -0.629 . . . . 0.0 113.763 179.631 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.402 ' O ' ' HA ' ' A' ' 101' ' ' ALA . 68.3 t80 -85.11 141.76 30.0 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -179.091 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.56 119.74 34.59 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 112.832 0.678 . . . . 0.0 112.832 -176.34 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 52.2 mt -127.56 141.25 46.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 N-CA-C 105.415 -2.069 . . . . 0.0 105.415 172.107 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 61.22 20.74 58.72 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 121.135 -0.555 . . . . 0.0 113.567 179.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 82.1 10.05 84.37 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 121.159 -0.543 . . . . 0.0 112.835 -178.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.404 ' HD3' ' O ' ' A' ' 37' ' ' ASN . 12.7 ptp180 -134.81 143.68 47.2 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 117.128 0.464 . . . . 0.0 111.564 -179.762 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.402 ' HA ' ' O ' ' A' ' 95' ' ' PHE . . . -81.33 121.16 25.86 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.508 -179.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 10.5 mt -70.03 138.7 52.37 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 179.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 24.2 tptm -106.4 116.2 31.51 Favored 'General case' 0 N--CA 1.415 -2.193 0 CA-C-N 115.181 -0.918 . . . . 0.0 108.575 177.557 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.499 HG22 HG22 ' A' ' 89' ' ' VAL . 5.8 mm -118.76 135.9 57.68 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.096 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 177.686 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -143.48 152.96 42.13 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 -178.105 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . 0.401 ' CD2' HG21 ' A' ' 89' ' ' VAL . 47.3 m-70 -84.16 135.01 34.55 Favored 'General case' 0 C--N 1.289 -2.055 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 176.551 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.414 HG21 ' HB2' ' A' ' 34' ' ' TYR . 5.9 t -154.49 163.49 40.12 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 106.024 -1.843 . . . . 0.0 106.024 -178.752 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -110.16 110.61 21.52 Favored 'General case' 0 N--CA 1.422 -1.829 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 171.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 26.5 t80 -106.96 140.72 39.32 Favored 'General case' 0 C--N 1.285 -2.213 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 -179.186 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.429 ' HA ' ' HD2' ' A' ' 111' ' ' PRO . 10.8 mmm180 -120.26 115.54 32.8 Favored Pre-proline 0 C--N 1.297 -1.715 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 175.253 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.429 ' HD2' ' HA ' ' A' ' 110' ' ' ARG . 39.3 Cg_endo -64.26 136.54 51.93 Favored 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 122.484 2.123 . . . . 0.0 112.837 -179.316 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 26.5 tptp -113.64 123.72 50.61 Favored 'General case' 0 N--CA 1.421 -1.876 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 175.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 34.0 mmt180 . . . . . 0 C--N 1.283 -2.3 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 178.717 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 . . . . . 0 N--CA 1.477 0.908 0 N-CA-C 111.368 0.136 . . . . 0.0 111.368 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 223' ' ' ARG . . . . . . . . . . . . . 9.7 ptm180 53.74 43.54 30.9 Favored 'General case' 0 N--CA 1.504 2.24 0 C-N-CA 126.68 1.992 . . . . 0.0 116.292 173.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 224' ' ' PHE . . . . . 0.477 ' HB2' HD11 ' A' ' 87' ' ' LEU . 32.8 m-85 -99.66 165.13 11.76 Favored 'General case' 0 C--N 1.28 -2.418 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 173.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 225' ' ' ALA . . . . . . . . . . . . . . . -127.05 84.74 2.29 Favored 'General case' 0 C--N 1.297 -1.698 0 CA-C-O 121.412 0.625 . . . . 0.0 110.274 -179.342 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 4.2 mp -126.02 132.07 71.02 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 176.616 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 227' ' ' MET . . . . . . . . . . . . . 93.1 mmm -72.35 137.92 81.18 Favored Pre-proline 0 C--N 1.317 -0.833 0 O-C-N 123.621 0.576 . . . . 0.0 110.337 178.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 228' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -63.16 160.81 32.78 Favored 'Trans proline' 0 CA--C 1.536 0.623 0 C-N-CA 123.752 2.968 . . . . 0.0 114.615 -174.28 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 229' ' ' GLY . . . . . 0.417 ' HA2' HG22 ' A' ' 56' ' ' VAL . . . -80.1 171.11 54.23 Favored Glycine 0 N--CA 1.442 -0.938 0 CA-C-N 115.077 -0.965 . . . . 0.0 113.438 -178.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 7.9 m -72.15 -15.7 61.97 Favored 'General case' 0 C--N 1.307 -1.261 0 C-N-CA 124.318 1.047 . . . . 0.0 111.772 -175.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 231' ' ' ARG . . . . . 0.499 ' HB2' ' OG ' ' A' ' 52' ' ' SER . 9.9 mmm180 -93.34 -0.03 56.76 Favored 'General case' 0 C--N 1.313 -1.007 0 O-C-N 122.175 -0.328 . . . . 0.0 110.946 -174.56 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 232' ' ' TRP . . . . . . . . . . . . . 21.2 t90 -75.15 127.41 33.14 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-O 122.655 1.216 . . . . 0.0 112.419 -176.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 233' ' ' ASP . . . . . 0.475 ' H ' HG23 ' A' ' 49' ' ' THR . 22.3 t70 -123.95 144.17 49.95 Favored 'General case' 0 C--N 1.263 -3.161 0 N-CA-C 102.424 -3.176 . . . . 0.0 102.424 174.444 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -42.12 63.74 0.0 OUTLIER Glycine 0 N--CA 1.49 2.276 0 C-N-CA 128.415 2.912 . . . . 0.0 116.375 -178.239 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 235' ' ' VAL . . . . . 0.447 ' N ' ' O ' ' B' ' 233' ' ' ASP . 55.5 t -110.64 127.99 67.29 Favored 'Isoleucine or valine' 0 C--N 1.247 -3.868 0 C-N-CA 127.627 2.371 . . . . 0.0 107.099 176.623 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 236' ' ' HIS . . . . . . . . . . . . . 33.2 t-80 -109.34 117.93 35.34 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 -176.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 237' ' ' ARG . . . . . 0.588 ' HG3' HG13 ' A' ' 50' ' ' VAL . 33.8 mmt180 -114.08 110.38 19.93 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 177.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 238' ' ' SER . . . . . . . . . . . . . 20.9 t -125.11 116.7 22.49 Favored 'General case' 0 C--N 1.29 -1.993 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.196 -178.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 239' ' ' ASN . . . . . 0.431 ' HB3' ' HA ' ' A' ' 91' ' ' ASN . 28.1 p-10 -82.36 16.58 2.0 Allowed 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.42 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 240' ' ' GLY . . . . . 0.5 ' O ' ' HG2' ' B' ' 244' ' ' LYS . . . -85.06 53.75 4.84 Favored Glycine 0 N--CA 1.426 -1.98 0 N-CA-C 110.204 -1.158 . . . . 0.0 110.204 177.024 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 37.8 p90 -75.18 -33.72 61.48 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -176.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -61.57 -45.33 94.6 Favored 'General case' 0 CA--C 1.507 -0.703 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.52 -178.033 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -62.28 -34.31 76.32 Favored 'General case' 0 C--O 1.212 -0.892 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.266 -179.564 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 244' ' ' LYS . . . . . 0.5 ' HG2' ' O ' ' B' ' 240' ' ' GLY . 71.6 mmtt -64.87 -47.79 76.59 Favored 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 -179.028 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 245' ' ' TRP . . . . . 0.47 ' HA ' ' HG3' ' B' ' 248' ' ' LYS . 37.8 m0 -66.14 -37.28 85.3 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.677 178.079 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 246' ' ' PHE . . . . . 0.566 ' O ' ' HG2' ' B' ' 249' ' ' GLN . 2.5 t80 -66.89 -30.36 70.5 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.809 176.612 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -77.7 -40.02 42.74 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.954 179.379 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 248' ' ' LYS . . . . . 0.47 ' HG3' ' HA ' ' B' ' 245' ' ' TRP . 0.0 OUTLIER -81.36 -19.26 43.09 Favored 'General case' 0 CA--C 1.506 -0.718 0 CA-C-O 120.84 0.352 . . . . 0.0 111.678 -175.908 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 249' ' ' GLN . . . . . 0.566 ' HG2' ' O ' ' B' ' 246' ' ' PHE . 3.0 pt20 -70.44 -0.56 8.58 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.739 -178.268 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 250' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -57.78 -32.18 67.27 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.992 177.2 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -89.83 106.56 18.55 Favored 'General case' 0 N--CA 1.428 -1.542 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 176.441 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 252' ' ' ILE . . . . . . . . . . . . . 37.9 pt -92.8 -33.93 5.69 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.851 0 CA-C-N 115.028 -0.987 . . . . 0.0 112.316 -174.004 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -89.26 -11.45 43.53 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-O 121.349 0.595 . . . . 0.0 110.745 -176.123 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 254' ' ' GLU . . . . . 0.438 ' OE1' ' HG2' ' B' ' 255' ' ' LYS . 0.2 OUTLIER -100.14 155.08 17.94 Favored 'General case' 0 C--N 1.287 -2.126 0 CA-C-N 114.971 -1.013 . . . . 0.0 111.16 -177.024 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 255' ' ' LYS . . . . . 0.438 ' HG2' ' OE1' ' B' ' 254' ' ' GLU . 0.1 OUTLIER -102.39 34.42 2.77 Favored 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 124.563 1.145 . . . . 0.0 111.548 -174.285 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 256' ' ' LYS . . . . . . . . . . . . . 44.0 mmtm . . . . . 0 C--N 1.311 -1.109 0 O-C-N 124.24 0.963 . . . . 0.0 111.976 179.302 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 . . . . . 0 CA--C 1.505 -0.785 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.516 ' HB2' ' CD1' ' A' ' 27' ' ' TYR . 2.4 mp0 -83.11 -44.28 15.3 Favored 'General case' 0 N--CA 1.414 -2.247 0 CA-C-O 121.782 0.801 . . . . 0.0 110.898 -176.302 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.516 ' CD1' ' HB2' ' A' ' 26' ' ' GLU . 88.7 m-85 -91.6 27.57 1.98 Allowed 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 114.737 -1.119 . . . . 0.0 113.229 -168.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -131.45 167.94 18.48 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 175.511 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.407 ' C ' ' H ' ' A' ' 31' ' ' ALA . 22.4 m-20 -125.39 21.2 7.94 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-O 121.567 0.698 . . . . 0.0 110.109 -178.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -77.2 15.34 0.74 Allowed 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.852 179.219 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.415 ' HA ' HG21 ' A' ' 85' ' ' THR . . . -86.04 -15.38 41.52 Favored 'General case' 0 N--CA 1.44 -0.953 0 C-N-CA 123.886 0.875 . . . . 0.0 110.46 -179.657 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 16.3 m-85 -99.72 145.18 27.95 Favored 'General case' 0 N--CA 1.433 -1.283 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 -177.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 24.7 pt -140.1 156.44 24.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 CA-C-O 121.157 0.504 . . . . 0.0 110.636 175.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 49.0 t80 -106.87 123.73 48.58 Favored 'General case' 0 N--CA 1.408 -2.564 0 CA-C-N 114.396 -1.275 . . . . 0.0 107.607 177.168 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.416 HG23 ' CD1' ' A' ' 104' ' ' ILE . 8.3 mt -107.89 127.57 63.88 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.55 0 N-CA-C 105.831 -1.915 . . . . 0.0 105.831 175.224 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -126.61 164.06 20.31 Favored Glycine 0 C--N 1.272 -2.975 0 N-CA-C 110.612 -0.995 . . . . 0.0 110.612 -179.076 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 70.94 39.9 0.97 Allowed 'General case' 0 CA--C 1.506 -0.74 0 C-N-CA 124.18 0.992 . . . . 0.0 110.715 -177.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.493 HD11 HD11 ' A' ' 47' ' ' ILE . 4.4 mm? -73.44 151.81 40.98 Favored 'General case' 0 CA--C 1.497 -1.07 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.867 176.007 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.506 ' HB3' ' HG ' ' A' ' 42' ' ' LEU . 50.2 t-20 -96.14 147.98 23.17 Favored 'General case' 0 C--N 1.286 -2.188 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 177.657 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.41 HH11 ' HD3' ' A' ' 40' ' ' ARG . 0.3 OUTLIER -63.39 -19.41 64.65 Favored 'General case' 0 C--N 1.298 -1.672 0 C-N-CA 123.326 0.651 . . . . 0.0 111.985 179.944 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.441 ' HG2' ' CG ' ' A' ' 39' ' ' ASN . 12.9 pt-20 -91.93 -3.54 55.81 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.903 -179.179 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.506 ' HG ' ' HB3' ' A' ' 39' ' ' ASN . 78.3 mt -91.09 124.03 35.0 Favored 'General case' 0 CA--C 1.504 -0.818 0 CA-C-O 121.117 0.485 . . . . 0.0 110.285 -179.63 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 67.2 p -109.72 173.78 6.17 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 114.705 -1.134 . . . . 0.0 109.409 -178.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.533 ' CG ' ' HB2' ' A' ' 62' ' ' LEU . 51.9 mt-10 -55.66 -38.91 70.2 Favored 'General case' 0 C--N 1.328 -0.333 0 O-C-N 123.47 0.481 . . . . 0.0 110.293 178.354 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -59.96 -43.11 98.43 Favored Glycine 0 C--O 1.24 0.483 0 CA-C-N 115.928 -0.578 . . . . 0.0 113.105 179.266 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -61.68 -49.17 77.57 Favored 'General case' 0 CA--C 1.499 -0.981 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.493 HD11 HD11 ' A' ' 38' ' ' LEU . 41.7 mt -60.86 -46.07 96.97 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.931 0 CA-C-N 114.833 -1.076 . . . . 0.0 110.63 -179.529 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 36.1 mt -60.07 -45.73 91.91 Favored 'General case' 0 CA--C 1.491 -1.293 0 C-N-CA 122.511 0.325 . . . . 0.0 111.81 -176.503 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.493 HG23 ' H ' ' B' ' 233' ' ' ASP . 97.5 m -62.88 -45.32 93.1 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 123.39 0.431 . . . . 0.0 111.751 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.447 HG13 ' HD2' ' B' ' 237' ' ' ARG . 76.6 t -67.28 -45.51 85.94 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.92 -179.645 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -66.96 -22.8 65.91 Favored 'General case' 0 N--CA 1.435 -1.184 0 C-N-CA 123.483 0.713 . . . . 0.0 111.941 -179.355 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.6 ' OG ' ' HB2' ' B' ' 231' ' ' ARG . 73.2 m -71.73 -16.54 62.22 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 116.177 -0.465 . . . . 0.0 112.141 176.139 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -73.53 -20.75 60.57 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 175.319 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.459 ' CE1' ' HB2' ' A' ' 91' ' ' ASN . 68.3 m-85 -97.76 -5.1 35.71 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-N 115.898 -0.592 . . . . 0.0 112.315 -176.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 151.7 -153.65 25.07 Favored Glycine 0 N--CA 1.423 -2.2 0 C-N-CA 120.511 -0.852 . . . . 0.0 111.317 179.212 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.461 ' HB ' ' HG2' ' A' ' 80' ' ' GLU . 99.5 t -106.61 104.51 51.26 Favored Pre-proline 0 C--N 1.305 -1.364 0 CA-C-O 120.469 0.176 . . . . 0.0 111.28 -177.466 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.555 ' HB3' HD21 ' A' ' 77' ' ' LEU . 87.8 Cg_endo -76.8 140.09 20.4 Favored 'Trans proline' 0 C--O 1.24 0.61 0 C-N-CA 123.011 2.474 . . . . 0.0 110.141 175.342 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 34.1 m -117.78 -26.04 2.77 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 C-N-CA 119.815 -0.754 . . . . 0.0 111.84 -179.35 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.617 ' HB3' ' HG2' ' A' ' 78' ' ' LYS . 30.5 t70 -149.52 136.48 19.65 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 -173.434 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 14.3 p -145.96 134.1 16.05 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.051 0 O-C-N 123.548 0.53 . . . . 0.0 110.165 -178.361 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 97.3 mt -121.37 120.15 61.12 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 175.173 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.533 ' HB2' ' CG ' ' A' ' 44' ' ' GLU . 0.1 OUTLIER -91.43 115.56 28.14 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 105.957 -1.868 . . . . 0.0 105.957 173.409 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 13.2 m -72.62 116.68 13.38 Favored 'General case' 0 N--CA 1.411 -2.379 0 N-CA-C 107.535 -1.284 . . . . 0.0 107.535 177.636 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 75.8 mtm180 -134.04 145.81 49.77 Favored 'General case' 0 C--N 1.287 -2.133 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 -174.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -87.61 119.26 27.73 Favored 'General case' 0 C--N 1.29 -1.989 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 177.245 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -60.2 -24.43 64.8 Favored 'General case' 0 C--N 1.311 -1.085 0 C-N-CA 123.432 0.693 . . . . 0.0 112.463 -176.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 35.5 m-80 -79.43 -50.4 10.86 Favored 'General case' 0 CA--C 1.507 -0.702 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.877 -175.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 50.3 p -87.1 -23.34 24.93 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-O 121.369 0.604 . . . . 0.0 111.632 -176.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 79.8 1.59 87.29 Favored Glycine 0 N--CA 1.439 -1.149 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.273 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -98.06 169.61 9.5 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-O 121.195 0.521 . . . . 0.0 109.873 -177.052 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 17.6 m -74.53 141.16 44.86 Favored 'General case' 0 C--N 1.294 -1.821 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.24 178.18 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 15.6 mm-40 -70.71 -17.0 62.83 Favored 'General case' 0 C--N 1.317 -0.831 0 C-N-CA 123.346 0.658 . . . . 0.0 112.154 -179.201 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 102.35 8.59 43.54 Favored Glycine 0 N--CA 1.431 -1.644 0 C-N-CA 120.27 -0.967 . . . . 0.0 111.636 179.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 34.9 p90 -148.78 159.86 43.75 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 177.044 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -156.07 172.73 17.9 Favored 'General case' 0 C--N 1.308 -1.231 0 O-C-N 123.581 0.551 . . . . 0.0 110.561 178.436 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -130.22 141.37 50.64 Favored 'General case' 0 C--N 1.308 -1.235 0 C-N-CA 123.723 0.809 . . . . 0.0 110.089 -179.517 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.555 HD21 ' HB3' ' A' ' 57' ' ' PRO . 9.4 tt -149.21 140.85 23.48 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 175.104 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.617 ' HG2' ' HB3' ' A' ' 59' ' ' ASP . 16.5 ptmt -125.93 144.28 50.75 Favored 'General case' 0 N--CA 1.431 -1.425 0 CA-C-O 121.421 0.629 . . . . 0.0 109.821 176.51 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -102.6 165.08 11.28 Favored 'General case' 0 C--N 1.283 -2.291 0 CA-C-N 115.164 -0.926 . . . . 0.0 109.362 179.518 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.461 ' HG2' ' HB ' ' A' ' 56' ' ' VAL . 8.2 pt-20 -76.95 -21.49 54.7 Favored 'General case' 0 N--CA 1.428 -1.563 0 C-N-CA 119.997 -0.681 . . . . 0.0 110.07 174.052 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -123.59 132.56 53.91 Favored 'General case' 0 N--CA 1.443 -0.815 0 C-N-CA 120.424 -0.51 . . . . 0.0 110.399 179.164 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -70.47 -19.87 62.91 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 -179.318 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 86.5 mtm180 -66.11 -33.66 76.29 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-O 122.166 0.984 . . . . 0.0 108.978 174.093 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 48.7 m -67.97 -36.98 80.98 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-N 114.86 -1.063 . . . . 0.0 112.208 177.531 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.478 ' O ' HG23 ' A' ' 89' ' ' VAL . 73.1 p -64.96 -45.3 86.27 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 120.244 -0.583 . . . . 0.0 110.9 -177.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 7.1 pt -63.25 -38.69 82.79 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.466 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.161 177.178 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.448 HD11 ' HB2' ' B' ' 224' ' ' PHE . 5.6 mt -59.23 -43.83 92.35 Favored 'General case' 0 CA--C 1.502 -0.893 0 O-C-N 123.785 0.678 . . . . 0.0 111.423 177.267 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.429 ' HB1' HD12 ' A' ' 92' ' ' LEU . . . -69.09 -46.53 67.53 Favored 'General case' 0 N--CA 1.424 -1.728 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.745 -179.418 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.478 HG23 ' O ' ' A' ' 85' ' ' THR . 92.7 t -56.64 -46.39 82.81 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.745 0 CA-C-O 121.648 0.737 . . . . 0.0 110.569 178.136 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -58.87 -40.14 83.44 Favored 'General case' 0 C--N 1.292 -1.926 0 C-N-CA 125.843 1.657 . . . . 0.0 112.329 -175.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.471 ' HA ' ' HB3' ' B' ' 239' ' ' ASN . 47.0 m-80 -98.46 -27.88 13.86 Favored 'General case' 0 C--N 1.294 -1.846 0 N-CA-C 113.129 0.788 . . . . 0.0 113.129 -175.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.429 HD12 ' HB1' ' A' ' 88' ' ' ALA . 15.5 mt -90.07 -30.73 17.51 Favored 'General case' 0 CA--C 1.471 -2.091 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.706 -171.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -65.98 124.74 23.35 Favored 'General case' 0 N--CA 1.425 -1.685 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 88.75 -5.48 84.57 Favored Glycine 0 C--N 1.308 -1.003 0 C-N-CA 121.167 -0.539 . . . . 0.0 112.65 -178.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 53.6 t80 -88.69 139.75 30.15 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 -179.041 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.457 ' HE3' ' HB2' ' A' ' 101' ' ' ALA . 12.3 mptt -95.87 118.18 32.01 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-O 120.92 0.391 . . . . 0.0 111.649 -176.292 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 53.0 mt -121.33 140.73 44.52 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 173.081 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 57.22 27.22 57.43 Favored Glycine 0 C--O 1.22 -0.756 0 C-N-CA 121.327 -0.463 . . . . 0.0 112.567 -179.582 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 88.07 -5.81 84.34 Favored Glycine 0 CA--C 1.536 1.376 0 N-CA-C 114.541 0.577 . . . . 0.0 114.541 179.028 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 16.8 ptp180 -126.34 149.89 48.89 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 118.16 0.98 . . . . 0.0 111.901 -177.039 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.457 ' HB2' ' HE3' ' A' ' 96' ' ' LYS . . . -84.84 116.8 23.5 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.525 -175.725 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.441 ' HA ' HD23 ' A' ' 102' ' ' LEU . 12.9 mt -66.51 141.4 57.89 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-O 121.76 0.791 . . . . 0.0 112.797 178.538 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 4.3 tppp? -117.2 116.59 27.58 Favored 'General case' 0 N--CA 1.411 -2.419 0 CA-C-N 114.67 -1.15 . . . . 0.0 108.123 176.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.435 HG22 HG22 ' A' ' 89' ' ' VAL . 4.1 mm -115.64 133.64 61.36 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.931 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 -179.69 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -143.6 150.89 39.47 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 -179.405 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 41.7 m-70 -79.42 131.63 36.14 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-O 121.132 0.492 . . . . 0.0 110.33 177.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 15.1 t -143.77 156.38 44.48 Favored 'General case' 0 C--N 1.288 -2.068 0 N-CA-C 106.072 -1.825 . . . . 0.0 106.072 -179.445 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 30.3 p90 -101.13 109.17 21.02 Favored 'General case' 0 N--CA 1.42 -1.944 0 C-N-CA 117.173 -1.811 . . . . 0.0 107.08 169.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 42.8 t80 -108.19 144.5 35.53 Favored 'General case' 0 C--N 1.29 -2.008 0 CA-C-N 114.87 -1.059 . . . . 0.0 108.647 -178.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.403 ' HA ' ' HD2' ' A' ' 111' ' ' PRO . 39.8 mmt180 -120.34 113.32 33.84 Favored Pre-proline 0 C--N 1.298 -1.645 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 173.783 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.403 ' HD2' ' HA ' ' A' ' 110' ' ' ARG . 55.3 Cg_endo -69.33 146.54 63.17 Favored 'Trans proline' 0 C--N 1.326 -0.644 0 C-N-CA 124.07 3.18 . . . . 0.0 114.6 -179.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.478 ' C ' ' HD3' ' A' ' 112' ' ' LYS . 10.9 tmtt? -120.62 125.5 47.91 Favored 'General case' 0 N--CA 1.426 -1.639 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 173.474 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 39.7 mmt180 . . . . . 0 C--N 1.305 -1.36 0 CA-C-O 118.947 -0.549 . . . . 0.0 110.303 177.755 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 6.7 m120 . . . . . 0 CA--C 1.502 -0.873 0 CA-C-O 119.59 -0.243 . . . . 0.0 110.637 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 223' ' ' ARG . . . . . . . . . . . . . 11.5 ptm180 57.56 34.03 24.03 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 126.457 1.903 . . . . 0.0 114.641 178.44 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 224' ' ' PHE . . . . . 0.448 ' HB2' HD11 ' A' ' 87' ' ' LEU . 44.9 m-85 -96.74 165.25 12.22 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 175.491 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 225' ' ' ALA . . . . . . . . . . . . . . . -117.79 21.68 12.76 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 112.851 0.685 . . . . 0.0 112.851 -173.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 4.6 mp -75.18 130.86 35.84 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 C-N-CA 120.031 -0.668 . . . . 0.0 110.022 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 227' ' ' MET . . . . . . . . . . . . . 26.3 ptm -71.56 151.72 93.77 Favored Pre-proline 0 C--N 1.318 -0.778 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.387 178.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 228' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -70.94 157.28 58.53 Favored 'Trans proline' 0 C--O 1.245 0.865 0 C-N-CA 123.225 2.617 . . . . 0.0 112.991 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . -84.37 173.44 49.85 Favored Glycine 0 C--N 1.317 -0.51 0 CA-C-N 115.704 -0.68 . . . . 0.0 113.089 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 24.8 m -77.71 -14.3 59.65 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -175.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 231' ' ' ARG . . . . . 0.6 ' HB2' ' OG ' ' A' ' 52' ' ' SER . 3.1 mmp_? -80.16 -7.15 58.8 Favored 'General case' 0 C--N 1.326 -0.43 0 O-C-N 121.964 -0.46 . . . . 0.0 110.365 177.657 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 232' ' ' TRP . . . . . . . . . . . . . 22.8 t90 -73.1 127.17 31.8 Favored 'General case' 0 CA--C 1.5 -0.966 0 CA-C-O 122.355 1.074 . . . . 0.0 111.819 -178.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 233' ' ' ASP . . . . . 0.493 ' H ' HG23 ' A' ' 49' ' ' THR . 26.9 t70 -123.23 146.47 47.81 Favored 'General case' 0 C--N 1.269 -2.92 0 N-CA-C 102.436 -3.172 . . . . 0.0 102.436 173.511 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -41.59 65.86 0.0 OUTLIER Glycine 0 N--CA 1.48 1.611 0 C-N-CA 128.101 2.763 . . . . 0.0 116.129 -179.472 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 235' ' ' VAL . . . . . 0.441 ' N ' ' O ' ' B' ' 233' ' ' ASP . 53.7 t -111.16 132.27 60.12 Favored 'Isoleucine or valine' 0 C--N 1.253 -3.597 0 C-N-CA 128.107 2.563 . . . . 0.0 106.279 174.412 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 236' ' ' HIS . . . . . . . . . . . . . 58.0 t-80 -112.68 120.69 42.4 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 237' ' ' ARG . . . . . 0.447 ' HD2' HG13 ' A' ' 50' ' ' VAL . 6.7 mmp_? -112.68 144.71 41.73 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 174.059 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 238' ' ' SER . . . . . . . . . . . . . 26.6 t -146.26 131.15 18.12 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 174.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 239' ' ' ASN . . . . . 0.471 ' HB3' ' HA ' ' A' ' 91' ' ' ASN . 28.1 p-10 -72.01 92.73 1.32 Allowed 'General case' 0 CA--C 1.512 -0.514 0 CA-C-O 122.153 0.977 . . . . 0.0 110.77 -179.743 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 240' ' ' GLY . . . . . 0.49 ' O ' ' HG2' ' B' ' 244' ' ' LYS . . . 78.23 81.7 0.66 Allowed Glycine 0 N--CA 1.412 -2.93 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -176.072 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 10.0 p90 -75.42 -32.85 60.84 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 178.582 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -60.5 -42.38 96.24 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.148 0.499 . . . . 0.0 110.285 -179.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -64.79 -35.42 81.03 Favored 'General case' 0 C--O 1.202 -1.439 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.677 179.668 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 244' ' ' LYS . . . . . 0.49 ' HG2' ' O ' ' B' ' 240' ' ' GLY . 39.6 mmtm -60.78 -47.46 86.23 Favored 'General case' 0 C--O 1.242 0.665 0 CA-C-O 121.29 0.567 . . . . 0.0 109.865 -178.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 245' ' ' TRP . . . . . . . . . . . . . 19.4 m0 -63.55 -41.05 98.45 Favored 'General case' 0 N--CA 1.437 -1.096 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.225 179.174 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 246' ' ' PHE . . . . . 0.524 ' HA ' ' HG2' ' B' ' 249' ' ' GLN . 3.6 t80 -68.14 -34.35 76.19 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.348 179.271 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -70.19 -35.35 73.89 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.699 -178.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.41 -21.73 22.89 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 120.357 -0.537 . . . . 0.0 111.789 -178.18 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 249' ' ' GLN . . . . . 0.524 ' HG2' ' HA ' ' B' ' 246' ' ' PHE . 3.5 pt20 -78.31 2.24 19.17 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.386 0.612 . . . . 0.0 110.402 -179.494 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 250' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -57.28 -31.93 66.1 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 114.892 -1.049 . . . . 0.0 112.864 178.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -77.18 142.66 39.53 Favored 'General case' 0 N--CA 1.433 -1.28 0 CA-C-O 121.986 0.898 . . . . 0.0 113.292 -176.768 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 252' ' ' ILE . . . . . . . . . . . . . 34.3 pt -130.67 -32.01 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 CA-C-N 114.487 -1.233 . . . . 0.0 113.078 -171.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -110.79 -23.05 11.25 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 121.624 0.726 . . . . 0.0 110.296 -175.65 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 254' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -72.21 166.06 23.16 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-N 114.038 -1.437 . . . . 0.0 114.117 -173.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 255' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -81.01 122.37 27.21 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 114.574 -1.194 . . . . 0.0 109.655 -176.233 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 256' ' ' LYS . . . . . . . . . . . . . 52.6 mttm . . . . . 0 C--N 1.295 -1.79 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 -177.821 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 15.3 m120 . . . . . 0 CA--C 1.499 -1.008 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -70.4 -27.15 64.07 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.63 0.729 . . . . 0.0 110.2 -179.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 49.7 m-85 -81.99 13.75 3.17 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 114.999 -1.0 . . . . 0.0 111.776 -177.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -138.75 152.24 47.78 Favored 'General case' 0 N--CA 1.425 -1.686 0 N-CA-C 105.555 -2.017 . . . . 0.0 105.555 174.222 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -116.08 22.18 13.15 Favored 'General case' 0 C--N 1.286 -2.19 0 CA-C-O 122.37 1.081 . . . . 0.0 109.294 179.361 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -76.73 18.95 0.3 Allowed 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 113.783 -1.553 . . . . 0.0 111.545 -176.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -94.48 -12.52 27.54 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.949 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -100.31 145.23 28.38 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 -177.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 23.1 pt -141.06 159.81 23.12 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 CA-C-O 121.025 0.44 . . . . 0.0 110.953 175.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 45.0 t80 -109.42 122.49 47.49 Favored 'General case' 0 N--CA 1.421 -1.901 0 CA-C-N 114.485 -1.234 . . . . 0.0 108.206 177.533 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.411 HG23 ' CD1' ' A' ' 104' ' ' ILE . 8.2 mt -108.56 128.0 64.55 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.164 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 174.562 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -129.98 165.6 22.33 Favored Glycine 0 C--N 1.283 -2.415 0 N-CA-C 110.832 -0.907 . . . . 0.0 110.832 -179.571 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 71.13 35.16 1.67 Allowed 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.865 1.266 . . . . 0.0 110.667 -177.359 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.421 HD11 HD11 ' A' ' 47' ' ' ILE . 4.5 mm? -68.47 152.77 44.93 Favored 'General case' 0 CA--C 1.497 -1.085 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.25 176.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.445 ' HB3' ' HG ' ' A' ' 42' ' ' LEU . 39.7 t-20 -91.63 151.94 20.47 Favored 'General case' 0 C--N 1.29 -1.988 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 176.55 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.517 ' HD3' ' OE1' ' A' ' 70' ' ' GLU . 1.0 OUTLIER -64.16 -17.21 63.27 Favored 'General case' 0 C--N 1.307 -1.253 0 C-N-CA 122.997 0.519 . . . . 0.0 111.734 179.837 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -97.27 3.55 51.26 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.107 -178.565 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.445 ' HG ' ' HB3' ' A' ' 39' ' ' ASN . 86.3 mt -98.46 117.33 32.64 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-O 121.589 0.709 . . . . 0.0 111.029 -179.128 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 68.2 p -107.23 174.74 5.76 Favored 'General case' 0 C--N 1.293 -1.866 0 CA-C-N 114.346 -1.297 . . . . 0.0 109.186 -179.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -54.46 -41.34 69.35 Favored 'General case' 0 C--O 1.209 -1.032 0 C-N-CA 123.19 0.596 . . . . 0.0 110.158 178.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.27 -39.47 96.08 Favored Glycine 0 CA--C 1.526 0.742 0 O-C-N 123.26 0.35 . . . . 0.0 112.901 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -66.8 -48.02 70.27 Favored 'General case' 0 CA--C 1.499 -1.004 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 179.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.421 HD11 HD11 ' A' ' 38' ' ' LEU . 42.0 mt -60.26 -46.36 94.92 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.782 0 CA-C-N 114.844 -1.071 . . . . 0.0 110.762 178.453 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 52.3 mt -59.77 -38.59 82.27 Favored 'General case' 0 CA--C 1.486 -1.502 0 C-N-CA 122.86 0.464 . . . . 0.0 111.525 -177.678 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.465 HG23 ' H ' ' B' ' 233' ' ' ASP . 62.1 m -64.38 -46.79 81.83 Favored 'General case' 0 N--CA 1.433 -1.281 0 O-C-N 123.615 0.572 . . . . 0.0 110.716 -179.115 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.547 HG13 ' HG3' ' B' ' 237' ' ' ARG . 89.6 t -67.72 -47.91 78.0 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.624 -179.581 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.464 ' HA ' ' HD2' ' A' ' 54' ' ' TYR . 3.7 m-85 -65.02 -25.07 67.69 Favored 'General case' 0 N--CA 1.435 -1.196 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.881 -177.145 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 59.8 m -67.59 -22.17 65.38 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.239 -0.437 . . . . 0.0 112.031 176.325 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -64.91 -28.94 69.88 Favored 'General case' 0 CA--C 1.559 1.322 0 CA-C-O 121.485 0.66 . . . . 0.0 109.917 175.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.464 ' HD2' ' HA ' ' A' ' 51' ' ' PHE . 49.1 m-85 -91.3 -18.24 24.65 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-O 121.24 0.543 . . . . 0.0 112.097 -175.204 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 165.19 -160.49 33.83 Favored Glycine 0 N--CA 1.419 -2.457 0 N-CA-C 111.011 -0.836 . . . . 0.0 111.011 179.484 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 62.2 t -100.2 110.8 60.92 Favored Pre-proline 0 C--N 1.294 -1.833 0 N-CA-C 110.347 -0.242 . . . . 0.0 110.347 -178.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.51 ' HB3' HD21 ' A' ' 77' ' ' LEU . 73.2 Cg_endo -76.05 141.07 23.33 Favored 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 122.645 2.23 . . . . 0.0 109.764 175.075 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 33.7 m -119.9 -13.57 9.1 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 C-N-CA 120.117 -0.633 . . . . 0.0 112.188 -179.275 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.496 ' HB3' ' HG2' ' A' ' 78' ' ' LYS . 33.2 t70 -164.09 136.85 5.07 Favored 'General case' 0 CA--C 1.501 -0.911 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.219 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 13.0 p -144.72 133.36 17.83 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 O-C-N 123.729 0.643 . . . . 0.0 110.01 -179.172 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.462 ' CD1' ' HB3' ' A' ' 111' ' ' PRO . 94.1 mt -121.9 128.98 75.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 176.019 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -99.36 117.28 33.45 Favored 'General case' 0 N--CA 1.419 -1.99 0 N-CA-C 105.364 -2.088 . . . . 0.0 105.364 173.394 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 62.8 m -78.61 117.82 20.14 Favored 'General case' 0 C--N 1.275 -2.655 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 176.131 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.431 ' HA ' ' HA ' ' A' ' 71' ' ' SER . 85.8 mtt180 -125.19 130.89 53.04 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 -175.401 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -69.17 116.76 9.99 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 177.55 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -61.77 -18.07 58.43 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 113.934 1.087 . . . . 0.0 113.934 -177.251 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 23.5 m-80 -81.66 -46.42 14.37 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 -177.58 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 33.9 p -85.76 -23.96 27.07 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.411 -179.253 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 69.94 19.36 75.26 Favored Glycine 0 N--CA 1.445 -0.73 0 CA-C-N 115.583 -0.735 . . . . 0.0 113.091 176.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.517 ' OE1' ' HD3' ' A' ' 40' ' ' ARG . 17.1 mm-40 -111.41 -78.76 0.58 Allowed 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 117.059 0.429 . . . . 0.0 111.363 -177.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.431 ' HA ' ' HA ' ' A' ' 64' ' ' ARG . 34.3 t -158.1 168.34 27.36 Favored 'General case' 0 N--CA 1.441 -0.914 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 -178.258 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 13.4 mm-40 -102.84 -7.29 21.7 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 172.172 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 87.21 4.23 81.44 Favored Glycine 0 N--CA 1.433 -1.514 0 C-N-CA 120.221 -0.99 . . . . 0.0 112.344 -179.393 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 31.5 p90 -142.1 155.34 45.35 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 177.509 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -149.75 171.84 16.07 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-O 120.94 0.4 . . . . 0.0 110.88 -179.375 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -130.3 140.85 50.63 Favored 'General case' 0 C--N 1.31 -1.118 0 C-N-CA 123.854 0.861 . . . . 0.0 109.963 -178.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.51 HD21 ' HB3' ' A' ' 57' ' ' PRO . 9.8 tt -149.94 140.55 22.55 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 175.532 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.496 ' HG2' ' HB3' ' A' ' 59' ' ' ASP . 16.9 ptmt -125.05 144.56 50.34 Favored 'General case' 0 N--CA 1.433 -1.276 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 177.781 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 61.3 m-85 -104.48 164.94 11.39 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-O 121.614 0.721 . . . . 0.0 112.321 -177.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -75.86 -30.74 59.0 Favored 'General case' 0 N--CA 1.437 -1.089 0 CA-C-N 114.33 -1.304 . . . . 0.0 109.4 175.671 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -122.01 133.22 54.81 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 -179.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -70.06 -19.93 63.26 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 114.254 1.205 . . . . 0.0 114.254 -177.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 88.4 mtm180 -65.8 -33.21 75.33 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-O 122.299 1.047 . . . . 0.0 109.863 174.135 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.502 ' OG ' HG21 ' B' ' 226' ' ' ILE . 66.2 m -63.27 -36.77 84.78 Favored 'General case' 0 C--N 1.288 -2.101 0 CA-C-N 114.985 -1.007 . . . . 0.0 112.947 178.852 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.447 ' O ' HG23 ' A' ' 89' ' ' VAL . 77.2 p -64.2 -45.54 87.85 Favored 'General case' 0 C--O 1.224 -0.25 0 C-N-CA 120.229 -0.588 . . . . 0.0 110.779 -177.554 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 5.2 pt -64.94 -38.86 83.85 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.309 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.837 177.77 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.569 HD11 ' HB2' ' B' ' 224' ' ' PHE . 6.4 mt -58.55 -43.53 89.32 Favored 'General case' 0 CA--C 1.505 -0.779 0 O-C-N 123.812 0.695 . . . . 0.0 110.668 177.719 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.472 ' O ' ' HB2' ' A' ' 92' ' ' LEU . . . -71.97 -43.76 64.65 Favored 'General case' 0 N--CA 1.42 -1.933 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.708 179.536 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.469 HG22 HG22 ' A' ' 104' ' ' ILE . 79.3 t -58.85 -49.04 84.35 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.751 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -71.18 -27.8 63.79 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -172.488 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.49 ' HA ' ' OD1' ' B' ' 239' ' ' ASN . 8.8 t30 -96.58 -25.62 15.54 Favored 'General case' 0 C--N 1.296 -1.759 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.761 -177.367 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.472 ' HB2' ' O ' ' A' ' 88' ' ' ALA . 12.1 mt -95.33 -22.66 17.61 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 122.052 -0.405 . . . . 0.0 111.471 -178.049 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -65.21 124.93 23.46 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 177.361 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 81.79 -0.99 87.59 Favored Glycine 0 C--O 1.243 0.666 0 C-N-CA 120.882 -0.675 . . . . 0.0 113.143 177.564 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 62.0 t80 -85.35 144.1 28.25 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 -178.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 11.8 mptt -99.88 118.78 37.05 Favored 'General case' 0 N--CA 1.44 -0.955 0 CA-C-O 121.336 0.589 . . . . 0.0 112.512 -176.396 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 58.6 mt -127.59 141.46 46.32 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.188 0 N-CA-C 105.842 -1.91 . . . . 0.0 105.842 173.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 61.1 20.06 57.66 Favored Glycine 0 CA--C 1.519 0.312 0 C-N-CA 121.143 -0.551 . . . . 0.0 112.373 -177.406 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 78.13 7.49 87.65 Favored Glycine 0 N--CA 1.436 -1.362 0 CA-C-N 115.834 -0.183 . . . . 0.0 113.217 -178.011 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 16.7 ptp180 -124.78 147.95 48.4 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 117.534 0.667 . . . . 0.0 110.405 -179.555 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -87.7 116.32 25.75 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 116.585 -0.28 . . . . 0.0 111.587 -175.631 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 12.7 mt -65.84 144.62 56.72 Favored 'General case' 0 C--O 1.252 1.186 0 CA-C-O 121.875 0.845 . . . . 0.0 113.103 179.679 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 29.2 tptp -118.72 115.47 24.55 Favored 'General case' 0 N--CA 1.416 -2.148 0 CA-C-N 114.806 -1.088 . . . . 0.0 108.216 176.076 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.469 HG22 HG22 ' A' ' 89' ' ' VAL . 4.7 mm -114.69 134.46 57.61 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.966 0 N-CA-C 105.859 -1.904 . . . . 0.0 105.859 178.328 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -143.12 151.99 41.32 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -176.138 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 56.2 m-70 -83.34 130.48 35.06 Favored 'General case' 0 C--N 1.295 -1.804 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 177.492 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 7.3 t -147.28 163.42 36.45 Favored 'General case' 0 C--N 1.291 -1.973 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 -178.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 46.5 m-85 -110.13 111.03 22.11 Favored 'General case' 0 N--CA 1.42 -1.96 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 171.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 63.7 t80 -107.73 139.13 42.77 Favored 'General case' 0 C--N 1.294 -1.819 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.783 -176.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 6.2 mpt_? -116.91 114.99 39.07 Favored Pre-proline 0 C--N 1.306 -1.325 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 170.386 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.462 ' HB3' ' CD1' ' A' ' 61' ' ' ILE . 49.0 Cg_endo -68.67 140.67 47.66 Favored 'Trans proline' 0 C--N 1.323 -0.769 0 C-N-CA 122.929 2.42 . . . . 0.0 114.525 -178.064 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -107.0 112.35 25.26 Favored 'General case' 0 N--CA 1.423 -1.812 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 170.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 31.0 mmm180 . . . . . 0 C--N 1.286 -2.176 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 -178.849 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 . . . . . 0 N--CA 1.466 0.363 0 CA-C-O 120.426 0.155 . . . . 0.0 110.899 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 223' ' ' ARG . . . . . . . . . . . . . 10.5 ptm180 51.9 46.53 26.42 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 127.049 2.139 . . . . 0.0 116.264 176.134 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 224' ' ' PHE . . . . . 0.569 ' HB2' HD11 ' A' ' 87' ' ' LEU . 63.4 m-85 -100.62 165.57 11.33 Favored 'General case' 0 C--N 1.289 -2.055 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 172.406 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 225' ' ' ALA . . . . . . . . . . . . . . . -124.88 83.85 2.21 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-O 121.672 0.748 . . . . 0.0 110.923 -177.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 226' ' ' ILE . . . . . 0.502 HG21 ' OG ' ' A' ' 84' ' ' SER . 4.0 mp -123.35 137.49 56.49 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.799 0 CA-C-N 115.177 -0.92 . . . . 0.0 108.89 178.113 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 227' ' ' MET . . . . . . . . . . . . . 65.8 mtt -61.92 134.2 94.13 Favored Pre-proline 0 C--N 1.322 -0.626 0 O-C-N 123.466 0.479 . . . . 0.0 111.516 -179.161 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 228' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -72.34 140.28 33.36 Favored 'Trans proline' 0 C--O 1.251 1.138 0 C-N-CA 123.13 2.554 . . . . 0.0 112.703 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . -65.65 164.01 39.16 Favored Glycine 0 C--N 1.317 -0.526 0 CA-C-N 115.573 -0.739 . . . . 0.0 113.372 -179.528 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 14.6 m -72.06 -18.08 61.96 Favored 'General case' 0 C--N 1.31 -1.149 0 C-N-CA 123.331 0.652 . . . . 0.0 112.375 -175.172 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 13.6 mmm180 -82.06 -3.45 54.67 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.92 0.391 . . . . 0.0 111.146 -177.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 232' ' ' TRP . . . . . . . . . . . . . 24.9 t90 -72.04 123.52 22.97 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-O 122.405 1.097 . . . . 0.0 111.502 179.639 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 233' ' ' ASP . . . . . 0.465 ' H ' HG23 ' A' ' 49' ' ' THR . 8.4 t70 -113.14 144.48 42.59 Favored 'General case' 0 C--N 1.276 -2.617 0 N-CA-C 101.095 -3.669 . . . . 0.0 101.095 171.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -48.4 61.22 0.0 OUTLIER Glycine 0 N--CA 1.487 2.059 0 C-N-CA 127.361 2.41 . . . . 0.0 115.836 -178.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 235' ' ' VAL . . . . . 0.437 ' N ' ' O ' ' B' ' 233' ' ' ASP . 38.8 t -109.17 122.21 63.45 Favored 'Isoleucine or valine' 0 C--N 1.251 -3.712 0 C-N-CA 129.003 2.921 . . . . 0.0 106.89 176.554 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 236' ' ' HIS . . . . . . . . . . . . . 51.0 t-80 -105.24 119.45 39.1 Favored 'General case' 0 C--N 1.292 -1.928 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 -179.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 237' ' ' ARG . . . . . 0.547 ' HG3' HG13 ' A' ' 50' ' ' VAL . 48.6 mmt-85 -126.54 109.41 12.12 Favored 'General case' 0 C--O 1.198 -1.657 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.001 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 238' ' ' SER . . . . . . . . . . . . . 40.0 t -142.91 126.75 17.14 Favored 'General case' 0 C--N 1.285 -2.235 0 O-C-N 121.921 -0.487 . . . . 0.0 110.2 -176.062 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 239' ' ' ASN . . . . . 0.49 ' OD1' ' HA ' ' A' ' 91' ' ' ASN . 35.5 p-10 -87.21 75.68 9.33 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 123.047 1.403 . . . . 0.0 110.992 178.706 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 240' ' ' GLY . . . . . 0.52 ' O ' ' HG2' ' B' ' 244' ' ' LYS . . . -138.84 30.96 2.43 Favored Glycine 0 N--CA 1.423 -2.199 0 CA-C-N 114.117 -1.401 . . . . 0.0 109.857 177.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 20.8 p90 -76.27 -38.12 56.63 Favored 'General case' 0 C--N 1.293 -1.868 0 C-N-CA 123.768 0.827 . . . . 0.0 112.318 179.684 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -60.71 -42.78 97.93 Favored 'General case' 0 C--O 1.243 0.741 0 C-N-CA 122.353 0.261 . . . . 0.0 111.281 -177.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -62.0 -34.99 77.2 Favored 'General case' 0 C--O 1.211 -0.935 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.476 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 244' ' ' LYS . . . . . 0.52 ' HG2' ' O ' ' B' ' 240' ' ' GLY . 43.9 mmtm -64.45 -47.85 77.52 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-O 121.133 0.492 . . . . 0.0 110.523 -177.718 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 245' ' ' TRP . . . . . . . . . . . . . 13.6 m0 -65.8 -39.12 90.6 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.225 178.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 246' ' ' PHE . . . . . 0.504 ' O ' ' HG2' ' B' ' 249' ' ' GLN . 2.7 t80 -64.97 -37.12 86.61 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.634 178.181 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -68.49 -35.42 77.5 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.591 -179.536 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.33 -16.71 28.67 Favored 'General case' 0 CA--C 1.509 -0.6 0 N-CA-C 111.887 0.329 . . . . 0.0 111.887 -177.782 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 249' ' ' GLN . . . . . 0.504 ' HG2' ' O ' ' B' ' 246' ' ' PHE . 3.2 pt20 -81.07 2.8 25.64 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-O 120.839 0.352 . . . . 0.0 110.456 -179.299 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 250' ' ' ASN . . . . . 0.436 ' OD1' ' HG3' ' B' ' 251' ' ' GLU . 7.9 p30 -52.37 -39.69 61.09 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.514 178.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . 0.436 ' HG3' ' OD1' ' B' ' 250' ' ' ASN . 46.2 mt-10 -133.66 121.36 21.88 Favored 'General case' 0 N--CA 1.435 -1.205 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 174.43 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 252' ' ' ILE . . . . . . . . . . . . . 38.1 pt -96.91 -34.34 4.91 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -174.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -100.46 -17.76 17.02 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-O 121.969 0.89 . . . . 0.0 109.58 -178.471 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 254' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -98.59 -172.31 2.29 Favored 'General case' 0 C--N 1.293 -1.88 0 CA-C-N 114.35 -1.295 . . . . 0.0 108.409 179.637 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 255' ' ' LYS . . . . . . . . . . . . . 20.1 pttm -51.92 141.61 17.32 Favored 'General case' 0 C--N 1.312 -1.032 0 C-N-CA 124.613 1.165 . . . . 0.0 111.708 178.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 256' ' ' LYS . . . . . . . . . . . . . 21.9 pttp . . . . . 0 C--N 1.304 -1.371 0 CA-C-O 118.134 -0.936 . . . . 0.0 110.541 -179.037 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 50.5 t30 . . . . . 0 CA--C 1.514 -0.411 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -69.01 -12.22 61.49 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-O 121.966 0.889 . . . . 0.0 112.235 -173.076 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 -87.0 11.55 13.39 Favored 'General case' 0 C--N 1.293 -1.864 0 CA-C-N 114.427 -1.261 . . . . 0.0 110.734 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 56.2 mttp -127.1 171.88 11.01 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 173.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -117.28 26.69 9.58 Favored 'General case' 0 CA--C 1.491 -1.294 0 CA-C-O 121.974 0.892 . . . . 0.0 109.648 -178.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -78.07 -0.27 27.39 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-N 114.596 -1.184 . . . . 0.0 111.477 -175.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.491 ' HA ' HG21 ' A' ' 85' ' ' THR . . . -82.24 -15.64 52.38 Favored 'General case' 0 CA--C 1.503 -0.847 0 CA-C-O 120.869 0.366 . . . . 0.0 110.322 179.235 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 57.5 m-85 -102.13 144.49 30.62 Favored 'General case' 0 N--CA 1.429 -1.496 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 -178.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 27.5 pt -143.24 162.55 16.85 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 CA-C-O 121.458 0.646 . . . . 0.0 110.869 -179.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.414 ' HB2' HG21 ' A' ' 107' ' ' THR . 8.2 t80 -114.45 125.88 54.33 Favored 'General case' 0 N--CA 1.412 -2.359 0 CA-C-N 114.085 -1.416 . . . . 0.0 108.123 175.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 10.2 mt -108.51 127.53 64.85 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.998 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 176.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -125.68 164.2 19.35 Favored Glycine 0 C--N 1.279 -2.596 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 -179.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 66.9 m-20 71.46 45.0 0.49 Allowed 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 125.346 1.458 . . . . 0.0 110.219 -177.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.483 HD11 HD11 ' A' ' 47' ' ' ILE . 4.2 mm? -76.21 144.63 40.31 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.281 177.08 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.436 ' HB3' ' HG ' ' A' ' 42' ' ' LEU . 42.8 t-20 -83.88 147.23 27.64 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 176.827 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.513 ' C ' ' HD2' ' A' ' 40' ' ' ARG . 6.6 ppt_? -59.2 -22.02 60.36 Favored 'General case' 0 C--N 1.311 -1.068 0 C-N-CA 123.78 0.832 . . . . 0.0 111.921 -179.73 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.422 ' N ' ' HD2' ' A' ' 40' ' ' ARG . 12.9 pt-20 -92.8 -10.99 34.9 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.818 -176.207 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.436 ' HG ' ' HB3' ' A' ' 39' ' ' ASN . 71.6 mt -79.86 132.5 36.12 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.214 0.531 . . . . 0.0 111.504 -176.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 35.1 p -119.86 173.73 6.87 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 114.852 -1.067 . . . . 0.0 110.44 -178.317 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 -55.35 -39.31 69.88 Favored 'General case' 0 C--O 1.221 -0.417 0 C-N-CA 123.2 0.6 . . . . 0.0 111.05 179.33 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.95 -38.58 95.69 Favored Glycine 0 N--CA 1.448 -0.559 0 CA-C-N 116.013 -0.54 . . . . 0.0 112.597 -179.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.408 ' O ' HG23 ' A' ' 50' ' ' VAL . 21.8 m-20 -67.08 -49.51 64.8 Favored 'General case' 0 CA--C 1.492 -1.273 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.483 HD11 HD11 ' A' ' 38' ' ' LEU . 37.7 mt -60.43 -47.12 93.89 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.931 0 CA-C-N 114.791 -1.095 . . . . 0.0 110.78 -179.246 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 36.7 mt -59.68 -42.36 92.78 Favored 'General case' 0 CA--C 1.494 -1.179 0 CA-C-N 116.572 -0.285 . . . . 0.0 111.714 -176.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.419 HG23 ' H ' ' B' ' 233' ' ' ASP . 68.8 m -65.66 -46.02 80.73 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 123.541 0.526 . . . . 0.0 111.649 -178.235 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.408 HG23 ' O ' ' A' ' 46' ' ' ASP . 58.4 t -67.69 -45.74 84.12 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-O 121.42 0.629 . . . . 0.0 110.39 -178.127 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.414 ' HA ' ' HD2' ' A' ' 54' ' ' TYR . 4.5 m-85 -64.63 -25.3 67.9 Favored 'General case' 0 N--CA 1.431 -1.387 0 CA-C-N 115.082 -0.963 . . . . 0.0 111.921 -179.452 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.57 ' OG ' ' HB2' ' B' ' 231' ' ' ARG . 66.9 m -70.23 -19.43 63.14 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 176.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -72.54 -20.9 61.26 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-O 121.669 0.747 . . . . 0.0 109.68 176.209 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.438 ' CE1' ' HB2' ' A' ' 91' ' ' ASN . 60.1 m-85 -94.65 -19.98 19.97 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.853 -178.663 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.436 ' O ' ' HA ' ' A' ' 52' ' ' SER . . . 167.17 -152.91 22.06 Favored Glycine 0 N--CA 1.424 -2.139 0 C-N-CA 120.741 -0.742 . . . . 0.0 111.403 179.017 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 87.7 t -105.58 110.57 64.38 Favored Pre-proline 0 C--N 1.295 -1.766 0 N-CA-C 110.307 -0.257 . . . . 0.0 110.307 -177.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.526 ' HB3' HD21 ' A' ' 77' ' ' LEU . 73.9 Cg_endo -78.24 135.99 14.01 Favored 'Trans proline' 0 N--CA 1.44 -1.65 0 C-N-CA 121.846 1.697 . . . . 0.0 109.2 174.685 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 35.8 m -113.18 -19.95 6.51 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 C-N-CA 119.726 -0.789 . . . . 0.0 111.57 -177.33 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.501 ' HB3' ' HG2' ' A' ' 78' ' ' LYS . 36.1 t70 -159.34 140.68 12.95 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 179.801 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 13.1 p -143.67 136.31 23.99 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 O-C-N 123.793 0.683 . . . . 0.0 109.868 -179.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.521 HD11 ' HB3' ' A' ' 111' ' ' PRO . 99.1 mt -122.37 125.82 73.32 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 C-N-CA 123.112 0.565 . . . . 0.0 109.503 173.19 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -98.71 118.64 35.9 Favored 'General case' 0 N--CA 1.419 -1.998 0 N-CA-C 104.963 -2.236 . . . . 0.0 104.963 173.252 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 17.8 m -81.03 116.52 21.02 Favored 'General case' 0 N--CA 1.408 -2.561 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 179.349 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.406 ' HG2' ' HA ' ' A' ' 71' ' ' SER . 64.8 mtm180 -128.54 141.15 51.46 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 -178.132 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -69.7 120.6 15.71 Favored 'General case' 0 C--N 1.296 -1.755 0 O-C-N 123.913 0.758 . . . . 0.0 109.206 178.603 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -61.44 -18.69 60.07 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 113.615 0.968 . . . . 0.0 113.615 -177.159 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 22.9 m-80 -82.18 -47.74 12.13 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-O 121.05 0.452 . . . . 0.0 110.625 -176.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 60.2 p -91.76 -23.46 19.74 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.393 -177.319 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.43 12.95 83.87 Favored Glycine 0 N--CA 1.444 -0.813 0 N-CA-C 111.693 -0.563 . . . . 0.0 111.693 -177.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -113.71 158.48 20.85 Favored 'General case' 0 C--N 1.323 -0.551 0 O-C-N 122.682 -0.305 . . . . 0.0 110.409 -177.015 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.406 ' HA ' ' HG2' ' A' ' 64' ' ' ARG . 38.8 t -51.61 140.33 18.68 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 124.084 0.953 . . . . 0.0 112.089 179.688 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -83.32 -2.77 56.51 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.446 177.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 95.54 11.69 55.1 Favored Glycine 0 N--CA 1.421 -2.335 0 CA-C-N 115.494 -0.775 . . . . 0.0 112.604 179.078 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 33.0 p90 -152.43 157.52 41.33 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 177.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -153.25 172.64 16.67 Favored 'General case' 0 N--CA 1.427 -1.583 0 O-C-N 123.509 0.506 . . . . 0.0 110.2 179.31 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -132.15 144.62 50.81 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 123.761 0.825 . . . . 0.0 110.053 -178.428 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.526 HD21 ' HB3' ' A' ' 57' ' ' PRO . 9.9 tt -153.78 140.72 19.23 Favored 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 175.634 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.501 ' HG2' ' HB3' ' A' ' 59' ' ' ASP . 18.8 ptmt -123.91 144.1 49.97 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 177.578 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.409 ' CD1' HG22 ' A' ' 85' ' ' THR . 39.9 m-85 -102.5 165.04 11.32 Favored 'General case' 0 C--N 1.29 -2.013 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.611 -178.348 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -73.48 -35.32 65.66 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 114.702 -1.136 . . . . 0.0 109.133 175.402 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -124.78 137.59 54.31 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.806 -178.045 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -70.19 -20.08 63.14 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -179.49 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 80.8 mtm180 -65.08 -34.55 78.68 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 122.219 1.009 . . . . 0.0 109.478 174.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.462 ' OG ' HG21 ' B' ' 226' ' ' ILE . 60.3 m -67.43 -37.41 82.97 Favored 'General case' 0 C--N 1.292 -1.92 0 CA-C-N 114.821 -1.082 . . . . 0.0 112.185 178.369 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.491 HG21 ' HA ' ' A' ' 31' ' ' ALA . 71.1 p -65.45 -45.12 85.02 Favored 'General case' 0 C--O 1.217 -0.635 0 C-N-CA 120.249 -0.58 . . . . 0.0 110.685 -177.792 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 3.7 pt -63.26 -39.2 84.36 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.317 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.075 177.409 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.466 HD21 ' CD1' ' B' ' 224' ' ' PHE . 30.0 mt -59.79 -43.24 94.5 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 123.44 0.463 . . . . 0.0 110.911 174.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -68.99 -46.5 67.9 Favored 'General case' 0 C--O 1.203 -1.374 0 CA-C-N 115.712 -0.677 . . . . 0.0 110.928 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.49 HG23 ' O ' ' A' ' 85' ' ' THR . 85.9 t -58.88 -48.93 84.78 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.062 0 CA-C-O 120.712 0.291 . . . . 0.0 110.954 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -67.36 -29.77 69.39 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 -174.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.473 ' HA ' ' OD1' ' B' ' 239' ' ' ASN . 11.0 m120 -97.98 -21.02 17.06 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 113.684 0.994 . . . . 0.0 113.684 -178.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 14.0 mt -98.92 -31.42 11.84 Favored 'General case' 0 CA--C 1.495 -1.172 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -176.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 52.6 t30 -66.39 124.98 24.21 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 85.21 -1.81 88.48 Favored Glycine 0 C--N 1.306 -1.128 0 C-N-CA 121.411 -0.423 . . . . 0.0 112.909 -179.151 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.538 ' CE2' ' HG3' ' B' ' 237' ' ' ARG . 64.1 t80 -90.09 137.85 32.0 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 179.468 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.421 ' HA ' ' HA ' ' A' ' 101' ' ' ALA . 0.4 OUTLIER -93.38 119.5 32.57 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-O 120.914 0.388 . . . . 0.0 111.712 -177.213 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 35.4 mt -118.35 142.45 33.01 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 173.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 71.58 -84.67 0.44 Allowed Glycine 0 N--CA 1.438 -1.195 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 -174.257 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -161.99 17.72 0.16 Allowed Glycine 0 N--CA 1.427 -1.955 0 N-CA-C 110.199 -1.161 . . . . 0.0 110.199 175.268 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 16.6 ptp180 -137.23 149.79 47.41 Favored 'General case' 0 N--CA 1.445 -0.719 0 O-C-N 122.798 -0.236 . . . . 0.0 110.532 -175.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.421 ' HA ' ' HA ' ' A' ' 96' ' ' LYS . . . -87.36 122.97 31.82 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.789 -177.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 14.8 mt -66.92 148.24 52.2 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-O 121.745 0.783 . . . . 0.0 112.923 179.013 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 54.3 tptt -121.94 116.47 24.42 Favored 'General case' 0 N--CA 1.418 -2.025 0 CA-C-N 114.911 -1.04 . . . . 0.0 108.824 175.131 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 3.9 mm -116.39 136.09 54.51 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.868 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -143.81 150.57 38.73 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 178.139 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 74.4 m-70 -83.34 137.8 33.81 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 178.057 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.414 HG21 ' HB2' ' A' ' 34' ' ' TYR . 9.0 t -158.62 155.38 28.12 Favored 'General case' 0 C--N 1.291 -1.959 0 N-CA-C 106.247 -1.76 . . . . 0.0 106.247 -177.215 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -93.82 111.83 23.59 Favored 'General case' 0 N--CA 1.435 -1.2 0 C-N-CA 117.571 -1.651 . . . . 0.0 108.057 172.76 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 30.5 t80 -106.5 135.96 47.09 Favored 'General case' 0 C--N 1.294 -1.845 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.676 -179.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 86.3 mmt-85 -122.5 124.61 26.72 Favored Pre-proline 0 C--N 1.298 -1.648 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 171.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.521 ' HB3' HD11 ' A' ' 61' ' ' ILE . 73.8 Cg_endo -74.83 145.22 31.89 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 122.622 2.215 . . . . 0.0 113.773 -178.605 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.446 ' C ' ' HD3' ' A' ' 112' ' ' LYS . 11.6 tmtt? -98.62 129.92 45.14 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 174.443 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.424 ' N ' ' HD3' ' A' ' 112' ' ' LYS . 98.8 mtt180 . . . . . 0 C--N 1.305 -1.338 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 179.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 50.5 t-20 . . . . . 0 C--O 1.204 -1.327 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 223' ' ' ARG . . . . . . . . . . . . 0.25 10.5 ptm180 68.37 17.94 9.15 Favored 'General case' 0 N--CA 1.495 1.803 0 C-N-CA 127.795 2.438 . . . . 0.0 114.476 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 224' ' ' PHE . . . . . 0.466 ' CD1' HD21 ' A' ' 87' ' ' LEU . 66.9 m-85 -96.99 159.41 14.93 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 176.682 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 225' ' ' ALA . . . . . . . . . . . . . . . -131.82 86.83 2.38 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 -179.507 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 226' ' ' ILE . . . . . 0.462 HG21 ' OG ' ' A' ' 84' ' ' SER . 4.3 mp -127.47 128.21 69.63 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.238 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.295 178.16 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 227' ' ' MET . . . . . . . . . . . . . 90.5 mmm -66.81 137.95 95.09 Favored Pre-proline 0 C--N 1.321 -0.656 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.561 177.156 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 228' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -66.25 157.18 61.31 Favored 'Trans proline' 0 C--O 1.248 0.975 0 C-N-CA 122.938 2.425 . . . . 0.0 113.183 -178.217 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . -73.36 170.34 52.43 Favored Glycine 0 N--CA 1.439 -1.127 0 CA-C-N 115.412 -0.813 . . . . 0.0 112.237 179.474 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 20.9 m -77.44 -18.24 57.37 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-O 121.101 0.477 . . . . 0.0 111.23 -177.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 231' ' ' ARG . . . . . 0.57 ' HB2' ' OG ' ' A' ' 52' ' ' SER . 37.9 mmt180 -79.64 -8.16 59.03 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.583 -178.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 232' ' ' TRP . . . . . . . . . . . . . 21.6 t90 -73.54 122.96 23.04 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-O 122.279 1.038 . . . . 0.0 113.05 -176.078 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 233' ' ' ASP . . . . . 0.451 ' O ' ' N ' ' B' ' 235' ' ' VAL . 12.2 t70 -120.47 137.52 54.3 Favored 'General case' 0 C--N 1.276 -2.622 0 N-CA-C 100.773 -3.788 . . . . 0.0 100.773 172.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -36.54 54.61 0.0 OUTLIER Glycine 0 N--CA 1.513 3.833 0 C-N-CA 128.979 3.18 . . . . 0.0 118.257 -175.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 235' ' ' VAL . . . . . 0.451 ' N ' ' O ' ' B' ' 233' ' ' ASP . 50.1 t -104.35 121.92 56.64 Favored 'Isoleucine or valine' 0 C--N 1.25 -3.736 0 C-N-CA 127.602 2.361 . . . . 0.0 107.526 176.528 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 236' ' ' HIS . . . . . 0.422 ' C ' ' HD2' ' B' ' 237' ' ' ARG . 34.9 t-80 -112.06 115.83 29.54 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 123.867 0.73 . . . . 0.0 110.118 -177.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 237' ' ' ARG . . . . . 0.538 ' HG3' ' CE2' ' A' ' 95' ' ' PHE . 2.1 mpt_? -119.07 109.5 15.98 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-O 121.215 0.531 . . . . 0.0 110.217 176.692 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 238' ' ' SER . . . . . . . . . . . . . 47.8 t -140.61 130.16 24.08 Favored 'General case' 0 N--CA 1.417 -2.09 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 179.515 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 239' ' ' ASN . . . . . 0.473 ' OD1' ' HA ' ' A' ' 91' ' ' ASN . 27.1 p-10 -89.26 -170.98 3.07 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 175.236 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 240' ' ' GLY . . . . . 0.445 ' O ' ' HG2' ' B' ' 244' ' ' LYS . . . 134.59 -11.19 4.61 Favored Glycine 0 C--O 1.198 -2.098 0 N-CA-C 110.88 -0.888 . . . . 0.0 110.88 -179.787 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 39.9 p90 -77.26 -34.18 55.83 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-O 120.932 0.396 . . . . 0.0 111.694 177.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -62.79 -41.65 99.36 Favored 'General case' 0 C--O 1.243 0.74 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.459 -174.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -62.98 -35.29 79.69 Favored 'General case' 0 C--O 1.21 -1.002 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.581 -178.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 244' ' ' LYS . . . . . 0.445 ' HG2' ' O ' ' B' ' 240' ' ' GLY . 69.8 mmtt -65.95 -42.99 89.28 Favored 'General case' 0 N--CA 1.439 -1.021 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 -177.381 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 245' ' ' TRP . . . . . . . . . . . . . 46.1 m0 -65.44 -41.99 92.87 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.695 178.182 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 246' ' ' PHE . . . . . 0.486 ' O ' ' HG2' ' B' ' 249' ' ' GLN . 3.0 t80 -66.53 -30.23 70.5 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 121.803 0.811 . . . . 0.0 110.949 178.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -77.44 -39.39 46.99 Favored 'General case' 0 C--N 1.295 -1.786 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.384 178.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.83 -15.33 39.5 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.083 0.468 . . . . 0.0 111.793 -175.117 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 249' ' ' GLN . . . . . 0.486 ' HG2' ' O ' ' B' ' 246' ' ' PHE . 3.9 pt20 -71.46 1.77 5.94 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.804 -179.169 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 250' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -65.34 -29.2 69.91 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 176.014 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -78.29 112.18 15.02 Favored 'General case' 0 N--CA 1.426 -1.642 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 176.4 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 252' ' ' ILE . . . . . . . . . . . . . 29.4 pt -103.51 -34.23 3.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.812 -172.164 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -100.67 -15.52 17.71 Favored 'General case' 0 CA--C 1.497 -1.077 0 CA-C-O 122.224 1.011 . . . . 0.0 108.668 179.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 254' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -98.38 -169.82 1.86 Allowed 'General case' 0 N--CA 1.417 -2.097 0 CA-C-N 113.843 -1.526 . . . . 0.0 110.493 177.415 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 255' ' ' LYS . . . . . . . . . . . . . 14.5 pttm -56.31 103.0 0.09 Allowed 'General case' 0 C--N 1.296 -1.732 0 C-N-CA 125.149 1.38 . . . . 0.0 114.33 -178.175 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 256' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt . . . . . 0 C--N 1.296 -1.758 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 174.341 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 32.0 t30 . . . . . 0 CA--C 1.509 -0.611 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 68.4 mm-40 -120.04 -42.2 2.61 Favored 'General case' 0 N--CA 1.427 -1.59 0 CA-C-N 116.078 -0.51 . . . . 0.0 112.13 -176.533 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -132.52 8.13 4.22 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 113.832 1.049 . . . . 0.0 113.832 -169.62 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.431 ' HB2' HE22 ' A' ' 82' ' ' GLN . 75.0 mmtt -134.15 -177.1 4.43 Favored 'General case' 0 C--N 1.295 -1.771 0 C-N-CA 120.006 -0.678 . . . . 0.0 111.336 -174.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -127.44 10.24 6.71 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-O 121.787 0.803 . . . . 0.0 109.665 176.131 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -81.06 30.54 0.32 Allowed 'General case' 0 N--CA 1.481 1.09 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.805 -178.317 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -94.64 -1.58 52.91 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.415 -178.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 16.9 m-85 -111.9 145.01 40.29 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 -175.013 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 28.3 pt -138.65 157.03 29.78 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.172 176.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 56.7 t80 -106.72 121.7 44.89 Favored 'General case' 0 N--CA 1.41 -2.429 0 CA-C-N 114.619 -1.173 . . . . 0.0 107.978 177.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.407 HG23 ' CD1' ' A' ' 104' ' ' ILE . 10.8 mt -108.38 128.03 64.26 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.18 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 175.567 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -130.25 173.35 19.99 Favored Glycine 0 C--N 1.28 -2.583 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 179.599 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 69.98 31.03 3.47 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.312 0.645 . . . . 0.0 111.16 -178.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -68.55 155.14 40.54 Favored 'General case' 0 CA--C 1.503 -0.85 0 CA-C-O 121.955 0.883 . . . . 0.0 112.231 178.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.523 ' HB3' ' HG ' ' A' ' 42' ' ' LEU . 54.5 t-20 -95.38 146.52 24.33 Favored 'General case' 0 C--N 1.288 -2.104 0 N-CA-C 105.955 -1.868 . . . . 0.0 105.955 174.541 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.478 ' C ' ' HD2' ' A' ' 40' ' ' ARG . 7.2 ppt_? -61.83 -23.01 65.98 Favored 'General case' 0 C--N 1.298 -1.654 0 C-N-CA 123.396 0.678 . . . . 0.0 111.435 179.087 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.465 ' HG2' ' CG ' ' A' ' 39' ' ' ASN . 12.7 pt-20 -88.9 -1.18 57.97 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-O 120.857 0.361 . . . . 0.0 111.33 -178.657 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.523 ' HG ' ' HB3' ' A' ' 39' ' ' ASN . 87.3 mt -91.48 124.63 35.79 Favored 'General case' 0 N--CA 1.432 -1.353 0 CA-C-O 121.618 0.723 . . . . 0.0 110.464 179.792 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 68.0 p -113.66 174.57 5.86 Favored 'General case' 0 C--N 1.286 -2.168 0 CA-C-N 114.213 -1.358 . . . . 0.0 108.82 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.3 mp0 -55.29 -41.4 72.24 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 123.423 0.689 . . . . 0.0 110.739 -179.553 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -61.54 -38.35 95.66 Favored Glycine 0 C--O 1.241 0.557 0 CA-C-N 116.168 -0.469 . . . . 0.0 113.207 -179.127 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -67.4 -48.44 67.34 Favored 'General case' 0 CA--C 1.503 -0.853 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 51.4 mt -59.08 -44.77 92.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 CA-C-N 114.595 -1.184 . . . . 0.0 110.788 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 48.2 mt -59.36 -45.47 91.31 Favored 'General case' 0 CA--C 1.502 -0.891 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.538 -178.394 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.448 HG23 ' H ' ' B' ' 233' ' ' ASP . 98.0 m -62.11 -45.83 91.73 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -179.839 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.586 HG13 ' HG3' ' B' ' 237' ' ' ARG . 98.7 t -65.39 -49.19 79.91 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 CA-C-O 121.246 0.545 . . . . 0.0 110.41 -179.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.469 ' HD2' ' HH ' ' A' ' 79' ' ' TYR . 5.3 m-85 -66.17 -24.04 66.57 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 123.885 0.874 . . . . 0.0 113.04 -178.121 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.454 ' OG ' ' HB2' ' B' ' 231' ' ' ARG . 63.0 m -70.59 -17.91 62.9 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 177.072 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -68.56 -25.12 64.74 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 119.683 -0.807 . . . . 0.0 109.285 176.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.468 ' HD2' ' HA ' ' A' ' 51' ' ' PHE . 64.5 m-85 -92.6 -15.96 26.23 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.114 -175.575 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.407 ' O ' ' HA ' ' A' ' 52' ' ' SER . . . 160.9 -158.61 30.2 Favored Glycine 0 N--CA 1.421 -2.353 0 C-N-CA 120.501 -0.857 . . . . 0.0 111.132 -179.556 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 57.5 t -102.26 111.02 64.0 Favored Pre-proline 0 C--N 1.302 -1.485 0 N-CA-C 111.798 0.296 . . . . 0.0 111.798 -175.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.5 ' HB3' HD21 ' A' ' 77' ' ' LEU . 87.1 Cg_endo -79.05 140.12 15.62 Favored 'Trans proline' 0 N--CA 1.449 -1.131 0 C-N-CA 122.96 2.44 . . . . 0.0 110.354 175.243 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 26.9 m -114.85 -21.95 5.04 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 C-N-CA 120.102 -0.639 . . . . 0.0 111.95 179.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.409 ' HB3' ' HG2' ' A' ' 78' ' ' LYS . 17.6 t70 -158.43 145.02 17.38 Favored 'General case' 0 C--O 1.247 0.944 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 -179.752 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 13.1 p -146.18 133.02 14.43 Favored 'Isoleucine or valine' 0 C--O 1.245 0.819 0 CA-C-O 121.5 0.667 . . . . 0.0 110.356 179.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.419 HD11 ' HB3' ' A' ' 111' ' ' PRO . 95.5 mt -121.06 126.98 75.82 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 177.647 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -99.55 122.04 42.05 Favored 'General case' 0 C--N 1.292 -1.902 0 N-CA-C 105.469 -2.049 . . . . 0.0 105.469 175.314 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 7.0 t -85.04 123.56 30.72 Favored 'General case' 0 N--CA 1.418 -2.062 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 179.198 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 73.4 mtt85 -119.5 141.17 49.43 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-O 120.901 0.381 . . . . 0.0 111.038 -179.368 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -76.07 124.35 27.26 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.942 -179.282 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -60.87 -25.5 66.72 Favored 'General case' 0 C--N 1.297 -1.705 0 CA-C-N 114.465 -1.243 . . . . 0.0 112.472 -178.293 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 25.0 m-80 -83.09 -51.38 7.58 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.083 0.468 . . . . 0.0 111.502 -176.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 47.2 p -86.63 -24.31 25.37 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 116.057 -0.519 . . . . 0.0 112.36 -174.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 81.79 -1.06 87.38 Favored Glycine 0 C--N 1.308 -0.987 0 N-CA-C 111.545 -0.622 . . . . 0.0 111.545 -177.4 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 36.3 mm-40 -101.04 176.44 5.26 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 110.238 -0.282 . . . . 0.0 110.238 -178.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 40.1 t -59.5 147.27 37.37 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.715 176.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 17.1 mm-40 -79.44 -7.44 58.4 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 123.759 0.823 . . . . 0.0 110.303 176.074 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 92.54 5.59 64.89 Favored Glycine 0 N--CA 1.425 -2.058 0 C-N-CA 120.594 -0.813 . . . . 0.0 111.651 -178.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 31.4 p90 -143.56 152.79 41.86 Favored 'General case' 0 N--CA 1.435 -1.181 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 178.56 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -148.12 171.97 15.03 Favored 'General case' 0 N--CA 1.427 -1.606 0 O-C-N 123.362 0.414 . . . . 0.0 110.165 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -130.37 139.99 50.62 Favored 'General case' 0 C--N 1.298 -1.655 0 C-N-CA 124.024 0.929 . . . . 0.0 109.952 -178.5 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.5 HD21 ' HB3' ' A' ' 57' ' ' PRO . 10.3 tt -146.93 140.85 25.95 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 175.739 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.409 ' HG2' ' HB3' ' A' ' 59' ' ' ASP . 21.7 ptmt -125.04 144.3 50.47 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 178.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.469 ' HH ' ' HD2' ' A' ' 51' ' ' PHE . 55.8 m-85 -108.49 164.59 12.21 Favored 'General case' 0 C--N 1.29 -2.013 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.614 -179.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -79.0 -35.49 42.78 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 174.165 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -106.49 123.73 48.53 Favored 'General case' 0 N--CA 1.439 -0.999 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 -177.451 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.431 HE22 ' HB2' ' A' ' 28' ' ' LYS . 96.7 mt-30 -69.47 -19.3 63.76 Favored 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 113.391 0.886 . . . . 0.0 113.391 -178.518 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 90.6 mtm180 -66.19 -33.24 75.31 Favored 'General case' 0 C--N 1.302 -1.5 0 CA-C-O 121.914 0.864 . . . . 0.0 109.261 173.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 56.9 m -65.33 -37.15 86.23 Favored 'General case' 0 N--CA 1.426 -1.639 0 CA-C-N 115.29 -0.868 . . . . 0.0 112.43 178.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.49 ' O ' HG23 ' A' ' 89' ' ' VAL . 64.9 p -62.73 -45.66 91.69 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 121.061 0.457 . . . . 0.0 110.741 -177.819 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 4.3 pt -66.17 -37.93 80.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.831 177.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.507 HD11 ' HB2' ' B' ' 224' ' ' PHE . 14.0 mt -59.41 -44.12 92.89 Favored 'General case' 0 CA--C 1.509 -0.62 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.641 175.26 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.485 ' HB1' HD12 ' A' ' 92' ' ' LEU . . . -70.16 -45.51 66.61 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.848 -178.313 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.49 HG23 ' O ' ' A' ' 85' ' ' THR . 87.7 t -56.55 -47.79 81.43 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.967 0 CA-C-O 121.43 0.634 . . . . 0.0 111.119 178.47 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -62.08 -33.74 74.98 Favored 'General case' 0 C--N 1.297 -1.695 0 C-N-CA 125.042 1.337 . . . . 0.0 112.722 -176.337 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.402 ' HB3' ' CE1' ' A' ' 54' ' ' TYR . 14.8 t-20 -98.44 -30.86 12.3 Favored 'General case' 0 C--N 1.293 -1.874 0 CA-C-N 116.145 -0.479 . . . . 0.0 112.232 -175.55 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.485 HD12 ' HB1' ' A' ' 88' ' ' ALA . 12.5 mt -93.8 -30.16 14.99 Favored 'General case' 0 CA--C 1.482 -1.648 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 -170.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 57.4 t30 -66.12 125.04 24.26 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 179.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 83.61 -0.69 89.48 Favored Glycine 0 CA--C 1.535 1.287 0 C-N-CA 120.424 -0.893 . . . . 0.0 112.502 -177.48 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 67.8 t80 -89.36 138.42 31.46 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -178.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.452 ' HA ' ' O ' ' A' ' 100' ' ' ARG . 0.3 OUTLIER -92.51 118.52 31.06 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 -175.824 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 55.0 mt -127.64 142.08 44.63 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.259 0 N-CA-C 106.193 -1.78 . . . . 0.0 106.193 172.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 58.47 21.88 50.18 Favored Glycine 0 CA--C 1.524 0.656 0 C-N-CA 121.63 -0.319 . . . . 0.0 113.514 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 87.25 10.75 70.66 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 121.647 -0.311 . . . . 0.0 113.483 179.07 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.452 ' O ' ' HA ' ' A' ' 96' ' ' LYS . 13.6 ptp180 -140.56 148.66 41.33 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 117.985 0.892 . . . . 0.0 111.889 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -82.83 118.02 23.12 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.956 -179.374 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 12.7 mt -65.88 149.56 50.0 Favored 'General case' 0 C--N 1.309 -1.189 0 C-N-CA 124.134 0.974 . . . . 0.0 113.611 178.666 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 55.3 tptt -116.09 120.16 38.15 Favored 'General case' 0 N--CA 1.423 -1.801 0 CA-C-N 114.964 -1.016 . . . . 0.0 108.734 174.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.448 HG22 HG22 ' A' ' 89' ' ' VAL . 4.8 mm -121.44 135.36 61.85 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 178.35 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -143.57 153.25 42.37 Favored 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 109.273 -0.639 . . . . 0.0 109.273 -179.412 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -83.54 137.7 33.74 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 177.645 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 12.3 t -155.16 156.48 35.81 Favored 'General case' 0 N--CA 1.425 -1.724 0 N-CA-C 107.929 -1.138 . . . . 0.0 107.929 -177.117 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 7.7 p90 -97.67 109.86 22.53 Favored 'General case' 0 N--CA 1.423 -1.808 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 168.637 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 29.1 t80 -108.2 135.49 49.44 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-N 115.055 -0.975 . . . . 0.0 110.207 -178.175 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.408 ' HA ' ' HD2' ' A' ' 111' ' ' PRO . 5.3 mpt_? -118.82 117.88 33.6 Favored Pre-proline 0 C--N 1.29 -1.982 0 N-CA-C 109.171 -0.678 . . . . 0.0 109.171 172.567 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.419 ' HB3' HD11 ' A' ' 61' ' ' ILE . 35.5 Cg_endo -61.73 140.56 86.72 Favored 'Trans proline' 0 C--O 1.241 0.627 0 C-N-CA 123.307 2.671 . . . . 0.0 113.783 -178.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 3.6 tmmm? -120.35 128.17 53.01 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 104.915 -2.254 . . . . 0.0 104.915 175.481 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 35.6 mmt180 . . . . . 0 C--N 1.297 -1.682 0 C-N-CA 120.236 -0.585 . . . . 0.0 110.125 -175.003 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 46.6 t30 . . . . . 0 N--CA 1.472 0.669 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 223' ' ' ARG . . . . . . . . . . . . . 11.7 ptm180 51.66 49.05 21.67 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 116.461 2.023 . . . . 0.0 116.461 173.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 224' ' ' PHE . . . . . 0.507 ' HB2' HD11 ' A' ' 87' ' ' LEU . 85.1 m-85 -106.25 165.42 11.26 Favored 'General case' 0 C--N 1.281 -2.403 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 173.402 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 225' ' ' ALA . . . . . . . . . . . . . . . -132.6 86.14 2.29 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-O 121.235 0.54 . . . . 0.0 110.432 179.523 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 3.7 mp -120.38 141.13 42.1 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.265 0 CA-C-N 115.101 -0.954 . . . . 0.0 109.348 178.582 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 227' ' ' MET . . . . . . . . . . . . . 68.6 mtt -69.29 139.08 89.52 Favored Pre-proline 0 N--CA 1.452 -0.341 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.354 177.568 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 228' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -69.09 159.0 55.67 Favored 'Trans proline' 0 C--O 1.243 0.726 0 C-N-CA 122.739 2.293 . . . . 0.0 112.893 -178.485 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . -75.3 168.76 54.79 Favored Glycine 0 N--CA 1.441 -0.98 0 CA-C-N 115.442 -0.799 . . . . 0.0 112.749 -179.685 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 9.4 t -77.61 -14.44 59.64 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 121.293 0.568 . . . . 0.0 110.305 -177.511 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 231' ' ' ARG . . . . . 0.454 ' HB2' ' OG ' ' A' ' 52' ' ' SER . 37.2 mmt180 -86.75 -3.93 59.11 Favored 'General case' 0 C--N 1.321 -0.644 0 O-C-N 122.139 -0.351 . . . . 0.0 111.08 -179.178 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 232' ' ' TRP . . . . . . . . . . . . . 21.7 t90 -74.77 128.25 35.12 Favored 'General case' 0 CA--C 1.497 -1.064 0 CA-C-O 122.385 1.088 . . . . 0.0 111.7 -179.142 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 233' ' ' ASP . . . . . 0.448 ' H ' HG23 ' A' ' 49' ' ' THR . 37.3 t70 -124.42 147.42 48.29 Favored 'General case' 0 C--N 1.263 -3.158 0 N-CA-C 103.038 -2.949 . . . . 0.0 103.038 172.671 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -40.01 60.71 0.0 OUTLIER Glycine 0 N--CA 1.501 3.022 0 C-N-CA 128.702 3.049 . . . . 0.0 116.93 -178.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 235' ' ' VAL . . . . . 0.447 ' N ' ' O ' ' B' ' 233' ' ' ASP . 59.1 t -106.34 133.85 49.63 Favored 'Isoleucine or valine' 0 C--N 1.256 -3.46 0 C-N-CA 127.898 2.479 . . . . 0.0 106.61 175.649 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 236' ' ' HIS . . . . . . . . . . . . . 41.1 t-80 -112.17 113.45 25.71 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 123.635 0.584 . . . . 0.0 109.449 -177.008 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 237' ' ' ARG . . . . . 0.586 ' HG3' HG13 ' A' ' 50' ' ' VAL . 40.2 mmt180 -114.64 110.84 20.38 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-O 121.264 0.554 . . . . 0.0 111.019 179.266 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 238' ' ' SER . . . . . . . . . . . . . 48.9 m -127.3 125.18 40.4 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-O 120.931 0.396 . . . . 0.0 111.152 179.311 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 239' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -60.28 116.19 4.07 Favored 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 123.848 0.859 . . . . 0.0 110.838 -176.027 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 240' ' ' GLY . . . . . 0.613 ' O ' ' HG2' ' B' ' 243' ' ' GLU . . . 80.85 39.57 13.39 Favored Glycine 0 C--O 1.194 -2.374 0 N-CA-C 111.309 -0.716 . . . . 0.0 111.309 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 17.7 p90 -55.76 -33.81 64.67 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -179.018 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -65.06 -40.9 95.38 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 111.885 0.328 . . . . 0.0 111.885 -176.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 243' ' ' GLU . . . . . 0.613 ' HG2' ' O ' ' B' ' 240' ' ' GLY . 11.4 pt-20 -66.31 -34.87 78.96 Favored 'General case' 0 C--O 1.207 -1.178 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 178.33 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 244' ' ' LYS . . . . . 0.583 ' HG2' ' O ' ' B' ' 240' ' ' GLY . 70.4 mmtt -66.0 -43.55 87.41 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 121.088 0.471 . . . . 0.0 110.555 -177.267 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 245' ' ' TRP . . . . . . . . . . . . . 46.7 m0 -63.94 -41.95 97.46 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.653 0.739 . . . . 0.0 109.358 178.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 246' ' ' PHE . . . . . 0.62 ' O ' ' HG2' ' B' ' 249' ' ' GLN . 1.7 t80 -68.46 -27.59 66.29 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 114.326 -1.306 . . . . 0.0 111.633 178.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -76.77 -39.64 50.98 Favored 'General case' 0 C--N 1.287 -2.12 0 O-C-N 121.907 -0.496 . . . . 0.0 111.597 -177.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 2.6 pptp? -85.89 -14.75 43.9 Favored 'General case' 0 CA--C 1.507 -0.675 0 C-N-CA 120.231 -0.588 . . . . 0.0 112.328 -173.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 249' ' ' GLN . . . . . 0.62 ' HG2' ' O ' ' B' ' 246' ' ' PHE . 3.5 pt20 -67.75 -0.6 4.25 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.755 -176.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 250' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -74.97 -20.78 59.52 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.975 177.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 27.0 mm-40 -64.83 146.49 54.81 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 115.136 -0.938 . . . . 0.0 113.193 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 252' ' ' ILE . . . . . . . . . . . . . 23.9 pt -97.71 -26.33 3.95 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 CA-C-N 115.045 -0.98 . . . . 0.0 111.118 177.179 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -85.22 -27.98 25.72 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 121.466 0.651 . . . . 0.0 109.696 178.19 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 254' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -99.67 169.68 9.1 Favored 'General case' 0 N--CA 1.422 -1.868 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.703 176.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 255' ' ' LYS . . . . . . . . . . . . . 14.6 ptmm? -94.26 171.26 8.94 Favored 'General case' 0 C--N 1.291 -1.943 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.468 -175.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 256' ' ' LYS . . . . . 0.548 ' HA ' ' HB2' ' B' ' 249' ' ' GLN . 28.5 ttpp . . . . . 0 N--CA 1.428 -1.539 0 CA-C-N 114.827 -1.079 . . . . 0.0 108.853 175.649 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 . . . . . 0 CA--C 1.51 -0.563 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.627 ' HG2' ' CD1' ' A' ' 27' ' ' TYR . 0.3 OUTLIER -83.2 -4.9 58.87 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 113.718 1.007 . . . . 0.0 113.718 -174.955 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.627 ' CD1' ' HG2' ' A' ' 26' ' ' GLU . 62.2 m-85 -114.03 23.58 12.82 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-O 121.578 0.704 . . . . 0.0 111.016 178.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -122.91 148.75 45.1 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 174.07 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -102.56 7.95 39.95 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 -172.611 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.46 ' HB2' ' HG2' ' A' ' 82' ' ' GLN . 88.0 m-20 -80.49 23.66 0.5 Allowed 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 121.133 0.492 . . . . 0.0 109.814 175.251 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.487 ' HA ' HG21 ' A' ' 85' ' ' THR . . . -100.35 1.98 42.02 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.874 -174.398 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 -99.13 144.5 28.2 Favored 'General case' 0 C--N 1.315 -0.929 0 C-N-CA 120.309 -0.556 . . . . 0.0 109.866 -175.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 33.6 pt -138.14 157.04 31.49 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 CA-C-O 121.107 0.479 . . . . 0.0 110.616 178.096 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 38.9 t80 -107.74 121.07 43.97 Favored 'General case' 0 N--CA 1.417 -2.091 0 CA-C-N 114.728 -1.124 . . . . 0.0 108.444 178.469 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.427 HG23 ' CD1' ' A' ' 104' ' ' ILE . 9.9 mt -108.58 127.79 64.75 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.882 0 N-CA-C 106.714 -1.587 . . . . 0.0 106.714 175.694 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -130.5 163.7 23.14 Favored Glycine 0 C--N 1.284 -2.32 0 N-CA-C 111.232 -0.747 . . . . 0.0 111.232 -179.478 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 67.2 m-20 73.73 38.68 0.59 Allowed 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.743 1.617 . . . . 0.0 110.219 -178.593 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.435 HD11 HD11 ' A' ' 47' ' ' ILE . 4.2 mm? -68.69 144.69 54.35 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.451 -0.795 . . . . 0.0 112.29 178.819 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.469 HD22 ' HA3' ' A' ' 98' ' ' GLY . 41.4 t-20 -89.34 151.5 22.04 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 177.476 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.507 ' HD2' ' N ' ' A' ' 41' ' ' GLU . 5.3 ppt_? -59.56 -26.42 65.36 Favored 'General case' 0 C--N 1.31 -1.135 0 C-N-CA 123.103 0.561 . . . . 0.0 111.828 177.745 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.507 ' N ' ' HD2' ' A' ' 40' ' ' ARG . 10.4 pt-20 -89.55 0.89 56.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.897 -177.655 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 80.8 mt -97.32 111.87 23.93 Favored 'General case' 0 CA--C 1.494 -1.177 0 CA-C-O 121.59 0.709 . . . . 0.0 111.211 -178.551 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 82.2 p -103.51 174.53 5.83 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-N 114.344 -1.298 . . . . 0.0 109.451 -178.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.498 ' HG3' ' HB2' ' A' ' 62' ' ' LEU . 2.0 mp0 -54.62 -40.66 69.16 Favored 'General case' 0 C--O 1.216 -0.676 0 C-N-CA 123.599 0.76 . . . . 0.0 109.586 177.738 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -59.48 -41.63 97.23 Favored Glycine 0 N--CA 1.445 -0.75 0 O-C-N 123.659 0.6 . . . . 0.0 113.163 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -66.69 -49.13 67.09 Favored 'General case' 0 CA--C 1.497 -1.071 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 -179.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.435 HD11 HD11 ' A' ' 38' ' ' LEU . 52.6 mt -58.37 -45.88 89.42 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.926 0 CA-C-N 114.992 -1.003 . . . . 0.0 110.493 179.735 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 35.0 mt -60.55 -45.71 92.87 Favored 'General case' 0 CA--C 1.5 -0.963 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 -177.365 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.491 HG23 ' H ' ' B' ' 233' ' ' ASP . 80.2 m -62.92 -45.59 91.78 Favored 'General case' 0 N--CA 1.439 -1.016 0 O-C-N 123.308 0.38 . . . . 0.0 111.563 179.313 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.484 HG13 ' HG3' ' B' ' 237' ' ' ARG . 77.4 t -65.79 -47.18 86.66 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.157 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.036 -179.156 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.444 ' HA ' ' HD2' ' A' ' 54' ' ' TYR . 3.8 m-85 -67.43 -22.95 65.49 Favored 'General case' 0 N--CA 1.429 -1.496 0 C-N-CA 123.624 0.77 . . . . 0.0 112.144 -178.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.408 ' OG ' ' HB2' ' B' ' 231' ' ' ARG . 68.3 m -69.13 -16.92 63.77 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.937 175.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -67.02 -26.63 66.87 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-O 121.246 0.546 . . . . 0.0 109.659 175.206 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.444 ' HD2' ' HA ' ' A' ' 51' ' ' PHE . 54.4 m-85 -95.73 -15.19 22.78 Favored 'General case' 0 CA--C 1.505 -0.784 0 CA-C-O 121.245 0.545 . . . . 0.0 112.392 -173.222 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 160.1 -152.19 22.96 Favored Glycine 0 N--CA 1.413 -2.849 0 N-CA-C 110.245 -1.142 . . . . 0.0 110.245 -179.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 65.3 t -104.74 109.21 62.7 Favored Pre-proline 0 C--N 1.288 -2.068 0 O-C-N 123.554 0.208 . . . . 0.0 110.466 -176.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.548 ' HB3' HD21 ' A' ' 77' ' ' LEU . 73.2 Cg_endo -77.57 135.58 14.74 Favored 'Trans proline' 0 N--CA 1.435 -1.966 0 C-N-CA 121.525 1.483 . . . . 0.0 108.595 174.259 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.422 ' CG2' ' HG3' ' A' ' 78' ' ' LYS . 35.2 m -109.85 -23.21 4.58 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 C-N-CA 119.309 -0.956 . . . . 0.0 111.81 -177.753 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.44 ' HB3' ' HG2' ' A' ' 78' ' ' LYS . 25.8 t70 -158.68 142.94 15.67 Favored 'General case' 0 CA--C 1.503 -0.836 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 14.6 p -140.79 135.12 33.72 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 178.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 86.4 mt -120.72 123.06 69.5 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.311 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 176.242 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.498 ' HB2' ' HG3' ' A' ' 44' ' ' GLU . 0.1 OUTLIER -98.61 119.64 37.69 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 177.298 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 28.3 m -83.91 116.79 22.95 Favored 'General case' 0 N--CA 1.404 -2.772 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 176.235 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 58.9 mtt180 -123.35 131.94 53.82 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 -175.625 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -66.37 127.05 30.77 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 175.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -60.77 -20.37 61.28 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 113.583 0.957 . . . . 0.0 113.583 -176.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 31.5 m-80 -81.04 -49.0 11.44 Favored 'General case' 0 CA--C 1.497 -1.065 0 C-N-CA 120.134 -0.626 . . . . 0.0 109.811 -177.492 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 72.3 p -88.35 -24.6 23.07 Favored 'General case' 0 C--N 1.312 -1.034 0 C-N-CA 120.22 -0.592 . . . . 0.0 111.528 -176.347 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 67.9 6.78 46.47 Favored Glycine 0 CA--C 1.527 0.798 0 CA-C-N 116.163 -0.471 . . . . 0.0 112.439 -178.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -90.74 -74.49 0.49 Allowed 'General case' 0 C--O 1.216 -0.708 0 CA-C-O 120.901 0.381 . . . . 0.0 111.503 -173.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 36.2 t -166.64 161.95 16.13 Favored 'General case' 0 N--CA 1.428 -1.536 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 -178.597 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -99.94 0.06 40.44 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 172.453 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 94.8 8.35 59.38 Favored Glycine 0 N--CA 1.427 -1.962 0 CA-C-N 114.96 -1.018 . . . . 0.0 112.472 178.582 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 37.2 p90 -150.09 154.99 39.05 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 179.258 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -150.1 170.47 18.83 Favored 'General case' 0 N--CA 1.427 -1.595 0 CA-C-O 120.925 0.393 . . . . 0.0 110.264 178.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -128.9 142.2 51.03 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.404 -179.021 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.548 HD21 ' HB3' ' A' ' 57' ' ' PRO . 9.8 tt -148.99 140.9 23.72 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 175.696 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.44 ' HG2' ' HB3' ' A' ' 59' ' ' ASP . 20.8 ptmt -122.66 144.02 49.41 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 178.665 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 45.8 m-85 -104.65 164.88 11.44 Favored 'General case' 0 C--N 1.29 -1.992 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.575 -179.233 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -71.15 -37.49 72.26 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 114.824 -1.08 . . . . 0.0 108.607 175.062 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -125.28 143.63 50.87 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.298 0.57 . . . . 0.0 111.74 -179.019 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.46 ' HG2' ' HB2' ' A' ' 30' ' ' ASN . 20.8 mp0 -69.93 -24.0 63.29 Favored 'General case' 0 C--N 1.312 -1.061 0 C-N-CA 124.91 1.284 . . . . 0.0 112.94 -177.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 56.1 mtm180 -67.88 -34.63 77.04 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-O 122.083 0.944 . . . . 0.0 109.592 175.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.455 ' OG ' HG21 ' B' ' 226' ' ' ILE . 48.6 m -66.04 -37.71 86.55 Favored 'General case' 0 C--N 1.286 -2.177 0 CA-C-N 114.808 -1.087 . . . . 0.0 111.619 175.798 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.512 ' O ' HG23 ' A' ' 89' ' ' VAL . 71.6 p -66.02 -45.33 81.87 Favored 'General case' 0 C--O 1.221 -0.402 0 C-N-CA 120.134 -0.626 . . . . 0.0 110.52 -178.058 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 8.3 pt -64.79 -37.39 80.03 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 C-N-CA 122.481 0.312 . . . . 0.0 111.111 177.521 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.434 HD23 ' HB3' ' B' ' 222' ' ' ASN . 9.7 mt -58.51 -44.08 89.35 Favored 'General case' 0 CA--C 1.504 -0.822 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.203 175.034 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.432 ' O ' ' HB2' ' A' ' 92' ' ' LEU . . . -71.56 -46.67 58.78 Favored 'General case' 0 N--CA 1.434 -1.269 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.953 -179.27 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.512 HG23 ' O ' ' A' ' 85' ' ' THR . 86.5 t -56.79 -49.9 76.83 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.201 0 CA-C-O 120.844 0.354 . . . . 0.0 111.429 -178.375 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -73.53 -28.65 62.0 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 112.751 0.649 . . . . 0.0 112.751 -173.127 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -87.76 -31.79 19.46 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-O 121.011 0.434 . . . . 0.0 110.572 -177.485 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.432 ' HB2' ' O ' ' A' ' 88' ' ' ALA . 10.0 mt -94.26 -30.32 14.62 Favored 'General case' 0 CA--C 1.501 -0.922 0 CA-C-N 116.03 -0.532 . . . . 0.0 112.386 -173.703 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 46.1 t30 -65.74 125.24 24.68 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 179.09 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 88.47 -7.73 80.91 Favored Glycine 0 N--CA 1.436 -1.35 0 CA-C-N 115.599 -0.728 . . . . 0.0 112.268 -178.048 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -81.94 138.96 34.88 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 -178.124 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.524 ' HE3' ' HB2' ' A' ' 101' ' ' ALA . 11.7 mptt -99.2 125.12 44.72 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-O 121.14 0.495 . . . . 0.0 111.68 -177.295 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 58.7 mt -127.69 141.39 46.51 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 N-CA-C 105.761 -1.94 . . . . 0.0 105.761 173.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.469 ' HA3' HD22 ' A' ' 39' ' ' ASN . . . 64.17 7.42 24.65 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 121.12 -0.562 . . . . 0.0 114.311 179.173 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 97.22 0.13 59.93 Favored Glycine 0 N--CA 1.436 -1.312 0 C-N-CA 121.118 -0.563 . . . . 0.0 112.492 -176.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 17.3 ptp180 -124.29 151.56 44.09 Favored 'General case' 0 C--N 1.317 -0.806 0 O-C-N 122.233 -0.569 . . . . 0.0 110.997 -179.493 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.524 ' HB2' ' HE3' ' A' ' 96' ' ' LYS . . . -89.73 120.03 30.65 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.513 -176.351 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 11.7 mt -68.7 145.15 54.11 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-O 121.71 0.766 . . . . 0.0 112.343 177.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.41 ' HE3' ' HB2' ' A' ' 105' ' ' ASP . 50.1 tptt -120.96 116.66 25.53 Favored 'General case' 0 N--CA 1.417 -2.106 0 CA-C-N 114.822 -1.081 . . . . 0.0 109.184 176.348 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.427 ' CD1' HG23 ' A' ' 35' ' ' ILE . 4.7 mm -119.37 134.31 63.38 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 179.574 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.41 ' HB2' ' HE3' ' A' ' 103' ' ' LYS . 27.5 t70 -144.89 157.74 44.05 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 177.417 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 2.8 m80 -81.96 131.63 35.25 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-O 121.236 0.541 . . . . 0.0 112.122 177.019 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 13.3 t -146.35 162.86 37.25 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 -177.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -110.25 110.91 21.91 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 107.046 -1.465 . . . . 0.0 107.046 171.057 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 74.4 t80 -107.2 138.98 42.36 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.228 -179.063 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.441 ' HD2' ' N ' ' A' ' 110' ' ' ARG . 4.2 mpt_? -115.25 115.42 42.66 Favored Pre-proline 0 C--N 1.312 -1.065 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 173.817 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -63.2 141.43 82.49 Favored 'Trans proline' 0 C--O 1.243 0.726 0 C-N-CA 123.318 2.679 . . . . 0.0 115.101 -177.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.445 ' C ' ' HD3' ' A' ' 112' ' ' LYS . 12.0 tmtt? -121.09 131.83 54.51 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 105.398 -2.075 . . . . 0.0 105.398 172.701 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 28.7 mmt180 . . . . . 0 C--N 1.303 -1.418 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 179.699 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 222' ' ' ASN . . . . . 0.434 ' HB3' HD23 ' A' ' 87' ' ' LEU . 64.7 t30 . . . . . 0 C--O 1.208 -1.121 0 N-CA-C 111.7 0.259 . . . . 0.0 111.7 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 223' ' ' ARG . . . . . . . . . . . . . 7.5 ptp180 86.53 8.95 0.24 Allowed 'General case' 0 N--CA 1.524 3.267 0 C-N-CA 126.461 1.904 . . . . 0.0 114.131 173.674 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 224' ' ' PHE . . . . . 0.432 ' HB2' HD11 ' A' ' 87' ' ' LEU . 38.0 m-85 -112.48 163.97 13.83 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -179.302 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 225' ' ' ALA . . . . . . . . . . . . . . . -131.63 81.61 1.99 Allowed 'General case' 0 C--N 1.31 -1.141 0 CA-C-O 121.25 0.547 . . . . 0.0 110.53 178.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 226' ' ' ILE . . . . . 0.455 HG21 ' OG ' ' A' ' 84' ' ' SER . 4.1 mp -121.66 137.73 54.33 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 176.563 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 227' ' ' MET . . . . . . . . . . . . . 65.9 mtt -69.22 137.64 89.25 Favored Pre-proline 0 C--N 1.311 -1.077 0 O-C-N 123.706 0.629 . . . . 0.0 110.135 179.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 228' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -67.43 154.03 75.0 Favored 'Trans proline' 0 C--O 1.248 1.023 0 C-N-CA 122.787 2.324 . . . . 0.0 112.269 179.606 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . -73.11 168.98 53.4 Favored Glycine 0 C--N 1.314 -0.668 0 CA-C-N 115.558 -0.747 . . . . 0.0 112.879 -179.65 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 23.4 m -76.67 -13.93 60.01 Favored 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 123.236 0.614 . . . . 0.0 112.157 -175.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 231' ' ' ARG . . . . . 0.408 ' HB2' ' OG ' ' A' ' 52' ' ' SER . 19.7 mmt180 -87.16 -0.05 56.08 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.954 0.406 . . . . 0.0 110.095 -178.313 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 232' ' ' TRP . . . . . . . . . . . . . 21.0 t90 -77.63 126.47 30.93 Favored 'General case' 0 N--CA 1.433 -1.3 0 CA-C-O 122.428 1.109 . . . . 0.0 112.392 -176.399 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 233' ' ' ASP . . . . . 0.491 ' H ' HG23 ' A' ' 49' ' ' THR . 26.1 t70 -121.84 144.3 48.91 Favored 'General case' 0 C--N 1.264 -3.117 0 N-CA-C 101.829 -3.397 . . . . 0.0 101.829 171.775 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -38.27 66.64 0.0 OUTLIER Glycine 0 N--CA 1.487 2.05 0 C-N-CA 128.065 2.745 . . . . 0.0 116.113 -178.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 235' ' ' VAL . . . . . 0.454 ' N ' ' O ' ' B' ' 233' ' ' ASP . 76.9 t -111.53 122.59 66.19 Favored 'Isoleucine or valine' 0 C--N 1.255 -3.536 0 C-N-CA 126.684 1.994 . . . . 0.0 107.887 175.265 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 236' ' ' HIS . . . . . . . . . . . . . 59.8 t-80 -112.78 122.5 47.85 Favored 'General case' 0 C--N 1.282 -2.327 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 178.19 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 237' ' ' ARG . . . . . 0.484 ' HG3' HG13 ' A' ' 50' ' ' VAL . 4.9 mmp_? -110.28 115.79 30.33 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 176.267 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 238' ' ' SER . . . . . 0.48 ' HB2' ' HB3' ' B' ' 241' ' ' PHE . 17.8 m -92.25 114.07 26.51 Favored 'General case' 0 C--N 1.283 -2.301 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -176.79 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 239' ' ' ASN . . . . . . . . . . . . . 17.5 p-10 -63.72 111.05 2.25 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.68 173.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 240' ' ' GLY . . . . . 0.536 ' O ' ' HG2' ' B' ' 244' ' ' LYS . . . 74.04 53.04 7.31 Favored Glycine 0 C--O 1.199 -2.077 0 N-CA-C 110.456 -1.058 . . . . 0.0 110.456 -178.158 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 241' ' ' PHE . . . . . 0.48 ' HB3' ' HB2' ' B' ' 238' ' ' SER . 51.1 p90 -64.42 -34.01 77.2 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 -176.825 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -63.8 -42.44 97.72 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 112.003 0.371 . . . . 0.0 112.003 -174.4 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 243' ' ' GLU . . . . . 0.494 ' HG2' ' O ' ' B' ' 240' ' ' GLY . 11.1 pt-20 -63.13 -34.7 78.19 Favored 'General case' 0 C--O 1.208 -1.08 0 N-CA-C 110.466 -0.198 . . . . 0.0 110.466 178.325 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 244' ' ' LYS . . . . . 0.536 ' HG2' ' O ' ' B' ' 240' ' ' GLY . 68.8 mmtt -67.72 -44.58 77.32 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 -179.046 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 245' ' ' TRP . . . . . . . . . . . . . 50.9 m0 -62.55 -41.52 98.95 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.725 178.036 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 246' ' ' PHE . . . . . 0.514 ' O ' ' HG2' ' B' ' 249' ' ' GLN . 5.1 t80 -65.53 -36.25 83.26 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.902 177.793 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -71.69 -35.67 70.34 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.206 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.19 -15.34 36.27 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 120.991 0.424 . . . . 0.0 111.704 -178.67 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 249' ' ' GLN . . . . . 0.514 ' HG2' ' O ' ' B' ' 246' ' ' PHE . 2.9 pt20 -81.53 2.96 26.69 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-O 120.982 0.42 . . . . 0.0 110.326 179.5 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 250' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -54.01 -27.83 34.33 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.911 177.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . 0.648 ' HB3' ' HB2' ' B' ' 254' ' ' GLU . 45.5 mt-10 -80.58 110.52 16.13 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 176.039 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 252' ' ' ILE . . . . . 0.645 HD13 ' H ' ' B' ' 252' ' ' ILE . 0.2 OUTLIER -112.72 -33.98 2.2 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 CA-C-N 115.843 -0.617 . . . . 0.0 112.165 -173.475 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -118.89 -6.26 10.55 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 -178.099 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 254' ' ' GLU . . . . . 0.648 ' HB2' ' HB3' ' B' ' 251' ' ' GLU . 16.8 mp0 -75.03 -169.92 1.02 Allowed 'General case' 0 C--N 1.294 -1.829 0 CA-C-N 112.549 -2.114 . . . . 0.0 111.957 -179.177 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 255' ' ' LYS . . . . . . . . . . . . . 58.0 mttm -83.44 96.97 8.73 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.857 -176.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 256' ' ' LYS . . . . . . . . . . . . . 24.5 ttmm . . . . . 0 C--N 1.296 -1.727 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 179.694 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 17.4 m120 . . . . . 0 CA--C 1.507 -0.676 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -72.85 -18.9 61.4 Favored 'General case' 0 CA--C 1.507 -0.7 0 CA-C-O 121.787 0.803 . . . . 0.0 110.779 -178.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -81.19 1.55 31.58 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 114.664 -1.153 . . . . 0.0 111.83 -177.283 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -121.3 144.34 48.69 Favored 'General case' 0 CA--C 1.483 -1.598 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 175.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -99.77 15.98 25.14 Favored 'General case' 0 C--N 1.277 -2.568 0 CA-C-O 122.914 1.34 . . . . 0.0 108.175 -179.256 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -79.93 5.72 13.15 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-N 112.709 -2.041 . . . . 0.0 109.724 -177.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -92.57 13.41 19.94 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.786 -174.617 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 11.3 m-30 -93.24 144.95 24.81 Favored 'General case' 0 C--N 1.309 -1.183 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.524 -176.603 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 21.4 pt -142.81 165.84 15.76 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.981 0 C-N-CA 123.291 0.636 . . . . 0.0 110.152 175.265 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.532 ' HB2' HG21 ' A' ' 107' ' ' THR . 54.7 t80 -116.2 126.4 53.59 Favored 'General case' 0 N--CA 1.413 -2.28 0 CA-C-N 114.776 -1.102 . . . . 0.0 109.114 178.217 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.453 HG23 ' CD1' ' A' ' 104' ' ' ILE . 9.1 mt -110.74 127.98 67.42 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.016 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 175.601 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -127.65 165.61 20.66 Favored Glycine 0 C--N 1.281 -2.494 0 N-CA-C 111.346 -0.701 . . . . 0.0 111.346 -178.486 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 66.39 41.52 3.26 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.708 1.203 . . . . 0.0 110.824 -176.506 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.477 HD11 HD11 ' A' ' 47' ' ' ILE . 4.1 mm? -68.56 146.57 52.97 Favored 'General case' 0 CA--C 1.496 -1.122 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.489 177.375 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.472 ' ND2' ' HA3' ' A' ' 98' ' ' GLY . 61.1 t30 -89.84 147.84 23.54 Favored 'General case' 0 C--N 1.291 -1.945 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 178.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.474 ' C ' ' HD2' ' A' ' 40' ' ' ARG . 2.3 ppt_? -58.87 -21.75 57.8 Favored 'General case' 0 C--N 1.318 -0.772 0 O-C-N 123.623 0.577 . . . . 0.0 112.494 -175.353 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.41 ' HG2' ' ND2' ' A' ' 39' ' ' ASN . 13.4 pt-20 -99.86 -1.01 38.54 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.383 -175.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.435 HD12 ' H ' ' A' ' 39' ' ' ASN . 81.3 mt -87.71 118.54 27.28 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-O 121.33 0.586 . . . . 0.0 110.459 178.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 77.0 p -105.31 174.09 6.03 Favored 'General case' 0 C--N 1.291 -1.943 0 CA-C-N 114.816 -1.084 . . . . 0.0 108.864 -178.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.519 ' CG ' ' HB2' ' A' ' 62' ' ' LEU . 70.2 mt-10 -56.38 -37.67 70.41 Favored 'General case' 0 C--O 1.216 -0.67 0 N-CA-C 109.954 -0.388 . . . . 0.0 109.954 177.598 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -61.62 -37.46 94.25 Favored Glycine 0 N--CA 1.445 -0.758 0 CA-C-N 115.722 -0.672 . . . . 0.0 113.113 179.529 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -67.26 -49.02 65.98 Favored 'General case' 0 CA--C 1.488 -1.432 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.279 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.477 HD11 HD11 ' A' ' 38' ' ' LEU . 46.7 mt -59.17 -45.67 92.62 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.14 0 CA-C-N 114.557 -1.202 . . . . 0.0 110.597 179.129 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.433 ' HG ' HG11 ' A' ' 60' ' ' VAL . 42.8 mt -59.65 -43.53 93.88 Favored 'General case' 0 CA--C 1.489 -1.369 0 C-N-CA 122.249 0.22 . . . . 0.0 111.137 -178.702 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.494 HG23 ' H ' ' B' ' 233' ' ' ASP . 72.3 m -63.26 -46.6 86.09 Favored 'General case' 0 C--N 1.309 -1.157 0 O-C-N 123.531 0.519 . . . . 0.0 111.137 -178.594 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.761 HG13 ' HG3' ' B' ' 237' ' ' ARG . 93.5 t -67.55 -46.89 82.18 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.702 -178.805 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.435 ' HA ' ' HD2' ' A' ' 54' ' ' TYR . 4.0 m-85 -68.54 -20.09 64.53 Favored 'General case' 0 N--CA 1.424 -1.751 0 CA-C-N 115.141 -0.936 . . . . 0.0 112.537 -177.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.43 ' CB ' ' HB2' ' B' ' 232' ' ' TRP . 59.1 m -71.1 -22.44 62.09 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 176.179 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -73.27 -20.69 60.77 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 119.164 -1.015 . . . . 0.0 109.97 176.233 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.435 ' HD2' ' HA ' ' A' ' 51' ' ' PHE . 62.0 m-85 -92.97 -11.01 34.32 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-O 121.232 0.539 . . . . 0.0 111.865 -179.208 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.417 ' O ' ' HA ' ' A' ' 52' ' ' SER . . . 156.96 -164.04 32.57 Favored Glycine 0 N--CA 1.424 -2.108 0 N-CA-C 110.954 -0.858 . . . . 0.0 110.954 179.091 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 80.9 t -96.31 109.75 49.04 Favored Pre-proline 0 C--N 1.299 -1.623 0 N-CA-C 110.078 -0.342 . . . . 0.0 110.078 -179.301 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.505 ' HB3' HD21 ' A' ' 77' ' ' LEU . 86.9 Cg_endo -79.41 136.87 12.8 Favored 'Trans proline' 0 N--CA 1.443 -1.442 0 C-N-CA 122.461 2.108 . . . . 0.0 109.301 176.14 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 33.8 m -110.84 -24.11 4.14 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 C-N-CA 119.2 -1.0 . . . . 0.0 111.67 -178.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.51 ' HB3' ' HG2' ' A' ' 78' ' ' LYS . 27.4 t70 -155.03 142.29 19.45 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -179.467 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.433 HG11 ' HG ' ' A' ' 48' ' ' LEU . 14.4 p -143.58 136.94 24.85 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 179.411 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 90.8 mt -121.88 121.17 63.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 175.08 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.519 ' HB2' ' CG ' ' A' ' 44' ' ' GLU . 0.2 OUTLIER -95.89 116.82 29.49 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 106.245 -1.761 . . . . 0.0 106.245 172.544 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 44.3 m -77.21 116.32 17.74 Favored 'General case' 0 N--CA 1.419 -1.998 0 N-CA-C 107.37 -1.345 . . . . 0.0 107.37 176.2 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.414 ' HA ' ' HA ' ' A' ' 71' ' ' SER . 21.1 mtp180 -117.24 128.21 54.86 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-O 120.819 0.342 . . . . 0.0 110.332 -175.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -67.61 127.37 32.49 Favored 'General case' 0 CA--C 1.489 -1.376 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.283 178.031 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -60.95 -29.69 69.78 Favored 'General case' 0 C--N 1.295 -1.766 0 C-N-CA 123.943 0.897 . . . . 0.0 112.595 -178.571 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 28.1 m-80 -79.92 -46.58 16.51 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 120.942 0.401 . . . . 0.0 110.782 -172.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 48.7 p -85.3 -24.49 27.68 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-O 121.402 0.62 . . . . 0.0 109.887 -179.689 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.71 7.53 61.68 Favored Glycine 0 N--CA 1.442 -0.962 0 CA-C-N 115.414 -0.812 . . . . 0.0 112.357 -178.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.454 ' OE2' ' HD3' ' A' ' 40' ' ' ARG . 36.7 mt-10 -106.03 -70.29 0.79 Allowed 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -173.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.414 ' HA ' ' HA ' ' A' ' 64' ' ' ARG . 32.0 t -157.4 159.26 37.2 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 -178.819 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 18.3 mm-40 -92.22 -16.07 26.69 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 173.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 94.73 12.76 55.25 Favored Glycine 0 N--CA 1.427 -1.962 0 C-N-CA 120.44 -0.886 . . . . 0.0 112.164 -177.416 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 33.4 p90 -151.59 153.32 34.27 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 176.397 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -150.11 175.71 11.49 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-O 120.836 0.351 . . . . 0.0 110.818 -179.44 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -136.5 144.12 44.15 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 123.576 0.75 . . . . 0.0 110.003 -177.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.505 HD21 ' HB3' ' A' ' 57' ' ' PRO . 10.2 tt -150.38 141.59 23.17 Favored 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 176.065 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.51 ' HG2' ' HB3' ' A' ' 59' ' ' ASP . 22.0 ptmt -124.03 144.34 49.89 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-O 121.294 0.569 . . . . 0.0 109.516 178.584 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -107.6 165.92 11.06 Favored 'General case' 0 C--N 1.286 -2.177 0 CA-C-N 115.406 -0.815 . . . . 0.0 111.683 -178.019 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -75.32 -29.05 59.9 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 115.002 -0.999 . . . . 0.0 108.77 172.536 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -119.63 136.72 54.27 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 -176.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 19.8 mp0 -69.77 -27.61 65.07 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.467 ' O ' HG12 ' A' ' 86' ' ' ILE . 90.0 mtm180 -65.61 -33.85 76.87 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 122.301 1.048 . . . . 0.0 110.032 179.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.45 ' OG ' HG21 ' B' ' 226' ' ' ILE . 51.6 m -58.53 -37.14 75.02 Favored 'General case' 0 C--N 1.281 -2.379 0 CA-C-N 114.781 -1.1 . . . . 0.0 111.734 176.237 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.462 ' O ' HG23 ' A' ' 89' ' ' VAL . 43.9 p -63.33 -45.07 92.95 Favored 'General case' 0 C--N 1.347 0.487 0 C-N-CA 120.452 -0.499 . . . . 0.0 110.731 -178.482 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.467 HG12 ' O ' ' A' ' 83' ' ' ARG . 4.1 pt -66.64 -38.15 81.01 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.508 178.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 13.6 mt -59.4 -44.25 92.84 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 123.38 0.425 . . . . 0.0 111.28 175.437 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -71.74 -46.42 58.57 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.212 -178.586 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 85' ' ' THR . 69.6 t -56.93 -44.09 81.78 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.104 0 CA-C-O 121.297 0.57 . . . . 0.0 111.09 178.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -63.69 -41.53 98.13 Favored 'General case' 0 C--N 1.29 -1.996 0 C-N-CA 123.291 0.637 . . . . 0.0 112.239 -176.064 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 40.0 m-80 -90.28 -29.73 17.96 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-N 115.632 -0.713 . . . . 0.0 112.869 -173.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 15.2 mt -93.37 -31.18 14.74 Favored 'General case' 0 CA--C 1.486 -1.502 0 N-CA-C 112.257 0.466 . . . . 0.0 112.257 -172.631 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.417 ' OD1' ' HD2' ' A' ' 103' ' ' LYS . 56.9 t30 -66.32 124.6 23.13 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.039 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 89.19 -2.59 83.76 Favored Glycine 0 C--N 1.308 -1.004 0 C-N-CA 121.33 -0.462 . . . . 0.0 112.269 -178.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 37.2 t80 -89.23 134.98 33.82 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 -179.096 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.448 ' HA ' ' O ' ' A' ' 100' ' ' ARG . 12.1 mptt -95.42 116.38 28.72 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-O 120.914 0.388 . . . . 0.0 111.826 -177.67 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 60.6 mt -119.3 141.45 39.23 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 N-CA-C 104.946 -2.242 . . . . 0.0 104.946 172.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.472 ' HA3' ' ND2' ' A' ' 39' ' ' ASN . . . 58.19 28.02 60.92 Favored Glycine 0 C--N 1.317 -0.496 0 C-N-CA 121.331 -0.461 . . . . 0.0 112.646 -178.775 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 79.99 -5.84 61.19 Favored Glycine 0 CA--C 1.529 0.907 0 CA-C-O 119.933 -0.37 . . . . 0.0 113.863 -179.447 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.448 ' O ' ' HA ' ' A' ' 96' ' ' LYS . 16.6 ptp180 -116.43 149.71 39.0 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 117.721 0.76 . . . . 0.0 111.198 -176.311 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -88.44 117.2 27.2 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.537 -175.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.423 HD23 ' HA ' ' A' ' 102' ' ' LEU . 10.4 mt -65.71 136.07 55.78 Favored 'General case' 0 CA--C 1.494 -1.191 0 CA-C-O 121.491 0.663 . . . . 0.0 111.961 178.503 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.417 ' HD2' ' OD1' ' A' ' 93' ' ' ASN . 27.4 tptp -113.6 116.29 29.26 Favored 'General case' 0 N--CA 1.41 -2.45 0 CA-C-N 115.218 -0.901 . . . . 0.0 108.633 176.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.453 ' CD1' HG23 ' A' ' 35' ' ' ILE . 5.3 mm -111.02 142.32 23.75 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.192 0 N-CA-C 106.265 -1.754 . . . . 0.0 106.265 177.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -144.6 151.66 39.36 Favored 'General case' 0 C--N 1.29 -1.995 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 178.564 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 69.7 m-70 -83.42 130.53 35.04 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 175.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.532 HG21 ' HB2' ' A' ' 34' ' ' TYR . 6.2 t -153.79 165.19 36.79 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 -177.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -107.6 112.28 24.93 Favored 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 105.604 -1.999 . . . . 0.0 105.604 168.214 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 25.8 t80 -104.84 132.41 51.11 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 -175.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 19.4 mmm180 -117.4 115.28 37.88 Favored Pre-proline 0 C--N 1.295 -1.777 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 178.685 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -68.42 137.55 39.95 Favored 'Trans proline' 0 C--N 1.322 -0.855 0 C-N-CA 123.404 2.736 . . . . 0.0 114.222 -176.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 27.5 tptp -98.58 119.52 37.45 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.461 177.482 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 28.3 mmt180 . . . . . 0 C--N 1.3 -1.546 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 177.18 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 51.4 t-20 . . . . . 0 C--O 1.219 -0.531 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 223' ' ' ARG . . . . . . . . . . . . 0.258 9.8 ptm180 69.62 22.08 6.38 Favored 'General case' 0 N--CA 1.498 1.942 0 C-N-CA 127.95 2.5 . . . . 0.0 114.942 177.429 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 224' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -97.01 163.85 12.77 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 122.029 -0.419 . . . . 0.0 109.973 177.58 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 225' ' ' ALA . . . . . . . . . . . . . . . -137.05 84.58 2.07 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-O 121.85 0.833 . . . . 0.0 110.447 179.104 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 226' ' ' ILE . . . . . 0.45 HG21 ' OG ' ' A' ' 84' ' ' SER . 3.9 mp -124.0 137.49 56.86 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 177.369 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 227' ' ' MET . . . . . . . . . . . . . 67.5 mtt -70.24 133.55 87.47 Favored Pre-proline 0 C--N 1.309 -1.162 0 O-C-N 123.427 0.454 . . . . 0.0 110.306 178.523 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 228' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -68.05 154.36 72.77 Favored 'Trans proline' 0 C--O 1.245 0.851 0 C-N-CA 122.785 2.323 . . . . 0.0 112.272 -179.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . -72.44 168.2 52.85 Favored Glycine 0 N--CA 1.44 -1.04 0 CA-C-N 115.557 -0.747 . . . . 0.0 113.035 -179.731 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 5.0 p -77.44 -23.52 50.51 Favored 'General case' 0 C--N 1.298 -1.646 0 C-N-CA 123.431 0.692 . . . . 0.0 112.354 -177.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 1.8 mmp_? -79.33 1.88 23.5 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.729 -176.127 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 232' ' ' TRP . . . . . 0.43 ' HB2' ' CB ' ' A' ' 52' ' ' SER . 24.4 t90 -79.33 123.37 27.41 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 122.031 0.919 . . . . 0.0 111.908 -178.83 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 233' ' ' ASP . . . . . 0.494 ' H ' HG23 ' A' ' 49' ' ' THR . 12.8 t70 -113.2 149.35 33.83 Favored 'General case' 0 C--N 1.284 -2.271 0 N-CA-C 102.645 -3.094 . . . . 0.0 102.645 172.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -48.54 59.47 0.0 OUTLIER Glycine 0 N--CA 1.491 2.331 0 C-N-CA 127.53 2.49 . . . . 0.0 115.884 -178.101 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 235' ' ' VAL . . . . . 0.442 ' N ' ' O ' ' B' ' 233' ' ' ASP . 55.6 t -111.59 123.6 67.57 Favored 'Isoleucine or valine' 0 C--N 1.25 -3.725 0 C-N-CA 128.884 2.874 . . . . 0.0 106.194 175.007 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 236' ' ' HIS . . . . . . . . . . . . . 47.5 t60 -110.81 125.02 53.13 Favored 'General case' 0 C--N 1.28 -2.425 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.352 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 237' ' ' ARG . . . . . 0.761 ' HG3' HG13 ' A' ' 50' ' ' VAL . 31.6 mmt180 -127.45 109.59 11.9 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-O 121.132 0.491 . . . . 0.0 109.792 178.643 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 238' ' ' SER . . . . . . . . . . . . . 21.1 t -129.26 154.12 47.12 Favored 'General case' 0 C--N 1.285 -2.202 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 -178.573 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 239' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -27.74 104.33 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 126.123 1.769 . . . . 0.0 112.509 -176.481 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 240' ' ' GLY . . . . . 0.606 ' O ' ' HG2' ' B' ' 244' ' ' LYS . . . -68.56 -39.05 86.98 Favored Glycine 0 C--O 1.191 -2.546 0 CA-C-N 115.059 -0.973 . . . . 0.0 112.083 -177.126 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -61.89 -33.08 73.56 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 116.914 0.357 . . . . 0.0 111.618 -179.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -60.34 -44.88 95.11 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.307 -175.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 243' ' ' GLU . . . . . 0.473 ' HG2' ' O ' ' B' ' 240' ' ' GLY . 9.8 pt-20 -67.59 -35.46 79.03 Favored 'General case' 0 C--O 1.201 -1.472 0 C-N-CA 120.799 -0.36 . . . . 0.0 110.543 179.532 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 244' ' ' LYS . . . . . 0.606 ' HG2' ' O ' ' B' ' 240' ' ' GLY . 67.7 mmtt -68.1 -42.15 80.73 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-O 121.004 0.431 . . . . 0.0 110.408 -176.497 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 245' ' ' TRP . . . . . . . . . . . . . 50.9 m0 -63.39 -43.04 98.72 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 178.545 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 246' ' ' PHE . . . . . 0.425 ' O ' ' HG2' ' B' ' 249' ' ' GLN . 5.5 t80 -67.14 -33.21 74.94 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 114.866 -1.061 . . . . 0.0 110.869 178.237 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -77.21 -21.4 53.92 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.98 -177.412 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.33 -30.04 13.64 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 119.934 -0.706 . . . . 0.0 110.806 179.255 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 249' ' ' GLN . . . . . 0.425 ' HG2' ' O ' ' B' ' 246' ' ' PHE . 3.7 pt20 -68.52 -12.19 60.9 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.074 -176.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 250' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -57.39 -30.13 64.65 Favored 'General case' 0 N--CA 1.482 1.153 0 CA-C-N 115.538 -0.755 . . . . 0.0 112.093 177.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -117.39 166.85 11.83 Favored 'General case' 0 N--CA 1.414 -2.261 0 CA-C-N 115.412 -0.813 . . . . 0.0 112.836 -175.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 252' ' ' ILE . . . . . . . . . . . . . 32.3 pt -126.26 -27.66 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 CA-C-N 113.879 -1.51 . . . . 0.0 109.8 176.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -125.99 -34.0 2.62 Favored 'General case' 0 C--O 1.221 -0.397 0 N-CA-C 113.356 0.872 . . . . 0.0 113.356 -175.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 254' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -77.03 165.98 23.91 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 113.963 1.098 . . . . 0.0 113.963 -179.097 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 255' ' ' LYS . . . . . . . . . . . . . 56.8 mttp -97.54 75.89 2.5 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 114.22 1.192 . . . . 0.0 114.22 -167.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 256' ' ' LYS . . . . . . . . . . . . . 1.9 ttpm? . . . . . 0 C--O 1.253 1.239 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 171.209 . . . . . . . . 0 0 . 1 stop_ save_